Citrus Sinensis ID: 006750
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 632 | 2.2.26 [Sep-21-2011] | |||||||
| Q8VYY5 | 565 | Receptor-like serine/thre | yes | no | 0.867 | 0.969 | 0.516 | 1e-171 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.452 | 0.375 | 0.478 | 1e-67 | |
| Q6R2J8 | 703 | Protein STRUBBELIG-RECEPT | no | no | 0.607 | 0.546 | 0.387 | 7e-67 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.457 | 0.424 | 0.473 | 5e-66 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.455 | 0.406 | 0.470 | 1e-65 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.455 | 0.401 | 0.468 | 7e-65 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.450 | 0.397 | 0.455 | 1e-64 | |
| Q8RWW0 | 744 | Receptor-like serine/thre | no | no | 0.450 | 0.383 | 0.456 | 2e-64 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.447 | 0.434 | 0.452 | 7e-64 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.452 | 0.402 | 0.454 | 2e-63 |
| >sp|Q8VYY5|NCRK_ARATH Receptor-like serine/threonine-protein kinase NCRK OS=Arabidopsis thaliana GN=NCRK PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 600 bits (1548), Expect = e-171, Method: Compositional matrix adjust.
Identities = 328/635 (51%), Positives = 412/635 (64%), Gaps = 87/635 (13%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
MK++V+ A L+ LI IQ+ G N+ CTC SS G++S+IL+ NCS SC+
Sbjct: 1 MKMRVETALAILLVLISIQQCY-------GGVSNYTCTCFSS--GNRSDILESNCSTSCN 51
Query: 61 CSPAVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKVV 120
C P +W C+C A+G P +A +++CF SC C++G+ K +++S K+V
Sbjct: 52 CRP-----DRDQWVCLCPANGFPVIAIGGSNSSCFTSCNCSAGATKSSKK--QYLSRKLV 104
Query: 121 VIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKESC-NSATNLISHRITSVPE 179
+++LL C +L ++AFL ++CY+ RK KF ++ +SSD+ES +S+ NLI+ + +
Sbjct: 105 IVILLFCGVLISLAFLASMICYICRKDKFSGQTPSVSSDRESSWHSSANLINRKSSVSQS 164
Query: 180 TRVEVVSPIDLATGCFLKTT--FCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGG 237
S GCF + FC SK TIHG I +FSY+ LE AT+KFS ++++G GG
Sbjct: 165 KISISSS----VAGCFFQNASLFCVSKPETIHGAIFQFSYTELEQATNKFSSNSVIGHGG 220
Query: 238 SSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297
SS VYRGQL DG+ A+KR T G + D++F TEV++LSRLHH HVVPL+GYCSEF GK
Sbjct: 221 SSCVYRGQLKDGKTAAIKRLNTPKGDDTDTLFSTEVELLSRLHHYHVVPLIGYCSEFHGK 280
Query: 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 357
A RLLVFE+M G+LRDCLDG L E M W+ R+++A+GAARGLEYLHEAAAPRILHRD+
Sbjct: 281 HAERLLVFEYMSYGSLRDCLDGELGEKMTWNIRISVALGAARGLEYLHEAAAPRILHRDV 340
Query: 358 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQGTFGYFAPEYAMVGRASLM 416
KS+NILLDEN +AKITDLGMAK L +DGL S SSSP +QGTFGYFAPEYA+ G AS M
Sbjct: 341 KSTNILLDENWHAKITDLGMAKCLSSDGLQSGSSSPTTGLQGTFGYFAPEYAIAGCASQM 400
Query: 417 SDVFSFGVVLLELITGRQPIHR-SITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFP 475
SDVFSFGVVLLELITGR+PI + S KGEESLV+WA PRLQDS VI ELPDPRL G F
Sbjct: 401 SDVFSFGVVLLELITGRKPIQKPSNNKGEESLVIWAVPRLQDSKRVIEELPDPRLNGKFA 460
Query: 476 KEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD-KSRRRNISLNLFQIFSAGGME 534
+EEMQIMAYLAKECL LDP++RPTM EVVQILSTI PD SRRRN +N
Sbjct: 461 EEEMQIMAYLAKECLLLDPESRPTMREVVQILSTITPDTSSRRRNFPINY---------- 510
Query: 535 KEPSIERPDNLFETLIESEELKKATSFGSPRCSQAVDTDITLNTRSNSKEEDTVSTEYME 594
L +S E KK + G R S S +E+
Sbjct: 511 --------------LFQSNEKKKESKVGWSRGG------------SKSGQEE-------- 536
Query: 595 KLLLLTSEVRSSRAPDIETVDLTEPRFESFCMKNV 629
ETVDLTEPRFESFC+ NV
Sbjct: 537 -----------------ETVDLTEPRFESFCLPNV 554
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 258 bits (658), Expect = 1e-67, Method: Compositional matrix adjust.
Identities = 144/301 (47%), Positives = 191/301 (63%), Gaps = 15/301 (4%)
Query: 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
FSY L AT+ FS N++G+GG VY+G L D R+VAVK+ K GG D F EVD
Sbjct: 418 FSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGG-QGDREFKAEVD 476
Query: 275 MLSRLHHCHVVPLVGYC-SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAI 333
+SR+HH +++ +VGYC SE R RLL+++++PN NL L G++W TRV I
Sbjct: 477 TISRVHHRNLLSMVGYCISENR-----RLLIYDYVPNNNLYFHLHAAGTPGLDWATRVKI 531
Query: 334 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS- 392
A GAARGL YLHE PRI+HRDIKSSNILL+ N +A ++D G+AK L D C++
Sbjct: 532 AAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAK-LALD----CNTHI 586
Query: 393 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 452
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ S G+ESLV WA
Sbjct: 587 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWAR 646
Query: 453 PRLQDSGTV--ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
P L ++ + L DP+L ++ EM M A C++ RP MS++V+ ++
Sbjct: 647 PLLSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVRAFDSL 706
Query: 511 A 511
A
Sbjct: 707 A 707
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6R2J8|SRF8_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 8 OS=Arabidopsis thaliana GN=SRF8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 255 bits (651), Expect = 7e-67, Method: Compositional matrix adjust.
Identities = 162/418 (38%), Positives = 236/418 (56%), Gaps = 34/418 (8%)
Query: 103 GSVSGVKASGKHISSKVVVIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKES 162
GS SGK +S VV ++ + + I L+L LC K K +R S +S +
Sbjct: 273 GSEEKSSDSGKGLSGGVVTGIVFGSLFVAGIIALVLYLCL--HKKKRKVRGSTRASQRSL 330
Query: 163 CNSATNLISHRITSVPETRVEVVSPI-DLATGCFLKTTFCRSKTWTIHGTIIR------- 214
S T V E RV+ V+ + DL + K T R +G+I R
Sbjct: 331 PLSGT-------PEVQEQRVKSVASVADLKSSPAEKVTVDRVMK---NGSISRIRSPITA 380
Query: 215 --FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLT 271
++ S+L+ AT+ FS NI+G+G VYR + +G+I+A+K+ + FL
Sbjct: 381 SQYTVSSLQVATNSFSQENIIGEGSLGRVYRAEFPNGKIMAIKKIDNAALSLQEEDNFLE 440
Query: 272 EVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMN--WDT 329
V +SRL H ++VPL GYC+E RLLV+E++ NGNL D L MN W+
Sbjct: 441 AVSNMSRLRHPNIVPLAGYCTE----HGQRLLVYEYVGNGNLDDTLHTNDDRSMNLTWNA 496
Query: 330 RVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 389
RV +A+G A+ LEYLHE P I+HR+ KS+NILLDE LN ++D G+A L +
Sbjct: 497 RVKVALGTAKALEYLHEVCLPSIVHRNFKSANILLDEELNPHLSDSGLAA-LTPNTERQV 555
Query: 390 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 449
S+ ++ G+FGY APE+A+ G ++ SDV++FGVV+LEL+TGR+P+ S T+ E+SLV
Sbjct: 556 ST---QVVGSFGYSAPEFALSGIYTVKSDVYTFGVVMLELLTGRKPLDSSRTRAEQSLVR 612
Query: 450 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507
WATP+L D +S++ DP L G +P + + A + C+Q +P+ RP MSEVVQ L
Sbjct: 613 WATPQLHDI-DALSKMVDPSLNGMYPAKSLSRFADIIALCIQPEPEFRPPMSEVVQQL 669
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 253 bits (645), Expect = 5e-66, Method: Compositional matrix adjust.
Identities = 141/298 (47%), Positives = 183/298 (61%), Gaps = 9/298 (3%)
Query: 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
FSY L T FS N++G+GG VY+G L+DGR VAVK+ K GG + F EV+
Sbjct: 327 FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKI-GGSQGEREFKAEVE 385
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 334
++SR+HH H+V LVGYC RLLV++++PN L L M W+TRV +A
Sbjct: 386 IISRVHHRHLVTLVGYCI----SEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVA 441
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 394
GAARG+ YLHE PRI+HRDIKSSNILLD + A + D G+AK + L + S+
Sbjct: 442 AGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVST-- 499
Query: 395 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 454
R+ GTFGY APEYA G+ S +DV+S+GV+LLELITGR+P+ S G+ESLV WA P
Sbjct: 500 RVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPL 559
Query: 455 LQDS--GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
L + EL DPRL +F EM M A C++ RP MS+VV+ L T+
Sbjct: 560 LGQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTL 617
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 251 bits (641), Expect = 1e-65, Method: Compositional matrix adjust.
Identities = 142/302 (47%), Positives = 192/302 (63%), Gaps = 14/302 (4%)
Query: 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
FSY L AT+ FS N++G+GG VY+G L DGR+VAVK+ K GG D F EV+
Sbjct: 365 FSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGG-QGDREFKAEVE 423
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 334
LSR+HH H+V +VG+C G R RLL+++++ N +L L G ++W TRV IA
Sbjct: 424 TLSRIHHRHLVSIVGHC--ISGDR--RLLIYDYVSNNDLYFHLHGE-KSVLDWATRVKIA 478
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS-P 393
GAARGL YLHE PRI+HRDIKSSNILL++N +A+++D G+A RL D C++
Sbjct: 479 AGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLA-RLALD----CNTHIT 533
Query: 394 ARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 453
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ S G+ESLV WA P
Sbjct: 534 TRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWARP 593
Query: 454 RLQDSGTV--ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511
+ + L DP+L G++ + EM M A C++ RP M ++V+ ++A
Sbjct: 594 LISHAIETEEFDSLADPKLGGNYVESEMFRMIEAAGACVRHLATKRPRMGQIVRAFESLA 653
Query: 512 PD 513
+
Sbjct: 654 AE 655
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 248 bits (634), Expect = 7e-65, Method: Compositional matrix adjust.
Identities = 140/299 (46%), Positives = 184/299 (61%), Gaps = 11/299 (3%)
Query: 213 IRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTE 272
I F+Y L T+ F S +VG+GG VY+G L +G+ VA+K+ K+ F E
Sbjct: 356 IHFTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYRE-FKAE 414
Query: 273 VDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA 332
V+++SR+HH H+V LVGYC R L++EF+PN L L G + + W RV
Sbjct: 415 VEIISRVHHRHLVSLVGYCI----SEQHRFLIYEFVPNNTLDYHLHGKNLPVLEWSRRVR 470
Query: 333 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS 392
IAIGAA+GL YLHE P+I+HRDIKSSNILLD+ A++ D G+A RL S+
Sbjct: 471 IAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLA-RLNDTAQSHIST- 528
Query: 393 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 452
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ S GEESLV WA
Sbjct: 529 --RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWAR 586
Query: 453 PRLQDS--GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 509
PRL ++ ISE+ DPRL+ D+ + E+ M A C++ RP M +VV+ L T
Sbjct: 587 PRLIEAIEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRALDT 645
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 248 bits (632), Expect = 1e-64, Method: Compositional matrix adjust.
Identities = 139/305 (45%), Positives = 187/305 (61%), Gaps = 20/305 (6%)
Query: 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
F+Y L AT+ FS +N++GQGG YV++G L +G+ VAVK+ K +G + F EV
Sbjct: 342 FNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLK-EGSSQGEREFQAEVG 400
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 334
++SR+HH H+V LVGYC A RLLV+EF+PN L L G M W +R+ IA
Sbjct: 401 IISRVHHRHLVALVGYCI----ADAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSSRLKIA 456
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 394
+G+A+GL YLHE P+I+HRDIK+SNIL+D AK+ D G+AK + +D S+
Sbjct: 457 VGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAK-IASDTNTHVST--- 512
Query: 395 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 454
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+PI + + SLV WA P
Sbjct: 513 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWARPL 572
Query: 455 LQDSGTVISELP------DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL- 507
L +SEL D +L ++ KEEM M A C++ RP M +V ++L
Sbjct: 573 LNQ----VSELGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVLE 628
Query: 508 STIAP 512
I+P
Sbjct: 629 GNISP 633
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 247 bits (631), Expect = 2e-64, Method: Compositional matrix adjust.
Identities = 137/300 (45%), Positives = 190/300 (63%), Gaps = 15/300 (5%)
Query: 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
F+ S LE ATD+FS ++G+GG VY+G + DG VAVK T+ N D F+ EV+
Sbjct: 337 FTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLL-TRDNQNRDREFIAEVE 395
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAI 333
MLSRLHH ++V L+G C E R R L++E + NG++ L EG ++WD R+ I
Sbjct: 396 MLSRLHHRNLVKLIGICIEGR----TRCLIYELVHNGSVESHLH----EGTLDWDARLKI 447
Query: 334 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP 393
A+GAARGL YLHE + PR++HRD K+SN+LL+++ K++D G+A R +G S+
Sbjct: 448 ALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA-REATEGSQHIST-- 504
Query: 394 ARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 453
R+ GTFGY APEYAM G + SDV+S+GVVLLEL+TGR+P+ S GEE+LV WA P
Sbjct: 505 -RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWARP 563
Query: 454 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 513
L + + +L DP L G + ++M +A +A C+ + RP M EVVQ L I D
Sbjct: 564 LLANR-EGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQALKLIYND 622
|
Required during the differentiation of the protoderm into shoots epidermis and cuticle. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 245 bits (626), Expect = 7e-64, Method: Compositional matrix adjust.
Identities = 134/296 (45%), Positives = 184/296 (62%), Gaps = 13/296 (4%)
Query: 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
F+Y L AT+ FS +N++GQGG YV++G L G+ VAVK+ K G + F EV+
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSG-QGEREFQAEVE 326
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 334
++SR+HH H+V L+GYC RLLV+EF+PN NL L G M W TR+ IA
Sbjct: 327 IISRVHHRHLVSLIGYCM----AGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIA 382
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 394
+G+A+GL YLHE P+I+HRDIK+SNIL+D AK+ D G+AK + +D S+
Sbjct: 383 LGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAK-IASDTNTHVST--- 438
Query: 395 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP- 453
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ + ++SLV WA P
Sbjct: 439 RVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPL 498
Query: 454 --RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507
R + G L D ++ ++ +EEM M A C++ RP MS++V+ L
Sbjct: 499 LNRASEEGD-FEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRAL 553
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 243 bits (621), Expect = 2e-63, Method: Compositional matrix adjust.
Identities = 136/299 (45%), Positives = 185/299 (61%), Gaps = 13/299 (4%)
Query: 214 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEV 273
F+Y L T+ FS NI+G+GG VY+G+L DG++VAVK+ K G D F EV
Sbjct: 340 HFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSG-QGDREFKAEV 398
Query: 274 DMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAI 333
+++SR+HH H+V LVGYC + RLL++E++PN L L G + W RV I
Sbjct: 399 EIISRVHHRHLVSLVGYCI----ADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRVRI 454
Query: 334 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP 393
AIG+A+GL YLHE P+I+HRDIKS+NILLD+ A++ D G+AK + + +
Sbjct: 455 AIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDS----TQTHVS 510
Query: 394 ARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 453
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ + GEESLV WA P
Sbjct: 511 TRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARP 570
Query: 454 RLQ---DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 509
L ++G SEL D RL+ + + E+ M A C++ RP M +VV+ L +
Sbjct: 571 LLHKAIETGD-FSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDS 628
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 632 | ||||||
| 297746278 | 635 | unnamed protein product [Vitis vinifera] | 1.0 | 0.995 | 0.683 | 0.0 | |
| 359478364 | 628 | PREDICTED: receptor-like serine/threonin | 0.988 | 0.995 | 0.678 | 0.0 | |
| 255578119 | 625 | kinase, putative [Ricinus communis] gi|2 | 0.985 | 0.996 | 0.660 | 0.0 | |
| 224106790 | 563 | predicted protein [Populus trichocarpa] | 0.816 | 0.916 | 0.705 | 0.0 | |
| 224132516 | 532 | predicted protein [Populus trichocarpa] | 0.776 | 0.922 | 0.722 | 0.0 | |
| 356542635 | 612 | PREDICTED: receptor-like serine/threonin | 0.958 | 0.990 | 0.590 | 0.0 | |
| 449456024 | 614 | PREDICTED: receptor-like serine/threonin | 0.962 | 0.990 | 0.585 | 0.0 | |
| 351727637 | 612 | protein kinase family protein precursor | 0.958 | 0.990 | 0.587 | 0.0 | |
| 147834997 | 1324 | hypothetical protein VITISV_037547 [Viti | 0.827 | 0.395 | 0.652 | 0.0 | |
| 449519593 | 610 | PREDICTED: receptor-like serine/threonin | 0.957 | 0.991 | 0.582 | 0.0 |
| >gi|297746278|emb|CBI16334.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 872 bits (2254), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 434/635 (68%), Positives = 509/635 (80%), Gaps = 3/635 (0%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
MKL V+V ACLI L+ IQ S+CD LS+ S W CTCSS+ QG Q+ IL NCS SCD
Sbjct: 1 MKLPVEVALACLISLLGIQLSLCDVLSDTSNINKWTCTCSSANQGSQNYILAGNCSTSCD 60
Query: 61 CSPAVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVS-GVKASGKHISSKV 119
CSPA GGS+ +WTCICAADG PKVA++S T+CF +C CTSGS + A KHISSKV
Sbjct: 61 CSPAGGGSTGDRWTCICAADGFPKVASDSGHTSCFTACNCTSGSPNEDAPARRKHISSKV 120
Query: 120 VVIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHRITSVP 178
VVI+LLLCV+LTT AFL VLCYVYRK K ++ V SSDKE SCNSATNLISH+I SVP
Sbjct: 121 VVIILLLCVVLTTFAFLASVLCYVYRKEKCPIQPPVFSSDKETSCNSATNLISHKINSVP 180
Query: 179 ETRVEVVSPIDLATGCFLK-TTFCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGG 237
E+RV++ SPI+ TGCF K ++ RSKT TIH TI++FSY LE+AT+KFS SN++G GG
Sbjct: 181 ESRVDIGSPINSLTGCFHKASSLFRSKTGTIHETIVQFSYYELENATNKFSNSNLIGVGG 240
Query: 238 SSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297
SSYVY GQL DG+ VAVKR KT+GGP+AD VFLTE+++LSRLHHCHVVPL+GYCSE +GK
Sbjct: 241 SSYVYCGQLKDGKTVAVKRLKTKGGPDADLVFLTEIELLSRLHHCHVVPLLGYCSESQGK 300
Query: 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 357
A RLLVFE+M NGNLRDCLDG + M+W TRV+IA+GAARGLEYLHEAAAPRILHRD+
Sbjct: 301 HAQRLLVFEYMLNGNLRDCLDGDSGKNMDWATRVSIALGAARGLEYLHEAAAPRILHRDV 360
Query: 358 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMS 417
KS+NILLDEN AKITDLGMAKRL+ADGLPSCS+SPARMQGTFGYFAPEYA+VGRAS MS
Sbjct: 361 KSTNILLDENWRAKITDLGMAKRLRADGLPSCSNSPARMQGTFGYFAPEYAIVGRASPMS 420
Query: 418 DVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKE 477
DVFSFGVVLLELI+GR+PIH+S KGEESLV+WATPRLQDSG V+SELPDP LKG+FP+E
Sbjct: 421 DVFSFGVVLLELISGRKPIHKSTNKGEESLVIWATPRLQDSGRVMSELPDPHLKGNFPEE 480
Query: 478 EMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNISLNLFQIFSAGGMEKEP 537
EMQIMA+LAKECL LDPDARPTMSE+VQILSTIAPDKSRRRNI +N FQ S M+ E
Sbjct: 481 EMQIMAFLAKECLLLDPDARPTMSEIVQILSTIAPDKSRRRNIPVNFFQRLSPHSMKSEA 540
Query: 538 SIERPDNLFETLIESEELKKATSFGSPRCSQAVDTDITLNTRSNSKEEDTVSTEYMEKLL 597
+ PD E+ ++ E + T+ + RCS +D D TL + + +VS EY+E+L+
Sbjct: 541 HMLIPDKKSESPVDVELRRAGTNKWTDRCSLPLDIDRTLCIGDSQTKAVSVSAEYIERLI 600
Query: 598 LLTSEVRSSRAPDIETVDLTEPRFESFCMKNVNSP 632
++TS RS R P ETVDLTEPRFESFCM N SP
Sbjct: 601 IMTSNARSWRGPADETVDLTEPRFESFCMANGRSP 635
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359478364|ref|XP_002282467.2| PREDICTED: receptor-like serine/threonine-protein kinase NCRK-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 860 bits (2223), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 431/635 (67%), Positives = 505/635 (79%), Gaps = 10/635 (1%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
MKL V+V ACLI L+ IQ S+C G W CTCSS+ QG Q+ IL NCS SCD
Sbjct: 1 MKLPVEVALACLISLLGIQLSLC-------GLNKWTCTCSSANQGSQNYILAGNCSTSCD 53
Query: 61 CSPAVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVS-GVKASGKHISSKV 119
CSPA GGS+ +WTCICAADG PKVA++S T+CF +C CTSGS + A KHISSKV
Sbjct: 54 CSPAGGGSTGDRWTCICAADGFPKVASDSGHTSCFTACNCTSGSPNEDAPARRKHISSKV 113
Query: 120 VVIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHRITSVP 178
VVI+LLLCV+LTT AFL VLCYVYRK K ++ V SSDKE SCNSATNLISH+I SVP
Sbjct: 114 VVIILLLCVVLTTFAFLASVLCYVYRKEKCPIQPPVFSSDKETSCNSATNLISHKINSVP 173
Query: 179 ETRVEVVSPIDLATGCFLK-TTFCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGG 237
E+RV++ SPI+ TGCF K ++ RSKT TIH TI++FSY LE+AT+KFS SN++G GG
Sbjct: 174 ESRVDIGSPINSLTGCFHKASSLFRSKTGTIHETIVQFSYYELENATNKFSNSNLIGVGG 233
Query: 238 SSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297
SSYVY GQL DG+ VAVKR KT+GGP+AD VFLTE+++LSRLHHCHVVPL+GYCSE +GK
Sbjct: 234 SSYVYCGQLKDGKTVAVKRLKTKGGPDADLVFLTEIELLSRLHHCHVVPLLGYCSESQGK 293
Query: 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 357
A RLLVFE+M NGNLRDCLDG + M+W TRV+IA+GAARGLEYLHEAAAPRILHRD+
Sbjct: 294 HAQRLLVFEYMLNGNLRDCLDGDSGKNMDWATRVSIALGAARGLEYLHEAAAPRILHRDV 353
Query: 358 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMS 417
KS+NILLDEN AKITDLGMAKRL+ADGLPSCS+SPARMQGTFGYFAPEYA+VGRAS MS
Sbjct: 354 KSTNILLDENWRAKITDLGMAKRLRADGLPSCSNSPARMQGTFGYFAPEYAIVGRASPMS 413
Query: 418 DVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKE 477
DVFSFGVVLLELI+GR+PIH+S KGEESLV+WATPRLQDSG V+SELPDP LKG+FP+E
Sbjct: 414 DVFSFGVVLLELISGRKPIHKSTNKGEESLVIWATPRLQDSGRVMSELPDPHLKGNFPEE 473
Query: 478 EMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNISLNLFQIFSAGGMEKEP 537
EMQIMA+LAKECL LDPDARPTMSE+VQILSTIAPDKSRRRNI +N FQ S M+ E
Sbjct: 474 EMQIMAFLAKECLLLDPDARPTMSEIVQILSTIAPDKSRRRNIPVNFFQRLSPHSMKSEA 533
Query: 538 SIERPDNLFETLIESEELKKATSFGSPRCSQAVDTDITLNTRSNSKEEDTVSTEYMEKLL 597
+ PD E+ ++ E + T+ + RCS +D D TL + + +VS EY+E+L+
Sbjct: 534 HMLIPDKKSESPVDVELRRAGTNKWTDRCSLPLDIDRTLCIGDSQTKAVSVSAEYIERLI 593
Query: 598 LLTSEVRSSRAPDIETVDLTEPRFESFCMKNVNSP 632
++TS RS R P ETVDLTEPRFESFCM N SP
Sbjct: 594 IMTSNARSWRGPADETVDLTEPRFESFCMANGRSP 628
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255578119|ref|XP_002529929.1| kinase, putative [Ricinus communis] gi|223530559|gb|EEF32437.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 851 bits (2198), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 419/634 (66%), Positives = 496/634 (78%), Gaps = 11/634 (1%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
MKLQV+V ACL+GLIWIQ+ +C G NW CTCS S QG+Q+ + K NCS SCD
Sbjct: 1 MKLQVEVALACLVGLIWIQQGLC-------GLNNWTCTCSLSSQGNQTYV-KSNCSTSCD 52
Query: 61 CSPAVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKVV 120
C+P GGS + W C CAADGLP++A+ S+D+TCF +C CTSGSV+ + KH S KVV
Sbjct: 53 CNPVAGGSKDSTWGCTCAADGLPRIASGSHDSTCFTACNCTSGSVAQAQEKRKHFSGKVV 112
Query: 121 VIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHRITSVPE 179
VI+LLLCVILTT+AFL + CYVYRK +S + SD+E S SATNLISH+ +S+ E
Sbjct: 113 VIILLLCVILTTLAFLASITCYVYRKDNCPFQSPIFISDRETSYTSATNLISHKASSLLE 172
Query: 180 TRVEVVSPIDLATGCFLKTTFCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGSS 239
T V + + ++ GCF + F R + I+GTI+RFSYS LEHAT FS SN++G GGSS
Sbjct: 173 TGVSIDTHLNPMPGCF-RRAFYRGSSDIINGTIVRFSYSELEHATKNFSNSNLIGLGGSS 231
Query: 240 YVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299
YVYRGQL +G+ VA+KR QGGP+ADS+F EV++LSRLHHCHVVPL+G CSEF+GK +
Sbjct: 232 YVYRGQLRNGKTVAIKRLNAQGGPDADSLFSKEVEVLSRLHHCHVVPLLGCCSEFQGKHS 291
Query: 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKS 359
RLLVFE+MPNGNLRDCLDG+ E M W+TRVAIAIGAARGLEYLHEAAAPRILHRD+KS
Sbjct: 292 KRLLVFEYMPNGNLRDCLDGISGESMKWETRVAIAIGAARGLEYLHEAAAPRILHRDVKS 351
Query: 360 SNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDV 419
+NILLDEN AKITDLGMAKRLKADG+PS SSSPARMQGTFGYFAPEYAMVGRASLMSDV
Sbjct: 352 TNILLDENWGAKITDLGMAKRLKADGVPSSSSSPARMQGTFGYFAPEYAMVGRASLMSDV 411
Query: 420 FSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEM 479
FSFGVVLLELI+GRQPIH+S KGEESLVLWATPRLQDS V+SELPD RLKG+FP+EEM
Sbjct: 412 FSFGVVLLELISGRQPIHKSTNKGEESLVLWATPRLQDSRRVVSELPDQRLKGNFPEEEM 471
Query: 480 QIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNISLNLFQIFSAGGMEKEPSI 539
QIMAYLAKECL LDPDARPTM E+VQILSTIAPDKSRRRNI +NLFQ+ M+ E I
Sbjct: 472 QIMAYLAKECLLLDPDARPTMREIVQILSTIAPDKSRRRNIPVNLFQMSFTRSMKMESHI 531
Query: 540 ERPDNLFETLIESEELKKATSFG-SPRCSQAVDTDITLNTRSNSKEEDTVSTEYMEKLLL 598
++ NL E +++ EL++ +S S S +D + TL+ R + E DTVS+EYME+L+L
Sbjct: 532 QKSGNLVEGSVDAAELRRESSAKQSALGSLPLDVEHTLSVRQKTMEVDTVSSEYMERLIL 591
Query: 599 LTSEVRSSRAPDIETVDLTEPRFESFCMKNVNSP 632
LTS+ RS R D E VDLTEPRFESF M N P
Sbjct: 592 LTSKARSWRVTDEEAVDLTEPRFESFRMANAKFP 625
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224106790|ref|XP_002314286.1| predicted protein [Populus trichocarpa] gi|222850694|gb|EEE88241.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 744 bits (1922), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/529 (70%), Positives = 435/529 (82%), Gaps = 13/529 (2%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
MKLQ+KV A LIGLIWIQ++ +SG W CTCS+S QG+QS I K NCS SCD
Sbjct: 1 MKLQLKVALAFLIGLIWIQQA-------KSGINKWTCTCSASYQGNQSYI-KSNCSTSCD 52
Query: 61 CSPAVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKVV 120
CSP + G G WTC C++DGLPKVA DTTCF +C CTSG+ + + KH SSK+V
Sbjct: 53 CSPGMPG---GMWTCTCSSDGLPKVATGIQDTTCFTACNCTSGTWFLWQYTRKHFSSKIV 109
Query: 121 VIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHRITSVPE 179
+++LLLCVILTT+AFL + CY+YRK K ++S V SD+E SCNSATNLISHR +SV E
Sbjct: 110 LVILLLCVILTTLAFLASITCYLYRKDKCLVQSPVFLSDRERSCNSATNLISHRASSVSE 169
Query: 180 TRVEVVSPIDLATGCFLKTTF-CRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGS 238
T++ V SPI+ +GCF K +F CRSKT I G +I F+YS LEHAT+KFS SN++G GGS
Sbjct: 170 TKIRVDSPINPISGCFRKASFLCRSKTEIIQGNLILFTYSELEHATNKFSHSNLIGLGGS 229
Query: 239 SYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298
SYVY GQL DGR VAVKR K QGGP+AD +F TEV++L++LHHCHVVPL+GYCS+F+GK
Sbjct: 230 SYVYHGQLKDGRTVAVKRLKAQGGPDADFLFSTEVELLAKLHHCHVVPLLGYCSKFQGKF 289
Query: 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 358
+ RLLVFE+MPNGNLRDCLDGVL E MNW TRV IAIGAARGLEYLHE+AAPRILHRD+K
Sbjct: 290 SERLLVFEYMPNGNLRDCLDGVLGEKMNWQTRVTIAIGAARGLEYLHESAAPRILHRDVK 349
Query: 359 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSD 418
S+NIL+DEN AKITDLGMAKRL+ DG+PS SSPARMQGTFGYFAPEYAM+GRAS MSD
Sbjct: 350 STNILMDENWRAKITDLGMAKRLRGDGVPSSPSSPARMQGTFGYFAPEYAMIGRASPMSD 409
Query: 419 VFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEE 478
VFSFGVVLLELITGRQPIH+S KGEESLVLWATP LQDSG V+ ELPDPRLKG+FP+EE
Sbjct: 410 VFSFGVVLLELITGRQPIHKSTNKGEESLVLWATPLLQDSGLVLLELPDPRLKGNFPEEE 469
Query: 479 MQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNISLNLFQI 527
+QIMAYLAKECL LDPDARP+M EVVQILSTIAP+KS+RRNI + LFQ+
Sbjct: 470 LQIMAYLAKECLLLDPDARPSMGEVVQILSTIAPEKSKRRNIPVKLFQV 518
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224132516|ref|XP_002328308.1| predicted protein [Populus trichocarpa] gi|222837823|gb|EEE76188.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 736 bits (1901), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 360/498 (72%), Positives = 416/498 (83%), Gaps = 7/498 (1%)
Query: 31 GQKNWKCTCSSSLQGDQSNILKLNCSRSCDCSPAVGGSSEGKWTCICAADGLPKVAANSY 90
G NW CTCS+S QG+QS K NCS SCDC+ G S G WTC C+ DGLPKVAA S
Sbjct: 1 GINNWTCTCSASYQGNQS-YTKSNCSTSCDCT---GRQSRGTWTCTCSTDGLPKVAAGSQ 56
Query: 91 DTTCFASCTCTSGSVSGVKASGKHISSKVVVIVLLLCVILTTIAFLMLVLCYVYRKGKFH 150
DTTCF +C CTSGS++ +A+ KHISSK+VV V+LLCVILTT+AFL Y+ RK K
Sbjct: 57 DTTCFTACNCTSGSLTDAQATRKHISSKIVV-VILLCVILTTLAFLASTTWYLCRKDKCP 115
Query: 151 LRSSVISSDKE-SCNSATNLISHRITSVPETRVEVVSPIDLATGCFLKTTF-CRSKTWTI 208
++S SD+E SCNSATNLISHR +SV ET++ V SPI+ +GCF K +F CRSKT I
Sbjct: 116 IQSPTFLSDRETSCNSATNLISHRASSVSETKIRVDSPINPISGCFRKASFLCRSKTEII 175
Query: 209 HGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV 268
HGT+I F+YS LEHATDKFS SN++G GGSSYVYRGQL DG VAVKR K QGG +AD +
Sbjct: 176 HGTLICFAYSELEHATDKFSHSNLIGLGGSSYVYRGQLKDGTTVAVKRLKAQGGTDADLL 235
Query: 269 FLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWD 328
F EV++L++LHHCHVVPL+GYCSEFRGK + RLLVFE+MPNGNLRDCLDG++ E MNW
Sbjct: 236 FSREVELLAKLHHCHVVPLLGYCSEFRGKLSERLLVFEYMPNGNLRDCLDGIMGENMNWQ 295
Query: 329 TRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS 388
TRV IAIGAARGLEYLHEAAAPRILHRD+KS+NIL+DE AKITDLGMAKRL+ADG+PS
Sbjct: 296 TRVTIAIGAARGLEYLHEAAAPRILHRDVKSTNILMDELWRAKITDLGMAKRLRADGVPS 355
Query: 389 CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 448
SSSPARMQGTFGYFAPEYAM+GRASLMSDVFSFGVVLLE+ITGRQPIH++ K EESLV
Sbjct: 356 SSSSPARMQGTFGYFAPEYAMIGRASLMSDVFSFGVVLLEVITGRQPIHKTTNKVEESLV 415
Query: 449 LWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508
LWATP LQDS VISELPDPRLKG+FP+EE+QIMAYLAKECL +DPD+RP+MSEVVQILS
Sbjct: 416 LWATPLLQDSRRVISELPDPRLKGNFPEEELQIMAYLAKECLLMDPDSRPSMSEVVQILS 475
Query: 509 TIAPDKSRRRNISLNLFQ 526
TIAP+KS+RRNI ++LFQ
Sbjct: 476 TIAPEKSKRRNIPVSLFQ 493
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356542635|ref|XP_003539772.1| PREDICTED: receptor-like serine/threonine-protein kinase NCRK-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 733 bits (1892), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/638 (59%), Positives = 465/638 (72%), Gaps = 32/638 (5%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
MK Q+K+ A +I L+WIQ S CD+ SE S W+C CS QG+QS L NCS+SCD
Sbjct: 1 MKPQLKIALALVISLLWIQHSFCDENSETSSLNKWRCRCS--FQGNQSYSLA-NCSKSCD 57
Query: 61 CSPAVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKVV 120
C + S WTC+C ++G P+VAA+ + CF++C CT G+VS S KH+SSK+V
Sbjct: 58 CH-SDSEESASVWTCVCDSNGFPQVAADGRSSNCFSTCNCTWGTVSRPGGSKKHVSSKIV 116
Query: 121 VIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHR--ITSV 177
V++LL+CVI TT+AFL+ ++C+VYRK + ++S + S+DKE S S TNLISHR +SV
Sbjct: 117 VVILLICVICTTMAFLVSLICHVYRKDRCTIQSPIFSTDKETSSGSTTNLISHRSGASSV 176
Query: 178 PETRVEVVSPIDLATGCFLKTTFC-RSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQG 236
PET+ + SPI TGCF K +F S T HG I FS + LE+AT+ FS SN++G G
Sbjct: 177 PETKYAINSPIYHITGCFQKASFLFGSPKETYHGNIFPFSLAELENATENFSSSNLIGVG 236
Query: 237 GSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 296
GSSYVY G+L DG VAVKR K QGGP ADS F E+++L+RLHHCH+VPL+GYCSE +G
Sbjct: 237 GSSYVYLGRLKDGSNVAVKRLKDQGGPEADSAFFKEIELLARLHHCHLVPLLGYCSELKG 296
Query: 297 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRD 356
K RLLVF++M NGNLRDCLDGV + ++W TRV IAIGAARGLEYLHEAAAPRILHRD
Sbjct: 297 KHVQRLLVFDYMANGNLRDCLDGVSGKHIDWATRVMIAIGAARGLEYLHEAAAPRILHRD 356
Query: 357 IKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLM 416
+KS+NILLDEN AKITDLGMAK L++D LPSCS+SPARMQGTFGYFAPEYA+VGRASL
Sbjct: 357 VKSTNILLDENWQAKITDLGMAKNLRSDDLPSCSNSPARMQGTFGYFAPEYAIVGRASLE 416
Query: 417 SDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPK 476
SDVFSFGVVLLELI+GR PIH+S K EESLV+WATPR QDS VI+EL DP+LKG+FP+
Sbjct: 417 SDVFSFGVVLLELISGRHPIHKSTGK-EESLVIWATPRFQDSRRVITELVDPQLKGNFPE 475
Query: 477 EEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKS-RRRNISLNLFQIFSAGGMEK 535
EE+Q+MAYLAKECL LDPD RPTMSEVVQILS+I+P KS RRRNI +LFQ
Sbjct: 476 EEVQVMAYLAKECLLLDPDTRPTMSEVVQILSSISPGKSRRRRNIPASLFQ--------- 526
Query: 536 EPSIERPDNLFETLIESEELKKATSFGSP-RCSQAVDTDITLNTRSNSKEEDTVSTEYME 594
EP ++++ ++A P S + D L+ + +K ED +S EYME
Sbjct: 527 EPE------------DAQKQRQAPPSKFPTHSSMPIYNDHNLSVENKNKAEDALSAEYME 574
Query: 595 KLLLLTSEVRSSRAPDIETVDLTEPRFESFCMKNVNSP 632
L+LLTS+ S A + E VDLTEPRFESFC+ N N P
Sbjct: 575 SLILLTSKSDGSCASEEEIVDLTEPRFESFCITNGNVP 612
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449456024|ref|XP_004145750.1| PREDICTED: receptor-like serine/threonine-protein kinase NCRK-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 729 bits (1883), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/635 (58%), Positives = 459/635 (72%), Gaps = 27/635 (4%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
M+ QV TF L+G I +Q+ IC S+ S NW C C S Q +Q L NCS SC
Sbjct: 1 MRHQVAATFLSLVGFILLQQVICADTSDFSTSGNWTCRCFSPHQENQGLTLGPNCSTSCS 60
Query: 61 CSPAVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKVV 120
C+ V GS WTC+C+ DG PKV AN+ D+ CF SC CT G + + S +HISS VV
Sbjct: 61 CTQDVEGSR--LWTCMCSTDGFPKVVANNRDSNCFTSCNCTYGLLPELPYSKRHISSNVV 118
Query: 121 VIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHRITSVPE 179
VI+L LCVI+ T+AF +LV+CY+ ++ K +R+ +IS DK+ S NS TNLISHR +S P+
Sbjct: 119 VIILSLCVIIITVAFFILVVCYLCQRDKCRVRAPIISLDKQISYNSLTNLISHRSSSTPD 178
Query: 180 TRVEVVSPIDLATGCF-LKTTFCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGS 238
++V + SP++ GCF + R+K+ ++ G II+FSYS LE+AT+KFS S++VG+GGS
Sbjct: 179 SKVMMDSPVNNIKGCFFMNQCLLRTKSRSLCGIIIQFSYSELENATEKFSSSHLVGRGGS 238
Query: 239 SYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298
S+VYRG+L DGR VAVKR QGGP+ D +FLTE+ +LSRL+HCHVVPL+GYC+E RGK
Sbjct: 239 SFVYRGELRDGRTVAVKRLNIQGGPDVDYLFLTEIQLLSRLNHCHVVPLLGYCTESRGKH 298
Query: 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 358
RLLV+E+MP GNLRDCLDG + M+W TRV IA+GAARGLEYLHEAAAPRILHRD+K
Sbjct: 299 TERLLVYEYMPKGNLRDCLDGASGKKMDWSTRVTIALGAARGLEYLHEAAAPRILHRDVK 358
Query: 359 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSD 418
S+NILLD++ AKITDLGMA RL+ D LPSCSSSPARMQGTFGYFAPEYA+VGRASL SD
Sbjct: 359 STNILLDKDWRAKITDLGMATRLRGDDLPSCSSSPARMQGTFGYFAPEYAIVGRASLKSD 418
Query: 419 VFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEE 478
VFSFGVVLLELITG+ PIH+S KGEESL +WA PRLQ+S VI+ELPDP L G FP+EE
Sbjct: 419 VFSFGVVLLELITGQHPIHKSAGKGEESLAIWAAPRLQNSRRVITELPDPHLDGTFPEEE 478
Query: 479 MQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNISLNLFQIFSAGGMEKEPS 538
MQIMAYLAKECL LDPDARPTM+EVVQ+LS I PDKSRR NIS N+FQ+ + ME++ S
Sbjct: 479 MQIMAYLAKECLLLDPDARPTMTEVVQVLSNITPDKSRRNNISANVFQVSQSLMMERQAS 538
Query: 539 IERPDNLFETLIESEELKKATSFGSPRCSQAVDTDITLNTRSNSKEEDTVSTEYMEKLLL 598
+ + R S +D D +L N +D VS E M+ L+
Sbjct: 539 SRKWLD--------------------RYSLPLDIDRSL-CADNYGNQDIVSFENMKTLVP 577
Query: 599 LTSEVRSSR--APDIETVDLTEPRFESFCMKNVNS 631
TS+ + R PD ETVDLTEPRFESFC+ NV S
Sbjct: 578 FTSKGNNLRVQGPDDETVDLTEPRFESFCIVNVKS 612
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351727637|ref|NP_001235120.1| protein kinase family protein precursor [Glycine max] gi|223452424|gb|ACM89539.1| protein kinase family protein [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 725 bits (1872), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/638 (58%), Positives = 463/638 (72%), Gaps = 32/638 (5%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
MK Q+K+ A ++ L+WIQ+S CD+ S+ S W+C CS QG+QS L NCS+SCD
Sbjct: 1 MKPQLKIALALVVSLLWIQQSFCDETSDTSSLNKWRCRCS--FQGNQSYSLA-NCSKSCD 57
Query: 61 CSPAVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKVV 120
C + S WTC+C ++G P+VAA+ + + CF +C CT G+ S S KH+SSK+V
Sbjct: 58 CF-SDSEESASVWTCVCDSNGFPQVAADGHSSNCFNACNCTWGTFSRPGGSKKHVSSKIV 116
Query: 121 VIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHR--ITSV 177
V++LL+CVI TT+AFL+ ++C+VYRK + + S + S DKE S S TNLISHR +SV
Sbjct: 117 VVILLICVICTTMAFLVSLICHVYRKDRCTIHSPIFSMDKETSSGSTTNLISHRSGTSSV 176
Query: 178 PETRVEVVSPIDLATGCFLKTTFC-RSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQG 236
PET+ + SPI TGCF K +F + T HG I FS + LE+AT+ FS SN++G G
Sbjct: 177 PETKYAMNSPIYHITGCFQKASFFFGNPKETYHGNIFPFSLAELENATENFSSSNLIGVG 236
Query: 237 GSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 296
GSSYVY G+L DG VAVKR K QGG ADS F E+++L+RLHHCH+VPL+GYCSE +G
Sbjct: 237 GSSYVYLGRLKDGSNVAVKRLKDQGGSEADSAFFKEIELLARLHHCHLVPLLGYCSELKG 296
Query: 297 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRD 356
K RLLVF++M NGNLRDCLDGV + ++W TRV IAIGAARGLEYLHEAAAPRILHRD
Sbjct: 297 KHVQRLLVFDYMANGNLRDCLDGVSGKHVDWATRVMIAIGAARGLEYLHEAAAPRILHRD 356
Query: 357 IKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLM 416
+KS+NILLDEN AKITDLGMAK L++D LPSCS+SPARMQGTFGYFAPEYA+VGRASL
Sbjct: 357 VKSTNILLDENWQAKITDLGMAKNLRSDDLPSCSNSPARMQGTFGYFAPEYAIVGRASLE 416
Query: 417 SDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPK 476
SDVFSFGVVLLELI+GR PIH+S K EESLV+WATPRLQDS VI EL DP+LKG+FP+
Sbjct: 417 SDVFSFGVVLLELISGRHPIHKSTGK-EESLVIWATPRLQDSRRVIRELVDPQLKGNFPE 475
Query: 477 EEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKS-RRRNISLNLFQIFSAGGMEK 535
EE+QIMAYLAKECL LDPD RPTMSEVVQIL +I+P KS RRRNI +LFQ
Sbjct: 476 EEVQIMAYLAKECLLLDPDTRPTMSEVVQILLSISPGKSRRRRNIPASLFQ--------- 526
Query: 536 EPSIERPDNLFETLIESEELKKATSFGSP-RCSQAVDTDITLNTRSNSKEEDTVSTEYME 594
EP ++E+ +++T P S + D L+ + +K ED VS E ME
Sbjct: 527 EPE------------DAEKQRQSTPSKFPTHSSLPIYNDHNLSVENKNKAEDAVSAENME 574
Query: 595 KLLLLTSEVRSSRAPDIETVDLTEPRFESFCMKNVNSP 632
L+LLTS+ SRA + E VDLTEPRFESFC+ N N+P
Sbjct: 575 SLILLTSKSDGSRASEEEIVDLTEPRFESFCITNGNAP 612
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147834997|emb|CAN61381.1| hypothetical protein VITISV_037547 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 725 bits (1872), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/567 (65%), Positives = 430/567 (75%), Gaps = 44/567 (7%)
Query: 110 ASGKHISSKVVVIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATN 168
A KHISSKVVVI+LLLCV+LTT AFL VLCYVYRK K ++ V SSDKE SCNSATN
Sbjct: 758 ARRKHISSKVVVIILLLCVVLTTFAFLASVLCYVYRKEKCPIQPPVFSSDKETSCNSATN 817
Query: 169 LISHRITSVPETRVEVVSPIDLATGCFLK-TTFCRSKTWTIHGTIIRFSYSALEHATDKF 227
LISH+I SVPE+RV++ SPI+ TGCF K ++ RSKT TIH TI++FSY LE+AT+KF
Sbjct: 818 LISHKINSVPESRVDIGSPINSLTGCFHKASSLFRSKTGTIHETIVQFSYYELENATNKF 877
Query: 228 SGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEV-------------- 273
S SN++G GGSSYVY GQL DG+ VAVKR KT+GGP+AD VFLTEV
Sbjct: 878 SNSNLIGVGGSSYVYCGQLKDGKTVAVKRLKTKGGPDADLVFLTEVLHHSAIIFNLFVEH 937
Query: 274 ----------------------------DMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 305
++LSRLHHCHVVPL+GYCSE +GK A RLLVF
Sbjct: 938 SFVASVIMGGVRTTEHSWRFYTMLLCQIELLSRLHHCHVVPLLGYCSESQGKHAQRLLVF 997
Query: 306 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD 365
E+M NGNLRDCLDG + M+W TRV+IA+GAARGLEYLHEAAAPRILHRD+KS+NILLD
Sbjct: 998 EYMLNGNLRDCLDGDSGKNMDWATRVSIALGAARGLEYLHEAAAPRILHRDVKSTNILLD 1057
Query: 366 ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVV 425
EN AKITDLGMAKRL+ADGLPSCS+SPARMQGTFGYFAPEYA+VGRAS MSDVFSFGVV
Sbjct: 1058 ENWRAKITDLGMAKRLRADGLPSCSNSPARMQGTFGYFAPEYAIVGRASPMSDVFSFGVV 1117
Query: 426 LLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYL 485
LLELI+GR+PIH+S KGEESLV+WATPRLQDSG V+SELPDP LKG+FP+EEMQIMA+L
Sbjct: 1118 LLELISGRKPIHKSTNKGEESLVIWATPRLQDSGRVMSELPDPHLKGNFPEEEMQIMAFL 1177
Query: 486 AKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNISLNLFQIFSAGGMEKEPSIERPDNL 545
AKECL LDPDARPTMSE+VQILSTIAPDKSRRRNI +N FQ S M+ E + PD
Sbjct: 1178 AKECLLLDPDARPTMSEIVQILSTIAPDKSRRRNIPVNFFQRLSPHSMKSEAHMLIPDKK 1237
Query: 546 FETLIESEELKKATSFGSPRCSQAVDTDITLNTRSNSKEEDTVSTEYMEKLLLLTSEVRS 605
E+ ++ E + T+ + RCS +D D TL + +VS EY+E+L+++TS RS
Sbjct: 1238 SESPVDVELRRAGTNKWTDRCSLPLDIDRTLCIGDXQTKAVSVSAEYIERLIIMTSNARS 1297
Query: 606 SRAPDIETVDLTEPRFESFCMKNVNSP 632
R P ETVDLTEPRFESFCM N SP
Sbjct: 1298 WRGPADETVDLTEPRFESFCMANGRSP 1324
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449519593|ref|XP_004166819.1| PREDICTED: receptor-like serine/threonine-protein kinase NCRK-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 720 bits (1859), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 369/634 (58%), Positives = 456/634 (71%), Gaps = 29/634 (4%)
Query: 1 MKLQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCD 60
M+ QV TF L+G I +Q+ IC S+ S NW C C S Q +Q L NCS SC
Sbjct: 1 MRHQVAATFLSLVGFILLQQVICADTSDFSTSGNWTCRCFSPHQENQGLTLGPNCSTSCS 60
Query: 61 CSPAVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKVV 120
C+ V GS WTC+C+ DG PKV AN+ D+ CF SC CT G + + S +HISS VV
Sbjct: 61 CTQDVEGSR--LWTCMCSTDGFPKVVANNRDSNCFTSCNCTYGLLPELPYSKRHISSNVV 118
Query: 121 VIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKE-SCNSATNLISHRITSVPE 179
VI+L LCVI+ T+AF +LV+CY+ ++ K +R+ +IS DK+ S NS TNLISH+ +S P+
Sbjct: 119 VIILSLCVIIITVAFFILVVCYLCQRDKCRVRAPIISLDKQISYNSLTNLISHKSSSTPD 178
Query: 180 TRVEVVSPIDLATGCFLKTTFCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGSS 239
++V + SP++ G + +K+ ++ G II+FSYS LE+AT+KFS S++VG+GGSS
Sbjct: 179 SKVMMDSPVNNIKGVLV---LLGTKSRSLCGIIIQFSYSELENATEKFSSSHLVGRGGSS 235
Query: 240 YVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299
+VYRG+L DGR VAVKR QGGP+ D +FLTE+ +LSRL+HCHVVPL+GYC+E RGK
Sbjct: 236 FVYRGELRDGRTVAVKRLNIQGGPDVDYLFLTEIQLLSRLNHCHVVPLLGYCTESRGKHT 295
Query: 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKS 359
RLLV+E+MP GNLRDCLDG + M+W TRV IA+GAARGLEYLHEAAAPRILHRD+KS
Sbjct: 296 ERLLVYEYMPKGNLRDCLDGASGKKMDWSTRVTIALGAARGLEYLHEAAAPRILHRDVKS 355
Query: 360 SNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDV 419
+NILLD++ AKITDLGMA RL+ D LPSCSSSPARMQGTFGYFAPEYA+VGRASL SDV
Sbjct: 356 TNILLDKDWRAKITDLGMATRLRGDDLPSCSSSPARMQGTFGYFAPEYAIVGRASLKSDV 415
Query: 420 FSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEM 479
FSFGVVLLELITG+ PIH+S KGEESL +WA PRLQ+S VI+ELPDP L G FP+EEM
Sbjct: 416 FSFGVVLLELITGQHPIHKSAGKGEESLAIWAAPRLQNSRRVITELPDPHLDGTFPEEEM 475
Query: 480 QIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNISLNLFQIFSAGGMEKEPSI 539
QIMAYLAKECL LDPDARPTM+EVVQ+LS I PDKSRR NIS NLFQ+ + ME++ S
Sbjct: 476 QIMAYLAKECLLLDPDARPTMTEVVQVLSNITPDKSRRNNISANLFQVSQSLMMERQASS 535
Query: 540 ERPDNLFETLIESEELKKATSFGSPRCSQAVDTDITLNTRSNSKEEDTVSTEYMEKLLLL 599
+ + R S +D D +L N +D VS E M+ L+
Sbjct: 536 RKWLD--------------------RYSLPLDIDRSL-CADNYGNQDIVSFENMKTLVPF 574
Query: 600 TSEVRSSR--APDIETVDLTEPRFESFCMKNVNS 631
TS+ + R PD ETVDLTEPRFESFC+ NV S
Sbjct: 575 TSKGNNLRVQGPDDETVDLTEPRFESFCIVNVKS 608
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 632 | ||||||
| TAIR|locus:2062824 | 565 | NCRK [Arabidopsis thaliana (ta | 0.818 | 0.915 | 0.546 | 7.1e-154 | |
| TAIR|locus:2132168 | 725 | AT4G02010 [Arabidopsis thalian | 0.507 | 0.442 | 0.457 | 7.2e-68 | |
| TAIR|locus:2028756 | 762 | PERK10 "proline-rich extensin- | 0.455 | 0.377 | 0.475 | 6.9e-63 | |
| TAIR|locus:2026925 | 708 | PERK9 "proline-rich extensin-l | 0.490 | 0.437 | 0.446 | 4.8e-62 | |
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.457 | 0.424 | 0.473 | 7.9e-62 | |
| TAIR|locus:2019938 | 718 | PERK11 "proline-rich extensin- | 0.503 | 0.442 | 0.450 | 1.3e-61 | |
| TAIR|locus:2038992 | 744 | ALE2 "Abnormal Leaf Shape 2" [ | 0.450 | 0.383 | 0.453 | 1.3e-61 | |
| TAIR|locus:2099009 | 400 | AT3G58690 [Arabidopsis thalian | 0.492 | 0.777 | 0.431 | 1.3e-61 | |
| UNIPROTKB|Q9ARH1 | 647 | Q9ARH1 "Receptor protein kinas | 0.447 | 0.437 | 0.462 | 1.9e-60 | |
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.447 | 0.434 | 0.456 | 3.1e-60 |
| TAIR|locus:2062824 NCRK [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1434 (509.9 bits), Expect = 7.1e-154, Sum P(2) = 7.1e-154
Identities = 297/543 (54%), Positives = 376/543 (69%)
Query: 3 LQVKVTFACLIGLIWIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRSCDCS 62
++++V A I L+ I C G N+ CTC SS G++S+IL+ NCS SC+C
Sbjct: 1 MKMRVETALAILLVLISIQQC-----YGGVSNYTCTCFSS--GNRSDILESNCSTSCNCR 53
Query: 63 PAVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTXXXXXXXXXXXXHISSKXXXX 122
P +W C+C A+G P +A +++CF SC C+ ++S K
Sbjct: 54 P-----DRDQWVCLCPANGFPVIAIGGSNSSCFTSCNCSAGATKSSKKQ--YLSRKLVIV 106
Query: 123 XXXXXXXXXXXAFLMLVLCYVYRKGKFHLRSSVISSDKESC-NSATNLISHRITSVPETR 181
AFL ++CY+ RK KF ++ +SSD+ES +S+ NLI+ + +SV +++
Sbjct: 107 ILLFCGVLISLAFLASMICYICRKDKFSGQTPSVSSDRESSWHSSANLINRK-SSVSQSK 165
Query: 182 VEVVSPIDLATGCFLKTT--FCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGSS 239
+ + S + GCF + FC SK TIHG I +FSY+ LE AT+KFS ++++G GGSS
Sbjct: 166 ISISSSV---AGCFFQNASLFCVSKPETIHGAIFQFSYTELEQATNKFSSNSVIGHGGSS 222
Query: 240 YVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299
VYRGQL DG+ A+KR T G + D++F TEV++LSRLHH HVVPL+GYCSEF GK A
Sbjct: 223 CVYRGQLKDGKTAAIKRLNTPKGDDTDTLFSTEVELLSRLHHYHVVPLIGYCSEFHGKHA 282
Query: 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKS 359
RLLVFE+M G+LRDCLDG L E M W+ R+++A+GAARGLEYLHEAAAPRILHRD+KS
Sbjct: 283 ERLLVFEYMSYGSLRDCLDGELGEKMTWNIRISVALGAARGLEYLHEAAAPRILHRDVKS 342
Query: 360 SNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQGTFGYFAPEYAMVGRASLMSD 418
+NILLDEN +AKITDLGMAK L +DGL S SSSP +QGTFGYFAPEYA+ G AS MSD
Sbjct: 343 TNILLDENWHAKITDLGMAKCLSSDGLQSGSSSPTTGLQGTFGYFAPEYAIAGCASQMSD 402
Query: 419 VFSFGVVLLELITGRQPIHR-SITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKE 477
VFSFGVVLLELITGR+PI + S KGEESLV+WA PRLQDS VI ELPDPRL G F +E
Sbjct: 403 VFSFGVVLLELITGRKPIQKPSNNKGEESLVIWAVPRLQDSKRVIEELPDPRLNGKFAEE 462
Query: 478 EMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD-KSRRRNISLNLFQIFSAGGMEKE 536
EMQIMAYLAKECL LDP++RPTM EVVQILSTI PD SRRRN +N +F + +KE
Sbjct: 463 EMQIMAYLAKECLLLDPESRPTMREVVQILSTITPDTSSRRRNFPINY--LFQSNEKKKE 520
Query: 537 PSI 539
+
Sbjct: 521 SKV 523
|
|
| TAIR|locus:2132168 AT4G02010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 689 (247.6 bits), Expect = 7.2e-68, P = 7.2e-68
Identities = 157/343 (45%), Positives = 207/343 (60%)
Query: 173 RITSVPETRVEVVSPIDLATGCFLKTTFCRSKTWTIHGTIIRF-SYSALEHATDKFSGSN 231
R P+ E V P +L G F + H RF SY L+ AT F ++
Sbjct: 333 REEKAPDPHKEAVKPRNLDAGSFGGSL--------PHPASTRFLSYEELKEATSNFESAS 384
Query: 232 IVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
I+G+GG VYRG L DG VA+K+ T GGP D F E+DMLSRLHH ++V LVGY
Sbjct: 385 ILGEGGFGKVYRGILADGTAVAIKKL-TSGGPQGDKEFQVEIDMLSRLHHRNLVKLVGYY 443
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMN----WDTRVAIAIGAARGLEYLHEA 347
S R + LL +E +PNG+L L G L G+N WDTR+ IA+ AARGL YLHE
Sbjct: 444 SS-RDS-SQHLLCYELVPNGSLEAWLHGPL--GLNCPLDWDTRMKIALDAARGLAYLHED 499
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
+ P ++HRD K+SNILL+ N NAK+ D G+AK+ +G + S+ R+ GTFGY APEY
Sbjct: 500 SQPSVIHRDFKASNILLENNFNAKVADFGLAKQAP-EGRGNHLST--RVMGTFGYVAPEY 556
Query: 408 AMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPD 467
AM G + SDV+S+GVVLLEL+TGR+P+ S G+E+LV W P L+D + EL D
Sbjct: 557 AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWTRPVLRDKDR-LEELVD 615
Query: 468 PRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
RL+G +PKE+ + +A C+ + RPTM EVVQ L +
Sbjct: 616 SRLEGKYPKEDFIRVCTIAAACVAPEASQRPTMGEVVQSLKMV 658
|
|
| TAIR|locus:2028756 PERK10 "proline-rich extensin-like receptor kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 642 (231.1 bits), Expect = 6.9e-63, P = 6.9e-63
Identities = 144/303 (47%), Positives = 192/303 (63%)
Query: 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
FSY L AT+ FS N++G+GG VY+G L D R+VAVK+ K GG D F EVD
Sbjct: 418 FSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGG-QGDREFKAEVD 476
Query: 275 MLSRLHHCHVVPLVGYC-SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAI 333
+SR+HH +++ +VGYC SE R RLL+++++PN NL L G++W TRV I
Sbjct: 477 TISRVHHRNLLSMVGYCISENR-----RLLIYDYVPNNNLYFHLHAAGTPGLDWATRVKI 531
Query: 334 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS- 392
A GAARGL YLHE PRI+HRDIKSSNILL+ N +A ++D G+AK L D C++
Sbjct: 532 AAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAK-LALD----CNTHI 586
Query: 393 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 452
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ S G+ESLV WA
Sbjct: 587 TTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWAR 646
Query: 453 PRLQDSGTV--ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
P L ++ + L DP+L ++ EM M A C++ RP MS++V+ ++
Sbjct: 647 PLLSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVRAFDSL 706
Query: 511 APD 513
A +
Sbjct: 707 AEE 709
|
|
| TAIR|locus:2026925 PERK9 "proline-rich extensin-like receptor kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 634 (228.2 bits), Expect = 4.8e-62, P = 4.8e-62
Identities = 145/325 (44%), Positives = 200/325 (61%)
Query: 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
FSY L AT+ FS N++G+GG VY+G L DGR+VAVK+ K GG D F EV+
Sbjct: 365 FSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGG-QGDREFKAEVE 423
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 334
LSR+HH H+V +VG+C G R RLL+++++ N +L L G ++W TRV IA
Sbjct: 424 TLSRIHHRHLVSIVGHC--ISGDR--RLLIYDYVSNNDLYFHLHGEK-SVLDWATRVKIA 478
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS-P 393
GAARGL YLHE PRI+HRDIKSSNILL++N +A+++D G+A RL D C++
Sbjct: 479 AGAARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLA-RLALD----CNTHIT 533
Query: 394 ARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 453
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ S G+ESLV WA P
Sbjct: 534 TRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWARP 593
Query: 454 RLQDSGTV--ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511
+ + L DP+L G++ + EM M A C++ RP M ++V+ ++A
Sbjct: 594 LISHAIETEEFDSLADPKLGGNYVESEMFRMIEAAGACVRHLATKRPRMGQIVRAFESLA 653
Query: 512 PDKSRRRNISLNLFQIFSAGGMEKE 536
+ + L ++F++ E
Sbjct: 654 AE-DLTNGMRLGESEVFNSAQQSAE 677
|
|
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 632 (227.5 bits), Expect = 7.9e-62, P = 7.9e-62
Identities = 141/298 (47%), Positives = 183/298 (61%)
Query: 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
FSY L T FS N++G+GG VY+G L+DGR VAVK+ K GG + F EV+
Sbjct: 327 FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKI-GGSQGEREFKAEVE 385
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 334
++SR+HH H+V LVGYC RLLV++++PN L L M W+TRV +A
Sbjct: 386 IISRVHHRHLVTLVGYCIS----EQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVA 441
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 394
GAARG+ YLHE PRI+HRDIKSSNILLD + A + D G+AK + L + S+
Sbjct: 442 AGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVST-- 499
Query: 395 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 454
R+ GTFGY APEYA G+ S +DV+S+GV+LLELITGR+P+ S G+ESLV WA P
Sbjct: 500 RVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPL 559
Query: 455 LQDS--GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
L + EL DPRL +F EM M A C++ RP MS+VV+ L T+
Sbjct: 560 LGQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTL 617
|
|
| TAIR|locus:2019938 PERK11 "proline-rich extensin-like receptor kinase 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 630 (226.8 bits), Expect = 1.3e-61, P = 1.3e-61
Identities = 150/333 (45%), Positives = 200/333 (60%)
Query: 213 IRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTE 272
I F+Y L T+ F S +VG+GG VY+G L +G+ VA+K+ K+ F E
Sbjct: 356 IHFTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYRE-FKAE 414
Query: 273 VDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA 332
V+++SR+HH H+V LVGYC R L++EF+PN L L G + + W RV
Sbjct: 415 VEIISRVHHRHLVSLVGYCIS----EQHRFLIYEFVPNNTLDYHLHGKNLPVLEWSRRVR 470
Query: 333 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS 392
IAIGAA+GL YLHE P+I+HRDIKSSNILLD+ A++ D G+A RL D S S+
Sbjct: 471 IAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLA-RLN-DTAQSHIST 528
Query: 393 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 452
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ S GEESLV WA
Sbjct: 529 --RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWAR 586
Query: 453 PRLQDS---GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 509
PRL ++ G ISE+ DPRL+ D+ + E+ M A C++ RP M +VV+ L T
Sbjct: 587 PRLIEAIEKGD-ISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRALDT 645
Query: 510 IAPDKSRRRN-ISLNLFQIFSAGGMEKEPSIER 541
D S N + + +++ +G E I R
Sbjct: 646 -RDDLSDLTNGVKVGQSRVYDSGQYSNEIRIFR 677
|
|
| TAIR|locus:2038992 ALE2 "Abnormal Leaf Shape 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 630 (226.8 bits), Expect = 1.3e-61, P = 1.3e-61
Identities = 136/300 (45%), Positives = 190/300 (63%)
Query: 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
F+ S LE ATD+FS ++G+GG VY+G + DG VAVK T+ N D F+ EV+
Sbjct: 337 FTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVKLL-TRDNQNRDREFIAEVE 395
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAI 333
MLSRLHH ++V L+G C E R R L++E + NG++ L EG ++WD R+ I
Sbjct: 396 MLSRLHHRNLVKLIGICIEGR----TRCLIYELVHNGSVESHLH----EGTLDWDARLKI 447
Query: 334 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP 393
A+GAARGL YLHE + PR++HRD K+SN+LL+++ K++D G+A+ +G S+
Sbjct: 448 ALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREA-TEGSQHIST-- 504
Query: 394 ARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 453
R+ GTFGY APEYAM G + SDV+S+GVVLLEL+TGR+P+ S GEE+LV WA P
Sbjct: 505 -RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWARP 563
Query: 454 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 513
L + + +L DP L G + ++M +A +A C+ + RP M EVVQ L I D
Sbjct: 564 LLANREG-LEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQALKLIYND 622
|
|
| TAIR|locus:2099009 AT3G58690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 630 (226.8 bits), Expect = 1.3e-61, P = 1.3e-61
Identities = 142/329 (43%), Positives = 203/329 (61%)
Query: 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
F++ L AT FS SN+VG GG VYRG L DGR VA+K G + F EV+
Sbjct: 75 FTFKQLHSATGGFSKSNVVGNGGFGLVYRGVLNDGRKVAIK-LMDHAGKQGEEEFKMEVE 133
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-----DGVLVEGMNWDT 329
+LSRL +++ L+GYCS+ + +LLV+EFM NG L++ L G + ++W+T
Sbjct: 134 LLSRLRSPYLLALLGYCSD----NSHKLLVYEFMANGGLQEHLYLPNRSGSVPPRLDWET 189
Query: 330 RVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 389
R+ IA+ AA+GLEYLHE +P ++HRD KSSNILLD N NAK++D G+AK + +D
Sbjct: 190 RMRIAVEAAKGLEYLHEQVSPPVIHRDFKSSNILLDRNFNAKVSDFGLAK-VGSDKAGGH 248
Query: 390 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 449
S+ R+ GT GY APEYA+ G + SDV+S+GVVLLEL+TGR P+ GE LV
Sbjct: 249 VST--RVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPVDMKRATGEGVLVS 306
Query: 450 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 509
WA P+L D V+ ++ DP L+G + +E+ +A +A C+Q + D RP M++VVQ +
Sbjct: 307 WALPQLADRDKVV-DIMDPTLEGQYSTKEVVQVAAIAAMCVQAEADYRPLMADVVQ---S 362
Query: 510 IAPDKSRRRNISLNLFQIFSAGGMEKEPS 538
+ P RR+ S L S+ + + P+
Sbjct: 363 LVPLVRNRRSAS-KLSGCSSSFSLARSPN 390
|
|
| UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)] | Back alignment and assigned GO terms |
|---|
Score = 619 (223.0 bits), Expect = 1.9e-60, P = 1.9e-60
Identities = 137/296 (46%), Positives = 185/296 (62%)
Query: 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
F+Y L AT+ FS +N++GQGG YV++G L G+ VAVK+ K G + F EV+
Sbjct: 263 FTYEELARATNGFSEANLLGQGGFGYVHKGVLPSGKEVAVKQLKVGSG-QGEREFQAEVE 321
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 334
++SR+HH H+V LVGYC G A RLLV+EF+PN NL L G M W TR+ IA
Sbjct: 322 IISRVHHRHLVSLVGYC--IAG--AKRLLVYEFVPNNNLELHLHGEGRPTMEWSTRLKIA 377
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 394
+G+A+GL YLHE P+I+HRDIK+SNIL+D AK+ D G+AK + +D S+
Sbjct: 378 LGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAK-IASDTNTHVST--- 433
Query: 395 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP- 453
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ + ++SLV WA P
Sbjct: 434 RVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPL 493
Query: 454 --RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507
R + G L D ++ + +EEM M A C++ RP MS++V+ L
Sbjct: 494 LNRASEQGD-FEGLADAKMNNGYDREEMARMVACAAACVRHSARRRPRMSQIVRAL 548
|
|
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 617 (222.3 bits), Expect = 3.1e-60, P = 3.1e-60
Identities = 135/296 (45%), Positives = 185/296 (62%)
Query: 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
F+Y L AT+ FS +N++GQGG YV++G L G+ VAVK+ K G + F EV+
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSG-QGEREFQAEVE 326
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 334
++SR+HH H+V L+GYC G RLLV+EF+PN NL L G M W TR+ IA
Sbjct: 327 IISRVHHRHLVSLIGYC--MAG--VQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIA 382
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 394
+G+A+GL YLHE P+I+HRDIK+SNIL+D AK+ D G+AK + +D S+
Sbjct: 383 LGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAK-IASDTNTHVST--- 438
Query: 395 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP- 453
R+ GTFGY APEYA G+ + SDVFSFGVVLLELITGR+P+ + ++SLV WA P
Sbjct: 439 RVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPL 498
Query: 454 --RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507
R + G L D ++ ++ +EEM M A C++ RP MS++V+ L
Sbjct: 499 LNRASEEGD-FEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRAL 553
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8VYY5 | NCRK_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5165 | 0.8670 | 0.9699 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.14 | LOW CONFIDENCE prediction! |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 632 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-49 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-46 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-43 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-43 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-42 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-40 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-39 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-30 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-27 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-25 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-25 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-23 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-23 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-22 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-21 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-20 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-18 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-17 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 8e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-16 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-15 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-12 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-09 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 7e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-05 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 6e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.001 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.001 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.001 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.001 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.002 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.002 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 5e-49
Identities = 78/278 (28%), Positives = 119/278 (42%), Gaps = 66/278 (23%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G+GG VY + G+ VA+K K + + L E+++L +L+H ++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 351
+ LV E+ G+L+D L ++ D + I + GLEYLH
Sbjct: 61 EDENH----LYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLHSN---G 112
Query: 352 ILHRDIKSSNILLDE-NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE-YAM 409
I+HRD+K NILLD N K+ D G++K L +D + + GT Y APE
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-----IVGTPAYMAPEVLLG 167
Query: 410 VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 469
G S SD++S GV+L EL P L+D
Sbjct: 168 KGYYSEKSDIWSLGVILYEL-----------------------PELKD------------ 192
Query: 470 LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507
L ++ LQ DP+ RP+ E+++ L
Sbjct: 193 ---------------LIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 2e-46
Identities = 96/282 (34%), Positives = 130/282 (46%), Gaps = 39/282 (13%)
Query: 232 IVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVG 289
+G G VY+ + G+IVAVK K + D E+ +L RL H ++V L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG--MNWDTRVAIAIGAARGLEYLHEA 347
F K + LV E+ G+L D L G ++ D IA+ RGLEYLH
Sbjct: 66 A---FEDKDHL-YLVMEYCEGGDLFD----YLSRGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ-GTFGYFAPE 406
I+HRD+K NILLDEN KI D G+AK SSS GT Y APE
Sbjct: 118 ---GIIHRDLKPENILLDENGVVKIADFGLAK------KLLKSSSSLTTFVGTPWYMAPE 168
Query: 407 YAMVGR-ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 465
+ G DV+S GV+L EL+TG+ P ++ + D +I +
Sbjct: 169 VLLGGNGYGPKVDVWSLGVILYELLTGKPP--------------FSGENILDQLQLIRRI 214
Query: 466 PDPRLKGDFPK--EEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
P L+ D PK + L K+CL DP RPT E++Q
Sbjct: 215 LGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 6e-44
Identities = 86/283 (30%), Positives = 128/283 (45%), Gaps = 55/283 (19%)
Query: 241 VYRGQLTDG-----RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 295
VY+G L VAVK K FL E ++ +L H ++V L+G C+E
Sbjct: 15 VYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-- 72
Query: 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHR 355
+ M +V E+MP G+L D L + ++ ++ A+ ARG+EYL +HR
Sbjct: 73 EEPLM--IVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHR 127
Query: 356 DIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSSPARMQGTFGYFAPEYAMVGRA 413
D+ + N L+ ENL KI+D G+++ L D P R + APE G+
Sbjct: 128 DLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR------WMAPESLKEGKF 181
Query: 414 SLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWATPRLQDSGTVISE 464
+ SDV+SFGV+L E+ T G +P + + KG RL
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGY---------RL--------P 224
Query: 465 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507
P + P E + L +C DP+ RPT SE+V+IL
Sbjct: 225 KPP-----NCPPE----LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 6e-43
Identities = 78/289 (26%), Positives = 118/289 (40%), Gaps = 57/289 (19%)
Query: 231 NIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
+G+G VY + G++VA+K K + L E+ +L +L H ++V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGA--ARGLEYLH 345
E K + V E+ G+L D L G L E A LEYLH
Sbjct: 65 VF-EDEDKLYL---VMEYCEGGDLFDLLKKRGRLSE------DEARFYLRQILSALEYLH 114
Query: 346 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 405
I+HRD+K NILLDE+ + K+ D G+A++L + GT Y AP
Sbjct: 115 SK---GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT------TFVGTPEYMAP 165
Query: 406 EYAMVGRASLMSDVFSFGVVLLELITGRQP---------IHRSITKGEESLVLWATPRLQ 456
E + D++S GV+L EL+TG+ P + + I K +
Sbjct: 166 EVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKP----------- 214
Query: 457 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
P P + D E ++ ++ L DP+ R T E +Q
Sbjct: 215 ---------PFPPPEWDISPEAKDLI----RKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 6e-43
Identities = 85/286 (29%), Positives = 123/286 (43%), Gaps = 62/286 (21%)
Query: 241 VYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 295
VY+G+L VAVK K FL E ++ +L H +VV L+G C+E
Sbjct: 15 VYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTE-- 72
Query: 296 GKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 352
+V E+M G+L L L + ++ A+ ARG+EYL
Sbjct: 73 --EEPLYIVMEYMEGGDLLSYLRKNRPKL----SLSDLLSFALQIARGMEYLESK---NF 123
Query: 353 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSSPARMQGTFGYFAPEYAMV 410
+HRD+ + N L+ ENL KI+D G+++ L D P R + APE
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR------WMAPESLKE 177
Query: 411 GRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWATPRLQDSGTV 461
G+ + SDV+SFGV+L E+ T G QP + + G RL
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGY---------RL------ 222
Query: 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507
P + P E +M +C DP+ RPT SE+V+IL
Sbjct: 223 --PQPP-----NCPPELYDLM----LQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 2e-42
Identities = 87/302 (28%), Positives = 130/302 (43%), Gaps = 66/302 (21%)
Query: 231 NIVGQG--GSSYVYRGQLTDG----RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 284
+G+G G VY+G+L VAVK K FL E ++ +L H +V
Sbjct: 1 KKLGEGAFGE--VYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNV 58
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNL-------RDCLDGVLVEGMNWDTRVAIAIGA 337
V L+G C+E LV E+M G+L R ++ ++ AI
Sbjct: 59 VRLLGVCTE----EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI 114
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS---PA 394
A+G+EYL + +HRD+ + N L+ E+L KI+D G+++ + D + P
Sbjct: 115 AKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPI 171
Query: 395 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEE 445
R + APE G + SDV+SFGV+L E+ T G P + + KG
Sbjct: 172 R------WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY- 224
Query: 446 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
RL P+ P E ++M C QLDP+ RPT SE+V+
Sbjct: 225 --------RL--------PKPE-----YCPDELYELM----LSCWQLDPEDRPTFSELVE 259
Query: 506 IL 507
L
Sbjct: 260 RL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 146 bits (372), Expect = 5e-40
Identities = 88/298 (29%), Positives = 131/298 (43%), Gaps = 71/298 (23%)
Query: 234 GQG--GSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
G+G G VY+G L VAVK K FL E ++ +L H ++V
Sbjct: 8 GEGAFGE--VYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEY 343
L+G C++ G+ +V E+MP G+L D L L + +A+ A+G+EY
Sbjct: 66 LLGVCTQ--GEPLY--IVTEYMPGGDLLDFLRKHGEKL----TLKDLLQMALQIAKGMEY 117
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
L +HRD+ + N L+ ENL KI+D G+++ + D R +G G
Sbjct: 118 LESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDY-------YRKRGG-GKL 166
Query: 404 -----APEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVL 449
APE G+ + SDV+SFGV+L E+ T G QP + + G
Sbjct: 167 PIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGY----- 221
Query: 450 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507
RL PR + P E ++M +C DP+ RPT SE+V+ L
Sbjct: 222 ----RL------------PRPENC-PDELYELM----LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 7e-39
Identities = 81/282 (28%), Positives = 120/282 (42%), Gaps = 38/282 (13%)
Query: 231 NIVGQGGSSYVYRGQLTD-GRIVAVK--RFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
++G+G VY D G ++AVK +++ E+ +LS L H ++V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEAL-EREIRILSSLQHPNIVRY 64
Query: 288 VGYCSEFRGKRAMRLLVF-EFMPNGNLRDCLD--GVLVEGMNWDTRV-AIAIGAARGLEY 343
G R + L +F E++ G+L L G L E + R I GL Y
Sbjct: 65 YGSE---RDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV---IRKYTRQI--LEGLAY 116
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
LH I+HRDIK +NIL+D + K+ D G AKRL + S ++GT +
Sbjct: 117 LHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGS---VRGTPYWM 170
Query: 404 APEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463
APE +D++S G ++E+ TG+ P G L+ + I
Sbjct: 171 APEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSE---LGNPMAALYKIGSSGEP-PEIP 226
Query: 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
E K DF L K CL+ DP RPT E++Q
Sbjct: 227 EHLSEEAK-DF----------LRK-CLRRDPKKRPTADELLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 77/277 (27%), Positives = 121/277 (43%), Gaps = 44/277 (15%)
Query: 233 VGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G+GG VY+ G+ VA+K K + + + + E+ +L + H ++V Y
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKI-INEIQILKKCKHPNIVKY--YG 64
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 351
S + +V EF G+L+D L + + + +GLEYLH
Sbjct: 65 SYLKKDELW--IVMEFCSGGSLKDLLKS-TNQTLTESQIAYVCKELLKGLEYLHSN---G 118
Query: 352 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR--MQGTFGYFAPEYAM 409
I+HRDIK++NILL + K+ D G++ +L S + AR M GT + APE
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQL--------SDTKARNTMVGTPYWMAPEVIN 170
Query: 410 VGRASLMSDVFSFGVVLLELITGRQPIHRS-ITKGEESLVLWAT---PRLQDSGTVISEL 465
+D++S G+ +EL G+ P K L AT P L++ E
Sbjct: 171 GKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA---LFKIATNGPPGLRN-----PEK 222
Query: 466 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 502
K DF K+CLQ +P+ RPT +
Sbjct: 223 WSDEFK-DF-----------LKKCLQKNPEKRPTAEQ 247
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 84/295 (28%), Positives = 131/295 (44%), Gaps = 32/295 (10%)
Query: 230 SNIVGQG--GSSYVYRGQLTD---GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 284
+G+G G + R G VAVK G S F E+++L L H ++
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 344
V G E G R++RL + E++P+G+LRD L + +N + + +G++YL
Sbjct: 69 VKYKG-VCEKPGGRSLRL-IMEYLPSGSLRDYLQR-HRDQINLKRLLLFSSQICKGMDYL 125
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG----LPSCSSSPARMQGTF 400
R +HRD+ + NIL++ KI+D G+AK L D + SP
Sbjct: 126 GSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF----- 177
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460
++APE + S SDV+SFGV L EL T P E L + + Q T
Sbjct: 178 -WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPA---EFLRMIGIAQGQMIVT 233
Query: 461 VISEL--PDPRLK--GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511
+ EL RL P E +M K C + +P RP+ ++++ I+ +
Sbjct: 234 RLLELLKEGERLPRPPSCPDEVYDLM----KLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 3e-29
Identities = 95/396 (23%), Positives = 149/396 (37%), Gaps = 39/396 (9%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRL-HHCHVVPLVG 289
+G+G VY + D ++VA+K + + V FL E+ +L+ L H ++V L
Sbjct: 8 LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAIAIGAARGLEYLHEAA 348
+ + LV E++ G+L D L + +G ++ + I LEYLH
Sbjct: 66 FFQDEGSL----YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK- 120
Query: 349 APRILHRDIKSSNILLDENLN-AKITDLGMAKRLKADGLPSCSSSPARMQ-GTFGYFAPE 406
I+HRDIK NILLD + K+ D G+AK L G S + GT GY APE
Sbjct: 121 --GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 407 YAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463
+ + AS SD++S G+ L EL+TG P S L +I
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL----------KIIL 228
Query: 464 ELPDPRLKGDFPKEEMQIMAYLAKE----CLQLDPDARPTMSEVVQI-------LSTIAP 512
ELP P L ++++ A + L DP R + S + L
Sbjct: 229 ELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDL 288
Query: 513 DKSRRRNISLNLFQIFSAGGMEKEPSIERPDNLFETLIESEELKKATSFGSPRCSQAVDT 572
+ + S L S+ L + + S ++
Sbjct: 289 SDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNS 348
Query: 573 DITLNTRSNSKEEDTVSTEYMEKLLLLTSEVRSSRA 608
L + ++SK L+S R +
Sbjct: 349 SSLLLSTASSKRSSLPKISARSSPSSLSSSSRQQAS 384
|
Length = 384 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 83/278 (29%), Positives = 130/278 (46%), Gaps = 38/278 (13%)
Query: 234 GQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG-YC 291
GQG S VY+ + G+I A+K+ G L E+ L +VV G +
Sbjct: 10 GQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY 69
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNWDTRVA-IAIGAARGLEYLHEAA 348
E G+ + +V E+M G+L D L G + E + +A IA +GL+YLH
Sbjct: 70 KE--GEIS---IVLEYMDGGSLADLLKKVGKIPEPV-----LAYIARQILKGLDYLHTKR 119
Query: 349 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYA 408
I+HRDIK SN+L++ KI D G++K L + L C++ GT Y +PE
Sbjct: 120 --HIIHRDIKPSNLLINSKGEVKIADFGISKVL-ENTLDQCNTF----VGTVTYMSPE-R 171
Query: 409 MVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPD 467
+ G + S +D++S G+ LLE G+ P + +Q I + P
Sbjct: 172 IQGESYSYAADIWSLGLTLLECALGKFPF-----LPPGQPSFFEL--MQ----AICDGPP 220
Query: 468 PRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
P L + E + +++ CLQ DP RP+ +E++Q
Sbjct: 221 PSLPAEEFSPEFR--DFISA-CLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 75/281 (26%), Positives = 124/281 (44%), Gaps = 44/281 (15%)
Query: 226 KFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHHCH 283
+ +++G+G VY+G L G VA+K+ + + E+D+L L H +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAA-RG 340
+V +G ++ ++ E+ NG+LR + G E + VA+ + +G
Sbjct: 61 IVKYIGS---IETSDSL-YIILEYAENGSLRQIIKKFGPFPE-----SLVAVYVYQVLQG 111
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
L YLHE ++HRDIK++NIL ++ K+ D G+A +L S GT
Sbjct: 112 LAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV-----VGTP 163
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460
+ APE + AS SD++S G ++EL+TG P + L
Sbjct: 164 YWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYY----------------DLNPMAA 207
Query: 461 V--ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT 499
+ I + P L E + +L +C Q DP+ RPT
Sbjct: 208 LFRIVQDDHPPLPEGISPE---LKDFL-MQCFQKDPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 79/298 (26%), Positives = 130/298 (43%), Gaps = 55/298 (18%)
Query: 233 VGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
+G+G V+ G+ D +VAVK K +A F E ++L+ H ++V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-----DGVLVEGMNWDTR-------VAIA 334
G C+E G + +VFE+M +G+L L D ++ + + IA
Sbjct: 73 FYGVCTE--GDPPI--MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 394
+ A G+ YL A+ +HRD+ + N L+ +L KI D GM++ + ++
Sbjct: 129 VQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVY-------TTDYY 178
Query: 395 RMQGT----FGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVL 449
R+ G + PE M + + SDV+SFGVVL E+ T G+QP + ++ E +
Sbjct: 179 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWY-GLSNEEVIECI 237
Query: 450 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507
G + L PR P E IM C + DP R + ++ + L
Sbjct: 238 -------TQGRL---LQRPR---TCPSEVYDIM----LGCWKRDPQQRINIKDIHERL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 83/275 (30%), Positives = 124/275 (45%), Gaps = 39/275 (14%)
Query: 249 GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 308
G +VAVK K + G S + E+++L L+H ++V G CSE GK L+ E++
Sbjct: 33 GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK--GLQLIMEYV 90
Query: 309 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL 368
P G+LRD L +N + A G+ YLH + +HRD+ + N+LLD +
Sbjct: 91 PLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDR 144
Query: 369 NAKITDLGMAK---------RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDV 419
KI D G+AK R++ DG SP ++A E + S SDV
Sbjct: 145 LVKIGDFGLAKAVPEGHEYYRVREDG-----DSPVF------WYAVECLKENKFSYASDV 193
Query: 420 FSFGVVLLELITGRQPIHRSITKGEESL----VLWATPRLQDSGTVISELPDPRLKGDFP 475
+SFGV L EL+T K EE + RL + LP P+ + P
Sbjct: 194 WSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPK---NCP 250
Query: 476 KEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
+E +M K C + + RPT ++ IL +
Sbjct: 251 QEVYILM----KNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 81/298 (27%), Positives = 117/298 (39%), Gaps = 64/298 (21%)
Query: 230 SNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQ-GGPNADSVFLTEVDMLSRLHHCHVVPL 287
N +G G VY L G ++AVK + Q P E+ +L L H ++V
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV-- 62
Query: 288 VGYCSEFRGKRAMR--LLVF-EFMPNGNLRDCLDGVLVEGMNWDTRV--AIAIGAARGLE 342
++ G R + +F E+ G L + +L G D V + GL
Sbjct: 63 -----KYYGVEVHREKVYIFMEYCSGGTLEE----LLEHGRILDEHVIRVYTLQLLEGLA 113
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
YLH I+HRDIK +NI LD N K+ D G A +LK + + GT Y
Sbjct: 114 YLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT-MGEEVQSLAGTPAY 169
Query: 403 FAPE------YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA----- 451
APE GRA +D++S G V+LE+ TG++P + +
Sbjct: 170 MAPEVITGGKGKGHGRA---ADIWSLGCVVLEMATGKRPWSELDNE-------FQIMFHV 219
Query: 452 ----TPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
P +PD K+ CL+ DP RPT SE++Q
Sbjct: 220 GAGHKP----------PIPDSLQLSPEGKD-------FLDRCLESDPKKRPTASELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 77/275 (28%), Positives = 131/275 (47%), Gaps = 28/275 (10%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
+G+G VY+G L VAVK ++ P+ FL E ++L + H ++V L+G C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 352
+ + +V E +P G+L L + + +++ AA G+EYL +
Sbjct: 63 Q----KQPIYIVMELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLE---SKNC 114
Query: 353 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR 412
+HRD+ + N L+ EN KI+D GM+ R + G+ + S Q + APE GR
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMS-REEEGGIYTVSD--GLKQIPIKWTAPEALNYGR 171
Query: 413 ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKG 472
+ SDV+S+G++L E + + ++ + T +SG +P P+L
Sbjct: 172 YTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-------TRERIESG---YRMPAPQL-- 219
Query: 473 DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507
P+E ++M +C DP+ RP+ SE+ L
Sbjct: 220 -CPEEIYRLM----LQCWAYDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 83/290 (28%), Positives = 129/290 (44%), Gaps = 59/290 (20%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
+G+G V G G+ VAVK K A + FL E +++ L H ++V L+G
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTA-AQA-FLAEASVMTTLRHPNLVQLLGVV- 69
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 352
+G +V E+M G+L D L + ++ A+ G+EYL E
Sbjct: 70 -LQGNPLY--IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NF 123
Query: 353 LHRDIKSSNILLDENLNAKITDLGMAK--RLKADG--LPSCSSSPARMQGTFGYFAPEYA 408
+HRD+ + N+L+ E+L AK++D G+AK D LP + APE
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP------------VKWTAPEAL 171
Query: 409 MVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPR--LQDSGTVIS-- 463
+ S SDV+SFG++L E+ + GR P PR L+D +
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPY----------------PRIPLKDVVPHVEKG 215
Query: 464 ---ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
E P+ P E ++M K+C +LDP RPT ++ + L+ I
Sbjct: 216 YRMEAPE-----GCPPEVYKVM----KDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 89/272 (32%), Positives = 127/272 (46%), Gaps = 42/272 (15%)
Query: 234 GQGGSSYVYRGQLTDGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
G G V+ G VAVK K G P A FL E ++ +L H +V L C
Sbjct: 15 GAGQFGEVWMGTWNGTTKVAVKTLK-PGTMSPEA---FLQEAQIMKKLRHDKLVQLYAVC 70
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCL-DGVLVEG--MNWDTRVAIAIGAARGLEYLHEAA 348
SE +V E+M G+L D L G EG + V +A A G+ YL
Sbjct: 71 SE----EEPIYIVTEYMSKGSLLDFLKSG---EGKKLRLPQLVDMAAQIAEGMAYLESR- 122
Query: 349 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYA 408
+HRD+ + NIL+ ENL KI D G+A+ ++ D + + ++ T APE A
Sbjct: 123 --NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAA 176
Query: 409 MVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPD 467
GR ++ SDV+SFG++L E++T GR P + +T E VL R G +P
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVP-YPGMTNRE---VLEQVER----GY---RMPR 225
Query: 468 PRLKGDFPKEEMQIMAYLAKECLQLDPDARPT 499
P + P+E +M +C DP+ RPT
Sbjct: 226 PP---NCPEELYDLM----LQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 6e-25
Identities = 80/282 (28%), Positives = 119/282 (42%), Gaps = 36/282 (12%)
Query: 221 EHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH 280
E ++F+ +G G V+ G + VA+K K+ F EV L RL
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQD-FQKEVQALKRLR 60
Query: 281 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA--A 338
H H++ L CS ++ E M G+L L EG I + A
Sbjct: 61 HKHLISLFAVCSVGEPV----YIITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVA 114
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD-GLPSCSSSPARMQ 397
G+ YL E +HRD+ + NIL+ E+L K+ D G+A+ +K D L S P +
Sbjct: 115 EGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK-- 169
Query: 398 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 457
+ APE A G S SDV+SFG++L E+ T Q + + E
Sbjct: 170 ----WTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE-------VYDQIT 218
Query: 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT 499
+G +P P P+E +IM EC +P+ RP+
Sbjct: 219 AGY---RMPCP---AKCPQEIYKIM----LECWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 8e-25
Identities = 78/285 (27%), Positives = 126/285 (44%), Gaps = 40/285 (14%)
Query: 227 FSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHHCHV 284
F N +G+G V++ + D R+ A+K+ + + E +L++L ++
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 344
+ Y F K + + V E+ NG+L L + D I GL +L
Sbjct: 62 IR---YYESFLDKGKLNI-VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHL 117
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQGTFGYF 403
H + +ILHRDIKS N+ LD N KI DLG+AK L S +++ A + GT Y
Sbjct: 118 H---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL------SDNTNFANTIVGTPYYL 168
Query: 404 APEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463
+PE + SDV++ GVVL E TG+ P + G +I
Sbjct: 169 SPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD-----------------ANNQGALIL 211
Query: 464 ELPDPRLKGDFP---KEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
++ ++G FP + Q +A L +CL D RP ++++
Sbjct: 212 KI----IRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 82/295 (27%), Positives = 130/295 (44%), Gaps = 58/295 (19%)
Query: 231 NIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
++G G V RG+L VA+K K FLTE ++ + H +++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG---MNWDTRVAIAIGAARGLEY 343
L G + + + M ++ E+M NG LD L E V + G A G++Y
Sbjct: 70 LEGVVT--KSRPVM--IITEYMENG----SLDKFLRENDGKFTVGQLVGMLRGIASGMKY 121
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK-ADGLPSCSS--SPARMQGTF 400
L E +HRD+ + NIL++ NL K++D G+++RL+ ++ + P R
Sbjct: 122 LSEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR----- 173
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSG 459
+ APE + + SDV+SFG+V+ E+++ G +P W QD
Sbjct: 174 -WTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERP-------------YWDMSN-QD-- 216
Query: 460 TVISE------LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508
VI LP P D P Q+M +C Q D + RPT S++V L
Sbjct: 217 -VIKAVEDGYRLPPPM---DCPSALYQLM----LDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 72/291 (24%), Positives = 124/291 (42%), Gaps = 60/291 (20%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVF-LTEVDMLSRLHHCHVVPLVGY 290
+G+G VY + +DG++ +K + L EV +L +L+H +++ Y
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNII---KY 64
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG--------MNWDTRVAIAIGAARGLE 342
F K + +V E+ G+L + EG ++W ++ +A L+
Sbjct: 65 YESFEEKGKL-CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA------LK 117
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
YLH +ILHRDIK NI L N K+ D G++K L + + + + GT Y
Sbjct: 118 YLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST-VDLAKT----VVGTPYY 169
Query: 403 FAPE------YAMVGRASLMSDVFSFGVVLLELITGRQPI-HRSITKGEESLVLWATPRL 455
+PE Y + SD++S G VL EL T + P ++ L L
Sbjct: 170 LSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHPFEGENL----LELAL------ 213
Query: 456 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506
++ P + + E + L LQ DP+ RP++++++Q
Sbjct: 214 ----KILKGQYPP-IPSQYSSE----LRNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 68/227 (29%), Positives = 112/227 (49%), Gaps = 37/227 (16%)
Query: 233 VGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
+G+G VY+G+LT VA+K K P F E +++S L H ++V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------------DGVLVEGMNWDTRVA 332
L+G C+ K ++FE++ +G+L + L D + ++ +
Sbjct: 73 LLGVCT----KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 333 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL-KAD--GLPSC 389
IAI A G+EYL ++ +HRD+ + N L+ E L KI+D G+++ + AD + S
Sbjct: 129 IAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 390 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
S P R + PE + G+ + SD++SFGVVL E+ + G QP
Sbjct: 186 SLLPVR------WMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 4e-23
Identities = 75/314 (23%), Positives = 121/314 (38%), Gaps = 74/314 (23%)
Query: 231 NIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRLHHCHVVPLV 288
+G+G VY+ + G +VA+K+ + + + + E+ +L +L H ++V L
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 289 G-YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR-------- 339
S+ +G M VFE+M + D L G+L V +
Sbjct: 65 EIVTSKGKGSIYM---VFEYMDH----D-LTGLLDS-----PEVKFTESQIKCYMKQLLE 111
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
GL+YLH ILHRDIK SNIL++ + K+ D G+A+ ++ R+ T
Sbjct: 112 GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN---RVI-T 164
Query: 400 FGYFAPE-------YAMVGRASLMSDVFSFGVVLLELITGRQPIHR-------------- 438
Y PE Y G D++S G +L EL G+ PI +
Sbjct: 165 LWYRPPELLLGATRY---GPE---VDMWSVGCILAELFLGK-PIFQGSTELEQLEKIFEL 217
Query: 439 --SITK----GEESLVLWATPRLQDS-GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQ 491
S T G L + + + + E K + L + L
Sbjct: 218 CGSPTDENWPGVSKLPWFENLKPKKPYKRRLRE----FFKHLIDPSALD----LLDKLLT 269
Query: 492 LDPDARPTMSEVVQ 505
LDP R + + +Q
Sbjct: 270 LDPKKRISADQALQ 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 4e-23
Identities = 82/270 (30%), Positives = 121/270 (44%), Gaps = 36/270 (13%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
+G G V+ G + VAVK K G FL E ++ +L H ++ L C+
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKP--GTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 352
+V E M G+L + L G + + +A A G+ YL A
Sbjct: 72 ----LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNY 124
Query: 353 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYAMV 410
+HRD+ + N+L+ EN K+ D G+A+ +K D AR F + APE A+
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKED------IYEAREGAKFPIKWTAPEAALY 178
Query: 411 GRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 469
R S+ SDV+SFG++L E++T GR P + +T E VL + +P P
Sbjct: 179 NRFSIKSDVWSFGILLTEIVTYGRMP-YPGMTNAE---VLQQVDQGY-------RMPCPP 227
Query: 470 LKGDFPKEEMQIMAYLAKECLQLDPDARPT 499
PKE IM +C + DPD RPT
Sbjct: 228 ---GCPKELYDIML----DCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 5e-23
Identities = 84/264 (31%), Positives = 123/264 (46%), Gaps = 29/264 (10%)
Query: 249 GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 308
G +VAVK+ + F E+++L L H ++V G C G+R +RL V E++
Sbjct: 33 GEVVAVKKLQ-HSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS-AGRRNLRL-VMEYL 89
Query: 309 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL 368
P G+LRD L E ++ + A +G+EYL + R +HRD+ + NIL++
Sbjct: 90 PYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYL---GSKRYVHRDLATRNILVESEN 145
Query: 369 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLE 428
KI D G+ K L D P + ++APE + S+ SDV+SFGVVL E
Sbjct: 146 RVKIGDFGLTKVLPQDKEYYKVREPG--ESPIFWYAPESLTESKFSVASDVWSFGVVLYE 203
Query: 429 LIT----GRQP---IHRSI--TKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEM 479
L T P R + K + +V L+++G LP P P E
Sbjct: 204 LFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNG----RLPAPP---GCPAEIY 256
Query: 480 QIMAYLAKECLQLDPDARPTMSEV 503
IM KEC DP RP+ SE+
Sbjct: 257 AIM----KECWNNDPSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 5e-23
Identities = 75/296 (25%), Positives = 128/296 (43%), Gaps = 58/296 (19%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 282
+ + +G+G S VY+ G+ VA+K+ + + + + E+ ++ H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK--QNKELIINEILIMKDCKHP 75
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA-RGL 341
++V +V E+M G+L D + V MN + ++A +GL
Sbjct: 76 NIVDYYD-SYLVGD---ELWVVMEYMDGGSLTDIITQNFVR-MN-EPQIAYVCREVLQGL 129
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
EYLH + ++HRDIKS NILL ++ + K+ D G A +L + S + GT
Sbjct: 130 EYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-----SKRNSVVGTPY 181
Query: 402 YFAPEYAMVGRASLMS---DVFSFGVVLLELITG-----RQPIHRSI----TKGEESLVL 449
+ APE V + D++S G++ +E+ G R+P R++ TKG
Sbjct: 182 WMAPE---VIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKG------ 232
Query: 450 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
P L++ E D +L K CL DP+ RP+ E++Q
Sbjct: 233 --IPPLKNPEKWSPEFKD----------------FLNK-CLVKDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 7e-23
Identities = 78/283 (27%), Positives = 116/283 (40%), Gaps = 32/283 (11%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
+K + +G+G V + +L G I A+K T P+ L E+++ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA--IAIGAARGL 341
+V G + + + E+ G+L V G +V IA +GL
Sbjct: 61 IVKYYGAFLD--ESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGL 118
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
YLH +I+HRDIK SNILL K+ D G++ L +S GT
Sbjct: 119 SYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGEL-------VNSLAGTFTGTSF 168
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461
Y APE S+ SDV+S G+ LLE+ R P +GE L + +
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF---PPEGEPPLGPI------ELLSY 219
Query: 462 ISELPDPRLKGDFPKEEMQI-----MAYLAKECLQLDPDARPT 499
I +P+P LK + I K+CL+ DP RPT
Sbjct: 220 IVNMPNPELKDE---PGNGIKWSEEFKDFIKQCLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 8e-23
Identities = 80/308 (25%), Positives = 127/308 (41%), Gaps = 51/308 (16%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKT-QGGPNADSVFLTEVDMLSRLHHC 282
+K+ +VG+G V + + G IVA+K+FK + + L EV +L +L H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 283 HVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 341
++V L +R RL LVFE++ L + L+ G+ D + + +
Sbjct: 61 NIVNLKEAF-----RRKGRLYLVFEYVER-TLLELLE-ASPGGLPPDAVRSYIWQLLQAI 113
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
Y H + I+HRDIK NIL+ E+ K+ D G A+ L+A + A T
Sbjct: 114 AYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA----TRW 166
Query: 402 YFAPE----YAMVGRASLMSDVFSFGVVLLELITGR---------------QPIHRSITK 442
Y APE G+ DV++ G ++ EL+ G Q +
Sbjct: 167 YRAPELLVGDTNYGKP---VDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPP 223
Query: 443 GEESLVLWATPRLQDSGTVISELPDP-----RLKGDFPKEEMQIMAYLAKECLQLDPDAR 497
+ L + PR +G E P R G + + K CL++DP R
Sbjct: 224 SHQEL-FSSNPRF--AGVAFPEPSQPESLERRYPGKVSSPALDFL----KACLRMDPKER 276
Query: 498 PTMSEVVQ 505
T E++Q
Sbjct: 277 LTCDELLQ 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 82/309 (26%), Positives = 132/309 (42%), Gaps = 72/309 (23%)
Query: 232 IVGQGGSSYVYRGQLT-DGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
++G G VY+G +G VA+K + + P A+ L E +++ + H HVV
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNL-------RDCLDGVLVEGMNWDTRVAIAIGAAR 339
L+G C + L+ + MP G L +D + + +NW ++A +
Sbjct: 74 LLGICL---SSQVQ--LITQLMPLGCLLDYVRNHKDNIGSQYL--LNWCVQIA------K 120
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG---LPSCSSSPARM 396
G+ YL E R++HRD+ + N+L+ + KITD G+AK L D P +
Sbjct: 121 GMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK- 176
Query: 397 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESL 447
+ A E + + SDV+S+GV + EL+T G +P I + KGE
Sbjct: 177 -----WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE--- 228
Query: 448 VLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507
LP P P + + L K C +D ++RPT E++
Sbjct: 229 ----------------RLPQP------PICTIDVYMVLVK-CWMIDAESRPTFKELINEF 265
Query: 508 STIAPDKSR 516
S +A D R
Sbjct: 266 SKMARDPQR 274
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 75/265 (28%), Positives = 110/265 (41%), Gaps = 41/265 (15%)
Query: 252 VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNG 311
VAVK K + FL E ++++L H +V L+G C K +LV E P G
Sbjct: 26 VAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC-----KGEPLMLVMELAPLG 80
Query: 312 NLRDCLDG----VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 367
L L + + +VA G+ YL +HRD+ + N+LL
Sbjct: 81 PLLKYLKKRREIPVSDLKELAHQVA------MGMAYLESK---HFVHRDLAARNVLLVNR 131
Query: 368 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYAMVGRASLMSDVFSFGVV 425
AKI+D GM++ L A A G + ++APE G+ S SDV+S+GV
Sbjct: 132 HQAKISDFGMSRALGAGS----DYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVT 187
Query: 426 LLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYL 485
L E + + + KG E + + +SG LP P P+E IM
Sbjct: 188 LWEAFSYGAKPYGEM-KGAEVI------AMLESG---ERLPRPEE---CPQEIYSIM--- 231
Query: 486 AKECLQLDPDARPTMSEVVQILSTI 510
C + P+ RPT SE+
Sbjct: 232 -LSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 82/285 (28%), Positives = 119/285 (41%), Gaps = 57/285 (20%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
G G S V + G+I+AVK + + L E+D+L H C+ +VG+
Sbjct: 10 GAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDIL---HKCNSPYIVGFYG 66
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNW-DTRV--AIAIGAARGLEYLHEAAA 349
F + + + E+M G LD +L E R+ IA+ +GL YLHE
Sbjct: 67 AFYNNGDISICM-EYMDGG----SLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH- 120
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRL---KADGLPSCSS--SPARMQGTFGYFA 404
+I+HRD+K SNIL++ K+ D G++ +L A SS +P R+QG Y
Sbjct: 121 -KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGN-DY-- 176
Query: 405 PEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 464
S+ SD++S G+ L+EL TGR P P +
Sbjct: 177 ---------SVKSDIWSLGLSLIELATGRFPY---------------PPENDPPDGIFEL 212
Query: 465 L------PDPRL-KGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 502
L P PRL G F + CL DP RP+ E
Sbjct: 213 LQYIVNEPPPRLPSGKFSPD----FQDFVNLCLIKDPRERPSYKE 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 2e-21
Identities = 86/278 (30%), Positives = 127/278 (45%), Gaps = 37/278 (13%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
+GQG V+ G VA+K K G FL E ++ +L H +VPL S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKP--GTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 352
E +V EFM G+L D L + + V +A A G+ Y+
Sbjct: 72 E-----EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NY 123
Query: 353 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYAMV 410
+HRD++++NIL+ +NL KI D G+A RL D + AR F + APE A+
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLA-RLIED-----NEYTARQGAKFPIKWTAPEAALY 177
Query: 411 GRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 469
GR ++ SDV+SFG++L EL+T GR P + + V + G +P P+
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV--------ERGY---RMPCPQ 226
Query: 470 LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507
P+ ++M K C + DPD RPT + L
Sbjct: 227 ---GCPESLHELM----KLCWKKDPDERPTFEYIQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 3e-21
Identities = 74/226 (32%), Positives = 109/226 (48%), Gaps = 36/226 (15%)
Query: 270 LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNW 327
LTE ++LSR++H +V L + + F+ + + LV E+ P G L L G E
Sbjct: 41 LTERNILSRINHPFIVKL--HYA-FQTEEKL-YLVLEYAPGGELFSHLSKEGRFSEE--- 93
Query: 328 DTRVAIA-IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386
R A I A LEYLH I++RD+K NILLD + + K+TD G+AK L ++G
Sbjct: 94 RARFYAAEIVLA--LEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG- 147
Query: 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHR 438
++ GT Y APE + D +S GV+L E++TG+ P I+
Sbjct: 148 SRTNT----FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYE 203
Query: 439 SITKGEESLVLWATPRLQDSGTVISEL----PDPRLKGDFPKEEMQ 480
I K + +P +D +IS L P RL G EE++
Sbjct: 204 KILKDPLRFPEFLSPEARD---LISGLLQKDPTKRL-GSGGAEEIK 245
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 4e-21
Identities = 83/311 (26%), Positives = 120/311 (38%), Gaps = 83/311 (26%)
Query: 233 VGQGGSSYVYRGQL-------TDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCH 283
+GQG VY G + R VA+K + FL E ++ + H
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETR-VAIK--TVNENASMRERIEFLNEASVMKEFNCHH 70
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL----------DGV----LVEGMNWDT 329
VV L+G S G+ + +V E M G+L+ L G+ L + +
Sbjct: 71 VVRLLGVVS--TGQPTL--VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM-- 124
Query: 330 RVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RL 381
A A G+ YL + +HRD+ + N ++ E+L KI D GM + R
Sbjct: 125 ----AAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177
Query: 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSI 440
GL P R + APE G + SDV+SFGVVL E+ T QP
Sbjct: 178 GGKGL-----LPVR------WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY---- 222
Query: 441 TKG---EESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDAR 497
+G EE L + G + D P+ + L + C Q +P R
Sbjct: 223 -QGLSNEEVL------KFVIDGGHL----------DLPENCPDKLLELMRMCWQYNPKMR 265
Query: 498 PTMSEVVQILS 508
PT E+V L
Sbjct: 266 PTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 5e-21
Identities = 79/287 (27%), Positives = 122/287 (42%), Gaps = 58/287 (20%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRLHHCHVVPLVG 289
G+G VY+ + L+D + A+K D+V E+ +L+ ++H +++
Sbjct: 9 GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV--NEIRILASVNHPNII---S 63
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNL------RDCLDGVLVEGMNWDTRVAIAIGAARGLEY 343
Y F + +V E+ P G+L R ++ E W I I RGL+
Sbjct: 64 YKEAFLDGNKL-CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR----IFIQLLRGLQA 118
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ-GTFGY 402
LHE +ILHRD+KS+NILL N KI DLG++K LK + A+ Q GT Y
Sbjct: 119 LHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLK--------KNMAKTQIGTPHY 167
Query: 403 FAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461
APE GR S SD++S G +L E+ T P
Sbjct: 168 MAPE-VWKGRPYSYKSDIWSLGCLLYEMATFAPPFE---------------------ARS 205
Query: 462 ISELPDPRLKGDFPK---EEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
+ +L +G +P Q + + LQ+ P RP +++
Sbjct: 206 MQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 6e-21
Identities = 89/313 (28%), Positives = 150/313 (47%), Gaps = 63/313 (20%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHC 282
+K+ +VG+G V + + + G+IVA+K+F +++ + + E+ ML +L H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 283 HVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDC------LDGVLVEGMNWDTRVAIAI 335
++V L+ +R RL LVFEF+ + L D LD V +
Sbjct: 61 NLVNLIEVF-----RRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQI------ 109
Query: 336 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 395
RG+E+ H + I+HRDIK NIL+ ++ K+ D G A+ L A G + A
Sbjct: 110 --LRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTDYVA- 162
Query: 396 MQGTFGYFAPEYAM----VGRASLMSDVFSFGVVLLELITGRQP----------IHRSIT 441
T Y APE + GRA D+++ G ++ E++TG +P ++ I
Sbjct: 163 ---TRWYRAPELLVGDTKYGRA---VDIWAVGCLVTEMLTG-EPLFPGDSDIDQLYH-II 214
Query: 442 KGEESLVLWATPRLQD--------SGTVISELPDPR-LKGDFPKEEMQIMAYLAKECLQL 492
K +L PR Q+ +G + E+ + L+ FPK ++ LAK+CL++
Sbjct: 215 KCLGNL----IPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLS-GLVLDLAKQCLRI 269
Query: 493 DPDARPTMSEVVQ 505
DPD RP+ S+++
Sbjct: 270 DPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 78/288 (27%), Positives = 118/288 (40%), Gaps = 46/288 (15%)
Query: 233 VGQGGSSYVYRGQLTD--GRI--VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLV 288
+G G V RG+ + G++ VAVK K+ + FL E ++ L H +++ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 289 GYCSEFRGKRAMRLLVFEFMPNGNLRDCL----DGVLVEGMNWDTRVAIAIGAARGLEYL 344
G M +V E P G+L D L G + D V IA G+ YL
Sbjct: 63 GVV---LTHPLM--MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA----NGMRYL 113
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 404
R +HRD+ + NILL + KI D G+ + L + ++ F + A
Sbjct: 114 ESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE--DHYVMEEHLKVPFAWCA 168
Query: 405 PEYAMVGRASLMSDVFSFGVVLLELIT-GRQP-IHRSITKGEESL--VLWATPRLQDSGT 460
PE S SDV+ FGV L E+ T G +P S G + L + RL
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS---GSQILKKIDKEGERL----- 220
Query: 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508
E P+ P++ +M +C +P RPT + + + L
Sbjct: 221 ---ERPE-----ACPQDIYNVM----LQCWAHNPADRPTFAALREFLP 256
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 84/270 (31%), Positives = 122/270 (45%), Gaps = 37/270 (13%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
+G G V+ G VAVK K G + FL E ++ +L H +V L S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKP--GTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 352
E +V E+M G+L D L + V +A A G+ Y+
Sbjct: 72 E-----EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NY 123
Query: 353 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYAMV 410
+HRD++S+NIL+ + L KI D G+A RL D + AR F + APE A+
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLA-RLIED-----NEYTARQGAKFPIKWTAPEAALY 177
Query: 411 GRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 469
GR ++ SDV+SFG++L EL+T GR P + + E VL R +P P
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVP-YPGMNNRE---VLEQVERGY-------RMPCP- 225
Query: 470 LKGDFPKEEMQIMAYLAKECLQLDPDARPT 499
D P ++M +C + DP+ RPT
Sbjct: 226 --QDCPISLHELML----QCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 2e-20
Identities = 70/206 (33%), Positives = 103/206 (50%), Gaps = 19/206 (9%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
+GQG V+ G VA+K K G + FL E ++ +L H +V L S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 352
E +V E+M G+L D L G + + + V +A A G+ Y+
Sbjct: 72 E-----EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NY 123
Query: 353 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYAMV 410
+HRD++++NIL+ ENL K+ D G+A RL D + AR F + APE A+
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLA-RLIED-----NEYTARQGAKFPIKWTAPEAALY 177
Query: 411 GRASLMSDVFSFGVVLLELIT-GRQP 435
GR ++ SDV+SFG++L EL T GR P
Sbjct: 178 GRFTIKSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 79/282 (28%), Positives = 121/282 (42%), Gaps = 38/282 (13%)
Query: 231 NIVGQGGSSYVYRGQ-LTDGRIVAVKRFK-TQGGPNADSVFLTEVDMLSRLHHCHVVPLV 288
++G G ++ VY L + VA+KR + + D + EV +S+ +H +VV
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDEL-RKEVQAMSQCNHPNVVKY- 64
Query: 289 GYCSEFRGKRAMRLLVFEFMPNGNLRDCL-----DGVLVEGMNWDTRVAIAIGAARGLEY 343
Y S F + LV ++ G+L D + G L E + +GLEY
Sbjct: 65 -YTS-FVVGDEL-WLVMPYLSGGSLLDIMKSSYPRGGLDE----AIIATVLKEVLKGLEY 117
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR--MQGTFG 401
LH +HRDIK+ NILL E+ + KI D G++ L G + R GT
Sbjct: 118 LHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGG---DRTRKVRKTFVGTPC 171
Query: 402 YFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460
+ APE +D++SFG+ +EL TG P + + L+L LQ+
Sbjct: 172 WMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSK--YPPMKVLML----TLQNDP- 224
Query: 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 502
L + K ++++ CLQ DP RPT E
Sbjct: 225 --PSLETGADYKKYSKSFRKMIS----LCLQKDPSKRPTAEE 260
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 59/172 (34%), Positives = 79/172 (45%), Gaps = 23/172 (13%)
Query: 270 LTEVDMLSRLHHCHVVP-LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMN 326
L E +L L+H P LV F+ + M LV + + G+LR L E
Sbjct: 48 LNERRILQELNH----PFLVNLWYSFQDEENM-YLVVDLLLGGDLRYHLSQKVKFSEEQ- 101
Query: 327 WDTRVAIA-IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 385
+ I I A LEYLH I+HRDIK NILLDE + ITD +A ++ D
Sbjct: 102 --VKFWICEIVLA--LEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154
Query: 386 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
L + +S GT GY APE S+ D +S GV E + G++P
Sbjct: 155 LTTSTS------GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYR 200
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 3e-20
Identities = 78/287 (27%), Positives = 122/287 (42%), Gaps = 55/287 (19%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
+G G V+ G+ VA+K + +G + D F+ E ++ +L H ++V L G C+
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR-EGAMSEDD-FIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
+ R +V E+M NG L + L G L G W + + +EYL
Sbjct: 70 KQRPIF----IVTEYMANGCLLNYLRERKGKL--GTEWLLDMCSDV--CEAMEYLESNG- 120
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT---FGYFAPE 406
+HRD+ + N L+ E+ K++D G+A R D + S QGT + PE
Sbjct: 121 --FIHRDLAARNCLVGEDNVVKVSDFGLA-RYVLDDQYTSS------QGTKFPVKWAPPE 171
Query: 407 YAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTV--IS 463
R S SDV+SFGV++ E+ + G+ P R +S V +S
Sbjct: 172 VFDYSRFSSKSDVWSFGVLMWEVFSEGKMPY----------------ERFSNSEVVESVS 215
Query: 464 E---LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507
L P+L P E IM C P+ RP +++ L
Sbjct: 216 AGYRLYRPKLA---PTEVYTIM----YSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 81/304 (26%), Positives = 125/304 (41%), Gaps = 54/304 (17%)
Query: 234 GQGGS-SYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
G GGS S V + G ++A K + L E+ ++ H C +V +
Sbjct: 16 GNGGSVSKVKH--IPTGTVMAKKVVHIGAKSSVRKQILRELQIM---HECRSPYIVSFYG 70
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG--MNWDTRVAIAIGAARGLEYLHEAAAP 350
F + + + EFM G+L D + +G + + IA+ GL YL+
Sbjct: 71 AFLNENNI-CMCMEFMDCGSL----DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH-- 123
Query: 351 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV 410
RI+HRDIK SNIL++ K+ D G++ L +S GT Y +PE
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSGEL-------INSIADTFVGTSTYMSPERIQG 176
Query: 411 GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV--------- 461
G+ ++ SDV+S G+ ++EL G+ P +A + D G
Sbjct: 177 GKYTVKSDVWSLGISIIELALGKFP--------------FAFSNIDDDGQDDPMGILDLL 222
Query: 462 --ISELPDPRL-KGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRR 518
I + P PRL DFP + + CL DP RPT ++ + I R
Sbjct: 223 QQIVQEPPPRLPSSDFP----EDLRDFVDACLLKDPTERPTPQQLCAMPPFI--QALRAS 276
Query: 519 NISL 522
N+ L
Sbjct: 277 NVDL 280
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 5e-20
Identities = 89/288 (30%), Positives = 127/288 (44%), Gaps = 56/288 (19%)
Query: 233 VGQGGSSYVYRG-QLTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
+G G VY G L DG AVK Q G A E+ +LS+L H ++V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 288 VGYCSEFRGKRAMRLLVF-EFMPNGNLRDCLD--GVLVEGM--NWDTRVAIAIGAARGLE 342
+G E L +F E +P G+L L G E + + TR + GLE
Sbjct: 68 LGTERE-----EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLY-TRQILL-----GLE 116
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA-DGLPSCSSSPARMQGTFG 401
YLH +HRDIK +NIL+D N K+ D GMAK++ S SP M
Sbjct: 117 YLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWM----- 168
Query: 402 YFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460
APE G L +D++S G +LE+ TG+ P + E ++ R ++
Sbjct: 169 --APEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL----EGVAAVFKIGRSKE--- 219
Query: 461 VISELPD---PRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
+ +PD K DF I+ +CLQ DP RPT +E+++
Sbjct: 220 -LPPIPDHLSDEAK-DF------IL-----KCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 6e-20
Identities = 82/299 (27%), Positives = 132/299 (44%), Gaps = 45/299 (15%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTDG-----RIVAVKRFKTQGGPNADSVFLTEVDMLSRL 279
D+ + S+++ +G ++ G L D V VK K ++ L E +L L
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65
Query: 280 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNL----RDCLDGVLVEGMNWDTR--VAI 333
H +++P++ C E +++ +M GNL + C G T+ V +
Sbjct: 66 SHQNILPILHVCIEDGEPP---FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHM 122
Query: 334 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL---KADGLPSCS 390
AI A G+ YLH+ ++H+DI + N ++DE L KITD +++ L L
Sbjct: 123 AIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE 179
Query: 391 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVL 449
+ P + + A E + S SDV+SFGV+L EL+T G+ P + I E + L
Sbjct: 180 NRPVK------WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP-YVEIDPFEMAAYL 232
Query: 450 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508
RL P E +MA C LDP+ RP+ S++VQ L+
Sbjct: 233 KDGYRLAQPINC-------------PDELFAVMAC----CWALDPEERPSFSQLVQCLT 274
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 8e-20
Identities = 75/282 (26%), Positives = 132/282 (46%), Gaps = 43/282 (15%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
+G G V+ G + R VA+K + G ++ F+ E ++ +L H +V L G C+
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIRE--GAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
E R+ LVFEFM +G L D L G + +T + + + G+ YL +
Sbjct: 70 E----RSPICLVFEFMEHGCLSDYLRAQRGKFSQ----ETLLGMCLDVCEGMAYLESSN- 120
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PARMQGTFGYFAPEY 407
++HRD+ + N L+ EN K++D GM + + D S + + P + + +PE
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK------WSSPEV 172
Query: 408 AMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 466
+ S SDV+SFGV++ E+ + G+ P + + + E + A RL
Sbjct: 173 FSFSKYSSKSDVWSFGVLMWEVFSEGKTP-YENRSNSEVVETINAGFRLY---------- 221
Query: 467 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508
PRL + ++M + C + P+ RP+ S ++ L+
Sbjct: 222 KPRLA---SQSVYELMQH----CWKERPEDRPSFSLLLHQLA 256
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 8e-20
Identities = 75/210 (35%), Positives = 107/210 (50%), Gaps = 23/210 (10%)
Query: 237 GSSYVYRGQLTDGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 294
G ++ + + T G I A+K K N LTE D+LS+ +VV L Y S F
Sbjct: 7 GRVFLAKKKST-GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL--YYS-F 62
Query: 295 RGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIA-IGAARGLEYLHEAAAPR 351
+GK+ + LV E++P G+L L+ G L E + R+ IA I A LEYLH
Sbjct: 63 QGKKNL-YLVMEYLPGGDLASLLENVGSLDEDV---ARIYIAEIVLA--LEYLHSNG--- 113
Query: 352 ILHRDIKSSNILLDENLNAKITDLGMAK---RLKADGLPSCSSSPARMQGTFGYFAPEYA 408
I+HRD+K NIL+D N + K+TD G++K + L R+ GT Y APE
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE-V 172
Query: 409 MVGRA-SLMSDVFSFGVVLLELITGRQPIH 437
++G+ S D +S G +L E + G P H
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVGIPPFH 202
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 9e-20
Identities = 66/218 (30%), Positives = 97/218 (44%), Gaps = 22/218 (10%)
Query: 233 VGQGGSSYVYRGQLTD-GRIVAVK-----RFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
+G+GG V Q+ G++ A K R K + G + + L E +L ++ +V
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKG---EQMALNEKKILEKVSSRFIVS 57
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE 346
L Y E + LV M G+L+ + V G + A GLE+LH+
Sbjct: 58 L-AYAFETKDDLC---LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ 113
Query: 347 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 406
RI++RD+K N+LLD++ N +I+DLG+A LK GT GY APE
Sbjct: 114 R---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG------GKKIKGRAGTPGYMAPE 164
Query: 407 YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 444
D F+ G L E+I GR P + K E
Sbjct: 165 VLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 1e-19
Identities = 75/288 (26%), Positives = 133/288 (46%), Gaps = 30/288 (10%)
Query: 231 NIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
N++ +G Y+G+ + +G VK + +S+ +E+ + +L H ++V L+G
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVKEIN-----DVNSIPSSEIADMGKLQHPNIVKLIG 750
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
C +G L+ E++ NL + L ++W+ R IAIG A+ L +LH +
Sbjct: 751 LCRSEKGA----YLIHEYIEGKNLSEVL-----RNLSWERRRKIAIGIAKALRFLHCRCS 801
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 409
P ++ ++ I++D + L + L D SS+ Y APE
Sbjct: 802 PAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA---------YVAPETRE 851
Query: 410 VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 469
+ SD++ FG++L+EL+TG+ P S+V WA R S + DP
Sbjct: 852 TKDITEKSDIYGFGLILIELLTGKSPADAE-FGVHGSIVEWA--RYCYSDCHLDMWIDPS 908
Query: 470 LKGDFPKEEMQIMAY--LAKECLQLDPDARPTMSEVVQILSTIAPDKS 515
++GD + +I+ LA C DP ARP ++V++ L + + S
Sbjct: 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956
|
Length = 968 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 78/296 (26%), Positives = 132/296 (44%), Gaps = 57/296 (19%)
Query: 233 VGQGGSSYVYRGQL-----TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
+G+ +Y+G L ++VA+K K P F E +++ LHH ++V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---------------DGVLVEGMNWDTRVA 332
+G ++ ++FE++ G+L + L DG + ++ +
Sbjct: 73 LGVVTQ----EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 333 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS 392
IAI A G+EYL ++ +H+D+ + NIL+ E L+ KI+DLG+++ + S+
Sbjct: 129 IAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIY-------SAD 178
Query: 393 PARMQGT----FGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESL 447
R+Q + PE M G+ S SD++SFGVVL E+ + G QP + +E +
Sbjct: 179 YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG--FSNQEVI 236
Query: 448 VLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV 503
+ +L LP D P M L EC Q P RP ++
Sbjct: 237 EMVRKRQL---------LPCSE---DCPPR----MYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 3e-19
Identities = 76/278 (27%), Positives = 133/278 (47%), Gaps = 39/278 (14%)
Query: 232 IVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
I+G+G V +G+ T G+ VAVK K A FL E ++++LHH ++V L+G
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 351
G +V E M GNL + L ++ + ++ A G+EYL + +
Sbjct: 69 LH-NGLY----IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKK 120
Query: 352 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG 411
++HRD+ + NIL+ E+ AK++D G+A R+ + G+ + S P + + APE
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLA-RVGSMGVDN-SKLPVK------WTAPEALKHK 172
Query: 412 RASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRL 470
+ S SDV+S+GV+L E+ + GR P P++ S + E +
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGRAPY----------------PKM--SLKEVKECVEKGY 214
Query: 471 KGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508
+ + P+ + L C + +P RP+ ++ + L
Sbjct: 215 RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 4e-19
Identities = 79/289 (27%), Positives = 120/289 (41%), Gaps = 39/289 (13%)
Query: 231 NIVGQGGSSYVYRGQLTDG----RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
++G+G VY G L D AVK FL E ++ H +V+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIG--AARGLEYL 344
L+G C G L+V +M +G+LR+ + E N + I G A+G+EYL
Sbjct: 61 LLGICLPSEG---SPLVVLPYMKHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYL 114
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT---FG 401
A+ + +HRD+ + N +LDE+ K+ D G+A+ D S G
Sbjct: 115 ---ASKKFVHRDLAARNCMLDESFTVKVADFGLAR----DIYDKEYYSVHNHTGAKLPVK 167
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461
+ A E + + SDV+SFGV+L EL+T P + + + ++ L R
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR------- 220
Query: 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
L P D E M C P+ RPT SE+V + I
Sbjct: 221 ---LLQPEYCPDPLYEVML-------SCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 6e-19
Identities = 81/280 (28%), Positives = 128/280 (45%), Gaps = 33/280 (11%)
Query: 233 VGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G+G V+ G+L D VAVK + P+ + FL E +L + H ++V L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI--GAARGLEYLHEAAA 349
++ K+ + +V E + G D L + EG + I + AA G+EYL +
Sbjct: 63 TQ---KQPI-YIVMELVQGG---DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---S 112
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 409
+HRD+ + N L+ E KI+D GM+ R + DG+ +S+ Q + APE
Sbjct: 113 KHCIHRDLAARNCLVTEKNVLKISDFGMS-REEEDGV--YASTGGMKQIPVKWTAPEALN 169
Query: 410 VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 469
GR S SDV+SFG++L E+ L A P S E +
Sbjct: 170 YGRYSSESDVWSFGILLW-----------------EAFSLGAVPYANLSNQQTREAIEQG 212
Query: 470 LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 509
++ P+ + L + C + DP RP+ S V Q L +
Sbjct: 213 VRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 8e-19
Identities = 82/298 (27%), Positives = 136/298 (45%), Gaps = 50/298 (16%)
Query: 232 IVGQGGSSYVYRG-QLTDGRIV----AVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
++G G VY+G + +G V A+K GP A+ F+ E +++ + H H+V
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNL-------RDCLDGVLVEGMNWDTRVAIAIGAAR 339
L+G C LV + MP+G L +D + L+ +NW ++A +
Sbjct: 74 LLGVCLS-----PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLL--LNWCVQIA------K 120
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
G+ YL E R++HRD+ + N+L+ + KITD G+A+ L+ D ++ +M
Sbjct: 121 GMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE-KEYNADGGKM--P 174
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 458
+ A E + + SDV+S+GV + EL+T G +P T+ P L +
Sbjct: 175 IKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--------EIPDLLEK 226
Query: 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSR 516
G LP P P + + + K C +D D+RP E+ S +A D R
Sbjct: 227 G---ERLPQP------PICTIDVYMVMVK-CWMIDADSRPKFKELAAEFSRMARDPQR 274
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 72/279 (25%), Positives = 121/279 (43%), Gaps = 35/279 (12%)
Query: 236 GGSSY--VYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
GG Y VY G VAVK K + FL E ++ + H ++V L+G C+
Sbjct: 15 GGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 352
+ ++ EFM GNL D L + +N + +A + +EYL
Sbjct: 73 ----REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 125
Query: 353 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR 412
+HRD+ + N L+ EN K+ D G+++ + D ++ A + + APE +
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWTAPESLAYNK 181
Query: 413 ASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLK 471
S+ SDV++FGV+L E+ T G P + L + EL + +
Sbjct: 182 FSIKSDVWAFGVLLWEIATYGMSP--------------YPGIDLSQ----VYELLEKGYR 223
Query: 472 GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
+ P+ + L + C Q +P RP+ +E+ Q T+
Sbjct: 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 4e-18
Identities = 73/278 (26%), Positives = 127/278 (45%), Gaps = 37/278 (13%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
+G G V+ G VA+K K G + FL E +++ +L H +V L +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQ--GSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 352
+ ++ E+M NG+L D L + + + +A A G+ ++
Sbjct: 72 -----QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NY 123
Query: 353 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYAMV 410
+HRD++++NIL+ E L KI D G+A+ ++ + AR F + APE
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDN------EYTAREGAKFPIKWTAPEAINY 177
Query: 411 GRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 469
G ++ SDV+SFG++L E++T GR P + +T E V+ R +P P
Sbjct: 178 GTFTIKSDVWSFGILLTEIVTYGRIP-YPGMTNPE---VIQNLERGY-------RMPRPD 226
Query: 470 LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507
+ P+E ++M + C + P+ RPT + +L
Sbjct: 227 ---NCPEELYELM----RLCWKEKPEERPTFEYLRSVL 257
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 5e-18
Identities = 71/271 (26%), Positives = 129/271 (47%), Gaps = 29/271 (10%)
Query: 249 GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 308
G VAVK K + G N + E+++L L+H ++V G C+E G ++L + EF+
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE-DGGNGIKL-IMEFL 90
Query: 309 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL 368
P+G+L++ L +N ++ A+ +G++YL + + +HRD+ + N+L++
Sbjct: 91 PSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEH 146
Query: 369 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLE 428
KI D G+ K ++ D + + ++APE + + + SDV+SFGV L E
Sbjct: 147 QVKIGDFGLTKAIETD--KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYE 204
Query: 429 LIT----GRQPIHRSI-----TKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEM 479
L+T P+ + T G+ ++ RL LP P + P+E
Sbjct: 205 LLTYCDSESSPMTLFLKMIGPTHGQMTVT-----RLVRVLEEGKRLPRP---PNCPEEVY 256
Query: 480 QIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
Q+M ++C + P R T +++ I
Sbjct: 257 QLM----RKCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 5e-18
Identities = 74/283 (26%), Positives = 123/283 (43%), Gaps = 40/283 (14%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKT--QGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
+G+G S VY+ L DGR+VA+K+ + A L E+D+L +L H +V+
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIK--- 66
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCL------DGVLVEGMNWDTRVAIAIGAARGLEY 343
Y + F + +V E G+L + ++ E W V + LE+
Sbjct: 67 YLASFI-ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC----SALEH 121
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
+H RI+HRDIK +N+ + K+ DLG+ + + + S + GT Y
Sbjct: 122 MHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-----LVGTPYYM 173
Query: 404 APEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463
+PE + SD++S G +L E+ + P G++ L I
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-----YGDKM-------NLYSLCKKIE 221
Query: 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506
+ P L D EE++ L C+ DP+ RP +S V+Q+
Sbjct: 222 KCDYPPLPADHYSEELR---DLVSRCINPDPEKRPDISYVLQV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 5e-18
Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 38/230 (16%)
Query: 232 IVGQGGSSYVYRGQL-TDGRIVAVK----RFKTQGGPNADSVFLTEVDMLSRL-HHCHVV 285
I+G+G S V + + A+K R + V E ++L+RL H ++
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEK-KVKYVK-IEKEVLTRLNGHPGII 65
Query: 286 PLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA--ARGLE 342
L Y + F+ + L V E+ PNG L L + G + D + A LE
Sbjct: 66 KL--YYT-FQDEE--NLYFVLEYAPNGEL---LQYIRKYG-SLDEKCTRFYAAEILLALE 116
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS--------CSSSPA 394
YLH I+HRD+K NILLD++++ KITD G AK L + P S
Sbjct: 117 YLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 395 RMQGTFGYF-------APEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
+ + F F +PE A SD+++ G ++ +++TG+ P
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 6e-18
Identities = 75/308 (24%), Positives = 125/308 (40%), Gaps = 70/308 (22%)
Query: 232 IVGQGGSSYVYRGQLT--DGRI--VAVKRFKTQGGPNAD-SVFLTEVDMLSRLHHCHVVP 286
I+G+G V GQL+ DG VAVK K ++ FL+E + H +V+
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 287 LVGYC--SEFRGKRAMRLLVFEFMPNGNLRDCL----DGVLVEGMNWDTRVAIAIGAARG 340
L+G C + K +++ FM +G+L L G L E + T + + A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
+EYL + +HRD+ + N +L E++ + D G++K++
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKI------------------- 163
Query: 401 GYFAPEYAMVGRASLM------------------SDVFSFGVVLLELITGRQPIHRSITK 442
++ +Y GR + M SDV++FGV + E+ T Q + +
Sbjct: 164 --YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN 221
Query: 443 GEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 502
E L RL+ + EL D L C + DP RPT ++
Sbjct: 222 HEIYDYLRHGNRLKQPEDCLDELYD-----------------LMYSCWRADPKDRPTFTK 264
Query: 503 VVQILSTI 510
+ ++L I
Sbjct: 265 LREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 6e-18
Identities = 66/201 (32%), Positives = 101/201 (50%), Gaps = 20/201 (9%)
Query: 232 IVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
++G+G V++G L D VAVK K FL+E +L + H ++V L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 292 SEFRGKRAMRLLVFEFMPNGN----LRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 347
++ R +V E +P G+ LR D + + + V A+ AA G+ YL
Sbjct: 62 TQ----RQPIYIVMELVPGGDFLSFLRKKKDELKTKQL-----VKFALDAAAGMAYLE-- 110
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
+ +HRD+ + N L+ EN KI+D GM+ R + DG+ SS Q + APE
Sbjct: 111 -SKNCIHRDLAARNCLVGENNVLKISDFGMS-RQEDDGI---YSSSGLKQIPIKWTAPEA 165
Query: 408 AMVGRASLMSDVFSFGVVLLE 428
GR S SDV+S+G++L E
Sbjct: 166 LNYGRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 7e-18
Identities = 85/293 (29%), Positives = 129/293 (44%), Gaps = 44/293 (15%)
Query: 233 VGQGGSSYVYRGQLTDGRIVA---VKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
+G G V G+ G A VK + P+ +FL EV L+H +V+ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGM-NWDTRVAIAIGAARGLEYLHE 346
C E LLV EF P G+L++ L + +V M D +A A GL +LH+
Sbjct: 63 QCIE----SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118
Query: 347 AAAPRILHRDIKSSNILLDENLNAKITDLGMA-KRLKADGLPS--CSSSPARMQGTFGYF 403
A +H D+ N L +L+ KI D G+A ++ D + C + P R +
Sbjct: 119 A---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR------WL 169
Query: 404 APEYAMVGRASLM-------SDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRL 455
APE + L+ S+++S GV + EL T QP + VL R
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP----YPDLSDEQVLKQVVRE 225
Query: 456 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508
QD +LP P+L + ++M + C LDP+ RPT EV ++L+
Sbjct: 226 QD-----IKLPKPQLDLKYSDRWYEVMQF----CW-LDPETRPTAEEVHELLT 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 86/288 (29%), Positives = 124/288 (43%), Gaps = 70/288 (24%)
Query: 248 DGRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 305
D +VAVK K P A F E ++L+ L H H+V G C G ++VF
Sbjct: 34 DKMLVAVKALKD---PTLAARKDFQREAELLTNLQHEHIVKFYGVC----GDGDPLIMVF 86
Query: 306 EFMPNGNLRDCLDG------VLVEG--------MNWDTRVAIAIGAARGLEYLHEAAAPR 351
E+M +G+L L +LV+G + + IA A G+ YL A+
Sbjct: 87 EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQH 143
Query: 352 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG----TFGYFAPEY 407
+HRD+ + N L+ NL KI D GM++ + S+ R+ G + PE
Sbjct: 144 FVHRDLATRNCLVGANLLVKIGDFGMSRDVY-------STDYYRVGGHTMLPIRWMPPES 196
Query: 408 AMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISE-- 464
M + + SDV+SFGV+L E+ T G+QP W Q S T + E
Sbjct: 197 IMYRKFTTESDVWSFGVILWEIFTYGKQP--------------W----FQLSNTEVIECI 238
Query: 465 -----LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507
L PR+ PKE IM C Q +P R + E+ +IL
Sbjct: 239 TQGRVLERPRV---CPKEVYDIML----GCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-18
Identities = 84/296 (28%), Positives = 133/296 (44%), Gaps = 59/296 (19%)
Query: 233 VGQGGSSYVYRGQL------TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
+G+G V+ + D +VAVK K + +A F E ++L+ L H H+V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQREAELLTVLQHQHIVR 71
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-----DGVLVEG--------MNWDTRVAI 333
G C+E R L+VFE+M +G+L L D ++ G + +AI
Sbjct: 72 FYGVCTEGR----PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 334 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP 393
A A G+ YL A+ +HRD+ + N L+ + L KI D GM++ + S+
Sbjct: 128 ASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY-------STDY 177
Query: 394 ARMQG----TFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR-SITKGEESL 447
R+ G + PE + + + SD++SFGVVL E+ T G+QP ++ S T+ E +
Sbjct: 178 YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237
Query: 448 VLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV 503
T EL PR P E IM + C Q +P R + ++
Sbjct: 238 ------------TQGRELERPR---TCPPEVYAIM----QGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 77/292 (26%), Positives = 116/292 (39%), Gaps = 61/292 (20%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
G+G V + + + G I+AVKR + L ++D+ R C Y
Sbjct: 10 GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP------YTV 63
Query: 293 EFRGKRAMRLLVFEFMPNGNLRD-CLD----GVLVEGMNWDTRV--AIAIGAARGLEYLH 345
F G V+ M + D LD V +G+ + IA+ + LEYLH
Sbjct: 64 TFYGALFREGDVWICM---EVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH 120
Query: 346 EAAAPRILHRDIKSSNILLDENLNAKITDLG--------MAKRLKADGLPSCSSSPARMQ 397
++HRD+K SN+L++ N K+ D G +AK + A P
Sbjct: 121 SKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKP---------- 168
Query: 398 GTFGYFAPEY---AMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 453
Y APE + + + SDV+S G+ ++EL TGR P W TP
Sbjct: 169 ----YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS-----------WKTP 213
Query: 454 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
Q V E P P+L + E Q +CL+ + RP E++Q
Sbjct: 214 FQQLKQVV--EEPSPQLPAEKFSPEFQ---DFVNKCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 72/263 (27%), Positives = 116/263 (44%), Gaps = 36/263 (13%)
Query: 249 GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 308
G VAVK K A FL E ++++L H ++V L+G E +G +V E+M
Sbjct: 29 GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIVEEKGGL---YIVTEYM 82
Query: 309 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL 368
G+L D L + D + ++ +EYL A +HRD+ + N+L+ E+
Sbjct: 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDN 139
Query: 369 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLE 428
AK++D G+ K +A P + + APE + S SDV+SFG++L E
Sbjct: 140 VAKVSDFGLTK--EASSTQDTGKLPVK------WTAPEALREKKFSTKSDVWSFGILLWE 191
Query: 429 LIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAK 487
+ + GR P R K PR++ K D P ++ + K
Sbjct: 192 IYSFGRVPYPRIPLKD-------VVPRVEKG-----------YKMDAPDGCPPVVYDVMK 233
Query: 488 ECLQLDPDARPTMSEVVQILSTI 510
+C LD RP+ ++ + L I
Sbjct: 234 QCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 69/286 (24%), Positives = 123/286 (43%), Gaps = 41/286 (14%)
Query: 232 IVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADS-----VFLTEVDMLSRLHHCHVV 285
+G G S Y+ + + G ++AVK+ +++ E+ +++RL+H H++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 286 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGLEY 343
++G E + L E+M G++ L G E + + RGL Y
Sbjct: 67 RMLGATCE----DSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI----INYTEQLLRGLSY 118
Query: 344 LHEAAAPRILHRDIKSSNILLDEN-LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
LHE +I+HRD+K +N+L+D +I D G A RL A ++ GT +
Sbjct: 119 LHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK-GTGAGEFQGQLLGTIAF 174
Query: 403 FAPEY---AMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459
APE GR+ DV+S G V++E+ T + P W + +
Sbjct: 175 MAPEVLRGEQYGRS---CDVWSVGCVIIEMATAKPP--------------WNAEKHSNHL 217
Query: 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
+I ++ P+ + + CL+L P+ RP E+++
Sbjct: 218 ALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 87/315 (27%), Positives = 140/315 (44%), Gaps = 67/315 (21%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHC 282
+K+ + +G+G V++ + + G+IVA+K+F +++ P + L E+ ML +L H
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFM-----------PNGNLRDCLDGVLVEGMNWDTRV 331
++V L+ FR KR + L VFE+ P G + L++ + W T
Sbjct: 61 NLVNLI---EVFRRKRKLHL-VFEYCDHTVLNELEKNPRG-----VPEHLIKKIIWQT-- 109
Query: 332 AIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS 391
+ + + H +HRD+K NIL+ + K+ D G A+ L G
Sbjct: 110 ------LQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY 160
Query: 392 SPARMQGTFGYFAPEYAMVGRASLMS--DVFSFGVVLLELITGRQPI--HRS-------I 440
R Y APE +VG DV++ G V EL+TG QP+ +S I
Sbjct: 161 VATRW-----YRAPEL-LVGDTQYGPPVDVWAIGCVFAELLTG-QPLWPGKSDVDQLYLI 213
Query: 441 TKGEESLVLWATPRLQD--------SGTVISELPDPR--LKGDFPKEEMQIMAYLAKECL 490
K L+ PR Q G I E P+ R L+ FP +++L K CL
Sbjct: 214 RKTLGDLI----PRHQQIFSTNQFFKGLSIPE-PETREPLESKFPNISSPALSFL-KGCL 267
Query: 491 QLDPDARPTMSEVVQ 505
Q+DP R + E+++
Sbjct: 268 QMDPTERLSCEELLE 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 4e-17
Identities = 84/305 (27%), Positives = 138/305 (45%), Gaps = 52/305 (17%)
Query: 226 KFSGSNIVGQGGSSYVYRG-QLTDG---RI-VAVKRFKTQGGPNADSVFLTEVDMLSRLH 280
+F ++G G VY+G + +G +I VA+K + P A+ L E +++ +
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 281 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL----DGVLVEGM-NWDTRVAIAI 335
+ HV L+G C + L+ + MP G L D + D + + + NW ++A
Sbjct: 68 NPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA--- 119
Query: 336 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 395
+G+ YL E R++HRD+ + N+L+ + KITD G+AK L AD
Sbjct: 120 ---KGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD------EKEYH 167
Query: 396 MQG---TFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWA 451
+G + A E + + SDV+S+GV + EL+T G +P + I E S +L
Sbjct: 168 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP-YDGIPASEISSILEK 226
Query: 452 TPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511
RL P P P + + + K C +D D+RP E++ S +A
Sbjct: 227 GERL----------PQP------PICTIDVYMIMVK-CWMIDADSRPKFRELIIEFSKMA 269
Query: 512 PDKSR 516
D R
Sbjct: 270 RDPQR 274
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 84/303 (27%), Positives = 136/303 (44%), Gaps = 60/303 (19%)
Query: 232 IVGQGGSSYVYRG-QLTDG---RI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
++G G VY+G + DG +I VA+K + P A+ L E +++ + +V
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNL----RDCLDGVLVEGM-NWDTRVAIAIGAARGL 341
L+G C + LV + MP G L R+ D + + + NW ++A +G+
Sbjct: 74 LLGICLT-----STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIA------KGM 122
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK-------ADGLPSCSSSPA 394
YL E R++HRD+ + N+L+ + KITD G+A+ L ADG P
Sbjct: 123 SYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADG----GKVPI 175
Query: 395 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATP 453
+ + A E + R + SDV+S+GV + EL+T G +P + + P
Sbjct: 176 K------WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPY--------DGIPAREIP 221
Query: 454 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 513
L + G LP P P + + + K C +D + RP E+V S +A D
Sbjct: 222 DLLEKG---ERLPQP------PICTIDVYMIMVK-CWMIDSECRPRFRELVDEFSRMARD 271
Query: 514 KSR 516
SR
Sbjct: 272 PSR 274
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 81/299 (27%), Positives = 135/299 (45%), Gaps = 52/299 (17%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G+G + VY+G+ T G IVA+K S + E+ ++ L H ++V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL---- 63
Query: 292 SEFRGKRAMRLLVFEFMPN---------GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 342
+ +LVFE+M G R LD V+ + +G+
Sbjct: 64 HDVIHTENKLMLVFEYMDKDLKKYMDTHGV-RGALDPNTVKSFTYQL--------LKGIA 114
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
+ HE R+LHRD+K N+L+++ K+ D G+A +A G+P + S + T Y
Sbjct: 115 FCHEN---RVLHRDLKPQNLLINKRGELKLADFGLA---RAFGIPVNTFSNEVV--TLWY 166
Query: 403 FAPEYAMVGRASLMS-DVFSFGVVLLELITGRQPIHRSITKGEESLV----LWATPRLQD 457
AP+ + R S D++S G ++ E+ITGR P+ T E+ L+ + TP +
Sbjct: 167 RAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR-PLFPG-TNNEDQLLKIFRIMGTPT-ES 223
Query: 458 SGTVISELPDPRLKGDFPKEEMQIMAY-----------LAKECLQLDPDARPTMSEVVQ 505
+ IS+LP+ K FP+ Q + L LQL+P+ R + + +Q
Sbjct: 224 TWPGISQLPE--YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 4e-17
Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 33/213 (15%)
Query: 232 IVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLT---EVDMLSRLHHCHVVPL 287
+G+G VY+ + G IVA+K+ + + + T E+ +L L H ++V L
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIR--LDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 347
+ +R + LVFE+ +L+ LD ++ + +I RGL Y H
Sbjct: 64 LDVI---HTERKL-YLVFEYCDM-DLKKYLD-KRPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE- 406
RILHRD+K NIL++ + K+ D G+A +A G+P + + + T Y APE
Sbjct: 118 ---RILHRDLKPQNILINRDGVLKLADFGLA---RAFGIPLRTYTHEVV--TLWYRAPEI 169
Query: 407 ------YAMVGRASLMSDVFSFGVVLLELITGR 433
Y S D++S G + E+ITG+
Sbjct: 170 LLGSKHY------STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 69/207 (33%), Positives = 100/207 (48%), Gaps = 31/207 (14%)
Query: 248 DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 307
D +VAVK K NA F E ++L+ L H H+V G C E G ++VFE+
Sbjct: 34 DKILVAVKTLK-DASDNARKDFHREAELLTNLQHEHIVKFYGVCVE--GDPL--IMVFEY 88
Query: 308 MPNGNLRDCL-----DGVLVEGMNWDTRVA------IAIGAARGLEYLHEAAAPRILHRD 356
M +G+L L D VL+ N + IA A G+ YL A+ +HRD
Sbjct: 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRD 145
Query: 357 IKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG----TFGYFAPEYAMVGR 412
+ + N L+ ENL KI D GM++ + S+ R+ G + PE M +
Sbjct: 146 LATRNCLVGENLLVKIGDFGMSRDVY-------STDYYRVGGHTMLPIRWMPPESIMYRK 198
Query: 413 ASLMSDVFSFGVVLLELIT-GRQPIHR 438
+ SDV+S GVVL E+ T G+QP ++
Sbjct: 199 FTTESDVWSLGVVLWEIFTYGKQPWYQ 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 67/231 (29%), Positives = 102/231 (44%), Gaps = 44/231 (19%)
Query: 231 NIVGQGGSSYVYRGQLTD------GRI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
N +G G VY G TD G I VAVK + FL E ++S +H +
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVE-----GMNWDTRVAIAIGAA 338
+V L+G C + ++ E M G+L L VE + + I + A
Sbjct: 61 IVKLLGVCLL----NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNA-----KITDLGMAK--------RLKADG 385
+G YL + +HRD+ + N L+ E KI D G+A+ R + +G
Sbjct: 117 KGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173
Query: 386 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
L P R + APE + G+ + SDV+SFGV++ E++T G+QP
Sbjct: 174 L-----LPVR------WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 6e-17
Identities = 65/221 (29%), Positives = 114/221 (51%), Gaps = 33/221 (14%)
Query: 232 IVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADS---------VFLTEVDMLSRLHH 281
++G G VY G + G ++AVK+ + +A S E+ +L L H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPS-VSASSKDRKRSMLDALAREIALLKELQH 65
Query: 282 CHVVPLVGYCSEFRGKRAMRLLVF-EFMPNGNLRDCLD--GVLVEGM--NWDTRVAIAIG 336
++V +G + A L +F E++P G++ L+ G E + N+ ++
Sbjct: 66 ENIVQYLGSSLD-----ADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL---- 116
Query: 337 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR- 395
+GL YLH I+HRDIK +NIL+D KI+D G++K+L+A+ L S ++ AR
Sbjct: 117 --KGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSL-STKTNGARP 170
Query: 396 -MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
+QG+ + APE + +D++S G +++E++TG+ P
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 6e-17
Identities = 73/291 (25%), Positives = 127/291 (43%), Gaps = 32/291 (10%)
Query: 230 SNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVF-LTEVDMLSRL---HHCHV 284
+G+G VY+ + L GR VA+K+ + + L E+ +L +L H ++
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63
Query: 285 VPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 343
V L+ C R R ++L LVFE + + +L L G+ +T + RG+++
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDF 122
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD-GLPSCSSSPARMQGTFGY 402
LH + RI+HRD+K NIL+ + KI D G+A+ + L S T Y
Sbjct: 123 LH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV-------TLWY 172
Query: 403 FAPEYAMVGRASLMS--DVFSFGVVLLELITGRQPIHRSITKGE---ESLVLWATPRLQD 457
APE + ++S + D++S G + EL R+P+ R ++ + + + P ++
Sbjct: 173 RAPEVLL--QSSYATPVDMWSVGCIFAELFR-RRPLFRGTSEADQLDKIFDVIGLPSEEE 229
Query: 458 SGTVISELPD---PRLKGDFPKEEMQIMAY---LAKECLQLDPDARPTMSE 502
+S F +I L K+ L +P R + E
Sbjct: 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFE 280
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 7e-17
Identities = 77/279 (27%), Positives = 128/279 (45%), Gaps = 39/279 (13%)
Query: 231 NIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
I+G G VY+ L RI+AVK ++E+++L + C ++G
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEIL---YKCDSPYIIG 63
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNL---RDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE 346
+ F + + + EFM G+L R + VL R+A+A+ +GL YL
Sbjct: 64 FYGAFFVENRISICT-EFMDGGSLDVYRKIPEHVL-------GRIAVAV--VKGLTYLW- 112
Query: 347 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 406
+ +ILHRD+K SN+L++ K+ D G++ +L +S GT Y APE
Sbjct: 113 --SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL-------VNSIAKTYVGTNAYMAPE 163
Query: 407 YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 466
+ + SDV+S G+ +EL GR P + I K + SL+ LQ ++ E P
Sbjct: 164 RISGEQYGIHSDVWSLGISFMELALGRFP-YPQIQKNQGSLM-----PLQLLQCIVDEDP 217
Query: 467 DPRLK-GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVV 504
P L G F ++ + + +C++ P RP ++
Sbjct: 218 -PVLPVGQFSEKFVHFIT----QCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 8e-17
Identities = 79/287 (27%), Positives = 133/287 (46%), Gaps = 45/287 (15%)
Query: 232 IVGQGGSSYVYRGQL-TDGR---IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
++G G V+RG L GR VA+K K FL+E ++ + H +++ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYL 344
G ++F K AM ++ E+M NG L L DG V + G A G++YL
Sbjct: 72 EGVVTKF--KPAM--IITEYMENGALDKYLRDHDGEFSSYQ----LVGMLRGIAAGMKYL 123
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 404
+ +HRD+ + NIL++ NL K++D G+++ L+ D + ++S ++ + A
Sbjct: 124 SDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTA 178
Query: 405 PEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463
PE + + SDV+SFG+V+ E+++ G +P W + I+
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGERP-------------YWDMSN-HEVMKAIN 224
Query: 464 E---LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507
+ LP P D P Q+M +C Q D RP ++V +L
Sbjct: 225 DGFRLPAPM---DCPSAVYQLML----QCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 9e-17
Identities = 76/287 (26%), Positives = 116/287 (40%), Gaps = 51/287 (17%)
Query: 232 IVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSV------FLTEVDMLSRLHHCHV 284
++GQG VY D GR +AVK+ P++ E+ +L L H +
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPF--DPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 285 VPLVGYCSEFRGKRAMRLLVF-EFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGL 341
V G C L +F E+MP G+++D L G L E + I G+
Sbjct: 67 VQYYG-CLRDDET----LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----EGV 117
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
EYLH I+HRDIK +NIL D N K+ D G +KRL+ + GT
Sbjct: 118 EYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS--VTGTPY 172
Query: 402 YFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 458
+ +PE GR +DV+S G ++E++T + P WA +
Sbjct: 173 WMSPEVISGEGYGRK---ADVWSVGCTVVEMLTEKPP--------------WAEFEAMAA 215
Query: 459 GTVISELP-DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVV 504
I+ P +P+L P + + RP+ E++
Sbjct: 216 IFKIATQPTNPQL----PSHVSPDARNFLRRTFVENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 9e-17
Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 21/215 (9%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV------FLTEVDMLSRLHHCHV 284
++G+G VY G G+++AVK+ + N + EVD+L L H ++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTS-NVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGLE 342
V +G C + + EF+P G++ L+ G L E + I G A
Sbjct: 65 VQYLGTCLD----DNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA---- 116
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQGTFG 401
YLH ++HRDIK +N++L N K+ D G A+RL GL S+ + M GT
Sbjct: 117 YLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 436
+ APE SD++S G + E+ TG+ P+
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 79/325 (24%), Positives = 142/325 (43%), Gaps = 56/325 (17%)
Query: 231 NIVGQGGSSYVYRGQLT-DGRIV--AVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVP 286
+++G+G V R + DG + A+K K N F E+++L +L HH +++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV--------------EGMNWDTRVA 332
L+G C R + E+ P GNL D L V + +
Sbjct: 68 LLGACE----NRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123
Query: 333 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS 392
A A G++YL E + +HRD+ + N+L+ ENL +KI D G+++ + +
Sbjct: 124 FASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRL 180
Query: 393 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 452
P R + A E + SDV+SFGV+L E+++ L T
Sbjct: 181 PVR------WMAIESLNYSVYTTKSDVWSFGVLLWEIVS-----------------LGGT 217
Query: 453 PRLQDSGTVISELPDPRLKG---DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 509
P G +EL + +G + P+ + L ++C + P RP +++ LS
Sbjct: 218 PY---CGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSR 274
Query: 510 IAPDKSRRRNISLNLFQIFSAGGME 534
+ ++R+ +++ LF+ F+ G++
Sbjct: 275 ML--EARKAYVNMALFENFTYAGID 297
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 73/293 (24%), Positives = 122/293 (41%), Gaps = 51/293 (17%)
Query: 232 IVGQGGSSYVYRG-QLTDGRIVAVKRF---KTQGGPNAD------SVFLTEVDMLSRLHH 281
++G+G VY +T G ++AVK+ T G + +E++ L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 282 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL------DGVLVEGMNWDTRVAIAI 335
++V +G F + E++P G++ CL + LV
Sbjct: 68 LNIVQYLG----FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV------ 117
Query: 336 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 395
GL YLH ILHRD+K+ N+L+D + KI+D G++K K+D + +
Sbjct: 118 --LEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK--KSDDIYD-NDQNMS 169
Query: 396 MQGTFGYFAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 453
MQG+ + APE S D++S G V+LE+ GR+P W+
Sbjct: 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP--------------WSDE 215
Query: 454 R-LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
+ + ++ P + D + C ++PD RPT E++Q
Sbjct: 216 EAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 82/336 (24%), Positives = 149/336 (44%), Gaps = 52/336 (15%)
Query: 217 YSALEHATDKFSGSNIVGQGGSSYVYRGQL-TDG-RI-VAVKRFKTQGGPNADSVFLTEV 273
Y LE KF +++G+G V + ++ DG R+ A+KR K + F E+
Sbjct: 1 YPVLEWNDIKFQ--DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGEL 58
Query: 274 DMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV---------- 322
++L +L HH +++ L+G C R L E+ P+GNL D L V
Sbjct: 59 EVLCKLGHHPNIINLLGACEH----RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 114
Query: 323 ----EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378
++ + A ARG++YL + + +HRD+ + NIL+ EN AKI D G++
Sbjct: 115 NSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS 171
Query: 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 438
+ + + P R + A E + SDV+S+GV+L E+++ +
Sbjct: 172 RGQEVYVKKTMGRLPVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 225
Query: 439 SITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP 498
+T E L RL+ E+ D L ++C + P RP
Sbjct: 226 GMTCAELYEKLPQGYRLEKPLNCDDEVYD-----------------LMRQCWREKPYERP 268
Query: 499 TMSEVVQILSTIAPDKSRRRNISLNLFQIFSAGGME 534
+ ++++ L+ + + R+ ++ L++ F+ G++
Sbjct: 269 SFAQILVSLNRML--EERKTYVNTTLYEKFTYAGID 302
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 71/286 (24%), Positives = 113/286 (39%), Gaps = 41/286 (14%)
Query: 231 NIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLT-EVDMLSRLHHCHVVPLV 288
+G+G V + + +DG+I+ K + L EV++L L H ++V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV--- 62
Query: 289 GYCSEFRGKRAMRL-LVFEFMPNGNL----RDC--LDGVLVEGMNWDTRVAIAIGAARGL 341
Y + L +V E+ G+L + C + E W + + L
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA----L 118
Query: 342 EYLH--EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
H +LHRD+K +NI LD N N K+ D G+AK L D SS GT
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD-----SSFAKTYVGT 173
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459
Y +PE SD++S G ++ EL P + + L
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT---ARNQLQLA----------- 219
Query: 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
+ I E R+ + E +++ K L +DPD RP+ E++Q
Sbjct: 220 SKIKEGKFRRIPYRYSSELNEVI----KSMLNVDPDKRPSTEELLQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 7e-16
Identities = 70/279 (25%), Positives = 121/279 (43%), Gaps = 40/279 (14%)
Query: 232 IVGQG--GSSYVYRGQLTDGRIVAVKRFK-TQGGPNADSVFLTEVDMLSRLHHCHVVPLV 288
++G+G G + +YR + D +V K T+ L E+ +LS L H +++
Sbjct: 7 VLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNII--- 62
Query: 289 GYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLH 345
Y + F + L+ E+ G L D + G L E + + + Y+H
Sbjct: 63 AYYNHFMDDNTL-LIEMEYANGGTLYDKIVRQKGQLFEE---EMVLWYLFQIVSAVSYIH 118
Query: 346 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 405
+A ILHRDIK+ NI L + K+ D G++K L ++ S + GT Y +P
Sbjct: 119 KAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE-----YSMAETVVGTPYYMSP 170
Query: 406 EYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 465
E + + SD+++ G VL EL+T + R+ ++ +Q + T +
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLT----LKRTFDATNPLNLVVKI--VQGNYTPV--- 221
Query: 466 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVV 504
+ E + ++ LQ DP+ RPT EV+
Sbjct: 222 -----VSVYSSELISLV----HSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 8e-16
Identities = 81/309 (26%), Positives = 128/309 (41%), Gaps = 50/309 (16%)
Query: 207 TIHGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNA 265
TI G + LE+ + +G G VY+ + G ++AVK+ + G
Sbjct: 4 TIDGQKYPADLNDLENLGE-------IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE 56
Query: 266 DSVFLTEVDMLSRLHHC-HVVPLVGY-CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV- 322
+ L ++D++ + H C ++V GY ++ M L+ CLD +L
Sbjct: 57 NKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM----------STCLDKLLKR 106
Query: 323 --EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380
+ D + + + L YL E ++HRD+K SNILLD + N K+ D G++ R
Sbjct: 107 IQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGR 164
Query: 381 LKADGLPSCSSSPARMQGTFGYFAPEY----AMVGRASLMSDVFSFGVVLLELITGRQPI 436
L D S + R G Y APE + + +DV+S G+ L+EL TG+ P
Sbjct: 165 L-VD-----SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPY 218
Query: 437 HRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDA 496
T+ E VL T I + P L + + CL D
Sbjct: 219 KNCKTEFE---VL----------TKILQEEPPSLPPN--EGFSPDFCSFVDLCLTKDHRK 263
Query: 497 RPTMSEVVQ 505
RP E++Q
Sbjct: 264 RPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 26/210 (12%)
Query: 233 VGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNA----DSVFLTEVDMLSRLHHCHVVPL 287
+G+G + VY+ GRIVA+K+ K A + L E+ +L L H +++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 347
+ F K + L VFEFM +L + + D + + + RGLEYLH
Sbjct: 68 L---DVFGHKSNINL-VFEFME-TDLEKVIKDKSIVLTPADIK-SYMLMTLRGLEYLHSN 121
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG---TFGYFA 404
ILHRD+K +N+L+ + K+ D G+A+ S S +M T Y A
Sbjct: 122 W---ILHRDLKPNNLLIASDGVLKLADFGLAR--------SFGSPNRKMTHQVVTRWYRA 170
Query: 405 PEYAMVGRA-SLMSDVFSFGVVLLELITGR 433
PE R + D++S G + EL+
Sbjct: 171 PELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 73/286 (25%), Positives = 125/286 (43%), Gaps = 55/286 (19%)
Query: 232 IVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
+G+G VY+ G++VA+K + + E+ +L + ++V G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYG- 65
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEA 347
S F K +V E+ G++ D + + L E + AI +GLEYLH
Sbjct: 66 -SYF--KNTDLWIVMEYCGAGSVSDIMKITNKTLTE----EEIAAILYQTLKGLEYLH-- 116
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ---GTFGYFA 404
+ + +HRDIK+ NILL+E AK+ D G++ +L + + A+ GT + A
Sbjct: 117 -SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL--------TDTMAKRNTVIGTPFWMA 167
Query: 405 PEYAMVGRASLMSDVFSFGVVLLELITGRQP---IH--RSITKGEESLVLWATPRLQDSG 459
PE + +D++S G+ +E+ G+ P IH R+I
Sbjct: 168 PEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI------------------- 208
Query: 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
+I P P L P++ K+CL DP+ RP+ +++Q
Sbjct: 209 FMIPNKPPPTLSD--PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 28/195 (14%)
Query: 251 IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 310
+VAVK + A + FL E+ ++SRL + +++ L+G C ++ E+M N
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCV----SDDPLCMITEYMEN 101
Query: 311 GNLRDCLDGVLVEG----------MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 360
G+L L +E ++ + +A+ A G++YL A+ +HRD+ +
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATR 158
Query: 361 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG----TFGYFAPEYAMVGRASLM 416
N L+ + KI D GM++ L S R+QG + A E ++G+ +
Sbjct: 159 NCLVGNHYTIKIADFGMSRNLY-------SGDYYRIQGRAVLPIRWMAWESILLGKFTTA 211
Query: 417 SDVFSFGVVLLELIT 431
SDV++FGV L E+ T
Sbjct: 212 SDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 35/201 (17%)
Query: 251 IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 310
+VAVK + NA + FL EV +LSRL +++ L+G C + ++ E+M N
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD----EDPLCMITEYMEN 103
Query: 311 GNLRDCLDG-VLVEG----------------MNWDTRVAIAIGAARGLEYLHEAAAPRIL 353
G+L L L + +++ + + +A+ A G++YL ++ +
Sbjct: 104 GDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFV 160
Query: 354 HRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG----TFGYFAPEYAM 409
HRD+ + N L+ ENL KI D GM++ L A R+QG + A E +
Sbjct: 161 HRDLATRNCLVGENLTIKIADFGMSRNLYA-------GDYYRIQGRAVLPIRWMAWECIL 213
Query: 410 VGRASLMSDVFSFGVVLLELI 430
+G+ + SDV++FGV L E++
Sbjct: 214 MGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 76/300 (25%), Positives = 124/300 (41%), Gaps = 69/300 (23%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
+ F+ +G+G VY+ ++VA+K + + E+ LS+ +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 284 VVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLD-GVLVEGMNWDTRVAIAI---GAA 338
+ G S +G +L ++ E+ G+ D L G L E IA
Sbjct: 61 ITKYYG--SFLKG---SKLWIIMEYCGGGSCLDLLKPGKLDET-------YIAFILREVL 108
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ- 397
GLEYLHE +HRDIK++NILL E + K+ D G++ +L +S+ ++
Sbjct: 109 LGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQL--------TSTMSKRNT 157
Query: 398 --GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP---IH--RSITKGEESLVLW 450
GT + APE +D++S G+ +EL G P +H R VL
Sbjct: 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR---------VL- 207
Query: 451 ATPRLQDSGTVISELPDPRLKGD-FPKEEMQIMAYLAKE----CLQLDPDARPTMSEVVQ 505
+I + P L+G+ F K K+ CL DP RP+ E+++
Sbjct: 208 ---------FLIPKNNPPSLEGNKFSKP--------FKDFVSLCLNKDPKERPSAKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 75/289 (25%), Positives = 131/289 (45%), Gaps = 46/289 (15%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
+G+G VY+ + G +VA+K+ + T+G P S + E+ +L L+H ++V L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKELNHPNIVKL 64
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 347
+ + LVFEF+ + +L+ +D + G+ + +GL + H
Sbjct: 65 L----DVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH-- 117
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
+ R+LHRD+K N+L++ K+ D G+A +A G+P + + + T Y APE
Sbjct: 118 -SHRVLHRDLKPQNLLINTEGAIKLADFGLA---RAFGVPVRTYTHEVV--TLWYRAPEI 171
Query: 408 AMVGR-ASLMSDVFSFGVVLLELITGRQ--PIHRSI--------TKGEESLVLWATPRLQ 456
+ + S D++S G + E++T R P I T G V+W
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG---- 227
Query: 457 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
++ LPD K FPK Q + + LD D R +S+++
Sbjct: 228 -----VTSLPD--YKPSFPKWARQDFSKVVP---PLDEDGRDLLSQMLH 266
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 78/284 (27%), Positives = 129/284 (45%), Gaps = 50/284 (17%)
Query: 236 GGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
G +Y VY+ + + G +VA+K K + G + + + E+ ML H ++V G S
Sbjct: 12 GSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEII-QQEISMLKECRHPNIVAYFG--S 68
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 352
R + +V E+ G+L+D V ++ + +GL YLHE
Sbjct: 69 YLRRDKLW--IVMEYCGGGSLQDIYQ-VTRGPLSELQIAYVCRETLKGLAYLHET---GK 122
Query: 353 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ---GTFGYFAPEYAM 409
+HRDIK +NILL E+ + K+ D G++ +L A + A+ + GT + APE A
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVSAQLTA--------TIAKRKSFIGTPYWMAPEVAA 174
Query: 410 V---GRASLMSDVFSFGVVLLELITGRQP---IH--RSITKGEESLVLWATPRLQDSGTV 461
V G D+++ G+ +EL + P +H R L+ +
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR---------ALFLISK------- 218
Query: 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
S P P+LK D K ++ K+CL DP RPT ++++Q
Sbjct: 219 -SNFPPPKLK-DKEKWSPVFHDFI-KKCLTKDPKKRPTATKLLQ 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 73/280 (26%), Positives = 124/280 (44%), Gaps = 40/280 (14%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLVGY 290
+G G V+ G + VAVK K P SV FL E +++ L H +V L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLK----PGTMSVQAFLEEANLMKTLQHDKLVRLYAV 69
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAP 350
+ K ++ E+M G+L D L + + + A G+ Y+
Sbjct: 70 VT----KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK--- 122
Query: 351 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYA 408
+HRD++++N+L+ E+L KI D G+A+ ++ + AR F + APE
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN------EYTAREGAKFPIKWTAPEAI 176
Query: 409 MVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPD 467
G ++ SDV+SFG++L E++T G+ P + ++ + L R+
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVTYGKIP-YPGMSNSDVMSALQRGYRM------------ 223
Query: 468 PRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507
PR++ + P E IM K C + + RPT + +L
Sbjct: 224 PRME-NCPDELYDIM----KTCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 69/268 (25%), Positives = 113/268 (42%), Gaps = 40/268 (14%)
Query: 251 IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 310
+V VK + N S F E+DM +L H +VV L+G C E ++ E+
Sbjct: 37 LVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE----AEPHYMILEYTDL 92
Query: 311 GNLRDCL-------DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNIL 363
G+L+ L + + ++ +VA+ A G+++L A R +HRD+ + N L
Sbjct: 93 GDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCL 149
Query: 364 LDENLNAKITDLGMAKRLKADGLPSCSSS--PARMQGTFGYFAPEYAMVGRASLMSDVFS 421
+ K++ L ++K + ++ P R + APE S SDV+S
Sbjct: 150 VSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR------WLAPEAVQEDDFSTKSDVWS 203
Query: 422 FGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQ 480
FGV++ E+ T G P ++ E L ELP P P +
Sbjct: 204 FGVLMWEVFTQGELP-FYGLSDEE---------VLNRLQAGKLELPVPE---GCPSRLYK 250
Query: 481 IMAYLAKECLQLDPDARPTMSEVVQILS 508
+M C ++P RP+ SE+V L
Sbjct: 251 LMT----RCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 4e-15
Identities = 82/291 (28%), Positives = 135/291 (46%), Gaps = 51/291 (17%)
Query: 232 IVGQGGSSYVYRGQLT-DGR---IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
++G G V RG+L G+ VA+K K+ FL+E ++ + H +++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR-VAIAIGAARGLEYLHE 346
G ++ R +++ EFM NG L L +G + V + G A G++YL E
Sbjct: 71 EGVVTKSRPV----MIITEFMENGALDSFLR--QNDGQFTVIQLVGMLRGIAAGMKYLSE 124
Query: 347 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL-PSCSSS-----PARMQGTF 400
+HRD+ + NIL++ NL K++D G+++ L+ D P+ +SS P R
Sbjct: 125 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR----- 176
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSG 459
+ APE + + SDV+S+G+V+ E+++ G +P W QD
Sbjct: 177 -WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP-------------YWDMSN-QDVI 221
Query: 460 TVISE---LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507
I + LP P D P Q+M +C Q D +ARP ++V L
Sbjct: 222 NAIEQDYRLPPPM---DCPTALHQLML----DCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 7e-15
Identities = 76/282 (26%), Positives = 129/282 (45%), Gaps = 54/282 (19%)
Query: 244 GQLTDGRI---------VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 294
G++ GR+ VA+K K FL+E ++ + H +++ L G +
Sbjct: 18 GEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-- 75
Query: 295 RGKRAMRLLVFEFMPNGNLRDCL---DG--VLVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
+ K M +V E+M NG+L L DG +++ V + G A G++YL +
Sbjct: 76 KSKPVM--IVTEYMENGSLDAFLRKHDGQFTVIQ------LVGMLRGIASGMKYLSDMGY 127
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 409
+HRD+ + NIL++ NL K++D G+++ L+ D P + + + + APE
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDD--PEAAYTTRGGKIPIRWTAPEAIA 182
Query: 410 VGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISE---L 465
+ + SDV+S+G+V+ E+++ G +P W QD I E L
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERP-------------YWEMSN-QDVIKAIEEGYRL 228
Query: 466 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507
P P D P Q+M +C Q D + RP ++V IL
Sbjct: 229 PAPM---DCPAALHQLML----DCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 7e-15
Identities = 71/281 (25%), Positives = 120/281 (42%), Gaps = 55/281 (19%)
Query: 251 IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 310
+VAVK K + + + F E +++ H ++V L+G C+ + M LL FE+M
Sbjct: 37 MVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV---GKPMCLL-FEYMAY 92
Query: 311 GNL----RDCLDGVLVEGMNWDTR----------------VAIAIGAARGLEYLHEAAAP 350
G+L R + + + IA A G+ YL E
Sbjct: 93 GDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER--- 149
Query: 351 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS---PARMQGTFGYFAPEY 407
+ +HRD+ + N L+ EN+ KI D G+++ + + S + P R + PE
Sbjct: 150 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIR------WMPPES 203
Query: 408 AMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 466
R + SDV+++GVVL E+ + G QP + E ++ + G V+S P
Sbjct: 204 IFYNRYTTESDVWAYGVVLWEIFSYGMQPYY---GMAHEEVIYYVR-----DGNVLS-CP 254
Query: 467 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507
D + P E +M + C P RP+ + + +IL
Sbjct: 255 D-----NCPLELYNLM----RLCWSKLPSDRPSFASINRIL 286
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 8e-15
Identities = 76/301 (25%), Positives = 126/301 (41%), Gaps = 56/301 (18%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
+G+G VY+ + G IVA+K+ K ++G P L E+ +L L+H +++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTA---LREIKLLKELNHPNIIKL 63
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 347
+ FR K + LVFEFM + +L + G+ + +GL + H
Sbjct: 64 L---DVFRHKGDL-YLVFEFM-DTDLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ----GTFGYF 403
ILHRD+K N+L++ K+ D G+A+ SP R T Y
Sbjct: 118 ---GILHRDLKPENLLINTEGVLKLADFGLARSF---------GSPVRPYTHYVVTRWYR 165
Query: 404 APE--YAMVGRASLMSDVFSFGVVLLELITGRQPIH--RS----ITKGEESLVLWATPRL 455
APE G ++ + D++S G + EL++ R P+ +S + K +L TP
Sbjct: 166 APELLLGDKGYSTPV-DIWSVGCIFAELLSRR-PLFPGKSEIDQLFKIFRTL---GTPDP 220
Query: 456 QDSGTVISELPDPRLKGDFPKEEMQ----IMAYLAKECLQL-------DPDARPTMSEVV 504
+ + L K FPK+ + + + L L DP R T + +
Sbjct: 221 EVW-PKFTSLARN-YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQAL 278
Query: 505 Q 505
Sbjct: 279 A 279
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 77/297 (25%), Positives = 127/297 (42%), Gaps = 48/297 (16%)
Query: 221 EHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLT----EVDM 275
E+ D+ ++G+G VY + L+ +A+K P DS ++ E+ +
Sbjct: 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEI-----PERDSRYVQPLHEEIAL 58
Query: 276 LSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD---GVLVEGMNWDTRVA 332
S L H ++V +G SE + E +P G+L L G L + N T +
Sbjct: 59 HSYLKHRNIVQYLGSDSE----NGFFKIFMEQVPGGSLSALLRSKWGPLKD--NEQTIIF 112
Query: 333 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA-KITDLGMAKRLKADGLPSCSS 391
GL+YLH+ +I+HRDIK N+L++ KI+D G +KRL G+ C+
Sbjct: 113 YTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA--GINPCTE 167
Query: 392 SPARMQGTFGYFAPEYAMVGRASL--MSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 449
+ GT Y APE G +D++S G ++E+ TG+ P GE +
Sbjct: 168 T---FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE---LGEPQAAM 221
Query: 450 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAY-LAKECLQLDPDARPTMSEVVQ 505
+ + E+P E + A C + DPD R + +++Q
Sbjct: 222 FKVGMFKIH----PEIP----------ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 71/220 (32%), Positives = 100/220 (45%), Gaps = 23/220 (10%)
Query: 233 VGQGGSSYVYRGQL-TDGRIVAVK-----RFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
+G+GG V Q+ G++ A K R K + G V E +L+++H +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMV---EKRILAKVHSRFIVS 57
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA--RGLEYL 344
L F+ K + LV M G+LR + V E + A A GLE+L
Sbjct: 58 LA---YAFQTKTDL-CLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 404
H+ RI++RD+K N+LLD + N +I+DLG+A LK DG S GT G+ A
Sbjct: 114 HQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELK-DG----QSKTKGYAGTPGFMA 165
Query: 405 PEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 444
PE D F+ GV L E+I R P K E
Sbjct: 166 PELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 81/313 (25%), Positives = 125/313 (39%), Gaps = 69/313 (22%)
Query: 234 GQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVF----LTEVDMLSRLHHCHVVPL- 287
G+G VY+ Q+ GR+VA+K+ N F L E+ +L +L H +VVPL
Sbjct: 17 GEGTFGEVYKARQIKTGRVVALKKILMH---NEKDGFPITALREIKILKKLKHPNVVPLI 73
Query: 288 ---VGYCSEFRGKRAMRLLVFEFM----------PNGNLRD----CLDGVLVEGMNWDTR 330
V + + KR +V +M P+ L + C L+EG+N
Sbjct: 74 DMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGIN---- 129
Query: 331 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 390
YLHE ILHRDIK++NIL+D KI D G+A R P+
Sbjct: 130 ------------YLHEN---HILHRDIKAANILIDNQGILKIADFGLA-RPYDGPPPNPK 173
Query: 391 SSPAR-------MQGTFGYFAPEYAMVGRASLMS-DVFSFGVVLLELITGRQPIHRSITK 442
+ T Y PE + R + D++ G V E+ T R PI + +
Sbjct: 174 GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR-PILQGKSD 232
Query: 443 GEESLVLWA---TPRLQDSGTVISELP---DPRLKGDFP-------KEEMQIMAYLAKEC 489
++ +++ TP +++ LP ++P + L +
Sbjct: 233 IDQLHLIFKLCGTPT-EETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKL 291
Query: 490 LQLDPDARPTMSE 502
L LDP R T S+
Sbjct: 292 LSLDPYKRLTASD 304
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 81/309 (26%), Positives = 126/309 (40%), Gaps = 61/309 (19%)
Query: 220 LEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSV--FLTEVDML 276
L T F ++G+G VY+ + G++VA+K D E ++L
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNIL 56
Query: 277 SRL-HHCHVVPLVG--YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGM----NWDT 329
+ +H ++ G G LV E G++ D + G+ +G W
Sbjct: 57 RKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-- 114
Query: 330 RVA-IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP- 387
+A I RGL YLHE +++HRDIK NILL +N K+ D G++ +L +
Sbjct: 115 -IAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR 170
Query: 388 -SCSSSPARMQGTFGYFAPEYAMVG---RASL--MSDVFSFGVVLLELITGRQP---IH- 437
+ +P M APE AS SDV+S G+ +EL G+ P +H
Sbjct: 171 NTFIGTPYWM-------APEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP 223
Query: 438 -RSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDA 496
R+ L+ PR P P LK P+ + ECL + +
Sbjct: 224 MRA---------LFKIPR----------NPPPTLKS--PENWSKKFNDFISECLIKNYEQ 262
Query: 497 RPTMSEVVQ 505
RP M E+++
Sbjct: 263 RPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRLH---HCHVVPL 287
+G G VY+ + G VA+K + Q + + + EV +L RL H ++V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 288 VGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE 346
+ C+ R R ++ LVFE + + +LR LD V G+ +T + RGL++LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH- 125
Query: 347 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 406
A I+HRD+K NIL+ K+ D G+A+ + SC + + T Y APE
Sbjct: 126 --ANCIVHRDLKPENILVTSGGQVKLADFGLAR------IYSCQMALTPVVVTLWYRAPE 177
Query: 407 YAMVGRASLMSDVFSFGVVLLELITGRQPI 436
+ + D++S G + E+ R+P+
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 83/309 (26%), Positives = 127/309 (41%), Gaps = 57/309 (18%)
Query: 221 EHATDKFSGSNIVGQGGSSYVYRGQLTD---GRI---VAVKRFKTQGGPNADSVFLTEVD 274
E + +K + +GQG VY G D G VAVK FL E
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR---- 330
++ HVV L+G S K L+V E M +G+L+ L + E N R
Sbjct: 62 VMKGFTCHHVVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 117
Query: 331 ----VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK------- 379
+ +A A G+ YL+ A + +HRD+ + N ++ + KI D GM +
Sbjct: 118 LQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 174
Query: 380 -RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 438
R GL P R + APE G + SD++SFGVVL E+ + + ++
Sbjct: 175 YRKGGKGL-----LPVR------WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ 223
Query: 439 SITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP 498
++ E+ L + D G + D P + + L + C Q +P RP
Sbjct: 224 GLSN-EQVLKF-----VMDGGYL-----------DQPDNCPERVTDLMRMCWQFNPKMRP 266
Query: 499 TMSEVVQIL 507
T E+V +L
Sbjct: 267 TFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 76/287 (26%), Positives = 125/287 (43%), Gaps = 68/287 (23%)
Query: 252 VAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 310
VAVK K S ++E++M+ + H +++ L+G C++ G +V E+ +
Sbjct: 45 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ-EGPL---YVVVEYAAH 100
Query: 311 GNLRDCL--------------DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRD 356
GNLRD L E + V+ A ARG+E+L A+ + +HRD
Sbjct: 101 GNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL---ASKKCIHRD 157
Query: 357 IKSSNILLDENLNAKITDLGMAK--------RLKADG-LPSCSSSPARMQGTFGYFAPEY 407
+ + N+L+ E+ KI D G+A+ R +G LP + APE
Sbjct: 158 LAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLP------------VKWMAPE- 204
Query: 408 AMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 466
A+ R + SDV+SFGV+L E+ T L +P G + EL
Sbjct: 205 ALFDRVYTHQSDVWSFGVLLWEIFT-----------------LGGSPY---PGIPVEELF 244
Query: 467 DPRLKG---DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
+G + P+ Q + +L ++C P RPT ++V+ L +
Sbjct: 245 KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 77/287 (26%), Positives = 128/287 (44%), Gaps = 60/287 (20%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
+G+G VY+ + G IVA+K+ + +G P S + E+ +L L+H ++V L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVP---STAIREISLLKELNHPNIVRL 63
Query: 288 --VGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 344
V + +L LVFEF+ + +L+ +D + G++ + +G+ Y
Sbjct: 64 LDVVHSEN-------KLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG------ 398
H + R+LHRD+K N+L+D K+ D G+A +A G+P ++
Sbjct: 116 H---SHRVLHRDLKPQNLLIDREGALKLADFGLA---RAFGVP--------VRTYTHEVV 161
Query: 399 TFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESL--------VL 449
T Y APE + R S D++S G + E++ R + G+ + L
Sbjct: 162 TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-----RRPLFPGDSEIDQLFRIFRTL 216
Query: 450 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDA 496
TP +D ++ LPD K FPK Q L+K LD D
Sbjct: 217 -GTPD-EDVWPGVTSLPD--YKPTFPKWARQ---DLSKVVPNLDEDG 256
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 71/256 (27%), Positives = 113/256 (44%), Gaps = 45/256 (17%)
Query: 276 LSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG----MNWDTRV 331
L LH C+ +VG+ F + + + E M G+L D VL + N ++
Sbjct: 50 LKVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSL----DQVLKKAGRIPENILGKI 104
Query: 332 AIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS 391
+IA+ RGL YL E I+HRD+K SNIL++ K+ D G++ +L + S ++
Sbjct: 105 SIAV--LRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMAN 156
Query: 392 SPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL---- 447
S GT Y +PE ++ SD++S G+ L+E+ GR PI K E++
Sbjct: 157 S---FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRP 213
Query: 448 ---VLWATPRLQDSGTV--------ISEL-------PDPRLKGDFPKEEMQIMAYLAKEC 489
SG I EL P P+L +E Q ++ K C
Sbjct: 214 VSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQ--DFVDK-C 270
Query: 490 LQLDPDARPTMSEVVQ 505
L+ +P R + E+ +
Sbjct: 271 LKKNPKERADLKELTK 286
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-14
Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 32/218 (14%)
Query: 232 IVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNAD------SVFLTEVDMLSRLHHCHV 284
++GQG VY D GR +A K + Q P + S E+ +L L H +
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAK--QVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGLE 342
V G C R ++ + + + E+MP G+++D L G L E + I G+
Sbjct: 67 VQYYG-CLRDRAEKTLTIFM-EYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EGMS 120
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK-----ADGLPSCSSSPARMQ 397
YLH + I+HRDIK +NIL D N K+ D G +KRL+ G+ S + +P M
Sbjct: 121 YLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM- 176
Query: 398 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
+PE +DV+S G ++E++T + P
Sbjct: 177 ------SPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 83/320 (25%), Positives = 138/320 (43%), Gaps = 59/320 (18%)
Query: 221 EHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVF----LTEVDM 275
+ DKF +G+G VY+ + D G +VA+K+ + N F + E+ +
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLD---NEKEGFPITAIREIKI 59
Query: 276 LSRLHHCHVVPLVGYCS------EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGM---N 326
L +L+H ++V L + +F+ + LVFE+M + L G+L G+ +
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHD-----LMGLLESGLVHFS 114
Query: 327 WDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386
D + GL Y H+ LHRDIK SNILL+ K+ D G+A+ ++
Sbjct: 115 EDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSE-- 169
Query: 387 PSCSSSPARMQGTFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGRQPIHRSITKGE 444
S P + ++ P ++G R DV+S G +L EL T ++PI ++ +
Sbjct: 170 ---ESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQA---NQ 222
Query: 445 ESLVLWATPRLQDSGTV-----ISELP-----------DPRLKGDF---PKEEMQIMAYL 485
E L RL S + +LP RL+ +F P + ++ ++
Sbjct: 223 ELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHM 282
Query: 486 AKECLQLDPDARPTMSEVVQ 505
L LDP R T E +
Sbjct: 283 ----LTLDPSKRCTAEEALN 298
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-14
Identities = 68/287 (23%), Positives = 128/287 (44%), Gaps = 45/287 (15%)
Query: 226 KFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 284
K++ +GQG S V+ + G+ VA+K+ Q P + + + E+ ++ L + ++
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKE-LIINEILVMKELKNPNI 78
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD-----CLDGVLVEGMNWDTRVAIAIGAAR 339
V + S G +V E++ G+L D C+D + A+ +
Sbjct: 79 VNFLD--SFLVGDEL--FVVMEYLAGGSLTDVVTETCMDEAQI--------AAVCRECLQ 126
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
LE+LH A +++HRDIKS N+LL + + K+TD G ++ + S + M GT
Sbjct: 127 ALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE-----QSKRSTMVGT 178
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP-IHRSITKGEESLVLWATPRLQDS 458
+ APE D++S G++ +E++ G P ++ + + + TP LQ+
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQN- 237
Query: 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
P++ I CL++D + R + E++Q
Sbjct: 238 ----------------PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 72/287 (25%), Positives = 116/287 (40%), Gaps = 42/287 (14%)
Query: 232 IVGQGGSSYVYRG---QLTDGRI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
+G+G VY+G + +I VAVK K P+ FL E ++ + H H+V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 347
+G +E +V E P G LR L V ++ + + + + L YL
Sbjct: 73 IGVITE-----NPVWIVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTALAYLE-- 124
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
+ R +HRDI + N+L+ K+ D G+++ L+ + S ++ + APE
Sbjct: 125 -SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK----WMAPES 179
Query: 408 AMVGRASLMSDVFSFGVVLLE-LITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 466
R + SDV+ FGV + E L+ G +P VI +
Sbjct: 180 INFRRFTSASDVWMFGVCMWEILMLGVKPFQ------------GVKNN-----DVIGRIE 222
Query: 467 DPRLKGD-FPKEEM--QIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
G+ P + L +C DP RP +E+ LS I
Sbjct: 223 ----NGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 72/285 (25%), Positives = 122/285 (42%), Gaps = 53/285 (18%)
Query: 232 IVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
++G+G VYRG + GR+VA+K + S EV +LS+L + Y
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 291 C-SEFRGKRAMRLLVFEFMPNGNLRD-----CLDGVLVEGMNWDTRVAIAIGAARGLEYL 344
S +G R ++ E+ G++R + + + + VA L+Y+
Sbjct: 68 YGSYLKGPRLW--IIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVA--------LKYI 117
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 404
H+ ++HRDIK++NIL+ N K+ D G+A L SS + GT + A
Sbjct: 118 HKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLN-----QNSSKRSTFVGTPYWMA 169
Query: 405 PEYAMVGRA-SLMSDVFSFGVVLLELITGRQPI-----HRSITKGEESLVLWATPRLQDS 458
PE G+ +D++S G+ + E+ TG P R++ +S PRL+D+
Sbjct: 170 PEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS----KPPRLEDN 225
Query: 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV 503
G + K + +A CL +P R + E+
Sbjct: 226 G--------------YSKLLREFVAA----CLDEEPKERLSAEEL 252
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 76/246 (30%), Positives = 114/246 (46%), Gaps = 40/246 (16%)
Query: 232 IVGQGGSSYVYRGQLTD-GRIVAVK-----RFKTQGGPNADSVFLTEVDMLSRLH--HCH 283
I+G+GG VY + D G++ A+K R K + G +++ L E MLS + C
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG---ETLALNERIMLSLVSTGDCP 57
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGL 341
+ + Y K + + + M G+L L GV E + R A GL
Sbjct: 58 FIVCMSYAFHTPDKLS---FILDLMNGGDLHYHLSQHGVFSEA---EMRF-YAAEIILGL 110
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS---PARMQG 398
E++H +++RD+K +NILLDE+ + +I+DLG+A C S P G
Sbjct: 111 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA----------CDFSKKKPHASVG 157
Query: 399 TFGYFAPEYAMVGRASLMS-DVFSFGVVLLELITGRQPI--HRSITKGE-ESLVLWATPR 454
T GY APE G A S D FS G +L +L+ G P H++ K E + + L
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 217
Query: 455 LQDSGT 460
L DS +
Sbjct: 218 LPDSFS 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 4e-14
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 29/203 (14%)
Query: 242 YRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301
+RGQ VA+K K G ++ F+ E ++ +L H +V L G C+ K+
Sbjct: 25 WRGQYD----VAIKMIKE--GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT----KQRPI 74
Query: 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAI---AIGAARGLEYLHEAAAPRILHRDIK 358
+V E+M NG CL L E + G+ YL + + +HRD+
Sbjct: 75 YIVTEYMSNG----CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLA 127
Query: 359 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PARMQGTFGYFAPEYAMVGRASLM 416
+ N L+D+ K++D G+++ + D S S P R + PE + + S
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVR------WSPPEVLLYSKFSSK 181
Query: 417 SDVFSFGVVLLELIT-GRQPIHR 438
SDV++FGV++ E+ + G+ P R
Sbjct: 182 SDVWAFGVLMWEVYSLGKMPYER 204
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 73/279 (26%), Positives = 122/279 (43%), Gaps = 57/279 (20%)
Query: 252 VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNG 311
VA+K + + G + + L H ++V L+G C A LV + P G
Sbjct: 39 VAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-----ASLQLVTQLSPLG 93
Query: 312 NL-------RDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL 364
+L RD LD + +NW ++A +G+ YL E R++HR++ + NILL
Sbjct: 94 SLLDHVRQHRDSLDPQRL--LNWCVQIA------KGMYYLEEH---RMVHRNLAARNILL 142
Query: 365 DENLNAKITDLGMAKRLKADG---LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFS 421
+ +I D G+A L D S +P + + A E + GR + SDV+S
Sbjct: 143 KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK------WMALESILFGRYTHQSDVWS 196
Query: 422 FGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGD-FPKEEM 479
+GV + E+++ G +P +A R E+PD KG+ + ++
Sbjct: 197 YGVTVWEMMSYGAEP--------------YAGMRPH-------EVPDLLEKGERLAQPQI 235
Query: 480 -QIMAYLAK-ECLQLDPDARPTMSEVVQILSTIAPDKSR 516
I Y+ +C +D + RPT E+ + +A D R
Sbjct: 236 CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPPR 274
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 69/277 (24%), Positives = 118/277 (42%), Gaps = 55/277 (19%)
Query: 252 VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNG 311
VAVK K + L+E ++L +++H HV+ L G CS+ LL+ E+ G
Sbjct: 33 VAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ----DGPLLLIVEYAKYG 88
Query: 312 NLR----------------------DCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
+LR LD + ++ A +RG++YL E
Sbjct: 89 SLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM-- 146
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEY 407
+++HRD+ + N+L+ E KI+D G+++ + + S R +G + A E
Sbjct: 147 -KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE-----DSYVKRSKGRIPVKWMAIES 200
Query: 408 AMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 466
+ SDV+SFGV+L E++T G P G L+ L +G
Sbjct: 201 LFDHIYTTQSDVWSFGVLLWEIVTLGGNPY-----PGIAPERLFN---LLKTG------- 245
Query: 467 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV 503
+ + P+ + M L C + +PD RPT +++
Sbjct: 246 ---YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 7e-14
Identities = 71/298 (23%), Positives = 126/298 (42%), Gaps = 40/298 (13%)
Query: 227 FSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHH 281
F+ ++G+G V QL + VAVK K ++D FL E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 282 CHVVPLVGYC--SEFRGKRAMRLLVFEFMPNGNLRDCL----DGVLVEGMNWDTRVAIAI 335
+V+ L+G S +G+ + +++ FM +G+L L G + T V I
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 336 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSS- 392
A G+EYL ++ +HRD+ + N +L+EN+ + D G++K++ + C+S
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 393 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 452
P + + A E + SDV++FGV + E++T Q + + E L
Sbjct: 178 PVK------WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG 231
Query: 453 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
RL+ P + ++ + L +C +P RP+ + L I
Sbjct: 232 NRLKQ-----------------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 67/278 (24%), Positives = 116/278 (41%), Gaps = 37/278 (13%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
+G G V+ VAVK K G + FL E +++ L H +V L +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKP--GSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 352
+ ++ EFM G+L D L + + A G+ ++ +
Sbjct: 72 -----KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NY 123
Query: 353 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYAMV 410
+HRD++++NIL+ +L KI D G+A+ ++ + AR F + APE
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDN------EYTAREGAKFPIKWTAPEAINF 177
Query: 411 GRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 469
G ++ SDV+SFG++L+E++T GR P + ++ E L R+ EL +
Sbjct: 178 GSFTIKSDVWSFGILLMEIVTYGRIP-YPGMSNPEVIRALERGYRMPRPENCPEELYNIM 236
Query: 470 LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507
+ C + P+ RPT + +L
Sbjct: 237 M-----------------RCWKNRPEERPTFEYIQSVL 257
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 76/274 (27%), Positives = 122/274 (44%), Gaps = 42/274 (15%)
Query: 250 RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 309
+VAVK + NA FL EV +LSRL ++ L+G C+ ++ E+M
Sbjct: 47 VLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDP----PLCMIMEYME 102
Query: 310 NGNL------RDCLDGVLVEGMN---WDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 360
NG+L L + T + +A A G+ YL +HRD+ +
Sbjct: 103 NGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATR 159
Query: 361 NILLDENLNAKITDLGMAKRL------KADGLPSCSSSPARMQGTFGYFAPEYAMVGRAS 414
N L+ +N KI D GM++ L + G P R + A E ++G+ +
Sbjct: 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPL---PIR------WMAWESVLLGKFT 210
Query: 415 LMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGD 473
SDV++FGV L E++T R+ + +T ++ ++ A +D G I LP P
Sbjct: 211 TKSDVWAFGVTLWEILTLCREQPYEHLT--DQQVIENAGHFFRDDGRQIY-LPRPPN--- 264
Query: 474 FPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507
PK+ ++M EC + D + RPT E+ L
Sbjct: 265 CPKDIYELM----LECWRRDEEDRPTFREIHLFL 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 69/278 (24%), Positives = 120/278 (43%), Gaps = 41/278 (14%)
Query: 233 VGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G+G + V + GR VAVK+ + + +F EV ++ H ++V + Y
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLF-NEVVIMRDYQHPNIVEM--YS 83
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 351
S G +V EF+ G L D V MN + + + + L +LH A
Sbjct: 84 SYLVGDELW--VVMEFLEGGALTDI---VTHTRMNEEQIATVCLAVLKALSFLH---AQG 135
Query: 352 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR--MQGTFGYFAPEYAM 409
++HRDIKS +ILL + K++D G ++ + P R + GT + APE +
Sbjct: 136 VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE-------VPRRKSLVGTPYWMAPE--V 186
Query: 410 VGRASLMS--DVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPD 467
+ R + D++S G++++E++ G P + P LQ + I +
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGEPP-------------YFNEPPLQ-AMKRIRDNLP 232
Query: 468 PRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
P+LK + + L DP R T +E++
Sbjct: 233 PKLKN--LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 8e-14
Identities = 65/219 (29%), Positives = 101/219 (46%), Gaps = 20/219 (9%)
Query: 221 EHATDKFSGSNIVGQGGSSYVYRGQLTDGRIV-AVKRFKTQGGPNADSVFLTEVDMLSRL 279
E D F + +G G V + Q ++ A K + P + + E L L
Sbjct: 1 ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRE---LQVL 57
Query: 280 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRV--AIAIGA 337
H C+ +VG+ F + + + E M G+L D VL E + ++I
Sbjct: 58 HECNSPYIVGFYGAFYSDGEISICM-EHMDGGSL----DQVLKEAKRIPEEILGKVSIAV 112
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
RGL YL E +I+HRD+K SNIL++ K+ D G++ +L + S ++S
Sbjct: 113 LRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANS---FV 163
Query: 398 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 436
GT Y +PE S+ SD++S G+ L+EL GR PI
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 8e-14
Identities = 63/235 (26%), Positives = 96/235 (40%), Gaps = 38/235 (16%)
Query: 232 IVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNA--DSVFLTEVDMLSRLHHCHVVPLV 288
++G+GG VY R VA+K+ + N FL E + + L H +VP+
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 289 GYCSEFRGKRAMRLLVFEFMP--NG--------NLRDC--LDGVLVEGMNWDTRVAIAIG 336
CS+ V+ MP G ++ L L E + ++I
Sbjct: 69 SICSDGD-------PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK 121
Query: 337 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR----------LKADGL 386
+EY+H +LHRD+K NILL I D G A + D
Sbjct: 122 ICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 387 PSCSSS---PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 438
C SS P ++ GT Y APE + AS +D+++ GV+L +++T P R
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233
|
Length = 932 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 31/219 (14%)
Query: 231 NIVGQGGSSYVYRGQLT-DGRIV--AVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVP 286
+++G+G V + ++ DG + A+KR K + F E+++L +L HH +++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV--------------EGMNWDTRVA 332
L+G C R L E+ P+GNL D L V ++ +
Sbjct: 61 LLGACE----HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 333 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS 392
A ARG++YL + + +HRD+ + NIL+ EN AKI D G+++ + +
Sbjct: 117 FAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 173
Query: 393 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 431
P R + A E + SDV+S+GV+L E+++
Sbjct: 174 PVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 69/222 (31%), Positives = 107/222 (48%), Gaps = 22/222 (9%)
Query: 227 FSGSNIVGQGGSSYVYRGQL-TDGRIVAVK-----RFKTQGGPNADSVFLTEVDMLSRLH 280
F ++G+GG V Q+ G++ A K R K + G +S+ L E +L +++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG---ESMALNEKQILEKVN 58
Query: 281 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 340
VV L Y E K A+ LV M G+L+ + + G V A G
Sbjct: 59 SRFVVSL-AYAYE--TKDAL-CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG 114
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
LE LH+ RI++RD+K NILLD++ + +I+DLG+A +P + R+ GT
Sbjct: 115 LEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVH-----VPEGQTIKGRV-GTV 165
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITK 442
GY APE R + D ++ G +L E+I G+ P + K
Sbjct: 166 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 71/301 (23%), Positives = 117/301 (38%), Gaps = 73/301 (24%)
Query: 231 NIVGQ-GGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
I+G+ G ++ VY+ Q G A K + + + F+ E+D+LS H ++V
Sbjct: 8 EIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELED-FMVEIDILSECKHPNIVG 66
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVE---GMNWDTRVAIAIGAARGLEY 343
L + K + + EF G LD +++E G+ + L +
Sbjct: 67 LYEAYF-YENKLWILI---EFCDGG----ALDSIMLELERGLTEPQIRYVCRQMLEALNF 118
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ------ 397
LH +++HRD+K+ NILL + + K+ D G++ + K+ +Q
Sbjct: 119 LHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST-----------LQKRDTFI 164
Query: 398 GTFGYFAPEYAMVGRAS-----LMSDVFSFGVVLLELITGRQPIHR--------SITKGE 444
GT + APE +D++S G+ L+EL P H I K E
Sbjct: 165 GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE 224
Query: 445 ESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVV 504
P L S D +L CL DPD RPT +E++
Sbjct: 225 -------PPTLDQPSKWSSSFND----------------FLKS-CLVKDPDDRPTAAELL 260
Query: 505 Q 505
+
Sbjct: 261 K 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 69/282 (24%), Positives = 121/282 (42%), Gaps = 38/282 (13%)
Query: 227 FSGSNIVGQGGSSYVYRGQLTDGR---IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
F+ +G+G V++G D R +VA+K + + E+ +LS+ +
Sbjct: 6 FTKLERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 343
V G S +G + ++ E++ G+ D L + T + + +GL+Y
Sbjct: 64 VTKYYG--SYLKGTKLW--IIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDY 116
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
LH + + +HRDIK++N+LL E + K+ D G+A +L + + GT +
Sbjct: 117 LH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-----FVGTPFWM 168
Query: 404 APEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463
APE +D++S G+ +EL G P + VL+ P+
Sbjct: 169 APEVIQQSAYDSKADIWSLGITAIELAKGEPP----NSDMHPMRVLFLIPK--------- 215
Query: 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
P L G+F K + + CL DP RPT E+++
Sbjct: 216 -NNPPTLTGEFSKPFKEFI----DACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 90/328 (27%), Positives = 143/328 (43%), Gaps = 41/328 (12%)
Query: 221 EHATDKFSGSNIVGQGGSSYVYR-GQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL 279
E D F + +G G V++ G I+A K + P + + E L L
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRE---LQVL 57
Query: 280 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGA 337
H C+ +VG+ F + + + E M G+L L G + E + +V+IA+
Sbjct: 58 HECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQIL--GKVSIAV-- 112
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
+GL YL E +I+HRD+K SNIL++ K+ D G++ +L + S ++S
Sbjct: 113 IKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANS---FV 163
Query: 398 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 457
GT Y +PE S+ SD++S G+ L+E+ GR PI K E +++ P D
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE--LMFGCPVEGD 221
Query: 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS--EVVQILSTIAPDKS 515
+ P PR G + +Y PD+RP M+ E++ + P K
Sbjct: 222 PAESETS-PRPRPPG------RPLSSY--------GPDSRPPMAIFELLDYIVNEPPPKL 266
Query: 516 RRRNISLNLFQIFSAGGMEKEPSIERPD 543
FQ F + K P+ ER D
Sbjct: 267 PSGVFGAE-FQDFVNKCLIKNPA-ERAD 292
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 77/291 (26%), Positives = 122/291 (41%), Gaps = 53/291 (18%)
Query: 232 IVGQGGSSYVYRG--QLTDGR--IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
I+G G + RG +L R VA+ + FL E L + H ++V L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYL 344
G + RG M +V E+M NG L L +G LV G + G A G++YL
Sbjct: 72 EGVIT--RGNTMM--IVTEYMSNGALDSFLRKHEGQLVAGQLMG----MLPGLASGMKYL 123
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS--SPARMQGTFGY 402
E +H+ + + +L++ +L KI+ + K++ + + S SP +
Sbjct: 124 SEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL------W 174
Query: 403 FAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPI----HRSITKGEESLVLWATPRLQD 457
APE S SDV+SFG+V+ E+++ G +P + + K E
Sbjct: 175 AAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF--------- 225
Query: 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508
LP PR + P Q+M +C Q + RP S++ ILS
Sbjct: 226 ------RLPAPR---NCPNLLHQLML----DCWQKERGERPRFSQIHSILS 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 67/282 (23%), Positives = 125/282 (44%), Gaps = 35/282 (12%)
Query: 226 KFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 284
K++ +GQG S VY + G+ VA+++ Q P + + + E+ ++ + ++
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNPNI 79
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 344
V Y + + +V E++ G+L D V M+ A+ + LE+L
Sbjct: 80 V---NYLDSYLVGDEL-WVVMEYLAGGSLTDV---VTETCMDEGQIAAVCRECLQALEFL 132
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 404
H + +++HRDIKS NILL + + K+TD G ++ + S + M GT + A
Sbjct: 133 H---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-----QSKRSTMVGTPYWMA 184
Query: 405 PEYAMVGRASLMSDVFSFGVVLLELITGRQP-IHRSITKGEESLVLWATPRLQDSGTVIS 463
PE D++S G++ +E+I G P ++ + + + TP LQ+
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN------ 238
Query: 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
P++ I CL +D + R + E++Q
Sbjct: 239 -----------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 72/278 (25%), Positives = 124/278 (44%), Gaps = 50/278 (17%)
Query: 252 VAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 310
VAVK K+ S ++E++M+ + H +++ L+G C++ ++ E+
Sbjct: 53 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ----DGPLYVIVEYASK 108
Query: 311 GNLRDCL--------------DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRD 356
GNLR+ L V E +++ V+ A ARG+EYL A+ + +HRD
Sbjct: 109 GNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRD 165
Query: 357 IKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SL 415
+ + N+L+ E+ KI D G+A+ + ++ R+ + APE A+ R +
Sbjct: 166 LAARNVLVTEDNVMKIADFGLARDIHHIDYYK-KTTNGRL--PVKWMAPE-ALFDRIYTH 221
Query: 416 MSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKG--- 472
SDV+SFGV+L E+ T L +P G + EL +G
Sbjct: 222 QSDVWSFGVLLWEIFT-----------------LGGSPY---PGVPVEELFKLLKEGHRM 261
Query: 473 DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
D P + + ++C P RPT ++V+ L I
Sbjct: 262 DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 66/282 (23%), Positives = 125/282 (44%), Gaps = 35/282 (12%)
Query: 226 KFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 284
K++ +GQG S VY + G+ VA+K+ Q P + + + E+ ++ + ++
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKE-LIINEILVMRENKNPNI 78
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 344
V Y + + +V E++ G+L D V M+ A+ + L++L
Sbjct: 79 V---NYLDSYLVGDEL-WVVMEYLAGGSLTDV---VTETCMDEGQIAAVCRECLQALDFL 131
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 404
H + +++HRDIKS NILL + + K+TD G ++ + S + M GT + A
Sbjct: 132 H---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-----QSKRSTMVGTPYWMA 183
Query: 405 PEYAMVGRASLMSDVFSFGVVLLELITGRQP-IHRSITKGEESLVLWATPRLQDSGTVIS 463
PE D++S G++ +E++ G P ++ + + + TP LQ+
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQN------ 237
Query: 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
P+ + CL++D D R + E++Q
Sbjct: 238 -----------PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 79/254 (31%), Positives = 116/254 (45%), Gaps = 41/254 (16%)
Query: 232 IVGQGGSSYVYRGQLTD-GRIVAVK-----RFKTQGGPNADSVFLTEVDMLSRLH--HCH 283
I+G+GG VY + D G++ A+K R K + G +++ L E MLS + C
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG---ETLALNERIMLSLVSTGDCP 57
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGL 341
+ + Y K + + M G+L L GV E + R A GL
Sbjct: 58 FIVCMTYAFHTPDKLC---FILDLMNGGDLHYHLSQHGVFSEK---EMRF-YATEIILGL 110
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
E++H +++RD+K +NILLDE+ + +I+DLG+A P GT G
Sbjct: 111 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS-------KKKPHASVGTHG 160
Query: 402 YFAPEYAMVGRASLMS-DVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460
Y APE G A S D FS G +L +L+ G P + TK + + R+ + T
Sbjct: 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-----DRM--TLT 213
Query: 461 VISELPD---PRLK 471
V ELPD P LK
Sbjct: 214 VNVELPDSFSPELK 227
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 83/311 (26%), Positives = 139/311 (44%), Gaps = 47/311 (15%)
Query: 252 VAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 310
VAVK K S ++E++M+ + H +++ L+G C++ + +LV E+
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ---DGPLYVLV-EYASK 102
Query: 311 GNLRDCLDGVLVEGMNW--DT------------RVAIAIGAARGLEYLHEAAAPRILHRD 356
GNLR+ L GM++ DT V+ A ARG+EYL A+ + +HRD
Sbjct: 103 GNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRD 159
Query: 357 IKSSNILLDENLNAKITDLGMAKRL-KADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-S 414
+ + N+L+ E+ KI D G+A+ + D ++ ++ + APE A+ R +
Sbjct: 160 LAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVK----WMAPE-ALFDRVYT 214
Query: 415 LMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDF 474
SDV+SFGV+L E+ T + I E +L R+ EL
Sbjct: 215 HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHEL--------- 265
Query: 475 PKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNISLNL-FQIFSAGGM 533
IM +EC P RPT ++V+ L + S + L++ F+ +S G
Sbjct: 266 ----YMIM----RECWHAVPSQRPTFKQLVEDLDRVLTVTSTDEYLDLSVPFEQYSPGCP 317
Query: 534 EKEPSIERPDN 544
+ S D+
Sbjct: 318 DSPSSCSSGDD 328
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-13
Identities = 75/285 (26%), Positives = 124/285 (43%), Gaps = 40/285 (14%)
Query: 226 KFSGSNIVGQG--GSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHC 282
K+ +VG+G G ++ R D ++V +K+ + + E +L L H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 342
+++ Y F +A+ ++V E+ P G L + + ++ DT + + L
Sbjct: 60 NII---EYYENFLEDKAL-MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH 115
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLN-AKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
++H ILHRD+K+ NILLD++ KI D G++K L S S + GT
Sbjct: 116 HVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL------SSKSKAYTVVGTPC 166
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461
Y +PE + SD+++ G VL EL S+ + E+ L A SGT
Sbjct: 167 YISPELCEGKPYNQKSDIWALGCVLYELA--------SLKRAFEAANLPALVLKIMSGTF 218
Query: 462 --ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVV 504
IS+ P L+ L L LDP RP +S+++
Sbjct: 219 APISDRYSPDLR------------QLILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 73/285 (25%), Positives = 128/285 (44%), Gaps = 41/285 (14%)
Query: 226 KFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 284
K++ +GQG S VY + G+ VA+K+ Q P + + + E+ ++ H ++
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKE-LIINEILVMRENKHPNI 78
Query: 285 VPLVG---YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAIAIGAARG 340
V + E +V E++ G+L D V+ E M+ A+ +
Sbjct: 79 VNYLDSYLVGDEL-------WVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQA 127
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
LE+LH + +++HRDIKS NILL + + K+TD G ++ + S + M GT
Sbjct: 128 LEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-----QSKRSTMVGTP 179
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460
+ APE D++S G++ +E++ G P +L L AT +GT
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE--NPLRALYLIAT-----NGT 232
Query: 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
P L+ P++ I CL++D + R + E++Q
Sbjct: 233 -------PELQN--PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 82/291 (28%), Positives = 122/291 (41%), Gaps = 40/291 (13%)
Query: 233 VGQGGSSYVYRGQLTDGRI---VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
+G G V G++ G V VK + FL E L H +++ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV-EGMNWDTRV--AIAIGAARGLEYLHE 346
C+E LLV EF P G+L+ L E M D +A A GL +LH+
Sbjct: 63 QCTEV----TPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 347 AAAPRILHRDIKSSNILLDENLNAKITDLGMAK-RLKADGLPSCSSSPARMQGTFGYFAP 405
+H D+ N LL +L KI D G++ + K D +P ++ + AP
Sbjct: 119 N---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY----VTPDQLWVPLRWIAP 171
Query: 406 EYA-------MVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQD 457
E +V + S+V+S GV + EL G QP +R ++ + VL T R Q
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQP-YRHLSDEQ---VLTYTVREQQ 227
Query: 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508
+LP PRLK ++M + L P+ RP+ EV +LS
Sbjct: 228 -----LKLPKPRLKLPLSDRWYEVMQFCW-----LQPEQRPSAEEVHLLLS 268
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 233 VGQGGSSYVYRGQL-TDGRIVAVK-----RFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
+G+GG V Q+ G++ A K R K + G + + L E ++L +++ +V
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSG---EKMALLEKEILEKVNSPFIVN 57
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE 346
L Y E + LV M G+L+ + V G+ + + + G+ +LH
Sbjct: 58 L-AYAFE---SKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS 113
Query: 347 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 406
I++RD+K N+LLD+ N +++DLG+A LK DG + GT GY APE
Sbjct: 114 M---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELK-DGKTITQRA-----GTNGYMAPE 164
Query: 407 YAMVGRASLMSDVFSFGVVLLELITGRQP 435
S D F+ G + E++ GR P
Sbjct: 165 ILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 75/283 (26%), Positives = 124/283 (43%), Gaps = 44/283 (15%)
Query: 234 GQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE 293
G GS Y + T G +A+K + + + + + E+D+L H V P Y +
Sbjct: 12 GNYGSVYKVLHRPT-GVTMAMKEIRLELDESKFNQIIMELDIL---HKA-VSP---YIVD 63
Query: 294 FRGKRAMRLLVF---EFMPNGNLRDCLDG-VLVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
F G + V+ E+M G+L G V EG+ D I +GL++L E
Sbjct: 64 FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH- 122
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ-GTFGYFAPEYA 408
I+HRD+K +N+L++ N K+ D G++ L A S A+ G Y APE
Sbjct: 123 -NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA--------SLAKTNIGCQSYMAPERI 173
Query: 409 MVGRA------SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 462
G ++ SDV+S G+ +LE+ GR P E ++A +L I
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY-----PPETYANIFA--QLS----AI 222
Query: 463 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
+ P L + + + +CL P+ RPT +++++
Sbjct: 223 VDGDPPTLPSGYSDDAQDFV----AKCLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 43/140 (30%), Positives = 68/140 (48%), Gaps = 24/140 (17%)
Query: 303 LVFEFMPNGNLRDCLDGVLVEGM-----NWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 357
LV E++ G DC L++ + +W + + G+E LH+ I+HRDI
Sbjct: 74 LVMEYLNGG---DC--ASLIKTLGGLPEDWAKQYIAEV--VLGVEDLHQRG---IIHRDI 123
Query: 358 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMS 417
K N+L+D+ + K+TD G+++ +GL + GT Y APE + MS
Sbjct: 124 KPENLLIDQTGHLKLTDFGLSR----NGL-----ENKKFVGTPDYLAPETILGVGDDKMS 174
Query: 418 DVFSFGVVLLELITGRQPIH 437
D +S G V+ E + G P H
Sbjct: 175 DWWSLGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 37/219 (16%)
Query: 241 VYRGQL---TDG---RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 294
VY+G L G + VA+K K + F E M SRL H ++V L+G +
Sbjct: 21 VYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT-- 78
Query: 295 RGKRAMRLLVFEFMPNGNLRDCL--------------DGVLVEGMNWDTRVAIAIGAARG 340
K ++F + + +L + L D + + V I A G
Sbjct: 79 --KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAG 136
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG---LPSCSSSPARMQ 397
+E+L ++ ++H+D+ + N+L+ + LN KI+DLG+ + + A L S P R
Sbjct: 137 MEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIR-- 191
Query: 398 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435
+ +PE M G+ S+ SD++S+GVVL E+ + G QP
Sbjct: 192 ----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 53/194 (27%), Positives = 95/194 (48%), Gaps = 27/194 (13%)
Query: 251 IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 310
+VAVK + NA + FL E+ ++SRL +++ L+ C ++ E+M N
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCIT----SDPLCMITEYMEN 103
Query: 311 GNLRDCLDGVLVEG---------MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSN 361
G+L L + +++ T + +A A G++YL ++ +HRD+ + N
Sbjct: 104 GDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRN 160
Query: 362 ILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG----TFGYFAPEYAMVGRASLMS 417
L+ +N KI D GM++ L S R+QG + + E ++G+ + S
Sbjct: 161 CLVGKNYTIKIADFGMSRNLY-------SGDYYRIQGRAVLPIRWMSWESILLGKFTTAS 213
Query: 418 DVFSFGVVLLELIT 431
DV++FGV L E++T
Sbjct: 214 DVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 16/212 (7%)
Query: 227 FSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQ--GGPNADSVFLTEVDMLSRLHHCH 283
F ++G+GG V Q+ G++ A KR + + +S+ L E +L +++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 343
VV L + K A+ LV M G+L+ + + G + + A GLE
Sbjct: 62 VVNLA---YAYETKDAL-CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLED 117
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
LH ++RD+K NILLD+ + +I+DLG+A + +P S R+ GT GY
Sbjct: 118 LHREN---TVYRDLKPENILLDDYGHIRISDLGLAVK-----IPEGESIRGRV-GTVGYM 168
Query: 404 APEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
APE R +L D + G ++ E+I G+ P
Sbjct: 169 APEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 8e-13
Identities = 56/172 (32%), Positives = 77/172 (44%), Gaps = 31/172 (18%)
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCL-DGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 348
Y + F+ K+ + +L E+ G L L D L + + R IA EYLH
Sbjct: 59 YRT-FKDKKYIYML-MEYCLGGELWTILRDRGLFD--EYTARFYIA-CVVLAFEYLHNRG 113
Query: 349 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS---CSSSPARMQGTFGYFAP 405
I++RD+K N+LLD N K+ D G AK+LK G + C GT Y AP
Sbjct: 114 ---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLK-SGQKTWTFC--------GTPEYVAP 161
Query: 406 EYAMVGRASLMSDVFSFGVVLLELITGRQP----------IHRSITKGEESL 447
E + D +S G++L EL+TGR P I+ I KG L
Sbjct: 162 EIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKL 213
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 8e-13
Identities = 56/211 (26%), Positives = 85/211 (40%), Gaps = 30/211 (14%)
Query: 233 VGQGGSSYVYR-GQLTDGRIVAVKRF----KTQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
+G+G V++ G VA+K+ G PN L E+ L H +VV L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPN---QALREIKALQACQHPYVVKL 64
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR----GLEY 343
+ F +LV E+MP+ L VL + A R G+ Y
Sbjct: 65 L---DVFPHGSGF-VLVMEYMPSD-----LSEVLRDEERPLPE-AQVKSYMRMLLKGVAY 114
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
+H I+HRD+K +N+L+ + KI D G+A+ + S A T Y
Sbjct: 115 MHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA----TRWYR 167
Query: 404 APEYAMVGRA-SLMSDVFSFGVVLLELITGR 433
APE R D+++ G + EL+ G
Sbjct: 168 APELLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 79/283 (27%), Positives = 125/283 (44%), Gaps = 51/283 (18%)
Query: 234 GQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV---FLTEVDMLSRLHHCHVVPLVGY 290
G GG+ Y + T GR+ A+K G + D+V E+++L ++H +VV
Sbjct: 85 GAGGTVYKVIHRPT-GRLYALKVIY---GNHEDTVRRQICREIEILRDVNHPNVVK---- 136
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAP 350
C + ++ EFM G+L +G + + VA I G+ YLH
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSL----EGTHIADEQFLADVARQI--LSGIAYLHRR--- 187
Query: 351 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY--- 407
I+HRDIK SN+L++ N KI D G++ R+ A + C+SS GT Y +PE
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVS-RILAQTMDPCNSS----VGTIAYMSPERINT 242
Query: 408 -----AMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 462
A G A D++S GV +LE GR P +G+ WA+ +
Sbjct: 243 DLNHGAYDGYA---GDIWSLGVSILEFYLGRFPFGVG-RQGD-----WASLM---CAICM 290
Query: 463 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
S+ P+ P + + CLQ +P R + +++Q
Sbjct: 291 SQPPEA------PATASREFRHFISCCLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 233 VGQGGSSYVYRGQ--LTDGRIVAVKRFKTQ----GGPNADSVFLTEVDMLSRLHHCHVVP 286
+G+G V++ + GR VA+KR + Q G P + + + L H +VV
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 287 LVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLH 345
L C+ R R +L LVFE + + +L LD V G+ +T + RGL++LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 346 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 405
+ R++HRD+K NIL+ + K+ D G+A+ + S + + T Y AP
Sbjct: 128 ---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR------IYSFQMALTSVVVTLWYRAP 178
Query: 406 EYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 438
E + + D++S G + E+ R+P+ R
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFR 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 232 IVGQGGSSYVYRGQL-TDGRIVAVKRF--KTQGGPNADSVFLTEVDMLSRLHHCHVVPLV 288
++G+GG V Q+ G++ A K+ K +++ L E +L +++ VV L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL- 65
Query: 289 GYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 348
Y E K A+ LV M G+L+ + + G + + V A GLE LH
Sbjct: 66 AYAYE--TKDAL-CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE- 121
Query: 349 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ-GTFGYFAPEY 407
RI++RD+K NILLD+ + +I+DLG+A + R + GT GY APE
Sbjct: 122 --RIVYRDLKPENILLDDYGHIRISDLGLAVEIP-------EGETIRGRVGTVGYMAPEV 172
Query: 408 AMVGRASLMSDVFSFGVVLLELITGRQP 435
R + D + G ++ E+I G+ P
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 72/288 (25%), Positives = 121/288 (42%), Gaps = 55/288 (19%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
+G G V+ G+ VA+K G ++ F+ E ++ +L H +V L G C+
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINE--GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
+ + +V EFM NG L + L G L + D +++ G+EYL +
Sbjct: 70 Q----QKPLYIVTEFMENGCLLNYLRQRQGKLSK----DMLLSMCQDVCEGMEYLERNS- 120
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 409
+HRD+ + N L+ K++D GM + + D SSS A+ + PE
Sbjct: 121 --FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD--EYTSSSGAKF--PVKWSPPEVFN 174
Query: 410 VGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWATPRLQDSGT 460
+ S SDV+SFGV++ E+ T G+ P + I++G
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF---------------- 218
Query: 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508
L P+L E M C P+ RPT +E+++ ++
Sbjct: 219 ---RLYRPKLASMTVYEVMY-------SCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 70/285 (24%), Positives = 126/285 (44%), Gaps = 44/285 (15%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
+G+G S VYR L DG VA+K+ + AD + E+D+L +L+H +V+
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCI--KEIDLLKQLNHPNVIK- 66
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDG------VLVEGMNWDTRVAIAIGAARGL 341
Y + F + + V E G+L + ++ E W V + L
Sbjct: 67 --YYASFIEDNELNI-VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SAL 119
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
E++H + R++HRDIK +N+ + K+ DLG+ + S +++ + GT
Sbjct: 120 EHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-----SKTTAAHSLVGTPY 171
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461
Y +PE + SD++S G +L E+ + P + + + L++ +
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY------GDKMNLYSLCK------K 219
Query: 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506
I + P L D EE++ L C+ DP+ RP ++ V +
Sbjct: 220 IEQCDYPPLPSDHYSEELR---QLVNMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 62/283 (21%), Positives = 122/283 (43%), Gaps = 36/283 (12%)
Query: 232 IVGQGGSSYVYRGQLTDGRIVAVKRFK--TQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
++ + + +Y+G + + V ++ FK +G + E+ L R+ +++ + G
Sbjct: 27 LIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AA 348
+ + L+ E+ G LR+ LD + +++ T++ +AI +GL L++
Sbjct: 86 FIIDIVDDLPRLSLILEYCTRGYLREVLD--KEKDLSFKTKLDMAIDCCKGLYNLYKYTN 143
Query: 349 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYA 408
P ++++ S + L+ EN KI G+ K L SS P + YF+ +
Sbjct: 144 KP---YKNLTSVSFLVTENYKLKIICHGLEKIL--------SSPPFKNVNFMVYFSYKML 192
Query: 409 --MVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 466
+ ++ D++S GVVL E+ TG+ P TK L +I++
Sbjct: 193 NDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL-------------IINKNN 239
Query: 467 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 509
+L D P + + + C D RP + E++ LS
Sbjct: 240 SLKLPLDCP----LEIKCIVEACTSHDSIKRPNIKEILYNLSL 278
|
Length = 283 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 66/221 (29%), Positives = 99/221 (44%), Gaps = 34/221 (15%)
Query: 227 FSGSNIVGQG--GSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHC 282
F+ +G G G+ Y R T +VA+K+ G + + + EV L +L H
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRT-NEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP 75
Query: 283 HVVPLVGYCSEFRG---KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR 339
+ + E++G + LV E+ G+ D L+ V + + AI GA +
Sbjct: 76 NTI-------EYKGCYLREHTAWLVMEYCL-GSASDILE-VHKKPLQEVEIAAICHGALQ 126
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQG 398
GL YLH + +HRDIK+ NILL E K+ D G A + SPA G
Sbjct: 127 GLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLV----------SPANSFVG 173
Query: 399 TFGYFAPE--YAM-VGRASLMSDVFSFGVVLLELITGRQPI 436
T + APE AM G+ DV+S G+ +EL + P+
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 80/307 (26%), Positives = 132/307 (42%), Gaps = 59/307 (19%)
Query: 221 EHATDKFSGSNIVGQGGSSYVYRGQLTDGRI-------VAVKRFKTQGGPNADSVFLTEV 273
E A +K + S +GQG VY G + G + VA+K FL E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 60
Query: 274 DMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR--- 330
++ + HVV L+G S+ + L++ E M G+L+ L + E N +
Sbjct: 61 SVMKEFNCHHVVRLLGVVSQGQPT----LVIMELMTRGDLKSYLRSLRPEMENNPVQAPP 116
Query: 331 -----VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK------ 379
+ +A A G+ YL+ A + +HRD+ + N ++ E+ KI D GM +
Sbjct: 117 SLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 173
Query: 380 --RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
R GL P R + +PE G + SDV+SFGVVL E+ T + +
Sbjct: 174 YYRKGGKGL-----LPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 222
Query: 438 RSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDAR 497
+ ++ E+ L R G ++ + PD + P ++M + C Q +P R
Sbjct: 223 QGMSN-EQVL------RFVMEGGLL-DKPD-----NCPDMLFELM----RMCWQYNPKMR 265
Query: 498 PTMSEVV 504
P+ E++
Sbjct: 266 PSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 27/212 (12%)
Query: 231 NIVGQGGSSYVYRGQ-LTDGRIVAVKRFKT---QGGPNADSVFLTEVDMLSRLHHCHVVP 286
N +G+G VYR + T G IVA+K+ + + G S L E+ +L L H ++V
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS--LREITLLLNLRHPNIVE 70
Query: 287 LVGYCSEFRGKRAMRL-LVFEFMPN--GNLRDCLDGVLVEGMNWDTRV-AIAIGAARGLE 342
L GK + LV E+ +L D + E ++V + + RGL+
Sbjct: 71 LKEVVV---GKHLDSIFLVMEYCEQDLASLLDNMPTPFSE-----SQVKCLMLQLLRGLQ 122
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
YLHE I+HRD+K SN+LL + KI D G+A+ GLP+ +P + T Y
Sbjct: 123 YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY---GLPAKPMTPKVV--TLWY 174
Query: 403 FAPEYAMVGRASLMS-DVFSFGVVLLELITGR 433
APE + + D+++ G +L EL+ +
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 34/219 (15%)
Query: 232 IVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNAD------SVFLTEVDMLSRLHHCHV 284
++GQG VY D GR +AVK + Q P + + E+ +L L H +
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVK--QVQFDPESPETSKEVNALECEIQLLKNLLHERI 66
Query: 285 VPLVGYCSEFRGKRAMRLLVF-EFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGL 341
V G R L +F E MP G+++D L G L E + I G+
Sbjct: 67 VQYYGC---LRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EGV 119
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK-----ADGLPSCSSSPARM 396
YLH + I+HRDIK +NIL D N K+ D G +KRL+ G+ S + +P M
Sbjct: 120 SYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWM 176
Query: 397 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
+PE +D++S G ++E++T + P
Sbjct: 177 -------SPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 77/302 (25%), Positives = 116/302 (38%), Gaps = 59/302 (19%)
Query: 231 NIVGQGGSSYVYRGQLTDGRI------VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 284
+G G VY G VAVK +S FL E ++S+ +H ++
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR---------VAIAI 335
V L+G E R R ++ E M G+L+ L E R + A
Sbjct: 72 VRLIGVSFE----RLPRFILLELMAGGDLKS----FLRENRPRPERPSSLTMKDLLFCAR 123
Query: 336 GAARGLEYLHEAAAPRILHRDIKSSNILLD---ENLNAKITDLGMAKRLKADGLPSCSSS 392
A+G +YL E +HRDI + N LL AKI D GMA+ + +S
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIY-------RAS 173
Query: 393 PARMQGT----FGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESL 447
R G + PE + G + +DV+SFGV+L E+ + G P + T E
Sbjct: 174 YYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP-YPGRTNQEVME 232
Query: 448 VLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507
+ RL P P +IM +C Q P+ RP + +++ +
Sbjct: 233 FVTGGGRLDPP----KGCPGPV---------YRIMT----DCWQHTPEDRPNFATILERI 275
Query: 508 ST 509
Sbjct: 276 QY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 26/201 (12%)
Query: 252 VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNG 311
VA+K K + + + E +++ +L + ++V ++G C + +LV E G
Sbjct: 25 VAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-----EAEALMLVMEMASGG 79
Query: 312 NLRDCL----DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 367
L L D + V + V + + G++YL +HRD+ + N+LL
Sbjct: 80 PLNKFLSGKKDEITVSNV-----VELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQ 131
Query: 368 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYFAPEYAMVGRASLMSDVFSFGVV 425
AKI+D G++K L AD S AR G + ++APE + S SDV+S+G+
Sbjct: 132 HYAKISDFGLSKALGADD----SYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGIT 187
Query: 426 LLELIT-GRQPIHRSITKGEE 445
+ E + G++P + KG E
Sbjct: 188 MWEAFSYGQKPYKK--MKGPE 206
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 63/265 (23%), Positives = 112/265 (42%), Gaps = 43/265 (16%)
Query: 252 VAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 310
VAVK K + ++E+ ++S L +H ++V L+G C+ L++ E+
Sbjct: 68 VAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT----IGGPILVITEYCCY 123
Query: 311 GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA 370
G+L + L + + ++ + A+G+ +L A+ +HRD+ + N+LL
Sbjct: 124 GDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIV 180
Query: 371 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELI 430
KI D G+A+ + D AR+ + APE + SDV+S+G++L E+
Sbjct: 181 KICDFGLARDIMNDS-NYVVKGNARL--PVKWMAPESIFNCVYTFESDVWSYGILLWEIF 237
Query: 431 TGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDF--------PKEEMQIM 482
+ L + P G + +K + P E IM
Sbjct: 238 S-----------------LGSNPY---PGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIM 277
Query: 483 AYLAKECLQLDPDARPTMSEVVQIL 507
K C DP RPT ++VQ++
Sbjct: 278 ----KTCWDADPLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 50/188 (26%), Positives = 84/188 (44%), Gaps = 33/188 (17%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
RGL+Y+H A ++HRD+K SN+L++E+ +I D GMA+ L SSSP +
Sbjct: 118 RGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGL--------SSSPTEHKY 166
Query: 399 -------TFGYFAPEYAMV-GRASLMSDVFSFGVVLLELI------TGRQPIHR-----S 439
T Y APE + + D++S G + E++ G+ +H+ S
Sbjct: 167 FMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILS 226
Query: 440 ITKGEESLVLWAT--PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDAR 497
+ VL R++ + FPK + + L++ LQ DP+ R
Sbjct: 227 VLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQ-MLQFDPEER 285
Query: 498 PTMSEVVQ 505
T+ + +Q
Sbjct: 286 ITVEQALQ 293
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG-Y 290
VG G VY+ + L G + AVK K + G + S+ E+ M+ HC++V G Y
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDF-SLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA-IAIGAARGLEYLHEAAA 349
S R + E+ G+L+D V G + ++A + +GL YLH
Sbjct: 76 LS-----REKLWICMEYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 409
+HRDIK +NILL +N + K+ D G+A ++ A + GT + APE A
Sbjct: 128 ---MHRDIKGANILLTDNGDVKLADFGVAAKITA-----TIAKRKSFIGTPYWMAPEVAA 179
Query: 410 V---GRASLMSDVFSFGVVLLELITGRQPI 436
V G + + D+++ G+ +EL + P+
Sbjct: 180 VEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 72/277 (25%), Positives = 122/277 (44%), Gaps = 48/277 (17%)
Query: 252 VAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 310
VAVK K S ++E++M+ + H +++ L+G C++ ++ E+
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ----DGPLYVIVEYASK 105
Query: 311 GNLRDCLDG--------------VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRD 356
GNLR+ L V E M + V+ ARG+EYL A+ + +HRD
Sbjct: 106 GNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRD 162
Query: 357 IKSSNILLDENLNAKITDLGMAKRL-KADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-S 414
+ + N+L+ EN KI D G+A+ + D ++ ++ + APE A+ R +
Sbjct: 163 LAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVK----WMAPE-ALFDRVYT 217
Query: 415 LMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGD 473
SDV+SFGV++ E+ T G P + I E +L R+ +EL
Sbjct: 218 HQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKLLKEGHRMDKPANCTNEL-------- 268
Query: 474 FPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
+ ++C P RPT ++V+ L I
Sbjct: 269 ---------YMMMRDCWHAIPSHRPTFKQLVEDLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 69/281 (24%), Positives = 121/281 (43%), Gaps = 36/281 (12%)
Query: 227 FSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV 285
F+ +G+G VY+G +VA+K + + E+ +LS+ ++
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 286 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA-RGLEYL 344
G S +G + ++ E++ G+ D L +E +T +A + +GL+YL
Sbjct: 66 RYYG--SYLKGTKLW--IIMEYLGGGSALDLLKPGPLE----ETYIATILREILKGLDYL 117
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 404
H + R +HRDIK++N+LL E + K+ D G+A +L + + GT + A
Sbjct: 118 H---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-----FVGTPFWMA 169
Query: 405 PEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 464
PE +D++S G+ +EL G P + VL+ P+
Sbjct: 170 PEVIKQSAYDFKADIWSLGITAIELAKGEPP----NSDLHPMRVLFLIPKNS-------- 217
Query: 465 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
P L+G + K + CL DP RPT E+++
Sbjct: 218 --PPTLEGQYSKP----FKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 71/284 (25%), Positives = 128/284 (45%), Gaps = 42/284 (14%)
Query: 227 FSGSNIVGQGGSSYVYRGQLTDGR---IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
F+ +G+G V++G D R +VA+K + + E+ +LS+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKG--IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD-GVLVEGMNWDTRVAIAIGAA-RGL 341
V G S + + ++ E++ G+ D L+ G L E T++A + +GL
Sbjct: 64 VTKYYG--SYLKDTKLW--IIMEYLGGGSALDLLEPGPLDE-----TQIATILREILKGL 114
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
+YLH + + +HRDIK++N+LL E+ K+ D G+A +L + GT
Sbjct: 115 DYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR-----NTFVGTPF 166
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461
+ APE +D++S G+ +EL G +P H + + VL+ P+
Sbjct: 167 WMAPEVIKQSAYDSKADIWSLGITAIELAKG-EPPHSELHPMK---VLFLIPKNN----- 217
Query: 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
P L+G++ K + + CL +P RPT E+++
Sbjct: 218 -----PPTLEGNYSKP----LKEFVEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 75/276 (27%), Positives = 119/276 (43%), Gaps = 37/276 (13%)
Query: 233 VGQGGSSYV-YRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G+G + V + G+ VAVK+ + + +F EV ++ HH +VV + Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF-NEVVIMRDYHHENVVDM--YN 86
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 351
S G +V EF+ G L D V MN + + + R L YLH
Sbjct: 87 SYLVGDELW--VVMEFLEGGALTDI---VTHTRMNEEQIATVCLSVLRALSYLHNQG--- 138
Query: 352 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR--MQGTFGYFAPEYAM 409
++HRDIKS +ILL + K++D G ++ + P R + GT + APE
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE-------VPKRKSLVGTPYWMAPEVIS 191
Query: 410 VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 469
D++S G++++E+I G P + P LQ + LP PR
Sbjct: 192 RLPYGTEVDIWSLGIMVIEMIDGEPP-------------YFNEPPLQAMRRIRDNLP-PR 237
Query: 470 LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
+K D K + +L L +P R T E++Q
Sbjct: 238 VK-DSHKVSSVLRGFL-DLMLVREPSQRATAQELLQ 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 80/301 (26%), Positives = 130/301 (43%), Gaps = 44/301 (14%)
Query: 219 ALEHATDKFSGSNIVGQGGSSYVYR-GQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLS 277
+L TD + +G+G VY+ DG + AVK + D E ++L
Sbjct: 16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQ 73
Query: 278 RL-HHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVA--I 333
L +H +VV G + +L LV E G++ + + G+L+ G D + I
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYI 133
Query: 334 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP 393
GA GL++LH RI+HRD+K +NILL K+ D G++ +L + L +S
Sbjct: 134 LYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV- 189
Query: 394 ARMQGTFGYFAPE---------YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 444
GT + APE Y+ R DV+S G+ +EL G P+
Sbjct: 190 ----GTPFWMAPEVIACEQQYDYSYDARC----DVWSLGITAIELGDGDPPLFDM----H 237
Query: 445 ESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVV 504
L+ PR P P L P++ + + +CL D +ARP+++ ++
Sbjct: 238 PVKTLFKIPR----------NPPPTLLH--PEKWCRSFNHFISQCLIKDFEARPSVTHLL 285
Query: 505 Q 505
+
Sbjct: 286 E 286
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 6e-12
Identities = 80/318 (25%), Positives = 126/318 (39%), Gaps = 90/318 (28%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGY 290
+G G VY + G +VA+K+ K + + + L EV L +L H ++V L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLK-- 64
Query: 291 CSE-FRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR--------G 340
E FR L VFE+M GNL M + R G
Sbjct: 65 --EVFREND--ELYFVFEYM-EGNLYQL--------MKDRKGKPFSESVIRSIIYQILQG 111
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP-ARMQGT 399
L ++H+ HRD+K N+L+ KI D G+A+ ++ S P T
Sbjct: 112 LAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIR-------SRPPYTDYVST 161
Query: 400 FGYFAPEYAMVGRASLMS---DVFSFGVVLLELITGRQP----------IHRSITKGEES 446
Y APE ++ R++ S D+++ G ++ EL T R P +++ I
Sbjct: 162 RWYRAPE--ILLRSTSYSSPVDIWALGCIMAELYTLR-PLFPGSSEIDQLYK-ICS---- 213
Query: 447 LVLWATPRLQD------------------SGTVISEL-PDPRLKGDFPKEEMQIMAYLAK 487
VL TP QD + T + +L P+ E + ++ K
Sbjct: 214 -VL-GTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNA------SPEAIDLI----K 261
Query: 488 ECLQLDPDARPTMSEVVQ 505
+ L+ DP RPT S+ +Q
Sbjct: 262 DMLRWDPKKRPTASQALQ 279
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 22/218 (10%)
Query: 227 FSGSNIVGQGGSSYVYRGQL-TDGRIVAVK-----RFKTQGGPNADSVFLTEVDMLSRLH 280
F ++G+GG V Q+ G++ A K R K + G +++ L E +L +++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG---EAMALNEKRILEKVN 58
Query: 281 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 340
VV L Y E K A+ LV M G+L+ + + G + + A G
Sbjct: 59 SRFVVSL-AYAYE--TKDAL-CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG 114
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
LE L RI++RD+K NILLD+ + +I+DLG+A + +P + R+ GT
Sbjct: 115 LEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQ-----IPEGETVRGRV-GTV 165
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 438
GY APE + + D + G ++ E+I G+ P +
Sbjct: 166 GYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 7e-12
Identities = 79/319 (24%), Positives = 125/319 (39%), Gaps = 68/319 (21%)
Query: 222 HATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVF----LTEVDML 276
K+ +GQG V++ + +IVA+K+ + N F L E+ +L
Sbjct: 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLME---NEKEGFPITALREIKIL 65
Query: 277 SRLHHCHVVPLVGYC----SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA 332
L H +VV L+ C + + + LVFEF + +L L V+
Sbjct: 66 QLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVK-FTLSEIKK 123
Query: 333 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS 392
+ GL Y+H +ILHRD+K++NIL+ ++ K+ D G+A+ S +S
Sbjct: 124 VMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSL----SKNSK 176
Query: 393 PARMQG---TFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHR---------- 438
P R T Y PE + R D++ G ++ E+ T R PI +
Sbjct: 177 PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTEQHQLTL 235
Query: 439 ------SITK----GEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAY---- 484
SIT G + L L+ ELP +G K + ++ Y
Sbjct: 236 ISQLCGSITPEVWPGVDKLELFKK----------MELP----QGQKRKVKERLKPYVKDP 281
Query: 485 ----LAKECLQLDPDARPT 499
L + L LDP R
Sbjct: 282 HALDLIDKLLVLDPAKRID 300
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 60/174 (34%), Positives = 84/174 (48%), Gaps = 30/174 (17%)
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS-CSSSPARM 396
ARG+E+L A+ + +HRD+ + NILL EN KI D G+A+ + D P AR+
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD--PDYVRKGSARL 238
Query: 397 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRL 455
+ APE + SDV+SFGV+L E+ + G P + + EE RL
Sbjct: 239 --PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP-YPGVQINEE-----FCQRL 290
Query: 456 QDSGTVIS--ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507
+D GT + E P + IM C Q DP RPT S +V+IL
Sbjct: 291 KD-GTRMRAPENATPEIYR--------IML----ACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 9e-12
Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 30/217 (13%)
Query: 232 IVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADS----VFLTEVDMLSRLHHCHVVP 286
++G+G VY D GR +AVK+ S E+ +L L H +V
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 287 LVGYCSEFRGKRAMRLLVF-EFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGLEY 343
G C R +L +F E+MP G+++D L G L E + I +G+ Y
Sbjct: 69 YYG-C--LRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL----QGVSY 121
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK-----ADGLPSCSSSPARMQG 398
LH + I+HRDIK +NIL D N K+ D G +KR++ G+ S + +P M
Sbjct: 122 LH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM-- 176
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
+PE +DV+S ++E++T + P
Sbjct: 177 -----SPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 72/276 (26%), Positives = 127/276 (46%), Gaps = 37/276 (13%)
Query: 233 VGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G+G + V + + G++VAVK+ + + +F EV ++ H +VV + Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF-NEVVIMRDYQHENVVEM--YN 84
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 351
S G +V EF+ G L D V MN + A+ + + L LH A
Sbjct: 85 SYLVGDELW--VVMEFLEGGALTDI---VTHTRMNEEQIAAVCLAVLKALSVLH---AQG 136
Query: 352 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG 411
++HRDIKS +ILL + K++D G ++ + +P S + GT + APE ++
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VPRRKS----LVGTPYWMAPE--LIS 189
Query: 412 RASLMS--DVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 469
R D++S G++++E++ G P + P L+ + LP P+
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGEPP-------------YFNEPPLKAMKMIRDNLP-PK 235
Query: 470 LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
LK + K + +L + L DP R T +E+++
Sbjct: 236 LK-NLHKVSPSLKGFLDR-LLVRDPAQRATAAELLK 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 78/313 (24%), Positives = 124/313 (39%), Gaps = 65/313 (20%)
Query: 224 TDKFSGSNIVGQGGSSYV--YRGQLTDGRIVAVKR----FKTQGGPNADSVFLTEVDMLS 277
T+++ VG G V R QLT G+ VA+K+ F T A + E+ +L
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPV--LAKRTY-RELKLLK 64
Query: 278 RLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA--IAI 335
L H +++ L F V E + R L+ + +
Sbjct: 65 HLRHENIISL---SDIFISPLEDIYFVTELLGTDLHR------LLTSRPLEKQFIQYFLY 115
Query: 336 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 395
RGL+Y+H A ++HRD+K SNIL++EN + KI D G+A+ +
Sbjct: 116 QILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR-----------IQDPQ 161
Query: 396 MQG---TFGYFAPEYAMV-GRASLMSDVFSFGVVLLELIT------GRQPIHR--SITKG 443
M G T Y APE + + + D++S G + E++ G+ +++ IT
Sbjct: 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITD- 220
Query: 444 EESLVLWATPRLQDSGTVISE--------LP--DPR-LKGDFPKEEMQIMAYLAKECLQL 492
L TP T+ SE LP +P F + + L K L
Sbjct: 221 -----LLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEK-MLVF 274
Query: 493 DPDARPTMSEVVQ 505
DP R + +E +
Sbjct: 275 DPQKRISAAEALA 287
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 67/238 (28%), Positives = 98/238 (41%), Gaps = 58/238 (24%)
Query: 233 VGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVD-------MLSRLHHCHV 284
+G G V + G+ A+K V L +V+ +L + H
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKA-----KIVKLKQVEHVLNEKRILQSIRH--- 60
Query: 285 VP-LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIA-IGAARG 340
P LV F+ + LV E++P G L L G E + R A + A
Sbjct: 61 -PFLVNLYGSFQDDSNL-YLVMEYVPGGELFSHLRKSGRFPEPV---ARFYAAQVVLA-- 113
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
LEYLH I++RD+K N+LLD + KITD G AKR+K C GT
Sbjct: 114 LEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC--------GTP 162
Query: 401 GYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 444
Y APE Y G+A D ++ G+++ E++ G P I+ I +G+
Sbjct: 163 EYLAPEIILSKGY---GKA---VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK 214
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 71/276 (25%), Positives = 122/276 (44%), Gaps = 46/276 (16%)
Query: 252 VAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 310
VAVK K + ++E++++ + H +++ L+G C++ ++ E+
Sbjct: 47 VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ----EGPLYVIVEYAAK 102
Query: 311 GNLRDCL------------DGVLV--EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRD 356
GNLR+ L D V E +++ V+ A ARG+EYL + R +HRD
Sbjct: 103 GNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL---ESRRCIHRD 159
Query: 357 IKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SL 415
+ + N+L+ E+ KI D G+A+ + +S R+ + APE A+ R +
Sbjct: 160 LAARNVLVTEDNVMKIADFGLARGVHDIDYYK-KTSNGRL--PVKWMAPE-ALFDRVYTH 215
Query: 416 MSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDF 474
SDV+SFG+++ E+ T G P + I E +L R+ EL
Sbjct: 216 QSDVWSFGILMWEIFTLGGSP-YPGIPVEELFKLLREGHRMDKPSNCTHEL--------- 265
Query: 475 PKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
L +EC P RPT ++V+ L +
Sbjct: 266 --------YMLMRECWHAVPTQRPTFKQLVEALDKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 61/237 (25%), Positives = 95/237 (40%), Gaps = 48/237 (20%)
Query: 232 IVGQGGSSYVYRGQL----TDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVV 285
++G+G V L G++ A+K + + + E D+L+ +V
Sbjct: 8 VIGRGAFGEV---WLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIV 64
Query: 286 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIA-IGAARGLE 342
L Y S F+ + + LV E+MP G+L + L V E R IA + A L+
Sbjct: 65 KL--YYS-FQDEEHL-YLVMEYMPGGDLMNLLIRKDVFPEET---ARFYIAELVLA--LD 115
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG----------------- 385
+H+ +HRDIK NIL+D + + K+ D G+ K++
Sbjct: 116 SVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172
Query: 386 -LPSCSSSPARMQ------GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
L R GT Y APE L D +S GV+L E++ G P
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 40/109 (36%), Positives = 56/109 (51%), Gaps = 15/109 (13%)
Query: 332 AIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS 391
IA+ + L YL E +I+HRD+K SNILLD N N K+ D G++ +L
Sbjct: 111 KIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV--------D 160
Query: 392 SPARMQ--GTFGYFAPEYAMVGRAS---LMSDVFSFGVVLLELITGRQP 435
S A+ + G Y APE + SDV+S G+ L E+ TG+ P
Sbjct: 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 69/230 (30%), Positives = 114/230 (49%), Gaps = 28/230 (12%)
Query: 233 VGQGGSSYVYRG--QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
+G+G + V++G +LT +VA+K + + A + EV +L L H ++V L
Sbjct: 13 LGEGTYATVFKGRSKLT-ENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAI-GAARGLEYLHEA 347
+R + L VFE++ + +L+ LD G L+ N V I + RGL Y H+
Sbjct: 72 ---IHTERCLTL-VFEYLDS-DLKQYLDNCGNLMSMHN----VKIFMFQLLRGLSYCHKR 122
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
+ILHRD+K N+L++E K+ D G+A +A +P+ + S + T Y P+
Sbjct: 123 ---KILHRDLKPQNLLINEKGELKLADFGLA---RAKSVPTKTYSNEVV--TLWYRPPD- 173
Query: 408 AMVGRASLMS--DVFSFGVVLLELITGRQPIHRSITKGEESLV--LWATP 453
++G + D++ G +L E+ TGR S K E L+ L TP
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTP 223
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 72/258 (27%), Positives = 118/258 (45%), Gaps = 38/258 (14%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
+G+G VY+G+ G+IVA+K+ + +G P S + E+ +L L H ++V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVP---STAIREISLLKELQHPNIVCL 64
Query: 288 VGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRV-AIAIGAARGLEYLH 345
+ RL L+FEF+ + +L+ LD + V + +G+ + H
Sbjct: 65 QDVLMQ-----ESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 346 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG----TFG 401
+ R+LHRD+K N+L+D K+ D G+A +A G+ P R+ T
Sbjct: 119 ---SRRVLHRDLKPQNLLIDNKGVIKLADFGLA---RAFGI------PVRVYTHEVVTLW 166
Query: 402 YFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIH--RSITKGEESLVLWATPRLQDS 458
Y APE + R S D++S G + E+ T + H I + + TP +D
Sbjct: 167 YRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPT-EDV 225
Query: 459 GTVISELPDPRLKGDFPK 476
++ LPD K FPK
Sbjct: 226 WPGVTSLPD--YKNTFPK 241
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 3e-11
Identities = 70/288 (24%), Positives = 116/288 (40%), Gaps = 36/288 (12%)
Query: 227 FSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHV 284
F +VG G VY+G+ + G++ A+K G + + E++ML + HH ++
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNI 65
Query: 285 VPLVGYCSEFR--GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 342
G + G LV EF G++ D + + + I RGL
Sbjct: 66 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
+LH+ +++HRDIK N+LL EN K+ D G++ +L GT +
Sbjct: 126 HLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD-----RTVGRRNTFIGTPYW 177
Query: 403 FAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 457
APE SD++S G+ +E+ G P + L+ PR
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP----LCDMHPMRALFLIPR--- 230
Query: 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
P PRLK ++ Q + CL + RPT ++++
Sbjct: 231 -------NPAPRLKSKKWSKKFQ---SFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 4e-11
Identities = 61/189 (32%), Positives = 85/189 (44%), Gaps = 42/189 (22%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
RGL+Y+H A I+HRD+K SNI ++E+ KI D G+A R D M G
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLA-RHTDD----------EMTG 174
Query: 399 ---TFGYFAPEYAMVGRASLMS-----DVFSFGVVLLELITGRQ--PIHRSITKGEESLV 448
T Y APE M+ M D++S G ++ EL+TG+ P I + + +
Sbjct: 175 YVATRWYRAPE-IMLNW---MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMN 230
Query: 449 LWATPR--------LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQ----LDPDA 496
L TP + + I LP K DF KE LA + L+ LDPD
Sbjct: 231 LVGTPDEELLQKISSESARNYIQSLP-QMPKKDF-KEVFSGANPLAIDLLEKMLVLDPDK 288
Query: 497 RPTMSEVVQ 505
R T +E +
Sbjct: 289 RITAAEALA 297
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 72/280 (25%), Positives = 117/280 (41%), Gaps = 43/280 (15%)
Query: 233 VGQGGSSYVYRG---QLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLV 288
+G G V +G + VAVK K P L E +++ +L + ++V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 289 GYCSEFRGKRAMRLLVFEFMPNGNLRDCLD---GVLVEGMNWDTRVAIAIGAARGLEYLH 345
G C + M LV E G L L V + + + + G++YL
Sbjct: 63 GIC---EAESWM--LVMELAELGPLNKFLQKNKHVTEKNI-----TELVHQVSMGMKYLE 112
Query: 346 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF--GYF 403
E +HRD+ + N+LL AKI+D G++K L AD + A+ G + ++
Sbjct: 113 ET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADE----NYYKAKTHGKWPVKWY 165
Query: 404 APEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463
APE + S SDV+SFGV++ E + Q ++ + E + ++ + R+
Sbjct: 166 APECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERM-------- 217
Query: 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV 503
E P P E M L K C D RP + V
Sbjct: 218 ECPQ-----RCPPE----MYDLMKLCWTYGVDERPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 69/226 (30%), Positives = 96/226 (42%), Gaps = 29/226 (12%)
Query: 225 DKFSGSNIVGQG--GSSYVYRGQLTDGRIVAVKRFKTQ--GGPNADSVFLTEVDMLSRLH 280
F ++VG+G G V R + T G I A+K K S F E D+LS
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT-GDIYAMKVMKKSVLLAQETVSFFEEERDILSI-S 58
Query: 281 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGA 337
+ +P + Y F+ K + LV E+ P G+L L + E M
Sbjct: 59 NSPWIPQLQYA--FQDKDNL-YLVMEYQPGGDLLSLLNRYEDQFDEDM-------AQFYL 108
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
A + +H +HRDIK N+L+D + K+ D G A RL A+ + + S P
Sbjct: 109 AELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN-SKLPV--- 164
Query: 398 GTFGYFAPEY--AMVGRASLMSDV----FSFGVVLLELITGRQPIH 437
GT Y APE M G V +S GV+ E+I GR P H
Sbjct: 165 GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 63/240 (26%), Positives = 105/240 (43%), Gaps = 41/240 (17%)
Query: 272 EVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD---GVLV---EGM 325
E +LS+L H ++V Y + G+ + +V F G+L L G L+ + +
Sbjct: 49 EAQLLSQLKHPNIV---AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVV 105
Query: 326 NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 385
W ++A+A L+YLHE ILHRD+K+ N+ L K+ DLG+A+ L+
Sbjct: 106 EWFVQIAMA------LQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE--- 153
Query: 386 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEE 445
+ + + GT Y +PE + SDV++ G + E+ T + H K
Sbjct: 154 --NQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK---HAFNAKDMN 208
Query: 446 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
SLV I E P + D+ E + L L P+ RP++ +++
Sbjct: 209 SLVY-----------RIIEGKLPPMPKDYSPE----LGELIATMLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G G VY+ + + G + A+K K + G + V E+ M+ H ++V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFA-VVQQEIIMMKDCKHSNIVAYFG-- 73
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA-IAIGAARGLEYLHEAAAP 350
S R R + EF G+L+D V G ++++A ++ +GL YLH
Sbjct: 74 SYLR--RDKLWICMEFCGGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKGK- 127
Query: 351 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV 410
+HRDIK +NILL +N + K+ D G++ ++ A + GT + APE A V
Sbjct: 128 --MHRDIKGANILLTDNGHVKLADFGVSAQITA-----TIAKRKSFIGTPYWMAPEVAAV 180
Query: 411 GRA---SLMSDVFSFGVVLLELITGRQPI 436
R + + D+++ G+ +EL + P+
Sbjct: 181 ERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 8e-11
Identities = 58/183 (31%), Positives = 90/183 (49%), Gaps = 20/183 (10%)
Query: 272 EVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRV 331
E D+L+ ++H +V L Y + GK L+ +F+ G+L L E M + V
Sbjct: 48 ERDILAEVNHPFIVKL-HYAFQTEGKL---YLILDFLRGGDLFTRLSK---EVMFTEEDV 100
Query: 332 AIAIGA-ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 390
+ A L++LH I++RD+K NILLDE + K+TD G++K D
Sbjct: 101 KFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAY 156
Query: 391 SSPARMQGTFGYFAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 448
S GT Y APE +V R + +D +SFGV++ E++TG P K +++
Sbjct: 157 S----FCGTVEYMAPE--VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210
Query: 449 LWA 451
L A
Sbjct: 211 LKA 213
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 8e-11
Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 12/99 (12%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
RGL+YLH A ++HRD+K SNIL++ N + KI D G+A+ + D +
Sbjct: 114 RGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE-----DEKGFLTE 165
Query: 399 ---TFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGR 433
T Y APE + R + D++S G + EL+T +
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 77/302 (25%), Positives = 137/302 (45%), Gaps = 41/302 (13%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ--LTDGRIVAVKRFK-TQGGPNADSVFLTEVDMLSRLHH 281
D++ +G+G VY+ + +T+ +A+K+ + Q S + E+ +L + H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTN-ETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 282 CHVVPL--VGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA 338
++V L V + + RL LVFE++ + +L+ +D N
Sbjct: 61 GNIVRLQDVVHSEK-------RLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQIL 112
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNA-KITDLGMAKRLKADGLPSCSSSPARMQ 397
RG+ Y H + R+LHRD+K N+L+D NA K+ D G+A +A G+P + + +
Sbjct: 113 RGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLA---RAFGIPVRTFTHEVV- 165
Query: 398 GTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQ--PIHRSITKGEESLVLWATPR 454
T Y APE + R S D++S G + E++ + P I + + + TP
Sbjct: 166 -TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPN 224
Query: 455 LQDSGTVISELPDPRLKGDFPKEEMQIMAY-----------LAKECLQLDPDARPTMSEV 503
+++ ++ LPD K FPK + +A L + L+LDP R T
Sbjct: 225 -EETWPGVTSLPD--YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAA 281
Query: 504 VQ 505
++
Sbjct: 282 LE 283
|
Length = 294 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 58/182 (31%), Positives = 85/182 (46%), Gaps = 40/182 (21%)
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS-CSSSPARM 396
ARG+E+L A+ + +HRD+ + NILL EN KI D G+A+ + D P AR+
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD--PDYVRKGDARL 237
Query: 397 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 456
+ APE + SDV+SFGV+L E+ + L A+P
Sbjct: 238 --PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS-----------------LGASPY-- 276
Query: 457 DSGTVISELPDPRLKG-------DFPKEEM-QIMAYLAKECLQLDPDARPTMSEVVQILS 508
G I E RLK ++ E+ IM +C +P+ RPT SE+V+IL
Sbjct: 277 -PGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIML----DCWHNNPEDRPTFSELVEILG 331
Query: 509 TI 510
+
Sbjct: 332 DL 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 73/289 (25%), Positives = 120/289 (41%), Gaps = 35/289 (12%)
Query: 233 VGQGGSSYVYRGQLT-DGRI--VAVKRFKTQGGPNAD-SVFLTEVDMLSRLHHCHVVPLV 288
+G+G V GQL D I VAVK K ++ FL+E + H +V+ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 289 GYC---SEFRGKRAMRLLVFEFMPNGNLRDCLD----GVLVEGMNWDTRVAIAIGAARGL 341
G C E G + +++ FM +G+L L G + + V A G+
Sbjct: 67 GVCLQTVESEGYPS-PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
EYL ++ +HRD+ + N +L+EN+N + D G++K++ +G A+M
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI-YNGDYYRQGRIAKM--PVK 179
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461
+ A E + SDV+SFGV + E+ T Q + + E L RL+
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQ---- 235
Query: 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
P + + + L C L+P RP+ + L
Sbjct: 236 -------------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 47/170 (27%), Positives = 79/170 (46%), Gaps = 24/170 (14%)
Query: 272 EVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNL----RDCLDGVLVEGM-- 325
E +L+++ H ++V + F + +V E+ G+L + + E
Sbjct: 48 EAVLLAKMKHPNIV---AFKESFEADGHL-YIVMEYCDGGDLMQKIKLQRGKLFPEDTIL 103
Query: 326 NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 385
W ++ + G++++HE R+LHRDIKS NI L +N K+ D G A+ L + G
Sbjct: 104 QWFVQMCL------GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154
Query: 386 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
+C+ GT Y PE + SD++S G +L EL T + P
Sbjct: 155 AYACT-----YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 67/283 (23%), Positives = 123/283 (43%), Gaps = 40/283 (14%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKT--QGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
+G+G S VYR L D + VA+K+ + A + E+D+L +L+H +V+
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIK--- 66
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCL------DGVLVEGMNWDTRVAIAIGAARGLEY 343
Y F + + V E G+L + ++ E W V + +E+
Sbjct: 67 YLDSFIEDNELNI-VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SAVEH 121
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
+H + R++HRDIK +N+ + K+ DLG+ + + +++ + GT Y
Sbjct: 122 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-----TTAAHSLVGTPYYM 173
Query: 404 APEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463
+PE + SD++S G +L E+ + P + G++ + + I
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY-----GDKMNLFSLCQK-------IE 221
Query: 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506
+ P L + E+++ L C+ DPD RP + V QI
Sbjct: 222 QCDYPPLPTEHYSEKLR---ELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 62/219 (28%), Positives = 106/219 (48%), Gaps = 25/219 (11%)
Query: 233 VGQGGSSYVYRG--QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
+G+G + VY+G +LTD +VA+K + + A + EV +L L H ++V L
Sbjct: 14 LGEGTYATVYKGRSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL--- 69
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGLEYLHEAA 348
+ LVFE++ + +L+ LD G + N + + RGL Y H
Sbjct: 70 -HDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLL---RGLNYCHRR- 123
Query: 349 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYA 408
++LHRD+K N+L++E K+ D G+A +A +P+ + S + T Y P+
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLA---RAKSIPTKTYSNEVV--TLWYRPPD-I 175
Query: 409 MVGRA--SLMSDVFSFGVVLLELITGRQPIHRSITKGEE 445
++G S D++ G + E+ TGR P+ T E+
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGR-PLFPGSTVEEQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 61/231 (26%), Positives = 97/231 (41%), Gaps = 25/231 (10%)
Query: 218 SALEHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDML 276
SAL F +VG G VY+G+ + G++ A+K + + E++ML
Sbjct: 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--EDEEEEIKLEINML 66
Query: 277 SRL-HHCHVVPLVGYCSEFR--GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAI 333
+ HH ++ G + G LV EF G++ D + + D I
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYI 126
Query: 334 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP 393
RGL +LH A +++HRDIK N+LL EN K+ D G++ +L +
Sbjct: 127 CREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--------DRTV 175
Query: 394 ARMQ---GTFGYFAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPI 436
R GT + APE SD++S G+ +E+ G P+
Sbjct: 176 GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 66/220 (30%), Positives = 96/220 (43%), Gaps = 32/220 (14%)
Query: 227 FSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCH 283
F G + +G G VY +VAVK+ G + + EV L +L H +
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 284 VVPLVGYCSEFRG---KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 340
+ E++G K LV E+ G+ D L+ V + + AI GA +G
Sbjct: 83 TI-------EYKGCYLKEHTAWLVMEYCL-GSASDLLE-VHKKPLQEVEIAAITHGALQG 133
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQGT 399
L YLH ++HRDIK+ NILL E K+ D G A + SSPA GT
Sbjct: 134 LAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASK----------SSPANSFVGT 180
Query: 400 FGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPI 436
+ APE + G+ DV+S G+ +EL + P+
Sbjct: 181 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 27/225 (12%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKT----QGGPNADSVFLTEVDMLSRL 279
D + +G+G VY+ + G++VA+K+ + +G P L E+ +L L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIP---PTALREISLLQML 57
Query: 280 HHC-HVVPL--VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGV---LVEGMNWDTRVAI 333
++V L V + E GK LVFE++ + +L+ +D + T +
Sbjct: 58 SESIYIVRLLDVEHVEEKNGK-PSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 334 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA-KITDLGMAKRLKADGLPSCSSS 392
+G+ + H+ ++HRD+K N+L+D+ KI DLG+ +A +P S +
Sbjct: 116 MYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLG---RAFSIPVKSYT 169
Query: 393 PARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPI 436
+ T Y APE + S D++S G + E+ +QP+
Sbjct: 170 HEIV--TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR-KQPL 211
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 66/213 (30%), Positives = 99/213 (46%), Gaps = 34/213 (15%)
Query: 233 VGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLVG 289
VGQGG V+ + D G IVA+KR K + V LTE D+L+ +V L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAI-----AIGAARGLE 342
Y F+ + L E++P G+ R L+ GVL E R + A+ A
Sbjct: 68 Y--AFQDDEYL-YLAMEYVPGGDFRTLLNNLGVLSED---HARFYMAEMFEAVDA----- 116
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
LHE +HRD+K N L+D + + K+TD G++K G+ + ++S + G+ Y
Sbjct: 117 -LHELG---YIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANS---VVGSPDY 164
Query: 403 FAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
APE D +S G +L E + G P
Sbjct: 165 MAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 52/176 (29%), Positives = 84/176 (47%), Gaps = 26/176 (14%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
GL++LH I++RD+K NILLD + + KI D GM K +C+ GT
Sbjct: 108 GLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-----FCGT 159
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH--------RSITKGEESLVLWA 451
Y APE + + + D +SFGV+L E++ G+ P H +SI W
Sbjct: 160 PDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWL 219
Query: 452 TPRLQDSGTVISEL----PDPRL--KGDFPKEEM-QIMAYLAKECLQLDPDARPTM 500
T +D ++ +L P+ RL KGD + + + + A E +++P +P +
Sbjct: 220 TREAKD---ILVKLFVREPERRLGVKGDIRQHPFFREIDWSALEEREIEPPFKPKV 272
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 233 VGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G G VY+ + + G + A K +T+ + ++ E+++L+ +H ++V L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-YMVEIEILATCNHPYIVKLLG-A 77
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 351
+ GK ++ EF P G +D +++E T I + + LE L + +
Sbjct: 78 FYWDGKLW---IMIEFCPGG----AVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK 130
Query: 352 ILHRDIKSSNILLDENLNAKITDLGM-AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV 410
I+HRD+K+ N+LL + + K+ D G+ AK +K L S GT + APE M
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQRRDS----FIGTPYWMAPEVVMC 184
Query: 411 GRAS-----LMSDVFSFGVVLLELITGRQPIH 437
+D++S G+ L+E+ P H
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHH 216
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-10
Identities = 49/174 (28%), Positives = 80/174 (45%), Gaps = 21/174 (12%)
Query: 269 FLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL--VFEFMPNGNLRDCL--DGVLVEG 324
F E + +RL+H ++V L+ G+ LL VFE++P LR+ L DG L G
Sbjct: 25 FRRETALCARLYHPNIVALLD-----SGEAPPGLLFAVFEYVPGRTLREVLAADGALPAG 79
Query: 325 MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRL 381
+ + L H I+HRD+K NI++ +AK+ D G+ L
Sbjct: 80 ----ETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLL 132
Query: 382 KA--DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 433
D + + + GT Y APE + SD++++G++ LE +TG+
Sbjct: 133 PGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 73/319 (22%), Positives = 121/319 (37%), Gaps = 51/319 (15%)
Query: 234 GQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFL-TEVDMLSRLHHCHVVPLVGYCS 292
++ + + T +VAVK+ D L E+ +L H +++P Y +
Sbjct: 11 EDLMIVHLAKHKPT-NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP---YVT 66
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI---GAARGLEYLHEAAA 349
F + +V M G+ D L EG+ +AIA L+Y+H
Sbjct: 67 SFIVDSEL-YVVSPLMAYGSCEDLLKTHFPEGLP---ELAIAFILKDVLNALDYIHSKG- 121
Query: 350 PRILHRDIKSSNILLDENLNAKITDL----GMAKRLKADGLPSCSSSPARMQGTFGYFAP 405
+HR +K+S+ILL + ++ L M K K + P + +P
Sbjct: 122 --FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD--FPKSSVKNLPWLSP 177
Query: 406 EYAMVGRASLM-----SDVFSFGVVLLELITGRQP---IHRSITKGEESLVLWATPRLQD 457
E V + +L SD++S G+ EL G P + + E+ V P L D
Sbjct: 178 E---VLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK--VRGTVPCLLD 232
Query: 458 SGTVI---SELPDPRLKGDFPKEEMQIMAY-----------LAKECLQLDPDARPTMSEV 503
T + R + P + + CLQ DP++RP+ S
Sbjct: 233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSAS-- 290
Query: 504 VQILSTIAPDKSRRRNISL 522
Q+L+ + +RRN SL
Sbjct: 291 -QLLNHSFFKQCKRRNTSL 308
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 56/222 (25%), Positives = 107/222 (48%), Gaps = 33/222 (14%)
Query: 226 KFSGSNIVGQG--GSSYVYRGQLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHHC 282
++ +G+G G Y+ + + +D +K P + EV +L+++ H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD---GVLVEG---MNWDTRVAIAIG 336
++V + + F+ + +V E+ G+L ++ GVL ++W ++++
Sbjct: 60 NIV---TFFASFQENGRL-FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL--- 112
Query: 337 AARGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKITDLGMAKRLK--ADGLPSCSSSP 393
GL+++H+ +ILHRDIKS NI L +N + AK+ D G+A++L + +C +P
Sbjct: 113 ---GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTP 166
Query: 394 ARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
Y +PE + +D++S G VL EL T + P
Sbjct: 167 Y-------YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 73/268 (27%), Positives = 120/268 (44%), Gaps = 35/268 (13%)
Query: 249 GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 308
GR VAVK + + +F EV ++ H +VV + Y S G+ L+ EF+
Sbjct: 46 GRQVAVKMMDLRKQQRRELLF-NEVVIMRDYQHQNVVEM--YKSYLVGEELWVLM--EFL 100
Query: 309 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL 368
G L D + +N + + + L YLH + ++HRDIKS +ILL +
Sbjct: 101 QGGALTDIVSQTR---LNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDG 154
Query: 369 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLE 428
K++D G ++ D +P S + GT + APE D++S G++++E
Sbjct: 155 RVKLSDFGFCAQISKD-VPKRKS----LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIE 209
Query: 429 LITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE 488
++ G P +S V A RL+DS P P+LK + K + +L +
Sbjct: 210 MVDGEPPYF------SDSPV-QAMKRLRDS-------PPPKLK-NAHKISPVLRDFLER- 253
Query: 489 CLQLDPDARPTMSEVVQ---ILSTIAPD 513
L +P R T E++ +L T P+
Sbjct: 254 MLTREPQERATAQELLDHPFLLQTGLPE 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 58/177 (32%), Positives = 89/177 (50%), Gaps = 30/177 (16%)
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS-CSSSPARM 396
A+G+E+L A+ + +HRD+ + NILL EN KI D G+A+ + D P AR+
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD--PDYVRKGDARL 243
Query: 397 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRL 455
+ APE ++ SDV+SFGV+L E+ + G P + + EE RL
Sbjct: 244 --PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEFCR-----RL 295
Query: 456 QDSGTVISELPDPRLKG-DFPKEEM-QIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
++ GT R++ D+ EM Q M +C +P RPT SE+V+ L +
Sbjct: 296 KE-GT--------RMRAPDYTTPEMYQTML----DCWHGEPSQRPTFSELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 69/257 (26%), Positives = 125/257 (48%), Gaps = 30/257 (11%)
Query: 233 VGQGGSSYVYRG--QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
+G+G + V++G +LT+ +VA+K + + A + EV +L L H ++V L
Sbjct: 14 LGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL--- 69
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAI-GAARGLEYLHEA 347
+ LVFE++ + +L+ +D G ++ N V I + RGL Y H
Sbjct: 70 -HDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHN----VKIFLYQILRGLAYCHRR 123
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
++LHRD+K N+L++E K+ D G+A +A +P+ + S + T Y P+
Sbjct: 124 ---KVLHRDLKPQNLLINERGELKLADFGLA---RAKSVPTKTYSNEVV--TLWYRPPD- 174
Query: 408 AMVGRA--SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV--LWATPRLQDSGTVIS 463
++G + S D++ G + E+ +GR S + E L+ L TP +++ IS
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPT-EETWPGIS 233
Query: 464 ELPDPRLKGDFPKEEMQ 480
+ + +FPK + Q
Sbjct: 234 SNDEFK-NYNFPKYKPQ 249
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 37/96 (38%), Positives = 51/96 (53%), Gaps = 8/96 (8%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
RGL+YLH A ILHRDIK N+L++ N KI D G+A+ + D S + +
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD--ESKHMTQEVV-- 166
Query: 399 TFGYFAPEYAMVGRASLMS-DVFSFGVVLLELITGR 433
T Y APE M R + D++S G + EL+ R
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 71/286 (24%), Positives = 122/286 (42%), Gaps = 50/286 (17%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
+G G VY+ Q + ++A + ++ E+D+L+ H ++V L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL---D 69
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE---YLHEAAA 349
F + + +L+ EF G +D V++E T I + + LE YLHE
Sbjct: 70 AFYYENNLWILI-EFCAGG----AVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN-- 122
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 409
+I+HRD+K+ NIL + + K+ D G++ + + S GT + APE M
Sbjct: 123 -KIIHRDLKAGNILFTLDGDIKLADFGVSAK-NTRTIQRRDS----FIGTPYWMAPEVVM 176
Query: 410 VGRAS-----LMSDVFSFGVVLLELITGRQPIH-----RSITKGEESLVLWATPRLQDSG 459
+ +DV+S G+ L+E+ P H R + K +S P L
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS----EPPTLAQPS 232
Query: 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
SE D +L K+CL+ + DAR T ++++Q
Sbjct: 233 RWSSEFKD----------------FL-KKCLEKNVDARWTTTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 8e-10
Identities = 80/310 (25%), Positives = 130/310 (41%), Gaps = 52/310 (16%)
Query: 227 FSGSNIVGQG--GSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHC 282
F+ +G G G+ Y R T+ +VA+K+ G + + + EV L R+ H
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTN-EVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHP 85
Query: 283 HVVPLVGYCSEFRG---KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR 339
+ + E++G + LV E+ G+ D L+ V + + AI GA +
Sbjct: 86 NSI-------EYKGCYLREHTAWLVMEYCL-GSASDLLE-VHKKPLQEVEIAAITHGALQ 136
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
GL YLH + ++HRDIK+ NILL E K+ D G A S +S GT
Sbjct: 137 GLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSA---------SIASPANSFVGT 184
Query: 400 FGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 456
+ APE + G+ DV+S G+ +EL + P+ + A L
Sbjct: 185 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN----------MNAMSALY 234
Query: 457 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSR 516
I++ P L+ + E CLQ P RPT E+++ + + + R
Sbjct: 235 H----IAQNESPTLQSN---EWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL---RER 284
Query: 517 RRNISLNLFQ 526
+ ++L Q
Sbjct: 285 PETVLIDLIQ 294
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 39/124 (31%), Positives = 52/124 (41%), Gaps = 19/124 (15%)
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
EYLH I++RD+K N+LLD + K+TD G AK++ C GT
Sbjct: 132 EYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC--------GTPE 180
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESLVLWATP 453
Y APE D ++ GV+L E I G P I+ I G W
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDG 240
Query: 454 RLQD 457
R +D
Sbjct: 241 RARD 244
|
Length = 329 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 37/101 (36%), Positives = 56/101 (55%), Gaps = 14/101 (13%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK-RLKADGLPS--CSSSPARM 396
GL++LH+ I++RD+K N+LLD++ + KI D GM K + +G S C
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC------- 157
Query: 397 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
GT Y APE + + D +SFGV+L E++ G+ P H
Sbjct: 158 -GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
D + +G+G + VY+G+ +G++VA+K + Q + E +L L H +
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 343
+V L + + LVFE++ + +L +D G++ + RGL Y
Sbjct: 65 IVLL----HDIIHTKETLTLVFEYV-HTDLCQYMDK-HPGGLHPENVKLFLFQLLRGLSY 118
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
+H+ ILHRD+K N+L+ + K+ D G+A +A +PS + S + T Y
Sbjct: 119 IHQR---YILHRDLKPQNLLISDTGELKLADFGLA---RAKSVPSHTYSNEVV--TLWYR 170
Query: 404 APEYAMVGRA--SLMSDVFSFGVVLLELITG 432
P+ ++G S D++ G + +E+I G
Sbjct: 171 PPD-VLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 35/97 (36%), Positives = 48/97 (49%), Gaps = 9/97 (9%)
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
L++LH+ I++RDIK NILLD + +TD G++K A+ S GT
Sbjct: 118 LDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS----FCGTI 170
Query: 401 GYFAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQP 435
Y APE G D +S GV+ EL+TG P
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 80/331 (24%), Positives = 129/331 (38%), Gaps = 84/331 (25%)
Query: 233 VGQGGSSYVYRGQL---TDGRIVAVKRFKTQGGPNADSVFLT-----EVDMLSRLHHCHV 284
+G+G VY+ + DG+ A+K+FK G ++ E+ +L L H +V
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFK---GDKEQYTGISQSACREIALLRELKHENV 64
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR-VAIAIGAA----- 338
V LV E K L+F++ + D L + + + + ++I +
Sbjct: 65 VSLVEVFLEHADKSVY--LLFDYAEH-------D--LWQIIKFHRQAKRVSIPPSMVKSL 113
Query: 339 -----RGLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMAKRLKADGLPSC 389
G+ YLH +LHRD+K +NIL+ E KI DLG+A+ A P
Sbjct: 114 LWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170
Query: 390 SSSPARMQGTFGYFAPEYAMVGRASLMS-DVFSFGVVLLELIT------GRQ-------P 435
P + T Y APE + R + D+++ G + EL+T GR+ P
Sbjct: 171 DLDPVVV--TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNP 228
Query: 436 IHR----SITKGEESLVLWATPRLQDSGTVISELPD-PRLKGDFPKEE---------MQI 481
R I + VL TP +D + +P+ L DF + M+
Sbjct: 229 FQRDQLERIFE-----VL-GTPTEKDWPDIKK-MPEYDTLMKDFKTKTYPSNSLAKWMEK 281
Query: 482 MAYLAKECLQL-------DPDARPTMSEVVQ 505
+ L DP R T E ++
Sbjct: 282 HKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 51/164 (31%), Positives = 75/164 (45%), Gaps = 32/164 (19%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
LE+LH+ I++RDIK NILLD N + +TD G++K D + S GT
Sbjct: 117 ALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS----FCGT 169
Query: 400 FGYFAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 457
Y AP+ G D +S GV++ EL+TG P GE++ + R+
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF---TVDGEKNSQAEISRRILK 226
Query: 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQL----DPDAR 497
S +P +P+E M+ LAK+ +Q DP R
Sbjct: 227 S--------EP----PYPQE----MSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 2e-09
Identities = 47/184 (25%), Positives = 82/184 (44%), Gaps = 24/184 (13%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ- 397
+ L+Y+H ++HRD+K SNILL+ + K+ D G+A+ L L +P
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL--SELEENPENPVLTDY 172
Query: 398 -GTFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 454
T Y APE ++G R + D++S G +L E++ G+ + T + ++
Sbjct: 173 VATRWYRAPE-ILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231
Query: 455 L--QD--------SGTVISELPDPR---LKGDFPKEEMQIMAYLAKECLQLDPDARPTMS 501
+D + T++ LP L PK + L K+ L +P+ R T
Sbjct: 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALD-LLKKLLVFNPNKRLTAE 290
Query: 502 EVVQ 505
E ++
Sbjct: 291 EALE 294
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 48/165 (29%), Positives = 70/165 (42%), Gaps = 29/165 (17%)
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQGTFGY 402
+H + ++HRDIKS+NILL N K+ D G +K A + S R GT Y
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAA----TVSDDVGRTFCGTPYY 211
Query: 403 FAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 462
APE S +D+FS GV+L EL+T ++P G +
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF---------------------DGENM 250
Query: 463 SELPDPRLKGDF---PKEEMQIMAYLAKECLQLDPDARPTMSEVV 504
E+ L G + P M + L DP RP+ S+++
Sbjct: 251 EEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 8/98 (8%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
GL++LH I++RD+K N++LD + + KI D GM K G + + GT
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKE-NVFG----DNRASTFCGT 159
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
Y APE + + D +SFGV+L E++ G+ P H
Sbjct: 160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 50/167 (29%), Positives = 76/167 (45%), Gaps = 27/167 (16%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
G+ Y+H+ RILHRD+K+ NI L NL KI D G+++ L + SC + GT
Sbjct: 118 GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLL----MGSCDLATT-FTGT 168
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459
Y +PE SD++S G +L E+ H + S+VL
Sbjct: 169 PYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLA---HAFEGQNFLSVVL---------- 215
Query: 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506
I E P P L + ++ IM + L DP RP+ +E+++
Sbjct: 216 -RIVEGPTPSLPETYSRQLNSIMQSM----LNKDPSLRPSAAEILRN 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 36/101 (35%), Positives = 51/101 (50%), Gaps = 14/101 (13%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
GL++LHE I++RD+K N+LLD + KI D GM K G + + GT
Sbjct: 108 GLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-----VTTSTFCGT 159
Query: 400 FGYFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
Y APE Y G A D ++ GV+L E++ G+ P
Sbjct: 160 PDYIAPEILSYQPYGPA---VDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 32/214 (14%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLVG 289
+G G VY + + + +VA+K+ G + + + EV L +L H + +
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI---- 78
Query: 290 YCSEFRG---KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE 346
++RG + LV E+ G+ D L+ V + + A+ GA +GL YLH
Sbjct: 79 ---QYRGCYLREHTAWLVMEYCL-GSASDLLE-VHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 347 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQGTFGYFAP 405
++HRD+K+ NILL E K+ D G A + +PA GT + AP
Sbjct: 134 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----------APANXFVGTPYWMAP 180
Query: 406 EYAMV---GRASLMSDVFSFGVVLLELITGRQPI 436
E + G+ DV+S G+ +EL + P+
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 38/109 (34%), Positives = 55/109 (50%), Gaps = 30/109 (27%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
RGL+Y+H A +LHRD+K SN+LL+ N + KI D G+A+ + S M
Sbjct: 119 RGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR--------TTSEKGDFMTE 167
Query: 399 ---TFGYFAPEYAMVGRASLMS--------DVFSFGVVLLELITGRQPI 436
T Y APE L++ DV+S G + EL+ GR+P+
Sbjct: 168 YVVTRWYRAPEL-------LLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 35/101 (34%), Positives = 52/101 (51%), Gaps = 14/101 (13%)
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
A GL +LH I++RD+K N++LD + KI D GM K G + +
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-----FC 162
Query: 398 GTFGYFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP 435
GT Y APE Y G++ D ++FGV+L E++ G+ P
Sbjct: 163 GTPDYIAPEIIAYQPYGKS---VDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 36/185 (19%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
+GL+Y+H A I+HRD+K N+ ++E+ KI D G+A++ + + M G
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ-----------TDSEMTG 174
Query: 399 ---TFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPI---HRSITKGEESLVLWA 451
T Y APE + + D++S G ++ E++TG+ P+ H + + E + +
Sbjct: 175 YVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK-PLFKGHDHLDQLMEIMKVTG 233
Query: 452 TP------RLQ--DSGTVISELPDPRLKGDF----PKEEMQIMAYLAKECLQLDPDARPT 499
TP +LQ D+ + +LP R K DF P + L K L LD ++R T
Sbjct: 234 TPSKEFVQKLQSEDAKNYVKKLPRFR-KKDFRSLLPNANPLAVNVLEK-MLVLDAESRIT 291
Query: 500 MSEVV 504
+E +
Sbjct: 292 AAEAL 296
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 58/230 (25%), Positives = 103/230 (44%), Gaps = 31/230 (13%)
Query: 232 IVGQG--GSSYVYRGQLTDGRIVAVKRF-KTQGGPNADSVFL-TEVDMLSRLHHCHVVPL 287
++G+G G + R + T ++ A+K K + +DS F E D+++ + VV L
Sbjct: 50 VIGRGAFGEVQLVRHKSTR-KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNW----DTRVAIAIGAARGLEY 343
F+ R + +V E+MP G+L + + V W V +A+ A + +
Sbjct: 109 F---YAFQDDRYL-YMVMEYMPGGDLVNLMSNYDVPE-KWARFYTAEVVLALDAIHSMGF 163
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
+H RD+K N+LLD++ + K+ D G ++ +G+ C ++ GT Y
Sbjct: 164 IH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA----VGTPDYI 210
Query: 404 APEYAMV----GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 449
+PE G D +S GV L E++ G P + G S ++
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 34/107 (31%), Positives = 54/107 (50%), Gaps = 23/107 (21%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
RGL+Y+H A +LHRD+K SN+LL+ N + KI D G+A+ + P
Sbjct: 117 RGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR----------IADPEHDHT 163
Query: 399 TF--------GYFAPEYAMVGRASLMS-DVFSFGVVLLELITGRQPI 436
F Y APE + + + D++S G +L E+++ R P+
Sbjct: 164 GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 8e-09
Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 18/154 (11%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
L+YLH +I++RD+K N++LD++ + KITD G+ K D +++ GT
Sbjct: 107 ALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-----AATMKTFCGT 158
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT---PRL- 455
Y APE D + GVV+ E++ GR P + + L+L PR
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTL 218
Query: 456 -QDSGTVISEL----PDPRLKGDFPKEEMQIMAY 484
D+ +++S L P+ RL G P + +IM +
Sbjct: 219 SADAKSLLSGLLIKDPNKRLGGG-PDDAKEIMRH 251
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 44/228 (19%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTDGR-IVAVKRFK-TQGGPNADSVFLTEVDMLSRLHHC 282
+KF +VG+G V + + + + IVA+K+FK ++ L E+ ML L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEF-----------MPNGNLRDCLDGV---LVEGMNWD 328
++V L FR +R LVFE+ MPNG + + L++ ++W
Sbjct: 61 NIVELK---EAFR-RRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW- 115
Query: 329 TRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS 388
H+ I+HRDIK N+L+ N K+ D G A+ L
Sbjct: 116 ---------------CHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE----G 153
Query: 389 CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 436
+++ T Y +PE + D++S G +L EL G QP+
Sbjct: 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDG-QPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 67/303 (22%), Positives = 130/303 (42%), Gaps = 63/303 (20%)
Query: 151 LRSSVISSDKESCNSATNLISHRITSVPETRVEVVSPIDLATGC------FLKTTFCRSK 204
L+S+ SS+K++ S ++SH P + ++L C ++ T +CR
Sbjct: 75 LKSTARSSEKQALMSELKIMSHL---GPHLNI-----VNLLGACTKGGPIYIITEYCR-- 124
Query: 205 TWTIHGTII----RFSYSALEHATDK-------FSGSNIVGQGGSSYVYRGQLTDGRIVA 253
+G ++ R ++ L++ DK SG + S+V G +DG +
Sbjct: 125 ----YGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMD 180
Query: 254 VKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNL 313
+ + + + ++ DM + + + Y S + +++P+
Sbjct: 181 MSK-------DESADYVPMQDMKGTVKYADIES-SNYESPYD----------QYLPSAPE 222
Query: 314 RDCLDGVLVEG--MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAK 371
R D ++ E +++ V + A G+E+L A+ +HRD+ + N+L+ E K
Sbjct: 223 RTRRDTLINESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVK 279
Query: 372 ITDLGMAKRLKADGLPSCSSSPARMQGTF---GYFAPEYAMVGRASLMSDVFSFGVVLLE 428
I D G+A+ + D S+ TF + APE + +SDV+SFG++L E
Sbjct: 280 ICDFGLARDIMRD------SNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWE 333
Query: 429 LIT 431
+ T
Sbjct: 334 IFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 43/163 (26%), Positives = 72/163 (44%), Gaps = 46/163 (28%)
Query: 303 LVFEFMPNGNLRDCLDGVLVEGMNWD----------TRVAIAIGAARGLEYLHEAAAPRI 352
+V E+MP G+L + + N+D V +A+ A + ++H
Sbjct: 120 MVMEYMPGGDLVNLMS-------NYDIPEKWARFYTAEVVLALDAIHSMGFIH------- 165
Query: 353 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM--- 409
RD+K N+LLD++ + K+ D G ++ A+G+ C ++ GT Y +PE
Sbjct: 166 --RDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA----VGTPDYISPEVLKSQG 219
Query: 410 ----VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 448
GR D +S GV L E++ G P + +SLV
Sbjct: 220 GDGYYGRE---CDWWSVGVFLYEMLVGDTPFY------ADSLV 253
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 53/187 (28%), Positives = 80/187 (42%), Gaps = 37/187 (19%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
GL+Y+H A +LHRD+K N+L++ + KI D G+A+ S +P G
Sbjct: 116 CGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR--------GFSENPGENAG 164
Query: 399 -------TFGYFAPEYAMVGRASLMS--DVFSFGVVLLELITGRQPI------------- 436
T Y APE M+ S DV+S G +L EL+ GR+P+
Sbjct: 165 FMTEYVATRWYRAPE-IMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQLNQI 222
Query: 437 -HRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPD 495
T EE+L +P+ Q+ + +P + FP + L K L DP
Sbjct: 223 LQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEK-LLAFDPT 281
Query: 496 ARPTMSE 502
R ++ E
Sbjct: 282 KRISVEE 288
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 44/168 (26%), Positives = 79/168 (47%), Gaps = 25/168 (14%)
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
L YLH+ RI+HRD+ +NI+L E+ ITD G+AK+ + + S + GT
Sbjct: 126 LRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE------SKLTSVVGTI 177
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460
Y PE +DV++FG +L ++ T + P + +T L +
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFY-------------STNMLSLATK 224
Query: 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508
++ + +P +G + + + + CL D +ARP + +V ++S
Sbjct: 225 IVEAVYEPLPEGMYS----EDVTDVITSCLTPDAEARPDIIQVSAMIS 268
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 27/212 (12%)
Query: 233 VGQGGSSYVYRGQLTD-GRIVAVKRFK----TQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
+G+G V++ + + IVA+KR + +G P S L E+ +L L H ++V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP---SSALREICLLKELKHKNIVRL 64
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 347
Y K+ LVFE+ + +L+ D + ++ + + +GL + H
Sbjct: 65 --YDVLHSDKKLT--LVFEYC-DQDLKKYFDSCNGD-IDPEIVKSFMFQLLKGLAFCHSH 118
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
+LHRD+K N+L+++N K+ D G+A +A G+P S + T Y P+
Sbjct: 119 ---NVLHRDLKPQNLLINKNGELKLADFGLA---RAFGIPVRCYSAEVV--TLWYRPPD- 169
Query: 408 AMVGRASLMS---DVFSFGVVLLELITGRQPI 436
+ G A L S D++S G + EL +P+
Sbjct: 170 VLFG-AKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 3e-08
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 57/218 (26%)
Query: 241 VYRGQ-LTDGRIVAVKRFKTQGGPNADSVF----LTEVDMLSRLHHCHVVPL----VG-- 289
VYR + G IVA+K+ K + F L E+++L +L H ++V + VG
Sbjct: 21 VYRARDKKTGEIVALKKLKME---KEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN 77
Query: 290 ----YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA----IAIGAARGL 341
Y +V E++ + +L+ L+E M + + + G+
Sbjct: 78 LDKIY------------MVMEYVEH-DLKS-----LMETMKQPFLQSEVKCLMLQLLSGV 119
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR----MQ 397
+LH+ ILHRD+K+SN+LL+ KI D G+A+ SP + +
Sbjct: 120 AHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREY---------GSPLKPYTQLV 167
Query: 398 GTFGYFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQ 434
T Y APE + S D++S G + EL+T +
Sbjct: 168 VTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKP 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 36/97 (37%), Positives = 51/97 (52%), Gaps = 10/97 (10%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL-PSCSSSPARMQG 398
L YLHE I++RD+K N+LLD + K+TD GM K +GL P ++S G
Sbjct: 108 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK----EGLRPGDTTS--TFCG 158
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
T Y APE D ++ GV++ E++ GR P
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (136), Expect = 3e-08
Identities = 72/280 (25%), Positives = 115/280 (41%), Gaps = 67/280 (23%)
Query: 267 SVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNG----NLRDCLDGVL 321
S + EV+++ L H ++V Y F K +L ++ EF G N++ C +
Sbjct: 57 SQLVIEVNVMRELKHKNIVR---YIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYK--M 111
Query: 322 VEGMNWDTRVAIAIGAARGLEYLHEAA----APRILHRDIKSSNILLD------------ 365
+ V I L Y H R+LHRD+K NI L
Sbjct: 112 FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171
Query: 366 -ENLN----AKITDLGMAKRLKADGLP-SCSSSPARMQGTFGYFAPEYAMVGRASL--MS 417
NLN AKI D G++K + + + SC +P Y++PE + S S
Sbjct: 172 ANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPY-------YWSPELLLHETKSYDDKS 224
Query: 418 DVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL---PDPRLKGDF 474
D+++ G ++ EL +G+ P H++ + +ISEL PD +KG
Sbjct: 225 DMWALGCIIYELCSGKTPFHKA----------------NNFSQLISELKRGPDLPIKGK- 267
Query: 475 PKEEMQIMAYLAKECLQLDPDARPTMSEVV--QILSTIAP 512
+E+ I L K L L RP+ + + QI+ + P
Sbjct: 268 -SKELNI---LIKNLLNLSAKERPSALQCLGYQIIKNVGP 303
|
Length = 1021 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 71/292 (24%), Positives = 117/292 (40%), Gaps = 43/292 (14%)
Query: 233 VGQGGSSYVYRGQLTDGRIVA---VKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
+G G V ++ VA VK K + FL + D L H +++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT----RVAIAIGAARGLEYLH 345
C E LLVFE+ G+L+ L N R+A I A G+ ++H
Sbjct: 63 QCVE----AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAA--GVTHMH 116
Query: 346 EAAAPRILHRDIKSSNILLDENLNAKITDLGMA-KRLKADGLPSCSSSPARMQGTFGYFA 404
+ LH D+ N L +L K+ D G+ R K D + + ++ + A
Sbjct: 117 KH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR----WLA 169
Query: 405 PEYAMVGRASLM-------SDVFSFGVVLLELI-TGRQPIHRSITKGEESLVLWATPRLQ 456
PE L+ S+V++ GV L EL QP ++ E VL + Q
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS-HLSDRE---VLNHVIKDQ 225
Query: 457 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508
+L P+L+ + + +++ + C L P+ R T EV ++L+
Sbjct: 226 Q-----VKLFKPQLELPYSERWYEVLQF----CW-LSPEKRATAEEVHRLLT 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 32/95 (33%), Positives = 47/95 (49%), Gaps = 8/95 (8%)
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
L +LHE I++RD+K N+LLD + K+TD GM K G + + GT
Sbjct: 109 LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-----DTTSTFCGTP 160
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
Y APE D ++ GV++ E++ GR P
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 60/257 (23%), Positives = 98/257 (38%), Gaps = 44/257 (17%)
Query: 189 DLATGCFLKTTFCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVY----RG 244
L+ + C + + + +++R Y+ L T G V+ G
Sbjct: 66 SLSPQTDVCQEPCETTSSSDPASVVRMQYNILSSLT----------PGSEGEVFVCTKHG 115
Query: 245 QLTDGRIV--AVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302
+++ AV KT G E+D+L + H ++ L+ +R K
Sbjct: 116 DEQRKKVIVKAVTGGKTPG---------REIDILKTISHRAIINLI---HAYRWKS---- 159
Query: 303 LVFEFMP--NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 360
V MP +L +D + + + I L YLH I+HRD+K+
Sbjct: 160 TVCMVMPKYKCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTE 214
Query: 361 NILLDENLNAKITDLGMAKRLKA-DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDV 419
NI LDE NA + D G A +L A P C GT +PE + +D+
Sbjct: 215 NIFLDEPENAVLGDFGAACKLDAHPDTPQCYG----WSGTLETNSPELLALDPYCAKTDI 270
Query: 420 FSFGVVLLELITGRQPI 436
+S G+VL E+ +
Sbjct: 271 WSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 50/193 (25%), Positives = 89/193 (46%), Gaps = 25/193 (12%)
Query: 265 ADSVFL-TEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVE 323
+DS F E D+++ + VV L +C+ F+ + + +V E+MP G+L + + V
Sbjct: 85 SDSAFFWEERDIMAFANSPWVVQL--FCA-FQDDKYL-YMVMEYMPGGDLVNLMSNYDVP 140
Query: 324 ---GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380
+ V +A+ A +H ++HRD+K N+LLD++ + K+ D G +
Sbjct: 141 EKWAKFYTAEVVLALDA------IHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK 191
Query: 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMV----GRASLMSDVFSFGVVLLELITGRQPI 436
+ G+ C ++ GT Y +PE G D +S GV L E++ G P
Sbjct: 192 MDETGMVRCDTA----VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
Query: 437 HRSITKGEESLVL 449
+ G S ++
Sbjct: 248 YADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 10/97 (10%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL-PSCSSSPARMQG 398
L +LHE I++RD+K N+LLD + + K+TD GM K +GL P ++S G
Sbjct: 108 ALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCK----EGLGPGDTTST--FCG 158
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
T Y APE D ++ GV++ E++ GR P
Sbjct: 159 TPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 20/103 (19%)
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
L YLH +++RD+K N++LD++ + KITD G+ K +DG ++ GT
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-----ATMKTFCGTP 159
Query: 401 GYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
Y APE Y GRA D + GVV+ E++ GR P +
Sbjct: 160 EYLAPEVLEDNDY---GRA---VDWWGLGVVMYEMMCGRLPFY 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 46/152 (30%), Positives = 72/152 (47%), Gaps = 18/152 (11%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
L+YLH + +++RD+K N++LD++ + KITD G+ K DG ++ GT
Sbjct: 107 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-----ATMKTFCGT 159
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL---- 455
Y APE D + GVV+ E++ GR P + + L+L R
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTL 219
Query: 456 -QDSGTVISEL----PDPRLKG--DFPKEEMQ 480
++ +++S L P RL G D KE MQ
Sbjct: 220 SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 59/211 (27%), Positives = 89/211 (42%), Gaps = 33/211 (15%)
Query: 303 LVFEFMPNGNLRDCLDGVLVEG--MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 360
LV E G++ D + G L G M I A GL++LH + +HRD+K +
Sbjct: 97 LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGN 153
Query: 361 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMS--- 417
NILL K+ D G++ +L + L +S GT + APE + L S
Sbjct: 154 NILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-----GTPFWMAPE-VIACEQQLDSTYD 207
Query: 418 ---DVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDF 474
DV+S G+ +EL G P + L+ PR P P L
Sbjct: 208 ARCDVWSLGITAIELGDGDPP----LADLHPMRALFKIPR----------NPPPTLHQ-- 251
Query: 475 PKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
P+ ++CL D + RPT+S+++Q
Sbjct: 252 PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 8/98 (8%)
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
+ GL +LH I++RD+K N++LD + KI D GM K DG+ + +
Sbjct: 111 SVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT-----FC 162
Query: 398 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
GT Y APE D +++GV+L E++ G+ P
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 39/103 (37%), Positives = 56/103 (54%), Gaps = 20/103 (19%)
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ--- 397
LEYLH + +++RDIK N++LD++ + KITD G+ K +DG A M+
Sbjct: 108 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--------ATMKTFC 156
Query: 398 GTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIH 437
GT Y APE GRA D + GVV+ E++ GR P +
Sbjct: 157 GTPEYLAPEVLEDNDYGRA---VDWWGLGVVMYEMMCGRLPFY 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 68/243 (27%), Positives = 110/243 (45%), Gaps = 33/243 (13%)
Query: 232 IVGQGGSSYVYRGQLTDG----RIVAVKRFKTQG-GPNADSVFLT--EVDMLSRLHHCHV 284
++G+GG V++ + G +I A+K K N T E ++L + H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAARGLE 342
V L+ Y + GK L+ E++ G L L+ G+ +E DT + LE
Sbjct: 63 VDLI-YAFQTGGKL---YLILEYLSGGELFMHLEREGIFME----DTACFYLSEISLALE 114
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
+LH+ I++RD+K NILLD + K+TD G+ K +G + GT Y
Sbjct: 115 HLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-----TVTHTFCGTIEY 166
Query: 403 FAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI---HR-----SITKGEESLVLWATPR 454
APE M D +S G ++ +++TG P +R I KG+ +L + TP
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPE 226
Query: 455 LQD 457
+D
Sbjct: 227 ARD 229
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 25/168 (14%)
Query: 272 EVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMN--W 327
E +L + H ++ L + +E +R + +L E++P G L L G +
Sbjct: 51 EKRVLKEVSHPFIIRL--FWTE-HDQRFLYML-MEYVPGGELFSYLRNSGRFSNSTGLFY 106
Query: 328 DTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP 387
+ + A+ EYLH + I++RD+K NILLD+ + K+TD G AK+L+
Sbjct: 107 ASEIVCAL------EYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT 157
Query: 388 SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
C GT Y APE + D ++ G+++ E++ G P
Sbjct: 158 LC--------GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 65/240 (27%), Positives = 97/240 (40%), Gaps = 55/240 (22%)
Query: 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 366
FM G+ L EGM+ I GA RGL YLH+ +HR+IK+S+IL+
Sbjct: 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY---IHRNIKASHILISG 136
Query: 367 NLNAKITDLGMAKRLKADG--------LPSCSSSPARMQGTFGYFAPEYAM--VGRASLM 416
+ ++ L L +G P S+S + +PE + ++
Sbjct: 137 DGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTS------VLPWLSPELLRQDLYGYNVK 190
Query: 417 SDVFSFGVVLLELITGRQP---IHRSIT-----KGEESLVLWAT------PRLQ------ 456
SD++S G+ EL TGR P + R+ KG L T R++
Sbjct: 191 SDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGV 250
Query: 457 DSG------------TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVV 504
DSG T+ SE RL+ K L + CLQ DP+ RP+ S ++
Sbjct: 251 DSGIGESVVAAGMTQTMTSE----RLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL 306
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 76/284 (26%), Positives = 127/284 (44%), Gaps = 38/284 (13%)
Query: 234 GQGGSSYVYRGQ--LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
G+G + VY+G+ LT ++VA+K + + A + E +L L H ++V L
Sbjct: 14 GEGSYATVYKGRSKLTG-QLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTL---- 68
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 351
+ + LVFE++ + +L+ +D G++ RGL Y H+ R
Sbjct: 69 HDIIHTKKTLTLVFEYL-DTDLKQYMDDC-GGGLSMHNVRLFLFQLLRGLAYCHQR---R 123
Query: 352 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG 411
+LHRD+K N+L+ E K+ D G+A +A +PS + S + T Y P+ +
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLA---RAKSVPSKTYSNEVV--TLWYRPPDVLLGS 178
Query: 412 RA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESL-----VLWATPRLQDSGTVISEL 465
S D++ G + E+ TGR P+ T E+ L VL TP +++ +S
Sbjct: 179 TEYSTSLDMWGVGCIFYEMATGR-PLFPGSTDVEDQLHKIFRVL-GTPT-EETWPGVSSN 235
Query: 466 PD----------PR-LKGDFPKEEMQIMAY-LAKECLQLDPDAR 497
P+ PR L P+ + LA + LQ +P R
Sbjct: 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKR 279
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 49/194 (25%), Positives = 73/194 (37%), Gaps = 40/194 (20%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
GL YLH A RI+HRD+K+ NI +++ I DLG A+ P + + + G
Sbjct: 168 EGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ------FPVVAPAFLGLAG 218
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 458
T APE + + +D++S G+VL E++ I E V L
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLK- 277
Query: 459 GTVISEL----------PDPRLKGDF---------PKEEMQIMA---------YLAKECL 490
+IS L P RL F P +L + L
Sbjct: 278 --IISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKML 335
Query: 491 QLDPDARPTMSEVV 504
D RP+ E++
Sbjct: 336 TFDAAMRPSAEEIL 349
|
Length = 357 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 51/173 (29%), Positives = 85/173 (49%), Gaps = 26/173 (15%)
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
A+G+++L A+ +HRD+ + N+LL + AKI D G+A+ + D AR+
Sbjct: 222 AQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS-NYVVKGNARL- 276
Query: 398 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQ 456
+ APE ++ SDV+S+G++L E+ + G+ P + I LV ++
Sbjct: 277 -PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP-YPGI------LVNSKFYKMV 328
Query: 457 DSGTVISELPDPRLKGDF-PKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508
G +S + DF P E IM K C L+P RPT S++ Q++
Sbjct: 329 KRGYQMS-------RPDFAPPEIYSIM----KMCWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 52/183 (28%), Positives = 80/183 (43%), Gaps = 32/183 (17%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
RGL+Y+H A I+HRD+K SN+ ++E+ KI D G+A+ + M G
Sbjct: 131 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH-----------TDDEMTG 176
Query: 399 ---TFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQ--PIHRSITKGEESLVLWAT 452
T Y APE + + D++S G ++ EL+TGR P I + + L L T
Sbjct: 177 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236
Query: 453 PRL--------QDSGTVISELPD-PRLKGD--FPKEEMQIMAYLAKECLQLDPDARPTMS 501
P + + I L P++ F + L K L LD D R T +
Sbjct: 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK-MLVLDSDKRITAA 295
Query: 502 EVV 504
+ +
Sbjct: 296 QAL 298
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 14/101 (13%)
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
A GL +LH I++RD+K N++LD + KI D GM K DG+ +
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV-----TTKTFC 162
Query: 398 GTFGYFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP 435
GT Y APE Y G++ D ++FGV+L E++ G+ P
Sbjct: 163 GTPDYIAPEIIAYQPYGKS---VDWWAFGVLLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 61/251 (24%), Positives = 108/251 (43%), Gaps = 42/251 (16%)
Query: 233 VGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G+G + VY+G +G++VA+K + + E +L L H ++V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLL---- 68
Query: 292 SEFRGKRAMRLLVFEFMPN----------GNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 341
+ + VFE+M G L + R+ + RGL
Sbjct: 69 HDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPY-----------NVRLFM-FQLLRGL 116
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
Y+H ILHRD+K N+L+ K+ D G+A +A +PS + S + T
Sbjct: 117 AYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLA---RAKSIPSQTYSSEVV--TLW 168
Query: 402 YFAPEYAMVGRASLMS--DVFSFGVVLLELITGRQPIHRSITKGEESLV-LWATPRL--Q 456
Y P+ ++G S D++ G + +E++ G QP ++ E L +W + +
Sbjct: 169 YRPPD-VLLGATDYSSALDIWGAGCIFIEMLQG-QPAFPGVSDVFEQLEKIWTVLGVPTE 226
Query: 457 DSGTVISELPD 467
D+ +S+LP+
Sbjct: 227 DTWPGVSKLPN 237
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 57/193 (29%), Positives = 91/193 (47%), Gaps = 50/193 (25%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
GL+Y+H A I+HRD+K N+ ++E+ KI D G+A+ + A M G
Sbjct: 128 CGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----------HADAEMTG 173
Query: 399 ---TFGYFAPEYAMVGRASLMS-----DVFSFGVVLLELITGRQPIHRSITKGEESL--- 447
T Y APE + + M D++S G ++ E++TG +++ KG++ L
Sbjct: 174 YVVTRWYRAPEVIL----NWMHYNQTVDIWSVGCIMAEMLTG-----KTLFKGKDYLDQL 224
Query: 448 --VLWAT--------PRLQD--SGTVISELPD-PR--LKGDFPKEEMQIMAYLAKECLQL 492
+L T +L+D + + I LP PR FPK Q + L K L+L
Sbjct: 225 TQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEK-MLEL 283
Query: 493 DPDARPTMSEVVQ 505
D D R T +E ++
Sbjct: 284 DVDKRLTATEALE 296
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 47/212 (22%), Positives = 90/212 (42%), Gaps = 36/212 (16%)
Query: 308 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 367
+ +++ L EG+ ++ ARG+E+L A+ +HRD+ + N+LL +
Sbjct: 217 SNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQG 273
Query: 368 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTF---GYFAPEYAMVGRASLMSDVFSFGV 424
KI D G+A+ + D S+ TF + APE + +SDV+S+G+
Sbjct: 274 KIVKICDFGLARDIMHD------SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327
Query: 425 VLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDF----PKEEMQ 480
+L E+ + L TP G ++ ++K + P Q
Sbjct: 328 LLWEIFS-----------------LGGTPY---PGMIVDSTFYNKIKSGYRMAKPDHATQ 367
Query: 481 IMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512
+ + +C +P+ RP+ + I+ ++ P
Sbjct: 368 EVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 46/162 (28%), Positives = 70/162 (43%), Gaps = 21/162 (12%)
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
L E + +++HRD+KS+NI L K+ D G +K+ +SS GT Y
Sbjct: 182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS---FCGTPYYL 238
Query: 404 APEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463
APE R S +D++S GV+L EL+T +HR + ++ V+
Sbjct: 239 APELWERKRYSKKADMWSLGVILYELLT----LHRPFKGPSQREIM---------QQVLY 285
Query: 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
DP FP M L L +P RPT +++
Sbjct: 286 GKYDP-----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322
|
Length = 478 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 39/103 (37%), Positives = 53/103 (51%), Gaps = 15/103 (14%)
Query: 351 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY--A 408
+HRDIK N+LLD+N + ++ D G RL ADG + S+ A GT Y +PE A
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG--TVQSNVA--VGTPDYISPEILQA 177
Query: 409 M---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 448
M GR D +S GV + E++ G P + ESLV
Sbjct: 178 MEDGKGRYGPECDWWSLGVCMYEMLYGETPFY------AESLV 214
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 48/167 (28%), Positives = 83/167 (49%), Gaps = 26/167 (15%)
Query: 272 EVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD---GVLV---EGM 325
EV +LS + H ++V Y F + +V ++ G+L ++ GVL + +
Sbjct: 49 EVAVLSNMKHPNIVQ---YQESFE-ENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQIL 104
Query: 326 NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 385
+W ++ +A L+++H+ +ILHRDIKS NI L ++ K+ D G+A+ L +
Sbjct: 105 DWFVQICLA------LKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS-- 153
Query: 386 LPSCSSSPARM-QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 431
+ AR GT Y +PE + SD+++ G VL E+ T
Sbjct: 154 ----TVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 55/234 (23%), Positives = 90/234 (38%), Gaps = 48/234 (20%)
Query: 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADS-------------VFLTEVDML 276
+G+G V + T G+IVA+K+ K N + L E+ ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 277 SRLHHCHVVPLVG-YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA--- 332
+ + H +++ LV Y LV + M +L+ +D R+
Sbjct: 75 NEIKHENIMGLVDVYVEG-----DFINLVMDIM-ASDLKKVVDR--------KIRLTESQ 120
Query: 333 ---IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 389
I + GL LH+ +HRD+ +NI ++ KI D G+A+R
Sbjct: 121 VKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDT 177
Query: 390 SSSPARMQG---------TFGYFAPEYAM-VGRASLMSDVFSFGVVLLELITGR 433
S MQ T Y APE M + D++S G + EL+TG+
Sbjct: 178 LSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 48/180 (26%), Positives = 76/180 (42%), Gaps = 42/180 (23%)
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
A+G+ +L A+ +HRD+ + NILL KI D G+A+ ++ D AR+
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS-NYVVKGNARL- 278
Query: 398 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP---------IHRSITKGEESL 447
+ APE + SDV+S+G++L E+ + G P ++ I +G L
Sbjct: 279 -PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML 337
Query: 448 VLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507
+P P E IM K C DP RPT ++VQ++
Sbjct: 338 ----SPECA------------------PSEMYDIM----KSCWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 47/181 (25%), Positives = 77/181 (42%), Gaps = 25/181 (13%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
R L+Y+H A + HRD+K NIL + + KI D G+A+ D + +
Sbjct: 114 RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD--YVA 168
Query: 399 TFGYFAPEY--AMVGRASLMSDVFSFGVVLLELITGRQPIH--RSITKGEESLV-LWATP 453
T Y APE + + + D++S G + E++TG+ P+ +++ + + L TP
Sbjct: 169 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQLDLITDLLGTP 227
Query: 454 RLQDSGTVISE------------LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS 501
+ V +E P P FP + + L + L DP RPT
Sbjct: 228 SPETISRVRNEKARRYLSSMRKKQPVP-FSQKFPNADPLALRLLER-LLAFDPKDRPTAE 285
Query: 502 E 502
E
Sbjct: 286 E 286
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 69/270 (25%), Positives = 104/270 (38%), Gaps = 58/270 (21%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHH 281
D F ++G+G V Q D G I A+K + + V E D+L
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 282 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMN-WDTRVAIAIGA 337
VV + F+ KR + L+ EF+P G++ L D + E + +AI A
Sbjct: 61 AWVVKMF---YSFQDKRNL-YLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDA 116
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK-----------ADGL 386
L ++H RDIK N+LLD + K++D G+ LK
Sbjct: 117 IHQLGFIH---------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNP 167
Query: 387 PSCSS-------------SPARMQ------GTFGYFAPEYAMVGRASLMSDVFSFGVVLL 427
PS S R Q GT Y APE M + + D +S GV++
Sbjct: 168 PSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227
Query: 428 ELITGRQPI--------HRSITKGEESLVL 449
E++ G P +R + +E+LV
Sbjct: 228 EMLIGYPPFCSETPQETYRKVMNWKETLVF 257
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 37/110 (33%), Positives = 54/110 (49%), Gaps = 15/110 (13%)
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
+H +HRDIK N+LLD N + ++ D G ++ DG + SS A GT Y
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG--TVQSSVA--VGTPDYI 170
Query: 404 APEY--AM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 448
+PE AM +G+ D +S GV + E++ G P + ESLV
Sbjct: 171 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY------AESLV 214
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 9e-07
Identities = 30/95 (31%), Positives = 46/95 (48%), Gaps = 8/95 (8%)
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
L +LH+ I++RD+K N+LLD + K+ D GM K +G + + GT
Sbjct: 109 LMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT-----STFCGTP 160
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
Y APE D ++ GV+L E++ G P
Sbjct: 161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 51/208 (24%), Positives = 77/208 (37%), Gaps = 64/208 (30%)
Query: 272 EVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT-- 329
E D+L+ + VV L Y S F+ + + L+ E++P G++ L M DT
Sbjct: 51 ERDILAEADNPWVVKL--YYS-FQDENYL-YLIMEYLPGGDMMTLL-------MKKDTFT 99
Query: 330 ---------RVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380
+AI + L Y+H RDIK N+LLD + K++D G+
Sbjct: 100 EEETRFYIAETILAIDSIHKLGYIH---------RDIKPDNLLLDAKGHIKLSDFGLCTG 150
Query: 381 LKADG---------------LPSCSSSP------------ARMQ------GTFGYFAPEY 407
LK S P R GT Y APE
Sbjct: 151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEV 210
Query: 408 AMVGRASLMSDVFSFGVVLLELITGRQP 435
+ + D +S GV++ E++ G P
Sbjct: 211 FLQTGYNKECDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 40/131 (30%), Positives = 57/131 (43%), Gaps = 22/131 (16%)
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
LE+LH+ I++RDIK NILLD + +TD G++K L GT
Sbjct: 118 LEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEF----LSEEKERTYSFCGTI 170
Query: 401 GYFAPEY--AMVGRASLMSDVFSFGVVLLELITGRQP------------IHRSITKGEES 446
Y APE G + D +S G+++ EL+TG P + R I K +
Sbjct: 171 EYMAPEIIRGKGGHGKAV-DWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP 229
Query: 447 LVLWATPRLQD 457
+ P QD
Sbjct: 230 FPSFIGPEAQD 240
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 55/233 (23%), Positives = 89/233 (38%), Gaps = 52/233 (22%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
VG+G +VY+ + DG+ K G E+ +L L H +V+ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 293 EFRGKRAMRLLVFEF-----------------------MPNGNLRDCLDGVLVEGMNWDT 329
++ L+F++ +P G ++ L +L
Sbjct: 69 SHADRKVW--LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL-------- 118
Query: 330 RVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMAKRLKADG 385
G+ YLH A +LHRD+K +NIL+ E KI D+G A+ +
Sbjct: 119 ---------DGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166
Query: 386 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMS-DVFSFGVVLLELITGRQPIH 437
P P + TF Y APE + R + D+++ G + EL+T H
Sbjct: 167 KPLADLDPVVV--TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 40/123 (32%), Positives = 56/123 (45%), Gaps = 24/123 (19%)
Query: 331 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 390
+ IAI + L Y+H RDIK NIL+D N + ++ D G +L DG +
Sbjct: 111 MVIAIDSVHQLHYVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDG--TVQ 159
Query: 391 SSPARMQGTFGYFAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEE 445
SS A GT Y +PE G+ D +S GV + E++ G P + E
Sbjct: 160 SSVA--VGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY------AE 211
Query: 446 SLV 448
SLV
Sbjct: 212 SLV 214
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 71/316 (22%), Positives = 116/316 (36%), Gaps = 89/316 (28%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYC 291
G+G S V + Q G+ A+K K L E+ L RL H +++ L+
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVL 67
Query: 292 SEFRGKRAMRL-LVFEFMPNGNL-------RDCLDGVLVEGMNWDTRVAIAIGAARGLEY 343
+ ++ RL LVFE M + NL + L V+ + + L++
Sbjct: 68 FD---RKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQL--------LKSLDH 115
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP-ARMQGTFGY 402
+H I HRDIK NIL+ +++ K+ D G + + S P T Y
Sbjct: 116 MHRNG---IFHRDIKPENILIKDDI-LKLADFGSCRGI-------YSKPPYTEYISTRWY 164
Query: 403 FAPE---------YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 453
APE M D+++ G V E+++ P+ G L
Sbjct: 165 RAPECLLTDGYYGPKM--------DIWAVGCVFFEILS-LFPLF----PGTNEL------ 205
Query: 454 RLQDSGTVISEL---PDPRLKG----------DFPKEEMQIMAYL----AKECLQL---- 492
D I ++ PD + +FP ++ + L + E L L
Sbjct: 206 ---DQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKL 262
Query: 493 ---DPDARPTMSEVVQ 505
DPD R T + ++
Sbjct: 263 LAYDPDERITAKQALR 278
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 54/197 (27%), Positives = 90/197 (45%), Gaps = 34/197 (17%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMAKRLKADGLPSCSSSPAR 395
G+ YLH A +LHRD+K +NIL+ E KI D+G A+ + P P
Sbjct: 120 GIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 396 MQGTFGYFAPEYAMVGRASLMS-DVFSFGVVLLELITG------RQ-------PIHRSIT 441
+ TF Y APE + R + D+++ G + EL+T RQ P H
Sbjct: 177 V--TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHD-- 232
Query: 442 KGEESLVLWATPRLQDSGTVISELPD-PRLKGDFPKE---EMQIMAYLAKECLQLDPDAR 497
+ + + P +D I ++P+ P L+ DF + ++ Y+ K ++ PD++
Sbjct: 233 QLDRIFSVMGFPADKDWED-IRKMPEYPTLQKDFRRTTYANSSLIKYMEKH--KVKPDSK 289
Query: 498 PTMSEVVQILSTIAPDK 514
+ ++Q L T+ P K
Sbjct: 290 VFL--LLQKLLTMDPTK 304
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 15/101 (14%)
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK-RLKADGLPS--CSSSPARMQ 397
LE+LH+ I++RD+K NILLD + + D G++K L + + C
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC-------- 157
Query: 398 GTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIH 437
GT Y APE + + + D +S GV++ E+ G P +
Sbjct: 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFY 198
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 56/192 (29%), Positives = 84/192 (43%), Gaps = 27/192 (14%)
Query: 252 VAVKRF---KTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 308
VA+KRF K D VF +E +L+ ++H V L G F+ + + LV EF+
Sbjct: 59 VAIKRFEKSKIIKQKQVDHVF-SERKILNYINHPFCVNLYG---SFKDESYL-YLVLEFV 113
Query: 309 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL--EYLHEAAAPRILHRDIKSSNILLDE 366
G L + V A L EYL I++RD+K N+LLD+
Sbjct: 114 IGGEFFT----FLRRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDK 166
Query: 367 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM-VGRASLMSDVFSFGVV 425
+ K+TD G AK + C GT Y APE + VG +D ++ G+
Sbjct: 167 DGFIKMTDFGFAKVVDTRTYTLC--------GTPEYIAPEILLNVGHGK-AADWWTLGIF 217
Query: 426 LLELITGRQPIH 437
+ E++ G P +
Sbjct: 218 IYEILVGCPPFY 229
|
Length = 340 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 18/99 (18%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
RGL+Y+H A I+HRD+K SN+ ++E+ +I D G+A++ + M G
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-----------ADDEMTG 174
Query: 399 ---TFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGR 433
T Y APE + + D++S G ++ EL+ G+
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 9e-06
Identities = 29/95 (30%), Positives = 47/95 (49%), Gaps = 8/95 (8%)
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
L +LH +++RD+K NILLD + K+ D GM K +G+ + + GT
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT-----FCGTP 160
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
Y APE D ++ GV++ E++ G+ P
Sbjct: 161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 1e-05
Identities = 34/108 (31%), Positives = 45/108 (41%), Gaps = 35/108 (32%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLN-AKITDLGMAKRLKADGLPSCSSSPARMQG 398
L LH+ I+H DIK N+L D + + D G+ K + G PSC G
Sbjct: 121 ALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKII---GTPSC------YDG 168
Query: 399 TFGYFAPE------YAMVGRASLMSDVFSF-----GVVLLELITGRQP 435
T YF+PE Y SF GV+ EL+TG+ P
Sbjct: 169 TLDYFSPEKIKGHNYD-----------VSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 30/99 (30%), Positives = 53/99 (53%), Gaps = 11/99 (11%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
RGL+Y+H A +LHRD+K +N+ ++ E+L KI D G+A+ + P S +
Sbjct: 125 RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVD----PHYSHKGYLSE 177
Query: 398 G--TFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGR 433
G T Y +P + + D+++ G + E++TG+
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 30/97 (30%), Positives = 46/97 (47%), Gaps = 8/97 (8%)
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
LE LH+ +++RD+K NILLD + + D G+ K D GT
Sbjct: 106 LENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-----DDKTNTFCGTP 157
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
Y APE + + D ++ GV+L E++TG P +
Sbjct: 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY 194
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 31/96 (32%), Positives = 46/96 (47%), Gaps = 8/96 (8%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
GL+YLHE +I++RD+K N+LLD KI D G+ K G + GT
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-----DRTSTFCGT 164
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
+ APE + D + GV++ E++ G P
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 34/107 (31%), Positives = 50/107 (46%), Gaps = 14/107 (13%)
Query: 331 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 390
+A A+G YLH I++RD+K NILLD + +TD G+ K +G+ S
Sbjct: 105 IASALG------YLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCK----EGIEH-S 150
Query: 391 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
+ + GT Y APE D + G VL E++ G P +
Sbjct: 151 KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 33/100 (33%), Positives = 47/100 (47%), Gaps = 8/100 (8%)
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
A L YLH I++RD+K NILLD + +TD G+ K +G+ + S +
Sbjct: 106 ASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCK----EGI-AQSDTTTTFC 157
Query: 398 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
GT Y APE D + G VL E++ G P +
Sbjct: 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 48/227 (21%)
Query: 234 GQGGSSYVYRGQLTDGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
G G+ Y+ R + T R A+K+ Q VF+ E D+L+ + VV + +
Sbjct: 12 GAYGAVYLVRHKETRQRF-AMKKINKQNLILRNQIQQVFV-ERDILTFAENPFVVSM--F 67
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR--------GLE 342
CS F KR + +V E++ G DC L++ + A+ + AR LE
Sbjct: 68 CS-FETKRHL-CMVMEYVEGG---DC--ATLLKNIG-----ALPVDMARMYFAETVLALE 115
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS----------- 391
YLH I+HRD+K N+L+ + K+TD G++K GL S ++
Sbjct: 116 YLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI----GLMSLTTNLYEGHIEKDT 168
Query: 392 ---SPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
++ GT Y APE + D ++ G++L E + G P
Sbjct: 169 REFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 64/246 (26%), Positives = 99/246 (40%), Gaps = 46/246 (18%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHH 281
+ F ++G+G V Q D G + A+K + + V E D+L
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 282 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGAAR 339
VV + F+ K + L+ EF+P G++ L L E +T+ IA
Sbjct: 61 LWVVKMF---YSFQDKLNL-YLIMEFLPGGDMMTLLMKKDTLTEE---ETQFYIA-ETVL 112
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA-----------DGLPS 388
++ +H+ +HRDIK N+LLD + K++D G+ LK LPS
Sbjct: 113 AIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169
Query: 389 -------CSSSPA------RMQ------GTFGYFAPEYAMVGRASLMSDVFSFGVVLLEL 429
S A R Q GT Y APE M + + D +S GV++ E+
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229
Query: 430 ITGRQP 435
+ G P
Sbjct: 230 LIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 62/219 (28%), Positives = 94/219 (42%), Gaps = 40/219 (18%)
Query: 231 NIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
NI+G G VY D VA+K K P + E+ ++ L+H +++ L
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIK--KVLQDPQYKN---RELLIMKNLNHINIIFLKD 126
Query: 290 Y----CSEFRGKRAMRLLVFEFMPN---------GNLRDCLDGVLVEGMNWDTRVAIAIG 336
Y C + K +V EF+P L LV+ ++
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL------- 179
Query: 337 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNA-KITDLGMAKRLKADGLPSCSSSPAR 395
R L Y+H + I HRD+K N+L+D N + K+ D G AK L A G S S +R
Sbjct: 180 -CRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA-GQRSVSYICSR 234
Query: 396 MQGTFGYFAPEYAMVGRASLMS--DVFSFGVVLLELITG 432
Y APE M+G + + D++S G ++ E+I G
Sbjct: 235 F-----YRAPEL-MLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 6e-05
Identities = 50/203 (24%), Positives = 84/203 (41%), Gaps = 34/203 (16%)
Query: 249 GRIVAVKRFKTQGGPNADSVFL-TEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 307
G V V+R + N FL E+ + +H ++VP Y + F + +V F
Sbjct: 25 GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVP---YRATFIADNEL-WVVTSF 80
Query: 308 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-- 365
M G+ +D + ++GM+ I G + L+Y+H +HR +K+S+IL+
Sbjct: 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVD 137
Query: 366 -----ENLNAKITDLGMAKRLKA-DGLPSCSS------SPARMQGTF-GYFAPEYAMVGR 412
L + ++ + +RL+ P S SP +Q GY A
Sbjct: 138 GKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK------- 190
Query: 413 ASLMSDVFSFGVVLLELITGRQP 435
SD++S G+ EL G P
Sbjct: 191 ----SDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 41/174 (23%), Positives = 67/174 (38%), Gaps = 47/174 (27%)
Query: 304 VFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSN 361
V +++P G++ L G+ E + R IA +E +H+ +HRDIK N
Sbjct: 79 VMDYIPGGDMMSLLIRLGIFEEDL---ARFYIA-ELTCAIESVHKMG---FIHRDIKPDN 131
Query: 362 ILLDENLNAKITDLGMAKRLK------------------------ADGLPSCSSSP---- 393
IL+D + + K+TD G+ + + C P
Sbjct: 132 ILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERR 191
Query: 394 -ARMQ---------GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
R GT Y APE + + + D +S GV+L E++ G+ P
Sbjct: 192 RKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFL 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 8e-05
Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 9/94 (9%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
G+++LH A I+HRD+K SNI++ + KI D G+A R +P + T
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTSF---MMTPYVV--T 180
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 433
Y APE + D++S G ++ E+I G
Sbjct: 181 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 37/108 (34%), Positives = 52/108 (48%), Gaps = 16/108 (14%)
Query: 331 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL-PSC 389
VA AIG YLH + I++RD+K NILLD + +TD G+ K +G+ P
Sbjct: 105 VASAIG------YLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK----EGVEPEE 151
Query: 390 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
++S GT Y APE D + G VL E++ G P +
Sbjct: 152 TTST--FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 35/132 (26%), Positives = 60/132 (45%), Gaps = 22/132 (16%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
G+++LH A I+HRD+K SNI++ + KI D G+A+ + + +P + T
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFM----MTPYVV--T 185
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459
Y APE + D++S G ++ EL+ G S++ T +
Sbjct: 186 RYYRAPEVILGMGYKENVDIWSVGCIMGELVKG-------------SVIFQGTDHIDQWN 232
Query: 460 TVISELPDPRLK 471
VI +L P +
Sbjct: 233 KVIEQLGTPSAE 244
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 33/101 (32%), Positives = 46/101 (45%), Gaps = 10/101 (9%)
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR-LKADGLPSCSSSPARM 396
A L YLH I++RD+K NILLD + +TD G+ K ++ +G S
Sbjct: 106 ASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST------F 156
Query: 397 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437
GT Y APE D + G VL E++ G P +
Sbjct: 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 30/137 (21%), Positives = 55/137 (40%), Gaps = 17/137 (12%)
Query: 232 IVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV-VPLVGY 290
++ G ++ VY D V +K ++ + EV +L L + VP V
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYV-LKINPSR---EKGADREREVAILQLLARKGLPVPKVLA 60
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAP 350
E G L+ E+ ++G ++ ++ + + IA A L LH+
Sbjct: 61 SGESDGWSY---LLMEW---------IEGETLDEVSEEEKEDIAEQLAELLAKLHQLPLL 108
Query: 351 RILHRDIKSSNILLDEN 367
+ H D+ NIL+D+
Sbjct: 109 VLCHGDLHPGNILVDDG 125
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 50/200 (25%), Positives = 75/200 (37%), Gaps = 51/200 (25%)
Query: 270 LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL----DGVLVEGM 325
LTE ++L+ L H + L Y S F+ + + LV ++ P G L L L E
Sbjct: 49 LTEQEILATLDHPFLPTL--YAS-FQTETYL-CLVMDYCPGGELFRLLQRQPGKCLSE-- 102
Query: 326 NWDTRVAIAIGAAR---GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITD------LG 376
AA LEYLH I++RD+K NILL E+ + ++D
Sbjct: 103 -----EVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154
Query: 377 MAKRLKADGLPSCSSSPARMQ------------------GTFGYFAPEYAMVGRASLMS- 417
+ + L S + GT Y APE V
Sbjct: 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE---VISGDGHGS 211
Query: 418 --DVFSFGVVLLELITGRQP 435
D ++ G++L E++ G P
Sbjct: 212 AVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 71/298 (23%), Positives = 113/298 (37%), Gaps = 65/298 (21%)
Query: 234 GQGGSSYVYRGQL---TDGRIVA-------VKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
GQG + +Y+G L +D IV V + ++ + F T ++S+L H H
Sbjct: 4 GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFET-ASLMSQLSHKH 62
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL----DGVLVEGMNWDTRVAIAIGAAR 339
+V L G C R ++V E++ G L L + V ++W ++ +A A
Sbjct: 63 LVKLYGVCV-----RDENIMVEEYVKFGPLDVFLHREKNNV---SLHW--KLDVAKQLAS 112
Query: 340 GLEYLHEAAAPRILHRDIKSSNILL-DENLN------AKITDLGMAKRLKADGLPSCSSS 392
L YL + +++H ++ NIL+ LN K++D G+P S
Sbjct: 113 ALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD---------PGIPITVLS 160
Query: 393 PARMQGTFGYFAPEYAMVGRASLMS--DVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450
+ APE G+ASL D +SFG LLE I S E
Sbjct: 161 REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLE-ICSNGEEPLSTLSSSEKE--- 216
Query: 451 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508
R + L A L +C DP RP+ +++ L+
Sbjct: 217 ---RFYQDQHRLPMPDCAEL------------ANLINQCWTYDPTKRPSFRAILRDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 8e-04
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 9/94 (9%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
G+++LH A I+HRD+K SNI++ + KI D G+A+ S +P + T
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----SFMMTPYVV--T 188
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 433
Y APE + D++S G ++ E+I G
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 31/103 (30%), Positives = 47/103 (45%), Gaps = 7/103 (6%)
Query: 331 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 390
+AI R ++YLHE RI+HRDIK+ NI ++ + + D G A + +
Sbjct: 185 LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA----CFPVDINA 237
Query: 391 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 433
+ GT APE D++S G+VL E+ T
Sbjct: 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 27/94 (28%), Positives = 43/94 (45%), Gaps = 13/94 (13%)
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP-ARMQGT 399
L+ LH I+ RD+ +NILLD+ + ++T ++ SC M
Sbjct: 98 LDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVE----DSCDGEAVENM--- 147
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 433
Y APE + + D +S G +L EL+TG+
Sbjct: 148 --YCAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 25/82 (30%), Positives = 41/82 (50%), Gaps = 17/82 (20%)
Query: 303 LVFEFMPNGNLRDCLDGVLVEGMNWD------TRVAIAIGAARGLEYLHEAAAPRILHRD 356
L+ EF+P G+L L + +D TR +A +E +H+ +HRD
Sbjct: 78 LIMEFLPGGDLMTML-------IKYDTFSEDVTRFYMA-ECVLAIEAVHKLG---FIHRD 126
Query: 357 IKSSNILLDENLNAKITDLGMA 378
IK NIL+D + K++D G++
Sbjct: 127 IKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 31/111 (27%), Positives = 54/111 (48%), Gaps = 14/111 (12%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
G+++LH A I+HRD+K SNI++ + KI D G+A+ S +P + T
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----SFMMTPYVV--T 181
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450
Y APE + D++S G ++ E++ H+ + G + + W
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-----HKILFPGRDYIDQW 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 33/143 (23%), Positives = 55/143 (38%), Gaps = 43/143 (30%)
Query: 353 LHRDIKSSNILLDENLNAKITDLGMAKRLK------------------------------ 382
+HRDIK NIL+D + + K+TD G+ +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 383 ---ADGLPSCSSSPARMQ---------GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELI 430
D L AR GT Y APE + + + D +S GV+L E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 431 TGRQP-IHRSITKGEESLVLWAT 452
G+ P + ++ + + ++ W T
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQT 265
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 27/81 (33%), Positives = 44/81 (54%), Gaps = 13/81 (16%)
Query: 303 LVFEFMPNGNLRDCLD--GVLVEGM--NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 358
LV E++ G+++ L G E M + + VA+A L+YLH I+HRD+K
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALA------LDYLHRHG---IIHRDLK 131
Query: 359 SSNILLDENLNAKITDLGMAK 379
N+L+ + K+TD G++K
Sbjct: 132 PDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 632 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.63 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.59 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.5 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.41 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.38 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.33 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.32 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.23 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.21 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.17 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.11 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.07 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.06 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.04 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.03 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.96 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.89 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.83 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.8 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.8 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.68 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.55 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.55 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.41 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.33 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.32 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.3 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.29 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.24 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.19 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.15 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.11 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.06 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.98 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.95 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.89 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.83 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.78 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.7 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.68 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.5 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.49 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.42 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.33 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.21 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.18 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.96 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.85 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.82 | |
| KOG1219 | 4289 | consensus Uncharacterized conserved protein, conta | 96.72 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.72 | |
| PLN02236 | 344 | choline kinase | 96.67 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.35 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.3 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.18 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.12 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.06 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.05 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.83 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.74 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.74 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.66 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.6 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 95.26 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.24 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.08 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.95 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.92 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-55 Score=462.30 Aligned_cols=289 Identities=54% Similarity=0.897 Sum_probs=252.9
Q ss_pred eeeeecHHHHHHhhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeee
Q 006750 211 TIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290 (632)
Q Consensus 211 ~~~~~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~ 290 (632)
....|+|.+|..||++|+..+.||+|+||.||+|.+.+|+.||||++....... ..+|.+|+.+|.+++|||+|+|+||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 356799999999999999999999999999999999999999999988765543 4559999999999999999999999
Q ss_pred eecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCe
Q 006750 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA 370 (632)
Q Consensus 291 ~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~v 370 (632)
|.+... .++||||||++|+|.++|+......++|..|++||.++|+||+|||+...|+||||||||+|||||+++++
T Consensus 140 C~e~~~---~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 140 CLEGGE---HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EecCCc---eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 997332 58999999999999999987543379999999999999999999999988899999999999999999999
Q ss_pred EEeccccceeccc-CCCCCCCCCCCcc-ccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe
Q 006750 371 KITDLGMAKRLKA-DGLPSCSSSPARM-QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 448 (632)
Q Consensus 371 kL~DFGla~~~~~-~~~~~~~~~~~~~-~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~ 448 (632)
||+|||+|+.... .. ..... .||.+|+|||++..+..+.|+|||||||+|+||+||+.|.+......+..++
T Consensus 217 KlsDFGLa~~~~~~~~------~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~ 290 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDT------SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLV 290 (361)
T ss_pred EccCccCcccCCcccc------ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHH
Confidence 9999999966543 21 11112 7999999999999999999999999999999999999998876655566688
Q ss_pred eccccccccccccccccCCCCCC-CCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 449 LWATPRLQDSGTVISELPDPRLK-GDFPK-EEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~~~~l~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
.|..+.+.+. .+.++.|+.+. ..++. .....+..++.+|++.+|..||+|.||++.|..+.
T Consensus 291 ~w~~~~~~~~--~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 291 EWAKPLLEEG--KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHHHHHHCc--chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 8887776654 67899999987 66664 57777999999999999999999999999996554
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=408.29 Aligned_cols=259 Identities=33% Similarity=0.511 Sum_probs=211.0
Q ss_pred cccceeeeeCceEEEEEEECCCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEE
Q 006750 228 SGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 228 ~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~E 306 (632)
...+.||+|+||+||+|.++....||||++..... ......|.+|+.+|++++|||||+|+|+|.+... .+.+|||
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~---~~~iVtE 120 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG---SLCIVTE 120 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC---ceEEEEE
Confidence 33456999999999999997544599999986532 2225679999999999999999999999987321 5799999
Q ss_pred eCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCC-CeEEeccccceecccCC
Q 006750 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITDLGMAKRLKADG 385 (632)
Q Consensus 307 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~-~vkL~DFGla~~~~~~~ 385 (632)
|+++|+|.++|+......+++..++.|+.|||+||+|||+++. ||||||||+||||+.++ ++||+|||+++......
T Consensus 121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999999999987545679999999999999999999999863 99999999999999997 99999999998765432
Q ss_pred CCCCCCCCCccccCCCCCChhhhh--cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccccc
Q 006750 386 LPSCSSSPARMQGTFGYFAPEYAM--VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463 (632)
Q Consensus 386 ~~~~~~~~~~~~GT~~Y~APE~~~--~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (632)
.......||+.|||||++. ...|+.|+||||||++||||+||+.||........ ..
T Consensus 199 -----~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~-----------------~~ 256 (362)
T KOG0192|consen 199 -----TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV-----------------AS 256 (362)
T ss_pred -----ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH-----------------HH
Confidence 1223367999999999999 66999999999999999999999999976544111 11
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006750 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 513 (632)
Q Consensus 464 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 513 (632)
.+.....+..+|..++..+..|+.+||+.||..||++.+|+..|+.+...
T Consensus 257 ~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 257 AVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred HHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 11112222233444556689999999999999999999999999987543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-48 Score=404.09 Aligned_cols=254 Identities=31% Similarity=0.451 Sum_probs=213.2
Q ss_pred ccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEE
Q 006750 227 FSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~E 306 (632)
+...+.||+|.||.||.|.++....||||.++.... ..+.|.+|+++|++|+|+|||+++|+|.. +..+|||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m--~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~----~~piyIVtE 281 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM--SPEAFLREAQIMKKLRHEKLVKLYGVCTK----QEPIYIVTE 281 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecccc--ChhHHHHHHHHHHhCcccCeEEEEEEEec----CCceEEEEE
Confidence 444678999999999999998888999999987532 33459999999999999999999999986 346899999
Q ss_pred eCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCC
Q 006750 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (632)
Q Consensus 307 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 386 (632)
||+.|+|.+||+...+..+...+.+.++.|||.||+||++++ +|||||.++||||+++..+||+|||||+...++.+
T Consensus 282 ~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 282 YMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY 358 (468)
T ss_pred ecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence 999999999998756667999999999999999999999998 99999999999999999999999999996554443
Q ss_pred CCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccccccccccc
Q 006750 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 465 (632)
Q Consensus 387 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (632)
.. .....-+..|+|||.+..+.++.|||||||||+||||+| |+.||......+ +-+.
T Consensus 359 ~~----~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e------------------v~~~ 416 (468)
T KOG0197|consen 359 TA----SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE------------------VLEL 416 (468)
T ss_pred ee----cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH------------------HHHH
Confidence 22 122234678999999999999999999999999999999 888886543321 1122
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 466 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 466 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
+....+-+.|..++..+.+||..||+.+|++|||+..+...|+.+.
T Consensus 417 le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 417 LERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred HhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 2233333456667777999999999999999999999999888774
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=419.56 Aligned_cols=262 Identities=28% Similarity=0.445 Sum_probs=222.0
Q ss_pred cCccccceeeeeCceEEEEEEECC------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 298 (632)
.+....+.||+|.||.||+|+..+ .+.||||.++..+..+..++|.+|+++|..|+|||||+|+|+|.+ +
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~----~ 561 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE----G 561 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc----C
Confidence 344456789999999999998543 468999999998888788899999999999999999999999997 5
Q ss_pred ceEEEEEEeCCCCChhhhhhccc--------cCC----CCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVL--------VEG----MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 366 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~--------~~~----l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~ 366 (632)
+.++||+|||..|||.+||+... +.. ++..+.+.||.|||.||+||-++. +|||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceecc
Confidence 57799999999999999996422 122 889999999999999999999998 999999999999999
Q ss_pred CCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccc
Q 006750 367 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEE 445 (632)
Q Consensus 367 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~ 445 (632)
+..|||+||||++..-..++... .....-.++|||||.++.++||.+||||||||+|||+++ |+.||++....+
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~---~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-- 713 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKV---RGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-- 713 (774)
T ss_pred ceEEEecccccchhhhhhhhhcc---cCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH--
Confidence 99999999999997765544321 112234689999999999999999999999999999999 999998765432
Q ss_pred hheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006750 446 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 514 (632)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 514 (632)
++..+....+ ...|+.++..++.||..||+.+|.+||++.||-..|.......
T Consensus 714 ---------------VIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 714 ---------------VIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred ---------------HHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 3333444444 5678888899999999999999999999999999998775443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=381.97 Aligned_cols=255 Identities=30% Similarity=0.415 Sum_probs=212.1
Q ss_pred ecHHHHHHhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeec
Q 006750 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE 293 (632)
Q Consensus 215 ~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~ 293 (632)
+++.+|+. .+.||+|..|+|||+.++ +++.+|+|++.....+...+++.+|++++++.+||+||.++|.|..
T Consensus 76 i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 45555554 578999999999999987 4899999999777777777889999999999999999999999986
Q ss_pred ccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHh-cCCCceeecCCCCCCeEecCCCCeEE
Q 006750 294 FRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKI 372 (632)
Q Consensus 294 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDLKp~NILl~~~~~vkL 372 (632)
.. . ...|+||||++|||++++... +.+++...-.|+.+|++||.|||+ .+ ||||||||+||||+..|++||
T Consensus 149 ~~--~-~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKi 220 (364)
T KOG0581|consen 149 NG--E-EISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKI 220 (364)
T ss_pred CC--c-eEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEe
Confidence 32 1 589999999999999999764 559999999999999999999996 65 999999999999999999999
Q ss_pred eccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccc
Q 006750 373 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 452 (632)
Q Consensus 373 ~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~ 452 (632)
+|||.++.+... ....++||..|||||.+.+..|+.++||||||+.++|+.+|+.||........ .|
T Consensus 221 cDFGVS~~lvnS-------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~----~~-- 287 (364)
T KOG0581|consen 221 CDFGVSGILVNS-------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL----DI-- 287 (364)
T ss_pred ccccccHHhhhh-------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC----CH--
Confidence 999999887643 34567899999999999999999999999999999999999999965411100 01
Q ss_pred cccccccccccccCC---CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 453 PRLQDSGTVISELPD---PRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 453 ~~~~~~~~~~~~~~~---~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
-..+..+.+ |.+... .++.+++.++..||++||.+||++.|+++.
T Consensus 288 ------~~Ll~~Iv~~ppP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 288 ------FELLCAIVDEPPPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ------HHHHHHHhcCCCCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 011222322 333322 256669999999999999999999999874
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=376.51 Aligned_cols=203 Identities=28% Similarity=0.464 Sum_probs=180.5
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
..+|...+.||+|+||+||+|+++. +..||||.+.... .++..+.+..|+.+|+.|+|||||+|++++.. ++.+
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~----~~~i 84 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED----DDFI 84 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec----CCeE
Confidence 3568888889999999999999864 8999999998764 44556668999999999999999999999886 5689
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCC------CCeEEecc
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN------LNAKITDL 375 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~------~~vkL~DF 375 (632)
|||||||+||||.+||+.. +.+++.++..++.|+|.||++||+++ ||||||||.||||+.+ -.+||+||
T Consensus 85 ~lVMEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred EEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 9999999999999999875 36999999999999999999999999 9999999999999764 45899999
Q ss_pred ccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccc
Q 006750 376 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (632)
Q Consensus 376 Gla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~ 441 (632)
|+|+.+.... ...+..|++.|||||+++..+|+.|+|+||+|+|||++++|+.||+....
T Consensus 160 GfAR~L~~~~------~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 160 GFARFLQPGS------MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred chhhhCCchh------HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 9999887542 34567899999999999999999999999999999999999999975443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-46 Score=390.53 Aligned_cols=249 Identities=27% Similarity=0.458 Sum_probs=213.1
Q ss_pred cCccccceeeeeCceEEEEEEE-CCCcEEEEEEeccC--CCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQ--GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~--~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
..|...+.||+|||..||.++. ..|+.||+|++... ......+...+||++.++|+|||||+++++|.+ ..+.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED----s~nV 93 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED----SNNV 93 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec----CCce
Confidence 4588889999999999999998 67999999999764 233445668999999999999999999999987 6688
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|||.|+|.+++|..++++ .+.+++.++..+..||+.||.|||+.+ |+|||||..|+||+++.++||+|||||..+
T Consensus 94 YivLELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~l 168 (592)
T KOG0575|consen 94 YIVLELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQL 168 (592)
T ss_pred EEEEEecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeee
Confidence 999999999999999984 367999999999999999999999999 999999999999999999999999999988
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
..++ ....+..|||.|.|||++.....+..+||||+|||||-||.|++||+.....+....+
T Consensus 169 e~~~-----Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I------------- 230 (592)
T KOG0575|consen 169 EYDG-----ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI------------- 230 (592)
T ss_pred cCcc-----cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH-------------
Confidence 7542 4566789999999999999999999999999999999999999999765433221111
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.... -.+|...+....+||..+|+.||.+|||+.+|+..
T Consensus 231 ----k~~~--Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 231 ----KLNE--YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ----HhcC--cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1000 12344556668899999999999999999999963
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-46 Score=373.73 Aligned_cols=254 Identities=25% Similarity=0.315 Sum_probs=204.1
Q ss_pred hhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC------hHHHHHHHHHHHHhcCCCCccceeeeeeccc
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN------ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 295 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~------~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~ 295 (632)
..+.|.+.+.||+|+||.|-+|..+ +|+.||||+++...... ......+|+++|++|+|||||++++++..
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~-- 247 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV-- 247 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec--
Confidence 4566788899999999999999765 59999999998653222 12235799999999999999999999986
Q ss_pred CCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCC---CCeEE
Q 006750 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN---LNAKI 372 (632)
Q Consensus 296 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~---~~vkL 372 (632)
....||||||++||+|.+++-++ +.+.+..-..++.|++.|+.|||++| |+||||||+|||+..+ ..+||
T Consensus 248 --~ds~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKI 320 (475)
T KOG0615|consen 248 --PDSSYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKI 320 (475)
T ss_pred --CCceEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEe
Confidence 45669999999999999998654 34777778899999999999999999 9999999999999766 77999
Q ss_pred eccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCC---CCcccchHhHhHHHHHHHhCCCCCCCccccccchhee
Q 006750 373 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 449 (632)
Q Consensus 373 ~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~---~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~ 449 (632)
+|||+|+..... ....+..||+.|.|||++.+.. +..++|+||+||+||-+++|.+||........
T Consensus 321 tDFGlAK~~g~~------sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s----- 389 (475)
T KOG0615|consen 321 TDFGLAKVSGEG------SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS----- 389 (475)
T ss_pred cccchhhccccc------eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-----
Confidence 999999987643 3456788999999999998654 34588999999999999999999965432210
Q ss_pred ccccccccccccccccCCCCCCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006750 450 WATPRLQDSGTVISELPDPRLKG--DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507 (632)
Q Consensus 450 ~~~~~~~~~~~~~~~~~~~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 507 (632)
....+...++.. ....+.+++..+||.+||..||++|||+.|+++.-
T Consensus 390 -----------l~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp 438 (475)
T KOG0615|consen 390 -----------LKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHP 438 (475)
T ss_pred -----------HHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence 011122222211 23345677789999999999999999999998753
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=362.20 Aligned_cols=275 Identities=27% Similarity=0.410 Sum_probs=216.0
Q ss_pred HHHhhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHh--cCCCCccceeeeeecccCC
Q 006750 220 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSR--LHHCHVVPLVGYCSEFRGK 297 (632)
Q Consensus 220 l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~--l~Hpniv~l~g~~~~~~~~ 297 (632)
......+....+.||+|.||.||+|.|+ |+.||||++..... ..|.+|-++++. |+|+||+.|++.-....+.
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE----~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE----RSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred HHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccch----hhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 3344566777899999999999999997 88999999986532 347888888775 4999999999987777777
Q ss_pred cceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHh-----cCCCceeecCCCCCCeEecCCCCeEE
Q 006750 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-----AAAPRILHRDIKSSNILLDENLNAKI 372 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~iiHrDLKp~NILl~~~~~vkL 372 (632)
..++|||++|.+.|||+|||.+ ..++....++++..+|.||+|||- +|.|.|.|||||+.||||..++...|
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 8899999999999999999986 458999999999999999999994 67899999999999999999999999
Q ss_pred eccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCC------CCcccchHhHhHHHHHHHhC----------CCCC
Q 006750 373 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR------ASLMSDVFSFGVVLLELITG----------RQPI 436 (632)
Q Consensus 373 ~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~------~s~ksDVwSlGviL~eLltG----------~~P~ 436 (632)
+|+|||.....+.. .........+||.+|||||++...- .-..+||||||+|+||+..+ ++||
T Consensus 358 ADLGLAv~h~~~t~-~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTD-TIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred eeceeeEEecccCC-cccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 99999987765431 2223455678999999999986432 13368999999999999873 5777
Q ss_pred CCccccccchheecccccccccccc-ccccCCCCCCCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 437 HRSITKGEESLVLWATPRLQDSGTV-ISELPDPRLKGD-FPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
+...+.+. .+.+...+ -.+-.+|.+... ...+....|.+||+.||..+|..|.|+-.|.+.|.++..
T Consensus 437 yd~Vp~DP---------s~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 437 YDVVPSDP---------SFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred ccCCCCCC---------CHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 65443321 11111111 111223333322 234667789999999999999999999999999998864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=357.74 Aligned_cols=256 Identities=24% Similarity=0.360 Sum_probs=204.8
Q ss_pred CccccceeeeeCceEEEEEE-ECCCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
+|.+++.||+|.||+|||+. +.+|..||.|.++-.. +....+....|+.+|++|+|||||++++.-.. .....++|
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~--~~~evlni 97 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI--EDNEVLNI 97 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh--ccchhhHH
Confidence 46677899999999999997 4579999999998543 33455668999999999999999999873222 22345899
Q ss_pred EEEeCCCCChhhhhhccc--cCCCCHHHHHHHHHHHHHhhHHHHhcCCCc--eeecCCCCCCeEecCCCCeEEeccccce
Q 006750 304 VFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPR--ILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
|||||.+|||.+.++... .+.+++.++++++.|+++||.++|+.- ++ |+||||||.||+|+++|.+||+||||++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHh
Confidence 999999999999996432 345999999999999999999999842 33 9999999999999999999999999999
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
.+.... ......+|||.||+||.+.+..|+.||||||+||++|||+.-+.||++..-.. +
T Consensus 177 ~l~s~~-----tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~---L------------ 236 (375)
T KOG0591|consen 177 FLSSKT-----TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS---L------------ 236 (375)
T ss_pred Hhcchh-----HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH---H------------
Confidence 987543 23456789999999999999999999999999999999999999997642110 0
Q ss_pred ccccccCCCCCCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006750 460 TVISELPDPRLKGDFP-KEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 507 (632)
-.++...... ++| ...+..+..|+..|+..||+.||+.-.+++.+
T Consensus 237 --~~KI~qgd~~-~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 237 --CKKIEQGDYP-PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred --HHHHHcCCCC-CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 0111111111 234 55677799999999999999999965555444
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-45 Score=388.89 Aligned_cols=262 Identities=24% Similarity=0.393 Sum_probs=220.1
Q ss_pred CccccceeeeeCceEEEEEEECC----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
...+.++||.|.||.||+|+++- ...||||.|+.....+.+.+|+.|..||.++.||||++|.|+... ....
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk----s~Pv 705 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK----SKPV 705 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec----Ccee
Confidence 34567899999999999999863 457999999998888888889999999999999999999999886 5567
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
+||+|||++|+|+.||+.+.++ +.+.+.+.++.+||.||+||-+++ +|||||.++||||+.+..+||+||||+|.+
T Consensus 706 MIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeec
Confidence 9999999999999999987654 999999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
.++.- . ......-.-..+|.|||.+...+++.+|||||||+++||.++ |..||-.....+
T Consensus 782 edd~~-~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd----------------- 842 (996)
T KOG0196|consen 782 EDDPE-A-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD----------------- 842 (996)
T ss_pred ccCCC-c-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH-----------------
Confidence 65431 1 111111223578999999999999999999999999999887 999986544332
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCcc
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKS 515 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 515 (632)
++.. +...++.+.|.+++..|.+||..||++|-.+||.+.||+..|++++....
T Consensus 843 VIka-Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 843 VIKA-IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred HHHH-HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 1111 12223334566777889999999999999999999999999999986644
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=356.76 Aligned_cols=243 Identities=28% Similarity=0.358 Sum_probs=201.6
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCC--ChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~--~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
.+.|+++++||+|+||.||.++.++ ++.+|+|++++.... ........|..+|.+++||.||+++-.+.+ ...
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt----~~k 99 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT----EEK 99 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc----CCe
Confidence 3568899999999999999998665 999999999876432 334568899999999999999999876665 668
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
+|||+||+.||.|..+|++. ..+++..+.-++..|+.||.|||+.+ ||||||||+|||||++|+++|+||||++.
T Consensus 100 LylVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~ 174 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKE 174 (357)
T ss_pred EEEEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchh
Confidence 89999999999999999864 45899999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
....+ ....+++||+.|||||++.+..|+..+|.||||+++|||++|.+||.........
T Consensus 175 ~~~~~-----~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~--------------- 234 (357)
T KOG0598|consen 175 DLKDG-----DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMY--------------- 234 (357)
T ss_pred cccCC-----CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHH---------------
Confidence 65442 3445589999999999999999999999999999999999999999765433211
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP 498 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 498 (632)
..+....+. ..|........++++++|..||++|.
T Consensus 235 --~~I~~~k~~-~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 235 --DKILKGKLP-LPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred --HHHhcCcCC-CCCccCCHHHHHHHHHHhccCHHHhc
Confidence 111111111 12333445588999999999999996
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=371.96 Aligned_cols=253 Identities=29% Similarity=0.496 Sum_probs=214.3
Q ss_pred HHHhhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 220 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 220 l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
|+...+....++.||.|+.|.||+|+++ ++.||||+++.- -..+|+.|++|+||||+.|.|+|.. ..
T Consensus 119 WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~el--------kETdIKHLRkLkH~NII~FkGVCtq----sP 185 (904)
T KOG4721|consen 119 WEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVREL--------KETDIKHLRKLKHPNIITFKGVCTQ----SP 185 (904)
T ss_pred ccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhh--------hhhhHHHHHhccCcceeeEeeeecC----Cc
Confidence 4444444556788999999999999996 788999998743 2468999999999999999999997 56
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
.++||||||..|-|..+|+.. +.+.....+.+..+||.||.|||.+. |||||||+-||||..+..|||+|||-++
T Consensus 186 cyCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~ 260 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSK 260 (904)
T ss_pred eeEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchH
Confidence 889999999999999999864 56889999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
.+..- .....+.||..|||||++...+.++|+|||||||+|||||||..||..... ..+.|.
T Consensus 261 e~~~~------STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----sAIIwG-------- 322 (904)
T KOG4721|consen 261 ELSDK------STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----SAIIWG-------- 322 (904)
T ss_pred hhhhh------hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----heeEEe--------
Confidence 76532 234567899999999999999999999999999999999999999964332 223332
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 513 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 513 (632)
+-...|....|..+++-|.-|++.||+..|..||++.+|+..|+-..++
T Consensus 323 -----VGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 323 -----VGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred -----ccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 2233455567777888899999999999999999999999998855443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=370.49 Aligned_cols=265 Identities=27% Similarity=0.416 Sum_probs=206.8
Q ss_pred HhhcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecc
Q 006750 222 HATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 294 (632)
Q Consensus 222 ~~t~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~ 294 (632)
...++|.+.+.||+|+||.||+|.+. +++.||||+++..........+.+|+.+|..+ +||||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 34577899999999999999999742 35789999998654444556699999999999 899999999988642
Q ss_pred cCCcceEEEEEEeCCCCChhhhhhccc-----------------------------------------------------
Q 006750 295 RGKRAMRLLVFEFMPNGNLRDCLDGVL----------------------------------------------------- 321 (632)
Q Consensus 295 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~----------------------------------------------------- 321 (632)
....++||||+++|+|.+++....
T Consensus 84 ---~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 84 ---NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 335799999999999999986421
Q ss_pred -------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCCCCCCCCCC
Q 006750 322 -------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 394 (632)
Q Consensus 322 -------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 394 (632)
...+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++........ ....
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~---~~~~ 234 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---VRKG 234 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcch---hccc
Confidence 124788899999999999999999998 999999999999999999999999999865432110 1122
Q ss_pred ccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccccccccccCCCCCCCC
Q 006750 395 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGD 473 (632)
Q Consensus 395 ~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 473 (632)
...+++.|+|||++.+..++.++||||||++||||++ |..||........... .+.......
T Consensus 235 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~-------------~~~~~~~~~---- 297 (338)
T cd05102 235 SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ-------------RLKDGTRMR---- 297 (338)
T ss_pred CCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHH-------------HHhcCCCCC----
Confidence 3346788999999999999999999999999999997 9999965332111000 000000111
Q ss_pred CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 474 FPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
.+...+..+.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus 298 ~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 298 APENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 122334458899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=359.43 Aligned_cols=259 Identities=29% Similarity=0.453 Sum_probs=206.5
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
.+|...+.||+|+||+||++...+ |+..|||.+....... .+.+.+|+.+|++|+|||||+++|....... ..+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~--~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSREN--DEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccC--eeeEe
Confidence 346667889999999999998765 9999999987663333 4558999999999999999999997544222 36899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC-CCCeEEeccccceecc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKITDLGMAKRLK 382 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~-~~~vkL~DFGla~~~~ 382 (632)
.|||+++|+|.+++.+... .+++..+..++.||++||+|||+++ |+||||||+||||+. ++.+||+|||+++...
T Consensus 94 ~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999999999999987655 6999999999999999999999998 999999999999999 7999999999998776
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCC-CCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGR-ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
... ..........||+.|||||++..+. ...++|||||||++.||+||+.||...... ...
T Consensus 170 ~~~--~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~--~~~-------------- 231 (313)
T KOG0198|consen 170 SKG--TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE--AEA-------------- 231 (313)
T ss_pred ccc--ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch--HHH--------------
Confidence 411 1123344578999999999999643 445999999999999999999999653100 000
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
+..+........+|...+....+++.+|+..+|+.|||+.++++...
T Consensus 232 ~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 232 LLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred HHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 00111111112456666677999999999999999999999998643
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=351.81 Aligned_cols=274 Identities=28% Similarity=0.422 Sum_probs=204.7
Q ss_pred ccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHh--cCCCCccceeeeeecccCCcceEEEEEE
Q 006750 229 GSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSR--LHHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 229 ~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~--l~Hpniv~l~g~~~~~~~~~~~~~lV~E 306 (632)
..++||+|+||.||||.+. ++.||||++... ..+.|.+|-+|.+. ++|+||++|+++-.........++||++
T Consensus 214 l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hHHHhhcCccceeehhhcc-CceeEEEecCHH----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 3467999999999999996 699999999753 33458888888775 4899999999886554444568899999
Q ss_pred eCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhc------CCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA------AAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 307 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
|.+.|+|.+||..+ .++|....+|+..+++||+|||+. ..|+|+|||||++||||.+|++..|+|||||..
T Consensus 289 fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 289 FHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred eccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 99999999999874 489999999999999999999974 357899999999999999999999999999999
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCC-C-----CcccchHhHhHHHHHHHhCCCCCCC-ccccccc--hheecc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGR-A-----SLMSDVFSFGVVLLELITGRQPIHR-SITKGEE--SLVLWA 451 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~-----s~ksDVwSlGviL~eLltG~~P~~~-~~~~~~~--~~~~~~ 451 (632)
+....-. ......+||.+|||||++.+.- + -.+.||||+|.+||||+++..-++. ..+.-+. ....-.
T Consensus 366 ~~p~~~~---~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 366 LEPGKPQ---GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred ecCCCCC---cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 8754322 2344588999999999997643 2 2468999999999999996543321 1100000 000111
Q ss_pred ccccccc-cccccccCCCCCCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006750 452 TPRLQDS-GTVISELPDPRLKGDFP-KEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 513 (632)
Q Consensus 452 ~~~~~~~-~~~~~~~~~~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 513 (632)
.|.+.+. ..++.+-.+|.++...- ...+..+.+.+..||..||+.|.|+.-+.+.+..+...
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 2222221 11233333444432211 13456789999999999999999999999988877543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=369.39 Aligned_cols=272 Identities=28% Similarity=0.450 Sum_probs=216.4
Q ss_pred eecHHHHHHhhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeee
Q 006750 214 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292 (632)
Q Consensus 214 ~~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~ 292 (632)
+.+.++|+...+++.+...||+|.||+||+|.|.+ .||||+++... .++..+.|++|+.+|++-+|.||+-|.|||.
T Consensus 381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~ 458 (678)
T KOG0193|consen 381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM 458 (678)
T ss_pred CccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc
Confidence 34456788888888889999999999999999963 49999998764 3344567999999999999999999999998
Q ss_pred cccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEE
Q 006750 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKI 372 (632)
Q Consensus 293 ~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL 372 (632)
. . .+.||+.+|+|-+|+.+|+... ..|+..+.+.||.|||+||.|||.++ |||||||+.||||.++++|||
T Consensus 459 ~----p-~~AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkI 529 (678)
T KOG0193|consen 459 N----P-PLAIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKI 529 (678)
T ss_pred C----C-ceeeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEE
Confidence 5 2 3489999999999999998654 45999999999999999999999998 999999999999999999999
Q ss_pred eccccceecccCCCCCCCCCCCccccCCCCCChhhhhc---CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhee
Q 006750 373 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 449 (632)
Q Consensus 373 ~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~---~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~ 449 (632)
+||||+..-..- ..........|...|||||+++. .+|+..+||||||+++|||++|.+||.... .+. +.
T Consensus 530 gDFGLatvk~~w---~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~--~dq--Ii 602 (678)
T KOG0193|consen 530 GDFGLATVKTRW---SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN--RDQ--II 602 (678)
T ss_pred ecccceeeeeee---ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC--hhh--eE
Confidence 999998754332 11222333458899999999974 568999999999999999999999997221 111 12
Q ss_pred ccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006750 450 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 513 (632)
Q Consensus 450 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 513 (632)
|...+ +. ..+.+. .....+++.|.+|+..||..++++||.+.+|+..|..+.+.
T Consensus 603 fmVGr----G~-----l~pd~s-~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 603 FMVGR----GY-----LMPDLS-KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred EEecc----cc-----cCccch-hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 21110 00 011111 12334566799999999999999999999999988888764
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=361.71 Aligned_cols=270 Identities=26% Similarity=0.386 Sum_probs=219.3
Q ss_pred HHHhhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 220 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 220 l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
.+.+.....+.++||+|-||.|.+.....+..||||+++..+....+.+|.+|+++|.+|+||||++|+|+|.. ++
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~----De 608 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ----DD 608 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec----CC
Confidence 44556777888999999999999999988899999999999888888899999999999999999999999997 55
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
.+++|+|||++|+|.+||.......+.-...++|+.|||.||+||.+.+ +|||||.++|||+|.++++||+|||+++
T Consensus 609 PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR 685 (807)
T KOG1094|consen 609 PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSR 685 (807)
T ss_pred chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccc
Confidence 7799999999999999998764444566677889999999999999998 9999999999999999999999999999
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh--CCCCCCCccccccchheecccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT--GRQPIHRSITKGEESLVLWATPRLQD 457 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt--G~~P~~~~~~~~~~~~~~~~~~~~~~ 457 (632)
-+-...+. ....+.+-.++|||||.+..++++.+||||+|||+|||+++ ...||........ +......+..
T Consensus 686 ~lysg~yy---~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~ 759 (807)
T KOG1094|consen 686 NLYSGDYY---RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRD 759 (807)
T ss_pred ccccCCce---eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCC
Confidence 76554432 22234456789999999999999999999999999999876 7889875543321 1111111111
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 458 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
.+ +..-...|.-++..+.++|.+||..+-.+||+++++...|.+.
T Consensus 760 ~~--------~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 760 QG--------RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CC--------cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11 1111123455566688999999999999999999999988654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=340.88 Aligned_cols=266 Identities=26% Similarity=0.405 Sum_probs=206.8
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
+.|+.+.++|+|+||.|||.+.++ |+.||||++..... +...+-.++|+++|++|+|||+|.|+.+|.. ...++
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr----krklh 77 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR----KRKLH 77 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh----cceeE
Confidence 357778899999999999999876 99999999986644 4444558899999999999999999998875 55789
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
||+|||+. ++.+-|... ..+++...+.+++.|+++|+.|+|+++ +|||||||+||||+.++.+||+|||+|+.+.
T Consensus 78 LVFE~~dh-TvL~eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~ 152 (396)
T KOG0593|consen 78 LVFEYCDH-TVLHELERY-PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLS 152 (396)
T ss_pred EEeeecch-HHHHHHHhc-cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhc
Confidence 99999965 444445543 356999999999999999999999998 9999999999999999999999999999886
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccc-cc---
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL-QD--- 457 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~-~~--- 457 (632)
.. ....+..+.|..|.|||.+.+ ..|+..+||||+||++.||++|.+-|.+..+-+....+......+ ++
T Consensus 153 ~p-----gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~ 227 (396)
T KOG0593|consen 153 AP-----GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQS 227 (396)
T ss_pred CC-----cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHH
Confidence 32 244567789999999999987 789999999999999999999999887655443322221111111 00
Q ss_pred --------ccccccccCCCC-CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 458 --------SGTVISELPDPR-LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 458 --------~~~~~~~~~~~~-l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.+-.+.+..++. +...+ +..+..+.+|++.||+.||++|++.+|++.
T Consensus 228 iF~~N~~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 228 IFSSNPFFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred HhccCCceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 011111111111 11112 233456889999999999999999999986
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=391.02 Aligned_cols=263 Identities=27% Similarity=0.435 Sum_probs=214.9
Q ss_pred cCccccceeeeeCceEEEEEEECC--Cc----EEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD--GR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~--g~----~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 298 (632)
.+.+..+.||+|.||.||.|...+ |. .||||.++.....+...+|++|..+|+.++|||||+++|+|.+ .
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~----~ 767 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD----S 767 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC----C
Confidence 445557889999999999998754 43 4999999988777788889999999999999999999999987 3
Q ss_pred ceEEEEEEeCCCCChhhhhhccc-----cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEe
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVL-----VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT 373 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~ 373 (632)
...+|++|||++|||..||+... ...++..+.+.++.|||+|++||++++ +|||||.++|+||+....|||+
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEc
Confidence 45699999999999999998652 234899999999999999999999998 9999999999999999999999
Q ss_pred ccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccc
Q 006750 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWAT 452 (632)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~ 452 (632)
|||||+.....++..... ...-...|||||.+..+.++.|+|||||||+|||++| |..||........
T Consensus 845 DFGlArDiy~~~yyr~~~---~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v-------- 913 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHG---EAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV-------- 913 (1025)
T ss_pred ccchhHhhhhchheeccC---ccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH--------
Confidence 999999655443322111 1233578999999999999999999999999999999 7888854332211
Q ss_pred cccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCcc
Q 006750 453 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKS 515 (632)
Q Consensus 453 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 515 (632)
+....... +.+.|..++..+.++|..||+.+|++||++..|++.+..+.+...
T Consensus 914 ---------~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 914 ---------LLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred ---------HHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 11011111 224566777779999999999999999999999998888765543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=346.38 Aligned_cols=264 Identities=25% Similarity=0.370 Sum_probs=212.6
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
+.|+....||.|..++||+|+.. .++.||||++.-+......+.+.+|+..|+.++||||++++..|.. +..+|+
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv----~~~LWv 101 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV----DSELWV 101 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe----cceeEE
Confidence 56788899999999999999854 5899999999987666666779999999999999999999988876 668899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||.||.+||+.+.+......++++..+..|+.++++||.|||.+| .||||||+.||||+.+|.|||+|||.+..+..
T Consensus 102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 999999999999998887788999999999999999999999999 99999999999999999999999999877665
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhc--CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
.+. ........++||+.|||||+++. ..|+.|+||||||++..||.+|..||....+-..........+....
T Consensus 179 ~G~-R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~---- 253 (516)
T KOG0582|consen 179 SGD-RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL---- 253 (516)
T ss_pred cCc-eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc----
Confidence 542 22222267899999999999653 56999999999999999999999999765432211110000000000
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
-..+..+-.......|.+++..||+.||.+|||++++++
T Consensus 254 -----t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 254 -----TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred -----cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 001111112233456899999999999999999999987
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=348.76 Aligned_cols=250 Identities=23% Similarity=0.381 Sum_probs=200.8
Q ss_pred cceeeeeCceEEEEEEECCCcEEEEEEeccCCCCC--hHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEe
Q 006750 230 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 307 (632)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~--~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey 307 (632)
...||+|++|.||+|.+ +|+.||||+++...... ..+.|.+|+.+|++++||||++++|++.+........++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 35799999999999998 58999999997653222 1356889999999999999999999987633334567999999
Q ss_pred CCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhc-CCCceeecCCCCCCeEecCCCCeEEeccccceecccCCC
Q 006750 308 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (632)
Q Consensus 308 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 386 (632)
+++|+|.+++... +.+++...+.++.+++.||.|||+. + ++||||||+|||+++++.+||+|||+++.....
T Consensus 104 ~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~-- 176 (283)
T PHA02988 104 CTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-- 176 (283)
T ss_pred CCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccc--
Confidence 9999999999754 4589999999999999999999985 6 889999999999999999999999999865422
Q ss_pred CCCCCCCCccccCCCCCChhhhhc--CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccc
Q 006750 387 PSCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 464 (632)
Q Consensus 387 ~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (632)
.....||..|+|||++.+ ..++.++|||||||++|||++|+.||............ ...
T Consensus 177 ------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i-------------~~~ 237 (283)
T PHA02988 177 ------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI-------------INK 237 (283)
T ss_pred ------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH-------------Hhc
Confidence 123458899999999976 68999999999999999999999999754322111100 001
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 465 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 465 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
...+ ..+...+..+.+|+.+||+.||++|||+.++++.|+.+
T Consensus 238 ~~~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 238 NNSL----KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CCCC----CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 1111 12223445689999999999999999999999999875
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=370.77 Aligned_cols=259 Identities=28% Similarity=0.404 Sum_probs=216.6
Q ss_pred ccceeeeeCceEEEEEEEC-C----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 229 GSNIVGQGGSSYVYRGQLT-D----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 229 ~~~~LG~G~fG~Vy~~~~~-~----g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
..++||.|+||+||+|.|- . .-+||||++......+...+|+.|+.+|.+|.|||+++|+|+|... .+.|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s-----~~ql 774 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS-----TLQL 774 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc-----hHHH
Confidence 3578999999999999863 2 3579999999888888888899999999999999999999999852 3679
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
|++||+.|+|.+|++... ..+..+..+.|..|||+||.|||++. ++||||..+||||..-..+||+|||+++.+..
T Consensus 775 vtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 999999999999998743 45899999999999999999999998 99999999999999999999999999998876
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVI 462 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (632)
+.... ......-.+.|||-|.+....|+.++|||||||++||++| |..|++.....+ +
T Consensus 851 d~~ey---~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e------------------I 909 (1177)
T KOG1025|consen 851 DEKEY---SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE------------------I 909 (1177)
T ss_pred ccccc---cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH------------------h
Confidence 64321 1112223578999999999999999999999999999999 899987654332 1
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCcccc
Q 006750 463 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRR 517 (632)
Q Consensus 463 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~ 517 (632)
.++.....+...|+.+...+..++.+||..|+..||+++++...+..++.+..+-
T Consensus 910 ~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqry 964 (1177)
T KOG1025|consen 910 PDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQRY 964 (1177)
T ss_pred hHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcceE
Confidence 2222222233456777777999999999999999999999999999998776543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=359.20 Aligned_cols=251 Identities=26% Similarity=0.417 Sum_probs=209.8
Q ss_pred hcCccccceeeeeCceEEEEEEE-CCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
...|....+||+|..|.||.|.. .+++.||||++.....+ ..+.+++|+.+|+..+|+|||+++..|.. ...+|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~-~keLilnEi~Vm~~~~H~NiVnfl~Sylv----~deLW 346 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP-KKELLLNEILVMRDLHHPNIVNFLDSYLV----GDELW 346 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC-chhhhHHHHHHHHhccchHHHHHHHHhcc----cceeE
Confidence 35677778999999999999975 45899999999876433 33458999999999999999999988776 46789
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+|||||+||+|.|.+... .+++.++..|+.++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+.
T Consensus 347 VVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~ 420 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQIS 420 (550)
T ss_pred EEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence 999999999999998764 3899999999999999999999999 9999999999999999999999999998876
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 462 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (632)
... ......+||+.|||||++....|+.|.||||||++++||+-|.+||....+-.... . +
T Consensus 421 ~~~-----~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAly-------L-------I 481 (550)
T KOG0578|consen 421 EEQ-----SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-------L-------I 481 (550)
T ss_pred ccc-----CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHH-------H-------H
Confidence 543 24567899999999999999999999999999999999999999996422211100 0 1
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 463 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 463 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
..--.|. ...++..+..+.+|+.+||+.|+++||++.|+++.
T Consensus 482 a~ng~P~--lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 482 ATNGTPK--LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred hhcCCCC--cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 1111122 23456677789999999999999999999999973
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=357.31 Aligned_cols=255 Identities=27% Similarity=0.365 Sum_probs=208.7
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCCh--HHHHHHHHHHHHhc-CCCCccceeeeeecccCCcc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNA--DSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~--~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~ 299 (632)
.++|..++.||+|+|++||+|+..+ ++.||||++.......+ .+-...|-.+|.+| .||.|++|+-.|.+ ..
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD----~~ 147 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD----EE 147 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec----cc
Confidence 4678889999999999999998654 89999999976532211 22367899999999 89999999987776 56
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
.+|+|+||+++|+|.++|+.. +.|++.-...++.+|+.||+|||+.| ||||||||+|||||.|++++|+|||.|+
T Consensus 148 sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence 789999999999999999875 55999999999999999999999999 9999999999999999999999999999
Q ss_pred ecccCCCC-----CC---CCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecc
Q 006750 380 RLKADGLP-----SC---SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA 451 (632)
Q Consensus 380 ~~~~~~~~-----~~---~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~ 451 (632)
.+...... .. ......++||..|.+||++.....+..+|+|+||||||.|+.|.+||....+--
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl-------- 294 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL-------- 294 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH--------
Confidence 88654321 00 111255899999999999999999999999999999999999999997543321
Q ss_pred ccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 452 TPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 452 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
...++.. +.-.+|+..+....+|+++.|..||.+|+|..+|.+.
T Consensus 295 ---------iFqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 295 ---------IFQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ---------HHHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 1111111 1123455555668999999999999999999999774
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=351.74 Aligned_cols=269 Identities=26% Similarity=0.346 Sum_probs=211.3
Q ss_pred hhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCccceeeeeecccCCcce
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~~~ 300 (632)
.-++|...++||.|.||.||+|+-. .|..||||+++.....-.+-.=++|++.|++|+ |||||+|..++.+. ...
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~---~~~ 84 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDN---DRI 84 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhcc---Cce
Confidence 3467888899999999999999854 599999999987654433334679999999998 99999999988763 228
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
+|+||||| ..+|++.++.+ .+.|++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+||||||.
T Consensus 85 L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 85 LYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred EeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence 99999999 57999999876 677999999999999999999999999 99999999999999888999999999998
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhh-cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe--ecccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV--LWATPRLQD 457 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~--~~~~~~~~~ 457 (632)
.... ...+..+.|..|.|||++. .+.|+.+.|+||+|||++|+.+-++-|.+..+.++...+ ....|....
T Consensus 160 v~Sk------pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~ 233 (538)
T KOG0661|consen 160 VRSK------PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDS 233 (538)
T ss_pred cccC------CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcccc
Confidence 7643 3456678999999999876 678999999999999999999999888765543322111 111111111
Q ss_pred c----------cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 458 S----------GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 458 ~----------~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
. +-.+.....-.+..-++. .+....+|+.+|+..||++|||+.|.++.
T Consensus 234 ~~eg~~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 234 WPEGYNLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred chhHHHHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0 001111111122222333 56668899999999999999999999985
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=349.70 Aligned_cols=270 Identities=27% Similarity=0.363 Sum_probs=205.5
Q ss_pred hcCccccceeeeeCceEEEEEEE-CCCcEEEEEEeccCCCCC-hHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~-~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
.+.|+..++||+|.||.||+|+. .+|+.||+|++....... ...-..+||.||++|+||||++|.+...+.. ...+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~--~~si 193 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL--SGSI 193 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC--CceE
Confidence 34566678899999999999985 459999999998765333 3334679999999999999999999988742 3578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|||+|||+ -||.-++.... -.|+..++..++.|++.||+|+|.++ |+|||||.+|||||++|.+||+|||||+++
T Consensus 194 YlVFeYMd-hDL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 194 YLVFEYMD-HDLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEEeccc-chhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 99999995 58888886532 34999999999999999999999999 999999999999999999999999999988
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe-ecccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV-LWATPRLQDSG 459 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~-~~~~~~~~~~~ 459 (632)
..... ...+..+-|+.|.|||.+.+. .|+...|+||.||||.||+.|++.|.+..+-.+...+ ........+.+
T Consensus 269 ~~~~~----~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W 344 (560)
T KOG0600|consen 269 TPSGS----APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW 344 (560)
T ss_pred cCCCC----cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence 76542 235566789999999999874 6999999999999999999999999876544332111 00110011111
Q ss_pred ccccccCC-----CCCC--C---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 460 TVISELPD-----PRLK--G---DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 460 ~~~~~~~~-----~~l~--~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
. ..+++. +... . +.....+....+|+..+|..||++|.|+.++++
T Consensus 345 ~-~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 345 P-VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred c-cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1 111111 1000 0 001122334678899999999999999999986
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=354.89 Aligned_cols=268 Identities=26% Similarity=0.377 Sum_probs=226.9
Q ss_pred HHHHHHhhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeeccc
Q 006750 217 YSALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 295 (632)
Q Consensus 217 ~~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~ 295 (632)
++.|+--..+.....+||.|.||.||.|.|+. .-.||||.++.+. -..++|+.|..+|+.++|||+|+|+|+|..
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt--MeveEFLkEAAvMKeikHpNLVqLLGVCT~-- 334 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTH-- 334 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc--hhHHHHHHHHHHHHhhcCccHHHHhhhhcc--
Confidence 35666666677778899999999999999986 6789999998764 345569999999999999999999999986
Q ss_pred CCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecc
Q 006750 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 375 (632)
Q Consensus 296 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DF 375 (632)
....|||+|||..|+|.+||+......++-...+.++.||+.||+||..++ +|||||.++|+|+.++..+||+||
T Consensus 335 --EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADF 409 (1157)
T KOG4278|consen 335 --EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADF 409 (1157)
T ss_pred --CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeecc
Confidence 557799999999999999999887777888899999999999999999888 999999999999999999999999
Q ss_pred ccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccc
Q 006750 376 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPR 454 (632)
Q Consensus 376 Gla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~ 454 (632)
||++....+.++. .....-.+.|.|||-+....++.|+|||+|||+|||+.| |-.||.+..-.
T Consensus 410 GLsRlMtgDTYTA----HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS------------ 473 (1157)
T KOG4278|consen 410 GLSRLMTGDTYTA----HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------------ 473 (1157)
T ss_pred chhhhhcCCceec----ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH------------
Confidence 9999987765432 222334678999999999999999999999999999998 77887543211
Q ss_pred cccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCcc
Q 006750 455 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKS 515 (632)
Q Consensus 455 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 515 (632)
.+.+++...++-+-|+.++..+++||+.||+.+|.+||++.|+-+.|+.++.+.+
T Consensus 474 ------qVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS 528 (1157)
T KOG4278|consen 474 ------QVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS 528 (1157)
T ss_pred ------HHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence 1233344444445677778889999999999999999999999999999987654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=353.53 Aligned_cols=249 Identities=25% Similarity=0.343 Sum_probs=204.5
Q ss_pred hhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC----ChHHHHHHHHHHHHhcC-CCCccceeeeeecccC
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP----NADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRG 296 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~----~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~ 296 (632)
..++|...+.||+|+||.|+.|... +|+.||||++...... ...+.+.+|+.++++++ ||||++++.++..
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t--- 91 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT--- 91 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec---
Confidence 4567889999999999999999764 5899999987654111 23445778999999998 9999999999876
Q ss_pred CcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCC-CCeEEecc
Q 006750 297 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKITDL 375 (632)
Q Consensus 297 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~-~~vkL~DF 375 (632)
....|+||||+.||+|.+++.. ...+.+.++..++.|++.|++|||+.+ |+||||||+|||++.+ +++||+||
T Consensus 92 -~~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DF 165 (370)
T KOG0583|consen 92 -PTKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDF 165 (370)
T ss_pred -CCeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecc
Confidence 4458999999999999999987 356899999999999999999999999 9999999999999999 99999999
Q ss_pred ccceecc-cCCCCCCCCCCCccccCCCCCChhhhhcCC-C-CcccchHhHhHHHHHHHhCCCCCCCccccccchheeccc
Q 006750 376 GMAKRLK-ADGLPSCSSSPARMQGTFGYFAPEYAMVGR-A-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 452 (632)
Q Consensus 376 Gla~~~~-~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~-s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~ 452 (632)
|++.... .+ .......||+.|+|||++.+.. | +.++||||+||+||.|++|+.||+.........
T Consensus 166 G~s~~~~~~~------~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~------ 233 (370)
T KOG0583|consen 166 GLSAISPGED------GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYR------ 233 (370)
T ss_pred ccccccCCCC------CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHH------
Confidence 9999873 22 3456678999999999999866 6 589999999999999999999998633221111
Q ss_pred cccccccccccccCCCCCCCCCCHHH-HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 453 PRLQDSGTVISELPDPRLKGDFPKEE-MQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 453 ~~~~~~~~~~~~~~~~~l~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.+.... ..+|... +..+..|+.+||..||.+|+++.+|++
T Consensus 234 -----------ki~~~~--~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 234 -----------KIRKGE--FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred -----------HHhcCC--ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 111111 1233333 566899999999999999999999984
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=364.30 Aligned_cols=266 Identities=27% Similarity=0.399 Sum_probs=212.7
Q ss_pred HHHHhhcCccccceeeeeCceEEEEEEECC--C--cE-EEEEEecc--CCCCChHHHHHHHHHHHHhcCCCCccceeeee
Q 006750 219 ALEHATDKFSGSNIVGQGGSSYVYRGQLTD--G--RI-VAVKRFKT--QGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291 (632)
Q Consensus 219 ~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~--g--~~-vAVK~l~~--~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~ 291 (632)
.|+...++....++||+|+||.||+|.++. + .. ||||..+. ........+|.+|.++|++++|||||+++|++
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344455566667899999999999998753 2 23 89999985 24455567799999999999999999999999
Q ss_pred ecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeE
Q 006750 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAK 371 (632)
Q Consensus 292 ~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vk 371 (632)
.. ...+|+|||+|+||+|.+||+.... .++..+++.++.++|.||+|||+++ ++||||.++|+|++.++.+|
T Consensus 231 ~~----~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 231 VL----EEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred cC----CCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEE
Confidence 86 5577999999999999999987543 5999999999999999999999998 99999999999999999999
Q ss_pred EeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheec
Q 006750 372 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLW 450 (632)
Q Consensus 372 L~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~ 450 (632)
|+||||++....-.. ......-...|+|||.+..+.|+.++|||||||++||+++ |..||........
T Consensus 303 ISDFGLs~~~~~~~~-----~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v------ 371 (474)
T KOG0194|consen 303 ISDFGLSRAGSQYVM-----KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV------ 371 (474)
T ss_pred eCccccccCCcceee-----ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH------
Confidence 999999876531110 0101134588999999999999999999999999999999 8889875443211
Q ss_pred cccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006750 451 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 514 (632)
Q Consensus 451 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 514 (632)
...+.....+...|...+..+..++..||..+|++||+|.++.+.|..+....
T Consensus 372 -----------~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 372 -----------KAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred -----------HHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 11121222222334455566888999999999999999999999999886543
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=347.49 Aligned_cols=248 Identities=25% Similarity=0.419 Sum_probs=211.8
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV 304 (632)
.|+..+.||+|.||.||+|.+. .++.||+|++.........++..+|+.+|..++++||.+++|.+.. +..++++
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~----g~~Lwii 89 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLK----GTKLWII 89 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheee----cccHHHH
Confidence 3566688999999999999875 4899999999988777778889999999999999999999999886 5678999
Q ss_pred EEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccC
Q 006750 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 384 (632)
||||.||++.+.|... ..+++..+.-|..++..||.|||.++ .+|||||+.||||..+|.+||+|||.+..+...
T Consensus 90 Mey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred HHHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeech
Confidence 9999999999999753 33588888889999999999999998 999999999999999999999999999887654
Q ss_pred CCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccc
Q 006750 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 464 (632)
Q Consensus 385 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (632)
. ....+++||+.|||||++....|+.|+||||||++.+||.+|.+|+....+.. +. ..+.+
T Consensus 165 ~-----~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr----vl----------flIpk 225 (467)
T KOG0201|consen 165 V-----KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR----VL----------FLIPK 225 (467)
T ss_pred h-----hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce----EE----------EeccC
Confidence 3 23467899999999999998899999999999999999999999986543311 00 12334
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 465 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 465 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
-..|.+.+.+. ..|.+|+..||+.||+.||++.++++
T Consensus 226 ~~PP~L~~~~S----~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 226 SAPPRLDGDFS----PPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CCCCccccccC----HHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 44566665444 44999999999999999999999996
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=358.97 Aligned_cols=261 Identities=25% Similarity=0.377 Sum_probs=203.4
Q ss_pred hhcCccccceeeeeCceEEEEEEE------CCCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeeccc
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQL------TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFR 295 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~ 295 (632)
..++|++.+.||+|+||.||+|.+ .++..||||+++........+.+.+|+.+|..+ +||||+++++++..
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~-- 110 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV-- 110 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc--
Confidence 345688899999999999999974 236689999998655445556689999999999 89999999999876
Q ss_pred CCcceEEEEEEeCCCCChhhhhhccc------------------------------------------------------
Q 006750 296 GKRAMRLLVFEFMPNGNLRDCLDGVL------------------------------------------------------ 321 (632)
Q Consensus 296 ~~~~~~~lV~Ey~~~gsL~~~L~~~~------------------------------------------------------ 321 (632)
....++||||+++|+|.+++....
T Consensus 111 --~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 111 --GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred --CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 446799999999999999986422
Q ss_pred -------------------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 322 -------------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 322 -------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
...++|..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceecc
Confidence 124789999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
..... .......++..|+|||++.+..++.++||||||+++|||++ |..||........ ...+
T Consensus 266 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~--~~~~----------- 329 (375)
T cd05104 266 NDSNY---VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK--FYKM----------- 329 (375)
T ss_pred Ccccc---cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH--HHHH-----------
Confidence 33211 11122335678999999999999999999999999999998 8888864322110 0000
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
+.....+ ..+...+..+.+|+.+||+.||++||++.+|++.|++.
T Consensus 330 ~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 330 IKEGYRM----LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHhCccC----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0000000 11112234588999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=339.61 Aligned_cols=256 Identities=23% Similarity=0.356 Sum_probs=203.9
Q ss_pred cCccccceeeeeCceEEEEEEEC----CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
++|++.+.||+|+||.||+|.++ .+..||+|+++..........|.+|+.++++++||||+++++++.. ...
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~ 80 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR----GNT 80 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec----CCC
Confidence 46788899999999999999764 3678999999876544555669999999999999999999999875 456
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.++++|||.+..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccc
Confidence 799999999999999997542 45899999999999999999999998 99999999999999999999999998765
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
...... .......++..|+|||.+.+..++.++||||||+++||+++ |+.||..........
T Consensus 157 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~------------- 219 (266)
T cd05064 157 DKSEAI----YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIK------------- 219 (266)
T ss_pred ccccch----hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH-------------
Confidence 432211 11112345678999999999999999999999999999875 999996543221000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
.+.+.... ..+..++..+.+++.+||+.+|.+||++.+|++.|..+
T Consensus 220 -~~~~~~~~----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 220 -AVEDGFRL----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -HHHCCCCC----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 00010111 12333445588999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=346.09 Aligned_cols=263 Identities=27% Similarity=0.413 Sum_probs=200.2
Q ss_pred cCccccceeeeeCceEEEEEEECC-----------------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccce
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-----------------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 287 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-----------------g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l 287 (632)
++|.+.+.||+|+||.||++.+.+ +..||||.+...........|.+|+.+|.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 567888999999999999997542 347999999865444455679999999999999999999
Q ss_pred eeeeecccCCcceEEEEEEeCCCCChhhhhhccc-----------------cCCCCHHHHHHHHHHHHHhhHHHHhcCCC
Q 006750 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL-----------------VEGMNWDTRVAIAIGAARGLEYLHEAAAP 350 (632)
Q Consensus 288 ~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~-----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 350 (632)
++++.+ ....++||||+++|+|.+++.... ...++|..+..++.|++.||.|||+.+
T Consensus 85 ~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~-- 158 (304)
T cd05096 85 LGVCVD----EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN-- 158 (304)
T ss_pred EEEEec----CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--
Confidence 999876 346799999999999999985421 123788999999999999999999998
Q ss_pred ceeecCCCCCCeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHH
Q 006750 351 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELI 430 (632)
Q Consensus 351 ~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLl 430 (632)
|+||||||+|||++.++.+||+|||+++........ .......++..|+|||++..+.++.++||||||+++|||+
T Consensus 159 -ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 234 (304)
T cd05096 159 -FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY---RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234 (304)
T ss_pred -ccccCcchhheEEcCCccEEECCCccceecccCcee---EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHH
Confidence 999999999999999999999999999865432211 1122334678999999999899999999999999999998
Q ss_pred h--CCCCCCCccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 431 T--GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 431 t--G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
+ +..||.......... .....+.... . ......+..++..+.+|+.+||+.||.+|||+.+|.+.|+
T Consensus 235 ~~~~~~p~~~~~~~~~~~---~~~~~~~~~~---~-----~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 235 MLCKEQPYGELTDEQVIE---NAGEFFRDQG---R-----QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HccCCCCCCcCCHHHHHH---HHHHHhhhcc---c-----cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 7 567776432211100 0000000000 0 0000112223455899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=343.18 Aligned_cols=251 Identities=24% Similarity=0.370 Sum_probs=199.6
Q ss_pred ccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 227 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
|...+.||+|+||.||++... +|+.||||.+..... ......+.+|+.+|++++|+||+++++++.+ ....++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~----~~~~~l 77 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET----KDALCL 77 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc----CCeEEE
Confidence 667789999999999999864 699999999875422 2233457899999999999999999988875 457899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||++.....
T Consensus 78 v~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 78 VLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred EEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 999999999998886544456899999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (632)
.. ......||+.|+|||++.+..++.++|||||||+||||++|+.||............ ..
T Consensus 155 ~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~-------------~~ 215 (285)
T cd05631 155 GE------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV-------------DR 215 (285)
T ss_pred CC------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH-------------HH
Confidence 21 123346899999999999999999999999999999999999999754322110000 00
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006750 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT-----MSEVVQ 505 (632)
Q Consensus 464 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 505 (632)
.+... ...++...+..+.+|+.+||+.||.+||+ +.++++
T Consensus 216 ~~~~~--~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 216 RVKED--QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred Hhhcc--cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 01000 11223334456889999999999999997 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=326.88 Aligned_cols=237 Identities=27% Similarity=0.339 Sum_probs=201.0
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCC--ChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~--~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|+..+.||.|+||.|.+++.+. |..+|+|+++...-. +..+...+|..+|+.+.||+++++++.+.+ ...+
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d----~~~l 119 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD----NSNL 119 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc----CCeE
Confidence 456778999999999999998764 899999999865322 233447789999999999999999988876 5688
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
||||||++||.|..+|++. +++++..+.-+|.+|+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+..
T Consensus 120 ymvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v 194 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRV 194 (355)
T ss_pred EEEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEe
Confidence 9999999999999999864 56999999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
... .-+.+|||.|+|||++....+...+|.|||||++|||+.|.+||........
T Consensus 195 ~~r--------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i----------------- 249 (355)
T KOG0616|consen 195 SGR--------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI----------------- 249 (355)
T ss_pred cCc--------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH-----------------
Confidence 643 4456799999999999999999999999999999999999999986554211
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDAR 497 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 497 (632)
..++....+ .+|......+.+|+...|+.|-.+|
T Consensus 250 Y~KI~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 250 YEKILEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HHHHHhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 122222222 3566666678999999999999888
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=358.55 Aligned_cols=263 Identities=24% Similarity=0.380 Sum_probs=205.0
Q ss_pred HhhcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecc
Q 006750 222 HATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 294 (632)
Q Consensus 222 ~~t~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~ 294 (632)
...++|.+.+.||+|+||.||+|.+. ++..||||+++..........+.+|+.+|+.+ +|+||+++++++..
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~- 113 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH- 113 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC-
Confidence 34567888999999999999998742 24589999998665444556689999999999 89999999999876
Q ss_pred cCCcceEEEEEEeCCCCChhhhhhccc-----------------------------------------------------
Q 006750 295 RGKRAMRLLVFEFMPNGNLRDCLDGVL----------------------------------------------------- 321 (632)
Q Consensus 295 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~----------------------------------------------------- 321 (632)
....++||||+++|+|.+++....
T Consensus 114 ---~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 114 ---GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ---CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 446799999999999999985421
Q ss_pred ---------------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCC
Q 006750 322 ---------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (632)
Q Consensus 322 ---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 386 (632)
...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence 124788999999999999999999998 99999999999999999999999999986543211
Q ss_pred CCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccccccccccc
Q 006750 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 465 (632)
Q Consensus 387 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (632)
. .......+++.|+|||++....++.++||||||+++|||++ |+.||........... .+...
T Consensus 268 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~-------------~~~~~ 331 (374)
T cd05106 268 Y---VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYK-------------MVKRG 331 (374)
T ss_pred e---eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHH-------------HHHcc
Confidence 0 11122335678999999998999999999999999999997 9999965332111000 00000
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 466 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 466 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
..+ ..+...+..+.+++.+||+.||.+|||+.+|++.|.++.
T Consensus 332 ~~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 332 YQM----SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred cCc----cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 011 111222345889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=343.18 Aligned_cols=265 Identities=24% Similarity=0.349 Sum_probs=210.2
Q ss_pred HhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-------------ChHHHHHHHHHHHHhcCCCCccce
Q 006750 222 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-------------NADSVFLTEVDMLSRLHHCHVVPL 287 (632)
Q Consensus 222 ~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-------------~~~~~f~~Ei~~l~~l~Hpniv~l 287 (632)
...++|++.+.||+|.||.|-+|+.. +++.||||++...... ...+...+||.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999999999999865 5999999999643210 112358899999999999999999
Q ss_pred eeeeecccCCcceEEEEEEeCCCCChhhhhhccccCC-CCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC
Q 006750 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 366 (632)
Q Consensus 288 ~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~ 366 (632)
+.+..+.. ...+|||+|||..|.+...=. ... ++..+++.++.+++.||+|||.++ ||||||||+|+||++
T Consensus 174 iEvLDDP~--s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 174 IEVLDDPE--SDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSS 245 (576)
T ss_pred EEeecCcc--cCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcC
Confidence 99887654 457899999999998876432 233 899999999999999999999999 999999999999999
Q ss_pred CCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCC----CCcccchHhHhHHHHHHHhCCCCCCCcccc
Q 006750 367 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR----ASLMSDVFSFGVVLLELITGRQPIHRSITK 442 (632)
Q Consensus 367 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~----~s~ksDVwSlGviL~eLltG~~P~~~~~~~ 442 (632)
+|++||+|||.+..+...............+|||.|+|||...++. .+.+.||||+||+||.|+.|+.||......
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~ 325 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL 325 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence 9999999999998774432222223344578999999999987643 477899999999999999999999653321
Q ss_pred ccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 443 GEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 443 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
. ...++....+..+..+++...+.+||+++|.+||+.|.+..+|....+...
T Consensus 326 ~-----------------l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 326 E-----------------LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred H-----------------HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 1 123334334433333355677999999999999999999999988776543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=317.18 Aligned_cols=267 Identities=25% Similarity=0.360 Sum_probs=205.7
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCCh-HHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNA-DSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~-~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
++|...+.||+|.||.||+|++. +|+.||||+++.....+. ....++|++.|+.++|+||+.|++++.. ...+.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~----~~~l~ 77 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH----KSNLS 77 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC----CCceE
Confidence 35777789999999999999865 599999999987643322 3347899999999999999999999876 45678
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
||+|||+ .+|+..++... ..++..++..++.++++||+|||.+. |+||||||.|+|++.+|.+||+|||+|+.+.
T Consensus 78 lVfEfm~-tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 78 LVFEFMP-TDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFG 152 (318)
T ss_pred EEEEecc-ccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccC
Confidence 9999995 69999997643 45999999999999999999999999 9999999999999999999999999999887
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe--ecccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV--LWATPRLQDSG 459 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~--~~~~~~~~~~~ 459 (632)
.... .....+-|..|.|||.+.+. .|+...|+||.|||+.||+-|.+-|.+..+-++...+ ....|...+..
T Consensus 153 ~p~~-----~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP 227 (318)
T KOG0659|consen 153 SPNR-----IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWP 227 (318)
T ss_pred CCCc-----ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCc
Confidence 5432 22333789999999999874 5999999999999999999887666554433221111 11111111110
Q ss_pred --------ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 460 --------TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 460 --------~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
..+...+.+.+..-++ .......+|+..+|..||.+|+++.|.+++
T Consensus 228 ~~~~lpdY~~~~~~P~~~~~~lf~-aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 228 EMTSLPDYVKIQQFPKPPLNNLFP-AASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccccccHHHHhcCCCCccccccc-cccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1122233333333333 334456899999999999999999999874
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=338.93 Aligned_cols=257 Identities=27% Similarity=0.448 Sum_probs=204.9
Q ss_pred cCccccceeeeeCceEEEEEEECC------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 298 (632)
++|++.+.||+|+||.||+|.... ...||+|.++..........|.+|+.++++++||||+++++++.. .
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~----~ 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK----E 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC----C
Confidence 357778999999999999998643 257999999865544455669999999999999999999998875 3
Q ss_pred ceEEEEEEeCCCCChhhhhhcccc--------------CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEe
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVLV--------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL 364 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl 364 (632)
...+++|||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||||+||++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~ 157 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLV 157 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEE
Confidence 467999999999999999965321 34889999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccc
Q 006750 365 DENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKG 443 (632)
Q Consensus 365 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~ 443 (632)
++++.++|+|||+++........ .......+++.|+|||++....++.++||||||+++|||++ |..||.......
T Consensus 158 ~~~~~~~L~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~ 234 (283)
T cd05048 158 GEGLTVKISDFGLSRDIYSADYY---RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE 234 (283)
T ss_pred cCCCcEEECCCcceeeccccccc---cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 99999999999999865432211 11223456889999999998899999999999999999998 999987543221
Q ss_pred cchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006750 444 EESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 509 (632)
Q Consensus 444 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 509 (632)
... .+.... ....+...+..+.+|+.+||+.||.+||++.+|++.|..
T Consensus 235 ~~~--------------~i~~~~----~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 VIE--------------MIRSRQ----LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHH--------------HHHcCC----cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 100 000000 111233445668999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=348.75 Aligned_cols=246 Identities=26% Similarity=0.400 Sum_probs=206.6
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
++|.+.+.||+|+||.||||+-+ +.+.||+|.+.+.. ..+....+.+|++++++|+|||||.++.+|.. ..+++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt----~~~~~ 77 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET----SAHLW 77 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc----cceEE
Confidence 46777889999999999999865 48999999987653 33445568999999999999999999988765 67889
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+|.||+.| +|..+|... ..+++..+..|+.+++.||.|||+.+ |+|||+||.||||+.++++|++|||+|+...
T Consensus 78 vVte~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~ 151 (808)
T KOG0597|consen 78 VVTEYAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMS 151 (808)
T ss_pred EEehhhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcc
Confidence 99999965 999999764 45999999999999999999999998 9999999999999999999999999999776
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 462 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (632)
... ...+.+.|||.|||||++.+..|+..+|+||+||||||+++|++||....... .+
T Consensus 152 ~~t-----~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~-----------------Lv 209 (808)
T KOG0597|consen 152 TNT-----SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQ-----------------LV 209 (808)
T ss_pred cCc-----eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHH-----------------HH
Confidence 542 34456779999999999999999999999999999999999999997432111 11
Q ss_pred cccC-CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 463 SELP-DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 463 ~~~~-~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
..+. ++. ..|...+..+..++...|.+||..|.+..+++.
T Consensus 210 ~~I~~d~v---~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 210 KSILKDPV---KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HHHhcCCC---CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 1111 111 234566777999999999999999999999886
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=353.85 Aligned_cols=249 Identities=24% Similarity=0.331 Sum_probs=207.2
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
-|..++.||.|+-|.|-+|++. +|+.+|||++..... ......+.+|+-+|+.|.||||+++++++.+ ..++|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~----~~~ly 88 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN----KQHLY 88 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc----CceEE
Confidence 3666788999999999999875 599999999976521 1122347899999999999999999999876 67899
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+|.||+++|-|+++|-.. +++++.++.+++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||+|....
T Consensus 89 lvlEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred EEEEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 999999999999999764 56999999999999999999999998 9999999999999999999999999998766
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCC-CcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
.+. ...+.+|++.|.|||++.+.+| +.++||||.|||||.||||++||++..-.. .
T Consensus 164 ~gk------lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~-----------------L 220 (786)
T KOG0588|consen 164 PGK------LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV-----------------L 220 (786)
T ss_pred CCc------cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH-----------------H
Confidence 553 3445679999999999999876 889999999999999999999997432211 1
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
+.++.... .+.|...+.+..+|+.+|+..||..|.|++||++.-.
T Consensus 221 LlKV~~G~--f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 221 LLKVQRGV--FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred HHHHHcCc--ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 11111111 1345566667899999999999999999999998543
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=344.42 Aligned_cols=269 Identities=25% Similarity=0.348 Sum_probs=203.9
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
.++|++.+.||+|+||.||+++.. +|..||+|++...........+.+|+++|++++||||+++++++.. ....+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 79 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS----DGEIS 79 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE----CCEEE
Confidence 467889999999999999999876 4889999999865444445669999999999999999999999875 45789
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ .|+||||||+|||++.++.+||+|||++....
T Consensus 80 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred EEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 999999999999999753 35899999999999999999999853 39999999999999999999999999987654
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec------------
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW------------ 450 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~------------ 450 (632)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||..............
T Consensus 156 ~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (331)
T cd06649 156 DS-------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHS 228 (331)
T ss_pred cc-------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccc
Confidence 32 12334699999999999999999999999999999999999999964322111000000
Q ss_pred cccccccccc-----------------cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006750 451 ATPRLQDSGT-----------------VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507 (632)
Q Consensus 451 ~~~~~~~~~~-----------------~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 507 (632)
..+....... ....+................+.+|+.+||+.||++|||+.++++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0000000000 00000000000000112345589999999999999999999998754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=354.50 Aligned_cols=264 Identities=24% Similarity=0.382 Sum_probs=207.3
Q ss_pred HhhcCccccceeeeeCceEEEEEEECC------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCccceeeeeecc
Q 006750 222 HATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEF 294 (632)
Q Consensus 222 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~ 294 (632)
...++|.+.+.||+|+||.||+|.+.. +..||||+++........+.|.+|+++|+++. ||||+++++++.+
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~- 112 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK- 112 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc-
Confidence 345678889999999999999998632 34799999976554455567999999999995 9999999999875
Q ss_pred cCCcceEEEEEEeCCCCChhhhhhccc-----------------------------------------------------
Q 006750 295 RGKRAMRLLVFEFMPNGNLRDCLDGVL----------------------------------------------------- 321 (632)
Q Consensus 295 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~----------------------------------------------------- 321 (632)
....|+||||+++|+|.++|....
T Consensus 113 ---~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 113 ---SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred ---CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 456899999999999999985421
Q ss_pred -----------------------------------------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCC
Q 006750 322 -----------------------------------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 360 (632)
Q Consensus 322 -----------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~ 360 (632)
...+++..++.++.|++.||+|||+.+ |+||||||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~ 266 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAAR 266 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChH
Confidence 124788899999999999999999998 999999999
Q ss_pred CeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCc
Q 006750 361 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (632)
Q Consensus 361 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~ 439 (632)
|||++.++.+||+|||+++........ .......+++.|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 267 Nill~~~~~~kL~DfGla~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 267 NVLLAQGKIVKICDFGLARDIMHDSNY---VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred hEEEeCCCEEEEEeCCcceeccccccc---cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 999999999999999999876432211 11223457788999999999899999999999999999997 99998643
Q ss_pred cccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 440 ITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
........ .+.....+ ..+...+..+.+++.+||+.+|++||++.+|.+.|..+.+
T Consensus 344 ~~~~~~~~-------------~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 344 IVDSTFYN-------------KIKSGYRM----AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred chhHHHHH-------------HHhcCCCC----CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 22111000 00000011 1223344568899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=344.37 Aligned_cols=261 Identities=26% Similarity=0.418 Sum_probs=204.9
Q ss_pred cCccccceeeeeCceEEEEEEECC-Cc----EEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~----~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
.+|+..+.||+|+||.||+|.+.. ++ .||||+++..........|.+|+.+++.++||||++++|++.. .
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~-----~ 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-----S 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC-----C
Confidence 458888999999999999998643 33 4899999765444555679999999999999999999999874 2
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..++|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccc
Confidence 4579999999999999997643 35899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
........ .......++..|+|||++....++.++||||||+++|||++ |+.||..........
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~------------ 222 (316)
T cd05108 158 LLGADEKE---YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS------------ 222 (316)
T ss_pred cccCCCcc---eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH------------
Confidence 76543211 01112234678999999999999999999999999999998 999986432211000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCcc
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKS 515 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 515 (632)
.+...... ..+..+...+..++.+||..+|++||++.+++..|..+..+..
T Consensus 223 --~~~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 223 --ILEKGERL----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred --HHhCCCCC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 00000000 1112223457889999999999999999999999988865543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=348.23 Aligned_cols=264 Identities=28% Similarity=0.427 Sum_probs=206.0
Q ss_pred hhcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeeccc
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFR 295 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~ 295 (632)
..++|.+.+.||+|+||.||+|... .++.||+|+++..........+..|+.++.++ +|+||++++++|...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~- 83 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP- 83 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-
Confidence 4467889999999999999999642 24789999998654444445688999999999 899999999988642
Q ss_pred CCcceEEEEEEeCCCCChhhhhhccc------------------------------------------------------
Q 006750 296 GKRAMRLLVFEFMPNGNLRDCLDGVL------------------------------------------------------ 321 (632)
Q Consensus 296 ~~~~~~~lV~Ey~~~gsL~~~L~~~~------------------------------------------------------ 321 (632)
....+++|||+++|+|.++|....
T Consensus 84 --~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 84 --GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred --CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 346789999999999999985421
Q ss_pred -----cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCCCCCCCCCCcc
Q 006750 322 -----VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARM 396 (632)
Q Consensus 322 -----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~ 396 (632)
...++|..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||+++.+...... ......
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~---~~~~~~ 235 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---VRKGDA 235 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcch---hhccCC
Confidence 125899999999999999999999998 999999999999999999999999999876432211 112234
Q ss_pred ccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccccccccccCCCCCCCCCC
Q 006750 397 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFP 475 (632)
Q Consensus 397 ~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 475 (632)
.++..|+|||++.+..++.++|||||||+||||++ |..||........ .. ..+.....+ ..+
T Consensus 236 ~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~-----------~~~~~~~~~----~~~ 298 (337)
T cd05054 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FC-----------RRLKEGTRM----RAP 298 (337)
T ss_pred CCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HH-----------HHHhccCCC----CCC
Confidence 56788999999999999999999999999999998 9999864322110 00 000000011 112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 476 KEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 476 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
......+.+++.+||+.+|++||++.+|++.|..++.
T Consensus 299 ~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 299 EYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 2233458899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=338.56 Aligned_cols=251 Identities=31% Similarity=0.510 Sum_probs=193.7
Q ss_pred ccceeeeeCceEEEEEEEC-----CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 229 GSNIVGQGGSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 229 ~~~~LG~G~fG~Vy~~~~~-----~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
..+.||.|.||.||+|.+. .+..|+||+++........+.|.+|++.+++++||||++++|++.. ....++
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~----~~~~~l 78 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE----NEPLFL 78 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES----SSSEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc----cccccc
Confidence 3578999999999999987 2678999999765444456779999999999999999999999984 334799
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||+++|+|.++|.......+++..+..|+.|++.||.|||+.+ ++|+||+++|||++.++.+||+|||++.....
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc
Confidence 999999999999998864566999999999999999999999998 99999999999999999999999999987632
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVI 462 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (632)
.... .......+...|+|||.+....++.++||||||+++|||++ |+.||........... +
T Consensus 156 ~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~--------------~ 218 (259)
T PF07714_consen 156 KSKY---KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEK--------------L 218 (259)
T ss_dssp SSSE---EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHH--------------H
T ss_pred cccc---cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------------c
Confidence 2111 11222346788999999999999999999999999999999 6788865422110000 0
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006750 463 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507 (632)
Q Consensus 463 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 507 (632)
.+... ...+..++..+.+++..||..+|++||++.+|++.|
T Consensus 219 ~~~~~----~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 219 KQGQR----LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HTTEE----TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccc----ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 00000 112223345588999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=341.04 Aligned_cols=246 Identities=24% Similarity=0.323 Sum_probs=199.0
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|.+.+.||+|+||.||+|... +|+.||||++.... .......+.+|+.++++++||||+++++++.+ ....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~ 76 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD----QRFL 76 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc----CCeE
Confidence 36888899999999999999876 58999999986432 12234458899999999999999999988765 4578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||||+++|+|.+++... +.+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 77 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~ 151 (291)
T cd05612 77 YMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKL 151 (291)
T ss_pred EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhc
Confidence 9999999999999999753 45899999999999999999999998 999999999999999999999999999765
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus 152 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~--------------- 208 (291)
T cd05612 152 RDR--------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYE--------------- 208 (291)
T ss_pred cCC--------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---------------
Confidence 422 223468999999999998889999999999999999999999996533211100
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT-----MSEVVQI 506 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 506 (632)
.+.... ..++......+.+|+.+||+.||.+||+ +.++++.
T Consensus 209 --~i~~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 209 --KILAGK--LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred --HHHhCC--cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 000000 0122223445889999999999999995 8877754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=359.43 Aligned_cols=276 Identities=22% Similarity=0.269 Sum_probs=217.9
Q ss_pred hhcCccccceeeeeCceEEEEEEECCC-cEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCccceeee-eecc-cCC-
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLTDG-RIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGY-CSEF-RGK- 297 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~~g-~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~-~~~~-~~~- 297 (632)
...++++.+.|.+|||+.||.|.+..+ ..||+|++-.. .........+||++|++|. |+|||.+++. .... .+.
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 345567789999999999999998775 99999999876 5566677999999999994 9999999993 3222 222
Q ss_pred cceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccc
Q 006750 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 377 (632)
..+.+|.||||.||+|-|+++.+....|++.++++|+.|+++|+++||... |+|||||||-+||||+.+++.||||||.
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence 467899999999999999998777677999999999999999999999985 6799999999999999999999999999
Q ss_pred ceecccCCCCCC----CCCCCccccCCCCCChhhhh---cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec
Q 006750 378 AKRLKADGLPSC----SSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450 (632)
Q Consensus 378 a~~~~~~~~~~~----~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~ 450 (632)
|......-.... ........-|+.|.|||++. +...++|+|||+|||+||-|+....||+.....
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-------- 264 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-------- 264 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--------
Confidence 864322110000 00011223689999999874 677899999999999999999999999753211
Q ss_pred cccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCcccccccC
Q 006750 451 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNIS 521 (632)
Q Consensus 451 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~ 521 (632)
.|....+..+-.+..+..|..||+.||+.||++||++.+|+..+..++.......++.
T Consensus 265 -------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~ 322 (738)
T KOG1989|consen 265 -------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY 322 (738)
T ss_pred -------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence 1222222222234667789999999999999999999999999998876655444443
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=345.47 Aligned_cols=243 Identities=25% Similarity=0.314 Sum_probs=195.6
Q ss_pred ceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEe
Q 006750 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 307 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey 307 (632)
+.||+|+||.||++... +|+.||||+++... .......+.+|+.+|++++||||+++++++.. ....|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~----~~~~~lv~e~ 76 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT----HDRLCFVMEY 76 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc----CCEEEEEEeC
Confidence 36999999999999875 58999999997542 22333458899999999999999999998875 5578999999
Q ss_pred CCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCCC
Q 006750 308 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP 387 (632)
Q Consensus 308 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 387 (632)
+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 77 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-- 149 (323)
T cd05571 77 ANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-- 149 (323)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--
Confidence 9999999998753 45899999999999999999999998 9999999999999999999999999987543221
Q ss_pred CCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccCC
Q 006750 388 SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPD 467 (632)
Q Consensus 388 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (632)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||............ .. .+
T Consensus 150 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~-------------~~--~~ 211 (323)
T cd05571 150 ---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-------------LM--EE 211 (323)
T ss_pred ---CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHH-------------Hc--CC
Confidence 2233457999999999999999999999999999999999999999653221110000 00 01
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006750 468 PRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQI 506 (632)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 506 (632)
. .++......+.+|+.+||+.||++|| ++.++++.
T Consensus 212 ~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 212 I----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred C----CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 1 12333445588999999999999999 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=331.66 Aligned_cols=255 Identities=27% Similarity=0.404 Sum_probs=204.2
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
.+|...+.||+|+||.||+|.+.+ ++.||+|++... ......+.+|++++++++||||+++++++.. ....++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~l 79 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR----EPPFYI 79 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcC----CCCcEE
Confidence 457778899999999999998764 889999998753 2334568999999999999999999998875 446799
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||+++++|.+++.......+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 999999999999997655556899999999999999999999998 99999999999999999999999999987653
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVI 462 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (632)
.... ......++..|+|||++.+..++.++||||||+++|||++ |..||.......... .+
T Consensus 157 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~--------------~~ 218 (263)
T cd05052 157 DTYT----AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE--------------LL 218 (263)
T ss_pred ceee----ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--------------HH
Confidence 3211 1112234678999999999999999999999999999998 889986432211000 00
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 463 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 463 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
.....+ ..+...+..+.+++.+||..+|++||++.++++.|+.+
T Consensus 219 ~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 219 EKGYRM----ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HCCCCC----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 011111 22233345588999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=330.07 Aligned_cols=255 Identities=23% Similarity=0.365 Sum_probs=204.9
Q ss_pred hcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
.++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++.. ....++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTK----EEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC----CCCcEE
Confidence 35688889999999999999998888899999987532 234568999999999999999999988765 446799
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||+++|+|.+++.......+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+++....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCC
Confidence 999999999999997655566899999999999999999999988 99999999999999999999999999987653
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVI 462 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (632)
.... ......++..|+|||++....++.++||||||+++|+|++ |+.||.......... . +
T Consensus 156 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~---~-----------~ 217 (261)
T cd05072 156 NEYT----AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMS---A-----------L 217 (261)
T ss_pred Ccee----ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHH---H-----------H
Confidence 2211 1122346778999999998899999999999999999998 999986432211000 0 0
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006750 463 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 509 (632)
Q Consensus 463 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 509 (632)
...........+ +..+.+++.+||..+|++||++.++.+.|+.
T Consensus 218 ~~~~~~~~~~~~----~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 218 QRGYRMPRMENC----PDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HcCCCCCCCCCC----CHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 001111111122 3448889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=344.99 Aligned_cols=246 Identities=25% Similarity=0.318 Sum_probs=198.9
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|.+.+.||+|+||.||+|++. +++.||||+++... .......+.+|+.+|++++||||+++++++.. ....
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~ 93 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD----ENRV 93 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc----CCEE
Confidence 56888899999999999999986 48999999987532 22334558899999999999999999998875 4578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 94 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 168 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKV 168 (329)
T ss_pred EEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence 9999999999999999753 45889999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 169 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---------------- 224 (329)
T PTZ00263 169 PDR--------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY---------------- 224 (329)
T ss_pred CCC--------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH----------------
Confidence 432 12346999999999999999999999999999999999999999643221100
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT-----MSEVVQI 506 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 506 (632)
..+....+ .+|......+.+|+.+||+.||.+||+ +.+++..
T Consensus 225 -~~i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 225 -EKILAGRL--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -HHHhcCCc--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 00111110 122223345889999999999999997 5776653
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=334.66 Aligned_cols=268 Identities=23% Similarity=0.298 Sum_probs=200.0
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
++|++.+.||+|+||.||+++++ +++.||||+++.... ......+.+|+.+++.++||||+++++++.. ....+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 76 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR----RGKLY 76 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec----CCEEE
Confidence 46888999999999999999986 488999999975432 2334558899999999999999999998865 45789
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||++++.|..+... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 77 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 151 (287)
T cd07848 77 LVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLS 151 (287)
T ss_pred EEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccc
Confidence 99999998777655432 245899999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccc-----
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD----- 457 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~----- 457 (632)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..................+..
T Consensus 152 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07848 152 EGSN----ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKL 227 (287)
T ss_pred cccc----ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHh
Confidence 3211 1223456899999999999888999999999999999999999999754321110000000000000
Q ss_pred --ccccccccCCCCCC------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 458 --SGTVISELPDPRLK------GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 458 --~~~~~~~~~~~~l~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
..........+... .......+..+.+|+.+||+.||++|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 228 FYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000001100 0111223456899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=330.04 Aligned_cols=256 Identities=27% Similarity=0.397 Sum_probs=205.2
Q ss_pred hhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
..++|++.+.||+|+||.||+|.+.+++.||||.++... .....|.+|+.++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 77 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL----EEPIY 77 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEec----CCCee
Confidence 346688889999999999999998778899999987543 234568999999999999999999998775 44679
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||+++++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+++...
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIK 154 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence 9999999999999997655456899999999999999999999998 9999999999999999999999999998775
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
..... .......+..|+|||++.+..++.++||||||+++|||++ |+.||...........
T Consensus 155 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-------------- 216 (261)
T cd05068 155 EDIYE----AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQ-------------- 216 (261)
T ss_pred CCccc----ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--------------
Confidence 32211 1111223468999999998899999999999999999999 9999864322110000
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 509 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 509 (632)
+.... ....+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 217 ~~~~~----~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 217 VDQGY----RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHcCC----CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 00000 011222334558899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=343.13 Aligned_cols=253 Identities=25% Similarity=0.342 Sum_probs=202.0
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|.+.+.||+|+||.||+|++.+ ++.||||+++.... ......+.+|++++..++||||+++++++.. ....
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~----~~~~ 76 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD----DEYL 76 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc----CCEE
Confidence 368889999999999999999864 89999999975421 2334558899999999999999999998875 5578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 77 ~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~ 151 (333)
T cd05600 77 YLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGI 151 (333)
T ss_pred EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccc
Confidence 9999999999999999653 45899999999999999999999998 999999999999999999999999999765
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccch-heeccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES-LVLWATPRLQDSGT 460 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~-~~~~~~~~~~~~~~ 460 (632)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... +..|..
T Consensus 152 ~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-------- 215 (333)
T cd05600 152 VT--------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE-------- 215 (333)
T ss_pred cc--------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc--------
Confidence 43 2234569999999999999999999999999999999999999997543221111 111100
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+..+... ......+..+.+|+.+||..+|.+||++.++++.
T Consensus 216 ---~~~~~~~~-~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 216 ---TLQRPVYD-DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ---cccCCCCC-ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 00011100 0001234558899999999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=334.55 Aligned_cols=266 Identities=23% Similarity=0.355 Sum_probs=198.9
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
++|...+.||.|+||.||+|... +++.||+|+++..........+.+|+.++++++||||+++++++.. ....++
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~l 80 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT----ERCLTL 80 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC----CCeEEE
Confidence 46888899999999999999875 5899999999765444444558899999999999999999998865 457899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||++ |+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 v~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 81 VFEYLD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred EEeCCC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 999996 59999886532 34789999999999999999999998 99999999999999999999999999976532
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec--cc------cc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--AT------PR 454 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~------~~ 454 (632)
.. .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.............. .. +.
T Consensus 156 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07871 156 PT-----KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG 230 (288)
T ss_pred CC-----ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhc
Confidence 21 12233468999999998875 5689999999999999999999999965432211110000 00 00
Q ss_pred cccccccccccCCCCCCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 455 LQDSGTVISELPDPRLKG----DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 455 ~~~~~~~~~~~~~~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.... ........+.... .........+.+|+.+||+.||.+|||+.|+++
T Consensus 231 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 231 ITSN-EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred cccc-hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000 0000111111100 001122345789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=328.51 Aligned_cols=257 Identities=26% Similarity=0.412 Sum_probs=204.7
Q ss_pred cCccccceeeeeCceEEEEEEECC----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
++|++.+.||+|+||.||+|.+.. ...||||+++..........|.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 79 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK----SRP 79 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec----CCc
Confidence 568888999999999999998753 458999998866555555679999999999999999999998865 446
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||||+|||+++++.++|+|||+++.
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 80 VMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhc
Confidence 799999999999999997643 35899999999999999999999988 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||..........
T Consensus 156 ~~~~~~~---~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~------------- 219 (266)
T cd05033 156 LEDSEAT---YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIK------------- 219 (266)
T ss_pred ccccccc---eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHH-------------
Confidence 7521110 11112335678999999998899999999999999999998 999985432211000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
.+.... ....+...+..+.+++.+||+.+|++||++.+|++.|..+
T Consensus 220 -~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 220 -AVEDGY----RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -HHHcCC----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000000 0011222344588999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=333.63 Aligned_cols=259 Identities=27% Similarity=0.402 Sum_probs=202.0
Q ss_pred HhhcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeeccc
Q 006750 222 HATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 295 (632)
Q Consensus 222 ~~t~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~ 295 (632)
..+++|+..+.||+|+||.||+|.+. .+..||||++...........|.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-- 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-- 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--
Confidence 35678999999999999999999753 2567999998654433344568999999999999999999998865
Q ss_pred CCcceEEEEEEeCCCCChhhhhhcccc--------CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCC
Q 006750 296 GKRAMRLLVFEFMPNGNLRDCLDGVLV--------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 367 (632)
Q Consensus 296 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~--------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~ 367 (632)
....++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||||+|||++++
T Consensus 81 --~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 81 --GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED 155 (277)
T ss_pred --CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCC
Confidence 4467999999999999999865321 23678999999999999999999988 9999999999999999
Q ss_pred CCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccch
Q 006750 368 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEES 446 (632)
Q Consensus 368 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~ 446 (632)
+.++|+|||+++......... ......+++.|+|||++.+..++.++||||||+++|||++ |..||..........
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~ 232 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYR---KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLR 232 (277)
T ss_pred CCEEECCCCCccccCCcceee---cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999987654322111 1112345788999999999999999999999999999999 688886432211000
Q ss_pred heeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 447 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
.. .+...+ ..+...+..+.+++.+||+.||++|||+.++++.|.
T Consensus 233 ~~--------------~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 233 FV--------------MEGGLL----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HH--------------HcCCcC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 00 000000 112233455899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=332.30 Aligned_cols=256 Identities=27% Similarity=0.420 Sum_probs=203.7
Q ss_pred cCccccceeeeeCceEEEEEEECC------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 298 (632)
++|.+.+.||+|+||.||+|...+ +..||||.++..........|.+|+++|++++||||+++++++.. .
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~ 80 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE----G 80 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec----C
Confidence 457778899999999999998643 478999999866544455679999999999999999999999876 3
Q ss_pred ceEEEEEEeCCCCChhhhhhccc------------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVL------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 366 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~ 366 (632)
...++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~ 157 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGY 157 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcC
Confidence 56799999999999999996532 134789999999999999999999998 999999999999999
Q ss_pred CCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccc
Q 006750 367 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEE 445 (632)
Q Consensus 367 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~ 445 (632)
++.++|+|||+++........ .......+++.|+|||++.+..++.++||||||+++|||++ |..||.........
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~ 234 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYY---RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI 234 (280)
T ss_pred CCeEEECCcccceecccCcce---ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 999999999999765332211 11223346788999999999999999999999999999998 99998654322111
Q ss_pred hheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 446 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
.. +..... ...+...+..+.+++.+||+.||++||++.||++.|+
T Consensus 235 ~~-----------------~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 235 EC-----------------ITQGRL-LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HH-----------------HHcCCc-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 00 000000 0112223455889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=312.16 Aligned_cols=271 Identities=25% Similarity=0.349 Sum_probs=212.0
Q ss_pred hcCccccceeeeeCceEEEEEE-ECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccC-CcceE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG-KRAMR 301 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~-~~~~~ 301 (632)
.++|.+.+.||+|||+-||+++ ..++..+|+|++.... .+..+..++|++..++++||||++++++...... .....
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 4568888999999999999998 4568999999998765 4555668999999999999999999998865443 34578
Q ss_pred EEEEEeCCCCChhhhhhccccC--CCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVE--GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
||+++|...|+|.+.++....+ .+++.+.++|+.++++||++||+.. |+++||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999999765433 4999999999999999999999986 569999999999999999999999999987
Q ss_pred ecccCCCC----CCCCCCCccccCCCCCChhhhhc---CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccc
Q 006750 380 RLKADGLP----SCSSSPARMQGTFGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 452 (632)
Q Consensus 380 ~~~~~~~~----~~~~~~~~~~GT~~Y~APE~~~~---~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~ 452 (632)
...-.-.. .....+....-|..|.|||.+.- ...++++|||||||+||+|+.|..||+.....+..-.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla----- 252 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA----- 252 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE-----
Confidence 64321100 00112233457899999998863 4579999999999999999999999975444322111
Q ss_pred cccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 453 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 453 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
-.+..+.+..+-....+..+.+++++|++.||.+||++.+++..++.+.
T Consensus 253 ----------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 253 ----------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ----------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1111111111111224556999999999999999999999999887664
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=327.77 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=199.6
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV 304 (632)
++|++.+.||+|+||.||++.++++..+|+|.+.... .....|.+|+.+|++++||||+++++++.. ....++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ----QKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEcc----CCCEEEE
Confidence 4577788999999999999999888899999986432 223568999999999999999999998875 4467999
Q ss_pred EEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccC
Q 006750 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 384 (632)
|||+++|+|.++++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 78 TEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 99999999999987543 34899999999999999999999998 999999999999999999999999998865432
Q ss_pred CCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccccccccc
Q 006750 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463 (632)
Q Consensus 385 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (632)
... ......++..|+|||++.+..++.++||||||+++|||++ |+.||........... +.
T Consensus 154 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~--------------i~ 215 (256)
T cd05114 154 EYT----SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEM--------------IS 215 (256)
T ss_pred cee----ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--------------HH
Confidence 211 1122335678999999988889999999999999999999 8999864332111000 00
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006750 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507 (632)
Q Consensus 464 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 507 (632)
+...+ ..+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 216 ~~~~~----~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 216 RGFRL----YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCC----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 00000 01112234588999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=330.73 Aligned_cols=257 Identities=28% Similarity=0.413 Sum_probs=208.3
Q ss_pred HhhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 222 HATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 222 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
....+|+..+.||.|+||.||+|.+.++..+|+|.+..... .....+..|+.+++.++||||+++++++.. ....
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~ 77 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSV----GEPV 77 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEec----CCCe
Confidence 34567888899999999999999998899999999876532 234568999999999999999999998875 4567
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
++||||+++|+|.+++.......+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||++...
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLI 154 (261)
T ss_pred EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhc
Confidence 99999999999999998765566899999999999999999999998 999999999999999999999999999776
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
..... ......++..|+|||++....++.++||||||+++|+|++ |+.||...........
T Consensus 155 ~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~------------- 216 (261)
T cd05148 155 KEDVY-----LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQ------------- 216 (261)
T ss_pred CCccc-----cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH-------------
Confidence 43221 1123346778999999998899999999999999999998 8999864332111000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 509 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 509 (632)
+. .......+...+..+.+++.+||+.||.+|||+.++++.|+.
T Consensus 217 -~~----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 217 -IT----AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred -HH----hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 00 001111223334558899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=332.34 Aligned_cols=271 Identities=24% Similarity=0.355 Sum_probs=198.7
Q ss_pred cCccccceeeeeCceEEEEEEEC--CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhc---CCCCccceeeeeeccc-CC
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT--DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRL---HHCHVVPLVGYCSEFR-GK 297 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vAVK~l~~~~~~-~~~~~f~~Ei~~l~~l---~Hpniv~l~g~~~~~~-~~ 297 (632)
++|.+.+.||+|+||.||+|+.. +++.||||+++..... .....+.+|+.+++.+ +||||+++++++.... ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 4788999998754322 2233467788887766 6999999999886422 12
Q ss_pred cceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccc
Q 006750 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 377 (632)
....++||||++ ++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 446899999995 69999997655556899999999999999999999998 99999999999999999999999999
Q ss_pred ceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe-eccc-c--
Q 006750 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV-LWAT-P-- 453 (632)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~-~~~~-~-- 453 (632)
++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||............ .... +
T Consensus 157 ~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~ 230 (290)
T cd07862 157 ARIYSFQ------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 230 (290)
T ss_pred eEeccCC------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence 9865432 1223456899999999999889999999999999999999999999754332111000 0000 0
Q ss_pred -ccccccccccccCCCCCCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 454 -RLQDSGTVISELPDPRLKG---DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 454 -~~~~~~~~~~~~~~~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.+............+.... .........+.+|+.+||+.||++|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000000000000000000 011123345789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=340.21 Aligned_cols=243 Identities=26% Similarity=0.326 Sum_probs=195.0
Q ss_pred ceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEe
Q 006750 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 307 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey 307 (632)
+.||+|+||.||++... +|+.||||++.... .......+.+|+.+|+.++||||+++++++.. ....++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~~lv~Ey 76 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT----KDRLCFVMEY 76 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc----CCEEEEEEeC
Confidence 36999999999999875 58999999997542 22334568899999999999999999988875 5578999999
Q ss_pred CCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCCC
Q 006750 308 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP 387 (632)
Q Consensus 308 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 387 (632)
+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 77 ~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-- 149 (328)
T cd05593 77 VNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-- 149 (328)
T ss_pred CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--
Confidence 9999999988653 45899999999999999999999998 9999999999999999999999999987543221
Q ss_pred CCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccCC
Q 006750 388 SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPD 467 (632)
Q Consensus 388 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (632)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||............. ...
T Consensus 150 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~---------------~~~ 211 (328)
T cd05593 150 ---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL---------------MED 211 (328)
T ss_pred ---cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc---------------cCC
Confidence 12234569999999999999999999999999999999999999996432211100000 001
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006750 468 PRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQI 506 (632)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 506 (632)
. .+|...+..+.+|+.+||+.||.+|| ++.++++.
T Consensus 212 ~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 212 I----KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred c----cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1 12333345588999999999999997 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=330.44 Aligned_cols=271 Identities=28% Similarity=0.383 Sum_probs=204.9
Q ss_pred cccceeeeeCceEEEEEEE-----CCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 228 SGSNIVGQGGSSYVYRGQL-----TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 228 ~~~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
...+.||+|+||+||++.. .+++.||+|.++..........|.+|+++|++++||||+++++++.... ....+
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~~~ 84 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQG--GKGLQ 84 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--CceEE
Confidence 7789999999999988653 3578999999986544444566899999999999999999999876532 34679
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||+++|+|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.++|+|||+++...
T Consensus 85 lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 85 LIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 99999999999999865 34899999999999999999999998 9999999999999999999999999998664
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 462 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (632)
..... ........++..|+|||.+....++.++||||||+++|||++|..||.......... ..+...... ...+
T Consensus 159 ~~~~~--~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~-~~~~~~~~~--~~~~ 233 (283)
T cd05080 159 EGHEY--YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEM-IGPKQGQMT--VVRL 233 (283)
T ss_pred Ccchh--hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhh-hcccccccc--hhhh
Confidence 32210 011122345677999999988889999999999999999999999986433211100 000000000 0001
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 463 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 463 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
.+..+.......+...+..+.+++..||+.+|++|||+.+|++.|..+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1111111122233344556899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=332.18 Aligned_cols=257 Identities=26% Similarity=0.429 Sum_probs=201.1
Q ss_pred cCccccceeeeeCceEEEEEEE-----CCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQL-----TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
+.|++.+.||+|+||.||+|.+ .++..||+|.+...........|.+|+.++++++||||+++++++.. ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~ 80 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ----EQ 80 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec----CC
Confidence 4577788999999999999985 24678999999865444444568999999999999999999998765 44
Q ss_pred eEEEEEEeCCCCChhhhhhccc---------------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEe
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVL---------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL 364 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl 364 (632)
..++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili 157 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILI 157 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEE
Confidence 6799999999999999985321 134789999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccc
Q 006750 365 DENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKG 443 (632)
Q Consensus 365 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~ 443 (632)
++++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~ 234 (283)
T cd05090 158 GEQLHVKISDLGLSREIYSADYY---RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE 234 (283)
T ss_pred cCCCcEEeccccccccccCCcce---ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 99999999999999876433211 11223346778999999988889999999999999999998 888986432211
Q ss_pred cchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006750 444 EESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 509 (632)
Q Consensus 444 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 509 (632)
.... +...... ..+...+..+.+++.+||+.||++||++.+|.+.|..
T Consensus 235 ~~~~--------------~~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEM--------------VRKRQLL----PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHH--------------HHcCCcC----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 0000 0000001 1222233458899999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=330.49 Aligned_cols=259 Identities=24% Similarity=0.374 Sum_probs=201.1
Q ss_pred cCccccceeeeeCceEEEEEEECC-Cc----EEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~----~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
++|...+.||+|+||.||+|.+.. ++ .+++|.+...........+..|+.+++++.||||+++++++.. .
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-----~ 81 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-----A 81 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-----C
Confidence 457778899999999999998743 44 4788887654433444568888999999999999999998752 3
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..++++||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccce
Confidence 4589999999999999997533 45899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
........ .......++..|+|||++.++.++.++||||||+++|||++ |+.||...........
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~----------- 223 (279)
T cd05111 158 LLYPDDKK---YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL----------- 223 (279)
T ss_pred eccCCCcc---cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-----------
Confidence 76433211 11223457789999999999999999999999999999998 9999865432111010
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 513 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 513 (632)
+.....+.. +..+...+..++.+||..||++|||+.++++.|..+..+
T Consensus 224 ---~~~~~~~~~----~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 224 ---LEKGERLAQ----PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred ---HHCCCcCCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 000000001 111223477899999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=347.08 Aligned_cols=243 Identities=21% Similarity=0.322 Sum_probs=203.3
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC--CChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~ 299 (632)
.++|...++||+|+||.|+++..+. ++.+|||++++... .+..+..+.|..++... +||.+++|+.++.. ..
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT----~~ 442 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT----KE 442 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc----CC
Confidence 4678899999999999999999875 88999999997743 33445578898888877 69999999988875 67
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
++|+||||+.||++..+.+. +.+++..+.-++..|+.||.|||+++ |||||||.+|||||.+|.+||+||||++
T Consensus 443 ~l~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred eEEEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 89999999999996655442 45999999999999999999999999 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
..... .....++.|||.|||||++.+..|+..+|.|||||+|||||.|..||.+..+.+....+...
T Consensus 517 e~m~~-----g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d-------- 583 (694)
T KOG0694|consen 517 EGMGQ-----GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND-------- 583 (694)
T ss_pred ccCCC-----CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--------
Confidence 65432 23567789999999999999999999999999999999999999999865544322211100
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM 500 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 500 (632)
+ ..+|..++.+...|++++|..+|++|.-+
T Consensus 584 -------~----~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 -------E----VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -------C----CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1 13566666778899999999999999766
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=343.97 Aligned_cols=248 Identities=26% Similarity=0.380 Sum_probs=192.5
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV 304 (632)
+|+..+.||+|+||.||+|.+. +|+.||||++...........|.+|+++|+.++|+||+++++++.. ....++|
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv 150 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH----NGEIQVL 150 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc----CCeEEEE
Confidence 3455688999999999999875 5899999999765444445668999999999999999999998865 4578999
Q ss_pred EEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccC
Q 006750 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 384 (632)
|||+++|+|.+.. ...+..+..++.|++.||+|||+.+ |+||||||+||||++++.+||+|||+++.....
T Consensus 151 ~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 151 LEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred EecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 9999999997532 2567788899999999999999998 999999999999999999999999999876432
Q ss_pred CCCCCCCCCCccccCCCCCChhhhhc-----CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc
Q 006750 385 GLPSCSSSPARMQGTFGYFAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 385 ~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
. .......||..|+|||++.. ...+.++|||||||++|||++|+.||.............
T Consensus 222 ~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---------- 286 (353)
T PLN00034 222 M-----DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC---------- 286 (353)
T ss_pred c-----ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH----------
Confidence 1 11233569999999998743 334678999999999999999999996322111000000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+.....+ ..+......+.+|+.+||+.||++||++.|+++.
T Consensus 287 -~~~~~~~~----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 287 -AICMSQPP----EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -HHhccCCC----CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000011 1222334558999999999999999999999875
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=327.32 Aligned_cols=255 Identities=24% Similarity=0.388 Sum_probs=205.1
Q ss_pred hhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
..+.|.+.+.||+|+||.||+|...+++.||+|.+..... ....|.+|+.++++++|+||+++++++. ....+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 76 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVVT-----QEPIY 76 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEEc-----cCCcE
Confidence 3467888999999999999999988899999999875432 3356899999999999999999998764 23579
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||+++|+|.+++.......+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 9999999999999997655566999999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
..... ......++..|+|||++....++.++||||||+++|||++ |+.||.......... .
T Consensus 154 ~~~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~--------------~ 215 (260)
T cd05067 154 DNEYT----AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ--------------N 215 (260)
T ss_pred CCCcc----cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHH--------------H
Confidence 32211 1122346778999999998899999999999999999999 999996433211100 0
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 509 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 509 (632)
+...... ..+...+..+.+++.+||..+|++||++.+++..|+.
T Consensus 216 ~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 216 LERGYRM----PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHcCCCC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0000111 1122233458999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=338.39 Aligned_cols=201 Identities=27% Similarity=0.419 Sum_probs=174.2
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
.++|++.+.||+|+||.||++.+. ++..+|+|++...........+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 79 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS----DGEIS 79 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE----CCEEE
Confidence 467899999999999999999876 4889999998765444444568999999999999999999999876 45789
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||+++|+|.+++... ..+++..+..++.+++.||.|||+.+ +|+||||||+|||++.++.+||+|||++....
T Consensus 80 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred EEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 999999999999999753 35889999999999999999999752 29999999999999999999999999987653
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~ 439 (632)
.. ......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 156 DS-------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred hh-------ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 22 122346899999999999888999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=332.96 Aligned_cols=267 Identities=23% Similarity=0.362 Sum_probs=197.8
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
.++|.+.+.||+|+||.||+|... +++.||||+++..........+.+|+.+++.++||||+++++++.. ....+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~ 79 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT----KETLT 79 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec----CCeEE
Confidence 367889999999999999999976 5899999999765433334457899999999999999999998875 45789
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||+ .++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 80 lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 80 LVFEYV-HTDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred EEEECC-CcCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 999999 47888888653 245899999999999999999999998 9999999999999999999999999987543
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccch-he--eccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES-LV--LWATPRLQDS 458 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~-~~--~~~~~~~~~~ 458 (632)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... .. ....+.. ..
T Consensus 155 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~ 228 (303)
T cd07869 155 VPS-----HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNE-DT 228 (303)
T ss_pred CCC-----ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCCh-hh
Confidence 221 12233468999999999875 458899999999999999999999997532211000 00 0000000 00
Q ss_pred ccccc---ccCCCCCCCCCCH---------HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 459 GTVIS---ELPDPRLKGDFPK---------EEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 459 ~~~~~---~~~~~~l~~~~~~---------~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
..... ...........+. .....+.+|+.+||+.||.+|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 229 WPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000 0000000000000 01244789999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=339.64 Aligned_cols=242 Identities=24% Similarity=0.285 Sum_probs=192.1
Q ss_pred eeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEeCC
Q 006750 233 VGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 309 (632)
Q Consensus 233 LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey~~ 309 (632)
||+|+||.||+|...+ ++.||+|+++... .......+.+|+.+|++++||||+++++++.. ....|+||||++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~ 76 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS----PEKLYLVLAFIN 76 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec----CCeEEEEEcCCC
Confidence 6999999999998764 8899999987432 22334558899999999999999999988875 457899999999
Q ss_pred CCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCCCCC
Q 006750 310 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 389 (632)
Q Consensus 310 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 389 (632)
+|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---- 147 (312)
T cd05585 77 GGELFHHLQRE--GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD---- 147 (312)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC----
Confidence 99999999753 45899999999999999999999998 9999999999999999999999999987543221
Q ss_pred CCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccCCCC
Q 006750 390 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 469 (632)
Q Consensus 390 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (632)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+....
T Consensus 148 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~-----------------~~~~~~~ 209 (312)
T cd05585 148 -DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY-----------------RKILQEP 209 (312)
T ss_pred -CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHH-----------------HHHHcCC
Confidence 1223456999999999999999999999999999999999999999643221100 0000000
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006750 470 LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507 (632)
Q Consensus 470 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 507 (632)
..++......+.+++.+||..||.+||++..+.+.|
T Consensus 210 --~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 210 --LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred --CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 112333445588999999999999998654444433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=338.52 Aligned_cols=257 Identities=24% Similarity=0.345 Sum_probs=202.0
Q ss_pred hhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
..++|+.+..||+|+||.||+++-++ |..+|+|+++.... .......+.|-.+|....+|.||+|+-.|.+ ..
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD----~~ 214 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD----KE 214 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC----CC
Confidence 45778999999999999999998665 99999999986532 2334458889999999999999999977775 66
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
++||||||++|||+..+|... ..|++..+..++.+++-|++-||+.| +|||||||+|+|||..|++||+||||+.
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred eeEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccc
Confidence 899999999999999999764 45899999999999999999999999 9999999999999999999999999986
Q ss_pred ecccC----------------------CCCC---CCC-----------------CCCccccCCCCCChhhhhcCCCCccc
Q 006750 380 RLKAD----------------------GLPS---CSS-----------------SPARMQGTFGYFAPEYAMVGRASLMS 417 (632)
Q Consensus 380 ~~~~~----------------------~~~~---~~~-----------------~~~~~~GT~~Y~APE~~~~~~~s~ks 417 (632)
-+... ..+. ... .....+|||-|||||++.+..|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 43210 0000 000 01125699999999999999999999
Q ss_pred chHhHhHHHHHHHhCCCCCCCccccccc-hheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCC
Q 006750 418 DVFSFGVVLLELITGRQPIHRSITKGEE-SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDA 496 (632)
Q Consensus 418 DVwSlGviL~eLltG~~P~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~ 496 (632)
|.||||||+||||.|.+||....+..-. .+..|... +..| -......+..+||.+|+. ||++
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~-----------l~fP-----~~~~~s~eA~DLI~rll~-d~~~ 432 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET-----------LKFP-----EEVDLSDEAKDLITRLLC-DPEN 432 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh-----------ccCC-----CcCcccHHHHHHHHHHhc-CHHH
Confidence 9999999999999999999876654321 22222211 1111 111223558899999999 9999
Q ss_pred CCC---HHHHHH
Q 006750 497 RPT---MSEVVQ 505 (632)
Q Consensus 497 RPs---~~evl~ 505 (632)
|.- +.||.+
T Consensus 433 RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 433 RLGSKGAEEIKK 444 (550)
T ss_pred hcCcccHHHHhc
Confidence 964 666654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=378.77 Aligned_cols=263 Identities=26% Similarity=0.497 Sum_probs=205.4
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
...|...+.||+|+||.||+|.+. ++..||||+++..... ...|+++|++++|||||+++|+|.+ ....|
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~----~~~~~ 759 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRS----EKGAY 759 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEc----CCCCE
Confidence 345777889999999999999874 6899999998754321 2456889999999999999999976 34579
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||+++|+|.++++. ++|..+..|+.|+|+||+|||....++|+||||||+||+++.++.+++. ||.+....
T Consensus 760 lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~ 833 (968)
T PLN00113 760 LIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC 833 (968)
T ss_pred EEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence 99999999999999953 8999999999999999999997655669999999999999999888876 66654332
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 462 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (632)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||+..... ......|....... ...
T Consensus 834 ~~---------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~--~~~ 901 (968)
T PLN00113 834 TD---------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSD--CHL 901 (968)
T ss_pred cC---------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCc--cch
Confidence 11 1235889999999999999999999999999999999999999543221 22233333222211 112
Q ss_pred cccCCCCCCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006750 463 SELPDPRLKG--DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 513 (632)
Q Consensus 463 ~~~~~~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 513 (632)
....++.+.. ..+......+.+++.+||+.||++||+|.||++.|+.+...
T Consensus 902 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 902 DMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred hheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 2334444433 23455666788999999999999999999999999988653
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=339.96 Aligned_cols=243 Identities=25% Similarity=0.301 Sum_probs=194.4
Q ss_pred ceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEe
Q 006750 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 307 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey 307 (632)
+.||+|+||.||++... +|+.||+|+++... .......+.+|+.+++.++||||+++++++.. ....|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~----~~~~~lv~E~ 76 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT----HDRLCFVMEY 76 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec----CCEEEEEEeC
Confidence 36999999999999875 58999999997542 22334457889999999999999999998875 4578999999
Q ss_pred CCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCCC
Q 006750 308 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP 387 (632)
Q Consensus 308 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 387 (632)
+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-- 149 (323)
T cd05595 77 ANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-- 149 (323)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--
Confidence 9999999988653 45899999999999999999999998 9999999999999999999999999987543221
Q ss_pred CCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccCC
Q 006750 388 SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPD 467 (632)
Q Consensus 388 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (632)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........... +..
T Consensus 150 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~-----------------~~~ 209 (323)
T cd05595 150 ---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL-----------------ILM 209 (323)
T ss_pred ---CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHH-----------------Hhc
Confidence 122345699999999999999999999999999999999999999964332211000 000
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006750 468 PRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQI 506 (632)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 506 (632)
.. ..++...+..+.+++.+||+.||.+|| ++.++++.
T Consensus 210 ~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 210 EE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CC--CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 00 012223345588999999999999998 78888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=342.13 Aligned_cols=246 Identities=24% Similarity=0.294 Sum_probs=198.6
Q ss_pred cCccccceeeeeCceEEEEEEECC--CcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD--GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~--g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
++|.+.+.||+|+||.||+|.+++ +..||+|++.... .......+.+|+.+++.++||||+++++++.+ ...
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~----~~~ 105 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD----ESY 105 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe----CCE
Confidence 468888999999999999998654 3689999986432 22334568899999999999999999999876 457
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 89999999999999999754 45899999999999999999999998 99999999999999999999999999986
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 181 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~-------------- 238 (340)
T PTZ00426 181 VDTR--------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQ-------------- 238 (340)
T ss_pred cCCC--------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHH--------------
Confidence 5321 234569999999999999889999999999999999999999997543211000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQI 506 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 506 (632)
.+..... .+|......+.+++++||+.||.+|+ ++.++++.
T Consensus 239 ---~i~~~~~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 239 ---KILEGII--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ---HHhcCCC--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0111000 12222334578899999999999995 78888754
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=319.91 Aligned_cols=270 Identities=24% Similarity=0.303 Sum_probs=208.4
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChH-HHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~-~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
++|+.++.|++|+||.||+|+++ +++.||+|+++........ -.-++||.+|.+++|||||.+-.+..-.. -+.+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~--~d~iy 153 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN--MDKIY 153 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc--cceee
Confidence 45677889999999999999876 4899999999876543321 22689999999999999999988776433 34589
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
||||||+ -||..+++... +++...++..+..|+++||+|||.++ |+|||||++|+|+++.|.+||+||||||.+.
T Consensus 154 ~VMe~~E-hDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 154 IVMEYVE-HDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eeHHHHH-hhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999995 59999998754 67999999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccchh----------eecc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL----------VLWA 451 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~----------~~~~ 451 (632)
.. ....+..+-|..|.|||.+.+. .|+...|+||+|||+.||+++++-|.+..+-.+... ..|.
T Consensus 229 sp-----~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwp 303 (419)
T KOG0663|consen 229 SP-----LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWP 303 (419)
T ss_pred CC-----cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCC
Confidence 54 2345667899999999999875 599999999999999999999998876544332111 1121
Q ss_pred cccccccc--ccccccCCCCCCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 452 TPRLQDSG--TVISELPDPRLKGDFPKE-EMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 452 ~~~~~~~~--~~~~~~~~~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
........ ....+.+...++..++.. ....-.+|+..+|..||.+|.|+.+.++.
T Consensus 304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 11111100 011111122233333332 44556789999999999999999999874
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=328.63 Aligned_cols=249 Identities=22% Similarity=0.342 Sum_probs=208.7
Q ss_pred hcCccccceeeeeCceEEEEEEE-CCCcEEEEEEeccCCCCChH--HHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNAD--SVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~--~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
..+|++.+.||+|.||.|-+|.. ..|+.||||.++.+...... -.+.+|++||+.|+||||+.++.+|.. ...
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN----kdK 127 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN----KDK 127 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC----Cce
Confidence 35677788999999999999976 56999999999877544433 347899999999999999999988875 567
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
+.|||||..+|.|+||+... +.+++.++..++.||..|+.|+|.++ ++|||||.+|||||.|+++||+||||+..
T Consensus 128 IvivMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNl 202 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNL 202 (668)
T ss_pred EEEEEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhh
Confidence 89999999999999999865 55999999999999999999999998 99999999999999999999999999988
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCC-CcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
+.... ..+++.|++-|.+||++.+.+| ++.+|-|||||+||-|+.|..||++.....
T Consensus 203 y~~~k------fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~---------------- 260 (668)
T KOG0611|consen 203 YADKK------FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR---------------- 260 (668)
T ss_pred hcccc------HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH----------------
Confidence 76543 3567889999999999998887 789999999999999999999998654432
Q ss_pred ccccccCCCCCCC-CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 460 TVISELPDPRLKG-DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 460 ~~~~~~~~~~l~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
.+.++....... ..|. ...-||++||..||++|.|+.+|....+
T Consensus 261 -lvrQIs~GaYrEP~~PS----dA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 261 -LVRQISRGAYREPETPS----DASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred -HHHHhhcccccCCCCCc----hHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 122232222221 1222 2566899999999999999999988655
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=331.62 Aligned_cols=259 Identities=25% Similarity=0.402 Sum_probs=202.9
Q ss_pred CccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
+|.+.+.||+|+||.||+|... ....+|+|.+...........+.+|+.+++.++||||+++++.+.. ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~ 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ----DG 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec----CC
Confidence 4677889999999999999863 2357999998765444445568999999999999999999998875 44
Q ss_pred eEEEEEEeCCCCChhhhhhccc----------------------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCC
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVL----------------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 357 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDL 357 (632)
..++||||+.+|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~di 153 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDL 153 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhh
Confidence 5799999999999999986421 134889999999999999999999998 999999
Q ss_pred CCCCeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCC
Q 006750 358 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPI 436 (632)
Q Consensus 358 Kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~ 436 (632)
||+|||+++++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||
T Consensus 154 kp~nill~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 230 (290)
T cd05045 154 AARNVLVAEGRKMKISDFGLSRDVYEEDSY---VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230 (290)
T ss_pred hhheEEEcCCCcEEeccccccccccCccch---hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCC
Confidence 999999999999999999999865432211 11122345778999999988889999999999999999998 99998
Q ss_pred CCccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 437 HRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
....... +..+ +.+. .....+...+..+.+++.+||+.+|++||++.++++.|+++..
T Consensus 231 ~~~~~~~---~~~~-----------~~~~----~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 231 PGIAPER---LFNL-----------LKTG----YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred CCCCHHH---HHHH-----------HhCC----CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 6433211 0000 0010 1111222334458899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=325.65 Aligned_cols=254 Identities=28% Similarity=0.437 Sum_probs=203.3
Q ss_pred hcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
.++|++.+.||+|+||.||+|...++..||+|.+..... ....|.+|+.++++++|+|++++++++.. ...++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-----~~~~l 77 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVSE-----EPIYI 77 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEECC-----CCcEE
Confidence 456888899999999999999988888999999976433 23458999999999999999999988642 34689
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||+++++|.+++.......+++.++..++.+++.||+|||+.+ |+||||||+||++++++.++|+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 999999999999997655556899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVI 462 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (632)
.... ......++..|+|||++.+..++.++||||||+++|||++ |..||.......... . +
T Consensus 155 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~---~-----------~ 216 (260)
T cd05070 155 NEYT----ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLE---Q-----------V 216 (260)
T ss_pred cccc----cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH---H-----------H
Confidence 2211 1122335678999999988899999999999999999999 888986432211000 0 0
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006750 463 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 509 (632)
Q Consensus 463 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 509 (632)
.. ......+...+..+.+|+.+||..+|++|||+.++.+.|+.
T Consensus 217 ~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 217 ER----GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred Hc----CCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 00 00111233334558999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=331.10 Aligned_cols=253 Identities=25% Similarity=0.381 Sum_probs=200.6
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
+|+..+.||+|+||+||++... +++.||||++..... ......+.+|+.++++++||||+++++++.. ....+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 76 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET----KDALC 76 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC----CCeEE
Confidence 3677899999999999999875 589999999875422 2223457889999999999999999988865 45789
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||+++|+|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+++...
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 77 LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIP 153 (285)
T ss_pred EEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 9999999999999886544456999999999999999999999998 9999999999999999999999999998754
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 462 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (632)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||............ .
T Consensus 154 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~-------------~ 214 (285)
T cd05605 154 EGE------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV-------------E 214 (285)
T ss_pred CCC------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH-------------H
Confidence 321 122346899999999999889999999999999999999999999653221100000 0
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006750 463 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQI 506 (632)
Q Consensus 463 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 506 (632)
..+. .....++...+..+.+|+.+||+.||.+|| ++.++++.
T Consensus 215 ~~~~--~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 215 RRVK--EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHhh--hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0000 001123334455688999999999999999 78888654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=338.25 Aligned_cols=272 Identities=23% Similarity=0.332 Sum_probs=197.6
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccC-CcceEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG-KRAMRL 302 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~-~~~~~~ 302 (632)
+|++.+.||+|+||.||+|... +|+.||||++.... .......+.+|+.++++++||||+++++++..... .....|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999875 58999999987532 22233458899999999999999999998764322 223579
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||+ +++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELM-ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecC-CCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 999999 57999988653 35899999999999999999999998 9999999999999999999999999998653
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhc--CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe-ecc-ccc----
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV-LWA-TPR---- 454 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~-~~~-~~~---- 454 (632)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||............ ... .+.
T Consensus 155 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 155 NDTPT--AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccCc--cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 32111 112234579999999999875 67899999999999999999999999653321100000 000 000
Q ss_pred --ccc--ccccccccC---CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 455 --LQD--SGTVISELP---DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 455 --~~~--~~~~~~~~~---~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
+.. ....+..+. ...+...++ .....+.+++.+||+.||++|||+.++++.
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFP-NADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcC-CCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000 000000000 000000011 123447899999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=324.56 Aligned_cols=259 Identities=24% Similarity=0.329 Sum_probs=205.3
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|++.+.||+|+||.||+|+.. +++.||||.++... .......|.+|+++++.++||||+++++++.. ....
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 77 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE----DNEL 77 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE----CCeE
Confidence 57888999999999999999865 58999999886432 23334568999999999999999999998875 4477
Q ss_pred EEEEEeCCCCChhhhhhccc--cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 302 LLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~ 154 (267)
T cd08228 78 NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccce
Confidence 99999999999999885422 234889999999999999999999998 9999999999999999999999999988
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
...... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||......... ..
T Consensus 155 ~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~-~~----------- 217 (267)
T cd08228 155 FFSSKT-----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS-LC----------- 217 (267)
T ss_pred eccchh-----HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHH-HH-----------
Confidence 764321 1122345889999999999888999999999999999999999998643221100 00
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
..+.....+. ..+...+..+.+++.+||+.+|++||++.+|++.|.++
T Consensus 218 ~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 218 QKIEQCDYPP---LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred HHHhcCCCCC---CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 0011111111 11223445689999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=325.94 Aligned_cols=256 Identities=28% Similarity=0.429 Sum_probs=204.0
Q ss_pred hcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
.++|.+.+.||+|+||.||+|.+.+...||+|+++.... ....|.+|++++++++||||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-----~~~~l 77 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-----EPIYI 77 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEECC-----CCcEE
Confidence 356888999999999999999987777899999975332 23468999999999999999999987643 34689
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||+++|+|.+++.......+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 999999999999997654456899999999999999999999998 99999999999999999999999999986643
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVI 462 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (632)
.... ......++..|+|||+..+..++.++||||||+++|||++ |..||........... +
T Consensus 155 ~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~--------------~ 216 (262)
T cd05071 155 NEYT----ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ--------------V 216 (262)
T ss_pred cccc----cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH--------------H
Confidence 3211 1122346778999999998899999999999999999999 8888854322111000 0
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 463 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 463 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
..... ...+...+..+.+++.+||+.+|++||++.++++.|+...
T Consensus 217 ~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 217 ERGYR----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred hcCCC----CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 00000 1122334455889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=332.68 Aligned_cols=264 Identities=27% Similarity=0.420 Sum_probs=206.7
Q ss_pred HHHhhcCccccceeeeeCceEEEEEEECC------CcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeee
Q 006750 220 LEHATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCS 292 (632)
Q Consensus 220 l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~ 292 (632)
++...++|+..+.||+|+||.||++...+ ...+|+|++...........+.+|+.++.++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 33445678888999999999999998642 3689999998654444445688999999999 8999999999887
Q ss_pred cccCCcceEEEEEEeCCCCChhhhhhcc--------------ccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCC
Q 006750 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGV--------------LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 358 (632)
Q Consensus 293 ~~~~~~~~~~lV~Ey~~~gsL~~~L~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLK 358 (632)
. ....++||||+++|+|.++++.. ....+++..++.++.|++.||+|||+.+ |+|||||
T Consensus 87 ~----~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlk 159 (293)
T cd05053 87 Q----EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLA 159 (293)
T ss_pred C----CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccc
Confidence 5 44679999999999999999642 2345899999999999999999999998 9999999
Q ss_pred CCCeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCC
Q 006750 359 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIH 437 (632)
Q Consensus 359 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~ 437 (632)
|+|||+++++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus 160 p~Nil~~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 236 (293)
T cd05053 160 ARNVLVTEDHVMKIADFGLARDIHHIDYY---RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 236 (293)
T ss_pred eeeEEEcCCCeEEeCccccccccccccce---eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCC
Confidence 99999999999999999999876433211 11122335678999999998999999999999999999998 889986
Q ss_pred CccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 438 RSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
.......... +.. ......+......+.+|+.+||..||++|||+.++++.|..+.
T Consensus 237 ~~~~~~~~~~--------------~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 237 GIPVEELFKL--------------LKE----GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCCHHHHHHH--------------HHc----CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 4322111000 000 0011122233455889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=309.00 Aligned_cols=251 Identities=24% Similarity=0.332 Sum_probs=210.5
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|++.+.||+|-||.||.|+.+ ++-.||+|++..... .....++.+|+++-+.|+||||+++++++.+ ....
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd----~~ri 97 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD----SKRI 97 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec----ccee
Confidence 56888999999999999999865 488999999875431 2234458999999999999999999999987 5577
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
||++||.++|.|...|+......+++.....+..|+|.||.|+|..+ |+||||||+|+|++.++.+||+|||-+...
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 99999999999999998766677999999999999999999999888 999999999999999999999999998764
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
.. .......||.-|++||...+..++..+|+|++|++.||++.|.+||.......-
T Consensus 175 p~-------~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et----------------- 230 (281)
T KOG0580|consen 175 PS-------NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET----------------- 230 (281)
T ss_pred CC-------CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH-----------------
Confidence 42 345678899999999999999999999999999999999999999975542211
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
..++..-. ..+|...+...+++|.+|+..+|.+|.+..|+++.-.
T Consensus 231 YkrI~k~~--~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw 275 (281)
T KOG0580|consen 231 YKRIRKVD--LKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPW 275 (281)
T ss_pred HHHHHHcc--ccCCcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence 11111111 1234445556899999999999999999999987643
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=323.31 Aligned_cols=250 Identities=26% Similarity=0.403 Sum_probs=196.8
Q ss_pred eeeeeCceEEEEEEEC---CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEeC
Q 006750 232 IVGQGGSSYVYRGQLT---DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 308 (632)
Q Consensus 232 ~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey~ 308 (632)
.||+|+||.||+|.+. ++..||+|++.........+.|.+|+.++++++||||+++++++.. ...++||||+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-----~~~~lv~e~~ 76 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-----EALMLVMEMA 76 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-----CCeEEEEEeC
Confidence 3899999999999764 3567999999766544445669999999999999999999998742 3569999999
Q ss_pred CCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCCCC
Q 006750 309 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS 388 (632)
Q Consensus 309 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 388 (632)
++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++.........
T Consensus 77 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 77 SGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 9999999997532 45899999999999999999999998 9999999999999999999999999998654332111
Q ss_pred CCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccccccccccCC
Q 006750 389 CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPD 467 (632)
Q Consensus 389 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (632)
.......++..|+|||++....++.++||||||+++|||++ |..||........... +.....
T Consensus 153 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~--------------~~~~~~ 216 (257)
T cd05115 153 --KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSF--------------IEQGKR 216 (257)
T ss_pred --eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH--------------HHCCCC
Confidence 11112234678999999988889999999999999999996 9999965432211000 000011
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 468 PRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
...+...+..+.+++.+||..+|++||++.+|.+.|..+
T Consensus 217 ----~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 217 ----LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 122333445688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=322.85 Aligned_cols=249 Identities=29% Similarity=0.438 Sum_probs=196.1
Q ss_pred ceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEeCC
Q 006750 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 309 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey~~ 309 (632)
+.||+|+||.||+|.+. +++.||+|.+...........|.+|++++++++||||+++++++.. ....++||||++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~ 76 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ----KQPIYIVMELVQ 76 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC----CCCeEEEEeecc
Confidence 36899999999999875 5899999998755444445669999999999999999999999875 446799999999
Q ss_pred CCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCCCCC
Q 006750 310 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 389 (632)
Q Consensus 310 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 389 (632)
+++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 77 ~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-- 150 (252)
T cd05084 77 GGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA-- 150 (252)
T ss_pred CCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccccc--
Confidence 999999996532 35899999999999999999999998 999999999999999999999999998764422111
Q ss_pred CCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccccccccccCCC
Q 006750 390 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDP 468 (632)
Q Consensus 390 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (632)
.......++..|+|||.+.++.++.++||||||+++|||++ |..||........... +..
T Consensus 151 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~--------------~~~---- 211 (252)
T cd05084 151 -STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA--------------IEQ---- 211 (252)
T ss_pred -ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHH--------------HHc----
Confidence 00111123567999999999999999999999999999998 8888854322111000 000
Q ss_pred CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 469 RLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 469 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
......+...+..+.+|+.+||+.+|++|||+.+|++.|.
T Consensus 212 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 212 GVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 0111122333455889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=327.07 Aligned_cols=260 Identities=26% Similarity=0.407 Sum_probs=204.1
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCc----EEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
++|...+.||+|+||+||+|.+. +++ .||+|+++..........+.+|+.+++.++||||+++++++.. .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~ 81 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-----S 81 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-----C
Confidence 56778899999999999999864 344 4899999866555556678999999999999999999998864 2
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..+++|||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCcee
Confidence 4589999999999999997542 35899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..||.......... +
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~---~-------- 223 (279)
T cd05109 158 LLDIDETE---YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD---L-------- 223 (279)
T ss_pred ecccccce---eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH---H--------
Confidence 76432211 01112235678999999998899999999999999999998 889985432211000 0
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 514 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 514 (632)
+.....+ ..+...+..+.+++.+||+.||+.||++.++++.|..+....
T Consensus 224 ---~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 224 ---LEKGERL----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ---HHCCCcC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 0000001 111223345889999999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=324.22 Aligned_cols=252 Identities=22% Similarity=0.359 Sum_probs=199.6
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV 304 (632)
++|.+.+.||+|+||.||+|.+.++..+|||.+.... .....|.+|+.++++++||||+++++++.+ ....++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK----QRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEcc----CCCcEEE
Confidence 3467788999999999999998777789999987543 223569999999999999999999999865 3456999
Q ss_pred EEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccC
Q 006750 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 384 (632)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++.....
T Consensus 78 ~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 78 TEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred EEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 99999999999997543 35899999999999999999999998 999999999999999999999999998865432
Q ss_pred CCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccccccccc
Q 006750 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463 (632)
Q Consensus 385 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (632)
.. .......++..|+|||++.+..++.++||||||+++|||++ |..||........... +.
T Consensus 154 ~~----~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~--------------~~ 215 (256)
T cd05113 154 EY----TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK--------------VS 215 (256)
T ss_pred ce----eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH--------------Hh
Confidence 21 11122346678999999998889999999999999999998 9999864332110000 00
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 464 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
....+ ..+...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus 216 ~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 216 QGLRL----YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred cCCCC----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 00001 111122355889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=340.07 Aligned_cols=258 Identities=28% Similarity=0.485 Sum_probs=216.9
Q ss_pred cCccccceeeeeCceEEEEEEECC---C--cEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD---G--RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~---g--~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
......++||.|.||.||+|...+ | -.||||.-+.+..++..+.|+.|..+|+.++||||++|+|+|.+ .
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-----~ 463 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-----Q 463 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-----c
Confidence 344556889999999999998653 2 36999999988888888889999999999999999999999985 3
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..|||||.++-|.|..||+.+. ..++..+...++.||..||+|||+.. +|||||..+|||+...--+||+||||++
T Consensus 464 P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred ceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhh
Confidence 5699999999999999998754 45999999999999999999999987 9999999999999999999999999999
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
....+.+... ....-...|||||.+...+++.+||||.|||.+||++. |..||+.....+
T Consensus 540 ~~ed~~yYka----S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD--------------- 600 (974)
T KOG4257|consen 540 YLEDDAYYKA----SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD--------------- 600 (974)
T ss_pred hccccchhhc----cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc---------------
Confidence 9887665332 23334678999999999999999999999999999988 999997654332
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 513 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 513 (632)
++..+- ..-+.+.|+.++..+..|+.+||..+|.+||.+.++...|..+...
T Consensus 601 --VI~~iE-nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 601 --VIGHIE-NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred --eEEEec-CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 111111 1112346677777799999999999999999999999999988653
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=328.76 Aligned_cols=258 Identities=27% Similarity=0.403 Sum_probs=201.1
Q ss_pred hhcCccccceeeeeCceEEEEEEECC------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccC
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 296 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 296 (632)
.+++|.+.+.||+|+||.||+|.+.+ +..||+|.+...........|.+|+.++++++|+||+++++++.+
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--- 80 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE--- 80 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc---
Confidence 34678889999999999999998753 568999988755444445569999999999999999999998875
Q ss_pred CcceEEEEEEeCCCCChhhhhhcccc-----CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCC---
Q 006750 297 KRAMRLLVFEFMPNGNLRDCLDGVLV-----EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL--- 368 (632)
Q Consensus 297 ~~~~~~lV~Ey~~~gsL~~~L~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~--- 368 (632)
....++||||+++++|.+++..... ..+++..++.++.||+.||+|||+.+ ++||||||+|||++.++
T Consensus 81 -~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~ 156 (277)
T cd05036 81 -RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGR 156 (277)
T ss_pred -CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCc
Confidence 3456899999999999999965432 24899999999999999999999998 99999999999998654
Q ss_pred CeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchh
Q 006750 369 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESL 447 (632)
Q Consensus 369 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~ 447 (632)
.+||+|||+++......... .......+..|+|||++.+..++.++|||||||++|||++ |..||...........
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~ 233 (277)
T cd05036 157 VAKIADFGMARDIYRASYYR---KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF 233 (277)
T ss_pred ceEeccCccccccCCcccee---cCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 59999999998763322110 1112234568999999999999999999999999999997 9999865332211100
Q ss_pred eeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 448 VLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
+.... ....+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus 234 --------------~~~~~----~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 --------------VTGGG----RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred --------------HHcCC----cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 00000 11122233455889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=328.31 Aligned_cols=262 Identities=27% Similarity=0.402 Sum_probs=207.8
Q ss_pred hcCccccceeeeeCceEEEEEEECC-----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 298 (632)
.++|.+.+.||+|+||.||+|.+.+ +..|++|++...........+.+|+.++++++||||+++++++... .
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~ 81 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED---G 81 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC---C
Confidence 4678888999999999999999765 7889999988655455566689999999999999999999988653 3
Q ss_pred ceEEEEEEeCCCCChhhhhhcccc------CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEE
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVLV------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKI 372 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL 372 (632)
...+++++|+++|+|.+++..... ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEE
Confidence 456999999999999999965322 35899999999999999999999998 999999999999999999999
Q ss_pred eccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecc
Q 006750 373 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWA 451 (632)
Q Consensus 373 ~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~ 451 (632)
+|||+++.+....... ......++..|+|||++.+..++.++||||||+++||+++ |+.||....... ...+
T Consensus 159 ~d~g~~~~~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~- 231 (280)
T cd05043 159 TDNALSRDLFPMDYHC---LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAY- 231 (280)
T ss_pred CCCCCcccccCCceEE---eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHH-
Confidence 9999998654332111 1122346778999999998889999999999999999999 999996533211 1100
Q ss_pred ccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 452 TPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 452 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
+........ +..++..+.+++.+||..||++|||+.++++.|..+..
T Consensus 232 ----------~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 232 ----------LKDGYRLAQ----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred ----------HHcCCCCCC----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 000001111 11223458899999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=345.66 Aligned_cols=265 Identities=23% Similarity=0.369 Sum_probs=205.8
Q ss_pred HHHhhcCccccceeeeeCceEEEEEEECC------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCccceeeeee
Q 006750 220 LEHATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCS 292 (632)
Q Consensus 220 l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~ 292 (632)
++...++|.+.+.||+|+||.||+|++.+ +..||||+++..........+.+|+.+|.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 34445567788999999999999998642 46899999986544444456899999999996 999999999987
Q ss_pred cccCCcceEEEEEEeCCCCChhhhhhcccc--------------------------------------------------
Q 006750 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLV-------------------------------------------------- 322 (632)
Q Consensus 293 ~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~-------------------------------------------------- 322 (632)
. ....++||||+++|+|.++|+....
T Consensus 112 ~----~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (401)
T cd05107 112 K----GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA 187 (401)
T ss_pred c----CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence 6 3467999999999999999964311
Q ss_pred ----------------------------------------------CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecC
Q 006750 323 ----------------------------------------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRD 356 (632)
Q Consensus 323 ----------------------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrD 356 (632)
..+++..++.++.|++.||+|||+.+ |+|||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrd 264 (401)
T cd05107 188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRD 264 (401)
T ss_pred CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCccc
Confidence 13678889999999999999999988 99999
Q ss_pred CCCCCeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCC
Q 006750 357 IKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP 435 (632)
Q Consensus 357 LKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P 435 (632)
|||+|||+++++.+||+|||+++........ .......+++.|+|||.+....++.++||||||+++|||++ |+.|
T Consensus 265 lkp~NiLl~~~~~~kL~DfGla~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P 341 (401)
T cd05107 265 LAARNVLICEGKLVKICDFGLARDIMRDSNY---ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTP 341 (401)
T ss_pred CCcceEEEeCCCEEEEEecCcceeccccccc---ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999865432211 11122357889999999998889999999999999999998 8889
Q ss_pred CCCccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 436 IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
|........... .+. .......+...+..+.+|+.+||+.+|.+||++.+|++.|+.++
T Consensus 342 ~~~~~~~~~~~~-------------~~~----~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 342 YPELPMNEQFYN-------------AIK----RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CCCCCchHHHHH-------------HHH----cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 854322111000 000 00011122233456899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=323.51 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=198.7
Q ss_pred CccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 305 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~ 305 (632)
+|++.+.||+|+||.||+|.++++..+|+|++..... ....|.+|+++++.++||||+++++++.. ....++||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~ 78 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTK----QRPIFIVT 78 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcC----CCceEEEE
Confidence 4677889999999999999988778899999864322 23458899999999999999999998765 44679999
Q ss_pred EeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCC
Q 006750 306 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 385 (632)
Q Consensus 306 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 385 (632)
||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 79 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 79 EYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred ecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccc
Confidence 9999999999997543 35899999999999999999999998 9999999999999999999999999998654321
Q ss_pred CCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccccccccc
Q 006750 386 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISE 464 (632)
Q Consensus 386 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (632)
.. ......++..|+|||++.+..++.++||||||+++|||++ |+.||.......... .+..
T Consensus 155 ~~----~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~--------------~~~~ 216 (256)
T cd05059 155 YT----SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE--------------SVSA 216 (256)
T ss_pred cc----ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH--------------HHHc
Confidence 11 1112234568999999999999999999999999999999 899986433211100 0011
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006750 465 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507 (632)
Q Consensus 465 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 507 (632)
.... ..+...+..+.+++.+||..+|++|||+.++++.|
T Consensus 217 ~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 217 GYRL----YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCcC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1111 11222344588999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=341.34 Aligned_cols=256 Identities=24% Similarity=0.327 Sum_probs=202.1
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|.+.+.||+|+||+||+|... +|+.||||+++... .......+.+|++++..++||||+++++++.+ ....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~ 76 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD----EEHL 76 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec----CCeE
Confidence 46888999999999999999976 58999999997542 22344568899999999999999999988775 5578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 151 (350)
T cd05573 77 YLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKM 151 (350)
T ss_pred EEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccC
Confidence 9999999999999999764 46899999999999999999999988 999999999999999999999999999866
Q ss_pred ccCCC------------------------CCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCC
Q 006750 382 KADGL------------------------PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437 (632)
Q Consensus 382 ~~~~~------------------------~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~ 437 (632)
..... ...........||+.|+|||++.+..++.++|||||||+||||++|+.||.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~ 231 (350)
T cd05573 152 NKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY 231 (350)
T ss_pred cccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCC
Confidence 44320 000012234569999999999999999999999999999999999999997
Q ss_pred Cccccccch-heeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 006750 438 RSITKGEES-LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT-MSEVVQI 506 (632)
Q Consensus 438 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~ 506 (632)
......... +..|. ..+..+. ....+..+.+|+.+||. ||.+||+ +.++++.
T Consensus 232 ~~~~~~~~~~i~~~~-----------~~~~~p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 232 SDTLQETYNKIINWK-----------ESLRFPP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCHHHHHHHHhccC-----------CcccCCC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 543221100 00000 0000111 01134458889999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=323.26 Aligned_cols=253 Identities=30% Similarity=0.444 Sum_probs=202.6
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV 304 (632)
++|.+.+.||+|+||.||+|.+.++..+|+|++.... .....|.+|+.++++++|||++++++++.. ...++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-----EPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-----CCcEEE
Confidence 4577888999999999999998777789999886543 234568999999999999999999988642 346899
Q ss_pred EEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccC
Q 006750 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 384 (632)
|||+++|+|.+++.......+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||+++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 99999999999997655456899999999999999999999998 999999999999999999999999999876432
Q ss_pred CCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccccccccc
Q 006750 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463 (632)
Q Consensus 385 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (632)
... ......++..|+|||++.+..++.++||||||+++|||++ |..||.......... + +.
T Consensus 156 ~~~----~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~---~-----------~~ 217 (260)
T cd05069 156 EYT----ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLE---Q-----------VE 217 (260)
T ss_pred ccc----ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---H-----------HH
Confidence 211 1122346778999999998999999999999999999999 899986533221100 0 00
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006750 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 509 (632)
Q Consensus 464 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 509 (632)
....+ ..+...+..+.+++.+||..||++||++.+|++.|+.
T Consensus 218 ~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 218 RGYRM----PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cCCCC----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 00011 1223344568999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=325.76 Aligned_cols=257 Identities=26% Similarity=0.417 Sum_probs=202.1
Q ss_pred HhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecccC--C
Q 006750 222 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRG--K 297 (632)
Q Consensus 222 ~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~--~ 297 (632)
.+++.|+..+.||+|+||.||+|.+. +++.||+|++.... .....+.+|+.+++++ +||||+++++++..... .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 45677888899999999999999875 48899999987543 3344588999999999 79999999999875332 1
Q ss_pred cceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccc
Q 006750 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 377 (632)
....|+||||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 346899999999999999998655556899999999999999999999998 99999999999999999999999999
Q ss_pred ceecccCCCCCCCCCCCccccCCCCCChhhhh-----cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccc
Q 006750 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 452 (632)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~ 452 (632)
+....... .......|++.|+|||++. ...++.++|||||||++|||++|+.||............
T Consensus 158 ~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~---- 228 (272)
T cd06637 158 SAQLDRTV-----GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---- 228 (272)
T ss_pred ceeccccc-----ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH----
Confidence 87654321 1223456899999999986 345788999999999999999999999643221111000
Q ss_pred cccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 453 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 453 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.....+.. .+...+..+.+|+.+||..+|.+|||+.++++
T Consensus 229 ----------~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 ----------PRNPAPRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ----------hcCCCCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00000111 11123345889999999999999999999976
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=336.06 Aligned_cols=243 Identities=26% Similarity=0.373 Sum_probs=193.6
Q ss_pred ceeeeeCceEEEEEEEC----CCcEEEEEEeccCC---CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 231 NIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
+.||+|+||.||+++.. +++.||||+++... .......+.+|+.+|+.++||||+++++++.. ....|+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~----~~~~~l 77 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT----GGKLYL 77 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec----CCeEEE
Confidence 57999999999999753 47899999987532 12233457889999999999999999998875 457899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||+++|+|.+++... ..+.+..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (323)
T cd05584 78 ILEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIH 152 (323)
T ss_pred EEeCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence 99999999999998753 44788899999999999999999998 99999999999999999999999999875432
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (632)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||........ +.
T Consensus 153 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~-----------------~~ 210 (323)
T cd05584 153 EG-----TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT-----------------ID 210 (323)
T ss_pred CC-----CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH-----------------HH
Confidence 21 122345699999999999988899999999999999999999999965332110 01
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006750 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQI 506 (632)
Q Consensus 464 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 506 (632)
.+.... ..++...+..+.+++.+||+.||++|| ++.++++.
T Consensus 211 ~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 211 KILKGK--LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HHHcCC--CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 111111 112333345588999999999999999 78887663
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=331.49 Aligned_cols=260 Identities=23% Similarity=0.360 Sum_probs=205.0
Q ss_pred hcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecccC
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRG 296 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~ 296 (632)
.++|...+.||+|+||.||++... .+..||||+++........+.+.+|+.+++++ +||||+++++++..
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--- 110 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI--- 110 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec---
Confidence 456888999999999999999742 25579999988654444456689999999999 89999999998875
Q ss_pred CcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccc
Q 006750 297 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 376 (632)
Q Consensus 297 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFG 376 (632)
....++||||+++|+|.++++......+++.++..++.|++.||+|||+.+ |+|+||||+|||++.++.++|+|||
T Consensus 111 -~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 111 -GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred -CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCc
Confidence 446799999999999999997654444899999999999999999999998 9999999999999999999999999
Q ss_pred cceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccc
Q 006750 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRL 455 (632)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~ 455 (632)
+++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||...........
T Consensus 187 ~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~-------- 255 (302)
T cd05055 187 LARDIMNDSNY---VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK-------- 255 (302)
T ss_pred ccccccCCCce---eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHH--------
Confidence 99865432210 11122346788999999999999999999999999999998 9999864332111000
Q ss_pred ccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 456 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 456 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
.+.....+ ..+...+..+.+++.+||..+|++||++.++++.|.++
T Consensus 256 -----~~~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 256 -----LIKEGYRM----AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -----HHHcCCcC----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00000001 11222234589999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=337.78 Aligned_cols=243 Identities=26% Similarity=0.325 Sum_probs=193.9
Q ss_pred ceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEe
Q 006750 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 307 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey 307 (632)
+.||+|+||.||++... +|+.||+|+++... .......+.+|+++++.++||||+++++++.. ....|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~----~~~~~lv~E~ 76 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT----HDRLCFVMEY 76 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc----CCEEEEEEeC
Confidence 36999999999999865 58999999997542 22334457889999999999999999988775 4578999999
Q ss_pred CCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHh-cCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCC
Q 006750 308 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (632)
Q Consensus 308 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 386 (632)
+++|+|.+++... ..+++..+..++.|++.||+|||+ .+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~- 150 (325)
T cd05594 77 ANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG- 150 (325)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-
Confidence 9999999988653 458999999999999999999997 67 9999999999999999999999999987543221
Q ss_pred CCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccC
Q 006750 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 466 (632)
Q Consensus 387 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (632)
.......||+.|+|||++.+..++.++||||||++||||++|+.||............. ..
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~---------------~~ 211 (325)
T cd05594 151 ----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL---------------ME 211 (325)
T ss_pred ----cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh---------------cC
Confidence 12234569999999999999999999999999999999999999996533211111000 00
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006750 467 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQI 506 (632)
Q Consensus 467 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 506 (632)
.. .++......+.+|+.+||+.||.+|+ ++.++++.
T Consensus 212 ~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 212 EI----RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CC----CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 01 12222334588999999999999996 89998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=342.24 Aligned_cols=256 Identities=22% Similarity=0.316 Sum_probs=197.9
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|++.+.||+|+||.||+|+.. +|+.||||++.... .......+.+|+.+|..++||||+++++++.. ....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~----~~~~ 76 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD----ENYL 76 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc----CCeE
Confidence 46888999999999999999876 48999999997532 12333457889999999999999999998876 5578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||+++.+
T Consensus 77 ~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 151 (364)
T cd05599 77 YLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151 (364)
T ss_pred EEEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceec
Confidence 9999999999999999753 45899999999999999999999998 999999999999999999999999998765
Q ss_pred ccCCCCCCC---------------------------------CCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHH
Q 006750 382 KADGLPSCS---------------------------------SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLE 428 (632)
Q Consensus 382 ~~~~~~~~~---------------------------------~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~e 428 (632)
......... .......||+.|+|||++....++.++|||||||++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 231 (364)
T cd05599 152 KKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE 231 (364)
T ss_pred cccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHH
Confidence 322110000 00112469999999999999999999999999999999
Q ss_pred HHhCCCCCCCccccccch-heeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC---HHHHH
Q 006750 429 LITGRQPIHRSITKGEES-LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT---MSEVV 504 (632)
Q Consensus 429 LltG~~P~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl 504 (632)
|++|+.||.......... ...|.. .+..+ . ....+..+.+|+.+|+. +|.+|++ +.+++
T Consensus 232 l~~G~~Pf~~~~~~~~~~~i~~~~~-----------~~~~~---~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll 294 (364)
T cd05599 232 MLVGYPPFCSDNPQETYRKIINWKE-----------TLQFP---D--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIK 294 (364)
T ss_pred hhcCCCCCCCCCHHHHHHHHHcCCC-----------ccCCC---C--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHh
Confidence 999999997543221110 000100 00000 0 01123457888999996 9999998 88886
Q ss_pred HH
Q 006750 505 QI 506 (632)
Q Consensus 505 ~~ 506 (632)
+.
T Consensus 295 ~h 296 (364)
T cd05599 295 SH 296 (364)
T ss_pred cC
Confidence 64
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=338.66 Aligned_cols=263 Identities=27% Similarity=0.413 Sum_probs=203.1
Q ss_pred hcCccccceeeeeCceEEEEEEE------CCCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecccC
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQL------TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRG 296 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~ 296 (632)
.++|.+.+.||+|+||.||+|.+ .+++.||||+++..........+.+|+.+|.++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-- 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-- 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC--
Confidence 46788999999999999999974 247899999998654444455688999999999 789999999988642
Q ss_pred CcceEEEEEEeCCCCChhhhhhccc-------------------------------------------------------
Q 006750 297 KRAMRLLVFEFMPNGNLRDCLDGVL------------------------------------------------------- 321 (632)
Q Consensus 297 ~~~~~~lV~Ey~~~gsL~~~L~~~~------------------------------------------------------- 321 (632)
....++||||+++|+|.+++....
T Consensus 84 -~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 84 -GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred -CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 346789999999999999986421
Q ss_pred ----------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCCCCCCC
Q 006750 322 ----------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS 391 (632)
Q Consensus 322 ----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 391 (632)
...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......... .
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~---~ 236 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---V 236 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcch---h
Confidence 123688899999999999999999998 999999999999999999999999999865332110 1
Q ss_pred CCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccccccccccCCCCC
Q 006750 392 SPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRL 470 (632)
Q Consensus 392 ~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 470 (632)
......+++.|+|||++.+..++.++||||||+++|||++ |..||........... .+.......
T Consensus 237 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-------------~~~~~~~~~- 302 (343)
T cd05103 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR-------------RLKEGTRMR- 302 (343)
T ss_pred hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHH-------------HHhccCCCC-
Confidence 1122346678999999998899999999999999999997 8999854321110000 000000111
Q ss_pred CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 471 KGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
.+......+.+++..||+.+|++||++.+|++.|..+..
T Consensus 303 ---~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 303 ---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred ---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111122348899999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=333.21 Aligned_cols=262 Identities=26% Similarity=0.404 Sum_probs=204.7
Q ss_pred hcCccccceeeeeCceEEEEEEEC--------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 294 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~ 294 (632)
.++|.+.+.||+|+||.||++... ++..+|+|.++..........+.+|+.+++.+ +||||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~- 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-
Confidence 356888999999999999999753 23579999998654444445688999999999 89999999999875
Q ss_pred cCCcceEEEEEEeCCCCChhhhhhcccc--------------CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCC
Q 006750 295 RGKRAMRLLVFEFMPNGNLRDCLDGVLV--------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 360 (632)
Q Consensus 295 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~ 360 (632)
....|+||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+.+ ++||||||+
T Consensus 96 ---~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~ 169 (307)
T cd05098 96 ---DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 169 (307)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHH
Confidence 4467999999999999999975321 24899999999999999999999998 999999999
Q ss_pred CeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCc
Q 006750 361 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (632)
Q Consensus 361 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~ 439 (632)
|||++.++.+||+|||+++........ .......+++.|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYY---KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchh---hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 999999999999999998765432110 11112234578999999998889999999999999999998 88888543
Q ss_pred cccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006750 440 ITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 513 (632)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 513 (632)
....... .+.. ......+...+..+.+|+.+||+.+|.+||++.+|++.|..+.+.
T Consensus 247 ~~~~~~~--------------~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 247 PVEELFK--------------LLKE----GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred CHHHHHH--------------HHHc----CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 2211000 0000 001122333445688999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=335.97 Aligned_cols=253 Identities=25% Similarity=0.313 Sum_probs=196.1
Q ss_pred CccccceeeeeCceEEEEEEEC----CCcEEEEEEeccCC---CCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCC
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGK 297 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~---~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~ 297 (632)
+|++.+.||+|+||.||+++.. +++.||+|++.... .......+..|+.++..+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~---- 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT---- 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec----
Confidence 4778899999999999999753 58899999987432 122334578899999999 69999999988765
Q ss_pred cceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccc
Q 006750 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 377 (632)
....++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 77 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~ 151 (332)
T cd05614 77 EAKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGL 151 (332)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcC
Confidence 45789999999999999998653 45899999999999999999999998 99999999999999999999999999
Q ss_pred ceecccCCCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccc
Q 006750 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 456 (632)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~ 456 (632)
++....... .......||+.|+|||++.+. .++.++||||||+++|||++|+.||.............
T Consensus 152 ~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~------- 220 (332)
T cd05614 152 SKEFLSEEK----ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS------- 220 (332)
T ss_pred CccccccCC----CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH-------
Confidence 986543221 122345699999999999865 47899999999999999999999996432211110000
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006750 457 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQI 506 (632)
Q Consensus 457 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 506 (632)
..+.. .++. ++...+..+.+++.+||+.||++|| ++.++++.
T Consensus 221 ---~~~~~-~~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 221 ---RRILK-CDPP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ---HHHhc-CCCC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 00000 1111 2233345588999999999999999 67777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=328.99 Aligned_cols=256 Identities=26% Similarity=0.376 Sum_probs=200.2
Q ss_pred CccccceeeeeCceEEEEEEECC------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
.|.+.+.||+|+||.||+|.+.+ +..||||+++..........|.+|+.+++.++||||+++++++.. ..
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~----~~ 81 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK----EQ 81 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----CC
Confidence 35667889999999999998642 578999999865443344568899999999999999999999875 34
Q ss_pred eEEEEEEeCCCCChhhhhhcc--------------ccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEec
Q 006750 300 MRLLVFEFMPNGNLRDCLDGV--------------LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD 365 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~ 365 (632)
..++++||+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~ 158 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVF 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEec
Confidence 679999999999999998421 1134889999999999999999999998 99999999999999
Q ss_pred CCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCcccccc
Q 006750 366 ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGE 444 (632)
Q Consensus 366 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~ 444 (632)
+++.+||+|||+++........ .......+++.|+|||++..+.++.++||||||+++|||++ |..||........
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYY---KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 235 (283)
T ss_pred CCCceEecccccccccccchhe---eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999998865432211 11223346789999999998899999999999999999998 8888864322110
Q ss_pred chheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006750 445 ESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 509 (632)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 509 (632)
...+.... ....+...+..+.+|+..||+.+|.+||++.+|+..|++
T Consensus 236 -----------------~~~i~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 -----------------IEMIRNRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -----------------HHHHHcCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 00111111 011233344558899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=323.07 Aligned_cols=260 Identities=24% Similarity=0.342 Sum_probs=198.4
Q ss_pred ccccceeeeeCceEEEEEEECC-Cc--EEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccC--Ccce
Q 006750 227 FSGSNIVGQGGSSYVYRGQLTD-GR--IVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRAM 300 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~-g~--~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~--~~~~ 300 (632)
|.+.+.||+|+||.||+|.+.+ +. .||||.++... .......|.+|+.+++.++|+||+++++++..... ....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3456889999999999998765 33 69999987542 22334568999999999999999999998754322 1235
Q ss_pred EEEEEEeCCCCChhhhhhcc----ccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccc
Q 006750 301 RLLVFEFMPNGNLRDCLDGV----LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 376 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFG 376 (632)
.++||||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 68999999999999987421 1234899999999999999999999988 9999999999999999999999999
Q ss_pred cceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccc
Q 006750 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRL 455 (632)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~ 455 (632)
+++........ .......+++.|+|||++.+..++.++||||||+++|||++ |+.||..........
T Consensus 158 ~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~--------- 225 (272)
T cd05075 158 LSKKIYNGDYY---RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYD--------- 225 (272)
T ss_pred cccccCcccce---ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH---------
Confidence 99876433211 11122346678999999999899999999999999999999 788886432211000
Q ss_pred ccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 456 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 456 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
.+....... .+...+..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 226 -----~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 226 -----YLRQGNRLK----QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -----HHHcCCCCC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000000001 1222334588999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=321.80 Aligned_cols=248 Identities=27% Similarity=0.390 Sum_probs=195.3
Q ss_pred eeeeeCceEEEEEEEC---CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEe
Q 006750 232 IVGQGGSSYVYRGQLT---DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 307 (632)
Q Consensus 232 ~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey 307 (632)
.||+|+||.||+|.++ ++..+|+|+++.... ....+.|.+|+.+++.++||||+++++++.. ...++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~lv~e~ 76 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-----ESWMLVMEL 76 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----CCcEEEEec
Confidence 5899999999999753 478999999875432 2344568999999999999999999998742 346899999
Q ss_pred CCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCCC
Q 006750 308 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP 387 (632)
Q Consensus 308 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 387 (632)
+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||.|||++.++.+||+|||+++........
T Consensus 77 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 77 AELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 9999999999653 45899999999999999999999998 999999999999999999999999999876433211
Q ss_pred CCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccccccccccC
Q 006750 388 SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 466 (632)
Q Consensus 388 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (632)
. .......++..|+|||.+....++.++||||||+++|||++ |+.||........... +....
T Consensus 152 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~--------------i~~~~ 215 (257)
T cd05116 152 Y--KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM--------------IESGE 215 (257)
T ss_pred e--eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--------------HHCCC
Confidence 0 11122335678999999988889999999999999999998 9999965322111000 00100
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006750 467 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 509 (632)
Q Consensus 467 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 509 (632)
.+ ..+...+..+.+++.+||+.||++||++.+|.+.|.+
T Consensus 216 ~~----~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 216 RM----ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CC----CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 11 1223344558899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=331.01 Aligned_cols=261 Identities=27% Similarity=0.409 Sum_probs=204.5
Q ss_pred hcCccccceeeeeCceEEEEEEEC--------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 294 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~ 294 (632)
.++|.+.+.||+|+||.||+|... ++..||+|.+...........+.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~- 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec-
Confidence 456788899999999999999742 24579999987654444456689999999999 89999999998875
Q ss_pred cCCcceEEEEEEeCCCCChhhhhhccc--------------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCC
Q 006750 295 RGKRAMRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 360 (632)
Q Consensus 295 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~ 360 (632)
....|+||||+++|+|.+++.... ...+++.++..++.|++.||.|||+.+ |+||||||+
T Consensus 93 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~ 166 (304)
T cd05101 93 ---DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAAR 166 (304)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccc
Confidence 446799999999999999996532 134789999999999999999999998 999999999
Q ss_pred CeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCc
Q 006750 361 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (632)
Q Consensus 361 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~ 439 (632)
|||++.++.+||+|||+++........ .......+++.|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYY---KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred eEEEcCCCcEEECCCccceeccccccc---ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999999999999999876432211 11222346778999999998889999999999999999998 78887543
Q ss_pred cccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 440 ITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
........ +..... ...+...+..+.+|+.+||+.+|.+||++.++++.|.++..
T Consensus 244 ~~~~~~~~--------------~~~~~~----~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 244 PVEELFKL--------------LKEGHR----MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred CHHHHHHH--------------HHcCCc----CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 22110000 000000 11122334558899999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=334.95 Aligned_cols=245 Identities=22% Similarity=0.330 Sum_probs=191.9
Q ss_pred ccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHH---HhcCCCCccceeeeeecccCCcce
Q 006750 227 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDML---SRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l---~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
|.+.+.||+|+||.||+|.+. +|+.||||+++... .....+.+.+|+.++ +.++||||+++++++.. ...
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~----~~~ 76 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT----EDH 76 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc----CCE
Confidence 566789999999999999875 48999999997532 222334566776655 56689999999998875 457
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.|+||||+++|+|..++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 77 ~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~ 150 (324)
T cd05589 77 VCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKE 150 (324)
T ss_pred EEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCcc
Confidence 8999999999999988864 45899999999999999999999998 99999999999999999999999999875
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus 151 ~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~-------------- 211 (324)
T cd05589 151 GMGFG-----DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD-------------- 211 (324)
T ss_pred CCCCC-----CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHH--------------
Confidence 33211 12334579999999999999999999999999999999999999996543211100
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQ 505 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 505 (632)
.+.... ..++...+..+.+++.+||+.||.+|| ++.++++
T Consensus 212 ---~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 212 ---SIVNDE--VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ---HHHhCC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 000000 012223345578899999999999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=318.70 Aligned_cols=251 Identities=28% Similarity=0.351 Sum_probs=203.3
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
+|+..+.||+|+||.||+|... +++.|++|.+.... .......+.+|++++++++||||+++++++.+ ....++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~l 76 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD----KGKLNI 76 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc----CCEEEE
Confidence 4677889999999999999875 48999999987542 23445568999999999999999999998875 457899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||+++++|.+++.......+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++....
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~ 153 (256)
T cd08529 77 VMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD 153 (256)
T ss_pred EEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccC
Confidence 999999999999998755566999999999999999999999998 99999999999999999999999999887654
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (632)
.. .......|++.|+|||++.+..++.++||||||+++|||++|+.||........ ... +.
T Consensus 154 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~-----------~~ 214 (256)
T cd08529 154 NT-----NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL---ILK-----------II 214 (256)
T ss_pred cc-----chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHH-----------HH
Confidence 32 112334688999999999999999999999999999999999999964432110 000 00
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 464 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
+...+ ..+......+.+++.+||+.+|++||++.++++.
T Consensus 215 ~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 215 RGVFP----PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred cCCCC----CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 00011 1222334558999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=353.08 Aligned_cols=264 Identities=25% Similarity=0.278 Sum_probs=206.2
Q ss_pred HHHHhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccC
Q 006750 219 ALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 296 (632)
Q Consensus 219 ~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 296 (632)
+.+...++|.+.+.||+|+||+||+|... +|+.||||++..... ......+.+|+.+|..++|+||+++...+.....
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 34445678999999999999999999864 599999999975432 2334558899999999999999998877654221
Q ss_pred ----CcceEEEEEEeCCCCChhhhhhccc--cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCe
Q 006750 297 ----KRAMRLLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA 370 (632)
Q Consensus 297 ----~~~~~~lV~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~v 370 (632)
....+++||||+++|+|.++|.... ...+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCE
Confidence 1224689999999999999996432 345899999999999999999999998 9999999999999999999
Q ss_pred EEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec
Q 006750 371 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450 (632)
Q Consensus 371 kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~ 450 (632)
||+|||+++.+..... ........||+.|+|||++.+..++.++||||||++||||++|+.||.........
T Consensus 183 kL~DFGls~~~~~~~~---~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~----- 254 (496)
T PTZ00283 183 KLGDFGFSKMYAATVS---DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVM----- 254 (496)
T ss_pred EEEecccCeecccccc---ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH-----
Confidence 9999999987643211 11223457999999999999999999999999999999999999999643221100
Q ss_pred cccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 451 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 451 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
..+.... ....+...+..+.+|+.+||+.||.+||++.++++.
T Consensus 255 ------------~~~~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 255 ------------HKTLAGR-YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ------------HHHhcCC-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0000000 011233344558999999999999999999999864
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=326.45 Aligned_cols=257 Identities=28% Similarity=0.412 Sum_probs=203.4
Q ss_pred hcCccccceeeeeCceEEEEEEECC------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCC
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 297 (632)
.++|.+.+.||+|+||.||+|.+.+ +..||+|.+...........|.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---- 80 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST---- 80 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC----
Confidence 4678889999999999999998753 368999998765444445568999999999999999999999876
Q ss_pred cceEEEEEEeCCCCChhhhhhccc--------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCC
Q 006750 298 RAMRLLVFEFMPNGNLRDCLDGVL--------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN 369 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~~L~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 369 (632)
....++||||+++|+|.+++.... ...++|..++.++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~ 157 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLT 157 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCC
Confidence 356799999999999999996532 123789999999999999999999998 999999999999999999
Q ss_pred eEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchhe
Q 006750 370 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLV 448 (632)
Q Consensus 370 vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~ 448 (632)
+||+|||+++........ .......+|..|+|||.+..+.++.++||||||+++|||++ |..||...........
T Consensus 158 ~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~- 233 (277)
T cd05032 158 VKIGDFGMTRDIYETDYY---RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF- 233 (277)
T ss_pred EEECCcccchhhccCccc---ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHH-
Confidence 999999999865443221 11223346789999999998889999999999999999998 8999854332111000
Q ss_pred eccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 449 LWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
+.....+ ..+...+..+.+++.+||+.+|++|||+.+++..|.
T Consensus 234 -------------~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 234 -------------VIDGGHL----DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -------------HhcCCCC----CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 0000011 122223456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=320.19 Aligned_cols=260 Identities=23% Similarity=0.333 Sum_probs=205.8
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|++.+.||+|+||.||++... +++.+|||.+..... ......|.+|+.+++.++||||+++++++.. ....
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~~ 77 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE----DNEL 77 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe----CCeE
Confidence 46778899999999999999864 689999998865322 2234568999999999999999999998876 4577
Q ss_pred EEEEEeCCCCChhhhhhcc--ccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 302 LLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
+++|||+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 78 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~ 154 (267)
T cd08229 78 NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhh
Confidence 9999999999999998642 2245899999999999999999999998 9999999999999999999999999987
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
...... .......|+..|+|||++.+..++.++||||||+++|+|++|..||...........
T Consensus 155 ~~~~~~-----~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~------------ 217 (267)
T cd08229 155 FFSSKT-----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC------------ 217 (267)
T ss_pred ccccCC-----cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHh------------
Confidence 654321 112234588999999999988899999999999999999999999864322110000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
..+.....+.+ .+...+..+.+++.+||+.||++|||+.+|++.+.++.
T Consensus 218 ~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 218 KKIEQCDYPPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred hhhhcCCCCCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 00111111111 12234456899999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=319.50 Aligned_cols=251 Identities=23% Similarity=0.290 Sum_probs=203.2
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV 304 (632)
+|++.+.||+|+||.||++... +++.+|+|.++........+.+.+|+.+++.++||||+++++++.. ....|+|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv 76 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA----DGHLYIV 76 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE----CCEEEEE
Confidence 4677899999999999999875 4889999998755444455668899999999999999999998865 5578999
Q ss_pred EEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccC
Q 006750 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 384 (632)
|||+++|+|.+++.......+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||+++.....
T Consensus 77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 99999999999987655556899999999999999999999998 999999999999999999999999999876432
Q ss_pred CCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccc
Q 006750 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 464 (632)
Q Consensus 385 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (632)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|..||........... +..
T Consensus 154 ~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~--------------~~~ 214 (255)
T cd08219 154 GA-----YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILK--------------VCQ 214 (255)
T ss_pred cc-----ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHH--------------Hhc
Confidence 21 12335688999999999988899999999999999999999999964322110000 000
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 465 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 465 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
...+ ..+...+..+.+|+.+||+.||++||++.+|+..
T Consensus 215 ~~~~----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 215 GSYK----PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCC----CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0000 1223344558899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=318.19 Aligned_cols=248 Identities=29% Similarity=0.444 Sum_probs=197.7
Q ss_pred ceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEeCCC
Q 006750 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 310 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey~~~ 310 (632)
++||+|+||.||+|...+++.||+|+++..........|.+|+++++.++||||+++++++.. ....++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ----RQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec----CCccEEEEECCCC
Confidence 368999999999999888999999998765544444568999999999999999999999875 3467999999999
Q ss_pred CChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCCCCCC
Q 006750 311 GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 390 (632)
Q Consensus 311 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 390 (632)
++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 77 ~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~---- 148 (250)
T cd05085 77 GDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY---- 148 (250)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc----
Confidence 99999986543 35899999999999999999999998 99999999999999999999999999876433211
Q ss_pred CCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccccccccccCCCC
Q 006750 391 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 469 (632)
Q Consensus 391 ~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (632)
.......++..|+|||++....++.++||||||+++|++++ |..||.......... .+......
T Consensus 149 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~--------------~~~~~~~~- 213 (250)
T cd05085 149 SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE--------------QVEKGYRM- 213 (250)
T ss_pred ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH--------------HHHcCCCC-
Confidence 11112234678999999998899999999999999999998 999986432211000 00001111
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 470 LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 470 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
..+...+..+.+++.+||..+|++||++.++++.|.
T Consensus 214 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 214 ---SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 122233455899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=330.80 Aligned_cols=259 Identities=25% Similarity=0.446 Sum_probs=200.8
Q ss_pred cCccccceeeeeCceEEEEEEECC-Cc--EEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcce
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GR--IVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~--~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~ 300 (632)
++|++.+.||+|+||.||+|.+.+ +. .+|+|.++..........|.+|++++.++ +||||+++++++.. ...
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~----~~~ 82 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----RGY 82 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC----CCC
Confidence 467788999999999999998753 54 46888776544444455688999999999 89999999999865 456
Q ss_pred EEEEEEeCCCCChhhhhhccc--------------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC
Q 006750 301 RLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 366 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~ 366 (632)
.|+||||+++|+|.++++... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~ 159 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGE 159 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecC
Confidence 799999999999999996432 124789999999999999999999998 999999999999999
Q ss_pred CCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccc
Q 006750 367 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEE 445 (632)
Q Consensus 367 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~ 445 (632)
++.+||+|||+++..... .......++..|+|||++.+..++.++||||||+++|||+| |..||.........
T Consensus 160 ~~~~kl~dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 233 (303)
T cd05088 160 NYVAKIADFGLSRGQEVY------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 233 (303)
T ss_pred CCcEEeCccccCcccchh------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH
Confidence 999999999998643211 01111234678999999988889999999999999999998 99998643221100
Q ss_pred hheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006750 446 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 514 (632)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 514 (632)
. .+.. ......+...+..+.+|+.+||+.+|++||++.++++.|..+....
T Consensus 234 ~-----------------~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 234 E-----------------KLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred H-----------------HHhc-CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 0 0000 0011112223345889999999999999999999999998775443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=317.60 Aligned_cols=259 Identities=25% Similarity=0.368 Sum_probs=206.5
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|+..+.||+|+||.||+|... +|+.||+|.++... .......+.+|++++++++|+|++++++++.. ....
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~----~~~~ 77 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE----NNEL 77 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec----CCeE
Confidence 57888999999999999999986 69999999986432 22334568999999999999999999999876 4567
Q ss_pred EEEEEeCCCCChhhhhhcc--ccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 302 LLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
++||||+++|+|.+++... ....+++..+..++.+++.||.|||+.+ |+||||+|+||+++.++.++|+|||+++
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~ 154 (267)
T cd08224 78 NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGR 154 (267)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceee
Confidence 9999999999999998643 2244899999999999999999999998 9999999999999999999999999987
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
...... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||........ ..
T Consensus 155 ~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~------------ 216 (267)
T cd08224 155 FFSSKT-----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SL------------ 216 (267)
T ss_pred eccCCC-----cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH-HH------------
Confidence 654321 112234588999999999988899999999999999999999999854321100 00
Q ss_pred ccccccCCCCCCCCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 460 TVISELPDPRLKGDFPK-EEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
...+... .....+. ..+..+.+++.+||..+|++||++.+|++.|..+.
T Consensus 217 --~~~~~~~-~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 217 --CKKIEKC-DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred --HhhhhcC-CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0000000 0011222 34456889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=319.52 Aligned_cols=250 Identities=28% Similarity=0.420 Sum_probs=200.0
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV 304 (632)
++|.+.+.||+|+||.||++... |..||+|.++... ..+.|.+|+.++++++|+|++++++++... ....++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~lv 78 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEE---KGGLYIV 78 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC---CCceEEE
Confidence 46788899999999999999875 7889999986532 244689999999999999999999986542 3457999
Q ss_pred EEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccC
Q 006750 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 384 (632)
|||+++++|.+++.......+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999999997655455899999999999999999999998 999999999999999999999999998765322
Q ss_pred CCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccccccccc
Q 006750 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463 (632)
Q Consensus 385 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (632)
. ....++..|+|||++.+..++.++||||||+++|||++ |+.||....... .... +.
T Consensus 156 ~--------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~-----------~~ 213 (256)
T cd05082 156 Q--------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR-----------VE 213 (256)
T ss_pred C--------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-----------Hh
Confidence 1 12234578999999998889999999999999999998 999985432111 0000 00
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 464 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
....+ ..+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 214 ~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 214 KGYKM----DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred cCCCC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 00011 12223345588999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=341.84 Aligned_cols=262 Identities=21% Similarity=0.267 Sum_probs=195.7
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
..+|++.+.||+|+||.||++.+. .++.||+|.... ..+.+|+.+|++|+||||+++++++.. ....+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~----~~~~~ 159 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTY----NKFTC 159 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEE----CCeeE
Confidence 467999999999999999999875 489999997542 237899999999999999999998875 45679
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+|||++ +++|.+++... ..+++.+++.++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 160 lv~e~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 160 LILPRY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred EEEecC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 999999 57999888653 45899999999999999999999998 9999999999999999999999999997543
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccc-----hh---eeccc--
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEE-----SL---VLWAT-- 452 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~-----~~---~~~~~-- 452 (632)
... ........||+.|+|||++.+..++.++|||||||+||||++|+.||......... .+ .....
T Consensus 234 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~ 309 (391)
T PHA03212 234 DIN----ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTH 309 (391)
T ss_pred ccc----ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCC
Confidence 211 11223457999999999999999999999999999999999999887543211100 00 00000
Q ss_pred c-ccc-ccccccc--------c-cCCCCCCCCC--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 453 P-RLQ-DSGTVIS--------E-LPDPRLKGDF--PKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 453 ~-~~~-~~~~~~~--------~-~~~~~l~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
+ ... .....+. . ...+...... ....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 310 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 310 PNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0 000 0000000 0 0000000000 01234568899999999999999999999863
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=328.70 Aligned_cols=258 Identities=26% Similarity=0.427 Sum_probs=200.9
Q ss_pred cCccccceeeeeCceEEEEEEECC-C--cEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcce
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-G--RIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g--~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~ 300 (632)
++|++.+.||+|+||.||+|.+.+ + ..+++|.++........+.|.+|+.++.++ +||||+++++++.. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----~~~ 77 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN----RGY 77 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc----CCc
Confidence 568888999999999999998754 3 357898887544334445689999999999 79999999998865 346
Q ss_pred EEEEEEeCCCCChhhhhhccc--------------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC
Q 006750 301 RLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 366 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~ 366 (632)
.++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~ 154 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGE 154 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECC
Confidence 799999999999999996432 124889999999999999999999998 999999999999999
Q ss_pred CCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccc
Q 006750 367 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEE 445 (632)
Q Consensus 367 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~ 445 (632)
++.+||+|||++....... .......+..|+|||++....++.++||||||+++|||++ |..||.........
T Consensus 155 ~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~ 228 (297)
T cd05089 155 NLASKIADFGLSRGEEVYV------KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY 228 (297)
T ss_pred CCeEEECCcCCCcccccee------ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 9999999999986432110 0111123567999999998889999999999999999997 99999643321100
Q ss_pred hheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006750 446 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 513 (632)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 513 (632)
. .+. .......+...+..+.+|+.+||+.+|.+||++.++++.|..+...
T Consensus 229 ~-----------------~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 229 E-----------------KLP-QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred H-----------------HHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0 000 0011112223345588999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=341.79 Aligned_cols=255 Identities=22% Similarity=0.297 Sum_probs=199.7
Q ss_pred HHhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCC
Q 006750 221 EHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (632)
Q Consensus 221 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 297 (632)
....++|++.+.||+|+||.||+++.. +++.||+|++.... .......+.+|+.+++.++||||+++++++..
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~---- 114 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD---- 114 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec----
Confidence 334578999999999999999999876 48999999996431 12233447889999999999999999988775
Q ss_pred cceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccc
Q 006750 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 377 (632)
....|+||||+++|+|.+++.. ..++...+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~ 188 (370)
T cd05596 115 DKYLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 188 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccc
Confidence 5578999999999999999865 34788889999999999999999998 99999999999999999999999999
Q ss_pred ceecccCCCCCCCCCCCccccCCCCCChhhhhcC----CCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccc
Q 006750 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG----RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 453 (632)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~----~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~ 453 (632)
+......... ......||+.|+|||++... .++.++|||||||+||||++|+.||.........
T Consensus 189 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-------- 256 (370)
T cd05596 189 CMKMDANGMV----RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY-------- 256 (370)
T ss_pred eeeccCCCcc----cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH--------
Confidence 9876433211 12345699999999998653 4789999999999999999999999654321110
Q ss_pred ccccccccccccCCCCCCCCCC--HHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 006750 454 RLQDSGTVISELPDPRLKGDFP--KEEMQIMAYLAKECLQLDPDA--RPTMSEVVQI 506 (632)
Q Consensus 454 ~~~~~~~~~~~~~~~~l~~~~~--~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 506 (632)
..+........++ ...+..+.+|+.+||..+|.+ ||++.++++.
T Consensus 257 ---------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 257 ---------SKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ---------HHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0011000000111 123455889999999999987 9999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=327.95 Aligned_cols=263 Identities=27% Similarity=0.397 Sum_probs=203.7
Q ss_pred HHhhcCccccceeeeeCceEEEEEEECC------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecc
Q 006750 221 EHATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 294 (632)
Q Consensus 221 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~ 294 (632)
+...++|++.+.||+|+||.||+|..++ +..||+|.++..........+.+|+.+++.++||||+++++++..
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 80 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK- 80 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC-
Confidence 3456789999999999999999997542 458999998755444444568899999999999999999998765
Q ss_pred cCCcceEEEEEEeCCCCChhhhhhccc--------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC
Q 006750 295 RGKRAMRLLVFEFMPNGNLRDCLDGVL--------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 366 (632)
Q Consensus 295 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~ 366 (632)
....++||||+++|+|.+++.... ...+.+..+..++.|++.||.|||+.+ |+||||||+|||+++
T Consensus 81 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~ 154 (288)
T cd05061 81 ---GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAH 154 (288)
T ss_pred ---CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcC
Confidence 346799999999999999996432 123577889999999999999999998 999999999999999
Q ss_pred CCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccc
Q 006750 367 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEE 445 (632)
Q Consensus 367 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~ 445 (632)
++.++|+|||+++........ .......++..|+|||.+.++.++.++||||||+++|||++ |..||.........
T Consensus 155 ~~~~~L~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~ 231 (288)
T cd05061 155 DFTVKIGDFGMTRDIYETDYY---RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL 231 (288)
T ss_pred CCcEEECcCCccccccccccc---cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999999865432211 11122345678999999999899999999999999999999 78888643221100
Q ss_pred hheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 446 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
. .+.+... ...+...+..+.+++.+||+.||++|||+.++++.|....
T Consensus 232 ~-----------------~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 232 K-----------------FVMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred H-----------------HHHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 0 0000000 0112223356899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=337.00 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=213.4
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
++|...+++|+|+||.++..+.+ ++..+++|.+.... ....+....+|+.++++++|||||.+.+.+.+ ++...+
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~---~~~~l~ 80 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE---DGQLLC 80 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc---CCceEE
Confidence 46778899999999999999865 47899999997653 33334457899999999999999999998876 233489
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
|||+||+||+|.+.|....+..+++..+..++.|++.|+.|||+.. |+|||||+.|||++.+..|+|+|||+|+...
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcC
Confidence 9999999999999998776667999999999999999999999887 9999999999999999999999999999887
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 462 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (632)
... ......+||+.||.||.+.+.+|..|+|||||||++|||++-+++|........ +
T Consensus 158 ~~~-----~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L-----------------i 215 (426)
T KOG0589|consen 158 PED-----SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL-----------------I 215 (426)
T ss_pred Cch-----hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH-----------------H
Confidence 653 234567899999999999999999999999999999999999999975443221 1
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 463 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 463 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.++.... ..+.|...+..+..+++.|+..+|..||++.+++..
T Consensus 216 ~ki~~~~-~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 216 LKINRGL-YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred HHHhhcc-CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1121111 234566677779999999999999999999999975
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=321.51 Aligned_cols=256 Identities=29% Similarity=0.428 Sum_probs=205.5
Q ss_pred hhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
..++|.+.+.||+|+||.||+|.+.+++.||||.+..... ....+.+|+.++++++|+||+++++++.. ....+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 77 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSE----EEPIY 77 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeec----CCceE
Confidence 4567889999999999999999988888999999875432 34568999999999999999999998764 34679
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||+++++|.+++.......+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.++|+|||++....
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIE 154 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceecc
Confidence 9999999999999998765556999999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
..... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.......... .
T Consensus 155 ~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~---~----------- 216 (261)
T cd05034 155 DDEYT----AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLE---Q----------- 216 (261)
T ss_pred chhhh----hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---H-----------
Confidence 32111 1112235678999999998899999999999999999999 999985432211000 0
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 509 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 509 (632)
+...... ..+...+..+.+++.+||..+|++||++.++++.|+.
T Consensus 217 ~~~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 217 VERGYRM----PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHcCCCC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0000001 1122224458899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=321.89 Aligned_cols=259 Identities=25% Similarity=0.427 Sum_probs=202.8
Q ss_pred hcCccccceeeeeCceEEEEEEECC-C---cEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTD-G---RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~-g---~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
.++|+..+.||+|+||.||+|.+.. + ..+|||.++..........|..|+.++++++||||+++++++.. ..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~ 79 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK----FK 79 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc----CC
Confidence 3567788999999999999998753 3 37999998765444445669999999999999999999999875 34
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..|+||||+++++|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~ 155 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSR 155 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccce
Confidence 6799999999999999997543 45899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
......... ........++.|+|||++....++.++||||||+++|||++ |+.||..........
T Consensus 156 ~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~------------ 221 (268)
T cd05063 156 VLEDDPEGT--YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMK------------ 221 (268)
T ss_pred ecccccccc--eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHH------------
Confidence 664322110 11111223567999999998889999999999999999997 999986432211000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
.+... .....+...+..+.+++.+||+.+|++||++.+|++.|.++
T Consensus 222 --~i~~~----~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 222 --AINDG----FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --HHhcC----CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00000 01111222334588999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=325.28 Aligned_cols=246 Identities=26% Similarity=0.367 Sum_probs=192.5
Q ss_pred eeeeCceEEEEEEEC-CCcEEEEEEeccCCCC--ChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEeCC
Q 006750 233 VGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 309 (632)
Q Consensus 233 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey~~ 309 (632)
||+|+||+||++... +|+.||||.+...... .....+..|+.+++.++|+||+++.+++.. ....++||||++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~----~~~~~lv~e~~~ 76 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT----KTDLCLVMTIMN 76 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC----CCeEEEEEeCCC
Confidence 699999999999875 5899999998754221 223457889999999999999999988765 456899999999
Q ss_pred CCChhhhhhcc--ccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCCC
Q 006750 310 NGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP 387 (632)
Q Consensus 310 ~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 387 (632)
+|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 77 ~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~-- 151 (280)
T cd05608 77 GGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ-- 151 (280)
T ss_pred CCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCC--
Confidence 99999887532 2245899999999999999999999998 9999999999999999999999999997654322
Q ss_pred CCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccCC
Q 006750 388 SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPD 467 (632)
Q Consensus 388 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (632)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||........... ....+..
T Consensus 152 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~-------------~~~~~~~ 215 (280)
T cd05608 152 ---SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE-------------LKQRILN 215 (280)
T ss_pred ---ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHH-------------HHHhhcc
Confidence 122345689999999999999999999999999999999999999964322111000 0001111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006750 468 PRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQ 505 (632)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 505 (632)
.. ..++...+..+.+++.+||+.||++|| ++.++++
T Consensus 216 ~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 216 DS--VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cC--CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 11 112333445588999999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=323.03 Aligned_cols=259 Identities=26% Similarity=0.404 Sum_probs=200.7
Q ss_pred CccccceeeeeCceEEEEEEECC-C---cEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLTD-G---RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~-g---~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
.|.+.+.||+|+||.||+|.+.. + ..||||.++..........|..|+.+++.++||||+++++++.. ....
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~~~ 80 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK----SRPV 80 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC----CCce
Confidence 46778899999999999998753 3 36999998765444445679999999999999999999998865 4567
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 81 MIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred EEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccc
Confidence 99999999999999997543 45899999999999999999999998 999999999999999999999999998765
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
.................+..|+|||++.+..++.++||||||+++||+++ |..||....... ...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~---------- 223 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINA---------- 223 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHH----------
Confidence 43221100001111112457999999999999999999999999999886 999986433211 0000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
+..... ...+.+.+..+.+++.+||..+|++||++.+|+..|+.+
T Consensus 224 -i~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 224 -IEQDYR----LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -HHcCCc----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000000 011223344588999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=340.24 Aligned_cols=256 Identities=20% Similarity=0.288 Sum_probs=194.7
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
.|...+.||+|+||+||+|... +++.||||++.... .......+.+|+.+|++++||||+++++++.+ ....|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~----~~~~~ 77 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD----KDNLY 77 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec----CCEEE
Confidence 5778899999999999999875 48899999997542 22334568899999999999999999999875 45789
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 78 lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~ 152 (381)
T cd05626 78 FVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFR 152 (381)
T ss_pred EEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccc
Confidence 999999999999999754 45899999999999999999999998 9999999999999999999999999986432
Q ss_pred cCCCCC------------------------------------------CCCCCCccccCCCCCChhhhhcCCCCcccchH
Q 006750 383 ADGLPS------------------------------------------CSSSPARMQGTFGYFAPEYAMVGRASLMSDVF 420 (632)
Q Consensus 383 ~~~~~~------------------------------------------~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVw 420 (632)
...... .........||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 232 (381)
T cd05626 153 WTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232 (381)
T ss_pred cccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcccee
Confidence 110000 00011235799999999999988899999999
Q ss_pred hHhHHHHHHHhCCCCCCCccccccc-hheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHH--hcccCCCCC
Q 006750 421 SFGVVLLELITGRQPIHRSITKGEE-SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE--CLQLDPDAR 497 (632)
Q Consensus 421 SlGviL~eLltG~~P~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~--cl~~dP~~R 497 (632)
||||++|||++|+.||......... ....|.. .+ .. ......+..+.+|+.+ |+..+|..|
T Consensus 233 SlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-----------~~---~~--~~~~~~s~~~~dli~~ll~~~~~~~~R 296 (381)
T cd05626 233 SVGVILFEMLVGQPPFLAPTPTETQLKVINWEN-----------TL---HI--PPQVKLSPEAVDLITKLCCSAEERLGR 296 (381)
T ss_pred ehhhHHHHHHhCCCCCcCCCHHHHHHHHHcccc-----------cc---CC--CCCCCCCHHHHHHHHHHccCcccccCC
Confidence 9999999999999999754322111 1111100 00 00 0011123346677777 456666679
Q ss_pred CCHHHHHHH
Q 006750 498 PTMSEVVQI 506 (632)
Q Consensus 498 Ps~~evl~~ 506 (632)
|++.++++.
T Consensus 297 ~~~~~~l~h 305 (381)
T cd05626 297 NGADDIKAH 305 (381)
T ss_pred CCHHHHhcC
Confidence 999999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=333.40 Aligned_cols=249 Identities=23% Similarity=0.337 Sum_probs=192.9
Q ss_pred ceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcceEEEEEE
Q 006750 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~~~lV~E 306 (632)
+.||+|+||.||++... +++.||||+++... .......+.+|..++..+ +||||+++++++.. ....|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~----~~~~~lv~e 76 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT----ESRLFFVIE 76 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc----CCEEEEEEe
Confidence 46999999999999875 48999999997542 223334588899999998 79999999998875 457899999
Q ss_pred eCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCC
Q 006750 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (632)
Q Consensus 307 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 386 (632)
|+++|+|.+++... +.+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 150 (329)
T cd05588 77 FVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG- 150 (329)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC-
Confidence 99999999988653 45999999999999999999999998 9999999999999999999999999987532211
Q ss_pred CCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccc--cchheeccccccccccccccc
Q 006750 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKG--EESLVLWATPRLQDSGTVISE 464 (632)
Q Consensus 387 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 464 (632)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ......+ ....
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~----------~~~~ 216 (329)
T cd05588 151 ----DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDY----------LFQV 216 (329)
T ss_pred ----CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHH----------HHHH
Confidence 12334579999999999999999999999999999999999999996432111 0000000 0000
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 006750 465 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT------MSEVVQ 505 (632)
Q Consensus 465 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~ 505 (632)
+..... .+|...+..+.+++.+||+.||.+||+ +.++++
T Consensus 217 ~~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 217 ILEKQI--RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred HHcCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 111111 123333455889999999999999998 556654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=331.47 Aligned_cols=239 Identities=24% Similarity=0.339 Sum_probs=188.3
Q ss_pred ceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcceEEEEEE
Q 006750 231 NIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~~~lV~E 306 (632)
+.||+|+||.||+|...+ ++.||||+++... .......+..|..++..+ +||||+++++++.. ....|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~----~~~~~lv~e 76 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT----KEHLFFVME 76 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc----CCEEEEEEc
Confidence 369999999999998764 8899999997542 122333466677777755 89999999988765 457899999
Q ss_pred eCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCC
Q 006750 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (632)
Q Consensus 307 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 386 (632)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~- 150 (316)
T cd05592 77 YLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE- 150 (316)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-
Confidence 99999999998753 35899999999999999999999998 9999999999999999999999999998653321
Q ss_pred CCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccC
Q 006750 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 466 (632)
Q Consensus 387 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (632)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........... +.. .
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~--------------i~~-~ 211 (316)
T cd05592 151 ----GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDS--------------ILN-D 211 (316)
T ss_pred ----CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHH--------------HHc-C
Confidence 122345699999999999998999999999999999999999999975432111000 000 0
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 006750 467 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 502 (632)
Q Consensus 467 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 502 (632)
.+ .++......+.+++.+||+.||.+||++.+
T Consensus 212 ~~----~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 212 RP----HFPRWISKEAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred CC----CCCCCCCHHHHHHHHHHccCCHHHcCCChH
Confidence 11 122233445788999999999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=325.87 Aligned_cols=259 Identities=28% Similarity=0.407 Sum_probs=202.9
Q ss_pred cCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 298 (632)
++|.+.+.||+|+||.||++... ++..+|+|.+.... ......|.+|++++++++||||+++++++.. .
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~ 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVE----G 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec----C
Confidence 56788899999999999999752 24569999887543 2334568999999999999999999999875 4
Q ss_pred ceEEEEEEeCCCCChhhhhhccc-----------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCC
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVL-----------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 367 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~ 367 (632)
...++||||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+|||++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~ 156 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGEN 156 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccC
Confidence 56799999999999999996432 124899999999999999999999998 9999999999999999
Q ss_pred CCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccch
Q 006750 368 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEES 446 (632)
Q Consensus 368 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~ 446 (632)
+.++|+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||..........
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~ 233 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYY---RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 233 (288)
T ss_pred CcEEeccCCccccccCCcee---ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999865432211 11122346788999999998899999999999999999998 899986443211000
Q ss_pred heeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 447 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
. +........ +...+..+.+|+.+||+.||.+|||+.++++.|..+..
T Consensus 234 ~--------------i~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 234 C--------------ITQGRVLQR----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred H--------------HHcCCcCCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 0 000000111 11223458999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=320.29 Aligned_cols=260 Identities=25% Similarity=0.392 Sum_probs=201.1
Q ss_pred ccccceeeeeCceEEEEEEECC----CcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCccceeeeeecccC--Ccc
Q 006750 227 FSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRA 299 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~--~~~ 299 (632)
|.+.+.||+|+||.||+|.+.. +..||||+++..... .....+.+|+.+++.++||||+++++++..... ...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567889999999999998643 368999999864322 234568999999999999999999998865332 223
Q ss_pred eEEEEEEeCCCCChhhhhhccc----cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecc
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVL----VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 375 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DF 375 (632)
..++||||+++|+|..++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 5799999999999999985421 235899999999999999999999998 999999999999999999999999
Q ss_pred ccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccc
Q 006750 376 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPR 454 (632)
Q Consensus 376 Gla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~ 454 (632)
|+++......... ......++..|+|||++....++.++||||||+++|||++ |..||....... ...+
T Consensus 158 g~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~---- 227 (273)
T cd05035 158 GLSKKIYSGDYYR---QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDY---- 227 (273)
T ss_pred cceeecccccccc---ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----
Confidence 9998765432211 1112235678999999988889999999999999999999 888885432211 0000
Q ss_pred cccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 455 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 455 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
+...... ..+...+..+.+++.+||+.||++||++.++++.|..+
T Consensus 228 -------~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 228 -------LRHGNRL----KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -------HHcCCCC----CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000011 12233445689999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=320.76 Aligned_cols=254 Identities=28% Similarity=0.399 Sum_probs=191.9
Q ss_pred ceeeeeCceEEEEEEECC---CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEe
Q 006750 231 NIVGQGGSSYVYRGQLTD---GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 307 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~---g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey 307 (632)
+.||+|+||.||+|.+.+ +..+|+|.++..........|.+|+.++++++||||+++++++.+ ....++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~ 76 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE----VTPYLLVMEF 76 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC----CCCcEEEEEC
Confidence 358999999999998653 467999998766544445568999999999999999999998875 3457999999
Q ss_pred CCCCChhhhhhcccc---CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccC
Q 006750 308 MPNGNLRDCLDGVLV---EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (632)
Q Consensus 308 ~~~gsL~~~L~~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 384 (632)
+++|+|.+++..... ...++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 77 CPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCc
Confidence 999999999965321 23678888899999999999999998 999999999999999999999999998754332
Q ss_pred CCCCCCCCCCccccCCCCCChhhhhcC-------CCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccc
Q 006750 385 GLPSCSSSPARMQGTFGYFAPEYAMVG-------RASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQ 456 (632)
Q Consensus 385 ~~~~~~~~~~~~~GT~~Y~APE~~~~~-------~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~ 456 (632)
... .......|+..|+|||++... .++.++||||||+++|||++ |+.||........... .. .
T Consensus 154 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~---~~---~ 224 (269)
T cd05087 154 DYY---VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY---TV---R 224 (269)
T ss_pred cee---ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH---Hh---h
Confidence 211 112234578899999988642 35889999999999999996 9999964332211000 00 0
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 457 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 457 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
........+.+....+ ..+.+++..|| .+|++|||+.+|++.|.
T Consensus 225 ---~~~~~~~~~~~~~~~~----~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 225 ---EQQLKLPKPRLKLPLS----DRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ---cccCCCCCCccCCCCC----hHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 0011122232222222 34778999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=341.20 Aligned_cols=256 Identities=21% Similarity=0.297 Sum_probs=195.2
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|.+.+.||+|+||.||++... +++.||||++.... .......+.+|++++++++||||+++++++.+ ....
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~----~~~~ 76 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD----AQYL 76 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc----CCee
Confidence 36888899999999999999875 58999999986432 22334558899999999999999999998875 5578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 77 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 77 YLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 9999999999999998753 45899999999999999999999998 999999999999999999999999999643
Q ss_pred ccCCCCC----------CC--------------------------------CCCCccccCCCCCChhhhhcCCCCcccch
Q 006750 382 KADGLPS----------CS--------------------------------SSPARMQGTFGYFAPEYAMVGRASLMSDV 419 (632)
Q Consensus 382 ~~~~~~~----------~~--------------------------------~~~~~~~GT~~Y~APE~~~~~~~s~ksDV 419 (632)
....... .. .......||+.|+|||++.+..++.++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 231 (377)
T cd05629 152 HKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDW 231 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceee
Confidence 2110000 00 00012469999999999999899999999
Q ss_pred HhHhHHHHHHHhCCCCCCCccccccch-heeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCC-
Q 006750 420 FSFGVVLLELITGRQPIHRSITKGEES-LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDAR- 497 (632)
Q Consensus 420 wSlGviL~eLltG~~P~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R- 497 (632)
|||||+||||++|+.||.......... ...|. ..+..+ . ....+..+.+|+.+|+. +|.+|
T Consensus 232 wSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-----------~~~~~p---~--~~~~s~~~~dli~~lL~-~~~~r~ 294 (377)
T cd05629 232 WSLGAIMFECLIGWPPFCSENSHETYRKIINWR-----------ETLYFP---D--DIHLSVEAEDLIRRLIT-NAENRL 294 (377)
T ss_pred EecchhhhhhhcCCCCCCCCCHHHHHHHHHccC-----------CccCCC---C--CCCCCHHHHHHHHHHhc-CHhhcC
Confidence 999999999999999996543211100 00110 000000 0 01123457889999997 67765
Q ss_pred --CCHHHHHHH
Q 006750 498 --PTMSEVVQI 506 (632)
Q Consensus 498 --Ps~~evl~~ 506 (632)
+++.++++.
T Consensus 295 ~r~~~~~~l~h 305 (377)
T cd05629 295 GRGGAHEIKSH 305 (377)
T ss_pred CCCCHHHHhcC
Confidence 599988764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=326.20 Aligned_cols=259 Identities=27% Similarity=0.400 Sum_probs=203.0
Q ss_pred cCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 298 (632)
.+|...+.||+|+||.||+|... ++..+++|.+.... ......|.+|+.++++++|+||+++++++.. .
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGD----G 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEcc----C
Confidence 35777889999999999999753 34569999986543 2333568999999999999999999999875 4
Q ss_pred ceEEEEEEeCCCCChhhhhhccc--------------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEe
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL 364 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl 364 (632)
...++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~ 156 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLV 156 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEE
Confidence 46799999999999999996532 134899999999999999999999998 9999999999999
Q ss_pred cCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccc
Q 006750 365 DENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKG 443 (632)
Q Consensus 365 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~ 443 (632)
+.++.++|+|||++......... .......++..|+|||++.+..++.++||||||+++|||++ |+.||.......
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 233 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDYY---RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE 233 (291)
T ss_pred ccCCcEEECCCCcccccCCCcee---ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999765432211 11223456789999999999999999999999999999999 999986543211
Q ss_pred cchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 444 EESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 444 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
.... +.....+. .+...+..+.+++.+||+.+|++||++.+|++.|..+..
T Consensus 234 ~~~~--------------~~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 234 VIEC--------------ITQGRVLE----RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHH--------------HhCCCCCC----CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 0000 00000001 112233458899999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=318.22 Aligned_cols=249 Identities=29% Similarity=0.437 Sum_probs=202.4
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV 304 (632)
++|...+.||.|+||.||+|... |+.||||.++.... ....+.+|+.++++++|+||+++++++.. ....++|
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~v 78 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQ----GNPLYIV 78 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcC----CCCeEEE
Confidence 46778899999999999999875 88999999986543 45568999999999999999999999875 4467999
Q ss_pred EEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccC
Q 006750 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 384 (632)
|||+++++|.+++.......+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 99999999999997655456999999999999999999999998 999999999999999999999999999876322
Q ss_pred CCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccccccccc
Q 006750 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463 (632)
Q Consensus 385 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (632)
. ....++..|+|||++..+.++.++||||||+++|||++ |+.||.......... .+.
T Consensus 156 ~--------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~--------------~~~ 213 (256)
T cd05039 156 Q--------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP--------------HVE 213 (256)
T ss_pred c--------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--------------HHh
Confidence 1 12234678999999998899999999999999999997 999986432211000 000
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006750 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 509 (632)
Q Consensus 464 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 509 (632)
.... ...+...+..+.+++.+||..+|++||++.++++.|..
T Consensus 214 ~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 214 KGYR----MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred cCCC----CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0001 11122234558899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=332.53 Aligned_cols=238 Identities=24% Similarity=0.310 Sum_probs=189.7
Q ss_pred ceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcceEEEEEE
Q 006750 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~~~lV~E 306 (632)
+.||+|+||.||+|+.+ +++.||||+++... .......+..|..++..+ +||||+++++++.. ....|+|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~----~~~~~iv~E 76 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT----PDRLFFVME 76 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc----CCEEEEEEc
Confidence 36999999999999876 48999999987532 223345578899998877 79999999998875 457899999
Q ss_pred eCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCC
Q 006750 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (632)
Q Consensus 307 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 386 (632)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 y~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~- 150 (320)
T cd05590 77 FVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG- 150 (320)
T ss_pred CCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-
Confidence 99999999988754 45899999999999999999999998 9999999999999999999999999987643221
Q ss_pred CCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccC
Q 006750 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 466 (632)
Q Consensus 387 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (632)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... .+.
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~-----------------~i~ 209 (320)
T cd05590 151 ----KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFE-----------------AIL 209 (320)
T ss_pred ----CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH-----------------HHh
Confidence 12234569999999999999999999999999999999999999996543221100 000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 006750 467 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS 501 (632)
Q Consensus 467 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 501 (632)
... ...+...+..+.+++.+||+.||.+||++.
T Consensus 210 ~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 210 NDE--VVYPTWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred cCC--CCCCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 000 011222344588999999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=346.01 Aligned_cols=269 Identities=22% Similarity=0.296 Sum_probs=195.7
Q ss_pred hhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecc----cCC
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF----RGK 297 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~----~~~ 297 (632)
...+|.+.+.||+|+||.||+|... +++.||||++.... ....+|+.+|+.++||||+++++++... ...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 3467999999999999999999875 48999999886432 1246799999999999999999876432 112
Q ss_pred cceEEEEEEeCCCCChhhhhhcc--ccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCC-CeEEec
Q 006750 298 RAMRLLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITD 374 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~-~vkL~D 374 (632)
...+++||||++ ++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||||+.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeec
Confidence 335679999996 5787777532 2345899999999999999999999998 99999999999998664 699999
Q ss_pred cccceecccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe--ecc
Q 006750 375 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV--LWA 451 (632)
Q Consensus 375 FGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~--~~~ 451 (632)
||+++...... ......||+.|+|||++.+ ..++.++|||||||+||||++|.+||............ ...
T Consensus 215 FGla~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~ 288 (440)
T PTZ00036 215 FGSAKNLLAGQ------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLG 288 (440)
T ss_pred cccchhccCCC------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 99998764321 2233568999999999876 46899999999999999999999999754322110000 000
Q ss_pred ccccccc---cc-----cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 452 TPRLQDS---GT-----VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 452 ~~~~~~~---~~-----~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+..... .. ....+....+...+|...+..+.+|+.+||..||.+|||+.|+++.
T Consensus 289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0000000 00 0000111111112333344568899999999999999999999863
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=318.30 Aligned_cols=250 Identities=28% Similarity=0.383 Sum_probs=197.8
Q ss_pred ceeeeeCceEEEEEEECC----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEE
Q 006750 231 NIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~E 306 (632)
+.||+|+||.||+|.+.. +..+|+|.+...........+.+|+.+++++.||||+++++++.. ...++|||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~v~e 75 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-----EPLMLVME 75 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-----CceEEEEE
Confidence 369999999999997543 368999999866554455679999999999999999999998652 35699999
Q ss_pred eCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCC
Q 006750 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (632)
Q Consensus 307 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 386 (632)
|+++|+|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++.......
T Consensus 76 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 76 LAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred eCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 999999999997643 5899999999999999999999998 99999999999999999999999999987644321
Q ss_pred CCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccccccccccc
Q 006750 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 465 (632)
Q Consensus 387 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (632)
. ........++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ...+. ...
T Consensus 151 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~-----------~~~ 214 (257)
T cd05060 151 Y--YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAML-----------ESG 214 (257)
T ss_pred c--cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHH-----------HcC
Confidence 1 111222235678999999998899999999999999999998 999986433211 11000 000
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 466 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 466 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
.. ...+...+..+.+++.+||..+|++||++.+|++.|..+
T Consensus 215 ~~----~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 215 ER----LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred Cc----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 00 012223335588999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=336.60 Aligned_cols=254 Identities=25% Similarity=0.297 Sum_probs=198.6
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|.+.+.||+|+||.||++... +|+.||||+++.... ......+.+|+.+++.++||||+++++++.+ ....
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~----~~~~ 76 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD----KDNL 76 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec----CCeE
Confidence 46888999999999999999875 589999999975422 2344558899999999999999999988765 4578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 152 (330)
T cd05601 77 YLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARL 152 (330)
T ss_pred EEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeEC
Confidence 99999999999999997642 45899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhh------cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAM------VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL 455 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~------~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~ 455 (632)
...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||.............
T Consensus 153 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~------ 222 (330)
T cd05601 153 TANKMV----NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM------ 222 (330)
T ss_pred CCCCce----eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHH------
Confidence 543211 122346899999999986 4567899999999999999999999996543221100000
Q ss_pred ccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 456 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 456 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.. ... +........+..+.+|+..||. +|.+||++.++++.
T Consensus 223 -~~----~~~----~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 223 -NF----QRF----LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -cC----CCc----cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 00 000 0000011233457889999998 99999999998753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=321.14 Aligned_cols=258 Identities=25% Similarity=0.387 Sum_probs=202.7
Q ss_pred cCccccceeeeeCceEEEEEEECC----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
.+|.+.+.||+|+||.||+|.+.. +..+|+|.++..........|.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 79 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK----SKP 79 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec----CCc
Confidence 467788999999999999998642 347999998765444445679999999999999999999999865 446
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.++||||+++++|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||+++.
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 799999999999999997643 45899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
....... ........++..|+|||++.+..++.++||||||+++||+++ |..||.......... .
T Consensus 156 ~~~~~~~--~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~---~--------- 221 (267)
T cd05066 156 LEDDPEA--AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIK---A--------- 221 (267)
T ss_pred cccccce--eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHH---H---------
Confidence 6432210 011112234568999999998899999999999999999887 999986543221100 0
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
+.+.... ..+...+..+.+++.+||+.+|.+||++.++++.|..+
T Consensus 222 --~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 222 --IEEGYRL----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --HhCCCcC----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0000001 11122334588999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=332.45 Aligned_cols=242 Identities=23% Similarity=0.297 Sum_probs=191.5
Q ss_pred CccccceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCC-CccceeeeeecccCCcceE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHC-HVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hp-niv~l~g~~~~~~~~~~~~ 301 (632)
+|++.+.||+|+||.||+|...+ ++.||||++.... .......+..|..++..+.|+ +|+++++++.. ....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~----~~~~ 76 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT----MDRL 76 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc----CCEE
Confidence 47788999999999999998764 7899999997532 223345588899999999665 57788877765 4578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 77 ~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 77 YFVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 9999999999999998653 45899999999999999999999998 999999999999999999999999998753
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus 152 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~--------------- 211 (324)
T cd05587 152 IFGG-----KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ--------------- 211 (324)
T ss_pred CCCC-----CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH---------------
Confidence 2211 12334569999999999999999999999999999999999999996433211100
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM 500 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 500 (632)
.+... ...++...+..+.+++.+||..||.+|++.
T Consensus 212 --~i~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 212 --SIMEH--NVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --HHHcC--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 00000 011222334458899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=338.79 Aligned_cols=257 Identities=22% Similarity=0.311 Sum_probs=199.3
Q ss_pred HHHHhhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeeccc
Q 006750 219 ALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 295 (632)
Q Consensus 219 ~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~ 295 (632)
.+....++|++.+.||+|+||.||++.... ++.||+|++.... .......+.+|+.+++.++||||+++++++..
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-- 114 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD-- 114 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--
Confidence 344456789999999999999999999764 8899999986421 12233458899999999999999999998875
Q ss_pred CCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecc
Q 006750 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 375 (632)
Q Consensus 296 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DF 375 (632)
....|+||||+++|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 115 --~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DF 186 (370)
T cd05621 115 --DKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADF 186 (370)
T ss_pred --CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEec
Confidence 55789999999999999998653 4889999999999999999999998 999999999999999999999999
Q ss_pred ccceecccCCCCCCCCCCCccccCCCCCChhhhhcC----CCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecc
Q 006750 376 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG----RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA 451 (632)
Q Consensus 376 Gla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~----~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~ 451 (632)
|++........ .......||+.|+|||++... .++.++|||||||+||||++|+.||.........
T Consensus 187 G~a~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~------ 256 (370)
T cd05621 187 GTCMKMDETGM----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY------ 256 (370)
T ss_pred ccceecccCCc----eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH------
Confidence 99987643221 112345699999999998753 3789999999999999999999999654321110
Q ss_pred ccccccccccccccCCCCCCCCCC--HHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 006750 452 TPRLQDSGTVISELPDPRLKGDFP--KEEMQIMAYLAKECLQLDPDA--RPTMSEVVQI 506 (632)
Q Consensus 452 ~~~~~~~~~~~~~~~~~~l~~~~~--~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 506 (632)
..+.+......++ ...+..+.+++..||..++.+ |+++.++++.
T Consensus 257 -----------~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 257 -----------SKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -----------HHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0111100000111 123455788899999755543 8899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=332.38 Aligned_cols=243 Identities=21% Similarity=0.295 Sum_probs=192.6
Q ss_pred ceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcceEEEEEE
Q 006750 231 NIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~~~lV~E 306 (632)
+.||+|+||.||+|+..+ ++.||||+++... .......+..|.+++..+ +||||+++++++.. ....|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~----~~~~~lv~E 76 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT----KDRLFFVME 76 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc----CCeEEEEEe
Confidence 369999999999998764 8899999987542 223334578899999876 89999999999875 457899999
Q ss_pred eCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCC
Q 006750 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (632)
Q Consensus 307 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 386 (632)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~- 150 (321)
T cd05591 77 YVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG- 150 (321)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC-
Confidence 99999999988653 45899999999999999999999998 9999999999999999999999999987643221
Q ss_pred CCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccC
Q 006750 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 466 (632)
Q Consensus 387 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (632)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... .+.
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~-----------------~i~ 209 (321)
T cd05591 151 ----VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE-----------------SIL 209 (321)
T ss_pred ----ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHH-----------------HHH
Confidence 12234569999999999999899999999999999999999999997543221100 000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 006750 467 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-------TMSEVVQI 506 (632)
Q Consensus 467 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~~ 506 (632)
.... .+|...+..+.+++.+||+.||++|| ++.++++.
T Consensus 210 ~~~~--~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 210 HDDV--LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred cCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 0000 11222334588999999999999999 67777653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=327.07 Aligned_cols=264 Identities=23% Similarity=0.352 Sum_probs=199.9
Q ss_pred hcCccccceeeeeCceEEEEEEECC---------------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCcccee
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTD---------------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLV 288 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~---------------g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~ 288 (632)
.++|.+.+.||+|+||.||++...+ ...||||+++..........|.+|+++|++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578888999999999999987532 2359999998654444556699999999999999999999
Q ss_pred eeeecccCCcceEEEEEEeCCCCChhhhhhcccc----------CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCC
Q 006750 289 GYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV----------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 358 (632)
Q Consensus 289 g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLK 358 (632)
+++.. ....++||||+++++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|||||
T Consensus 84 ~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlk 156 (295)
T cd05097 84 GVCVS----DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLA 156 (295)
T ss_pred EEEcC----CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccC
Confidence 99875 4567999999999999999854321 13789999999999999999999998 9999999
Q ss_pred CCCeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh--CCCCC
Q 006750 359 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT--GRQPI 436 (632)
Q Consensus 359 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt--G~~P~ 436 (632)
|+|||+++++.+||+|||+++........ .......++..|+|||++..+.++.++||||||+++|||++ |..||
T Consensus 157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~ 233 (295)
T cd05097 157 TRNCLVGNHYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY 233 (295)
T ss_pred hhhEEEcCCCcEEecccccccccccCcce---eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999765432211 11222345788999999998999999999999999999998 56777
Q ss_pred CCccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 437 HRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
............ ........ ... ....+...+..+.+|+.+||..||++||++.+|++.|.
T Consensus 234 ~~~~~~~~~~~~---~~~~~~~~---~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 234 SLLSDEQVIENT---GEFFRNQG---RQI-----YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred cccChHHHHHHH---HHhhhhcc---ccc-----cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 543221100000 00000000 000 00111122345899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=323.97 Aligned_cols=247 Identities=24% Similarity=0.336 Sum_probs=192.3
Q ss_pred eeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEeCC
Q 006750 233 VGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 309 (632)
Q Consensus 233 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey~~ 309 (632)
||+|+||.||++... +|+.||+|.+..... ......+..|++++++++||||+++++++.. ....++||||++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~----~~~~~lv~e~~~ 76 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES----KTHLCLVMSLMN 76 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec----CCeEEEEEecCC
Confidence 699999999999875 489999999864322 1223346679999999999999999988765 457899999999
Q ss_pred CCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCCCCC
Q 006750 310 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 389 (632)
Q Consensus 310 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 389 (632)
+|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 77 g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---- 149 (277)
T cd05607 77 GGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---- 149 (277)
T ss_pred CCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc----
Confidence 999999886655556899999999999999999999998 9999999999999999999999999987664321
Q ss_pred CCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccCCCC
Q 006750 390 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 469 (632)
Q Consensus 390 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (632)
......||..|+|||++.+..++.++|||||||++|||++|+.||............ ........
T Consensus 150 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~-------------~~~~~~~~ 214 (277)
T cd05607 150 --TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL-------------KRRTLEDE 214 (277)
T ss_pred --eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH-------------HHHhhccc
Confidence 112345899999999999888999999999999999999999999643221110000 00011111
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 470 LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 470 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
... .....+..+.+|+.+||+.||++||++.|+++.
T Consensus 215 ~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 215 VKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred ccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 100 011233458899999999999999999877643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=335.42 Aligned_cols=207 Identities=23% Similarity=0.363 Sum_probs=173.7
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|+..+.||+|+||+||++... +++.||||+++... .......+.+|+.++.+++||||+++++++.+ ....
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~----~~~~ 76 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD----KLNL 76 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec----CCeE
Confidence 46888999999999999999875 48999999997532 12233457889999999999999999998875 4578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 77 ~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~ 151 (363)
T cd05628 77 YLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGL 151 (363)
T ss_pred EEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence 9999999999999999753 45899999999999999999999998 999999999999999999999999998765
Q ss_pred ccCCCCC------------------------------CCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh
Q 006750 382 KADGLPS------------------------------CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 431 (632)
Q Consensus 382 ~~~~~~~------------------------------~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt 431 (632)
....... .........||+.|+|||++.+..++.++|||||||+||||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~ 231 (363)
T cd05628 152 KKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231 (363)
T ss_pred cccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHh
Confidence 3211000 0001123579999999999999999999999999999999999
Q ss_pred CCCCCCCcc
Q 006750 432 GRQPIHRSI 440 (632)
Q Consensus 432 G~~P~~~~~ 440 (632)
|+.||....
T Consensus 232 G~~Pf~~~~ 240 (363)
T cd05628 232 GYPPFCSET 240 (363)
T ss_pred CCCCCCCCC
Confidence 999996543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=325.01 Aligned_cols=264 Identities=27% Similarity=0.406 Sum_probs=203.2
Q ss_pred hcCccccceeeeeCceEEEEEEECC-----------------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTD-----------------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~-----------------g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~ 286 (632)
..+|.+.+.||+|+||.||+|.+.+ +..||+|++...........|.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578889999999999999997643 24689999986655555667999999999999999999
Q ss_pred eeeeeecccCCcceEEEEEEeCCCCChhhhhhccc---------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCC
Q 006750 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL---------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 357 (632)
Q Consensus 287 l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDL 357 (632)
+++++.. ....++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||
T Consensus 84 ~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dl 156 (296)
T cd05051 84 LLGVCTV----DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDL 156 (296)
T ss_pred EEEEEec----CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---cccccc
Confidence 9999875 356799999999999999996543 125899999999999999999999998 999999
Q ss_pred CCCCeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh--CCCC
Q 006750 358 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT--GRQP 435 (632)
Q Consensus 358 Kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt--G~~P 435 (632)
||+||+++.++.++|+|||+++........ .......+++.|+|||++....++.++||||||+++|||++ |..|
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 233 (296)
T cd05051 157 ATRNCLVGKNYTIKIADFGMSRNLYSSDYY---RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQP 233 (296)
T ss_pred chhceeecCCCceEEccccceeecccCcce---eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCC
Confidence 999999999999999999999865433211 11223446788999999998899999999999999999998 6778
Q ss_pred CCCccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 436 IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
|........ ........... ........+...+..+.+++.+||+.||.+|||+.+|++.|.
T Consensus 234 ~~~~~~~~~---~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 234 YEHLTDQQV---IENAGHFFRDD--------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCCcChHHH---HHHHHhccccc--------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 754322110 00000000000 000001112223345899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=331.81 Aligned_cols=242 Identities=23% Similarity=0.296 Sum_probs=192.5
Q ss_pred CccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC--CChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcceE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
+|.+.+.||+|+||.||+|.... ++.||||+++.... ......+..|..++..+ +|++|+++++++.. ....
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~----~~~~ 76 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT----MDRL 76 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec----CCEE
Confidence 47778999999999999998764 78999999875421 22234467788888887 68899999988765 4578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 77 ~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~ 151 (323)
T cd05616 77 YFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 151 (323)
T ss_pred EEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceec
Confidence 9999999999999998653 45899999999999999999999998 999999999999999999999999999754
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 152 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~---------------- 210 (323)
T cd05616 152 MWDG-----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF---------------- 210 (323)
T ss_pred CCCC-----CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHH----------------
Confidence 3221 1223456999999999999999999999999999999999999999654321110
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM 500 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 500 (632)
..+.... ..+|...+..+.+++.+||+.||.+|++.
T Consensus 211 -~~i~~~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 211 -QSIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -HHHHhCC--CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 0001000 11233344558899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=331.84 Aligned_cols=246 Identities=24% Similarity=0.320 Sum_probs=189.8
Q ss_pred ceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcceEEEEEE
Q 006750 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~~~lV~E 306 (632)
+.||+|+||.||+|... +++.||+|+++... .......+.+|+.++.++ +||||+++++++.. ....|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~----~~~~~lv~E 76 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT----ESRLFFVIE 76 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe----CCEEEEEEe
Confidence 46999999999999876 48899999997542 223334577899988877 89999999998875 457899999
Q ss_pred eCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCC
Q 006750 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (632)
Q Consensus 307 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 386 (632)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~- 150 (329)
T cd05618 77 YVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG- 150 (329)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-
Confidence 99999999988653 45899999999999999999999998 9999999999999999999999999987543221
Q ss_pred CCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccC
Q 006750 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 466 (632)
Q Consensus 387 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (632)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||............ ........+.
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~--------~~~~~~~~i~ 218 (329)
T cd05618 151 ----DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN--------TEDYLFQVIL 218 (329)
T ss_pred ----CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccc--------cHHHHHHHHh
Confidence 1223457999999999999999999999999999999999999999632211100000 0000000011
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 006750 467 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM 500 (632)
Q Consensus 467 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 500 (632)
... ..+|...+..+.+++.+||+.||.+||++
T Consensus 219 ~~~--~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 219 EKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred cCC--CCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 111 12333444558899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=318.02 Aligned_cols=254 Identities=26% Similarity=0.397 Sum_probs=199.4
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.++++++||||+++++++.. ....++
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~----~~~~~i 83 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLS----REKLWI 83 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEe----CCEEEE
Confidence 56888999999999999999874 588999999975432 233457899999999999999999998875 457799
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 84 CMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 99999999999998653 45899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhh---cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
.. .......|+..|+|||.+. ...++.++||||||+++|||++|+.||......... ..+..
T Consensus 159 ~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--~~~~~-------- 223 (267)
T cd06646 159 TI-----AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--FLMSK-------- 223 (267)
T ss_pred cc-----cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--eeeec--------
Confidence 21 1123346889999999884 345788999999999999999999998643321110 11000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 507 (632)
.....+... .....+..+.+++.+||..+|++||++.++++.|
T Consensus 224 --~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 224 --SNFQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred --CCCCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 001111111 1112345688999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=329.52 Aligned_cols=241 Identities=23% Similarity=0.362 Sum_probs=190.2
Q ss_pred ceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcceEEEEEE
Q 006750 231 NIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~~~lV~E 306 (632)
+.||+|+||.||+|.+.+ ++.||||+++... .......+..|..++..+ +||||+++++++.+ ....|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~----~~~~~lv~e 76 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT----KENLFFVME 76 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe----CCEEEEEEe
Confidence 369999999999999764 7899999997542 122334467788888765 99999999998875 457899999
Q ss_pred eCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCC
Q 006750 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (632)
Q Consensus 307 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 386 (632)
|+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 y~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 150 (316)
T cd05619 77 YLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD- 150 (316)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-
Confidence 99999999998753 45899999999999999999999998 9999999999999999999999999987543211
Q ss_pred CCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccC
Q 006750 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 466 (632)
Q Consensus 387 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (632)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||............ . ..
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i--------------~-~~ 211 (316)
T cd05619 151 ----AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI--------------R-MD 211 (316)
T ss_pred ----CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHH--------------H-hC
Confidence 1223456999999999999989999999999999999999999999653321110000 0 00
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 006750 467 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS-EVV 504 (632)
Q Consensus 467 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 504 (632)
.+. ++......+.+++.+||+.||.+||++. ++.
T Consensus 212 ~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 212 NPC----YPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CCC----CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 111 1222334578999999999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=324.00 Aligned_cols=257 Identities=25% Similarity=0.408 Sum_probs=201.9
Q ss_pred hcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCC
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 297 (632)
.++|+..+.||+|+||.||+|.+. ++..||+|++...........|.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~---- 79 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV---- 79 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC----
Confidence 467888999999999999999864 3678999999765444445669999999999999999999998875
Q ss_pred cceEEEEEEeCCCCChhhhhhccc--------------------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCC
Q 006750 298 RAMRLLVFEFMPNGNLRDCLDGVL--------------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 357 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~~L~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDL 357 (632)
....++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl 156 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDL 156 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccc
Confidence 346799999999999999996421 123788999999999999999999998 999999
Q ss_pred CCCCeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCC
Q 006750 358 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPI 436 (632)
Q Consensus 358 Kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~ 436 (632)
||+|||++.++.++|+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||
T Consensus 157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~ 233 (288)
T cd05050 157 ATRNCLVGENMVVKIADFGLSRNIYSADYY---KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233 (288)
T ss_pred cHhheEecCCCceEECccccceecccCccc---cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999998765432211 11122235678999999998999999999999999999998 88888
Q ss_pred CCccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 437 HRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
.......... .+.+.... ..+...+..+.+|+.+||+.+|++|||+.|+++.|+
T Consensus 234 ~~~~~~~~~~-----------------~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 234 YGMAHEEVIY-----------------YVRDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCCCHHHHHH-----------------HHhcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 6432211000 00000000 112233455889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=328.58 Aligned_cols=261 Identities=26% Similarity=0.416 Sum_probs=203.0
Q ss_pred hcCccccceeeeeCceEEEEEEEC--------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 294 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~ 294 (632)
.++|.+.+.||+|+||.||++... ....+|+|+++..........+.+|+.+++++ +||||+++++++..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ- 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc-
Confidence 456788899999999999999752 24579999988654444455688999999999 69999999998875
Q ss_pred cCCcceEEEEEEeCCCCChhhhhhccc--------------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCC
Q 006750 295 RGKRAMRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 360 (632)
Q Consensus 295 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~ 360 (632)
....++||||+++|+|.+++.... ...+++.++..++.|++.||.|||+.+ |+||||||+
T Consensus 90 ---~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~ 163 (314)
T cd05099 90 ---EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAAR 163 (314)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccce
Confidence 446799999999999999996532 134899999999999999999999998 999999999
Q ss_pred CeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCc
Q 006750 361 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (632)
Q Consensus 361 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~ 439 (632)
|||++.++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYY---KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccc---cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999865432110 11112234568999999999899999999999999999999 88888543
Q ss_pred cccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 440 ITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
........ +...... ..+...+..+.+++.+||..+|++||++.++++.|..+..
T Consensus 241 ~~~~~~~~--------------~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 241 PVEELFKL--------------LREGHRM----DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred CHHHHHHH--------------HHcCCCC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 22110000 0000001 1222333458899999999999999999999999987743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=323.24 Aligned_cols=252 Identities=27% Similarity=0.393 Sum_probs=198.6
Q ss_pred ccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC--ChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 227 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
|+..+.||+|+||.||++... +++.||||.+...... .....+.+|+.++++++|+|++++++.+.. ....++
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~----~~~~~l 77 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET----KDALCL 77 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec----CCEEEE
Confidence 666788999999999999875 4899999998754322 223457889999999999999999988875 457899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||+++|+|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 78 v~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 78 VLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 999999999999986655556999999999999999999999988 99999999999999999999999999876543
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (632)
.. ......||..|+|||++.+..++.++||||||+++|||++|+.||............. ....
T Consensus 155 ~~------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~----------~~~~ 218 (285)
T cd05630 155 GQ------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE----------RLVK 218 (285)
T ss_pred Cc------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH----------hhhh
Confidence 21 1123468999999999999999999999999999999999999996532211000000 0000
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 006750 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT-----MSEVVQI 506 (632)
Q Consensus 464 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 506 (632)
.. .. .++......+.+|+.+||+.||++||| +.|+++.
T Consensus 219 ~~-~~----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 219 EV-QE----EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred hh-hh----hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 00 01 122223345889999999999999999 7888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=323.20 Aligned_cols=274 Identities=24% Similarity=0.374 Sum_probs=204.2
Q ss_pred CccccceeeeeCceEEEEEEEC-----CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-----~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
.|.+.+.||+|+||.||++.+. ++..||+|.++..........|.+|+.+++.++||||+++++++.... ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG--GNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC--CCc
Confidence 4677899999999999999742 478999999976554555567999999999999999999999886532 346
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||+++.
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred eEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 799999999999999996542 35899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
....... ........++..|+|||++.+..++.++||||||+++|||++++.|................. ... ...
T Consensus 159 ~~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~-~~~-~~~ 234 (284)
T cd05079 159 IETDKEY--YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHG-QMT-VTR 234 (284)
T ss_pred cccCccc--eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccc-ccc-HHH
Confidence 6433211 011223457788999999988889999999999999999999887653221100000000000 000 000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
.+..+.. ......+...+..+.+|+.+||+.+|++||++.++++.|+.+
T Consensus 235 ~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 235 LVRVLEE-GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHc-CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000000 001111223445689999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=324.74 Aligned_cols=266 Identities=24% Similarity=0.352 Sum_probs=201.4
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
++|++.+.||+|+||.||++.+. ++..+|+|.++..........+.+|++++++++||||+++++++.. ....++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~l 76 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS----DGEISI 76 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee----CCEEEE
Confidence 36888999999999999999875 4889999998765433344568899999999999999999999875 557899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHh-cCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+ ++||||||+|||++.++.++|+|||++....
T Consensus 77 v~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 77 CMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred EeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 99999999999999754 458999999999999999999997 46 9999999999999999999999999987553
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc---
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG--- 459 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~--- 459 (632)
.. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.......................
T Consensus 152 ~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (308)
T cd06615 152 DS-------MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHR 224 (308)
T ss_pred cc-------ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcc
Confidence 22 12334688999999999888899999999999999999999999864332111111000000000000
Q ss_pred ----------------ccccccCCCCCCCCCCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006750 460 ----------------TVISELPDPRLKGDFPK-EEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507 (632)
Q Consensus 460 ----------------~~~~~~~~~~l~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 507 (632)
.....+... .....+. .....+.+|+.+||..+|++||++.+|++..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 225 PVSGHPPDSPRPMAIFELLDYIVNE-PPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred cccCCCCCccchhhHHHHHHHHhcC-CCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000000000 0000111 1334588999999999999999999998764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=334.31 Aligned_cols=239 Identities=24% Similarity=0.312 Sum_probs=191.1
Q ss_pred ceeeeeCceEEEEEEE----CCCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEE
Q 006750 231 NIVGQGGSSYVYRGQL----TDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 305 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~----~~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~ 305 (632)
+.||+|+||.||++.. .+|+.||+|++..... ......+.+|+++|++++||||+++++++.. ....|+||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 77 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT----EGKLYLIL 77 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc----CCEEEEEE
Confidence 5799999999999875 2589999999975422 2233457889999999999999999998875 45789999
Q ss_pred EeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCC
Q 006750 306 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 385 (632)
Q Consensus 306 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 385 (632)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 78 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 78 DFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 999999999998653 45899999999999999999999998 9999999999999999999999999987654321
Q ss_pred CCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccccccc
Q 006750 386 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 465 (632)
Q Consensus 386 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (632)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... .+
T Consensus 153 -----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~-----------------~i 210 (318)
T cd05582 153 -----KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT-----------------MI 210 (318)
T ss_pred -----CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHH-----------------HH
Confidence 12234569999999999998889999999999999999999999996533211100 00
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 006750 466 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 502 (632)
Q Consensus 466 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 502 (632)
.... ..++...+..+.+|+.+||+.||++||++.+
T Consensus 211 ~~~~--~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 211 LKAK--LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HcCC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0000 0123333455889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=329.76 Aligned_cols=242 Identities=23% Similarity=0.327 Sum_probs=192.7
Q ss_pred ceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcceEEEEEE
Q 006750 231 NIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~~~lV~E 306 (632)
+.||+|+||.||+|.+.. ++.||||+++... .......+..|..++..+ +||||+++++++.. ....|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~----~~~~~lv~e 76 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT----KDRLFFVME 76 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc----CCEEEEEEc
Confidence 469999999999998764 8899999997542 223344578899999888 79999999998875 457899999
Q ss_pred eCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCC
Q 006750 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (632)
Q Consensus 307 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 386 (632)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 150 (318)
T cd05570 77 YVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG- 150 (318)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC-
Confidence 99999999988653 35899999999999999999999998 9999999999999999999999999987532221
Q ss_pred CCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccC
Q 006750 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 466 (632)
Q Consensus 387 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (632)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .+.
T Consensus 151 ----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~-----------------~i~ 209 (318)
T cd05570 151 ----VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ-----------------SIL 209 (318)
T ss_pred ----CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHH-----------------HHH
Confidence 12234568999999999999999999999999999999999999996433211000 000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 006750 467 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM-----SEVVQ 505 (632)
Q Consensus 467 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 505 (632)
... ..++...+..+.+|+.+||+.||.+||++ .++++
T Consensus 210 ~~~--~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 210 EDE--VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred cCC--CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 000 01222334558899999999999999999 77654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=339.89 Aligned_cols=256 Identities=21% Similarity=0.287 Sum_probs=194.7
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|++.+.||+|+||.||+++.. +++.||||++.... .......+.+|+++|++++||||+++++.+.+ ....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~----~~~~ 76 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD----KDNL 76 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc----CCEE
Confidence 36888999999999999999875 48999999986432 12233458899999999999999999998875 5578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+
T Consensus 77 ~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 77 YFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 9999999999999999753 35889999999999999999999998 999999999999999999999999998543
Q ss_pred ccCCCC--------------------------------------CCCCCCCccccCCCCCChhhhhcCCCCcccchHhHh
Q 006750 382 KADGLP--------------------------------------SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFG 423 (632)
Q Consensus 382 ~~~~~~--------------------------------------~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlG 423 (632)
...... ..........||+.|+|||++.+..++.++||||||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 231 (376)
T cd05598 152 RWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 231 (376)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecc
Confidence 210000 000011235799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCccccccch-heeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC---C
Q 006750 424 VVLLELITGRQPIHRSITKGEES-LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP---T 499 (632)
Q Consensus 424 viL~eLltG~~P~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP---s 499 (632)
|+||||++|+.||.......... ...|.. ....+ .....+..+.+++.+|+ .+|.+|+ +
T Consensus 232 vilyell~G~~Pf~~~~~~~~~~~i~~~~~-----------~~~~~-----~~~~~s~~~~~li~~l~-~~p~~R~~~~t 294 (376)
T cd05598 232 VILYEMLVGQPPFLADTPAETQLKVINWET-----------TLHIP-----SQAKLSREASDLILRLC-CGAEDRLGKNG 294 (376)
T ss_pred ceeeehhhCCCCCCCCCHHHHHHHHhccCc-----------cccCC-----CCCCCCHHHHHHHHHHh-cCHhhcCCCCC
Confidence 99999999999997543321111 111100 00000 01122334667777766 5999999 8
Q ss_pred HHHHHHH
Q 006750 500 MSEVVQI 506 (632)
Q Consensus 500 ~~evl~~ 506 (632)
+.++++.
T Consensus 295 ~~ell~h 301 (376)
T cd05598 295 ADEIKAH 301 (376)
T ss_pred HHHHhCC
Confidence 8888764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=318.81 Aligned_cols=253 Identities=28% Similarity=0.406 Sum_probs=189.2
Q ss_pred eeeeeCceEEEEEEECC---CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEeC
Q 006750 232 IVGQGGSSYVYRGQLTD---GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 308 (632)
Q Consensus 232 ~LG~G~fG~Vy~~~~~~---g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey~ 308 (632)
.||+|+||.||+|...+ ...+|+|.+...........|.+|+.+++.++||||+++++++.. ....++||||+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~----~~~~~lv~e~~ 77 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE----SIPYLLVLEFC 77 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECC----CCceEEEEEeC
Confidence 58999999999997543 457889987655444445568999999999999999999998875 44679999999
Q ss_pred CCCChhhhhhcccc---CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCC
Q 006750 309 PNGNLRDCLDGVLV---EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 385 (632)
Q Consensus 309 ~~gsL~~~L~~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 385 (632)
++|+|.+++..... ...++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccch
Confidence 99999999975432 23568888999999999999999998 9999999999999999999999999987543322
Q ss_pred CCCCCCCCCccccCCCCCChhhhhc-------CCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccc
Q 006750 386 LPSCSSSPARMQGTFGYFAPEYAMV-------GRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQD 457 (632)
Q Consensus 386 ~~~~~~~~~~~~GT~~Y~APE~~~~-------~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 457 (632)
.. .......+++.|+|||++.. ..++.++||||||+++|||++ |..||............ ..
T Consensus 155 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~------~~- 224 (269)
T cd05042 155 YY---ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV------VR- 224 (269)
T ss_pred he---eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH------hh-
Confidence 11 11123346778999998753 356889999999999999999 78888643221100000 00
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 458 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
.....+..+.+... .+..+..++..|| .||++|||+.+|++.|.
T Consensus 225 --~~~~~~~~~~~~~~----~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 225 --EQDIKLPKPQLDLK----YSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred --ccCccCCCCccccc----CCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 00111222322222 3344677888898 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=329.56 Aligned_cols=241 Identities=24% Similarity=0.348 Sum_probs=190.1
Q ss_pred ceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcceEEEEEE
Q 006750 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~~~lV~E 306 (632)
+.||+|+||.||+|.+. +|+.||||+++.... ......+..|..++..+ +||||+++++++.. ....|+|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~----~~~~~lv~E 76 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT----KEHLFFVME 76 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe----CCEEEEEEC
Confidence 46999999999999876 488999999975421 22334467788888765 89999999998875 557899999
Q ss_pred eCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCC
Q 006750 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (632)
Q Consensus 307 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 386 (632)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||+++......
T Consensus 77 ~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 150 (316)
T cd05620 77 FLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD- 150 (316)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC-
Confidence 99999999998653 45899999999999999999999998 9999999999999999999999999987532211
Q ss_pred CCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccC
Q 006750 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 466 (632)
Q Consensus 387 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (632)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........... +. ..
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~--------------~~-~~ 211 (316)
T cd05620 151 ----NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFES--------------IR-VD 211 (316)
T ss_pred ----CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH--------------HH-hC
Confidence 123345699999999999999999999999999999999999999964332110000 00 00
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 006750 467 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS-EVV 504 (632)
Q Consensus 467 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 504 (632)
.+. ++......+.+++.+||+.||.+||++. +++
T Consensus 212 ~~~----~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 212 TPH----YPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCC----CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 111 1222334588999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=321.44 Aligned_cols=270 Identities=25% Similarity=0.344 Sum_probs=197.5
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC-hHHHHHHHHHHHHhc---CCCCccceeeeeecccC-Ccc
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRL---HHCHVVPLVGYCSEFRG-KRA 299 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~-~~~~f~~Ei~~l~~l---~Hpniv~l~g~~~~~~~-~~~ 299 (632)
+|++.+.||+|+||+||+|... +|+.||+|.++...... ....+.+|+.+++.+ +||||+++++++..... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999876 48999999987543222 223466788877766 69999999998865322 245
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..++||||++ ++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccc
Confidence 6799999996 58999987655556899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccc-hheecc-cc---c
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEE-SLVLWA-TP---R 454 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~-~~~~~~-~~---~ 454 (632)
...... ......||..|+|||++.+..++.++|||||||++|||++|++||......... ...... .+ .
T Consensus 157 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07863 157 IYSCQM------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 230 (288)
T ss_pred cccCcc------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 654321 123346899999999999989999999999999999999999998644322110 000000 00 0
Q ss_pred cccccccccccCCCCC---CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 455 LQDSGTVISELPDPRL---KGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 455 ~~~~~~~~~~~~~~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
+............+.. ...........+.+++.+||+.||++|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000000000000 00111223455789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=346.26 Aligned_cols=250 Identities=22% Similarity=0.269 Sum_probs=198.4
Q ss_pred ccccceeeeeCceEEEEEEEC-C-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEE
Q 006750 227 FSGSNIVGQGGSSYVYRGQLT-D-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~-~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV 304 (632)
|.+.+.||+|+||.||+|... + ++.||+|.+.... ......+.+|+.+|+.++||||+++++++.. ....|||
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~----~~~~~lv 143 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKS----DDKLLLI 143 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE----CCEEEEE
Confidence 777899999999999999754 3 6788888765432 2333457889999999999999999999876 4578999
Q ss_pred EEeCCCCChhhhhhccc--cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 305 FEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
|||+++|+|.++|.... ...+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence 99999999999886432 235889999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 462 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (632)
.... ........||+.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 221 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~----------------- 280 (478)
T PTZ00267 221 DSVS---LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIM----------------- 280 (478)
T ss_pred Cccc---cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----------------
Confidence 3221 11233456999999999999999999999999999999999999999643221100
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 463 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 463 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
..+..... ...+...+..+.+|+.+||..||++||++.++++
T Consensus 281 ~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 281 QQVLYGKY-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHhCCC-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 00000000 0122233455899999999999999999999975
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=317.98 Aligned_cols=255 Identities=23% Similarity=0.372 Sum_probs=203.6
Q ss_pred hhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
..++|.+.+.||+|+||.||++.+.++..+|+|.+.... .....|.+|+.++++++|+||+++.+++.. ...+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 76 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-----EPIY 76 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-----CCeE
Confidence 346788899999999999999998778889999887532 234568999999999999999999988764 3569
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
++|||+++|+|.+++.......+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 9999999999999997655556899999999999999999999998 9999999999999999999999999998664
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
.... .......++..|+|||++....++.++||||||+++|++++ |+.||.......... +
T Consensus 154 ~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~---~----------- 215 (260)
T cd05073 154 DNEY----TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR---A----------- 215 (260)
T ss_pred CCCc----ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHH---H-----------
Confidence 3221 11222346678999999998889999999999999999999 899986432211100 0
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 509 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 509 (632)
+...... ..+...+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 216 ~~~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 216 LERGYRM----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HhCCCCC----CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0000000 1112233458899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=321.39 Aligned_cols=275 Identities=27% Similarity=0.345 Sum_probs=201.1
Q ss_pred cCccccceeeeeCceEEEEEEEC-----CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-----~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
..|.+.+.||+|+||.||++... ++..||||++.... ......|.+|++++++++||||+++++++.... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG--RR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC--CC
Confidence 45777899999999999999743 47899999987543 233456899999999999999999999875432 34
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccc
Confidence 6799999999999999996532 34899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
......... .......++..|+|||++.+..++.++||||||+++|||++|..|+............. ........
T Consensus 157 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 232 (284)
T cd05081 157 VLPQDKEYY--KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGN--DKQGQMIV 232 (284)
T ss_pred cccCCCcce--eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccc--ccccccch
Confidence 764322110 01111224456999999998899999999999999999999887754321110000000 00000000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
..+.+..........+...+..+.+|+.+||..+|++|||+.+|++.|+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000000000111112223345589999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=327.12 Aligned_cols=266 Identities=23% Similarity=0.356 Sum_probs=198.4
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
++|...+.||+|+||.||+|... +++.||+|.++..........+.+|+.++++++||||+++++++.. ....++
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~l 81 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT----DKSLTL 81 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee----CCeEEE
Confidence 46888899999999999999875 4889999999765444444558899999999999999999999875 457899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||++ ++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 82 VFEYLD-KDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred EEeCCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 999996 58888886532 34899999999999999999999998 99999999999999999999999999976433
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecc--c------cc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA--T------PR 454 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~--~------~~ 454 (632)
.. .......+|+.|+|||++.+ ..++.++||||||+++|||++|+.||............... . +.
T Consensus 157 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
T cd07872 157 PT-----KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG 231 (309)
T ss_pred Cc-----cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Confidence 21 11223468899999998865 56899999999999999999999999654332111111000 0 00
Q ss_pred cccccccccccCCCCCCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 455 LQDSGTVISELPDPRLKG----DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 455 ~~~~~~~~~~~~~~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
+... ........+.... ......+..+.+|+.+||+.||.+|||+.|+++
T Consensus 232 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 232 ISSN-DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hcch-hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000 0000000000000 001123445789999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=321.88 Aligned_cols=251 Identities=27% Similarity=0.371 Sum_probs=197.3
Q ss_pred ccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC--ChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 227 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
|+..+.||+|+||+||+|.+. +++.||+|.+...... .....+.+|+++|++++|+||+++.+++.. +...++
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~----~~~~~l 77 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET----KDALCL 77 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec----CCEEEE
Confidence 566788999999999999875 5899999998754221 223447889999999999999999988765 457899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||+++++|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05632 78 VLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPE 154 (285)
T ss_pred EEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCC
Confidence 999999999999887554456999999999999999999999998 99999999999999999999999999876532
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (632)
.. ......|+..|+|||++.+..++.++||||||+++|||++|..||............. .
T Consensus 155 ~~------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~-------------~ 215 (285)
T cd05632 155 GE------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD-------------R 215 (285)
T ss_pred CC------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------------H
Confidence 21 1223468999999999998899999999999999999999999996433211100000 0
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006750 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT-----MSEVVQ 505 (632)
Q Consensus 464 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 505 (632)
.+... ...++...+..+.+|+..||+.||++||+ +.++++
T Consensus 216 ~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 216 RVLET--EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred hhhcc--ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 00000 00122233445789999999999999999 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=319.10 Aligned_cols=250 Identities=26% Similarity=0.457 Sum_probs=194.2
Q ss_pred ceeeeeCceEEEEEEECC-Cc--EEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcceEEEEEE
Q 006750 231 NIVGQGGSSYVYRGQLTD-GR--IVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~-g~--~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~~~lV~E 306 (632)
+.||+|+||.||+|.+.+ +. .+|+|.++..........+.+|++++.++ +||||+++++++.. ....++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~----~~~~~lv~e 76 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----RGYLYLAIE 76 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec----CCCceEEEE
Confidence 358999999999998754 43 57889887544444556689999999999 89999999999875 346799999
Q ss_pred eCCCCChhhhhhccc--------------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEE
Q 006750 307 FMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKI 372 (632)
Q Consensus 307 y~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL 372 (632)
|+++|+|.+++.... ...+++.++..++.|++.||+|||+.+ ++||||||+|||+++++.+||
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl 153 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKI 153 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEE
Confidence 999999999986432 124789999999999999999999988 999999999999999999999
Q ss_pred eccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecc
Q 006750 373 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWA 451 (632)
Q Consensus 373 ~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~ 451 (632)
+|||++...... ........+..|+|||++....++.++||||||+++|||++ |..||..........
T Consensus 154 ~dfgl~~~~~~~------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~----- 222 (270)
T cd05047 154 ADFGLSRGQEVY------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE----- 222 (270)
T ss_pred CCCCCccccchh------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHH-----
Confidence 999998632211 01111224567999999988889999999999999999997 999986432211000
Q ss_pred ccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 452 TPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 452 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
.+.. ......+......+.+|+.+||..+|.+|||+.++++.|..+.
T Consensus 223 ------------~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 223 ------------KLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ------------HHhC-CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0000 0000112223345889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=323.20 Aligned_cols=264 Identities=24% Similarity=0.372 Sum_probs=200.5
Q ss_pred hcCccccceeeeeCceEEEEEEEC-----------------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-----------------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-----------------~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~ 286 (632)
.++|++.+.||+|+||.||++... ++..||+|++...........|.+|+.+|+.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356888999999999999998543 244799999986554445567999999999999999999
Q ss_pred eeeeeecccCCcceEEEEEEeCCCCChhhhhhcccc---------CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCC
Q 006750 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV---------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 357 (632)
Q Consensus 287 l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDL 357 (632)
+++++.. ....++||||+++|+|.+++..... ..+++.++..++.|++.||+|||+.+ |+||||
T Consensus 84 ~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl 156 (296)
T cd05095 84 LLAVCIT----SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDL 156 (296)
T ss_pred EEEEEec----CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccC
Confidence 9999875 3467999999999999999865321 23778899999999999999999998 999999
Q ss_pred CCCCeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh--CCCC
Q 006750 358 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT--GRQP 435 (632)
Q Consensus 358 Kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt--G~~P 435 (632)
||+|||++.++.++|+|||+++........ .......+++.|+|||....+.++.++||||||+++|||++ |..|
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p 233 (296)
T cd05095 157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP 233 (296)
T ss_pred ChheEEEcCCCCEEeccCcccccccCCcce---eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999865432211 11122335678999999988899999999999999999998 6788
Q ss_pred CCCccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 436 IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
|............ ........ ..... ..+..++..+.+|+.+||+.||++||++.+|++.|.
T Consensus 234 ~~~~~~~~~~~~~---~~~~~~~~---~~~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 234 YSQLSDEQVIENT---GEFFRDQG---RQVYL-----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ccccChHHHHHHH---HHHHhhcc---ccccC-----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 8543221110000 00000000 00000 111223355889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=338.41 Aligned_cols=254 Identities=21% Similarity=0.289 Sum_probs=192.1
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
.|+..+.||+|+||+||+|+.. +++.||||++.... .......+.+|+.++++++||||+++++++.+ ....|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~----~~~~~ 77 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD----KDNLY 77 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe----CCEEE
Confidence 5788899999999999999875 48899999987532 12234458899999999999999999999875 45789
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 78 lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~ 152 (382)
T cd05625 78 FVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (382)
T ss_pred EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccc
Confidence 999999999999998753 45889999999999999999999998 9999999999999999999999999986432
Q ss_pred cCCCC------------------------------------------CCCCCCCccccCCCCCChhhhhcCCCCcccchH
Q 006750 383 ADGLP------------------------------------------SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVF 420 (632)
Q Consensus 383 ~~~~~------------------------------------------~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVw 420 (632)
..... ..........||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 232 (382)
T cd05625 153 WTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEE
Confidence 10000 000011235699999999999999999999999
Q ss_pred hHhHHHHHHHhCCCCCCCccccccch-heeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 006750 421 SFGVVLLELITGRQPIHRSITKGEES-LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT 499 (632)
Q Consensus 421 SlGviL~eLltG~~P~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs 499 (632)
||||+||||++|+.||.......... ...|. .....+ .....+..+.+++.+++ .+|.+|++
T Consensus 233 SlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-----------~~~~~p-----~~~~~s~~~~~li~~l~-~~p~~R~~ 295 (382)
T cd05625 233 SVGVILYEMLVGQPPFLAQTPLETQMKVINWQ-----------TSLHIP-----PQAKLSPEASDLIIKLC-RGPEDRLG 295 (382)
T ss_pred echHHHHHHHhCCCCCCCCCHHHHHHHHHccC-----------CCcCCC-----CcccCCHHHHHHHHHHc-cCHhHcCC
Confidence 99999999999999997543221110 00000 000001 11112334666676665 59999987
Q ss_pred ---HHHHHH
Q 006750 500 ---MSEVVQ 505 (632)
Q Consensus 500 ---~~evl~ 505 (632)
+.++++
T Consensus 296 ~~~~~ei~~ 304 (382)
T cd05625 296 KNGADEIKA 304 (382)
T ss_pred CCCHHHHhc
Confidence 777764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=316.72 Aligned_cols=255 Identities=25% Similarity=0.406 Sum_probs=193.7
Q ss_pred ceeeeeCceEEEEEEECC----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEE
Q 006750 231 NIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~E 306 (632)
+.||+|+||.||+|.+.+ +..||+|++...........+.+|+.+++.++||||+++++++... ....++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS---EGSPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC---CCCcEEEEe
Confidence 368999999999998642 4579999986543334455688999999999999999999987642 234689999
Q ss_pred eCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCC
Q 006750 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (632)
Q Consensus 307 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 386 (632)
|+.+|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++.......
T Consensus 78 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 78 YMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 999999999997543 34688889999999999999999998 99999999999999999999999999976543221
Q ss_pred CCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCC-CCCCCccccccchheecccccccccccccccc
Q 006750 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR-QPIHRSITKGEESLVLWATPRLQDSGTVISEL 465 (632)
Q Consensus 387 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (632)
.. ........++..|+|||++....++.++||||||+++|||++|. +||....... .... +...
T Consensus 154 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~-----------~~~~ 218 (262)
T cd05058 154 YS-VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVY-----------LLQG 218 (262)
T ss_pred ee-ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH-----------HhcC
Confidence 11 11122334677899999998889999999999999999999964 5554321110 0000 0000
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 466 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 466 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
..+. .+...+..+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus 219 ~~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 219 RRLL----QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCC----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 0011 11122345889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=320.07 Aligned_cols=252 Identities=25% Similarity=0.367 Sum_probs=196.8
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV 304 (632)
+|...+.||+|+||.||+|.+. +++.||+|++...........|.+|++++++++||||+++++++.. ....++|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv 77 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV----ENRISIC 77 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE----CCEEEEE
Confidence 5677889999999999999864 5899999998765444445568999999999999999999999876 4567899
Q ss_pred EEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccC
Q 006750 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 384 (632)
|||+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++......
T Consensus 78 ~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~ 148 (279)
T cd06619 78 TEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS 148 (279)
T ss_pred EecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence 9999999997652 3788899999999999999999998 999999999999999999999999999765432
Q ss_pred CCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccc
Q 006750 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 464 (632)
Q Consensus 385 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (632)
......||..|+|||++.+..++.++||||||+++|+|++|+.||............. ... ..+..
T Consensus 149 -------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~----~~~---~~~~~ 214 (279)
T cd06619 149 -------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL----QLL---QCIVD 214 (279)
T ss_pred -------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchH----HHH---HHHhc
Confidence 1233568999999999998899999999999999999999999996532211100000 000 00000
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006750 465 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507 (632)
Q Consensus 465 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 507 (632)
...+.+. ....+..+.+++.+||+.+|++||++.++++.-
T Consensus 215 ~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 215 EDPPVLP---VGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred cCCCCCC---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 0111111 111234488999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=313.99 Aligned_cols=250 Identities=32% Similarity=0.486 Sum_probs=202.0
Q ss_pred ceeeeeCceEEEEEEECC----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEE
Q 006750 231 NIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~E 306 (632)
+.||+|+||.||+|.... +..||||+++..........+.+|+++++.++|+||+++++++.. ....++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~~lv~e 76 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE----EEPLYLVLE 76 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC----CCceEEEEE
Confidence 369999999999998764 789999999876544445679999999999999999999998876 457799999
Q ss_pred eCCCCChhhhhhccc-------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 307 FMPNGNLRDCLDGVL-------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 307 y~~~gsL~~~L~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
|+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||.+.
T Consensus 77 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~ 153 (262)
T cd00192 77 YMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSR 153 (262)
T ss_pred eccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccc
Confidence 999999999997642 255899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
....... ........++..|+|||.+....++.++||||||+++|||++ |..||........ .
T Consensus 154 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~---------- 217 (262)
T cd00192 154 DVYDDDY---YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV---L---------- 217 (262)
T ss_pred ccccccc---cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH---H----------
Confidence 7654321 112334557889999999988899999999999999999999 6999865422110 0
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
..+.. ......+...+..+.+++.+||..+|.+||++.++++.|.
T Consensus 218 ----~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 218 ----EYLRK-GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----HHHHc-CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 00000 0011223333556889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=315.11 Aligned_cols=254 Identities=23% Similarity=0.350 Sum_probs=201.3
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC----ChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP----NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~----~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
++|...+.||+|+||.||++... +++.||+|.+...... .....+.+|++++++++||||+++++++.. ..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~ 77 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD----DE 77 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc----CC
Confidence 56888999999999999999865 5899999998754221 123458899999999999999999999875 44
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.++|+|||+++
T Consensus 78 ~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~ 152 (263)
T cd06625 78 TLSIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 152 (263)
T ss_pred eEEEEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccce
Confidence 789999999999999998753 45889999999999999999999998 9999999999999999999999999997
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
........ ........|+..|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus 153 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------------- 217 (263)
T cd06625 153 RLQTICSS--GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF------------- 217 (263)
T ss_pred eccccccc--cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH-------------
Confidence 65432110 011123457889999999999889999999999999999999999986432211000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
...........+......+.+++.+||..+|.+|||+.++++.
T Consensus 218 ----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 218 ----KIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ----HHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0000111112333344558899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=315.44 Aligned_cols=251 Identities=27% Similarity=0.370 Sum_probs=198.8
Q ss_pred ceeeeeCceEEEEEEECC--C--cEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEE
Q 006750 231 NIVGQGGSSYVYRGQLTD--G--RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~--g--~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~E 306 (632)
+.||+|++|.||+|.+.+ + ..||||.+...........|.+|+.++++++||||+++++++.. ...++|||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~v~e 75 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-----HPLMMVTE 75 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-----CeEEEEEE
Confidence 368999999999998753 3 36999999876543455679999999999999999999998764 46799999
Q ss_pred eCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCC
Q 006750 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (632)
Q Consensus 307 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 386 (632)
|+++|+|.+++.......+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 76 LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred ecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccc
Confidence 999999999997654346899999999999999999999998 99999999999999999999999999987654221
Q ss_pred CCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccccccccccc
Q 006750 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 465 (632)
Q Consensus 387 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (632)
. ........++..|+|||++....++.++||||||+++|||++ |+.||............ ..
T Consensus 153 ~--~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~--------------~~- 215 (257)
T cd05040 153 H--YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI--------------DK- 215 (257)
T ss_pred c--eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--------------Hh-
Confidence 1 111123457889999999999899999999999999999998 99998643222110000 00
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 466 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 466 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
.......+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 216 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 216 --EGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --cCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 00000112223455889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=317.13 Aligned_cols=256 Identities=24% Similarity=0.274 Sum_probs=207.0
Q ss_pred CccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
.|+..+.||.|.-|+||++++++ +..+|+|++..... .+...+...|-+||+.++||.++.|++.+.. +.+.+
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet----~~~~c 153 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET----DKYSC 153 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec----cceeE
Confidence 35567889999999999999876 68999999976532 2333457789999999999999999998875 66889
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+|||||+||+|...++.+..+.+++..+.-++..++-||+|||-.| ||+|||||+||||.++|++-|+||.|+....
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 9999999999999999888888999999999999999999999999 9999999999999999999999999976432
Q ss_pred cC-------C--------------------------C------------------CCCCCCCCccccCCCCCChhhhhcC
Q 006750 383 AD-------G--------------------------L------------------PSCSSSPARMQGTFGYFAPEYAMVG 411 (632)
Q Consensus 383 ~~-------~--------------------------~------------------~~~~~~~~~~~GT~~Y~APE~~~~~ 411 (632)
.. . . .........++||-.|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 10 0 0 0000122347799999999999999
Q ss_pred CCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcc
Q 006750 412 RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQ 491 (632)
Q Consensus 412 ~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~ 491 (632)
..+.++|.|+|||+||||+.|..||.+.....-... ++-..+...-....+..+.+||++.|.
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~N-----------------Iv~~~l~Fp~~~~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRN-----------------IVGQPLKFPEEPEVSSAAKDLIRKLLV 373 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHH-----------------HhcCCCcCCCCCcchhHHHHHHHHHhc
Confidence 999999999999999999999999987654432221 221122111122455668999999999
Q ss_pred cCCCCCCC----HHHHHH
Q 006750 492 LDPDARPT----MSEVVQ 505 (632)
Q Consensus 492 ~dP~~RPs----~~evl~ 505 (632)
+||.+|.. +.||.+
T Consensus 374 KdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred cChhhhhccccchHHhhc
Confidence 99999988 777765
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=353.88 Aligned_cols=265 Identities=26% Similarity=0.347 Sum_probs=203.3
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|.+.+.||+|+||.||+|.+. +|+.||||++..... ......|.+|++++++++||||+++++++.+ ....
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d----~~~l 77 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD----GDPV 77 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee----CCEE
Confidence 57888999999999999999876 489999999975432 2234569999999999999999999998875 4577
Q ss_pred EEEEEeCCCCChhhhhhccc---------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEE
Q 006750 302 LLVFEFMPNGNLRDCLDGVL---------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKI 372 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL 372 (632)
|+||||++||+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.++|
T Consensus 78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKL 154 (932)
T PRK13184 78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVI 154 (932)
T ss_pred EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEE
Confidence 99999999999999986421 233678889999999999999999998 999999999999999999999
Q ss_pred eccccceecccCCC-------------CCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCc
Q 006750 373 TDLGMAKRLKADGL-------------PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS 439 (632)
Q Consensus 373 ~DFGla~~~~~~~~-------------~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~ 439 (632)
+|||+++....... ...........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 99999987622110 00001122357999999999999999999999999999999999999999653
Q ss_pred cccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhhCC
Q 006750 440 ITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-TMSEVVQILSTIAP 512 (632)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~ 512 (632)
....... . ..+..+.... .....+..+.+++.+||..||++|| ++.++.+.|.....
T Consensus 235 ~~~ki~~----~-----------~~i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 235 KGRKISY----R-----------DVILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred chhhhhh----h-----------hhccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 2211000 0 0011110000 0112334588899999999999995 66777777776654
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=329.37 Aligned_cols=245 Identities=23% Similarity=0.300 Sum_probs=190.2
Q ss_pred ceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcceEEEEEE
Q 006750 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~~~lV~E 306 (632)
+.||+|+||.||++... +++.||||+++.... ......+.+|+.++.++ +||||+++++++.. ....|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e 76 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT----TSRLFLVIE 76 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe----CCEEEEEEe
Confidence 46999999999999875 478999999986422 23344588899999988 79999999998865 457899999
Q ss_pred eCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCC
Q 006750 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (632)
Q Consensus 307 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 386 (632)
|+++|+|.+++... +.+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~- 150 (327)
T cd05617 77 YVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG- 150 (327)
T ss_pred CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC-
Confidence 99999999988643 45999999999999999999999998 9999999999999999999999999987532211
Q ss_pred CCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccC
Q 006750 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 466 (632)
Q Consensus 387 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (632)
.......||+.|+|||++.+..++.++||||||++||||++|+.||.............+. ...+.
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~----------~~~~~ 216 (327)
T cd05617 151 ----DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL----------FQVIL 216 (327)
T ss_pred ----CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHH----------HHHHH
Confidence 1223456999999999999999999999999999999999999999643221111000000 00001
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 006750 467 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS 501 (632)
Q Consensus 467 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 501 (632)
... ..+|...+..+.+++.+||+.||.+|+++.
T Consensus 217 ~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 217 EKP--IRIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred hCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 110 112333344578999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=329.71 Aligned_cols=262 Identities=26% Similarity=0.401 Sum_probs=204.2
Q ss_pred hhcCccccceeeeeCceEEEEEEECC--------CcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeec
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLTD--------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 293 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~ 293 (632)
...+|.+.+.||+|+||.||++.... +..||+|.++..........+.+|+++++++ +||||+++++++..
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 34568889999999999999997421 2379999988654444456789999999999 89999999999875
Q ss_pred ccCCcceEEEEEEeCCCCChhhhhhccc--------------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCC
Q 006750 294 FRGKRAMRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKS 359 (632)
Q Consensus 294 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp 359 (632)
....++||||+++|+|.+++.... ...++|.+++.++.|++.||+|||+.+ |+||||||
T Consensus 90 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp 162 (334)
T cd05100 90 ----DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAA 162 (334)
T ss_pred ----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eecccccc
Confidence 446799999999999999996532 234889999999999999999999998 99999999
Q ss_pred CCeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCC
Q 006750 360 SNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR 438 (632)
Q Consensus 360 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~ 438 (632)
+|||++.++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 239 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYY---KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239 (334)
T ss_pred ceEEEcCCCcEEECCcccceeccccccc---ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 9999999999999999999865432111 11122334578999999999999999999999999999998 8888854
Q ss_pred ccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 439 SITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
......... +... .....+...+..+.+++.+||+.+|++||++.++++.|..+..
T Consensus 240 ~~~~~~~~~--------------~~~~----~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 240 IPVEELFKL--------------LKEG----HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred CCHHHHHHH--------------HHcC----CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 322111000 0000 0011222333458899999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=315.50 Aligned_cols=257 Identities=25% Similarity=0.401 Sum_probs=203.4
Q ss_pred cCccccceeeeeCceEEEEEEECC----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
++|.+.+.||+|+||.||+|.+.+ ...||||...........+.|.+|+.++++++||||+++++++.. ..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~ 80 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-----NP 80 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-----CC
Confidence 457778999999999999998643 247999998765544455679999999999999999999998764 24
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.++||||+++|+|.+++.... ..+++..++.++.+++.||+|||+.+ ++|+||||+|||++.++.++|+|||+++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeee
Confidence 589999999999999997542 35899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
........ .....++..|+|||.+....++.++||||||+++|||++ |..||...........
T Consensus 157 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~------------ 220 (270)
T cd05056 157 LEDESYYK----ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR------------ 220 (270)
T ss_pred ccccccee----cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH------------
Confidence 65432111 112235578999999988889999999999999999986 9999965432211100
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
+....... .+...+..+.+++.+||..+|++|||+.++++.|..+..
T Consensus 221 --~~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 221 --IENGERLP----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred --HHcCCcCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00000111 122334458899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=327.50 Aligned_cols=243 Identities=22% Similarity=0.303 Sum_probs=191.5
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcC-CCCccceeeeeecccCCcceE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~~~~ 301 (632)
+|...+.||+|+||.||+|... +|+.||||++.... .......+..|..++..+. |++|+++.+++.. ....
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~----~~~~ 76 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT----VDRL 76 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec----CCEE
Confidence 3667789999999999999875 48999999997532 2233345788999998885 5778888887765 4578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||||+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 77 ~lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~ 151 (323)
T cd05615 77 YFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEH 151 (323)
T ss_pred EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEecccccccc
Confidence 9999999999999998653 45899999999999999999999998 999999999999999999999999998754
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 152 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~---------------- 210 (323)
T cd05615 152 MVDG-----VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELF---------------- 210 (323)
T ss_pred CCCC-----ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH----------------
Confidence 3221 1223456999999999999989999999999999999999999999754321100
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS 501 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 501 (632)
..+.... ..+|...+..+.+++.+||+.+|.+|++..
T Consensus 211 -~~i~~~~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 211 -QSIMEHN--VSYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred -HHHHhCC--CCCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 0011000 012233345578899999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=334.40 Aligned_cols=261 Identities=20% Similarity=0.273 Sum_probs=199.6
Q ss_pred HHHHHhhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecc
Q 006750 218 SALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 294 (632)
Q Consensus 218 ~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~ 294 (632)
.++....++|++.+.||+|+||.||++.... ++.||+|++.... .......+.+|+.+++.++||||+++++++..
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~- 114 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD- 114 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-
Confidence 3455566899999999999999999998764 8899999986421 12223457889999999999999999998875
Q ss_pred cCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEec
Q 006750 295 RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITD 374 (632)
Q Consensus 295 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~D 374 (632)
....|+||||+++|+|.+++.. ..++...+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 115 ---~~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~D 185 (371)
T cd05622 115 ---DRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLAD 185 (371)
T ss_pred ---CCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEe
Confidence 5578999999999999999865 34788899999999999999999998 99999999999999999999999
Q ss_pred cccceecccCCCCCCCCCCCccccCCCCCChhhhhcC----CCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec
Q 006750 375 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG----RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450 (632)
Q Consensus 375 FGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~----~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~ 450 (632)
||+++....... .......||+.|+|||++... .++.++|||||||+||||++|+.||............
T Consensus 186 fG~a~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i-- 259 (371)
T cd05622 186 FGTCMKMNKEGM----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI-- 259 (371)
T ss_pred CCceeEcCcCCc----ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHH--
Confidence 999987643321 112345699999999998753 3789999999999999999999999754321110000
Q ss_pred cccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 006750 451 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDA--RPTMSEVVQIL 507 (632)
Q Consensus 451 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L 507 (632)
+... ..+....+...+..+.+++..||..++.+ ||++.++++..
T Consensus 260 -----------~~~~--~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 260 -----------MNHK--NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred -----------HcCC--CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 0000 00000111233455888999999844433 67888888754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=318.13 Aligned_cols=260 Identities=27% Similarity=0.422 Sum_probs=204.2
Q ss_pred cCccccceeeeeCceEEEEEEECC-Cc----EEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~----~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
.+|...+.||+|+||.||+|.+.+ |. .||+|.+...........+.+|+.++++++||||+++++++.. .
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 81 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-----S 81 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----C
Confidence 457778999999999999998653 33 6999998766554455668999999999999999999999874 3
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccc
Confidence 5799999999999999997643 34899999999999999999999988 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
........ .......++..|+|||.+....++.++||||||+++|||++ |+.||...........
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~----------- 223 (279)
T cd05057 158 LLDVDEKE---YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDL----------- 223 (279)
T ss_pred cccCcccc---eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH-----------
Confidence 76532211 01111224678999999988899999999999999999998 9999865332110000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 514 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 514 (632)
+.... ....+......+.+++.+||..+|+.||++.++++.|..+..+.
T Consensus 224 ---~~~~~----~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 224 ---LEKGE----RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred ---HhCCC----CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 00000 00112222344788999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=336.69 Aligned_cols=250 Identities=27% Similarity=0.375 Sum_probs=206.5
Q ss_pred cccceeeeeCceEEEEEEECC--Cc--EEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 228 SGSNIVGQGGSSYVYRGQLTD--GR--IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 228 ~~~~~LG~G~fG~Vy~~~~~~--g~--~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
...++||+|.||.|++|.|+. |+ .||||.++.........+|++|+.+|.+|+|||+++|||+..+ ....|
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-----qp~mM 187 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-----QPAMM 187 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-----chhhH
Confidence 345789999999999999874 43 6999999987666677789999999999999999999999874 35689
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
|||+++.|||.+.|+......|-......++.|||.||.||..++ +|||||..+|+||-....|||+||||.+.+..
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999998744455888899999999999999999988 99999999999999999999999999998865
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVI 462 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (632)
+.... .-.....-.+.|+|||.+....++.+||||+|||++|||+| |..||-+.... .+
T Consensus 265 ned~Y--vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~------------------qI 324 (1039)
T KOG0199|consen 265 NEDMY--VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI------------------QI 324 (1039)
T ss_pred CCcce--EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH------------------HH
Confidence 43211 01111224578999999999999999999999999999999 78898654321 12
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 463 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 463 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.+.+|..-+..-|+.+++.++++++.||..+|++|||+..|.+
T Consensus 325 L~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 325 LKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred HHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 2233333344567788888999999999999999999999974
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=328.78 Aligned_cols=238 Identities=24% Similarity=0.290 Sum_probs=186.4
Q ss_pred ceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHH-HHHhcCCCCccceeeeeecccCCcceEEEEEE
Q 006750 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVD-MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~-~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~E 306 (632)
+.||+|+||+||+|... +|+.||||++.... .......+..|.. +++.++||||+++++++.. ....|+|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~----~~~~~lv~e 76 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT----ADKLYFVLD 76 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe----CCEEEEEEc
Confidence 36999999999999975 58999999987432 1222234555555 5678899999999988865 457899999
Q ss_pred eCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCC
Q 006750 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (632)
Q Consensus 307 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 386 (632)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~- 150 (323)
T cd05575 77 YVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS- 150 (323)
T ss_pred CCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-
Confidence 99999999998753 45899999999999999999999998 9999999999999999999999999987543211
Q ss_pred CCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccC
Q 006750 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 466 (632)
Q Consensus 387 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (632)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .+.
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-----------------~i~ 209 (323)
T cd05575 151 ----KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD-----------------NIL 209 (323)
T ss_pred ----CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHH-----------------HHH
Confidence 22334569999999999999999999999999999999999999996532211000 000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 006750 467 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS 501 (632)
Q Consensus 467 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 501 (632)
.... ..+...+..+.+++.+||+.||.+||++.
T Consensus 210 ~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 210 NKPL--RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred cCCC--CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 0000 11122244588999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=319.43 Aligned_cols=264 Identities=26% Similarity=0.408 Sum_probs=206.8
Q ss_pred ecHHHHHHhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeee
Q 006750 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCS 292 (632)
Q Consensus 215 ~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~ 292 (632)
.++.++..+.+.|++.+.||.|+||.||+|.+. +++.+|+|++.... .....+..|+.+++++ +|+||+++++++.
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 355667777889999999999999999999875 48999999986542 2334588999999999 7999999999886
Q ss_pred ccc--CCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCe
Q 006750 293 EFR--GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA 370 (632)
Q Consensus 293 ~~~--~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~v 370 (632)
... ......|++|||+++|+|.+++.......+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+
T Consensus 84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence 432 22457899999999999999997655556889999999999999999999998 9999999999999999999
Q ss_pred EEeccccceecccCCCCCCCCCCCccccCCCCCChhhhh-----cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccc
Q 006750 371 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEE 445 (632)
Q Consensus 371 kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~ 445 (632)
+|+|||++....... .......|++.|+|||.+. ...++.++||||||+++|||++|+.||.........
T Consensus 161 ~l~dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~ 235 (282)
T cd06636 161 KLVDFGVSAQLDRTV-----GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL 235 (282)
T ss_pred EEeeCcchhhhhccc-----cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh
Confidence 999999987653221 1223456899999999875 346788999999999999999999999643321111
Q ss_pred hheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 446 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.. +.....+.. .....+..+.+|+.+||..||.+||++.+|++
T Consensus 236 ~~--------------~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 236 FL--------------IPRNPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hh--------------HhhCCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 000011111 11223345899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=320.00 Aligned_cols=250 Identities=26% Similarity=0.408 Sum_probs=200.8
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
.+|+..+.||+|+||.||+|... +++.||+|.+...... ....+.+|+.+++.+.||||+++++++.. ....++
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~----~~~~~l 94 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLV----GDELWV 94 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEe----CCEEEE
Confidence 46888899999999999999864 5899999998765433 34558899999999999999999998875 457899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||+++++|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 95 v~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 95 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred eecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 9999999999999864 34899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (632)
.. .......|++.|+|||++.+..++.++|||||||++|+|++|+.||........ ...+.
T Consensus 169 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~~~------------ 229 (296)
T cd06654 169 EQ-----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLIA------------ 229 (296)
T ss_pred cc-----cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHHHh------------
Confidence 21 112234688999999999988899999999999999999999999965432111 00000
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 464 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.........+......+.+++.+||..+|++||++.++++.
T Consensus 230 --~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 230 --TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred --cCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 00000011233344568899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=316.10 Aligned_cols=274 Identities=25% Similarity=0.340 Sum_probs=208.0
Q ss_pred hhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccC-CCCChHHHHHHHHHHHHhcCCCCccceeeeeec-ccCCcc
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQ-GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE-FRGKRA 299 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~-~~~~~~ 299 (632)
+...|...+.||+|+||.|+.+..+ +|+.||||++... ......++-.+|+++|+.++|+||+.+++.+.. ..+.-.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3445666788999999999999875 4899999999743 233344567899999999999999999998875 233345
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..|+|+|+| +-+|.+.|+.. +.++...+..+..|+++||+|+|+.+ |+||||||+|+|++.+..+||+|||||+
T Consensus 100 DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence 789999999 78999999763 44899999999999999999999998 9999999999999999999999999999
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhh-cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
..... ......+..+.|..|.|||++. ...|+...||||.||||.||++|++-|.+...-.+..++....+.-...
T Consensus 174 ~~~~~---~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 174 YLDKF---FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred ecccc---CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 87643 1123456778999999999886 4679999999999999999999999987655433322222111111000
Q ss_pred ----------cccccccC---CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 459 ----------GTVISELP---DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 459 ----------~~~~~~~~---~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
...+..++ ...+...+| .......+|+.+||..||.+|+|++|.++.
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00111111 111111122 333457889999999999999999999873
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=318.77 Aligned_cols=247 Identities=24% Similarity=0.373 Sum_probs=199.3
Q ss_pred ccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEE
Q 006750 227 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 305 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~ 305 (632)
|+..+.||+|+||.||+|.+. +++.||+|.+...........+.+|+.++++++||||+++++++.. ....|+||
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~ 81 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK----GTKLWIIM 81 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc----CCceEEEE
Confidence 556678999999999999865 4889999998755444455668999999999999999999998875 45679999
Q ss_pred EeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCC
Q 006750 306 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 385 (632)
Q Consensus 306 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 385 (632)
||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 82 EYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 99999999999864 45899999999999999999999988 9999999999999999999999999987654321
Q ss_pred CCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccccccc
Q 006750 386 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 465 (632)
Q Consensus 386 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (632)
. ......|+..|+|||++.+..++.++||||||+++|||++|+.||.......... .+...
T Consensus 156 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--------------~~~~~ 216 (277)
T cd06642 156 I-----KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF--------------LIPKN 216 (277)
T ss_pred h-----hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh--------------hhhcC
Confidence 1 1223458899999999998889999999999999999999999986432211000 00011
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 466 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 466 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
..+.+ +...+..+.+++.+||+.+|++||++.++++.
T Consensus 217 ~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 217 SPPTL----EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCCC----CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11112 22334558899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=316.41 Aligned_cols=250 Identities=25% Similarity=0.363 Sum_probs=202.5
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
++|+..+.||.|+||.||+|.+. +++.||+|++...........+.+|+.+++.++|+||+++++++.+ ....++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~~ 76 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK----GSKLWI 76 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE----CCeEEE
Confidence 35778889999999999999876 4899999999765444455668999999999999999999998875 457899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
|+||+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++....
T Consensus 77 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 77 IMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred EEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 99999999999998753 6899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (632)
.. .......|++.|+|||++.+..++.++||||||+++|+|++|+.||.......... .+.
T Consensus 151 ~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~--------------~~~ 211 (274)
T cd06609 151 TM-----SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF--------------LIP 211 (274)
T ss_pred cc-----cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH--------------Hhh
Confidence 31 12233468899999999998889999999999999999999999996432111000 000
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 464 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
....+.+... ..+..+.+++.+||..+|++||++.++++.
T Consensus 212 ~~~~~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 212 KNNPPSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred hcCCCCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1111111111 033458889999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=319.79 Aligned_cols=255 Identities=27% Similarity=0.412 Sum_probs=198.8
Q ss_pred cCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 298 (632)
.+|...+.||+|+||.||++... ++..+|+|.+.... ......|.+|+++++.++|+||+++++++.. .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~ 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTE----G 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEec----C
Confidence 45667789999999999999642 35689999887532 3344569999999999999999999998875 3
Q ss_pred ceEEEEEEeCCCCChhhhhhcccc-------------CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEec
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVLV-------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD 365 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~ 365 (632)
...++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||||+|||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~ 156 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVG 156 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEc
Confidence 467999999999999999965321 24889999999999999999999998 99999999999999
Q ss_pred CCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCcccccc
Q 006750 366 ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGE 444 (632)
Q Consensus 366 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~ 444 (632)
+++.+||+|||+++........ .......+++.|+|||++.+..++.++||||||+++|||++ |..||........
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 233 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYY---RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA 233 (280)
T ss_pred CCCCEEECCCCceeEcCCCcee---ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH
Confidence 9999999999999765432111 11122345788999999999999999999999999999998 8999864332211
Q ss_pred chheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 445 ESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
.... ...... ..+...+..+.+|+.+||+.||++||++.+|++.|.
T Consensus 234 ~~~~--------------~~~~~~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 234 IECI--------------TQGREL----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHH--------------HcCccC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1100 000001 111223344889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=311.99 Aligned_cols=252 Identities=23% Similarity=0.329 Sum_probs=201.3
Q ss_pred CccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
+|++.+.||+|++|.||++.... ++.||+|++..... ....+.+.+|++++++++|+|++++++.+.. .....|+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~l 77 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG---EDGLLYI 77 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC---CCCEEEE
Confidence 47788999999999999998754 78999999875432 2334568899999999999999999887643 2346799
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||+++++|.+++.......+++.++..++.+++.||+|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 78 v~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 78 VMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred EecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 999999999999997655556899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (632)
.. .......|++.|+|||++.+..++.++||||||+++|+|++|+.||..........
T Consensus 155 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~----------------- 212 (257)
T cd08223 155 QC-----DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY----------------- 212 (257)
T ss_pred cC-----CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH-----------------
Confidence 21 12234568899999999999999999999999999999999999986432111000
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 464 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+....+ ...+...+..+.+++.+||+.+|++||++.++++.
T Consensus 213 ~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 213 RIIEGKL-PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHHhcCC-CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000 11223344568999999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=319.09 Aligned_cols=262 Identities=23% Similarity=0.343 Sum_probs=203.6
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
++|++.+.||+|+||+||++... +|+.||+|++...........|.+|+++++.++||||+++++++.. ....++
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~l 80 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN----ENNICM 80 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec----CCEEEE
Confidence 45777889999999999999875 4899999998765544555679999999999999999999999876 457899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHh-cCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
||||+++++|.+++... ..+++..+..++.+++.||.|||+ .+ ++||||||+||++++++.++|+|||++....
T Consensus 81 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 81 CMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred EEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 99999999999998653 458999999999999999999997 45 9999999999999999999999999987543
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 462 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (632)
.. ......|+..|+|||++.+..++.++|||||||++|+|++|+.||............ ...+. ..+
T Consensus 156 ~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~---~~~~~---~~~ 222 (284)
T cd06620 156 NS-------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDD---PMGIL---DLL 222 (284)
T ss_pred hh-------ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhh---hhHHH---HHH
Confidence 22 122346899999999998889999999999999999999999999754332110000 00000 000
Q ss_pred cccCCCCCCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006750 463 SELPDPRLKGDFP-KEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 509 (632)
Q Consensus 463 ~~~~~~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 509 (632)
..+...... ..+ ...+..+.+|+.+||+.||++||++.|+++...-
T Consensus 223 ~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~ 269 (284)
T cd06620 223 QQIVQEPPP-RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269 (284)
T ss_pred HHHhhccCC-CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 111110000 111 1234558899999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=316.53 Aligned_cols=250 Identities=27% Similarity=0.443 Sum_probs=195.7
Q ss_pred ceeeeeCceEEEEEEECC-------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 231 NIVGQGGSSYVYRGQLTD-------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~-------g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
+.||+|+||.||+|...+ ++.+|||.+...........|.+|+.+++.++||||+++++++.. ....++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~~ 76 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL----NEPQYI 76 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC----CCCeEE
Confidence 368999999999998643 367999998765444455679999999999999999999998865 346799
Q ss_pred EEEeCCCCChhhhhhccc-----cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCC-----CeEEe
Q 006750 304 VFEFMPNGNLRDCLDGVL-----VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-----NAKIT 373 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~-----~vkL~ 373 (632)
||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ ++|+||||+||+++.++ .++|+
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~ 153 (269)
T cd05044 77 IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIG 153 (269)
T ss_pred EEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEEC
Confidence 999999999999996532 123889999999999999999999988 99999999999999877 89999
Q ss_pred ccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccc
Q 006750 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWAT 452 (632)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~ 452 (632)
|||+++........ .......++..|+|||++.++.++.++||||||+++|||++ |+.||........ ...
T Consensus 154 dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~---~~~-- 225 (269)
T cd05044 154 DFGLARDIYKSDYY---RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV---LQH-- 225 (269)
T ss_pred Cccccccccccccc---ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH---HHH--
Confidence 99999765433211 11122346788999999999999999999999999999998 9999864322110 000
Q ss_pred cccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 453 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 453 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
+.. ......+...+..+.+++.+||..+|.+||++.+|++.|.
T Consensus 226 ---------~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 226 ---------VTA----GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ---------Hhc----CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 000 0001122334456889999999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=318.54 Aligned_cols=267 Identities=26% Similarity=0.356 Sum_probs=206.1
Q ss_pred ecHHHHHHhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeee
Q 006750 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCS 292 (632)
Q Consensus 215 ~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~ 292 (632)
+.++.+..+.++|++.+.||+|+||.||++... +++.+|+|++.... .....+.+|+.+++++ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 344667778899999999999999999999875 48899999886432 2234588999999999 7999999999885
Q ss_pred ccc-CCcceEEEEEEeCCCCChhhhhhcc--ccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCC
Q 006750 293 EFR-GKRAMRLLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN 369 (632)
Q Consensus 293 ~~~-~~~~~~~lV~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 369 (632)
... ......++||||+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGG 162 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCC
Confidence 432 2345789999999999999988642 2245889999999999999999999998 999999999999999999
Q ss_pred eEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhc-----CCCCcccchHhHhHHHHHHHhCCCCCCCcccccc
Q 006750 370 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 444 (632)
Q Consensus 370 vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~ 444 (632)
++|+|||+++....... ......|++.|+|||++.. ..++.++|||||||++|||++|+.||........
T Consensus 163 ~kl~dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~ 237 (286)
T cd06638 163 VKLVDFGVSAQLTSTRL-----RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA 237 (286)
T ss_pred EEEccCCceeecccCCC-----ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH
Confidence 99999999887643221 1223468999999998753 4578899999999999999999999864322111
Q ss_pred chheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006750 445 ESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507 (632)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 507 (632)
.. . ......+.+. .+......+.+|+.+||+.||++|||+.++++.+
T Consensus 238 ~~--~------------~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 238 LF--K------------IPRNPPPTLH--QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred Hh--h------------ccccCCCccc--CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00 0 0000001110 1111234588999999999999999999998754
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=329.01 Aligned_cols=270 Identities=20% Similarity=0.263 Sum_probs=198.9
Q ss_pred hhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccC--Cc
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KR 298 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~--~~ 298 (632)
..++|...+.||+|+||.||++... .++.||||++..... ......+.+|+.+++.++||||+++++++..... ..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999865 488999999975432 2334568899999999999999999998864321 22
Q ss_pred ceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccc
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 378 (632)
...|+||||++ ++|.+++.. .+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 95 ~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 95 QDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred ceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCccc
Confidence 45799999995 577776643 3889999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec--cc----
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--AT---- 452 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~---- 452 (632)
+..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.............. ..
T Consensus 167 ~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (355)
T cd07874 167 RTAGTS------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_pred ccCCCc------cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 865332 122345689999999999998999999999999999999999999965432111000000 00
Q ss_pred ------cccc---cccccccccCCCC------C--CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 453 ------PRLQ---DSGTVISELPDPR------L--KGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 453 ------~~~~---~~~~~~~~~~~~~------l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
+... ........+..+. . ....+......+.+|+.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000 0000000000000 0 001112234557899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=313.50 Aligned_cols=248 Identities=23% Similarity=0.363 Sum_probs=208.4
Q ss_pred ccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEE
Q 006750 227 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 305 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~ 305 (632)
|.++.+||+|+||.||+|.++. |++||||.+.... ..+++..|+.+|++...|++|+++|.+.. ...+|+||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s---DLQEIIKEISIMQQC~S~yVVKYYGSYFK----~sDLWIVM 107 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT---DLQEIIKEISIMQQCKSKYVVKYYGSYFK----HSDLWIVM 107 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc---hHHHHHHHHHHHHHcCCchhhhhhhhhcc----CCceEeeh
Confidence 6667889999999999998764 9999999987653 34458899999999999999999998765 55789999
Q ss_pred EeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCC
Q 006750 306 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 385 (632)
Q Consensus 306 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 385 (632)
|||..|++.+.++.+ .+++++.++..++...++||+|||... -+|||||+.||||+.+|.+||+|||.|-.+.+..
T Consensus 108 EYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 108 EYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred hhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 999999999999764 367999999999999999999999987 8999999999999999999999999998765432
Q ss_pred CCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccccccc
Q 006750 386 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 465 (632)
Q Consensus 386 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (632)
....++.||+.|||||++..-.|..++||||||++..||..|++||..--+-.. . -.+..-
T Consensus 184 -----AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA-------I-------FMIPT~ 244 (502)
T KOG0574|consen 184 -----AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA-------I-------FMIPTK 244 (502)
T ss_pred -----HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce-------e-------EeccCC
Confidence 344567899999999999999999999999999999999999999854221100 0 011122
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 466 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 466 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
+.|.+ ..|+..+..+.++++.||-++|++|-|+.++++.
T Consensus 245 PPPTF--~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 245 PPPTF--KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCCC--CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 23333 3477888899999999999999999999998874
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=328.55 Aligned_cols=242 Identities=22% Similarity=0.273 Sum_probs=187.4
Q ss_pred ceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHH-HHHhcCCCCccceeeeeecccCCcceEEEEEE
Q 006750 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVD-MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~f~~Ei~-~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~E 306 (632)
+.||+|+||.||+|+.. +++.||+|++..... ......+..|.. +++.++||||+++++++.. ....|+|||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~----~~~~~lv~e 76 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT----ADKLYFVLD 76 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc----CCeEEEEEe
Confidence 36999999999999876 478899999875321 122233444544 5678899999999988875 457899999
Q ss_pred eCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCC
Q 006750 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (632)
Q Consensus 307 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 386 (632)
|+++|+|.+++... ..+.+..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 77 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~- 150 (325)
T cd05602 77 YINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN- 150 (325)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC-
Confidence 99999999998753 44788889999999999999999998 9999999999999999999999999997543211
Q ss_pred CCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccC
Q 006750 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 466 (632)
Q Consensus 387 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (632)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .+.
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-----------------~i~ 209 (325)
T cd05602 151 ----GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD-----------------NIL 209 (325)
T ss_pred ----CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHH-----------------HHH
Confidence 12334569999999999999999999999999999999999999996433221100 000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 467 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 467 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.... ..+...+..+.+++.+||+.||.+||++.+.+.
T Consensus 210 ~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 210 NKPL--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred hCCc--CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 0000 112223345889999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=316.38 Aligned_cols=256 Identities=25% Similarity=0.401 Sum_probs=201.0
Q ss_pred cCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 298 (632)
.+|.+.+.||+|+||.||+|+.+ +.+.|++|.+...........|.+|++++++++|+||+++++++.+ .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~ 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE----A 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC----C
Confidence 46788899999999999999864 2467999998765443345679999999999999999999998865 3
Q ss_pred ceEEEEEEeCCCCChhhhhhcccc-------CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeE
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVLV-------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAK 371 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vk 371 (632)
...++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~ 157 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVK 157 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEE
Confidence 467999999999999999975431 15899999999999999999999998 99999999999999999999
Q ss_pred EeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheec
Q 006750 372 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLW 450 (632)
Q Consensus 372 L~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~ 450 (632)
|+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||........ ..
T Consensus 158 l~~~~~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~---~~- 229 (275)
T cd05046 158 VSLLSLSKDVYNSEY----YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV---LN- 229 (275)
T ss_pred EcccccccccCcccc----cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH---HH-
Confidence 999999875432211 12223356788999999988889999999999999999999 7888854322110 00
Q ss_pred cccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 451 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 451 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
......+....+...+..+.+++.+||+.+|.+||++.++++.|.
T Consensus 230 -------------~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 230 -------------RLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -------------HHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 000000111112223345889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=312.20 Aligned_cols=251 Identities=27% Similarity=0.446 Sum_probs=198.7
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV 304 (632)
.+|+..+.||+|+||.||+|.+.++..+|+|++..... ....|.+|++++++++|||++++++++.. ....++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCTE----RSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC--CHHHHHHHHHHHHhCCCCCeeeEEEEEcc----CCceEEE
Confidence 35777889999999999999987788999999875432 23458999999999999999999998765 4467999
Q ss_pred EEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccC
Q 006750 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 384 (632)
|||+++++|.+++.... ..+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++.....
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 78 FEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 99999999999987543 34899999999999999999999998 999999999999999999999999998765432
Q ss_pred CCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccccccccc
Q 006750 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463 (632)
Q Consensus 385 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (632)
.. .......++..|+|||++.++.++.++||||||+++|||++ |+.||.......... .+.
T Consensus 154 ~~----~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~--------------~~~ 215 (256)
T cd05112 154 QY----TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVE--------------TIN 215 (256)
T ss_pred cc----cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH--------------HHh
Confidence 11 11122335678999999998899999999999999999998 999986432211000 000
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006750 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507 (632)
Q Consensus 464 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 507 (632)
+.... ..+...+..+.+|+.+||+.+|++||++.++++.|
T Consensus 216 ~~~~~----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 216 AGFRL----YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCC----CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 00000 01111234588999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=314.21 Aligned_cols=249 Identities=23% Similarity=0.333 Sum_probs=203.0
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV 304 (632)
.|+..+.||.|+||.||+|.+. ++..||||.+...........+.+|+.+++++.||||+++++++.. ....++|
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv 80 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK----GTKLWII 80 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE----CCEEEEE
Confidence 4666788999999999999875 4889999998765444445668999999999999999999999876 4578999
Q ss_pred EEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccC
Q 006750 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 384 (632)
|||+++|+|.+++.. ..+++.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 81 MEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred EecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 999999999999864 35889999999999999999999998 999999999999999999999999999776433
Q ss_pred CCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccc
Q 006750 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 464 (632)
Q Consensus 385 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (632)
.. ......++..|+|||++.+..++.++||||||+++|||++|..||..........
T Consensus 155 ~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------------------ 211 (277)
T cd06640 155 QI-----KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF------------------ 211 (277)
T ss_pred cc-----ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh------------------
Confidence 21 1223458889999999998889999999999999999999999986433211000
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006750 465 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507 (632)
Q Consensus 465 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 507 (632)
..........+...+..+.+++.+||+.+|++||++.++++.-
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06640 212 LIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK 254 (277)
T ss_pred hhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence 0001111223445566789999999999999999999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=311.13 Aligned_cols=249 Identities=29% Similarity=0.456 Sum_probs=197.9
Q ss_pred ceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEeCCC
Q 006750 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 310 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey~~~ 310 (632)
++||.|+||.||++.+.+++.||+|++...........|.+|++++++++|+||+++++++.. ....++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ----KQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec----CCCeEEEEEcCCC
Confidence 368999999999999877999999998765444345569999999999999999999998875 4567999999999
Q ss_pred CChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCCCCCC
Q 006750 311 GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 390 (632)
Q Consensus 311 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 390 (632)
++|.+++.... ..+++..++.++.+++.||+|||+++ ++||||||+|||++.++.++|+|||++.........
T Consensus 77 ~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~--- 149 (251)
T cd05041 77 GSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT--- 149 (251)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcce---
Confidence 99999996542 35899999999999999999999998 999999999999999999999999999765422111
Q ss_pred CCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccccccccccCCCC
Q 006750 391 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 469 (632)
Q Consensus 391 ~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (632)
.......++..|+|||++.++.++.++||||||+++|||++ |..||........... +.. .
T Consensus 150 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~--------------~~~----~ 211 (251)
T cd05041 150 VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER--------------IES----G 211 (251)
T ss_pred eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH--------------Hhc----C
Confidence 11112234667999999998899999999999999999999 7888854432111100 000 0
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 470 LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 470 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
.....+...+..+.+++.+||..+|++||++.+|++.|.
T Consensus 212 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 212 YRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 011122333456899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=327.85 Aligned_cols=270 Identities=23% Similarity=0.272 Sum_probs=197.7
Q ss_pred hhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccC--Cc
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KR 298 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~--~~ 298 (632)
..++|...+.||+|+||.||++... +|+.||||++.... .......+.+|+.+++.++||||+++++++..... ..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999875 48999999997542 22334558899999999999999999998864321 12
Q ss_pred ceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccc
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 378 (632)
...|+||||++ ++|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCc
Confidence 35799999996 567666642 3788999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe--eccccc--
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV--LWATPR-- 454 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~--~~~~~~-- 454 (632)
+..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||............ ....+.
T Consensus 171 ~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 244 (359)
T cd07876 171 RTACTN------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAE 244 (359)
T ss_pred cccccC------ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHH
Confidence 764322 1223356899999999999999999999999999999999999999754321100000 000000
Q ss_pred ----------------cccccccccccCCCCC---CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 455 ----------------LQDSGTVISELPDPRL---KGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 455 ----------------~~~~~~~~~~~~~~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
....+....+...... ....+......+.+|+.+||..||++|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000000000000 000111223458899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=322.36 Aligned_cols=260 Identities=27% Similarity=0.441 Sum_probs=201.9
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCc----EEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~----~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
.+|+..+.||+|+||.||+|.+. +|. .||+|.+...........+.+|+.+++.++||||++++|++.. .
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----~ 81 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-----P 81 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-----C
Confidence 45677889999999999999864 343 5799988765444444568999999999999999999998864 2
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..++++||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccc
Confidence 3579999999999999987542 35899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
........ .......++..|+|||++.+..++.++||||||+++|||++ |+.||............
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~---------- 224 (303)
T cd05110 158 LLEGDEKE---YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL---------- 224 (303)
T ss_pred cccCcccc---cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----------
Confidence 76432211 11122345778999999998999999999999999999997 89998643221111100
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 514 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 514 (632)
...... ..+...+..+..++..||..+|++||++.++++.|..+..+.
T Consensus 225 ----~~~~~~----~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 225 ----EKGERL----PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred ----HCCCCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 000000 011122345788999999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=327.07 Aligned_cols=254 Identities=24% Similarity=0.293 Sum_probs=210.5
Q ss_pred hhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCC--hHHHHHHHHHHHHhcC-CCCccceeeeeecccCCc
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~--~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~ 298 (632)
....|.+.+.||+|.||.||+++.+. |+.+|+|.+....... ....+.+|+.+|++|. |||||.+.+++.. .
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~----~ 108 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED----P 108 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc----C
Confidence 34567888999999999999999876 9999999998664432 3456899999999997 9999999999986 5
Q ss_pred ceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCC----CCeEEec
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN----LNAKITD 374 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~----~~vkL~D 374 (632)
...++|||++.||.|.+.+... .+++..+..++.|++.+++|||+.+ |+||||||+|+|+... +.+|++|
T Consensus 109 ~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 109 DSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred CeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEee
Confidence 5789999999999999999765 3999999999999999999999998 9999999999999533 5799999
Q ss_pred cccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccc
Q 006750 375 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 454 (632)
Q Consensus 375 FGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~ 454 (632)
||++...... ......+||+.|+|||++....|+..+||||+||++|.|++|..||...........+...
T Consensus 183 FGla~~~~~~------~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~--- 253 (382)
T KOG0032|consen 183 FGLAKFIKPG------ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG--- 253 (382)
T ss_pred CCCceEccCC------ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC---
Confidence 9999987652 3455678999999999999999999999999999999999999999765433221111100
Q ss_pred cccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006750 455 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507 (632)
Q Consensus 455 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 507 (632)
+..+..+.....+..+.++++.++..||..|+|+.++++.-
T Consensus 254 ------------~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~Hp 294 (382)
T KOG0032|consen 254 ------------DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHP 294 (382)
T ss_pred ------------CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCc
Confidence 01122233344566789999999999999999999999953
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=336.12 Aligned_cols=264 Identities=21% Similarity=0.258 Sum_probs=195.0
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
..+|.+.+.||+|+||.||++.+.. ++.||||..... .+.+|+++|++|+|+||+++++++.. ....+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~-------~~~~E~~iL~~L~HpnIv~l~~~~~~----~~~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYA-------SSVHEARLLRRLSHPAVLALLDVRVV----GGLTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccccc-------CHHHHHHHHHHCCCCCCCcEEEEEEE----CCEEE
Confidence 4579999999999999999998765 889999964321 26789999999999999999998875 45679
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+|||++ .++|.+++.... ..++|.+++.|+.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 237 lv~e~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 237 LVLPKY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFAR 311 (461)
T ss_pred EEEEcc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence 999999 579999886532 35999999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCcccccc--------chheeccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE--------ESLVLWATPR 454 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~--------~~~~~~~~~~ 454 (632)
..... .......||+.|+|||++.+..++.++|||||||+||||++|..|+........ .....+....
T Consensus 312 ~~~~~---~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~ 388 (461)
T PHA03211 312 GSWST---PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVH 388 (461)
T ss_pred ccccc---ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccc
Confidence 32211 112345699999999999999999999999999999999998876643221100 0000100000
Q ss_pred ccccc-----cccc-------ccCCCCCC-CCCC--HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 455 LQDSG-----TVIS-------ELPDPRLK-GDFP--KEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 455 ~~~~~-----~~~~-------~~~~~~l~-~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
..... .... ....+... .... ......+.+|+.+||+.||.+|||+.|+++.
T Consensus 389 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 389 VDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 0000 00000000 0000 0122357889999999999999999999875
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=331.32 Aligned_cols=271 Identities=24% Similarity=0.291 Sum_probs=197.6
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCC-cceEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK-RAMRL 302 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~-~~~~~ 302 (632)
+|++.+.||+|+||.||++... +|+.||||++.... .......+.+|+.+|+.++||||+++++++...... ....|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999874 58999999986532 222345688999999999999999999998753311 12679
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||+. ++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999995 6888887543 45899999999999999999999998 9999999999999999999999999998754
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec--cccccccc-
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATPRLQDS- 458 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~~~~~~- 458 (632)
.... .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.............. ..+.....
T Consensus 155 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 155 PDES----KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR 230 (372)
T ss_pred cCcc----ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 3221 122334688999999998874 479999999999999999999999975432211100000 00000000
Q ss_pred -------cccccccCCC-CCC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 459 -------GTVISELPDP-RLK--GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 459 -------~~~~~~~~~~-~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.........+ ... ..........+.+|+.+||+.||.+|||+.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000 000 01112224458899999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=312.47 Aligned_cols=246 Identities=28% Similarity=0.415 Sum_probs=197.3
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV 304 (632)
++|++.+.||+|+||.||++.. .++.||+|.++... ....+.+|+.++++++|||++++++++.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILH-----NGLYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-----CCcEEE
Confidence 4578889999999999999985 57889999986532 33468999999999999999999998754 235899
Q ss_pred EEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccC
Q 006750 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 384 (632)
|||+++++|.+++.......+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 99999999999997655556899999999999999999999988 999999999999999999999999998764321
Q ss_pred CCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccccccccc
Q 006750 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463 (632)
Q Consensus 385 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (632)
......+..|+|||++.++.++.++||||||+++|||++ |+.||........... +.
T Consensus 154 --------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~--------------~~ 211 (254)
T cd05083 154 --------VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC--------------VE 211 (254)
T ss_pred --------CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH--------------Hh
Confidence 112234578999999998899999999999999999998 9999864432111000 00
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 464 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
....+ ..+...+..+.+++.+||+.+|+.||++.++++.|.
T Consensus 212 ~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 212 KGYRM----EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CCCCC----CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 00011 112223345889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=311.59 Aligned_cols=268 Identities=24% Similarity=0.306 Sum_probs=219.6
Q ss_pred cHHHHHHhhcCccccceeeeeCceEEEEEEECC------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceee
Q 006750 216 SYSALEHATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289 (632)
Q Consensus 216 ~~~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g 289 (632)
...+|..-..+++...++-+|.||.||.|.|.+ .+.|-||.++..+.+-....|+.|--++..+.|||+..+.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 345667777888888999999999999997653 46788999998887777778999999999999999999999
Q ss_pred eeecccCCcceEEEEEEeCCCCChhhhhhc------cccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeE
Q 006750 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDG------VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNIL 363 (632)
Q Consensus 290 ~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NIL 363 (632)
++.+. ....+++|.++.-|+|..||.. ...+.++-.+.+.++.|++.||+|||+++ |||.||.++|++
T Consensus 355 V~ie~---~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCv 428 (563)
T KOG1024|consen 355 VSIED---YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCV 428 (563)
T ss_pred EEeec---cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcce
Confidence 99873 4467999999999999999972 22344788899999999999999999999 999999999999
Q ss_pred ecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCcccc
Q 006750 364 LDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITK 442 (632)
Q Consensus 364 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~ 442 (632)
||+..++||+|=.|+|.+.+.++..-.... ..+..||+||.+....|+..+|||||||+||||+| |+.|+..-++.
T Consensus 429 Idd~LqVkltDsaLSRDLFP~DYhcLGDnE---nRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf 505 (563)
T KOG1024|consen 429 IDDQLQVKLTDSALSRDLFPGDYHCLGDNE---NRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF 505 (563)
T ss_pred ehhheeEEeccchhccccCcccccccCCCC---CCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH
Confidence 999999999999999988776654332222 24678999999999999999999999999999999 89998644332
Q ss_pred ccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 443 GEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 443 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
+... .. ....+...|-++++++..+|..||..+|++||+++|++.-|.+.
T Consensus 506 Em~~-yl-----------------kdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 506 EMEH-YL-----------------KDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred HHHH-HH-----------------hccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 2111 00 11111123455666699999999999999999999999998765
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=309.75 Aligned_cols=249 Identities=26% Similarity=0.403 Sum_probs=202.0
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
++|+..+.||.|+||.||+|.+.+ ++.+|+|.+..... ...+.+|++++++++||||+++++++.. ....|+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~----~~~~~l 75 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFK----NTDLWI 75 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeec----CCcEEE
Confidence 578888999999999999999875 88999999875432 5569999999999999999999999876 457899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
+|||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 76 ~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 76 VMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred EEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 999999999999986532 45899999999999999999999998 99999999999999999999999999887643
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (632)
.. .......|+..|+|||++.+..++.++||||||+++|+|++|+.||........... +.
T Consensus 152 ~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~--------------~~ 212 (256)
T cd06612 152 TM-----AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM--------------IP 212 (256)
T ss_pred Cc-----cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh--------------hc
Confidence 21 112234588999999999988999999999999999999999999864322111000 00
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 464 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
....+.+ ..+......+.+++.+||+.||++|||+.+|++
T Consensus 213 ~~~~~~~--~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 213 NKPPPTL--SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred cCCCCCC--CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 0000111 122334456889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=315.98 Aligned_cols=274 Identities=26% Similarity=0.362 Sum_probs=205.6
Q ss_pred CccccceeeeeCceEEEEEEEC-----CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-----~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
.|...+.||+|+||.||+|.+. ++..||||+++..........|.+|+++++.++||||+++++++.... ...
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~--~~~ 82 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPG--GRS 82 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCC--CCc
Confidence 4666789999999999999864 368999999986544334567999999999999999999999876532 346
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 799999999999999997643 34899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
........ .......++..|+|||.+....++.++||||||+++|||++|+.|+................ .....
T Consensus 159 ~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~---~~~~~ 233 (284)
T cd05038 159 LPEDKDYY--YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQG---QMIVT 233 (284)
T ss_pred cccCCcce--eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccc---cccHH
Confidence 65322110 11112345667999999998899999999999999999999999986432211100000000 00000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
.+.+..........+..++..+.+|+.+||+.+|++||++.+|++.|..+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 234 RLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 00111111111122233345688999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=332.54 Aligned_cols=207 Identities=24% Similarity=0.372 Sum_probs=173.4
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|+..+.||+|+||.||++... +++.||||+++... .......+.+|+.++..++||||+++++++.. ....
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~----~~~~ 76 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD----KRNL 76 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCEE
Confidence 46888899999999999999876 48999999997432 22334558889999999999999999988875 5578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.++|+|||+++..
T Consensus 77 ~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~ 151 (360)
T cd05627 77 YLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGL 151 (360)
T ss_pred EEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence 9999999999999998753 45899999999999999999999998 999999999999999999999999998755
Q ss_pred ccCCCCC------------------------------CCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh
Q 006750 382 KADGLPS------------------------------CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 431 (632)
Q Consensus 382 ~~~~~~~------------------------------~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt 431 (632)
....... .........||+.|+|||++.+..++.++|||||||++|||++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~t 231 (360)
T cd05627 152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231 (360)
T ss_pred ccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeeccc
Confidence 3211000 0001123579999999999999999999999999999999999
Q ss_pred CCCCCCCcc
Q 006750 432 GRQPIHRSI 440 (632)
Q Consensus 432 G~~P~~~~~ 440 (632)
|+.||....
T Consensus 232 G~~Pf~~~~ 240 (360)
T cd05627 232 GYPPFCSET 240 (360)
T ss_pred CCCCCCCCC
Confidence 999997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=312.74 Aligned_cols=257 Identities=25% Similarity=0.384 Sum_probs=199.8
Q ss_pred HHHhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCc
Q 006750 220 LEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 220 l~~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 298 (632)
++.+++++.....||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+.++++++|+||+++++++.. .
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~ 77 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSE----N 77 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeecc----C
Confidence 4556777777789999999999999865 47889999887543 2334568999999999999999999999875 4
Q ss_pred ceEEEEEEeCCCCChhhhhhccccCCC--CHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC-CCCeEEecc
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVLVEGM--NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKITDL 375 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~-~~~vkL~DF 375 (632)
...++||||+++++|.+++.... ..+ ++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.++|+||
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~df 153 (268)
T cd06624 78 GFFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDF 153 (268)
T ss_pred CEEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecc
Confidence 57899999999999999997532 234 88889999999999999999998 999999999999976 678999999
Q ss_pred ccceecccCCCCCCCCCCCccccCCCCCChhhhhcCC--CCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccc
Q 006750 376 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR--ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 453 (632)
Q Consensus 376 Gla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~--~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~ 453 (632)
|++........ ......|++.|+|||++.... ++.++||||||+++|+|++|+.||........ ..+..
T Consensus 154 g~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~- 224 (268)
T cd06624 154 GTSKRLAGINP-----CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKV- 224 (268)
T ss_pred hhheecccCCC-----ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhh-
Confidence 99876543211 122345889999999986543 78999999999999999999999864321110 00000
Q ss_pred ccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 454 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 454 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
........++......+.+++.+||+.+|.+|||+.++++.
T Consensus 225 ------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 225 ------------GMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ------------hhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00001112333444558899999999999999999999763
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=309.73 Aligned_cols=253 Identities=25% Similarity=0.455 Sum_probs=199.7
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC--------hHHHHHHHHHHHHhcCCCCccceeeeeecccC
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN--------ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 296 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~--------~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 296 (632)
+|.+...||+|+||.||+|... +++.||+|.+....... ..+.+.+|+.++++++||||+++++++.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 77 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--- 77 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Confidence 3677789999999999999865 48899999886543221 12458899999999999999999998876
Q ss_pred CcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccc
Q 006750 297 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 376 (632)
Q Consensus 297 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFG 376 (632)
....++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||
T Consensus 78 -~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg 151 (267)
T cd06628 78 -ADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFG 151 (267)
T ss_pred -CCccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccC
Confidence 45779999999999999999754 45899999999999999999999998 9999999999999999999999999
Q ss_pred cceecccCCCCC-CCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccc
Q 006750 377 MAKRLKADGLPS-CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL 455 (632)
Q Consensus 377 la~~~~~~~~~~-~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~ 455 (632)
+++......... .........|+..|+|||.+.+..++.++||||||+++|+|++|+.||..........
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--------- 222 (267)
T cd06628 152 ISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF--------- 222 (267)
T ss_pred CCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH---------
Confidence 998775322111 1111223568899999999998889999999999999999999999996432211000
Q ss_pred ccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 456 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 456 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.+.....+. .+...+..+.+++.+||+.||.+||++.+|++
T Consensus 223 -----~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 223 -----KIGENASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -----HHhccCCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 001111122 22333455889999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=337.31 Aligned_cols=271 Identities=17% Similarity=0.198 Sum_probs=195.5
Q ss_pred cHHHHHHhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCC------Ccccee
Q 006750 216 SYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC------HVVPLV 288 (632)
Q Consensus 216 ~~~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hp------niv~l~ 288 (632)
..+++...+++|.+.+.||+|+||+||+|.+. .++.||||+++... .....+..|+.++..++|. ++++++
T Consensus 120 ~~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~ 197 (467)
T PTZ00284 120 LGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQ 197 (467)
T ss_pred cCCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence 34456667889999999999999999999875 48899999996432 2233466788888777654 478888
Q ss_pred eeeecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHh-cCCCceeecCCCCCCeEecCC
Q 006750 289 GYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDEN 367 (632)
Q Consensus 289 g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDLKp~NILl~~~ 367 (632)
+++... ....++|||++ +++|.+++... ..+++..+..|+.||+.||+|||+ .+ |+||||||+||||+.+
T Consensus 198 ~~~~~~---~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~ 268 (467)
T PTZ00284 198 RYFQNE---TGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETS 268 (467)
T ss_pred EEEEcC---CceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecC
Confidence 877642 34679999998 78999988653 458999999999999999999997 47 9999999999999876
Q ss_pred C----------------CeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh
Q 006750 368 L----------------NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 431 (632)
Q Consensus 368 ~----------------~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt 431 (632)
+ .+||+|||++..... ......||+.|+|||++.+..++.++|||||||+||||++
T Consensus 269 ~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~--------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ellt 340 (467)
T PTZ00284 269 DTVVDPVTNRALPPDPCRVRICDLGGCCDERH--------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYT 340 (467)
T ss_pred CcccccccccccCCCCceEEECCCCccccCcc--------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHh
Confidence 5 499999998754321 2234679999999999999999999999999999999999
Q ss_pred CCCCCCCccccccchheeccccccccc----------ccccccc--CCCCCC--------C--CC-CHHHHHHHHHHHHH
Q 006750 432 GRQPIHRSITKGEESLVLWATPRLQDS----------GTVISEL--PDPRLK--------G--DF-PKEEMQIMAYLAKE 488 (632)
Q Consensus 432 G~~P~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~--~~~~l~--------~--~~-~~~~~~~l~~li~~ 488 (632)
|+.||..................+... ....... ..+... . .. .......+.+|+.+
T Consensus 341 G~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 420 (467)
T PTZ00284 341 GKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYG 420 (467)
T ss_pred CCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHH
Confidence 999997543221111100000000000 0000000 000000 0 00 00112457799999
Q ss_pred hcccCCCCCCCHHHHHH
Q 006750 489 CLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 489 cl~~dP~~RPs~~evl~ 505 (632)
||+.||.+|||+.|+++
T Consensus 421 mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 421 LLHYDRQKRLNARQMTT 437 (467)
T ss_pred hCCcChhhCCCHHHHhc
Confidence 99999999999999997
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=309.74 Aligned_cols=259 Identities=27% Similarity=0.393 Sum_probs=205.0
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
++|++.+.||.|+||+||+|... ++..+|+|++...........+.+|+++++.++|+||+++++.+.. ....++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~i 76 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV----GDELWL 76 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee----CCEEEE
Confidence 46888999999999999999865 5889999999765444455679999999999999999999998765 457899
Q ss_pred EEEeCCCCChhhhhhcccc-CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 304 VFEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
||||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||+|+||++++++.++|+|||++....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~ 153 (267)
T cd06610 77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLA 153 (267)
T ss_pred EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhc
Confidence 9999999999999976433 45899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
...... ........|+..|+|||++... .++.++||||||+++|||++|+.||.......... ..
T Consensus 154 ~~~~~~-~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~--~~----------- 219 (267)
T cd06610 154 DGGDRT-RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLM--LT----------- 219 (267)
T ss_pred cCcccc-ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHH--HH-----------
Confidence 432211 0122345689999999998877 78999999999999999999999996443211000 00
Q ss_pred ccccCCCCCCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 462 ISELPDPRLKGDF-PKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 462 ~~~~~~~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.. ...+.+.... ....+..+.+++.+||..||++||++.+|++
T Consensus 220 ~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 220 LQ-NDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred hc-CCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00 0111111111 1233455889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=327.72 Aligned_cols=270 Identities=21% Similarity=0.264 Sum_probs=198.6
Q ss_pred hhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeeccc--CCc
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR--GKR 298 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~--~~~ 298 (632)
..++|...+.||+|+||.||++... .++.||||++.... .......+.+|+.+++.++||||+++++++.... ...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3578999999999999999999865 48899999997542 2233455889999999999999999999875432 123
Q ss_pred ceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccc
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 378 (632)
...|+||||++ ++|.+++.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 45799999995 578777743 3789999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec--ccc---
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATP--- 453 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~--- 453 (632)
+...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||.............. ..+
T Consensus 174 ~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (364)
T cd07875 174 RTAGTSF------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE 247 (364)
T ss_pred cccCCCC------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 7654321 22345689999999999999999999999999999999999999965432111000000 000
Q ss_pred ---ccc--------c----ccccccccCCCCC---CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 454 ---RLQ--------D----SGTVISELPDPRL---KGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 454 ---~~~--------~----~~~~~~~~~~~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+. . .......+....+ ...........+.+|+.+||+.||.+|||+.++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 0 0000000000000 001111123457899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=326.04 Aligned_cols=238 Identities=23% Similarity=0.274 Sum_probs=185.8
Q ss_pred ceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHH-HHHhcCCCCccceeeeeecccCCcceEEEEEE
Q 006750 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVD-MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~-~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~E 306 (632)
+.||+|+||.||+|+.. +|+.||+|++.... .......+..|.. +++.++||||+++++++.. ....|+|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~----~~~~~lv~e 76 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT----AEKLYFVLD 76 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc----CCEEEEEEc
Confidence 36999999999999875 48999999987432 1222334555554 6788899999999988765 457899999
Q ss_pred eCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCC
Q 006750 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (632)
Q Consensus 307 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 386 (632)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 77 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 150 (321)
T cd05603 77 YVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE- 150 (321)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-
Confidence 99999999888653 45889999999999999999999998 9999999999999999999999999987532211
Q ss_pred CCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccC
Q 006750 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 466 (632)
Q Consensus 387 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (632)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .+.
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-----------------~i~ 209 (321)
T cd05603 151 ----ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD-----------------NIL 209 (321)
T ss_pred ----CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHH-----------------HHh
Confidence 12334569999999999998899999999999999999999999996543211000 000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 006750 467 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS 501 (632)
Q Consensus 467 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 501 (632)
... ..++......+.+++.+||+.||.+||+..
T Consensus 210 ~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 210 HKP--LQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred cCC--CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 000 012233345588999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=315.49 Aligned_cols=270 Identities=25% Similarity=0.325 Sum_probs=202.0
Q ss_pred ccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCC-cceEEEE
Q 006750 227 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK-RAMRLLV 304 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~-~~~~~lV 304 (632)
|...+++|.|+||.||+|.+.. ++.||||+.-.+..- -.+|+++|+.+.|||||+|+-++....+. .-+..+|
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4556899999999999999764 799999998765432 24799999999999999999888765554 3466799
Q ss_pred EEeCCCCChhhhhhcc--ccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCC-CCeEEeccccceec
Q 006750 305 FEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKITDLGMAKRL 381 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~-~~vkL~DFGla~~~ 381 (632)
||||+ .+|.++++.. ..+.++...+.-+..|+.+||+|||+.+ |+||||||.|+|+|.+ |.+||+|||.|+.+
T Consensus 101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 99996 5999999742 2355888888999999999999999988 9999999999999976 88999999999988
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccch--heeccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES--LVLWATPRLQDS 458 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~--~~~~~~~~~~~~ 458 (632)
..+. ......-|..|.|||.+.+ ..|+.+.||||.||++.||+-|++-|.+.....+.. ......|..++.
T Consensus 177 ~~~e------pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 177 VKGE------PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred ccCC------CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 7542 3345667899999999987 569999999999999999999999987644332211 111122221111
Q ss_pred cc---cccccCCCCCCC-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhhhC
Q 006750 459 GT---VISELPDPRLKG-----DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ--ILSTIA 511 (632)
Q Consensus 459 ~~---~~~~~~~~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~i~ 511 (632)
.. ...+...|.+.. -+......+..+|+.++|..+|.+|.++.|++. .++.+.
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 00 000111122111 122334455889999999999999999999985 344443
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=319.04 Aligned_cols=265 Identities=23% Similarity=0.364 Sum_probs=199.0
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
++|...+.||+|+||.||+|... +++.||+|.++..........+.+|+.++++++||||+++++++.. ....++
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~----~~~~~l 81 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT----EKSLTL 81 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec----CCeEEE
Confidence 46888899999999999999875 4889999998765444444557899999999999999999999875 457899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||++ ++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+|||+++++.++|+|||++.....
T Consensus 82 v~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 82 VFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred EEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 999996 6999988654 245899999999999999999999998 99999999999999999999999999876432
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchh----------eeccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL----------VLWAT 452 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~----------~~~~~ 452 (632)
.. .......+++.|+|||++.+ ..++.++||||||+++|||++|+.||........... ..|..
T Consensus 157 ~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (301)
T cd07873 157 PT-----KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 231 (301)
T ss_pred CC-----CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchh
Confidence 21 11223457899999998875 4578999999999999999999999975432211100 00000
Q ss_pred cccccccccccccCCCCCCCC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 453 PRLQDSGTVISELPDPRLKGD----FPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 453 ~~~~~~~~~~~~~~~~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
... .........+..... .....+..+.+|+.+||+.||.+|||+.++++.
T Consensus 232 --~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 232 --ILS-NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred --hhc-cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000 000000001111111 111234457899999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=313.00 Aligned_cols=253 Identities=24% Similarity=0.340 Sum_probs=188.2
Q ss_pred eeeeeCceEEEEEEECCC---cEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEeC
Q 006750 232 IVGQGGSSYVYRGQLTDG---RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 308 (632)
Q Consensus 232 ~LG~G~fG~Vy~~~~~~g---~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey~ 308 (632)
.||+|+||.||+|...++ ..+++|.+...........|.+|+.+++.++||||+++++++.. ....|+||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~----~~~~~lv~e~~ 77 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE----AIPYLLVFEYC 77 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC----CCccEEEEecC
Confidence 599999999999975443 35667777655444455679999999999999999999999875 44679999999
Q ss_pred CCCChhhhhhccc--cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCC
Q 006750 309 PNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (632)
Q Consensus 309 ~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 386 (632)
++|+|.+++++.. ...+++..+..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchh
Confidence 9999999997532 234677788899999999999999998 99999999999999999999999999864322111
Q ss_pred CCCCCCCCccccCCCCCChhhhhc-------CCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccc
Q 006750 387 PSCSSSPARMQGTFGYFAPEYAMV-------GRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 387 ~~~~~~~~~~~GT~~Y~APE~~~~-------~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
. .......|+..|+|||++.. ..++.++||||||+++|||++ |..||............ +.
T Consensus 155 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~------~~-- 223 (268)
T cd05086 155 I---ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV------IK-- 223 (268)
T ss_pred h---hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------Hh--
Confidence 0 11223457899999998753 245789999999999999997 56677543221110000 00
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
.....+.++.+...+. ..+.+++..|| .+|++||++.+|++.|.
T Consensus 224 -~~~~~~~~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 224 -DQQVKLFKPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred -hcccccCCCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 0011223333333333 34777889999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=309.61 Aligned_cols=255 Identities=26% Similarity=0.430 Sum_probs=200.2
Q ss_pred CccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCC-----ChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGP-----NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~-----~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
+|...+.||+|+||.||+|...+++.+|||.+...... .....+.+|++++++++|+||+++++++.+ ...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~ 76 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD----DNT 76 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec----CCe
Confidence 47778999999999999999888999999998754221 122458899999999999999999999876 457
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 151 (265)
T cd06631 77 ISIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARR 151 (265)
T ss_pred EEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHh
Confidence 89999999999999999653 35889999999999999999999998 99999999999999999999999999876
Q ss_pred cccCCCC-CCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc
Q 006750 381 LKADGLP-SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 381 ~~~~~~~-~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
....... ..........|+..|+|||++.+..++.++||||||+++|+|++|+.||............ .
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~-------~--- 221 (265)
T cd06631 152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI-------G--- 221 (265)
T ss_pred hhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh-------h---
Confidence 5321111 0111223456899999999999888999999999999999999999999643221110000 0
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
......+.+ +......+.+++.+||+.+|++||++.++++
T Consensus 222 --~~~~~~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 222 --AHRGLMPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred --hccCCCCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000111122 2233445889999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=353.65 Aligned_cols=261 Identities=22% Similarity=0.335 Sum_probs=200.5
Q ss_pred HHHHhhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccC
Q 006750 219 ALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 296 (632)
Q Consensus 219 ~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 296 (632)
..+...++|.+.+.||+|+||+||++.+.. +..||+|++..... ......|..|+.+|++|+|||||++++++....
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~- 85 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA- 85 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC-
Confidence 344556789999999999999999998764 78899999875432 233456899999999999999999999886532
Q ss_pred CcceEEEEEEeCCCCChhhhhhccc--cCCCCHHHHHHHHHHHHHhhHHHHhcCC----CceeecCCCCCCeEecC----
Q 006750 297 KRAMRLLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAA----PRILHRDIKSSNILLDE---- 366 (632)
Q Consensus 297 ~~~~~~lV~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~iiHrDLKp~NILl~~---- 366 (632)
...+||||||+++|+|.++|.... ...+++..++.|+.||+.||.|||+.+. .+|+||||||+||||+.
T Consensus 86 -~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 86 -NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred -CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 346899999999999999997532 2459999999999999999999998542 34999999999999964
Q ss_pred -------------CCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhc--CCCCcccchHhHhHHHHHHHh
Q 006750 367 -------------NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELIT 431 (632)
Q Consensus 367 -------------~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDVwSlGviL~eLlt 431 (632)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||||||||++
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLT 238 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccccc------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHH
Confidence 3348999999998654321 1234569999999999864 458999999999999999999
Q ss_pred CCCCCCCccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 432 GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 432 G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
|+.||........... .+... +.+. ....+..+.+||..||..+|.+||++.|++.
T Consensus 239 Gk~PF~~~~~~~qli~-------------~lk~~--p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 239 GKTPFHKANNFSQLIS-------------ELKRG--PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCCCCCcCCcHHHHHH-------------HHhcC--CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 9999964322110000 00111 1110 0112345889999999999999999999984
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=330.50 Aligned_cols=245 Identities=29% Similarity=0.418 Sum_probs=201.1
Q ss_pred ccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC--ChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 227 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
|..++.||.|+||.||.|++. +.++||||++.-.... ....+++.|+.+|++|+|||++.+.|+|.. ....||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr----e~TaWL 103 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR----EHTAWL 103 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec----cchHHH
Confidence 566788999999999999864 5889999999755322 233568999999999999999999999986 556799
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||| -||-.|+|.-. .+++-+.++..|..+.+.||+|||+.+ .||||||+.||||++.|.|||+|||.|....+
T Consensus 104 VMEYC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P 178 (948)
T KOG0577|consen 104 VMEYC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP 178 (948)
T ss_pred HHHHH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc
Confidence 99999 67888887643 367999999999999999999999998 99999999999999999999999999976543
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhh---cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
...++|||.|||||++. .+.|+-|+||||||++..||.-.++|++....-. +..+
T Consensus 179 ---------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS-------ALYH------ 236 (948)
T KOG0577|consen 179 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYH------ 236 (948)
T ss_pred ---------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH-------HHHH------
Confidence 34678999999999986 5789999999999999999999999987543211 0011
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
+..--.|.+. ..+.+..|..++..||++-|.+|||..++++.
T Consensus 237 -IAQNesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 237 -IAQNESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred -HHhcCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 1111122222 34566779999999999999999999999874
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=316.14 Aligned_cols=253 Identities=25% Similarity=0.395 Sum_probs=199.3
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
++|++.+.||+|+||.||++.+. +|..||+|.++..........+.+|+.++++++||||+++++++.. ....|+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~~l 76 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI----EGAVYM 76 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec----CCeEEE
Confidence 35778899999999999999986 5899999998765433444568999999999999999999998875 457899
Q ss_pred EEEeCCCCChhhhhhccc-cCCCCHHHHHHHHHHHHHhhHHHHhc-CCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 304 VFEFMPNGNLRDCLDGVL-VEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
||||+++++|.++++... ...+++..+..++.+++.||.|||+. + |+||||||+||+++.++.++|+|||++...
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 153 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL 153 (286)
T ss_pred EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999999999987532 23589999999999999999999974 6 999999999999999999999999998765
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcC------CCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVG------RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL 455 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~------~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~ 455 (632)
... ......|++.|+|||++.+. .++.++|||||||++|+|++|+.||..........
T Consensus 154 ~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~--------- 217 (286)
T cd06622 154 VAS-------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA--------- 217 (286)
T ss_pred cCC-------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH---------
Confidence 322 12234588899999988544 35889999999999999999999996432211000
Q ss_pred ccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 456 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 456 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+..+.... ....+......+.+++.+||+.+|++||++.+++..
T Consensus 218 -----~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 218 -----QLSAIVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -----HHHHHhhcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 001111100 112333455668899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=321.07 Aligned_cols=270 Identities=21% Similarity=0.316 Sum_probs=195.0
Q ss_pred cceeeee--CceEEEEEEEC-CCcEEEEEEeccCCCCC-hHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEE
Q 006750 230 SNIVGQG--GSSYVYRGQLT-DGRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 305 (632)
Q Consensus 230 ~~~LG~G--~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~-~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~ 305 (632)
.++||+| +||+||++..+ +|+.||||+++...... ....+.+|+.+++.++||||+++++++.. ....++||
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~----~~~~~lv~ 78 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA----DNELWVVT 78 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE----CCEEEEEE
Confidence 4679999 78999999875 58999999997654322 33457789999999999999999999876 45789999
Q ss_pred EeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCC
Q 006750 306 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 385 (632)
Q Consensus 306 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 385 (632)
||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++|||.+.......
T Consensus 79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 9999999999997654456999999999999999999999998 9999999999999999999999998755432211
Q ss_pred CC--CCCCCCCccccCCCCCChhhhhc--CCCCcccchHhHhHHHHHHHhCCCCCCCccccccc-hheecccccccc---
Q 006750 386 LP--SCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEE-SLVLWATPRLQD--- 457 (632)
Q Consensus 386 ~~--~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~-~~~~~~~~~~~~--- 457 (632)
.. ..........++..|+|||++.+ ..++.++|||||||++|||++|+.||......... .......+...+
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTT 235 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccc
Confidence 10 00011122357788999999976 45899999999999999999999999643211100 000000000000
Q ss_pred ----------------c----cccccccC---CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 458 ----------------S----GTVISELP---DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 458 ----------------~----~~~~~~~~---~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
. +....... ...............+.+|+.+||+.||++|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 0 00000000 0000011222344568899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=319.23 Aligned_cols=257 Identities=24% Similarity=0.304 Sum_probs=202.1
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCC--hHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~--~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|...+.||+|+||.||++...+ ++.||+|.+....... ....+..|+++++.++||||+++++++.. ....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~ 76 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT----ETYL 76 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec----CCEE
Confidence 367888999999999999998765 8999999997654332 44568899999999999999999998865 4578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||||+.+++|.+++.......+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 153 (316)
T cd05574 77 CLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQS 153 (316)
T ss_pred EEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence 99999999999999997655566999999999999999999999998 999999999999999999999999998765
Q ss_pred ccCCCCC------------------------CCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCC
Q 006750 382 KADGLPS------------------------CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437 (632)
Q Consensus 382 ~~~~~~~------------------------~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~ 437 (632)
....... .........||..|+|||++.+..++.++||||||+++|+|++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 154 DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 3221100 0011223568999999999998889999999999999999999999996
Q ss_pred CccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 006750 438 RSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT----MSEVVQ 505 (632)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~ 505 (632)
........ ..+.............+..+.+++.+||..||++||+ +.++++
T Consensus 234 ~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 234 GSNRDETF-----------------SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CCchHHHH-----------------HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 44322110 0001111100111113456899999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=323.00 Aligned_cols=256 Identities=21% Similarity=0.277 Sum_probs=193.1
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|.+.+.||+|+||.||+++.. +++.||||++.... .......|.+|+.++..++|+||+++++++.+ ....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~ 76 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD----ENNL 76 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec----CCeE
Confidence 46888999999999999999876 48999999986421 12233458899999999999999999998875 4578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 77 ~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 152 (331)
T cd05597 77 YLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRL 152 (331)
T ss_pred EEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeec
Confidence 9999999999999999653 245899999999999999999999998 999999999999999999999999999765
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhc-----CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 456 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~ 456 (632)
..... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||............ .
T Consensus 153 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i-------~ 221 (331)
T cd05597 153 LADGT----VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI-------M 221 (331)
T ss_pred CCCCC----ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHH-------H
Confidence 43321 11123469999999999873 45788999999999999999999999643221110000 0
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCC--CCCCCHHHHHHH
Q 006750 457 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDP--DARPTMSEVVQI 506 (632)
Q Consensus 457 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP--~~RPs~~evl~~ 506 (632)
... .....+..... .+..+.+++.+|+..++ ..||++.++++.
T Consensus 222 ~~~---~~~~~~~~~~~----~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 222 NHK---EHFQFPPDVTD----VSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred cCC---CcccCCCccCC----CCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 000 00000111111 33447778888775433 347899888875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.61 Aligned_cols=241 Identities=24% Similarity=0.278 Sum_probs=187.5
Q ss_pred ceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHH-HHHhcCCCCccceeeeeecccCCcceEEEEEE
Q 006750 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVD-MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~-~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~E 306 (632)
+.||+|+||.||+|... +|+.||||++.... .......+..|.. +++.++||||+++++++.. ....|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~----~~~~~lv~e 76 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT----TEKLYFVLD 76 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec----CCEEEEEEc
Confidence 36999999999999875 58999999987532 1223334566655 4677899999999988875 457899999
Q ss_pred eCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCC
Q 006750 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (632)
Q Consensus 307 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 386 (632)
|+++|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 77 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-- 149 (325)
T cd05604 77 FVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-- 149 (325)
T ss_pred CCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--
Confidence 99999999988643 45899999999999999999999998 999999999999999999999999998753221
Q ss_pred CCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccC
Q 006750 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 466 (632)
Q Consensus 387 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (632)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .+.
T Consensus 150 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~-----------------~~~ 209 (325)
T cd05604 150 ---SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD-----------------NIL 209 (325)
T ss_pred ---CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHH-----------------HHH
Confidence 112334569999999999999999999999999999999999999996533211100 000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 006750 467 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVV 504 (632)
Q Consensus 467 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 504 (632)
...+ ..+...+..+.+++.+||+.+|.+||++.+.+
T Consensus 210 ~~~~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 210 HKPL--VLRPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred cCCc--cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 0000 01112334478899999999999999886443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=309.80 Aligned_cols=271 Identities=25% Similarity=0.351 Sum_probs=202.0
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCC-ccceeeeeeccc--CCcce
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCH-VVPLVGYCSEFR--GKRAM 300 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~f~~Ei~~l~~l~Hpn-iv~l~g~~~~~~--~~~~~ 300 (632)
.|...++||+|+||+||+|+.. +|+.||+|+++..... ..-....+|+.+|++|+|+| |++|++++.... +....
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 3555667999999999999865 5899999999866442 22233689999999999999 999999987643 12337
Q ss_pred EEEEEEeCCCCChhhhhhcccc--CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccc
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLV--EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 378 (632)
.++||||+ .-+|.++++.... +.++...+..+..|+++||+|||+++ |+||||||.||||+++|.+||+|||+|
T Consensus 92 l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchH
Confidence 89999999 5799999987553 45788899999999999999999999 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe--ecccccc
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV--LWATPRL 455 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~--~~~~~~~ 455 (632)
+.+.-. ....+..++|..|.|||++.+. .|+...||||+|||+.||++++.-|.+..+..+...+ ....|..
T Consensus 168 ra~~ip-----~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 168 RAFSIP-----MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNE 242 (323)
T ss_pred HHhcCC-----cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCc
Confidence 965422 2335567899999999999876 7999999999999999999999888765442211100 0111111
Q ss_pred ccccccccccCCCC-----CC--CCCCHHH---HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 456 QDSGTVISELPDPR-----LK--GDFPKEE---MQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 456 ~~~~~~~~~~~~~~-----l~--~~~~~~~---~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.. +..+..+++-. .. ....... .....+++.+||+.+|.+|.|+...+.+
T Consensus 243 ~~-Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 243 KD-WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cC-CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 10 11111111110 00 0011111 1257789999999999999999999875
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.81 Aligned_cols=250 Identities=24% Similarity=0.385 Sum_probs=201.5
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
..+|+..+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.+++.++|+||+++++++.. ....+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~~~ 92 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLV----GDELW 92 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEec----CCEEE
Confidence 367888999999999999999864 599999999975433 334558899999999999999999999875 45789
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++....
T Consensus 93 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 93 VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred EeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence 99999999999999864 34899999999999999999999998 9999999999999999999999999987654
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 462 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (632)
.... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||........... .+
T Consensus 167 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-~~------------ 228 (297)
T cd06656 167 PEQS-----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IA------------ 228 (297)
T ss_pred CCcc-----CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-ec------------
Confidence 3321 12234688999999999988899999999999999999999999964332111000 00
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 463 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 463 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
....+. ...+...+..+.+++.+||..+|++||++.++++
T Consensus 229 -~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 229 -TNGTPE--LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred -cCCCCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000001 1123334455889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=309.08 Aligned_cols=252 Identities=23% Similarity=0.290 Sum_probs=203.1
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
+|+..+.||.|+||.||.++.. +++.+++|.+.... .......+.+|++++++++|+||+++++++.+ ....++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~~~~ 76 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD----DNTLLI 76 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec----CCeEEE
Confidence 4778899999999999999865 48899999987543 33445568999999999999999999999876 457899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
+|||+++|+|.+++.......+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 77 ~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~ 153 (256)
T cd08221 77 EMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGS 153 (256)
T ss_pred EEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccc
Confidence 999999999999997654456899999999999999999999998 99999999999999999999999999987644
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (632)
... ......|++.|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus 154 ~~~-----~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~----------------- 211 (256)
T cd08221 154 EYS-----MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV----------------- 211 (256)
T ss_pred ccc-----cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHH-----------------
Confidence 321 2234568999999999988889999999999999999999999986432211000
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006750 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507 (632)
Q Consensus 464 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 507 (632)
.+....+. ..+...+..+.+++.+||..+|.+||++.++++.+
T Consensus 212 ~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 212 KIVQGNYT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred HHHcCCCC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 00000000 11123344588999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=312.34 Aligned_cols=252 Identities=26% Similarity=0.390 Sum_probs=197.1
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
++|.+.+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.+++.++||||+++++++.. ....|+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~----~~~~~l 83 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLR----RDKLWI 83 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEe----CCEEEE
Confidence 46777788999999999999875 489999999876532 233457899999999999999999998875 457899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||+++++|.+++... ..+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 84 CMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred EEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 99999999999998653 45899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhh---cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
.. .......|+..|+|||++. ...++.++|||||||++|+|++|+.||..............
T Consensus 159 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~---------- 223 (267)
T cd06645 159 TI-----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK---------- 223 (267)
T ss_pred cc-----cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc----------
Confidence 21 1223456899999999874 45688999999999999999999999864332111100000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.....+.... ....+..+.+++.+||..+|++||++.+|++
T Consensus 224 --~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 224 --SNFQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred --cCCCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0001111111 0012234889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=317.05 Aligned_cols=266 Identities=26% Similarity=0.391 Sum_probs=206.3
Q ss_pred ecHHHHHHhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeee
Q 006750 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCS 292 (632)
Q Consensus 215 ~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~ 292 (632)
+++.++..++++|.+.+.||+|+||.||++... +++.+|+|++.... .....+.+|+.++.++ +|||++++++++.
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 445667778899999999999999999999875 58899999986532 2334578899999999 8999999999987
Q ss_pred cccC-CcceEEEEEEeCCCCChhhhhhcc--ccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCC
Q 006750 293 EFRG-KRAMRLLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN 369 (632)
Q Consensus 293 ~~~~-~~~~~~lV~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 369 (632)
.... .....++||||+++|+|.++++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence 5432 234689999999999999988642 2345899999999999999999999998 999999999999999999
Q ss_pred eEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcC-----CCCcccchHhHhHHHHHHHhCCCCCCCcccccc
Q 006750 370 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-----RASLMSDVFSFGVVLLELITGRQPIHRSITKGE 444 (632)
Q Consensus 370 vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-----~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~ 444 (632)
+||+|||++........ ......|+..|+|||++... .++.++|||||||++|||++|+.||........
T Consensus 167 ~kl~dfg~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~ 241 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL-----RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT 241 (291)
T ss_pred EEEeecccchhcccccc-----cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH
Confidence 99999999886543221 11234588999999988643 368999999999999999999999864322111
Q ss_pred chheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 445 ESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
. .. +.....+.+ ..+......+.+++.+||+.+|++||++.++++.
T Consensus 242 ~--~~------------~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 242 L--FK------------IPRNPPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred H--HH------------HhcCCCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 00 000001111 1122334458999999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=309.67 Aligned_cols=254 Identities=23% Similarity=0.368 Sum_probs=197.1
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC----CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG----PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~----~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
.+|...+.||+|+||.||+|... ++..||+|++..... ......+.+|+.++++++||||+++++++.... ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~ 79 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRA--EK 79 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCC--CC
Confidence 46888899999999999999875 489999999864322 122345888999999999999999999876422 34
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..+++|||+++++|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||+++
T Consensus 80 ~~~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 80 TLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 678999999999999999753 34899999999999999999999988 9999999999999999999999999987
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
........ ........++..|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~-------------- 218 (266)
T cd06651 155 RLQTICMS--GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI-------------- 218 (266)
T ss_pred cccccccc--CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH--------------
Confidence 65432111 11122345889999999999888999999999999999999999999643211100
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
...........++......+..++ .||..+|++||++.+|++
T Consensus 219 ---~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 219 ---FKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ---HHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 000000011123333445567777 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=309.08 Aligned_cols=255 Identities=24% Similarity=0.339 Sum_probs=199.1
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC----CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG----PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~----~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
.+|++.+.||+|+||.||+|...+ |+.||||.+..... ......+.+|+.++++++||||+++++++.+.. ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~ 79 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM--ER 79 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC--Cc
Confidence 468888999999999999998754 89999998864321 122345888999999999999999999876532 24
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..++||||+++++|.+++... ..+++.....++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||+++
T Consensus 80 ~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 80 TLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred eEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence 678999999999999998753 34788999999999999999999998 9999999999999999999999999988
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
........ ........|+..|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-------------- 218 (265)
T cd06652 155 RLQTICLS--GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI-------------- 218 (265)
T ss_pred cccccccc--ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH--------------
Confidence 65432111 11223346899999999998888999999999999999999999999643211100
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+..........+......+.+++.+||. +|++||++.+|++.
T Consensus 219 ---~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 219 ---FKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ---HHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 00011111122345555668889999985 99999999999763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=308.35 Aligned_cols=252 Identities=31% Similarity=0.488 Sum_probs=200.4
Q ss_pred ccccceeeeeCceEEEEEEECC-----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 227 FSGSNIVGQGGSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
|++.+.||.|+||.||++.+.+ +..||+|+++..........+..|+.++..++|+||+++++++.+ ....
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~ 76 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE----EEPL 76 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC----CCee
Confidence 3456889999999999998764 388999999766544456679999999999999999999998876 3567
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
+++|||+++++|.+++.......+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||+++..
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceec
Confidence 99999999999999997654333899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
....... .....+++.|+|||.+....++.++||||||+++|+|++ |+.||.......... .
T Consensus 154 ~~~~~~~----~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~---~---------- 216 (258)
T smart00219 154 YDDDYYK----KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLE---Y---------- 216 (258)
T ss_pred ccccccc----cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---H----------
Confidence 5442211 112237889999999988889999999999999999998 788876422111000 0
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 507 (632)
+...... ..+...+..+.+++.+||..+|++|||+.++++.|
T Consensus 217 -~~~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 217 -LKKGYRL----PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -HhcCCCC----CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0000001 11222345588899999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=319.50 Aligned_cols=199 Identities=25% Similarity=0.350 Sum_probs=161.9
Q ss_pred cceeeeeCceEEEEEEEC---CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEE
Q 006750 230 SNIVGQGGSSYVYRGQLT---DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~E 306 (632)
.++||+|+||+||+|... +++.||+|.+..... ...+.+|+.+|++++||||+++++++.... ....++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHA--DRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCC--CcEEEEEEe
Confidence 357999999999999865 367899999875422 234789999999999999999999886432 346799999
Q ss_pred eCCCCChhhhhhccc-------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEe----cCCCCeEEecc
Q 006750 307 FMPNGNLRDCLDGVL-------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDL 375 (632)
Q Consensus 307 y~~~gsL~~~L~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl----~~~~~vkL~DF 375 (632)
|+ +++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+||
T Consensus 81 ~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred cc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 99 468888875321 124889999999999999999999998 9999999999999 45678999999
Q ss_pred ccceecccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCc
Q 006750 376 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 439 (632)
Q Consensus 376 Gla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~ 439 (632)
|+++........ ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 157 G~a~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 157 GFARLFNSPLKP--LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CceeccCCCCcc--ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 999876432211 112334578999999999876 45899999999999999999999999644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=324.42 Aligned_cols=256 Identities=19% Similarity=0.262 Sum_probs=193.8
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|.+.+.||+|+||.||+++.. +++.||+|++.... .......+.+|+.++..++|+||+++++++.. ....
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~----~~~~ 76 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD----ENYL 76 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCEE
Confidence 46888999999999999999876 48899999986421 12233447889999999999999999998875 5578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 77 ~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~ 152 (331)
T cd05624 77 YLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKM 152 (331)
T ss_pred EEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeec
Confidence 99999999999999997532 45899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhc-----CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 456 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~ 456 (632)
..... .......||+.|+|||++.+ +.++.++||||||++||||++|+.||.............
T Consensus 153 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~------- 221 (331)
T cd05624 153 NQDGT----VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM------- 221 (331)
T ss_pred cCCCc----eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHH-------
Confidence 43321 11223469999999999875 567899999999999999999999996433211100000
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 006750 457 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDA--RPTMSEVVQI 506 (632)
Q Consensus 457 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 506 (632)
.. .....-+... ...+..+.+++.+|+..++.+ |+++.++++.
T Consensus 222 ~~---~~~~~~p~~~----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 222 NH---EERFQFPSHI----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cC---CCcccCCCcc----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00 0000001111 122345788899988865544 4677777654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=324.30 Aligned_cols=256 Identities=20% Similarity=0.267 Sum_probs=193.9
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|.+.+.||+|+||.||+++++. ++.||+|++.... .......|.+|+.++..++|+||+++++++.. ....
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~ 76 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD----ENNL 76 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec----CCEE
Confidence 368888999999999999999765 7899999986421 12223448889999999999999999988875 4578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~ 152 (332)
T cd05623 77 YLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKL 152 (332)
T ss_pred EEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheec
Confidence 99999999999999997532 45899999999999999999999998 999999999999999999999999999765
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhh-----cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 456 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~ 456 (632)
..... .......||+.|+|||++. ...++.++|||||||+||||++|+.||.............
T Consensus 153 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~------- 221 (332)
T cd05623 153 MEDGT----VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM------- 221 (332)
T ss_pred ccCCc----ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHh-------
Confidence 43221 1122346999999999986 3468899999999999999999999996533211110000
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 006750 457 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDA--RPTMSEVVQI 506 (632)
Q Consensus 457 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 506 (632)
.. ......+.. ....+..+.+|+.+|+..++.. |+++.++++.
T Consensus 222 ~~---~~~~~~p~~----~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 222 NH---KERFQFPAQ----VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CC---CccccCCCc----cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 000001111 1123445778888888654444 6889888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=314.85 Aligned_cols=266 Identities=23% Similarity=0.347 Sum_probs=195.9
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
+|++.+.||+|+||.||+|... +++.||||+++.... ......+.+|+.++++++||||+++++++.. ....|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~~ 76 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ----ESRLYL 76 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee----CCeEEE
Confidence 4777889999999999999875 589999999875432 2233458899999999999999999999875 457899
Q ss_pred EEEeCCCCChhhhhhcccc-CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 304 VFEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
||||++ ++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++....
T Consensus 77 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 77 IFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152 (285)
T ss_pred EEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence 999996 689988865432 45899999999999999999999998 9999999999999999999999999997653
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccchh----------eecc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL----------VLWA 451 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~----------~~~~ 451 (632)
... .......+++.|+|||++.+. .++.++||||||+++|||++|+.||........... ..|.
T Consensus 153 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd07861 153 IPV-----RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWP 227 (285)
T ss_pred CCc-----ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhh
Confidence 221 112233578999999988754 578999999999999999999999975432110000 0000
Q ss_pred ccc-cccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 452 TPR-LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 452 ~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
... ...............+. ......+..+.+++.+||+.||.+|||+.+|+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 228 GVTSLPDYKNTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred cchhhHHHHhhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 00000000000000000 001123445789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=311.60 Aligned_cols=257 Identities=27% Similarity=0.425 Sum_probs=202.7
Q ss_pred hhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeeccc--CCc
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFR--GKR 298 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~--~~~ 298 (632)
++++|++.+.||.|+||.||+|... +++.+++|++..... ....|.+|+.+++++ .|+||+++++++.... ...
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 5688999999999999999999985 478999999875432 345689999999999 7999999999987644 234
Q ss_pred ceEEEEEEeCCCCChhhhhhccc--cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccc
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 376 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFG 376 (632)
...++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 56899999999999999986543 356899999999999999999999998 9999999999999999999999999
Q ss_pred cceecccCCCCCCCCCCCccccCCCCCChhhhhc-----CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecc
Q 006750 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA 451 (632)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~ 451 (632)
++....... .......|+..|+|||++.. ..++.++||||||++||+|++|+.||.......... .
T Consensus 159 ~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~-- 229 (275)
T cd06608 159 VSAQLDSTL-----GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF--K-- 229 (275)
T ss_pred cceecccch-----hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH--H--
Confidence 987654321 12233458899999998753 346889999999999999999999996432111000 0
Q ss_pred ccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 452 TPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 452 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
+.....+.+ ..+...+..+.+|+.+||..||++|||+.++++
T Consensus 230 ----------~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 ----------IPRNPPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ----------hhccCCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 000011111 112334556889999999999999999999976
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=326.71 Aligned_cols=193 Identities=23% Similarity=0.301 Sum_probs=164.6
Q ss_pred hhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
...+|.+.+.||+|+||.||+|.... ++.||+|+..... ...|+.++++++||||+++++++.. ....
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~-------~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~ 132 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT-------TLIEAMLLQNVNHPSVIRMKDTLVS----GAIT 132 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc-------cHHHHHHHHhCCCCCCcChhheEEe----CCee
Confidence 34679999999999999999998764 7889999754321 4679999999999999999999876 4567
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
++||||+ .++|.+++... ...+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 133 ~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 133 CMVLPHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred EEEEEcc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 9999999 57999988653 345999999999999999999999998 999999999999999999999999998753
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCC
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH 437 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~ 437 (632)
... .......||+.|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus 208 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 208 VVA------PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred ccC------cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 321 12234569999999999999999999999999999999999766553
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=308.88 Aligned_cols=251 Identities=21% Similarity=0.281 Sum_probs=201.5
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
+|+..+.||+|+||.||++... +|+.||+|.+.... .......+.+|+.++++++||||+++++++.. ....++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~l 76 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE----NGNLYI 76 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC----CCeEEE
Confidence 4778899999999999999865 58999999987542 22334568999999999999999999998865 457899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||+++++|.+++.......+++.+++.++.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++.....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 77 VMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153 (256)
T ss_pred EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence 999999999999997654456899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (632)
... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||..........
T Consensus 154 ~~~-----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~----------------- 211 (256)
T cd08218 154 TVE-----LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL----------------- 211 (256)
T ss_pred chh-----hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHH-----------------
Confidence 211 1223458899999999998899999999999999999999999986432211000
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 464 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+.... ....+......+.+++.+||+.+|++||++.+|++.
T Consensus 212 ~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 212 KIIRGS-YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HHhcCC-CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 000000 011223334558999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=307.47 Aligned_cols=254 Identities=27% Similarity=0.418 Sum_probs=202.3
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
.++|...+.||.|+||.||+|... +++.+|+|.+...... ....+.+|++++++++||||+++++++.. ....+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~~~ 76 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLR----RDKLW 76 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEe----CCEEE
Confidence 357888899999999999999875 4789999999765332 44568999999999999999999998865 45789
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
++|||+++++|.+++.... ..+++.++..++.|++.||.|||+.+ |+|+||||+||++++++.++|+|||++....
T Consensus 77 l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 152 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLT 152 (262)
T ss_pred EEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhh
Confidence 9999999999999987542 45899999999999999999999998 9999999999999999999999999987654
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcC---CCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVG---RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~---~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
... .......++..|+|||.+... .++.++||||||+++|||++|+.||.............
T Consensus 153 ~~~-----~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~---------- 217 (262)
T cd06613 153 ATI-----AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS---------- 217 (262)
T ss_pred hhh-----hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----------
Confidence 321 122335688999999998776 78999999999999999999999996543221110000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
......+.+ ..+...+..+.+++.+||..+|.+|||+.+|+.
T Consensus 218 --~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 218 --KSNFPPPKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred --hccCCCccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000111111 122334556899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=329.59 Aligned_cols=264 Identities=21% Similarity=0.273 Sum_probs=196.3
Q ss_pred hcCccccceeeeeCceEEEEEEECC---CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTD---GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~---g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
..+|.+.+.||+|+||.||++...+ +..||||.+.... .+.+|+++|++++||||+++++++.. ...
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~------~~~~E~~il~~l~h~~iv~~~~~~~~----~~~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK------TPGREIDILKTISHRAIINLIHAYRW----KST 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc------cHHHHHHHHHhcCCCCccceeeeEee----CCE
Confidence 4579999999999999999997542 5789999886432 25789999999999999999988865 457
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.++||||+ +++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||+++.
T Consensus 161 ~~lv~e~~-~~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 161 VCMVMPKY-KCDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACK 234 (392)
T ss_pred EEEEehhc-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccc
Confidence 89999999 4789998843 256999999999999999999999998 99999999999999999999999999976
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecc-------cc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA-------TP 453 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~-------~~ 453 (632)
...... ........||+.|+|||++.+..++.++|||||||+||||++|+.||............... ..
T Consensus 235 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~ 311 (392)
T PHA03207 235 LDAHPD---TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPL 311 (392)
T ss_pred cCcccc---cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcc
Confidence 543221 11223457999999999999999999999999999999999999999754332110000000 00
Q ss_pred cccccc-----cc---ccccCCCCCCC-C-C-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 454 RLQDSG-----TV---ISELPDPRLKG-D-F-PKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 454 ~~~~~~-----~~---~~~~~~~~l~~-~-~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+.... .. ......+.... . + .......+.+++.+||..||++||++.+++..
T Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 312 EFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred ccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 00 00000000000 0 0 01123457889999999999999999999875
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=311.03 Aligned_cols=240 Identities=22% Similarity=0.378 Sum_probs=185.5
Q ss_pred ceeeeeCceEEEEEEECC-------------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCC
Q 006750 231 NIVGQGGSSYVYRGQLTD-------------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~-------------g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 297 (632)
+.||+|+||.||+|.+.+ ...||+|.+.... ......|.+|+.+++.++||||+++++++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~---- 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVR---- 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEec----
Confidence 358999999999998532 2358999876543 2334468899999999999999999999875
Q ss_pred cceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCC-------e
Q 006750 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN-------A 370 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~-------v 370 (632)
....++||||+++|+|..++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCcee
Confidence 345699999999999999886532 45899999999999999999999998 999999999999987664 8
Q ss_pred EEeccccceecccCCCCCCCCCCCccccCCCCCChhhhh-cCCCCcccchHhHhHHHHHHH-hCCCCCCCccccccchhe
Q 006750 371 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM-VGRASLMSDVFSFGVVLLELI-TGRQPIHRSITKGEESLV 448 (632)
Q Consensus 371 kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~s~ksDVwSlGviL~eLl-tG~~P~~~~~~~~~~~~~ 448 (632)
+++|||++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|+.||...........
T Consensus 152 ~l~d~g~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~- 221 (262)
T cd05077 152 KLSDPGIPITVLSR---------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF- 221 (262)
T ss_pred EeCCCCCCccccCc---------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH-
Confidence 99999998654321 2235788999999887 567899999999999999998 58888754321110000
Q ss_pred eccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 449 LWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
...... ........+.+|+.+||+.||++||++.+|++.|+
T Consensus 222 -----------------~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 222 -----------------YEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -----------------HhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 000000 01111245889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=315.02 Aligned_cols=239 Identities=24% Similarity=0.422 Sum_probs=184.5
Q ss_pred eeeeeCceEEEEEEECC-------------------------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccc
Q 006750 232 IVGQGGSSYVYRGQLTD-------------------------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286 (632)
Q Consensus 232 ~LG~G~fG~Vy~~~~~~-------------------------g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~ 286 (632)
.||+|+||.||+|.+.. ...||+|++.... ......|.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH-RDIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH-HHHHHHHHHHHHHHhcCCCCCeee
Confidence 59999999999997521 1358999986543 223345889999999999999999
Q ss_pred eeeeeecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC
Q 006750 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 366 (632)
Q Consensus 287 l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~ 366 (632)
+++++.. ....++||||+++|+|..++.... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.
T Consensus 81 ~~~~~~~----~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~ 152 (274)
T cd05076 81 VHGVCVR----GSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLAR 152 (274)
T ss_pred EEEEEEe----CCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEec
Confidence 9999876 446799999999999999986532 45899999999999999999999998 999999999999976
Q ss_pred CC-------CeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHH-hCCCCCC
Q 006750 367 NL-------NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELI-TGRQPIH 437 (632)
Q Consensus 367 ~~-------~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLl-tG~~P~~ 437 (632)
.+ .+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||.
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~~---------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 223 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALSR---------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLK 223 (274)
T ss_pred cCcccCccceeeecCCccccccccc---------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcc
Confidence 44 3799999997643221 12347788999998875 56899999999999999995 6899986
Q ss_pred CccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 438 RSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
........... .. ... .+......+.+++.+||+.+|++|||+.+|++.|.
T Consensus 224 ~~~~~~~~~~~--------------~~--~~~----~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 224 ERTPSEKERFY--------------EK--KHR----LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ccChHHHHHHH--------------Hh--ccC----CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 44322111000 00 001 11111234889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=312.45 Aligned_cols=253 Identities=29% Similarity=0.483 Sum_probs=197.0
Q ss_pred ccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHH-HHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEE
Q 006750 227 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADS-VFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~-~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV 304 (632)
|+..+.||+|+||+||+++... ++.||+|++.......... ...+|+.++++++||||+++++++.. ....++|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----~~~~~~v 76 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD----DNYLYIV 76 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE----SSEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc----ccccccc
Confidence 5667899999999999999875 6789999998764333222 24569999999999999999999876 5577999
Q ss_pred EEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccC
Q 006750 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 384 (632)
|||+++++|.+++.. ...+++..+..++.|++.||++||+.+ |+|+||||+||++++++.++|+|||.+......
T Consensus 77 ~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~ 151 (260)
T PF00069_consen 77 MEYCPGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN 151 (260)
T ss_dssp EEEETTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTST
T ss_pred ccccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 999999999999982 355899999999999999999999998 999999999999999999999999999764111
Q ss_pred CCCCCCCCCCccccCCCCCChhhhh-cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccccc
Q 006750 385 GLPSCSSSPARMQGTFGYFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463 (632)
Q Consensus 385 ~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (632)
........+|..|+|||++. +..++.++||||||+++|+|++|..||................ . .
T Consensus 152 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~---~------~ 217 (260)
T PF00069_consen 152 -----NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKIL---K------R 217 (260)
T ss_dssp -----TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHH---H------T
T ss_pred -----ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcc---c------c
Confidence 12233456899999999998 8889999999999999999999999997551111111000000 0 0
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 464 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
...... .........+.+++.+||+.||++||++.++++
T Consensus 218 ~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 218 PLPSSS---QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHT---TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccccc---cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 000011256899999999999999999999976
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=324.07 Aligned_cols=269 Identities=22% Similarity=0.313 Sum_probs=197.5
Q ss_pred HhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccC--C
Q 006750 222 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--K 297 (632)
Q Consensus 222 ~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~--~ 297 (632)
...++|.+.+.||+|+||.||+|... +++.||||++..... ......+.+|+.+|++++||||+++++++..... .
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 45678999999999999999999865 588999999875422 2233457889999999999999999998754321 1
Q ss_pred cceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccc
Q 006750 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 377 (632)
....|++|+++ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 24578999998 8899988754 35899999999999999999999998 99999999999999999999999999
Q ss_pred ceecccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccch-heecc-ccc
Q 006750 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES-LVLWA-TPR 454 (632)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~-~~~~~-~~~ 454 (632)
++..... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.......... ..... .+.
T Consensus 165 ~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07878 165 ARQADDE--------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS 236 (343)
T ss_pred ceecCCC--------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9865422 223468999999999876 568999999999999999999999996432111000 00000 000
Q ss_pred ------cccc--ccc---ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 455 ------LQDS--GTV---ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 455 ------~~~~--~~~---~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
+... ... +.......+.. ........+.+|+.+||+.||.+|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQQDLKK-IFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccchhHHH-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 000 00000000000 000112347789999999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=315.40 Aligned_cols=249 Identities=24% Similarity=0.416 Sum_probs=200.1
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
.+|+..+.||.|+||.||+|... +|+.||+|.+..... .....+.+|+.+++.++||||+++++++.. ....|+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-PKKELIINEILVMKELKNPNIVNFLDSFLV----GDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-chHHHHHHHHHHHHhcCCCceeeeeeeEec----CceEEE
Confidence 45888899999999999999864 589999999875433 334568899999999999999999999875 457899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||+++++|.+++.. ..+++.++..++.+++.||+|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 94 v~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 94 VMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred EEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 9999999999999864 34899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (632)
... ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||............ .
T Consensus 168 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~--------------~ 228 (296)
T cd06655 168 EQS-----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--------------A 228 (296)
T ss_pred ccc-----cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--------------H
Confidence 321 122346889999999999888999999999999999999999999654322111000 0
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 464 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
....+.+ ..+...+..+.+++.+||..||.+||++.++++
T Consensus 229 ~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 229 TNGTPEL--QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred hcCCccc--CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000000 112233445888999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=306.39 Aligned_cols=250 Identities=24% Similarity=0.352 Sum_probs=199.6
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
+|+..+.||+|+||.||++... +++.+|||.+.... .......+.+|+.+|++++||||+++++.+.. ....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~~l 76 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE----DKALMI 76 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec----CCEEEE
Confidence 4778899999999999999875 58899999987543 23345568999999999999999999988764 457899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCC-CeEEeccccceecc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITDLGMAKRLK 382 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~-~vkL~DFGla~~~~ 382 (632)
||||+++++|.+++.......+++..+..++.+++.||+|||+++ ++|+||||+||++++++ .++|+|||++....
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (256)
T cd08220 77 VMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILS 153 (256)
T ss_pred EEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecC
Confidence 999999999999998755556899999999999999999999998 99999999999998654 57999999998764
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 462 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (632)
... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||........ ..
T Consensus 154 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~------------- 211 (256)
T cd08220 154 SKS------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---VL------------- 211 (256)
T ss_pred CCc------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---HH-------------
Confidence 321 12234688999999999988899999999999999999999999864332110 00
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 463 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 463 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+.... ....+...+..+.+++.+||+.+|++|||+.++++.
T Consensus 212 -~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 212 -KIMSGT-FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -HHHhcC-CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 000000 011222334458899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=311.12 Aligned_cols=260 Identities=28% Similarity=0.382 Sum_probs=203.2
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
++|...+.||.|++|.||++.+. +++.+|+|.+...........+.+|++++++++||||+++++++.... ....++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDES--SSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC--CCeEEE
Confidence 36778899999999999999985 489999999986544445566999999999999999999999986533 346799
Q ss_pred EEEeCCCCChhhhhhcc--ccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 304 VFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
||||+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccc
Confidence 99999999999987542 2345899999999999999999999998 999999999999999999999999998755
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccc--cchheecccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKG--EESLVLWATPRLQDSG 459 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~--~~~~~~~~~~~~~~~~ 459 (632)
.... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ......+
T Consensus 156 ~~~~-------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 219 (287)
T cd06621 156 VNSL-------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY--------- 219 (287)
T ss_pred cccc-------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH---------
Confidence 3221 123457889999999999999999999999999999999999997542210 0011110
Q ss_pred ccccccCCCCCCCCCC--HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006750 460 TVISELPDPRLKGDFP--KEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 507 (632)
+.....+.+....+ ...+..+.+++.+||..+|.+|||+.|+++.-
T Consensus 220 --~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 220 --IVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred --HhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 00001111111111 12345689999999999999999999998843
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=316.87 Aligned_cols=198 Identities=25% Similarity=0.354 Sum_probs=161.0
Q ss_pred ceeeeeCceEEEEEEECC---CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEe
Q 006750 231 NIVGQGGSSYVYRGQLTD---GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 307 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~---g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey 307 (632)
.+||+|+||.||+|...+ +..||+|.+.... ....+.+|+.+|++++||||+++++++.... ....++||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHS--DRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccC--CCeEEEEEee
Confidence 579999999999998753 5789999987542 2234789999999999999999999886532 4467999999
Q ss_pred CCCCChhhhhhcc-------ccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEe----cCCCCeEEeccc
Q 006750 308 MPNGNLRDCLDGV-------LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLG 376 (632)
Q Consensus 308 ~~~gsL~~~L~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl----~~~~~vkL~DFG 376 (632)
++ ++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 95 5888877421 1224889999999999999999999998 9999999999999 567789999999
Q ss_pred cceecccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCc
Q 006750 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRS 439 (632)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~ 439 (632)
+++........ ........||+.|+|||++.+ ..++.++||||||+++|||+||+.||...
T Consensus 158 ~a~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 158 FARLFNSPLKP--LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ceeccCCCccc--ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 99876433211 112234568999999999876 45899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=306.58 Aligned_cols=256 Identities=26% Similarity=0.443 Sum_probs=201.2
Q ss_pred CccccceeeeeCceEEEEEEE-CCCcEEEEEEeccCCCC-----ChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 226 KFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGP-----NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~-----~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
+|+..+.||+|+||.||+|.. .+++.||+|++...... .....+.+|+.++++++|+||+++++++.+ ..
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~ 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE----DS 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc----CC
Confidence 477789999999999999986 45899999998754321 123568999999999999999999999875 45
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCC-CeEEeccccc
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITDLGMA 378 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~-~vkL~DFGla 378 (632)
..++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++ .++|+|||++
T Consensus 77 ~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~ 151 (268)
T cd06630 77 HFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAA 151 (268)
T ss_pred eEEEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccc
Confidence 779999999999999999753 45899999999999999999999998 99999999999998776 5999999998
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccc
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
......... .........||..|+|||.+.+..++.++||||||+++|+|++|..||...........
T Consensus 152 ~~~~~~~~~-~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~----------- 219 (268)
T cd06630 152 ARLAAKGTG-AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL----------- 219 (268)
T ss_pred ccccccccc-CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH-----------
Confidence 876543211 11122345689999999999888899999999999999999999999864322111110
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
+.+..........+......+.+++.+||..+|++||++.++++
T Consensus 220 ---~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 220 ---IFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---HHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00111111112344455566889999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=307.47 Aligned_cols=249 Identities=25% Similarity=0.412 Sum_probs=199.3
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC---CCCccceeeeeecccCCcceE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH---HCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~---Hpniv~l~g~~~~~~~~~~~~ 301 (632)
.|+..+.||+|+||.||+|.+. +++.||||.++..........+.+|+.++++++ |||++++++++.. ....
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~----~~~~ 77 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK----GPRL 77 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee----CCEE
Confidence 4677789999999999999874 589999999876544455566889999999996 9999999998875 4577
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
++||||+++++|.++++.. .+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++...
T Consensus 78 ~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 78 WIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred EEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 9999999999999998652 5899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
.... .......|+..|+|||++.++ .++.++||||||+++|+|++|+.||..........
T Consensus 152 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-------------- 212 (277)
T cd06917 152 NQNS-----SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-------------- 212 (277)
T ss_pred CCCc-----cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh--------------
Confidence 5432 122334689999999988754 46899999999999999999999996432211100
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+.....+.+... ..+..+.+++.+||+.||++||++.++++.
T Consensus 213 ~~~~~~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 213 LIPKSKPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ccccCCCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0011111122111 133458899999999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=310.58 Aligned_cols=268 Identities=24% Similarity=0.352 Sum_probs=199.0
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
++|+..+.||+|+||.||+|.+. +|+.||+|++..... ....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~~~ 76 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR----KRKLH 76 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee----CCEEE
Confidence 46888899999999999999986 489999999875432 2233458899999999999999999998875 45779
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||+++++|..++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 77 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07847 77 LVFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILT 151 (286)
T ss_pred EEEeccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecC
Confidence 999999999888876542 35899999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe-eccccccc----
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV-LWATPRLQ---- 456 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~-~~~~~~~~---- 456 (632)
.... ......++..|+|||++.+ ..++.++||||||+++|||++|+.||............ ........
T Consensus 152 ~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07847 152 GPGD-----DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 226 (286)
T ss_pred CCcc-----cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 4321 1223457889999999876 56789999999999999999999999654322111000 00000000
Q ss_pred --cccccccccCCCCCCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 457 --DSGTVISELPDPRLKGDFP-----KEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 457 --~~~~~~~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
...........+......+ ...+..+.+|+.+||+.+|++||++.+++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 227 IFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred hcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000000001111100000 1224558899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=306.35 Aligned_cols=238 Identities=24% Similarity=0.434 Sum_probs=187.5
Q ss_pred ceeeeeCceEEEEEEECCCc-----------EEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 231 NIVGQGGSSYVYRGQLTDGR-----------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g~-----------~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
+.||+|+||.||+|.+.+.. .|++|.+...... ...|.+|+.+|++++||||+++++++.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-----D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-----C
Confidence 36899999999999986532 5888887654322 4569999999999999999999999875 2
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCC-------CeEE
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-------NAKI 372 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~-------~vkL 372 (632)
..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEe
Confidence 3589999999999999997643 25899999999999999999999998 99999999999999887 7999
Q ss_pred eccccceecccCCCCCCCCCCCccccCCCCCChhhhhcC--CCCcccchHhHhHHHHHHHh-CCCCCCCccccccchhee
Q 006750 373 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG--RASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVL 449 (632)
Q Consensus 373 ~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~--~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~ 449 (632)
+|||++..... .....++..|+|||++... .++.++||||||+++|||++ |..||...........
T Consensus 150 ~Dfg~a~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~-- 218 (259)
T cd05037 150 SDPGIPITVLS---------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF-- 218 (259)
T ss_pred CCCCccccccc---------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH--
Confidence 99999886543 1123467789999999876 78999999999999999999 5777754422111100
Q ss_pred ccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 450 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 450 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
+.. .... +......+.+++.+||..+|.+||++.+|++.|+
T Consensus 219 ~~~---------~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 219 YQD---------QHRL---------PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred Hhc---------CCCC---------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 0000 0001145889999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=306.60 Aligned_cols=253 Identities=25% Similarity=0.319 Sum_probs=201.4
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
+|++.+.||.|+||.||++... +++.||+|++..... ....+.+..|++++++++||||+++++++.... ....++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~~~ 78 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRS--NQTLYI 78 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCC--CCEEEE
Confidence 4777889999999999999864 588999999875432 333456889999999999999999998876432 346799
Q ss_pred EEEeCCCCChhhhhhccc--cCCCCHHHHHHHHHHHHHhhHHHH-----hcCCCceeecCCCCCCeEecCCCCeEEeccc
Q 006750 304 VFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLH-----EAAAPRILHRDIKSSNILLDENLNAKITDLG 376 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH-----~~~~~~iiHrDLKp~NILl~~~~~vkL~DFG 376 (632)
+|||+++++|.+++.... ...+++..++.++.|++.||.||| +.+ ++|+||||+||++++++.+||+|||
T Consensus 79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g 155 (265)
T cd08217 79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFG 155 (265)
T ss_pred EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccc
Confidence 999999999999996532 345899999999999999999999 666 9999999999999999999999999
Q ss_pred cceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccc
Q 006750 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 456 (632)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~ 456 (632)
++........ ......|++.|+|||++....++.++||||||+++|+|++|+.||....... ...
T Consensus 156 ~~~~~~~~~~-----~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~------- 220 (265)
T cd08217 156 LAKILGHDSS-----FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LAS------- 220 (265)
T ss_pred ccccccCCcc-----cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHH-------
Confidence 9987654321 1223468999999999998889999999999999999999999996543111 000
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 457 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 457 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+..... ...+...+..+.+++.+||+.+|++||++.+|++.
T Consensus 221 ----~~~~~~~----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 221 ----KIKEGKF----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----HHhcCCC----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0011111 12333445568999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=312.37 Aligned_cols=267 Identities=22% Similarity=0.306 Sum_probs=194.6
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
+|+..+.||+|+||.||+|... +|+.||+|+++.... ......+.+|+.++++++||||+++++++.+ ....++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~----~~~~~l 76 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS----DKKLTL 76 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc----CCceEE
Confidence 4777889999999999999875 589999999875422 2223447889999999999999999998865 457899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
|+||++ ++|.+++.... ..+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.++|+|||+++....
T Consensus 77 v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 151 (284)
T cd07839 77 VFEYCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGI 151 (284)
T ss_pred EEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCC
Confidence 999996 68888876532 45899999999999999999999998 99999999999999999999999999976543
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec--cccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATPRLQDSGT 460 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~~~~~~~~ 460 (632)
.. .......+++.|+|||++.+. .++.++||||||+++|||++|..|+.............. ..........
T Consensus 152 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd07839 152 PV-----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWP 226 (284)
T ss_pred CC-----CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhH
Confidence 21 112234578999999998764 479999999999999999999998753322111000000 0000000000
Q ss_pred cccccCCC----CCC-----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 461 VISELPDP----RLK-----GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 461 ~~~~~~~~----~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+....+. ... .......+..+.+++.+||+.||.+|||+.++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 227 GVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred HhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00000000 000 01112234568899999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=312.81 Aligned_cols=252 Identities=23% Similarity=0.365 Sum_probs=197.9
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
+.|++.+.||.|+||.||+|.... ++.||+|.+.... ......+.+|+.+++.++||||+++++++.. ....++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~l 86 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYW----DGKLWI 86 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe----CCeEEE
Confidence 568888999999999999998765 8999999987542 3345568899999999999999999998865 457899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||+++++|..++.+.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 87 v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 87 MIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred EEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence 999999999998876533 45899999999999999999999998 99999999999999999999999999875432
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhh-----cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
.. .......+++.|+|||++. ...++.++||||||+++|||++|+.||........ ...
T Consensus 163 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~--------- 226 (292)
T cd06644 163 TL-----QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLK--------- 226 (292)
T ss_pred cc-----cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HHH---------
Confidence 21 1223456889999999885 34568899999999999999999999864322110 000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
+.....+.. ..+...+..+.+++.+||..+|++||++.++++.
T Consensus 227 ---~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 227 ---IAKSEPPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ---HhcCCCccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000001111 1122334458899999999999999999999763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=308.94 Aligned_cols=247 Identities=24% Similarity=0.378 Sum_probs=199.2
Q ss_pred ccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEE
Q 006750 227 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 305 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~ 305 (632)
|+..+.||+|+||.||+|.+. ++..||||.+...........|.+|+.++++++||||+++++++.. ....++||
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~ 81 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK----DTKLWIIM 81 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe----CCeEEEEE
Confidence 666788999999999999865 5899999998755444445668999999999999999999999875 45789999
Q ss_pred EeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCC
Q 006750 306 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 385 (632)
Q Consensus 306 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 385 (632)
||+++++|.+++.. ..+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 82 EYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 99999999999864 35899999999999999999999998 9999999999999999999999999987654321
Q ss_pred CCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccccccc
Q 006750 386 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 465 (632)
Q Consensus 386 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (632)
. ......|+..|+|||++.+..++.++||||||+++|+|++|..||........... +...
T Consensus 156 ~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~--------------~~~~ 216 (277)
T cd06641 156 I-----KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL--------------IPKN 216 (277)
T ss_pred h-----hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH--------------HhcC
Confidence 1 12234588899999999888899999999999999999999999854322110000 0001
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 466 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 466 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
..+.+ +...+..+.+++.+||+.+|.+||++.++++.
T Consensus 217 ~~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 217 NPPTL----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCC----CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11112 22233458889999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.18 Aligned_cols=253 Identities=26% Similarity=0.376 Sum_probs=199.8
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
.++|++.+.||.|+||.||++.+. ++..||+|.+.... ......|.+|++++++++||||+++++++.. ....|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFY----ENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEec----CCeEE
Confidence 456888899999999999999875 58999999987542 2334568999999999999999999999875 45779
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++....
T Consensus 79 lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 79 ILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred EEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 9999999999999987532 45899999999999999999999998 9999999999999999999999999987653
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhh-----cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 457 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~ 457 (632)
... .......||+.|+|||++. ...++.++||||||+++|||++|+.||........ ...
T Consensus 155 ~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~~-------- 219 (280)
T cd06611 155 STL-----QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LLK-------- 219 (280)
T ss_pred ccc-----cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HHH--------
Confidence 321 1223456899999999885 34467899999999999999999999965422110 000
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 458 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
+.....+.+ ..+...+..+.+++.+||+.+|.+||++.++++.
T Consensus 220 ----~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 220 ----ILKSEPPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ----HhcCCCCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000011111 1122334458899999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=313.65 Aligned_cols=268 Identities=26% Similarity=0.410 Sum_probs=198.5
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
++|+..+.||+|+||.||+|.+++ ++.||+|++...... ...+.+.+|+++++.++||||+++++++.. ....+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 76 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR----KKRLY 76 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc----CCeEE
Confidence 367888999999999999999864 899999998654332 234568899999999999999999999864 55789
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||+++++|.++.... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 77 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~ 151 (286)
T cd07846 77 LVFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLA 151 (286)
T ss_pred EEEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeecc
Confidence 999999999998876543 34899999999999999999999998 9999999999999999999999999988754
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccc----
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD---- 457 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~---- 457 (632)
... .......++..|+|||++.+ ..++.++||||||+++|||++|+.||..................+..
T Consensus 152 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07846 152 APG-----EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQE 226 (286)
T ss_pred CCc-----cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHH
Confidence 332 12233458899999999875 45788999999999999999999998643221100000000000000
Q ss_pred ---ccccccccCCCCCCC-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 458 ---SGTVISELPDPRLKG-----DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 458 ---~~~~~~~~~~~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
..........+.... ......+..+.+|+.+||+.+|++||++.++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000000000010000 0112234568899999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=310.62 Aligned_cols=251 Identities=24% Similarity=0.326 Sum_probs=196.1
Q ss_pred ccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEE
Q 006750 227 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 305 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~ 305 (632)
|++.+.||.|+||.||+|.+.. +..+++|.+.... ......+.+|+++++.++||||+++++++.. ....++||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~----~~~~~~v~ 81 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYY----ENNLWILI 81 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEee----CCEEEEEE
Confidence 5667889999999999998764 7889999886542 2334568899999999999999999998875 45779999
Q ss_pred EeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCC
Q 006750 306 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 385 (632)
Q Consensus 306 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 385 (632)
||+++++|..++.+. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 82 e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 82 EFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred EecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc
Confidence 999999999987643 245899999999999999999999998 9999999999999999999999999987653221
Q ss_pred CCCCCCCCCccccCCCCCChhhhh-----cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 386 LPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 386 ~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||........... .
T Consensus 158 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~--~---------- 220 (282)
T cd06643 158 -----QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLK--I---------- 220 (282)
T ss_pred -----cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHH--H----------
Confidence 1223356899999999884 34578899999999999999999999864322111000 0
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 507 (632)
.....+.+ ..+...+..+.+++.+||+.||++||++.++++.-
T Consensus 221 --~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 221 --AKSEPPTL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred --hhcCCCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 00000111 11222345588999999999999999999987643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=310.52 Aligned_cols=252 Identities=27% Similarity=0.386 Sum_probs=192.8
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHH-HHhcCCCCccceeeeeecccCCcceEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDM-LSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~-l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
++|++.+.||+|+||.||++.+. +|+.||+|+++..........+..|+.+ ++.++||||+++++++.. ....|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~----~~~~~ 76 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR----EGDVW 76 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec----CCcEE
Confidence 46888899999999999999876 4999999999765433344456667775 556699999999999875 44679
Q ss_pred EEEEeCCCCChhhhhhccc--cCCCCHHHHHHHHHHHHHhhHHHHhc-CCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 303 LVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
+||||++ |+|.+++.... ...+++..++.++.|++.||+|||++ + ++||||||+|||++.++.+||+|||+++
T Consensus 77 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~ 152 (283)
T cd06617 77 ICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISG 152 (283)
T ss_pred EEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccc
Confidence 9999995 78988886432 23589999999999999999999986 6 9999999999999999999999999988
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhc----CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV----GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL 455 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~----~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~ 455 (632)
...... ......|+..|+|||++.+ ..++.++|+||||+++|||++|+.||........ ...
T Consensus 153 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~------- 218 (283)
T cd06617 153 YLVDSV------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ-QLK------- 218 (283)
T ss_pred cccccc------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH-HHH-------
Confidence 654321 1223458899999998864 4468899999999999999999999853221100 000
Q ss_pred ccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 456 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 456 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
... ....+.+. ....+..+.+++.+||..+|++||++.++++.
T Consensus 219 ----~~~-~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 219 ----QVV-EEPSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred ----HHH-hcCCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00111111 11233458899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=308.18 Aligned_cols=254 Identities=29% Similarity=0.410 Sum_probs=202.3
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
++|+..+.||.|+||.||++.+. +++.||+|++...........+.+|++++++++||||+++++++.. ....++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~~l 76 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN----NGDISI 76 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec----CCEEEE
Confidence 35677789999999999999886 4899999999876544555679999999999999999999998876 457899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHh-cCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
|+||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+ ++|+||||+||++++++.++|+|||++....
T Consensus 77 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 77 CMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred EEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 999999999999997643 568999999999999999999999 77 9999999999999999999999999987654
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 462 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (632)
... .....++..|+|||++.+..++.++||||||+++|+|++|+.||.......... ..... .+
T Consensus 153 ~~~-------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~--------~~ 216 (265)
T cd06605 153 NSL-------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI-FELLQ--------YI 216 (265)
T ss_pred HHH-------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH-HHHHH--------HH
Confidence 321 111568899999999999999999999999999999999999996442111100 00000 00
Q ss_pred cccCCCCCCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 463 SELPDPRLKGDFPKE-EMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 463 ~~~~~~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.....+. .+.. .+..+.+++.+||..+|.+|||+.+++..
T Consensus 217 ~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 217 VNEPPPR----LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred hcCCCCC----CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 0111111 1221 44558899999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=299.76 Aligned_cols=251 Identities=23% Similarity=0.295 Sum_probs=199.6
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
+++|++.+.||+|.|+.||+.... .|+.+|+|+++... .....+.+.+|+.|-+.|+||||++|...+.+ ..+.
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~----~~~~ 85 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE----ESFH 85 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc----ccee
Confidence 567788889999999999998654 58999999887542 22344568999999999999999999877665 6688
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC---CCCeEEeccccc
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLNAKITDLGMA 378 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~---~~~vkL~DFGla 378 (632)
|||+|+|.|++|..-|-.+ .-+++..+-....||+.+|.|+|.++ |||||+||.|+||-. .--+||+|||+|
T Consensus 86 ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred EEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceE
Confidence 9999999999997766433 33788889999999999999999999 999999999999943 334899999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccc
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
..+..+ ...-..+|||+|||||++...+|+..+|||+.|||||-|+.|++||.+.......
T Consensus 161 i~l~~g------~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rly------------- 221 (355)
T KOG0033|consen 161 IEVNDG------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY------------- 221 (355)
T ss_pred EEeCCc------cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHH-------------
Confidence 987732 3455678999999999999999999999999999999999999999753221100
Q ss_pred cccccccCCC--CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 459 GTVISELPDP--RLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 459 ~~~~~~~~~~--~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
..+... .+.+..-+.......+|+++||..||.+|.|+.|.++.
T Consensus 222 ----e~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 222 ----EQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred ----HHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 011110 11111222334558899999999999999999998864
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=311.69 Aligned_cols=239 Identities=23% Similarity=0.397 Sum_probs=185.5
Q ss_pred eeeeeCceEEEEEEECC--------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 232 IVGQGGSSYVYRGQLTD--------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 232 ~LG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
.||+|+||.||+|.... ...||+|.+.... ....+.|.+|+.+++.++||||+++++++.. ....++
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~----~~~~~l 76 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVC----GDESIM 76 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEe----CCCcEE
Confidence 58999999999998643 2348888876432 3334568899999999999999999999875 345699
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCC--------eEEecc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN--------AKITDL 375 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~--------vkL~DF 375 (632)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. ++++||
T Consensus 77 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 77 VQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred EEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccc
Confidence 999999999999997643 35899999999999999999999998 999999999999987765 589999
Q ss_pred ccceecccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCC-CCCCCccccccchheecccc
Q 006750 376 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGR-QPIHRSITKGEESLVLWATP 453 (632)
Q Consensus 376 Gla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~-~P~~~~~~~~~~~~~~~~~~ 453 (632)
|++..... .....+++.|+|||++.+ ..++.++||||||+++|||++|. .||...........
T Consensus 153 g~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~------ 217 (258)
T cd05078 153 GISITVLP---------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF------ 217 (258)
T ss_pred ccccccCC---------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH------
Confidence 98765432 123457889999999986 45799999999999999999995 55543221110000
Q ss_pred ccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 454 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 454 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
... .. .++......+.+|+.+||+.||++|||+.++++.|+
T Consensus 218 --------~~~--~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 218 --------YED--RH----QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --------HHc--cc----cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 01 122222345889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=298.32 Aligned_cols=254 Identities=28% Similarity=0.395 Sum_probs=203.2
Q ss_pred HHhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC-------hHHHHHHHHHHHHhc-CCCCccceeeee
Q 006750 221 EHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-------ADSVFLTEVDMLSRL-HHCHVVPLVGYC 291 (632)
Q Consensus 221 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~-------~~~~f~~Ei~~l~~l-~Hpniv~l~g~~ 291 (632)
+...++|...+.||+|..++|-+...+ +|..+|+|++....... ..+.-.+|+.+|+++ .||||+.+.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 445567888999999999999998765 48889999986443221 122356799999999 899999999988
Q ss_pred ecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeE
Q 006750 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAK 371 (632)
Q Consensus 292 ~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vk 371 (632)
.. ....++|+|.|+.|.|.|+|.... .++++...+|+.|+..|++|||..+ |+||||||+|||+|++.++|
T Consensus 93 es----~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~ 163 (411)
T KOG0599|consen 93 ES----DAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIK 163 (411)
T ss_pred cC----cchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceE
Confidence 75 668899999999999999998653 4899999999999999999999998 99999999999999999999
Q ss_pred EeccccceecccCCCCCCCCCCCccccCCCCCChhhhhc------CCCCcccchHhHhHHHHHHHhCCCCCCCccccccc
Q 006750 372 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV------GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEE 445 (632)
Q Consensus 372 L~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~------~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~ 445 (632)
|+|||+|..+..+ .......|||+|+|||.+.. ..|+...|+|++|||+|-|+.|.+||.....--.
T Consensus 164 isDFGFa~~l~~G------ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlM- 236 (411)
T KOG0599|consen 164 ISDFGFACQLEPG------EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLM- 236 (411)
T ss_pred EeccceeeccCCc------hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHH-
Confidence 9999999988764 34567889999999998853 3589999999999999999999999964321110
Q ss_pred hheeccccccccccccccccCCCCC--CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 446 SLVLWATPRLQDSGTVISELPDPRL--KGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
+.-+..... ..+-..+.+....+|+.+||+.||.+|.|+.|++..
T Consensus 237 ----------------LR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 237 ----------------LRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred ----------------HHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 001111111 111123445568899999999999999999999873
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=303.44 Aligned_cols=248 Identities=28% Similarity=0.417 Sum_probs=198.4
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC----CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG----PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~----~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
+|+..+.||+|+||.||+|... +++.|++|.+..... .+....+.+|+.+++.++|+||+++++++.. ...
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~ 76 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE----EDN 76 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec----CCe
Confidence 4667789999999999999986 689999999865432 2234568999999999999999999998865 457
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.+||+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~ 151 (258)
T cd06632 77 LYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQ 151 (258)
T ss_pred EEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCcccee
Confidence 79999999999999999754 35899999999999999999999998 99999999999999999999999999887
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCC-CCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGR-ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
..... ......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||.......... ...
T Consensus 152 ~~~~~------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~------ 215 (258)
T cd06632 152 VVEFS------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVF----KIG------ 215 (258)
T ss_pred ccccc------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHH----HHH------
Confidence 54332 123345889999999987766 8999999999999999999999996543111000 000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.....+ ..+......+.+++.+||..+|++||++.++++
T Consensus 216 ---~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 216 ---RSKELP----PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ---hcccCC----CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 000011 122333455888999999999999999999976
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=323.65 Aligned_cols=241 Identities=24% Similarity=0.256 Sum_probs=183.9
Q ss_pred eeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHHHHHhc---CCCCccceeeeeecccCCcceEEEEEE
Q 006750 233 VGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRL---HHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 233 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~f~~Ei~~l~~l---~Hpniv~l~g~~~~~~~~~~~~~lV~E 306 (632)
||+|+||+||+|+.. +++.||||++..... ......+..|..++..+ +||||+++++++.. ....|+|||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~----~~~~~lv~e 76 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT----DSDLYLVTD 76 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec----CCeEEEEEc
Confidence 699999999999876 489999999864321 12223356677777665 69999999988875 457899999
Q ss_pred eCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCC
Q 006750 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (632)
Q Consensus 307 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 386 (632)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||+++......
T Consensus 77 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~- 150 (330)
T cd05586 77 YMSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN- 150 (330)
T ss_pred CCCCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-
Confidence 99999999998753 45899999999999999999999998 9999999999999999999999999987543221
Q ss_pred CCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccccccc
Q 006750 387 PSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 465 (632)
Q Consensus 387 ~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (632)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||............. . .
T Consensus 151 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~-------~-----~-- 212 (330)
T cd05586 151 ----KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIA-------F-----G-- 212 (330)
T ss_pred ----CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHH-------c-----C--
Confidence 122345699999999998764 48999999999999999999999996533211100000 0 0
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC----CHHHHHH
Q 006750 466 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP----TMSEVVQ 505 (632)
Q Consensus 466 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~ 505 (632)
...+.. ......+.+++.+||+.||.+|| ++.++++
T Consensus 213 -~~~~~~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 213 -KVRFPK---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -CCCCCC---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 000100 11234478899999999999998 4555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=306.67 Aligned_cols=256 Identities=25% Similarity=0.430 Sum_probs=196.4
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC--C-------hHHHHHHHHHHHHhcCCCCccceeeeeeccc
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--N-------ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 295 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~-------~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~ 295 (632)
+|...+.||.|+||.||+|... +|+.||||.++..... . ..+.+.+|+.+++.++|||++++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 4667789999999999999865 5899999988642111 1 12357889999999999999999998865
Q ss_pred CCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecc
Q 006750 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 375 (632)
Q Consensus 296 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DF 375 (632)
....++||||+++++|.+++++. ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+||
T Consensus 80 --~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~ 152 (272)
T cd06629 80 --EEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDF 152 (272)
T ss_pred --CCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeec
Confidence 45779999999999999999765 45899999999999999999999998 999999999999999999999999
Q ss_pred ccceecccCCCCCCCCCCCccccCCCCCChhhhhcCC--CCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccc
Q 006750 376 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR--ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 453 (632)
Q Consensus 376 Gla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~--~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~ 453 (632)
|+++....... ........|+..|+|||.+.... ++.++||||||+++||+++|..||........ ....
T Consensus 153 ~~~~~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~--- 224 (272)
T cd06629 153 GISKKSDDIYD---NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA--MFKL--- 224 (272)
T ss_pred ccccccccccc---ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH--HHHh---
Confidence 99876532211 11123456889999999987654 89999999999999999999999853221110 0000
Q ss_pred ccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 454 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 454 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
......+..........+..+.+++.+||..+|++||++.+|++.
T Consensus 225 --------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 225 --------GNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred --------hccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 000001111111212234568899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=305.35 Aligned_cols=260 Identities=24% Similarity=0.358 Sum_probs=198.2
Q ss_pred ccccceeeeeCceEEEEEEEC----CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCC--cc
Q 006750 227 FSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK--RA 299 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~--~~ 299 (632)
|.+.+.||+|+||.||+|.+. .++.||||++..... ....+.+.+|+.++++++||||+++++++...... ..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556788999999999999864 368899999976532 23345688999999999999999999988653322 12
Q ss_pred eEEEEEEeCCCCChhhhhhccc----cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecc
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVL----VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 375 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DF 375 (632)
..+++++|+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 4578999999999998874321 124789999999999999999999998 999999999999999999999999
Q ss_pred ccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccc
Q 006750 376 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPR 454 (632)
Q Consensus 376 Gla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~ 454 (632)
|+++........ .......+++.|++||.+....++.++||||||+++|||++ |+.||.......... +.
T Consensus 158 g~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~---~~--- 228 (273)
T cd05074 158 GLSKKIYSGDYY---RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYN---YL--- 228 (273)
T ss_pred cccccccCCcce---ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHH---HH---
Confidence 999866432210 11122345678999999998899999999999999999999 888886432211000 00
Q ss_pred cccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 455 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 455 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
....... .+...+..+.+++.+||+.+|++||++.++++.|..+
T Consensus 229 --------~~~~~~~----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 229 --------IKGNRLK----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred --------HcCCcCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000001 1122334589999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=320.50 Aligned_cols=254 Identities=24% Similarity=0.363 Sum_probs=202.2
Q ss_pred hcCccccceeeeeCceEEEEEEECCCcEEEEEEeccC-CCCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcceE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQ-GGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~-~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
-..|+++++||+||.+.||++...+.+.||+|++... .+......|.+|+.+|.+| .|.+||+|++|-.. +.++
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~----d~~l 435 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT----DGYL 435 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc----CceE
Confidence 3568888999999999999999888888998887644 4445556699999999999 79999999988664 6789
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
||||||= .-||..+|+........| .+..+..|++.++.++|+.+ |||.||||.|+|+-. |.+||+|||.|...
T Consensus 436 YmvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAI 509 (677)
T ss_pred EEEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhccc
Confidence 9999987 679999998766554556 78889999999999999999 999999999999864 58999999999987
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcC-----------CCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVG-----------RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-----------~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~ 450 (632)
..+... -.....+||+.||+||.+... +.++++||||||||||+|+.|+.||......
T Consensus 510 ~~DTTs---I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~-------- 578 (677)
T KOG0596|consen 510 QPDTTS---IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ-------- 578 (677)
T ss_pred Cccccc---eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH--------
Confidence 765431 233457899999999998632 2578999999999999999999999643211
Q ss_pred cccccccccccccccCCCCCCCCCCHHHH-HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 451 ATPRLQDSGTVISELPDPRLKGDFPKEEM-QIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 451 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~-~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
...+..+.+|.-.-++|.--. ..+.++|+.||..||.+||++.++++.
T Consensus 579 --------~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 579 --------IAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred --------HHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 113444555543333332111 128899999999999999999999874
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=306.30 Aligned_cols=253 Identities=21% Similarity=0.357 Sum_probs=197.2
Q ss_pred CccccceeeeeCceEEEEEEECC--CcEEEEEEeccCC---------CCChHHHHHHHHHHHHh-cCCCCccceeeeeec
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLTD--GRIVAVKRFKTQG---------GPNADSVFLTEVDMLSR-LHHCHVVPLVGYCSE 293 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~--g~~vAVK~l~~~~---------~~~~~~~f~~Ei~~l~~-l~Hpniv~l~g~~~~ 293 (632)
+|++.+.||+|+||.||+|.+.. ++.+|||.+.... .......+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37778899999999999999865 7889999886331 11223447788988875 699999999999875
Q ss_pred ccCCcceEEEEEEeCCCCChhhhhhcc--ccCCCCHHHHHHHHHHHHHhhHHHHh-cCCCceeecCCCCCCeEecCCCCe
Q 006750 294 FRGKRAMRLLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNA 370 (632)
Q Consensus 294 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDLKp~NILl~~~~~v 370 (632)
....++||||+++++|.+++... ....+++..++.++.|++.||.|||+ .+ ++|+||+|+|||++.++.+
T Consensus 81 ----~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~ 153 (269)
T cd08528 81 ----NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKV 153 (269)
T ss_pred ----CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcE
Confidence 45789999999999999988542 23458999999999999999999996 55 9999999999999999999
Q ss_pred EEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec
Q 006750 371 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450 (632)
Q Consensus 371 kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~ 450 (632)
+|+|||++....... ......|+..|+|||++.+..++.++||||||+++|||++|+.||...........
T Consensus 154 ~l~dfg~~~~~~~~~------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~--- 224 (269)
T cd08528 154 TITDFGLAKQKQPES------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATK--- 224 (269)
T ss_pred EEecccceeeccccc------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHH---
Confidence 999999998754331 22345688999999999988899999999999999999999999864322110000
Q ss_pred cccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 451 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 451 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
.......+.. ....+..+.+++.+||+.||++||++.|+...+.
T Consensus 225 ----------~~~~~~~~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 225 ----------IVEAVYEPLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ----------HhhccCCcCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0000001111 1122345889999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=309.95 Aligned_cols=267 Identities=24% Similarity=0.394 Sum_probs=195.1
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
++|+..+.||+|+||.||+|..+ +++.||||.+...........+.+|++++++++|+||+++++++.. ....++
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~l 80 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT----KKTLTL 80 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec----CCeEEE
Confidence 56888899999999999999876 5899999998755433333447889999999999999999999875 457899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||++ ++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 v~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 81 VFEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSV 155 (291)
T ss_pred EEecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCC
Confidence 999997 59999887543 36899999999999999999999998 99999999999999999999999999875432
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecc---cc------
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA---TP------ 453 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~---~~------ 453 (632)
.. .......++..|+|||++.+ ..++.++||||||+++|||++|+.||.............+. .+
T Consensus 156 ~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07844 156 PS-----KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWP 230 (291)
T ss_pred CC-----ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhh
Confidence 11 11122346889999998875 45899999999999999999999999644311100000000 00
Q ss_pred ccccc---cc-cccccCCCCCCCCCC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 454 RLQDS---GT-VISELPDPRLKGDFP-KEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 454 ~~~~~---~~-~~~~~~~~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
..... .. .........+....+ ......+.+++.+||+.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 231 GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000 00 000000000000000 001145778999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=311.95 Aligned_cols=254 Identities=27% Similarity=0.362 Sum_probs=193.7
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCccceeeeeecccCCcceEEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
+|...+.||+|+||.||++... +++.||+|.+...........+.+|+.++.++. |+||+++++++.. ....++
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~----~~~~~~ 80 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR----EGDCWI 80 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec----CCcEEE
Confidence 3445678999999999999875 489999999876544445556899999999995 9999999998865 446789
Q ss_pred EEEeCCCCChhhhhh---ccccCCCCHHHHHHHHHHHHHhhHHHHhc-CCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 304 VFEFMPNGNLRDCLD---GVLVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~---~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
+|||+. ++|.++.. ......+++..+..++.+++.||+|||+. + |+||||||+|||++.++.++|+|||+++
T Consensus 81 ~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 156 (288)
T cd06616 81 CMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISG 156 (288)
T ss_pred EEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhH
Confidence 999985 56655432 22235689999999999999999999975 6 9999999999999999999999999997
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcC---CCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVG---RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 456 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~---~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~ 456 (632)
...... ......|+..|+|||++... .++.++||||||+++|||++|+.||........ ...
T Consensus 157 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~-------- 221 (288)
T cd06616 157 QLVDSI------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFD-QLT-------- 221 (288)
T ss_pred HhccCC------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHH-HHh--------
Confidence 654321 12233588999999998766 689999999999999999999999964321000 000
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 457 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 457 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
. ......+.+....+...+..+.+|+.+||+.+|++|||+.+|++.
T Consensus 222 ---~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 222 ---Q-VVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred ---h-hcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000111222222223345568999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=310.77 Aligned_cols=269 Identities=21% Similarity=0.287 Sum_probs=196.4
Q ss_pred hhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++++|.+.+.||+|+||.||+|... +|+.||+|++...........+.+|+.+++.++|+||+++++++.. ....
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~~~~ 78 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT----KETL 78 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec----CCeE
Confidence 3567889999999999999999875 5899999999765444444457899999999999999999998875 4577
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
++||||+. ++|.+++.... ..+.+..+..++.|++.||+|||+.+ |+|+||||+|||++.++.++|+|||+++..
T Consensus 79 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 79 TFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAK 153 (291)
T ss_pred EEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccccccc
Confidence 99999995 78877775432 34788899999999999999999998 999999999999999999999999998764
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccc----
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ---- 456 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~---- 456 (632)
.... .......+++.|+|||++.+ ..++.++||||||+++|||++|+.||.......+.....|......
T Consensus 154 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 228 (291)
T cd07870 154 SIPS-----QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDT 228 (291)
T ss_pred CCCC-----CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhh
Confidence 3221 11223457899999998875 4578899999999999999999999975432211110011000000
Q ss_pred -----cccccccccCCCCCCCCC---C--HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 457 -----DSGTVISELPDPRLKGDF---P--KEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 457 -----~~~~~~~~~~~~~l~~~~---~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.................. . ......+.+++.+|+..||.+|||+.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 229 WPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000000000 0 001345788999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=324.04 Aligned_cols=244 Identities=27% Similarity=0.424 Sum_probs=200.4
Q ss_pred eeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEeCCC
Q 006750 232 IVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 310 (632)
Q Consensus 232 ~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey~~~ 310 (632)
+||+|.+|+||.|++.+ ...+|||-+...... ..+-+.+|+.+-++|+|.|||+++|.+.+ ..+.-|.||-++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr-~~QPLhEEIaLH~~LrHkNIVrYLGs~se----nGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR-EVQPLHEEIALHSTLRHKNIVRYLGSVSE----NGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccch-hhccHHHHHHHHHHHhhHhHHHHhhccCC----CCeEEEEeecCCC
Confidence 59999999999999765 567999998765432 23337899999999999999999999876 4577899999999
Q ss_pred CChhhhhhccccCCC--CHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEec-CCCCeEEeccccceecccCCCC
Q 006750 311 GNLRDCLDGVLVEGM--NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGLP 387 (632)
Q Consensus 311 gsL~~~L~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~-~~~~vkL~DFGla~~~~~~~~~ 387 (632)
|||.++|+..- +++ .+.+.--+..||+.||.|||++. |||||||-+||||+ -.|.+||+|||-++++..-
T Consensus 657 GSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--- 729 (1226)
T KOG4279|consen 657 GSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--- 729 (1226)
T ss_pred CcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC---
Confidence 99999998654 345 67888889999999999999998 99999999999996 5688999999999877532
Q ss_pred CCCCCCCccccCCCCCChhhhhcC--CCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccccccc
Q 006750 388 SCSSSPARMQGTFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 465 (632)
Q Consensus 388 ~~~~~~~~~~GT~~Y~APE~~~~~--~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (632)
.....++.||..|||||++..+ .|+.++|||||||++.||.||++||......... +.++
T Consensus 730 --nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA----------------MFkV 791 (1226)
T KOG4279|consen 730 --NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA----------------MFKV 791 (1226)
T ss_pred --CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh----------------hhhh
Confidence 2345567899999999999865 4899999999999999999999999754332111 1111
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 466 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 466 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
---....++|.+.+.....+|.+|+.+||.+||++.++++
T Consensus 792 GmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 792 GMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 1112234678899999999999999999999999999986
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=301.39 Aligned_cols=253 Identities=30% Similarity=0.437 Sum_probs=204.9
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
++|++.+.||+|++|.||+|...+ ++.||||++...........+.+|+..+.+++|+||+++++++.. ....++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~l 76 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK----EGEISI 76 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc----CCeEEE
Confidence 367888999999999999998875 999999999876543445679999999999999999999999876 457899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHh-cCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
||||+++++|.+++... ..+++..++.++.|++.||+|||+ .+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 77 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~ 151 (264)
T cd06623 77 VLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLE 151 (264)
T ss_pred EEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 99999999999999754 558999999999999999999999 88 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 462 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (632)
.... ......++..|+|||.+....++.++||||||+++|+|++|+.||............. .+
T Consensus 152 ~~~~-----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~-----------~~ 215 (264)
T cd06623 152 NTLD-----QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ-----------AI 215 (264)
T ss_pred cCCC-----cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH-----------HH
Confidence 3321 1224568899999999998899999999999999999999999996543211111000 00
Q ss_pred cccCCCCCCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 463 SELPDPRLKGDFPKE-EMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 463 ~~~~~~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.....+. .+.. .+..+.+++..||..+|++||++.++++.
T Consensus 216 ~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 216 CDGPPPS----LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred hcCCCCC----CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0111111 1222 34558899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=309.74 Aligned_cols=267 Identities=19% Similarity=0.223 Sum_probs=190.7
Q ss_pred hcCccccceeeeeCceEEEEEEECC----CcEEEEEEeccCCCCChHH----------HHHHHHHHHHhcCCCCccceee
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADS----------VFLTEVDMLSRLHHCHVVPLVG 289 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~----------~f~~Ei~~l~~l~Hpniv~l~g 289 (632)
.++|.+.+.||+|+||.||+|.+.+ +..+|+|+..........+ ....+...+..+.|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3678899999999999999998754 3567777654332211111 1223344556678999999999
Q ss_pred eeecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCC
Q 006750 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN 369 (632)
Q Consensus 290 ~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 369 (632)
++..........+++++++ ..++.+.+... ...++..+..++.|++.||+|||+.+ |+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCc
Confidence 7765443344568888987 45777766542 23678889999999999999999998 999999999999999999
Q ss_pred eEEeccccceecccCCCCC--CCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchh
Q 006750 370 AKITDLGMAKRLKADGLPS--CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL 447 (632)
Q Consensus 370 vkL~DFGla~~~~~~~~~~--~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~ 447 (632)
++|+|||+|+.+....... .........||+.|+|||++.+..++.++|||||||+||||++|+.||...........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 9999999998775332111 01112234699999999999999999999999999999999999999975432211100
Q ss_pred eeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006750 448 VLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507 (632)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 507 (632)
.... ..+..+..+.+. ....+..+.+++..||..+|++||++.++++.|
T Consensus 245 ~~~~--------~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 245 AAKC--------DFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HhHH--------HHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 0000 001111111111 112235588999999999999999999999876
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=310.27 Aligned_cols=260 Identities=20% Similarity=0.262 Sum_probs=199.7
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|...+.||+|+||.||++.... ++.||+|.+..... ......+.+|+++++.++||||+++++.+.. ....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~ 76 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET----KRHL 76 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec----CCEE
Confidence 368888999999999999998764 78999999875432 2234458899999999999999999988865 4578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+++..
T Consensus 77 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~ 151 (305)
T cd05609 77 CMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIG 151 (305)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCcccc
Confidence 9999999999999999654 45899999999999999999999998 999999999999999999999999998742
Q ss_pred ccCCCCC----------CCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecc
Q 006750 382 KADGLPS----------CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA 451 (632)
Q Consensus 382 ~~~~~~~----------~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~ 451 (632)
....... .........|+..|+|||++....++.++||||||+++|||++|..||............
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~--- 228 (305)
T cd05609 152 LMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV--- 228 (305)
T ss_pred CcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---
Confidence 2111000 000112345788999999998888999999999999999999999999643221100000
Q ss_pred ccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006750 452 TPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 509 (632)
Q Consensus 452 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 509 (632)
.......+.... ..+..+.+++.+||+.+|++||++.++.+.|..
T Consensus 229 ---------~~~~~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 229 ---------ISDDIEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ---------HhcccCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 000111111111 233448899999999999999997767666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=311.64 Aligned_cols=245 Identities=25% Similarity=0.389 Sum_probs=194.6
Q ss_pred cceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEeC
Q 006750 230 SNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 308 (632)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey~ 308 (632)
...||+|+||.||++... ++..||||.+.... ......+.+|+.+++.++|+||+++++.+.. ....++||||+
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~----~~~~~lv~e~~ 101 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLV----GDELWVVMEFL 101 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheec----CCeEEEEEeCC
Confidence 456999999999999875 48899999986543 2344568899999999999999999998875 45779999999
Q ss_pred CCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCCCC
Q 006750 309 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS 388 (632)
Q Consensus 309 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 388 (632)
++++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 102 ~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--- 172 (292)
T cd06658 102 EGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--- 172 (292)
T ss_pred CCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc---
Confidence 99999998854 34899999999999999999999998 9999999999999999999999999987553221
Q ss_pred CCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccCCC
Q 006750 389 CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDP 468 (632)
Q Consensus 389 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 468 (632)
.......|+..|+|||++.+..++.++||||||+++|||++|+.||........... +.....+
T Consensus 173 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~--------------~~~~~~~ 236 (292)
T cd06658 173 --PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR--------------IRDNLPP 236 (292)
T ss_pred --ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------------HHhcCCC
Confidence 122335689999999999888899999999999999999999999864322111000 0011111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 469 RLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 469 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+.. .......+..++.+||..||.+|||+.++++.
T Consensus 237 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 237 RVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1111 11223458889999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=307.64 Aligned_cols=267 Identities=22% Similarity=0.303 Sum_probs=197.7
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC----ChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP----NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~----~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
+|...+.||+|+||.||+|... +|+.||||.+...... .....+..|++++++++|+||+++++++.. ...
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~ 76 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH----KSN 76 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec----CCE
Confidence 4677889999999999999875 5899999999765332 223447789999999999999999999876 457
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.++||||+ +|+|.+++.... ..+++..++.++.|+++||.|||+.+ |+|+||||+|||++.++.++|+|||+++.
T Consensus 77 ~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~ 151 (298)
T cd07841 77 INLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARS 151 (298)
T ss_pred EEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeee
Confidence 89999999 999999997643 35999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe-eccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV-LWATPRLQDS 458 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~-~~~~~~~~~~ 458 (632)
..... .......+++.|+|||.+.+ ..++.++||||||+++|||++|.+||............ ..........
T Consensus 152 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (298)
T cd07841 152 FGSPN-----RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEEN 226 (298)
T ss_pred ccCCC-----ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhh
Confidence 65432 11223356788999998865 46789999999999999999998777543321100000 0000000000
Q ss_pred cc---cccccCCCCCC-----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 459 GT---VISELPDPRLK-----GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 459 ~~---~~~~~~~~~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.. ........... .......+..+.+++.+||..+|.+|||+.++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00 00000000000 01112334568899999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=302.77 Aligned_cols=251 Identities=22% Similarity=0.319 Sum_probs=198.7
Q ss_pred CccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
+|+..+.||+|+||.||+|..+. |..||+|.+..... ......+.+|+.+++.++|+||+++++.+.. ....++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~----~~~~~l 76 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE----NGRLFI 76 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc----CCeEEE
Confidence 47788999999999999998764 88999999875422 2334468899999999999999999998765 457899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCC-eEEeccccceecc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN-AKITDLGMAKRLK 382 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~-vkL~DFGla~~~~ 382 (632)
||||+++++|.+++.......+++..+..++.|++.||.|||+.+ ++|+||||+||++++++. ++|+|||.+....
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~ 153 (257)
T cd08225 77 VMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN 153 (257)
T ss_pred EEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhcc
Confidence 999999999999997655456899999999999999999999998 999999999999988854 6999999987664
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 462 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (632)
... .......|++.|+|||++....++.++||||||+++|||++|..||.........
T Consensus 154 ~~~-----~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~----------------- 211 (257)
T cd08225 154 DSM-----ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLV----------------- 211 (257)
T ss_pred CCc-----ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH-----------------
Confidence 321 1122345889999999998888999999999999999999999998643221100
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 463 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 463 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+...... ...+...+..+.+++.+||..+|++|||+.++++.
T Consensus 212 ~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 212 LKICQGYF-APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHHhcccC-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 00000000 01112233458899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=308.42 Aligned_cols=245 Identities=26% Similarity=0.342 Sum_probs=198.3
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|+..+.||+|+||.||++.+. +++.||+|++.... .......+.+|++++++++||||+++++++.. ....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 76 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD----DSNL 76 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc----CCeE
Confidence 46888899999999999999876 48999999987532 22334568899999999999999999998875 4578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+|||++.++.+||+|||++...
T Consensus 77 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~ 151 (290)
T cd05580 77 YLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRV 151 (290)
T ss_pred EEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCcccc
Confidence 9999999999999999764 45899999999999999999999998 999999999999999999999999998875
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
... .....|++.|+|||.+.+...+.++||||||+++|+|++|+.||.........
T Consensus 152 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------- 207 (290)
T cd05580 152 KGR--------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIY---------------- 207 (290)
T ss_pred CCC--------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH----------------
Confidence 432 22345889999999998888999999999999999999999999643311000
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQ 505 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 505 (632)
..+.... ..++......+.+++.+||..||.+|| ++.++++
T Consensus 208 -~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 208 -EKILEGK--VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -HHHhcCC--ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 0000000 012223345588999999999999998 6777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=340.65 Aligned_cols=266 Identities=25% Similarity=0.387 Sum_probs=214.1
Q ss_pred HHHHhhcCccccceeeeeCceEEEEEEECC--------CcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceee
Q 006750 219 ALEHATDKFSGSNIVGQGGSSYVYRGQLTD--------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVG 289 (632)
Q Consensus 219 ~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g 289 (632)
.++...++..+.+.||+|.||.|++|.... ...||||.++........+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 455566666677799999999999997531 4579999999887777778899999999999 7999999999
Q ss_pred eeecccCCcceEEEEEEeCCCCChhhhhhccc------------c--CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeec
Q 006750 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL------------V--EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHR 355 (632)
Q Consensus 290 ~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~------------~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHr 355 (632)
+|.. ....++|+||+..|+|.+||+... . ..++..+.+.++.|||.||+||++.. ++||
T Consensus 370 ~~t~----~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHR 442 (609)
T KOG0200|consen 370 ACTQ----DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHR 442 (609)
T ss_pred eecc----CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccch
Confidence 9987 456799999999999999997654 0 12889999999999999999999987 9999
Q ss_pred CCCCCCeEecCCCCeEEeccccceecccCCCCCCCCCCCccc--cCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-C
Q 006750 356 DIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ--GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-G 432 (632)
Q Consensus 356 DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~--GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G 432 (632)
||.++||||+.+..+||+|||+|+.......... ..-. -...|||||.+....|+.++|||||||+||||+| |
T Consensus 443 DLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~----~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG 518 (609)
T KOG0200|consen 443 DLAARNVLITKNKVIKIADFGLARDHYNKDYYRT----KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLG 518 (609)
T ss_pred hhhhhhEEecCCCEEEEccccceeccCCCCceEe----cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCC
Confidence 9999999999999999999999997655433211 1111 2456999999999999999999999999999999 7
Q ss_pred CCCCCCccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 433 RQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 433 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
..||....... .+ .+......+...|..+...+..+|+.||+.+|++||++.++++.|...+.
T Consensus 519 ~~PYp~~~~~~--~l---------------~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 519 GTPYPGIPPTE--EL---------------LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred CCCCCCCCcHH--HH---------------HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 88885421110 00 11122222234566667779999999999999999999999999988543
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=324.58 Aligned_cols=277 Identities=25% Similarity=0.380 Sum_probs=206.0
Q ss_pred cccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccC--CcceEEEE
Q 006750 228 SGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRAMRLLV 304 (632)
Q Consensus 228 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~--~~~~~~lV 304 (632)
...+.||+|+||.||+|+.+ .|+.||||.++........+.+.+|+++|++|+|||||+++++=.+... ......+|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 33467999999999999965 5999999999988777778889999999999999999999886443220 13456899
Q ss_pred EEeCCCCChhhhhhccc-cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEec--CCCC--eEEeccccce
Q 006750 305 FEFMPNGNLRDCLDGVL-VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD--ENLN--AKITDLGMAK 379 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~--~~~~--vkL~DFGla~ 379 (632)
||||.||||+..|++.. ..+|++.+.+.++.+++.||.|||+++ |+||||||.||++- .+|+ .||+|||.|+
T Consensus 96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 99999999999997643 346999999999999999999999998 99999999999993 3333 7999999999
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhh-cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
-+..+. ....++||..|++||++. .+.|+..+|.|||||++|+..||..||-.........-+.|....-...
T Consensus 173 el~d~s------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 173 ELDDNS------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS 246 (732)
T ss_pred cCCCCC------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence 887653 456788999999999998 4889999999999999999999999996543332111122222111111
Q ss_pred cccccccCC---C-----CC--CCCCCHHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHhhhCCC
Q 006750 459 GTVISELPD---P-----RL--KGDFPKEEMQIMAYLAKECLQLDPDARP--TMSEVVQILSTIAPD 513 (632)
Q Consensus 459 ~~~~~~~~~---~-----~l--~~~~~~~~~~~l~~li~~cl~~dP~~RP--s~~evl~~L~~i~~~ 513 (632)
+..+..... | .+ ...........+-..+..+|..+|.+|. .+.+....+..|+..
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 111100000 0 00 1112233334455666777888888888 777777777666543
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=306.81 Aligned_cols=267 Identities=21% Similarity=0.282 Sum_probs=199.5
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
+|.+.+.||+|+||.||+|.+. +|+.||||++..... ......+.+|+.++++++||||+++++++.. ....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~~~ 76 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH----GSGFVL 76 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec----CCeeEE
Confidence 4778899999999999999875 589999999976542 2334568999999999999999999998876 557899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||+ +++|.+++.... ..+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 77 v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~ 151 (286)
T cd07832 77 VMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSE 151 (286)
T ss_pred Eeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccC
Confidence 99999 999999987543 56999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe-e-cc------ccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV-L-WA------TPR 454 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~-~-~~------~~~ 454 (632)
... .......|+..|+|||++.+. .++.++||||||+++|||++|++||............ . .. .+.
T Consensus 152 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07832 152 EEP----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPG 227 (286)
T ss_pred CCC----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhh
Confidence 321 112334689999999988654 4689999999999999999998777543321110000 0 00 000
Q ss_pred cccccccccccCCCCCC----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 455 LQDSGTVISELPDPRLK----GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 455 ~~~~~~~~~~~~~~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
..... ....+..+... ..........+.+++.+||..+|++||++.++++.
T Consensus 228 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 228 LTSLP-DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred ccCcc-hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 00000000000 00111234668999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=310.37 Aligned_cols=246 Identities=23% Similarity=0.378 Sum_probs=195.3
Q ss_pred ccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEe
Q 006750 229 GSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 307 (632)
Q Consensus 229 ~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey 307 (632)
....||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.++||||+++++++.. ....++||||
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~----~~~~~iv~e~ 99 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLV----GEELWVLMEF 99 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheee----CCeEEEEEec
Confidence 3457999999999999875 589999999875433 334568899999999999999999998875 4578999999
Q ss_pred CCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCCC
Q 006750 308 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP 387 (632)
Q Consensus 308 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 387 (632)
+++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 100 ~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-- 171 (297)
T cd06659 100 LQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-- 171 (297)
T ss_pred CCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--
Confidence 999999998754 34899999999999999999999998 9999999999999999999999999987554321
Q ss_pred CCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccCC
Q 006750 388 SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPD 467 (632)
Q Consensus 388 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (632)
.......|+..|+|||++.+..++.++||||||+++|||++|+.||........... +.....
T Consensus 172 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~--------------~~~~~~ 234 (297)
T cd06659 172 ---PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR--------------LRDSPP 234 (297)
T ss_pred ---ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------------HhccCC
Confidence 112335689999999999988999999999999999999999999964332111000 000000
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 468 PRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
+.. .........+.+++.+||+.+|.+||++.++++.
T Consensus 235 ~~~--~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 235 PKL--KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCc--cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000 0111223447889999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=300.20 Aligned_cols=255 Identities=27% Similarity=0.414 Sum_probs=199.8
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
+|...+.||+|+||.||+|... +++.||+|.++..... .....+.+|+.++++++|+||+++++++.. ....++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----~~~~~l 76 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH----REKVYI 76 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec----CCEEEE
Confidence 4778899999999999999875 5899999999865432 345668999999999999999999998764 457899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
|+||+++++|.+++... ..+++..+..++.+++.||.|||+.+ |+|+||+|+||++++++.+||+|||++.....
T Consensus 77 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~ 151 (264)
T cd06626 77 FMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN 151 (264)
T ss_pred EEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence 99999999999999753 34789999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCC---CCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~---~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
..... ........++..|+|||++.+.. .+.++||||||+++||+++|+.||.......... ..
T Consensus 152 ~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~--~~---------- 218 (264)
T cd06626 152 NTTTM-GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM--FH---------- 218 (264)
T ss_pred CCCcc-cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH--HH----------
Confidence 33211 11122356889999999998766 8999999999999999999999996432111100 00
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
+.....+.+.. .......+.+++.+||+.+|.+||++.+++.
T Consensus 219 -~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 219 -VGAGHKPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -HhcCCCCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00001111111 1112445788999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=306.34 Aligned_cols=250 Identities=25% Similarity=0.396 Sum_probs=200.1
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
++|.+.+.||+|+||.||++... ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.. ....|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~----~~~~~l 93 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKHPNIVNYLDSYLV----GDELWV 93 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc-hHHHHHHHHHHHHhhcCCCCeeehhheeee----CCcEEE
Confidence 67888899999999999999864 588999999865432 334568999999999999999999998875 456799
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
|+||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 94 v~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 94 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred EEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 9999999999999865 34789999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (632)
.. .......|++.|+|||.+....++.++||||||+++|++++|+.||.......... .. .
T Consensus 168 ~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~--~~------------~ 228 (293)
T cd06647 168 EQ-----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--LI------------A 228 (293)
T ss_pred cc-----cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee--eh------------h
Confidence 22 11223468899999999988889999999999999999999999996433211100 00 0
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 464 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
....+. ...+......+.+++.+||..+|++||++.+++..
T Consensus 229 ~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 229 TNGTPE--LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cCCCCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000011 11122334558899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=306.74 Aligned_cols=268 Identities=27% Similarity=0.390 Sum_probs=199.9
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
++|+..+.||+|+||.||+|.+. +++.||||+++... .......+.+|++++++++|+||+++++++.. ....+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~ 76 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR----KGRLY 76 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE----CCEEE
Confidence 36888899999999999999876 48899999987543 23334568999999999999999999999876 45789
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||++++.|..++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++....
T Consensus 77 iv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~ 151 (288)
T cd07833 77 LVFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALR 151 (288)
T ss_pred EEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccC
Confidence 999999887776655432 44899999999999999999999998 9999999999999999999999999988765
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccc----
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD---- 457 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~---- 457 (632)
.... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||..................+..
T Consensus 152 ~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07833 152 ARPA----SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQE 227 (288)
T ss_pred CCcc----ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhh
Confidence 4321 122335688999999999887 8899999999999999999999998643221110000000000000
Q ss_pred ---cccccc--ccCCCC----CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 458 ---SGTVIS--ELPDPR----LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 458 ---~~~~~~--~~~~~~----l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
...... +..... ....++...+..+.+|+.+||..+|++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 228 LFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred hcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000000 000000 000122233566899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=300.37 Aligned_cols=254 Identities=23% Similarity=0.337 Sum_probs=199.4
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC----CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG----GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~----~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
.+|.+.+.||+|+||.||+|.+. ++..||+|++.... .......|.+|++++++++|+||+++++++.... ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~--~~ 79 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE--EK 79 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC--CC
Confidence 46888899999999999999875 48999999875321 2233456889999999999999999999876532 34
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++
T Consensus 80 ~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 80 KLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence 678999999999999998753 34889999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
........ ........|+..|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------------- 217 (264)
T cd06653 155 RIQTICMS--GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA--------------- 217 (264)
T ss_pred cccccccc--CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH---------------
Confidence 65421110 1112345689999999999988899999999999999999999999964321110
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
+............|......+.+++.+||. +|..||++.+++.
T Consensus 218 --~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 218 --IFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred --HHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 001111111123445555668999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=321.14 Aligned_cols=197 Identities=26% Similarity=0.329 Sum_probs=171.4
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-C-----CCccceeeeeecccCCc
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-H-----CHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H-----pniv~l~g~~~~~~~~~ 298 (632)
+|.+.+.||+|+||.|-++.+. +++.||||+++... ....+-..|+.+|..|+ | -|+|++++|+.. .
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f----r 260 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF----R 260 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc----c
Confidence 7899999999999999999865 49999999998653 33344678999999996 4 389999999986 6
Q ss_pred ceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCC--CCeEEeccc
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN--LNAKITDLG 376 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~--~~vkL~DFG 376 (632)
.+.+||+|.+ .-+|+++|+.+...+++...+..|+.||+.||.+||+.+ |||+||||+||||.+- ..+||+|||
T Consensus 261 ~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 261 NHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred cceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecc
Confidence 7899999999 679999999888888999999999999999999999998 9999999999999653 369999999
Q ss_pred cceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCcc
Q 006750 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (632)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~ 440 (632)
.|...... .-....+..|.|||++.+.+|+.+.||||||||+.||++|.+-|.+..
T Consensus 337 SSc~~~q~--------vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 337 SSCFESQR--------VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred cccccCCc--------ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 99876532 224567889999999999999999999999999999999977665543
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=308.00 Aligned_cols=267 Identities=21% Similarity=0.322 Sum_probs=196.2
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
+|+..+.||.|+||.||+|+.. +|+.||||+++.... ......+.+|++++++++||||+++++++.. ....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~~ 76 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT----ENKLYL 76 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc----CCcEEE
Confidence 4778899999999999999875 589999999875432 2233458899999999999999999998865 457799
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||+. ++|.+++.......+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 77 v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~ 152 (284)
T cd07860 77 VFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 152 (284)
T ss_pred Eeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999995 68999987655566899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCC-CCcccchHhHhHHHHHHHhCCCCCCCccccccc-hheeccccc-------
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGR-ASLMSDVFSFGVVLLELITGRQPIHRSITKGEE-SLVLWATPR------- 454 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~-~~~~~~~~~------- 454 (632)
.. .......+++.|+|||++.+.. ++.++||||||+++|||+||+.||......... ....+....
T Consensus 153 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07860 153 PV-----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 227 (284)
T ss_pred Cc-----cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhh
Confidence 21 1122335788999999887644 688999999999999999999999643321100 000000000
Q ss_pred ccc---ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 455 LQD---SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 455 ~~~---~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
... ............+. .........+.+++.+||+.||.+||++.++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 228 VTSLPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhHHHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000 00000000000000 0011123447889999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=308.68 Aligned_cols=248 Identities=22% Similarity=0.336 Sum_probs=206.1
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC-hHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~-~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
-|...+.||+|.|..|-+|++- .|..||||++....... ....+.+|+..|+.++|||||+||.+... +..+||
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT----QTKlyL 94 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT----QTKLYL 94 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc----cceEEE
Confidence 3666788999999999999743 59999999997654332 23458899999999999999999987654 668899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEec-CCCCeEEeccccceecc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLK 382 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~-~~~~vkL~DFGla~~~~ 382 (632)
|+|+-.+|+|++||-... .++.+..+.+++.||+.|+.|+|..+ +|||||||+||.+- .-|-+||+|||++..+.
T Consensus 95 iLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 999999999999996543 56999999999999999999999998 99999999999774 45779999999998776
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCC-CcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
++ .......|++.|-|||++.+..| .+++||||||||||.|++|++||+...+.+-
T Consensus 171 PG------~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET----------------- 227 (864)
T KOG4717|consen 171 PG------KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET----------------- 227 (864)
T ss_pred Cc------chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-----------------
Confidence 54 34556789999999999998776 5689999999999999999999976554321
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
+..+.|-. ...|...+.+..+||..||..||.+|.+.++|+..
T Consensus 228 LTmImDCK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 228 LTMIMDCK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred hhhhhccc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 22222222 24677788889999999999999999999999864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=340.61 Aligned_cols=262 Identities=28% Similarity=0.412 Sum_probs=198.8
Q ss_pred HHhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccC---
Q 006750 221 EHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--- 296 (632)
Q Consensus 221 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~--- 296 (632)
..-..+|+..+.||+||||.|||++.+ ||+.||||++.............+|+.+|++|+|||||+++..+.+...
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 344567888899999999999999876 7999999999876544555568899999999999999998754321000
Q ss_pred --------------------------------------------------------------------------------
Q 006750 297 -------------------------------------------------------------------------------- 296 (632)
Q Consensus 297 -------------------------------------------------------------------------------- 296 (632)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred --------------------------------CcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHH
Q 006750 297 --------------------------------KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 344 (632)
Q Consensus 297 --------------------------------~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yL 344 (632)
....+||-||||+.-.|.++++++... -.....++++.+|+.||+|+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHH
Confidence 014678999999998888888765322 14678899999999999999
Q ss_pred HhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc----c--------CCCCCC-CCCCCccccCCCCCChhhhhcC
Q 006750 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK----A--------DGLPSC-SSSPARMQGTFGYFAPEYAMVG 411 (632)
Q Consensus 345 H~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~----~--------~~~~~~-~~~~~~~~GT~~Y~APE~~~~~ 411 (632)
|++| ||||||||.||+|+++..|||+|||+|.... . +..... ....+..+||.-|+|||++.+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9999 9999999999999999999999999998722 0 011111 1245678899999999999754
Q ss_pred ---CCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccCCCCCCCC--CCHHHHHHHHHHH
Q 006750 412 ---RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGD--FPKEEMQIMAYLA 486 (632)
Q Consensus 412 ---~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~--~~~~~~~~l~~li 486 (632)
.|+.|+|+|||||||+||+. ||....+... .+..+.++.++.+ +.......=+.+|
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~----------------iL~~LR~g~iP~~~~f~~~~~~~e~slI 851 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERAS----------------ILTNLRKGSIPEPADFFDPEHPEEASLI 851 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHHHHH----------------HHHhcccCCCCCCcccccccchHHHHHH
Confidence 49999999999999999984 5654333211 1222223332222 2333334456899
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 006750 487 KECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 487 ~~cl~~dP~~RPs~~evl~ 505 (632)
.++++.||.+|||+.|+++
T Consensus 852 ~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 852 RWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHhcCCCccCCCHHHHhh
Confidence 9999999999999999986
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=304.72 Aligned_cols=254 Identities=26% Similarity=0.409 Sum_probs=203.0
Q ss_pred HhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 222 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 222 ~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
..++.|+..+.||+|+||.||+|.+. ++..||+|++..... ....+.+|+++++.++|+|++++++++.. ...
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~ 89 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLV----GDE 89 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEE----CCE
Confidence 45667888899999999999999986 588999999976533 44568999999999999999999999876 457
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.|+|+||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+|||++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 165 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQ 165 (286)
T ss_pred EEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhh
Confidence 899999999999999998643 36999999999999999999999988 99999999999999999999999999875
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
..... .......++..|+|||++.+..++.++||||||+++|+|++|+.||.......... .+.
T Consensus 166 ~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~--~~~--------- 229 (286)
T cd06614 166 LTKEK-----SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF--LIT--------- 229 (286)
T ss_pred hccch-----hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHH---------
Confidence 54321 11223457889999999988889999999999999999999999986432211100 000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
... .+.. ..+...+..+.+++.+||+.+|.+||++.++++.
T Consensus 230 --~~~-~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 230 --TKG-IPPL--KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred --hcC-CCCC--cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 000 0000 0111234558899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=301.70 Aligned_cols=248 Identities=25% Similarity=0.315 Sum_probs=199.7
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
+|.+.+.||.|+||.||++... +++.||+|.+..... ......+.+|++++++++||||+++++++.. ....+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 76 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD----EENMY 76 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC----CCeEE
Confidence 4778899999999999999876 489999999975432 2345568999999999999999999988764 55789
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++....
T Consensus 77 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~ 151 (258)
T cd05578 77 LVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVT 151 (258)
T ss_pred EEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccC
Confidence 999999999999999764 46899999999999999999999998 9999999999999999999999999987664
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 462 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (632)
... ......|+..|+|||++....++.++|+||||+++|+|++|+.||............
T Consensus 152 ~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------------- 211 (258)
T cd05578 152 PDT------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR-------------- 211 (258)
T ss_pred CCc------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH--------------
Confidence 331 123345889999999999888999999999999999999999999754321111100
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 006750 463 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM--SEVV 504 (632)
Q Consensus 463 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl 504 (632)
..... .....+...+..+.+++.+||..||.+||++ .+++
T Consensus 212 ~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 212 AKQET--ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HHhcc--ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 00000 1112233344668899999999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=312.09 Aligned_cols=270 Identities=21% Similarity=0.257 Sum_probs=199.9
Q ss_pred hhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccC--Cc
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KR 298 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~--~~ 298 (632)
..++|+..+.||+|+||.||+|... +|+.||||++.... .......+.+|+.++++++||||+++++++..... ..
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999875 58999999986432 22334457889999999999999999998764321 22
Q ss_pred ceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccc
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 378 (632)
...|+||||+. ++|.+.+... +++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccc
Confidence 35799999995 6888887542 889999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe----------
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV---------- 448 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~---------- 448 (632)
+...... ......||..|+|||.+.+..++.++||||||+++|+|++|+.||............
T Consensus 166 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 239 (353)
T cd07850 166 RTAGTSF------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE 239 (353)
T ss_pred eeCCCCC------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 8654321 122345889999999999999999999999999999999999999643211100000
Q ss_pred ----------eccccccccccccccccC----CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 449 ----------LWATPRLQDSGTVISELP----DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 449 ----------~~~~~~~~~~~~~~~~~~----~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+.............++. .+......+......+.+++.+||+.||.+|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000000000111 0111111122345568899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=307.60 Aligned_cols=248 Identities=27% Similarity=0.387 Sum_probs=195.1
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC--ChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
..|...+.||+|+||.||+|... +|+.||+|.+...... .....+.+|+++++.++||||+++++++.. ....
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~----~~~~ 90 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR----EHTA 90 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe----CCeE
Confidence 45788899999999999999875 5899999998644322 233458899999999999999999999876 4467
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||||++ |+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++...
T Consensus 91 ~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 91 WLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred EEEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceec
Confidence 99999996 68877775432 45899999999999999999999998 999999999999999999999999998764
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhh---cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
... ....|++.|+|||++. ...++.++||||||+++|||++|+.||.............
T Consensus 166 ~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~--------- 227 (307)
T cd06607 166 SPA---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA--------- 227 (307)
T ss_pred CCC---------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHh---------
Confidence 322 2345788999999874 4568899999999999999999999986432211000000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 507 (632)
....+.+ .+...+..+.+++.+||..+|++||++.+|+...
T Consensus 228 -----~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 228 -----QNDSPTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred -----cCCCCCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0000111 1223445689999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=312.24 Aligned_cols=274 Identities=23% Similarity=0.297 Sum_probs=199.2
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccC-CcceE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG-KRAMR 301 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~-~~~~~ 301 (632)
.++|.+.+.||+|+||.||+|... +|+.||||++...........+.+|+.++++++||||+++++++..... .....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 578999999999999999999865 5899999998754434445568899999999999999999988764321 23457
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||||+. ++|.+++.. +.+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeec
Confidence 99999995 588887754 45899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe-ec-cccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV-LW-ATPRLQDS 458 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~-~~-~~~~~~~~ 458 (632)
...... ........||..|+|||.+.+ ..++.++||||||+++|+|++|+.||............ .. ..+.....
T Consensus 157 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 157 DPEHDH--TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred cccccc--cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 432211 112234568999999998764 56899999999999999999999999643211100000 00 00000000
Q ss_pred c--------ccccccCCC-CCC-CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 459 G--------TVISELPDP-RLK-GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 459 ~--------~~~~~~~~~-~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
. ......... ... .......+..+.+++.+||+.+|++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 000000000 000 00001224458899999999999999999999885
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=303.00 Aligned_cols=245 Identities=28% Similarity=0.400 Sum_probs=191.7
Q ss_pred eeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEeCC
Q 006750 233 VGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 309 (632)
Q Consensus 233 LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey~~ 309 (632)
||+|+||+||++... +|+.||+|.+.... .......+..|+++|++++||||+++++++.. ....|+||||++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~e~~~ 76 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET----KDDLCLVMTLMN 76 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec----CCeEEEEEecCC
Confidence 689999999999865 58999999986532 12234457889999999999999999988765 457799999999
Q ss_pred CCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCCCCC
Q 006750 310 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 389 (632)
Q Consensus 310 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 389 (632)
+++|.+++.......+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++.......
T Consensus 77 ~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---- 149 (277)
T cd05577 77 GGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---- 149 (277)
T ss_pred CCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC----
Confidence 999999997655456999999999999999999999998 9999999999999999999999999987654321
Q ss_pred CCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccCCCC
Q 006750 390 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 469 (632)
Q Consensus 390 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (632)
......++..|+|||++.+..++.++||||||+++|+|++|+.||............ ......
T Consensus 150 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------------~~~~~~-- 212 (277)
T cd05577 150 --KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL-------------KRRTLE-- 212 (277)
T ss_pred --ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH-------------Hhcccc--
Confidence 122345788999999998888999999999999999999999999654321110000 000000
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006750 470 LKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQ 505 (632)
Q Consensus 470 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 505 (632)
.....+...+..+.+++.+||+.+|.+|| ++.+++.
T Consensus 213 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 213 MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 01112233345588999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=303.09 Aligned_cols=266 Identities=25% Similarity=0.389 Sum_probs=197.6
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV 304 (632)
+|+..+.||.|++|.||+|... +|+.||||.++..........+.+|+.++++++||||+++++++.. ....++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv 76 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT----ENKLMLV 76 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee----CCcEEEE
Confidence 4778899999999999999986 4899999999865444444567899999999999999999999876 4467999
Q ss_pred EEeCCCCChhhhhhccc-cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 305 FEFMPNGNLRDCLDGVL-VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
|||++ ++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||+++....
T Consensus 77 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~ 152 (284)
T cd07836 77 FEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGI 152 (284)
T ss_pred EecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence 99997 58999886533 235899999999999999999999998 99999999999999999999999999975533
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccchh--eeccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL--VLWATPRLQDSGT 460 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~--~~~~~~~~~~~~~ 460 (632)
.. .......++..|+|||++.+. .++.++||||||+++|+|++|+.||........... ..+..+.... ..
T Consensus 153 ~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 226 (284)
T cd07836 153 PV-----NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTEST-WP 226 (284)
T ss_pred Cc-----cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh-HH
Confidence 21 112234578899999988664 578999999999999999999999965432211000 0000000000 00
Q ss_pred cccccCC--CCCC-------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 461 VISELPD--PRLK-------GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 461 ~~~~~~~--~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.+..... .... ....+..+..+.+++.+||+.||.+||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 227 GISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 0000 0111223456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=320.70 Aligned_cols=251 Identities=23% Similarity=0.356 Sum_probs=201.2
Q ss_pred CccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV 304 (632)
-|.+...||.|+||.||+|..++ +-..|-|++... .....++|+-||+||....||+||+|++.|.. .+.++|+
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~----enkLwil 107 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYF----ENKLWIL 107 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhc----cCceEEE
Confidence 35556779999999999998776 445667777654 34556679999999999999999999988765 5578999
Q ss_pred EEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccC
Q 006750 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 384 (632)
.|||.||-....+-. ..+.+.+.++..++.|++.||.|||++. |||||||+.|||++-+|.++|+|||.+......
T Consensus 108 iEFC~GGAVDaimlE-L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t 183 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLE-LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST 183 (1187)
T ss_pred EeecCCchHhHHHHH-hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH
Confidence 999999999888754 3467999999999999999999999998 999999999999999999999999998654321
Q ss_pred CCCCCCCCCCccccCCCCCChhhhh-----cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc
Q 006750 385 GLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 385 ~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
......+.|||.|||||+.+ ..+|+.++||||||++|.||.-+.+|-+...+.. ...
T Consensus 184 -----~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR---Vll---------- 245 (1187)
T KOG0579|consen 184 -----RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---VLL---------- 245 (1187)
T ss_pred -----HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH---HHH----------
Confidence 12344578999999999886 4679999999999999999999999976433211 000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+.+--.|.+. -|......+.+++++||..||..||++.++++.
T Consensus 246 -KiaKSePPTLl--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 246 -KIAKSEPPTLL--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -HHhhcCCCccc--CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 11111223332 356667789999999999999999999999873
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=305.99 Aligned_cols=269 Identities=23% Similarity=0.340 Sum_probs=199.4
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
++|+..+.||.|+||.||+|.+. +++.+|+|.++..... .....+.+|+.++++++||||+++++++.... ....|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--~~~~~ 82 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN--LDKIY 82 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC--CCcEE
Confidence 46888899999999999999986 4899999999754322 22334788999999999999999999886532 25789
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||++ ++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+|||++.++.++|+|||++....
T Consensus 83 lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred EEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 9999996 59999887543 35899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccch-hee---------cc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEES-LVL---------WA 451 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~-~~~---------~~ 451 (632)
... .......+++.|+|||++.+. .++.++||||||+++|||++|..||.......... ... |.
T Consensus 158 ~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (293)
T cd07843 158 SPL-----KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232 (293)
T ss_pred CCc-----cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence 431 112234578899999988754 46899999999999999999999996543211100 000 00
Q ss_pred cc-cccccc-ccccccCCCCCCCCCCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 452 TP-RLQDSG-TVISELPDPRLKGDFPKE-EMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 452 ~~-~~~~~~-~~~~~~~~~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.. .+.... ..........+...++.. ....+.+++.+||+.+|++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 000000 000111111122223322 3556889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=303.90 Aligned_cols=271 Identities=22% Similarity=0.272 Sum_probs=195.3
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhc-CCCCccceeeeeecccC-Ccce
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRG-KRAM 300 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~-~~~~ 300 (632)
++|+..+.||+|+||.||+|.+. +|+.||||+++..... .....+.+|+.+++.+ +||||+++++++..... ....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999875 5899999998754322 2234588999999999 57999999998875332 2234
Q ss_pred EEEEEEeCCCCChhhhhhccc---cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC-CCCeEEeccc
Q 006750 301 RLLVFEFMPNGNLRDCLDGVL---VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKITDLG 376 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~-~~~vkL~DFG 376 (632)
.|+||||+++ +|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999975 8999886432 235899999999999999999999998 999999999999998 8899999999
Q ss_pred cceecccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccch-heec-ccc
Q 006750 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES-LVLW-ATP 453 (632)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~-~~~~-~~~ 453 (632)
+++.+.... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.......... .... ..+
T Consensus 157 ~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 231 (295)
T cd07837 157 LGRAFSIPV-----KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTP 231 (295)
T ss_pred cceecCCCc-----cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 988653321 11222357889999998865 457999999999999999999999996533211100 0000 000
Q ss_pred ccccccccccccC----CCCCC----CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 454 RLQDSGTVISELP----DPRLK----GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 454 ~~~~~~~~~~~~~----~~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
..... ....... .+... ....+.....+.+++.+||..||.+||++.+++.
T Consensus 232 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 232 TEQVW-PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred ChhhC-cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000 0000000 00000 0001123455889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=294.10 Aligned_cols=255 Identities=25% Similarity=0.385 Sum_probs=204.9
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
+|...+.||+|++|.||+|... +++.|++|++..... ....+.+.+|+.++++++||||+++++.+.... ....++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~~l 78 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE--KNTLNI 78 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC--CCeEEE
Confidence 4677889999999999999987 589999999876532 234556899999999999999999999887532 257899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 79 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 79 FLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 999999999999997643 6899999999999999999999988 99999999999999999999999999987754
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (632)
.... .......++..|+|||.+.....+.++||||||+++|+|++|+.||........ . ..
T Consensus 154 ~~~~---~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~-------------~~ 214 (260)
T cd06606 154 IETG---EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA---A-------------LY 214 (260)
T ss_pred cccc---ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---H-------------HH
Confidence 4210 012335688999999999888899999999999999999999999965431100 0 01
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 464 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+.........+...+..+.+++.+||..+|++||++.++++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 215 KIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred hccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 1111111122334445669999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=322.24 Aligned_cols=245 Identities=24% Similarity=0.378 Sum_probs=194.8
Q ss_pred ceeeeeCceEEEEEEECC-CcEEEEEEec---cCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEE
Q 006750 231 NIVGQGGSSYVYRGQLTD-GRIVAVKRFK---TQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~---~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~E 306 (632)
.+||+|+|-+||+|.+.. |-.||--.++ ....+...++|..|+.+|+.|+||||++++.++.+..+ ....+|+|
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n--~~in~iTE 123 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN--KTINFITE 123 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC--ceeeeeee
Confidence 569999999999998753 7777744333 33445556789999999999999999999999887654 57789999
Q ss_pred eCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC-CCCeEEeccccceecccCC
Q 006750 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKITDLGMAKRLKADG 385 (632)
Q Consensus 307 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~-~~~vkL~DFGla~~~~~~~ 385 (632)
.+..|+|..|+.+. +.++...+..|+.||++||.|||++. |||||||||-+||+|+. -|.|||+|+|||......
T Consensus 124 L~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s- 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS- 199 (632)
T ss_pred cccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc-
Confidence 99999999999865 45889999999999999999999985 67999999999999975 588999999999987643
Q ss_pred CCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccccccc
Q 006750 386 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 465 (632)
Q Consensus 386 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (632)
......|||.|||||++. ..|.+.+||||||+.++||+|+..||.......... .+++..+
T Consensus 200 ------~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIY------------KKV~SGi 260 (632)
T KOG0584|consen 200 ------HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIY------------KKVTSGI 260 (632)
T ss_pred ------ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHH------------HHHHcCC
Confidence 233478999999999877 789999999999999999999999996544332111 0111111
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 466 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 466 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
....+..--. ..+.+||.+|+.. ..+|||+.|+++
T Consensus 261 KP~sl~kV~d----Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 261 KPAALSKVKD----PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred CHHHhhccCC----HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 1111111111 2388999999999 999999999997
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=302.84 Aligned_cols=266 Identities=21% Similarity=0.320 Sum_probs=196.2
Q ss_pred ccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEE
Q 006750 227 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV 304 (632)
|+..+.||.|++|.||+|.+. +|..||||++...... .....+.+|+++++.++|||++++++++.. ....|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~----~~~~~iv 76 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS----ENKLYLV 76 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc----CCeEEEE
Confidence 566789999999999999875 5999999998754322 223458899999999999999999999875 4578999
Q ss_pred EEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccC
Q 006750 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 384 (632)
|||+ +++|.+++.......+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||+++.....
T Consensus 77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~ 152 (283)
T cd07835 77 FEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVP 152 (283)
T ss_pred Eecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCC
Confidence 9999 579999987654446899999999999999999999988 999999999999999999999999999765322
Q ss_pred CCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccc-hheecccc-------cc
Q 006750 385 GLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEE-SLVLWATP-------RL 455 (632)
Q Consensus 385 ~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~-~~~~~~~~-------~~ 455 (632)
. .......+++.|+|||++.+. .++.++||||||+++|+|++|+.||......... ....+... ..
T Consensus 153 ~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (283)
T cd07835 153 V-----RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV 227 (283)
T ss_pred c-----cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhh
Confidence 1 112223568899999987654 5789999999999999999999999654321110 00000000 00
Q ss_pred cc---ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 456 QD---SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 456 ~~---~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.. ..........+... ......+..+.+++.+||+.+|.+|||+.++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 228 TSLPDYKPTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhchhhhhhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 00000000000000 1112233458899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=302.16 Aligned_cols=247 Identities=23% Similarity=0.372 Sum_probs=195.9
Q ss_pred ccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEE
Q 006750 227 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 305 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~ 305 (632)
|...+.||+|++|.||++... +++.+|+|++.... ....+.+.+|+.+++.++||||+++++++.. ....++|+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~----~~~~~~v~ 95 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLV----GDELWVVM 95 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEc----CCeEEEEE
Confidence 444578999999999999864 58999999986543 2334558899999999999999999998875 45779999
Q ss_pred EeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCC
Q 006750 306 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 385 (632)
Q Consensus 306 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 385 (632)
||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||+|+||+++.++.++|+|||++.......
T Consensus 96 e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 96 EFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169 (285)
T ss_pred eccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence 99999999999876 35899999999999999999999998 9999999999999999999999999887554321
Q ss_pred CCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccccccc
Q 006750 386 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 465 (632)
Q Consensus 386 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (632)
.......|++.|+|||.+.+..++.++||||||+++|||++|+.||........... +...
T Consensus 170 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~--------------~~~~ 230 (285)
T cd06648 170 -----PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR--------------IRDN 230 (285)
T ss_pred -----cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHH--------------HHhc
Confidence 112234589999999999888899999999999999999999999864322111000 0001
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 466 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 466 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
..+... .+...+..+.+++.+||+.+|++||++.++++
T Consensus 231 ~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 231 LPPKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCCCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 111111 11113345899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=312.73 Aligned_cols=274 Identities=22% Similarity=0.296 Sum_probs=200.0
Q ss_pred hhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccC-CCCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcc
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQ-GGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~ 299 (632)
..++|++.+.||+|+||.||+|.+. +|+.+|||++... ........+.+|+.+++++ +||||+++++++.... ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~--~~ 82 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN--DK 82 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC--Cc
Confidence 4567888899999999999999876 4889999988643 2223334577899999999 9999999999886522 34
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..|+||||++ ++|.+++... .++|..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 6799999996 6999988653 5889999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccc--
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ-- 456 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~-- 456 (632)
..................||..|+|||++.+ ..++.++||||||+++|+|++|+.||....................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 7654322111122334568999999998764 5678999999999999999999999964332211000000000000
Q ss_pred --------cccccccccCC---CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 457 --------DSGTVISELPD---PRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 457 --------~~~~~~~~~~~---~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.....+..+.. ..+. ......+..+.+++.+||+.||++|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLD-ELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchh-hhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000000 0000 0111134568899999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=298.63 Aligned_cols=243 Identities=26% Similarity=0.365 Sum_probs=194.9
Q ss_pred eeeeCceEEEEEEECC-CcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEeCC
Q 006750 233 VGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 309 (632)
Q Consensus 233 LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey~~ 309 (632)
||.|+||.||++.... ++.||+|++..... ......+.+|+.++++++||||+++++++.+ ....++||||++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~ 76 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD----KKYIYMLMEYCL 76 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc----CCccEEEEecCC
Confidence 6899999999999864 89999999875432 2344569999999999999999999998765 456799999999
Q ss_pred CCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCCCCC
Q 006750 310 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 389 (632)
Q Consensus 310 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 389 (632)
+++|.+++.+. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 ~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---- 147 (262)
T cd05572 77 GGELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---- 147 (262)
T ss_pred CCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc----
Confidence 99999999764 34899999999999999999999988 9999999999999999999999999998764321
Q ss_pred CCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccCCCC
Q 006750 390 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 469 (632)
Q Consensus 390 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (632)
......|+..|+|||.+....++.++|+||||+++|+|++|..||......... ....+....
T Consensus 148 --~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------~~~~~~~~~ 210 (262)
T cd05572 148 --KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME---------------IYNDILKGN 210 (262)
T ss_pred --ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH---------------HHHHHhccC
Confidence 122345889999999998888999999999999999999999999654321100 011111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006750 470 LKGDFPKEEMQIMAYLAKECLQLDPDARPT-----MSEVVQ 505 (632)
Q Consensus 470 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 505 (632)
....+|......+.+++.+||..+|++||+ +.|+++
T Consensus 211 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 211 GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 112233333556899999999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=315.45 Aligned_cols=250 Identities=28% Similarity=0.343 Sum_probs=207.6
Q ss_pred HhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 222 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 222 ~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
.-...|.+...||+|.|+.|.+|+.. .+..||||.+...... .....+.+|+++|+.|+|||||+++.+... ..
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t----~~ 128 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET----EA 128 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee----cc
Confidence 44577899999999999999999865 4899999999866433 333458999999999999999999998875 66
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
.+|+||||+.+|.|++||... ..+...++..++.|+.+|++|||+++ |+|||||++||||+.+.++||+|||++.
T Consensus 129 ~lylV~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~ 203 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFST 203 (596)
T ss_pred eeEEEEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccce
Confidence 899999999999999999765 33666899999999999999999998 9999999999999999999999999999
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCC-CcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
.+... .......|++.|.|||++.+..| ++++|+||+|++||-|+.|.+||++..-.
T Consensus 204 ~~~~~------~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk---------------- 261 (596)
T KOG0586|consen 204 FFDYG------LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK---------------- 261 (596)
T ss_pred eeccc------ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc----------------
Confidence 88643 34556789999999999998664 88999999999999999999999754322
Q ss_pred cccccccCCCCCCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006750 459 GTVISELPDPRLKG--DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507 (632)
Q Consensus 459 ~~~~~~~~~~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 507 (632)
++.++.+.+ .+|........+|++++|.++|.+|++++++.+.-
T Consensus 262 -----~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 262 -----ELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred -----cccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 222222221 12333444578899999999999999999998743
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=301.40 Aligned_cols=243 Identities=26% Similarity=0.346 Sum_probs=185.9
Q ss_pred eeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC--ChHHHHHHHHHHHHh---cCCCCccceeeeeecccCCcceEEEEE
Q 006750 232 IVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSR---LHHCHVVPLVGYCSEFRGKRAMRLLVF 305 (632)
Q Consensus 232 ~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~f~~Ei~~l~~---l~Hpniv~l~g~~~~~~~~~~~~~lV~ 305 (632)
.||+|+||.||++... +++.+|+|.+...... .....+.+|..+++. .+||||+.+++++.. ....++||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~ 76 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT----PDKLCFIL 76 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec----CCeEEEEE
Confidence 4899999999999875 4899999998754322 222334555544443 479999999988875 44679999
Q ss_pred EeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCC
Q 006750 306 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 385 (632)
Q Consensus 306 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 385 (632)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||++.......
T Consensus 77 e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~ 151 (279)
T cd05633 77 DLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (279)
T ss_pred ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence 999999999998753 45999999999999999999999998 9999999999999999999999999987553221
Q ss_pred CCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccc
Q 006750 386 LPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 464 (632)
Q Consensus 386 ~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (632)
.....||..|+|||.+.. ..++.++||||||+++|||++|..||............. ...
T Consensus 152 -------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~------------~~~ 212 (279)
T cd05633 152 -------PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR------------MTL 212 (279)
T ss_pred -------ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH------------Hhh
Confidence 122458999999998864 568999999999999999999999996443221111000 000
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006750 465 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQI 506 (632)
Q Consensus 465 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 506 (632)
......+...+..+.+++.+||+.||.+|| ++.++++.
T Consensus 213 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 213 ----TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ----cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 011123333445688999999999999999 59988774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=304.40 Aligned_cols=277 Identities=22% Similarity=0.297 Sum_probs=196.7
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCccceeeeeecccC----C
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG----K 297 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~----~ 297 (632)
.++|+..+.||+|+||.||+|... +++.||||++...... .....+.+|+.++++++||||+++++++..... .
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 356888999999999999999875 4899999998654322 223346789999999999999999998865321 2
Q ss_pred cceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccc
Q 006750 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 377 (632)
....++||||+. ++|.+++.... ..+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 346699999995 58888886532 35899999999999999999999998 99999999999999999999999999
Q ss_pred ceecccCCCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccc----
Q 006750 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT---- 452 (632)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~---- 452 (632)
+.......... ........++..|+|||++.+. .++.++||||||+++|||++|+.||................
T Consensus 166 ~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 166 ARAFSLSKNSK-PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred cccccCCcccC-CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 98664322111 1122334578899999988764 47889999999999999999999986543211100000000
Q ss_pred ccc-ccc--cccccccCCCC-----CCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 453 PRL-QDS--GTVISELPDPR-----LKGDF-PKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 453 ~~~-~~~--~~~~~~~~~~~-----l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
+.. ... ......+..+. ..... +......+.+|+.+||..||.+|||+.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000 000 00000000000 00000 00012346789999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=310.94 Aligned_cols=276 Identities=22% Similarity=0.321 Sum_probs=202.4
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
.++|++.+.||+|+||.||+|... +|+.||+|++..... ......+.+|+.+|++++||||+++++++..........
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 467888999999999999999875 499999999875432 233455788999999999999999999876544445678
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
++||||+. |+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 6999998653 44899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec--cccc--c-
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATPR--L- 455 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~~--~- 455 (632)
....... ........|+..|+|||++.. ..++.++||||||+++|||++|+.||.............. ..+. .
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 158 SSSPTEH-KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred cccCcCC-CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 4432211 112234568999999998865 4689999999999999999999999965322110000000 0000 0
Q ss_pred -----ccccccccccCCC-CCC-CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 456 -----QDSGTVISELPDP-RLK-GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 456 -----~~~~~~~~~~~~~-~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
............. ... .......+..+.+++.+||+.+|++||++.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000000000 000 00112234568999999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=305.63 Aligned_cols=250 Identities=26% Similarity=0.381 Sum_probs=195.5
Q ss_pred ccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC--ChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 227 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
|...+.||+|+||.||+|+.. ++..||+|++...... .....+.+|+.++++++|||++++++++.. ....++
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~l 102 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR----EHTAWL 102 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee----CCeEEE
Confidence 666788999999999999875 5899999998754222 233458899999999999999999999876 456799
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||++ |+|.+++... ...+++.++..++.+++.||.|||+.+ |+||||+|+||+++.++.++|+|||++.....
T Consensus 103 v~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 103 VMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred EEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 999996 5888877543 345899999999999999999999998 99999999999999999999999999865432
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhh---cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
.....|++.|+|||++. .+.++.++||||||+++|||++|+.||..........
T Consensus 178 ---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~-------------- 234 (317)
T cd06635 178 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-------------- 234 (317)
T ss_pred ---------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH--------------
Confidence 12345889999999874 4568999999999999999999999986432111000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
.+.............+..+.+++.+||+.+|.+||++.++++.+..+.
T Consensus 235 ---~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 235 ---HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ---HHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 000000000112233455889999999999999999999998765543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=300.52 Aligned_cols=264 Identities=23% Similarity=0.269 Sum_probs=193.1
Q ss_pred ccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcceEEEE
Q 006750 227 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~~~lV 304 (632)
|++.+.||+|+||.||+|... +++.||+|+++............+|+.++.++ .|+|++++++++.+.. ....++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~--~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK--TGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC--CCcEEEE
Confidence 556788999999999999865 58999999987653333333456899999999 4999999999987632 2467999
Q ss_pred EEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccC
Q 006750 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 384 (632)
|||++ |+|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||||+||+++. +.+||+|||+++.....
T Consensus 79 ~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 79 FELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred EecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 99996 68888886532 45899999999999999999999998 999999999999999 99999999999866432
Q ss_pred CCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe-ecccc-------cc
Q 006750 385 GLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV-LWATP-------RL 455 (632)
Q Consensus 385 ~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~-~~~~~-------~~ 455 (632)
. ......++..|+|||++.. ..++.++|||||||++|||++|..||............ ..... ..
T Consensus 153 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 153 P------PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred C------CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 1 1123457899999997654 56789999999999999999999999654321100000 00000 00
Q ss_pred ccccccccccCCCCCCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 456 QDSGTVISELPDPRLKG----DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 456 ~~~~~~~~~~~~~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.... ......+.... ......+..+.+++.+||+.+|++||++.++++.
T Consensus 227 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 227 RKSR--HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccc--cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000 00000000000 0112345678999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=307.61 Aligned_cols=268 Identities=23% Similarity=0.330 Sum_probs=195.0
Q ss_pred eeeee--CceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEe
Q 006750 232 IVGQG--GSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 307 (632)
Q Consensus 232 ~LG~G--~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey 307 (632)
.||+| +||+||++.+. +|+.||||++..... ....+.+.+|+.+++.++||||+++++++.. ....++||||
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~----~~~~~~v~e~ 80 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT----GSWLWVISPF 80 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec----CCceEEEEec
Confidence 46666 99999999875 599999999875432 2234568899999999999999999999876 4567999999
Q ss_pred CCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCCC
Q 006750 308 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP 387 (632)
Q Consensus 308 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~ 387 (632)
+.+++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+.........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 99999999998765556899999999999999999999998 999999999999999999999999865433221111
Q ss_pred C--CCCCCCccccCCCCCChhhhhcC--CCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe-e------ccccccc
Q 006750 388 S--CSSSPARMQGTFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV-L------WATPRLQ 456 (632)
Q Consensus 388 ~--~~~~~~~~~GT~~Y~APE~~~~~--~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~-~------~~~~~~~ 456 (632)
. .........++..|+|||++.+. .++.++||||||+++|||++|+.||............ . +......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccc
Confidence 0 00111122356789999998763 4789999999999999999999999654321110000 0 0000000
Q ss_pred cc----------------cc-----cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 457 DS----------------GT-----VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 457 ~~----------------~~-----~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.. .. ....+....+....+......+.+|+.+||..||++|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00 00 0001111222223344566778999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=302.48 Aligned_cols=267 Identities=22% Similarity=0.332 Sum_probs=195.2
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
++|+..+.||+|+||.||+|.+. +|+.||+|++...... .....+.+|++++++++||||+++++++.. ....|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 77 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS----EKRLY 77 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec----CCeEE
Confidence 46888899999999999999876 5899999998654322 233458899999999999999999999875 45789
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC-CCCeEEeccccceec
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKITDLGMAKRL 381 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~-~~~vkL~DFGla~~~ 381 (632)
+||||++ ++|.+++.......+++..+..++.|++.||+|||+.+ ++||||+|+||+++. ++.+||+|||++...
T Consensus 78 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 78 LVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred EEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 9999995 68888886544444788899999999999999999998 999999999999985 557999999999765
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe--eccccc----
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV--LWATPR---- 454 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~--~~~~~~---- 454 (632)
.... .......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||............ .+..+.
T Consensus 154 ~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (294)
T PLN00009 154 GIPV-----RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETW 228 (294)
T ss_pred CCCc-----cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 3221 11223457899999998876 45789999999999999999999999654322111100 000000
Q ss_pred -----cccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 455 -----LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 455 -----~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
+.+............+. ......+..+.+++.+||+.+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 229 PGVTSLPDYKSAFPKWPPKDLA-TVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccccchhhhhhcccCCCCCHH-HhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000000000000000 011223345889999999999999999999986
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=304.75 Aligned_cols=271 Identities=25% Similarity=0.308 Sum_probs=197.4
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
.++|++.+.||+|+||.||+|.+. +|+.||+|+++..... .....+.+|+.++++++|+||+++++++.... ....
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~~ 83 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH--LDSI 83 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC--CCeE
Confidence 457888999999999999999975 4899999998754322 22234678999999999999999999886422 2467
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
++||||+. ++|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 84 FLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 99999995 58998887533 45899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe-ecccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV-LWATPRLQDSG 459 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~-~~~~~~~~~~~ 459 (632)
.... .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||............ .+.........
T Consensus 159 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07845 159 GLPA-----KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW 233 (309)
T ss_pred CCcc-----CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 5321 11222346788999998875 55799999999999999999999999654332211100 00000000000
Q ss_pred cccc--------ccCCCCCCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 460 TVIS--------ELPDPRLKG--DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 460 ~~~~--------~~~~~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.... .+....... ......+..+.+++.+||+.||++|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 000000000 0001124557889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=293.96 Aligned_cols=251 Identities=26% Similarity=0.366 Sum_probs=202.2
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
+|...+.||.|+||.||++.+. +++.||+|++..... ......+.+|+++++.++|||++++++.+.. ....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~----~~~~~l 76 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE----KGKLCI 76 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec----CCEEEE
Confidence 4777889999999999999876 489999999976533 2445568899999999999999999998775 357899
Q ss_pred EEEeCCCCChhhhhhccc--cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 304 VFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
||||+++++|.+++.... ...+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 153 (258)
T cd08215 77 VMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVL 153 (258)
T ss_pred EEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeec
Confidence 999999999999997643 356999999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
.... .......|++.|+|||.+....++.++||||||+++|+|++|+.||.......... .
T Consensus 154 ~~~~-----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~--------------~ 214 (258)
T cd08215 154 SSTV-----DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELAL--------------K 214 (258)
T ss_pred ccCc-----ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHH--------------H
Confidence 5432 12233468899999999988889999999999999999999999986432111000 0
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
......+ ..+......+.+++.+||..+|++||++.++++.
T Consensus 215 ~~~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 215 ILKGQYP----PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HhcCCCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000011 1222334458899999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.75 Aligned_cols=269 Identities=19% Similarity=0.253 Sum_probs=194.2
Q ss_pred cceeeeeCceEEEEEEECCCcEEEEEEeccC-CCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEeC
Q 006750 230 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQ-GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 308 (632)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~-~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey~ 308 (632)
.+.+|.|+++.||++.. +++.||||+++.. ........+.+|+.+++.++|+||+++++++.. ....+++|||+
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~----~~~~~~~~e~~ 81 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV----DSELYVVSPLM 81 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec----CCeEEEEEecc
Confidence 34455556666666654 5899999999765 233445569999999999999999999998875 45679999999
Q ss_pred CCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCCC-
Q 006750 309 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP- 387 (632)
Q Consensus 309 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~- 387 (632)
++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||.+.........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 82 AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 9999999998655556899999999999999999999998 999999999999999999999999998765432211
Q ss_pred -CCCCCCCccccCCCCCChhhhhc--CCCCcccchHhHhHHHHHHHhCCCCCCCccccccch--h----ee-cccccccc
Q 006750 388 -SCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES--L----VL-WATPRLQD 457 (632)
Q Consensus 388 -~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~--~----~~-~~~~~~~~ 457 (632)
..........++..|+|||++.. ..++.++||||||+++|||++|+.||.......... . .. +.......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhh
Confidence 11112234457889999999875 358899999999999999999999997532211000 0 00 00000000
Q ss_pred ccccccc----cCCCC----CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 458 SGTVISE----LPDPR----LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 458 ~~~~~~~----~~~~~----l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
....... ..++. ............+.+|+.+||+.||++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000000 00000 1112233445668899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=291.73 Aligned_cols=250 Identities=27% Similarity=0.441 Sum_probs=200.7
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV 304 (632)
.|+..+.||+|++|.||++... +++.+++|++..... .....+.+|+.++++++|+|++++++++.. ....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLK----KDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEec----CCeEEEE
Confidence 3677789999999999999986 589999999976543 345568999999999999999999998875 3567999
Q ss_pred EEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccC
Q 006750 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 384 (632)
+||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 76 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 76 MEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred EecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 99999999999987643 46899999999999999999999988 999999999999999999999999998776543
Q ss_pred CCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccc
Q 006750 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 464 (632)
Q Consensus 385 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (632)
.. .....|+..|+|||++....++.++||||||+++|+|++|+.||............ ..
T Consensus 152 ~~------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--------------~~ 211 (253)
T cd05122 152 KA------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI--------------AT 211 (253)
T ss_pred cc------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH--------------Hh
Confidence 21 23456889999999999888999999999999999999999998643211100000 00
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 465 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 465 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
...+.+.. +...+..+.+++.+||+.||.+|||+.++++.
T Consensus 212 ~~~~~~~~--~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 212 NGPPGLRN--PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cCCCCcCc--ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00011110 11123458899999999999999999999763
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=300.43 Aligned_cols=265 Identities=25% Similarity=0.333 Sum_probs=196.8
Q ss_pred ccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCccceeeeeecccCCcceEEEE
Q 006750 227 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~~~~~lV 304 (632)
|.+.+.||+|+||+||+|...+ ++.||||++.............+|+..+++++ ||||+++++++.. ....++|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~----~~~~~lv 76 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE----NDELYFV 76 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc----CCcEEEE
Confidence 5667889999999999999864 88999999876543333334678999999998 9999999998876 4577999
Q ss_pred EEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccC
Q 006750 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 384 (632)
|||+ +|+|.+++.......+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 77 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 77 FEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152 (283)
T ss_pred EecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence 9999 889999987655456899999999999999999999998 999999999999999999999999999865432
Q ss_pred CCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchh-e---------ecccc
Q 006750 385 GLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL-V---------LWATP 453 (632)
Q Consensus 385 ~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~-~---------~~~~~ 453 (632)
. ......++..|+|||++.. ..++.++||||||+++|||++|+.||........... . .|...
T Consensus 153 ~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd07830 153 P------PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEG 226 (283)
T ss_pred C------CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhH
Confidence 1 1223458899999998754 4579999999999999999999999865432111000 0 00000
Q ss_pred cc-c-cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 454 RL-Q-DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 454 ~~-~-~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.. . .....+.......+. .........+.+++.+||+.+|++||++.|++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 227 YKLASKLGFRFPQFAPTSLH-QLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhhhccccccccccccccHH-HHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00 0 000000000000000 0111113558899999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=288.13 Aligned_cols=258 Identities=27% Similarity=0.429 Sum_probs=203.7
Q ss_pred eeecHHHHHHhhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeee
Q 006750 213 IRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGY 290 (632)
Q Consensus 213 ~~~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~ 290 (632)
...+..+|+. +..||.|..|.|++++.+. |..+|||.+......++.++++..++++..- .-|.||+.+||
T Consensus 87 ~~~dindl~~-------l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~Gy 159 (391)
T KOG0983|consen 87 YQADINDLEN-------LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGY 159 (391)
T ss_pred cccChHHhhh-------HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeE
Confidence 3444555554 4679999999999998765 8999999999887777777888899887766 48999999999
Q ss_pred eecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCe
Q 006750 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA 370 (632)
Q Consensus 291 ~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~v 370 (632)
|.. ....++.||.| ..-++.+|.+ ..+++++..+-++...+++||.||.+++ .|+|||+||+|||+|+.|++
T Consensus 160 Fi~----n~dV~IcMelM-s~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~Gni 231 (391)
T KOG0983|consen 160 FIT----NTDVFICMELM-STCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNI 231 (391)
T ss_pred Eee----CchHHHHHHHH-HHHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCE
Confidence 986 34557889998 3445555544 4567999999999999999999999876 59999999999999999999
Q ss_pred EEeccccceecccCCCCCCCCCCCccccCCCCCChhhhh---cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchh
Q 006750 371 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL 447 (632)
Q Consensus 371 kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~ 447 (632)
||+|||++-++.+.. ..++..|-+.|||||.+. ...|+.++||||||+.|+||.||+.||.......+...
T Consensus 232 KlCDFGIsGrlvdSk------AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt 305 (391)
T KOG0983|consen 232 KLCDFGISGRLVDSK------AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT 305 (391)
T ss_pred Eeecccccceeeccc------ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH
Confidence 999999998876543 344567999999999986 35689999999999999999999999976544322110
Q ss_pred eeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 448 VLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.++.+.+ |.+.+.. ..+..+.+++..||..|+.+||.+.++++.
T Consensus 306 ------------kvln~eP-P~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 306 ------------KVLNEEP-PLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ------------HHHhcCC-CCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1122222 4443321 255669999999999999999999999874
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=293.95 Aligned_cols=249 Identities=27% Similarity=0.334 Sum_probs=200.4
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
+|++.+.||+|+||.||++... +++.+|+|.+.... .......+.+|+++++.++|+||+++++++.. ....++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~ 76 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD----GNKLCI 76 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc----CCEEEE
Confidence 4777899999999999999765 58899999987543 22334558899999999999999999988875 457899
Q ss_pred EEEeCCCCChhhhhhccc--cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 304 VFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
||||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++...
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~ 153 (256)
T cd08530 77 VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVL 153 (256)
T ss_pred EehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhh
Confidence 999999999999986522 245899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
.... .....|++.|+|||.+.+..++.++|+||||+++|||++|+.||.......... .
T Consensus 154 ~~~~-------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~--------------~ 212 (256)
T cd08530 154 KKNM-------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY--------------K 212 (256)
T ss_pred ccCC-------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--------------H
Confidence 5431 122357899999999999889999999999999999999999996433211000 0
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
+... .....+......+.+++.+||..+|++||++.++++.
T Consensus 213 ~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 213 VQRG----KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HhcC----CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 0112233445668999999999999999999999763
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=301.98 Aligned_cols=253 Identities=27% Similarity=0.417 Sum_probs=193.4
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcceEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
++|++.+.||+|+||.||+|.+.+ ++.||||+++..........+..|+.++.++ .||||+++++++.. ....|
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~~~ 90 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT----DSDVF 90 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec----CCeEE
Confidence 567788999999999999999875 8999999997654444445577888877777 59999999999876 45789
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHh-cCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
+||||+ +++|.+++... ...+++..+..++.|++.||+|||+ .+ |+||||+|+||++++++.+||+|||++...
T Consensus 91 ~v~e~~-~~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 91 ICMELM-STCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred EEeecc-CcCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 999998 45787776543 2468999999999999999999997 46 999999999999999999999999998765
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCC----CCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGR----ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 457 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~----~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~ 457 (632)
.... ......++..|+|||++.+.. ++.++||||||+++|||++|+.||.......+ .....
T Consensus 166 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~------- 231 (296)
T cd06618 166 VDSK------AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE-VLTKI------- 231 (296)
T ss_pred cCCC------cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH-HHHHH-------
Confidence 4321 112235788999999987554 78999999999999999999999964221100 00000
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006750 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507 (632)
Q Consensus 458 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 507 (632)
+... .+... ........+.+|+.+||+.||.+||++.++++.-
T Consensus 232 ----~~~~-~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 232 ----LQEE-PPSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred ----hcCC-CCCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 0000 00000 0111234588999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=296.15 Aligned_cols=267 Identities=24% Similarity=0.349 Sum_probs=196.6
Q ss_pred ccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCC-hHHHHHHHHHHHHhc---CCCCccceeeeeecccC-Ccce
Q 006750 227 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRL---HHCHVVPLVGYCSEFRG-KRAM 300 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~-~~~~f~~Ei~~l~~l---~Hpniv~l~g~~~~~~~-~~~~ 300 (632)
|++.+.||+|+||.||+|+++. ++.||+|+++...... ....+.+|+.+++++ +|||++++++++..... ....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5667899999999999999875 8999999997543222 233467788877766 59999999999876432 2234
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.+++|||++ ++|.+++.......+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence 799999996 58999887654446999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccch-h---------eec
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES-L---------VLW 450 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~-~---------~~~ 450 (632)
..... ......++..|+|||++.+..++.++||||||+++|||++|+.||.......... . ..|
T Consensus 157 ~~~~~------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 157 YSFEM------ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEW 230 (287)
T ss_pred ccCCc------ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhc
Confidence 64332 1223357889999999999999999999999999999999999986543211100 0 000
Q ss_pred cccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 451 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 451 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
....... ............ ..........+.+++.+||+.||.+||++.++++
T Consensus 231 ~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 231 PRNVSLP-RSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCcccc-hhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000 000000000000 1112234456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=299.69 Aligned_cols=207 Identities=25% Similarity=0.334 Sum_probs=168.5
Q ss_pred CccccceeeeeCceEEEEEEECC---CcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLTD---GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~---g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
+|.+.+.||+|+||.||+|.... ++.||+|.+.... .......+.+|+.++++++||||+++++++.... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~ 78 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHA--DKS 78 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC--Cce
Confidence 47778899999999999998754 7899999998632 1223345788999999999999999999987632 357
Q ss_pred EEEEEEeCCCCChhhhhhccc---cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC----CCCeEEe
Q 006750 301 RLLVFEFMPNGNLRDCLDGVL---VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE----NLNAKIT 373 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~----~~~vkL~ 373 (632)
.++||||++ ++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+
T Consensus 79 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~ 154 (316)
T cd07842 79 VYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIG 154 (316)
T ss_pred EEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEEC
Confidence 899999996 57777764322 125889999999999999999999998 999999999999999 9999999
Q ss_pred ccccceecccCCCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCcc
Q 006750 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSI 440 (632)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~ 440 (632)
|||+++........ ........+|..|+|||++.+. .++.++||||||+++|+|++|+.||....
T Consensus 155 Dfg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 155 DLGLARLFNAPLKP--LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred CCccccccCCCccc--ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 99999876433211 1122345688999999988764 57999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=342.34 Aligned_cols=260 Identities=28% Similarity=0.395 Sum_probs=209.1
Q ss_pred HHHhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCC
Q 006750 220 LEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (632)
Q Consensus 220 l~~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 297 (632)
+...+-+|.....||.|.||.||-|... +|...|||-++.... ......+.+|+.+|..|+|||+|+++|+-..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH---- 1305 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH---- 1305 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec----
Confidence 5566778889999999999999999854 599999998875422 3334558899999999999999999998665
Q ss_pred cceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccc
Q 006750 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 377 (632)
+...+|.||||++|+|.+.++.. +-.++.....+..|++.|++|||+.| ||||||||.||||+.+|.+|++|||.
T Consensus 1306 Rekv~IFMEyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGs 1380 (1509)
T KOG4645|consen 1306 REKVYIFMEYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGS 1380 (1509)
T ss_pred HHHHHHHHHHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccc
Confidence 45678999999999999998643 33677777788899999999999999 99999999999999999999999999
Q ss_pred ceecccCCCCCCCCCCCccccCCCCCChhhhhcC---CCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccc
Q 006750 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG---RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 454 (632)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~---~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~ 454 (632)
|..+... ............||+.|||||++.+. ....++||||+||++.||+||+.||...... |+
T Consensus 1381 a~ki~~~-~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~a--- 1449 (1509)
T KOG4645|consen 1381 AVKIKNN-AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WA--- 1449 (1509)
T ss_pred eeEecCc-hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hH---
Confidence 9887654 22223455678899999999999754 3577899999999999999999999754432 11
Q ss_pred cccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 455 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 455 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+..+.. .-...+|+..+..=.+++..||..||..|.++.|+++.
T Consensus 1450 ------IMy~V~~-gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1450 ------IMYHVAA-GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ------HHhHHhc-cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1111111 11224666777888999999999999999999888764
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=299.64 Aligned_cols=268 Identities=25% Similarity=0.344 Sum_probs=197.3
Q ss_pred ccccceeeeeCceEEEEEEECC-CcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEE
Q 006750 227 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV 304 (632)
|++.+.||.|+||.||+|...+ ++.+|+|++.... .......+.+|++++++++|||++++++++.... ....++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG--KGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC--CCcEEEE
Confidence 5667899999999999998764 8999999998653 2233455889999999999999999999987632 2578999
Q ss_pred EEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccC
Q 006750 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 384 (632)
|||++ ++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++......
T Consensus 79 ~e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 79 FEYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ecccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 99996 58999886542 45899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec--ccccccccccc
Q 006750 385 GLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATPRLQDSGTV 461 (632)
Q Consensus 385 ~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~~~~~~~~~ 461 (632)
.. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.............. ..+.. .....
T Consensus 154 ~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 228 (287)
T cd07840 154 NS----ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTD-ENWPG 228 (287)
T ss_pred Cc----ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch-hhccc
Confidence 21 11223457889999997764 4579999999999999999999999975442211100000 00000 00000
Q ss_pred cccc-----CC------CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 462 ISEL-----PD------PRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 462 ~~~~-----~~------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
...+ .. ..+...+...++..+.+++.+||..+|.+||++.++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 229 VSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000 00 000000111124568899999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=300.38 Aligned_cols=275 Identities=25% Similarity=0.325 Sum_probs=199.0
Q ss_pred HhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeeccc----
Q 006750 222 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR---- 295 (632)
Q Consensus 222 ~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~---- 295 (632)
...++|++.+.||+|+||.||+|.+. +|+.||||+++.... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999986 489999999975432 223345788999999999999999999886533
Q ss_pred --CCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEe
Q 006750 296 --GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT 373 (632)
Q Consensus 296 --~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~ 373 (632)
......++||||+++ +|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence 112378999999975 777777653 345899999999999999999999998 9999999999999999999999
Q ss_pred ccccceecccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe-ecc
Q 006750 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV-LWA 451 (632)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~-~~~ 451 (632)
|||++........ .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||............ ...
T Consensus 159 dfg~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~ 234 (302)
T cd07864 159 DFGLARLYNSEES----RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLC 234 (302)
T ss_pred cccccccccCCcc----cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 9999987654321 11122346788999998865 45789999999999999999999999643321110000 000
Q ss_pred cccccccccccccc-----CC------CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 452 TPRLQDSGTVISEL-----PD------PRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 452 ~~~~~~~~~~~~~~-----~~------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
..........+.+. .+ ...... ....+..+.+++..||+.||.+||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000000000000 00 000000 11124458899999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.33 Aligned_cols=270 Identities=23% Similarity=0.328 Sum_probs=196.0
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccC--Ccc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRA 299 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~--~~~ 299 (632)
.++|...+.||+|+||.||+|... +|+.||||++.... .......+.+|+.+++.++||||+++++++..... ...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999865 58999999987532 22233458899999999999999999998864321 123
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..++|+||+. .+|.+++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||+++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 5699999995 47776653 34899999999999999999999998 9999999999999999999999999987
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccc----c
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP----R 454 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~----~ 454 (632)
.... ......+|..|+|||++.+ ..++.++||||||+++|||++|+.||................. .
T Consensus 166 ~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07879 166 HADA--------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE 237 (342)
T ss_pred CCCC--------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 5432 1223467889999999876 4689999999999999999999999975432111100000000 0
Q ss_pred ----ccc--ccc---cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhhh
Q 006750 455 ----LQD--SGT---VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI--LSTI 510 (632)
Q Consensus 455 ----~~~--~~~---~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i 510 (632)
... ... .........+...+ ......+.+|+.+||+.||.+||++.+++.. ++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 000 000 00000000000000 1123457899999999999999999999853 5444
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=288.13 Aligned_cols=248 Identities=27% Similarity=0.467 Sum_probs=200.4
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
+|++.+.||+|++|.||++... +++.||+|.+...... .....+.+|++++++++|||++++++++.. ....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~ 76 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET----SDSLYI 76 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe----CCEEEE
Confidence 4777899999999999999876 4889999999765432 344568999999999999999999998865 457899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 77 v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 151 (254)
T cd06627 77 ILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLND 151 (254)
T ss_pred EEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCC
Confidence 99999999999998764 45899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (632)
... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ..+.. .
T Consensus 152 ~~~-----~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~----~~~~~----------~ 212 (254)
T cd06627 152 VSK-----DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA----ALFRI----------V 212 (254)
T ss_pred Ccc-----cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH----HHHHH----------h
Confidence 321 1233468899999999988889999999999999999999999986432111 00000 0
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 464 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
....+ ..+...+..+.+++.+||..+|++||++.+++.
T Consensus 213 ~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 213 QDDHP----PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ccCCC----CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 00111 122233455889999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=294.79 Aligned_cols=245 Identities=23% Similarity=0.308 Sum_probs=186.6
Q ss_pred ceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHHHHH-hcCCCCccceeeeeecccCCcceEEEEEE
Q 006750 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLS-RLHHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~f~~Ei~~l~-~l~Hpniv~l~g~~~~~~~~~~~~~lV~E 306 (632)
+.||.|+||.||+|... +|+.||||++..... ......+..|..++. .++|+|++++++++.. ....|+|||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e 77 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS----KDYLYLVME 77 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc----CCeEEEEEe
Confidence 46899999999999875 489999999865321 112223455555544 4589999999999875 457899999
Q ss_pred eCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCC
Q 006750 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (632)
Q Consensus 307 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 386 (632)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++....
T Consensus 78 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--- 149 (260)
T cd05611 78 YLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--- 149 (260)
T ss_pred ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc---
Confidence 99999999999754 45899999999999999999999998 99999999999999999999999999876432
Q ss_pred CCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccC
Q 006750 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 466 (632)
Q Consensus 387 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (632)
.....|+..|+|||.+.+..++.++||||||+++|||++|..||............ .. ...
T Consensus 150 ------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~----------~~~- 210 (260)
T cd05611 150 ------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI--LS----------RRI- 210 (260)
T ss_pred ------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--Hh----------ccc-
Confidence 22345889999999998888999999999999999999999999643321100000 00 000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 467 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 467 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
..........+..+.+++.+||+.+|++||++.++.+.|.
T Consensus 211 --~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 211 --NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred --CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 0011111223455889999999999999998766655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=304.23 Aligned_cols=272 Identities=21% Similarity=0.286 Sum_probs=195.9
Q ss_pred CccccceeeeeCceEEEEEEECC---CcEEEEEEeccCCC-CChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcce
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLTD---GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~---g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~ 300 (632)
+|.+.+.||+|+||.||++.... +..||||++..... ......+.+|+.+++++ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 47778899999999999998753 67999999875322 22345588999999999 699999999876543333456
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.|++++|+. ++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 789999995 7999988643 45899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccch-------------
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES------------- 446 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~------------- 446 (632)
........ ........||..|+|||++.+ ..++.++||||||+++|+|++|+.||..........
T Consensus 155 ~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 155 FSENPGEN-AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred cccccccc-cccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 65432211 112234578999999998765 468999999999999999999999986533111000
Q ss_pred heeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 447 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
...+..+................+.. ........+.+++.+||+.||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000000000000000000 01112345889999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=305.78 Aligned_cols=271 Identities=23% Similarity=0.313 Sum_probs=198.9
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccC-Ccce
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG-KRAM 300 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~-~~~~ 300 (632)
.++|.+.+.||+|+||+||+|... +++.||||.+.... .......+.+|+.+++.++|+||+++++++..... ....
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457888999999999999999865 48999999987532 22233457889999999999999999998765321 1235
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.|+||||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 799999995 7899888653 45899999999999999999999998 99999999999999999999999999986
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe-e-ccccc---
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV-L-WATPR--- 454 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~-~-~~~~~--- 454 (632)
..... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||............ . ...+.
T Consensus 158 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 158 TSEKG-----DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED 232 (337)
T ss_pred cCCCc-----ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence 54321 11223457899999998875 56899999999999999999999999643211100000 0 00000
Q ss_pred -----cccccccccc---cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 455 -----LQDSGTVISE---LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 455 -----~~~~~~~~~~---~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.......+.. ..++... ......+..+.+++.+||+.+|++|||+.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0000000000 0011110 0112334558899999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=302.91 Aligned_cols=254 Identities=26% Similarity=0.359 Sum_probs=203.3
Q ss_pred HHHHhh-cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecc
Q 006750 219 ALEHAT-DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 294 (632)
Q Consensus 219 ~l~~~t-~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~ 294 (632)
+++..+ +.|..-++||+||||.||-...++ |+.+|.|.+.... ........++|-.+|.+++.+.||.+--.+..
T Consensus 178 E~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT- 256 (591)
T KOG0986|consen 178 ELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET- 256 (591)
T ss_pred HhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC-
Confidence 343333 678888999999999999997654 9999999886442 12333457889999999999999988654443
Q ss_pred cCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEec
Q 006750 295 RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITD 374 (632)
Q Consensus 295 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~D 374 (632)
.+.+++|+..|+||||.-+|-+.....+++..++-++.+|+-||++||+.. ||.|||||+|||||+.|+++|+|
T Consensus 257 ---kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISD 330 (591)
T KOG0986|consen 257 ---KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISD 330 (591)
T ss_pred ---CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeec
Confidence 567899999999999999998776667999999999999999999999998 99999999999999999999999
Q ss_pred cccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccc
Q 006750 375 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 454 (632)
Q Consensus 375 FGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~ 454 (632)
+|||..+...+ .....+||.+|||||++.++.|+...|.|||||+||||+.|+.||.....+....-+
T Consensus 331 LGLAvei~~g~------~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEv------ 398 (591)
T KOG0986|consen 331 LGLAVEIPEGK------PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEV------ 398 (591)
T ss_pred cceEEecCCCC------ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHH------
Confidence 99999876543 233448999999999999999999999999999999999999999654433211000
Q ss_pred cccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 006750 455 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM 500 (632)
Q Consensus 455 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 500 (632)
-..+.. -...+++..++...+|.+..|+.||.+|.-.
T Consensus 399 -------drr~~~--~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 399 -------DRRTLE--DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred -------HHHHhc--chhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 000000 0113556666778889999999999999744
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=299.96 Aligned_cols=277 Identities=25% Similarity=0.338 Sum_probs=197.9
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC-hHHHHHHHHHHHHhcCCCCccceeeeeecccC----C
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG----K 297 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~-~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~----~ 297 (632)
.++|++.+.||+|+||.||+|.+. +++.||||++....... ....+.+|++++++++||||+++++++.+... .
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 467899999999999999999876 48999999986543222 22347889999999999999999988765332 2
Q ss_pred cceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccc
Q 006750 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 377 (632)
....++||||+. ++|...+... ...+++..+..++.|+++||.|||+.+ |+|+||||+|||+++++.++|+|||+
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCcc
Confidence 446799999995 5787777643 245999999999999999999999998 99999999999999999999999999
Q ss_pred ceecccCCCCC------CCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccchhee-
Q 006750 378 AKRLKADGLPS------CSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL- 449 (632)
Q Consensus 378 a~~~~~~~~~~------~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~- 449 (632)
++......... .........|++.|+|||++.+. .++.++||||||+++|||++|+.||.............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 98664332111 01122345678999999988654 58999999999999999999999986543221111000
Q ss_pred -ccccccc--cccccccccCCCCCCCCCC-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 450 -WATPRLQ--DSGTVISELPDPRLKGDFP-------KEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 450 -~~~~~~~--~~~~~~~~~~~~~l~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
+..+... .....+....+.......+ ......+.+++.+||+.||.+|||+.+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000000 0000000000000000011 112245889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=294.18 Aligned_cols=248 Identities=28% Similarity=0.387 Sum_probs=194.0
Q ss_pred eeeeCceEEEEEEECC-CcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEeCC
Q 006750 233 VGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 309 (632)
Q Consensus 233 LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey~~ 309 (632)
||.|+||.||++.+.+ |+.+|+|++..... ......+.+|++++++++||||+++++.+.. ....|+||||++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~~~lv~e~~~ 76 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG----KKNLYLVMEYLP 76 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec----CcEEEEEEecCC
Confidence 6899999999999875 99999999875432 2344568899999999999999999988764 557899999999
Q ss_pred CCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCCC--
Q 006750 310 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP-- 387 (632)
Q Consensus 310 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~-- 387 (632)
+++|.+++.+. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 77 ~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 151 (265)
T cd05579 77 GGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151 (265)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence 99999999764 35899999999999999999999998 999999999999999999999999998765432110
Q ss_pred -CCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccC
Q 006750 388 -SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 466 (632)
Q Consensus 388 -~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (632)
..........++..|+|||.+.....+.++||||||+++|+|++|..||........... +.
T Consensus 152 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~-----------------~~ 214 (265)
T cd05579 152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQN-----------------IL 214 (265)
T ss_pred ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----------------Hh
Confidence 000122335688899999999888899999999999999999999999964432111000 00
Q ss_pred CCCCCCCCCHH--HHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 467 DPRLKGDFPKE--EMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 467 ~~~l~~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
.... ..+.. .+..+..++.+||+.+|.+|||+..+.+.|+
T Consensus 215 ~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 215 NGKI--EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred cCCc--CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0000 01111 2455889999999999999999966666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=295.29 Aligned_cols=242 Identities=26% Similarity=0.351 Sum_probs=185.1
Q ss_pred eeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC--ChHHHHHHHHHH---HHhcCCCCccceeeeeecccCCcceEEEEE
Q 006750 232 IVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDM---LSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 305 (632)
Q Consensus 232 ~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~f~~Ei~~---l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~ 305 (632)
.||+|+||.||+|... +++.||+|.+...... .....+..|..+ ++...||||+++++++.. ....++||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~----~~~~~~v~ 76 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT----PDKLSFIL 76 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec----CCEEEEEE
Confidence 3899999999999865 4899999998754222 222224445443 444579999999988775 45779999
Q ss_pred EeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCC
Q 006750 306 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 385 (632)
Q Consensus 306 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 385 (632)
||++||+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 77 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~- 150 (278)
T cd05606 77 DLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 150 (278)
T ss_pred ecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc-
Confidence 999999999988653 45999999999999999999999998 999999999999999999999999998755322
Q ss_pred CCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccc
Q 006750 386 LPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 464 (632)
Q Consensus 386 ~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (632)
......|+..|+|||++.++ .++.++||||||+++|||++|+.||............ ....
T Consensus 151 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~------------~~~~ 212 (278)
T cd05606 151 ------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID------------RMTL 212 (278)
T ss_pred ------CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH------------HHhh
Confidence 12234689999999998754 6899999999999999999999999754222111100 0000
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006750 465 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQ 505 (632)
Q Consensus 465 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 505 (632)
...+. .+...+..+.+++.+||..+|.+|| ++.++++
T Consensus 213 ~~~~~----~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 213 TMAVE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ccCCC----CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 01111 2223345588999999999999999 9999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=299.66 Aligned_cols=250 Identities=26% Similarity=0.373 Sum_probs=194.2
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
.|+..+.||+|+||.||+|+.. +++.+|+|.+.... .......+.+|+++++.++|+|++++++++.. ....+
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 91 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR----EHTAW 91 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc----CCeeE
Confidence 3666788999999999999975 48899999986432 22233458899999999999999999999876 45679
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||+. |+|.+++... ...+++.++..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++....
T Consensus 92 lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 92 LVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EEEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 9999996 6888877543 245899999999999999999999998 9999999999999999999999999987654
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhh---cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
.. ....|++.|+|||++. ...++.++||||||+++|+|++|+.||.......... .+
T Consensus 167 ~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~--------- 226 (308)
T cd06634 167 PA---------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HI--------- 226 (308)
T ss_pred Cc---------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH--HH---------
Confidence 22 2345889999999975 3567889999999999999999999986432111000 00
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
.....+.. .+......+.+|+.+||..+|++||++.++++.....
T Consensus 227 ---~~~~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 227 ---AQNESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred ---hhcCCCCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 00000111 1123345588999999999999999999999865433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=292.23 Aligned_cols=248 Identities=20% Similarity=0.233 Sum_probs=190.4
Q ss_pred HHHHhhcCcccccee--eeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecc
Q 006750 219 ALEHATDKFSGSNIV--GQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 294 (632)
Q Consensus 219 ~l~~~t~~f~~~~~L--G~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~ 294 (632)
+.....++|.+.+.+ |+|+||.||++..+ ++..+|+|.+....... .|+.....+ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~~- 80 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVTT- 80 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEec-
Confidence 344455677777776 99999999999865 58899999987542211 123233223 79999999999876
Q ss_pred cCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCC-CeEEe
Q 006750 295 RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKIT 373 (632)
Q Consensus 295 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~-~vkL~ 373 (632)
....++||||+++|+|.+++... ..+++.++..++.|+++||.|||+.+ ++||||||+||+++.++ .++|+
T Consensus 81 ---~~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~ 152 (267)
T PHA03390 81 ---LKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLC 152 (267)
T ss_pred ---CCeeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEe
Confidence 44789999999999999999764 36999999999999999999999998 99999999999999988 99999
Q ss_pred ccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccc
Q 006750 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 453 (632)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~ 453 (632)
|||+++..... ....|+..|+|||++.+..++.++||||||+++|||++|+.||....... .....+.
T Consensus 153 dfg~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~-- 220 (267)
T PHA03390 153 DYGLCKIIGTP---------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLL-- 220 (267)
T ss_pred cCccceecCCC---------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHH--
Confidence 99998765422 12358899999999998889999999999999999999999997432211 0000000
Q ss_pred ccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 006750 454 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT-MSEVVQ 505 (632)
Q Consensus 454 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 505 (632)
..... ....+...+..+.+++.+||+.+|.+||+ +.++++
T Consensus 221 ----------~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 221 ----------KRQQK--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ----------Hhhcc--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00000 00122234456899999999999999996 688875
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=322.70 Aligned_cols=202 Identities=19% Similarity=0.228 Sum_probs=158.4
Q ss_pred hhcCccccceeeeeCceEEEEEEECC--CcEEEEEEec--------------c--CCCCChHHHHHHHHHHHHhcCCCCc
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLTD--GRIVAVKRFK--------------T--QGGPNADSVFLTEVDMLSRLHHCHV 284 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~~--g~~vAVK~l~--------------~--~~~~~~~~~f~~Ei~~l~~l~Hpni 284 (632)
..++|.+.+.||+|+||+||++.++. +..+++|.+. . .........|.+|+.+|++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45789999999999999999987543 2223222111 0 0112233458899999999999999
Q ss_pred cceeeeeecccCCcceEEEEEEeCCCCChhhhhhccc---cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCC
Q 006750 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL---VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSN 361 (632)
Q Consensus 285 v~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~N 361 (632)
+++++++.. ....|+|++++ +++|.+++.... ........+..|+.|++.||+|||+.+ |+||||||+|
T Consensus 226 v~l~~~~~~----~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~N 297 (501)
T PHA03210 226 LKIEEILRS----EANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLEN 297 (501)
T ss_pred CcEeEEEEE----CCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHH
Confidence 999999876 44679999999 568888774322 112345677889999999999999998 9999999999
Q ss_pred eEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCC
Q 006750 362 ILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 436 (632)
Q Consensus 362 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~ 436 (632)
|||+.++.+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||+||||++|..++
T Consensus 298 ILl~~~~~vkL~DFGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 298 IFLNCDGKIVLGDFGTAMPFEKERE----AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred EEECCCCCEEEEeCCCceecCcccc----cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999999999987654321 1223457999999999999999999999999999999999987654
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=296.46 Aligned_cols=252 Identities=24% Similarity=0.347 Sum_probs=193.3
Q ss_pred CccccceeeeeCceEEEEEEE----CCCcEEEEEEeccCC---CCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCC
Q 006750 226 KFSGSNIVGQGGSSYVYRGQL----TDGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGK 297 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~----~~g~~vAVK~l~~~~---~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~ 297 (632)
+|++.+.||.|+||.||++.. .+|..||+|+++... .....+.+.+|+.++.++ +|+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~---- 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT---- 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec----
Confidence 467788999999999999986 368999999987532 122335588899999999 69999999988765
Q ss_pred cceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccc
Q 006750 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 377 (632)
....|+||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||+
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 151 (290)
T cd05613 77 DTKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 151 (290)
T ss_pred CCeEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcc
Confidence 45679999999999999999754 45889999999999999999999998 99999999999999999999999999
Q ss_pred ceecccCCCCCCCCCCCccccCCCCCChhhhhcC--CCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccc
Q 006750 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL 455 (632)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~--~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~ 455 (632)
++....... .......|+..|+|||.+... .++.++||||||+++|+|++|..||...........
T Consensus 152 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~-------- 219 (290)
T cd05613 152 SKEFHEDEV----ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAE-------- 219 (290)
T ss_pred ceecccccc----cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHH--------
Confidence 987543321 112235688999999998753 468899999999999999999999853221110000
Q ss_pred ccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006750 456 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQ 505 (632)
Q Consensus 456 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 505 (632)
....+... ...++......+.+++.+||+.||++|| ++.+++.
T Consensus 220 -----~~~~~~~~--~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 220 -----ISRRILKS--EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -----HHHHhhcc--CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 00000000 0112333445688999999999999997 5666644
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=297.83 Aligned_cols=243 Identities=24% Similarity=0.390 Sum_probs=192.8
Q ss_pred ceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEeCC
Q 006750 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 309 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey~~ 309 (632)
..||+|+||.||++... +|+.||||++.... ......+.+|+.+++.++|+||+++++++.. ....++||||++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~ 100 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLV----GDELWVVMEFLE 100 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEe----CCEEEEEEecCC
Confidence 56999999999999875 58999999986433 3344568999999999999999999998876 457899999999
Q ss_pred CCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCCCCC
Q 006750 310 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 389 (632)
Q Consensus 310 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 389 (632)
+++|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 101 ~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~---- 170 (292)
T cd06657 101 GGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV---- 170 (292)
T ss_pred CCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc----
Confidence 9999998754 34899999999999999999999998 9999999999999999999999999987654321
Q ss_pred CCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccCCCC
Q 006750 390 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 469 (632)
Q Consensus 390 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (632)
.......|++.|+|||++....++.++||||||+++|+|++|..||........... +.....+.
T Consensus 171 -~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~--------------~~~~~~~~ 235 (292)
T cd06657 171 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM--------------IRDNLPPK 235 (292)
T ss_pred -ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------------HHhhCCcc
Confidence 112334688999999999888899999999999999999999999864322110000 00001111
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 470 LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 470 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
+. .....+..+.+++.+||..+|.+||++.++++
T Consensus 236 ~~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 236 LK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred cC--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 11 01122334788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=291.89 Aligned_cols=250 Identities=24% Similarity=0.309 Sum_probs=193.4
Q ss_pred CccccceeeeeCceEEEEEEECC-CcEEEEEEeccCC----CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG----GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~----~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
+|.+.+.||+|+||.||++.+.. +..+++|+++... .......+..|+.+++.++||||+++++++.+ ...
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 76 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE----RDA 76 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc----CCc
Confidence 47778999999999999998754 4556666665321 22233457789999999999999999998865 346
Q ss_pred EEEEEEeCCCCChhhhhhcc--ccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccc
Q 006750 301 RLLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 378 (632)
.++||||+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++ +.++|+|||++
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~ 152 (260)
T cd08222 77 FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVS 152 (260)
T ss_pred eEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCce
Confidence 79999999999999988642 2345999999999999999999999998 999999999999976 46999999998
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccc
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
+...... .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||..........
T Consensus 153 ~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~------------ 215 (260)
T cd08222 153 RLLMGSC-----DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVL------------ 215 (260)
T ss_pred eecCCCc-----ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH------------
Confidence 7764321 12233458899999999988888999999999999999999999985322110000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+.....+ ..+...+..+.+++.+||..+|++||++.++++.
T Consensus 216 --~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 216 --RIVEGPTP----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred --HHHcCCCC----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 00011111 1233445568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=295.67 Aligned_cols=253 Identities=28% Similarity=0.396 Sum_probs=201.0
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcC-CCCccceeeeeecccCCcce
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~~~ 300 (632)
++|...+.||+|+||.||+|... +|+.||+|++.... .......+.+|++++++++ ||||+++++++.. ...
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~----~~~ 76 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD----EEN 76 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC----Cce
Confidence 46888899999999999999876 58999999987532 2223355889999999998 9999999998765 457
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~ 151 (280)
T cd05581 77 LYFVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKV 151 (280)
T ss_pred EEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccc
Confidence 79999999999999999764 35999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCC---------------CCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccc
Q 006750 381 LKADGLPSC---------------SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEE 445 (632)
Q Consensus 381 ~~~~~~~~~---------------~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~ 445 (632)
......... ........|+..|+|||.+....++.++||||||++++++++|+.||.........
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 231 (280)
T cd05581 152 LDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF 231 (280)
T ss_pred cCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence 654321100 01223456889999999998888999999999999999999999999654321100
Q ss_pred hheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 006750 446 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM----SEVVQ 505 (632)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~ 505 (632)
..+. .....++...+..+.+++.+||+.+|.+||++ .++++
T Consensus 232 -----------------~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 -----------------QKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -----------------HHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0000 01112233334558899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=297.66 Aligned_cols=245 Identities=28% Similarity=0.410 Sum_probs=191.3
Q ss_pred ccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC--ChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 227 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
|...+.||+|+||.||+|+.. +|+.||+|++...... .....+.+|+.+++.++|||++++++++.+ ....|+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~l 98 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK----EHTAWL 98 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe----CCEEEE
Confidence 555678999999999999875 4899999998754322 233458899999999999999999999876 457799
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||+. |+|.+++... ...+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 99 v~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~ 173 (313)
T cd06633 99 VMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP 173 (313)
T ss_pred EEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC
Confidence 999995 6888887643 245899999999999999999999998 99999999999999999999999999864321
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhh---cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
.....|+..|+|||++. ...++.++||||||+++|||++|..||.............
T Consensus 174 ---------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~----------- 233 (313)
T cd06633 174 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA----------- 233 (313)
T ss_pred ---------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-----------
Confidence 22346889999999984 4568899999999999999999999986533211110000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
....+.. .....+..+.+|+.+||+.+|.+||++.++++.
T Consensus 234 ---~~~~~~~---~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 234 ---QNDSPTL---QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ---hcCCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000111 111223448899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=296.72 Aligned_cols=256 Identities=24% Similarity=0.321 Sum_probs=196.8
Q ss_pred CccccceeeeeCceEEEEEEEC----CCcEEEEEEeccCC---CCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCC
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGK 297 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~---~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~ 297 (632)
+|++.+.||+|+||.||++... +++.||||.++... .......+.+|+.++.++ +||||+++++.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~---- 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT---- 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec----
Confidence 3677889999999999999753 47889999987432 122334588999999999 69999999988764
Q ss_pred cceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccc
Q 006750 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 377 (632)
....++||||+++|+|.+++... ..+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~ 151 (288)
T cd05583 77 DTKLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGL 151 (288)
T ss_pred CCEEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcc
Confidence 45679999999999999998653 45899999999999999999999988 99999999999999999999999999
Q ss_pred ceecccCCCCCCCCCCCccccCCCCCChhhhhcCC--CCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccc
Q 006750 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR--ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL 455 (632)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~--~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~ 455 (632)
++....... .......|+..|+|||.+.+.. .+.++||||||+++|||++|..||.......... . +
T Consensus 152 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--~-----~ 220 (288)
T cd05583 152 SKEFLAEEE----ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS--E-----I 220 (288)
T ss_pred ccccccccc----cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHH--H-----H
Confidence 876543321 1122345889999999987655 7889999999999999999999985322110000 0 0
Q ss_pred ccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006750 456 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 509 (632)
Q Consensus 456 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 509 (632)
.. ..... .+ ..+......+.+++.+||+.||++|||+.++.+.|..
T Consensus 221 ~~--~~~~~--~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 221 SR--RILKS--KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HH--HHHcc--CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 00 00000 11 1222233458899999999999999999988887764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=303.22 Aligned_cols=274 Identities=23% Similarity=0.312 Sum_probs=201.1
Q ss_pred HHHHHHhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecc
Q 006750 217 YSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 294 (632)
Q Consensus 217 ~~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~ 294 (632)
..++..++++|.+.+.||+|+||.||+|... +|+.||||++.... .......+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 4567778899999999999999999999864 58999999987542 222334588899999999999999999987643
Q ss_pred cC--CcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEE
Q 006750 295 RG--KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKI 372 (632)
Q Consensus 295 ~~--~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL 372 (632)
.. .....|++++++ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence 21 123468888887 8899988764 34899999999999999999999998 999999999999999999999
Q ss_pred eccccceecccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe-ec
Q 006750 373 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV-LW 450 (632)
Q Consensus 373 ~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~-~~ 450 (632)
+|||+++..... .....||..|+|||.+.+ ..++.++||||||+++|||++|+.||............ ..
T Consensus 162 ~dfg~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (345)
T cd07877 162 LDFGLARHTDDE--------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 233 (345)
T ss_pred eccccccccccc--------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 999998764321 223468899999998876 56889999999999999999999998543221100000 00
Q ss_pred cc---cc----cccc--cc---cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 451 AT---PR----LQDS--GT---VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 451 ~~---~~----~~~~--~~---~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.. +. +... .. .+.......+. .........+.+++.+||+.||.+||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00 00 0000 00 00000010000 0001123457899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=291.33 Aligned_cols=266 Identities=23% Similarity=0.311 Sum_probs=198.3
Q ss_pred ccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEE
Q 006750 227 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV 304 (632)
|...+.||.|++|.||++... +|+.+++|+++..... .....+.+|+.++++++|+||+++++++.. ....++|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~v 76 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH----KGDLYLV 76 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc----CCCEEEE
Confidence 456788999999999999875 5899999998765332 334568899999999999999999998875 4578999
Q ss_pred EEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccC
Q 006750 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 384 (632)
|||++ ++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||.+......
T Consensus 77 ~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 77 FEFMD-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred EeccC-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence 99996 58988887643 46899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe--eccc------ccc
Q 006750 385 GLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV--LWAT------PRL 455 (632)
Q Consensus 385 ~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~--~~~~------~~~ 455 (632)
. .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||............ .... ...
T Consensus 152 ~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd05118 152 V-----RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKF 226 (283)
T ss_pred c-----ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccc
Confidence 2 112234578899999998876 7899999999999999999999998654321110000 0000 000
Q ss_pred ccc-cccccccCCCCC--CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 456 QDS-GTVISELPDPRL--KGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 456 ~~~-~~~~~~~~~~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
... ............ ........+..+.+++.+||+.||.+||++.+++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 227 TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000 000000000000 011123345678999999999999999999999763
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=302.07 Aligned_cols=273 Identities=24% Similarity=0.302 Sum_probs=201.4
Q ss_pred CccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeeccc-CCcceEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR-GKRAMRL 302 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~-~~~~~~~ 302 (632)
+|.+.+.||.|+||.||+|...+ ++.||||++..... ....+.+.+|+.+++.++||||+++++++.... ......|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 47788999999999999999764 89999999876432 334456899999999999999999999887643 1223679
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||++ ++|.+++... ..+++..+..++.+++.||+|||+.+ |+||||||.|||++.++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999996 5899988653 36999999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe-ec-cccc-----
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV-LW-ATPR----- 454 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~-~~-~~~~----- 454 (632)
..... ........+|..|+|||++.+. .++.++||||||+++|+|++|+.||............ .. ..+.
T Consensus 155 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 155 PDEDE--KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ccccc--cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 43210 0112334688999999999887 7899999999999999999999999654321110000 00 0000
Q ss_pred ---cccccccccccCCCC--CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 455 ---LQDSGTVISELPDPR--LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 455 ---~~~~~~~~~~~~~~~--l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.......+....... -........+..+.+++.+||+.+|++||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000000000000 0000111234558899999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=303.88 Aligned_cols=272 Identities=21% Similarity=0.300 Sum_probs=194.9
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCC-----
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK----- 297 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~----- 297 (632)
..+|...+.||.|+||.||+|... +|..||+|++..... .....+.+|++++++++||||+++++++......
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 367888999999999999999875 489999999876543 3445588999999999999999999876543211
Q ss_pred -----cceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEec-CCCCeE
Q 006750 298 -----RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAK 371 (632)
Q Consensus 298 -----~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~-~~~~vk 371 (632)
....++||||++ ++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++ +++.++
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 135789999996 699888854 35899999999999999999999998 99999999999997 456789
Q ss_pred EeccccceecccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec
Q 006750 372 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450 (632)
Q Consensus 372 L~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~ 450 (632)
|+|||+++........ ........|+..|+|||.+.. ..++.++||||||+++|+|++|+.||..............
T Consensus 156 l~dfg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~ 233 (342)
T cd07854 156 IGDFGLARIVDPHYSH--KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233 (342)
T ss_pred ECCcccceecCCcccc--ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999865432111 011123357889999998754 5688999999999999999999999965432211111100
Q ss_pred ccccccc--ccccccc--------cCCCCC-CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 451 ATPRLQD--SGTVISE--------LPDPRL-KGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 451 ~~~~~~~--~~~~~~~--------~~~~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
..+.... ....... ...+.. ...........+.+|+.+||..||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000000 0000000 000000 00011123345789999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=301.31 Aligned_cols=270 Identities=22% Similarity=0.308 Sum_probs=198.5
Q ss_pred HHHhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCC
Q 006750 220 LEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (632)
Q Consensus 220 l~~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 297 (632)
+....++|++.+.||+|+||.||++... +|..||||++..... ......+.+|+.+|++++||||+++++++......
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3445788999999999999999999865 589999999864322 22334588999999999999999999988643211
Q ss_pred --cceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecc
Q 006750 298 --RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 375 (632)
Q Consensus 298 --~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DF 375 (632)
....++||||+ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+||
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 13468999999 7899988864 35899999999999999999999998 999999999999999999999999
Q ss_pred ccceecccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccc
Q 006750 376 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 454 (632)
Q Consensus 376 Gla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~ 454 (632)
|++...... .....+++.|+|||++.+ ..++.++||||||+++|+|++|+.||..................
T Consensus 163 g~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 234 (343)
T cd07880 163 GLARQTDSE--------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGT 234 (343)
T ss_pred ccccccccC--------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 998765321 223457899999999876 45899999999999999999999999644321110000000000
Q ss_pred --------ccc--ccccccccC---CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 455 --------LQD--SGTVISELP---DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 455 --------~~~--~~~~~~~~~---~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
+.. .......+. ...+ ..........+.+++.+|++.||.+|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CCHHHHHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 000000000 0000 0011223345789999999999999999999985
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=286.86 Aligned_cols=248 Identities=25% Similarity=0.315 Sum_probs=200.2
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC--ChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|..+++||+|.||.|.+++-+ .|+.+|+|+++....- .+...-+.|-.+|+..+||.+..|.-.+.. ...+
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt----~drl 243 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT----QDRL 243 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc----CceE
Confidence 45777889999999999999865 4999999999876432 223335779999999999999887644443 6688
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
++||||.+||.|.-+|.+. +.+++....-+...|+.||.|||+++ ||.||||.+|+|||.+|++||+||||.+--
T Consensus 244 CFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc
Confidence 9999999999999999764 45888888889999999999999998 999999999999999999999999999865
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
... ......+.|||.|+|||++....|+..+|.|-+||++|||++|++||+.........++.
T Consensus 319 I~~-----g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl------------ 381 (516)
T KOG0690|consen 319 IKY-----GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL------------ 381 (516)
T ss_pred ccc-----cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH------------
Confidence 433 245567899999999999999999999999999999999999999998654432222111
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQ 505 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 505 (632)
+.++ .+|...+.+...|+...|..||.+|. ++.||.+
T Consensus 382 ~ed~-------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 382 MEDL-------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred hhhc-------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 1111 24555556678889999999999995 3555543
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=290.33 Aligned_cols=265 Identities=26% Similarity=0.366 Sum_probs=196.4
Q ss_pred ccccceeeeeCceEEEEEEECC-CcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEE
Q 006750 227 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV 304 (632)
|+..+.||+|+||.||+|+..+ ++.||+|++.... .......+..|+.++++++|+|++++++++.. ....++|
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~~~v 76 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT----ERKLYLV 76 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc----CCceEEE
Confidence 4556789999999999998764 8999999998653 22333457899999999999999999998875 3577999
Q ss_pred EEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccC
Q 006750 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 384 (632)
|||++ ++|.+++.... ..+++..+..++.+++.||+|||+.+ |+||||+|+||++++++.++|+|||+++.....
T Consensus 77 ~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~ 151 (282)
T cd07829 77 FEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIP 151 (282)
T ss_pred ecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCC
Confidence 99997 69999997643 35899999999999999999999998 999999999999999999999999999876432
Q ss_pred CCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccch-h---------eecccc
Q 006750 385 GLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEES-L---------VLWATP 453 (632)
Q Consensus 385 ~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~-~---------~~~~~~ 453 (632)
.. ......++..|+|||.+... .++.++||||||+++|||++|+.||.......... . ..|...
T Consensus 152 ~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07829 152 LR-----TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV 226 (282)
T ss_pred cc-----ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhh
Confidence 21 12233467889999998776 78999999999999999999999986533211100 0 000000
Q ss_pred -ccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 454 -RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 454 -~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
....................++ .....+.+++..||..||++||++.+++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 227 TKLPDYKPTFPKFPPKDLEKVLP-RLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccccccccCccchHHhcc-cccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000000000000000000111 124568999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=298.69 Aligned_cols=269 Identities=22% Similarity=0.297 Sum_probs=197.5
Q ss_pred HHHhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCC
Q 006750 220 LEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (632)
Q Consensus 220 l~~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 297 (632)
+..++++|++.+.||.|+||.||+|... +++.||||++.... .......+.+|+++++.++||||+++++++...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--- 81 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP--- 81 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC---
Confidence 3456789999999999999999999865 58999999886432 223345688999999999999999999988642
Q ss_pred cceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccc
Q 006750 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 377 (632)
....++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||+|+|||++.++.++|+|||+
T Consensus 82 ~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~ 154 (328)
T cd07856 82 LEDIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGL 154 (328)
T ss_pred CCcEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccc
Confidence 33578999999 6799988864 34788889999999999999999998 99999999999999999999999999
Q ss_pred ceecccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchh-eeccccc-
Q 006750 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL-VLWATPR- 454 (632)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~-~~~~~~~- 454 (632)
+..... ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||........... ..+....
T Consensus 155 ~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 226 (328)
T cd07856 155 ARIQDP--------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPP 226 (328)
T ss_pred ccccCC--------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 875432 1223457889999998765 5689999999999999999999999964322110000 0000000
Q ss_pred --ccc---ccccccccCCCCCCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 455 --LQD---SGTVISELPDPRLKGDFP-----KEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 455 --~~~---~~~~~~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
+.. ..........-......+ ......+.+++.+||+.+|++||++.+++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 227 DDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 000000000000000111 1223568899999999999999999999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=298.42 Aligned_cols=271 Identities=23% Similarity=0.307 Sum_probs=193.9
Q ss_pred cCcc-ccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC-------------hHHHHHHHHHHHHhcCCCCccceee
Q 006750 225 DKFS-GSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-------------ADSVFLTEVDMLSRLHHCHVVPLVG 289 (632)
Q Consensus 225 ~~f~-~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~-------------~~~~f~~Ei~~l~~l~Hpniv~l~g 289 (632)
++|. +.+.||.|+||+||+|.+. +++.||||+++...... ....+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4454 3467999999999999875 58999999986543221 0124778999999999999999999
Q ss_pred eeecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCC
Q 006750 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN 369 (632)
Q Consensus 290 ~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 369 (632)
++.. ....++||||+. |+|.+++... ..+++.....++.|++.||+|||+.+ |+|+||+|+||+++.++.
T Consensus 88 ~~~~----~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~ 157 (335)
T PTZ00024 88 VYVE----GDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGI 157 (335)
T ss_pred EEec----CCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCC
Confidence 9875 457899999996 6999998653 34899999999999999999999998 999999999999999999
Q ss_pred eEEeccccceecccCCCC---------CCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCc
Q 006750 370 AKITDLGMAKRLKADGLP---------SCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 439 (632)
Q Consensus 370 vkL~DFGla~~~~~~~~~---------~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~ 439 (632)
++|+|||+++........ ..........+++.|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999876522110 001112233578899999998764 4699999999999999999999999654
Q ss_pred cccccchhe-ec-cccc---ccccc-----ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 440 ITKGEESLV-LW-ATPR---LQDSG-----TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 440 ~~~~~~~~~-~~-~~~~---~~~~~-----~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
......... .. ..+. +.... ........+... ......+..+.+++.+||+.+|++||++.+++..
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 238 NEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred CHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 322110000 00 0000 00000 000000000000 0111223458899999999999999999999874
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=309.61 Aligned_cols=265 Identities=26% Similarity=0.391 Sum_probs=217.9
Q ss_pred cHHHHHHhhcCccccceeeeeCceEEEEEEE-CCCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeec
Q 006750 216 SYSALEHATDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 293 (632)
Q Consensus 216 ~~~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~ 293 (632)
.++.+-..++-|++.+.||.|.+|.||+++. ++++.+|||++....+.+ ++...|.++|+.+ .|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d--eEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE--EEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc--HHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 3445555677888899999999999999985 459999999998765433 4478899999998 89999999999864
Q ss_pred c-cCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEE
Q 006750 294 F-RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKI 372 (632)
Q Consensus 294 ~-~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL 372 (632)
. .+.++.+|||||||.+||..|++++..++.+.|..+..|+..+++||.+||... ++|||||-.||||+.++.|||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence 3 345779999999999999999998887788999999999999999999999988 999999999999999999999
Q ss_pred eccccceecccCCCCCCCCCCCccccCCCCCChhhhhc-----CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchh
Q 006750 373 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL 447 (632)
Q Consensus 373 ~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~ 447 (632)
.|||++..+... -....+..||+.|||||++.. ..|+.++|+||||++-.||--|.+|+...-+.-
T Consensus 165 vDFGvSaQldsT-----~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr---- 235 (953)
T KOG0587|consen 165 VDFGVSAQLDST-----VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR---- 235 (953)
T ss_pred eeeeeeeeeecc-----cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh----
Confidence 999999877543 234456789999999999964 347889999999999999999999985432210
Q ss_pred eeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 448 VLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
..+.-...|.....-|....+.+.++|..||.+|.++||++.+++++
T Consensus 236 ------------aLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 236 ------------ALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ------------hhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 01111122333333577888899999999999999999999999863
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=280.62 Aligned_cols=254 Identities=24% Similarity=0.289 Sum_probs=204.4
Q ss_pred hhcCcccc-ceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcc
Q 006750 223 ATDKFSGS-NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 223 ~t~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~ 299 (632)
.+++|++. ++||-|-.|.|-....+ .|+.+|+|++.... ...+|+++--.. .|||||.++++|........
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP------KARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH------HHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 45666654 56899999999999765 48999999997542 256888876555 79999999999988777788
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC---CCCeEEeccc
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLNAKITDLG 376 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~---~~~vkL~DFG 376 (632)
.+++|||.|+||.|...++.+..+.+++.++-.|..||+.|+.|||+.+ |.||||||+|+|... |-.+||+|||
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 9999999999999999998887788999999999999999999999998 999999999999954 4568999999
Q ss_pred cceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccc
Q 006750 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 456 (632)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~ 456 (632)
+|+.-... ....+..-|+.|.|||++...+|+...|+||+||++|-|++|.+||+....... .+
T Consensus 210 FAK~t~~~------~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai-------sp--- 273 (400)
T KOG0604|consen 210 FAKETQEP------GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-------SP--- 273 (400)
T ss_pred cccccCCC------ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC-------Ch---
Confidence 99875432 233445679999999999999999999999999999999999999975432110 00
Q ss_pred cccccccccCCCCCCCCCC----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 457 DSGTVISELPDPRLKGDFP----KEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 457 ~~~~~~~~~~~~~l~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
....++..... .|| ...++...++|+.+|..+|.+|.|+.+++..
T Consensus 274 ---gMk~rI~~gqy--~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 274 ---GMKRRIRTGQY--EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ---hHHhHhhccCc--cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 00111111111 233 3456678899999999999999999999874
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=300.55 Aligned_cols=268 Identities=25% Similarity=0.349 Sum_probs=197.2
Q ss_pred hhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccC--Cc
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KR 298 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~--~~ 298 (632)
..++|...+.||+|+||.||+|... +++.||||++.... .......+.+|+.++++++||||+++++++..... ..
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999986 48899999987532 22233457889999999999999999987754221 12
Q ss_pred ceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccc
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 378 (632)
...++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccc
Confidence 3479999999 7799998865 45899999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe-eccc-c--
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV-LWAT-P-- 453 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~-~~~~-~-- 453 (632)
...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||............ .... +
T Consensus 166 ~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 237 (343)
T cd07851 166 RHTDDE--------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE 237 (343)
T ss_pred cccccc--------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence 765422 223457889999998865 46789999999999999999999999644322110000 0000 0
Q ss_pred ----cccc--cccc---ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 454 ----RLQD--SGTV---ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 454 ----~~~~--~~~~---~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+.. .... +.....+.+.. .....+..+.+++.+||+.+|.+|||+.+|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKE-VFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHH-HhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000 0000 00000000000 001124568899999999999999999999763
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=281.66 Aligned_cols=237 Identities=30% Similarity=0.374 Sum_probs=190.7
Q ss_pred eeeeCceEEEEEEECC-CcEEEEEEeccCCCCC--hHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEeCC
Q 006750 233 VGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMP 309 (632)
Q Consensus 233 LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~--~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey~~ 309 (632)
||.|+||.||++...+ ++.+|+|++....... ....+..|+.++++++||||+++++.+.. ....++||||++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~~v~e~~~ 76 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT----EEKLYLVLEYAP 76 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec----CCeeEEEEecCC
Confidence 6899999999998764 8999999987653322 34468999999999999999999988764 557899999999
Q ss_pred CCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCCCCC
Q 006750 310 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 389 (632)
Q Consensus 310 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 389 (632)
+++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 77 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~---- 147 (250)
T cd05123 77 GGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG---- 147 (250)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC----
Confidence 99999999754 35899999999999999999999988 9999999999999999999999999998764321
Q ss_pred CCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccCCCC
Q 006750 390 SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 469 (632)
Q Consensus 390 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (632)
.......++..|+|||.+.+...+.++|+||||+++|+|++|+.||......... ..+...
T Consensus 148 -~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~-----------------~~~~~~- 208 (250)
T cd05123 148 -SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIY-----------------EKILKD- 208 (250)
T ss_pred -CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH-----------------HHHhcC-
Confidence 1223456889999999998888999999999999999999999999643321100 000000
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 006750 470 LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 502 (632)
Q Consensus 470 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 502 (632)
...++...+..+.+++.+||..||++||++.+
T Consensus 209 -~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 209 -PLRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred -CCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 11223333455889999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=315.06 Aligned_cols=146 Identities=26% Similarity=0.356 Sum_probs=128.5
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|.+.+.||+|+||.||+|.+. +++.||||+++.... ......+.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~----~~~~ 79 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS----ANNV 79 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE----CCEE
Confidence 57888999999999999999986 589999999975432 2223568899999999999999999988765 4578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
||||||+.+++|.+++... ..+++..++.|+.||+.||.|||..+ |+||||||+||||+.++.+||+|||+++
T Consensus 80 ~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999999753 35889999999999999999999998 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=280.82 Aligned_cols=261 Identities=25% Similarity=0.318 Sum_probs=198.0
Q ss_pred eeecHHHHHHhhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeee
Q 006750 213 IRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGY 290 (632)
Q Consensus 213 ~~~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~ 290 (632)
..|+-+.|+. +..||.|+||+|+|-.++. |+..|||+++.........+|+.|.+...+- +-||||+++|.
T Consensus 59 ~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa 131 (361)
T KOG1006|consen 59 HTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA 131 (361)
T ss_pred cccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence 4455555555 4679999999999998764 9999999999887767777899999875554 89999999999
Q ss_pred eecccCCcceEEEEEEeCCCCChhhhhh---ccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCC
Q 006750 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLD---GVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 367 (632)
Q Consensus 291 ~~~~~~~~~~~~lV~Ey~~~gsL~~~L~---~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~ 367 (632)
+.. +...|+.||+| .-||..+-. ......+++...-.|...++.||.||.+.- .|||||+||+||||+..
T Consensus 132 ~F~----EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~ 204 (361)
T KOG1006|consen 132 LFS----EGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRH 204 (361)
T ss_pred hhc----CCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecC
Confidence 875 44679999999 567766543 222345888888899999999999998765 59999999999999999
Q ss_pred CCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhc--CCCCcccchHhHhHHHHHHHhCCCCCCCccccccc
Q 006750 368 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEE 445 (632)
Q Consensus 368 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~ 445 (632)
|.+||+|||.+-.+... -..+.-.|-..|||||.+.. ..|+.+|||||||++|||+.||..||.......++
T Consensus 205 G~vKLCDFGIcGqLv~S------iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeq 278 (361)
T KOG1006|consen 205 GDVKLCDFGICGQLVDS------IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQ 278 (361)
T ss_pred CCEeeecccchHhHHHH------HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHH
Confidence 99999999998766432 12233468889999999863 34899999999999999999999999654321111
Q ss_pred hheeccccccccccccccccCCCCCCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 446 SLVLWATPRLQDSGTVISELPDPRLKGDF-PKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.. .+ ..--.|.+..+. ..+.+..|..++..|+.+|-..||.+.++.++
T Consensus 279 l~------------~V-v~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 279 LC------------QV-VIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HH------------HH-HcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 00 00 000112222111 12345669999999999999999999998763
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=277.54 Aligned_cols=206 Identities=25% Similarity=0.343 Sum_probs=170.4
Q ss_pred cCccccceeeeeCceEEEEEEECC-----CcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCccceeeeeecccCCc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-----GRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 298 (632)
..|+....||+|.+|.||+|.-.+ ...+|+|+++..... .......+|+.+++.|+||||+.|..++... +
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~---d 100 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH---D 100 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc---C
Confidence 458888999999999999996432 237999999876332 2334478999999999999999999988764 4
Q ss_pred ceEEEEEEeCCCCChhhhhhc---cccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCC----CCeE
Q 006750 299 AMRLLVFEFMPNGNLRDCLDG---VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN----LNAK 371 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~----~~vk 371 (632)
...++++||.+ -+|.+.|+- ...+.++...+..|+.||+.|+.|||++. |+||||||.||||..+ |.||
T Consensus 101 ~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeE
Confidence 47899999995 589888842 22345899999999999999999999999 9999999999999877 8999
Q ss_pred EeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCc
Q 006750 372 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRS 439 (632)
Q Consensus 372 L~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~ 439 (632)
|+|||+++.+...-.+- .....++.|..|.|||.+.+. .|+.+.|||+.|||+.||++-.+-|...
T Consensus 177 IaDlGlaR~~~~plkpl--~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPL--ASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred eecccHHHHhhcccccc--ccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 99999999886543221 234567789999999999875 5899999999999999999988777644
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=276.60 Aligned_cols=219 Identities=20% Similarity=0.203 Sum_probs=174.6
Q ss_pred eCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEeCCCCChh
Q 006750 236 GGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLR 314 (632)
Q Consensus 236 G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~ 314 (632)
|.||.||++.+. +++.||+|++.... .+.+|...+....||||+++++++.. ....++||||+++|+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVS----EDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheec----CCeEEEEEecCCCCCHH
Confidence 899999999875 58999999997542 24455556666689999999998875 45789999999999999
Q ss_pred hhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCCCCCCCCCC
Q 006750 315 DCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 394 (632)
Q Consensus 315 ~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 394 (632)
+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|||++...... ..
T Consensus 74 ~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--------~~ 140 (237)
T cd05576 74 SHISKF--LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--------CD 140 (237)
T ss_pred HHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc--------cc
Confidence 998654 34899999999999999999999998 999999999999999999999999987655422 11
Q ss_pred ccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccCCCCCCCCC
Q 006750 395 RMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDF 474 (632)
Q Consensus 395 ~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 474 (632)
...++..|+|||++....++.++||||+|+++|||++|+.|+....... ..... ...
T Consensus 141 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------------------~~~~~----~~~ 197 (237)
T cd05576 141 GEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------------------NTHTT----LNI 197 (237)
T ss_pred cCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------------------ccccc----cCC
Confidence 2345678999999988889999999999999999999998874321100 00000 012
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCH
Q 006750 475 PKEEMQIMAYLAKECLQLDPDARPTM 500 (632)
Q Consensus 475 ~~~~~~~l~~li~~cl~~dP~~RPs~ 500 (632)
+......+.+++.+||+.||++||++
T Consensus 198 ~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 198 PEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred cccCCHHHHHHHHHHccCCHHHhcCC
Confidence 22334558899999999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=271.77 Aligned_cols=269 Identities=22% Similarity=0.339 Sum_probs=204.1
Q ss_pred cHHHHHHhhcCccccceeeeeCceEEEEEE-ECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeec
Q 006750 216 SYSALEHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 293 (632)
Q Consensus 216 ~~~~l~~~t~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~ 293 (632)
+++++...|+ +.||+|+++.|--++ +.+|..+|||++.+. ....+.+..+|++++... .|+||++|+.++.+
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 3566666664 579999999999886 567999999999876 345666789999999999 69999999999876
Q ss_pred ccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCC---e
Q 006750 294 FRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN---A 370 (632)
Q Consensus 294 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~---v 370 (632)
+...|||||-|.||+|..+|+.. +.+++.++.++..+||.||.|||.+| |.||||||+|||-..... +
T Consensus 148 ----d~~FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPv 218 (463)
T KOG0607|consen 148 ----DTRFYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPV 218 (463)
T ss_pred ----cceEEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCce
Confidence 56789999999999999999765 45999999999999999999999999 999999999999965443 7
Q ss_pred EEeccccceecccCC--CCCCCCCCCccccCCCCCChhhhh-----cCCCCcccchHhHhHHHHHHHhCCCCCCCccccc
Q 006750 371 KITDLGMAKRLKADG--LPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSITKG 443 (632)
Q Consensus 371 kL~DFGla~~~~~~~--~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~ 443 (632)
||+||.|..-..... .+.......+.+|+..|||||+.. ...|+.+.|.||||||||-||+|.+||.+.-...
T Consensus 219 KiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d 298 (463)
T KOG0607|consen 219 KICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD 298 (463)
T ss_pred eeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc
Confidence 999999876543222 222223345678999999999774 3468999999999999999999999997654321
Q ss_pred cchheecccccccc--ccccccccCCCCCCCCCCHH----HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 444 EESLVLWATPRLQD--SGTVISELPDPRLKGDFPKE----EMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 444 ~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~~~~----~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
- -|.....-. .......+.+.. .++|+. .+.+..+++...+..|+.+|.++.++++
T Consensus 299 C----GWdrGe~Cr~CQ~~LFesIQEGk--YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 299 C----GWDRGEVCRVCQNKLFESIQEGK--YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred C----CccCCCccHHHHHHHHHHHhccC--CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 0 111100000 000111111111 134443 4556778999999999999999999887
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=284.16 Aligned_cols=242 Identities=24% Similarity=0.310 Sum_probs=196.3
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChH--HHHHHHHHHHHhc-CCCCccceeeeeecccCCcce
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNAD--SVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~--~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~ 300 (632)
.+|..+.+||+|+||.|.+|.-+. .+.+|||+++.+..-+.. +--+.|-.+|... +-|.++++..++.. .+.
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT----mDR 424 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT----MDR 424 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh----hhh
Confidence 457788999999999999998664 678999999876432221 2235677777766 67788999887765 457
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
+|+||||+.||+|.-++++. ..+.+..++-+|..||-||-+||+++ ||.||||.+|||||.+|++||+|||+++.
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccc
Confidence 89999999999999999865 44888999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
-..++ ....++.||+.|+|||++...+|+..+|.|||||+||||+.|++||++..+.+..
T Consensus 500 ni~~~-----~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF--------------- 559 (683)
T KOG0696|consen 500 NIFDG-----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF--------------- 559 (683)
T ss_pred cccCC-----cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH---------------
Confidence 44332 3456789999999999999999999999999999999999999999865543211
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT 499 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs 499 (632)
..+.+.. -.+|...+.+...+.+..|.+.|.+|..
T Consensus 560 --~aI~ehn--vsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 560 --QAIMEHN--VSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred --HHHHHcc--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence 1111111 1356667777888899999999999953
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=285.93 Aligned_cols=260 Identities=27% Similarity=0.375 Sum_probs=198.8
Q ss_pred cCccccceeeeeCceEEEEEEE-CCCcEEEEEEeccCCCCChH------HHHHHHHHHHHhcCCCCccceeeeeecccCC
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNAD------SVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~------~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 297 (632)
++|-.+.+||+|||+.||+|.+ ...+.||||+-......... +...+|..|-+.|.||.||++++|+.-.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD--- 539 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD--- 539 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec---
Confidence 4677788899999999999974 45889999987654333222 2366899999999999999999998752
Q ss_pred cceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEec---CCCCeEEec
Q 006750 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD---ENLNAKITD 374 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~---~~~~vkL~D 374 (632)
....+-|+|||+|.+|.-||... +.+++.++..|+.||+.||.||.+.. |+|||.||||.||||- .-|.+||+|
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred cccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeee
Confidence 34568999999999999999865 45899999999999999999999884 6799999999999994 457799999
Q ss_pred cccceecccCCCCCC--CCCCCccccCCCCCChhhhhcC----CCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe
Q 006750 375 LGMAKRLKADGLPSC--SSSPARMQGTFGYFAPEYAMVG----RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 448 (632)
Q Consensus 375 FGla~~~~~~~~~~~--~~~~~~~~GT~~Y~APE~~~~~----~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~ 448 (632)
|||++....+.+... ........||..|++||.+.-+ +.+.|+||||.|||+|..+.|+.||........ +.
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd--IL 694 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD--IL 694 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH--HH
Confidence 999998876544321 1234456799999999988643 478999999999999999999999975433211 00
Q ss_pred eccccccccccccc--cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 449 LWATPRLQDSGTVI--SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 449 ~~~~~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
. ....+ .++.-| .-+..+.....+|++||+..-++|.+..++..
T Consensus 695 q--------eNTIlkAtEVqFP-----~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 695 Q--------ENTILKATEVQFP-----PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred h--------hhchhcceeccCC-----CCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 0 00000 111111 11223445788999999999999988887754
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=313.50 Aligned_cols=258 Identities=22% Similarity=0.295 Sum_probs=202.1
Q ss_pred HHHHHhhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCccceeeeeecc
Q 006750 218 SALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 294 (632)
Q Consensus 218 ~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~ 294 (632)
.++.-..++|.++++||+|+||.|..++.+. +++||+|+++.-.. ......|..|-++|..-+.+=|+++.-.|.+
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD- 146 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD- 146 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC-
Confidence 4555667889999999999999999999865 89999999975211 1223348889999988888889998766665
Q ss_pred cCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEec
Q 006750 295 RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITD 374 (632)
Q Consensus 295 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~D 374 (632)
..++|+|||||+||||-.+|.... .+++.-+.-++..|+-||.-||+.| +|||||||+|||||..|++||+|
T Consensus 147 ---~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 147 ---ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred ---ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeecc
Confidence 678999999999999999997654 5888888889999999999999999 99999999999999999999999
Q ss_pred cccceecccCCCCCCCCCCCccccCCCCCChhhhh----c-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhee
Q 006750 375 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM----V-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 449 (632)
Q Consensus 375 FGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~----~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~ 449 (632)
||.+-....++... ....+|||-|.+||++. + +.|+..+|.||+||++|||+.|..||+...-.+-+
T Consensus 219 FGsClkm~~dG~V~----s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY---- 290 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVR----SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETY---- 290 (1317)
T ss_pred chhHHhcCCCCcEE----eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHH----
Confidence 99988777665322 33467999999999996 3 67999999999999999999999999854322111
Q ss_pred ccccccccccccccccCCCCCCCCCC--HHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 006750 450 WATPRLQDSGTVISELPDPRLKGDFP--KEEMQIMAYLAKECLQLDPDARPT---MSEVVQI 506 (632)
Q Consensus 450 ~~~~~~~~~~~~~~~~~~~~l~~~~~--~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~ 506 (632)
.+|.+..-...+| ...+....+||...+. +|+.|.. +.++...
T Consensus 291 -------------~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 291 -------------GKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred -------------HHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 1122211111233 2345557777777665 7788877 8887654
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=250.76 Aligned_cols=267 Identities=23% Similarity=0.336 Sum_probs=200.6
Q ss_pred CccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCCh-HHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNA-DSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~-~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
+|...++||+|.+|+||+|+..+ ++.||+|+++-+...+. -...++|+-+|+.++|+|||+++++... +..+-+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs----dkkltl 78 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS----DKKLTL 78 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc----CceeEE
Confidence 35556789999999999998654 89999999986543322 2347899999999999999999988764 557789
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
|+||| ..+|..|.+... ..++...+..++.|+++||.++|+++ +.||||||.|.||+.+|++|++|||+++.+.-
T Consensus 79 vfe~c-dqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgi 153 (292)
T KOG0662|consen 79 VFEFC-DQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI 153 (292)
T ss_pred eHHHh-hHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence 99999 569999987654 45999999999999999999999998 99999999999999999999999999997753
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCC-CCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccc-ccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGR-ASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATP-RLQDSGT 460 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~-~~~~~~~ 460 (632)
.- ......+.|..|.+|.++.+.+ |+...|+||-|||+.|+.. |++.|.+.....+...+.|... ...+.+.
T Consensus 154 pv-----rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wp 228 (292)
T KOG0662|consen 154 PV-----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWP 228 (292)
T ss_pred ce-----EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCC
Confidence 21 2233456799999999998765 8999999999999999998 5555555443332222222111 1122233
Q ss_pred cccccCCCCCCCCCCH---------HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 461 VISELPDPRLKGDFPK---------EEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~---------~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+..++|-..-..+|. .....=++|+.+.+.-+|.+|.++++.++.
T Consensus 229 s~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 229 SMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred ccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 3444444333222221 111223678889999999999999988763
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=264.59 Aligned_cols=238 Identities=31% Similarity=0.420 Sum_probs=190.5
Q ss_pred CceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEeCCCCChhh
Q 006750 237 GSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD 315 (632)
Q Consensus 237 ~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~ 315 (632)
+||.||+|...+ |+.+|+|++...........+.+|++.+++++|+||+++++++.. ....+++|||+++++|.+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----~~~~~l~~e~~~~~~L~~ 76 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED----EDKLYLVMEYCDGGDLFD 76 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee----CCEEEEEEeCCCCCCHHH
Confidence 589999999875 899999999866544435679999999999999999999999875 357799999999999999
Q ss_pred hhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCCCCCCCCCCc
Q 006750 316 CLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 395 (632)
Q Consensus 316 ~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~ 395 (632)
++.... .+++..+..++.+++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++....... ....
T Consensus 77 ~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~------~~~~ 145 (244)
T smart00220 77 LLKKRG--RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG------LLTT 145 (244)
T ss_pred HHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc------cccc
Confidence 987543 2899999999999999999999998 9999999999999999999999999998765431 2234
Q ss_pred cccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccCCCCCCCCCC
Q 006750 396 MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFP 475 (632)
Q Consensus 396 ~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 475 (632)
..++..|+|||.+....++.++||||||+++|+|++|..||....... .... .+..........
T Consensus 146 ~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~~~--------------~~~~~~~~~~~~ 209 (244)
T smart00220 146 FVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--ELFK--------------KIGKPKPPFPPP 209 (244)
T ss_pred ccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHH--------------HHhccCCCCccc
Confidence 458889999999998889999999999999999999999986531111 0000 000000000000
Q ss_pred H-HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 476 K-EEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 476 ~-~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
. ..+..+.+++.+||..+|++||++.++++
T Consensus 210 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 210 EWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred cccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 0 03345889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-33 Score=267.24 Aligned_cols=275 Identities=22% Similarity=0.297 Sum_probs=197.9
Q ss_pred ccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCC-hHHHHHHHHHHHHhcCCCCccceeeeeeccc----CCcce
Q 006750 227 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR----GKRAM 300 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~-~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~----~~~~~ 300 (632)
|....+||+|.||.||+|+.++ |+.||+|+.-...... .-...++|+++|..|.|+|++.++..|.... +....
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 4445779999999999998765 7889998875433222 1233689999999999999999999885432 23456
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.|+||++|+ -+|.-+|.... ..++..++.++..++..||.|+|... |+|||+||.|+||+.++.+||+|||+++.
T Consensus 99 ~ylVf~~ce-hDLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 99 FYLVFDFCE-HDLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred eeeeHHHhh-hhHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccc
Confidence 899999995 58888886543 45899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhee-ccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL-WATPRLQDS 458 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~-~~~~~~~~~ 458 (632)
+...+.... ...+..+.|..|.+||.+.+ ..|+.+.|||.-|||+.||++|.+-+++........++. .....-.+.
T Consensus 174 fs~~~n~~k-prytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 174 FSTSKNVVK-PRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred eecccccCC-CCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 765432221 23455667999999999886 568999999999999999999998887655433221110 000000000
Q ss_pred cc------cccccCCCCCC-CCCC--HHH------HHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006750 459 GT------VISELPDPRLK-GDFP--KEE------MQIMAYLAKECLQLDPDARPTMSEVVQIL 507 (632)
Q Consensus 459 ~~------~~~~~~~~~l~-~~~~--~~~------~~~l~~li~~cl~~dP~~RPs~~evl~~L 507 (632)
+. ....+.-+.+. +.+. ++. -+...+|+..++..||.+|+++.+++..-
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 00 00011000000 0000 000 12467899999999999999999998653
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=282.66 Aligned_cols=245 Identities=23% Similarity=0.297 Sum_probs=193.8
Q ss_pred cceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEe
Q 006750 230 SNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEF 307 (632)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey 307 (632)
.+.||+|.||+||-|+.+ +|+.||||++.+.. ..+...++.+|+.||..++||.||.|...|.. .+..|+|||-
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET----~ervFVVMEK 644 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET----PERVFVVMEK 644 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC----CceEEEEehh
Confidence 378999999999999875 59999999997653 33445668999999999999999999877664 5578999999
Q ss_pred CCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCC---CCeEEeccccceecccC
Q 006750 308 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN---LNAKITDLGMAKRLKAD 384 (632)
Q Consensus 308 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~---~~vkL~DFGla~~~~~~ 384 (632)
+ .|+..+.|-......+++....-++.||+-||.|||.++ |+|.||||+||||.+. -++||+|||+|++....
T Consensus 645 l-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 645 L-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred h-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 9 566666654444566899888899999999999999998 9999999999999644 45999999999998754
Q ss_pred CCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccc
Q 006750 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 464 (632)
Q Consensus 385 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (632)
. ....++||+.|+|||+++...|...-|+||.|||+|--++|..||....+-.++ ++.+ .
T Consensus 721 s------FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ--IQNA------------a 780 (888)
T KOG4236|consen 721 S------FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ--IQNA------------A 780 (888)
T ss_pred h------hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH--hhcc------------c
Confidence 2 345678999999999999999999999999999999999999999643221111 0000 0
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 465 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 465 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
..-| .....+.+....+||...|+..-.+|-+..+-+.
T Consensus 781 FMyP---p~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 781 FMYP---PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred cccC---CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 0111 1122345556788999999999999999887654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=289.79 Aligned_cols=241 Identities=23% Similarity=0.280 Sum_probs=194.7
Q ss_pred hhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcce
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~ 300 (632)
.++.|.....+|.|+|+.|-.+... +++..+||++...... -.+|+.++... +||||+++.+++.+ ..+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-----~~~e~~~~~~~~~h~niv~~~~v~~~----~~~ 390 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-----NQDEIPISLLVRDHPNIVKSHDVYED----GKE 390 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc-----cccccchhhhhcCCCcceeecceecC----Cce
Confidence 4677888888999999999999865 4889999999866221 34677777666 89999999999876 567
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEe-cCCCCeEEeccccce
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL-DENLNAKITDLGMAK 379 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl-~~~~~vkL~DFGla~ 379 (632)
.|+|||++.|+-|.+.+.... .....+..|+.+|+.++.|||++| ++||||||+|||+ ++.++++|+|||.++
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWS 464 (612)
T ss_pred eeeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhh
Confidence 899999999998888776432 223778889999999999999998 9999999999999 699999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
....+ .....-|..|.|||++....|+.++|+||||++||+||+|+.||.......+
T Consensus 465 ~~~~~--------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e--------------- 521 (612)
T KOG0603|consen 465 ELERS--------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE--------------- 521 (612)
T ss_pred hCchh--------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH---------------
Confidence 77654 1122457889999999999999999999999999999999999965433210
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
....+..+ .+....+....+|+.+||+.||.+||++.++...
T Consensus 522 -i~~~i~~~----~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 522 -IHTRIQMP----KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred -HHHhhcCC----ccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 11222222 2335566678999999999999999999999764
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=299.62 Aligned_cols=264 Identities=20% Similarity=0.254 Sum_probs=170.7
Q ss_pred hhcCccccceeeeeCceEEEEEEECC-----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeec-cc-
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE-FR- 295 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~-~~- 295 (632)
..++|...+.||+|+||.||+|.+.+ +..||||++..... .+.+..| .+....+.+++.++..+.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 45789999999999999999998754 68999999864321 1112221 1222233333333222111 11
Q ss_pred CCcceEEEEEEeCCCCChhhhhhccccC------------------CCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCC
Q 006750 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVE------------------GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 357 (632)
Q Consensus 296 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDL 357 (632)
......++||||+++++|.+++...... ......+..++.|++.||+|||+.+ |+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcC
Confidence 2345789999999999999998643210 0123345679999999999999998 999999
Q ss_pred CCCCeEecC-CCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcC----------------------CCC
Q 006750 358 KSSNILLDE-NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG----------------------RAS 414 (632)
Q Consensus 358 Kp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~----------------------~~s 414 (632)
||+||||+. ++.+||+|||+|+...... ........||+.|+|||.+... .++
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~----~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGI----NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCcccccccc----ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 999999985 5789999999998654322 1223456789999999966422 234
Q ss_pred cccchHhHhHHHHHHHhCCCCCCCccccc-------cchheeccccccccccccccccCCCCCCC--CCCHHHHHHHHHH
Q 006750 415 LMSDVFSFGVVLLELITGRQPIHRSITKG-------EESLVLWATPRLQDSGTVISELPDPRLKG--DFPKEEMQIMAYL 485 (632)
Q Consensus 415 ~ksDVwSlGviL~eLltG~~P~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~--~~~~~~~~~l~~l 485 (632)
.++|||||||+||||+++..|+....... ......|... ......+.+.. ...........+|
T Consensus 358 ~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~d~~~~~~~dL 429 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKL--------VEPRASPDLRRGFEVLDLDGGAGWEL 429 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHh--------hccccchhhhhhhhhccccchHHHHH
Confidence 56799999999999999877754321100 0001111100 00000000000 0000111234589
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 006750 486 AKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 486 i~~cl~~dP~~RPs~~evl~~ 506 (632)
+.+||+.||.+|||+.++++.
T Consensus 430 i~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 430 LKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHHHccCCcccCCCHHHHhCC
Confidence 999999999999999999874
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=276.31 Aligned_cols=268 Identities=22% Similarity=0.263 Sum_probs=200.8
Q ss_pred HHhhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcC--CCC----ccceeeeeec
Q 006750 221 EHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH--HCH----VVPLVGYCSE 293 (632)
Q Consensus 221 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~--Hpn----iv~l~g~~~~ 293 (632)
...+++|.+...+|+|.||.|-...+.. +..||||+++.- ....+..+-|+++|.+|. -|+ +|.+.+++..
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 3448899999999999999999997654 789999999854 233445678999999993 232 5566555543
Q ss_pred ccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEec--------
Q 006750 294 FRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-------- 365 (632)
Q Consensus 294 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~-------- 365 (632)
..+.+||+|.+ |-|+.++|..+...+++...+..|+.|++++++|||+.+ ++|-||||+|||+-
T Consensus 163 ----rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 163 ----RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred ----cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEe
Confidence 56789999999 779999999887788999999999999999999999998 99999999999992
Q ss_pred ------------CCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCC
Q 006750 366 ------------ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 433 (632)
Q Consensus 366 ------------~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~ 433 (632)
.+..++|+|||.|+..... ....+.|..|.|||++.+..++..+||||+||||+||.+|.
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~--------hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~ 306 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEH--------HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGE 306 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceeccC--------cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccc
Confidence 1345899999999875432 34567899999999999999999999999999999999999
Q ss_pred CCCCCccccccchh---eecccccc--ccc-------------------c--ccccccCCCCCC-CCCCHHHHHHHHHHH
Q 006750 434 QPIHRSITKGEESL---VLWATPRL--QDS-------------------G--TVISELPDPRLK-GDFPKEEMQIMAYLA 486 (632)
Q Consensus 434 ~P~~~~~~~~~~~~---~~~~~~~~--~~~-------------------~--~~~~~~~~~~l~-~~~~~~~~~~l~~li 486 (632)
..|+.....+.... +.-..|.. ... + ..+.+.+.|.-. -.....+...|.+|+
T Consensus 307 ~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl 386 (415)
T KOG0671|consen 307 TLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLL 386 (415)
T ss_pred eecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence 99876653321100 00000000 000 0 000111111000 011234455689999
Q ss_pred HHhcccCCCCCCCHHHHHHH
Q 006750 487 KECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 487 ~~cl~~dP~~RPs~~evl~~ 506 (632)
++||..||.+|+|+.|++..
T Consensus 387 ~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 387 RRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHccCccccccHHHHhcC
Confidence 99999999999999999863
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=288.91 Aligned_cols=265 Identities=20% Similarity=0.277 Sum_probs=182.6
Q ss_pred hhcCccccceeeeeCceEEEEEEE-----------------CCCcEEEEEEeccCCCCC-------------hHHHHHHH
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQL-----------------TDGRIVAVKRFKTQGGPN-------------ADSVFLTE 272 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~-----------------~~g~~vAVK~l~~~~~~~-------------~~~~f~~E 272 (632)
..++|.+.++||+|+||+||+|.+ .+++.||||+++...... ..+.+..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999964 235789999987542211 11124457
Q ss_pred HHHHHhcCCCCc-----cceeeeeecccC----CcceEEEEEEeCCCCChhhhhhcccc---------------------
Q 006750 273 VDMLSRLHHCHV-----VPLVGYCSEFRG----KRAMRLLVFEFMPNGNLRDCLDGVLV--------------------- 322 (632)
Q Consensus 273 i~~l~~l~Hpni-----v~l~g~~~~~~~----~~~~~~lV~Ey~~~gsL~~~L~~~~~--------------------- 322 (632)
+.++.+++|.++ ++++++|..... .....+|||||+++|+|.++|+....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 778888876654 678888764211 13457999999999999999864211
Q ss_pred -CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCC
Q 006750 323 -EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401 (632)
Q Consensus 323 -~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~ 401 (632)
..++|..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... .......+|+.
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~----~~~~~g~~tp~ 375 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN----FNPLYGMLDPR 375 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc----cCccccCCCcc
Confidence 12567889999999999999999998 99999999999999999999999999976533211 11112235789
Q ss_pred CCChhhhhcCC----------------------CCcccchHhHhHHHHHHHhCCC-CCCCcccccc------chheeccc
Q 006750 402 YFAPEYAMVGR----------------------ASLMSDVFSFGVVLLELITGRQ-PIHRSITKGE------ESLVLWAT 452 (632)
Q Consensus 402 Y~APE~~~~~~----------------------~s~ksDVwSlGviL~eLltG~~-P~~~~~~~~~------~~~~~~~~ 452 (632)
|+|||.+.... ...+.||||+||+||+|++|.. ||........ .....|.
T Consensus 376 Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r- 454 (507)
T PLN03224 376 YSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR- 454 (507)
T ss_pred eeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH-
Confidence 99999875322 1234799999999999999986 6643211100 0111111
Q ss_pred cccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCC---CCCCCHHHHHHH
Q 006750 453 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDP---DARPTMSEVVQI 506 (632)
Q Consensus 453 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~~ 506 (632)
....................+|+.++|..+| .+|+|+.|++++
T Consensus 455 -----------~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 455 -----------MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred -----------hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0111111111122334557889999998766 689999999874
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=281.70 Aligned_cols=250 Identities=22% Similarity=0.294 Sum_probs=203.6
Q ss_pred cCccccceeeeeCceEEEEEEECCCc-EEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTDGR-IVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~-~vAVK~l~~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
.++.....||-||||.|=++..+... .+|+|+++.... ....+....|-.+|...+.|.||++|..|.+ ..+.
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd----~kyv 495 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD----SKYV 495 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc----chhh
Confidence 34555677999999999999876533 489999986643 3334458889999999999999999977665 6788
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+.||-|-||.|...|+.+ +.++..+..-++..+..|++|||.++ ||.|||||+|++||.+|-+||.|||+|+.+
T Consensus 496 YmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKI 570 (732)
T ss_pred hhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHh
Confidence 9999999999999999864 45899999999999999999999999 999999999999999999999999999988
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
..+. ..-++.||+.|.|||++.....+..+|.||||+++|||++|.+||....+.....++...
T Consensus 571 ~~g~------KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG---------- 634 (732)
T KOG0614|consen 571 GSGR------KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG---------- 634 (732)
T ss_pred ccCC------ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh----------
Confidence 7643 345688999999999999999999999999999999999999999876544322222111
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT-----MSEVVQI 506 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 506 (632)
.-...+|........+|+++....+|.+|.- +.+|.+.
T Consensus 635 -------id~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 635 -------IDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred -------hhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 1111355555666788999999999999975 4555543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=257.50 Aligned_cols=251 Identities=22% Similarity=0.308 Sum_probs=193.7
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~ 299 (632)
.++|..+++||+|++..|..+++.. .+.+|+|+++..- ..+...=...|-.+..+- +||.+|.|..++.. ..
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt----es 324 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT----ES 324 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc----cc
Confidence 4678999999999999999998764 7899999998652 112222255677777766 89999999887765 56
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
.+++|.||++||+|.-++++. +.+++..+.-+...|.-||.|||+.| ||.||||.+|+|||..|++||+|+|+.+
T Consensus 325 rlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred eEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhh
Confidence 789999999999999888764 45999999999999999999999999 9999999999999999999999999987
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
.-... .....++.|||.|.|||++.+..|+...|.|+|||+++||+.|+.||+......... ....
T Consensus 400 e~l~~-----gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~---------nted 465 (593)
T KOG0695|consen 400 EGLGP-----GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDM---------NTED 465 (593)
T ss_pred cCCCC-----CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCccc---------chhH
Confidence 64433 234567899999999999999999999999999999999999999997432211100 0000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT 499 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs 499 (632)
....-+....+ .+|...+-....+++..|++||.+|..
T Consensus 466 ylfqvilekqi--riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 466 YLFQVILEKQI--RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred HHHHHHhhhcc--cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 01111111111 133334444667788889999999853
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=280.67 Aligned_cols=246 Identities=30% Similarity=0.435 Sum_probs=185.8
Q ss_pred ccccceeeeeCceE-EEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcceEEEE
Q 006750 227 FSGSNIVGQGGSSY-VYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 227 f~~~~~LG~G~fG~-Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~~~lV 304 (632)
|...+++|.|+.|+ ||+|.. +|+.||||++-... .....+|+..|+.- .|||||++++.-. ++...||.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~----~~~A~rEi~lL~eSD~H~NviRyyc~E~----d~qF~YIa 581 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF----FDFAQREIQLLQESDEHPNVIRYYCSEQ----DRQFLYIA 581 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh----HHHHHHHHHHHHhccCCCceEEEEeecc----CCceEEEE
Confidence 44456789999876 799998 48999999986432 22367899999988 8999999976433 26689999
Q ss_pred EEeCCCCChhhhhhcc--ccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC---C--CCeEEecccc
Q 006750 305 FEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---N--LNAKITDLGM 377 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~---~--~~vkL~DFGl 377 (632)
.|.| .-+|.+++... ......-...+.+..|++.||++||+.+ ||||||||.||||+. + ..++|+|||+
T Consensus 582 lELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfgl 657 (903)
T KOG1027|consen 582 LELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGL 657 (903)
T ss_pred ehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccc
Confidence 9999 67999999763 1111222456788999999999999998 999999999999965 3 4689999999
Q ss_pred ceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhC-CCCCCCccccccchheeccccccc
Q 006750 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITG-RQPIHRSITKGEESLVLWATPRLQ 456 (632)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG-~~P~~~~~~~~~~~~~~~~~~~~~ 456 (632)
++.+..+... ........||-+|+|||++.....+..+|||||||++|+.++| ..||..........+
T Consensus 658 sKkl~~~~sS--~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl--------- 726 (903)
T KOG1027|consen 658 SKKLAGGKSS--FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL--------- 726 (903)
T ss_pred ccccCCCcch--hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh---------
Confidence 9998765432 1235567899999999999999999999999999999999996 899975443311100
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 457 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 457 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.....+..+ . ..+. + +..+||.+|++++|..||++.+|+.
T Consensus 727 ~~~~~L~~L-----~-~~~d-~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 727 TGNYTLVHL-----E-PLPD-C--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred cCccceeee-----c-cCch-H--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 000000000 0 1111 1 5789999999999999999999986
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=242.63 Aligned_cols=206 Identities=27% Similarity=0.385 Sum_probs=170.2
Q ss_pred HHHhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCC
Q 006750 220 LEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGK 297 (632)
Q Consensus 220 l~~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~ 297 (632)
++...+.......||+|++|.|-+-++. +|+..|||++...-..+...+.++|+++..+- .-|.+|.++|....
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r---- 116 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR---- 116 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc----
Confidence 4445555566778999999999888764 59999999999877667777789999987666 89999999997664
Q ss_pred cceEEEEEEeCCCCChhhhhhccc--cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecc
Q 006750 298 RAMRLLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 375 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DF 375 (632)
....++.||.| .-||..|-+... +..+++..+-+||..+..||.|||++- .++|||+||+||||+.+|++|++||
T Consensus 117 egdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDF 193 (282)
T KOG0984|consen 117 EGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDF 193 (282)
T ss_pred cccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccc
Confidence 44679999999 578888765432 345889999999999999999999975 4999999999999999999999999
Q ss_pred ccceecccCCCCCCCCCCCccccCCCCCChhhhhc----CCCCcccchHhHhHHHHHHHhCCCCCCC
Q 006750 376 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV----GRASLMSDVFSFGVVLLELITGRQPIHR 438 (632)
Q Consensus 376 Gla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~----~~~s~ksDVwSlGviL~eLltG~~P~~~ 438 (632)
|.+-.+.+.- ..+-..|-..|||||.+.. ..|+.||||||||++++||.+++.||+.
T Consensus 194 GIsG~L~dSi------Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 194 GISGYLVDSI------AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred ccceeehhhh------HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 9998776432 1122357889999998863 3689999999999999999999999964
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-30 Score=268.21 Aligned_cols=209 Identities=23% Similarity=0.317 Sum_probs=169.9
Q ss_pred CccccceeeeeCceEEEEEEE-CCCcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
-|..++.||-|+||.|.++.- +....||+|.|.+..- .......+.|-+||..-.++=||+|+-.|.+ +..+|
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD----kdnLY 705 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD----KDNLY 705 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc----CCceE
Confidence 466778899999999999964 3477899999875421 1222347789999999999999999876665 66889
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||++||++..+|-+. +-|.+..+.-++..+..|+++.|..| +|||||||+|||||.+|++||+||||+.-+.
T Consensus 706 FVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccce
Confidence 999999999999998764 34788888888999999999999999 9999999999999999999999999986442
Q ss_pred c---CCC------CCC-----C-------C----------------CCCccccCCCCCChhhhhcCCCCcccchHhHhHH
Q 006750 383 A---DGL------PSC-----S-------S----------------SPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVV 425 (632)
Q Consensus 383 ~---~~~------~~~-----~-------~----------------~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGvi 425 (632)
- ..+ ... . . .....+||+.|+|||++....++.-+|.||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 1 000 000 0 0 0123569999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCccccc
Q 006750 426 LLELITGRQPIHRSITKG 443 (632)
Q Consensus 426 L~eLltG~~P~~~~~~~~ 443 (632)
||||+.|+.||......+
T Consensus 861 l~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGE 878 (1034)
T ss_pred HHHHhhCCCCccCCCCCc
Confidence 999999999998765543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=235.76 Aligned_cols=211 Identities=35% Similarity=0.541 Sum_probs=181.8
Q ss_pred eeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEeCCCC
Q 006750 233 VGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNG 311 (632)
Q Consensus 233 LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey~~~g 311 (632)
||+|++|.||++...+ ++.+++|++...........+.+|+..++.+.|++++++++++.. ....+++|||++++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----~~~~~~~~e~~~~~ 76 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED----ENHLYLVMEYCEGG 76 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec----CCeEEEEEecCCCC
Confidence 6899999999999865 899999999866443234569999999999999999999998875 35779999999999
Q ss_pred ChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC-CCCeEEeccccceecccCCCCCCC
Q 006750 312 NLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKITDLGMAKRLKADGLPSCS 390 (632)
Q Consensus 312 sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~ 390 (632)
+|.+++.... ..+++..+..++.+++++|.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........
T Consensus 77 ~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---- 148 (215)
T cd00180 77 SLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---- 148 (215)
T ss_pred cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----
Confidence 9999987542 35899999999999999999999998 999999999999999 89999999999987654321
Q ss_pred CCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccCCCC
Q 006750 391 SSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 469 (632)
Q Consensus 391 ~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 469 (632)
......+...|++||.+... ..+.++|+|++|+++++|
T Consensus 149 -~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------- 187 (215)
T cd00180 149 -LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------- 187 (215)
T ss_pred -hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------
Confidence 12334578899999999877 889999999999999999
Q ss_pred CCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 470 LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 470 l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
..+.+++..|+..+|++||++.++++.
T Consensus 188 ----------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 227889999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=253.44 Aligned_cols=135 Identities=26% Similarity=0.345 Sum_probs=119.7
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-----C---CCccceeeeeeccc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-----H---CHVVPLVGYCSEFR 295 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~-----H---pniv~l~g~~~~~~ 295 (632)
.+|.+.++||.|.|++||++.+. +.+.||+|+.+.. +...+..+.||++|++++ | .+||+|++.|....
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 67889999999999999999865 4789999999864 334445789999999983 3 36999999999888
Q ss_pred CCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEe
Q 006750 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL 364 (632)
Q Consensus 296 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl 364 (632)
.++.+.+||+|++ |-+|..+|.....++++...+.+|+.||+.||.|||... +|||-||||+||||
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 8889999999999 889999998888888999999999999999999999876 59999999999999
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-31 Score=252.12 Aligned_cols=270 Identities=24% Similarity=0.305 Sum_probs=193.6
Q ss_pred cccceeeeeCceEEEEEEE-CCCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCC-cceEEEE
Q 006750 228 SGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK-RAMRLLV 304 (632)
Q Consensus 228 ~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~-~~~~~lV 304 (632)
+..+-||-|+||.||.+.+ ++|+.||.|++..-. .-...+.+.+|+++|..++|.|++..++.......+ -.++|+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3457899999999999976 469999999986432 122335588999999999999999887665321111 1246889
Q ss_pred EEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccC
Q 006750 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 384 (632)
+|.| ..+|...|-. .+.++...+.-+..||++||+|||+.+ |.||||||.|+|++.|..+||+|||+|+....+
T Consensus 136 TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 136 TELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchh
Confidence 9999 5788888753 366888899999999999999999998 999999999999999999999999999987654
Q ss_pred CCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccchh--eeccccccccccc-
Q 006750 385 GLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL--VLWATPRLQDSGT- 460 (632)
Q Consensus 385 ~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~--~~~~~~~~~~~~~- 460 (632)
+. ...+..+-|..|.|||++++. .|+...||||.|||+.||+..+..|+...+-....+ .....+.......
T Consensus 210 ~~----~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A 285 (449)
T KOG0664|consen 210 DR----LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA 285 (449)
T ss_pred hh----hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence 32 233445678999999999975 589999999999999999988888865443322111 1222222222111
Q ss_pred -------cccccC-CCCCCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006750 461 -------VISELP-DPRLKG----DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507 (632)
Q Consensus 461 -------~~~~~~-~~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 507 (632)
.++.-. .|.+.- .-+.....+...+...++..||+.|.+..+.+..+
T Consensus 286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 011100 111110 01112223345677888999999999998887654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-29 Score=259.43 Aligned_cols=197 Identities=22% Similarity=0.302 Sum_probs=167.9
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChH-------HHHHHHHHHHHhcC---CCCccceeeeeec
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNAD-------SVFLTEVDMLSRLH---HCHVVPLVGYCSE 293 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~-------~~f~~Ei~~l~~l~---Hpniv~l~g~~~~ 293 (632)
..|+..+.||.|+||.|+.+.++. ...|+||.+.+...-... -..-.|+.||..|+ |+||++++.+|.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 458889999999999999999865 678999998765321110 01446999999997 9999999999886
Q ss_pred ccCCcceEEEEEEeC-CCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEE
Q 006750 294 FRGKRAMRLLVFEFM-PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKI 372 (632)
Q Consensus 294 ~~~~~~~~~lV~Ey~-~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL 372 (632)
+.++||+||-. ++-+|.++|... ..+++.++.-|+.||+.|+++||+++ |||||||-+|+.++.+|-+||
T Consensus 641 ----dd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~kl 711 (772)
T KOG1152|consen 641 ----DDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKL 711 (772)
T ss_pred ----CCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEE
Confidence 66889999976 566999999764 44999999999999999999999999 999999999999999999999
Q ss_pred eccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCC-CcccchHhHhHHHHHHHhCCCCCC
Q 006750 373 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIH 437 (632)
Q Consensus 373 ~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDVwSlGviL~eLltG~~P~~ 437 (632)
+|||.|..... .....++||..|.|||++.+.+| +..-|||++|++||.++....||+
T Consensus 712 idfgsaa~~ks-------gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 712 IDFGSAAYTKS-------GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eeccchhhhcC-------CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999876543 34456889999999999998776 777899999999999999999986
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=233.68 Aligned_cols=200 Identities=30% Similarity=0.422 Sum_probs=170.5
Q ss_pred ccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEE
Q 006750 227 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 305 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~ 305 (632)
|...+.||.|++|.||++...+ ++.+|+|.+...........+.+|++.+++++|+|++++++++.. ....++++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~----~~~~~~v~ 76 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED----PEPLYLVM 76 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec----CCceEEEE
Confidence 4566889999999999999875 899999999865433245678999999999999999999998775 35679999
Q ss_pred EeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCC
Q 006750 306 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 385 (632)
Q Consensus 306 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 385 (632)
||+++++|.+++..... .+++..+..++.+++.+|.+||+.+ ++|+||+|.||+++.++.++|+|||++.......
T Consensus 77 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 77 EYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred eccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 99999999999976432 1899999999999999999999998 9999999999999999999999999998775432
Q ss_pred CCCCCCCCCccccCCCCCChhhh-hcCCCCcccchHhHhHHHHHHHhCCCCCCC
Q 006750 386 LPSCSSSPARMQGTFGYFAPEYA-MVGRASLMSDVFSFGVVLLELITGRQPIHR 438 (632)
Q Consensus 386 ~~~~~~~~~~~~GT~~Y~APE~~-~~~~~s~ksDVwSlGviL~eLltG~~P~~~ 438 (632)
........++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 153 ----~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 ----AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ----cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 0122345678899999998 666788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-29 Score=264.00 Aligned_cols=253 Identities=26% Similarity=0.401 Sum_probs=199.0
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
.++|.....+|.|.+|.|||+++. .++..|||+++-..... .....+|+-+++..+||||+.++|-+.. ....+
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd-~~~iqqei~~~~dc~h~nivay~gsylr----~dklw 88 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD-FSGIQQEIGMLRDCRHPNIVAYFGSYLR----RDKLW 88 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc-ccccccceeeeecCCCcChHHHHhhhhh----hcCcE
Confidence 456778889999999999999875 49999999998765433 2336789999999999999999998876 44679
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+.||||.+|+|++.-+.. ..+++.++..++....+||+|||+++ -+|||||-.|||+++.|.+|++|||.+..+.
T Consensus 89 icMEycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQIT 163 (829)
T ss_pred EEEEecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhh
Confidence 999999999999976643 56899999999999999999999998 8999999999999999999999999987654
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhh---cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
.. ......+.||+.|||||+.. .+.|...+|||++|+.-.|+---++|....-+.. .+.....
T Consensus 164 at-----i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr--~l~LmTk------- 229 (829)
T KOG0576|consen 164 AT-----IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR--ALFLMTK------- 229 (829)
T ss_pred hh-----hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH--HHHHhhc-------
Confidence 32 23445678999999999874 5679999999999999999988777754332211 1110000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.....|.+.. .......+.+|++.++..+|.+||++..+++
T Consensus 230 ---S~~qpp~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 230 ---SGFQPPTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ---cCCCCCcccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 0011122221 2234456899999999999999999988765
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=252.51 Aligned_cols=210 Identities=26% Similarity=0.294 Sum_probs=173.6
Q ss_pred eecHHHHHHhhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcC------CCCccc
Q 006750 214 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH------HCHVVP 286 (632)
Q Consensus 214 ~~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~------Hpniv~ 286 (632)
.|.+.--+....+|.+....|+|-|++|.+|.+.. |+.||||++....... +.=+.|+++|++|+ --|.++
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~--KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH--KTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh--hhhhHHHHHHHHhhccCchhhhHHHH
Confidence 35555566677899999999999999999998765 8899999998653222 22468999999995 237888
Q ss_pred eeeeeecccCCcceEEEEEEeCCCCChhhhhhcccc-CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEec
Q 006750 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD 365 (632)
Q Consensus 287 l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~ 365 (632)
|+-.|.. .++++||+|-+ ..+|.++|..... -+|....+..++.|+.-||.+|...+ |+|.||||.|||++
T Consensus 499 l~r~F~h----knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVN 570 (752)
T KOG0670|consen 499 LFRHFKH----KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVN 570 (752)
T ss_pred HHHHhhh----cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEec
Confidence 8877665 67899999998 6899999976432 23888899999999999999999998 99999999999998
Q ss_pred CCCC-eEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCcc
Q 006750 366 ENLN-AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (632)
Q Consensus 366 ~~~~-vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~ 440 (632)
+..+ +||||||.|.....+.. +.+..+..|.|||++.+.+|+...|+||.||+||||.||+..|.+..
T Consensus 571 E~k~iLKLCDfGSA~~~~enei-------tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 571 ESKNILKLCDFGSASFASENEI-------TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred cCcceeeeccCccccccccccc-------cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 7654 79999999987765432 23445678999999999999999999999999999999998886543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-28 Score=227.16 Aligned_cols=257 Identities=20% Similarity=0.292 Sum_probs=191.9
Q ss_pred hcCccccceeeeeCceEEEEEE-ECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCccceeeeeecccCCcceE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~~~~ 301 (632)
.++|++.+++|+|-++.||.|. ..+++.++||+++.-. .+.+.+|+.+|..|. ||||++|++...+.. ....
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~--Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK----KKKIKREIKILQNLRGGPNIIKLLDIVKDPE--SKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH----HHHHHHHHHHHHhccCCCCeeehhhhhcCcc--ccCc
Confidence 4678889999999999999997 4568899999998543 234899999999995 999999999987755 3466
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCC-CCeEEecccccee
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKITDLGMAKR 380 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~-~~vkL~DFGla~~ 380 (632)
.||+||+++.+...+- ..++...+.....+++.||.|+|++| |+|||+||.|++||.. ..++|+|+|||.+
T Consensus 111 aLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred hhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhh
Confidence 8999999998877654 34778889999999999999999999 9999999999999864 5699999999998
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec---------
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--------- 450 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--------- 450 (632)
+.... ...-.+.+..|--||.+.. ..|+..-|+|||||+|..|+..+.||........+ ++..
T Consensus 183 YHp~~------eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQ-LVkIakVLGt~el 255 (338)
T KOG0668|consen 183 YHPGK------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVKIAKVLGTDEL 255 (338)
T ss_pred cCCCc------eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHH-HHHHHHHhChHHH
Confidence 86543 2233456677889998875 55788999999999999999999998654322211 0000
Q ss_pred ----------ccccccc-----ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 451 ----------ATPRLQD-----SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 451 ----------~~~~~~~-----~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
..+.+.+ ....+.....+.-..-. ..+..+|+.+.|..|-.+|||+.|.+.
T Consensus 256 ~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~----~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 256 YAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLV----SPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHHHccCCChhHhhHhhccccccHHHhCCccccccC----ChHHHHHHHHHHhhccccccchHHHhc
Confidence 0000000 00001111111111111 244778999999999999999999875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-28 Score=236.74 Aligned_cols=261 Identities=24% Similarity=0.317 Sum_probs=191.6
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccC-CCCChHHHHHHHHHHHHhcCCCCccceeeeeecccC--CcceE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQ-GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRAMR 301 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~-~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~--~~~~~ 301 (632)
+|..++.+|.|.- .|..+.+. .++.||+|++... ......+...+|..++..++|+||++++.++..... .-...
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 4555677888887 55555432 4889999988654 222333457899999999999999999998864322 13456
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||||| .++|.+.+. ..++..++..|..|++.|++|||+.+ |+||||||+||++..+..+||.|||+|+..
T Consensus 97 y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 97 YLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhccc
Confidence 9999999 679998886 33788999999999999999999999 999999999999999999999999999875
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccc--------
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP-------- 453 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~-------- 453 (632)
..+ ...+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+... +.+|...
T Consensus 169 ~~~------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~-----idQ~~ki~~~lgtpd 237 (369)
T KOG0665|consen 169 DTD------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH-----IDQWNKIIEQLGTPD 237 (369)
T ss_pred Ccc------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH-----HHHHHHHHHHhcCCC
Confidence 433 234567789999999999998899999999999999999999887753221 1111100
Q ss_pred -----cccccc------------ccccc-cCCCCCCCC--CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 454 -----RLQDSG------------TVISE-LPDPRLKGD--FPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 454 -----~~~~~~------------~~~~~-~~~~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.++..+ ....+ ++|...... .+.-......+++.+||..||++|.++.++++.
T Consensus 238 ~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 238 PSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 000000 00111 111111111 111223457889999999999999999999873
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-26 Score=237.63 Aligned_cols=267 Identities=22% Similarity=0.288 Sum_probs=199.0
Q ss_pred CccccceeeeeCceEEEEEEECCC--cEEEEEEeccCCCCChHHHHHHHHHHHHhcCC----CCccceeeeeecccCCcc
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLTDG--RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHH----CHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~g--~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~H----pniv~l~g~~~~~~~~~~ 299 (632)
+|.+.+.||+|+||.||++..... ..+|+|........... .+..|+.+|..+.+ +++..+++... ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~---~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGR---STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEecc---CCCc
Confidence 788999999999999999987653 58999988765433332 47889999999963 57888877663 1245
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCC-----CCeEEec
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-----LNAKITD 374 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~-----~~vkL~D 374 (632)
+.|+||+.+ |.+|.++......+.++..+.+.|+.|++.+|++||+.| ++||||||.|+++... ..+.|.|
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEe
Confidence 779999999 899999886555567999999999999999999999999 9999999999999765 4699999
Q ss_pred cccceecc--cCCCC--CCCCC-CCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhee
Q 006750 375 LGMAKRLK--ADGLP--SCSSS-PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 449 (632)
Q Consensus 375 FGla~~~~--~~~~~--~~~~~-~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~ 449 (632)
||+++.+. ..... ..... .....||..|+++..+.+...+.+.|+||+++++.|++.|.+||...........
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~-- 248 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK-- 248 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH--
Confidence 99999432 22211 11111 2346799999999999999999999999999999999999999965433211110
Q ss_pred ccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006750 450 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 514 (632)
Q Consensus 450 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 514 (632)
+.+..............+..+..++..+-..+...+|.+..+...|.......
T Consensus 249 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 249 ------------FEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred ------------HHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 00000000000011112233666666677799999999999999988775544
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=236.61 Aligned_cols=272 Identities=25% Similarity=0.388 Sum_probs=196.6
Q ss_pred HHHhhcCccccceeeeeCceEEEEEEEC----CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecc
Q 006750 220 LEHATDKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 294 (632)
Q Consensus 220 l~~~t~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~ 294 (632)
+....+.|...++||.|.|++||++.+. ..+.||+|.+.....+. ...+|+++|..+ .+.||+++.+++..
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~---ri~~El~~L~~~gG~~ni~~~~~~~rn- 106 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPS---RILNELEMLYRLGGSDNIIKLNGCFRN- 106 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCch---HHHHHHHHHHHhccchhhhcchhhhcc-
Confidence 4445677888999999999999999754 36789999998665444 378999999999 79999999988765
Q ss_pred cCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC-CCCeEEe
Q 006750 295 RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKIT 373 (632)
Q Consensus 295 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~-~~~vkL~ 373 (632)
.+...+|+||++.-.-.+++.. ++..++...+..+..||+++|..| ||||||||+|+|.+. .+.-.|.
T Consensus 107 ---nd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~Lv 175 (418)
T KOG1167|consen 107 ---NDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLV 175 (418)
T ss_pred ---CCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEE
Confidence 5577999999999888888754 678899999999999999999999 999999999999975 4567899
Q ss_pred ccccceecccCC-------------CC-------CC-------------------CCCCCccccCCCCCChhhhhc-CCC
Q 006750 374 DLGMAKRLKADG-------------LP-------SC-------------------SSSPARMQGTFGYFAPEYAMV-GRA 413 (632)
Q Consensus 374 DFGla~~~~~~~-------------~~-------~~-------------------~~~~~~~~GT~~Y~APE~~~~-~~~ 413 (632)
|||||....... .+ .. ........||++|.|||++.. ...
T Consensus 176 DFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Q 255 (418)
T KOG1167|consen 176 DFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQ 255 (418)
T ss_pred echhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCc
Confidence 999997321100 00 00 001123569999999999875 668
Q ss_pred CcccchHhHhHHHHHHHhCCCCCCCccccccc---------------------hheeccccccccc------cccc-ccc
Q 006750 414 SLMSDVFSFGVVLLELITGRQPIHRSITKGEE---------------------SLVLWATPRLQDS------GTVI-SEL 465 (632)
Q Consensus 414 s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~---------------------~~~~~~~~~~~~~------~~~~-~~~ 465 (632)
+.++||||-|||++-+++++.||......... ....|........ ...+ .+.
T Consensus 256 ttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~ 335 (418)
T KOG1167|consen 256 TTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIES 335 (418)
T ss_pred CCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhh
Confidence 99999999999999999999999755433210 0011110000000 0000 000
Q ss_pred CCC--C--CC-CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 466 PDP--R--LK-GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 466 ~~~--~--l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
..+ . .. ....+..+..+.+|+.+|+..||.+|.|+++.++.
T Consensus 336 ~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 336 IYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 000 0 00 11112233468899999999999999999999874
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.7e-27 Score=223.65 Aligned_cols=252 Identities=19% Similarity=0.325 Sum_probs=182.7
Q ss_pred hhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcce
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~ 300 (632)
..+.|.+.+.||+|.||.+-+++++. .+.+++|.+.... ....+|.+|...--.| .|.||+.-+.+..+ ..+.
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~--tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq---t~d~ 96 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ--TTQADFVREFHYSFFLSPHQHIIDTYEVAFQ---TSDA 96 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch--hhHHHHHHHhccceeeccchhhhHHHHHHhh---cCce
Confidence 34678899999999999999999875 7889999987653 3445699998776566 79999988766544 2447
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEe-c-CCCCeEEeccccc
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL-D-ENLNAKITDLGMA 378 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl-~-~~~~vkL~DFGla 378 (632)
+++++||++.|+|..-+.. .++.+.....++.|+++||.|+|+.+ +||||||.+|||| + +...+||+|||+.
T Consensus 97 YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t 170 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLT 170 (378)
T ss_pred EEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccc
Confidence 7899999999999987754 45888899999999999999999998 9999999999999 3 3447999999998
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhcC-----CCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccc
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-----RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 453 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-----~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~ 453 (632)
+.... ......-+..|.+||..... ...+.+|||.||+++|.++||.+||+....... ....|..
T Consensus 171 ~k~g~--------tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~-~Y~~~~~- 240 (378)
T KOG1345|consen 171 RKVGT--------TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK-PYWEWEQ- 240 (378)
T ss_pred cccCc--------eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc-hHHHHHH-
Confidence 76432 12223345679999977532 247789999999999999999999984433221 1111111
Q ss_pred ccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 006750 454 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVV 504 (632)
Q Consensus 454 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 504 (632)
+... ... .-|.....+.+. +..+.++-+..+|++|--..++.
T Consensus 241 -w~~r--k~~--~~P~~F~~fs~~----a~r~Fkk~lt~~~~drcki~~~k 282 (378)
T KOG1345|consen 241 -WLKR--KNP--ALPKKFNPFSEK----ALRLFKKSLTPRFKDRCKIWTAK 282 (378)
T ss_pred -Hhcc--cCc--cCchhhcccCHH----HHHHHHHhcCCcccccchhHHHH
Confidence 1100 001 112222223333 56677888999999994444443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-26 Score=216.00 Aligned_cols=281 Identities=20% Similarity=0.249 Sum_probs=213.7
Q ss_pred hcCccccceeeeeCceEEEEEE-ECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCC-CCccceeeeeecccCCcceE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHH-CHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~H-pniv~l~g~~~~~~~~~~~~ 301 (632)
.++|...+.||.|+||.+|.|. ..+|..||||+........ ++..|..+...|+| ..|..+..|..+ ..+-
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp---qL~yEskvY~iL~~g~GiP~i~~y~~e----~~yn 86 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP---QLLYESKVYRILQGGVGIPHIRHYGTE----KDYN 86 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc---chhHHHHHHHHhccCCCCchhhhhccc----cccc
Confidence 4678899999999999999997 4579999999987654322 37889999999965 456666666555 4456
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCC---CCeEEeccccc
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN---LNAKITDLGMA 378 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~---~~vkL~DFGla 378 (632)
.+|||.+ |.||+++++-. .+.++..+++.++-|++.-++|+|.++ ++||||||+|+|..-+ ..+.++|||||
T Consensus 87 vlVMdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred eeeeecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccch
Confidence 8999999 89999987643 356999999999999999999999999 9999999999999644 35899999999
Q ss_pred eecccC--CCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccc
Q 006750 379 KRLKAD--GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 456 (632)
Q Consensus 379 ~~~~~~--~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~ 456 (632)
+.+.+. ..+..........||.+|.+-..+.+...+.+.|+-|+|.+|..+.-|.+||++...........
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE------- 234 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE------- 234 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH-------
Confidence 987653 22334455667889999999999999999999999999999999999999998754432211000
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCcccccccCcchhhh
Q 006750 457 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNISLNLFQI 527 (632)
Q Consensus 457 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~~~ 527 (632)
...+....++-..+...+|.+ +.-.+..|-..--++-|+..-+.+.+.-+.....-.....++|-..
T Consensus 235 kI~EkK~s~~ie~LC~G~P~E----F~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~l 301 (341)
T KOG1163|consen 235 KISEKKMSTPIEVLCKGFPAE----FAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTML 301 (341)
T ss_pred HHHHhhcCCCHHHHhCCCcHH----HHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHH
Confidence 000000011112233344444 7778889999999999999999998888877766666666666543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-26 Score=223.16 Aligned_cols=277 Identities=18% Similarity=0.206 Sum_probs=208.9
Q ss_pred CccccceeeeeCceEEEEEE-ECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcceEEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
.|.+.++||+|+||.++.|+ +-++++||||....... ..++..|....+.| .-++|...+-+..+ +.+-.|
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~---APQLrdEYr~YKlL~g~~GIP~vYYFGqe----G~~NiL 101 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE---APQLRDEYRTYKLLGGTEGIPQVYYFGQE----GKYNIL 101 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCC---cchHHHHHHHHHHHcCCCCCCceeeeccc----cchhhh
Confidence 58889999999999999997 45799999998764432 23478889999988 57788887755444 345589
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCC-----CCeEEeccccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-----LNAKITDLGMA 378 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~-----~~vkL~DFGla 378 (632)
|+|++ |.||+|+.+- .++.|+.++++.||.|++.-++|+|++. +|.|||||+|+||..- ..+.|+|||+|
T Consensus 102 VidLL-GPSLEDLFD~-CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDL-CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhhh-CcCHHHHHHH-hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccch
Confidence 99999 8999998764 4467999999999999999999999998 9999999999999543 34899999999
Q ss_pred eecccCC--CCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccc
Q 006750 379 KRLKADG--LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 456 (632)
Q Consensus 379 ~~~~~~~--~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~ 456 (632)
+.+.+.. .+..........||.+||+-..+.+...+.+.|+-|||-+++..|-|.+||++......... .+
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k-------Ye 249 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK-------YE 249 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH-------HH
Confidence 9886543 23445566678899999999999999999999999999999999999999987543321110 01
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCcccccccCcchh
Q 006750 457 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNISLNLF 525 (632)
Q Consensus 457 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~ 525 (632)
.+.+..+..-...+....+.+|...+...-.++-++-|+++-+...+..++.+......-.++|.
T Consensus 250 ----KIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~ 314 (449)
T KOG1165|consen 250 ----KIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWM 314 (449)
T ss_pred ----HhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccccccccc
Confidence 11111111111111223344577777888889999999999998888887765554444444444
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=221.67 Aligned_cols=279 Identities=22% Similarity=0.333 Sum_probs=205.6
Q ss_pred cccccccCCcccccceeeeecHHHHHHhhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccC-CCCChHHHHHHHHH
Q 006750 196 LKTTFCRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQ-GGPNADSVFLTEVD 274 (632)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~-~~~~~~~~f~~Ei~ 274 (632)
..+++.+.++.+..+++.+|+--++. .....-+|.+...|..|+|+|. |..+++|+++.. .......+|..|.-
T Consensus 165 kdt~wkgtktr~rdatlsr~~gid~~----~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp 239 (448)
T KOG0195|consen 165 KDTTWKGTKTRTRDATLSRYTGIDVS----SLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFP 239 (448)
T ss_pred cccccccccccccccccccccCcchh----hhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCc
Confidence 33334444444444444444322221 1222346888999999999996 556777888754 33444556999999
Q ss_pred HHHhcCCCCccceeeeeecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceee
Q 006750 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILH 354 (632)
Q Consensus 275 ~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH 354 (632)
.|+-+.||||++++|.|.. ...+.+|..||+.|||+..|++...-..+..++++++.++|+|++|||+.. |-|.-
T Consensus 240 ~lrifshpnilpvlgacns----ppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr 314 (448)
T KOG0195|consen 240 ALRIFSHPNILPVLGACNS----PPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPR 314 (448)
T ss_pred ceeeecCCchhhhhhhccC----CCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhh
Confidence 9999999999999999986 457799999999999999999876555888999999999999999999985 44566
Q ss_pred cCCCCCCeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCC---CCcccchHhHhHHHHHHHh
Q 006750 355 RDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELIT 431 (632)
Q Consensus 355 rDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~---~s~ksDVwSlGviL~eLlt 431 (632)
.-|.+..++||++.+++|+ .+-+++... .....-.+.||+||.++..+ .-..+|+|||+++||||.|
T Consensus 315 ~~lns~hvmidedltaris-mad~kfsfq---------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~t 384 (448)
T KOG0195|consen 315 FYLNSKHVMIDEDLTARIS-MADTKFSFQ---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNT 384 (448)
T ss_pred hhcccceEEecchhhhhee-cccceeeee---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhc
Confidence 6799999999999998875 111221111 11122458899999998654 3457999999999999999
Q ss_pred CCCCCCCccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 432 GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 432 G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
...||....+-+-. -++.-..++..+|+..+..|.+|+.-|++.||.+||.+..|+-+|+++.
T Consensus 385 revpfadlspmecg-----------------mkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 385 REVPFADLSPMECG-----------------MKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cccccccCCchhhh-----------------hhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 99999754432211 1122233444567777788999999999999999999999999998763
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-26 Score=270.31 Aligned_cols=205 Identities=19% Similarity=0.201 Sum_probs=141.8
Q ss_pred HhcCC-CCccceeeeeeccc---CCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCce
Q 006750 277 SRLHH-CHVVPLVGYCSEFR---GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRI 352 (632)
Q Consensus 277 ~~l~H-pniv~l~g~~~~~~---~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 352 (632)
+.++| +||+++++++.... ......+++|||+ +++|.++|+.. ...+++.+++.++.||++||+|||+++ |
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 35556 58888888773222 1123567888988 67999999753 345999999999999999999999998 9
Q ss_pred eecCCCCCCeEecC-------------------CCCeEEeccccceecccCC------CC-----CCCCCCCccccCCCC
Q 006750 353 LHRDIKSSNILLDE-------------------NLNAKITDLGMAKRLKADG------LP-----SCSSSPARMQGTFGY 402 (632)
Q Consensus 353 iHrDLKp~NILl~~-------------------~~~vkL~DFGla~~~~~~~------~~-----~~~~~~~~~~GT~~Y 402 (632)
+||||||+||||+. ++.+|++|||+++...... .. ..........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 4455666666665421100 00 000011224689999
Q ss_pred CChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHH
Q 006750 403 FAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIM 482 (632)
Q Consensus 403 ~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 482 (632)
||||++.+..++.++|||||||+||||++|..|+...... ... .......+... ......
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~----~~~-----------~~~~~~~~~~~-----~~~~~~ 241 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT----MSS-----------LRHRVLPPQIL-----LNWPKE 241 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH----HHH-----------HHHhhcChhhh-----hcCHHH
Confidence 9999999999999999999999999999998886422110 000 00001111111 111235
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 006750 483 AYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 483 ~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
..++.+||+.+|.+||++.|+++.
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhhc
Confidence 578889999999999999999874
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.4e-25 Score=209.47 Aligned_cols=166 Identities=20% Similarity=0.200 Sum_probs=126.2
Q ss_pred CChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCCCCCC
Q 006750 311 GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 390 (632)
Q Consensus 311 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 390 (632)
|+|.++++.. ...+++.+++.|+.|++.||.|||+.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc-----
Confidence 7899999753 346999999999999999999999875 999999999999999 99998754321
Q ss_pred CCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccCCCCC
Q 006750 391 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRL 470 (632)
Q Consensus 391 ~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 470 (632)
..||+.|||||++.+..++.++||||||+++|||++|+.||......... ...+ .........
T Consensus 64 -----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~-~~~~-----------~~~~~~~~~ 126 (176)
T smart00750 64 -----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAI-LEIL-----------LNGMPADDP 126 (176)
T ss_pred -----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHH-HHHH-----------HHHhccCCc
Confidence 25899999999999999999999999999999999999999643221110 0000 000000000
Q ss_pred -CCCCCHHHHH--HHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 471 -KGDFPKEEMQ--IMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 471 -~~~~~~~~~~--~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
....+..... .+.+++.+||..+|.+||++.++++.+..+
T Consensus 127 ~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 127 RDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred cccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 0011222333 589999999999999999999999988655
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=225.45 Aligned_cols=180 Identities=23% Similarity=0.222 Sum_probs=135.1
Q ss_pred HhhcCccccceeeeeCceEEEEEEEC--CCcEEEEEEeccCC----CCChHHHHHHHHHHHHhcCCCCccceeeeeeccc
Q 006750 222 HATDKFSGSNIVGQGGSSYVYRGQLT--DGRIVAVKRFKTQG----GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 295 (632)
Q Consensus 222 ~~t~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vAVK~l~~~~----~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~ 295 (632)
...++|...+.||+|+||+||+|.++ +++.||||++.... .......|.+|+++|++++|+|+++.+..+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 34577999999999999999999875 57889999876331 122345699999999999999999533211
Q ss_pred CCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCC-CCCCeEecCCCCeEEec
Q 006750 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI-KSSNILLDENLNAKITD 374 (632)
Q Consensus 296 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDL-Kp~NILl~~~~~vkL~D 374 (632)
...|+||||++|++|... .. .. ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|
T Consensus 91 ---~~~~LVmE~~~G~~L~~~-~~-----~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHLA-RP-----HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred ---CCcEEEEEccCCCCHHHh-Cc-----cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEE
Confidence 135999999999999732 11 11 1467889999999999998 999999 99999999999999999
Q ss_pred cccceecccCCCCCC---CCCCCccccCCCCCChhhhhcCC------CCcccchH
Q 006750 375 LGMAKRLKADGLPSC---SSSPARMQGTFGYFAPEYAMVGR------ASLMSDVF 420 (632)
Q Consensus 375 FGla~~~~~~~~~~~---~~~~~~~~GT~~Y~APE~~~~~~------~s~ksDVw 420 (632)
||+|+.+........ ........+++.|+|||++...+ .+..+|-|
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 999998765431111 01124567899999999886432 33446666
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.9e-22 Score=205.06 Aligned_cols=260 Identities=31% Similarity=0.447 Sum_probs=196.3
Q ss_pred ccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCC--hHHHHHHHHHHHHhcCCC-CccceeeeeecccCCcceEEE
Q 006750 227 FSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHC-HVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~--~~~~f~~Ei~~l~~l~Hp-niv~l~g~~~~~~~~~~~~~l 303 (632)
|...+.||.|+||.||++... ..+++|.+....... ....|.+|+.++..+.|+ +++++..++.. ....++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----~~~~~~ 75 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD----EGSLYL 75 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec----CCEEEE
Confidence 556788999999999999986 889999998765544 366799999999999888 79999988843 334799
Q ss_pred EEEeCCCCChhhhhhcccc-CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCC-CeEEeccccceec
Q 006750 304 VFEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITDLGMAKRL 381 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~-~vkL~DFGla~~~ 381 (632)
+++|+.+++|.+++..... ..+.......+..|++.++.|+|..+ ++|||+||+||+++..+ .++++|||+++..
T Consensus 76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~ 152 (384)
T COG0515 76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLL 152 (384)
T ss_pred EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceec
Confidence 9999999999977764321 25889999999999999999999998 99999999999999988 6999999999865
Q ss_pred ccCCCCCCC-CCCCccccCCCCCChhhhhc---CCCCcccchHhHhHHHHHHHhCCCCCCCcccc-ccchheeccccccc
Q 006750 382 KADGLPSCS-SSPARMQGTFGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPIHRSITK-GEESLVLWATPRLQ 456 (632)
Q Consensus 382 ~~~~~~~~~-~~~~~~~GT~~Y~APE~~~~---~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~-~~~~~~~~~~~~~~ 456 (632)
......... .......||..|+|||.+.+ ..++...|+||+|++++++++|..||...... ......
T Consensus 153 ~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~-------- 224 (384)
T COG0515 153 PDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL-------- 224 (384)
T ss_pred CCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHH--------
Confidence 543321110 12456779999999999987 68899999999999999999999997544321 000000
Q ss_pred cccccccccCCCCCCCCCC----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 457 DSGTVISELPDPRLKGDFP----KEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 457 ~~~~~~~~~~~~~l~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
..+.....+....... ......+.+++..++..+|..|.+..+....
T Consensus 225 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 225 ---KIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ---HHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000011000000111 1223457889999999999999999887764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-22 Score=224.53 Aligned_cols=258 Identities=21% Similarity=0.230 Sum_probs=184.0
Q ss_pred cccceeeeeCceEEEEEEEC-CCcEEEEEEecc----C-CCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 228 SGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKT----Q-GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 228 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~----~-~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
...+++|.|.+|.|+..... .....+.|.+.. . ........+..|+-+-..|+|||++..+..+.+... .
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~----~ 396 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG----I 396 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc----c
Confidence 34678999999988877643 344455554431 1 111111125567777888999999888776665332 2
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
+-+||||++ +|..++... ..+...++..++.|+..|++|+|+.| |.|||||++|++++.+|.+||+|||.+..+
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVF 470 (601)
T ss_pred hhhhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceee
Confidence 344999999 999998753 35888999999999999999999999 999999999999999999999999999877
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCC-cccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRAS-LMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s-~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
....... ........|+..|+|||++.+..|. ...||||.|+++..|++|+.||.......... .....
T Consensus 471 ~~~~e~~-~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~~~~~-------- 540 (601)
T KOG0590|consen 471 RYPWEKN-IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-KTNNY-------- 540 (601)
T ss_pred ccCcchh-hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-hhhcc--------
Confidence 5432211 1234567899999999999988875 46899999999999999999996544332211 00000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
........-...+...++.....++.++|+.||.+|.|+.+|++.
T Consensus 541 -~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 541 -SDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred -ccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 000000000011223445567889999999999999999999873
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.2e-21 Score=185.54 Aligned_cols=140 Identities=16% Similarity=0.169 Sum_probs=108.5
Q ss_pred cceeeeeCceEEEEEEECCCcEEEEEEeccCCCCC-h-------H-----------------HHHHHHHHHHHhcCCCCc
Q 006750 230 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPN-A-------D-----------------SVFLTEVDMLSRLHHCHV 284 (632)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~-~-------~-----------------~~f~~Ei~~l~~l~Hpni 284 (632)
...||+|+||.||+|...+|+.||||+++...... . . .....|+..|.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 35799999999999998889999999997542211 1 0 112349999999988877
Q ss_pred cceeeeeecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHH-HhcCCCceeecCCCCCCeE
Q 006750 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL-HEAAAPRILHRDIKSSNIL 363 (632)
Q Consensus 285 v~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiHrDLKp~NIL 363 (632)
.....+... ..+|||||+++++|...+.. ...+++..+..++.|++.+|.|| |+.+ |+||||||+|||
T Consensus 82 ~~p~~~~~~------~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIl 150 (190)
T cd05147 82 PCPEPILLK------SHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLL 150 (190)
T ss_pred CCCcEEEec------CCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEE
Confidence 543322111 23899999998877655322 24589999999999999999999 6888 999999999999
Q ss_pred ecCCCCeEEeccccceec
Q 006750 364 LDENLNAKITDLGMAKRL 381 (632)
Q Consensus 364 l~~~~~vkL~DFGla~~~ 381 (632)
++ ++.++|+|||+|...
T Consensus 151 i~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 151 YH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred EE-CCcEEEEEccccccC
Confidence 98 478999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-21 Score=188.97 Aligned_cols=177 Identities=12% Similarity=0.128 Sum_probs=136.0
Q ss_pred HhhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChH--HH------HHHHHHHHHhcCCCCccceeeeeec
Q 006750 222 HATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNAD--SV------FLTEVDMLSRLHHCHVVPLVGYCSE 293 (632)
Q Consensus 222 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~--~~------f~~Ei~~l~~l~Hpniv~l~g~~~~ 293 (632)
...++|...++||.|+||.||++.. ++..+|||.+......... .. |.+|+..+.++.|++|..+..++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4578999999999999999999766 5778999999755322221 12 5789999999999999999888654
Q ss_pred ccCC----cceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCC
Q 006750 294 FRGK----RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN 369 (632)
Q Consensus 294 ~~~~----~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 369 (632)
.... ....+|||||++|.+|.++.. ++. ....+++.+|..+|+.+ ++|||+||+||+++.++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 2211 235689999999999988732 222 24568999999999999 99999999999999988
Q ss_pred eEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHH
Q 006750 370 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELI 430 (632)
Q Consensus 370 vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLl 430 (632)
++|+|||.......+.. ...++....+..++|+|+|||+|.-+.
T Consensus 173 i~liDfg~~~~~~e~~a-----------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKA-----------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhh-----------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 99999998865432211 011444556678999999999988664
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.5e-21 Score=206.01 Aligned_cols=235 Identities=22% Similarity=0.349 Sum_probs=170.3
Q ss_pred HHhcCCCCccceeeeeecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeec
Q 006750 276 LSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHR 355 (632)
Q Consensus 276 l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHr 355 (632)
|+.+.|.|+.+++|.+.+ ....++|.+||..|+|.|.+... ...++|.....+..+++.||+|||+.. -..|+
T Consensus 1 l~~l~h~n~~~f~g~~~~----~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVD----GPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEec----CCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeee
Confidence 467899999999999997 36779999999999999999763 356999999999999999999999764 23999
Q ss_pred CCCCCCeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcC-------CCCcccchHhHhHHHHH
Q 006750 356 DIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-------RASLMSDVFSFGVVLLE 428 (632)
Q Consensus 356 DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-------~~s~ksDVwSlGviL~e 428 (632)
.|++.|+++|..+.+||+|||+......... ........-..-|.|||.+... ..+.+.||||||++++|
T Consensus 74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~---~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e 150 (484)
T KOG1023|consen 74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAE---PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE 150 (484)
T ss_pred eeccccceeeeeEEEEechhhhccccccccc---ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence 9999999999999999999999877643100 0111112234679999988753 14778999999999999
Q ss_pred HHhCCCCCCCccccccc-hheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006750 429 LITGRQPIHRSITKGEE-SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507 (632)
Q Consensus 429 LltG~~P~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 507 (632)
+++...||+........ .++... .. .-....+|.+... .+....+..++..||..+|..||++.+|...+
T Consensus 151 i~~r~~~~~~~~~~~~~~eii~~~----~~---~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~ 221 (484)
T KOG1023|consen 151 ILFRSGPFDLRNLVEDPDEIILRV----KK---GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKL 221 (484)
T ss_pred HHhccCccccccccCChHHHHHHH----Hh---cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhh
Confidence 99999999753332211 111110 00 0111222222211 13334588899999999999999999999999
Q ss_pred hhhCCCcccccccCcchhhhhh
Q 006750 508 STIAPDKSRRRNISLNLFQIFS 529 (632)
Q Consensus 508 ~~i~~~~~~~~~~~~~~~~~~~ 529 (632)
..+........++....+....
T Consensus 222 ~~~~~~~~~~~nl~D~m~~~le 243 (484)
T KOG1023|consen 222 LTINKGGSSKGNLMDSLFRMLE 243 (484)
T ss_pred hhhcccccccchhHHHHHHHHH
Confidence 9887765433344444444433
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.6e-20 Score=178.66 Aligned_cols=140 Identities=22% Similarity=0.226 Sum_probs=110.9
Q ss_pred cceeeeeCceEEEEEEECCCcEEEEEEeccCCCCC---------------------h----HHHHHHHHHHHHhcCCCCc
Q 006750 230 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPN---------------------A----DSVFLTEVDMLSRLHHCHV 284 (632)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~---------------------~----~~~f~~Ei~~l~~l~Hpni 284 (632)
.+.||+|+||.||+|.+.+|+.||||+++...... . ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999998789999999998652110 0 1124678999999999987
Q ss_pred cceeeeeecccCCcceEEEEEEeCCCCChhhh-hhccccCCCCHHHHHHHHHHHHHhhHHHHh-cCCCceeecCCCCCCe
Q 006750 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDC-LDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNI 362 (632)
Q Consensus 285 v~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~-L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDLKp~NI 362 (632)
.....+... ..+|||||++|+++... +.. ..++......++.+++.+|.+||+ .+ |+||||||+||
T Consensus 82 ~~p~~~~~~------~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NI 149 (190)
T cd05145 82 PVPEPILLK------KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNI 149 (190)
T ss_pred CCceEEEec------CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhE
Confidence 544433222 23899999988865443 332 347888999999999999999999 88 99999999999
Q ss_pred EecCCCCeEEeccccceecc
Q 006750 363 LLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 363 Ll~~~~~vkL~DFGla~~~~ 382 (632)
|++ ++.++|+|||++....
T Consensus 150 ll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 150 LYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred EEE-CCCEEEEEcccceecC
Confidence 999 7899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.9e-20 Score=175.26 Aligned_cols=191 Identities=16% Similarity=0.065 Sum_probs=141.6
Q ss_pred cccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCC---hHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcceEEE
Q 006750 228 SGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPN---ADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 228 ~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~---~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
.+...|++|+||+||.+.. ++..++.+.+....... ....|.+|+++|++| +|+++++++++. ..++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~--------~~~l 75 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD--------GRHL 75 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc--------CEEE
Confidence 3456799999999998765 68888888887653311 122588999999999 568899998751 2499
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCC-CCCCeEecCCCCeEEeccccceecc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI-KSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDL-Kp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+|||+.|.+|.+.+.. ....++.|++.+|+++|+.| |+|||| ||+|||++.++.++|+|||+|....
T Consensus 76 vmeyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 76 DRSYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred EEeeecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 9999999999764321 11356789999999999999 999999 7999999999999999999998654
Q ss_pred cCCCCC---CCC-----CCCccccCCCCCChhhhhcC-CCC-cccchHhHhHHHHHHHhCCCCCCCc
Q 006750 383 ADGLPS---CSS-----SPARMQGTFGYFAPEYAMVG-RAS-LMSDVFSFGVVLLELITGRQPIHRS 439 (632)
Q Consensus 383 ~~~~~~---~~~-----~~~~~~GT~~Y~APE~~~~~-~~s-~ksDVwSlGviL~eLltG~~P~~~~ 439 (632)
...... ... .......++.|++|+...-. ..+ ...+.++-|.-+|.++||+.|....
T Consensus 144 ~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 144 PRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred CcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 321000 000 00112368889999865432 333 5678899999999999999987543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.3e-19 Score=181.15 Aligned_cols=234 Identities=22% Similarity=0.313 Sum_probs=150.2
Q ss_pred cccceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCC-----------CCccceeeeee-
Q 006750 228 SGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHH-----------CHVVPLVGYCS- 292 (632)
Q Consensus 228 ~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~H-----------pniv~l~g~~~- 292 (632)
...+.||.|+|+.||.+.+.. |+.+|||++.... .....+.+.+|.-....+.+ .-++++ +...
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~-d~~~i 93 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL-DLLRI 93 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S-EEEEE
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee-EEEEE
Confidence 345789999999999999865 8999999986543 23344557777655555432 112221 1111
Q ss_pred -------cccCCcc-----eEEEEEEeCCCCChhhhhhc---cc--cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeec
Q 006750 293 -------EFRGKRA-----MRLLVFEFMPNGNLRDCLDG---VL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHR 355 (632)
Q Consensus 293 -------~~~~~~~-----~~~lV~Ey~~~gsL~~~L~~---~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHr 355 (632)
....... ..+++|+-+ .+||.+++.. .. ...+....++.+..|+++.+++||..| ++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 0000011 347788888 6799888642 11 112445666778899999999999999 9999
Q ss_pred CCCCCCeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcC--------CCCcccchHhHhHHHH
Q 006750 356 DIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG--------RASLMSDVFSFGVVLL 427 (632)
Q Consensus 356 DLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~--------~~s~ksDVwSlGviL~ 427 (632)
||+|+|+|++.+|.++|+||+.......... ....+..|.+||..... .++.+.|.|++|+++|
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~--------~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly 241 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYR--------CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY 241 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEE--------GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceee--------ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence 9999999999999999999998776543210 02345789999977542 4788999999999999
Q ss_pred HHHhCCCCCCCccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCC
Q 006750 428 ELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDAR 497 (632)
Q Consensus 428 eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R 497 (632)
.|++|+.||........... ....+. +.++.+..||..+|+.||++|
T Consensus 242 ~lWC~~lPf~~~~~~~~~~~----------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 242 SLWCGRLPFGLSSPEADPEW----------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHSS-STCCCGGGSTSGG----------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHccCCCCCCCccccccc----------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999975443321110 011233 556669999999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-20 Score=210.50 Aligned_cols=255 Identities=22% Similarity=0.220 Sum_probs=176.2
Q ss_pred CccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHH--HHhcCCCCccceeeeeecccCCcceEEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDM--LSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~--l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
++...+.||++.|=.|.+|+++.|. |+||++-.....-....|.++++- ...++|||.+++..+-.. ....||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t----~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVT----DKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHh----hHHHHH
Confidence 5666788999999999999998887 999998765433333445544433 445599999998765332 445588
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec--
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL-- 381 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~-- 381 (632)
|-+|. .-+|+|.|.-+ --+...+...|+.|++.||..+|..+ |+|+|||.+||||+.-.=+.|+||.--+..
T Consensus 99 vRqyv-khnLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 99 VRQYV-KHNLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHHHH-hhhhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccC
Confidence 88888 56899887542 22777888999999999999999999 999999999999998777899999765421
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcC-----------CCCcccchHhHhHHHHHHHh-CCCCCCCccccccchhee
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVG-----------RASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVL 449 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-----------~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~ 449 (632)
+.+.-........+-..-..|.|||.+... ..+++.||||+||++.||++ |++||.-.. +..
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~a 246 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLA 246 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHh
Confidence 211100000000111123569999987531 15778999999999999999 688875221 000
Q ss_pred ccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006750 450 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 509 (632)
Q Consensus 450 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 509 (632)
+......+....+.++.|+ .++.|+..|++.||.+|.++++.++.-..
T Consensus 247 Yr~~~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 247 YRSGNADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred HhccCccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 0000000111123333333 27789999999999999999999986443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.8e-19 Score=179.62 Aligned_cols=203 Identities=22% Similarity=0.256 Sum_probs=142.0
Q ss_pred CCCCccceeeeeecc-----------------------cCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHH
Q 006750 280 HHCHVVPLVGYCSEF-----------------------RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIG 336 (632)
Q Consensus 280 ~Hpniv~l~g~~~~~-----------------------~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ 336 (632)
+|||||++.++|.+. -+....+|+||..+ .-+|.+||..+ ..+.....-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~---~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR---HRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC---CCchHHHHHHHHH
Confidence 599999999887541 11345789999988 46999999653 3567778888999
Q ss_pred HHHhhHHHHhcCCCceeecCCCCCCeEe--cCCCC--eEEeccccceecccCCCCCCC-CCCCccccCCCCCChhhhhcC
Q 006750 337 AARGLEYLHEAAAPRILHRDIKSSNILL--DENLN--AKITDLGMAKRLKADGLPSCS-SSPARMQGTFGYFAPEYAMVG 411 (632)
Q Consensus 337 ia~gL~yLH~~~~~~iiHrDLKp~NILl--~~~~~--vkL~DFGla~~~~~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~ 411 (632)
++.|+.|||.++ |.|||+|++|||| |+|+. ++|+|||.+-....-+..... ...-..-|...-||||+....
T Consensus 350 lLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 999999999999 9999999999999 44443 689999986543322211111 112234478889999988643
Q ss_pred C------CCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHH
Q 006750 412 R------ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYL 485 (632)
Q Consensus 412 ~------~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~l 485 (632)
+ .-.|+|.|+.|-+-||++....||+.... ..+.. . ...+-.-|. .|+.++..+.++
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe---m~L~~---r-------~Yqe~qLPa----lp~~vpp~~rql 489 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE---MLLDT---R-------TYQESQLPA----LPSRVPPVARQL 489 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccch---heech---h-------hhhhhhCCC----CcccCChHHHHH
Confidence 2 24589999999999999999999986221 11100 0 011111222 344455558889
Q ss_pred HHHhcccCCCCCCCHHHHHHH
Q 006750 486 AKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 486 i~~cl~~dP~~RPs~~evl~~ 506 (632)
+...|+.||.+|++..-....
T Consensus 490 V~~lL~r~pskRvsp~iAANv 510 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAANV 510 (598)
T ss_pred HHHHhcCCccccCCccHHHhH
Confidence 999999999999987544443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1e-18 Score=170.70 Aligned_cols=140 Identities=19% Similarity=0.232 Sum_probs=106.2
Q ss_pred cccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-----CCCCccceeeeeecccCCcceEE
Q 006750 228 SGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-----HHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 228 ~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-----~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
...+.||+|+||.||. .-.++.. +||++..... .....+.+|+.+++.+ .||||++++|++....+......
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~-~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGD-GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEecccc-chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 3457899999999996 2223444 7998875432 2345689999999999 57999999999987543333345
Q ss_pred EEEEe--CCCCChhhhhhccccCCCCHHHHHHHHHHHHHhh-HHHHhcCCCceeecCCCCCCeEecC----CCCeEEecc
Q 006750 303 LVFEF--MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL-EYLHEAAAPRILHRDIKSSNILLDE----NLNAKITDL 375 (632)
Q Consensus 303 lV~Ey--~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~iiHrDLKp~NILl~~----~~~vkL~DF 375 (632)
+|+|| +.+|+|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++. ++.++|+||
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 89999 5579999999652 25554 35677888777 9999999 999999999999973 347999995
Q ss_pred ccc
Q 006750 376 GMA 378 (632)
Q Consensus 376 Gla 378 (632)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 444
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.1e-20 Score=198.59 Aligned_cols=225 Identities=24% Similarity=0.291 Sum_probs=177.3
Q ss_pred eeeeCceEEEEEE----ECCCcEEEEEEeccCCCCCh-HHHHHHHHHHHHhcC-CCCccceeeeeecccCCcceEEEEEE
Q 006750 233 VGQGGSSYVYRGQ----LTDGRIVAVKRFKTQGGPNA-DSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 233 LG~G~fG~Vy~~~----~~~g~~vAVK~l~~~~~~~~-~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~~~~~lV~E 306 (632)
+|+|.||.|+++. .+.|..+|+|+++....... ......|..++...+ ||.+|++.-.+.. +...+++++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt----~~kl~l~ld 77 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT----DGKLYLILD 77 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc----ccchhHhhh
Confidence 7899999999864 23488899999876532221 113566888888885 9999998755543 456799999
Q ss_pred eCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCC
Q 006750 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (632)
Q Consensus 307 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 386 (632)
|..||+|...+... ..+...........++-+++++|+.+ |+|||+|++||+++.+|++++.|||+++.......
T Consensus 78 ~~rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 78 FLRGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred hcccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 99999999887653 33666777777888999999999999 99999999999999999999999999987654322
Q ss_pred CCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccC
Q 006750 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 466 (632)
Q Consensus 387 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (632)
..||..|||||++. .....+|.||||++.+||+||..||... .+..++
T Consensus 153 ---------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~---------------------~~~~Il 200 (612)
T KOG0603|consen 153 ---------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD---------------------TMKRIL 200 (612)
T ss_pred ---------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH---------------------HHHHHh
Confidence 16899999999988 5677899999999999999999999641 111121
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 006750 467 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM 500 (632)
Q Consensus 467 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 500 (632)
. .....|.+......+++..++..+|..|.-.
T Consensus 201 ~--~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 201 K--AELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred h--hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 1 1224677888888999999999999999654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.4e-18 Score=198.24 Aligned_cols=200 Identities=22% Similarity=0.248 Sum_probs=158.5
Q ss_pred HHHHhhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC---CCCccceeeeeeccc
Q 006750 219 ALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH---HCHVVPLVGYCSEFR 295 (632)
Q Consensus 219 ~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~---Hpniv~l~g~~~~~~ 295 (632)
+++.-...|.+.+.||+|+||+||+|...+|+.||+|+-+.....+ |.--.+++.+|+ -+-|..+..++..
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE----fYI~~q~~~RLk~~~~~~~~~~~~a~~~-- 765 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE----FYICLQVMERLKPQMLPSIMHISSAHVF-- 765 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee----eeehHHHHHhhchhhhcchHHHHHHHcc--
Confidence 3444557788999999999999999998889999999988765443 555556666776 2233333333332
Q ss_pred CCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEec-------CCC
Q 006750 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-------ENL 368 (632)
Q Consensus 296 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~-------~~~ 368 (632)
.+..+||+||.+.|+|.++++ ..+.++|...+.++.|+++.+++||..+ |||+||||+|+||. ++.
T Consensus 766 --~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~ 838 (974)
T KOG1166|consen 766 --QNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSK 838 (974)
T ss_pred --CCcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCccc
Confidence 334589999999999999998 3466999999999999999999999999 99999999999993 344
Q ss_pred CeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCC
Q 006750 369 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQ 434 (632)
Q Consensus 369 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~ 434 (632)
.++|+|||-+-...--. .........+|-.+--+|+..+..++...|.|-|+-+++-||.|+.
T Consensus 839 ~l~lIDfG~siDm~lfp---~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 839 GLYLIDFGRSIDMKLFP---DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ceEEEecccceeeeEcC---CCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 58999999986443210 0123455678899999999999999999999999999999999974
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-17 Score=163.09 Aligned_cols=144 Identities=20% Similarity=0.141 Sum_probs=111.6
Q ss_pred HHHhhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCC---------------------ChHHHHHHHHHHHHh
Q 006750 220 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGP---------------------NADSVFLTEVDMLSR 278 (632)
Q Consensus 220 l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~---------------------~~~~~f~~Ei~~l~~ 278 (632)
+......|.+.+.||+|+||.||++...+|+.||||++...... .....+..|+.++..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 33333447778999999999999999888999999987643210 011236778999999
Q ss_pred cCCCC--ccceeeeeecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecC
Q 006750 279 LHHCH--VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRD 356 (632)
Q Consensus 279 l~Hpn--iv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrD 356 (632)
+.|++ ++..++. ...++||||++|++|.+.... .....++.+++.++.++|+.+ |+|||
T Consensus 90 l~~~~i~v~~~~~~--------~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g---i~H~D 150 (198)
T cd05144 90 LYEEGFPVPKPIDW--------NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG---IIHGD 150 (198)
T ss_pred HHHcCCCCCceeec--------CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC---CCcCC
Confidence 98874 4444432 134899999999999875431 235678889999999999988 99999
Q ss_pred CCCCCeEecCCCCeEEeccccceecc
Q 006750 357 IKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 357 LKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
|||+||++++++.++|+|||++....
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCcccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2e-17 Score=162.72 Aligned_cols=135 Identities=20% Similarity=0.312 Sum_probs=110.8
Q ss_pred ceeeeeCceEEEEEEECCCcEEEEEEeccCCCCC-------hHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPN-------ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~-------~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
+.||+|++|.||+|.+ +|..|+||+........ ....+.+|+.++..+.|+++.....++.. ....++
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~----~~~~~l 76 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD----PENFII 76 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe----CCCCEE
Confidence 5799999999999988 67789999876433211 11347889999999999998776666544 234589
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
||||++|++|.+++... .+ .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 77 v~e~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 77 VMEYIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999999998642 22 88899999999999999998 99999999999999 78899999999864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-17 Score=166.14 Aligned_cols=144 Identities=19% Similarity=0.168 Sum_probs=111.1
Q ss_pred cCccccceeeeeCceEEEEEE--ECCCcEEEEEEeccCCCC-------------------C----hHHHHHHHHHHHHhc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQ--LTDGRIVAVKRFKTQGGP-------------------N----ADSVFLTEVDMLSRL 279 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~--~~~g~~vAVK~l~~~~~~-------------------~----~~~~f~~Ei~~l~~l 279 (632)
.-|.+.+.||+|+||.||+|. ..+|+.||||+++..... . ....+..|+..+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 347788999999999999998 457999999998754211 0 112356899999999
Q ss_pred CCCC--ccceeeeeecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCC
Q 006750 280 HHCH--VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 357 (632)
Q Consensus 280 ~Hpn--iv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDL 357 (632)
.+.. +.+++++. ..++||||++|++|..++... ..+.......++.|++.+|.+||+.+ .|+||||
T Consensus 108 ~~~~i~~p~~~~~~--------~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Di 175 (237)
T smart00090 108 YEAGVPVPKPIAWR--------RNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDL 175 (237)
T ss_pred HhcCCCCCeeeEec--------CceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCC
Confidence 7533 33444321 238999999998887765322 23566677899999999999999886 4999999
Q ss_pred CCCCeEecCCCCeEEeccccceec
Q 006750 358 KSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 358 Kp~NILl~~~~~vkL~DFGla~~~ 381 (632)
||+||+++ ++.++|+|||++...
T Consensus 176 kp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 176 SEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred ChhhEEEE-CCCEEEEEChhhhcc
Confidence 99999999 889999999998754
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1e-18 Score=183.81 Aligned_cols=177 Identities=25% Similarity=0.378 Sum_probs=132.3
Q ss_pred ceEEEEEEeCCCCChhhhhhc-cccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccc
Q 006750 299 AMRLLVFEFMPNGNLRDCLDG-VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 377 (632)
.++|+.|++|...+|.+||.+ ......++.....++.|++.|++| ++ .+|||+||.||+...+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 368999999999999999964 344558999999999999999999 66 99999999999999999999999999
Q ss_pred ceecccCCCCC-CCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccc
Q 006750 378 AKRLKADGLPS-CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRL 455 (632)
Q Consensus 378 a~~~~~~~~~~-~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~ 455 (632)
........... .....+...||..||+||.+.+..|+.|+||||||+||+||+. -..+++.....
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~------------- 469 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATL------------- 469 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhh-------------
Confidence 87765543111 1234556789999999999999999999999999999999997 23333211100
Q ss_pred ccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 006750 456 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 502 (632)
Q Consensus 456 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 502 (632)
. ..-....+|....++|.+ ..|+.+++...|.+||++.+
T Consensus 470 ~---d~r~g~ip~~~~~d~p~e-----~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 470 T---DIRDGIIPPEFLQDYPEE-----YTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred h---hhhcCCCChHHhhcCcHH-----HHHHHHhcCCCcccCchHHH
Confidence 0 000111122222233332 46888999999999994443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.3e-17 Score=159.70 Aligned_cols=132 Identities=22% Similarity=0.326 Sum_probs=104.3
Q ss_pred eeeeeCceEEEEEEECCCcEEEEEEeccCCCCC-------hHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEE
Q 006750 232 IVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPN-------ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 232 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~-------~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV 304 (632)
.||+|+||.||+|.+ +|..|++|......... ....+.+|++++..++|+++.....++.. ....++|
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~----~~~~~lv 75 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD----PDNKTIV 75 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE----CCCCEEE
Confidence 389999999999996 57889999865432111 12447789999999988876544434333 2245899
Q ss_pred EEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|||++|++|.+++..... .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||+++..
T Consensus 76 ~e~~~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 76 MEYIEGKPLKDVIEEGND---------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred EEEECCccHHHHHhhcHH---------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999999998754211 78999999999999998 99999999999999 789999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.7e-17 Score=183.23 Aligned_cols=144 Identities=19% Similarity=0.297 Sum_probs=111.5
Q ss_pred HHHHHhhcCccccceeeeeCceEEEEEEECCCcEEEEEEe-ccCCC-C-----ChHHHHHHHHHHHHhcCCCCccceeee
Q 006750 218 SALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRF-KTQGG-P-----NADSVFLTEVDMLSRLHHCHVVPLVGY 290 (632)
Q Consensus 218 ~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l-~~~~~-~-----~~~~~f~~Ei~~l~~l~Hpniv~l~g~ 290 (632)
.........|...+.||+|+||+||+|.+.+.. +++|+. ..... . .....+.+|+++++.++|++++....+
T Consensus 326 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~ 404 (535)
T PRK09605 326 IKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIY 404 (535)
T ss_pred ccccccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEE
Confidence 333344455667899999999999999886543 444432 22111 1 112458899999999999999887766
Q ss_pred eecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCe
Q 006750 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA 370 (632)
Q Consensus 291 ~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~v 370 (632)
+.. ....++||||++|++|.+++. ....++.+++.+|.|||+.+ ++||||||+|||+ +++.+
T Consensus 405 ~~~----~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~ 466 (535)
T PRK09605 405 DVD----PEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRL 466 (535)
T ss_pred EEe----CCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcE
Confidence 554 234589999999999999875 35678999999999999998 9999999999999 57789
Q ss_pred EEecccccee
Q 006750 371 KITDLGMAKR 380 (632)
Q Consensus 371 kL~DFGla~~ 380 (632)
+|+|||+++.
T Consensus 467 ~liDFGla~~ 476 (535)
T PRK09605 467 YLIDFGLGKY 476 (535)
T ss_pred EEEeCccccc
Confidence 9999999875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.7e-17 Score=185.82 Aligned_cols=211 Identities=22% Similarity=0.323 Sum_probs=143.3
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
.+|...++|-.|++|.||..+++. .+.+|+|+-+..- +++ ||..+.+ ..+.
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l-------ilR-----------nilt~a~----------npfv 134 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-------ILR-----------NILTFAG----------NPFV 134 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccch-------hhh-----------ccccccC----------Ccce
Confidence 567778999999999999998864 6678885433211 111 2333321 1233
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
| ||-...+..... ++. +++.+++|||+.+ |+|||+||+|.||+.-|++|++|||+++....
T Consensus 135 v------gDc~tllk~~g~--lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 135 V------GDCATLLKNIGP--LPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred e------chhhhhcccCCC--Ccc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 3 455555543222 222 2277899999998 99999999999999999999999999875422
Q ss_pred CCCC--------CC--CCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccc
Q 006750 384 DGLP--------SC--SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 453 (632)
Q Consensus 384 ~~~~--------~~--~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~ 453 (632)
...+ .. ......+.||+.|.|||++....|+..+|.|++|+|+||.+.|..||++..+.+....+.-.
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd-- 273 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD-- 273 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh--
Confidence 1110 00 01234467999999999999999999999999999999999999999876544322211110
Q ss_pred ccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC
Q 006750 454 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP 498 (632)
Q Consensus 454 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP 498 (632)
++..+.-....+ .+.++++.++|+.+|..|-
T Consensus 274 ----------~i~wpE~dea~p----~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 274 ----------DIEWPEEDEALP----PEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ----------hccccccCcCCC----HHHHHHHHHHHHhChHhhc
Confidence 111111112233 3478899999999999993
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.4e-16 Score=148.50 Aligned_cols=137 Identities=24% Similarity=0.260 Sum_probs=98.9
Q ss_pred cceeeeeCceEEEEEEECCCcEEEEEEeccCCCCC-hHHH----------------------HHHHHHHHHhcCCCC--c
Q 006750 230 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPN-ADSV----------------------FLTEVDMLSRLHHCH--V 284 (632)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~-~~~~----------------------f~~Ei~~l~~l~Hpn--i 284 (632)
.+.||+|+||.||+|...+|+.||||+++...... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999987542211 1111 135666666664432 4
Q ss_pred cceeeeeecccCCcceEEEEEEeCCCCChhhh-hhccccCCCCHHHHHHHHHHHHHhhHHHHh-cCCCceeecCCCCCCe
Q 006750 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDC-LDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNI 362 (632)
Q Consensus 285 v~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~-L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDLKp~NI 362 (632)
.+.+++. ..++||||++++++... +.... .. .....++.+++.++.++|. .+ |+|+||||+||
T Consensus 82 ~~~~~~~--------~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Ni 146 (187)
T cd05119 82 PKPIDLN--------RHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNI 146 (187)
T ss_pred CceEecC--------CCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhE
Confidence 4444321 24899999998654322 21111 11 5678899999999999998 77 99999999999
Q ss_pred EecCCCCeEEeccccceecc
Q 006750 363 LLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 363 Ll~~~~~vkL~DFGla~~~~ 382 (632)
+++ ++.++|+|||.+....
T Consensus 147 li~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 147 LVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred EEE-CCcEEEEECccccccc
Confidence 999 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.6e-15 Score=138.15 Aligned_cols=135 Identities=21% Similarity=0.194 Sum_probs=111.7
Q ss_pred ccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCC--CCccceeeeeecccCCcceEEEEEE
Q 006750 229 GSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHH--CHVVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 229 ~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~H--pniv~l~g~~~~~~~~~~~~~lV~E 306 (632)
+.+.||.|.++.||++...+ ..++||....... ...+.+|+.++..++| .++++++++... ....+++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~----~~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGES----DGWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC----CCccEEEEE
Confidence 35679999999999999854 7899999865433 3458999999999976 588888877654 246799999
Q ss_pred eCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 307 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
|++++++..+ +......++.+++.+|++||.....+++|+||+|+||+++..+.++++|||+++.
T Consensus 74 ~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 74 WIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9998877654 5567778899999999999986445599999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.63 E-value=3.6e-15 Score=149.39 Aligned_cols=139 Identities=17% Similarity=0.197 Sum_probs=106.4
Q ss_pred ceee-eeCceEEEEEEECCCcEEEEEEeccCC------------CCChHHHHHHHHHHHHhcCCCCc--cceeeeeeccc
Q 006750 231 NIVG-QGGSSYVYRGQLTDGRIVAVKRFKTQG------------GPNADSVFLTEVDMLSRLHHCHV--VPLVGYCSEFR 295 (632)
Q Consensus 231 ~~LG-~G~fG~Vy~~~~~~g~~vAVK~l~~~~------------~~~~~~~f~~Ei~~l~~l~Hpni--v~l~g~~~~~~ 295 (632)
..|| .||.|+||++... +..++||++.... .......+.+|+.++.+|.|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5688 8999999999875 7789999885321 01223457889999999998875 67777654322
Q ss_pred CCcceEEEEEEeCCC-CChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEec
Q 006750 296 GKRAMRLLVFEFMPN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITD 374 (632)
Q Consensus 296 ~~~~~~~lV~Ey~~~-gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~D 374 (632)
......++||||++| .+|.+++... .++.. .+.+++.+|.+||+.| |+||||||.|||++.++.++|+|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEE
Confidence 212233699999997 6999988642 34443 3568899999999999 99999999999999988999999
Q ss_pred ccccee
Q 006750 375 LGMAKR 380 (632)
Q Consensus 375 FGla~~ 380 (632)
||.++.
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 999865
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.8e-16 Score=176.01 Aligned_cols=257 Identities=25% Similarity=0.287 Sum_probs=186.7
Q ss_pred CccccceeeeeCceEEEEEEECC--CcEEEEEEeccCC-CCChHHHHHHHHHHHHhcC-CCCccceeeeeecccCCcceE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLTD--GRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~--g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~~~~ 301 (632)
.|...+.||+|+|+.|-...... ...+|+|.+.... ..........|..+-+.+. |+|++++++.... ....
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~----~~~~ 96 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS----PRSY 96 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC----Cccc
Confidence 35556779999999999887533 5567777776543 2222233445777777775 9999999987665 5567
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHH-hcCCCceeecCCCCCCeEecCCC-CeEEeccccce
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLH-EAAAPRILHRDIKSSNILLDENL-NAKITDLGMAK 379 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~iiHrDLKp~NILl~~~~-~vkL~DFGla~ 379 (632)
+++++|..+|++.+.+........+....-..+.|+..++.|+| +.+ +.||||||+|.+++..+ ..+++|||+|.
T Consensus 97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhc
Confidence 99999999999999883222224666777888999999999999 888 99999999999999999 99999999999
Q ss_pred eccc-CCCCCCCCCCCcccc-CCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccc
Q 006750 380 RLKA-DGLPSCSSSPARMQG-TFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 456 (632)
Q Consensus 380 ~~~~-~~~~~~~~~~~~~~G-T~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~ 456 (632)
.+.. .+. ........| ++.|+|||...+ .......|+||.|+++.-+++|..||+........ ...|.....
T Consensus 174 ~~~~~~g~---~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~~~- 248 (601)
T KOG0590|consen 174 AYRNKNGA---ERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSNKG- 248 (601)
T ss_pred cccccCCc---ceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeeccccc-
Confidence 8876 332 123344567 999999998887 46688899999999999999999999765544321 111111110
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 457 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 457 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
................++.+++..+|..|.+.+++...
T Consensus 249 ------------~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 249 ------------RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ------------ccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 00001111222235667788888999999999988653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.3e-13 Score=150.06 Aligned_cols=147 Identities=23% Similarity=0.244 Sum_probs=102.9
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCCh---------------------------------------
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNA--------------------------------------- 265 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~--------------------------------------- 265 (632)
..|. .+.||.|++|.||+|++++|+.||||+.+.......
T Consensus 118 ~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~ 196 (437)
T TIGR01982 118 AEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR 196 (437)
T ss_pred hhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence 3444 367999999999999999999999999865421100
Q ss_pred HHHHHHHHHHHHhc----CCCCccceeeeeecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHH-h
Q 006750 266 DSVFLTEVDMLSRL----HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR-G 340 (632)
Q Consensus 266 ~~~f~~Ei~~l~~l----~Hpniv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~-g 340 (632)
+-+|.+|...+.++ +|.+-+.+-.++.+.. ...+|||||++|++|.+++.... ... .+..++..++. .
T Consensus 197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~---~~~vLvmE~i~G~~L~~~~~~~~-~~~---~~~~ia~~~~~~~ 269 (437)
T TIGR01982 197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRT---SERVLTMEWIDGIPLSDIAALDE-AGL---DRKALAENLARSF 269 (437)
T ss_pred HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhc---CCceEEEEeECCcccccHHHHHh-cCC---CHHHHHHHHHHHH
Confidence 00244555555555 2333344444443322 23589999999999998865321 112 23456666665 4
Q ss_pred hHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 341 L~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+..+|..| ++|+|++|.||+++.++.++++|||++..+.
T Consensus 270 l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 270 LNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 78889888 9999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.8e-13 Score=145.62 Aligned_cols=252 Identities=22% Similarity=0.257 Sum_probs=180.2
Q ss_pred Cccccceeee--eCceEEEEEEE---CCCcEEEEEEeccCCC-CChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCc
Q 006750 226 KFSGSNIVGQ--GGSSYVYRGQL---TDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 226 ~f~~~~~LG~--G~fG~Vy~~~~---~~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~ 298 (632)
.|.+...+|. |.+|.||.+.. .++..+|+|+-+.... +.....=.+|+...+.+ .|+|.++....+.. .
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~----~ 190 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG----S 190 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc----C
Confidence 4555677999 99999999986 3588999998554322 22222235677777777 69999997665554 5
Q ss_pred ceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHH----hhHHHHhcCCCceeecCCCCCCeEecCC-CCeEEe
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR----GLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKIT 373 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~iiHrDLKp~NILl~~~-~~vkL~ 373 (632)
...|+-+|++ +.+|.++..... ..++....+.+..+..+ ||.++|... ++|-|+||.||++..+ ...+++
T Consensus 191 ~~lfiqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 191 GILFIQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred Ccceeeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecC
Confidence 5678999999 689998886543 33667777777777777 999999988 9999999999999999 889999
Q ss_pred ccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccc
Q 006750 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 453 (632)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~ 453 (632)
|||+...+.............+..|...|++||.. .+.++..+|+|++|.+..+-.++..+...... ..|..
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~W~~- 337 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN------SSWSQ- 337 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC------CCccc-
Confidence 99999988776544333333444688899999954 56788899999999999999988665432111 11211
Q ss_pred ccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 454 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 454 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
+....+..++.......+...+..+++.+|-.|++.+.+..
T Consensus 338 -----------~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 -----------LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -----------cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11111112222222334556888899999999999887754
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.7e-13 Score=133.79 Aligned_cols=209 Identities=21% Similarity=0.293 Sum_probs=141.6
Q ss_pred HHHHhcCCCCccceeeeeecccC-CcceEEEEEEeCCCCChhhhhhccc--cCCCCHHHHHHHHHHHHHhhHHHHhcCCC
Q 006750 274 DMLSRLHHCHVVPLVGYCSEFRG-KRAMRLLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAP 350 (632)
Q Consensus 274 ~~l~~l~Hpniv~l~g~~~~~~~-~~~~~~lV~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 350 (632)
.-|-++-|-|||++..|+.+... ......++.|||.-|+|..+|++.. ...+......+++.||..||.|||+. .|
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 34556679999999999876543 3456789999999999999997643 23477888889999999999999998 47
Q ss_pred ceeecCCCCCCeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHH
Q 006750 351 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELI 430 (632)
Q Consensus 351 ~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLl 430 (632)
+|+|+++.-+-|++..++-+|+.----.. ....-............+-++|.|||+-.....+..+|||+||...+||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccc-cchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 79999999999999999888875311111 00000000001122234678999999877777888999999999999998
Q ss_pred hCCCCCCCccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 431 TGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 431 tG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.|..--........... .. ...+..+-++. -+.++.+|++..|..||+|.+++.
T Consensus 277 ilEiq~tnseS~~~~ee------~i---a~~i~~len~l------------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEE------NI---ANVIIGLENGL------------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCcceeehhh------hh---hhheeeccCcc------------ccCcCcccccCCCCCCcchhhhhc
Confidence 87654221111100000 00 00000011110 234678899999999999998865
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.33 E-value=5.2e-12 Score=119.47 Aligned_cols=130 Identities=17% Similarity=0.086 Sum_probs=96.6
Q ss_pred ceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCcc-ceeeeeecccCCcceEEEEEEeCC
Q 006750 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV-PLVGYCSEFRGKRAMRLLVFEFMP 309 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv-~l~g~~~~~~~~~~~~~lV~Ey~~ 309 (632)
+.|+.|.++.||++... +..|++|+....... ...+..|+.+++.+.+.+++ +++.+.. ...++||||++
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~--~~~~~~E~~~l~~l~~~~~~P~~~~~~~------~~~~lv~e~i~ 74 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL--LINRENEAENSKLAAEAGIGPKLYYFDP------ETGVLITEFIE 74 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCccc--ccCHHHHHHHHHHHHHhCCCCceEEEeC------CCCeEEEEecC
Confidence 56888999999999875 778999997654321 22368899999999665554 4544322 12379999999
Q ss_pred CCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcC--CCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 310 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA--APRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 310 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
|.++.+.. . ....++.+++++|+.||..+ ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 75 G~~l~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCcccccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 98886530 1 11245678999999999886 23369999999999999 66899999999753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=5e-12 Score=139.31 Aligned_cols=153 Identities=18% Similarity=0.193 Sum_probs=98.0
Q ss_pred HHhhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCC---------------------------------hH
Q 006750 221 EHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPN---------------------------------AD 266 (632)
Q Consensus 221 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~---------------------------------~~ 266 (632)
+.....|+. +.||.|++|.||+|++++ |+.||||+++...... ..
T Consensus 116 ~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~ 194 (537)
T PRK04750 116 EEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFE 194 (537)
T ss_pred HHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence 344556776 789999999999999987 9999999997542100 00
Q ss_pred H------HHHHHHHHHHhcC----CCCccceeeeeecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHH
Q 006750 267 S------VFLTEVDMLSRLH----HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIG 336 (632)
Q Consensus 267 ~------~f~~Ei~~l~~l~----Hpniv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ 336 (632)
. +|.+|...+.+++ +.+.+.+-.++.+. ....+|||||++|++|.++-.-. ..+.+.........+
T Consensus 195 ~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~---st~~VLvmE~i~G~~l~d~~~l~-~~g~d~~~la~~~v~ 270 (537)
T PRK04750 195 KTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDY---CSETVMVMERMYGIPVSDVAALR-AAGTDMKLLAERGVE 270 (537)
T ss_pred HHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeeccc---CCCceEEEeeecCccHHhHHHHH-hcCCCHHHHHHHHHH
Confidence 1 1444555555542 44444444444432 22458999999999998752111 112222221111111
Q ss_pred HHHhhHHHHhcCCCceeecCCCCCCeEecCCC----CeEEeccccceeccc
Q 006750 337 AARGLEYLHEAAAPRILHRDIKSSNILLDENL----NAKITDLGMAKRLKA 383 (632)
Q Consensus 337 ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~----~vkL~DFGla~~~~~ 383 (632)
.-+..++..| ++|+|+||.||+++.++ .+++.|||++..+..
T Consensus 271 --~~~~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 271 --VFFTQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred --HHHHHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 1123344567 99999999999999888 899999999987643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.5e-10 Score=111.39 Aligned_cols=136 Identities=18% Similarity=0.210 Sum_probs=98.4
Q ss_pred ceeeeeCceEEEEEEECC-------CcEEEEEEeccCCC---------------------CChHHHHH----HHHHHHHh
Q 006750 231 NIVGQGGSSYVYRGQLTD-------GRIVAVKRFKTQGG---------------------PNADSVFL----TEVDMLSR 278 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~-------g~~vAVK~l~~~~~---------------------~~~~~~f~----~Ei~~l~~ 278 (632)
..||.|--+.||.|...+ +..+|||+.+.... ......+. +|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997653 47999999864311 01122333 79999999
Q ss_pred cCC--CCccceeeeeecccCCcceEEEEEEeCCCCChhh-hhhccccCCCCHHHHHHHHHHHHHhhHHH-HhcCCCceee
Q 006750 279 LHH--CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD-CLDGVLVEGMNWDTRVAIAIGAARGLEYL-HEAAAPRILH 354 (632)
Q Consensus 279 l~H--pniv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~-~L~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiH 354 (632)
+.. -++..++++. ..+|||||+.++.+.. .|.. ..++..+...+..+++.+|..| |..+ |+|
T Consensus 83 l~~~Gv~vP~pi~~~--------~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVH 148 (197)
T cd05146 83 MQKAGIPCPEVVVLK--------KHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECN---LVH 148 (197)
T ss_pred HHHcCCCCCeEEEec--------CCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 943 4667777542 2389999997654422 1221 1244556677889999999999 7888 999
Q ss_pred cCCCCCCeEecCCCCeEEeccccceec
Q 006750 355 RDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 355 rDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
+||++.|||+++ +.++|+|||.+...
T Consensus 149 GDLs~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 149 ADLSEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred CCCCHHHEEEEC-CcEEEEECCCceeC
Confidence 999999999974 67999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.6e-10 Score=114.11 Aligned_cols=146 Identities=21% Similarity=0.232 Sum_probs=110.7
Q ss_pred ceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCC--CccceeeeeecccCCcceEEEEEEeC
Q 006750 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC--HVVPLVGYCSEFRGKRAMRLLVFEFM 308 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hp--niv~l~g~~~~~~~~~~~~~lV~Ey~ 308 (632)
+.|+.|.++.||++...+|..+++|+............+..|+++++.+.+. ++.+++.+..... .....++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~-~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS-VLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC-ccCCceEEEEEe
Confidence 5689999999999998777899999986543322334589999999999653 4567776654321 112458999999
Q ss_pred CCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcC----------------------------------------
Q 006750 309 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA---------------------------------------- 348 (632)
Q Consensus 309 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------- 348 (632)
+|.+|.+.+.. ..++......++.+++++|..||+..
T Consensus 83 ~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 83 DGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 99998876532 34677788888889999999998521
Q ss_pred -------------CCceeecCCCCCCeEecC--CCCeEEecccccee
Q 006750 349 -------------APRILHRDIKSSNILLDE--NLNAKITDLGMAKR 380 (632)
Q Consensus 349 -------------~~~iiHrDLKp~NILl~~--~~~vkL~DFGla~~ 380 (632)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999998 56689999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3e-11 Score=130.18 Aligned_cols=249 Identities=22% Similarity=0.219 Sum_probs=175.8
Q ss_pred HHHhhcCccccceeeeeCceEEEEEEEC--CCcEEEEEEeccCCCCChHHH-HHHHHHHHHhc-CCCCccceeeeeeccc
Q 006750 220 LEHATDKFSGSNIVGQGGSSYVYRGQLT--DGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRL-HHCHVVPLVGYCSEFR 295 (632)
Q Consensus 220 l~~~t~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vAVK~l~~~~~~~~~~~-f~~Ei~~l~~l-~Hpniv~l~g~~~~~~ 295 (632)
....+.+|..+..||.|.|+.|++...+ ++..|++|.+.........+. -+.|+.+...+ .|.+++++...+.+.+
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 3445678888999999999999998644 588999999876543333222 35677777777 6889998776666533
Q ss_pred CCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCC-CCeEEec
Q 006750 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKITD 374 (632)
Q Consensus 296 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~-~~vkL~D 374 (632)
..|+--|||+++++...+ .....++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|
T Consensus 340 ----~~~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~ 410 (524)
T KOG0601|consen 340 ----QGYIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGD 410 (524)
T ss_pred ----cccCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccc
Confidence 447889999999988766 23355888889999999999999999888 9999999999999886 7789999
Q ss_pred cccceecccCCCCCCCCCCCccccCCCCC--ChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccc
Q 006750 375 LGMAKRLKADGLPSCSSSPARMQGTFGYF--APEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 452 (632)
Q Consensus 375 FGla~~~~~~~~~~~~~~~~~~~GT~~Y~--APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~ 452 (632)
||....+.... ....+.-+++ +++......+..+.|++|||.-+.|.++|..--.. ...|.
T Consensus 411 ~~~~t~~~~~~--------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~--------~~~~~- 473 (524)
T KOG0601|consen 411 FGCWTRLAFSS--------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES--------GVQSL- 473 (524)
T ss_pred cccccccceec--------ccccccccccccchhhccccccccccccccccccccccccCcccCcc--------cccce-
Confidence 99986532211 1112233444 45555567789999999999999999988643211 01111
Q ss_pred cccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006750 453 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507 (632)
Q Consensus 453 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 507 (632)
.+..-.-+.+ +... ..+..+.+.+...++..||.+.++....
T Consensus 474 --------~i~~~~~p~~----~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 474 --------TIRSGDTPNL----PGLK-LQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred --------eeecccccCC----CchH-HhhhhhhhhhcCCccccchhhhhhcccc
Confidence 1111111111 1112 4467778888999999999998876544
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.8e-09 Score=117.63 Aligned_cols=167 Identities=18% Similarity=0.255 Sum_probs=123.4
Q ss_pred ECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEeCCCCChhhhhhccccCCC
Q 006750 246 LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGM 325 (632)
Q Consensus 246 ~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l 325 (632)
..++.+|.|..++.... .......+-++.|+.|+||||++++..... ....|||+|.+ -.|..++...
T Consensus 34 k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~----~~~~ylvTErV--~Pl~~~lk~l----- 101 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEE----EGTLYLVTERV--RPLETVLKEL----- 101 (690)
T ss_pred eccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcc----cCceEEEeecc--ccHHHHHHHh-----
Confidence 34588899988876654 334446788999999999999999987665 45789999998 4677777653
Q ss_pred CHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCCh
Q 006750 326 NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 405 (632)
Q Consensus 326 ~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~AP 405 (632)
........+.||+.||.|||+.+ .++|++|.-.-|+|+..|..||++|-++........+ .....---.|..|
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~-----~~~~~~~~s~~~P 174 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP-----AKSLYLIESFDDP 174 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc-----cccchhhhcccCh
Confidence 35556667889999999999766 4999999999999999999999999988654322110 0001111235666
Q ss_pred hhhhcCCCCcccchHhHhHHHHHHHhCC
Q 006750 406 EYAMVGRASLMSDVFSFGVVLLELITGR 433 (632)
Q Consensus 406 E~~~~~~~s~ksDVwSlGviL~eLltG~ 433 (632)
+.+.... -..|.|-||++++|++.|.
T Consensus 175 ~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 175 EEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred hhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 6443222 2469999999999999993
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.9e-09 Score=108.15 Aligned_cols=145 Identities=18% Similarity=0.138 Sum_probs=103.3
Q ss_pred eeeeeCceEEEEEEECCCcEEEEEEeccCCCCCh----------HHHHHHHHHHHHhcCCC--CccceeeeeecccCC-c
Q 006750 232 IVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNA----------DSVFLTEVDMLSRLHHC--HVVPLVGYCSEFRGK-R 298 (632)
Q Consensus 232 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~----------~~~f~~Ei~~l~~l~Hp--niv~l~g~~~~~~~~-~ 298 (632)
.+-......|++..+ +|+.|.||+......... ...+.+|...+.+|... .++.++++....... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 344444455777776 578999997754331111 11378999999888433 344556665432111 2
Q ss_pred ceEEEEEEeCCCC-ChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC-------CCCe
Q 006750 299 AMRLLVFEFMPNG-NLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-------NLNA 370 (632)
Q Consensus 299 ~~~~lV~Ey~~~g-sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~-------~~~v 370 (632)
...+||||++++. +|.+++........+......++.+++..+.-||..| |+|+|+++.|||++. +..+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceE
Confidence 3468999999876 8999986433344566778899999999999999999 999999999999975 4679
Q ss_pred EEecccccee
Q 006750 371 KITDLGMAKR 380 (632)
Q Consensus 371 kL~DFGla~~ 380 (632)
.|+||+.++.
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998853
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=4.3e-11 Score=135.15 Aligned_cols=252 Identities=21% Similarity=0.257 Sum_probs=163.1
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
+.|.+.+-+-+|.|+.++.+.-.. |...++|....... ....+....+-.++-..+||-+++..--+. .....
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~----~rsP~ 879 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFP----CRSPL 879 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCC----CCCCc
Confidence 345555667889999998876432 54455554432210 000111222323333334555554432211 24567
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
+||++|+.+++|...|+... ..+..-.......+.++++|||... +.|||++|.|+|+..++..+++|||+....
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred chhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 99999999999999987643 3454455556667788999999886 899999999999999999999999854322
Q ss_pred cc----CCC------------------CCC----CCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCC
Q 006750 382 KA----DGL------------------PSC----SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435 (632)
Q Consensus 382 ~~----~~~------------------~~~----~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P 435 (632)
.- .+. ... ........||+.|.+||...+......+|.|++|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 10 000 000 0112345699999999999999999999999999999999999999
Q ss_pred CCCccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 006750 436 IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS 501 (632)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 501 (632)
|............ .-..+..+ ..+......+.+++...+..+|.+|..+.
T Consensus 1035 ~na~tpq~~f~ni------------~~~~~~~p----~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQIFENI------------LNRDIPWP----EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhhhhhcc------------ccCCCCCC----CCccccChhhhhhhhhhhccCchhccCcc
Confidence 9755433211100 00111111 12334445578888999999999997665
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.6e-09 Score=99.66 Aligned_cols=129 Identities=24% Similarity=0.366 Sum_probs=92.5
Q ss_pred eeeeeCceEEEEEEECCCcEEEEEEeccC--CCCChH-----HHHHHHHHHHHhcCCCCc--cceeeeeecccCCcceEE
Q 006750 232 IVGQGGSSYVYRGQLTDGRIVAVKRFKTQ--GGPNAD-----SVFLTEVDMLSRLHHCHV--VPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 232 ~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~~~~~-----~~f~~Ei~~l~~l~Hpni--v~l~g~~~~~~~~~~~~~ 302 (632)
.+++|+-+.+|.+.+. |..+++|.-... ..+..+ ..-.+|..+|.++.--.| ..++. .+ .....
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~d--vD----~~~~~ 75 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYD--VD----PDNGL 75 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEE--Ec----CCCCE
Confidence 5788999999999875 444666643222 122222 225679999998854433 33333 23 23458
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
|+|||++|..|.++|... ...++..+-.-+.-||..+ |+|+||.++||++..+. +.++||||+..
T Consensus 76 I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 76 IVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999999999988754 2445666667778899999 99999999999998774 99999999874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=4.1e-09 Score=97.84 Aligned_cols=144 Identities=19% Similarity=0.267 Sum_probs=100.0
Q ss_pred ccceeeeeCceEEEEEEECCCcEEEEEEeccCC--CCC-----hHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 229 GSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG--GPN-----ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 229 ~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~--~~~-----~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
....|-+|+-+.|+++.+. |+...||.-.... .+. ...+-++|..+|.++.--.|.--.=++.+.. .-
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~----~~ 85 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY----GG 85 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC----CC
Confidence 3567889999999999985 7777777533221 111 1234678999999885444432222233322 22
Q ss_pred EEEEEeCCC-CChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCC---eEEecccc
Q 006750 302 LLVFEFMPN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN---AKITDLGM 377 (632)
Q Consensus 302 ~lV~Ey~~~-gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~---vkL~DFGl 377 (632)
.|+|||++| .++.+++...........-...++..|-+.+.-||..+ |+|+||..+||+|..++. +.++|||+
T Consensus 86 ~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgl 162 (229)
T KOG3087|consen 86 QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGL 162 (229)
T ss_pred eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecc
Confidence 799999976 48888886544333333333778888889999999999 999999999999965443 58999999
Q ss_pred cee
Q 006750 378 AKR 380 (632)
Q Consensus 378 a~~ 380 (632)
+..
T Consensus 163 s~~ 165 (229)
T KOG3087|consen 163 SSV 165 (229)
T ss_pred hhc
Confidence 754
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.96 E-value=8.3e-09 Score=98.96 Aligned_cols=126 Identities=26% Similarity=0.285 Sum_probs=81.7
Q ss_pred EEEEEEECCCcEEEEEEeccCCC------------CC--------h-----HHHHHHHHHHHHhcCCC--Cccceeeeee
Q 006750 240 YVYRGQLTDGRIVAVKRFKTQGG------------PN--------A-----DSVFLTEVDMLSRLHHC--HVVPLVGYCS 292 (632)
Q Consensus 240 ~Vy~~~~~~g~~vAVK~l~~~~~------------~~--------~-----~~~f~~Ei~~l~~l~Hp--niv~l~g~~~ 292 (632)
.||.|...+|..+|||+.+.... .. . .....+|.+.|.++... ++.+++.+-.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~ 80 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNR 80 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEET
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeC
Confidence 48999998899999999864321 00 0 11256799999999765 5667765422
Q ss_pred cccCCcceEEEEEEeCC--CCChhhhhhccccCCCCHHHHHHHHHHHHHhhHH-HHhcCCCceeecCCCCCCeEecCCCC
Q 006750 293 EFRGKRAMRLLVFEFMP--NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY-LHEAAAPRILHRDIKSSNILLDENLN 369 (632)
Q Consensus 293 ~~~~~~~~~~lV~Ey~~--~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~iiHrDLKp~NILl~~~~~ 369 (632)
.+|||||++ |..+..+.... ++......++.+++..+.. +|..| |+|+||.+.|||++++ .
T Consensus 81 --------~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 81 --------NVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp --------TEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-C
T ss_pred --------CEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-e
Confidence 289999998 55555433321 1133455667777775555 57887 9999999999999988 9
Q ss_pred eEEeccccceec
Q 006750 370 AKITDLGMAKRL 381 (632)
Q Consensus 370 vkL~DFGla~~~ 381 (632)
+.|+|||.+...
T Consensus 145 ~~iIDf~qav~~ 156 (188)
T PF01163_consen 145 VYIIDFGQAVDS 156 (188)
T ss_dssp EEE--GTTEEET
T ss_pred EEEEecCcceec
Confidence 999999998654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.89 E-value=3.9e-08 Score=104.20 Aligned_cols=219 Identities=16% Similarity=0.229 Sum_probs=151.8
Q ss_pred CceEEEEEEE-CCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEeCCC-CChh
Q 006750 237 GSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPN-GNLR 314 (632)
Q Consensus 237 ~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey~~~-gsL~ 314 (632)
.-.+.||+.. .||..|++|+++.......-+ -..-+++.+++.|+|+|+|..++......+.-+++||+|+++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk-~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNK-DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCccc-chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 3467899864 479999999995433222111 234578899999999999999887544456678999999975 5777
Q ss_pred hhhhcc-------------ccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 315 DCLDGV-------------LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 315 ~~L~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
++--.. .+...++..+|.++.|+..||.++|+.| +.-+-|.+.+||++.+.+++|+..|.....
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeee
Confidence 654211 1123678899999999999999999999 888999999999999999999999988776
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
..+... | +. --.+-|.=.||.+++.|.||..--...... +. ..
T Consensus 444 ~~d~~~-----------------~--le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~-------------~~--s~ 486 (655)
T KOG3741|consen 444 QEDPTE-----------------P--LE---SQQQNDLRDLGLLLLALATGTENSNRTDST-------------QS--SH 486 (655)
T ss_pred cCCCCc-----------------c--hh---HHhhhhHHHHHHHHHHHhhcccccccccch-------------HH--HH
Confidence 544210 0 11 123569999999999999996431100000 00 00
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
+ ..+....+..+++++......++++ -++.+++.+
T Consensus 487 ~---------~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 487 L---------TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred H---------HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 0 0123344555777888787888776 566666654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.1e-07 Score=96.35 Aligned_cols=266 Identities=15% Similarity=0.137 Sum_probs=158.7
Q ss_pred cceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeee---ecccCCcceEEEEE
Q 006750 230 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYC---SEFRGKRAMRLLVF 305 (632)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~---~~~~~~~~~~~lV~ 305 (632)
.+.||+|+-+.+|-.--- +. -+-|++........ ...+..|... .||-+-.-+.+= ....+.....-+.|
T Consensus 16 gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~----aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQ----AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CccccCCccceeeecchh-hc-hhheeecCCCchHH----HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 567999999999975321 12 34566665432221 1224445555 566444311110 01111223356788
Q ss_pred EeCCCC-Chhhhhhc----cccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 306 EFMPNG-NLRDCLDG----VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 306 Ey~~~g-sL~~~L~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
..+.+. .+..+++. ...-...|...++++..+|.+.+-||+.| .+-+|++++|+|+.+++.+.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 887654 23333321 11123789999999999999999999999 89999999999999999999998544333
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhh-----cCCCCcccchHhHhHHHHHHHhC-CCCCCCccccccchhe---ecc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITG-RQPIHRSITKGEESLV---LWA 451 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSlGviL~eLltG-~~P~~~~~~~~~~~~~---~~~ 451 (632)
...+ ......+|...|++||.-. +..-+...|.|-|||++++|+.| +.||.+.......... ..+
T Consensus 167 ~~ng------~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia 240 (637)
T COG4248 167 NANG------TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA 240 (637)
T ss_pred ccCC------ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence 2222 2233456899999999664 33457789999999999999997 8998653211110000 000
Q ss_pred ccccccccc-cccccCCCCCCCCCC-HHHHHHHHHHHHHhccc--CCCCCCCHHHHHHHHhhhCCC
Q 006750 452 TPRLQDSGT-VISELPDPRLKGDFP-KEEMQIMAYLAKECLQL--DPDARPTMSEVVQILSTIAPD 513 (632)
Q Consensus 452 ~~~~~~~~~-~~~~~~~~~l~~~~~-~~~~~~l~~li~~cl~~--dP~~RPs~~evl~~L~~i~~~ 513 (632)
...+..... .....+.| ...| .-.+..+..|..+|+.. ++.-|||++-.+..|..+...
T Consensus 241 ~g~f~ya~~~~~g~~p~P---~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 241 HGRFAYASDQRRGLKPPP---RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred cceeeechhccCCCCCCC---CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 001100000 00001111 1122 22334466677778754 367899999999888776544
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.80 E-value=5.4e-08 Score=95.40 Aligned_cols=128 Identities=27% Similarity=0.267 Sum_probs=94.8
Q ss_pred CcEEEEEEeccCCCC------ChHHHHHHHHHHHHhcCCC--CccceeeeeecccCCcceEEEEEEeCCCC-Chhhhhhc
Q 006750 249 GRIVAVKRFKTQGGP------NADSVFLTEVDMLSRLHHC--HVVPLVGYCSEFRGKRAMRLLVFEFMPNG-NLRDCLDG 319 (632)
Q Consensus 249 g~~vAVK~l~~~~~~------~~~~~f~~Ei~~l~~l~Hp--niv~l~g~~~~~~~~~~~~~lV~Ey~~~g-sL~~~L~~ 319 (632)
++.+.+|.+...... -......+|...+.+|... .+.+.+++.....+.....++|+|++++. +|.+++..
T Consensus 32 ~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~ 111 (206)
T PF06293_consen 32 GRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ 111 (206)
T ss_pred ceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh
Confidence 556666654322111 1233478899988888433 45577777665433334568999999874 89999876
Q ss_pred cccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCC---CeEEeccccceec
Q 006750 320 VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL---NAKITDLGMAKRL 381 (632)
Q Consensus 320 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~---~vkL~DFGla~~~ 381 (632)
... ++......++.+++..+.-||+.| |+|+|+++.|||++.+. .+.++||+-++..
T Consensus 112 ~~~--~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 112 WEQ--LDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hcc--cchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 322 566778889999999999999999 99999999999998887 7999999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.1e-07 Score=91.90 Aligned_cols=144 Identities=21% Similarity=0.149 Sum_probs=107.8
Q ss_pred eeeeCceEEEEEEECCCcEEEEEEeccC--CC---CChHHHHHHHHHHHHhcCC--CCccceeeeeecccCCcceEEEEE
Q 006750 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQ--GG---PNADSVFLTEVDMLSRLHH--CHVVPLVGYCSEFRGKRAMRLLVF 305 (632)
Q Consensus 233 LG~G~fG~Vy~~~~~~g~~vAVK~l~~~--~~---~~~~~~f~~Ei~~l~~l~H--pniv~l~g~~~~~~~~~~~~~lV~ 305 (632)
-|+||-+.|++..+. |..+-+|+-... .. +.....|.+|+..|.+|.. -.+.+.+.+.....+....-+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 477899999998874 557999986521 11 3345669999999999943 335555522222222344568999
Q ss_pred EeCCC-CChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCC--eEEecccccee
Q 006750 306 EFMPN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN--AKITDLGMAKR 380 (632)
Q Consensus 306 Ey~~~-gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~--vkL~DFGla~~ 380 (632)
|-++| -||.+++......+.+...+..+..+++..+.-||+.+ +.|+|+.+.|||++.++. ++++||--++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97753 58999886644445678888999999999999999999 999999999999986667 99999987654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.4e-07 Score=93.20 Aligned_cols=135 Identities=21% Similarity=0.184 Sum_probs=96.6
Q ss_pred ccccceeeeeCceEEEEEEECCCcEEEEEEeccCCC---------------------CChHHHHHHHHHHHHhcCCC--C
Q 006750 227 FSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG---------------------PNADSVFLTEVDMLSRLHHC--H 283 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~---------------------~~~~~~f~~Ei~~l~~l~Hp--n 283 (632)
..+...||-|--+.||.|...+|..+|||.=+...+ .-.+....+|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 345688999999999999999999999996532210 00122357899999999655 6
Q ss_pred ccceeeeeecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeE
Q 006750 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNIL 363 (632)
Q Consensus 284 iv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NIL 363 (632)
+.+.+++ +...+||||++|-.|...- ++....-.|+..|+.-+.-+-..| |||+|+.+-|||
T Consensus 173 VP~P~~~--------nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIl 234 (304)
T COG0478 173 VPKPIAW--------NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNIL 234 (304)
T ss_pred CCCcccc--------ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEE
Confidence 7776643 2348999999987766532 122233334444555455555667 999999999999
Q ss_pred ecCCCCeEEeccccce
Q 006750 364 LDENLNAKITDLGMAK 379 (632)
Q Consensus 364 l~~~~~vkL~DFGla~ 379 (632)
++++|.++++||-.+.
T Consensus 235 V~~dg~~~vIDwPQ~v 250 (304)
T COG0478 235 VTEDGDIVVIDWPQAV 250 (304)
T ss_pred EecCCCEEEEeCcccc
Confidence 9999999999997654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=3.6e-08 Score=108.07 Aligned_cols=153 Identities=22% Similarity=0.322 Sum_probs=100.9
Q ss_pred HHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccC-CCCCC---CCCCCccccCCCCCChhhhhcC
Q 006750 336 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD-GLPSC---SSSPARMQGTFGYFAPEYAMVG 411 (632)
Q Consensus 336 ~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~-~~~~~---~~~~~~~~GT~~Y~APE~~~~~ 411 (632)
+++.||.|+|... .+||++|.|++|.++.++..||+.|+.+...... .++-. ...+.-.+-...|.|||++...
T Consensus 107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 4458999999764 6999999999999999999999999987654431 11100 0111223345789999999998
Q ss_pred CCCcccchHhHhHHHHHHHhCCCCC-CCccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhc
Q 006750 412 RASLMSDVFSFGVVLLELITGRQPI-HRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECL 490 (632)
Q Consensus 412 ~~s~ksDVwSlGviL~eLltG~~P~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl 490 (632)
..+.++|+||+|+++|.+..|..+. ............ ...+..-...++...+.++.+=+.+++
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~---------------~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS---------------RNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhh---------------hcccccccccccccCcHHHHHHHHHHh
Confidence 8999999999999999999655543 221111100000 000000001122334444677778889
Q ss_pred ccCCCCCCCHHHHHH
Q 006750 491 QLDPDARPTMSEVVQ 505 (632)
Q Consensus 491 ~~dP~~RPs~~evl~ 505 (632)
..++.-||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998877654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=4.2e-07 Score=99.96 Aligned_cols=152 Identities=20% Similarity=0.242 Sum_probs=98.6
Q ss_pred HHhhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHH---------------------------------
Q 006750 221 EHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADS--------------------------------- 267 (632)
Q Consensus 221 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~--------------------------------- 267 (632)
+.....|+. .-|+.++-|.||+|++++|+.||||+.+..-......
T Consensus 122 ee~F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~ 200 (517)
T COG0661 122 EELFSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK 200 (517)
T ss_pred HHHHHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence 333445543 5789999999999999999999999987543211100
Q ss_pred ------HHHHHHHHHHhc----CCCCccceeeeeecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHH
Q 006750 268 ------VFLTEVDMLSRL----HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA 337 (632)
Q Consensus 268 ------~f~~Ei~~l~~l----~Hpniv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~i 337 (632)
++.+|..-+.++ ++..-+++-.++.+.. ....|+|||++|-.+.+...-.. .+++...+.....++
T Consensus 201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t---~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~ 276 (517)
T COG0661 201 RLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYT---TRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA 276 (517)
T ss_pred HHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhcc---CCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH
Confidence 133455444444 2222333444444422 24589999999999998843222 345644443333332
Q ss_pred HHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 338 a~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
. +..+-..| ++|.|..|.||+++.++.+.+.|||+...+.
T Consensus 277 f--~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 277 F--LRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred H--HHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 2 23333356 9999999999999999999999999987654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.41 E-value=4.8e-06 Score=81.76 Aligned_cols=153 Identities=23% Similarity=0.302 Sum_probs=104.0
Q ss_pred ecHHHHHHhhcCccccceee---eeCceEEEEEEECCCcEEEEEEeccCCCCChH--------HH---------------
Q 006750 215 FSYSALEHATDKFSGSNIVG---QGGSSYVYRGQLTDGRIVAVKRFKTQGGPNAD--------SV--------------- 268 (632)
Q Consensus 215 ~~~~~l~~~t~~f~~~~~LG---~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~--------~~--------------- 268 (632)
.++..|....++..+....| .|--..||+|...++..+|||+++........ ..
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 45666777777777776666 56667899999888999999999754321100 01
Q ss_pred HHHHHHHHHhcC--CCCccceeeeeecccCCcceEEEEEEeCCCCCh-hhhhhccccCCCCHHHHHHHHHHHHHhhHHHH
Q 006750 269 FLTEVDMLSRLH--HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNL-RDCLDGVLVEGMNWDTRVAIAIGAARGLEYLH 345 (632)
Q Consensus 269 f~~Ei~~l~~l~--Hpniv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL-~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH 345 (632)
...|+.-|+++. +-.+.+-+++... .|||||+....+ .-.|... ++...+...+..++++.+.-|-
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~~n--------VLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l~ 183 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFRNN--------VLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRLY 183 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeecCC--------eEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHHH
Confidence 245888888883 4455565554332 799999954311 1111111 1233356777788888888887
Q ss_pred h-cCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 346 E-AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 346 ~-~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
. .+ +||+||..=|||+. ++.+.|+|||-|....
T Consensus 184 ~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 184 KEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred HhcC---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 6 55 99999999999999 7799999999886543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.33 E-value=4e-06 Score=83.07 Aligned_cols=145 Identities=21% Similarity=0.239 Sum_probs=85.9
Q ss_pred ceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCC--CccceeeeeecccCCcceEEEEEEeC
Q 006750 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC--HVVPLVGYCSEFRGKRAMRLLVFEFM 308 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hp--niv~l~g~~~~~~~~~~~~~lV~Ey~ 308 (632)
+.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.|... .+.+++.+..... .....+++|+++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~-~~~~~~~~~~~i 77 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDE-FNGFPYLLMEYI 77 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETE-ETSEEEEEEEEE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccc-ccccceEEEEEe
Confidence 568999999999999876 68999997643 3345578999999988433 3556766443222 233479999999
Q ss_pred CCCChhh----------------hh---hccc--cCCCCHHH---------HHHH------------HHHHHH-hhHHHH
Q 006750 309 PNGNLRD----------------CL---DGVL--VEGMNWDT---------RVAI------------AIGAAR-GLEYLH 345 (632)
Q Consensus 309 ~~gsL~~----------------~L---~~~~--~~~l~~~~---------~~~i------------~~~ia~-gL~yLH 345 (632)
+|..+.. .+ +... ...+.+.. .... ...+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9988887 11 1110 01111111 0000 111222 333343
Q ss_pred hc----CCCceeecCCCCCCeEec-CCCCeEEecccccee
Q 006750 346 EA----AAPRILHRDIKSSNILLD-ENLNAKITDLGMAKR 380 (632)
Q Consensus 346 ~~----~~~~iiHrDLKp~NILl~-~~~~vkL~DFGla~~ 380 (632)
.. ....++|+|+.|.|||++ +++.+-|+||+.+..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 21 344599999999999999 556667999998754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.32 E-value=3e-06 Score=93.03 Aligned_cols=151 Identities=17% Similarity=0.173 Sum_probs=95.6
Q ss_pred HhhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHH----------------------------------
Q 006750 222 HATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADS---------------------------------- 267 (632)
Q Consensus 222 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~---------------------------------- 267 (632)
.....|+ .+-||.-+.|.||+|++++|+.||||+-+..-......
T Consensus 159 ~if~~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ 237 (538)
T KOG1235|consen 159 DIFSEFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQ 237 (538)
T ss_pred HHHHhcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHh
Confidence 3334444 35689999999999999999999999987543211000
Q ss_pred --HHHHHHHHHHh----cCCCC---ccceeeeeecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHH
Q 006750 268 --VFLTEVDMLSR----LHHCH---VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA 338 (632)
Q Consensus 268 --~f~~Ei~~l~~----l~Hpn---iv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia 338 (632)
+|.+|.+-..+ +.|-+ -|.+-.++.+. .....|+||||+|..+.|.- .....+++...+..-+.++.
T Consensus 238 ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~---st~RVLtME~~~G~~i~Dl~-~i~~~gi~~~~i~~~l~~~~ 313 (538)
T KOG1235|consen 238 ELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL---STKRVLTMEYVDGIKINDLD-AIDKRGISPHDILNKLVEAY 313 (538)
T ss_pred hcchHHHHHhHHHHHHHHHhcccccceeCCeehhhc---CcceEEEEEecCCccCCCHH-HHHHcCCCHHHHHHHHHHHH
Confidence 14444443333 23555 12233333332 23568999999999887753 22224466665555444443
Q ss_pred HhhHHHHhcCCCceeecCCCCCCeEecC----CCCeEEeccccceecc
Q 006750 339 RGLEYLHEAAAPRILHRDIKSSNILLDE----NLNAKITDLGMAKRLK 382 (632)
Q Consensus 339 ~gL~yLH~~~~~~iiHrDLKp~NILl~~----~~~vkL~DFGla~~~~ 382 (632)
.-+- =..| ++|.|=.|.||+++. ++.+.+.|||+.....
T Consensus 314 ~~qI--f~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 314 LEQI--FKTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHHH--HhcC---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 2222 2235 999999999999983 6789999999987654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.30 E-value=9.3e-06 Score=78.97 Aligned_cols=143 Identities=15% Similarity=0.192 Sum_probs=93.9
Q ss_pred HhhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHH---------HHHHHHHHhcCCCC---ccceee
Q 006750 222 HATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVF---------LTEVDMLSRLHHCH---VVPLVG 289 (632)
Q Consensus 222 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f---------~~Ei~~l~~l~Hpn---iv~l~g 289 (632)
...++|...+++-......|.+-.. +|..+++|..+.... ...+.| .+.+..+.++.... ...++.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~-r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENR-RPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhh-hHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 3467888888888777777777776 478899998876432 222222 23444444443322 223222
Q ss_pred eeecc-cCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCC
Q 006750 290 YCSEF-RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL 368 (632)
Q Consensus 290 ~~~~~-~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~ 368 (632)
+.... .+-....+|+|||++|..|.++.. ++. .++..++.+|.-||..| ++|+|..|.|++++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~- 171 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN- 171 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-
Confidence 22211 111234568999999998877642 222 24556778899999999 9999999999999966
Q ss_pred CeEEecccccee
Q 006750 369 NAKITDLGMAKR 380 (632)
Q Consensus 369 ~vkL~DFGla~~ 380 (632)
.++++||+..+.
T Consensus 172 ~i~iID~~~k~~ 183 (229)
T PF06176_consen 172 GIRIIDTQGKRM 183 (229)
T ss_pred cEEEEECccccc
Confidence 499999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.29 E-value=1e-05 Score=80.51 Aligned_cols=139 Identities=13% Similarity=0.173 Sum_probs=81.5
Q ss_pred ceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCC--ccceeeeeecccCCcceEEEEEEeC
Q 006750 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH--VVPLVGYCSEFRGKRAMRLLVFEFM 308 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpn--iv~l~g~~~~~~~~~~~~~lV~Ey~ 308 (632)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-. +.+.+++... .....+|||++
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~----~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVED----GGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEec----CCeeeeeeeec
Confidence 46899999999984 24567888876532 2233688999999986443 3566665543 23457899999
Q ss_pred CCCC-hhhhh---------------------hccccCCCCHHHHHH-HHH----------HHH-HhhHHHHhc-CCCcee
Q 006750 309 PNGN-LRDCL---------------------DGVLVEGMNWDTRVA-IAI----------GAA-RGLEYLHEA-AAPRIL 353 (632)
Q Consensus 309 ~~gs-L~~~L---------------------~~~~~~~l~~~~~~~-i~~----------~ia-~gL~yLH~~-~~~~ii 353 (632)
+|.+ +...+ +.............. +.. .+. ....+|... ..+.++
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 8863 22111 110000111111000 000 000 012222211 124578
Q ss_pred ecCCCCCCeEecCCCCeEEecccccee
Q 006750 354 HRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 354 HrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
|+|+.|.||++++++ +.|+||+.+..
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999999888 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.24 E-value=4.1e-06 Score=80.66 Aligned_cols=102 Identities=23% Similarity=0.266 Sum_probs=83.0
Q ss_pred HHHHHHHHhcCC-CCccceeeeeecccCCcceEEEEEEeCCCCChhhh---hhccccCCCCHHHHHHHHHHHHHhhHHHH
Q 006750 270 LTEVDMLSRLHH-CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDC---LDGVLVEGMNWDTRVAIAIGAARGLEYLH 345 (632)
Q Consensus 270 ~~Ei~~l~~l~H-pniv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~---L~~~~~~~l~~~~~~~i~~~ia~gL~yLH 345 (632)
..|.-+|+.+++ +++++++|+|-. ++|.||...+++... +... ...+|..+.+||.++++.+++|+
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~--------~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~ 76 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR--------FYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELD 76 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC--------EEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHh
Confidence 468888999965 699999999964 789999987766421 1111 23689999999999999999999
Q ss_pred hcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 346 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 346 ~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
+.....+.-.|++++|+-+++++++|++|...+-..
T Consensus 77 ~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 77 HGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 855445889999999999999999999999876544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.19 E-value=9.9e-06 Score=75.41 Aligned_cols=128 Identities=19% Similarity=0.194 Sum_probs=89.3
Q ss_pred ccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCcc-ceeeeeecccCCcceEEEEEEe
Q 006750 229 GSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV-PLVGYCSEFRGKRAMRLLVFEF 307 (632)
Q Consensus 229 ~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv-~l~g~~~~~~~~~~~~~lV~Ey 307 (632)
..+.|++|++|.||++.+. |..+|+|+-+.++. +..+..|.++|..+.-.++. +++.|-.+ ++.|||
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~---r~~l~kEakiLeil~g~~~~p~vy~yg~~--------~i~me~ 93 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP---RRNLEKEAKILEILAGEGVTPEVYFYGED--------FIRMEY 93 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCCcc---hhhHHHHHHHHHHhhhcCCCceEEEechh--------hhhhhh
Confidence 3577999999999999996 55899998776543 33489999999999877665 45554332 567999
Q ss_pred CCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCC-CCCeEecCCCCeEEecccccee
Q 006750 308 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK-SSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 308 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLK-p~NILl~~~~~vkL~DFGla~~ 380 (632)
+.|-.|.+.-.. .+-.+...++ ..---|-..| |-|..|. |..++|-.++.+.|+||.-|+.
T Consensus 94 i~G~~L~~~~~~-----~~rk~l~~vl----E~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 94 IDGRPLGKLEIG-----GDRKHLLRVL----EKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hcCcchhhhhhc-----ccHHHHHHHH----HHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 998888876442 1233333333 3322344456 9999995 5555555555999999999874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.15 E-value=4.1e-07 Score=98.77 Aligned_cols=185 Identities=17% Similarity=0.116 Sum_probs=131.3
Q ss_pred ccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCC-ccceeeeeecccCCcceEEEEE
Q 006750 227 FSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH-VVPLVGYCSEFRGKRAMRLLVF 305 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpn-iv~l~g~~~~~~~~~~~~~lV~ 305 (632)
+...+-+++|+.+.+||.+....+...++.+... ....-++++|.+++||| .++.++-+. .+.+.++++
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~----~E~~~~i~~ 313 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYD----GEDYLWIPM 313 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCC----cccccchhh
Confidence 3334557899999999998654555556665543 12456889999999999 444443222 356789999
Q ss_pred EeCCCC-ChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccC
Q 006750 306 EFMPNG-NLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (632)
Q Consensus 306 Ey~~~g-sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 384 (632)
+++.+| +-..-... ....+...+...+...-.+++++||+.. =+|+| ||+..+ +..+..||+....+...
T Consensus 314 ~i~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 314 RICSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred hhhcCCccccccCCh-hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence 999877 22222211 1112444555666677788999999864 48999 887766 57899999998876543
Q ss_pred CCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCC
Q 006750 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 436 (632)
Q Consensus 385 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~ 436 (632)
. ......+|+.|+|||+.....+..+.|+|++|+--.++--|-+|-
T Consensus 385 ~------~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 385 M------KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred c------ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 2 345567999999999999999999999999998767777666553
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.11 E-value=4.4e-05 Score=90.27 Aligned_cols=83 Identities=13% Similarity=0.215 Sum_probs=58.6
Q ss_pred cceeeeeCceEEEEEEECCC---cEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCc--cceeeeeecccCCcceEEE
Q 006750 230 SNIVGQGGSSYVYRGQLTDG---RIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHV--VPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~g---~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~-Hpni--v~l~g~~~~~~~~~~~~~l 303 (632)
.+.|+.|.+..+|+....++ ..+++|+............+.+|+.+|+.|. |.++ .+++++|.+... ....|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v-~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV-IGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc-CCCceE
Confidence 46788999999999887654 4678887654332233345889999999995 6665 677877765322 134689
Q ss_pred EEEeCCCCCh
Q 006750 304 VFEFMPNGNL 313 (632)
Q Consensus 304 V~Ey~~~gsL 313 (632)
||||++|..+
T Consensus 122 VME~v~G~~~ 131 (822)
T PLN02876 122 IMEYLEGRIF 131 (822)
T ss_pred EEEecCCccc
Confidence 9999987654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.06 E-value=3.8e-05 Score=77.23 Aligned_cols=138 Identities=22% Similarity=0.180 Sum_probs=82.0
Q ss_pred eeeeCc-eEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCccceeeeeecccCCcceEEEEEEeCCC
Q 006750 233 VGQGGS-SYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRLLVFEFMPN 310 (632)
Q Consensus 233 LG~G~f-G~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~~~~~lV~Ey~~~ 310 (632)
|-.|.. ..||+.... +..+.||+..... ...+.+|+++++.+. +--+.+++++... ....++|||+++|
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~----~~~~~lv~e~i~G 76 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSD----DGRAWLLTSAVPG 76 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEec----CCccEEEEEeeCC
Confidence 344555 789999764 4788889876543 223678999999883 4345566665543 1245899999999
Q ss_pred CChhhhh-------------------hccccC--CCC--HHHHHHHHHH--------------------HHHhhHHHHh-
Q 006750 311 GNLRDCL-------------------DGVLVE--GMN--WDTRVAIAIG--------------------AARGLEYLHE- 346 (632)
Q Consensus 311 gsL~~~L-------------------~~~~~~--~l~--~~~~~~i~~~--------------------ia~gL~yLH~- 346 (632)
.+|.... +..... ++. .......... +...+..|-.
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 8876432 111000 111 0011100000 1111122211
Q ss_pred ---cCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 347 ---AAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 347 ---~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
...+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 123558999999999999998778899999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.98 E-value=7.5e-05 Score=71.84 Aligned_cols=130 Identities=25% Similarity=0.391 Sum_probs=91.8
Q ss_pred cCccccceeeeeCc-eEEEEEEECCCcEEEEEEecc---CCC-------C----------ChHHHHHHHHHHHHhcC---
Q 006750 225 DKFSGSNIVGQGGS-SYVYRGQLTDGRIVAVKRFKT---QGG-------P----------NADSVFLTEVDMLSRLH--- 280 (632)
Q Consensus 225 ~~f~~~~~LG~G~f-G~Vy~~~~~~g~~vAVK~l~~---~~~-------~----------~~~~~f~~Ei~~l~~l~--- 280 (632)
..++..+.||.|.- |.||+++.. |+.+|+|+++. ... . ....-|..|.....+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67778899999999 999999984 78999999321 100 0 01123888998888874
Q ss_pred CCCc--cceeeeeeccc--------------CCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHH
Q 006750 281 HCHV--VPLVGYCSEFR--------------GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 344 (632)
Q Consensus 281 Hpni--v~l~g~~~~~~--------------~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yL 344 (632)
+.++ |+.+||..-.. .......||.||.+... .+... -+.+|.+-|..+
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~----~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIR----DIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchh----HHHHHHHHHHHH
Confidence 4566 89999874321 11234568888886543 12222 244566778889
Q ss_pred HhcCCCceeecCCCCCCeEecCCCCeEEeccccc
Q 006750 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (632)
Q Consensus 345 H~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 378 (632)
|..+ |+-+|+++.|.. .-+|+|||.+
T Consensus 181 ~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCC---eeeccCcccccc-----CCEEEecccC
Confidence 9998 999999999997 5689999864
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00021 Score=74.08 Aligned_cols=81 Identities=12% Similarity=0.052 Sum_probs=57.3
Q ss_pred cccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCC---CCccceeeeeecccCCcceEEEE
Q 006750 228 SGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHH---CHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 228 ~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~H---pniv~l~g~~~~~~~~~~~~~lV 304 (632)
...+.||.|..+.||+....++ .+++|..+... ....|..|.+.|+.|.- -.+.++++++..... ....+||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~-~g~~~LV 91 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARSFS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS-PGPDVLL 91 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEecccc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc-CCCeEEE
Confidence 3346799999999999987656 47777754311 12358999999999943 367788887754221 2346999
Q ss_pred EEeCCCCCh
Q 006750 305 FEFMPNGNL 313 (632)
Q Consensus 305 ~Ey~~~gsL 313 (632)
||+++++++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998765
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00022 Score=69.13 Aligned_cols=134 Identities=22% Similarity=0.312 Sum_probs=89.8
Q ss_pred cceeeeeCceEEEEEEECCCcEEEEEEeccCC---------------CCChHHHHHHHHHHHHhcC------CCCcccee
Q 006750 230 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG---------------GPNADSVFLTEVDMLSRLH------HCHVVPLV 288 (632)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~---------------~~~~~~~f~~Ei~~l~~l~------Hpniv~l~ 288 (632)
...||+|+.-.||.- .+.....||+..... ......++.+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 467999999999984 345568888887654 1122345777887777666 88899999
Q ss_pred eeeecccCCcceEEEEEEeCCC------CChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCe
Q 006750 289 GYCSEFRGKRAMRLLVFEFMPN------GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNI 362 (632)
Q Consensus 289 g~~~~~~~~~~~~~lV~Ey~~~------gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NI 362 (632)
|+.....+ .-+|+|.+.+ .+|.+++.. ..++. .....+.+. ..||-+.+ |+.+||+|.||
T Consensus 84 G~veT~~G----~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~~~~~L~~f---~~~l~~~~---Iv~~dl~~~NI 149 (199)
T PF10707_consen 84 GFVETNLG----LGLVVELIRDADGNISPTLEDYLKE---GGLTE-ELRQALDEF---KRYLLDHH---IVIRDLNPHNI 149 (199)
T ss_pred EEEecCCc----eEEEEEEEECCCCCcCccHHHHHHc---CCccH-HHHHHHHHH---HHHHHHcC---CeecCCCcccE
Confidence 99876443 3677777632 267777743 23554 444444443 45666666 99999999999
Q ss_pred EecCC---C-CeEEec-cccce
Q 006750 363 LLDEN---L-NAKITD-LGMAK 379 (632)
Q Consensus 363 Ll~~~---~-~vkL~D-FGla~ 379 (632)
++..+ . .+.|+| ||-..
T Consensus 150 v~~~~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 150 VVQRRDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred EEEecCCCceEEEEEeCCCCcc
Confidence 99432 2 477787 55543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00014 Score=72.73 Aligned_cols=76 Identities=17% Similarity=0.149 Sum_probs=46.0
Q ss_pred ceeeeeCce-EEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCC---CccceeeeeecccCCcceEEEEEE
Q 006750 231 NIVGQGGSS-YVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC---HVVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 231 ~~LG~G~fG-~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hp---niv~l~g~~~~~~~~~~~~~lV~E 306 (632)
+.|+.|+.. .||+. +..+++|..+.. .....+.+|.++|..|... .+.++++..... +.....+++|+
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~---~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~-~~~~~~~~l~~ 74 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA---GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPG-EGYPWPWSVYR 74 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc---chHHHHHHHHHHHHHHhccCCCCCCceeecCCCc-cCCCcceEEEE
Confidence 456766665 59975 234777875532 1234588999999988532 334444433221 11124588999
Q ss_pred eCCCCChh
Q 006750 307 FMPNGNLR 314 (632)
Q Consensus 307 y~~~gsL~ 314 (632)
+++|.++.
T Consensus 75 ~i~G~~l~ 82 (235)
T cd05155 75 WLEGETAT 82 (235)
T ss_pred eecCCCCC
Confidence 99997774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00032 Score=69.93 Aligned_cols=74 Identities=15% Similarity=0.145 Sum_probs=49.0
Q ss_pred ceeeeeCceEEEEEEECC--CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCcc-ceeeeeecccCCcceEEEEEEe
Q 006750 231 NIVGQGGSSYVYRGQLTD--GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV-PLVGYCSEFRGKRAMRLLVFEF 307 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~--g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv-~l~g~~~~~~~~~~~~~lV~Ey 307 (632)
+.|..|-...+|+....+ +..|++|+........ ....+|+.+++.+...+++ ++++... -.+||||
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~--~d~~~E~~~~~~l~~~gl~P~v~~~~~--------~~~l~e~ 73 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI--IDRERELRIHKLLSKHGLAPKLYATFQ--------NGLIYEF 73 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce--ecHHHHHHHHHHHHhCCCCCeEEEEeC--------CcEEEEe
Confidence 457778888999998764 6789999876432211 1245799999998544444 4443221 1479999
Q ss_pred CCCCChh
Q 006750 308 MPNGNLR 314 (632)
Q Consensus 308 ~~~gsL~ 314 (632)
++|-++.
T Consensus 74 i~G~~l~ 80 (235)
T cd05157 74 IPGRTLE 80 (235)
T ss_pred eCCCcCC
Confidence 9987763
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00028 Score=71.53 Aligned_cols=137 Identities=14% Similarity=0.063 Sum_probs=79.0
Q ss_pred eeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCc-cceeeeeecccCCcceEEEEEEeCCCC
Q 006750 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV-VPLVGYCSEFRGKRAMRLLVFEFMPNG 311 (632)
Q Consensus 233 LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpni-v~l~g~~~~~~~~~~~~~lV~Ey~~~g 311 (632)
+..|-.+.+|+... ++..+++|+.......-. ....+|..+++.+....+ .++++... -++||||++|.
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~i~~~~--------~~~v~e~i~G~ 73 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALG-VDRQREYQILQALSALGLAPKPILVNE--------HWLLVEWLEGE 73 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCccccccc-CcHHHHHHHHHHHHhcCCCCceEEEeC--------CEEEEEeccCc
Confidence 45577889999874 577888987654322211 125789999999954434 34444321 26899999987
Q ss_pred Chhhh-----------------hhccc--cCCCCHHHH-HHHHHH---------HHHhhHHHHhc-----CCCceeecCC
Q 006750 312 NLRDC-----------------LDGVL--VEGMNWDTR-VAIAIG---------AARGLEYLHEA-----AAPRILHRDI 357 (632)
Q Consensus 312 sL~~~-----------------L~~~~--~~~l~~~~~-~~i~~~---------ia~gL~yLH~~-----~~~~iiHrDL 357 (632)
.+... |+... ..+++.... .....+ +...+..+-.. ..+.++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 66431 11111 111222211 111111 11112222211 1235899999
Q ss_pred CCCCeEecCCCCeEEecccccee
Q 006750 358 KSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 358 Kp~NILl~~~~~vkL~DFGla~~ 380 (632)
.|.||++++++ +.|+||..|..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999876 78999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00013 Score=84.91 Aligned_cols=201 Identities=21% Similarity=0.184 Sum_probs=138.4
Q ss_pred HHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcC
Q 006750 269 FLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 348 (632)
Q Consensus 269 f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 348 (632)
...|+..+.++.|+|++.+++|..+.....-...+..+++..-++...+... ...+..+.+.+..++..||+|+|+..
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 4556777888899999999988876443332334567888888888888654 45788899999999999999999885
Q ss_pred CCceeecCCCCC---CeEecCCCCeEEe--ccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCC--CcccchHh
Q 006750 349 APRILHRDIKSS---NILLDENLNAKIT--DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA--SLMSDVFS 421 (632)
Q Consensus 349 ~~~iiHrDLKp~---NILl~~~~~vkL~--DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~--s~ksDVwS 421 (632)
..|.-|..+ +-..+..+.+.++ ||+..+.+...... ....-+..|.+||......+ +...|+|.
T Consensus 307 ---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~------~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~ 377 (1351)
T KOG1035|consen 307 ---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS------FSDLLAEIRNADEDLKENTAKKSRLTDLWC 377 (1351)
T ss_pred ---cceeEEecccccccccCccceeecchhhhcccccCCCcccc------hhhcCccccccccccccccchhhhhhHHHH
Confidence 666666555 5555666777777 88888766543221 11123456788887765544 44579999
Q ss_pred HhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 006750 422 FGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS 501 (632)
Q Consensus 422 lGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 501 (632)
+|..+..+..|..+-.... .+.+-+...... .+.+....|+..++++|++..
T Consensus 378 lgll~~~~~~~~~i~~~~~------------------------~~~~~l~~~~~~----~~~d~~~~~~~~~~~~Rl~~~ 429 (1351)
T KOG1035|consen 378 LGLLLLQLSQGEDISEKSA------------------------VPVSLLDVLSTS----ELLDALPKCLDEDSEERLSAL 429 (1351)
T ss_pred HHHHHhhhhhcCccccccc------------------------chhhhhccccch----hhhhhhhhhcchhhhhccchh
Confidence 9999999998765532110 000111111111 366778899999999999999
Q ss_pred HHHHHHh
Q 006750 502 EVVQILS 508 (632)
Q Consensus 502 evl~~L~ 508 (632)
+++....
T Consensus 430 ~ll~~~f 436 (1351)
T KOG1035|consen 430 ELLTHPF 436 (1351)
T ss_pred hhhhchh
Confidence 9987644
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00066 Score=70.26 Aligned_cols=145 Identities=14% Similarity=0.091 Sum_probs=84.7
Q ss_pred cceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCC--ccceeeeeecc--cCCcceEEEEE
Q 006750 230 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH--VVPLVGYCSEF--RGKRAMRLLVF 305 (632)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpn--iv~l~g~~~~~--~~~~~~~~lV~ 305 (632)
.+.|..|....+|+....+ ..+++|+.... .......|+.++..|.+.. +.+++...... .......++||
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKV----SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCCC----ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 4557778778999987654 46888987641 2234677888888884433 44544321100 00123458999
Q ss_pred EeCCCCChhh----hh----------hccc----c-----CCCCHHHHHH----------HHHHHHHhhHHHHhc----C
Q 006750 306 EFMPNGNLRD----CL----------DGVL----V-----EGMNWDTRVA----------IAIGAARGLEYLHEA----A 348 (632)
Q Consensus 306 Ey~~~gsL~~----~L----------~~~~----~-----~~l~~~~~~~----------i~~~ia~gL~yLH~~----~ 348 (632)
+|++|..+.. .+ +... . ....|..... ....+...+.++... .
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999877643 00 1100 0 0122322210 111233445555431 1
Q ss_pred CCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 349 APRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 349 ~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
+..++|+|+.|.|||++++..+.|+||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 2359999999999999998777899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0021 Score=69.04 Aligned_cols=76 Identities=21% Similarity=0.196 Sum_probs=53.5
Q ss_pred ceeeeeCceEEEEEEECCC-cEEEEEEeccC-----C-CCChHHHHHHHHHHHHhc-C--CCCccceeeeeecccCCcce
Q 006750 231 NIVGQGGSSYVYRGQLTDG-RIVAVKRFKTQ-----G-GPNADSVFLTEVDMLSRL-H--HCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g-~~vAVK~l~~~-----~-~~~~~~~f~~Ei~~l~~l-~--Hpniv~l~g~~~~~~~~~~~ 300 (632)
+.||.|.+..||++...+| +.|+||.-... . .+-...++..|.+.|..+ . ..++.+++.+.. ..
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~------~~ 105 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE------EL 105 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC------CC
Confidence 5689999999999998877 58999985421 1 122344577888888887 2 245777776632 24
Q ss_pred EEEEEEeCCCCC
Q 006750 301 RLLVFEFMPNGN 312 (632)
Q Consensus 301 ~~lV~Ey~~~gs 312 (632)
.++||||+++..
T Consensus 106 ~~lVME~L~~~~ 117 (401)
T PRK09550 106 AVTVMEDLSDHK 117 (401)
T ss_pred CEEEEecCCCcc
Confidence 589999998643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00096 Score=69.33 Aligned_cols=139 Identities=22% Similarity=0.260 Sum_probs=82.6
Q ss_pred ceeeeeCceEEEEEEECC-------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCcc-ceeeeeecccCCcceEE
Q 006750 231 NIVGQGGSSYVYRGQLTD-------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV-PLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~-------g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv-~l~g~~~~~~~~~~~~~ 302 (632)
+.|..|-...+|+....+ ++.+++|+....... .....+|..++..+....+. ++++++.. .
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~--~~~r~~E~~~~~~l~~~g~~P~~~~~~~~--------~ 73 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL--LIDRERELVVFARLSERNLGPKLYGIFPN--------G 73 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc--eechHHHHHHHHHHHhCCCCCceEEEeCC--------C
Confidence 345557777999988654 578999997654322 12357888899888543333 55554421 3
Q ss_pred EEEEeCCCCChhhh-----------------hhccccC-------CC--CHHHHHH------------------------
Q 006750 303 LVFEFMPNGNLRDC-----------------LDGVLVE-------GM--NWDTRVA------------------------ 332 (632)
Q Consensus 303 lV~Ey~~~gsL~~~-----------------L~~~~~~-------~l--~~~~~~~------------------------ 332 (632)
+|+||++|..+... |+..... .. -|.....
T Consensus 74 ~v~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (302)
T cd05156 74 RIEEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVEL 153 (302)
T ss_pred chhheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhH
Confidence 58999988776431 0111110 00 0111110
Q ss_pred --HHHHHHHhhHHHHh------cCCCceeecCCCCCCeEecCC----CCeEEeccccce
Q 006750 333 --IAIGAARGLEYLHE------AAAPRILHRDIKSSNILLDEN----LNAKITDLGMAK 379 (632)
Q Consensus 333 --i~~~ia~gL~yLH~------~~~~~iiHrDLKp~NILl~~~----~~vkL~DFGla~ 379 (632)
+...+..-+.+|-. .....++|+|+.+.|||++++ +.+.++||..|.
T Consensus 154 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 154 SLFLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 11122223334432 123468999999999999874 789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0035 Score=65.67 Aligned_cols=144 Identities=15% Similarity=0.149 Sum_probs=76.5
Q ss_pred ceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCC--ccceeeeeec--ccCCcceEEEEEE
Q 006750 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH--VVPLVGYCSE--FRGKRAMRLLVFE 306 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpn--iv~l~g~~~~--~~~~~~~~~lV~E 306 (632)
+.|+.|....+|+....+| .+++|++. ... ......|+.++..|...+ +.+.+..... ........+++++
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFE-RLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEec-cCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 4566777789999987655 68889876 211 122445666666663222 3333321000 0001234689999
Q ss_pred eCCCCChhh-----------hh---hccc---------cCCCCH-HHHHHH------------HHH-HHHhhHHHHhc--
Q 006750 307 FMPNGNLRD-----------CL---DGVL---------VEGMNW-DTRVAI------------AIG-AARGLEYLHEA-- 347 (632)
Q Consensus 307 y~~~gsL~~-----------~L---~~~~---------~~~l~~-~~~~~i------------~~~-ia~gL~yLH~~-- 347 (632)
|++|..+.. .| +... ...+.| .....- ..+ +...++.+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 998875421 11 1110 001112 111111 111 11122222211
Q ss_pred --CCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 348 --AAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 348 --~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
-+..++|+|+.|.|||++.+...-|+||+.+.
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 23459999999999999977556899999875
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0055 Score=63.88 Aligned_cols=146 Identities=14% Similarity=0.112 Sum_probs=82.2
Q ss_pred cceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCC--ccceeeeeecc--cCCcceEEEEE
Q 006750 230 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH--VVPLVGYCSEF--RGKRAMRLLVF 305 (632)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpn--iv~l~g~~~~~--~~~~~~~~lV~ 305 (632)
.+.++.|....+|+....+| .+++|+...... ......|++++..|.... +.+++...... .......+++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCCC---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 34567777789999876555 577888754321 223556777777774322 44444321100 00123568999
Q ss_pred EeCCCCChhhh-----------h---hccccC----------CCCHHHHHH------------HHHHHHHhhHHHHh---
Q 006750 306 EFMPNGNLRDC-----------L---DGVLVE----------GMNWDTRVA------------IAIGAARGLEYLHE--- 346 (632)
Q Consensus 306 Ey~~~gsL~~~-----------L---~~~~~~----------~l~~~~~~~------------i~~~ia~gL~yLH~--- 346 (632)
+|++|..+... | +..... .-.|..... ....+.+.++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 99988654211 1 110000 011221111 11123345555543
Q ss_pred -cCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 347 -AAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 347 -~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
.-...++|+|+.+.||+++.++...|+||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 123469999999999999988777899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.00085 Score=68.39 Aligned_cols=145 Identities=17% Similarity=0.157 Sum_probs=98.8
Q ss_pred ecHHHHHHhhcC---ccccceeeeeCceEEEEEEECCCcEEEEEEeccCC-------------------CCC--hHHHHH
Q 006750 215 FSYSALEHATDK---FSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG-------------------GPN--ADSVFL 270 (632)
Q Consensus 215 ~~~~~l~~~t~~---f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~-------------------~~~--~~~~f~ 270 (632)
++|..|....++ ++..++||-|--+.||.+...+|++.++|.-+-.. ... .+-...
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~ 158 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT 158 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence 455556555443 56789999999999999999889999998532110 000 011245
Q ss_pred HHHHHHHhcC-CCC-ccceeeeeecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcC
Q 006750 271 TEVDMLSRLH-HCH-VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 348 (632)
Q Consensus 271 ~Ei~~l~~l~-Hpn-iv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~ 348 (632)
+|+..|+.|. |-. +.+.+++. ..++|||++.|-.|.+.-+- .+..++..-+ ..-+.-|...|
T Consensus 159 kEfafmkaL~e~gfpVPkpiD~~--------RH~Vvmelv~g~Pl~~v~~v-----~d~~~ly~~l---m~~Iv~la~~G 222 (465)
T KOG2268|consen 159 KEFAFMKALYERGFPVPKPIDHN--------RHCVVMELVDGYPLRQVRHV-----EDPPTLYDDL---MGLIVRLANHG 222 (465)
T ss_pred HHHHHHHHHHHcCCCCCCccccc--------ceeeHHHhhcccceeeeeec-----CChHHHHHHH---HHHHHHHHHcC
Confidence 7999999883 433 44444432 34899999999888765321 2333433333 33345566677
Q ss_pred CCceeecCCCCCCeEecCCCCeEEeccccc
Q 006750 349 APRILHRDIKSSNILLDENLNAKITDLGMA 378 (632)
Q Consensus 349 ~~~iiHrDLKp~NILl~~~~~vkL~DFGla 378 (632)
+||+|..-=||++++++.++++||--.
T Consensus 223 ---lIHgDFNEFNimv~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 223 ---LIHGDFNEFNIMVKDDDKIVVIDFPQM 249 (465)
T ss_pred ---ceecccchheeEEecCCCEEEeechHh
Confidence 999999999999999999999999754
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0097 Score=61.78 Aligned_cols=140 Identities=18% Similarity=0.196 Sum_probs=82.3
Q ss_pred ceeeeeCceEEEEEEECCCcEEEEEEecc-CCCCChHHHHHHHHHHHHhcCC--CCccceeeeeecccCCcceEEEEEEe
Q 006750 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKT-QGGPNADSVFLTEVDMLSRLHH--CHVVPLVGYCSEFRGKRAMRLLVFEF 307 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~-~~~~~~~~~f~~Ei~~l~~l~H--pniv~l~g~~~~~~~~~~~~~lV~Ey 307 (632)
+.+-.|..-.+|..... ++.+++. ... ...........+|+.+|+.+.- --+.+.+++|.+.. -...|.||+|
T Consensus 31 ~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~--~g~pf~v~~~ 106 (321)
T COG3173 31 EEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGY--LGTPFYVMEW 106 (321)
T ss_pred eeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCC--CCCceEEEEE
Confidence 33433444445555544 7788888 332 2222233346788888888743 23445666666533 2356999999
Q ss_pred CCCCChhhhhhccccCCCCHHHHHHHH-HHHHHhh---------------------------------------------
Q 006750 308 MPNGNLRDCLDGVLVEGMNWDTRVAIA-IGAARGL--------------------------------------------- 341 (632)
Q Consensus 308 ~~~gsL~~~L~~~~~~~l~~~~~~~i~-~~ia~gL--------------------------------------------- 341 (632)
++|..+.+.+.... .. .+++ ..++..|
T Consensus 107 veGe~~~~~~~~~~---~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~ 179 (321)
T COG3173 107 VEGEVVWSALPPES---LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL 179 (321)
T ss_pred ecceeccCcCCccc---ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence 98854433321100 00 0111 1333333
Q ss_pred -----HHHHhcC-----CCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 342 -----EYLHEAA-----APRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 342 -----~yLH~~~-----~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
.||+... .+.++|+|+.+.|++++.+.-+=|.||+++..-
T Consensus 180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 3443322 357999999999999999888999999998653
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.012 Score=60.44 Aligned_cols=31 Identities=29% Similarity=0.478 Sum_probs=25.8
Q ss_pred CceeecCCCCCCeEecCCCC-eEEecccccee
Q 006750 350 PRILHRDIKSSNILLDENLN-AKITDLGMAKR 380 (632)
Q Consensus 350 ~~iiHrDLKp~NILl~~~~~-vkL~DFGla~~ 380 (632)
+.++|+|+.+.|||+++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 46999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.0068 Score=62.36 Aligned_cols=73 Identities=25% Similarity=0.271 Sum_probs=45.3
Q ss_pred cceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC---CCCccceeeeeecccCCcceEEEEEE
Q 006750 230 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH---HCHVVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~---Hpniv~l~g~~~~~~~~~~~~~lV~E 306 (632)
.+.++.|....+|+.. .+++.+.||+-... ....|..|.+-|+.|. --.+.+.+++.... ...|||||
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~----~~~fLlle 92 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSES----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD----DDAFLLLE 92 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEEGG----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S----SCCEEEEE
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecChh----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec----CCceEEEE
Confidence 4568889999999988 56889999987622 2234899999999883 33566777776542 23499999
Q ss_pred eCCCC
Q 006750 307 FMPNG 311 (632)
Q Consensus 307 y~~~g 311 (632)
|++.+
T Consensus 93 ~l~~~ 97 (288)
T PF03881_consen 93 FLEMG 97 (288)
T ss_dssp -----
T ss_pred eecCC
Confidence 99876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1219 consensus Uncharacterized conserved protein, contains laminin, cadherin and EGF domains [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.003 Score=76.78 Aligned_cols=47 Identities=21% Similarity=0.467 Sum_probs=27.9
Q ss_pred cCCccceEEecCCCCCCcccccccCCCCCcccCCCCC-CCCCCceeeee
Q 006750 30 SGQKNWKCTCSSSLQGDQSNILKLNCSRSCDCSPAVG-GSSEGKWTCIC 77 (632)
Q Consensus 30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~~-~~~~~~~~c~~ 77 (632)
++..+|.|.|++-|-||--=+--.+|.+ =-|+-|.+ .-+.+.+.|.|
T Consensus 3881 ~~~ggy~CkCpsqysG~~CEi~~epC~s-nPC~~GgtCip~~n~f~CnC 3928 (4289)
T KOG1219|consen 3881 QPKGGYKCKCPSQYSGNHCEIDLEPCAS-NPCLTGGTCIPFYNGFLCNC 3928 (4289)
T ss_pred CCCCceEEeCcccccCcccccccccccC-CCCCCCCEEEecCCCeeEeC
Confidence 4466999999999999754443356653 23433211 01455666666
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.00019 Score=85.20 Aligned_cols=161 Identities=13% Similarity=-0.010 Sum_probs=113.1
Q ss_pred HHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEeCCCCChhhhhhccccCC--CCHHHHHHHHHHHHHhhHHHHh
Q 006750 269 FLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG--MNWDTRVAIAIGAARGLEYLHE 346 (632)
Q Consensus 269 f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~--l~~~~~~~i~~~ia~gL~yLH~ 346 (632)
...|.+.++...|+++.....-..... ....|.+++|+.+|.+.+.|-....+. ++..-+...-.+......-+|.
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~--s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSE--STEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCC--ChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 445666666778998887654332222 335589999999999999985433221 3332233223332445555554
Q ss_pred cC--CCceeecCCCCCCeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhH
Q 006750 347 AA--APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGV 424 (632)
Q Consensus 347 ~~--~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGv 424 (632)
.. ....+|++||+-|.+|..+.++|++++|+.+...+. ........+++.|++|+....-.++.++|+|..|+
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-----~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~ 1428 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-----LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSL 1428 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCch-----HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHH
Confidence 32 234699999999999999999999999999843322 12233456788999999999999999999999999
Q ss_pred HHHHHHhCCCCC
Q 006750 425 VLLELITGRQPI 436 (632)
Q Consensus 425 iL~eLltG~~P~ 436 (632)
-+|++..|..+|
T Consensus 1429 ~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1429 SLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHhcccHHH
Confidence 999999888776
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.019 Score=60.95 Aligned_cols=138 Identities=17% Similarity=0.147 Sum_probs=80.1
Q ss_pred eeeeeCceEEEEEEECC-----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCcc-ceeeeeecccCCcceEEEEE
Q 006750 232 IVGQGGSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV-PLVGYCSEFRGKRAMRLLVF 305 (632)
Q Consensus 232 ~LG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv-~l~g~~~~~~~~~~~~~lV~ 305 (632)
.|-.|-.-.+|+..+.+ ++.|++|+...... ... ...+|..+++.+..-++. ++++.+.. ..|+
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~--------g~v~ 112 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFF-DRDDEIRTFECMSRHGQGPRLLGRFPN--------GRVE 112 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eee-chHHHHHHHHHHHHcCCCCceEEEECC--------ceEE
Confidence 34447778899987543 36899998865432 211 246799999998554444 55555422 2589
Q ss_pred EeCCCCChhhh-----------------hhccc--c-C-CCCHHHHHHHHHH-----------------HHHhhHHHH--
Q 006750 306 EFMPNGNLRDC-----------------LDGVL--V-E-GMNWDTRVAIAIG-----------------AARGLEYLH-- 345 (632)
Q Consensus 306 Ey~~~gsL~~~-----------------L~~~~--~-~-~l~~~~~~~i~~~-----------------ia~gL~yLH-- 345 (632)
+|+++.+|... ++... . . ...|..+..+..+ +...+..|.
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 99987776421 11111 0 0 1113333222211 111122222
Q ss_pred --h-cCCCceeecCCCCCCeEecC-CCCeEEeccccce
Q 006750 346 --E-AAAPRILHRDIKSSNILLDE-NLNAKITDLGMAK 379 (632)
Q Consensus 346 --~-~~~~~iiHrDLKp~NILl~~-~~~vkL~DFGla~ 379 (632)
. .....++|+|+++.|||+++ ++.+.|+||..+.
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1 11235899999999999986 4679999998875
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.066 Score=57.49 Aligned_cols=74 Identities=18% Similarity=0.178 Sum_probs=49.5
Q ss_pred cceeeeeCceEEEEEEECCCcEEEEEEeccCCC------CChHHHHHHHHHHHHhcC---CCCccceeeeeecccCCcce
Q 006750 230 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG------PNADSVFLTEVDMLSRLH---HCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~------~~~~~~f~~Ei~~l~~l~---Hpniv~l~g~~~~~~~~~~~ 300 (632)
.+.||.|....||+.... +..++||.-..... +....+-..|...|+.+. ..++.+++.++.+ .
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded------~ 109 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT------M 109 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC------C
Confidence 467899999999998864 55689997652111 112222344567776653 3578889888764 3
Q ss_pred EEEEEEeCCC
Q 006750 301 RLLVFEFMPN 310 (632)
Q Consensus 301 ~~lV~Ey~~~ 310 (632)
.+++|||+++
T Consensus 110 ~vlvME~L~~ 119 (418)
T PLN02756 110 ALIGMRYLEP 119 (418)
T ss_pred CEEEEeecCC
Confidence 4889999976
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.027 Score=58.71 Aligned_cols=138 Identities=20% Similarity=0.237 Sum_probs=92.6
Q ss_pred ceeeeeCceEEEEEEECCCcEEEEEEeccCCCC---------------------ChHHH----HHHHHHHHHhcCCCCcc
Q 006750 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGP---------------------NADSV----FLTEVDMLSRLHHCHVV 285 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~---------------------~~~~~----f~~Ei~~l~~l~Hpniv 285 (632)
..|..|--..||.|.-.+|..+|||+++..-.. ..++. ...|+.-|++|+...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 446778889999999999999999998743100 00111 34588888888766644
Q ss_pred ceeeeeecccCCcceEEEEEEeCCCCChh-hhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEe
Q 006750 286 PLVGYCSEFRGKRAMRLLVFEFMPNGNLR-DCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL 364 (632)
Q Consensus 286 ~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~-~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl 364 (632)
----... ....|||+|+..-.-. -.|.. -.++...+..+-.+++.-|.-|.... ++||.||.-=|+|+
T Consensus 230 ~PePIlL------k~hVLVM~FlGrdgw~aPkLKd---~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 230 CPEPILL------KNHVLVMEFLGRDGWAAPKLKD---ASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY 298 (520)
T ss_pred CCCceee------ecceEeeeeccCCCCcCccccc---ccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE
Confidence 2211111 1337999999421111 11111 23666777888888888888887765 59999999999998
Q ss_pred cCCCCeEEecccccee
Q 006750 365 DENLNAKITDLGMAKR 380 (632)
Q Consensus 365 ~~~~~vkL~DFGla~~ 380 (632)
-+ |.+.|+|.+-+.-
T Consensus 299 hd-G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 299 HD-GKLYIIDVSQSVE 313 (520)
T ss_pred EC-CEEEEEEcccccc
Confidence 64 5899999887643
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.052 Score=57.26 Aligned_cols=73 Identities=22% Similarity=0.180 Sum_probs=47.2
Q ss_pred eeeeeCceEEEEEEECCC-cEEEEEEecc------CCCCChHHHHHHHHHHHHhcC--CC-CccceeeeeecccCCcceE
Q 006750 232 IVGQGGSSYVYRGQLTDG-RIVAVKRFKT------QGGPNADSVFLTEVDMLSRLH--HC-HVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 232 ~LG~G~fG~Vy~~~~~~g-~~vAVK~l~~------~~~~~~~~~f~~Ei~~l~~l~--Hp-niv~l~g~~~~~~~~~~~~ 301 (632)
.||.|....||++...+| +.|+||.-.. ...+-...+...|...|+... -| .+.+++.|- ....
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D------~e~~ 75 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD------TEMA 75 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc------cccc
Confidence 479999999999998654 5899996431 122333334556777776652 23 455666442 3355
Q ss_pred EEEEEeCCC
Q 006750 302 LLVFEFMPN 310 (632)
Q Consensus 302 ~lV~Ey~~~ 310 (632)
.+|||+++.
T Consensus 76 ~~vMEdL~~ 84 (370)
T TIGR01767 76 VTVMEDLSH 84 (370)
T ss_pred eehHhhCcc
Confidence 799999954
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.059 Score=56.02 Aligned_cols=29 Identities=24% Similarity=0.360 Sum_probs=25.1
Q ss_pred CceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 350 PRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 350 ~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 45899999999999987 578999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.084 Score=55.39 Aligned_cols=142 Identities=20% Similarity=0.316 Sum_probs=83.6
Q ss_pred eeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCC------ccceeeeeecccCCcceEEEEEE
Q 006750 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH------VVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 233 LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpn------iv~l~g~~~~~~~~~~~~~lV~E 306 (632)
|.+ .-..||+....+|+. ++|+.... . ...+...|...|..|.-.. +..+=|-....-......+.|++
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~-~--~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG-W--TRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC-C--CHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 444 556799998877776 89988765 2 2334667788888773221 22222222111111136789999
Q ss_pred eCCCCChhh-hh--------------h----ccc------cCCCCHHH-------------HHHHHHHHHHhhHHHHhcC
Q 006750 307 FMPNGNLRD-CL--------------D----GVL------VEGMNWDT-------------RVAIAIGAARGLEYLHEAA 348 (632)
Q Consensus 307 y~~~gsL~~-~L--------------~----~~~------~~~l~~~~-------------~~~i~~~ia~gL~yLH~~~ 348 (632)
|++|..+.. .- + +.. .....|.. ......++...+..+.+.-
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999988873 11 0 110 01133431 0113334444555555422
Q ss_pred C-------CceeecCCCCCCeEecCCCC-eEEeccccce
Q 006750 349 A-------PRILHRDIKSSNILLDENLN-AKITDLGMAK 379 (632)
Q Consensus 349 ~-------~~iiHrDLKp~NILl~~~~~-vkL~DFGla~ 379 (632)
. ..+||+|+.|.|||++.+.. +.++|||-+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1 12899999999999999875 8899999875
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.021 Score=56.00 Aligned_cols=30 Identities=27% Similarity=0.449 Sum_probs=21.3
Q ss_pred ceeecCCCCCCeEe-cCCCCeEEecccccee
Q 006750 351 RILHRDIKSSNILL-DENLNAKITDLGMAKR 380 (632)
Q Consensus 351 ~iiHrDLKp~NILl-~~~~~vkL~DFGla~~ 380 (632)
.++|+||.+.|||+ +.++.++++||-.|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 47899999999999 8889999999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.075 Score=56.00 Aligned_cols=138 Identities=15% Similarity=0.165 Sum_probs=78.1
Q ss_pred eeeeeCceEEEEEEECC----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCcc-ceeeeeecccCCcceEEEEEE
Q 006750 232 IVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV-PLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 232 ~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv-~l~g~~~~~~~~~~~~~lV~E 306 (632)
.|..|=...+|+....+ +..|++|+....... .-...+|..+++.+..-++. ++++++.. -+|.+
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~--~IdR~~E~~il~~l~~~gl~P~~l~~~~~--------G~i~~ 90 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY--VIDRERELQAIKYLSAAGFGAKLLGVFGN--------GMIQS 90 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe--EechHHHHHHHHHHHhcCCCCceeEEeCC--------cEeeh
Confidence 34446677889887543 237899988654321 12246899999999655554 55555421 15899
Q ss_pred eCCCCChhh-------hh----------hcccc---CCC-CHHHHHHHHHHH----------------------HHhhHH
Q 006750 307 FMPNGNLRD-------CL----------DGVLV---EGM-NWDTRVAIAIGA----------------------ARGLEY 343 (632)
Q Consensus 307 y~~~gsL~~-------~L----------~~~~~---~~l-~~~~~~~i~~~i----------------------a~gL~y 343 (632)
|+++..|.. .+ +.... ... -|..+..+..++ ..-+..
T Consensus 91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (330)
T PLN02421 91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE 170 (330)
T ss_pred hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence 997766532 11 11110 001 133322222111 111111
Q ss_pred HH----hcC-CCceeecCCCCCCeEecC-CCCeEEeccccce
Q 006750 344 LH----EAA-APRILHRDIKSSNILLDE-NLNAKITDLGMAK 379 (632)
Q Consensus 344 LH----~~~-~~~iiHrDLKp~NILl~~-~~~vkL~DFGla~ 379 (632)
+. ..+ +..++|.|+.+.|||+++ ++.++++||..|.
T Consensus 171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 11 111 234799999999999974 5689999999874
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.078 Score=55.31 Aligned_cols=30 Identities=20% Similarity=0.273 Sum_probs=27.3
Q ss_pred ceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 351 RILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 351 ~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.++|+|+.+.|+|++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 599999999999999999999999998754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.1 Score=63.24 Aligned_cols=145 Identities=19% Similarity=0.233 Sum_probs=79.6
Q ss_pred ceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC--CCC--ccceeee----ee---cccCCcc
Q 006750 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH--HCH--VVPLVGY----CS---EFRGKRA 299 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~--Hpn--iv~l~g~----~~---~~~~~~~ 299 (632)
+.|+ |..-.+|+....+|..+++|+.+.... ......|..+|..|. ++. +.+++-. .. .......
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~---~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~ 106 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEP---RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEP 106 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCccc---hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCce
Confidence 3454 456788999887888999999986432 222445566666552 222 2232211 10 1111122
Q ss_pred eEEEEEEeCCCCChhhhh-----------------hc----c----ccCCCCHHH-----------------HHHHHHHH
Q 006750 300 MRLLVFEFMPNGNLRDCL-----------------DG----V----LVEGMNWDT-----------------RVAIAIGA 337 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L-----------------~~----~----~~~~l~~~~-----------------~~~i~~~i 337 (632)
..+-+++|++|..|.+.. +. . ..+.+.|.. ...++.++
T Consensus 107 ~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~ 186 (1013)
T PRK06148 107 RLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERF 186 (1013)
T ss_pred EEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHH
Confidence 457789999998776511 00 0 011233422 11222222
Q ss_pred HHhhH-----HHHhcCCCceeecCCCCCCeEecCCC--CeE-Eecccccee
Q 006750 338 ARGLE-----YLHEAAAPRILHRDIKSSNILLDENL--NAK-ITDLGMAKR 380 (632)
Q Consensus 338 a~gL~-----yLH~~~~~~iiHrDLKp~NILl~~~~--~vk-L~DFGla~~ 380 (632)
...+. .|.. -...+||+|+.+.|||++.+. .+. |+|||.+..
T Consensus 187 ~~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 187 LARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 22221 1211 123499999999999998875 555 999998753
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.66 E-value=0.035 Score=57.82 Aligned_cols=75 Identities=16% Similarity=0.174 Sum_probs=60.2
Q ss_pred cceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccc
Q 006750 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 377 (632)
..+.|++|++- |++|.-. ....|.+.+.++.+.+..+.-|...- +.=|||+.-.||||+ +|++-|+||-+
T Consensus 298 ~~y~yl~~kdh-gt~is~i------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 298 TLYLYLHFKDH-GTPISII------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred ceEEEEEEecC-Cceeeee------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeee
Confidence 45778888887 6666532 23578999999999888777776554 589999999999999 99999999999
Q ss_pred ceecc
Q 006750 378 AKRLK 382 (632)
Q Consensus 378 a~~~~ 382 (632)
+|...
T Consensus 368 sRl~~ 372 (488)
T COG5072 368 SRLSY 372 (488)
T ss_pred eeccc
Confidence 99543
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.012 Score=63.50 Aligned_cols=72 Identities=21% Similarity=0.325 Sum_probs=47.5
Q ss_pred EEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEeCCCCChhhhhhcc
Q 006750 241 VYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGV 320 (632)
Q Consensus 241 Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~ 320 (632)
.+.|....|.+. ..-+.. .+. ..+.+....+++.+.|+|+..++.+.. +......+|||++ +.||++++...
T Consensus 5 ~~~a~~~~~~~c-~nglpl--t~~-s~~ilgr~~~lktl~~~~l~~yl~~~r---~~~~r~IVV~e~~-~~Sled~~~~~ 76 (725)
T KOG1093|consen 5 TFFAQEKPGDVC-SNGLPL--TPN-SIQILGRFQYLKSLQHDNLCQYLDFSR---GKHERVIVVMEHY-TMSLEDILKTG 76 (725)
T ss_pred EEehhcCCCccc-cCCCcC--CCc-HHHHhhhhHHHHhhcCccceeeEeeec---CccceEEEEehhh-ccchHHHHHhc
Confidence 455655555543 222221 122 234677889999999999998886643 3344578999999 78999988643
|
|
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=95.26 E-value=0.012 Score=40.61 Aligned_cols=31 Identities=26% Similarity=0.329 Sum_probs=13.3
Q ss_pred cEEEEehHHHHHHHHHHHHHHHHHhhhccCC
Q 006750 118 KVVVIVLLLCVILTTIAFLMLVLCYVYRKGK 148 (632)
Q Consensus 118 ~~~~ii~i~~~~~~~l~~l~~~~~~~~rr~k 148 (632)
.+.+.+++++.+++++++++++++++|||+|
T Consensus 10 ~vaIa~~VvVPV~vI~~vl~~~l~~~~rR~k 40 (40)
T PF08693_consen 10 TVAIAVGVVVPVGVIIIVLGAFLFFWYRRKK 40 (40)
T ss_pred eEEEEEEEEechHHHHHHHHHHhheEEeccC
Confidence 3344444333333334444444444455543
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.24 E-value=0.21 Score=53.64 Aligned_cols=74 Identities=16% Similarity=0.236 Sum_probs=45.4
Q ss_pred ceeeeeCceEEEEEEECCC--c-----EEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCcc-ceeeeeecccCCcceEE
Q 006750 231 NIVGQGGSSYVYRGQLTDG--R-----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV-PLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g--~-----~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv-~l~g~~~~~~~~~~~~~ 302 (632)
+.|..|-...+|++...++ . .|.++...... ...-+-.+|+.+++.+...++- ++++.+.. +
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~--~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~--------g 125 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN--SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD--------F 125 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCC--ceEeccHHHHHHHHHHHhCCCCCeEEEecCC--------E
Confidence 3454577889999976543 2 24444432221 1111246789999999666555 55554432 6
Q ss_pred EEEEeCCCCChh
Q 006750 303 LVFEFMPNGNLR 314 (632)
Q Consensus 303 lV~Ey~~~gsL~ 314 (632)
+|+||++|-.|.
T Consensus 126 ~l~efIeGr~l~ 137 (383)
T PTZ00384 126 TIQEWVEGNTMG 137 (383)
T ss_pred EEEEEeccccCC
Confidence 999999987764
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.08 E-value=0.11 Score=50.53 Aligned_cols=152 Identities=16% Similarity=0.192 Sum_probs=89.8
Q ss_pred CceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEeCCCCChhhh
Q 006750 237 GSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDC 316 (632)
Q Consensus 237 ~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~ 316 (632)
+..+.-+++-+=| +..+|++......-....|..+..++++++ .|+++.. + ....+-+|.|+|-....
T Consensus 74 gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N---D---n~~~yGvIlE~Cy~~~i--- 141 (308)
T PF07387_consen 74 GNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN---D---NNYKYGVILERCYKIKI--- 141 (308)
T ss_pred CceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec---C---CCceeEEEEeeccCccc---
Confidence 4444444443323 355666654433323445888999998886 3677651 1 23345688999832110
Q ss_pred hhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCCCCCCCCCCcc
Q 006750 317 LDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARM 396 (632)
Q Consensus 317 L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~ 396 (632)
+ .. .++.-=+++|.-.|+.. +..+|+|-.|+||+-|..|.+||.|-+..-.
T Consensus 142 --------~---~~-N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~---------------- 192 (308)
T PF07387_consen 142 --------N---FS-NFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE---------------- 192 (308)
T ss_pred --------c---hh-HHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhh----------------
Confidence 1 11 11111146778889553 4599999999999999999999999775321
Q ss_pred ccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCC
Q 006750 397 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 433 (632)
Q Consensus 397 ~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~ 433 (632)
.+..|.--| ....+.++.+=+|=.-++++....
T Consensus 193 -~~V~~vN~~---Y~~lT~~aE~~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 193 -NQVNMVNIE---YESLTQEAEVKVFVKSCLKLVEKQ 225 (308)
T ss_pred -heeeEEeee---ccccChHHHHHHHHHHHHHHHHHH
Confidence 011122211 123466777777777777777643
|
The function of this family is unknown. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.95 E-value=0.14 Score=54.80 Aligned_cols=75 Identities=20% Similarity=0.143 Sum_probs=49.4
Q ss_pred cceeeeeCceEEEEEEECC-CcEEEEEEec----c-CCCCChHHHHHHHHHHHHhcC--CC-CccceeeeeecccCCcce
Q 006750 230 SNIVGQGGSSYVYRGQLTD-GRIVAVKRFK----T-QGGPNADSVFLTEVDMLSRLH--HC-HVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~----~-~~~~~~~~~f~~Ei~~l~~l~--Hp-niv~l~g~~~~~~~~~~~ 300 (632)
.+.||.|.-..||++.+.+ ++.|+||.-. . ...+-...+..-|.+.|+.+. -| ++.+++.+- ...
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D------~e~ 107 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD------SVM 107 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC------cHH
Confidence 3578999999999999853 5679998643 1 122333445566778877662 33 466676542 335
Q ss_pred EEEEEEeCCC
Q 006750 301 RLLVFEFMPN 310 (632)
Q Consensus 301 ~~lV~Ey~~~ 310 (632)
..+|||+++.
T Consensus 108 ~~~vMEdL~~ 117 (409)
T PRK12396 108 NCCVMEDLSD 117 (409)
T ss_pred hhHHHHhCcc
Confidence 5799999964
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.92 E-value=0.33 Score=47.70 Aligned_cols=75 Identities=25% Similarity=0.301 Sum_probs=48.8
Q ss_pred ceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCC---ccceeeeeecccCCcceEEEEEEe
Q 006750 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH---VVPLVGYCSEFRGKRAMRLLVFEF 307 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpn---iv~l~g~~~~~~~~~~~~~lV~Ey 307 (632)
+.+..|.--..|...+ +...+.||+-.. .....|..|+.-|..|.-.| +.+++.+-.. ..+.|+||||
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n~~----~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~----~~~sylVle~ 92 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCNQR----EQLSMFTAEADGLELLARSNTITVPKVIAVGAS----RDHSYLVLEY 92 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEecch----hhHHHHHHHHHHHHHHHhcCCccccceEEecCC----CCeeEEEEee
Confidence 3444455555566554 467899997432 23345889998888875444 5566554443 5577999999
Q ss_pred CCCCChh
Q 006750 308 MPNGNLR 314 (632)
Q Consensus 308 ~~~gsL~ 314 (632)
++-|.+.
T Consensus 93 L~~~~~d 99 (286)
T COG3001 93 LPTGPLD 99 (286)
T ss_pred ccCCCCC
Confidence 9987765
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 632 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-51 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-50 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-43 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-43 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-34 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-34 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-33 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-31 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-21 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-20 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-20 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-19 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-19 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-19 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-18 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-18 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 8e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-16 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-14 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-14 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-14 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-14 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-14 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-14 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-14 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-13 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-13 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-13 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-13 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 9e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-07 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-07 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-06 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 7e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-04 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-04 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 8e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 9e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 384 bits (988), Expect = e-130
Identities = 117/302 (38%), Positives = 177/302 (58%), Gaps = 14/302 (4%)
Query: 210 GTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVF 269
G + RFS L+ A+D FS NI+G+GG VY+G+L DG +VAVKR K + + F
Sbjct: 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQF 74
Query: 270 LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL--VEGMNW 327
TEV+M+S H +++ L G+C RLLV+ +M NG++ CL ++W
Sbjct: 75 QTEVEMISMAVHRNLLRLRGFCMT----PTERLLVYPYMANGSVASCLRERPESQPPLDW 130
Query: 328 DTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP 387
R IA+G+ARGL YLH+ P+I+HRD+K++NILLDE A + D G+AK L
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDT 189
Query: 388 SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES- 446
++ ++GT G+ APEY G++S +DVF +GV+LLELITG++ + ++
Sbjct: 190 HVTT---AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246
Query: 447 -LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
L+ W L++ + L D L+G++ EE++ + +A C Q P RP MSEVV+
Sbjct: 247 MLLDWVKGLLKEKK--LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304
Query: 506 IL 507
+L
Sbjct: 305 ML 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 371 bits (956), Expect = e-125
Identities = 113/296 (38%), Positives = 162/296 (54%), Gaps = 15/296 (5%)
Query: 214 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEV 273
R LE AT+ F ++G G VY+G L DG VA+KR F TE+
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRT-PESSQGIEEFETEI 86
Query: 274 DMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL--VEGMNWDTRV 331
+ LS H H+V L+G+C E R +L++++M NGNL+ L G M+W+ R+
Sbjct: 87 ETLSFCRHPHLVSLIGFCDE----RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 332 AIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS 391
I IGAARGL YLH A I+HRD+KS NILLDEN KITD G++K + + S
Sbjct: 143 EICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK-KGTELDQTHLS 198
Query: 392 SPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA 451
+ ++GT GY PEY + GR + SDV+SFGVVL E++ R I +S+ + +L WA
Sbjct: 199 T--VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA 256
Query: 452 TPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507
++G + ++ DP L E ++ A +CL L + RP+M +V+ L
Sbjct: 257 VE-SHNNGQ-LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 352 bits (905), Expect = e-118
Identities = 98/308 (31%), Positives = 155/308 (50%), Gaps = 26/308 (8%)
Query: 214 RFSYSALEHATDKFS------GSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNA-- 265
FS+ L++ T+ F G N +G+GG VY+G + + VAVK+
Sbjct: 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72
Query: 266 -DSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-DGVLVE 323
F E+ ++++ H ++V L+G+ S+ LV+ +MPNG+L D L
Sbjct: 73 LKQQFDQEIKVMAKCQHENLVELLGFSSD----GDDLCLVYVYMPNGSLLDRLSCLDGTP 128
Query: 324 GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383
++W R IA GAA G+ +LHE +HRDIKS+NILLDE AKI+D G+A+ +
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEK 185
Query: 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKG 443
+S R+ GT Y APE + G + SD++SFGVVLLE+ITG + +
Sbjct: 186 FAQTVMTS---RIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEH--RE 239
Query: 444 EESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV 503
+ L+ + T I + D ++ D ++ M +A +CL + RP + +V
Sbjct: 240 PQLLLDIKEEIEDEEKT-IEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKV 297
Query: 504 VQILSTIA 511
Q+L +
Sbjct: 298 QQLLQEMT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 269 bits (690), Expect = 1e-85
Identities = 81/319 (25%), Positives = 125/319 (39%), Gaps = 25/319 (7%)
Query: 209 HGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV 268
H + + L + + +G V++ QL VAVK F Q
Sbjct: 8 HSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD--KQSWQ 64
Query: 269 FLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWD 328
EV L + H +++ +G L+ F G+L D L ++W+
Sbjct: 65 NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWN 121
Query: 329 TRVAIAIGAARGLEYLHEAAA-------PRILHRDIKSSNILLDENLNAKITDLGMAKRL 381
IA ARGL YLHE P I HRDIKS N+LL NL A I D G+A +
Sbjct: 122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181
Query: 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVG-----RASLMSDVFSFGVVLLELITGRQPI 436
+A + GT Y APE A L D+++ G+VL EL +
Sbjct: 182 EAGKSAGDTHGQV---GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238
Query: 437 HRSITKGEESL--VLWATPRLQD-SGTVISELPDPRLKGDFPKEE-MQIMAYLAKECLQL 492
+ + + P L+D V+ + P L+ + K M ++ +EC
Sbjct: 239 DGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDH 298
Query: 493 DPDARPTMSEVVQILSTIA 511
D +AR + V + ++ +
Sbjct: 299 DAEARLSAGCVGERITQMQ 317
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 225 bits (574), Expect = 2e-68
Identities = 72/335 (21%), Positives = 126/335 (37%), Gaps = 34/335 (10%)
Query: 213 IRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTE 272
+ + S D ++G+G VY+G L D R VAVK F F+ E
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA----NRQNFINE 55
Query: 273 VDM--LSRLHHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDT 329
++ + + H ++ + M LV E+ PNG+L L +W +
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVS 112
Query: 330 RVAIAIGAARGLEYLHEAAA------PRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383
+A RGL YLH P I HRD+ S N+L+ + I+D G++ RL
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 384 DGLPSCSSSPARM---QGTFGYFAPEYAM-------VGRASLMSDVFSFGVVLLELITGR 433
+ L GT Y APE A D+++ G++ E+
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 434 QPIHRSITKGEESL----VLWATPRLQD-SGTVISELPDPRLKGDFPKEE--MQIMAYLA 486
+ + E + + P +D V E P+ + + ++ +
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 487 KECLQLDPDARPTMSEVVQILSTIAPDKSRRRNIS 521
++C D +AR T + ++ + R +++S
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 9e-62
Identities = 80/286 (27%), Positives = 133/286 (46%), Gaps = 36/286 (12%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLV 288
+G G V+R + G VAVK Q +A+ V FL EV ++ RL H ++V +
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQD-FHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 289 GYCSEFRGKRAMRL-LVFEFMPNGNLRDCL-DGVLVEGMNWDTRVAIAIGAARGLEYLHE 346
G + + L +V E++ G+L L E ++ R+++A A+G+ YLH
Sbjct: 101 GAVT-----QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH- 154
Query: 347 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 406
P I+HR++KS N+L+D+ K+ D G++ RLKA S S+ GT + APE
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS-RLKASTFLSSKSAA----GTPEWMAPE 209
Query: 407 YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT-PRLQDSGTVISEL 465
++ SDV+SFGV+L EL T +QP W Q V +
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATLQQP--------------WGNLNPAQVVAAVGFKC 255
Query: 466 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511
+ + + +A + + C +P RP+ + ++ +L +
Sbjct: 256 KRLEIPRNLNPQ----VAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 5e-59
Identities = 72/292 (24%), Positives = 124/292 (42%), Gaps = 56/292 (19%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
+VG+G V + + + VA+K+ +++ + F+ E+ LSR++H ++V L G
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGV-LVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
C LV E+ G+L + L G + ++ + ++G+ YLH
Sbjct: 70 CLN------PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 350 PRILHRDIKSSNILLDENLN-AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYA 408
++HRD+K N+LL KI D G A ++ + +G+ + APE
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ--------THMTNNKGSAAWMAPEVF 175
Query: 409 MVGRASLMSDVFSFGVVLLELITGRQP----------IHRSITKGEESLVLWATPRLQDS 458
S DVFS+G++L E+IT R+P I ++ G R
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT---------RP--- 223
Query: 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
L + PK + L C DP RP+M E+V+I++ +
Sbjct: 224 -----PLIK-----NLPKP----IESLMTRCWSKDPSQRPSMEEIVKIMTHL 261
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-58
Identities = 63/287 (21%), Positives = 113/287 (39%), Gaps = 41/287 (14%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVG 289
+ + S +++G+ G + VK K + F E L H +V+P++G
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
C L+ +MP G+L + L ++ V A+ ARG+ +LH
Sbjct: 75 ACQSPPAPHPT--LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLE 131
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 409
P I + S ++++DE++ A+I+ + ++ G + APE A+
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPG----------RMYAPAWVAPE-AL 180
Query: 410 VGRASLM----SDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA--TPRLQDSGTVIS 463
+ +D++SF V+L EL+T P +A + ++ V
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVP--------------FADLSN-MEIGMKVAL 225
Query: 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
E R P ++ L K C+ DP RP +V IL +
Sbjct: 226 E--GLRP--TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 5e-58
Identities = 69/296 (23%), Positives = 114/296 (38%), Gaps = 25/296 (8%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDM--LSRLHHCHVVPLV 288
VG+G V+RG G VAVK F ++ + + E ++ L H +++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFI 68
Query: 289 GYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 348
R L+ + G+L D L + ++ + + I + A GL +LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 349 A-----PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
P I HRD+KS NIL+ +N I DLG+A + + GT Y
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 404 APE------YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE--ESLVLWATPRL 455
APE + D+++FG+VL E+ +V
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 456 QDSGTVISELPDPRLKGDFPKEE-MQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
V + P + + + + +A L KEC +P AR T + + L+ I
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 2e-57
Identities = 87/296 (29%), Positives = 126/296 (42%), Gaps = 53/296 (17%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV---FLTEVDMLSRLHHCHVVPL 287
I+G GG VYR G VAVK + + E + + L H +++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 347
G C K LV EF G L L G + + D V A+ ARG+ YLH+
Sbjct: 72 RGVCL----KEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDE 124
Query: 348 AAPRILHRDIKSSNILLDE--------NLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
A I+HRD+KSSNIL+ + N KITD G+A R ++ G
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA-REWHR------TTKMSAAGA 177
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA--TPRLQD 457
+ + APE S SDV+S+GV+L EL+TG P + L
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP--------------FRGIDG-LAV 222
Query: 458 SGTVISE---LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
+ V LP P P+ ++M ++C DP +RP+ + ++ L+TI
Sbjct: 223 AYGVAMNKLALPIPS---TCPEPFAKLM----EDCWNPDPHSRPSFTNILDQLTTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 3e-57
Identities = 69/298 (23%), Positives = 123/298 (41%), Gaps = 53/298 (17%)
Query: 231 NIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV------FLTEVDMLSRLHHCH 283
+G+GG V++G+ + D +VA+K + F EV ++S L+H +
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 343
+V L G +V EF+P G+L L + W ++ + + A G+EY
Sbjct: 85 IVKLYGLMHN------PPRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEY 137
Query: 344 LHEAAAPRILHRDIKSSNILLDE-----NLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
+ P I+HRD++S NI L + AK+ D G++ + + G
Sbjct: 138 MQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-QQSVHSVSGLL-------G 188
Query: 399 TFGYFAPEYAMVGRASL---MSDVFSFGVVLLELITGRQPIHRSITKGE---ESLVLWAT 452
F + APE + +D +SF ++L ++TG P + G+ +++
Sbjct: 189 NFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGP-FDEYSYGKIKFINMIREEG 246
Query: 453 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
R +P+ D P + + + C DP RP S +V+ LS +
Sbjct: 247 LRP--------TIPE-----DCPPR----LRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 1e-56
Identities = 67/301 (22%), Positives = 126/301 (41%), Gaps = 33/301 (10%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDM--LSRLHHCHVVPLV 288
+G+G V+RG+ G VAVK F ++ + + E ++ L H +++ +
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFI 102
Query: 289 GYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 348
++ G LV ++ +G+L D L+ + + + +A+ A GL +LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 349 A-----PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
P I HRD+KS NIL+ +N I DLG+A R + + R GT Y
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR-VGTKRYM 218
Query: 404 APE------YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT-KGEESLVLWATPRLQ 456
APE + +D+++ G+V E+ + ++ + P ++
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 457 DSGTVIS------ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
+ V+ +P+ + + +IM +EC + AR T + + LS +
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIM----RECWYANGAARLTALRIKKTLSQL 334
Query: 511 A 511
+
Sbjct: 335 S 335
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 3e-56
Identities = 67/301 (22%), Positives = 126/301 (41%), Gaps = 33/301 (10%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDM--LSRLHHCHVVPLV 288
+G+G V+ G+ G VAVK F T ++ + E ++ + H +++ +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFI 97
Query: 289 GYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 348
+ G L+ ++ NG+L D L ++ + + +A + GL +LH
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 349 A-----PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
P I HRD+KS NIL+ +N I DLG+A + +D R+ GT Y
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-GTKRYM 213
Query: 404 APE------YAMVGRASLMSDVFSFGVVLLELITGRQPI-HRSITKGEESLVLWATPRLQ 456
PE ++ +M+D++SFG++L E+ + ++ + P +
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273
Query: 457 DSGTVIS------ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
D ++ P+ + ++ M L EC +P +R T V + L+ +
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQ----MGKLMTECWAHNPASRLTALRVKKTLAKM 329
Query: 511 A 511
+
Sbjct: 330 S 330
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 7e-56
Identities = 74/288 (25%), Positives = 118/288 (40%), Gaps = 41/288 (14%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G G VY+G+ VAVK P F EV +L + H +++ +GY
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 351
+ +V ++ +L L + IA ARG++YLH A
Sbjct: 90 TA-----PQLAIVTQWCEGSSLYHHLH-ASETKFEMKKLIDIARQTARGMDYLH---AKS 140
Query: 352 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE---YA 408
I+HRD+KS+NI L E+ KI D G+A + G+ + APE
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS---GSILWMAPEVIRMQ 197
Query: 409 MVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA--TPRLQDSGTVISE-- 464
S SDV++FG+VL EL+TG+ P ++ R Q V
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLP--------------YSNINNRDQIIEMVGRGSL 243
Query: 465 -LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511
+++ + PK ++M ECL+ D RP+ ++ + +A
Sbjct: 244 SPDLSKVRSNCPKRMKRLM----AECLKKKRDERPSFPRILAEIEELA 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 5e-55
Identities = 72/321 (22%), Positives = 116/321 (36%), Gaps = 48/321 (14%)
Query: 231 NIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
++G+G + G ++ +K + FL EV ++ L H +V+ +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRT-FLKEVKVMRCLEHPNVLKFIG 74
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHE 346
+ KR + E++ G LR + D W RV+ A A G+ YLH
Sbjct: 75 VLY--KDKRLN--FITEYIKGGTLRGIIKSMDSQY----PWSQRVSFAKDIASGMAYLHS 126
Query: 347 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ--------- 397
I+HRD+ S N L+ EN N + D G+A+ + + +
Sbjct: 127 M---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 398 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 457
G + APE DVFSFG+VL E+I PR D
Sbjct: 184 GNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD------------YLPRTMD 231
Query: 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI------- 510
G + D + P I C LDP+ RP+ ++ L T+
Sbjct: 232 FGLNVRGFLDRYCPPNCPPSFFPIT----VRCCDLDPEKRPSFVKLEHWLETLRMHLAGH 287
Query: 511 APDKSRRRNISLNLFQIFSAG 531
P + + ++ + G
Sbjct: 288 LPLGPQLEQLDRGFWETYRRG 308
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 5e-53
Identities = 64/309 (20%), Positives = 111/309 (35%), Gaps = 45/309 (14%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLV 288
++G+G VY G+ G VA++ + N D + F EV + H +VV +
Sbjct: 39 ELIGKGRFGQVYHGRW-HGE-VAIRLIDIER-DNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 289 GYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 347
G C L ++ L + + ++ + IA +G+ YLH
Sbjct: 96 GACM-----SPPHLAIITSLCKGRTLYSVVRDAKIV-LDVNKTRQIAQEIVKGMGYLH-- 147
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
A ILH+D+KS N+ D ITD G+ G + APE
Sbjct: 148 -AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 408 AMVGRASLM---------SDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT-PRLQD 457
SDVF+ G + EL P + T P
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP--------------FKTQPAEAI 251
Query: 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRR 517
+ + + + KE I+ C + + RPT ++++ +L + P ++RR
Sbjct: 252 IWQMGTGMKPNLSQIGMGKEISDIL----LFCWAFEQEERPTFTKLMDMLEKL-PKRNRR 306
Query: 518 RNISLNLFQ 526
+ + ++
Sbjct: 307 LSHPGHFWK 315
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-40
Identities = 77/293 (26%), Positives = 112/293 (38%), Gaps = 40/293 (13%)
Query: 234 GQG--GSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
G+G G V G +VAVK K GP S + E+D+L L+H H++
Sbjct: 40 GEGHFGK--VSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE 346
G C + LV E++P G+LRD L + + A G+ YLH
Sbjct: 98 YKGCCEDAGAASLQ--LVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHA 152
Query: 347 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-----MQGTFG 401
+HRD+ + N+LLD + KI D G+AK +
Sbjct: 153 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY----- 204
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGT 460
APE + SDV+SFGV L EL+T E + +
Sbjct: 205 --APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262
Query: 461 VISE---LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
++ LP P P E +M K C + + RPT ++ IL T+
Sbjct: 263 LLERGERLPRPD---KCPAEVYHLM----KNCWETEASFRPTFENLIPILKTV 308
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 82/311 (26%), Positives = 118/311 (37%), Gaps = 45/311 (14%)
Query: 234 GQG--GSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
G+G GS V + G +VAVK+ + GP+ F E+ +L LH +V
Sbjct: 32 GKGNFGS--VELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEY 343
G + LV E++P+G LRD L L + + + +G+EY
Sbjct: 89 YRGVSYGPGRQSLR--LVMEYLPSGCLRDFLQRHRARL----DASRLLLYSSQICKGMEY 142
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-----MQG 398
L R +HRD+ + NIL++ + KI D G+AK L D P +
Sbjct: 143 LGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY-- 197
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQD 457
APE S SDV+SFGVVL EL T + S P L
Sbjct: 198 -----APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252
Query: 458 SGTVISE---LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 514
++ E LP P P E ++M K C P RP+ S + L +
Sbjct: 253 LLELLEEGQRLPAPP---ACPAEVHELM----KLCWAPSPQDRPSFSALGPQLDMLWSGS 305
Query: 515 SRRRNISLNLF 525
+
Sbjct: 306 RGCETHAFTAH 316
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 5e-39
Identities = 64/287 (22%), Positives = 114/287 (39%), Gaps = 56/287 (19%)
Query: 232 IVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHHCHVVPLVG 289
+G+G VY+G VA + + ++ F E +ML L H ++V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGM--NWDTRVAIAIGAARGLEYLH 345
+ +LV E M +G L+ L V+ + +W ++ +GL++LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI------LKGLQFLH 146
Query: 346 EAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 404
P I+HRD+K NI + + KI DLG+A +A + + GT + A
Sbjct: 147 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA-------VIGTPEFMA 198
Query: 405 PEYAMVGRASLMSDVFSFGVVLLELITGRQP---------IHRSITKGEESLVLWATPRL 455
PE DV++FG+ +LE+ T P I+R +T G +
Sbjct: 199 PEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA-------- 249
Query: 456 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 502
++ P +K + + C++ + D R ++ +
Sbjct: 250 -----SFDKVAIPEVK-EI----------IEG-CIRQNKDERYSIKD 279
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 5e-39
Identities = 70/299 (23%), Positives = 122/299 (40%), Gaps = 44/299 (14%)
Query: 231 NIVGQG--GSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
+G+G G V + G VAVK K + G N + E+++L L+H +
Sbjct: 27 RDLGEGHFGK--VELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARG 340
+V G C+E G L+ EF+P+G+L++ L + N ++ A+ +G
Sbjct: 85 IVKYKGICTEDGGNGIK--LIMEFLPSGSLKEYLPKNKNKI----NLKQQLKYAVQICKG 138
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR----- 395
++YL + +HRD+ + N+L++ KI D G+ K ++ D
Sbjct: 139 MDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFW 195
Query: 396 MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPR 454
APE M + + SDV+SFGV L EL+T +
Sbjct: 196 Y-------APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT 248
Query: 455 LQDSGTVISE---LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
+ + E LP P + P E Q+M ++C + P R + +++ +
Sbjct: 249 VTRLVNTLKEGKRLPCPP---NCPDEVYQLM----RKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-38
Identities = 73/287 (25%), Positives = 115/287 (40%), Gaps = 61/287 (21%)
Query: 241 VYRGQLTDGRI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299
V+ G+L VAVK + P+ + FL E +L + H ++V L+G C+ ++
Sbjct: 130 VFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT----QKQ 185
Query: 300 MRLLVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDI 357
+V E + G+ L +G + T + + AA G+EYL +HRD+
Sbjct: 186 PIYIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDL 239
Query: 358 KSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF-----APEYAMVGR 412
+ N L+ E KI+D GM++ A G APE GR
Sbjct: 240 AARNCLVTEKNVLKISDFGMSREEADG-------VYAASGGL-RQVPVKWTAPEALNYGR 291
Query: 413 ASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWATPRLQDSGTVIS 463
S SDV+SFG++L E + G P + KG RL
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG---------RL-------- 334
Query: 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
P+ P ++M ++C +P RP+ S + Q L +I
Sbjct: 335 PCPE-----LCPDAVFRLM----EQCWAYEPGQRPSFSTIYQELQSI 372
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 8e-38
Identities = 73/295 (24%), Positives = 115/295 (38%), Gaps = 40/295 (13%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G+GG SYV + L DG A+KR E DM +H +++ LV YC
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA--IAIGAARGLEYLHEAAA 349
RG + L+ F G L + ++ + +G + +G RGLE +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ------GTFGYF 403
HRD+K +NILL + + DLG + S +Q T Y
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH--VEGSRQALTLQDWAAQRCTISYR 210
Query: 404 APE------YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 457
APE + ++ +DV+S G VL ++ G P KG +S+ L
Sbjct: 211 APELFSVQSHCVIDER---TDVWSLGCVLYAMMFGEGPYDMVFQKG-DSVAL-------- 258
Query: 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512
V ++L P + L + +DP RP + ++ L + P
Sbjct: 259 --AVQNQLSIP-QSPRHSSA----LWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 73/300 (24%), Positives = 116/300 (38%), Gaps = 46/300 (15%)
Query: 231 NIVGQG--GSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
+G+G GS V + G +VAVK+ + F E+++L L H +
Sbjct: 47 QQLGKGNFGS--VEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDN 103
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARG 340
+V G C + L+ E++P G+LRD L + + + +G
Sbjct: 104 IVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERI----DHIKLLQYTSQICKG 157
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR----- 395
+EYL R +HRD+ + NIL++ KI D G+ K L D P
Sbjct: 158 MEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFW 214
Query: 396 MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL 455
APE + S+ SDV+SFGVVL EL T + + + ++
Sbjct: 215 Y-------APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 267
Query: 456 --QDSGTVISE---LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
++ LP P P E IM EC + + RP+ ++ + I
Sbjct: 268 IVFHLIELLKNNGRLPRPD---GCPDEIYMIM----TECWNNNVNQRPSFRDLALRVDQI 320
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-37
Identities = 73/301 (24%), Positives = 115/301 (38%), Gaps = 46/301 (15%)
Query: 234 GQGGSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLV 288
G GS V + G +VAVK+ + F E+++L L H ++V
Sbjct: 21 GNFGS--VEMCRYDPLQDNTGEVVAVKKLQ-HSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 289 GYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLH 345
G C + L+ E++P G+LRD L + + + +G+EYL
Sbjct: 78 GVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKERI----DHIKLLQYTSQICKGMEYLG 131
Query: 346 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-----MQGTF 400
R +HRD+ + NIL++ KI D G+ K L D P
Sbjct: 132 TK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY---- 184
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460
APE + S+ SDV+SFGVVL EL T + + + ++
Sbjct: 185 ---APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF-H 240
Query: 461 VISE------LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 514
+I LP P P E IM EC + + RP+ ++ + I +
Sbjct: 241 LIELLKNNGRLPRPD---GCPDEIYMIM----TECWNNNVNQRPSFRDLALRVDQIRDNM 293
Query: 515 S 515
+
Sbjct: 294 A 294
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-37
Identities = 77/313 (24%), Positives = 123/313 (39%), Gaps = 68/313 (21%)
Query: 231 NIVGQGGSSYVYRGQLTDGR-----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV 285
++G G VY+G VA+K + P A+ L E +++ + + HV
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 286 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLE 342
L+G C L+ + MP G L D + + + + A+G+
Sbjct: 81 RLLGICLT---STVQ--LITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQIAKGMN 131
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
YL + R++HRD+ + N+L+ + KITD G+AK L A+ G
Sbjct: 132 YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-------EKEYHAEG-GK 180
Query: 403 F-----APEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLV 448
A E + + SDV+S+GV + EL+T G +P I + KGE
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE---- 236
Query: 449 LWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508
R LP P + IM ++C +D D+RP E++ S
Sbjct: 237 -----R----------LPQPP---ICTIDVYMIM----RKCWMIDADSRPKFRELIIEFS 274
Query: 509 TIAPDKSRRRNIS 521
+A D R I
Sbjct: 275 KMARDPQRYLVIQ 287
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-36
Identities = 67/292 (22%), Positives = 112/292 (38%), Gaps = 55/292 (18%)
Query: 234 GQGGSSYVYRGQLT--DGRI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
G G V +G +I VA+K K + E ++ +L + ++V L+G
Sbjct: 19 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 78
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEA 347
C + M LV E G L L + + + G++YL E
Sbjct: 79 CQA---EALM--LVMEMAGGGPLHKFLVGKREEI----PVSNVAELLHQVSMGMKYLEEK 129
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
+HRD+ + N+LL AKI+D G++K L AD + S + ++APE
Sbjct: 130 ---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW--PLKWYAPEC 184
Query: 408 AMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWATPRLQDS 458
+ S SDV+S+GV + E ++ G++P + I +G+ R
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---------R---- 231
Query: 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
+ P + P E +M +C + RP V Q +
Sbjct: 232 ------MECPP---ECPPELYALM----SDCWIYKWEDRPDFLTVEQRMRAC 270
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-36
Identities = 80/312 (25%), Positives = 133/312 (42%), Gaps = 66/312 (21%)
Query: 232 IVGQGGSSYVYRGQLTDGRI-----VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
++G G VY+G L VA+K K FL E ++ + H +++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEY 343
L G S + K M ++ E+M NG L L DG + V + G A G++Y
Sbjct: 111 LEGVIS--KYKPMM--IITEYMENGALDKFLREKDGEF----SVLQLVGMLRGIAAGMKY 162
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS----PAR-MQG 398
L +HRD+ + NIL++ NL K++D G+++ L+ D + ++S P R
Sbjct: 163 LANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT-- 217
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVL 449
APE + + SDV+SFG+V+ E++T G +P + ++I G
Sbjct: 218 -----APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF----- 267
Query: 450 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 509
R LP P D P Q+M +C Q + RP +++V IL
Sbjct: 268 ----R----------LPTPM---DCPSAIYQLM----MQCWQQERARRPKFADIVSILDK 306
Query: 510 IAPDKSRRRNIS 521
+ + ++
Sbjct: 307 LIRAPDSLKTLA 318
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-36
Identities = 79/347 (22%), Positives = 131/347 (37%), Gaps = 74/347 (21%)
Query: 231 NIVGQGGSSYVYRGQLTDGR-----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV 285
++G G V++G V +K + + G + + + L H H+V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 286 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLE 342
L+G C LV +++P G+L D + G L + + A+G+
Sbjct: 79 RLLGLCPG---SSLQ--LVTQYLPLGSLLDHVRQHRGAL----GPQLLLNWGVQIAKGMY 129
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS---PAR-MQG 398
YL E ++HR++ + N+LL ++ D G+A L D S P + M
Sbjct: 130 YLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM-- 184
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVL 449
A E G+ + SDV+S+GV + EL+T G +P + + KGE
Sbjct: 185 -----ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE----- 234
Query: 450 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 509
R L P+ + +M +C +D + RPT E+ +
Sbjct: 235 ----R----------LAQPQ---ICTIDVYMVM----VKCWMIDENIRPTFKELANEFTR 273
Query: 510 IAPDKSRRRNISLNLFQIFSAGGMEKEPSIERPDNLFETLIESEELK 556
+A D R I S G+ P P L +E EL+
Sbjct: 274 MARDPPRYLVIKRE-----SGPGIAPGPE---PHGLTNKKLEEVELE 312
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-36
Identities = 53/286 (18%), Positives = 99/286 (34%), Gaps = 49/286 (17%)
Query: 233 VGQGGSSYVYRG--QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
+ GG ++Y + +GR V +K G A ++ + E L+ + H +V + +
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147
Query: 291 CSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
+V E++ +L+ L +A + L YLH
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKL----PVAEAIAYLLEILPALSYLHSI-- 201
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 409
+++ D+K NI+L E K+ DLG R+ + G + GT G+ APE
Sbjct: 202 -GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY---------LYGTPGFQAPEIVR 250
Query: 410 VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPR 469
++ +D+++ G L L +G + LP+
Sbjct: 251 -TGPTVATDIYTVGRTLAALTLDLPT---------------------RNGRYVDGLPEDD 288
Query: 470 LKGDFPKE-EMQIMAYLAKECLQLDPDARP-TMSEVVQILSTIAPD 513
+ + DP R T E+ L+ + +
Sbjct: 289 PVLKTYDSYGRLLRRAIDP-----DPRQRFTTAEEMSAQLTGVLRE 329
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 70/321 (21%), Positives = 127/321 (39%), Gaps = 65/321 (20%)
Query: 221 EHATDKFSGSN-----IVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
H DK G + ++G GG V++ + DG+ +KR K N + EV
Sbjct: 2 AHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN---NEKA--EREVK 56
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRL------------LVFEFMPNGNLRDCLD---- 318
L++L H ++V G F + EF G L ++
Sbjct: 57 ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 116
Query: 319 GVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378
L + + + + +G++Y+H ++++RD+K SNI L + KI D G+
Sbjct: 117 EKLDKVLALE----LFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLV 169
Query: 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 438
LK DG R +GT Y +PE D+++ G++L EL+
Sbjct: 170 TSLKNDGK------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF- 222
Query: 439 SITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP 498
++ ++L D + F K+E ++ ++ L P+ RP
Sbjct: 223 ------------------ETSKFFTDLRDGIISDIFDKKEKTLL----QKLLSKKPEDRP 260
Query: 499 TMSEVVQ--ILSTIAPDKSRR 517
SE+++ + +P+K+ R
Sbjct: 261 NTSEILRTLTVWKKSPEKNER 281
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 81/310 (26%), Positives = 131/310 (42%), Gaps = 67/310 (21%)
Query: 231 NIVGQGGSSYVYRGQLTDGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
I+G G S V G+L VA+K K FL+E ++ + H +++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEY 343
L G + RG+ AM +V E+M NG+L L DG V + G G+ Y
Sbjct: 115 LEGVVT--RGRLAM--IVTEYMENGSLDTFLRTHDGQF----TIMQLVGMLRGVGAGMRY 166
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-----MQG 398
L + +HRD+ + N+L+D NL K++D G+++ L+ D + +++ +
Sbjct: 167 LSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT-- 221
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVL 449
APE S SDV+SFGVV+ E++ G +P + S+ +G
Sbjct: 222 -----APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY----- 271
Query: 450 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 509
R LP P P Q+M +C D RP S++V +L
Sbjct: 272 ----R----------LPAPM---GCPHALHQLM----LDCWHKDRAQRPRFSQIVSVLDA 310
Query: 510 I--APDKSRR 517
+ +P+ R
Sbjct: 311 LIRSPESLRA 320
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-35
Identities = 74/302 (24%), Positives = 118/302 (39%), Gaps = 65/302 (21%)
Query: 231 NIVGQGGSSYVYRGQLTDGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
++G+G VY G L D AVK S FLTE ++ H +V+
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEY 343
L+G C G L+V +M +G+LR+ + + + A+G++Y
Sbjct: 91 LLGICLRSEGS---PLVVLPYMKHGDLRNFIRNETHNPTVK----DLIGFGLQVAKGMKY 143
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
L A+ + +HRD+ + N +LDE K+ D G+A+ + + G
Sbjct: 144 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY-------DKEYYSVHNKTGAK 193
Query: 404 ------APEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLV 448
A E + + SDV+SFGV+L EL+T G P I + +G
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR---- 249
Query: 449 LWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508
R L P P ++M +C + RP+ SE+V +S
Sbjct: 250 -----R----------LLQPE---YCPDPLYEVM----LKCWHPKAEMRPSFSELVSRIS 287
Query: 509 TI 510
I
Sbjct: 288 AI 289
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-35
Identities = 79/345 (22%), Positives = 136/345 (39%), Gaps = 66/345 (19%)
Query: 231 NIVGQGGSSYVYRGQLTDGR-----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV 285
++G G VY+G VA+K + P A+ L E +++ + + HV
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 286 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLE 342
L+G C + L+ + MP G L D + + + + A+G+
Sbjct: 81 RLLGICLT-----STVQLITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQIAKGMN 131
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS---PAR-MQG 398
YL + R++HRD+ + N+L+ + KITD G+AK L A+ + P + M
Sbjct: 132 YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM-- 186
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVL 449
A E + + SDV+S+GV + EL+T G +P I + KGE
Sbjct: 187 -----ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE----- 236
Query: 450 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 509
R LP P + IM +C +D D+RP E++ S
Sbjct: 237 ----R----------LPQPP---ICTIDVYMIM----VKCWMIDADSRPKFRELIIEFSK 275
Query: 510 IAPDKSRRRNISLNLFQIFSAGGMEKEPSIERPDNLFETLIESEE 554
+A D R I + + + + +++++E
Sbjct: 276 MARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADE 320
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-35
Identities = 67/285 (23%), Positives = 107/285 (37%), Gaps = 41/285 (14%)
Query: 224 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 282
+ VG+G V+R + G AVK+ + + E+ + L
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE------ELVACAGLSSP 110
Query: 283 HVVPLVGYCSEFRGKRAMRLLVF-EFMPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAA- 338
+VPL G + G + +F E + G+L + G L E R +G A
Sbjct: 111 RIVPLYG--AVREGPW---VNIFMELLEGGSLGQLIKQMGCLPE-----DRALYYLGQAL 160
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
GLEYLH RILH D+K+ N+LL + A + D G A L+ DGL + +
Sbjct: 161 EGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 398 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 457
GT + APE M D++S ++L ++ G P + +
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY----FRGPLCLKIAS--- 270
Query: 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 502
P + Q + +E L+ +P R + E
Sbjct: 271 -----EPPPIREIPPSCAPLTAQAI----QEGLRKEPVHRASAME 306
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 8e-35
Identities = 75/313 (23%), Positives = 122/313 (38%), Gaps = 61/313 (19%)
Query: 231 NIVGQGGSSYVYRGQLTDGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
++G+G VY G L D AVK S FLTE ++ H +V+
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR--VAIAIGAARGLEYL 344
L+G C G L+V +M +G+LR+ + E N + + + A+G+++L
Sbjct: 155 LLGICLRSEGS---PLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFL 208
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF- 403
A+ + +HRD+ + N +LDE K+ D G+A+ + T
Sbjct: 209 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY-----DKEFDSVH-NKTGAKLP 259
Query: 404 ----APEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLW 450
A E + + SDV+SFGV+L EL+T G P I + +G
Sbjct: 260 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR------ 313
Query: 451 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
L P P ++M +C + RP+ SE+V +S I
Sbjct: 314 -------------RLLQPE---YCPDPLYEVM----LKCWHPKAEMRPSFSELVSRISAI 353
Query: 511 APDKSRRRNISLN 523
+ +N
Sbjct: 354 FSTFIGEHYVHVN 366
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 70/311 (22%), Positives = 113/311 (36%), Gaps = 69/311 (22%)
Query: 231 NIVGQGGSSYVYRGQLTDGR----IVAVKRFKTQGGPNADSV-FLTEVDMLSRLHHCHVV 285
I+G+G V G L VAVK K + FL+E + H +V+
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 286 PLVGYCSEFRGKRAMRLLV-FEFMPNGNL----RDCLDGVLVEGMNWDTRVAIAIGAARG 340
L+G C E + + +V FM G+L + + T + + A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RLKADGLPSCSSS 392
+EYL + LHRD+ + N +L +++ + D G++K R
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK-----M 211
Query: 393 PAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITK 442
P + + A E + SDV++FGV + E+ T G P ++ +
Sbjct: 212 PVKWI-------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264
Query: 443 GEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 502
G RL + P+ D E +IM C + DP RPT S
Sbjct: 265 GH---------RL--------KQPE-----DCLDELYEIM----YSCWRTDPLDRPTFSV 298
Query: 503 VVQILSTIAPD 513
+ L +
Sbjct: 299 LRLQLEKLLES 309
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 1e-34
Identities = 73/298 (24%), Positives = 116/298 (38%), Gaps = 64/298 (21%)
Query: 232 IVGQGGSSYVYRGQLTDGRI----VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
I+G+G VY G T+ + VAVK K + F++E ++ L H H+V L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYL 344
+G E ++ E P G L L L T V ++ + + YL
Sbjct: 79 IGIIEE-----EPTWIIMELYPYGELGHYLERNKNSL----KVLTLVLYSLQICKAMAYL 129
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PAR-MQGTFG 401
+HRDI NIL+ K+ D G+++ ++ + S + P + M
Sbjct: 130 ESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----- 181
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWAT 452
+PE R + SDV+ F V + E+++ G+QP + + KG+
Sbjct: 182 --SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD-------- 231
Query: 453 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
R LP P P +M C DP RP +E+V LS +
Sbjct: 232 -R----------LPKPD---LCPPVLYTLM----TRCWDYDPSDRPRFTELVCSLSDV 271
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 1e-34
Identities = 79/307 (25%), Positives = 132/307 (42%), Gaps = 53/307 (17%)
Query: 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
+ A E + +GQG V+ G VA+K K G + FL E
Sbjct: 174 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQ 231
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 334
++ +L H +V L SE + +V E+M G+L D L G + + V +A
Sbjct: 232 VMKKLRHEKLVQLYAVVSE---EPIY--IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMA 286
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS-- 392
A G+ Y+ +HRD++++NIL+ ENL K+ D G+A+ ++ + + +
Sbjct: 287 AQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 343
Query: 393 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKG 443
P + + APE A+ GR ++ SDV+SFG++L EL T GR P + + +G
Sbjct: 344 PIK------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 397
Query: 444 EESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV 503
R +P P + P+ +M +C + +P+ RPT +
Sbjct: 398 Y---------R----------MPCPP---ECPESLHDLM----CQCWRKEPEERPTFEYL 431
Query: 504 VQILSTI 510
L
Sbjct: 432 QAFLEDY 438
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 1e-34
Identities = 71/293 (24%), Positives = 119/293 (40%), Gaps = 53/293 (18%)
Query: 234 GQGGSSYVYRGQLTDGRI---VAVKRFKT-QGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
G G+ V +G ++ VAVK K P L E +++ +L + ++V ++G
Sbjct: 28 GNFGT--VKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 85
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
C + M LV E G L L + + + + G++YL E+
Sbjct: 86 ICE---AESWM--LVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES-- 136
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM 409
+HRD+ + N+LL AKI+D G++K L+AD + + + ++APE
Sbjct: 137 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW--PVKWYAPECIN 193
Query: 410 VGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWATPRLQDSGT 460
+ S SDV+SFGV++ E + G++P + + KGE R
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE---------R------ 238
Query: 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 513
+ P P+E +M C D + RP + V L D
Sbjct: 239 ----MGCPA---GCPREMYDLM----NLCWTYDVENRPGFAAVELRLRNYYYD 280
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 77/312 (24%), Positives = 132/312 (42%), Gaps = 65/312 (20%)
Query: 231 NIVGQGGSSYVYRGQLTDGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
+VG G V G+L VA+K K FL E ++ + H +++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEY 343
L G + + K M +V E+M NG+L L D V + G A G++Y
Sbjct: 111 LEGVVT--KSKPVM--IVTEYMENGSLDSFLRKHDAQF----TVIQLVGMLRGIASGMKY 162
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS----PAR-MQG 398
L + +HRD+ + NIL++ NL K++D G+ + L+ D + ++ P R
Sbjct: 163 LSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT-- 217
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVL 449
+PE + + SDV+S+G+VL E+++ G +P + +++ +G
Sbjct: 218 -----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY----- 267
Query: 450 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 509
R LP P D P Q+M +C Q D + RP ++V IL
Sbjct: 268 ----R----------LPPPM---DCPAALYQLM----LDCWQKDRNNRPKFEQIVSILDK 306
Query: 510 IAPDKSRRRNIS 521
+ + + I+
Sbjct: 307 LIRNPGSLKIIT 318
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 70/309 (22%), Positives = 117/309 (37%), Gaps = 70/309 (22%)
Query: 231 NIVGQGGSSYVYRGQLTDG----RIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHHCHVV 285
++G+G V QL VAVK K ++D FL E + H HV
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 286 PLVGYCSEFRGKRAMR--LLVFEFMPNGN----LRDCLDGVLVEGMNWDTRVAIAIGAAR 339
LVG R K + +++ FM +G+ L G + T V + A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RLKADGLPSCSS 391
G+EYL ++ +HRD+ + N +L E++ + D G+++ R
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASK----- 200
Query: 392 SPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSIT 441
P + + A E ++ SDV++FGV + E++T G+ P I+ +
Sbjct: 201 LPVKWL-------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI 253
Query: 442 KGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS 501
G RL + P + +E +M +C DP RP+ +
Sbjct: 254 GGN---------RL--------KQPP-----ECMEEVYDLM----YQCWSADPKQRPSFT 287
Query: 502 EVVQILSTI 510
+ L I
Sbjct: 288 CLRMELENI 296
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 72/300 (24%), Positives = 119/300 (39%), Gaps = 61/300 (20%)
Query: 231 NIVGQGGSSYVYRGQLTDGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP 286
++G+G VY G+ D A+K FL E ++ L+H +V+
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR--VAIAIGAARGLEYL 344
L+G G + ++ +M +G+L + N + ++ + ARG+EYL
Sbjct: 87 LIGIMLPPEG---LPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYL 140
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF- 403
A + +HRD+ + N +LDE+ K+ D G+A+ + + Q
Sbjct: 141 ---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR------EYYSVQQHRHARLP 191
Query: 404 ----APEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLW 450
A E R + SDV+SFGV+L EL+T G P + + +G
Sbjct: 192 VKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR------ 245
Query: 451 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
R LP P P Q+M ++C + DP RPT +V + I
Sbjct: 246 ---R----------LPQPE---YCPDSLYQVM----QQCWEADPAVRPTFRVLVGEVEQI 285
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 68/316 (21%), Positives = 119/316 (37%), Gaps = 61/316 (19%)
Query: 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVD 274
Y + E + +G G V G+ VA+K K G ++ F+ E
Sbjct: 14 LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAK 71
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRV 331
++ L H +V L G C+ K+ ++ E+M NG L + L +
Sbjct: 72 VMMNLSHEKLVQLYGVCT----KQRPIFIITEYMANGCLLNYLREMRHRF----QTQQLL 123
Query: 332 AIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS 391
+ +EYL + + LHRD+ + N L+++ K++D G+++ + D S
Sbjct: 124 EMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 180
Query: 392 S--PAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRS 439
S P R PE M + S SD+++FGV++ E+ + G+ P
Sbjct: 181 SKFPVRWS-------PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 233
Query: 440 ITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT 499
I +G R L P ++ IM C D RPT
Sbjct: 234 IAQGL---------R----------LYRPH---LASEKVYTIM----YSCWHEKADERPT 267
Query: 500 MSEVVQILSTIAPDKS 515
++ + + ++S
Sbjct: 268 FKILLSNILDVMDEES 283
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-34
Identities = 71/297 (23%), Positives = 123/297 (41%), Gaps = 53/297 (17%)
Query: 231 NIVGQGGSSYVYRGQLTDGRI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
+ +G G VY G + VAVK K FL E ++ + H ++V L+G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
C+ ++ EFM GNL D L + ++ + +A + +EYL +
Sbjct: 284 VCTR--EPPFY--IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-- 337
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF--APEY 407
+HR++ + N L+ EN K+ D G+++ + D + A F APE
Sbjct: 338 -NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD------TYTAHAGAKFPIKWTAPES 390
Query: 408 AMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWATPRLQDS 458
+ S+ SDV++FGV+L E+ T G P ++ + K R+
Sbjct: 391 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---------RM--- 438
Query: 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKS 515
P P++ ++M + C Q +P RP+ +E+ Q T+ + S
Sbjct: 439 -------ERPE---GCPEKVYELM----RACWQWNPSDRPSFAEIHQAFETMFQESS 481
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-34
Identities = 75/295 (25%), Positives = 124/295 (42%), Gaps = 61/295 (20%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
+G G V+ G + VA+K + G ++ F+ E +++ +L H +V L G
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEA 347
C ++A LV EFM +G L D L G+ +T + + + G+ YL
Sbjct: 72 CL----EQAPICLVTEFMEHGCLSDYLRTQRGLF----AAETLLGMCLDVCEGMAYL--- 120
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PAR-MQGTFGYFA 404
++HRD+ + N L+ EN K++D GM + + D S + + P + +
Sbjct: 121 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA-------S 173
Query: 405 PEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWATPRL 455
PE R S SDV+SFGV++ E+ + G+ P + I+ G R
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF---------R- 223
Query: 456 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
L PR QIM C + P+ RP S +++ L+ I
Sbjct: 224 ---------LYKPR---LASTHVYQIM----NHCWRERPEDRPAFSRLLRQLAEI 262
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 73/298 (24%), Positives = 129/298 (43%), Gaps = 55/298 (18%)
Query: 231 NIVGQGGSSYVYRGQLTDGRI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
+ +G G VY G + VAVK K + + FL E ++ + H ++V L+G
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 76
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
C+ R ++ EFM GNL D L + ++ + +A + +EYL
Sbjct: 77 VCT--REPPFY--IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL---EK 129
Query: 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PAR-MQGTFGYFAPE 406
+HRD+ + N L+ EN K+ D G+++ + D + + + P + APE
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT-------APE 182
Query: 407 YAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWATPRLQD 457
+ S+ SDV++FGV+L E+ T G P ++ + K R+
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---------RM-- 231
Query: 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKS 515
E P+ P++ ++M + C Q +P RP+ +E+ Q T+ + S
Sbjct: 232 ------ERPE-----GCPEKVYELM----RACWQWNPSDRPSFAEIHQAFETMFQESS 274
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-34
Identities = 66/292 (22%), Positives = 112/292 (38%), Gaps = 55/292 (18%)
Query: 234 GQGGSSYVYRGQLT--DGRI-VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
G G V +G +I VA+K K + E ++ +L + ++V L+G
Sbjct: 345 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 404
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEA 347
C + M LV E G L L + + + G++YL E
Sbjct: 405 CQA---EALM--LVMEMAGGGPLHKFLVGKREEI----PVSNVAELLHQVSMGMKYLEEK 455
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
+HR++ + N+LL AKI+D G++K L AD + S + ++APE
Sbjct: 456 ---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW--PLKWYAPEC 510
Query: 408 AMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWATPRLQDS 458
+ S SDV+S+GV + E ++ G++P + I +G+ R
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---------R---- 557
Query: 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
+ P + P E +M +C + RP V Q +
Sbjct: 558 ------MECPP---ECPPELYALM----SDCWIYKWEDRPDFLTVEQRMRAC 596
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-34
Identities = 73/301 (24%), Positives = 113/301 (37%), Gaps = 64/301 (21%)
Query: 232 IVGQGGSSYVYRGQLTDGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
+G+G V++G VA+K K + FL E + + H H+V L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYL 344
+G +E ++ E G LR L L + + A + L YL
Sbjct: 82 IGVITE---NPVW--IIMELCTLGELRSFLQVRKYSLDLA----SLILYAYQLSTALAYL 132
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PAR-MQGTFG 401
R +HRDI + N+L+ N K+ D G+++ ++ S P + M
Sbjct: 133 ESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----- 184
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWAT 452
APE R + SDV+ FGV + E++ G +P + I GE
Sbjct: 185 --APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-------- 234
Query: 453 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512
R LP P + P +M +C DP RP +E+ LSTI
Sbjct: 235 -R----------LPMPP---NCPPTLYSLM----TKCWAYDPSRRPRFTELKAQLSTILE 276
Query: 513 D 513
+
Sbjct: 277 E 277
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-34
Identities = 66/294 (22%), Positives = 113/294 (38%), Gaps = 61/294 (20%)
Query: 232 IVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G G V G+ VAVK K G ++ F E + +L H +V G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKE--GSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 348
S K +V E++ NG L + L L + + G+ +L
Sbjct: 73 S----KEYPIYIVTEYISNGCLLNYLRSHGKGL----EPSQLLEMCYDVCEGMAFL---E 121
Query: 349 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PAR-MQGTFGYFAP 405
+ + +HRD+ + N L+D +L K++D GM + + D S + P + AP
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS-------AP 174
Query: 406 EYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWATPRLQ 456
E + S SDV++FG+++ E+ + G+ P + +++G R
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH---------R-- 223
Query: 457 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
L P QIM C P+ RPT +++ + +
Sbjct: 224 --------LYRPH---LASDTIYQIM----YSCWHELPEKRPTFQQLLSSIEPL 262
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 5e-34
Identities = 69/297 (23%), Positives = 124/297 (41%), Gaps = 53/297 (17%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 284
+ +G G V+ VAVK K G + FL E +++ L H +
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP--GSMSVEAFLAEANVMKTLQHDKL 245
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 344
V L ++ + ++ EFM G+L D L + + A G+ ++
Sbjct: 246 VKLHAVVTK---EPIY--IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 300
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PARMQGTFGY 402
+ +HRD++++NIL+ +L KI D G+A+ ++ + + + P + +
Sbjct: 301 EQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK------W 351
Query: 403 FAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWATP 453
APE G ++ SDV+SFG++L+E++T GR P + R++ +G
Sbjct: 352 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY--------- 402
Query: 454 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
R +P P + P+E IM C + P+ RPT + +L
Sbjct: 403 R----------MPRPE---NCPEELYNIM----MRCWKNRPEERPTFEYIQSVLDDF 442
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 8e-34
Identities = 79/308 (25%), Positives = 132/308 (42%), Gaps = 53/308 (17%)
Query: 214 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEV 273
+ A E + +GQG V+ G VA+K K G + FL E
Sbjct: 256 GLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK--PGTMSPEAFLQEA 313
Query: 274 DMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAI 333
++ +L H +V L SE + +V E+M G+L D L G + + V +
Sbjct: 314 QVMKKLRHEKLVQLYAVVSE---EPIY--IVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 368
Query: 334 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS- 392
A A G+ Y+ +HRD++++NIL+ ENL K+ D G+A+ ++ + + +
Sbjct: 369 AAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 425
Query: 393 -PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITK 442
P + + APE A+ GR ++ SDV+SFG++L EL T GR P + + +
Sbjct: 426 FPIK------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479
Query: 443 GEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 502
G R +P P + P+ +M +C + +P+ RPT
Sbjct: 480 GY---------R----------MPCPP---ECPESLHDLM----CQCWRKEPEERPTFEY 513
Query: 503 VVQILSTI 510
+ L
Sbjct: 514 LQAFLEDY 521
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 78/304 (25%), Positives = 113/304 (37%), Gaps = 59/304 (19%)
Query: 232 IVGQGGSSYVYRGQLTDGRI----VAVKRFK--TQGGPNADSVFLTEVDMLSRLHHCHVV 285
+G G V RG+ VAVK K P A F+ EV+ + L H +++
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 286 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLE 342
L G +V E P G+L D L G T A+ A G+
Sbjct: 85 RLYGVVLT---PPMK--MVTELAPLGSLLDRLRKHQGHF----LLGTLSRYAVQVAEGMG 135
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
YL R +HRD+ + N+LL KI D G+ + L + ++ F +
Sbjct: 136 YLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV--PFAW 190
Query: 403 FAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP---------IHRSITKGEESLVLWAT 452
APE S SD + FGV L E+ T G++P +H+ +GE
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE-------- 242
Query: 453 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512
RL P P D P++ +M +C P+ RPT + L P
Sbjct: 243 -RL----------PRPE---DCPQDIYNVM----VQCWAHKPEDRPTFVALRDFLLEAQP 284
Query: 513 DKSR 516
R
Sbjct: 285 TDMR 288
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-33
Identities = 71/282 (25%), Positives = 114/282 (40%), Gaps = 59/282 (20%)
Query: 241 VYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300
V G G VAVK K A FL E ++++L H ++V L+G E +G
Sbjct: 209 VMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIVEEKGGL-- 262
Query: 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 360
+V E+M G+L D L + D + ++ +EYL +HRD+ +
Sbjct: 263 -YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAAR 318
Query: 361 NILLDENLNAKITDLGMAKRLKADGLPSCSSS--PAR-MQGTFGYFAPEYAMVGRASLMS 417
N+L+ E+ AK++D G+ K + + + P + APE + S S
Sbjct: 319 NVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWT-------APEALREKKFSTKS 367
Query: 418 DVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWATPRLQDSGTVISELPDP 468
DV+SFG++L E+ + GR P + + KG + + P
Sbjct: 368 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---------K----------MDAP 408
Query: 469 RLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
P +M K C LD RPT ++ + L I
Sbjct: 409 D---GCPPAVYDVM----KNCWHLDAATRPTFLQLREQLEHI 443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 78/316 (24%), Positives = 122/316 (38%), Gaps = 65/316 (20%)
Query: 231 NIVGQG--GSSYVYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 282
+GQG G VY G VA+K FL E ++ +
Sbjct: 31 RELGQGSFGM--VYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------DGVLVEGMNWDTRVAIA 334
HVV L+G S + L++ E M G+L+ L + ++ + + +A
Sbjct: 89 HVVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RLKADGL 386
A G+ YL A + +HRD+ + N ++ E+ KI D GM + R GL
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 201
Query: 387 PSCSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGE 444
P R M +PE G + SDV+SFGVVL E+ T QP ++ +
Sbjct: 202 -----LPVRWM-------SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ-GLSNEQ 248
Query: 445 ESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVV 504
VL R G + L P + P ++M + C Q +P RP+ E++
Sbjct: 249 ---VL----RFVMEGGL---LDKPD---NCPDMLFELM----RMCWQYNPKMRPSFLEII 291
Query: 505 QILSTIAPDKSRRRNI 520
+ R +
Sbjct: 292 SSIKEEMEPGFREVSF 307
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 67/301 (22%), Positives = 121/301 (40%), Gaps = 42/301 (13%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHH 281
F +G+G S VYR L DG VA+K+ + +A + + E+D+L +L+H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 282 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL------DGVLVEGMNWDTRVAIAI 335
+V+ Y + F + +V E G+L + ++ E W +
Sbjct: 92 PNVI---KYYASFIEDNEL-NIVLELADAGDLSRMIKHFKKQKRLIPERTVWK----YFV 143
Query: 336 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 395
LE++H R++HRDIK +N+ + K+ DLG+ + S ++ A
Sbjct: 144 QLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF------SSKTTAAH 194
Query: 396 -MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 454
+ GT Y +PE + SD++S G +L E+ + P + SL
Sbjct: 195 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLYSLCK----- 248
Query: 455 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 514
+ P + +E + L C+ DP+ RP ++ V + +
Sbjct: 249 -----KIEQCDYPPLPSDHYSEE----LRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299
Query: 515 S 515
+
Sbjct: 300 A 300
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 66/287 (22%), Positives = 118/287 (41%), Gaps = 34/287 (11%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLVG 289
+G GG S V+ + L D R VAVK + + F E + L+H +V +
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG--MNWDTRVAIAIGAARGLEYLHEA 347
+ +V E++ LRD ++ M + + A + L + H+
Sbjct: 80 TGEAETPAGPLPYIVMEYVDGVTLRD----IVHTEGPMTPKRAIEVIADACQALNFSHQN 135
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
I+HRD+K +NI++ K+ D G+A+ + G ++ + GT Y +PE
Sbjct: 136 ---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA--VIGTAQYLSPEQ 190
Query: 408 AMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPD 467
A SDV+S G VL E++TG P G+ + + A +++ +
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPPF-----TGDSPVSV-AYQHVRE------DPIP 238
Query: 468 PR-LKGDFPKE-EMQIMAYLAKECLQLDPDARP-TMSEVVQILSTIA 511
P + + ++ LAK +P+ R T +E+ L +
Sbjct: 239 PSARHEGLSADLDAVVLKALAK-----NPENRYQTAAEMRADLVRVH 280
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 8e-33
Identities = 73/292 (25%), Positives = 121/292 (41%), Gaps = 59/292 (20%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
+G+G V G G VAVK K A FL E ++++L H ++V L+G
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGV 82
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAP 350
E +G +V E+M G+L D L + D + ++ +EYL
Sbjct: 83 IVEEKGGL---YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL---EGN 136
Query: 351 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PAR-MQGTFGYFAPEY 407
+HRD+ + N+L+ E+ AK++D G+ K + + + P + APE
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWT-------APEA 185
Query: 408 AMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWATPRLQDS 458
+ S SDV+SFG++L E+ + GR P + + KG ++
Sbjct: 186 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---------KM--- 233
Query: 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
+ PD P ++M K C LD RP+ ++ + L I
Sbjct: 234 -----DAPD-----GCPPAVYEVM----KNCWHLDAAMRPSFLQLREQLEHI 271
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 63/290 (21%), Positives = 107/290 (36%), Gaps = 40/290 (13%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG-- 289
+G+GG V+ + D A+KR + A + EV L++L H +V
Sbjct: 13 LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 290 -----YCSEFRGKRAMRL-LVFEFMPNGNLRDCLDG-VLVEGMNWDTRVAIAIGAARGLE 342
+ L + + NL+D ++G +E + I + A +E
Sbjct: 73 LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ----- 397
+LH ++HRD+K SNI + K+ D G+ + D +P
Sbjct: 133 FLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 398 --GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL 455
GT Y +PE S D+FS G++L EL ++ T+ E L
Sbjct: 190 QVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL------LYPFSTQMERVRTL------ 237
Query: 456 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
T + L P L E ++ ++ L P RP +++
Sbjct: 238 ----TDVRNLKFPPLFTQKYPCEYVMV----QDMLSPSPMERPEAINIIE 279
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 70/292 (23%), Positives = 129/292 (44%), Gaps = 55/292 (18%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
+G G V+ G VAVK K G + FL E +++ +L H +V L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLK--QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAP 350
+ + + ++ E+M NG+L D L + + + +A A G+ ++
Sbjct: 77 VT----QEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---EER 128
Query: 351 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PAR-MQGTFGYFAPEY 407
+HRD++++NIL+ + L+ KI D G+A+ ++ + + + P + APE
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT-------APEA 181
Query: 408 AMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWATPRLQDS 458
G ++ SDV+SFG++L E++T GR P + +++ +G R+
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY---------RM--- 229
Query: 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
PD + P+E Q+M + C + P+ RPT + +L
Sbjct: 230 -----VRPD-----NCPEELYQLM----RLCWKERPEDRPTFDYLRSVLEDF 267
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 78/286 (27%), Positives = 125/286 (43%), Gaps = 39/286 (13%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLVG 289
+G GG S VY + VA+K +++ F EV S+L H ++V ++
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAIAIGAARGLEYLHEAA 348
E LV E++ L + ++ G ++ DT + G+++ H+
Sbjct: 79 VDEE----DDCYYLVMEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDM- 130
Query: 349 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYA 408
RI+HRDIK NIL+D N KI D G+AK L L + + GT YF+PE A
Sbjct: 131 --RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL----TQTNHVLGTVQYFSPEQA 184
Query: 409 MVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDP 468
+D++S G+VL E++ G P G E+ V A +QD +P+
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPPF-----NG-ETAVSIAIKHIQD------SVPNV 232
Query: 469 --RLKGDFPKE-EMQIMAYLAKECLQLDPDARP-TMSEVVQILSTI 510
++ D P+ I+ K D R T+ E+ LS++
Sbjct: 233 TTDVRKDIPQSLSNVILRATEK-----DKANRYKTIQEMKDDLSSV 273
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 5e-32
Identities = 62/288 (21%), Positives = 109/288 (37%), Gaps = 33/288 (11%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFL-TEVDMLSRLHHC 282
+ + +G G + + +DG+I+ K A+ L +EV++L L H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 283 HVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA--AR 339
++V Y + L +V E+ G+L + E D + +
Sbjct: 66 NIV---RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 340 GLEYLHE--AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
L+ H +LHRD+K +N+ LD N K+ D G+A+ L D + +
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-----FV 177
Query: 398 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 457
GT Y +PE + SD++S G +L EL P ++ L
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT---AFSQKELAG-------- 226
Query: 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
I E R+ + E + + L L RP++ E+++
Sbjct: 227 ---KIREGKFRRIPYRYSDE----LNEIITRMLNLKDYHRPSVEEILE 267
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-32
Identities = 69/295 (23%), Positives = 107/295 (36%), Gaps = 43/295 (14%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPL-- 287
VG+GG VY + RIVA+K + E RL HVVP+
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD 101
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAIAIGAARGLEYLHE 346
G E G + + +L L +G + VAI L+ H
Sbjct: 102 FG---EIDG---QLYVDMRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHA 152
Query: 347 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 406
A HRD+K NIL+ + A + D G+A + L + GT Y APE
Sbjct: 153 A---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL----TQLGNTVGTLYYMAPE 205
Query: 407 YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 466
A+ +D+++ VL E +TG P G++ V+ A + +P
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPPYQ-----GDQLSVMGA--HINQ------AIP 252
Query: 467 DPR-LKGDFPKE-EMQIMAYLAKECLQLDPDAR-PTMSEVVQILSTIAPDKSRRR 518
P ++ P + I +AK +P+ R T ++ + R
Sbjct: 253 RPSTVRPGIPVAFDAVIARGMAK-----NPEDRYVTCGDLSAAAHAALATADQDR 302
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 9e-32
Identities = 81/301 (26%), Positives = 123/301 (40%), Gaps = 68/301 (22%)
Query: 241 VYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 294
V+ + + +VAVK K A F E ++L+ L H H+V G C
Sbjct: 31 VFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-- 87
Query: 295 RGKRAMRLLVFEFMPNGNLRDCL-----DGVLVEGMNWDTR---------VAIAIGAARG 340
++VFE+M +G+L L D +++ + IA A G
Sbjct: 88 --DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASG 145
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RLKADGLPSCSSS 392
+ YL A+ +HRD+ + N L+ NL KI D GM++ R+ +
Sbjct: 146 MVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM-----L 197
Query: 393 PAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLW 450
P R M PE M + + SDV+SFGV+L E+ T G+QP ++ E V+
Sbjct: 198 PIRWM-------PPESIMYRKFTTESDVWSFGVILWEIFTYGKQP-WFQLSNTE---VI- 245
Query: 451 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
G V L PR PKE +M C Q +P R + E+ +IL +
Sbjct: 246 ---ECITQGRV---LERPR---VCPKEVYDVM----LGCWQREPQQRLNIKEIYKILHAL 292
Query: 511 A 511
Sbjct: 293 G 293
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 74/307 (24%), Positives = 118/307 (38%), Gaps = 61/307 (19%)
Query: 231 NIVGQGGSSYVYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 284
+G G VY GQ++ VAVK + FL E ++S+ +H ++
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-----DGVLVEGMNWDTRVAIAIGAAR 339
V +G + R ++ E M G+L+ L + + +A A
Sbjct: 96 VRCIGVSL----QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLD---ENLNAKITDLGMAK--------RLKADGLPS 388
G +YL +HRDI + N LL AKI D GMA+ R +
Sbjct: 152 GCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM-- 206
Query: 389 CSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEES 446
P + M PE M G + +D +SFGV+L E+ + G P + S + E
Sbjct: 207 ---LPVKWM-------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQE-- 253
Query: 447 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506
VL SG + P+ + P +IM +C Q P+ RP + +++
Sbjct: 254 -VL----EFVTSGGR---MDPPK---NCPGPVYRIM----TQCWQHQPEDRPNFAIILER 298
Query: 507 LSTIAPD 513
+ D
Sbjct: 299 IEYCTQD 305
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 72/295 (24%), Positives = 124/295 (42%), Gaps = 59/295 (20%)
Query: 241 VYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 294
VY+G L VA+K K + F E + +RL H +VV L+G +
Sbjct: 25 VYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT-- 82
Query: 295 RGKRAMRLLVFEFMPNGNLRDCL--------DGVLVEGMNWDTR------VAIAIGAARG 340
K ++F + +G+L + L G + + V + A G
Sbjct: 83 --KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAG 140
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
+EYL ++ ++H+D+ + N+L+ + LN KI+DLG+ + + ++ ++ G
Sbjct: 141 MEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY-------AADYYKLLGN- 189
Query: 401 GYF-----APEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPR 454
APE M G+ S+ SD++S+GVVL E+ + G QP + + + V+
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP-YCGYSNQD---VV----E 241
Query: 455 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 509
+ + V LP P D P +M EC P RP ++ L
Sbjct: 242 MIRNRQV---LPCPD---DCPAWVYALM----IECWNEFPSRRPRFKDIHSRLRA 286
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 83/311 (26%), Positives = 128/311 (41%), Gaps = 67/311 (21%)
Query: 234 GQGGSSYVYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
G+G V+ + + +VAVK K + +A F E ++L+ L H H+V
Sbjct: 50 GEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQREAELLTMLQHQHIVRF 108
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-----DGVLVEGMNWDTR--------VAIA 334
G C+ + L+VFE+M +G+L L D L+ G +A+A
Sbjct: 109 FGVCT----EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RLKADGL 386
A G+ YL A +HRD+ + N L+ + L KI D GM++ R+ +
Sbjct: 165 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221
Query: 387 PSCSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGE 444
P R M PE + + + SDV+SFGVVL E+ T G+QP ++ E
Sbjct: 222 -----LPIRWM-------PPESILYRKFTTESDVWSFGVVLWEIFTYGKQP-WYQLSNTE 268
Query: 445 ESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVV 504
+ G L PR P E IM + C Q +P R ++ +V
Sbjct: 269 ---AI----DCITQGRE---LERPR---ACPPEVYAIM----RGCWQREPQQRHSIKDVH 311
Query: 505 QILSTIAPDKS 515
L +A
Sbjct: 312 ARLQALAQAPP 322
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 77/311 (24%), Positives = 129/311 (41%), Gaps = 60/311 (19%)
Query: 234 GQG--GSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHV 284
G+G G V R VAVK K + ++E+ +L + HH +V
Sbjct: 36 GRGAFGQ--VIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------------DGVLVEGMNWDTR 330
V L+G C++ G +++ EF GNL L + + + + +
Sbjct: 94 VNLLGACTKPGGPL---MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 331 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG---LP 387
+ + A+G+E+L A+ + +HRD+ + NILL E KI D G+A+ + D
Sbjct: 151 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 388 SCSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEE 445
+ P + M APE ++ SDV+SFGV+L E+ + G P + + EE
Sbjct: 208 GDARLPLKWM-------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEE 259
Query: 446 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
L++ + P E Q M +C +P RPT SE+V+
Sbjct: 260 FCRR-----LKEGTR----MRAPD---YTTPEMYQTM----LDCWHGEPSQRPTFSELVE 303
Query: 506 ILSTIAPDKSR 516
L + ++
Sbjct: 304 HLGNLLQANAQ 314
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 3e-31
Identities = 72/304 (23%), Positives = 115/304 (37%), Gaps = 62/304 (20%)
Query: 232 IVGQGGSSYVYRGQLTDGR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL 287
+G+G V++G VA+K K + FL E + + H H+V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLEYL 344
+G +E ++ E G LR L L + + A + L YL
Sbjct: 457 IGVITE---NPVW--IIMELCTLGELRSFLQVRKFSLDLA----SLILYAYQLSTALAYL 507
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS--PARMQGTFGY 402
R +HRDI + N+L+ N K+ D G+++ ++ S P + +
Sbjct: 508 ESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK------W 558
Query: 403 FAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKGEESLVLWATP 453
APE R + SDV+ FGV + E++ G +P + I GE
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE--------- 609
Query: 454 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 513
R LP P + P +M +C DP RP +E+ LSTI +
Sbjct: 610 R----------LPMPP---NCPPTLYSLM----TKCWAYDPSRRPRFTELKAQLSTILEE 652
Query: 514 KSRR 517
+ +
Sbjct: 653 EKLQ 656
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 66/352 (18%), Positives = 128/352 (36%), Gaps = 47/352 (13%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVF-LTEVDMLSRLHHC 282
+K+ +G+G + DGR +K + + EV +L+ + H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL----DGVLVEGMNWDTRVAIAIGAA 338
++V Y F ++ +V ++ G+L + + E D +
Sbjct: 84 NIV---QYRESFEENGSL-YIVMDYCEGGDLFKRINAQKGVLFQEDQILD----WFVQIC 135
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
L+++H+ +ILHRDIKS NI L ++ ++ D G+A+ L + + + G
Sbjct: 136 LALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA-----CIG 187
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 458
T Y +PE + SD+++ G VL EL T + ++LVL
Sbjct: 188 TPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE---AGSMKNLVL--------- 235
Query: 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE------VVQILSTIAP 512
I P + + + + L + + +P RP+++ + + +
Sbjct: 236 --KIISGSFPPVSLHYSYD----LRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLS 289
Query: 513 DKSRRRNISLNLFQIFSAGGMEKEPSIERPDNLFETLIESEELKKATSFGSP 564
+ L F F + N + + K A +G P
Sbjct: 290 PQLIAEEFCLKTFSKFGS-QPIPAKRPASGQNSISVMPAQKITKPAAKYGIP 340
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 9e-31
Identities = 77/341 (22%), Positives = 142/341 (41%), Gaps = 80/341 (23%)
Query: 231 NIVGQGGSSYVYRGQLTDG---RIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVP 286
+++G+G V + ++ A+KR K + F E+++L +L HH +++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL------DGVLVEGMNWDTR--------VA 332
L+G C R L E+ P+GNL D L + + T +
Sbjct: 91 LLGACE----HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 333 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK-----RLKADGLP 387
A ARG++YL + + +HRD+ + NIL+ EN AKI D G+++ K G
Sbjct: 147 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR- 202
Query: 388 SCSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IH 437
P R M A E + SDV+S+GV+L E+++ G P ++
Sbjct: 203 ----LPVRWM-------AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 251
Query: 438 RSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDAR 497
+ +G R L P + E +M ++C + P R
Sbjct: 252 EKLPQGY---------R----------LEKPL---NCDDEVYDLM----RQCWREKPYER 285
Query: 498 PTMSEVVQILSTIAPDKSRRRNISLNLFQIFSAGGMEKEPS 538
P+ ++++ L+ + + R+ ++ L++ F+ G++
Sbjct: 286 PSFAQILVSLNRML--EERKTYVNTTLYEKFTYAGIDCSAE 324
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 70/308 (22%), Positives = 120/308 (38%), Gaps = 65/308 (21%)
Query: 241 VYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 293
V VAVK K+ + ++E+ ++S L H ++V L+G C+
Sbjct: 62 VVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT- 120
Query: 294 FRGKRAMRLLVFEFMPNGNLRDCL----------DGVLVEGMNWDTR--VAIAIGAARGL 341
L++ E+ G+L + L + TR + + A+G+
Sbjct: 121 ---HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGM 177
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RLKADGLPSCSSSP 393
+L A+ +HRD+ + N+LL AKI D G+A+ +K + P
Sbjct: 178 AFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR-----LP 229
Query: 394 AR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWA 451
+ M APE ++ SDV+S+G++L E+ + G P + I +
Sbjct: 230 VKWM-------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNP-YPGILVNSKFY---- 277
Query: 452 TPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511
+L G + P PK IM + C L+P RPT ++ L A
Sbjct: 278 --KLVKDGYQ---MAQPA---FAPKNIYSIM----QACWALEPTHRPTFQQICSFLQEQA 325
Query: 512 PDKSRRRN 519
+ R R+
Sbjct: 326 QEDRRERD 333
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 74/307 (24%), Positives = 119/307 (38%), Gaps = 61/307 (19%)
Query: 231 NIVGQGGSSYVYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 284
+G G VY GQ++ VAVK + FL E ++S+ +H ++
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTR--VAIAIGAAR 339
V +G + R ++ E M G+L+ L + + + +A A
Sbjct: 137 VRCIGVSL----QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 192
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLD---ENLNAKITDLGMAK--------RLKADGLPS 388
G +YL +HRDI + N LL AKI D GMA+ R +
Sbjct: 193 GCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM-- 247
Query: 389 CSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEES 446
P + M PE M G + +D +SFGV+L E+ + G P + S + E
Sbjct: 248 ---LPVKWM-------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP-YPSKSNQE-- 294
Query: 447 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506
VL SG + P+ + P +IM +C Q P+ RP + +++
Sbjct: 295 -VL----EFVTSGGR---MDPPK---NCPGPVYRIM----TQCWQHQPEDRPNFAIILER 339
Query: 507 LSTIAPD 513
+ D
Sbjct: 340 IEYCTQD 346
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 63/288 (21%), Positives = 97/288 (33%), Gaps = 47/288 (16%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRL-HH 281
F + +G G V++ + DGR+ AVKR + D L EV ++ H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 282 CHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLD---GVLVEGMNWDTRVAIAIGA 337
V L + G L L E +L+ + L E W
Sbjct: 117 PCCVRL--EQAWEEGGI---LYLQTELC-GPSLQQHCEAWGASLPEAQVWG----YLRDT 166
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
L +LH ++H D+K +NI L K+ D G+ L G +
Sbjct: 167 LLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV------QE 217
Query: 398 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 457
G Y APE + G +DVFS G+ +LE+ + H
Sbjct: 218 GDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNMELPH-------------------- 256
Query: 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
G +L L +F + + L+ DP R T ++
Sbjct: 257 GGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 59/317 (18%), Positives = 112/317 (35%), Gaps = 81/317 (25%)
Query: 234 GQGGSSYVYRGQLTDGRI--------VAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV 285
GQG + +++G + V +K + N F M+S+L H H+V
Sbjct: 17 GQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD-KAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 286 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIAIGAARGLE 342
G C +LV EF+ G+L L + N ++ +A A +
Sbjct: 76 LNYGVCV----CGDENILVQEFVKFGSLDTYLKKNKNCI----NILWKLEVAKQLAAAMH 127
Query: 343 YLHEAAAPRILHRDIKSSNILLD--------ENLNAKITDLGMAKRLKADGLPSCSSSPA 394
+L ++H ++ + NILL K++D G++ + +
Sbjct: 128 FL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI---LQERI 181
Query: 395 R-MQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELIT-GRQP--------IHRSITKG 443
+ PE + +L +D +SFG L E+ + G +P +
Sbjct: 182 PWV-------PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR 234
Query: 444 EESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV 503
+LP P+ E ++ C+ +PD RP+ +
Sbjct: 235 H-------------------QLPAPK-----AAELANLI----NNCMDYEPDHRPSFRAI 266
Query: 504 VQILSTI-APDKSRRRN 519
++ L+++ PD R +
Sbjct: 267 IRDLNSLFTPDLVPRGS 283
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 69/295 (23%), Positives = 115/295 (38%), Gaps = 59/295 (20%)
Query: 241 VYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 293
V VAVK K ++E+ +LS L +H ++V L+G C+
Sbjct: 39 VVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT- 97
Query: 294 FRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR----------------VAIAIGA 337
L++ E+ G+L + L + T ++ +
Sbjct: 98 ---IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQV 154
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG---LPSCSSSPA 394
A+G+ +L A+ +HRD+ + NILL KI D G+A+ +K D + + P
Sbjct: 155 AKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV 211
Query: 395 R-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWAT 452
+ M APE + SDV+S+G+ L EL + G P + + +
Sbjct: 212 KWM-------APESIFNCVYTFESDVWSYGIFLWELFSLGSSP-YPGMPVDSKFY----- 258
Query: 453 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507
++ G + P P E IM K C DP RPT ++VQ++
Sbjct: 259 -KMIKEGFR---MLSPE---HAPAEMYDIM----KTCWDADPLKRPTFKQIVQLI 302
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 65/350 (18%), Positives = 127/350 (36%), Gaps = 52/350 (14%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRL-HHC-HVVPL 287
+G GGSS V++ +I A+K + N + E+ L++L H ++ L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA--ARGLEYLH 345
Y + + +V E N +L L + + D + + +H
Sbjct: 122 YDY---EITDQYI-YMVMEC-GNIDLNS----WLKKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 346 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 405
+ I+H D+K +N L+ + K+ D G+A +++ D S G Y P
Sbjct: 173 QH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV---GAVNYMPP 225
Query: 406 E-----------YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 454
E + S SDV+S G +L + G+ P +
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--------------FQQ-- 269
Query: 455 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ---ILSTIA 511
+ + + + + DP + +FP + + + K CL+ DP R ++ E++ +
Sbjct: 270 IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 329
Query: 512 PDKSRRRNISLNLFQIFS-AGGMEKEPSIERPDNLFETLIESEELKKATS 560
P + + + + G+ SI + E ++S
Sbjct: 330 PVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSS 379
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 68/313 (21%), Positives = 121/313 (38%), Gaps = 75/313 (23%)
Query: 241 VYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 294
V++ + +VAVK K + + + F E +++ + ++V L+G C+
Sbjct: 63 VFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA-- 120
Query: 295 RGKRAMRLLVFEFMPNGNLRDCL--------DGVLVEGMNWDTR--------------VA 332
L+FE+M G+L + L + ++ R +
Sbjct: 121 --VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLC 178
Query: 333 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RLKAD 384
IA A G+ YL + + +HRD+ + N L+ EN+ KI D G+++ + +
Sbjct: 179 IARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGN 235
Query: 385 GLPSCSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITK 442
P R M PE R + SDV+++GVVL E+ + G QP + +
Sbjct: 236 DA-----IPIRWM-------PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP-YYGMAH 282
Query: 443 GEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 502
E V+ G + L P + P E +M + C P RP+
Sbjct: 283 EE---VI----YYVRDGNI---LACPE---NCPLELYNLM----RLCWSKLPADRPSFCS 325
Query: 503 VVQILSTIAPDKS 515
+ +IL +
Sbjct: 326 IHRILQRMCERAE 338
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 6e-30
Identities = 64/318 (20%), Positives = 113/318 (35%), Gaps = 50/318 (15%)
Query: 224 TDKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNADSVFL-TEVDMLSRL 279
+ ++G+G V + G V V+R + N FL E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 280 HHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA 338
+H ++VP + L +V FM G+ +D + ++GMN I G
Sbjct: 84 NHPNIVPY--RATFIADNE---LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVL 138
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSSPARM 396
+ L+Y+H +HR +K+S+IL+ + ++ L + + G P
Sbjct: 139 KALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 397 QGTFGYFAPEYAMVGRASLM-----SDVFSFGVVLLELITGRQP---------------- 435
+ +PE V + +L SD++S G+ EL G P
Sbjct: 196 VKVLPWLSPE---VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG 252
Query: 436 ----IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE--- 488
+ + T E L + + + +SG S + +
Sbjct: 253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHH 312
Query: 489 ----CLQLDPDARPTMSE 502
CLQ +PDARP+ S
Sbjct: 313 FVEQCLQRNPDARPSAST 330
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-30
Identities = 72/321 (22%), Positives = 125/321 (38%), Gaps = 78/321 (24%)
Query: 241 VYRGQLTDGR--------IVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYC 291
V + VAVK K S ++E++M+ + H +++ L+G C
Sbjct: 51 VVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCL--------------DGVLVEGMNWDTRVAIAIGA 337
+ + ++ E+ GNLR+ L + V E M + V+
Sbjct: 111 T----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQL 166
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
ARG+EYL A+ + +HRD+ + N+L+ EN KI D G+A+ + +
Sbjct: 167 ARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID--------YYKK 215
Query: 398 GTFGYF-----APEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKG 443
T G APE + SDV+SFGV++ E+ T G P + + + +G
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275
Query: 444 EESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV 503
R+ + P + E +M ++C P RPT ++
Sbjct: 276 H---------RM--------DKPA-----NCTNELYMMM----RDCWHAVPSQRPTFKQL 309
Query: 504 VQILSTIAPDKSRRRNISLNL 524
V+ L I + + L+
Sbjct: 310 VEDLDRILTLTTNEEYLDLSQ 330
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 9e-30
Identities = 60/291 (20%), Positives = 113/291 (38%), Gaps = 48/291 (16%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRL--HHCHVVPL 287
+G GGSS V++ +I A+K + N + E+ L++L H ++ L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA--ARGLEYLH 345
Y + + +V E N +L L + + D + + +H
Sbjct: 94 YDY---EITDQYI-YMVMECG-NIDLNS----WLKKKKSIDPWERKSYWKNMLEAVHTIH 144
Query: 346 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 405
+ I+H D+K +N L+ + K+ D G+A +++ D S GT Y P
Sbjct: 145 QH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV---GTVNYMPP 197
Query: 406 E-----------YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 454
E + S SDV+S G +L + G+ P +
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--------------FQQ-- 241
Query: 455 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
+ + + + + DP + +FP + + + K CL+ DP R ++ E++
Sbjct: 242 IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 71/307 (23%), Positives = 121/307 (39%), Gaps = 78/307 (25%)
Query: 241 VYRGQLTDGR--------IVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYC 291
V + VAVK K S ++E++M+ + H +++ L+G C
Sbjct: 97 VVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCL--------------DGVLVEGMNWDTRVAIAIGA 337
+ + ++ E+ GNLR+ L + V E M + V+
Sbjct: 157 T----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQL 212
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
ARG+EYL A+ + +HRD+ + N+L+ EN KI D G+A+ + +
Sbjct: 213 ARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID--------YYKK 261
Query: 398 GTFGYF-----APEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRSITKG 443
T G APE + SDV+SFGV++ E+ T G P + + + +G
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 321
Query: 444 EESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV 503
R+ + P + E +M ++C P RPT ++
Sbjct: 322 H---------RM--------DKPA-----NCTNELYMMM----RDCWHAVPSQRPTFKQL 355
Query: 504 VQILSTI 510
V+ L I
Sbjct: 356 VEDLDRI 362
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 69/280 (24%), Positives = 120/280 (42%), Gaps = 42/280 (15%)
Query: 232 IVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
++G+G VY G L++ +A+K + + + E+ + L H ++V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPL-HEEIALHKHLKHKNIVQYLGS 87
Query: 291 CSEFRGKRAMRLLVF-EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA-RGLEYLHEAA 348
SE + +F E +P G+L L + + + GL+YLH+
Sbjct: 88 FSE-----NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN- 141
Query: 349 APRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
+I+HRDIK N+L++ + KI+D G +KRL G+ C+ + GT Y APE
Sbjct: 142 --QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL--AGINPCTET---FTGTLQYMAPEI 194
Query: 408 AMVGR--ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 465
G +D++S G ++E+ TG+ P + GE ++ V E+
Sbjct: 195 IDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL---GEPQAAMFKVGM----FKVHPEI 247
Query: 466 PD---PRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 502
P+ K F +C + DPD R ++
Sbjct: 248 PESMSAEAK-AF-----------ILKCFEPDPDKRACAND 275
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 66/350 (18%), Positives = 128/350 (36%), Gaps = 52/350 (14%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRL--HHCHVVPL 287
+G GGSS V++ +I A+K + N + E+ L++L H ++ L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA--ARGLEYLH 345
Y + + +V E N +L L + + D + + +H
Sbjct: 75 YDY---EITDQYI-YMVMEC-GNIDLNS----WLKKKKSIDPWERKSYWKNMLEAVHTIH 125
Query: 346 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 405
+ I+H D+K +N L+ + K+ D G+A +++ D S GT Y P
Sbjct: 126 QH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV---GTVNYMPP 178
Query: 406 E-----------YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 454
E + S SDV+S G +L + G+ P +
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ----------------Q 222
Query: 455 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ---ILSTIA 511
+ + + + + DP + +FP + + + K CL+ DP R ++ E++ +
Sbjct: 223 IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282
Query: 512 PDKSRRRNISLNLFQIF-SAGGMEKEPSIERPDNLFETLIESEELKKATS 560
P + + + + G+ SI + E ++S
Sbjct: 283 PVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSS 332
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 77/363 (21%), Positives = 128/363 (35%), Gaps = 66/363 (18%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
+ S+I+GQG ++ V+RG+ G + A+K F V + E ++L +L+H +
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT---RVAIAIGA--A 338
+V L + E ++L+ EF P G+L VL E N + +
Sbjct: 69 IVKL--FAIEEETTTRHKVLIMEFCPCGSLYT----VLEEPSNAYGLPESEFLIVLRDVV 122
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMAKRLKADGL--PSCSSS 392
G+ +L E I+HR+IK NI+ D K+TD G A+ L+ D
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--- 176
Query: 393 PARMQGTFGYFAPEYAMVGRASLMS----------DVFSFGVVLLELITGRQP------- 435
GT Y P+ M RA L D++S GV TG P
Sbjct: 177 -----GTEEYLHPD--MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229
Query: 436 -----IHRSITKGEESLVLWATPRLQDSGTVIS-ELPDPRLKGDFPKEEMQIMAYLAKEC 489
+ I G+ S + + ++ S ++P + + +
Sbjct: 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLT---PVLANI 286
Query: 490 LQLDPDARPTMSEVVQILSTIAPDKSRRRNISLNLFQIFSAGGMEKEPSIERPDNLFETL 549
L+ D + + S I + + +FS M N
Sbjct: 287 LEADQEKCWGFDQFFAETSDI---------LHRMVIHVFSLQQMTAHKIYIHSYNTATIF 337
Query: 550 IES 552
E
Sbjct: 338 HEL 340
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 73/312 (23%), Positives = 129/312 (41%), Gaps = 69/312 (22%)
Query: 234 GQG--GSSYVYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV 285
G+G G V + + VAVK K P+ L+E ++L +++H HV+
Sbjct: 32 GEGEFGK--VVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 286 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL----------------------DGVLVE 323
L G CS + LL+ E+ G+LR L D
Sbjct: 90 KLYGACS----QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 324 GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383
+ ++ A ++G++YL A +++HRD+ + NIL+ E KI+D G+++ +
Sbjct: 146 ALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 384 DG---LPSCSSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR 438
+ S P + M A E + SDV+SFGV+L E++T G P +
Sbjct: 203 EDSYVKRSQGRIPVKWM-------AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP-YP 254
Query: 439 SITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP 498
I + L +G + P + +E ++M +C + +PD RP
Sbjct: 255 GIPPER---LF----NLLKTGHR---MERPD---NCSEEMYRLM----LQCWKQEPDKRP 297
Query: 499 TMSEVVQILSTI 510
+++ + L +
Sbjct: 298 VFADISKDLEKM 309
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 69/289 (23%), Positives = 120/289 (41%), Gaps = 52/289 (17%)
Query: 224 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 282
+ F+ +G+G V++G ++VA+K + + E+ +LS+
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-DGVLVEGMNWDTRVAIAI---GAA 338
+V Y S + + ++ E++ G+ D L G L E IA
Sbjct: 81 YVTKY--YGSYLKDTKLW--IIMEYLGGGSALDLLEPGPLDETQ-------IATILREIL 129
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
+GL+YLH + +HRDIK++N+LL E+ K+ D G+A +L + + G
Sbjct: 130 KGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-----FVG 181
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP---IH--RSITKGEESLVLWATP 453
T + APE +D++S G+ +EL G P +H + VL+ P
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK---------VLFLIP 232
Query: 454 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 502
+ P L+G++ K + + CL +P RPT E
Sbjct: 233 K----------NNPPTLEGNYSKP----LKEFVEACLNKEPSFRPTAKE 267
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-29
Identities = 34/311 (10%), Positives = 79/311 (25%), Gaps = 69/311 (22%)
Query: 232 IVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSV---------------------- 268
++GQ G V P ++++
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 269 -----FLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM--PNGNLRDCLDGVL 321
F+ D++ ++ + E R ++ M + L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRL--DERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 202
Query: 322 VEG--MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379
+ R+ + + R L LH ++H ++ +I+LD+ +T
Sbjct: 203 STHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-----SLMSDVFSFGVVLLELITGRQ 434
R A + A G+ + D ++ G+ + +
Sbjct: 260 RDGASAVSPIGRGF----APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
Query: 435 PIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDP 494
P G + + +P P + L + L+
Sbjct: 316 PNTDDAALGGSEWIFRSCKN----------IPQP-------------VRALLEGFLRYPK 352
Query: 495 DARPTMSEVVQ 505
+ R + ++
Sbjct: 353 EDRLLPLQAME 363
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 70/314 (22%), Positives = 119/314 (37%), Gaps = 57/314 (18%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
+ S+I+GQG ++ V+RG+ G + A+K F V + E ++L +L+H +
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT---RVAIAIGA--A 338
+V L + E ++L+ EF P G+L VL E N + +
Sbjct: 69 IVKL--FAIEEETTTRHKVLIMEFCPCGSLYT----VLEEPSNAYGLPESEFLIVLRDVV 122
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMAKRLKADGL--PSCSSS 392
G+ +L E I+HR+IK NI+ D K+TD G A+ L+ D
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--- 176
Query: 393 PARMQGTFGYFAPEYAMVGRASLMS----------DVFSFGVVLLELITGRQP------- 435
GT Y P+ M RA L D++S GV TG P
Sbjct: 177 -----GTEEYLHPD--MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229
Query: 436 -----IHRSITKGEESLVLWATPRLQDSGTVIS-ELPDPRLKGDFPKEEMQIMAYLAKEC 489
+ I G+ S + + ++ S ++P + ++ +
Sbjct: 230 RRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVS---CSLSRGLQVLLTPVLANI 286
Query: 490 LQLDPDARPTMSEV 503
L+ D + +
Sbjct: 287 LEADQEKCWGFDQF 300
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 67/313 (21%), Positives = 108/313 (34%), Gaps = 65/313 (20%)
Query: 224 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 282
F ++GQG V + + D R A+K+ + S L+EV +L+ L+H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQ 62
Query: 283 HVVPLVG-YCSEFRGKRAMRL--------LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAI 333
+VV + + M + E+ NG L D ++ R
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYD----LIHSENLNQQRDEY 118
Query: 334 A-----IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS 388
I L Y+H I+HRD+K NI +DE+ N KI D G+AK +
Sbjct: 119 WRLFRQI--LEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 389 CSSSPARMQ---------GTFGYFAPE-YAMVGRASLMSDVFSFGVVLLELITG------ 432
S GT Y A E G + D++S G++ E+I
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGME 233
Query: 433 RQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQL 492
R I + + P + K E +I+ + +
Sbjct: 234 RVNILKKLRSVSIE-------------------FPPDFDDNKMKVEKKII----RLLIDH 270
Query: 493 DPDARPTMSEVVQ 505
DP+ RP ++
Sbjct: 271 DPNKRPGARTLLN 283
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 66/308 (21%), Positives = 114/308 (37%), Gaps = 64/308 (20%)
Query: 241 VYRGQLTDGR------IVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 293
V VAVK K + + ++E+ M+++L H ++V L+G C+
Sbjct: 61 VMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT- 119
Query: 294 FRGKRAMRLLVFEFMPNGNLRDCL---------DGVLVEGMNWDTR------------VA 332
L+FE+ G+L + L D + E +
Sbjct: 120 ---LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLC 176
Query: 333 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL---PSC 389
A A+G+E+L +HRD+ + N+L+ KI D G+A+ + +D
Sbjct: 177 FAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGN 233
Query: 390 SSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESL 447
+ P + M APE G ++ SDV+S+G++L E+ + G P + I
Sbjct: 234 ARLPVKWM-------APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP-YPGIPVDANFY 285
Query: 448 VLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507
+L +G + P +E IM + C D RP+ + L
Sbjct: 286 ------KLIQNGFK---MDQPF---YATEEIYIIM----QSCWAFDSRKRPSFPNLTSFL 329
Query: 508 STIAPDKS 515
D
Sbjct: 330 GCQLADAE 337
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 7e-29
Identities = 71/311 (22%), Positives = 123/311 (39%), Gaps = 86/311 (27%)
Query: 241 VYRGQLTD--------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYC 291
V + VAVK K+ S ++E++M+ + H +++ L+G C
Sbjct: 85 VVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR--------------VAIAIGA 337
+ + ++ E+ GNLR+ L G+ + V+ A
Sbjct: 145 T----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQV 200
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK--------RLKADGLPSC 389
ARG+EYL A+ + +HRD+ + N+L+ E+ KI D G+A+ + +G
Sbjct: 201 ARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR--- 254
Query: 390 SSSPAR-MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQP--------IHRS 439
P + M APE + SDV+SFGV+L E+ T G P + +
Sbjct: 255 --LPVKWM-------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305
Query: 440 ITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT 499
+ +G R+ + P + E +M ++C P RPT
Sbjct: 306 LKEGH---------RM--------DKPS-----NCTNELYMMM----RDCWHAVPSQRPT 339
Query: 500 MSEVVQILSTI 510
++V+ L I
Sbjct: 340 FKQLVEDLDRI 350
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 68/312 (21%), Positives = 106/312 (33%), Gaps = 72/312 (23%)
Query: 224 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRL-H 280
T +F +G G V++ DG I A+KR K + D L EV + L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 281 HCHVVPLVGYCSEFRGKRAMRLLVF-EFMPNGNLRDCL------DGVLVEGMNWDTRVAI 333
H HVV + + +L+ E+ G+L D + E D +
Sbjct: 70 HSHVVRY--FSAWAEDDH---MLIQNEYCNGGSLADAISENYRIMSYFKEAELKD----L 120
Query: 334 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-------------------LNAKITD 374
+ RGL Y+H ++H DIK SNI + + KI D
Sbjct: 121 LLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177
Query: 375 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGR 433
LG R+ SSP +G + A E +D+F+ + ++
Sbjct: 178 LGHVTRI---------SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
Query: 434 QPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLD 493
PR D I + PR+ +E L K + D
Sbjct: 229 PL-----------------PRNGDQWHEIRQGRLPRIPQVLSQE----FTELLKVMIHPD 267
Query: 494 PDARPTMSEVVQ 505
P+ RP+ +V+
Sbjct: 268 PERRPSAMALVK 279
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-28
Identities = 86/339 (25%), Positives = 131/339 (38%), Gaps = 43/339 (12%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL--VGY 290
G GG YV R G VA+K+ + + P + E+ ++ +L+H +VV V
Sbjct: 23 GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPD 82
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCL-----DGVLVEGMNWDTRVAIA-IGAARGLEYL 344
+ + LL E+ G+LR L L EG R ++ I +A L YL
Sbjct: 83 GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG---PIRTLLSDISSA--LRYL 137
Query: 345 HEAAAPRILHRDIKSSNILLD---ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
HE RI+HRD+K NI+L + L KI DLG AK L L C+ GT
Sbjct: 138 HEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL--CTEF----VGTLQ 188
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH--------RSITKGEESLVLWATP 453
Y APE + ++ D +SFG + E ITG +P + + + +
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248
Query: 454 RLQDSGTVISELPDP-RLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512
L + S LP P L G + + + + L R T + + A
Sbjct: 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCM----LMWHQRQRGTDPQNPNVGCFQAL 304
Query: 513 DKSRRRNISLNLFQIFSAGGMEKEPSIERPDNLFETLIE 551
D +SL L + + + + L
Sbjct: 305 DS----ILSLKLLSVMNMVSGRVHTYPVTENENLQNLKS 339
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 1e-28
Identities = 41/305 (13%), Positives = 73/305 (23%), Gaps = 52/305 (17%)
Query: 232 IVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLV 288
+ G S V+ + A+K F + + +RL
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 289 GYCSEFRGKRAMRL----------------------LVFEFMP--NGNLRDCLDGVLVEG 324
A+ + L+ L LD V V
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 325 MNWDTRVAIAIGA--ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382
+ + A R L ++H N+ + + + D+ ++
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQPIHRSI 440
G S Y E+ A + + + G+ + + P
Sbjct: 246 TRGPASS--------VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 441 TKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM 500
+ W P L+ GT DF K L L D R
Sbjct: 298 PGIKG---SWKRPSLRVPGTDSLAFGSCTPLPDFVKT-------LIGRFLNFDRRRRLLP 347
Query: 501 SEVVQ 505
E ++
Sbjct: 348 LEAME 352
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 77/292 (26%), Positives = 123/292 (42%), Gaps = 36/292 (12%)
Query: 225 DKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
D + ++G G ++ V VA+KR + + L E+ +S+ HH +
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 284 VVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTR---VAIAI---G 336
+V Y S L LV + + G++ D + ++ +G + IA
Sbjct: 75 IVSY--YTSFVVKDE---LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129
Query: 337 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARM 396
GLEYLH+ +HRD+K+ NILL E+ + +I D G++ L G + +
Sbjct: 130 VLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 397 QGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL 455
GT + APE R +D++SFG+ +EL TG P H K VL T +
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH----KYPPMKVLMLTLQ- 241
Query: 456 QDSGTVISELPDPRLKGDFPKEEM-----QIMAYLAKECLQLDPDARPTMSE 502
P L+ +EM + + CLQ DP+ RPT +E
Sbjct: 242 ---------NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAE 284
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 64/296 (21%), Positives = 106/296 (35%), Gaps = 53/296 (17%)
Query: 226 KFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHV 284
F +++G G + + D R VAVKR + AD EV +L H +V
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR----EVQLLRESDEHPNV 80
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 344
+ +C+E R + + E L++ ++ + + + GL +L
Sbjct: 81 IRY--FCTEK--DRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHL 134
Query: 345 HEAAAPRILHRDIKSSNILLDE-----NLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
H I+HRD+K NIL+ + A I+D G+ K+L S GT
Sbjct: 135 HSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV--PGT 189
Query: 400 FGYFAPEY---AMVGRASLMSDVFSFGVVLLELITGRQP-------IHRSITKGEESLVL 449
G+ APE + D+FS G V +I+ +I G SL
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSL-- 247
Query: 450 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
L + L ++ + +DP RP+ V++
Sbjct: 248 ---DCLHPEKHEDVIARE-----------------LIEKMIAMDPQKRPSAKHVLK 283
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 68/302 (22%), Positives = 120/302 (39%), Gaps = 51/302 (16%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGY 290
+ +GG ++VY Q + GR A+KR + ++ + EV + +L H ++V
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAI-IQEVCFMKKLSGHPNIVQFCSA 94
Query: 291 CSEFR---GKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAIAIGAARGLEYLHE 346
S + L+ + G L + L + G ++ DT + I R ++++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 347 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ-------GT 399
P I+HRD+K N+LL K+ D G A + S S+ + T
Sbjct: 155 QKPP-IIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 400 FGYFAPEYAMVGRASLM-----SDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 454
Y PE ++ S D+++ G +L L + P E+ L
Sbjct: 214 PMYRTPE--IIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF-------EDGAKL----- 259
Query: 455 LQDSGTVISELPDPRLKGDF--PKEEMQ--IMAYLAKECLQLDPDARPTMSEVVQILSTI 510
I + G + P + Q + L + LQ++P+ R +++EVV L I
Sbjct: 260 ------RI-------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306
Query: 511 AP 512
A
Sbjct: 307 AA 308
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 69/279 (24%), Positives = 110/279 (39%), Gaps = 39/279 (13%)
Query: 233 VGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC-HVVPLVGY 290
+G+G V + + G+I+AVKR + L ++D+ R C V Y
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTF--Y 72
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRV--AIAIGAARGLEYLHEAA 348
+ FR + E M + +L V+ +G + IA+ + LE+LH
Sbjct: 73 GALFREGDVW--ICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 349 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE-- 406
++HRD+K SN+L++ K+ D G++ L + G Y APE
Sbjct: 130 --SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD------DVAKDIDAGCKPYMAPERI 181
Query: 407 --YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 464
S+ SD++S G+ ++EL R P W TP + E
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILRFPYDS-----------WGTP--FQQLKQVVE 228
Query: 465 LPDPRLKGD-FPKEEMQIMAYLAKECLQLDPDARPTMSE 502
P P+L D F E +CL+ + RPT E
Sbjct: 229 EPSPQLPADKFSAE----FVDFTSQCLKKNSKERPTYPE 263
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 70/295 (23%), Positives = 123/295 (41%), Gaps = 57/295 (19%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 282
K++ +GQG S VY + G+ VA+++ Q P + + E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII-NEILVMRENKNP 77
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD-GVLVEGMNWDTRVAIAI---GAA 338
++V + S G +V E++ G+L D + + EG IA
Sbjct: 78 NIVNYLD--SYLVGDELW--VVMEYLAGGSLTDVVTETCMDEGQ-------IAAVCRECL 126
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
+ LE+LH +++HRDIKS NILL + + K+TD G ++ + S + M G
Sbjct: 127 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-----QSKRSTMVG 178
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRS--------ITKGEESLVLW 450
T + APE D++S G++ +E+I G P I
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-------N 231
Query: 451 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
TP LQ+ + + D +L + CL++D + R + E++Q
Sbjct: 232 GTPELQNPEKLSAIFRD----------------FLNR-CLEMDVEKRGSAKELLQ 269
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 68/295 (23%), Positives = 113/295 (38%), Gaps = 57/295 (19%)
Query: 224 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 282
+G+G + V + GR VAVK + + +F EV ++ H
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF-NEVVIMRDYQHF 102
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD-GVLVEGMNWDTRVAIAI---GAA 338
+VV + S G+ ++ EF+ G L D + L E IA
Sbjct: 103 NVVEMYK--SYLVGEELW--VLMEFLQGGALTDIVSQVRLNEEQ-------IATVCEAVL 151
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
+ L YLH A ++HRDIKS +ILL + K++D G ++ D + G
Sbjct: 152 QALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD-----VPKRKSLVG 203
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP---IH-----RSITKGEESLVLW 450
T + APE + D++S G++++E++ G P + +
Sbjct: 204 TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD-------S 256
Query: 451 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
P+L++S V L D +L + L DP R T E++
Sbjct: 257 PPPKLKNSHKVSPVLRD----------------FLER-MLVRDPQERATAQELLD 294
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 78/318 (24%), Positives = 122/318 (38%), Gaps = 74/318 (23%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCH 283
+ I+G G S V GR VAVKR + + L E+ +L+ H +
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML----IDFCDIALMEIKLLTESDDHPN 70
Query: 284 VVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLD--GVLVEGM-NWDTRVAIAI--GA 337
V+ YCSE L + E N NL+D ++ V E + I++
Sbjct: 71 VIRY--YCSE---TTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLD-------------ENLNAKITDLGMAKRLKAD 384
A G+ +LH +I+HRD+K NIL+ ENL I+D G+ K+L +
Sbjct: 125 ASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 385 GLPSCSSSPARMQ---GTFGYFAPE-------YAMVGRASLMSDVFSFGVVLLELITGRQ 434
SS + GT G+ APE R + D+FS G V +++ +
Sbjct: 182 Q----SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237
Query: 435 P-------IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAK 487
+I +G SL + +I+E D L
Sbjct: 238 HPFGDKYSRESNIIRGIFSLDEMKCLHDRS---LIAEATD-----------------LIS 277
Query: 488 ECLQLDPDARPTMSEVVQ 505
+ + DP RPT +V++
Sbjct: 278 QMIDHDPLKRPTAMKVLR 295
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 3e-26
Identities = 40/318 (12%), Positives = 89/318 (27%), Gaps = 82/318 (25%)
Query: 232 IVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV---------------------- 268
++GQ G V P ++++
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 269 -----FLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD----- 318
F+ D++ ++ + E R ++ M NL+ +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLD--ERDMWVLSRFFLYPRM-QSNLQTFGEVLLSH 196
Query: 319 GVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378
+ + R+ + + R L LH ++H ++ +I+LD+ +T
Sbjct: 197 SSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 379 KRLKADGLPSCSSSPARMQGTFGYFAPEY--------AMVGRASLMS---DVFSFGVVLL 427
R + + G+ PE R +LM+ D ++ G+V+
Sbjct: 254 VRD---------GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304
Query: 428 ELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAK 487
+ PI + G + R + P+ L +
Sbjct: 305 WIWCADLPITKDAALGGSEWIF-------------------RSCKNIPQPVRA----LLE 341
Query: 488 ECLQLDPDARPTMSEVVQ 505
L+ + R + ++
Sbjct: 342 GFLRYPKEDRLLPLQAME 359
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 72/290 (24%), Positives = 113/290 (38%), Gaps = 66/290 (22%)
Query: 234 GQGGSSYVYRGQLTD-GRIVAVK-RFKTQ-GGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
G+GG + + D + A K K+ P+ E+ + L H HVV G+
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 109
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 348
F + +V E +L + L E + R G +YLH
Sbjct: 110 ---FEDNDFV-FVVLELCRRRSLLELHKRRKALTE---PEAR-YYLRQIVLGCQYLHRN- 160
Query: 349 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP---SCSSSPARMQGTFGYFAP 405
R++HRD+K N+ L+E+L KI D G+A +++ DG C GT Y AP
Sbjct: 161 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--------GTPNYIAP 210
Query: 406 EYAMVGRA--SLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESLVLWATPRL 455
E ++ + S DV+S G ++ L+ G+ P + I K E S+ P
Sbjct: 211 E--VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA 268
Query: 456 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
L ++ LQ DP ARPT++E++
Sbjct: 269 AS---------------------------LIQKMLQTDPTARPTINELLN 291
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 72/307 (23%), Positives = 124/307 (40%), Gaps = 48/307 (15%)
Query: 214 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTE 272
SAL F +VG G VY+G+ + G++ A+K G + E
Sbjct: 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE--IKQE 70
Query: 273 VDMLSRL-HHCHVVPLVG-YCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDT 329
++ML + HH ++ G + + +L LV EF G++ D + + +
Sbjct: 71 INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW 130
Query: 330 RVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC 389
I RGL +LH+ +++HRDIK N+LL EN K+ D G++ +L
Sbjct: 131 IAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN 187
Query: 390 SSSPARMQGTFGYFAPEYAMVGRASLMS-----DVFSFGVVLLELITGRQP---IH--RS 439
+ GT + APE + D++S G+ +E+ G P +H R
Sbjct: 188 T-----FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR- 241
Query: 440 ITKGEESLVLWATPRLQDSGTVISELPDPRLKG-DFPKEEMQIMAYLAKECLQLDPDARP 498
L+ +I P PRLK + K+ +++ CL + RP
Sbjct: 242 --------ALF----------LIPRNPAPRLKSKKWSKK---FQSFIES-CLVKNHSQRP 279
Query: 499 TMSEVVQ 505
++++
Sbjct: 280 ATEQLMK 286
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 69/290 (23%), Positives = 120/290 (41%), Gaps = 47/290 (16%)
Query: 224 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 282
+ F +G+G VY+ G+IVA+K+ + + E+ ++ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL---QEIIKEISIMQQCDSP 84
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD---CLDGVLVEGMNWDTRVAIAI---G 336
HVV G S F+ +V E+ G++ D + L E IA
Sbjct: 85 HVVKYYG--SYFKNTDLW--IVMEYCGAGSVSDIIRLRNKTLTEDE-------IATILQS 133
Query: 337 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARM 396
+GLEYLH R +HRDIK+ NILL+ +AK+ D G+A +L + +
Sbjct: 134 TLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT-----V 185
Query: 397 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL-VLWATPRL 455
GT + APE + ++D++S G+ +E+ G+ P + ++
Sbjct: 186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYA-----DIHPMRAIF----- 235
Query: 456 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
+I P P + P+ K+CL P+ R T ++++Q
Sbjct: 236 -----MIPTNPPPTFRK--PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 72/290 (24%), Positives = 113/290 (38%), Gaps = 66/290 (22%)
Query: 234 GQGGSSYVYRGQLTD-GRIVAVK-RFKTQ-GGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
G+GG + + D + A K K+ P+ E+ + L H HVV G+
Sbjct: 24 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 83
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 348
F + +V E +L + L E + R G +YLH
Sbjct: 84 ---FEDNDFV-FVVLELCRRRSLLELHKRRKALTE---PEAR-YYLRQIVLGCQYLHRN- 134
Query: 349 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP---SCSSSPARMQGTFGYFAP 405
R++HRD+K N+ L+E+L KI D G+A +++ DG C GT Y AP
Sbjct: 135 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--------GTPNYIAP 184
Query: 406 EYAMVGRA--SLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESLVLWATPRL 455
E ++ + S DV+S G ++ L+ G+ P + I K E S+ P
Sbjct: 185 E--VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA 242
Query: 456 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
L ++ LQ DP ARPT++E++
Sbjct: 243 AS---------------------------LIQKMLQTDPTARPTINELLN 265
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 44/292 (15%), Positives = 85/292 (29%), Gaps = 65/292 (22%)
Query: 233 VGQGGSSYVYRGQLTD---GRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPL 287
G ++ D R VA+ QG D + L+ LSR+ V +
Sbjct: 39 HGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 347
+ RA L+V E++ G+L++ D + + A + H A
Sbjct: 97 LDVVHT----RAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRA 148
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
+ S + + + + +
Sbjct: 149 G---VALSIDHPSRVRVSIDGDVVL-------------------------AYPATMPD-- 178
Query: 408 AMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPD 467
A+ D+ G L L+ R P+ + G S + A + +
Sbjct: 179 -----ANPQDDIRGIGASLYALLVNRWPLPEA---GVRSGLAPAERDTAG------QPIE 224
Query: 468 PR-LKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRR 518
P + D P + ++ +A +Q D R S ++ ++ R
Sbjct: 225 PADIDRDIPFQ----ISAVAARSVQGDGGIRSA-STLLNLMQQATAVADRTE 271
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 60/302 (19%), Positives = 115/302 (38%), Gaps = 64/302 (21%)
Query: 224 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 282
+ + +G G VY+ + G + A K +T+ + ++ E+++L+ H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-YIVEIEILATCDHP 76
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD---CLDGVLVEGMNWDTRVAIAI---G 336
++V L+G + + + ++ EF P G + LD L E I +
Sbjct: 77 YIVKLLG--AYYHDGKLW--IMIEFCPGGAVDAIMLELDRGLTEPQ-------IQVVCRQ 125
Query: 337 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARM 396
L +LH RI+HRD+K+ N+L+ + ++ D G++ + S
Sbjct: 126 MLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-----F 177
Query: 397 QGTFGYFAPEYAMVGRASLMS-----DVFSFGVVLLELITGRQP---IH-----RSITKG 443
GT + APE M D++S G+ L+E+ P ++ I K
Sbjct: 178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS 237
Query: 444 EESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV 503
+ P L E D +L L +P+ RP+ +++
Sbjct: 238 D-------PPTLLTPSKWSVEFRD----------------FLKI-ALDKNPETRPSAAQL 273
Query: 504 VQ 505
++
Sbjct: 274 LE 275
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 48/309 (15%), Positives = 103/309 (33%), Gaps = 63/309 (20%)
Query: 234 GQGGSSYVYRGQLTDGRIVAVK--------RFKTQGGPNADSVFLT--------EVDMLS 277
QG + + + + A+K + + N D + + E+ +++
Sbjct: 40 NQGKFNKIILCEKD-NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 278 RLHHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLD--GVLVEGMNWDTRVAIA 334
+ + + + G + +++E+M N ++ + VL + + +
Sbjct: 99 DIKNEYCLTCEGI---ITNYD--EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVI 153
Query: 335 IGAAR----GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP-SC 389
+ Y+H I HRD+K SNIL+D+N K++D G ++ + + S
Sbjct: 154 KCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR 211
Query: 390 SSSPARMQGTFGYFAPEYAMV----GRASLMSDVFSFGVVLLELITGRQP---------I 436
GT+ + PE D++S G+ L + P +
Sbjct: 212 --------GTYEFMPPE--FFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261
Query: 437 HRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDA 496
+I P ++ +F E K L+ +P
Sbjct: 262 FNNIRTKNIEY-----PLDRNHFLYPLTNKKSTCSNNFLSNEDID---FLKLFLRKNPAE 313
Query: 497 RPTMSEVVQ 505
R T + ++
Sbjct: 314 RITSEDALK 322
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 67/302 (22%), Positives = 112/302 (37%), Gaps = 53/302 (17%)
Query: 233 VGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G G V++ G ++A K + P + + E+ +L + ++V Y
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF--YG 98
Query: 292 SEFRGKR---AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRV--AIAIGAARGLEYLHE 346
+ + M E M G LD VL + ++ ++I +GL YL E
Sbjct: 99 AFYSDGEISICM-----EHMDGG----SLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 347 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR-MQGTFGYFAP 405
+I+HRD+K SNIL++ K+ D G++ +L S A GT Y +P
Sbjct: 150 KH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--------IDSMANSFVGTRSYMSP 199
Query: 406 EYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 465
E S+ SD++S G+ L+E+ GR PI K E +
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259
Query: 466 PDPRLKGDF-----PKEEMQIMAYLAKE--------------------CLQLDPDARPTM 500
P L P +++ Y+ E CL +P R +
Sbjct: 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 319
Query: 501 SE 502
+
Sbjct: 320 KQ 321
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-25
Identities = 73/293 (24%), Positives = 111/293 (37%), Gaps = 71/293 (24%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVK-RFKTQ-GGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
G+G + VYR + + G VA+K K EV + +L H ++ L Y
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY 79
Query: 291 CSEFRGKRAMRL-LVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIA-IGAARGLEYLH 345
F + LV E NG + L E + R + I G+ YLH
Sbjct: 80 ---FEDSN--YVYLVLEMCHNGEMNRYLKNRVKPFSE---NEARHFMHQI--ITGMLYLH 129
Query: 346 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP---SCSSSPARMQGTFGY 402
ILHRD+ SN+LL N+N KI D G+A +LK C GT Y
Sbjct: 130 SH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--------GTPNY 178
Query: 403 FAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESLVLWAT 452
+PE + R+ L SDV+S G + L+ GR P + + + + +
Sbjct: 179 ISPE--IATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLS 236
Query: 453 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
+D +I +L L+ +P R ++S V+
Sbjct: 237 IEAKD---LIHQL------------------------LRRNPADRLSLSSVLD 262
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 72/285 (25%), Positives = 110/285 (38%), Gaps = 47/285 (16%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC-HVVPLVGY 290
+G+G V + G+I+AVKR ++ L ++D++ R C ++V Y
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQF--Y 87
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRV-------AIAIGAARGLEY 343
+ FR + E M + D + V I + + L +
Sbjct: 88 GALFREGDCW--ICMELM-ST----SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
L E +I+HRDIK SNILLD + N K+ D G++ +L S + R G Y
Sbjct: 141 LKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD------SIAKTRDAGCRPYM 192
Query: 404 APEYAMVGRA----SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR--LQD 457
APE + + SDV+S G+ L EL TGR P + W + L
Sbjct: 193 APERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK-----------WNSVFDQLT- 240
Query: 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 502
+ + P+L +E CL D RP E
Sbjct: 241 ---QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 68/279 (24%), Positives = 112/279 (40%), Gaps = 40/279 (14%)
Query: 233 VGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC-HVVPLVGY 290
+G G V++ + G ++AVK+ + G + L ++D++ + H C ++V +
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQC--F 90
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAP 350
+ + E M G + L + + + + + L YL E
Sbjct: 91 GTFITNTDVF--IAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH-- 144
Query: 351 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV 410
++HRD+K SNILLDE K+ D G++ RL + R G Y APE
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD------DKAKDRSAGCAAYMAPERIDP 198
Query: 411 GRA-----SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 465
+ +DV+S G+ L+EL TG+ P T E VL T + +
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE---VL----------TKVLQE 245
Query: 466 PDPRLKGD--FPKEEMQIMAYLAKECLQLDPDARPTMSE 502
P L G F + K+CL D RP ++
Sbjct: 246 EPPLLPGHMGFSGD----FQSFVKDCLTKDHRKRPKYNK 280
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 72/297 (24%), Positives = 109/297 (36%), Gaps = 65/297 (21%)
Query: 224 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFL--TEVDMLSRLH 280
FS +G G VY + + + +VA+K+ G + + EV L +L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 281 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD---CLDGVLVEGMNWDTRVAIAI-- 335
H + + G R A LV E+ G+ D L E IA
Sbjct: 113 HPNTIQYRG--CYLREHTAW--LVMEYCL-GSASDLLEVHKKPLQEVE-------IAAVT 160
Query: 336 -GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG----MAKRLKADGLPSCS 390
GA +GL YLH ++HRD+K+ NILL E K+ D G MA
Sbjct: 161 HGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---------- 207
Query: 391 SSPARMQGTFGYFAPEYAMVGRAS---LMSDVFSFGVVLLELITGRQPIHRSITKGEESL 447
GT + APE + DV+S G+ +EL + P+ ++
Sbjct: 208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-----NMNAM 259
Query: 448 -VLWATPRLQDSGTVISELPDPRLK-GDFPKEEMQIMAYLAKECLQLDPDARPTMSE 502
L+ I++ P L+ G + + ++ CLQ P RPT
Sbjct: 260 SALY----------HIAQNESPALQSGHWSEY---FRNFVDS-CLQKIPQDRPTSEV 302
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 73/298 (24%), Positives = 113/298 (37%), Gaps = 66/298 (22%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKR-FKTQ-GGPNADSVFLTEVDMLSRLHH 281
+ F +G+G VY + I+A+K FK Q + EV++ S L H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 282 CHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGAA 338
+++ L GY F R+ L+ E+ P G + L E T I A
Sbjct: 69 PNILRLYGY---FHDAT--RVYLILEYAPLGTVYRELQKLSKFDE---QRTATYIT-ELA 119
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP-SCSSSPARMQ 397
L Y H R++HRDIK N+LL KI D G + + C
Sbjct: 120 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-------- 168
Query: 398 GTFGYFAPEYAMVGRAS--LMSDVFSFGVVLLELITGRQP--------IHRSITKGEESL 447
GT Y PE M+ D++S GV+ E + G+ P ++ I++ E +
Sbjct: 169 GTLDYLPPE--MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF 226
Query: 448 VLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
+ T +D +IS L L+ +P RP + EV++
Sbjct: 227 PDFVTEGARD---LISRL------------------------LKHNPSQRPMLREVLE 257
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 45/237 (18%), Positives = 85/237 (35%), Gaps = 32/237 (13%)
Query: 277 SRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD-GVLVEGMNWDTRVAIAI 335
R+ VG K + + + NL+D ++ +E + I I
Sbjct: 113 RRMDPFSTKNTVGQLQPSSPKVYL-YIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI 171
Query: 336 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 395
A +E+LH ++HRD+K SNI + K+ D G+ + D +P
Sbjct: 172 QIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 228
Query: 396 MQ-------GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 448
GT Y +PE S D+FS G++L EL+ E +
Sbjct: 229 AYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM------ERVRI 282
Query: 449 LWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
+ +++ + P ++ + ++ L P RP +++++
Sbjct: 283 I---TDVRN-----LKFPLL------FTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-23
Identities = 73/373 (19%), Positives = 130/373 (34%), Gaps = 75/373 (20%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLH 280
+D++ G ++G+G V G+ AVK + L EV +L +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 281 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA--IAIGAA 338
H +++ L + + + LV E G L D ++ + A I
Sbjct: 85 HPNIMKLYEFFED----KGYFYLVGEVYTGGELFD----EIISRKRFSEVDAARIIRQVL 136
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPAR 395
G+ Y+H+ +I+HRD+K N+LL ++ N +I D G++ +A
Sbjct: 137 SGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS------KKMKD 187
Query: 396 MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL 455
GT Y APE + G DV+S GV+L L++G P + + V
Sbjct: 188 KIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKY-- 244
Query: 456 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----CLQLDPDARPTMSEVVQ------ 505
F + + ++ AK+ L P R + + +
Sbjct: 245 -----------------TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQT 287
Query: 506 -ILSTIAPDKSRRRNISLNL--FQIFS----------AGGMEKEPSIERPDNLFETL--- 549
I+ D N LN+ FQ + + + +F +
Sbjct: 288 YTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLTSQDETKELTAIFHKMDKN 347
Query: 550 ----IESEELKKA 558
++ EL +
Sbjct: 348 GDGQLDRAELIEG 360
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 71/312 (22%), Positives = 114/312 (36%), Gaps = 48/312 (15%)
Query: 203 SKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRF-KTQ 260
+ T F S H ++ + +G G V A+K KT
Sbjct: 15 YFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS 74
Query: 261 GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGV 320
+++S L EV +L L H +++ L + + KR L V E G L D
Sbjct: 75 VSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED---KRNYYL-VMECYKGGELFD----E 126
Query: 321 LVEGMNWDTRVAIAI--GAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDL 375
++ M ++ A I G+ YLH+ I+HRD+K N+LL +++ KI D
Sbjct: 127 IIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDF 183
Query: 376 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
G++ + GT Y APE + + DV+S GV+L L+ G P
Sbjct: 184 GLSAVFENQ------KKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236
Query: 436 IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----CLQ 491
+ V + K F E + ++ AK+ LQ
Sbjct: 237 FGGQTDQEILRKVE-------------------KGKYTFDSPEWKNVSEGAKDLIKQMLQ 277
Query: 492 LDPDARPTMSEV 503
D R + +
Sbjct: 278 FDSQRRISAQQA 289
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 73/301 (24%), Positives = 117/301 (38%), Gaps = 89/301 (29%)
Query: 234 GQGGSSYVYRG--QLTDGRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
G+G + V LT GR VA+K KTQ P + EV ++ L+H ++V L +
Sbjct: 24 GKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--F 80
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGAAR--------G 340
E L+ E+ G + D L G + E AR
Sbjct: 81 --EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE------------ARSKFRQIVSA 126
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSSPARMQG 398
++Y H+ RI+HRD+K+ N+LLD ++N KI D G + G C + P
Sbjct: 127 VQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPP----- 178
Query: 399 TFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 444
Y APE Y G DV+S GV+L L++G P + + +G+
Sbjct: 179 ---YAAPELFQGKKYD--GPE---VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK 230
Query: 445 ESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVV 504
+ + + ++ L K L L+P R T+ +++
Sbjct: 231 YRIPFYMSTDCEN---------------------------LLKRFLVLNPIKRGTLEQIM 263
Query: 505 Q 505
+
Sbjct: 264 K 264
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 8e-21
Identities = 68/300 (22%), Positives = 112/300 (37%), Gaps = 70/300 (23%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKR-FKTQ-GGPNADSVFLTEVDMLSRLHH 281
D F +G+G VY + + I+A+K FK+Q + E+++ S L H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 282 CHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAIGA- 337
+++ + Y F ++ R+ L+ EF P G L L G E + +
Sbjct: 74 PNILRMYNY---FHDRK--RIYLMLEFAPRGELYKELQKHGRFDE------QRSATFMEE 122
Query: 338 -ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP-SCSSSPAR 395
A L Y HE +++HRDIK N+L+ KI D G + + C
Sbjct: 123 LADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC------ 173
Query: 396 MQGTFGYFAPEYAMVGRAS--LMSDVFSFGVVLLELITGRQP--------IHRSITKGEE 445
GT Y PE M+ + D++ GV+ E + G P HR I +
Sbjct: 174 --GTLDYLPPE--MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL 229
Query: 446 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
+ + +D +IS+L L+ P R + V++
Sbjct: 230 KFPPFLSDGSKD---LISKL------------------------LRYHPPQRLPLKGVME 262
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 71/318 (22%), Positives = 117/318 (36%), Gaps = 72/318 (22%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLT---EVDMLSRLH 280
K+ +GQG V++ + G+ VA+K+ + + +T E+ +L L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLK 74
Query: 281 HCHVVPL----VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIG 336
H +VV L S + + LVF+F + D L G+L + V +
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH----D-LAGLL-------SNVLVKFT 122
Query: 337 AA----------RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386
+ GL Y+H +ILHRD+K++N+L+ + K+ D G+A+ L
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF---SL 176
Query: 387 PSCSSSPARMQG---TFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPI------ 436
+S P R T Y PE + R D++ G ++ E+ T PI
Sbjct: 177 AK-NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS-PIMQGNTE 234
Query: 437 ----HR------SIT----KGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIM 482
SIT ++ L+ L ++K
Sbjct: 235 QHQLALISQLCGSITPEVWPNVDNYELYEKLELVKG-------QKRKVKDRLKAYVRDPY 287
Query: 483 AY-LAKECLQLDPDARPT 499
A L + L LDP R
Sbjct: 288 ALDLIDKLLVLDPAQRID 305
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 75/331 (22%), Positives = 119/331 (35%), Gaps = 74/331 (22%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 282
F ++G G S V+ Q G++ A+K K S+ E+ +L ++ H
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE-NEIAVLKKIKHE 66
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAIGAARG 340
++V L + LV + + G L D GV E D + I
Sbjct: 67 NIVTLEDI---YESTTHY-YLVMQLVSGGELFDRILERGVYTEK---DASLVIQQ-VLSA 118
Query: 341 LEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
++YLHE I+HRD+K N+L +EN ITD G++K + M
Sbjct: 119 VKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----------NGIMS 165
Query: 398 ---GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEES 446
GT GY APE S D +S GV+ L+ G P + I +G
Sbjct: 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYY- 224
Query: 447 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----CLQLDPDARPTMSE 502
+F ++ AK+ L+ DP+ R T +
Sbjct: 225 --------------------------EFESPFWDDISESAKDFICHLLEKDPNERYTCEK 258
Query: 503 VVQ---ILSTIAPDKSRRRNISLNLFQIFSA 530
+ I A + ++SL + + A
Sbjct: 259 ALSHPWIDGNTALHRDIYPSVSLQIQK-NFA 288
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 3e-20
Identities = 66/303 (21%), Positives = 101/303 (33%), Gaps = 61/303 (20%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSV------------FL 270
+ + +G G V + A+K K
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 271 TEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDT 329
E+ +L L H +++ L + LV EF G L + ++ +D
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFED-----KKYFYLVTEFYEGGELFE----QIINRHKFDE 145
Query: 330 RVAIAIGA--ARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKAD 384
A I G+ YLH+ I+HRDIK NILL + LN KI D G++ D
Sbjct: 146 CDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD 202
Query: 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 444
GT Y APE + + + DV+S GV++ L+ G P +
Sbjct: 203 ------YKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI 255
Query: 445 ESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----CLQLDPDARPTM 500
V + K F + + ++ AKE L D + R T
Sbjct: 256 IKKVE-------------------KGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTA 296
Query: 501 SEV 503
E
Sbjct: 297 EEA 299
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 5e-20
Identities = 65/306 (21%), Positives = 115/306 (37%), Gaps = 48/306 (15%)
Query: 209 HGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD- 266
H + R + ++++ ++G+G V + + AVK N D
Sbjct: 6 HHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT 65
Query: 267 SVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMN 326
S L EV++L +L H +++ L + + + V E G L D +++
Sbjct: 66 STILREVELLKKLDHPNIMKLFEILED---SSSFYI-VGELYTGGELFD----EIIKRKR 117
Query: 327 WDTRVA--IAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRL 381
+ A I G+ Y+H+ I+HRD+K NILL +++ + KI D G++
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174
Query: 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441
+ + GT Y APE + G DV+S GV+L L++G P +
Sbjct: 175 QQNTKMK------DRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNE 227
Query: 442 KGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----CLQLDPDAR 497
V F + + ++ AK+ L P R
Sbjct: 228 YDILKRVETGKY-------------------AFDLPQWRTISDDAKDLIRKMLTFHPSLR 268
Query: 498 PTMSEV 503
T ++
Sbjct: 269 ITATQC 274
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 8e-20
Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 29/225 (12%)
Query: 223 ATDKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNADSVF----LTEVDM 275
AT ++ +G G +Y VY+ + G VA+K + G + EV +
Sbjct: 7 ATSRYEPVAEIGVG--AYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 276 LSRLH---HCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRV 331
L RL H +VV L+ C+ R R +++ LVFE + +LR LD G+ +T
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123
Query: 332 AIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSS 391
+ RGL++LH I+HRD+K NIL+ K+ D G+A+ S
Sbjct: 124 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIY---------S 171
Query: 392 SPARMQG---TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 433
+ T Y APE + + D++S G + E+ +
Sbjct: 172 YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 74/299 (24%), Positives = 112/299 (37%), Gaps = 76/299 (25%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVK---RFKTQGGPNADSVFLTEVDMLSRLHHCHVVPL-- 287
G+G V AVK + K + PN ++ E+ +L RL H +V+ L
Sbjct: 14 GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVD 73
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR-------- 339
V Y E + +V E+ G +++ LD V + A
Sbjct: 74 VLYNEE----KQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQ--------AHGYFCQLID 120
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA---KRLKADGLPSCSSSPARM 396
GLEYLH + I+H+DIK N+LL KI+ LG+A AD C +S
Sbjct: 121 GLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDT--CRTS---- 171
Query: 397 QGTFGYFAPEYAMVGR--ASLMSDVFSFGVVLLELITGRQPIH--------RSITKGEES 446
QG+ + PE A + D++S GV L + TG P +I KG +
Sbjct: 172 QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA 231
Query: 447 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
+ P L D L K L+ +P R ++ ++ Q
Sbjct: 232 IPGDCGPPLSD---------------------------LLKGMLEYEPAKRFSIRQIRQ 263
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 70/298 (23%), Positives = 106/298 (35%), Gaps = 82/298 (27%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVKR------FKTQGGPNADSVFLTEVDMLSRLHHC--HV 284
G GG VY G ++D VA+K PN V + EV +L ++ V
Sbjct: 52 GSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKVSSGFSGV 110
Query: 285 VPLVGYCSEFRGKRAMRLLVFEF-MPNGNLRDCLD--GVLVEGMNWDTRVAIAIGAAR-- 339
+ L+ ++ + +L+ E P +L D + G L E + AR
Sbjct: 111 IRLL----DWFERPDSFVLILERPEPVQDLFDFITERGALQEEL------------ARSF 154
Query: 340 ------GLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKITDLGMAKRLKADGL--PSCS 390
+ + H +LHRDIK NIL+D N K+ D G LK D +
Sbjct: 155 FWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFD- 209
Query: 391 SSPARMQGTFGYFAPEYAMVGR-ASLMSDVFSFGVVLLELITGRQPIH--RSITKGEESL 447
GT Y PE+ R + V+S G++L +++ G P I +G+
Sbjct: 210 -------GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF 262
Query: 448 VLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
+ Q L + CL L P RPT E+
Sbjct: 263 RQRVSSECQH---------------------------LIRWCLALRPSDRPTFEEIQN 293
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 66/327 (20%), Positives = 117/327 (35%), Gaps = 82/327 (25%)
Query: 233 VGQGGSSYVYRGQ---LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
VG+G +VY+ + D + A+K+ + G + E+ +L L H +V+ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA---CREIALLRELKHPNVISLQK 85
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA----------R 339
++ L+F++ + +L + + + + +
Sbjct: 86 VFLSHADRKVW--LLFDYAEH-DLWHIIK---FHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNA----KITDLGMAKRLKADGLPSCSSSPAR 395
G+ YLH +LHRD+K +NIL+ KI D+G A RL L +
Sbjct: 140 GIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA-RLFNSPLKPLADLDPV 195
Query: 396 MQGTFGYFAPE-------YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 448
+ TF Y APE Y + D+++ G + EL+T PI + +
Sbjct: 196 VV-TFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE-PIF----HCRQEDI 243
Query: 449 LWATPRLQDS--------GT-------VISELPD-PRLKGDFPKEEMQIMAY-------- 484
+ P D G I ++P+ L DF + +
Sbjct: 244 KTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHK 303
Query: 485 ---------LAKECLQLDPDARPTMSE 502
L ++ L +DP R T +
Sbjct: 304 VKPDSKAFHLLQKLLTMDPIKRITSEQ 330
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 81/317 (25%), Positives = 127/317 (40%), Gaps = 57/317 (17%)
Query: 223 ATDKFSGS---------NIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTE 272
+TD FSG +++G+G + V L + AVK + Q G VF E
Sbjct: 2 STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF-RE 60
Query: 273 VDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDT 329
V+ML + H +V+ L+ + E LVFE M G++ E
Sbjct: 61 VEMLYQCQGHRNVLELIEFFEE----EDRFYLVFEKMRGGSILSHIHKRRHFNE------ 110
Query: 330 RVAIAI--GAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKAD 384
A + A L++LH I HRD+K NIL ++ KI D + +K +
Sbjct: 111 LEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167
Query: 385 GLPSCSSSPARMQ--GTFGYFAPEYAMVGRASLMS--------DVFSFGVVLLELITGRQ 434
G S S+P + G+ Y APE V A D++S GV+L L++G
Sbjct: 168 GDCSPISTPELLTPCGSAEYMAPE---VVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224
Query: 435 PIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKG--DFPKEEMQIMAYLAKE---- 488
P A P Q+ L + +G +FP ++ ++ AK+
Sbjct: 225 PFVGRCGSDCGWDRGEACPACQN------MLFESIQEGKYEFPDKDWAHISCAAKDLISK 278
Query: 489 CLQLDPDARPTMSEVVQ 505
L D R + ++V+Q
Sbjct: 279 LLVRDAKQRLSAAQVLQ 295
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 77/340 (22%), Positives = 122/340 (35%), Gaps = 81/340 (23%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVK-----RFKTQGGPNADSVFLTEVDMLS 277
D + ++G+G S V R G+ AVK +F + G + + + E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK-REASICH 81
Query: 278 RLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT---RVAIA 334
L H H+V L+ S M +VFEFM +L ++ VA
Sbjct: 82 MLKHPHIVELLETYSS----DGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASH 134
Query: 335 IGAAR----GLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLP 387
R L Y H+ I+HRD+K +LL + + K+ G+A +L G
Sbjct: 135 Y--MRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG-- 187
Query: 388 SCSSSPARMQ---GTFGYFAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQP------- 435
GT + APE +V R DV+ GV+L L++G P
Sbjct: 188 ------LVAGGRVGTPHFMAPE--VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER 239
Query: 436 IHRSITKGEESLV--LWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLD 493
+ I KG+ + W+ ISE K+ L + L LD
Sbjct: 240 LFEGIIKGKYKMNPRQWSH---------ISES---------AKD-------LVRRMLMLD 274
Query: 494 PDARPTMSEVVQ---ILSTIAPDKSRRRNISLNLFQIFSA 530
P R T+ E + + ++ + F+A
Sbjct: 275 PAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNA 314
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 4e-19
Identities = 72/316 (22%), Positives = 114/316 (36%), Gaps = 84/316 (26%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVK-----RFKTQGGPNADSV--FLTEVDM 275
D++ S +G G V + + VA++ +F AD TE+++
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 276 LSRLHHCHVVPLVGYCSE---FRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTR 330
L +L+H ++ + + + +V E M G L D + L E +
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDYY--------IVLELMEGGELFDKVVGNKRLKEA---TCK 242
Query: 331 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLP 387
++YLHE I+HRD+K N+LL +E+ KITD G +K L L
Sbjct: 243 -LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 298
Query: 388 S--CSSSPARMQGTFGYFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP------- 435
C GT Y APE + D +S GV+L ++G P
Sbjct: 299 RTLC--------GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 350
Query: 436 --IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----C 489
+ IT G K +F E ++ A +
Sbjct: 351 VSLKDQITSG---------------------------KYNFIPEVWAEVSEKALDLVKKL 383
Query: 490 LQLDPDARPTMSEVVQ 505
L +DP AR T E ++
Sbjct: 384 LVVDPKARFTTEEALR 399
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 6e-19
Identities = 56/336 (16%), Positives = 86/336 (25%), Gaps = 88/336 (26%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSV----FLTEVDMLSR 278
K+ +GQG V + I A+K + TEV ++ +
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 279 LHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD-------------------CLDG 319
LHH ++ L + LV E G+L D
Sbjct: 85 LHHPNIARLYEVYED----EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 320 VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR----------------ILHRDIKSSNIL 363
E +I E I HRDIK N L
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200
Query: 364 L--DENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE--YAMVGRASLMSDV 419
+++ K+ D G++K GT + APE D
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLN-NGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259
Query: 420 FSFGVVLLELITGRQP--------IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLK 471
+S GV+L L+ G P + K
Sbjct: 260 WSAGVLLHLLLMGAVPFPGVNDADTISQVLNK---------------------------K 292
Query: 472 GDFPKEEMQIMAYLAKE----CLQLDPDARPTMSEV 503
F +++ LA++ L + D R
Sbjct: 293 LCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA 328
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 7e-19
Identities = 82/315 (26%), Positives = 132/315 (41%), Gaps = 73/315 (23%)
Query: 225 DKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNADSVF----LTEVDMLS 277
+K+ +VG+G SY V + + GRIVA+K+F + D + + E+ +L
Sbjct: 25 EKYENLGLVGEG--SYGMVMKCRNKDTGRIVAIKKFLES---DDDKMVKKIAMREIKLLK 79
Query: 278 RLHHCHVVPLVGYCSE-FRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI 335
+L H ++V L+ E + K+ R LVFEF+ + + D L+ + G+++
Sbjct: 80 QLRHENLVNLL----EVCKKKK--RWYLVFEFVDH-TILDDLE-LFPNGLDYQVVQKYLF 131
Query: 336 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 395
G+ + H I+HRDIK NIL+ ++ K+ D G A R A A
Sbjct: 132 QIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFA-RTLAAPGEVYDDEVA- 186
Query: 396 MQGTFGYFAPE-------YAM-VGRASLMSDVFSFGVVLLELITGR----------Q--- 434
T Y APE Y V DV++ G ++ E+ G Q
Sbjct: 187 ---TRWYRAPELLVGDVKYGKAV-------DVWAIGCLVTEMFMGEPLFPGDSDIDQLYH 236
Query: 435 -------PIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAK 487
I R + ++A RL + L+ +PK ++ LAK
Sbjct: 237 IMMCLGNLIPR-HQELFNKNPVFAGVRLPEI------KEREPLERRYPKLSEVVID-LAK 288
Query: 488 ECLQLDPDARPTMSE 502
+CL +DPD RP +E
Sbjct: 289 KCLHIDPDKRPFCAE 303
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 8e-19
Identities = 62/301 (20%), Positives = 97/301 (32%), Gaps = 88/301 (29%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVK---RFKTQGGPNADSVFLT----EVDMLSRLHHCHVV 285
G G +V+ + V VK + K + L E+ +LSR+ H +++
Sbjct: 33 GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92
Query: 286 PLVGYCSEFRGKRAMRLLVFEFMPNGN-LRDCLD--GVLVEGMNWDTRVAIAIGAAR--- 339
++ + + LV E +G L +D L E + A
Sbjct: 93 KVL----DIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPL------------ASYIF 136
Query: 340 -----GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSS 392
+ YL I+HRDIK NI++ E+ K+ D G A L+ L C
Sbjct: 137 RQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC--- 190
Query: 393 PARMQGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQPIH--RSITKGE 444
GT Y APE Y G +++S GV L L+ P +
Sbjct: 191 -----GTIEYCAPEVLMGNPYR--GPE---LEMWSLGVTLYTLVFEENPFCELEETVEAA 240
Query: 445 ESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVV 504
+ L L LQ P+ R T+ ++V
Sbjct: 241 IHPPYLVSKELMS---------------------------LVSGLLQPVPERRTTLEKLV 273
Query: 505 Q 505
Sbjct: 274 T 274
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 73/405 (18%), Positives = 135/405 (33%), Gaps = 96/405 (23%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHH 281
T+++ +G+G S V R ++ G+ A T+ D E + L H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 282 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAI--GA 337
++V L SE L+F+ + G L + E A
Sbjct: 70 PNIVRLHDSISE----EGHHYLIFDLVTGGELFEDIVAREYYSE------ADASHCIQQI 119
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPA 394
+ + H+ ++HR++K N+LL + K+ D G+A ++ +
Sbjct: 120 LEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--------Q 168
Query: 395 RMQ---GTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IH 437
GT GY +PE Y G+ D+++ GV+L L+ G P ++
Sbjct: 169 AWFGFAGTPGYLSPEVLRKDPY---GKP---VDLWACGVILYILLVGYPPFWDEDQHRLY 222
Query: 438 RSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----CLQLD 493
+ I G DFP E + AK+ L ++
Sbjct: 223 QQIKAG---------------------------AYDFPSPEWDTVTPEAKDLINKMLTIN 255
Query: 494 PDARPTMSEVVQ---ILSTIAPDKSRRRNISLNLFQIFSAGGMEK-EPSIERPDNLFETL 549
P R T +E ++ I R +++ + F+A K + +I
Sbjct: 256 PSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNA--RRKLKGAILTVMLATRNF 313
Query: 550 IESEELKKATSFGSPRCSQAVDTDITLNTRSNSKEEDTVSTEYME 594
++ + Q ++ + S +K D T +
Sbjct: 314 SVRKQEIIKVTE------QLIEAISNGDFESYTKMCDPGMTAFEP 352
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 66/304 (21%), Positives = 118/304 (38%), Gaps = 71/304 (23%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 282
D + +G G V+R + GR+ K T + +V E+ ++++LHH
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV-KNEISIMNQLHHP 108
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR--- 339
++ L F K M +L+ EF+ G L D + E I R
Sbjct: 109 KLINLHDA---FEDKYEM-VLILEFLSGGEL---FDRIAAEDYKMSEAEVINY--MRQAC 159
Query: 340 -GLEYLHEAAAPRILHRDIKSSNILL--DENLNAKITDLGMAKRLKADGLPSCSSSPARM 396
GL+++HE I+H DIK NI+ + + KI D G+A +L D +
Sbjct: 160 EGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV------T 210
Query: 397 QGTFGYFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEE 445
T + APE VG +D+++ GV+ L++G P +++ + +
Sbjct: 211 TATAEFAAPEIVDREPVGFY---TDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD- 266
Query: 446 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----CLQLDPDARPTMS 501
W +F ++ ++ AK+ LQ +P R T+
Sbjct: 267 ----W----------------------EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVH 300
Query: 502 EVVQ 505
+ ++
Sbjct: 301 DALE 304
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 66/294 (22%), Positives = 124/294 (42%), Gaps = 39/294 (13%)
Query: 225 DKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
+ + + +G+G + VY+G +VA+K + + A + EV +L L H +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 284 VVPL--VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 341
+V L + ++++ LVFE++ +L+ LD +N RGL
Sbjct: 62 IVTLHDI-----IHTEKSL-TLVFEYLDK-DLKQYLDDCGN-IINMHNVKLFLFQLLRGL 113
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
Y H ++LHRD+K N+L++E K+ D G+A +A +P+ + + T
Sbjct: 114 AYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLA---RAKSIPTKTYDNEVV--TLW 165
Query: 402 YFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA---TPRLQD 457
Y P+ + S D++ G + E+ TGR P+ T E+ ++ TP +
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR-PLFPGSTVEEQLHFIFRILGTPTEET 224
Query: 458 -SGTVISELPDPRLKGDFPKEEMQIMAY-----------LAKECLQLDPDARPT 499
G I + + ++PK + + L + LQ + R +
Sbjct: 225 WPG--ILSNEEFK-TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRIS 275
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 38/238 (15%), Positives = 76/238 (31%), Gaps = 35/238 (14%)
Query: 220 LEHATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEV 273
+ + +++G+G + VY D + +K K P + +
Sbjct: 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK-PANPWEFYIGTQLM 118
Query: 274 DMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD---GVLVEGMNWDTR 330
+ L + F+ LV E G L + ++ + M
Sbjct: 119 ERLKPSMQHMFMKFY-SAHLFQNGSV---LVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174
Query: 331 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL-----------DENLNAKITDLGMAK 379
++ A+ +E +H+ I+H DIK N +L D + + DLG +
Sbjct: 175 ISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRAS--LMSDVFSFGVVLLELITGRQP 435
+K + ++ T G+ E M+ D F + ++ G
Sbjct: 232 DMKLFPKGTIFTAKC---ETSGFQCVE--MLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 68/327 (20%), Positives = 106/327 (32%), Gaps = 111/327 (33%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVK---------------RFKTQGGPNADSVFLTEVDMLS 277
G+G V D A+K R +G A + +
Sbjct: 22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81
Query: 278 R----------LHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-DGVLVEGMN 326
+ L H +VV L +VFE + G + + L E
Sbjct: 82 QVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED-- 137
Query: 327 WDTRVAIAIGAAR--------GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378
AR G+EYLH +I+HRDIK SN+L+ E+ + KI D G++
Sbjct: 138 ----------QARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 379 KRLK-ADGLPSCSS-SPARMQGTFGYFAPE--------YAMVGRASLMSDVFSFGVVLLE 428
K +D L S + +PA + APE ++ G+A DV++ GV L
Sbjct: 185 NEFKGSDALLSNTVGTPA-------FMAPESLSETRKIFS--GKA---LDVWAMGVTLYC 232
Query: 429 LITGRQP--------IHRSITKGEESLVLWA--TPRLQDSGTVISELPDPRLKGDFPKEE 478
+ G+ P +H I L+D
Sbjct: 233 FVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKD--------------------- 271
Query: 479 MQIMAYLAKECLQLDPDARPTMSEVVQ 505
L L +P++R + E+
Sbjct: 272 ------LITRMLDKNPESRIVVPEIKL 292
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 66/307 (21%), Positives = 106/307 (34%), Gaps = 98/307 (31%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVKR------FKTQGGPNADSVFLTEVDMLSRLH----HC 282
G+GG V+ G LTD VA+K ++ + L EV +L ++ H
Sbjct: 40 GKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGGHP 98
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD-----GVLVEGMNWDTRVAIAIGA 337
V+ L+ ++ + +LV E +D D G L EG
Sbjct: 99 GVIRLL----DWFETQEGFMLVLERPLPA--QDLFDYITEKGPLGEGP------------ 140
Query: 338 AR--------GLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGL-- 386
+R +++ H ++HRDIK NIL+D AK+ D G L D
Sbjct: 141 SRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLH-DEPYT 196
Query: 387 PSCSSSPARMQGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQPIH--R 438
GT Y PE Y + V+S G++L +++ G P +
Sbjct: 197 DFD--------GTRVYSPPEWISRHQYH--ALP---ATVWSLGILLYDMVCGDIPFERDQ 243
Query: 439 SITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP 498
I + E +P L + CL P +RP
Sbjct: 244 EILEAELHFPAHVSPDCCA---------------------------LIRRCLAPKPSSRP 276
Query: 499 TMSEVVQ 505
++ E++
Sbjct: 277 SLEEILL 283
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 75/313 (23%), Positives = 112/313 (35%), Gaps = 76/313 (24%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSV--------FLTEVD 274
+ + I+G+G SS V R + AVK GG + + L EVD
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 275 MLSRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRV 331
+L ++ H +++ L LVF+ M G L D L E +TR
Sbjct: 76 ILRKVSGHPNIIQLKDTYET----NTFFFLVFDLMKKGELFDYLTEKVTLSEK---ETRK 128
Query: 332 AI-AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS-- 388
+ A+ + LH+ I+HRD+K NILLD+++N K+TD G + +L
Sbjct: 129 IMRAL--LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV 183
Query: 389 CSSSPARMQGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP------- 435
C GT Y APE D++S GV++ L+ G P
Sbjct: 184 C--------GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 235
Query: 436 -IHRSITKGEESLVL--WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQL 492
+ R I G W S+ K+ L L +
Sbjct: 236 LMLRMIMSGNYQFGSPEWDD---------YSDT---------VKD-------LVSRFLVV 270
Query: 493 DPDARPTMSEVVQ 505
P R T E +
Sbjct: 271 QPQKRYTAEEALA 283
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 3e-18
Identities = 81/305 (26%), Positives = 141/305 (46%), Gaps = 61/305 (20%)
Query: 225 DKFSGSNIVGQGGSSY--VYRGQLTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLSR 278
+K+ VG+G +Y VY+ + + GRIVA+KR + +G P S + E+ +L
Sbjct: 21 EKYQKLEKVGEG--TYGVVYKAKDSQGRIVALKRIRLDAEDEGIP---STAIREISLLKE 75
Query: 279 LHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA 338
LHH ++V L+ +R + LVFEFM +L+ LD + + +
Sbjct: 76 LHHPNIVSLI---DVIHSERCL-TLVFEFMEK-DLKKVLD---------ENKTGLQDSQI 121
Query: 339 --------RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 390
RG+ + H+ RILHRD+K N+L++ + K+ D G+A +A G+P S
Sbjct: 122 KIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLA---RAFGIPVRS 175
Query: 391 SSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 449
+ + T Y AP+ M + S D++S G + E+ITG+ P+ +T ++ +
Sbjct: 176 YTHEVV--TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKI 232
Query: 450 WA---TPRLQD-SGTVISELPDPRLKGDFPKEEMQIMAY-----------LAKECLQLDP 494
++ TP ++ + ELP + + F E + + L L DP
Sbjct: 233 FSILGTPNPREWPQ--VQELPLWK-QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDP 289
Query: 495 DARPT 499
+ R +
Sbjct: 290 NKRIS 294
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 3e-18
Identities = 76/315 (24%), Positives = 122/315 (38%), Gaps = 73/315 (23%)
Query: 225 DKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNADSVF----LTEVDMLS 277
+K+ +G+G SY V++ + G+IVA+K+F D V L E+ ML
Sbjct: 3 EKYEKIGKIGEG--SYGVVFKCRNRDTGQIVAIKKFLES---EDDPVIKKIALREIRMLK 57
Query: 278 RLHHCHVVPL--VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI 335
+L H ++V L V FR KR + LVFE+ + + LD G+ +I
Sbjct: 58 QLKHPNLVNLLEV-----FRRKRRL-HLVFEYCDH-TVLHELDRYQR-GVPEHLVKSITW 109
Query: 336 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 395
+ + + H+ +HRD+K NIL+ ++ K+ D G A RL A
Sbjct: 110 QTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFA-RLLTGPSDYYDDEVA- 164
Query: 396 MQGTFGYFAPE-------YAMVGRASLMSDVFSFGVVLLELITGR----------QPIHR 438
T Y +PE Y DV++ G V EL++G Q ++
Sbjct: 165 ---TRWYRSPELLVGDTQY------GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ-LYL 214
Query: 439 SITK-----------GEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAK 487
I K + ++ ++ D L+ FP + L
Sbjct: 215 -IRKTLGDLIPRHQQVFSTNQYFSGVKIPDP------EDMEPLELKFPNISYPALGLLKG 267
Query: 488 ECLQLDPDARPTMSE 502
CL +DP R T +
Sbjct: 268 -CLHMDPTERLTCEQ 281
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 4e-18
Identities = 69/299 (23%), Positives = 107/299 (35%), Gaps = 84/299 (28%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVK---RFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
G G V G+ G VAVK R K + + E+ L H H++ L
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK-REIQNLKLFRHPHIIKL-- 76
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAIGAAR-------- 339
Y + +V E++ G L D C G + E AR
Sbjct: 77 Y--QVISTPTDFFMVMEYVSGGELFDYICKHGRVEEM------------EARRLFQQILS 122
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSSPARMQ 397
++Y H ++HRD+K N+LLD ++NAKI D G++ + SC SP
Sbjct: 123 AVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-GSPN--- 175
Query: 398 GTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEES 446
Y APE ++ A D++S GV+L L+ G P + + I G
Sbjct: 176 ----YAAPE--VISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY 229
Query: 447 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
+ + + L LQ+DP R T+ ++ +
Sbjct: 230 IPEYLNRSVAT---------------------------LLMHMLQVDPLKRATIKDIRE 261
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 4e-18
Identities = 77/299 (25%), Positives = 137/299 (45%), Gaps = 50/299 (16%)
Query: 225 DKFSGSNIVGQGGSSY--VYRGQLTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLSR 278
+K+ G +G+G +Y VY+ Q G A+K+ + +G P S + E+ +L
Sbjct: 2 EKYHGLEKIGEG--TYGVVYKAQNNYGETFALKKIRLEKEDEGIP---STTIREISILKE 56
Query: 279 LHHCHVVPL--VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIG 336
L H ++V L V K+ + +LVFE + +L+ LD V G+ T + +
Sbjct: 57 LKHSNIVKLYDV-----IHTKKRL-VLVFEHLDQ-DLKKLLD-VCEGGLESVTAKSFLLQ 108
Query: 337 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARM 396
G+ Y H+ R+LHRD+K N+L++ KI D G+A +A G+P + +
Sbjct: 109 LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLA---RAFGIPVRKYTHEIV 162
Query: 397 QGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA---T 452
T Y AP+ M + S D++S G + E++ G P+ +++ ++ + ++ T
Sbjct: 163 --TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT-PLFPGVSEADQLMRIFRILGT 219
Query: 453 PRLQD-SGTVISELPDPRLKGDFPKEEMQIMAY-----------LAKECLQLDPDARPT 499
P ++ ++ELP +F E L + L+LDP+ R T
Sbjct: 220 PNSKNWPN--VTELPK--YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT 274
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 4e-18
Identities = 68/299 (22%), Positives = 122/299 (40%), Gaps = 48/299 (16%)
Query: 225 DKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLS 277
K+ +G+G +Y V++ + IVA+KR + +G P S L E+ +L
Sbjct: 2 QKYEKLEKIGEG--TYGTVFKAKNRETHEIVALKRVRLDDDDEGVP---SSALREICLLK 56
Query: 278 RLHHCHVVPL--VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI 335
L H ++V L V + + LVFEF +L+ D ++ + +
Sbjct: 57 ELKHKNIVRLHDV-----LHSDKKL-TLVFEFCDQ-DLKKYFDSCNG-DLDPEIVKSFLF 108
Query: 336 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 395
+GL + H +LHRD+K N+L++ N K+ + G+A +A G+P S
Sbjct: 109 QLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLA---RAFGIPVRCYSAEV 162
Query: 396 MQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA--- 451
+ T Y P+ + S D++S G + EL +P+ ++ ++
Sbjct: 163 V--TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220
Query: 452 TPRLQD-SGTVISELPD----------PRLKGDFPKEEMQIMAYLAKECLQLDPDARPT 499
TP + +++LPD L PK L + L+ +P R +
Sbjct: 221 TPTEEQWPS--MTKLPDYKPYPMYPATTSLVNVVPKLNATGRD-LLQNLLKCNPVQRIS 276
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 5e-18
Identities = 65/235 (27%), Positives = 103/235 (43%), Gaps = 54/235 (22%)
Query: 224 TDKFSGSNIVGQGGSSY--VYRGQLTDGRIVAVKRFKTQGGPNADSVF-LTEVDMLSRLH 280
++ ++G G S+ V++ +L + VA+K+ D F E+ ++ +
Sbjct: 39 EIAYTNCKVIGNG--SFGVVFQAKLVESDEVAIKKVL------QDKRFKNRELQIMRIVK 90
Query: 281 HCHVVPLVGY-CSEFRGKRAMRL-LVFEFMP---------NGNLRDCLDGVLVEGMNWDT 329
H +VV L + S K + L LV E++P L+ + +L++ +
Sbjct: 91 HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQL 150
Query: 330 RVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA-KITDLGMAKRLKADGLPS 388
R L Y+H I HRDIK N+LLD K+ D G AK L A G P+
Sbjct: 151 --------LRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA-GEPN 198
Query: 389 ----CSSSPARMQGTFGYFAPEYAMVGRASLMS---DVFSFGVVLLELITGRQPI 436
CS R Y APE + G A+ + D++S G V+ EL+ G QP+
Sbjct: 199 VSYICS----RY-----YRAPE-LIFG-ATNYTTNIDIWSTGCVMAELMQG-QPL 241
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 78/303 (25%), Positives = 128/303 (42%), Gaps = 42/303 (13%)
Query: 222 HATDKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSR 278
++ +F +G G +Y VY+G T G VA+K K S + E+ ++
Sbjct: 2 SSSSQFKQLEKLGNG--TYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKE 59
Query: 279 LHHCHVVPL--VGYCSEFRGKRAMRLLVFEFMPN---GNLRDCLDGVLVEGMNWDTRVAI 333
L H ++V L V + + LVFEFM N + G G+ +
Sbjct: 60 LKHENIVRLYDV-----IHTENKL-TLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYF 113
Query: 334 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSP 393
+GL + HE +ILHRD+K N+L+++ K+ D G+A +A G+P + S
Sbjct: 114 QWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA---RAFGIPVNTFSS 167
Query: 394 ARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA- 451
+ T Y AP+ M R S D++S G +L E+ITG+ P+ E+ +++
Sbjct: 168 EVV--TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK-PLFPGTNDEEQLKLIFDI 224
Query: 452 --TP---------RLQDSGTVISELPDPRLKGDFPKEEMQIMAY----LAKECLQLDPDA 496
TP +L I + P L+ + + LQL+PD
Sbjct: 225 MGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDM 284
Query: 497 RPT 499
R +
Sbjct: 285 RLS 287
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 6e-18
Identities = 71/329 (21%), Positives = 117/329 (35%), Gaps = 83/329 (25%)
Query: 221 EHATDKFSGSNIVGQGGSSY--VYRGQLTD-GRIVAVKR-FKTQGGPNADSVF----LTE 272
D+F + GQG ++ V G+ G VA+K+ D F L
Sbjct: 19 RKEMDRFQVERMAGQG--TFGTVQLGKEKSTGMSVAIKKVI-------QDPRFRNRELQI 69
Query: 273 VDMLSRLHHCHVVPL--VGYCSEFRGKRAMRL-LVFEFMP---------NGNLRDCLDGV 320
+ L+ LHH ++V L Y R +R + L +V E++P + +
Sbjct: 70 MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPI 129
Query: 321 LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAK 379
L++ + R + LH + + HRDIK N+L++ + K+ D G AK
Sbjct: 130 LIKVFLFQL--------IRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180
Query: 380 RLKADGLPS----CSSSPARMQGTFGYFAPEYAMVGRASLMS---DVFSFGVVLLELITG 432
+L P+ CS R Y APE + G + D++S G + E++ G
Sbjct: 181 KLSPSE-PNVAYICS----RY-----YRAPEL-IFG-NQHYTTAVDIWSVGCIFAEMMLG 228
Query: 433 R------QPIH--RSITKGEESLVLWATPRLQDSGTVIS---ELPDPRLKG-----DFPK 476
I + VL P + + ++ KG F
Sbjct: 229 EPIFRGDNSAGQLHEIVR-----VL-GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSD 282
Query: 477 EEMQIMA---YLAKECLQLDPDARPTMSE 502
++ L LQ P+ R E
Sbjct: 283 HSLKDAKEAYDLLSALLQYLPEERMKPYE 311
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 7e-18
Identities = 66/234 (28%), Positives = 102/234 (43%), Gaps = 51/234 (21%)
Query: 224 TDKFSGSNIVGQGGSSY--VYRGQLTD-GRIVAVKRFKTQGGPNADSVF-LTEVDMLSRL 279
++ + ++G G S+ VY+ +L D G +VA+K+ D F E+ ++ +L
Sbjct: 53 EVSYTDTKVIGNG--SFGVVYQAKLCDSGELVAIKKVL------QDKRFKNRELQIMRKL 104
Query: 280 HHCHVVPLVGY-CSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIG- 336
HC++V L + S K + L LV +++P + + + +
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARH------YSRAKQTLPVIY 157
Query: 337 -------AARGLEYLHEAAAPRILHRDIKSSNILLDENLNA-KITDLGMAKRLKADGLPS 388
R L Y+H I HRDIK N+LLD + K+ D G AK+L P+
Sbjct: 158 VKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PN 213
Query: 389 ----CSSSPARMQGTFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGRQPI 436
CS R Y APE + G + DV+S G VL EL+ G QPI
Sbjct: 214 VSYICS----RY-----YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLG-QPI 256
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 7e-18
Identities = 72/281 (25%), Positives = 117/281 (41%), Gaps = 39/281 (13%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVF--LTEVDMLSRLHH 281
D F ++G+GG V+ Q+ G++ A K+ + + E +L+++H
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 282 CHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA--A 338
+V L Y F K L LV M G++R + V + + AI A
Sbjct: 245 RFIVSLA-YA--FETKT--DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
GLE+LH+ I++RD+K N+LLD++ N +I+DLG+A LKA + G
Sbjct: 300 SGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ-----TKTKGYAG 351
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP------------IHRSITKGEES 446
T G+ APE + D F+ GV L E+I R P + + + + +
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT 411
Query: 447 LVLWATPRLQDSGTVISEL----PDPRLKGDFPKEEMQIMA 483
+P +D L P+ RL G +
Sbjct: 412 YPDKFSPASKD---FCEALLQKDPEKRL-GFRDGSCDGLRT 448
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 7e-18
Identities = 68/319 (21%), Positives = 123/319 (38%), Gaps = 70/319 (21%)
Query: 209 HGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD- 266
H + R + ++++ ++G+G V + + AVK N D
Sbjct: 6 HHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT 65
Query: 267 SVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMN 326
S L EV++L +L H +++ L + + +V E G L D +++
Sbjct: 66 STILREVELLKKLDHPNIMKLFEILED----SSSFYIVGELYTGGELFD----EIIKRKR 117
Query: 327 WDTRVA--IAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRL 381
+ A I G+ Y+H+ I+HRD+K NILL +++ + KI D G++
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174
Query: 382 KADGLPSCSSSPARMQ---GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--- 435
+ + +M+ GT Y APE + G DV+S GV+L L++G P
Sbjct: 175 QQNT---------KMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYG 224
Query: 436 -----IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE-- 488
I + + G K F + + ++ AK+
Sbjct: 225 KNEYDILKRVETG---------------------------KYAFDLPQWRTISDDAKDLI 257
Query: 489 --CLQLDPDARPTMSEVVQ 505
L P R T ++ ++
Sbjct: 258 RKMLTFHPSLRITATQCLE 276
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 7e-18
Identities = 52/176 (29%), Positives = 77/176 (43%), Gaps = 32/176 (18%)
Query: 270 LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNW 327
E+ ++ L H +V L Y F+ + M +V + + G+LR L + E
Sbjct: 63 FKELQIMQGLEHPFLVNLW-YS--FQDEEDM-FMVVDLLLGGDLRYHLQQNVHFKEE--- 115
Query: 328 DTRVAIA-IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386
++ I + A L+YL RI+HRD+K NILLDE+ + ITD +A L +
Sbjct: 116 TVKLFICELVMA--LDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170
Query: 387 PS--CSSSPARMQGTFGYFAPEYAMVGRASLMS-----DVFSFGVVLLELITGRQP 435
+ GT Y APE M D +S GV EL+ GR+P
Sbjct: 171 ITTMA--------GTKPYMAPE--MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 9e-18
Identities = 55/305 (18%), Positives = 112/305 (36%), Gaps = 72/305 (23%)
Query: 221 EHATDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL 279
+ +K+ + +G+G V+R + + + K K +G E+ +L+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL--VKKEISILNIA 58
Query: 280 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR 339
H +++ L F + +++FEF+ ++ + + + R ++
Sbjct: 59 RHRNILHLHES---FESMEEL-VMIFEFISGLDI---FERINTSAFELNEREIVSY--VH 109
Query: 340 ----GLEYLHEAAAPRILHRDIKSSNILL--DENLNAKITDLGMAKRLKADGLPSCSSSP 393
L++LH I H DI+ NI+ + KI + G A++LK
Sbjct: 110 QVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---- 162
Query: 394 ARMQGTFGYFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITK 442
+ Y+APE + +V A +D++S G ++ L++G P I +I
Sbjct: 163 --LFTAPEYYAPEVHQHDVVSTA---TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN 217
Query: 443 GEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----CLQLDPDARP 498
E + F +E + ++ A + L + +R
Sbjct: 218 AE-----Y----------------------TFDEEAFKEISIEAMDFVDRLLVKERKSRM 250
Query: 499 TMSEV 503
T SE
Sbjct: 251 TASEA 255
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 65/346 (18%), Positives = 116/346 (33%), Gaps = 93/346 (26%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVK-----RFKTQGGPNADSVFLTEVDMLS 277
D + +G G + V + + + G A K + + + EV +L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 278 RLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAI 335
++ H +V+ L + + + +L+ E + G L D L E A
Sbjct: 71 QVLHHNVITLHDV---YENRTDV-VLILELVSGGELFDFLAQKESLSE--------EEAT 118
Query: 336 GAAR----GLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMAKRLKADGLP 387
+ G+ YLH +I H D+K NI+L + K+ D G+A ++
Sbjct: 119 SFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-- 173
Query: 388 SCSSSPARMQGTFG---YFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP------ 435
+ FG + APE Y +G +D++S GV+ L++G P
Sbjct: 174 -------EFKNIFGTPEFVAPEIVNYEPLGLE---ADMWSIGVITYILLSGASPFLGDTK 223
Query: 436 --IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----C 489
+IT + DF +E + LAK+
Sbjct: 224 QETLANITSVS-----Y----------------------DFDEEFFSHTSELAKDFIRKL 256
Query: 490 LQLDPDARPTMSEV-----VQILSTIAPDKSRRRNISLNLFQIFSA 530
L + R T+ E + + R ++L F+
Sbjct: 257 LVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYV 302
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 62/293 (21%), Positives = 105/293 (35%), Gaps = 54/293 (18%)
Query: 229 GSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVP 286
++G G + V G+ A+K EVD + H+V
Sbjct: 33 SKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------PKARQEVDHHWQASGGPHIVC 86
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT-----RVAIAIGAARGL 341
++ + L++ E M G L + G T + IG A +
Sbjct: 87 ILDVYENMHHGKRCLLIIMECMEGGEL---FSRIQERGDQAFTEREAAEIMRDIGTA--I 141
Query: 342 EYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
++LH I HRD+K N+L +++ K+TD G AK + L +P
Sbjct: 142 QFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL----QTPC---Y 191
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 458
T Y APE + D++S GV++ L+ G P ++ S
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP-------------FYSNTGQAIS 238
Query: 459 GTVISELPDPRLKG--DFPKEEMQIMAYLAKE----CLQLDPDARPTMSEVVQ 505
+ + G FP E ++ AK+ L+ DP R T+++ +
Sbjct: 239 PGMKRRI----RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 66/346 (19%), Positives = 117/346 (33%), Gaps = 93/346 (26%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSV-----FLTEVDMLS 277
D + +G G + V + + + G A K K + + EV +L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 278 RLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAI 335
++ H +++ L + + + +L+ E + G L D L E A
Sbjct: 71 QVLHPNIITLHDV---YENRTDV-VLILELVSGGELFDFLAQKESLSE--------EEAT 118
Query: 336 GAAR----GLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMAKRLKADGLP 387
+ G+ YLH +I H D+K NI+L + K+ D G+A ++
Sbjct: 119 SFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-- 173
Query: 388 SCSSSPARMQGTFG---YFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP------ 435
+ FG + APE Y +G +D++S GV+ L++G P
Sbjct: 174 -------EFKNIFGTPEFVAPEIVNYEPLGLE---ADMWSIGVITYILLSGASPFLGDTK 223
Query: 436 --IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----C 489
+IT + DF +E + LAK+
Sbjct: 224 QETLANITAVS-----Y----------------------DFDEEFFSQTSELAKDFIRKL 256
Query: 490 LQLDPDARPTMSEV-----VQILSTIAPDKSRRRNISLNLFQIFSA 530
L + R T+ E + + T R ++L F+
Sbjct: 257 LVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYV 302
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 33/224 (14%)
Query: 225 DKFSGSNIVGQGGSSY--VYRGQ--LTDGRIVAVKRFK----TQGGPNADSVFLTEVDML 276
++ +G+G +Y V++ + GR VA+KR + +G P + EV +L
Sbjct: 11 QQYECVAEIGEG--AYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP---LSTIREVAVL 65
Query: 277 SRLH---HCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVA 332
L H +VV L C+ R R +L LVFE + +L LD V G+ +T
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124
Query: 333 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS 392
+ RGL++LH R++HRD+K NIL+ + K+ D G+A+ S
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---------SF 172
Query: 393 PARMQG---TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR 433
+ T Y APE + + D++S G + E+ +
Sbjct: 173 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 69/228 (30%), Positives = 104/228 (45%), Gaps = 31/228 (13%)
Query: 232 IVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLV 288
I+G+G S V + R A+K + + + V E D++SRL H V L
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 95
Query: 289 GYCSEFRGKRAMRL-LVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIA-IGAARGLEYL 344
Y + F+ +L + NG L + G E TR A I +A LEYL
Sbjct: 96 -YFT-FQDDE--KLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAEIVSA--LEYL 146
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 404
H I+HRD+K NILL+E+++ +ITD G AK L + + ++S GT Y +
Sbjct: 147 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS---FVGTAQYVS 200
Query: 405 PEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGE 444
PE A SD+++ G ++ +L+ G P I + I K E
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 248
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 74/323 (22%), Positives = 117/323 (36%), Gaps = 59/323 (18%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 282
+D F + +G+G +S VYR Q + A+K K + TE+ +L RL H
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT---VDKKIVRTEIGVLLRLSHP 108
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAI-AIGAAR 339
+++ L LV E + G L D G E D A+ I
Sbjct: 109 NIIKLKEIFET----PTEISLVLELVTGGELFDRIVEKGYYSER---DAADAVKQI--LE 159
Query: 340 GLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPARM 396
+ YLHE I+HRD+K N+L + KI D G++K ++ L +
Sbjct: 160 AVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK------TV 210
Query: 397 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 456
GT GY APE D++S G++ L+ G +P +
Sbjct: 211 CGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFY------------------- 251
Query: 457 DSGTVISELPDPRLKG--DFPKEEMQIMAYLAKE----CLQLDPDARPTMSEVVQ---IL 507
+ L F ++ AK+ + LDP R T + +Q +
Sbjct: 252 -DERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT 310
Query: 508 STIAPDKSRRRNISLNLFQIFSA 530
A + + Q F+A
Sbjct: 311 GKAANFVH--MDTAQKKLQEFNA 331
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 70/352 (19%), Positives = 118/352 (33%), Gaps = 84/352 (23%)
Query: 210 GTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD-S 267
G F +A +D + +G+G S V R T G A K T+ D
Sbjct: 14 GRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ 73
Query: 268 VFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNW 327
E + +L H ++V L E + LVF+ + G L + +V +
Sbjct: 74 KLEREARICRKLQHPNIVRLHDSIQE----ESFHYLVFDLVTGGELFE----DIVAREFY 125
Query: 328 DTRVAIAIGA--ARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLK 382
A + Y H I+HR++K N+LL + K+ D G+A +
Sbjct: 126 SEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182
Query: 383 ADGLPSCSSSPARMQ---GTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGR 433
GT GY +PE Y + D+++ GV+L L+ G
Sbjct: 183 DSE---------AWHGFAGTPGYLSPEVLKKDPY---SKP---VDIWACGVILYILLVGY 227
Query: 434 QP--------IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYL 485
P ++ I G D+P E +
Sbjct: 228 PPFWDEDQHRLYAQIKAG---------------------------AYDYPSPEWDTVTPE 260
Query: 486 AKE----CLQLDPDARPTMSEVVQ---ILSTIAPDKSRRRNISLNLFQIFSA 530
AK L ++P R T + ++ I + + R +++ + F+A
Sbjct: 261 AKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNA 312
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 82.3 bits (203), Expect = 5e-17
Identities = 53/191 (27%), Positives = 87/191 (45%), Gaps = 32/191 (16%)
Query: 331 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 390
+ + A+G+E+L A+ + +HRD+ + NILL E KI D G+A+ + D
Sbjct: 196 ICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252
Query: 391 SS---PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEES 446
P + + APE ++ SDV+SFGV+L E+ + G P + + EE
Sbjct: 253 GDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP-YPGVKIDEEF 305
Query: 447 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEM-QIMAYLAKECLQLDPDARPTMSEVVQ 505
RL++ + P D+ EM Q M +C +P RPT SE+V+
Sbjct: 306 C-----RRLKEGTR----MRAP----DYTTPEMYQTM----LDCWHGEPSQRPTFSELVE 348
Query: 506 ILSTIAPDKSR 516
L + ++
Sbjct: 349 HLGNLLQANAQ 359
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 9e-06
Identities = 25/94 (26%), Positives = 40/94 (42%), Gaps = 10/94 (10%)
Query: 231 NIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCH 283
+G+G V R VAVK K + ++E+ +L + HH +
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL 317
VV L+G C++ G +++ EF GNL L
Sbjct: 88 VVNLLGACTKPGGP---LMVIVEFCKFGNLSTYL 118
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 5e-17
Identities = 69/301 (22%), Positives = 105/301 (34%), Gaps = 84/301 (27%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
G+G V VAVK + +++ E+ + L+H +VV Y
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEICINKMLNHENVVKF--Y- 71
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAIGAAR--------GL 341
R + ++ L E+ G L D D + E A+ G+
Sbjct: 72 -GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP------------DAQRFFHQLMAGV 118
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP-----SCSSSPARM 396
YLH I HRDIK N+LLDE N KI+D G+A + + C
Sbjct: 119 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------- 168
Query: 397 QGTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELITGRQPIH---------RSITKGE 444
GT Y APE ++ R + DV+S G+VL ++ G P + +
Sbjct: 169 -GTLPYVAPE--LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225
Query: 445 ESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVV 504
L W I P L + L +P AR T+ ++
Sbjct: 226 TYLNPWKK---------ID--SAPLA--------------LLHKILVENPSARITIPDIK 260
Query: 505 Q 505
+
Sbjct: 261 K 261
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 74/312 (23%), Positives = 116/312 (37%), Gaps = 75/312 (24%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVK-------RFKTQGGPNADSVFLTEVDM 275
K+ +++G+G SS V R G AVK R + E +
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 276 LSRLH-HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVA 332
L ++ H H++ L+ + LVF+ M G L D L E +TR
Sbjct: 153 LRQVAGHPHIITLIDSYES----SSFMFLVFDLMRKGELFDYLTEKVALSEK---ETRSI 205
Query: 333 I-AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS--C 389
+ ++ + +LH I+HRD+K NILLD+N+ +++D G + L+ C
Sbjct: 206 MRSL--LEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC 260
Query: 390 SSSPARMQGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP-------- 435
GT GY APE D+++ GV+L L+ G P
Sbjct: 261 --------GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL 312
Query: 436 IHRSITKGEESLVL--WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLD 493
+ R I +G+ W S K+ L LQ+D
Sbjct: 313 MLRMIMEGQYQFSSPEWDD---------RSST---------VKD-------LISRLLQVD 347
Query: 494 PDARPTMSEVVQ 505
P+AR T + +Q
Sbjct: 348 PEARLTAEQALQ 359
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 73/317 (23%), Positives = 116/317 (36%), Gaps = 86/317 (27%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVK-----RFKTQGGPNADSV--FLTEVDM 275
D++ S +G G V + + VA+K +F AD TE+++
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 276 LSRLHHCHVVPLVGYCSE---FRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTR 330
L +L+H ++ + + + +V E M G L D + L E +
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDYY--------IVLELMEGGELFDKVVGNKRLKEA---TCK 117
Query: 331 VAI-AIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGL 386
+ + ++YLHE I+HRD+K N+LL +E+ KITD G +K L L
Sbjct: 118 LYFYQM--LLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172
Query: 387 --PSCSSSPARMQGTFGYFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP------ 435
C GT Y APE + D +S GV+L ++G P
Sbjct: 173 MRTLC--------GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224
Query: 436 ---IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE---- 488
+ IT G K +F E ++ A +
Sbjct: 225 QVSLKDQITSG---------------------------KYNFIPEVWAEVSEKALDLVKK 257
Query: 489 CLQLDPDARPTMSEVVQ 505
L +DP AR T E ++
Sbjct: 258 LLVVDPKARFTTEEALR 274
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-16
Identities = 70/272 (25%), Positives = 115/272 (42%), Gaps = 38/272 (13%)
Query: 232 IVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVF--LTEVDMLSRLHHCHVVPLV 288
++G+GG V Q+ G++ A K+ + + L E +L +++ VV L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 289 GYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 347
Y + K L LV M G+L+ + + G V A GLE LH
Sbjct: 251 -YA--YETKD--ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
RI++RD+K NILLD++ + +I+DLG+A + +G GT GY APE
Sbjct: 306 ---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP-EGQTIKG-----RVGTVGYMAPEV 356
Query: 408 AMVGRASLMSDVFSFGVVLLELITGRQP------------IHRSITKGEESLVLWATPRL 455
R + D ++ G +L E+I G+ P + R + + E +P+
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQA 416
Query: 456 QDSGTVISEL----PDPRLKGDFPKEEMQIMA 483
+ + S+L P RL G ++
Sbjct: 417 RS---LCSQLLCKDPAERL-GCRGGSAREVKE 444
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 71/302 (23%), Positives = 117/302 (38%), Gaps = 71/302 (23%)
Query: 226 KFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 284
S + I+G G V++ + G +A K KT+G + + V E+ ++++L H ++
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEV-KNEISVMNQLDHANL 148
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR----G 340
+ L F K + +LV E++ G L D ++ E N I + G
Sbjct: 149 IQLYDA---FESKNDI-VLVMEYVDGGEL---FDRIIDESYNLTELDTILF--MKQICEG 199
Query: 341 LEYLHEAAAPRILHRDIKSSNILL--DENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
+ ++H+ ILH D+K NIL + KI D G+A+R K G
Sbjct: 200 IRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV------NFG 250
Query: 399 TFGYFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESL 447
T + APE Y V +D++S GV+ L++G P +I
Sbjct: 251 TPEFLAPEVVNYDFVSFP---TDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACR--- 304
Query: 448 VLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----CLQLDPDARPTMSEV 503
W D EE Q ++ AKE L + R + SE
Sbjct: 305 --W----------------------DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEA 340
Query: 504 VQ 505
++
Sbjct: 341 LK 342
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 66/301 (21%), Positives = 102/301 (33%), Gaps = 84/301 (27%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
G+G V VAVK + +++ E+ + L+H +VV Y
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEICINKMLNHENVVKF--Y- 71
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAIGAAR--------GL 341
R + ++ L E+ G L D D + E A+ G+
Sbjct: 72 -GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP------------DAQRFFHQLMAGV 118
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLP-----SCSSSPARM 396
YLH I HRDIK N+LLDE N KI+D G+A + + C
Sbjct: 119 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------- 168
Query: 397 QGTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 453
GT Y APE ++ R + DV+S G+VL ++ G P
Sbjct: 169 -GTLPYVAPE--LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD---------------- 209
Query: 454 RLQDSGTVISELPDPRLKGDFPKEEMQIM--AYLAKEC-------LQLDPDARPTMSEVV 504
E D + + + L +P AR T+ ++
Sbjct: 210 ---QPSDSCQEYSD-WKEKKT-----YLNPWKKIDSAPLALLHKILVENPSARITIPDIK 260
Query: 505 Q 505
+
Sbjct: 261 K 261
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 61/333 (18%), Positives = 112/333 (33%), Gaps = 90/333 (27%)
Query: 234 GQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRL-HHCHVVPLVGY 290
G+G + V + + G+ A K K + + L E+ +L V+ L
Sbjct: 38 GRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRD-CLD---GVLVEGMNWDTRVAIAIGAAR----GLE 342
+ + +L+ E+ G + CL ++ E I + G+
Sbjct: 98 ---YENTSEI-ILILEYAAGGEIFSLCLPELAEMVSE--------NDVIRLIKQILEGVY 145
Query: 343 YLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
YLH+ I+H D+K NILL + KI D GM++++ ++
Sbjct: 146 YLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---------ELREI 193
Query: 400 FG---YFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEE 445
G Y APE Y + A +D+++ G++ L+T P + +I++
Sbjct: 194 MGTPEYLAPEILNYDPITTA---TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN- 249
Query: 446 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----CLQLDPDARPTMS 501
D+ +E ++ LA + L +P+ RPT
Sbjct: 250 ----V----------------------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAE 283
Query: 502 EVVQ----ILSTIAPDKSRRRNISLNLFQIFSA 530
+ S + Q S
Sbjct: 284 ICLSHSWLQQWDFENLFHPEETSSSSQTQDHSV 316
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 2e-16
Identities = 63/310 (20%), Positives = 109/310 (35%), Gaps = 77/310 (24%)
Query: 221 EHATDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL 279
+H D + +G G V+R + G A K T + ++V E+ +S L
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV-RKEIQTMSVL 211
Query: 280 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR 339
H +V L F M ++++EFM G L + V E A+ R
Sbjct: 212 RHPTLVNLHDA---FEDDNEM-VMIYEFMSGGEL---FEKVADEHNKMSEDEAVEY--MR 262
Query: 340 ----GLEYLHEAAAPRILHRDIKSSNILL--DENLNAKITDLGMAKRLKADGLPSCSSSP 393
GL ++HE +H D+K NI+ + K+ D G+ L
Sbjct: 263 QVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-------- 311
Query: 394 ARMQGTFG---YFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRS 439
++ T G + APE VG +D++S GV+ L++G P R+
Sbjct: 312 -SVKVTTGTAEFAAPEVAEGKPVGYY---TDMWSVGVLSYILLSGLSPFGGENDDETLRN 367
Query: 440 ITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----CLQLDPD 495
+ + W + ++ K+ L DP+
Sbjct: 368 VKSCD-----W----------------------NMDDSAFSGISEDGKDFIRKLLLADPN 400
Query: 496 ARPTMSEVVQ 505
R T+ + ++
Sbjct: 401 TRMTIHQALE 410
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 2e-16
Identities = 74/302 (24%), Positives = 111/302 (36%), Gaps = 90/302 (29%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVK---RFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
G G V G+ G VAVK R K + + E+ L H H++ L
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR-REIQNLKLFRHPHIIKL-- 81
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAIGAAR-------- 339
Y + + +V E++ G L D C +G L E +R
Sbjct: 82 Y--QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEK------------ESRRLFQQILS 127
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSSPARMQ 397
G++Y H ++HRD+K N+LLD ++NAKI D G++ + SC SP
Sbjct: 128 GVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-GSPN--- 180
Query: 398 GTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKG 443
Y APE YA G D++S GV+L L+ G P + + I G
Sbjct: 181 ----YAAPEVISGRLYA--GPE---VDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG 231
Query: 444 EESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV 503
+ P + L K LQ+DP R T+ ++
Sbjct: 232 IFYTPQYLNPSVIS---------------------------LLKHMLQVDPMKRATIKDI 264
Query: 504 VQ 505
+
Sbjct: 265 RE 266
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 2e-16
Identities = 69/316 (21%), Positives = 115/316 (36%), Gaps = 88/316 (27%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVK-----RFKTQGGPNADSVFLTEVDMLS 277
D + +G G + V + Q G+ A K R + + EV++L
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 278 RLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIAI 335
+ H +++ L F K + +L+ E + G L D L L E A
Sbjct: 64 EIRHPNIITLHDI---FENKTDV-VLILELVSGGELFDFLAEKESLTE--------DEAT 111
Query: 336 GAAR----GLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMAKRLKADGLP 387
+ G+ YLH RI H D+K NI+L N K+ D G+A +++A
Sbjct: 112 QFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN-- 166
Query: 388 SCSSSPARMQGTFG---YFAPE---YAMVGRASLMSDVFSFGVVLLELITGRQP------ 435
+ FG + APE Y +G +D++S GV+ L++G P
Sbjct: 167 -------EFKNIFGTPEFVAPEIVNYEPLGLE---ADMWSIGVITYILLSGASPFLGETK 216
Query: 436 --IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----C 489
+I+ + DF +E + LAK+
Sbjct: 217 QETLTNISAVN-----Y----------------------DFDEEYFSNTSELAKDFIRRL 249
Query: 490 LQLDPDARPTMSEVVQ 505
L DP R T+++ ++
Sbjct: 250 LVKDPKRRMTIAQSLE 265
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 49/172 (28%), Positives = 84/172 (48%), Gaps = 38/172 (22%)
Query: 225 DKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFKTQGGPNA-DSVFLT---EVDMLS 277
++ + +G+G + VY+ + +IVA+K+ K A D + T E+ +L
Sbjct: 10 KRYEKLDFLGEG--QFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 67
Query: 278 RLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA 337
L H +++ L+ F K + LVF+FM D L+ ++ + + + +
Sbjct: 68 ELSHPNIIGLLDA---FGHKSNI-SLVFDFME----TD-LEVII-KDNS------LVLTP 111
Query: 338 A----------RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379
+ +GLEYLH+ ILHRD+K +N+LLDEN K+ D G+AK
Sbjct: 112 SHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 3e-16
Identities = 76/286 (26%), Positives = 115/286 (40%), Gaps = 52/286 (18%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVF--LTEVDMLSRLHH 281
+ FS I+G+GG VY + D G++ A+K + L E MLS +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 282 CH---VVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCL--DGVLVEGMNWDTRVAIA- 334
+V + Y K L + + M G+L L GV E D R A
Sbjct: 249 GDCPFIVCMS-YAFHTPDK----LSFILDLMNGGDLHYHLSQHGVFSEA---DMRFYAAE 300
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS-CSSSP 393
I GLE++H +++RD+K +NILLDE+ + +I+DLG+A +
Sbjct: 301 I--ILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---- 351
Query: 394 ARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQP-----------IHRSIT 441
GT GY APE G A +D FS G +L +L+ G P I R
Sbjct: 352 ----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407
Query: 442 KGEESLVLWATPRLQDSGTVISEL----PDPRLKGDFPKEEMQIMA 483
L +P L+ ++ L + RL G + ++
Sbjct: 408 TMAVELPDSFSPELRS---LLEGLLQRDVNRRL-GCLGRGAQEVKE 449
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 69/302 (22%), Positives = 105/302 (34%), Gaps = 91/302 (30%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVK---RFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
G+G V + VA+K R + V E+ L L H H++ L
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE-REISYLKLLRHPHIIKL-- 74
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAIGAAR-------- 339
Y + ++V E+ G L D + E R
Sbjct: 75 Y--DVITTPTDIVMVIEYA-GGELFDYIVEKKRMTED------------EGRRFFQQIIC 119
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL--PSCSSSPARMQ 397
+EY H +I+HRD+K N+LLD+NLN KI D G++ + SC SP
Sbjct: 120 AIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC-GSPN--- 172
Query: 398 GTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKG 443
Y APE YA G DV+S G+VL ++ GR P + + +
Sbjct: 173 ----YAAPEVINGKLYA--GPE---VDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC 223
Query: 444 EESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV 503
+ + +P Q L + + DP R T+ E+
Sbjct: 224 VYVMPDFLSPGAQS---------------------------LIRRMIVADPMQRITIQEI 256
Query: 504 VQ 505
+
Sbjct: 257 RR 258
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 61/318 (19%), Positives = 103/318 (32%), Gaps = 66/318 (20%)
Query: 209 HGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADS 267
H + R + D F +G G V+ + + G +K
Sbjct: 6 HHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME 65
Query: 268 VFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNW 327
E+++L L H +++ + F M + V E G L + + G
Sbjct: 66 QIEAEIEVLKSLDHPNIIKIFEV---FEDYHNMYI-VMETCEGGELLERIVSAQARGKAL 121
Query: 328 DTRVAIAI--GAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLK 382
+ L Y H ++H+D+K NIL + KI D G+A+ K
Sbjct: 122 SEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178
Query: 383 ADGLPSCSSSPARMQ---GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP---- 435
+D GT Y APE + D++S GVV+ L+TG P
Sbjct: 179 SD---------EHSTNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGT 228
Query: 436 ----IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE--- 488
+ + T E ++ E + A +
Sbjct: 229 SLEEVQQKATYKEP---------------------------NYAVECRPL-TPQAVDLLK 260
Query: 489 -CLQLDPDARPTMSEVVQ 505
L DP+ RP+ ++V+
Sbjct: 261 QMLTKDPERRPSAAQVLH 278
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 73/360 (20%), Positives = 126/360 (35%), Gaps = 98/360 (27%)
Query: 210 GTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVK-----RFKTQGGP 263
GT+ R E+ D + +G G + V + + + G A K R K+
Sbjct: 1 GTVFR-----QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRG 55
Query: 264 NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--DGVL 321
+ EV +L + H +V+ L + K + +L+ E + G L D L L
Sbjct: 56 VSREDIEREVSILKEIQHPNVITLHEV---YENKTDV-ILILELVAGGELFDFLAEKESL 111
Query: 322 VEGMNWDTRVAIAIGAAR----GLEYLHEAAAPRILHRDIKSSNILL----DENLNAKIT 373
E A + G+ YLH +I H D+K NI+L KI
Sbjct: 112 TE--------EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKII 160
Query: 374 DLGMAKRLKADGLPSCSSSPARMQGTFG---YFAPE---YAMVGRASLMSDVFSFGVVLL 427
D G+A ++ + FG + APE Y +G +D++S GV+
Sbjct: 161 DFGLAHKIDFGN---------EFKNIFGTPEFVAPEIVNYEPLGLE---ADMWSIGVITY 208
Query: 428 ELITGRQP--------IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEM 479
L++G P +++ + +F E
Sbjct: 209 ILLSGASPFLGDTKQETLANVSAVN-----Y----------------------EFEDEYF 241
Query: 480 QIMAYLAKE----CLQLDPDARPTMSEV-----VQILSTIAPDKSRRRNISLNLFQIFSA 530
+ LAK+ L DP R T+ + ++ T + +++ F+ F+A
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEKFKKFAA 301
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 68/306 (22%), Positives = 122/306 (39%), Gaps = 58/306 (18%)
Query: 225 DKFSGSNIVGQGGSSY--VYRGQ-LTDGRIVAVKRFK----TQGGPNADSVFLTEVDMLS 277
D++ +G+G +Y VY+ VA+KR + +G P + EV +L
Sbjct: 34 DRYRRITKLGEG--TYGEVYKAIDTVTNETVAIKRIRLEHEEEGVP---GTAIREVSLLK 88
Query: 278 RLHHCHVVPL--VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI 335
L H +++ L V + L+FE+ N +L+ +D ++ +
Sbjct: 89 ELQHRNIIELKSV-----IHHNHRL-HLIFEYAEN-DLKKYMD--KNPDVSMRVIKSFLY 139
Query: 336 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA-----KITDLGMAKRLKADGLPSCS 390
G+ + H R LHRD+K N+LL + + KI D G+A +A G+P
Sbjct: 140 QLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA---RAFGIPIRQ 193
Query: 391 SSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 449
+ + T Y PE + R S D++S + E++ P+ ++ ++ +
Sbjct: 194 FTHEII--TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT-PLFPGDSEIDQLFKI 250
Query: 450 WA---TPRLQD-SGTVISELPDPRLKGDFPKEEMQIMAY------------LAKECLQLD 493
+ P G ++ LPD K FPK + + L L++D
Sbjct: 251 FEVLGLPDDTTWPG--VTALPD--WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMD 306
Query: 494 PDARPT 499
P R +
Sbjct: 307 PVKRIS 312
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 85/368 (23%), Positives = 131/368 (35%), Gaps = 80/368 (21%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HH 281
TD + +G G S R AVK + E+++L R H
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK----SKRDPT-EEIEILLRYGQH 75
Query: 282 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAIGA-- 337
+++ L + +V E M G L D E R A A+
Sbjct: 76 PNIITLKDVYDD----GKYVYVVTELMKGGELLDKILRQKFFSE------REASAVLFTI 125
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILL-DENLNA---KITDLGMAKRLKADGLPSCSSSP 393
+ +EYLH ++HRD+K SNIL DE+ N +I D G AK+L+A+ +P
Sbjct: 126 TKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTP 180
Query: 394 ARMQGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL 447
T + APE Y A D++S GV+L ++TG P E
Sbjct: 181 C---YTANFVAPEVLERQGY---DAA---CDIWSLGVLLYTMLTGYTPFANGPDDTPE-- 229
Query: 448 VLWATPRLQDSGTVISELPDPRLKG--DFPKEEMQIMAYLAKE----CLQLDPDARPTMS 501
E+ G ++ AK+ L +DP R T +
Sbjct: 230 ----------------EILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAA 273
Query: 502 EVVQ----ILSTIAPDKSRRRNISLNLFQ-----IFSAGGMEKEPSIERPDNLFETLIES 552
V++ + P R + +L + +SA + P +E TL +
Sbjct: 274 LVLRHPWIVHWDQLPQYQLNRQDAPHLVKGAMAATYSALNRNQSPVLEPVGR--STLAQR 331
Query: 553 EELKKATS 560
+KK TS
Sbjct: 332 RGIKKITS 339
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 5e-16
Identities = 57/297 (19%), Positives = 100/297 (33%), Gaps = 58/297 (19%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 282
++ N +G+G V Q A K+ + D E++++ L H
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK-QEIEIMKSLDHP 66
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA--IAIGAARG 340
+++ L + LV E G L + +V + A I
Sbjct: 67 NIIRLYETFED----NTDIYLVMELCTGGELFE----RVVHKRVFRESDAARIMKDVLSA 118
Query: 341 LEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
+ Y H+ + HRD+K N L + K+ D G+A R K M+
Sbjct: 119 VAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---------MMR 166
Query: 398 ---GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 454
GT Y +P+ + G D +S GV++ L+ G P
Sbjct: 167 TKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPPFS----------------- 208
Query: 455 LQDSGTVISELPDPRLKG--DFPKEEMQIMAYLAKE----CLQLDPDARPTMSEVVQ 505
SE+ +G FP+++ ++ A+ L P R T + ++
Sbjct: 209 ----APTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 1e-15
Identities = 65/311 (20%), Positives = 103/311 (33%), Gaps = 83/311 (26%)
Query: 224 TDKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNAD-SVFLTEVDMLSRLHH 281
+D + +G+G S V R T G A K T+ D E + +L H
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 282 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAI-AIGAA 338
++V L E + LVF+ + G L + E D I I
Sbjct: 65 PNIVRLHDSIQE----ESFHYLVFDLVTGGELFEDIVAREFYSEA---DASHCIQQI--L 115
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPAR 395
+ Y H I+HR++K N+LL + K+ D G+A +
Sbjct: 116 ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---------A 163
Query: 396 MQ---GTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHR 438
GT GY +PE Y + D+++ GV+L L+ G P ++
Sbjct: 164 WHGFAGTPGYLSPEVLKKDPY---SKP---VDIWACGVILYILLVGYPPFWDEDQHRLYA 217
Query: 439 SITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----CLQLDP 494
I G D+P E + AK L ++P
Sbjct: 218 QIKAG---------------------------AYDYPSPEWDTVTPEAKSLIDSMLTVNP 250
Query: 495 DARPTMSEVVQ 505
R T + ++
Sbjct: 251 KKRITADQALK 261
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 64/307 (20%), Positives = 99/307 (32%), Gaps = 96/307 (31%)
Query: 234 GQGGSSYVYRGQ-LTDGRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
G G + +VAVK + ++V E+ L H ++V
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQ-REIINHRSLRHPNIVRF--K- 82
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRD--CLDGVLVEGMNWDTRVAIAIGAAR--------GL 341
E ++ E+ G L + C G E AR G+
Sbjct: 83 -EVILTPTHLAIIMEYASGGELYERICNAGRFSED------------EARFFFQQLLSGV 129
Query: 342 EYLHEAAAPRILHRDIKSSNILLDEN--LNAKITDLGMAKRLKADGLP--SCSSSPARMQ 397
Y H + +I HRD+K N LLD + KI D G +K P +
Sbjct: 130 SYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-------- 178
Query: 398 GTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 454
GT Y APE ++ R ++DV+S GV L ++ G P
Sbjct: 179 GTPAYIAPE--VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE----------------- 219
Query: 455 LQDSGTVISELPDPRLKGDFPKEEMQIMA---------YLAKEC-------LQLDPDARP 498
DP D+ K +I++ ++ EC DP R
Sbjct: 220 ------------DPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRI 267
Query: 499 TMSEVVQ 505
++ E+
Sbjct: 268 SIPEIKT 274
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 62/288 (21%), Positives = 107/288 (37%), Gaps = 53/288 (18%)
Query: 234 GQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYC 291
G+G S + + AVK + ++ E+ L H ++V L
Sbjct: 20 GEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA--ARGLEYLHEAAA 349
+ + LV E + G L + + + ++ A I + ++H+
Sbjct: 76 HD----QLHTFLVMELLNGGEL---FERIKKKK-HFSETEASYIMRKLVSAVSHMHDV-- 125
Query: 350 PRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLP---SCSSSPARMQGTFGYF 403
++HRD+K N+L ++NL KI D G A+ D P C T Y
Sbjct: 126 -GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC--------FTLHYA 176
Query: 404 APEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463
APE D++S GV+L +++G+ P + R + T
Sbjct: 177 APELLNQNGYDESCDLWSLGVILYTMLSGQVP-------------FQSHDR-SLTCTSAV 222
Query: 464 ELPDPRLKG--DFPKEEMQIMAYLAKE----CLQLDPDARPTMSEVVQ 505
E+ KG F E + ++ AK+ L +DP+ R MS +
Sbjct: 223 EIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 67/316 (21%), Positives = 107/316 (33%), Gaps = 63/316 (19%)
Query: 234 GQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYC 291
G G + V + A+K + EV++ R H+V +V
Sbjct: 71 GLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVY 124
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT-----RVAIAIGAARGLEYLHE 346
R L+V E + G L + G T + +IG A ++YLH
Sbjct: 125 ENLYAGRKCLLIVMECLDGGEL---FSRIQDRGDQAFTEREASEIMKSIGEA--IQYLHS 179
Query: 347 AAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSPARMQ---GTF 400
I HRD+K N+L N K+TD G AK + + T
Sbjct: 180 I---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---------SLTTPCYTP 227
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460
Y APE + D++S GV++ L+ G P ++ L S
Sbjct: 228 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP-------------FYSNHGLAIS-- 272
Query: 461 VISELPDPRLKG--DFPKEEMQIMAYLAKE----CLQLDPDARPTMSEVVQ----ILSTI 510
+ G +FP E ++ K L+ +P R T++E + + ST
Sbjct: 273 --PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 330
Query: 511 APDKSRRRNISLNLFQ 526
P + L +
Sbjct: 331 VPQTPLHTSRVLKEDK 346
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 6e-15
Identities = 55/217 (25%), Positives = 89/217 (41%), Gaps = 30/217 (13%)
Query: 232 IVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPLV 288
++G+G V +L + ++ A+K F E D+L + L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL- 139
Query: 289 GYCSEFRGKRAMRL-LVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIA-IGAARGLEY 343
+ + F+ L LV ++ G+L L + L E M R +A + A ++
Sbjct: 140 -HYA-FQDDN--NLYLVMDYYVGGDLLTLLSKFEDRLPEEM---ARFYLAEMVIA--IDS 190
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
+H+ +HRDIK NIL+D N + ++ D G +L DG S GT Y
Sbjct: 191 VHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV----AVGTPDYI 243
Query: 404 APE-----YAMVGRASLMSDVFSFGVVLLELITGRQP 435
+PE GR D +S GV + E++ G P
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 59/247 (23%), Positives = 93/247 (37%), Gaps = 42/247 (17%)
Query: 232 IVGQG--GSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPL 287
++G+G V + + T G++ A+K V F E D+L + L
Sbjct: 68 VIGRGAFSEVAVVKMKQT-GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 288 VGYCSEFRGKRAMRL-LVFEFMPNGNLRDCL---DGVLVEGMNWDTRVAIA-IGAARGLE 342
+ + F+ + L LV E+ G+L L + M R +A I A ++
Sbjct: 127 --HFA-FQDEN--YLYLVMEYYVGGDLLTLLSKFGERIPAEM---ARFYLAEIVMA--ID 176
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
+H +HRDIK NILLD + ++ D G +L+ADG GT Y
Sbjct: 177 SVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV----AVGTPDY 229
Query: 403 FAPE-------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESL 447
+PE G D ++ GV E+ G+ P + I +E L
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL 289
Query: 448 VLWATPR 454
L
Sbjct: 290 SLPLVDE 296
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 74/346 (21%), Positives = 125/346 (36%), Gaps = 92/346 (26%)
Query: 220 LEHATDKFSGSNIVGQGGSSY--VYRGQLTD-GRIVAVKRFKTQGGPNADSVF-LTEVDM 275
LE ++ K+S +G G S+ V + G+ A+K+ D + E+D+
Sbjct: 2 LETSSKKYSLGKTLGTG--SFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDI 53
Query: 276 LSRLHHCHVVPL--VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT---- 329
+ L H +++ L Y + + + G + +N
Sbjct: 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 330 ------------RVAIAIGAA-----------------RGLEYLHEAAAPRILHRDIKSS 360
+V + + R + ++H I HRDIK
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQ 170
Query: 361 NILLDENLNA-KITDLGMAKRLKADGLPS----CSSSPARMQGTFGYFAPEYAMVGRASL 415
N+L++ N K+ D G AK+L PS CS R Y APE M+G A+
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICS----RF-----YRAPEL-MLG-ATE 218
Query: 416 MS---DVFSFGVVLLELITGRQPIHRSITKGEESL--------VLWATPRLQDSGTVISE 464
+ D++S G V ELI G +P+ GE S+ ++ TP + +
Sbjct: 219 YTPSIDLWSIGCVFGELILG-KPLF----SGETSIDQLVRIIQIM-GTPTKEQMIRMNPH 272
Query: 465 LPD---PRLKGD-----FPKEEMQIMAYLAKECLQLDPDARPTMSE 502
+ P LK P+ + L ++ L+ +PD R E
Sbjct: 273 YTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYE 318
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 58/247 (23%), Positives = 101/247 (40%), Gaps = 37/247 (14%)
Query: 232 IVGQG--GSSYVYRGQLTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPL 287
++G+G G + R + T ++ A+K F E D+++ + VV L
Sbjct: 76 VIGRGAFGEVQLVRHKST-RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 288 VGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLD-GVLVEGMNWDTRVAIA-IGAARGLEYL 344
+ + F+ R L +V E+MP G+L + + + E R A + A L+ +
Sbjct: 135 --FYA-FQDDR--YLYMVMEYMPGGDLVNLMSNYDVPEKW---ARFYTAEVVLA--LDAI 184
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 404
H +HRD+K N+LLD++ + K+ D G ++ +G+ C + GT Y +
Sbjct: 185 HSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT----AVGTPDYIS 237
Query: 405 PE----YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESLVLWAT 452
PE G D +S GV L E++ G P + I + SL
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDD 297
Query: 453 PRLQDSG 459
+
Sbjct: 298 NDISKEA 304
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 56/312 (17%), Positives = 110/312 (35%), Gaps = 53/312 (16%)
Query: 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVF----LTEVDMLSR 278
++ +G G V R VA+K+ P + E+ ++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL---SRPFQNQTHAKRAYRELVLMKC 117
Query: 279 LHHCHVVPLVGYCSEFRGKRAMR--LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIG 336
++H +++ L+ + + + LV E M + L V+ ++ + +
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA----N-LCQVIQMELDHERMSYLLYQ 172
Query: 337 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARM 396
G+++LH A I+HRD+K SNI++ + KI D G+A+ + M
Sbjct: 173 MLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---------M 220
Query: 397 QG---TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQ--PIHRSITKGEESLVLWA 451
T Y APE + D++S G ++ E++ + P I + + +
Sbjct: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 280
Query: 452 TPRLQDSGTV-------ISELPDPR---LKGDFPKEEMQIMAYLAKEC-----------L 490
TP + + + P FP + K L
Sbjct: 281 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 340
Query: 491 QLDPDARPTMSE 502
+DP R ++ +
Sbjct: 341 VIDPAKRISVDD 352
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 63/335 (18%), Positives = 107/335 (31%), Gaps = 109/335 (32%)
Query: 224 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HH 281
D + +G+G S V+ +T+ V VK K P E+ +L L
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK----PVKKKKIKREIKILENLRGG 90
Query: 282 CHVVPL---VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDG------------VLVEGMN 326
+++ L V LVFE + N + + +L
Sbjct: 91 PNIITLADIVKDPVSRT-----PALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL----- 140
Query: 327 WDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADG 385
+ L+Y H I+HRD+K N+++D E+ ++ D G+A+
Sbjct: 141 ------------KALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE------ 179
Query: 386 LPSCSSSPAR-MQG---TFGYFAPE---------YAMVGRASLMSDVFSFGVVLLELITG 432
P + + + PE Y++ D++S G +L +I
Sbjct: 180 ----FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSL--------DMWSLGCMLASMIFR 227
Query: 433 RQP-------IH--RSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPK------- 476
++P I K VL T L D + DPR +
Sbjct: 228 KEPFFHGHDNYDQLVRIAK-----VL-GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE 281
Query: 477 ----EEMQIMAY-----LAKECLQLDPDARPTMSE 502
E Q + + L+ D +R T E
Sbjct: 282 RFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 316
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 57/319 (17%), Positives = 108/319 (33%), Gaps = 67/319 (21%)
Query: 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVF----LTEVDMLSR 278
++ +G G V R VA+K+ P + E+ ++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL---SRPFQNQTHAKRAYRELVLMKC 80
Query: 279 LHHCHVVPLVGYCSEFRGKRAMR--LLVFEFMPNGNLRDC-LDGVLVEGMNWDTRVAIAI 335
++H +++ L+ + + + +V E M D L V+ ++ + +
Sbjct: 81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM------DANLCQVIQMELDHERMSYLLY 134
Query: 336 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 395
G+++LH A I+HRD+K SNI++ + KI D G+A+ +
Sbjct: 135 QMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--------- 182
Query: 396 MQG---TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQ------PIH--RSITKGE 444
M T Y APE + D++S G ++ E+I G I + +
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE-- 240
Query: 445 ESLVLWATPRLQDSGTV-------ISELPD-PR--LKGDFPKEEMQIMAYLAKEC----- 489
TP + + + P + FP + K
Sbjct: 241 ----QLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQAR 296
Query: 490 ------LQLDPDARPTMSE 502
L +D R ++ E
Sbjct: 297 DLLSKMLVIDASKRISVDE 315
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 50/162 (30%), Positives = 70/162 (43%), Gaps = 29/162 (17%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
LE+LH+ I++RDIK NILLD N + +TD G++K AD GT
Sbjct: 171 ALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD----FCGT 223
Query: 400 FGYFAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQP------------IHRSITKGEE 445
Y AP+ G + D +S GV++ EL+TG P I R I K E
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 283
Query: 446 SLVLWATPRLQDSGTVISEL----PDPRLKGDFPKEEMQIMA 483
+ +D +I L P RL G P++ +I
Sbjct: 284 PYPQEMSALAKD---LIQRLLMKDPKKRL-GCGPRDADEIKE 321
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 62/326 (19%), Positives = 106/326 (32%), Gaps = 76/326 (23%)
Query: 222 HATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKR-FKTQGGPNADSVF---------LT 271
++ + G V G ++G VA+KR F T ++ L
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 272 EVDMLSRLHHCHVVPLV-----GYCSEFRGKRAMRLLVFEFMPNGNLRDC-LDGVLVEGM 325
E+ +L+ HH +++ L LV E M L V+ +
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKL----YLVTELM------RTDLAQVIHDQR 128
Query: 326 NWDTRVAIA-----IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380
+ I I GL LHEA ++HRD+ NILL +N + I D +A+
Sbjct: 129 IVISPQHIQYFMYHI--LLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLARE 183
Query: 381 LKADGLPSCSSSPARMQG---TFGYFAPEYAMVGRASLMS--DVFSFGVVLLELITGRQ- 434
AD Y APE ++ D++S G V+ E+ +
Sbjct: 184 DTADA---------NKTHYVTHRWYRAPE-LVMQFKGFTKLVDMWSAGCVMAEMFNRKAL 233
Query: 435 -----PIH--RSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAY--- 484
+ I + + TP+++D S L+ +
Sbjct: 234 FRGSTFYNQLNKIVE------VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVP 287
Query: 485 --------LAKECLQLDPDARPTMSE 502
L + L+ +P R + +
Sbjct: 288 TADPVALDLIAKMLEFNPQRRISTEQ 313
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 68/312 (21%), Positives = 116/312 (37%), Gaps = 61/312 (19%)
Query: 222 HATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVF----LTEVDML 276
+ VG G V G VA+K+ P +F E+ +L
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL---SRPFQSEIFAKRAYRELLLL 77
Query: 277 SRLHHCHVVPLVGYCSEFRGKRAMR--LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 334
+ H +V+ L+ + R LV FM +L+ + E + +
Sbjct: 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSE----EKIQYLV 132
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 394
+GL+Y+H A ++HRD+K N+ ++E+ KI D G+A+ A+
Sbjct: 133 YQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE---------- 179
Query: 395 RMQG---TFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGRQ------PIH--RSIT 441
M G T Y APE ++ + D++S G ++ E++TG+ + I
Sbjct: 180 -MTGYVVTRWYRAPE-VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 237
Query: 442 KGEESLVLWATPRLQDSGTVISE--------LPDPR---LKGDFPKEEMQIMAYLAKECL 490
K + P + + + LP FP+ Q L K L
Sbjct: 238 K------VTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEK-ML 290
Query: 491 QLDPDARPTMSE 502
+LD D R T ++
Sbjct: 291 ELDVDKRLTAAQ 302
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 66/347 (19%), Positives = 107/347 (30%), Gaps = 92/347 (26%)
Query: 221 EHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVK------RFKTQGGPNADSVFLTEV 273
E D++ +++G+G V + + VA+K F Q EV
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA--------QIEV 101
Query: 274 DMLSRL--------HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGM 325
+L + ++ V L + FR + VFE + + NL D L G+
Sbjct: 102 RLLELMNKHDTEMKYYI--VHLKRH-FMFRNHLCL---VFEML-SYNLYDLLRNTNFRGV 154
Query: 326 NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA--KITDLGMAKRLKA 383
+ + A L +L I+H D+K NILL + KI D G +
Sbjct: 155 SLNLTRKFAQQMCTALLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSS----- 208
Query: 384 DGLPSCSSSPAR---MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR------- 433
C +Q F Y +PE + L D++S G +L+E+ TG
Sbjct: 209 -----CQLGQRIYQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262
Query: 434 ------------------------------------QPIHRSITKGEESLVLWATPRLQD 457
+ G+ T +L +
Sbjct: 263 EVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHN 322
Query: 458 SGTVISELPDPRLKGDFPKEEMQIMAY--LAKECLQLDPDARPTMSE 502
V + P R G+ + + L L DP R
Sbjct: 323 ILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYY 369
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 6e-12
Identities = 51/202 (25%), Positives = 81/202 (40%), Gaps = 37/202 (18%)
Query: 270 LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNG----NLRDCLDGVLVEG 324
L E +L ++ +V L F+ L +V E++ G +LR G E
Sbjct: 89 LNEKRILQAVNFPFLVKLEFS---FKDNS--NLYMVMEYVAGGEMFSHLRRI--GRFSEP 141
Query: 325 MNWDTRVAIA-IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383
R A I EYLH +++RD+K N+L+D+ ++TD G AKR+K
Sbjct: 142 H---ARFYAAQIVLT--FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP-------- 435
C GT APE + + D ++ GV++ E+ G P
Sbjct: 194 RTWTLC--------GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245
Query: 436 IHRSITKGEESLVLWATPRLQD 457
I+ I G+ + L+D
Sbjct: 246 IYEKIVSGKVRFPSHFSSDLKD 267
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 6e-12
Identities = 42/162 (25%), Positives = 71/162 (43%), Gaps = 36/162 (22%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
L +LH+ I++RD+K NI+L+ + K+TD G+ K DG + + GT
Sbjct: 133 ALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-----FCGT 184
Query: 400 FGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEE 445
Y APE + RA D +S G ++ +++TG P I K +
Sbjct: 185 IEYMAPEILMRSGH---NRA---VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL 238
Query: 446 SLVLWATPRLQDSGTVISEL----PDPRLKGDFPKEEMQIMA 483
+L + T +D ++ +L RL G P + ++ A
Sbjct: 239 NLPPYLTQEARD---LLKKLLKRNAASRL-GAGPGDAGEVQA 276
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 1e-11
Identities = 45/162 (27%), Positives = 71/162 (43%), Gaps = 36/162 (22%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
L++LH I++RD+K NILLDE + K+TD G++K + S GT
Sbjct: 138 ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-----FCGT 189
Query: 400 FGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEE 445
Y APE + ++ +D +SFGV++ E++TG P I K +
Sbjct: 190 VEYMAPEVVNRRGH---TQS---ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL 243
Query: 446 SLVLWATPRLQDSGTVISEL----PDPRLKGDFPKEEMQIMA 483
+ + +P Q ++ L P RL G P +I
Sbjct: 244 GMPQFLSPEAQS---LLRMLFKRNPANRL-GAGPDGVEEIKR 281
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 47/162 (29%), Positives = 70/162 (43%), Gaps = 35/162 (21%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
L+YLH +++RD+K N++LD++ + KITD G+ K DG + GT
Sbjct: 260 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-----FCGT 312
Query: 400 FGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEE 445
Y APE Y GRA D + GVV+ E++ GR P + I E
Sbjct: 313 PEYLAPEVLEDNDY---GRA---VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI 366
Query: 446 SLVLWATPRLQDSGTVISEL----PDPRLKGDFPKEEMQIMA 483
P + ++S L P RL G ++ +IM
Sbjct: 367 RFPRTLGPEAKS---LLSGLLKKDPKQRL-GGGSEDAKEIMQ 404
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 50/165 (30%), Positives = 74/165 (44%), Gaps = 42/165 (25%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ-- 397
LEYLH +++RDIK N++LD++ + KITD G+ K +DG A M+
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--------ATMKTF 165
Query: 398 -GTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITK 442
GT Y APE Y GRA D + GVV+ E++ GR P + I
Sbjct: 166 CGTPEYLAPEVLEDNDY---GRA---VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219
Query: 443 GEESLVLWATPRLQDSGTVISEL----PDPRLKGDFPKEEMQIMA 483
E +P + +++ L P RL G P + ++M
Sbjct: 220 EEIRFPRTLSPEAKS---LLAGLLKKDPKQRL-GGGPSDAKEVME 260
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 53/188 (28%), Positives = 79/188 (42%), Gaps = 46/188 (24%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
RGL+Y+H A I+HRD+K SN+ ++E+ KI D G+A+ + M G
Sbjct: 143 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-----------HTADEMTG 188
Query: 399 ---TFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGRQ------PIH--RSITKGEE 445
T Y APE M+ + D++S G ++ EL+TGR I + I +
Sbjct: 189 YVATRWYRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR--- 244
Query: 446 SLVLWATPRLQDSGTVISE--------LPD-PR--LKGDFPKEEMQIMAYLAKECLQLDP 494
L TP + + SE L P+ F + L K L LD
Sbjct: 245 ---LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK-MLVLDS 300
Query: 495 DARPTMSE 502
D R T ++
Sbjct: 301 DKRITAAQ 308
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 45/195 (23%), Positives = 77/195 (39%), Gaps = 46/195 (23%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
R ++ LH + ++HRD+K SN+L++ N + K+ D G+A+ + + + +
Sbjct: 123 RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 399 TFGYF------APEYAMVGRASLMS--------DVFSFGVVLLELIT------GRQPIH- 437
+ APE +++ DV+S G +L EL GR H
Sbjct: 180 V-EFVATRWYRAPEV-------MLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ 231
Query: 438 -RSITK------GEESLVLWATPRLQDSGTVISELPDPR---LKGDFPKEEMQIMAYLAK 487
I + L +PR ++ I LP L+ FP+ + + L +
Sbjct: 232 LLLIFGIIGTPHSDNDLRCIESPRARE---YIKSLPMYPAAPLEKMFPRVNPKGIDLLQR 288
Query: 488 ECLQLDPDARPTMSE 502
L DP R T E
Sbjct: 289 -MLVFDPAKRITAKE 302
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 4e-11
Identities = 57/238 (23%), Positives = 97/238 (40%), Gaps = 57/238 (23%)
Query: 270 LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNG----NLRDCLDGVLVEG 324
E MLS + H ++ + + + F+ + ++ ++ +++ G LR
Sbjct: 54 NDERLMLSIVTHPFIIRM--WGT-FQDAQ--QIFMIMDYIEGGELFSLLRKS--QRFPNP 106
Query: 325 MNWDTRVAIA-IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383
+ + A + A LEYLH I++RD+K NILLD+N + KITD G AK +
Sbjct: 107 V---AKFYAAEVCLA--LEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158
Query: 384 DGLPSCSSSPARMQGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP-- 435
C GT Y APE Y ++ D +SFG+++ E++ G P
Sbjct: 159 VTYTLC--------GTPDYIAPEVVSTKPY---NKS---IDWWSFGILIYEMLAGYTPFY 204
Query: 436 ------IHRSITKGEESLVLWATPRLQDSGTVISEL--PDP--RLKGDFPKEEMQIMA 483
+ I E + ++D ++S L D RL G+ +
Sbjct: 205 DSNTMKTYEKILNAELRFPPFFNEDVKD---LLSRLITRDLSQRL-GNLQNGTEDVKN 258
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 40/212 (18%), Positives = 78/212 (36%), Gaps = 54/212 (25%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
+ ++YLH +LHRD+K SNILL+ + K+ D G+++ + + + +
Sbjct: 120 KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 399 TFGYFAPEYAMVG-------RA--SLMS--------DVFSFGVVLLELITGRQ------P 435
T + + + RA L+ D++S G +L E++ G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236
Query: 436 IH--RSITK-----GEESLVLWATPRLQDSGTVISELP-----------------DPRLK 471
++ I E + +P + +I L L
Sbjct: 237 MNQLERIIGVIDFPSNEDVESIQSPFAKT---MIESLKEKVEIRQSNKRDIFTKWKNLLL 293
Query: 472 GDFPKEEMQIMAY-LAKECLQLDPDARPTMSE 502
PK + A L + LQ +P+ R + ++
Sbjct: 294 KINPKADCNEEALDLLDKLLQFNPNKRISAND 325
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 6e-11
Identities = 45/185 (24%), Positives = 75/185 (40%), Gaps = 34/185 (18%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
RGL+Y+H A +LHRD+K SN+LL+ + KI D G+A+ D +
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD-----HDHTGFLTE 190
Query: 399 ---TFGYFAPEYAMVGRASLMS--DVFSFGVVLLELITGRQ------PIH--RSITK--- 442
T Y APE M+ D++S G +L E+++ R + I
Sbjct: 191 YVATRWYRAPE-IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 249
Query: 443 --GEESLVLWATPRLQDSGTVISELPD-PR--LKGDFPKEEMQIMAYLAKECLQLDPDAR 497
+E L + ++ + LP + FP + + + L K L +P R
Sbjct: 250 SPSQEDLNCIINLKARN---YLLSLPHKNKVPWNRLFPNADSKALDLLDK-MLTFNPHKR 305
Query: 498 PTMSE 502
+ +
Sbjct: 306 IEVEQ 310
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 7e-11
Identities = 67/311 (21%), Positives = 114/311 (36%), Gaps = 58/311 (18%)
Query: 222 HATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVF----LTEVDML 276
+ VG G V G VA+K+ P +F E+ +L
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL---YRPFQSELFAKRAYRELRLL 78
Query: 277 SRLHHCHVVPLVGYCSEFRGKRAMR--LLVFEFMPNGNLRDC-LDGVL-VEGMNWDTRVA 332
+ H +V+ L+ + LV FM L ++ E + D
Sbjct: 79 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM------GTDLGKLMKHEKLGEDRIQF 132
Query: 333 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS 392
+ +GL Y+H A I+HRD+K N+ ++E+ KI D G+A++ ++
Sbjct: 133 LVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-------- 181
Query: 393 PARMQG---TFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGRQ------PIH--RS 439
M G T Y APE ++ R + D++S G ++ E+ITG+ + +
Sbjct: 182 ---MTGYVVTRWYRAPE-VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE 237
Query: 440 ITK-----GEESLVLWATPRLQDSGTVISELPDPR---LKGDFPKEEMQIMAYLAKECLQ 491
I K E + + ++ + LP+ + L K L
Sbjct: 238 IMKVTGTPPAEFVQRLQSDEAKN---YMKGLPELEKKDFASILTNASPLAVNLLEK-MLV 293
Query: 492 LDPDARPTMSE 502
LD + R T E
Sbjct: 294 LDAEQRVTAGE 304
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 9e-11
Identities = 62/298 (20%), Positives = 101/298 (33%), Gaps = 76/298 (25%)
Query: 225 DKFSGSNIVGQGGSSYVYRG-QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHC 282
D S ++G G + V + A+K + EV++ R
Sbjct: 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCP 71
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDT-----RVAIAIGA 337
H+V +V R L+V E + G L + G T + +IG
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGEL---FSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGL-PSCSSSP 393
A ++YLH I HRD+K N+L N K+TD G AK + SC
Sbjct: 129 A--IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKYDKSC---- 179
Query: 394 ARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 453
D++S GV++ L+ G P ++
Sbjct: 180 ------------------------DMWSLGVIMYILLCGYPP-------------FYSNH 202
Query: 454 RLQDSGTVISELPDPRLKG--DFPKEEMQIMAYLAKE----CLQLDPDARPTMSEVVQ 505
L S + + + G +FP E ++ K L+ +P R T++E +
Sbjct: 203 GLAISPGMKTRI----RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 63.9 bits (155), Expect = 9e-11
Identities = 42/156 (26%), Positives = 67/156 (42%), Gaps = 24/156 (15%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
GL +L I++RD+K N++LD + KI D GM K DG+ + + GT
Sbjct: 454 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-----FCGT 505
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESLVLWA 451
Y APE D ++FGV+L E++ G+ P + +SI + +
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSM 565
Query: 452 TPRLQDSGTVISEL----PDPRLKGDFPKEEMQIMA 483
+ ++ + L P RL G P+ E I
Sbjct: 566 SK---EAVAICKGLMTKHPGKRL-GCGPEGERDIKE 597
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 42/156 (26%), Positives = 65/156 (41%), Gaps = 24/156 (15%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
GL +L I++RD+K N++LD + KI D GM K DG+ + + GT
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-----FCGT 184
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESLVLWA 451
Y APE D ++FGV+L E++ G+ P + +SI + +
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSM 244
Query: 452 TPRLQDSGTVISEL----PDPRLKGDFPKEEMQIMA 483
+ + L P RL G P+ E I
Sbjct: 245 SKEAVA---ICKGLMTKHPGKRL-GCGPEGERDIKE 276
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 33/102 (32%), Positives = 50/102 (49%), Gaps = 20/102 (19%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
L +LH+ I++RD+K N+LLD + K+ D GM K +G+ + + GT
Sbjct: 136 ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-----FCGT 187
Query: 400 FGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP 435
Y APE Y G A D ++ GV+L E++ G P
Sbjct: 188 PDYIAPEILQEMLY---GPA---VDWWAMGVLLYEMLCGHAP 223
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 70/343 (20%), Positives = 115/343 (33%), Gaps = 91/343 (26%)
Query: 221 EHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVK------RFKTQGGPNADSVFLTEV 273
+H ++ ++G+G V + + VA+K RF Q E+
Sbjct: 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA--------AEEI 144
Query: 274 DMLSRL------HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNW 327
+L L + +V+ ++ FR M FE + + NL + + +G +
Sbjct: 145 RILEHLRKQDKDNTMNVIHMLEN-FTFRNHICM---TFELL-SMNLYELIKKNKFQGFSL 199
Query: 328 DTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA--KITDLGMAKRLKADG 385
A + L+ LH+ RI+H D+K NILL + + K+ D G
Sbjct: 200 PLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG--------- 247
Query: 386 LPSCSSSPAR------MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR------ 433
SS +Q F Y APE + R + D++S G +L EL+TG
Sbjct: 248 ----SSCYEHQRVYTYIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302
Query: 434 --------------QPIHRSITKG---------EESLVLWATPRLQDSGTVISELPDPRL 470
P + + + L D V++ R
Sbjct: 303 DEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRG 362
Query: 471 KGDFPKEEMQIMAYLAKE-----------CLQLDPDARPTMSE 502
K P E + L CL+ DP R T +
Sbjct: 363 KLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 39/188 (20%), Positives = 72/188 (38%), Gaps = 40/188 (21%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
RGL+Y+H A +LHRD+K +N+ ++ E+L KI D G+A+ + S +
Sbjct: 131 RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPH-----YSHKGHLS 182
Query: 398 G---TFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGRQ------PIH--RSITKGE 444
T Y +P ++ + D+++ G + E++TG+ + + I +
Sbjct: 183 EGLVTKWYRSPR-LLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE-- 239
Query: 445 ESLVLWATPRLQDSGTV-------ISELPDPR---LKGDFPKEEMQIMAYLAKECLQLDP 494
+D + I L P + + +L + L P
Sbjct: 240 ----SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQ-ILTFSP 294
Query: 495 DARPTMSE 502
R T E
Sbjct: 295 MDRLTAEE 302
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 33/105 (31%), Positives = 43/105 (40%), Gaps = 26/105 (24%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS---CSSSPARM 396
L YLH I++RD+K NILLD + +TD G+ K + C
Sbjct: 151 ALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC------- 200
Query: 397 QGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP 435
GT Y APE Y R D + G VL E++ G P
Sbjct: 201 -GTPEYLAPEVLHKQPY---DRT---VDWWCLGAVLYEMLYGLPP 238
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 62/365 (16%), Positives = 114/365 (31%), Gaps = 110/365 (30%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G G S V+ + + VA+K K+ ++ E+ +L + +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD--EIRLLKSVRNSD-------- 94
Query: 292 SEFRGKRAMRLLVFEFM---PNG------------NLRDCLDGVLVEGMNWDTRVAIAIG 336
+ + L+ +F NG +L + +G+ I
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQ 154
Query: 337 AARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSSP 393
+GL+YLH RI+H DIK NILL ++ + + +R A + S
Sbjct: 155 VLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 394 ARMQG--------------------------------------TFGYFAPEYAMVGRA-S 414
A T Y + E ++G +
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLE-VLIGSGYN 271
Query: 415 LMSDVFSFGVVLLELITGR--------------------------QPIHRSITKGEESLV 448
+D++S + EL TG + + I G+ S
Sbjct: 272 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKE 331
Query: 449 LWATPRLQDSGTV--ISELPDPRL------KGDFPKEEMQIMAYLAKECLQLDPDARPTM 500
+ G + I++L L K ++ +EE L+L P+ R T
Sbjct: 332 FF-----TKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATA 386
Query: 501 SEVVQ 505
+E ++
Sbjct: 387 AECLR 391
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 36/105 (34%), Positives = 50/105 (47%), Gaps = 26/105 (24%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS---CSSSPARM 396
L YLHE I++RD+K N+LLD + K+TD GM K G + C
Sbjct: 122 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC------- 171
Query: 397 QGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP 435
GT Y APE Y G + D ++ GV++ E++ GR P
Sbjct: 172 -GTPNYIAPEILRGEDY---GFS---VDWWALGVLMFEMMAGRSP 209
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 36/99 (36%), Positives = 54/99 (54%), Gaps = 14/99 (14%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR-LKADGLPS--CSSSPARM 396
GL++LH I++RD+K NILLD++ + KI D GM K + D + C
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC------- 179
Query: 397 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP 435
GT Y APE + + + D +SFGV+L E++ G+ P
Sbjct: 180 -GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 36/105 (34%), Positives = 50/105 (47%), Gaps = 26/105 (24%)
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPS---CSSSPARM 396
L YLHE I++RD+K N+LLD + K+TD GM K G + C
Sbjct: 165 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC------- 214
Query: 397 QGTFGYFAPE------YAMVGRASLMSDVFSFGVVLLELITGRQP 435
GT Y APE Y G + D ++ GV++ E++ GR P
Sbjct: 215 -GTPNYIAPEILRGEDY---GFS---VDWWALGVLMFEMMAGRSP 252
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 60.7 bits (146), Expect = 4e-10
Identities = 37/224 (16%), Positives = 63/224 (28%), Gaps = 57/224 (25%)
Query: 201 CRSKTWTIHGTIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVK--RFK 258
C K + FS+ T+K +G+G V++ D VA+K +
Sbjct: 5 CSQKG------PVPFSHCL---PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIE 54
Query: 259 TQGGPNADS-----VFLTEVDML-----------------SRLHHCHVV------PLVGY 290
N L E+ + L+ H V L+
Sbjct: 55 GPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKA 114
Query: 291 CSEFRGKRAMRL------------LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA 338
+ + +V EF G L+ + + + T +I
Sbjct: 115 WDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLT 171
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382
L + R HRD+ N+LL + K+ K
Sbjct: 172 ASLAVAEAS--LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSST 213
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 64/325 (19%), Positives = 112/325 (34%), Gaps = 74/325 (22%)
Query: 232 IVGQGGSSYVYRGQ-LTDGRIVAVK------RFKTQGGPNADSVFLTEVDMLSRLHHC-- 282
+G G S V+ + + + VA+K + E+ +L R++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA--------EDEIKLLQRVNDADN 77
Query: 283 ---------HVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTRVA 332
H++ L+ + +G + + +VFE + NL + G+
Sbjct: 78 TKEDSMGANHILKLLDH-FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ 135
Query: 333 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE------NLNAKITDLGMAKRLKADGL 386
I+ GL+Y+H I+H DIK N+L++ + KI DLG A
Sbjct: 136 ISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 193
Query: 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQ--PIHRSITKGE 444
S + Y +PE + +D++S ++ ELITG + +
Sbjct: 194 NSIQTRE--------YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245
Query: 445 ESLVLWA--------TPRLQDSGT-------------VISELPDPRL------KGDFPKE 477
+ + L +G IS+L L K F K+
Sbjct: 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKD 305
Query: 478 EMQIMAYLAKECLQLDPDARPTMSE 502
E + ++ LQLDP R
Sbjct: 306 EAKEISDFLSPMLQLDPRKRADAGG 330
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 26/123 (21%), Positives = 50/123 (40%), Gaps = 37/123 (30%)
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
G ++HE+ I+HRD+K +N LL+++ + K+ D G+A+ + ++ + + +
Sbjct: 140 LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 399 TFG-----------------YFAPEYAMVGRASLMS---------DVFSFGVVLLELITG 432
Y APE L+ D++S G + EL+
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPE--------LILLQENYTKSIDIWSTGCIFAELLNM 248
Query: 433 RQP 435
Q
Sbjct: 249 LQS 251
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 42/222 (18%), Positives = 77/222 (34%), Gaps = 54/222 (24%)
Query: 222 HATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVF----LTEVDML 276
D++ +++G G +V + R+VA+K+ D + L E+ +L
Sbjct: 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI---LRVFEDLIDCKRILREIAIL 106
Query: 277 SRLHHCHVVPLV-----GYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGMNWDTR 330
+RL+H HVV ++ +F L +V E D +
Sbjct: 107 NRLNHDHVVKVLDIVIPKDVEKFDE-----LYVVLEIAD-----------------SDFK 144
Query: 331 VAIAIGAA--------------RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 376
G++Y+H A ILHRD+K +N L++++ + K+ D G
Sbjct: 145 KLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFG 201
Query: 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSD 418
+A R S P + ++
Sbjct: 202 LA-RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTG 242
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 53/339 (15%), Positives = 105/339 (30%), Gaps = 74/339 (21%)
Query: 221 EHATDKFSGSNIVGQGGSSYVYRG--QLTDGRIVAVK------RFKTQGGPNADSVFLTE 272
+ +++ +G+G V VA+K +++ E
Sbjct: 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA--------RLE 66
Query: 273 VDMLSRL--------HHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVE 323
+++L ++ C V + F G + + FE + N + L +
Sbjct: 67 INVLKKIKEKDKENKFLC--VLMSD-WFNFHG----HMCIAFELL-GKNTFEFLKENNFQ 118
Query: 324 GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383
+A L +LHE ++ H D+K NIL + + + + K+
Sbjct: 119 PYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175
Query: 384 DGLPSC------SSSPARMQGT------FGYFAPEYAMVGRASLMSDVFSFGVVLLELIT 431
S S++ T Y PE + + DV+S G +L E
Sbjct: 176 VKNTSIRVADFGSATFDHEHHTTIVATRH-YRPPEVILELGWAQPCDVWSIGCILFEYYR 234
Query: 432 GR--------------------QPIHRSITKGEESLVLW--ATPRLQDSGTVISELPDPR 469
G I + + + ++S + +
Sbjct: 235 GFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK 294
Query: 470 -LKGDFPKE--EMQIMAYLAKECLQLDPDARPTMSEVVQ 505
LK ++ E + L + L+ DP R T++E +
Sbjct: 295 PLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 45/212 (21%), Positives = 74/212 (34%), Gaps = 23/212 (10%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G G +Y G + G VA+K + E + + +P + +C
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVK---TKHPQLHIESKIYKMMQGGVGIPTIRWC 73
Query: 292 SEFRGKRAMRLLVFEFM-PN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
M V E + P+ +L + + T + +A +EY+H
Sbjct: 74 GAEGDYNVM---VMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMISRIEYIHSK-- 124
Query: 350 PRILHRDIKSSNILLDENLNAK---ITDLGMAKRLK--ADGLPSCSSSPARMQGTFGYFA 404
+HRD+K N L+ I D G+AK+ + + GT Y A
Sbjct: 125 -NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-A 182
Query: 405 PEYAMVGR-ASLMSDVFSFGVVLLELITGRQP 435
+G S D+ S G VL+ G P
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 38/158 (24%), Positives = 60/158 (37%), Gaps = 25/158 (15%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVK--RFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVG 289
+G G + G+ L VA+K K++ E +L +P V
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVY 71
Query: 290 YCSEFRGKRAMRLLVFEFM-PN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 347
Y AM V E + P+ +L D D + T + IAI +EY+H
Sbjct: 72 YFGPCGKYNAM---VLELLGPSLEDLFDLCDRT----FSLKTVLMIAIQLISRMEYVHSK 124
Query: 348 AAPRILHRDIKSSNILL--DENLNAK---ITDLGMAKR 380
+++RD+K N L+ N + I D +AK
Sbjct: 125 N---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 46/214 (21%), Positives = 78/214 (36%), Gaps = 27/214 (12%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G G +Y G + VA+K + L E + L +P V +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVK---TKHPQLLYESKIYRILQGGTGIPNVRWF 71
Query: 292 SEFRGKRAMRLLVFEFM-PN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
+ V + + P+ +L + ++ T + +A +E++H +
Sbjct: 72 GVEGDYNVL---VMDLLGPSLEDLFNFCSR----KLSLKTVLMLADQMINRVEFVHSKS- 123
Query: 350 PRILHRDIKSSNILLDENLNAK---ITDLGMAKRLK--ADGLPSCSSSPARMQGTFGYFA 404
LHRDIK N L+ A I D G+AK+ + + + GT Y A
Sbjct: 124 --FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-A 180
Query: 405 PEYAMVGRASLMS---DVFSFGVVLLELITGRQP 435
+G S D+ S G VL+ + G P
Sbjct: 181 SVNTHLGIE--QSRRDDLESLGYVLMYFLRGSLP 212
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 42/230 (18%), Positives = 81/230 (35%), Gaps = 39/230 (16%)
Query: 233 VGQGGSSYVYRGQ---------LTDGRIVAVKRFKTQGGPNADSVFLT------EVDMLS 277
+ +Y + ++K G + F +V+
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 278 RLHHCHV--VPLVGYCSEFRGKRAMRLLVFEFMPNG-NLRDCLDGVLVEGMNWDTRVAIA 334
+L+ + +P + K R LV + G +L+ LD ++ + + +A
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDK--YRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVA 165
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT--DLGMAKRLKADG--LPSCS 390
LE+LHE +H ++ + NI +D +++T G A R G +
Sbjct: 166 CRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222
Query: 391 SSPARMQGTFGYFAPEYAMV----GRA-SLMSDVFSFGVVLLELITGRQP 435
S + +G E+ + G S SD+ S G +L+ + G P
Sbjct: 223 GSRSPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 42/214 (19%), Positives = 76/214 (35%), Gaps = 25/214 (11%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G+G ++ G L + + VA+K + + E L C +P V Y
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRR---SDAPQLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 292 SEFRGKRAMRLLVFEFM-PN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
+ + V + + P+ +L D + T A ++ +HE +
Sbjct: 75 GQEGLHNVL---VIDLLGPSLEDLLDLCGRK----FSVKTVAMAAKQMLARVQSIHEKS- 126
Query: 350 PRILHRDIKSSNILLDENLNAK-----ITDLGMAKRLK--ADGLPSCSSSPARMQGTFGY 402
+++RDIK N L+ + + D GM K + + GT Y
Sbjct: 127 --LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184
Query: 403 FAPEYAMVGR-ASLMSDVFSFGVVLLELITGRQP 435
+GR S D+ + G V + + G P
Sbjct: 185 -MSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 54/294 (18%), Positives = 90/294 (30%), Gaps = 52/294 (17%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV------- 284
+G GG +Y A K + + +E+ R+
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVE--YQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 285 -------VPLVGYCSEFRGK-RAMRLLVFEFM-PN-GNLRDC-----LDGVLVEGMNWDT 329
+PL K R+ R +V E + + + VL
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQ------- 155
Query: 330 RVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT--DLGMAKRLKADG-- 385
+ I LEY+HE +H DIK++N+LL ++ D G++ R +G
Sbjct: 156 ---LGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
Query: 386 LPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGE 444
+ GT F A G A S SDV G +L + G+ P +++
Sbjct: 210 KQYQENPRKGHNGTI-EFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268
Query: 445 ESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP 498
+ + + G E Q + L D +P
Sbjct: 269 AVQTA----KTNLLDELPQSVLKWAPSGSSCCEIAQFLVC----AHSLAYDEKP 314
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 4e-07
Identities = 86/561 (15%), Positives = 147/561 (26%), Gaps = 154/561 (27%)
Query: 17 WIQRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCSRS----------CDCSPA-- 64
++ I + + S L D K N SR + PA
Sbjct: 93 FLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKN 152
Query: 65 -----VGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTCTSGSVSGVKASGKHISSKV 119
V GS GK T + A D SY C + + + V
Sbjct: 153 VLIDGVLGS--GK-TWV-ALD-----VCLSYKVQC-----KMDFKIFWLNLKNCNSPETV 198
Query: 120 VVIVLLLCVILTTIAFLMLVLCYVYRKGKFHLRSSVISSDKESCNSATNLISHRITSVPE 179
+ ++ L + + RS S+ K +S + + S P
Sbjct: 199 LEMLQKLLYQID---------------PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY 243
Query: 180 TR----------VEVVSPIDLATGC-FLKTTFCRSKTWTIHGTIIRFSYSALEHATDKFS 228
+ + +L C L TT R K T + ++ +L+H + +
Sbjct: 244 ENCLLVLLNVQNAKAWNAFNL--SCKILLTT--RFKQVTDFLSAATTTHISLDHHSMTLT 299
Query: 229 GSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEV-DMLSRLHH-CHVVP 286
+ Y+ D R + R P S+ + D L+ + HV
Sbjct: 300 PDEVKSL-LLKYL------DCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHV-- 350
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLD--GVLVEGMN---------WD------- 328
C + L V E P R D V + W
Sbjct: 351 ---NCDKLTTIIESSLNVLE--PA-EYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDV 404
Query: 329 --------TRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380
+ + ++ ++K + + L+ I D
Sbjct: 405 MVVVNKLHKYSLVEKQPKESTISIPS------IYLELK-VKLENEYALHRSIVD----HY 453
Query: 381 LKADGLPSCSSSPARMQGTF----GYFAPEYAMVGRASLMSDVF-SFGVVLLELITGRQP 435
S P + F G+ R +L VF F + Q
Sbjct: 454 NIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFL-------EQK 506
Query: 436 IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDF-----PKEEMQIMAYL----- 485
I T W G++++ L + + PK E + A L
Sbjct: 507 IRHDST-------AWNAS-----GSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPK 554
Query: 486 AKECLQLDPDARPTMSEVVQI 506
+E L +++I
Sbjct: 555 IEENLICSKYTD-----LLRI 570
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 8e-04
Identities = 31/229 (13%), Positives = 69/229 (30%), Gaps = 64/229 (27%)
Query: 461 VISELPDPRLKGDFP-----------KEEMQIMAYLAKECLQLDPD--ARPTMSEVVQIL 507
+ +++ ++ L K Q+DP+ +R S +++
Sbjct: 167 ALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLR 226
Query: 508 STIAPDKSRR--------------RNIS----LNLFQI---------------FSAGGME 534
+ RR N+ N F + F +
Sbjct: 227 IHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATT 286
Query: 535 KEPSIERPDNLFETLIESEEL-KKATS---FGSPRCSQAVDTD-ITLNTRSNSKEEDTVS 589
S++ T E + L K PR + + T+ L+ + S + +
Sbjct: 287 THISLDHHSMTL-TPDEVKSLLLKYLDCRPQDLPR--EVLTTNPRRLSIIAESIRDGLAT 343
Query: 590 TEYMEKLLL--LTSEVRSSRAPDIETVDLTEPR--FESFCM--KNVNSP 632
+ + + LT+ + SS + ++ E R F+ + + + P
Sbjct: 344 WDNWKHVNCDKLTTIIESS----LNVLEPAEYRKMFDRLSVFPPSAHIP 388
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 59/340 (17%), Positives = 111/340 (32%), Gaps = 76/340 (22%)
Query: 221 EHATDKFSGSNIVGQGGSSYVYRGQ--LTDGRIVAVK------RFKTQGGPNADSVFLTE 272
+ + ++ + +G+G V GR VAVK R+ +E
Sbjct: 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA--------RSE 61
Query: 273 VDMLSRL--------HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG 324
+ +L L C V ++ E G + VFE + + D +
Sbjct: 62 IQVLEHLNTTDPNSTFRC--VQMLE-WFEHHGHICI---VFELL-GLSTYDFIKENGFLP 114
Query: 325 MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384
D +A + + +LH ++ H D+K NIL ++ + + + + +
Sbjct: 115 FRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171
Query: 385 GLPSC------SSSPAR------MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITG 432
P S++ + Y APE + S DV+S G +L+E G
Sbjct: 172 INPDIKVVDFGSATYDDEHHSTLVSTRH-YRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
Query: 433 R--------------------QPIHRSITKGE------ESLVLWATPRLQDSGTVISELP 466
I K + W +G +S
Sbjct: 231 FTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDW--DEHSSAGRYVSRAC 288
Query: 467 DPRLKGDFPKE-EMQIMAYLAKECLQLDPDARPTMSEVVQ 505
P + ++ E + + L ++ L+ DP R T+ E ++
Sbjct: 289 KPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK 328
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 49/250 (19%), Positives = 80/250 (32%), Gaps = 63/250 (25%)
Query: 221 EHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVK------RFKTQGGPNADSVFLTEV 273
+ F +G G V Q + + + AVK ++ E
Sbjct: 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA--------KIEA 82
Query: 274 DMLSRL-------HHCHVVPLVGYCSEFRGKRAMRL-LVFEFMPNGNLRDCLDGVLVEGM 325
D+L ++ ++ V G + + L+FE + +L + + G
Sbjct: 83 DILKKIQNDDINNNNI--VKYHG-KFMYYD----HMCLIFEPL-GPSLYEIITRNNYNGF 134
Query: 326 NWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 385
+ + I + L YL + + H D+K NILLD+ K
Sbjct: 135 HIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191
Query: 386 LPSCSSSPARMQGTFG-----------------YFAPE------YAMVGRASLMSDVFSF 422
+ S FG Y APE + + SD++SF
Sbjct: 192 QIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSF 245
Query: 423 GVVLLELITG 432
G VL EL TG
Sbjct: 246 GCVLAELYTG 255
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 39/165 (23%), Positives = 66/165 (40%), Gaps = 21/165 (12%)
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKIT--DLGMAKRLKADG----LPSCSSSPA 394
LEY+HE +H DIK+SN+LL+ ++ D G+A R +G +
Sbjct: 165 LEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRC- 220
Query: 395 RMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 453
GT F A G A S D+ G +++ +TG P ++ + V +
Sbjct: 221 -HDGTI-EFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY--VRDSKI 276
Query: 454 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP 498
R +++ + + P + P E + M LD +P
Sbjct: 277 RYRENIASLMDKCFP--AANAPGEIAKYMET----VKLLDYTEKP 315
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 632 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.7 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.09 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.04 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.66 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.65 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.49 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.35 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.35 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.28 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.05 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.0 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.95 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.86 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.59 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.54 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.5 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.38 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.25 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.21 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.21 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.98 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.92 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.77 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.68 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.22 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.78 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.68 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 93.26 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 92.99 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 92.84 | |
| 3h5c_B | 317 | Vitamin K-dependent protein Z; protein Z-protein Z | 89.23 | |
| 1z6c_A | 87 | Vitamin K-dependent protein S; EGF module, blood c | 88.53 | |
| 1lmj_A | 86 | Fibrillin 1; EGF, calcium, microfibril, neonatal, | 86.65 | |
| 1aut_L | 114 | Activated protein C; serine proteinase, plasma cal | 83.63 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.09 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 82.81 | |
| 1x7a_L | 146 | Coagulation factor IX, light chain; inhibition, bl | 82.33 | |
| 2w2n_E | 107 | LDL receptor, low-density lipoprotein receptor; hy | 80.15 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 80.11 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=457.72 Aligned_cols=257 Identities=26% Similarity=0.370 Sum_probs=209.4
Q ss_pred CccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
++...+.||+|+||+||+|.+. +++.||||+++........+.|.+|+.+|++|+|||||+++|+|.+ ..
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~----~~ 102 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK----DQ 102 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS----SS
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE----CC
Confidence 3455688999999999999873 4689999999876666666789999999999999999999999986 44
Q ss_pred eEEEEEEeCCCCChhhhhhccc--------------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEec
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD 365 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~ 365 (632)
..+||||||++|||.++|.... ...++|.+++.|+.|||+||+|||+++ ||||||||+||||+
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVY 179 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEEC
Confidence 6799999999999999996432 235999999999999999999999998 99999999999999
Q ss_pred CCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCcccccc
Q 006750 366 ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGE 444 (632)
Q Consensus 366 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~ 444 (632)
+++++||+|||+|+.....+.. .......||+.|||||++.++.++.++|||||||+||||+| |+.||........
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~---~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~ 256 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYY---KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 256 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCB---CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH
T ss_pred CCCCEEECCcccceeccCCCce---eEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999876543221 22344579999999999999999999999999999999998 8999975433211
Q ss_pred chheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 445 ESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
... +..-.. .+.|..++..+.+|+.+||+.||++||||.||++.|+.+
T Consensus 257 ~~~--------------i~~~~~----~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 257 VEM--------------IRNRQV----LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHH--------------HHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHH--------------HHcCCC----CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 100 011011 123444556689999999999999999999999999765
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-55 Score=450.60 Aligned_cols=264 Identities=28% Similarity=0.419 Sum_probs=205.3
Q ss_pred HHhhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 221 EHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 221 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
+...++|.+.+.||+|+||+||+|++++ .||||+++... .....+.|.+|+.+|++++|||||+++|++.+ .
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-----~ 104 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-----D 104 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-----C
Confidence 3345677888999999999999999753 59999997543 33345679999999999999999999999864 2
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
.+|||||||+||+|.++|+... ..++|.+++.|+.|||.||+|||+++ ||||||||+||||++++.+||+|||+|+
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~ 180 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLAT 180 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCB
T ss_pred eEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCce
Confidence 4699999999999999997543 45999999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhc---CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 456 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~---~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~ 456 (632)
....... ........||+.|||||++.+ +.|+.++|||||||+||||+||+.||............
T Consensus 181 ~~~~~~~---~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~-------- 249 (307)
T 3omv_A 181 VKSRWSG---SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM-------- 249 (307)
T ss_dssp C---------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH--------
T ss_pred ecccCCc---ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHH--------
Confidence 7643221 122345679999999999974 46899999999999999999999999754322111100
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 457 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 457 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
.......|.+. ..+..++..+.+|+.+||+.||++||||.||++.|+.+.
T Consensus 250 ----~~~~~~~p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 250 ----VGRGYASPDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp ----HHTTCCCCCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred ----HhcCCCCCCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 00111122211 233344556899999999999999999999999988763
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-55 Score=453.13 Aligned_cols=258 Identities=28% Similarity=0.406 Sum_probs=208.6
Q ss_pred cCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 298 (632)
++|.+.+.||+|+||+||+|++. +++.||||+++.. .....+.|.+|+++|++|+|||||+++|+|.+ .
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~----~ 87 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVE----G 87 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----S
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee----C
Confidence 45777899999999999999874 3788999999754 33445679999999999999999999999986 4
Q ss_pred ceEEEEEEeCCCCChhhhhhccc-----------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCC
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVL-----------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 367 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~ 367 (632)
...|||||||++|+|.++|+... ...++|.+++.|+.|||.||+|||+++ |+||||||+||||+++
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCC
Confidence 56899999999999999996532 245999999999999999999999998 9999999999999999
Q ss_pred CCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccch
Q 006750 368 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEES 446 (632)
Q Consensus 368 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~ 446 (632)
+.+||+|||+|+........ .......||+.|||||++.+..|+.++|||||||+||||+| |+.||..........
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~---~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 241 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYY---RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 241 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCE---EETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred CcEEECCcccceecCCCCce---eecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99999999999876543221 11233569999999999999999999999999999999999 899997543221110
Q ss_pred heeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 447 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
. +..-..+ ..|..++..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 242 ~--------------i~~~~~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 242 C--------------ITQGRVL----QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp H--------------HHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H--------------HHcCCCC----CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 0 0011111 223344456899999999999999999999999998764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=454.71 Aligned_cols=258 Identities=28% Similarity=0.420 Sum_probs=203.3
Q ss_pred cCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 298 (632)
++|.+.++||+|+||+||+|+++ +++.||||+++.. .....+.|.+|+++|++|+|||||+++|+|.+ .
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~----~ 115 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTE----G 115 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----S
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----C
Confidence 45677889999999999999875 3789999999754 33445679999999999999999999999986 4
Q ss_pred ceEEEEEEeCCCCChhhhhhccc-------------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEec
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVL-------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD 365 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~ 365 (632)
...|||||||++|+|.++|+... ..+++|.+++.|+.|||.||+|||+.+ |+||||||+||||+
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVG 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEEC
Confidence 56899999999999999996532 235999999999999999999999998 99999999999999
Q ss_pred CCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCcccccc
Q 006750 366 ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGE 444 (632)
Q Consensus 366 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~ 444 (632)
+++.+||+|||+|+........ .......||+.|||||++.+..++.++|||||||+||||+| |+.||........
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~---~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~ 269 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYY---RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA 269 (329)
T ss_dssp TTTEEEECCCC-------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH
T ss_pred CCCcEEEcccccceeccCCCcc---eecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999999876543221 12234579999999999999999999999999999999999 8999975432211
Q ss_pred chheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 445 ESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
... +.+-.++ ..|..++..+.+|+.+||+.||++|||+.||++.|+.+.
T Consensus 270 ~~~--------------i~~g~~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 270 IDC--------------ITQGREL----ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp HHH--------------HHHTCCC----CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHH--------------HHcCCCC----CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 110 1111111 223334455899999999999999999999999998874
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-54 Score=452.98 Aligned_cols=271 Identities=26% Similarity=0.388 Sum_probs=219.0
Q ss_pred ecHHHHHHhhcCccccceeeeeCceEEEEEEECC------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCccce
Q 006750 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPL 287 (632)
Q Consensus 215 ~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~-Hpniv~l 287 (632)
++...|+...++|++.+.||+|+||+||+|.+.. ++.||||+++........+.|.+|+.+|+++. |||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4455677778899999999999999999998653 36899999987665555667999999999995 5999999
Q ss_pred eeeeecccCCcceEEEEEEeCCCCChhhhhhccc--------------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCcee
Q 006750 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRIL 353 (632)
Q Consensus 288 ~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ii 353 (632)
+|+|.+. ...+|||||||++|+|.++|+... ...++|.+++.++.|||+||+|||+++ ||
T Consensus 134 ~g~~~~~---~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---ii 207 (353)
T 4ase_A 134 LGACTKP---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CI 207 (353)
T ss_dssp EEEECCT---TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred EEEEEec---CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---ee
Confidence 9998752 335799999999999999996532 234899999999999999999999998 99
Q ss_pred ecCCCCCCeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-C
Q 006750 354 HRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-G 432 (632)
Q Consensus 354 HrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G 432 (632)
||||||+||||++++.+||+|||+|+....+... .......||+.|||||++.+..|+.++|||||||+||||+| |
T Consensus 208 HRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~---~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G 284 (353)
T 4ase_A 208 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDY---VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 284 (353)
T ss_dssp CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTS---EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred cCccCccceeeCCCCCEEECcchhhhhcccCCCc---eeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCC
Confidence 9999999999999999999999999876543211 12234679999999999999999999999999999999998 8
Q ss_pred CCCCCCccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 433 RQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 433 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
+.||.......... ..+.+-..+ ..|..++..+.+|+.+||+.||++|||+.||++.|..++
T Consensus 285 ~~Pf~~~~~~~~~~-------------~~i~~g~~~----~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll 346 (353)
T 4ase_A 285 ASPYPGVKIDEEFC-------------RRLKEGTRM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 346 (353)
T ss_dssp CCSSTTCCCSHHHH-------------HHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHH-------------HHHHcCCCC----CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 99997543221100 011111122 223334455889999999999999999999999998875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-53 Score=441.34 Aligned_cols=256 Identities=25% Similarity=0.297 Sum_probs=204.6
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
+.|...+.||+|+||.||+|++. +|+.||||+++.... +.+|+.+|++|+|||||++++++.+ ...+||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~----~~~~~i 127 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVRE----GPWVNI 127 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEE----TTEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEE----CCEEEE
Confidence 45777889999999999999976 499999999986432 3579999999999999999999876 557899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCC-CeEEeccccceecc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITDLGMAKRLK 382 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~-~vkL~DFGla~~~~ 382 (632)
|||||+||+|.++|+.. ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+|+.+.
T Consensus 128 vmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp EECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred EEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 99999999999999764 45999999999999999999999998 99999999999999987 59999999999876
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 462 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (632)
.+.............||+.|||||++.+..|+.++|||||||+||||++|+.||...........+.
T Consensus 203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~------------- 269 (336)
T 4g3f_A 203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA------------- 269 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH-------------
T ss_pred CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH-------------
Confidence 5432221122334679999999999999999999999999999999999999997543322111100
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 463 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 463 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
..... ...++..++..+.+|+.+||+.||.+|||+.|+++.|...+
T Consensus 270 ~~~~~---~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 270 SEPPP---IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp HSCCG---GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCCC---chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 00000 01123344556889999999999999999999999887664
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-53 Score=432.70 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=199.8
Q ss_pred cccceeeeeCceEEEEEEECC-CcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEE
Q 006750 228 SGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 305 (632)
Q Consensus 228 ~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~ 305 (632)
...+.||+|+||+||+|.+.. +..||||++.... .....+.|.+|+.+|++|+|||||++++++.........+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 445679999999999999864 8999999997543 23344569999999999999999999999876544456789999
Q ss_pred EeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC-CCCeEEeccccceecccC
Q 006750 306 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKITDLGMAKRLKAD 384 (632)
Q Consensus 306 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~-~~~vkL~DFGla~~~~~~ 384 (632)
|||+||+|.++|.+. ..+++..+..++.||+.||+|||+++ ++|+||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~- 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 184 (290)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred eCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-
Confidence 999999999999764 46999999999999999999999885 35999999999999974 78999999999975432
Q ss_pred CCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccc
Q 006750 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 464 (632)
Q Consensus 385 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (632)
.......||+.|||||++.+ .|+.++|||||||+||||+||+.||.......... ..
T Consensus 185 ------~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~----------------~~ 241 (290)
T 3fpq_A 185 ------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY----------------RR 241 (290)
T ss_dssp ------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH----------------HH
T ss_pred ------CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHH----------------HH
Confidence 22345689999999998864 69999999999999999999999996432211100 00
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 465 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 465 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
+........++...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 242 i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 242 VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000011122223458899999999999999999999863
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-53 Score=443.50 Aligned_cols=252 Identities=22% Similarity=0.288 Sum_probs=202.0
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
++|++.+.||+|+||+||+|+.. +|+.||||+++.... ....+.|.+|+.+|++|+|||||++++++.+ ...+|
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~----~~~~y 99 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE----NGSLY 99 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TTEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE----CCEEE
Confidence 57999999999999999999975 599999999976532 2344569999999999999999999999876 56789
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
||||||+||+|.++|.......+++.+++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+...
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeec
Confidence 9999999999999997655556899999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 462 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (632)
... ......+||+.|||||++.+..|+.++|||||||+||||++|+.||...........+ .
T Consensus 177 ~~~-----~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i-------------~ 238 (350)
T 4b9d_A 177 STV-----ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI-------------I 238 (350)
T ss_dssp HHH-----HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-------------H
T ss_pred CCc-----ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH-------------H
Confidence 321 1123467999999999999999999999999999999999999999754322111000 0
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 463 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 463 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
. ...+. .+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 239 ~-~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 239 S-GSFPP----VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp H-TCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c-CCCCC----CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 01111 222334558899999999999999999999863
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-53 Score=439.51 Aligned_cols=281 Identities=24% Similarity=0.323 Sum_probs=205.6
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV 304 (632)
++|.+.+.||+|+||+||+|++ +|+.||||+++... .....+..|+..+.+++|||||+++|+|.+.......+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~--~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc--hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 3567788999999999999998 58999999997532 12222445666667889999999999998755445578999
Q ss_pred EEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhc-----CCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA-----AAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
||||++|+|.++|+. ..++|..+++++.|+++||+|||++ +.++|+||||||+||||+.++++||+|||+|+
T Consensus 80 ~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 999999999999975 4589999999999999999999986 13359999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcC------CCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe-eccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVG------RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV-LWAT 452 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~------~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~-~~~~ 452 (632)
......... ........||+.|||||++.+. .++.++|||||||+||||+||+.||............ ....
T Consensus 157 ~~~~~~~~~-~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 157 RHDSATDTI-DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEETTTTEE-SCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred cccCCCCce-eeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 775432111 1223346799999999999754 3678999999999999999998887543221110000 0000
Q ss_pred cccccc-cccccccCCCCCCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 453 PRLQDS-GTVISELPDPRLKGDF-PKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 453 ~~~~~~-~~~~~~~~~~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
+..... ........+|.+.... +.+.+..+.+|+.+||+.||++||||.||++.|+++..
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 000000 0011122233322211 23456779999999999999999999999999988753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-52 Score=436.69 Aligned_cols=250 Identities=23% Similarity=0.370 Sum_probs=206.9
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
..|+..+.||+|+||+||+|++. +|+.||||+++.... ...+.+.+|+.+|++++|||||++++++.+ ...+||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~----~~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLV----GDELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEE----TTEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----CCEEEE
Confidence 56889999999999999999986 599999999975433 233458999999999999999999999886 557899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
|||||+||+|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 149 vmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 222 (346)
T 4fih_A 149 VMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222 (346)
T ss_dssp EECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence 9999999999999975 45999999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (632)
.. ......+||+.|||||++.+..|+.++|||||||+||||++|+.||........... +.
T Consensus 223 ~~-----~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~--------------i~ 283 (346)
T 4fih_A 223 EV-----PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM--------------IR 283 (346)
T ss_dssp SS-----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH--------------HH
T ss_pred CC-----CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH--------------HH
Confidence 32 223456899999999999999999999999999999999999999975432211110 11
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 464 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
....+.+ ..+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 284 ~~~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 284 DNLPPRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp HSSCCCC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCCCCCC--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111111 1223345568999999999999999999999763
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-52 Score=429.07 Aligned_cols=250 Identities=26% Similarity=0.351 Sum_probs=206.1
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|++.+.||+|+||+||+|+.. +|+.||||++.... .....+.+.+|+++|++|+|||||++++++.+ ...+
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~ 107 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD----DEKL 107 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe----CCEE
Confidence 46899999999999999999875 59999999997431 22344569999999999999999999999876 5678
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|||||||+||+|.++|... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 108 yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~ 182 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL 182 (311)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceec
Confidence 9999999999999999764 45999999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
..... .......+||+.|||||++.+..|+.++|||||||+||||++|+.||..........
T Consensus 183 ~~~~~---~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~--------------- 244 (311)
T 4aw0_A 183 SPESK---QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFA--------------- 244 (311)
T ss_dssp CTTTT---CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---------------
T ss_pred CCCCC---cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---------------
Confidence 54321 122345689999999999999999999999999999999999999997543221111
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.+.... ..+|...+..+.+|+.+||+.||.+|||+.|++.
T Consensus 245 --~i~~~~--~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 245 --KIIKLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp --HHHHTC--CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred --HHHcCC--CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 000000 0123334455889999999999999999998743
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-51 Score=437.94 Aligned_cols=251 Identities=24% Similarity=0.372 Sum_probs=207.4
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
.+.|+..+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+.+|++|+|||||++++++.. ...+|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~----~~~~~ 224 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLV----GDELW 224 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEEEE----TTEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEEEE----CCEEE
Confidence 356999999999999999999986 499999999976543 334458999999999999999999999986 55789
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
||||||+||+|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+.
T Consensus 225 iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~ 298 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 298 (423)
T ss_dssp EEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred EEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECC
Confidence 99999999999999964 45999999999999999999999999 9999999999999999999999999999875
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 462 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (632)
... ......+||+.|||||++.+..|+.++|||||||+||||++|+.||........... +
T Consensus 299 ~~~-----~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~--------------i 359 (423)
T 4fie_A 299 KEV-----PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM--------------I 359 (423)
T ss_dssp SSC-----CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH--------------H
T ss_pred CCC-----ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH--------------H
Confidence 432 233456899999999999999999999999999999999999999975432211110 1
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 463 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 463 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.....+.+. .+...+..+.+|+.+||..||++|||+.|+++.
T Consensus 360 ~~~~~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 360 RDNLPPRLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp HHSCCCCCS--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HcCCCCCCc--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111111 122334558899999999999999999999863
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=415.91 Aligned_cols=247 Identities=25% Similarity=0.296 Sum_probs=189.9
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|++.+.||+|+||+||+|... +|+.||||+++... .......+.+|+.+|++++|||||++++++.+ ....
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~----~~~~ 88 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS----KDEI 88 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC----SSEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE----CCEE
Confidence 57999999999999999999875 59999999997543 22334569999999999999999999999875 5678
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||||+ +|+|.++|... ..+++.++..++.|++.||+|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 89 ~ivmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 162 (275)
T 3hyh_A 89 IMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIM 162 (275)
T ss_dssp EEEEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC---
T ss_pred EEEEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeec
Confidence 9999999 78999999754 45999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCC-CcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
.... ......||+.|||||++.+..+ +.++|||||||+||||++|+.||............
T Consensus 163 ~~~~------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i------------ 224 (275)
T 3hyh_A 163 TDGN------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI------------ 224 (275)
T ss_dssp ------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------------
T ss_pred CCCC------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------------
Confidence 5332 2335679999999999988775 68999999999999999999999653321110000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
... .. .+|...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 225 --~~~-~~----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 225 --SNG-VY----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp --HHT-CC----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred --HcC-CC----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 000 01 1223334558899999999999999999999873
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=423.26 Aligned_cols=248 Identities=24% Similarity=0.309 Sum_probs=195.0
Q ss_pred cCccccceeeeeCceEEEEEEEC----CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
++|++.+.||+|+||+||+|+.. .++.||||+++.... ......+.+|+++|++++|||||++++++.+ ..
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~ 99 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT----EG 99 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE----TT
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE----CC
Confidence 46899999999999999999863 378999999975321 1222348899999999999999999999876 56
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..|||||||+||+|.++|... ..+++.++..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~ 174 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK 174 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEE
T ss_pred EEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccce
Confidence 789999999999999999764 45999999999999999999999999 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
...... .......||+.|||||++.+..|+.++|||||||+||||++|+.||...........+
T Consensus 175 ~~~~~~-----~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i----------- 238 (304)
T 3ubd_A 175 ESIDHE-----KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI----------- 238 (304)
T ss_dssp C----------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----------
T ss_pred eccCCC-----ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH-----------
Confidence 754332 2234567999999999999999999999999999999999999999754322111100
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM-----SEVVQ 505 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 505 (632)
... .. .+|...+..+.+|+.+||+.||++|||+ +|+++
T Consensus 239 --~~~--~~----~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 239 --LKA--KL----GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp --HHC--CC----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred --HcC--CC----CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 000 01 1233344568899999999999999984 56654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=415.55 Aligned_cols=258 Identities=22% Similarity=0.361 Sum_probs=191.4
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccC-------
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG------- 296 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~------- 296 (632)
++|++.+.||+|+||+||+|+++ +|+.||||+++........+.+.+|+.+|++|+|||||++++++.+...
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45889999999999999999975 5999999999866544455679999999999999999999999875332
Q ss_pred -CcceEEEEEEeCCCCChhhhhhcccc-CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEec
Q 006750 297 -KRAMRLLVFEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITD 374 (632)
Q Consensus 297 -~~~~~~lV~Ey~~~gsL~~~L~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~D 374 (632)
....+|+|||||++|+|.+++..... ....+..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 13357999999999999999975432 23677889999999999999999998 99999999999999999999999
Q ss_pred cccceecccCCCCCC-------CCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchh
Q 006750 375 LGMAKRLKADGLPSC-------SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL 447 (632)
Q Consensus 375 FGla~~~~~~~~~~~-------~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~ 447 (632)
||+|+....+..... .......+||+.|||||++.+..|+.++|||||||+||||++ ||........
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~--- 235 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR--- 235 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH---
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH---
Confidence 999988754322110 112234679999999999999999999999999999999996 7753211100
Q ss_pred eeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 448 VLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.+..+...... .........+.+|+.+||+.||.+|||+.|+++
T Consensus 236 -------------~~~~~~~~~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 236 -------------TLTDVRNLKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -------------HHHHHHTTCCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------------HHHHHhcCCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00001111000 011223345678999999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=407.64 Aligned_cols=275 Identities=23% Similarity=0.316 Sum_probs=203.9
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCccceeeeeeccc--CCcc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR--GKRA 299 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~--~~~~ 299 (632)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++..... ...+.+.+|+.+|++|+|||||++++++.... ....
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 367999999999999999999975 5999999999765332 23456889999999999999999999876431 2345
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
.+|||||||+ |+|.++|... +.+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 7899999995 7899999753 56999999999999999999999999 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec--cccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATPRLQ 456 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~~~~ 456 (632)
.+....... .......+||+.|||||++.+. .++.++||||+|||||||++|+.||...........+.. ..+...
T Consensus 207 ~~~~~~~~~-~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 207 GLCTSPAEH-QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp CC--------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred ecccCcccc-ccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 764432111 1234457899999999998875 579999999999999999999999976443221111100 000000
Q ss_pred c--------ccccccccCCCCCCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 457 D--------SGTVISELPDPRLKGD---FPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 457 ~--------~~~~~~~~~~~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
. ....+..+. +..... .....+..+.+|+.+||..||.+|||+.|+++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLP-PRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GTC-----CHHHHHHSSC-CCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HhhhhhhhhhhhhhhcCC-CcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 000000000 000000 001123457899999999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=394.08 Aligned_cols=290 Identities=40% Similarity=0.689 Sum_probs=235.7
Q ss_pred eeeeecHHHHHHhhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeee
Q 006750 211 TIIRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290 (632)
Q Consensus 211 ~~~~~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~ 290 (632)
....|++.+++.+.++|.+.+.||+|+||.||+|.+.+|+.||||++...........|.+|+.++++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 35689999999999999999999999999999999888999999999866444444458999999999999999999999
Q ss_pred eecccCCcceEEEEEEeCCCCChhhhhhcccc--CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCC
Q 006750 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV--EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL 368 (632)
Q Consensus 291 ~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~ 368 (632)
+.. ....++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+...++|+||||||+|||++.++
T Consensus 96 ~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~ 171 (326)
T 3uim_A 96 CMT----PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 171 (326)
T ss_dssp ECC----SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC
T ss_pred Eec----CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC
Confidence 875 4466999999999999999976432 3499999999999999999999999222399999999999999999
Q ss_pred CeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCcccc--ccch
Q 006750 369 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITK--GEES 446 (632)
Q Consensus 369 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~--~~~~ 446 (632)
.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ....
T Consensus 172 ~~kl~Dfg~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 247 (326)
T 3uim_A 172 EAVVGDFGLAKLMDYKDT----HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247 (326)
T ss_dssp CEEECCCSSCEECCSSSS----CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSB
T ss_pred CEEeccCccccccCcccc----cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchh
Confidence 999999999987653321 1223345999999999999999999999999999999999999999632211 1111
Q ss_pred heeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 447 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
...|...... ...+..+.+..+...++...+..+.+++.+||+.||.+|||+.+|++.|+..
T Consensus 248 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 248 LLDWVKGLLK--EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp HHHHHTTTTS--SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHHhh--chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 2222222221 1234556666777778888999999999999999999999999999999864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=397.60 Aligned_cols=206 Identities=21% Similarity=0.337 Sum_probs=171.8
Q ss_pred HHHHhhcCccccceeeeeCceEEEEEEEC----CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeec
Q 006750 219 ALEHATDKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 293 (632)
Q Consensus 219 ~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~ 293 (632)
.+....++|++.+.||+|+||+||+|+.+ .++.||||++.... ....+.+|+++|+.+ +||||+++++++.+
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 34456788999999999999999999763 36889999986542 234588999999998 79999999998876
Q ss_pred ccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCC-CCeEE
Q 006750 294 FRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKI 372 (632)
Q Consensus 294 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~-~~vkL 372 (632)
....|+||||+++|+|.+++. .+++.++..++.|++.||+|||+++ |+||||||+||||+.+ +.+||
T Consensus 92 ----~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl 159 (361)
T 4f9c_A 92 ----NDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYAL 159 (361)
T ss_dssp ----TTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEE
T ss_pred ----CCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEE
Confidence 568899999999999999984 3899999999999999999999999 9999999999999876 79999
Q ss_pred eccccceecccCCCCC-----------------------CCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHH
Q 006750 373 TDLGMAKRLKADGLPS-----------------------CSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLE 428 (632)
Q Consensus 373 ~DFGla~~~~~~~~~~-----------------------~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~e 428 (632)
+|||+|+......... ........+||+.|+|||++.+. .++.++||||+||||||
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~e 239 (361)
T 4f9c_A 160 VDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLS 239 (361)
T ss_dssp CCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHH
T ss_pred CcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHH
Confidence 9999998654322100 00122345799999999999875 58999999999999999
Q ss_pred HHhCCCCCCCc
Q 006750 429 LITGRQPIHRS 439 (632)
Q Consensus 429 LltG~~P~~~~ 439 (632)
|++|+.||...
T Consensus 240 ll~G~~Pf~~~ 250 (361)
T 4f9c_A 240 LLSGRYPFYKA 250 (361)
T ss_dssp HHHTCSSSSCC
T ss_pred HHHCCCCCCCC
Confidence 99999999654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=387.63 Aligned_cols=286 Identities=39% Similarity=0.651 Sum_probs=234.3
Q ss_pred eecHHHHHHhhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeec
Q 006750 214 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE 293 (632)
Q Consensus 214 ~~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~ 293 (632)
++++.+++.++++|...+.||+|+||.||+|.+.+|+.||||++.... ....+.|.+|+.++++++||||+++++++..
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES-SQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC-SSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 455566777889999999999999999999998889999999987653 3455679999999999999999999999875
Q ss_pred ccCCcceEEEEEEeCCCCChhhhhhcccc--CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeE
Q 006750 294 FRGKRAMRLLVFEFMPNGNLRDCLDGVLV--EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAK 371 (632)
Q Consensus 294 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vk 371 (632)
....++||||+++|+|.+++..... ..++|..++.++.|++.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 107 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~k 179 (321)
T 2qkw_B 107 ----RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179 (321)
T ss_dssp ----TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEE
T ss_pred ----CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEE
Confidence 4467999999999999999965432 34999999999999999999999998 99999999999999999999
Q ss_pred EeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecc
Q 006750 372 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA 451 (632)
Q Consensus 372 L~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~ 451 (632)
|+|||+++....... ........||+.|+|||++.+..++.++||||||+++|||++|+.||.............|.
T Consensus 180 l~Dfg~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~ 256 (321)
T 2qkw_B 180 ITDFGISKKGTELDQ---THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA 256 (321)
T ss_dssp ECCCTTCEECSSSSC---CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT
T ss_pred Eeecccccccccccc---cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh
Confidence 999999987543221 11223456899999999999999999999999999999999999999765544333322222
Q ss_pred ccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 452 TPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 452 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
..... ...+..+.++.+....+...+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 257 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 257 VESHN--NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp HHHHT--TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhccc--cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 11111 122345556666667788889999999999999999999999999999987753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=413.34 Aligned_cols=249 Identities=26% Similarity=0.342 Sum_probs=198.7
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHH---HHHHHHhcCCCCccceeeeeecccCCc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLT---EVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~f~~---Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 298 (632)
++|.+.++||+|+||.||+|+... |+.||||+++... .......+.+ ++.+++.++|||||++++++.+ .
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~----~ 264 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT----P 264 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC----S
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE----C
Confidence 679999999999999999999864 9999999996431 1112222344 4566777899999999999876 5
Q ss_pred ceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccc
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 378 (632)
..+||||||++||+|.++|... ..+++..+..++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA 339 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA 339 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEeccccee
Confidence 6889999999999999999764 45999999999999999999999999 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccc
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 457 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~ 457 (632)
+.+... .....+||+.|||||++.. ..|+.++|||||||+||||++|+.||..........+..
T Consensus 340 ~~~~~~-------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~-------- 404 (689)
T 3v5w_A 340 CDFSKK-------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-------- 404 (689)
T ss_dssp EECSSC-------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH--------
T ss_pred eecCCC-------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--------
Confidence 876543 2344689999999999975 579999999999999999999999997543322111100
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006750 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT-----MSEVVQ 505 (632)
Q Consensus 458 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 505 (632)
.+... ...+|...+..+.+|+.+||+.||.+|++ +.||++
T Consensus 405 ------~i~~~--~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 405 ------MTLTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ------HHHHC--CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ------hhcCC--CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 00000 01233344456899999999999999998 688765
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=413.95 Aligned_cols=253 Identities=23% Similarity=0.275 Sum_probs=205.9
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
.++|.+.+.||+|+||.||+|..+ +|+.||||++.... ....+.+.+|+.+|+.|+|||||++++++.+ ...+|
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~----~~~~~ 230 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFED----DNEMV 230 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC----SSEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE----CCEEE
Confidence 468999999999999999999986 49999999997643 2334568899999999999999999999876 56889
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCC--CCeEEecccccee
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN--LNAKITDLGMAKR 380 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~--~~vkL~DFGla~~ 380 (632)
||||||+||+|.++|.... ..+++.++..++.||+.||+|||+++ |+||||||+||||+.+ +.+||+|||+|+.
T Consensus 231 iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp EEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred EEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 9999999999999996532 45999999999999999999999999 9999999999999854 8899999999998
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
+.... ......||+.|||||++.+..|+.++|||||||+||||++|+.||...........+...
T Consensus 307 ~~~~~------~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~--------- 371 (573)
T 3uto_A 307 LDPKQ------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC--------- 371 (573)
T ss_dssp CCTTS------EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT---------
T ss_pred ccCCC------ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhC---------
Confidence 75432 234567999999999999999999999999999999999999999754332211111000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
+..+........+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 372 ------~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 372 ------DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp ------CCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0001111112234458899999999999999999999874
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=383.73 Aligned_cols=260 Identities=27% Similarity=0.413 Sum_probs=210.8
Q ss_pred hcCccccceeeeeCceEEEEEEEC--------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 294 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~ 294 (632)
.++|.+.+.||+|+||.||+|.+. ++..||||+++..........+.+|+.+|+++ +||||+++++++..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS-
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc-
Confidence 467888999999999999999863 35689999998765444556799999999999 89999999999875
Q ss_pred cCCcceEEEEEEeCCCCChhhhhhccc--------------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCC
Q 006750 295 RGKRAMRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 360 (632)
Q Consensus 295 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~ 360 (632)
....|+||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ |+||||||+
T Consensus 159 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~ 232 (370)
T 2psq_A 159 ---DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR 232 (370)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGG
T ss_pred ---CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchh
Confidence 446799999999999999997543 134899999999999999999999998 999999999
Q ss_pred CeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCc
Q 006750 361 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (632)
Q Consensus 361 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~ 439 (632)
||||+.++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~ 309 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYY---KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTT---CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred hEEECCCCCEEEccccCCcccCcccce---ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999999876543221 12233457889999999999999999999999999999999 99999653
Q ss_pred cccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 440 ITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
....... .+.....+ ..+..++..+.+|+.+||+.||.+||++.|+++.|+.+.
T Consensus 310 ~~~~~~~--------------~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 310 PVEELFK--------------LLKEGHRM----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp CGGGHHH--------------HHHTTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHH--------------HHhcCCCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 3221100 01111111 223334455899999999999999999999999998875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=376.41 Aligned_cols=262 Identities=26% Similarity=0.407 Sum_probs=209.7
Q ss_pred hcCccccceeeeeCceEEEEEEEC----CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
.++|.+.+.||+|+||.||+|.+. .+..||||+++..........|.+|+.+|++++||||+++++++.. ..
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~ 123 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR----GR 123 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG----GG
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe----CC
Confidence 357888999999999999999985 3557999999876555556679999999999999999999999875 45
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred ccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccc
Confidence 6799999999999999996542 45999999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
......... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........
T Consensus 200 ~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~----------- 266 (325)
T 3kul_A 200 VLEDDPDAA--YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS----------- 266 (325)
T ss_dssp ECC----CC--EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH-----------
T ss_pred ccccCccce--eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-----------
Confidence 765432111 11223446788999999999999999999999999999999 9999965432211110
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 513 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 513 (632)
+...... ..+...+..+.+|+.+||..||.+|||+.+|++.|+.+...
T Consensus 267 ---~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 267 ---VEEGYRL----PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp ---HHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ---HHcCCCC----CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 0111111 12233345588999999999999999999999999988643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=374.75 Aligned_cols=266 Identities=27% Similarity=0.390 Sum_probs=204.1
Q ss_pred HHHhhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCccceeeeeecccCCc
Q 006750 220 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 220 l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 298 (632)
++...++|.+.+.||+|+||+||+|++ +|+.||||++...... .....|.+|+.+|++++||||+++++++.. .
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~ 106 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ----P 106 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----T
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE----C
Confidence 334457889999999999999999987 5889999999765432 234568999999999999999999999875 4
Q ss_pred ceEEEEEEeCCCCChhhhhhcccc-CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccc
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 377 (632)
...++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 467999999999999999975422 23899999999999999999999885 3499999999999999999999999999
Q ss_pred ceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccc
Q 006750 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 457 (632)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~ 457 (632)
++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.............
T Consensus 186 a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~-------- 252 (309)
T 3p86_A 186 SRLKASTF-----LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG-------- 252 (309)
T ss_dssp ---------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH--------
T ss_pred Cccccccc-----cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------
Confidence 97654321 12334569999999999999999999999999999999999999997543321111000
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006750 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 513 (632)
Q Consensus 458 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 513 (632)
...... ..+...+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 253 -----~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 253 -----FKCKRL----EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp -----HSCCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred -----hcCCCC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 001111 22333345588999999999999999999999999988654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=374.96 Aligned_cols=276 Identities=28% Similarity=0.375 Sum_probs=210.9
Q ss_pred hcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
.++|.+.+.||+|+||+||+|++. ++.||||++.... .....+..|+.+|++++||||+++++++..........++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 356888999999999999999986 7999999996532 2334467799999999999999999999875544556899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhc----------CCCceeecCCCCCCeEecCCCCeEEe
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA----------AAPRILHRDIKSSNILLDENLNAKIT 373 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------~~~~iiHrDLKp~NILl~~~~~vkL~ 373 (632)
||||+++|+|.++++. ..+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+
T Consensus 100 v~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred EEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence 9999999999999975 3489999999999999999999988 7 9999999999999999999999
Q ss_pred ccccceecccCCCCCCCCCCCccccCCCCCChhhhhcC-----CCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe
Q 006750 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-----RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 448 (632)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-----~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~ 448 (632)
|||+++........ .......||+.|+|||++.+. .++.++||||||+++|||++|+.||............
T Consensus 174 DFg~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 250 (322)
T 3soc_A 174 DFGLALKFEAGKSA---GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250 (322)
T ss_dssp CCTTCEEECTTSCC---CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred cCCcccccccccCc---cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence 99999877543321 223345799999999999863 4567899999999999999999999764432211110
Q ss_pred ec--ccccccccc-ccccccCCCCCCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 449 LW--ATPRLQDSG-TVISELPDPRLKGDF-PKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 449 ~~--~~~~~~~~~-~~~~~~~~~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
.. ..+...... ........+.+...+ ....+..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 000000000 001111122222111 2245667999999999999999999999999998874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=360.39 Aligned_cols=284 Identities=33% Similarity=0.544 Sum_probs=226.0
Q ss_pred eeeecHHHHHHhhcCcccc------ceeeeeCceEEEEEEECCCcEEEEEEeccCC---CCChHHHHHHHHHHHHhcCCC
Q 006750 212 IIRFSYSALEHATDKFSGS------NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRLHHC 282 (632)
Q Consensus 212 ~~~~~~~~l~~~t~~f~~~------~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~---~~~~~~~f~~Ei~~l~~l~Hp 282 (632)
...|++.++..++++|... +.||+|+||.||+|.. +++.||||++.... .....+.|.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 3678999999999999988 8999999999999987 58899999997542 233456799999999999999
Q ss_pred CccceeeeeecccCCcceEEEEEEeCCCCChhhhhhccc-cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCC
Q 006750 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL-VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSN 361 (632)
Q Consensus 283 niv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~N 361 (632)
||+++++++.. ....++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 91 ~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~N 163 (307)
T 2nru_A 91 NLVELLGFSSD----GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSAN 163 (307)
T ss_dssp TBCCEEEEECS----SSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred CeEEEEEEEec----CCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHH
Confidence 99999999875 446799999999999999997533 345999999999999999999999998 9999999999
Q ss_pred eEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccc
Q 006750 362 ILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (632)
Q Consensus 362 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~ 441 (632)
||++.++.+||+|||+++........ .......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.....
T Consensus 164 ili~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 239 (307)
T 2nru_A 164 ILLDEAFTAKISDFGLARASEKFAQT---VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE 239 (307)
T ss_dssp EEECTTCCEEECCCTTCEECCSCSSC---EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred EEEcCCCcEEEeeccccccccccccc---ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence 99999999999999999876432211 11234569999999998764 588999999999999999999999975433
Q ss_pred cccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 442 KGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 442 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
..... .+. .........+....++.+ ...+...+..+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus 240 ~~~~~--~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 240 PQLLL--DIK-EEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp SSBTT--HHH-HHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred hHHHH--HHH-HHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 22110 000 000001111222233333 2456777888999999999999999999999999999875
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=363.85 Aligned_cols=251 Identities=25% Similarity=0.405 Sum_probs=206.0
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
.++|.+.+.||+|+||+||+|... +|+.||||++...... ..+.+.+|+.++++++||||+++++++.. ....+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLV----GDELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TTEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-HHHHHHHHHHHHhcCCCCCCCeEeEEEEE----CCEEE
Confidence 467999999999999999999864 5899999999755433 34568999999999999999999999876 45789
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||+++|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 94 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp EEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 999999999999999753 5899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 462 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (632)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.............
T Consensus 168 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~------------- 229 (297)
T 3fxz_A 168 PEQ-----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA------------- 229 (297)
T ss_dssp STT-----CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-------------
T ss_pred Ccc-----cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------------
Confidence 432 12334579999999999999999999999999999999999999996543221110000
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 463 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 463 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
....+ ....+...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 230 -~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 230 -TNGTP--ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp -HHCSC--CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -hCCCC--CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00000 011233445568999999999999999999999873
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=365.83 Aligned_cols=263 Identities=24% Similarity=0.386 Sum_probs=208.3
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
++|.+.+.||+|+||+||+|.+. +++.||+|++... .......|.+|+++|++++||||+++++++.+ ....++
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~~l 84 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK----DKRLNF 84 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE----TTEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEec----CCeeEE
Confidence 56788899999999999999986 4899999998643 33445669999999999999999999999886 457899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||+++|+|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp EEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred EEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 99999999999999764 345999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCC---------CCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccc
Q 006750 384 DGLPSC---------SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 454 (632)
Q Consensus 384 ~~~~~~---------~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~ 454 (632)
...... ........||+.|+|||++.+..++.++||||||+++|||++|..||............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~------ 234 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL------ 234 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB------
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh------
Confidence 322110 01112457999999999999999999999999999999999999998643322111100
Q ss_pred cccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 455 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 455 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
......+......++ ..+.+|+.+||+.||++|||+.++++.|+.+..
T Consensus 235 ------~~~~~~~~~~~~~~~----~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 235 ------NVRGFLDRYCPPNCP----PSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp ------CHHHHHHHTCCTTCC----TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------hhhccccccCCCCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 000111111112233 348899999999999999999999999988753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=384.43 Aligned_cols=260 Identities=27% Similarity=0.423 Sum_probs=208.8
Q ss_pred hhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
..++|.+.+.||+|+||.||+|.+. +++.||||+++..........|.+|+.+|++++||||+++++++.. ....
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~ 187 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ----KQPI 187 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS----SSSC
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec----CCCc
Confidence 3457888899999999999999986 6899999999865433334458999999999999999999999875 4467
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||||+++|+|.++++... ..+++..++.++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 99999999999999997542 35899999999999999999999998 999999999999999999999999999865
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
...... .......+|+.|+|||++..+.++.++||||||+++|||++ |..||...........
T Consensus 264 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~------------- 327 (377)
T 3cbl_A 264 ADGVYA---ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF------------- 327 (377)
T ss_dssp TTSEEE---CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHH-------------
T ss_pred CCCcee---ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------------
Confidence 432111 11112346788999999999999999999999999999998 9999965432211100
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
+...... ..+..++..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 328 -~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 328 -VEKGGRL----PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp -HHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHcCCCC----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 0011111 123333455889999999999999999999999998774
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=370.35 Aligned_cols=260 Identities=26% Similarity=0.417 Sum_probs=203.3
Q ss_pred cCccccceeeeeCceEEEEEEECC-Cc----EEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~----~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
++|...+.||+|+||+||+|.+.. ++ .||+|.++..........|.+|+.++++++||||+++++++.. .
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~ 89 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-----S 89 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES-----S
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----C
Confidence 568888999999999999998653 44 4688988765555566779999999999999999999999875 2
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 90 TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp SEEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred CeEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCccee
Confidence 3689999999999999997643 45999999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
........ .......||+.|+|||++.+..++.++||||||+++|||++ |+.||...........
T Consensus 166 ~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~----------- 231 (327)
T 3poz_A 166 LLGAEEKE---YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI----------- 231 (327)
T ss_dssp HHTTTCC----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-----------
T ss_pred EccCCccc---ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHH-----------
Confidence 76543221 12233457889999999999999999999999999999999 9999975433211110
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 514 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 514 (632)
+.... ....+...+..+.+|+.+||+.||.+||++.++++.|..+....
T Consensus 232 ---~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 280 (327)
T 3poz_A 232 ---LEKGE----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp ---HHTTC----CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred ---HHcCC----CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence 01111 11122333455889999999999999999999999999886654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=381.34 Aligned_cols=262 Identities=25% Similarity=0.405 Sum_probs=199.3
Q ss_pred hcCccccceeeeeCceEEEEEEEC----CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
.++|.+.+.||+|+||.||+|++. ++..||||+++..........|.+|+.+|++++||||+++++++.. ..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~ 119 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK----SK 119 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----SS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee----CC
Confidence 357889999999999999999875 4778999999866544555679999999999999999999999875 44
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..++||||+++|+|.++++.. ...+++..++.++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred ceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 679999999999999999754 245999999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
......... .......+|+.|+|||++.+..++.++||||||++||||++ |+.||...........
T Consensus 196 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~----------- 262 (373)
T 2qol_A 196 VLEDDPEAA--YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA----------- 262 (373)
T ss_dssp --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHH-----------
T ss_pred ccccCCccc--eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----------
Confidence 765432111 11222346788999999999999999999999999999998 9999965432211000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 513 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 513 (632)
+.. ......+..++..+.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus 263 ---i~~----~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 263 ---VDE----GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp ---HHT----TEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---HHc----CCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 000 000111223345588999999999999999999999999988644
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=380.48 Aligned_cols=272 Identities=27% Similarity=0.397 Sum_probs=216.9
Q ss_pred eecHHHHHHhhcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccc
Q 006750 214 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVP 286 (632)
Q Consensus 214 ~~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~ 286 (632)
.+....++...++|.+.+.||+|+||.||+|.+. +++.||||+++..........|.+|+++|+++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 4556677788899999999999999999999742 36899999998765545556799999999999 8999999
Q ss_pred eeeeeecccCCcceEEEEEEeCCCCChhhhhhcccc--------------------------------------------
Q 006750 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV-------------------------------------------- 322 (632)
Q Consensus 287 l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~-------------------------------------------- 322 (632)
+++++.+. ....++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~---~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (359)
T 3vhe_A 91 LLGACTKP---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF 167 (359)
T ss_dssp EEEEECST---TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred eeeeeecC---CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence 99998752 3347999999999999999975432
Q ss_pred --------------------CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 323 --------------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 323 --------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
..+++..++.++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 244 (359)
T 3vhe_A 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIY 244 (359)
T ss_dssp ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeec
Confidence 12899999999999999999999998 9999999999999999999999999998664
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
..... .......||+.|+|||++.+..++.++||||||+++|||++ |+.||........... .
T Consensus 245 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-------------~ 308 (359)
T 3vhe_A 245 KDPDY---VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR-------------R 308 (359)
T ss_dssp SCTTC---EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH-------------H
T ss_pred ccccc---hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHH-------------H
Confidence 33211 12334568999999999999999999999999999999998 9999965432211100 0
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
+....... .+...+..+.+++.+||+.||.+|||+.+|++.|..+.
T Consensus 309 ~~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 309 LKEGTRMR----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp HHHTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcCCCCC----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 11111111 22223345889999999999999999999999998775
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=363.72 Aligned_cols=267 Identities=26% Similarity=0.369 Sum_probs=206.5
Q ss_pred hcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHh--cCCCCccceeeeeecccCCcceE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSR--LHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~--l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
.++|.+.+.||+|+||+||+|++ +|+.||||++... ....+..|.+++.. ++||||+++++++..........
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 46789999999999999999998 5899999998643 33456777777776 79999999999987655556678
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHH--------hcCCCceeecCCCCCCeEecCCCCeEEe
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLH--------EAAAPRILHRDIKSSNILLDENLNAKIT 373 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~iiHrDLKp~NILl~~~~~vkL~ 373 (632)
++||||+++|+|.++++. ..+++..++.++.|++.||+||| +.+ |+||||||+||||+.++.+||+
T Consensus 82 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 999999999999999964 35899999999999999999999 776 9999999999999999999999
Q ss_pred ccccceecccCCCCCCCCCCCccccCCCCCChhhhhcC------CCCcccchHhHhHHHHHHHhC----------CCCCC
Q 006750 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG------RASLMSDVFSFGVVLLELITG----------RQPIH 437 (632)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~------~~s~ksDVwSlGviL~eLltG----------~~P~~ 437 (632)
|||+++......... ........||+.|+|||++.+. .++.++||||||+++|||++| +.||.
T Consensus 156 Dfg~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQL-DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCTTCEEEETTTTEE-ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eCCCeeecccccccc-cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999998765432211 1112334799999999999876 455799999999999999999 77775
Q ss_pred CccccccchheeccccccccccccccccCCCCCCC-CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 438 RSITKGEESLVLWATPRLQDSGTVISELPDPRLKG-DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
.............. ........+.+.. ..+...+..+.+|+.+||+.||.+|||+.+|++.|+.+
T Consensus 235 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 235 DVVPNDPSFEDMRK--------VVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTSCSSCCHHHHHH--------HHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCCCcchhhhhH--------HHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 43322111000000 0000111111111 12345677899999999999999999999999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=374.36 Aligned_cols=268 Identities=24% Similarity=0.391 Sum_probs=214.1
Q ss_pred HHHHhhcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeee
Q 006750 219 ALEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292 (632)
Q Consensus 219 ~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~ 292 (632)
.++...++|.+.+.||+|+||.||+|.+. +++.||||+++..........|.+|+.++++++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34455788999999999999999999875 248999999987655455567999999999999999999999987
Q ss_pred cccCCcceEEEEEEeCCCCChhhhhhccc----------------------cCCCCHHHHHHHHHHHHHhhHHHHhcCCC
Q 006750 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVL----------------------VEGMNWDTRVAIAIGAARGLEYLHEAAAP 350 (632)
Q Consensus 293 ~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 350 (632)
. ....++||||+++|+|.+++.... ...+++.+++.++.|++.||.|||+.+
T Consensus 121 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-- 194 (343)
T 1luf_A 121 V----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-- 194 (343)
T ss_dssp S----SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred c----CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 5 446799999999999999997532 145899999999999999999999998
Q ss_pred ceeecCCCCCCeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHH
Q 006750 351 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELI 430 (632)
Q Consensus 351 ~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLl 430 (632)
|+||||||+|||++.++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||+
T Consensus 195 -ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 270 (343)
T 1luf_A 195 -FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY---KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270 (343)
T ss_dssp -CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB---C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred -eecCCCCcceEEECCCCeEEEeecCCCcccccCccc---cccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHH
Confidence 999999999999999999999999999876433211 1223346889999999999999999999999999999999
Q ss_pred h-CCCCCCCccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006750 431 T-GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 509 (632)
Q Consensus 431 t-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 509 (632)
+ |+.||........... +.....+ ..+...+..+.+|+.+||+.||.+||++.+|++.|..
T Consensus 271 t~g~~p~~~~~~~~~~~~--------------~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~ 332 (343)
T 1luf_A 271 SYGLQPYYGMAHEEVIYY--------------VRDGNIL----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 332 (343)
T ss_dssp TTTCCTTTTSCHHHHHHH--------------HHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hcCCCcCCCCChHHHHHH--------------HhCCCcC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHH
Confidence 9 9999965432211000 0000011 1222334458899999999999999999999999999
Q ss_pred hCCCc
Q 006750 510 IAPDK 514 (632)
Q Consensus 510 i~~~~ 514 (632)
+....
T Consensus 333 ~~~~~ 337 (343)
T 1luf_A 333 MCERA 337 (343)
T ss_dssp TTC--
T ss_pred HHhhh
Confidence 87544
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=363.42 Aligned_cols=263 Identities=22% Similarity=0.358 Sum_probs=213.1
Q ss_pred eeecHHHHHHhhcC----------ccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCC
Q 006750 213 IRFSYSALEHATDK----------FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHH 281 (632)
Q Consensus 213 ~~~~~~~l~~~t~~----------f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~H 281 (632)
..++++++..+++. |...+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.+|++++|
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CSHHHHHHHHHHHTTCCC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch-hHHHHHHHHHHHHHhCCC
Confidence 35788888888765 777789999999999999987 699999999976543 344568999999999999
Q ss_pred CCccceeeeeecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCC
Q 006750 282 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSN 361 (632)
Q Consensus 282 pniv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~N 361 (632)
|||+++++++.. ....++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|
T Consensus 102 ~niv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~N 171 (321)
T 2c30_A 102 FNVVEMYKSYLV----GEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDS 171 (321)
T ss_dssp TTBCCEEEEEEE----TTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred CCcceEEEEEEE----CCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence 999999999876 4578999999999999999875 35999999999999999999999998 9999999999
Q ss_pred eEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccc
Q 006750 362 ILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (632)
Q Consensus 362 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~ 441 (632)
||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 172 Ill~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~ 246 (321)
T 2c30_A 172 ILLTLDGRVKLSDFGFCAQISKDV-----PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP 246 (321)
T ss_dssp EEECTTCCEEECCCTTCEECCSSS-----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred EEECCCCcEEEeeeeeeeecccCc-----cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999998765432 122345799999999999999999999999999999999999999965432
Q ss_pred cccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006750 442 KGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507 (632)
Q Consensus 442 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 507 (632)
..... .+.....+.+. .+...+..+.+++.+||+.||++|||+.++++.-
T Consensus 247 ~~~~~--------------~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 247 VQAMK--------------RLRDSPPPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp HHHHH--------------HHHHSSCCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred HHHHH--------------HHhcCCCCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 11100 01111111111 1222344588999999999999999999998753
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=354.36 Aligned_cols=258 Identities=22% Similarity=0.352 Sum_probs=209.6
Q ss_pred hcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
.++|.+.+.||+|+||.||+|.+.++..||||+++.... ....+.+|+.++++++||||+++++++.. ....++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~l 80 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKLVKFYGVCSK----EYPIYI 80 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB--CHHHHHHHHHHHHHCCCTTBCCEEEEECS----SSSEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC--cHHHHHHHHHHHHhCCCCCEeeEEEEEcc----CCceEE
Confidence 467888999999999999999998888999999986532 34568999999999999999999999865 456799
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp EEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred EEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecch
Confidence 999999999999997642 45999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVI 462 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (632)
.... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||........... +
T Consensus 157 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~--------------~ 218 (268)
T 3sxs_A 157 DQYV----SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK--------------V 218 (268)
T ss_dssp TCEE----ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH--------------H
T ss_pred hhhh----cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH--------------H
Confidence 3211 1223446788999999999899999999999999999999 9999965432211100 0
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006750 463 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 513 (632)
Q Consensus 463 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 513 (632)
....... .+...+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 219 ~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 219 SQGHRLY----RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp HTTCCCC----CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred HcCCCCC----CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 0000111 1122234588999999999999999999999999988644
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=392.39 Aligned_cols=265 Identities=23% Similarity=0.364 Sum_probs=215.1
Q ss_pred HHHHHhhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCC
Q 006750 218 SALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (632)
Q Consensus 218 ~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 297 (632)
..++...++|.+.+.||+|+||.||+|.++++..||||+++... ...+.|.+|+.+|++++||||+++++++..
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~---- 254 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK---- 254 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHTTCCCTTBCCEEEEECS----
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC--ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC----
Confidence 34555677899999999999999999999888999999998643 345679999999999999999999999752
Q ss_pred cceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccc
Q 006750 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 377 (632)
...++||||+++|+|.++|+......+++..++.++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 255 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 330 (454)
T 1qcf_A 255 -EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGL 330 (454)
T ss_dssp -SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred -CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCC
Confidence 35699999999999999998655456899999999999999999999998 99999999999999999999999999
Q ss_pred ceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccc
Q 006750 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQ 456 (632)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~ 456 (632)
++....... .......+|+.|+|||++....++.++||||||++||||++ |+.||...........
T Consensus 331 a~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~--------- 397 (454)
T 1qcf_A 331 ARVIEDNEY----TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA--------- 397 (454)
T ss_dssp GGGBCCHHH----HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH---------
T ss_pred ceEcCCCce----eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH---------
Confidence 987643211 11123346789999999999999999999999999999999 9999965432211000
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006750 457 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 514 (632)
Q Consensus 457 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 514 (632)
+...... ..+..++..+.+|+.+||+.||++|||+.+|++.|+.+....
T Consensus 398 -----i~~~~~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 398 -----LERGYRM----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp -----HHHTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred -----HHcCCCC----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 0000011 122334455889999999999999999999999999886543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=368.73 Aligned_cols=249 Identities=25% Similarity=0.354 Sum_probs=203.8
Q ss_pred hcCccccceeeeeCceEEEEEEE-CCCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
.++|.+.+.||+|+||.||+|.+ .+|+.||||++.... .......+.+|+.+|+.++||||+++++++.. ....
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~ 89 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET----EKTL 89 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC----SSEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE----CCEE
Confidence 46789999999999999999997 469999999997543 22334568899999999999999999999875 4578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 164 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEF 164 (328)
T ss_dssp EEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred EEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence 9999999999999999754 45999999999999999999999998 999999999999999999999999999866
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCC-cccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRAS-LMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s-~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
.... ......||+.|+|||++.+..+. .++||||||++||||++|+.||............
T Consensus 165 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i------------ 226 (328)
T 3fe3_A 165 TVGG------KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV------------ 226 (328)
T ss_dssp SSSC------GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------------
T ss_pred CCCC------ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------------
Confidence 4332 23345799999999999987764 8999999999999999999999754322111100
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
..... ..|...+..+.+|+.+||..||.+|||+.|+++.
T Consensus 227 -----~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 227 -----LRGKY--RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -----HHCCC--CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -----HhCCC--CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000 1222234458899999999999999999999874
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=360.76 Aligned_cols=264 Identities=27% Similarity=0.387 Sum_probs=206.0
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC--hHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~--~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
.++|.+.+.||+|+||.||+|... +++.||||++....... ....|.+|+.++++++||||+++++++.. ...
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~----~~~ 85 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE----DDC 85 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC----SSE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee----CCe
Confidence 467889999999999999999875 58999999986543322 33568999999999999999999999875 557
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.|+||||+++|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 160 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKA 160 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred EEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence 89999999999999999754 45999999999999999999999998 99999999999999999999999999986
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...........
T Consensus 161 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~------------- 223 (294)
T 4eqm_A 161 LSETSL----TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK------------- 223 (294)
T ss_dssp C-----------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHH-------------
T ss_pred cccccc----cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH-------------
Confidence 643321 122345699999999999999999999999999999999999999965432111000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhhCCCc
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-TMSEVVQILSTIAPDK 514 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~~~ 514 (632)
.+... .+......+...+..+.+++.+||+.||.+|| ++.++.+.|..+....
T Consensus 224 ~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 224 HIQDS-VPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp HHSSC-CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred Hhhcc-CCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 00000 00000011222335588999999999999998 9999999998876543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=358.58 Aligned_cols=255 Identities=28% Similarity=0.423 Sum_probs=208.0
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV 304 (632)
++|.+.+.||+|+||.||+|.+.+++.||||++.... ...+.+.+|+.++++++||||+++++++.+ ....++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv 83 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE----QAPICLV 83 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS--BCHHHHHHHHHHHHTCCCTTBCCEEEEECS----SSSEEEE
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc--cCHHHHHHHHHHHHhCCCCCEeeEEEEEec----CCceEEE
Confidence 5688889999999999999999889999999998643 234569999999999999999999999875 4467999
Q ss_pred EEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccC
Q 006750 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 384 (632)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccc
Confidence 99999999999997533 45899999999999999999999998 999999999999999999999999999865432
Q ss_pred CCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccccccccc
Q 006750 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463 (632)
Q Consensus 385 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (632)
.. .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||........... +.
T Consensus 160 ~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~--------------~~ 221 (269)
T 4hcu_A 160 QY----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED--------------IS 221 (269)
T ss_dssp HH----HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH--------------HH
T ss_pred cc----ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--------------Hh
Confidence 11 11223457888999999999999999999999999999999 9999965432211000 00
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 464 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
....+. .+...+..+.+++.+||+.||.+|||+.++++.|..+.
T Consensus 222 ~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 222 TGFRLY----KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp TTCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCccCC----CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 111111 12223345889999999999999999999999998874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=381.90 Aligned_cols=255 Identities=27% Similarity=0.393 Sum_probs=208.3
Q ss_pred HHhhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 221 EHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 221 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
+...++|.+.+.||+|+||.||+|.+. |+.||||+++... ..+.|.+|+.+|++++||||+++++++.+. ...
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~ 261 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEE---KGG 261 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECT---TSC
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcC---CCc
Confidence 344577889999999999999999985 7899999998653 345699999999999999999999998752 236
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.|+||||+++|+|.+++.......+++..++.++.|++.||+|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKE 338 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence 799999999999999998755445899999999999999999999998 99999999999999999999999999985
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
.... .....+|+.|+|||++.+..++.++||||||++||||++ |+.||..........
T Consensus 339 ~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~------------- 397 (450)
T 1k9a_A 339 ASST--------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP------------- 397 (450)
T ss_dssp CC--------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH-------------
T ss_pred cccc--------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-------------
Confidence 4321 122357889999999999999999999999999999998 999996543221110
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
.+..... ...|..++..+.+|+.+||+.||.+|||+.+|++.|+.+.
T Consensus 398 -~i~~~~~----~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 398 -RVEKGYK----MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp -HHHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHcCCC----CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 0011111 1223334456899999999999999999999999998774
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=360.23 Aligned_cols=276 Identities=23% Similarity=0.324 Sum_probs=214.2
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
++|.+.+.||+|+||+||+|.+.. |+.||||+++..........+.+|+++|++++||||+++++++.... ....++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~~~l 86 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT--TRHKVL 86 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT--TCCEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCC--CceEEE
Confidence 568889999999999999999865 89999999986544455567899999999999999999999887533 336799
Q ss_pred EEEeCCCCChhhhhhcccc-CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEe----cCCCCeEEeccccc
Q 006750 304 VFEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMA 378 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl----~~~~~vkL~DFGla 378 (632)
||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||| +.++.+||+|||++
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 9999999999999976433 23999999999999999999999998 9999999999999 78888999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhh--------cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhee-
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAM--------VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL- 449 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~--------~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~- 449 (632)
+...... ......||+.|+|||++. +..++.++||||||+++|||++|+.||.............
T Consensus 164 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 237 (319)
T 4euu_A 164 RELEDDE------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (319)
T ss_dssp EECCTTC------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHH
T ss_pred eecCCCC------ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Confidence 8765432 223456999999999987 4778999999999999999999999996433211110000
Q ss_pred -ccccccccccccccc--------cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 450 -WATPRLQDSGTVISE--------LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 450 -~~~~~~~~~~~~~~~--------~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
............+.. .........++......+.+|+.+||+.||++|||+.|+++......
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 000000000000000 00111222456788888999999999999999999999999887654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=374.92 Aligned_cols=262 Identities=26% Similarity=0.394 Sum_probs=211.9
Q ss_pred hhcCccccceeeeeCceEEEEEEEC--------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeec
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 293 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~ 293 (632)
..++|.+.+.||+|+||.||+|.+. .+..||||+++..........+.+|+++++++ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3567888999999999999999863 24689999998765555556799999999999 99999999999875
Q ss_pred ccCCcceEEEEEEeCCCCChhhhhhcccc--------------CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCC
Q 006750 294 FRGKRAMRLLVFEFMPNGNLRDCLDGVLV--------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKS 359 (632)
Q Consensus 294 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp 359 (632)
....++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+.+ |+||||||
T Consensus 147 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp 219 (382)
T 3tt0_A 147 ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAA 219 (382)
T ss_dssp ----SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred ----CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCc
Confidence 4467999999999999999976431 34999999999999999999999998 99999999
Q ss_pred CCeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCC
Q 006750 360 SNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR 438 (632)
Q Consensus 360 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~ 438 (632)
+||||+.++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~ 296 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYY---KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTT---CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ceEEEcCCCcEEEcccCccccccccccc---ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999876543211 22334467899999999999999999999999999999999 9999965
Q ss_pred ccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 439 SITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
........ .+.....+. .+...+..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 297 ~~~~~~~~--------------~~~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 297 VPVEELFK--------------LLKEGHRMD----KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp CCHHHHHH--------------HHHTTCCCC----CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHH--------------HHHcCCCCC----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 43221100 011111111 222333458899999999999999999999999998853
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=366.08 Aligned_cols=255 Identities=26% Similarity=0.318 Sum_probs=201.9
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
.++|.+.+.||+|+||.||+|.+. +++.||||++.........+.+.+|+.+++.++||||+++++++.+ ....|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~ 81 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE----GNIQY 81 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC----SSEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec----CCeEE
Confidence 467899999999999999999876 5899999999765444444568999999999999999999999875 55779
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 82 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 82 LFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (323)
T ss_dssp EEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceec
Confidence 999999999999999753 34999999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCC-CcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
.... ........||+.|+|||++.+..+ +.++||||||+++|||++|+.||.......... ..+...
T Consensus 157 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-~~~~~~-------- 224 (323)
T 3tki_A 157 YNNR---ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SDWKEK-------- 224 (323)
T ss_dssp ETTE---ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH-HHHHTT--------
T ss_pred cCCc---ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH-HHHhcc--------
Confidence 3321 112234579999999999987765 789999999999999999999997543321110 011000
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
..........+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 225 -------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 225 -------KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -------CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -------cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00001112234457899999999999999999999874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=387.52 Aligned_cols=263 Identities=28% Similarity=0.422 Sum_probs=209.1
Q ss_pred HHHhhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 220 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 220 l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
++...++|.+.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+.+|++++||||+++++++.+ .
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~ 251 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-----E 251 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----S
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----C
Confidence 444567788899999999999999999888889999998643 234569999999999999999999999864 3
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..++||||+++|+|.++|.......+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~ 328 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLAR 328 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccce
Confidence 4699999999999999998655566999999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
....... .......+|+.|+|||++....++.++||||||++||||++ |+.||...........
T Consensus 329 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~----------- 393 (452)
T 1fmk_A 329 LIEDNEY----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ----------- 393 (452)
T ss_dssp ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-----------
T ss_pred ecCCCce----ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-----------
Confidence 7654321 11223457889999999999999999999999999999999 9999965432211000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 514 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 514 (632)
+.... ....+..++..+.+|+.+||+.||++|||+.+|++.|+.+....
T Consensus 394 ---i~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 394 ---VERGY----RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp ---HHTTC----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ---HHcCC----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 00001 11223334456889999999999999999999999999886543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=393.43 Aligned_cols=264 Identities=25% Similarity=0.399 Sum_probs=215.1
Q ss_pred HHHHhhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCC
Q 006750 219 ALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (632)
Q Consensus 219 ~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 297 (632)
.++....+|.+.+.||+|+||.||+|.+.. +..||||+++... ...+.|.+|+.+|++++||||+++++++..
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---- 287 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR---- 287 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc--cchHHHHHHHHHHHhcCCCCEeeEEEEEec----
Confidence 344456778889999999999999999875 8899999997643 235669999999999999999999999876
Q ss_pred cceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccc
Q 006750 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 377 (632)
....|+||||+++|+|.++|+......+++..++.++.|++.||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 288 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~ 364 (495)
T 1opk_A 288 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGL 364 (495)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTC
T ss_pred CCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeeccc
Confidence 446799999999999999998755566999999999999999999999998 99999999999999999999999999
Q ss_pred ceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccc
Q 006750 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQ 456 (632)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~ 456 (632)
++....... .......+|+.|+|||++....++.++||||||++||||++ |+.||..........
T Consensus 365 a~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~---------- 430 (495)
T 1opk_A 365 SRLMTGDTY----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE---------- 430 (495)
T ss_dssp EECCTTCCE----ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH----------
T ss_pred ceeccCCce----eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHH----------
Confidence 987653321 11223446789999999999999999999999999999999 999986543221100
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006750 457 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 513 (632)
Q Consensus 457 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 513 (632)
.+.. ......+..++..+.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus 431 ----~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 431 ----LLEK----DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp ----HHHT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred ----HHHc----CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 0111 111122333445588999999999999999999999999987643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=375.73 Aligned_cols=288 Identities=19% Similarity=0.252 Sum_probs=213.0
Q ss_pred hhcCccccceeeeeCceEEEEEEECC------CcEEEEEEeccCCCCCh----------HHHHHHHHHHHHhcCCCCccc
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNA----------DSVFLTEVDMLSRLHHCHVVP 286 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~~~----------~~~f~~Ei~~l~~l~Hpniv~ 286 (632)
..++|.+.+.||+|+||.||+|.+.+ ++.||||++........ ...+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34578889999999999999998865 47899999875431100 011334555666778999999
Q ss_pred eeeeeecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEec-
Q 006750 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD- 365 (632)
Q Consensus 287 l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~- 365 (632)
+++++..........|+||||+ +++|.+++... ...+++..++.|+.|++.||+|||+.+ |+||||||+||||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence 9999987555456789999999 99999999763 356999999999999999999999998 99999999999999
Q ss_pred -CCCCeEEeccccceecccCCCCCC--CCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCcccc
Q 006750 366 -ENLNAKITDLGMAKRLKADGLPSC--SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITK 442 (632)
Q Consensus 366 -~~~~vkL~DFGla~~~~~~~~~~~--~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~ 442 (632)
.++.+||+|||+++.+........ ........||+.|+|||++.+..++.++||||||++||||++|+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 889999999999988755432211 11224456999999999999999999999999999999999999999753322
Q ss_pred ccchheeccccccccccccccccCCCCCC-CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCcccccccC
Q 006750 443 GEESLVLWATPRLQDSGTVISELPDPRLK-GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNIS 521 (632)
Q Consensus 443 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~ 521 (632)
.... .+...... ..+..+.++.+. ..++ ..+.+|+..||..||.+||++.+|++.|..+...........
T Consensus 268 ~~~~--~~~~~~~~---~~~~~~~~~~~~~~~~~----~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~ 338 (364)
T 3op5_A 268 PKYV--RDSKIRYR---ENIASLMDKCFPAANAP----GEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGK 338 (364)
T ss_dssp HHHH--HHHHHHHH---HCHHHHHHHHSCTTCCC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HHHH--HHHHHHhh---hhHHHHHHHhcccccCH----HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCc
Confidence 1110 00000000 001111111111 1233 448899999999999999999999999998876554444444
Q ss_pred cch
Q 006750 522 LNL 524 (632)
Q Consensus 522 ~~~ 524 (632)
++|
T Consensus 339 ~dw 341 (364)
T 3op5_A 339 LDL 341 (364)
T ss_dssp CCC
T ss_pred cce
Confidence 443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=364.10 Aligned_cols=277 Identities=24% Similarity=0.320 Sum_probs=205.4
Q ss_pred hcCccccceeeeeCceEEEEEEEC-----CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-----~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 298 (632)
.++|++.+.||+|+||+||+|++. +++.||||++.... ......|.+|+.+|++++||||+++++++.... .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG--R 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH--H
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--C
Confidence 356888999999999999999852 58999999997542 333456899999999999999999999986532 3
Q ss_pred ceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccc
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 378 (632)
...++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred CceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccc
Confidence 35799999999999999997643 34999999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccc
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
+........ ........+|..|+|||++.+..++.++||||||+++|||++|..|+................... .
T Consensus 162 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~--~ 237 (295)
T 3ugc_A 162 KVLPQDKEF--FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM--I 237 (295)
T ss_dssp C---------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHH--H
T ss_pred ccccCCcce--eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccch--h
Confidence 876543211 112223457888999999999999999999999999999999999986432111000000000000 0
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
...+.+..........+..++..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 238 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 00000000011111223344456899999999999999999999999998874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=376.83 Aligned_cols=262 Identities=25% Similarity=0.360 Sum_probs=209.6
Q ss_pred hcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCC
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 297 (632)
.++|.+.+.||+|+||.||+|.+. +++.||||+++..........+.+|+.++++++||||+++++++..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---- 145 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ---- 145 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence 467888999999999999999853 3678999999765555555679999999999999999999999875
Q ss_pred cceEEEEEEeCCCCChhhhhhcccc-----CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCC---C
Q 006750 298 RAMRLLVFEFMPNGNLRDCLDGVLV-----EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL---N 369 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~~L~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~---~ 369 (632)
....++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+.+ |+||||||+||||+.++ .
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCC
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCce
Confidence 4456999999999999999975432 34899999999999999999999998 99999999999998554 5
Q ss_pred eEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchhe
Q 006750 370 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLV 448 (632)
Q Consensus 370 vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~ 448 (632)
+||+|||+++....... ........||+.|+|||++.+..++.++||||||+++|||++ |..||...........
T Consensus 223 ~kL~DFG~a~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~- 298 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGY---YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF- 298 (367)
T ss_dssp EEECCCHHHHHHHHHSS---CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-
T ss_pred EEECCCccccccccccc---cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-
Confidence 99999999986543321 122334568999999999999999999999999999999998 9999965432211100
Q ss_pred eccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006750 449 LWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 513 (632)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 513 (632)
+....... .+...+..+.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus 299 -------------i~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 299 -------------VTSGGRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp -------------HHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -------------HHcCCCCC----CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 00111111 2223334588999999999999999999999999887543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=365.66 Aligned_cols=262 Identities=25% Similarity=0.386 Sum_probs=211.1
Q ss_pred hhcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccC
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 296 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 296 (632)
..++|.+.+.||+|+||.||+|... +++.||||+++..........+.+|+.+|++++||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--- 97 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ--- 97 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec---
Confidence 3567888999999999999999862 3589999999866555555679999999999999999999999875
Q ss_pred CcceEEEEEEeCCCCChhhhhhcccc----------------------CCCCHHHHHHHHHHHHHhhHHHHhcCCCceee
Q 006750 297 KRAMRLLVFEFMPNGNLRDCLDGVLV----------------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILH 354 (632)
Q Consensus 297 ~~~~~~lV~Ey~~~gsL~~~L~~~~~----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH 354 (632)
....++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+.+ |+|
T Consensus 98 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH 173 (314)
T 2ivs_A 98 -DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVH 173 (314)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred -CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccc
Confidence 4467999999999999999975432 23899999999999999999999998 999
Q ss_pred cCCCCCCeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CC
Q 006750 355 RDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GR 433 (632)
Q Consensus 355 rDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~ 433 (632)
|||||+|||++.++.+||+|||+++........ .......+|+.|+|||++.+..++.++||||||+++|||++ |+
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 250 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSY---VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 250 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCE---ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred cccchheEEEcCCCCEEEccccccccccccccc---eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999876543211 11233457889999999999999999999999999999999 99
Q ss_pred CCCCCccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 434 QPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 434 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
.||........... +.....+. .+...+..+.+|+.+||+.||.+||++.++++.|+.+..
T Consensus 251 ~p~~~~~~~~~~~~--------------~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 251 NPYPGIPPERLFNL--------------LKTGHRME----RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp CSSTTCCGGGHHHH--------------HHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHH--------------hhcCCcCC----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99965432211110 11111111 222334458899999999999999999999999988753
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=371.13 Aligned_cols=267 Identities=23% Similarity=0.385 Sum_probs=208.6
Q ss_pred HHhhcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeec
Q 006750 221 EHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSE 293 (632)
Q Consensus 221 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~ 293 (632)
+...++|.+.+.||+|+||.||+|.+. ++..||||+++..........+.+|+.+|+++ +||||+++++++..
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 334578899999999999999999862 36689999998655455556799999999999 99999999999876
Q ss_pred ccCCcceEEEEEEeCCCCChhhhhhcccc---------------------CCCCHHHHHHHHHHHHHhhHHHHhcCCCce
Q 006750 294 FRGKRAMRLLVFEFMPNGNLRDCLDGVLV---------------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRI 352 (632)
Q Consensus 294 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 352 (632)
....++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |
T Consensus 121 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 193 (344)
T 1rjb_A 121 ----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---C 193 (344)
T ss_dssp ----SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred ----CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 4467999999999999999975432 23799999999999999999999998 9
Q ss_pred eecCCCCCCeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-
Q 006750 353 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT- 431 (632)
Q Consensus 353 iHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt- 431 (632)
+||||||+||||+.++.+||+|||++......... .......||+.|+|||++.+..++.++||||||+++|||++
T Consensus 194 vH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 270 (344)
T 1rjb_A 194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY---VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 270 (344)
T ss_dssp EETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS---EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred ccCCCChhhEEEcCCCcEEeCCCccCcccccCccc---eeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcC
Confidence 99999999999999999999999999876543211 11233457889999999999999999999999999999998
Q ss_pred CCCCCCCccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 432 GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 432 G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
|..||........... .+.....+ ..+...+..+.+|+.+||..||.+|||+.+|++.|..+.
T Consensus 271 g~~p~~~~~~~~~~~~-------------~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 271 GVNPYPGIPVDANFYK-------------LIQNGFKM----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp SCCSSTTCCCSHHHHH-------------HHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCCcccCCcHHHHHH-------------HHhcCCCC----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 9999965432211000 00111111 122233455889999999999999999999999999887
Q ss_pred CCc
Q 006750 512 PDK 514 (632)
Q Consensus 512 ~~~ 514 (632)
...
T Consensus 334 ~~~ 336 (344)
T 1rjb_A 334 ADA 336 (344)
T ss_dssp ---
T ss_pred HHH
Confidence 554
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=368.79 Aligned_cols=254 Identities=21% Similarity=0.317 Sum_probs=204.8
Q ss_pred hhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC-----hHHHHHHHHHHHHhcCCCCccceeeeeecccC
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-----ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 296 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~-----~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 296 (632)
..++|.+.+.||+|+||.||++... +|+.||||+++...... ..+.+.+|+.+|++++||||+++++++..
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--- 86 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN--- 86 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC---
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe---
Confidence 3567899999999999999999986 48999999997653321 34568999999999999999999999875
Q ss_pred CcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCC----CeEE
Q 006750 297 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL----NAKI 372 (632)
Q Consensus 297 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~----~vkL 372 (632)
....|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||
T Consensus 87 -~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl 160 (361)
T 2yab_A 87 -RTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKL 160 (361)
T ss_dssp -SSEEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEE
T ss_pred -CCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEE
Confidence 55789999999999999999753 45999999999999999999999998 99999999999998877 7999
Q ss_pred eccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccc
Q 006750 373 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 452 (632)
Q Consensus 373 ~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~ 452 (632)
+|||+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.............
T Consensus 161 ~DFG~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~--- 231 (361)
T 2yab_A 161 IDFGLAHEIEDGV------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT--- 231 (361)
T ss_dssp CCCSSCEECCTTC------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH---
T ss_pred EecCCceEcCCCC------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---
Confidence 9999998765432 2334569999999999999999999999999999999999999997543221110000
Q ss_pred cccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 453 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 453 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.. ...+........+..+.+|+.+||..||.+|||+.|+++.
T Consensus 232 -----------~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 232 -----------AV-SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp -----------TT-CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -----------hc-CCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 0000000011223458899999999999999999999874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=353.76 Aligned_cols=255 Identities=32% Similarity=0.479 Sum_probs=196.3
Q ss_pred hcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCC---CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG---PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
.++|...+.||+|+||.||+|.+. |+.||||+++.... ....+.+.+|+++++.++||||+++++++.. ...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 80 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK----EPN 80 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC----C--
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec----CCc
Confidence 357888999999999999999985 89999999875432 2234568999999999999999999999875 446
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC--------CCCeEE
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE--------NLNAKI 372 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~--------~~~vkL 372 (632)
.++||||+++++|.+++.. +.+++..++.++.|++.||+|||+.+..+|+||||||+|||++. ++.+||
T Consensus 81 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred eEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 7999999999999999864 46999999999999999999999987556899999999999986 778999
Q ss_pred eccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccc
Q 006750 373 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 452 (632)
Q Consensus 373 ~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~ 452 (632)
+|||+++...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||..........
T Consensus 158 ~Dfg~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------ 224 (271)
T 3dtc_A 158 TDFGLAREWHRTT-------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY------ 224 (271)
T ss_dssp CCCCC--------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH------
T ss_pred ccCCccccccccc-------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------
Confidence 9999998654321 223469999999999999999999999999999999999999996543221100
Q ss_pred cccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 453 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 453 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
...........+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 225 -----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 225 -----------GVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -----------HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -----------hhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 00001111122333345589999999999999999999999999754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=359.77 Aligned_cols=257 Identities=22% Similarity=0.358 Sum_probs=206.4
Q ss_pred hhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
..++|.+.+.||+|+||.||++.+.++..||||+++.... ....+.+|++++++++||||+++++++.. ....+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~ 95 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTK----QRPIF 95 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECS----SSSEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC--CHHHHHHHHHHHhcCCCCCEeeEEEEEec----CCCeE
Confidence 3467888999999999999999998888999999986532 34569999999999999999999999875 45679
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 96 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp EEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred EEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 9999999999999997643 45999999999999999999999998 9999999999999999999999999998654
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
.... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........
T Consensus 172 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~-------------- 233 (283)
T 3gen_A 172 DDEY----TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-------------- 233 (283)
T ss_dssp CHHH----HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH--------------
T ss_pred cccc----ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHH--------------
Confidence 3211 11223347888999999999999999999999999999998 9999975432211110
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
+....... .+...+..+.+|+.+||+.||.+|||+.++++.|..+.
T Consensus 234 ~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 234 IAQGLRLY----RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp HHTTCCCC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcccCCC----CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 01111111 12222345889999999999999999999999998875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=366.88 Aligned_cols=260 Identities=23% Similarity=0.373 Sum_probs=205.3
Q ss_pred cCccccceeeeeCceEEEEEEECC-Cc----EEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~----~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
++|.+.+.||+|+||.||+|.+.. ++ .||+|.+...........+.+|+.++++++||||+++++++.. .
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~ 87 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-----S 87 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-----S
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-----C
Confidence 568888999999999999998753 44 3888888655444444458899999999999999999998852 3
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred ccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccc
Confidence 5789999999999999997642 45899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
........ .......||+.|+|||++.+..++.++||||||+++|||++ |+.||............
T Consensus 164 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~---------- 230 (325)
T 3kex_A 164 LLPPDDKQ---LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL---------- 230 (325)
T ss_dssp GSCCCTTC---CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH----------
T ss_pred ccCccccc---ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH----------
Confidence 76543221 12334568889999999999999999999999999999999 99999754322111110
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 514 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 514 (632)
....... .+...+..+.+|+.+||..||.+||++.++++.|..+....
T Consensus 231 ----~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 231 ----EKGERLA----QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp ----HTTCBCC----CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred ----HcCCCCC----CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 0000111 11112233788999999999999999999999999987654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=365.71 Aligned_cols=277 Identities=17% Similarity=0.177 Sum_probs=213.0
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcceE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
.++|.+.+.||+|+||.||+|... +|+.||||++....... .+.+|+.+++++ +||||+++++++.. ....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~E~~~l~~l~~h~~i~~~~~~~~~----~~~~ 80 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAP---QLHLEYRFYKQLGSGDGIPQVYYFGPC----GKYN 80 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSC---CHHHHHHHHHHHCSCTTSCCEEEEEEE----TTEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchH---HHHHHHHHHHHhhCCCCCCEEEEEEec----CCcc
Confidence 367888999999999999999974 58999999997653322 388999999999 99999999999876 4578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCC-----eEEeccc
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN-----AKITDLG 376 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~-----vkL~DFG 376 (632)
++||||+ +++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||||+.++. +||+|||
T Consensus 81 ~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg 155 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFA 155 (330)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred EEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence 9999999 99999999764 356999999999999999999999998 999999999999998887 9999999
Q ss_pred cceecccCCCCC--CCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccc
Q 006750 377 MAKRLKADGLPS--CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 454 (632)
Q Consensus 377 la~~~~~~~~~~--~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~ 454 (632)
+++......... .........||+.|+|||++.+..++.++||||||+++|||++|+.||................
T Consensus 156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~-- 233 (330)
T 2izr_A 156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG-- 233 (330)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHH--
T ss_pred cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHH--
Confidence 999765432211 1112345679999999999999999999999999999999999999997643222111000000
Q ss_pred cccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCcccccccCcch
Q 006750 455 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNISLNL 524 (632)
Q Consensus 455 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~ 524 (632)
. .........+... .+ .+.+|+..||..||.+||++.+|++.|..+...........++|
T Consensus 234 --~---~~~~~~~~~~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 293 (330)
T 2izr_A 234 --D---TKRATPIEVLCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDW 293 (330)
T ss_dssp --H---HHHHSCHHHHTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTT
T ss_pred --h---hhccCCHHHHhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccC
Confidence 0 0000000000111 22 58999999999999999999999999998765544333333444
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=365.04 Aligned_cols=249 Identities=25% Similarity=0.319 Sum_probs=203.7
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|.+.+.||+|+||.||+|+.. +|+.||||+++... .......+.+|+.+|+.++||||+++++++.. ....
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~----~~~~ 80 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT----HDRL 80 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC----SSEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe----CCEE
Confidence 57888999999999999999976 49999999997531 22334568899999999999999999999876 4578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 81 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 155 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence 9999999999999999753 45899999999999999999999998 999999999999999999999999999864
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||............
T Consensus 156 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i------------- 217 (337)
T 1o6l_A 156 ISDG-----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------------- 217 (337)
T ss_dssp CCTT-----CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------------
T ss_pred ccCC-----CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHH-------------
Confidence 3321 2234567999999999999999999999999999999999999999654322111000
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQI 506 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 506 (632)
... .. .+|...+..+.+|+.+||+.||.+|| ++.+|++.
T Consensus 218 ~~~--~~----~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 218 LME--EI----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHC--CC----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HcC--CC----CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 000 01 12233345588999999999999999 89998764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=353.99 Aligned_cols=259 Identities=24% Similarity=0.367 Sum_probs=198.6
Q ss_pred hhcCccccceeeeeCceEEEEEEECC----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCc
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 298 (632)
..++|.+.+.||+|+||.||+|.+.. +..||||+++........+.|.+|+.++++++||||+++++++.+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 87 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----- 87 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-----
Confidence 34678889999999999999998753 557999998865544555679999999999999999999998743
Q ss_pred ceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccc
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 378 (632)
...++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC----
T ss_pred CccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccc
Confidence 3568999999999999999754 245899999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccc
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQD 457 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 457 (632)
+....... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||...........
T Consensus 164 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~---------- 229 (281)
T 1mp8_A 164 RYMEDSTY----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR---------- 229 (281)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH----------
T ss_pred cccCcccc----cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHH----------
Confidence 87654321 11223457889999999999999999999999999999997 9999975432211100
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 458 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
+....... .+...+..+.+++.+||+.||++|||+.++++.|..+..
T Consensus 230 ----i~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 230 ----IENGERLP----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp ----HHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHcCCCCC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00001111 223334558899999999999999999999999988753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=356.68 Aligned_cols=277 Identities=17% Similarity=0.201 Sum_probs=213.5
Q ss_pred hcCccccceeeeeCceEEEEEEE-CCCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcceE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
.++|.+.+.||+|+||.||+|.. .+|+.||||++....... .+.+|+.+++++ +|+|++++++++.. ....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~e~~~~~~l~~~~~i~~~~~~~~~----~~~~ 81 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP---QLRDEYRTYKLLAGCTGIPNVYYFGQE----GLHN 81 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSC---CHHHHHHHHHHTTTCTTCCCEEEEEEE----TTEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccH---HHHHHHHHHHHHhcCCCCCeEEeecCC----Ccee
Confidence 46788999999999999999996 459999999987553322 378999999999 89999999998865 5578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCC-----eEEeccc
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN-----AKITDLG 376 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~-----vkL~DFG 376 (632)
++||||+ +++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 82 ~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 9999999 99999999754 345999999999999999999999998 999999999999987776 9999999
Q ss_pred cceecccCCCCC--CCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccc
Q 006750 377 MAKRLKADGLPS--CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 454 (632)
Q Consensus 377 la~~~~~~~~~~--~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~ 454 (632)
+++......... .........||+.|+|||++.+..++.++||||||+++|||++|+.||................
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~-- 234 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG-- 234 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH--
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH--
Confidence 998776532211 1122345679999999999999999999999999999999999999997643221111100000
Q ss_pred cccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCcccccccCcc
Q 006750 455 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNISLN 523 (632)
Q Consensus 455 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~ 523 (632)
. .......+.+...++ ..+.+|+.+||+.||++||++.+|++.|..+...........++
T Consensus 235 --~---~~~~~~~~~~~~~~~----~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~d 294 (298)
T 1csn_A 235 --E---KKQSTPLRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFD 294 (298)
T ss_dssp --H---HHHHSCHHHHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCG
T ss_pred --h---hccCccHHHHHhhCc----HHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccc
Confidence 0 000000011111233 45889999999999999999999999999886554433333333
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=356.39 Aligned_cols=259 Identities=25% Similarity=0.391 Sum_probs=210.2
Q ss_pred HHhhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 221 EHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 221 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
+...++|.+.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++++||||+++++++.. ..
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~ 81 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-----EP 81 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SS
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc--ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-----CC
Confidence 33456788899999999999999999888899999997543 234569999999999999999999998763 24
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.++||||+++++|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 158 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL 158 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCccccc
Confidence 699999999999999997654446999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
...... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........
T Consensus 159 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~------------ 222 (279)
T 1qpc_A 159 IEDNEY----TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN------------ 222 (279)
T ss_dssp CSSSCE----ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH------------
T ss_pred ccCccc----ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH------------
Confidence 654321 11223457889999999998999999999999999999999 8999965332111000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
+....... .+...+..+.+|+.+||..||++|||+.++++.|+.+.
T Consensus 223 --~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 223 --LERGYRMV----RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp --HHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HhcccCCC----CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 00111111 12223345889999999999999999999999998875
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=362.91 Aligned_cols=260 Identities=22% Similarity=0.336 Sum_probs=203.0
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccC------
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG------ 296 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~------ 296 (632)
.++|++.+.||+|+||.||+|++. +|+.||||+++........+.+.+|+.+|++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467889999999999999999986 6999999999876655666779999999999999999999999865321
Q ss_pred -----------------------------------------------CcceEEEEEEeCCCCChhhhhhcccc-CCCCHH
Q 006750 297 -----------------------------------------------KRAMRLLVFEFMPNGNLRDCLDGVLV-EGMNWD 328 (632)
Q Consensus 297 -----------------------------------------------~~~~~~lV~Ey~~~gsL~~~L~~~~~-~~l~~~ 328 (632)
.....++||||+++|+|.+++..... ....+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 12247999999999999999975432 236788
Q ss_pred HHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCCCCC-------CCCCCccccCCC
Q 006750 329 TRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSC-------SSSPARMQGTFG 401 (632)
Q Consensus 329 ~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~-------~~~~~~~~GT~~ 401 (632)
.++.++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++.......... ........||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999998 99999999999999999999999999987754321100 112334579999
Q ss_pred CCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccCCCCCCCCCCHHHHHH
Q 006750 402 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQI 481 (632)
Q Consensus 402 Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 481 (632)
|+|||++.+..++.++||||||+++|||++|..|+...... ......... ..........
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~-------------------~~~~~~~~~-~~~~~~~~~~ 301 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRI-------------------ITDVRNLKF-PLLFTQKYPQ 301 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHH-------------------HHHHHTTCC-CHHHHHHCHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHH-------------------HHHhhccCC-CcccccCChh
Confidence 99999999999999999999999999999998775321100 000000000 0112233455
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 482 MAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 482 l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
+.+|+.+||+.||.+|||+.|+++.
T Consensus 302 ~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 302 EHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHccCCCCcCCCHHHHhhc
Confidence 7899999999999999999999873
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=361.73 Aligned_cols=263 Identities=25% Similarity=0.375 Sum_probs=210.9
Q ss_pred hhcCccccceeeeeCceEEEEEEE------CCCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeeccc
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQL------TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFR 295 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~ 295 (632)
..++|.+.+.||+|+||.||+|.+ .+++.||||+++........+.+.+|+.+++++ +||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 98 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec--
Confidence 346788899999999999999985 246899999998665444556799999999999 99999999999876
Q ss_pred CCcceEEEEEEeCCCCChhhhhhcccc----------------CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCC
Q 006750 296 GKRAMRLLVFEFMPNGNLRDCLDGVLV----------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKS 359 (632)
Q Consensus 296 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp 359 (632)
....++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||
T Consensus 99 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp 173 (313)
T 1t46_A 99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAA 173 (313)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred --CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCcc
Confidence 4466999999999999999975432 24899999999999999999999998 99999999
Q ss_pred CCeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCC
Q 006750 360 SNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHR 438 (632)
Q Consensus 360 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~ 438 (632)
+|||++.++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 250 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNY---VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTS---EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ceEEEcCCCCEEEccccccccccccccc---eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 9999999999999999999876543211 11233457889999999999999999999999999999999 9999965
Q ss_pred ccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 439 SITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
......... .+.....+. .+...+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus 251 ~~~~~~~~~-------------~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 251 MPVDSKFYK-------------MIKEGFRML----SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp CCSSHHHHH-------------HHHHTCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccchhHHHH-------------HhccCCCCC----CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 432211000 011111111 122233458899999999999999999999999987753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=361.28 Aligned_cols=253 Identities=23% Similarity=0.330 Sum_probs=203.7
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-----ChHHHHHHHHHHHHhcCCCCccceeeeeecccCC
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-----NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-----~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 297 (632)
.++|.+.+.||+|+||.||+|... +|+.||||+++..... .....+.+|+.+|++++||||+++++++..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---- 85 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN---- 85 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe----
Confidence 456888999999999999999986 4899999999765322 134669999999999999999999999875
Q ss_pred cceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCC----CeEEe
Q 006750 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL----NAKIT 373 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~----~vkL~ 373 (632)
....++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~ 160 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKII 160 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEE
Confidence 45789999999999999999753 45999999999999999999999998 99999999999998887 79999
Q ss_pred ccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccc
Q 006750 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 453 (632)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~ 453 (632)
|||+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.............
T Consensus 161 Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~---- 230 (326)
T 2y0a_A 161 DFGLAHKIDFGN------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS---- 230 (326)
T ss_dssp CCTTCEECCTTS------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH----
T ss_pred ECCCCeECCCCC------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH----
Confidence 999998765332 2234569999999999999999999999999999999999999996543221110000
Q ss_pred ccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 454 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 454 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.. ............+..+.+|+.+||..||.+|||+.++++.
T Consensus 231 ----------~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 231 ----------AV-NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp ----------HT-CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ----------hc-CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 0000000011223458899999999999999999999874
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=352.95 Aligned_cols=256 Identities=23% Similarity=0.345 Sum_probs=205.7
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
++|.+.+.||+|+||.||+|+++ ++.||||+++.... ....+.|.+|+.++++++||||+++++++.... ....++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~~~l 86 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP--APHPTL 86 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT--SSSCEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC--CCCeEe
Confidence 56888899999999999999985 88999999986542 233456999999999999999999999987632 246799
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||+++|+|.+++.......+++..++.++.|++.||+|||+.+ ++|+||||||+|||++.++.++|+|||++....
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~- 164 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ- 164 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence 999999999999998755456999999999999999999999875 349999999999999999999999998875422
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCCCCc---ccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASL---MSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~---ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
.....||+.|+|||++.+..++. ++||||||+++|||++|+.||...........
T Consensus 165 ---------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~------------- 222 (271)
T 3kmu_A 165 ---------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK------------- 222 (271)
T ss_dssp ---------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHH-------------
T ss_pred ---------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHH-------------
Confidence 12346899999999998765444 89999999999999999999965432211000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
.......+. .+...+..+.+++.+||+.||++|||+.++++.|..+.
T Consensus 223 ~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 223 VALEGLRPT----IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp HHHSCCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHhcCCCCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 011111222 22333445889999999999999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=359.64 Aligned_cols=263 Identities=26% Similarity=0.391 Sum_probs=214.4
Q ss_pred HHHHhhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCC
Q 006750 219 ALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (632)
Q Consensus 219 ~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 297 (632)
.++...++|.+.+.||+|+||.||+|.+.. +..||||++... ....+.|.+|+.++++++||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---- 80 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR---- 80 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC--STHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc----
Confidence 334456778899999999999999999875 889999999754 3445669999999999999999999999875
Q ss_pred cceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccc
Q 006750 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 377 (632)
....++||||+++++|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~ 157 (288)
T 3kfa_A 81 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGL 157 (288)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCG
T ss_pred CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCcc
Confidence 456799999999999999998765566999999999999999999999999 99999999999999999999999999
Q ss_pred ceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccc
Q 006750 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQ 456 (632)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~ 456 (632)
+........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||..........
T Consensus 158 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~---------- 223 (288)
T 3kfa_A 158 SRLMTGDTY----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE---------- 223 (288)
T ss_dssp GGTSCSSSS----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH----------
T ss_pred ceeccCCcc----ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----------
Confidence 987653321 12233457889999999999999999999999999999999 999986543221110
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 457 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 457 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
.+...... ..+...+..+.+|+.+||..||.+|||+.++++.|..+..
T Consensus 224 ----~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 224 ----LLEKDYRM----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp ----HHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHhccCCC----CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 01111111 1223334558899999999999999999999999987753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=357.82 Aligned_cols=269 Identities=25% Similarity=0.339 Sum_probs=200.7
Q ss_pred hhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
..++|.+.+.||+|+||+||+|.+.+|+.||||++..... ......+.+|+.+|++++||||+++++++.. ....
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~ 94 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS----ERCL 94 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC----SSCE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc----CCEE
Confidence 3467889999999999999999998899999999975532 2334568999999999999999999999875 4578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
++||||++ |+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 95 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 169 (311)
T 3niz_A 95 TLVFEFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAF 169 (311)
T ss_dssp EEEEECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred EEEEcCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceec
Confidence 99999997 58888886543 45999999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec-ccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW-ATPRLQDSG 459 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~-~~~~~~~~~ 459 (632)
.... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.............. .........
T Consensus 170 ~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 244 (311)
T 3niz_A 170 GIPV-----RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW 244 (311)
T ss_dssp TSCC-----C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTS
T ss_pred CCCc-----ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHh
Confidence 4321 12334568999999999876 5689999999999999999999999975443321111000 000000000
Q ss_pred ccccc------cCCCCCCC----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 460 TVISE------LPDPRLKG----DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 460 ~~~~~------~~~~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
....+ ........ .........+.+|+.+||+.||.+|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp GGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000 00000000 011122345789999999999999999999987
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=357.07 Aligned_cols=251 Identities=24% Similarity=0.320 Sum_probs=195.0
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-------------------------ChHHHHHHHHHHHHh
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-------------------------NADSVFLTEVDMLSR 278 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-------------------------~~~~~f~~Ei~~l~~ 278 (632)
++|.+.+.||+|+||.||+|... +++.||||++...... ...+.+.+|+.+|++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 67888999999999999999875 4899999999754311 112458999999999
Q ss_pred cCCCCccceeeeeecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCC
Q 006750 279 LHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIK 358 (632)
Q Consensus 279 l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLK 358 (632)
++||||+++++++.... ....|+||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+|||||
T Consensus 93 l~h~~iv~~~~~~~~~~--~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPN--EDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp CCCTTBCCEEEEEECSS--SSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred CCCCCCCeEEEEEEcCC--CCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 99999999999987532 4478999999999999987653 45999999999999999999999998 9999999
Q ss_pred CCCeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCC---CCcccchHhHhHHHHHHHhCCCC
Q 006750 359 SSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELITGRQP 435 (632)
Q Consensus 359 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~---~s~ksDVwSlGviL~eLltG~~P 435 (632)
|+|||++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.|
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 239 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA-----LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC-----EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred HHHEEECCCCCEEEecCCCccccccccc-----cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 9999999999999999999987654321 123356999999999987655 47889999999999999999999
Q ss_pred CCCccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 436 IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
|............ ............++ ..+.+|+.+||+.||++|||+.|+++
T Consensus 240 f~~~~~~~~~~~~-------------~~~~~~~~~~~~~~----~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 240 FMDERIMCLHSKI-------------KSQALEFPDQPDIA----EDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SCCSSHHHHHHHH-------------HHCCCCCCSSSCCC----HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCccHHHHHHHH-------------hcccCCCCCccccC----HHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 9643221100000 00000000111233 44889999999999999999999975
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=357.41 Aligned_cols=270 Identities=24% Similarity=0.368 Sum_probs=190.3
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
.++|.+.+.||+|+||.||+|... +|+.||||+++..........+.+|+.+|++++||||+++++++.. ....+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~~ 79 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT----ENKLT 79 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC----TTEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE----CCeEE
Confidence 457888999999999999999875 4899999999866554455668999999999999999999999875 45789
Q ss_pred EEEEeCCCCChhhhhhccc----cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccc
Q 006750 303 LVFEFMPNGNLRDCLDGVL----VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 378 (632)
+||||++ |+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 80 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 155 (317)
T 2pmi_A 80 LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLA 155 (317)
T ss_dssp EEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSC
T ss_pred EEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccc
Confidence 9999997 69999986532 235899999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhee-ccccccc
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL-WATPRLQ 456 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~-~~~~~~~ 456 (632)
+...... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||............. .......
T Consensus 156 ~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 230 (317)
T 2pmi_A 156 RAFGIPV-----NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNE 230 (317)
T ss_dssp EETTSCC-----CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCT
T ss_pred eecCCCc-----ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 8764321 12234568999999999976 468999999999999999999999997543321111000 0000000
Q ss_pred cccccccccC--CCCCC------------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 457 DSGTVISELP--DPRLK------------GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 457 ~~~~~~~~~~--~~~l~------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.....+.... .+.+. ...+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 231 SLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp TTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0000000000 00000 00011223458899999999999999999999763
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=359.88 Aligned_cols=276 Identities=23% Similarity=0.344 Sum_probs=207.5
Q ss_pred cCccccceeeeeCceEEEEEEE-----CCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQL-----TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
++|++.+.||+|+||.||+|.+ .+++.||||+++..........+.+|+.+|++++||||+++++++.... ..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~ 98 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG--GN 98 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----C
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC--Cc
Confidence 3477789999999999999984 3589999999986655555677999999999999999999999987632 24
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred eEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 6799999999999999996543 45999999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
........ ........||..|+|||++.+..++.++||||||+++|||++|..|+.............+.. ....
T Consensus 175 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~ 249 (302)
T 4e5w_A 175 AIETDKEY--YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG---QMTV 249 (302)
T ss_dssp ECCTTCCE--EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCG---GGHH
T ss_pred cccCCCcc--eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCccc---ccCH
Confidence 76543211 112334568889999999999999999999999999999999999874322110000000000 0000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
..+............+...+..+.+|+.+||+.||.+|||+.++++.|+.++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 250 TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0000000111111233344456899999999999999999999999998764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=364.80 Aligned_cols=261 Identities=26% Similarity=0.409 Sum_probs=209.2
Q ss_pred hcCccccceeeeeCceEEEEEEEC--------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 294 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~ 294 (632)
.++|.+.+.||+|+||.||+|.+. ++..||||+++..........+.+|+.+++++ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~- 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc-
Confidence 467888999999999999999873 46789999998765545556799999999999 99999999999875
Q ss_pred cCCcceEEEEEEeCCCCChhhhhhcccc--------------CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCC
Q 006750 295 RGKRAMRLLVFEFMPNGNLRDCLDGVLV--------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 360 (632)
Q Consensus 295 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~ 360 (632)
....++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+
T Consensus 113 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~ 186 (334)
T 2pvf_A 113 ---DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAAR 186 (334)
T ss_dssp ---SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred ---CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccc
Confidence 4467999999999999999975431 24899999999999999999999998 999999999
Q ss_pred CeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCc
Q 006750 361 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (632)
Q Consensus 361 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~ 439 (632)
|||++.++.+||+|||+++........ .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYY---KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSE---ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred eEEEcCCCCEEEccccccccccccccc---cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 999999999999999999876543211 12233457889999999999999999999999999999999 99999654
Q ss_pred cccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 440 ITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
....... .+.....+. .+...+..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 264 ~~~~~~~--------------~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 264 PVEELFK--------------LLKEGHRMD----KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp CHHHHHH--------------HHHHTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHH--------------HHhcCCCCC----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 3211100 001111111 122333458899999999999999999999999998854
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=365.07 Aligned_cols=268 Identities=26% Similarity=0.391 Sum_probs=213.6
Q ss_pred HHHHHhhcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeee
Q 006750 218 SALEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291 (632)
Q Consensus 218 ~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~ 291 (632)
++++...++|.+.+.||+|+||.||+|.+. +++.||||++...........|.+|+.++++++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 445566788999999999999999999864 36889999998665445556699999999999999999999998
Q ss_pred ecccCCcceEEEEEEeCCCCChhhhhhccc--------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeE
Q 006750 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVL--------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNIL 363 (632)
Q Consensus 292 ~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NIL 363 (632)
.. ....++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+|||
T Consensus 98 ~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIl 170 (322)
T 1p4o_A 98 SQ----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCM 170 (322)
T ss_dssp CS----SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEE
T ss_pred cc----CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEE
Confidence 75 446799999999999999996532 134799999999999999999999998 999999999999
Q ss_pred ecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCcccc
Q 006750 364 LDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITK 442 (632)
Q Consensus 364 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~ 442 (632)
++.++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 171 i~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 247 (322)
T 1p4o_A 171 VAEDFTVKIGDFGMTRDIYETDYY---RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 247 (322)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCE---EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred EcCCCeEEECcCcccccccccccc---ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH
Confidence 999999999999999866433211 11123357889999999999999999999999999999999 88998654322
Q ss_pred ccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006750 443 GEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 513 (632)
Q Consensus 443 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 513 (632)
..... +.....+ ..+...+..+.+|+.+||+.||.+|||+.++++.|..+...
T Consensus 248 ~~~~~--------------~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 248 QVLRF--------------VMEGGLL----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp HHHHH--------------HHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HHHHH--------------HHcCCcC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 11000 0000001 11223334588999999999999999999999999987654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=361.85 Aligned_cols=253 Identities=20% Similarity=0.249 Sum_probs=204.0
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
.++|.+.+.||+|+||.||++.... ++.||+|++... ......+.+|+.+|+.++||||+++++++.+ ....+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~ 77 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFES----MEELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEE----TTEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEec----CCEEE
Confidence 5689999999999999999999764 889999999754 2334558999999999999999999999876 45789
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC--CCCeEEecccccee
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE--NLNAKITDLGMAKR 380 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~--~~~vkL~DFGla~~ 380 (632)
+||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 78 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~ 153 (321)
T 1tki_A 78 MIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence 999999999999999753 245999999999999999999999998 999999999999987 78999999999987
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.............
T Consensus 154 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~----------- 216 (321)
T 1tki_A 154 LKPGD------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM----------- 216 (321)
T ss_dssp CCTTC------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-----------
T ss_pred CCCCC------ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH-----------
Confidence 65331 2234569999999999998889999999999999999999999996543221111000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 507 (632)
..... .........+..+.+|+.+||..||.+|||+.|+++.-
T Consensus 217 --~~~~~--~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 217 --NAEYT--FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp --HTCCC--CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred --cCCCC--CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 00000 00000012234588999999999999999999999843
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=367.02 Aligned_cols=263 Identities=25% Similarity=0.378 Sum_probs=197.0
Q ss_pred CccccceeeeeCceEEEEEEECC----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
.|...+.||+|+||.||+|.+.+ +..||||.++..........|.+|+.+|++++||||+++++++.+. ....
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~---~~~~ 166 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS---EGSP 166 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC---SSCC
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC---CCCe
Confidence 35667899999999999998642 2468999998665555667799999999999999999999987642 3356
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccc
Confidence 89999999999999997532 45899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
....... ........+|+.|+|||++.+..++.++||||||+++|||++ |.+||...........
T Consensus 243 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~------------- 308 (373)
T 3c1x_A 243 YDKEFDS-VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY------------- 308 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH-------------
T ss_pred ccccccc-ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH-------------
Confidence 4432111 112234457889999999999999999999999999999999 6667754322211100
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 514 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 514 (632)
+....... .+..++..+.+++.+||+.||++|||+.++++.|..+....
T Consensus 309 -~~~~~~~~----~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 309 -LLQGRRLL----QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp -HHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred -HHcCCCCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 00001111 12223345889999999999999999999999999886543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=391.16 Aligned_cols=264 Identities=28% Similarity=0.420 Sum_probs=214.0
Q ss_pred HHHHhhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCc
Q 006750 219 ALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 219 ~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 298 (632)
.++...++|.+.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+.+|++++||||+++++++.+
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----- 333 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE----- 333 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC--CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-----
Confidence 3445567788899999999999999999888889999998653 234569999999999999999999999864
Q ss_pred ceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccc
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 378 (632)
...||||||+++|+|.++|.......+++.+++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a 410 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA 410 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccc
Confidence 34699999999999999998655556999999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccc
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQD 457 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 457 (632)
+....... .......+|..|+|||++....++.++||||||++||||++ |+.||...........
T Consensus 411 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~---------- 476 (535)
T 2h8h_A 411 RLIEDNEY----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ---------- 476 (535)
T ss_dssp TTCCCHHH----HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH----------
T ss_pred eecCCCce----ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----------
Confidence 86543211 11223347789999999999999999999999999999999 9999965432211000
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006750 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 514 (632)
Q Consensus 458 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 514 (632)
+..... ...+..++..+.+||.+||+.||++|||+.+|++.|+.+....
T Consensus 477 ----i~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 477 ----VERGYR----MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp ----HHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred ----HHcCCC----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 000011 1123334455889999999999999999999999999886543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=367.18 Aligned_cols=264 Identities=22% Similarity=0.350 Sum_probs=210.5
Q ss_pred HhhcCccccceeeeeCceEEEEEEECC------CcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecc
Q 006750 222 HATDKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 294 (632)
Q Consensus 222 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~------g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~ 294 (632)
...++|.+.+.||+|+||.||+|.+.. ...||||++...........+.+|+.+|+++ +||||+++++++..
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 121 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH- 121 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec-
Confidence 345778889999999999999998753 2489999998765555566799999999999 89999999999875
Q ss_pred cCCcceEEEEEEeCCCCChhhhhhccc------------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCe
Q 006750 295 RGKRAMRLLVFEFMPNGNLRDCLDGVL------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNI 362 (632)
Q Consensus 295 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NI 362 (632)
....++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||
T Consensus 122 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 195 (333)
T 2i1m_A 122 ---GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNV 195 (333)
T ss_dssp ---SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGC
T ss_pred ---CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceE
Confidence 446799999999999999996532 235899999999999999999999998 99999999999
Q ss_pred EecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccc
Q 006750 363 LLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSIT 441 (632)
Q Consensus 363 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~ 441 (632)
|++.++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 196 l~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 272 (333)
T 2i1m_A 196 LLTNGHVAKIGDFGLARDIMNDSNY---IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272 (333)
T ss_dssp EEEGGGEEEBCCCGGGCCGGGCTTS---EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred EECCCCeEEECccccccccccccce---eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence 9999999999999999876543211 11233457889999999999999999999999999999999 8999865432
Q ss_pred cccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 442 KGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 442 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
...... .+....... .+...+..+.+|+..||+.||.+|||+.+|++.|..+..
T Consensus 273 ~~~~~~-------------~~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 273 NSKFYK-------------LVKDGYQMA----QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp SHHHHH-------------HHHHTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHH-------------HHhcCCCCC----CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 211100 001111111 122223458899999999999999999999999987753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=364.17 Aligned_cols=254 Identities=21% Similarity=0.271 Sum_probs=203.7
Q ss_pred hhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
..++|.+.+.||+|+||.||+|... +|+.||||++...... ...+.+.+|+.+|++++||||+++++++.+ ...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~~ 102 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE----ESF 102 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC----SSE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe----CCE
Confidence 4577999999999999999999876 4899999999765332 334568999999999999999999999876 457
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCC---CCeEEecccc
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN---LNAKITDLGM 377 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~---~~vkL~DFGl 377 (632)
.|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.+ +.+||+|||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 89999999999999998753 45899999999999999999999998 9999999999999765 4599999999
Q ss_pred ceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccc
Q 006750 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 457 (632)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~ 457 (632)
+....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.............
T Consensus 178 a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~-------- 243 (362)
T 2bdw_A 178 AIEVNDSE------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK-------- 243 (362)
T ss_dssp CBCCTTCC------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------
T ss_pred ceEecCCc------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--------
Confidence 98765321 2334579999999999999999999999999999999999999996543211100000
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 458 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.... ..........+..+.+|+.+||+.||.+||++.++++.
T Consensus 244 -----~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 244 -----AGAY--DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -----HTCC--CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -----hCCC--CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 00001112234558899999999999999999999874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=361.54 Aligned_cols=261 Identities=26% Similarity=0.420 Sum_probs=204.0
Q ss_pred hcCccccceeeeeCceEEEEEEECC-Cc----EEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~----~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 298 (632)
.++|.+.+.||+|+||.||+|.+.. ++ .||+|.+...........+.+|+.++++++||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----- 88 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT----- 88 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES-----
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec-----
Confidence 3678889999999999999998753 44 3688888766556666779999999999999999999999875
Q ss_pred ceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccc
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 378 (632)
...++|++|+.+|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 89 ~~~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 89 STVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp SSEEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred CCceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 23689999999999999997643 45999999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccc
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQD 457 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 457 (632)
+........ .......||+.|+|||++.+..++.++||||||+++|||++ |+.||...........
T Consensus 165 ~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~---------- 231 (327)
T 3lzb_A 165 KLLGAEEKE---YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---------- 231 (327)
T ss_dssp ------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH----------
T ss_pred eEccCcccc---ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH----------
Confidence 876443211 12223457889999999999999999999999999999999 9999975433211110
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006750 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 514 (632)
Q Consensus 458 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 514 (632)
+...... ..+...+..+.+|+.+||+.||.+||++.++++.|..+....
T Consensus 232 ----~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 232 ----LEKGERL----PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp ----HHTTCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred ----HHcCCCC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 0111111 122333445889999999999999999999999999987554
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=361.70 Aligned_cols=271 Identities=24% Similarity=0.354 Sum_probs=197.5
Q ss_pred HHHhhcCccccceeeeeCceEEEEEEECC-C---cEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecc
Q 006750 220 LEHATDKFSGSNIVGQGGSSYVYRGQLTD-G---RIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 294 (632)
Q Consensus 220 l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~-g---~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~ 294 (632)
+....++|.+.+.||+|+||.||+|.+.. + ..||||+++... .....+.|.+|+.++++++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 34456789999999999999999998754 3 279999997653 233456699999999999999999999998763
Q ss_pred cCC--cceEEEEEEeCCCCChhhhhhcccc----CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCC
Q 006750 295 RGK--RAMRLLVFEFMPNGNLRDCLDGVLV----EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL 368 (632)
Q Consensus 295 ~~~--~~~~~lV~Ey~~~gsL~~~L~~~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~ 368 (632)
... ....++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCC
Confidence 321 1234899999999999999964321 24899999999999999999999998 99999999999999999
Q ss_pred CeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchh
Q 006750 369 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESL 447 (632)
Q Consensus 369 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~ 447 (632)
.+||+|||+++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...........
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~ 251 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYY---RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251 (323)
T ss_dssp CEEECCCCC--------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred CEEEeeccccccccccccc---cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 9999999999876543221 11223457889999999999999999999999999999999 8999975433211110
Q ss_pred eeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006750 448 VLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 514 (632)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 514 (632)
+...... ..+...+..+.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus 252 --------------~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 252 --------------LIGGNRL----KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp --------------HHTTCCC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred --------------HhcCCCC----CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 0000011 122233345889999999999999999999999999886543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=353.89 Aligned_cols=263 Identities=27% Similarity=0.436 Sum_probs=196.1
Q ss_pred hhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
..++|.+.+.||+|+||+||+|.+. ..||||+++.... ....+.|.+|+.+|++++||||+++++++. ....
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~ 94 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-----APQL 94 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SSSC
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-----CCcc
Confidence 3467888999999999999999864 3599999976543 233456999999999999999999999764 2356
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred EEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccc
Confidence 99999999999999996543 45999999999999999999999998 999999999999999999999999999765
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhh---cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
..... ........||+.|+|||++. ...++.++||||||+++|||++|+.||.............
T Consensus 171 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~--------- 238 (289)
T 3og7_A 171 SRWSG---SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV--------- 238 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHH---------
T ss_pred ccccc---cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHh---------
Confidence 43211 12233456999999999986 6678999999999999999999999997543221110000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
......+.+ ......++..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus 239 ---~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 239 ---GRGSLSPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp ---HHTSCCCCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ---cccccCcch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 000001111 11122334558999999999999999999999999998764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=358.11 Aligned_cols=272 Identities=27% Similarity=0.402 Sum_probs=215.8
Q ss_pred eecHHHHHHhhcCccccceeeeeCceEEEEEEE------CCCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccc
Q 006750 214 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQL------TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVP 286 (632)
Q Consensus 214 ~~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~------~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~ 286 (632)
.+....++...++|.+.+.||+|+||.||+|.+ .+++.||||+++..........+.+|+.+++++ +||||++
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 345556666778999999999999999999985 246899999998765544556799999999999 7999999
Q ss_pred eeeeeecccCCcceEEEEEEeCCCCChhhhhhcccc--------------CCCCHHHHHHHHHHHHHhhHHHHhcCCCce
Q 006750 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLV--------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRI 352 (632)
Q Consensus 287 l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 352 (632)
+++++... ....++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+.+ |
T Consensus 96 ~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i 169 (316)
T 2xir_A 96 LLGACTKP---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---C 169 (316)
T ss_dssp EEEEECCT---TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred EEEEEecC---CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 99998752 3357999999999999999976432 12789999999999999999999998 9
Q ss_pred eecCCCCCCeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-
Q 006750 353 LHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT- 431 (632)
Q Consensus 353 iHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt- 431 (632)
+||||||+|||++.++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++
T Consensus 170 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~ 246 (316)
T 2xir_A 170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY---VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 246 (316)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTS---EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred ccccCccceEEECCCCCEEECCCccccccccCccc---eeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999876432211 11233567899999999999999999999999999999998
Q ss_pred CCCCCCCccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 432 GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 432 G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
|+.||........... .+........ +...+..+.+++.+||+.||.+|||+.++++.|..+.
T Consensus 247 g~~p~~~~~~~~~~~~-------------~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 247 GASPYPGVKIDEEFCR-------------RLKEGTRMRA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp SCCSSTTCCCSHHHHH-------------HHHHTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCcccchhHHHHH-------------HhccCccCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 9999965432211000 0011111111 2223345889999999999999999999999998875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=355.63 Aligned_cols=270 Identities=26% Similarity=0.390 Sum_probs=205.5
Q ss_pred HHHhhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhc--CCCCccceeeeeecccCC
Q 006750 220 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL--HHCHVVPLVGYCSEFRGK 297 (632)
Q Consensus 220 l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l--~Hpniv~l~g~~~~~~~~ 297 (632)
-....++|.+.+.||+|+||.||+|++. |+.||||++... ....+..|.+++..+ +||||+++++++......
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 3445678999999999999999999986 899999998643 233456666666655 999999999998875444
Q ss_pred cceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhc--------CCCceeecCCCCCCeEecCCCC
Q 006750 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA--------AAPRILHRDIKSSNILLDENLN 369 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------~~~~iiHrDLKp~NILl~~~~~ 369 (632)
....++||||+++|+|.++++. ..+++..++.++.|++.||+|||+. + |+||||||+|||++.++.
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSC
T ss_pred CCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCC
Confidence 4678999999999999999965 3589999999999999999999988 6 999999999999999999
Q ss_pred eEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcc------cchHhHhHHHHHHHhC----------C
Q 006750 370 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLM------SDVFSFGVVLLELITG----------R 433 (632)
Q Consensus 370 vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~k------sDVwSlGviL~eLltG----------~ 433 (632)
+||+|||+++......... ........||+.|+|||++.+...+.+ +||||||+++|||++| +
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEV-DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp EEECCCTTCEECC----------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred EEEEeCCCceeeccccccc-cCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 9999999998765432111 111234579999999999988776665 9999999999999999 5
Q ss_pred CCCCCccccccchheeccccccccccccccccCCCCCCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 434 QPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFP-----KEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 434 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
.||........... .....+....+....+ ..++..+.+|+.+||+.||.+|||+.+|++.|+
T Consensus 260 ~p~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 327 (337)
T 3mdy_A 260 LPYHDLVPSDPSYE------------DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327 (337)
T ss_dssp CTTTTTSCSSCCHH------------HHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred ccHhhhcCCCCchh------------hhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHH
Confidence 55543221111000 0000011111122222 367788999999999999999999999999999
Q ss_pred hhCCC
Q 006750 509 TIAPD 513 (632)
Q Consensus 509 ~i~~~ 513 (632)
.+...
T Consensus 328 ~l~~~ 332 (337)
T 3mdy_A 328 KMSES 332 (337)
T ss_dssp HHHHT
T ss_pred HHHhh
Confidence 88544
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=351.05 Aligned_cols=267 Identities=25% Similarity=0.388 Sum_probs=198.5
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
++|.+.+.||+|+||+||+|...+|+.||||++..... ......+.+|+.++++++||||+++++++.. ....++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~l 77 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT----KKRLVL 77 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC----SSCEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc----CCeEEE
Confidence 46888999999999999999998899999999975432 2233568899999999999999999999875 457899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||++ ++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 78 v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (288)
T 1ob3_A 78 VFEHLD-QDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (288)
T ss_dssp EEECCS-EEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred EEEecC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence 999996 59999987532 45899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec--cccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATPRLQDSGT 460 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~~~~~~~~ 460 (632)
.. .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.............. ..+... ...
T Consensus 153 ~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~ 226 (288)
T 1ob3_A 153 PV-----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK-NWP 226 (288)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT-TST
T ss_pred cc-----cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChh-hch
Confidence 21 12234468999999999976 4589999999999999999999999975432211100000 000000 000
Q ss_pred ccccc--CCCCCC-------CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 461 VISEL--PDPRLK-------GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 461 ~~~~~--~~~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
...+. .++.+. ..+....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000 000000 01112234458899999999999999999999863
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=366.29 Aligned_cols=249 Identities=23% Similarity=0.308 Sum_probs=198.4
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~ 299 (632)
.++|.+.+.||+|+||.||+|+... |+.||||+++... .......+.+|..+|+.+ +||||+++++++.. ..
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~----~~ 97 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT----PD 97 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----SS
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe----CC
Confidence 4679999999999999999999764 8999999997531 122344588999999998 79999999999875 45
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEcccccee
Confidence 789999999999999999764 45999999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...........
T Consensus 173 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~------------ 235 (353)
T 3txo_A 173 EGICNG-----VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA------------ 235 (353)
T ss_dssp CSCC--------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------------
T ss_pred ecccCC-----ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHH------------
Confidence 643221 223456799999999999999999999999999999999999999975433211110
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM------SEVVQ 505 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~ 505 (632)
+.... ..+|...+..+.+|+.+||+.||.+||++ .++++
T Consensus 236 -----i~~~~--~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 236 -----ILNDE--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -----HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -----HHcCC--CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 00000 01233334558899999999999999998 66665
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=351.44 Aligned_cols=256 Identities=27% Similarity=0.467 Sum_probs=202.3
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChH------HHHHHHHHHHHhcCCCCccceeeeeecccC
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNAD------SVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 296 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~------~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 296 (632)
.++|.+.+.||+|+||.||+|.+. +++.||||++......... +.|.+|+.++++++||||+++++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 95 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP-- 95 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT--
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC--
Confidence 367888899999999999999985 5899999999765433221 5689999999999999999999988642
Q ss_pred CcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCC-----eE
Q 006750 297 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN-----AK 371 (632)
Q Consensus 297 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~-----vk 371 (632)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||||+|||++.++. +|
T Consensus 96 ----~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 96 ----PRMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp ----TEEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred ----CeEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEE
Confidence 279999999999999886543 46999999999999999999999885 34999999999999988776 99
Q ss_pred EeccccceecccCCCCCCCCCCCccccCCCCCChhhhh--cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhee
Q 006750 372 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM--VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 449 (632)
Q Consensus 372 L~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~--~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~ 449 (632)
|+|||+++.... ......||+.|+|||++. ...++.++||||||+++|||++|+.||.............
T Consensus 170 l~Dfg~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 241 (287)
T 4f0f_A 170 VADFGLSQQSVH--------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM 241 (287)
T ss_dssp ECCCTTCBCCSS--------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHH
T ss_pred eCCCCccccccc--------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHH
Confidence 999999975432 223356999999999984 4557899999999999999999999996543221100000
Q ss_pred ccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 450 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 450 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
.......+ ..+...+..+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus 242 -----------~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 242 -----------IREEGLRP----TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp -----------HHHSCCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred -----------HhccCCCC----CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 00111112 22333445589999999999999999999999999754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=349.29 Aligned_cols=262 Identities=25% Similarity=0.368 Sum_probs=203.8
Q ss_pred cCccccceeeeeCceEEEEEEECC----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
.+|.+.+.||+|+||.||+|.+.+ ...||||.+...........|.+|+.++++++||||+++++++... ...
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~ 101 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS---EGS 101 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS---SSC
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC---CCc
Confidence 357778999999999999998643 2368999998755555566799999999999999999999987642 345
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred eEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 68999999999999999753 345899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhC-CCCCCCccccccchheecccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITG-RQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG-~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
........ ........||+.|+|||.+.+..++.++||||||+++|||++| .+||...........
T Consensus 178 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~------------ 244 (298)
T 3f66_A 178 MYDKEYYS-VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY------------ 244 (298)
T ss_dssp CSCGGGCB-C-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH------------
T ss_pred ccccchhc-cccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH------------
Confidence 64432111 1223345688999999999999999999999999999999995 455543222111000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
+....... .+...+..+.+++.+||+.||.+|||+.++++.|..+..
T Consensus 245 --~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 245 --LLQGRRLL----QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp --HHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HhcCCCCC----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00011111 122223458899999999999999999999999998754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=359.76 Aligned_cols=247 Identities=23% Similarity=0.271 Sum_probs=194.1
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcce
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~ 300 (632)
.++|+..++||+|+||+||+|.+. +|+.||||++...... .....+..|+..+.++ +||||+++++++.+ ...
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~----~~~ 131 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE----GGI 131 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TTE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe----CCE
Confidence 367999999999999999999987 6999999998754322 2333466677666666 99999999999976 557
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.++||||+ +++|.+++.... ..++|..++.++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||++..
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVE 206 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred EEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeee
Confidence 89999999 789999987643 45999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
..... ......||+.|+|||++.+ .++.++||||||+++|||++|..|+.......
T Consensus 207 ~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~----------------- 262 (311)
T 3p1a_A 207 LGTAG------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ----------------- 262 (311)
T ss_dssp CC------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH-----------------
T ss_pred cccCC------CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-----------------
Confidence 64332 2233469999999998875 79999999999999999999977664321100
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+........++...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 263 ---~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 263 ---QLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ---HHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---HHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 0000001111112233558899999999999999999999873
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=361.24 Aligned_cols=247 Identities=24% Similarity=0.286 Sum_probs=200.7
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|.+.+.||+|+||.||+|.+. +|+.||||++.... .......+.+|+.+|+.++||||+++++++.. ....
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~ 84 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT----PTDI 84 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe----CCEE
Confidence 67889999999999999999974 58999999986431 12223458999999999999999999999876 4578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
++||||+ +|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 85 ~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIM 158 (336)
T ss_dssp EEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred EEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceec
Confidence 9999999 78999998654 45999999999999999999999999 999999999999999999999999999866
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCC-CcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
.... ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.........
T Consensus 159 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~--------------- 217 (336)
T 3h4j_B 159 TDGN------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF--------------- 217 (336)
T ss_dssp TTSB------TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB---------------
T ss_pred cCCc------ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH---------------
Confidence 4432 2234569999999999987765 78999999999999999999999653221110
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
..+... ....|...+..+.+|+.+||..||.+|||+.|+++.
T Consensus 218 --~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 218 --KKVNSC--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp --CCCCSS--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred --HHHHcC--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 011100 011233344558899999999999999999999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=348.01 Aligned_cols=257 Identities=25% Similarity=0.391 Sum_probs=204.4
Q ss_pred hcCccccceeeeeCceEEEEEEECC----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
.++|.+.+.||+|+||.||+|.+.+ +..||||++.........+.|.+|+.++++++||||+++++++.+ .
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~ 85 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-----E 85 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-----S
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----C
Confidence 4678889999999999999998643 346999999876554556679999999999999999999998763 2
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred CCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCc
Confidence 358999999999999999754 245899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........
T Consensus 162 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~----------- 226 (281)
T 3cc6_A 162 YIEDEDY----YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV----------- 226 (281)
T ss_dssp CC-------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH-----------
T ss_pred ccccccc----cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH-----------
Confidence 7654321 11223457889999999999999999999999999999998 9999964332211110
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
+....... .+...+..+.+++.+||..||.+||++.++++.|+.+.
T Consensus 227 ---~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 227 ---LEKGDRLP----KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp ---HHHTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HhcCCCCC----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 00000111 12223345889999999999999999999999998774
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=360.14 Aligned_cols=272 Identities=29% Similarity=0.386 Sum_probs=209.4
Q ss_pred ccccceeeeeCceEEEEEEEC-----CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 227 FSGSNIVGQGGSSYVYRGQLT-----DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~-----~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
|.+.+.||+|+||+||++.+. +++.||||+++..........|.+|+++|++++||||+++++++.... ....
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~~ 110 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG--AASL 110 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--TTEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC--CceE
Confidence 477899999999999998753 588999999987655555667999999999999999999999987632 3478
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
++||||+++|+|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 111 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccc
Confidence 9999999999999999753 4899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
...... ........||+.|+|||++.+..++.++||||||+++|||++|+.||.......... ..+...... ...
T Consensus 185 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~--~~~ 259 (318)
T 3lxp_A 185 PEGHEY--YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL-IGIAQGQMT--VLR 259 (318)
T ss_dssp CTTCSE--EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-HCSCCHHHH--HHH
T ss_pred cccccc--cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhh-hcccccchh--HHH
Confidence 543211 012233458889999999999999999999999999999999999986432211000 000000000 000
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
+.+..........+...+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 01111111112233344456899999999999999999999999998774
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=359.56 Aligned_cols=255 Identities=25% Similarity=0.303 Sum_probs=201.5
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccC----CCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQ----GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 298 (632)
.++|.+.+.||+|+||.||+|... +|+.||||++... ......+.+.+|+.+|+.++||||+++++++.. .
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~ 98 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS----D 98 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE----T
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe----C
Confidence 457899999999999999999875 5899999998632 122235569999999999999999999999876 4
Q ss_pred ceEEEEEEeCCCCChhhhhhccc--cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCC---eEEe
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN---AKIT 373 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~---vkL~ 373 (632)
...|+||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~ 175 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLG 175 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEEC
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEe
Confidence 57899999999999998886432 234899999999999999999999998 999999999999987655 9999
Q ss_pred ccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccc
Q 006750 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 453 (632)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~ 453 (632)
|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||............ ..
T Consensus 176 Dfg~a~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~---~~ 247 (351)
T 3c0i_A 176 GFGVAIQLGESGL-----VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGII---KG 247 (351)
T ss_dssp CCTTCEECCTTSC-----BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHH---HT
T ss_pred cCcceeEecCCCe-----eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHH---cC
Confidence 9999987654321 123456999999999999999999999999999999999999999753211000000 00
Q ss_pred ccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 454 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 454 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.. ...+... ...+..+.+|+.+||+.||++|||+.++++.
T Consensus 248 ~~---------~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 248 KY---------KMNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp CC---------CCCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CC---------CCCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 0000000 1123458899999999999999999999873
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=347.56 Aligned_cols=268 Identities=21% Similarity=0.309 Sum_probs=201.0
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
++|++.+.||+|+||+||+|... +|+.||||++..... ......+.+|+.++++++||||+++++++.. ....+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 77 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS----DKKLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE----TTEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe----CCEEE
Confidence 57889999999999999999986 489999999976543 3334668999999999999999999999876 45789
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||+++ +|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 78 lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 152 (292)
T 3o0g_A 78 LVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp EEEECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecC
Confidence 99999964 666666543 245999999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCC-CCcccchHhHhHHHHHHHhCCCCCCCccccccchheec--ccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGR-ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATPRLQDSG 459 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~~~~~~~ 459 (632)
... .......||+.|+|||++.+.. ++.++||||||+++|||++|..||.............. .........
T Consensus 153 ~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~ 227 (292)
T 3o0g_A 153 IPV-----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp SCC-----SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred Ccc-----ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhh
Confidence 321 2233456899999999998765 89999999999999999999888654322111000000 000000000
Q ss_pred ccccccC---------CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 460 TVISELP---------DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 460 ~~~~~~~---------~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
....... ............+..+.+|+.+||+.||++|||+.|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000000 0001111223344568899999999999999999999873
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=348.62 Aligned_cols=256 Identities=27% Similarity=0.407 Sum_probs=207.5
Q ss_pred hcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
.++|.+.+.||+|+||.||+|.+.+++.||||++..... ..+.+.+|+.++++++||||+++++++.. ....++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~l 80 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLE----QAPICL 80 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEECS----SSSCEE
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEcc----CCCeEE
Confidence 356888899999999999999998889999999986532 33569999999999999999999999875 446799
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp EECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred EEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccc
Confidence 999999999999997542 45899999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVI 462 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (632)
... .......||+.|+|||++.+..++.++||||||+++|||++ |+.||........... +
T Consensus 157 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~--------------i 218 (267)
T 3t9t_A 157 DQY----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED--------------I 218 (267)
T ss_dssp HHH----HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH--------------H
T ss_pred ccc----cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHH--------------H
Confidence 211 11223457889999999999999999999999999999999 8999865332111000 0
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 463 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 463 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
....... .+...+..+.+++.+||+.||.+||++.++++.|..+.
T Consensus 219 ~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 219 STGFRLY----KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp HTTCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCCcCC----CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0000111 12223345889999999999999999999999998874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=351.32 Aligned_cols=259 Identities=25% Similarity=0.348 Sum_probs=207.7
Q ss_pred cCccccc-eeeeeCceEEEEEEEC---CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 225 DKFSGSN-IVGQGGSSYVYRGQLT---DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 225 ~~f~~~~-~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
++|.+.+ .||+|+||.||+|.+. ++..||||+++........+.+.+|+.++++++||||+++++++. ...
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~ 83 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-----AEA 83 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----SSS
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-----CCC
Confidence 3455555 8999999999999864 578899999987655555667999999999999999999999984 235
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred cEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceee
Confidence 79999999999999999753 345999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
....... ........||+.|+|||++.+..++.++||||||+++|||++ |+.||..........
T Consensus 160 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~------------- 224 (287)
T 1u59_A 160 LGADDSY--YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA------------- 224 (287)
T ss_dssp CTTCSCE--ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH-------------
T ss_pred eccCcce--eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH-------------
Confidence 6543211 112233457899999999998899999999999999999998 999996543221110
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
.+.....+. .+...+..+.+++.+||..||.+||++.++++.|+.+..
T Consensus 225 -~i~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 225 -FIEQGKRME----CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp -HHHTTCCCC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHhcCCcCC----CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 001111111 223334558899999999999999999999999988753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=371.31 Aligned_cols=256 Identities=21% Similarity=0.263 Sum_probs=203.4
Q ss_pred HhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 222 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 222 ~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
...++|.+.+.||+|+||.||++... +|+.||+|++...... .....+.+|+.+|++++||||+++++++.+ ..
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~----~~ 83 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE----EG 83 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC----SS
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE----CC
Confidence 34677999999999999999999875 5899999999765322 234558999999999999999999999875 55
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEec---CCCCeEEeccc
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD---ENLNAKITDLG 376 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~---~~~~vkL~DFG 376 (632)
..|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++ .++.+||+|||
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG 158 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFG 158 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred EEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCc
Confidence 789999999999999999754 45999999999999999999999998 99999999999998 46789999999
Q ss_pred cceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccc
Q 006750 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 456 (632)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~ 456 (632)
+++...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...............
T Consensus 159 ~a~~~~~~~-----~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~----- 228 (444)
T 3soa_A 159 LAIEVEGEQ-----QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAG----- 228 (444)
T ss_dssp SCBCCCTTC-----CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-----
T ss_pred eeEEecCCC-----ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC-----
Confidence 998765432 1223457999999999999999999999999999999999999999654322111100000
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 457 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 457 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
......+ .....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 229 -----~~~~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 229 -----AYDFPSP-----EWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -----CCCCCTT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -----CCCCCcc-----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0001111 111233458899999999999999999999984
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=359.47 Aligned_cols=263 Identities=25% Similarity=0.392 Sum_probs=203.1
Q ss_pred hcCccccceeeeeCceEEEEEEECC-----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~-----g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 298 (632)
..+|...+.||+|+||.||+|.+.. +..||||+++..........|.+|+.++++++||||+++++++.. .
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~ 118 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK----Y 118 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----S
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec----C
Confidence 3567778999999999999998653 246999999866544455669999999999999999999999875 4
Q ss_pred ceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccc
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 378 (632)
...++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred CCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcc
Confidence 5679999999999999999753 245999999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccc
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQD 457 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 457 (632)
+........ ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||..........
T Consensus 195 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~----------- 261 (333)
T 1mqb_A 195 RVLEDDPEA--TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK----------- 261 (333)
T ss_dssp ------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-----------
T ss_pred hhhcccccc--ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHH-----------
Confidence 876543211 111223346889999999999999999999999999999999 999996433211100
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006750 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 514 (632)
Q Consensus 458 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 514 (632)
.+...... ..+...+..+.+|+.+||+.||.+||++.++++.|+.+....
T Consensus 262 ---~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 262 ---AINDGFRL----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp ---HHHTTCCC----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred ---HHHCCCcC----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 00000011 112233455889999999999999999999999999886443
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=347.94 Aligned_cols=255 Identities=25% Similarity=0.429 Sum_probs=208.5
Q ss_pred hhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeeccc------
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR------ 295 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~------ 295 (632)
..++|.+.+.||+|+||.||+|.+. +|+.||||+++... ..+.+|++++++++||||+++++++....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 4467889999999999999999986 69999999997543 23789999999999999999999875421
Q ss_pred ------CCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCC
Q 006750 296 ------GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN 369 (632)
Q Consensus 296 ------~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~ 369 (632)
......++||||+++|+|.+++.......+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 12446799999999999999998765567999999999999999999999998 999999999999999999
Q ss_pred eEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhee
Q 006750 370 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 449 (632)
Q Consensus 370 vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~ 449 (632)
+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|||++|..|+......
T Consensus 161 ~kl~Dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~------- 227 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF------- 227 (284)
T ss_dssp EEECCCTTCEESSCCS------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHH-------
T ss_pred EEECcchhheeccccc------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHH-------
Confidence 9999999998765432 123346999999999999999999999999999999999999987432110
Q ss_pred ccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006750 450 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 514 (632)
Q Consensus 450 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 514 (632)
...+....+...++ ..+.+|+.+||+.||.+|||+.++++.|..+....
T Consensus 228 ------------~~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 228 ------------FTDLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp ------------HHHHHTTCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred ------------HHHhhcccccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 00111111122233 34788999999999999999999999999886543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=366.86 Aligned_cols=279 Identities=23% Similarity=0.316 Sum_probs=215.8
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
++|.+.+.||+|+||.||+|.+.. |+.||||+++..........+.+|+++|++++||||+++++++.... ....++
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~~~l 86 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT--TRHKVL 86 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT--TCCEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC--CCeeEE
Confidence 568889999999999999999865 89999999986544455567899999999999999999999987533 336799
Q ss_pred EEEeCCCCChhhhhhcccc-CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEe----cCCCCeEEeccccc
Q 006750 304 VFEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL----DENLNAKITDLGMA 378 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl----~~~~~vkL~DFGla 378 (632)
||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 9999999999999976433 23999999999999999999999998 9999999999999 77888999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhc--------CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhee-
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMV--------GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL- 449 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--------~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~- 449 (632)
+...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.............
T Consensus 164 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 237 (396)
T 4eut_A 164 RELEDDE------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (396)
T ss_dssp EECCCGG------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred eEccCCC------ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence 8765432 1233569999999999875 567889999999999999999999996433211110000
Q ss_pred -ccccccccccccccc--------cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006750 450 -WATPRLQDSGTVISE--------LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 514 (632)
Q Consensus 450 -~~~~~~~~~~~~~~~--------~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 514 (632)
............+.. ..+......++......+.+++.+||+.||++||++.++++.+..++...
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 000000000000000 00111122456788888999999999999999999999999999886553
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=362.65 Aligned_cols=253 Identities=22% Similarity=0.249 Sum_probs=192.2
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
.++|.+.+.||+|+||+||+++.. +++.||||++...... ...+.+|+.++++++||||+++++++.. ....+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~~ 92 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI--DENVQREIINHRSLRHPNIVRFKEVILT----PTHLA 92 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS--CHHHHHHHHHHHHCCCTTBCCEEEEEEC----SSEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc--cHHHHHHHHHHHhCCCCCCCcEEEEEee----CCEEE
Confidence 467889999999999999999986 5899999999765432 3458899999999999999999999875 45789
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCC--eEEecccccee
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN--AKITDLGMAKR 380 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~--vkL~DFGla~~ 380 (632)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||||+.++. +||+|||+++.
T Consensus 93 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 93 IIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 999999999999999653 45999999999999999999999998 999999999999987766 99999999975
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcc-cchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLM-SDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~k-sDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
.... .......||+.|+|||++.+..++.+ +||||||+++|||++|+.||...........
T Consensus 168 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~------------ 229 (361)
T 3uc3_A 168 SVLH------SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRK------------ 229 (361)
T ss_dssp -------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHH------------
T ss_pred cccc------CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHH------------
Confidence 4322 12234569999999999988887665 8999999999999999999975433211110
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+..+.............+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 230 -~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 230 -TIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp -HHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred -HHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0011111111101111223458899999999999999999999874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=366.09 Aligned_cols=253 Identities=23% Similarity=0.308 Sum_probs=197.6
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC--CChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~ 299 (632)
.++|.+.+.||+|+||.||+|+... ++.||||+++.... ......+.+|..+|.++ +||||+++++++.. ..
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~----~~ 126 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT----ES 126 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC----SS
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE----CC
Confidence 3578899999999999999999864 88999999975422 22233478999999887 89999999999875 55
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~ 201 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK 201 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceee
Confidence 789999999999999999754 45999999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||............. ..
T Consensus 202 ~~~~~~-----~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~--------~~ 268 (396)
T 4dc2_A 202 EGLRPG-----DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT--------ED 268 (396)
T ss_dssp CCCCTT-----CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CC--------HH
T ss_pred ecccCC-----CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhh--------HH
Confidence 633221 23345679999999999999999999999999999999999999996432211100000 00
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM 500 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 500 (632)
.....+.... ..+|...+..+.+|+.+||+.||.+||++
T Consensus 269 ~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 269 YLFQVILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred HHHHHHhccc--cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 0000000000 12333344558899999999999999995
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=362.87 Aligned_cols=276 Identities=22% Similarity=0.327 Sum_probs=205.7
Q ss_pred hcCccccceeeee--CceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 224 TDKFSGSNIVGQG--GSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 224 t~~f~~~~~LG~G--~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
.++|++.+.||+| +||.||+|... +|+.||||+++..... .....+.+|+.+|++++||||+++++++.. ..
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~ 99 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA----DN 99 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TT
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE----CC
Confidence 3568889999999 99999999986 5999999999765322 234558889999999999999999999886 45
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..|+||||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||++.
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNL 176 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccce
Confidence 7899999999999999998765566999999999999999999999998 9999999999999999999999999987
Q ss_pred ecccCCC--CCCCCCCCccccCCCCCChhhhhc--CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec-cccc
Q 006750 380 RLKADGL--PSCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW-ATPR 454 (632)
Q Consensus 380 ~~~~~~~--~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~-~~~~ 454 (632)
....... ...........||+.|+|||++.+ ..++.++||||||+++|||++|+.||.............. ..+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 256 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence 6543221 111122334579999999999987 6799999999999999999999999975433221110000 0000
Q ss_pred cccccc-----------------cccc-----cCCC----CCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 455 LQDSGT-----------------VISE-----LPDP----RLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 455 ~~~~~~-----------------~~~~-----~~~~----~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
+..... .... ...+ ......+...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 000000 0000 0000 00011233345568999999999999999999999864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=352.66 Aligned_cols=254 Identities=28% Similarity=0.498 Sum_probs=197.3
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV 304 (632)
++|.+.+.||+|+||.||+|.+. ++.||||++... ...+.|.+|+.+|++++||||+++++++.+ ..++|
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~lv 77 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACLN------PVCLV 77 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCTT------TTEEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC------CcEEE
Confidence 56788899999999999999985 788999998643 345669999999999999999999998763 35899
Q ss_pred EEeCCCCChhhhhhcccc-CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCC-eEEeccccceecc
Q 006750 305 FEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN-AKITDLGMAKRLK 382 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~-vkL~DFGla~~~~ 382 (632)
|||+++|+|.+++..... ..+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||++....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 999999999999975432 24789999999999999999999932223999999999999998887 7999999997654
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 462 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (632)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.||......... ..+. .
T Consensus 158 ~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~----------~ 217 (307)
T 2eva_A 158 TH--------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWA----------V 217 (307)
T ss_dssp ---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH--HHHH----------H
T ss_pred cc--------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH--HHHH----------H
Confidence 22 22345999999999999999999999999999999999999999643221100 0000 0
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 463 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 463 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
.....+.....++ ..+.+|+.+||+.||.+|||+.++++.|..+..
T Consensus 218 ~~~~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 218 HNGTRPPLIKNLP----KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp HTTCCCCCBTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred hcCCCCCcccccC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 0111122222333 448899999999999999999999999998754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=366.01 Aligned_cols=259 Identities=22% Similarity=0.269 Sum_probs=195.3
Q ss_pred hcCcccc-ceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcce
Q 006750 224 TDKFSGS-NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 224 t~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~ 300 (632)
.++|.+. +.||+|+||+||++.+. +|+.||||+++.. ..+.+|+.++.++ +||||+++++++.........
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 3456665 68999999999999876 4899999999632 3478899987555 899999999998754444567
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC---CCCeEEecccc
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLNAKITDLGM 377 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~---~~~vkL~DFGl 377 (632)
.|+||||+++|+|.+++.......+++..+..|+.|++.||.|||+.+ |+||||||+||||+. ++.+||+|||+
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 899999999999999998755556999999999999999999999998 999999999999987 78899999999
Q ss_pred ceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccc
Q 006750 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 457 (632)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~ 457 (632)
++...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||............ ...+.
T Consensus 211 a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---~~~i~- 280 (400)
T 1nxk_A 211 AKETTSHN------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIR- 280 (400)
T ss_dssp CEECC-----------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSH---HHHHH-
T ss_pred ccccCCCC------ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHH---HHHHH-
Confidence 98754321 233457899999999999999999999999999999999999999754322110000 00000
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 458 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
..... +........+..+.+|+.+||+.||.+|||+.++++.-.
T Consensus 281 ----~~~~~---~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 281 ----MGQYE---FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp ----HTCCC---CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred ----cCccc---CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 00000 000011223445889999999999999999999998543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=355.86 Aligned_cols=246 Identities=26% Similarity=0.305 Sum_probs=201.8
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|.+.+.||+|+||.||+++.. +|+.||||+++... .....+.+.+|+.+|+.++||||+++++++.+ ....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~----~~~~ 81 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD----AQQI 81 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC----SSEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe----CCEE
Confidence 56888999999999999999986 59999999997531 12334558899999999999999999999875 4578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~ 156 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV 156 (318)
T ss_dssp EEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred EEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceec
Confidence 9999999999999999753 45899999999999999999999998 999999999999999999999999999875
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus 157 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--------------- 213 (318)
T 1fot_A 157 PDV--------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE--------------- 213 (318)
T ss_dssp SSC--------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---------------
T ss_pred CCc--------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH---------------
Confidence 432 234569999999999999999999999999999999999999996543221110
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQI 506 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 506 (632)
.+....+ .+|...+..+.+|+.+||..||.+|| ++.++++.
T Consensus 214 --~i~~~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 214 --KILNAEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp --HHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --HHHhCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 0000000 12223345588999999999999999 88888753
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=349.78 Aligned_cols=252 Identities=27% Similarity=0.399 Sum_probs=199.0
Q ss_pred hcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
.++|.+.+.||+|+||.||+|.+. |+.||||+++... ..+.|.+|+.++++++||||+++++++.+. ....++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~l 92 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEE---KGGLYI 92 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC-----CCEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC---CCceEE
Confidence 467888999999999999999885 8899999997543 345689999999999999999999987642 335799
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||+++|+|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 999999999999997654444899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVI 462 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (632)
. .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......... .+
T Consensus 170 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~--------------~~ 227 (278)
T 1byg_A 170 T--------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP--------------RV 227 (278)
T ss_dssp --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH--------------HH
T ss_pred c--------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH--------------HH
Confidence 2 122357889999999999999999999999999999998 999996543211100 00
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 463 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 463 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
.....+ ..+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 228 ~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 228 EKGYKM----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp TTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCCCC----CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 111111 122333455889999999999999999999999998773
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=358.37 Aligned_cols=265 Identities=24% Similarity=0.337 Sum_probs=198.9
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC--hHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~--~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
.++|.+.+.||+|+||.||+|.+. +++.||||+++...... ....|.+|+.++++++||||+++++++.........
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 467899999999999999999974 58999999998654332 234689999999999999999999998765544456
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.|+||||+++|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 69999999999999999754 45999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
....... ........||+.|+|||++.+..++.++||||||+++|||++|+.||............
T Consensus 166 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~------------ 231 (311)
T 3ork_A 166 IADSGNS--VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH------------ 231 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH------------
T ss_pred ccccccc--cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH------------
Confidence 6543211 11223456999999999999999999999999999999999999999654322110000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH-HHhhh
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ-ILSTI 510 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~-~L~~i 510 (632)
......+ ........+..+.+|+.+||+.||.+||+..++++ .|..+
T Consensus 232 -~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 232 -VREDPIP--PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp -HHCCCCC--HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -hcCCCCC--cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0000000 00001112345889999999999999997766654 44433
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=366.07 Aligned_cols=250 Identities=28% Similarity=0.375 Sum_probs=201.1
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|.+.+.||+|+||.||++.... ++.||||++.... .......+.+|+.+|+.++||||+++++++.. ....
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~~~~ 90 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD----EEDM 90 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SSEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe----CCEE
Confidence 568889999999999999998764 8999999986432 22334568899999999999999999999876 4578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 91 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp EEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 9999999999999999753 45999999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhc---CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~---~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
... .......||+.|+|||++.. ..++.++||||||+++|||++|+.||...............
T Consensus 166 ~~~------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~------- 232 (384)
T 4fr4_A 166 PRE------TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF------- 232 (384)
T ss_dssp CTT------CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH-------
T ss_pred cCC------CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH-------
Confidence 533 22345679999999999874 45899999999999999999999999743322211111000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT-MSEVVQ 505 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 505 (632)
. .... .+|...+..+.+|+.+||+.||.+||+ +.+|++
T Consensus 233 ----~-~~~~----~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 233 ----E-TTVV----TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ----H-HCCC----CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ----h-hccc----CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0 0001 123334456899999999999999998 666654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=387.07 Aligned_cols=258 Identities=24% Similarity=0.356 Sum_probs=203.2
Q ss_pred cCccccc-eeeeeCceEEEEEEEC---CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 225 DKFSGSN-IVGQGGSSYVYRGQLT---DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 225 ~~f~~~~-~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
+++.+.+ .||+|+||.||+|.+. ++..||||+++........+.|.+|+.+|++++||||+++++++.. ..
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-----~~ 409 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-----EA 409 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-----SS
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-----CC
Confidence 3344444 7999999999999874 4678999999876555566779999999999999999999999864 24
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.++||||+++|+|.++|... ...+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKA 485 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred eEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence 79999999999999999754 345999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
....... ........+|+.|+|||++.+..++.++|||||||+||||++ |+.||...........
T Consensus 486 ~~~~~~~--~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~------------ 551 (613)
T 2ozo_A 486 LGADDSY--YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF------------ 551 (613)
T ss_dssp CC----------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHH------------
T ss_pred ccCCCce--eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH------------
Confidence 6433211 011222346789999999999999999999999999999998 9999975433211100
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
+...... ..+..++..+.+|+..||+.||++||++.+|++.|+.+.
T Consensus 552 --i~~~~~~----~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 552 --IEQGKRM----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp --HHTTCCC----CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --HHcCCCC----CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 0111111 223334455899999999999999999999999998764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=345.76 Aligned_cols=279 Identities=19% Similarity=0.254 Sum_probs=213.0
Q ss_pred hcCccccceeeeeCceEEEEEEE-CCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
.++|.+.+.||+|+||.||+|.. .+|+.||||++...... ..+.+|+.+++.++|++++..+.++... ....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~---~~~~~ 81 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAE---GDYNV 81 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEE---TTEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCC---CCceE
Confidence 46899999999999999999997 46999999998765432 2489999999999999888777766542 45779
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEe---cCCCCeEEeccccce
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAK 379 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl---~~~~~vkL~DFGla~ 379 (632)
+||||+ +++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 82 lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 999999 99999999743 246999999999999999999999998 9999999999999 488899999999998
Q ss_pred ecccCCCCC--CCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccc
Q 006750 380 RLKADGLPS--CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 457 (632)
Q Consensus 380 ~~~~~~~~~--~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~ 457 (632)
......... .........||+.|+|||++.+..++.++||||||+++|||++|+.||................ .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----~ 232 (296)
T 3uzp_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS----E 232 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH----H
T ss_pred cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhc----c
Confidence 776543211 0112345679999999999999999999999999999999999999997543221111000000 0
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCcccccccCcch
Q 006750 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNISLNL 524 (632)
Q Consensus 458 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~ 524 (632)
.......+.+...++ ..+.+|+.+||+.||.+|||+.+|++.|..+...........++|
T Consensus 233 ---~~~~~~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw 292 (296)
T 3uzp_A 233 ---KKMSTPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDW 292 (296)
T ss_dssp ---HHHHSCHHHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGG
T ss_pred ---cccCCchHHHHhhCC----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccc
Confidence 000000001111233 448899999999999999999999999998866554443333433
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=355.46 Aligned_cols=250 Identities=24% Similarity=0.330 Sum_probs=193.3
Q ss_pred hcCccccceeeeeCceEEEEEEE----CCCcEEEEEEeccCCC---CChHHHHHHHHHHHHhcCCCCccceeeeeecccC
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQL----TDGRIVAVKRFKTQGG---PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 296 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~----~~g~~vAVK~l~~~~~---~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 296 (632)
.++|.+.+.||+|+||.||+++. .+|+.||||+++.... ......+.+|+.+|++++||||+++++++..
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--- 92 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT--- 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC---
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc---
Confidence 35688899999999999999987 3689999999976431 2233457899999999999999999999875
Q ss_pred CcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccc
Q 006750 297 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 376 (632)
Q Consensus 297 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFG 376 (632)
....|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 93 -~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg 166 (327)
T 3a62_A 93 -GGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFG 166 (327)
T ss_dssp -SSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCS
T ss_pred -CCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCC
Confidence 45789999999999999999754 45899999999999999999999998 9999999999999999999999999
Q ss_pred cceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccc
Q 006750 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 456 (632)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~ 456 (632)
+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus 167 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---------- 231 (327)
T 3a62_A 167 LCKESIHDG-----TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID---------- 231 (327)
T ss_dssp CC---------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH----------
T ss_pred cccccccCC-----ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHH----------
Confidence 997643321 12234579999999999999999999999999999999999999997543221100
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006750 457 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQI 506 (632)
Q Consensus 457 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 506 (632)
.+.... ..++...+..+.+|+.+||..||.+|| ++.++++.
T Consensus 232 -------~i~~~~--~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 232 -------KILKCK--LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp -------HHHHTC--CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred -------HHHhCC--CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 000000 012223345588999999999999999 77888764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=360.60 Aligned_cols=255 Identities=23% Similarity=0.344 Sum_probs=197.7
Q ss_pred hcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCC--CCccceeeeeecccCCcce
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHH--CHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~H--pniv~l~g~~~~~~~~~~~ 300 (632)
.++|.+.+.||+|+||.||++...+++.||||++..... ......|.+|+.+|++++| |||+++++++.. ...
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~----~~~ 83 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT----DQY 83 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----SSE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee----CCE
Confidence 356888999999999999999988899999999976532 2334568999999999976 999999999875 557
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.|+|||+ .+|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+||||+ ++.+||+|||+++.
T Consensus 84 ~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQ 156 (343)
T ss_dssp EEEEECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred EEEEEeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccc
Confidence 8999995 588999999763 46999999999999999999999998 99999999999997 57899999999987
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhc-----------CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhee
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMV-----------GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 449 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----------~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~ 449 (632)
....... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........
T Consensus 157 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----- 228 (343)
T 3dbq_A 157 MQPDTTS---VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS----- 228 (343)
T ss_dssp C---------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-----
T ss_pred cCccccc---ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH-----
Confidence 6543211 12234579999999999875 6789999999999999999999999964322110
Q ss_pred ccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 450 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 450 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
.+..+.++.....++...+..+.+|+.+||+.||.+|||+.++++...
T Consensus 229 -----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 229 -----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp -----------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred -----------HHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 011111222222233333345889999999999999999999987543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=350.02 Aligned_cols=262 Identities=24% Similarity=0.367 Sum_probs=205.2
Q ss_pred ccccceeeeeCceEEEEEEECC-C---cEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 227 FSGSNIVGQGGSSYVYRGQLTD-G---RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~-g---~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
|...+.||+|+||+||+|.+.+ + ..||||++.........+.|.+|+.++++++||||+++++++... ....+
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~ 99 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP---EGLPH 99 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS---SSCCE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC---CCCcE
Confidence 4556889999999999998643 2 379999998655445556799999999999999999999998752 23448
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||+.+|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 100 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp EEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999999763 355899999999999999999999998 9999999999999999999999999998654
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 462 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (632)
...... ........+|+.|+|||.+.+..++.++||||||+++|+|++|..|+........... .+
T Consensus 176 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~-------------~~ 241 (298)
T 3pls_A 176 DREYYS-VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH-------------FL 241 (298)
T ss_dssp TGGGGC-SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHH-------------HH
T ss_pred CCcccc-cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHH-------------Hh
Confidence 322111 1223345688999999999999999999999999999999997666543322111100 00
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006750 463 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 513 (632)
Q Consensus 463 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 513 (632)
....... .+...+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 242 ~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 242 AQGRRLP----QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp HTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hcCCCCC----CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1111111 1222334588999999999999999999999999987543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=373.56 Aligned_cols=266 Identities=19% Similarity=0.247 Sum_probs=208.7
Q ss_pred ecHHHHHHhhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeee
Q 006750 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291 (632)
Q Consensus 215 ~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~ 291 (632)
+.+.++....++|.+.+.||+|+||+||+|++.+ ++.||||+++... .......+.+|+.+|..++||||+++++++
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3455666778999999999999999999999875 8899999996421 111122388999999999999999999998
Q ss_pred ecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeE
Q 006750 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAK 371 (632)
Q Consensus 292 ~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vk 371 (632)
.+ ....|+||||+++|+|.++|... ...+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+|
T Consensus 144 ~~----~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vk 215 (437)
T 4aw2_A 144 QD----DNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIR 215 (437)
T ss_dssp EC----SSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEE
T ss_pred ee----CCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEE
Confidence 76 55789999999999999999763 245999999999999999999999998 99999999999999999999
Q ss_pred EeccccceecccCCCCCCCCCCCccccCCCCCChhhhh-----cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccch
Q 006750 372 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES 446 (632)
Q Consensus 372 L~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~ 446 (632)
|+|||+++....... .......||+.|+|||++. ...++.++|||||||++|||++|+.||..........
T Consensus 216 L~DFGla~~~~~~~~----~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~ 291 (437)
T 4aw2_A 216 LADFGSCLKLMEDGT----VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 291 (437)
T ss_dssp ECCCTTCEECCTTSC----EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred EcchhhhhhcccCCC----cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHH
Confidence 999999987654321 1123357999999999997 4568999999999999999999999997543221111
Q ss_pred heeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 006750 447 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDA--RPTMSEVVQI 506 (632)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 506 (632)
.... ....+..|.....++ ..+.+|+.+||..+|++ ||++.|+++.
T Consensus 292 ~i~~----------~~~~~~~p~~~~~~s----~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 292 KIMN----------HKERFQFPTQVTDVS----ENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHHT----------HHHHCCCCSSCCCSC----HHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hhhh----------ccccccCCcccccCC----HHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 1000 000111122112233 44888999999888888 9999999874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=346.62 Aligned_cols=277 Identities=19% Similarity=0.246 Sum_probs=208.7
Q ss_pred hhcCccccceeeeeCceEEEEEEE-CCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
..++|.+.+.||+|+||.||+|.. .+++.||||++....... .+.+|+.+++.++|++++..++++... ....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~e~~~l~~l~~~~~i~~~~~~~~~---~~~~ 80 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP---QLHIESKIYKMMQGGVGIPTIRWCGAE---GDYN 80 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CC---CHHHHHHHHHHHTTSTTCCCEEEEEEE---TTEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccch---HHHHHHHHHHHhcCCCCCCeeeeecCC---CCce
Confidence 457899999999999999999997 458999999876543322 388999999999999888887776542 4577
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEe---cCCCCeEEeccccc
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMA 378 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl---~~~~~vkL~DFGla 378 (632)
++||||+ +++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a 155 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence 9999999 99999999753 245999999999999999999999998 9999999999999 78999999999999
Q ss_pred eecccCCCCC--CCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccc
Q 006750 379 KRLKADGLPS--CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 456 (632)
Q Consensus 379 ~~~~~~~~~~--~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~ 456 (632)
+......... .........||+.|+|||++.+..++.++||||||+++|||++|+.||.................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--- 232 (296)
T 4hgt_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE--- 232 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH---
T ss_pred eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhc---
Confidence 8876543211 11223456799999999999999999999999999999999999999975433221111000000
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCcccccccC
Q 006750 457 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNIS 521 (632)
Q Consensus 457 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~ 521 (632)
.......+.+...++ ..+.+|+..||+.||++|||+.+|++.|..+...........
T Consensus 233 ----~~~~~~~~~~~~~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~ 289 (296)
T 4hgt_A 233 ----KKMSTPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYV 289 (296)
T ss_dssp ----HHHHSCHHHHTTTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCC
T ss_pred ----ccccchhhhhhccCC----HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCc
Confidence 000000000111223 458899999999999999999999999998875554333333
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=346.43 Aligned_cols=251 Identities=22% Similarity=0.309 Sum_probs=197.4
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
++|.+.+.||+|+||.||++... ++..||+|++...........+.+|+++|++++||||+++++++.. ....++
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~~l 97 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED----YHNMYI 97 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SSEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec----CCeEEE
Confidence 56888999999999999999875 4899999999876555556779999999999999999999999875 457899
Q ss_pred EEEeCCCCChhhhhhcc--ccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEe---cCCCCeEEeccccc
Q 006750 304 VFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMA 378 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl---~~~~~vkL~DFGla 378 (632)
||||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 99999999999998543 2356999999999999999999999998 9999999999999 45678999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccc
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
+...... ......||+.|+|||++. +.++.++||||||+++|||++|+.||.............+..+
T Consensus 175 ~~~~~~~------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~----- 242 (285)
T 3is5_A 175 ELFKSDE------HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP----- 242 (285)
T ss_dssp CC----------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-----
T ss_pred eecCCcc------cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCc-----
Confidence 8664332 223456999999999875 5789999999999999999999999975432211111100000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.........+ ..+.+|+.+||+.||.+|||+.|+++
T Consensus 243 -------~~~~~~~~~~----~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 243 -------NYAVECRPLT----PQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -------CCCC--CCCC----HHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred -------ccccccCcCC----HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000111123 34788999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=359.78 Aligned_cols=281 Identities=25% Similarity=0.393 Sum_probs=203.5
Q ss_pred hcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHH--HHhcCCCCccceeeeeecc-cCCcce
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDM--LSRLHHCHVVPLVGYCSEF-RGKRAM 300 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~--l~~l~Hpniv~l~g~~~~~-~~~~~~ 300 (632)
.++|.+.+.||+|+||.||+|++ +++.||||++... ....+..|.++ +..++||||+++++++... ......
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 36788899999999999999987 5899999999743 22335555555 4458999999999866542 223446
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhc---------CCCceeecCCCCCCeEecCCCCeE
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA---------AAPRILHRDIKSSNILLDENLNAK 371 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------~~~~iiHrDLKp~NILl~~~~~vk 371 (632)
.++||||+++|+|.+++... ..++..+..++.|++.||+|||+. + |+||||||+||||+.++.+|
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred EEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 78999999999999999653 358999999999999999999998 7 99999999999999999999
Q ss_pred EeccccceecccCCCCC---CCCCCCccccCCCCCChhhhhc-------CCCCcccchHhHhHHHHHHHhCCCCCCCccc
Q 006750 372 ITDLGMAKRLKADGLPS---CSSSPARMQGTFGYFAPEYAMV-------GRASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (632)
Q Consensus 372 L~DFGla~~~~~~~~~~---~~~~~~~~~GT~~Y~APE~~~~-------~~~s~ksDVwSlGviL~eLltG~~P~~~~~~ 441 (632)
|+|||+++......... .........||+.|+|||++.+ ..++.++||||||+++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999998775432211 0112234569999999999976 4567899999999999999999888754332
Q ss_pred cccchhee----cccccccccc-ccccccCCCCCCCCC--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006750 442 KGEESLVL----WATPRLQDSG-TVISELPDPRLKGDF--PKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 514 (632)
Q Consensus 442 ~~~~~~~~----~~~~~~~~~~-~~~~~~~~~~l~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 514 (632)
........ ...+...... ........+.+.... ....+..+.+|+.+||+.||++|||+.|+++.|..+....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 21110000 0000000000 000111122222211 2346667999999999999999999999999999886443
Q ss_pred c
Q 006750 515 S 515 (632)
Q Consensus 515 ~ 515 (632)
.
T Consensus 321 ~ 321 (336)
T 3g2f_A 321 E 321 (336)
T ss_dssp C
T ss_pred H
Confidence 3
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=357.64 Aligned_cols=260 Identities=25% Similarity=0.428 Sum_probs=204.4
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcE--EEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcce
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRI--VAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~--vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~ 300 (632)
++|.+.+.||+|+||.||+|.+. ++.. ||||+++..........+.+|+.+|+++ +||||+++++++.. ...
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----~~~ 100 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----RGY 100 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE----TTE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee----CCc
Confidence 56888899999999999999875 4654 4999998654445555699999999999 99999999999876 457
Q ss_pred EEEEEEeCCCCChhhhhhccc--------------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC
Q 006750 301 RLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 366 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~ 366 (632)
.|+||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGE 177 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECG
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcC
Confidence 899999999999999997532 235999999999999999999999998 999999999999999
Q ss_pred CCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccc
Q 006750 367 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEE 445 (632)
Q Consensus 367 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~ 445 (632)
++.+||+|||+++..... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.........
T Consensus 178 ~~~~kL~Dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~ 251 (327)
T 1fvr_A 178 NYVAKIADFGLSRGQEVY------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 251 (327)
T ss_dssp GGCEEECCTTCEESSCEE------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred CCeEEEcccCcCcccccc------ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH
Confidence 999999999999754321 11223457889999999999889999999999999999998 99999654322110
Q ss_pred hheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCcc
Q 006750 446 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKS 515 (632)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 515 (632)
. .+...... ..+...+..+.+|+.+||..||.+|||+.++++.|..+....+
T Consensus 252 ~--------------~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 252 E--------------KLPQGYRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp H--------------HGGGTCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred H--------------HhhcCCCC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 0 00011111 1222333558899999999999999999999999998865543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=360.02 Aligned_cols=246 Identities=22% Similarity=0.285 Sum_probs=202.4
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|.+.+.||+|+||.||+++.. +|+.||||++.... .......+.+|+.+|+.++||||+++++++.+ ....
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~~ 116 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD----NSNL 116 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc----CCEE
Confidence 57888999999999999999986 58999999986432 12334568899999999999999999999875 4578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 117 ~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~ 191 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceec
Confidence 9999999999999999764 45999999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus 192 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~--------------- 248 (350)
T 1rdq_E 192 KGR--------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE--------------- 248 (350)
T ss_dssp SSC--------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---------------
T ss_pred cCC--------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHH---------------
Confidence 432 234579999999999999999999999999999999999999997543221100
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT-----MSEVVQI 506 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 506 (632)
.+.... ..+|...+..+.+|+.+||+.||.+||+ +.+|++.
T Consensus 249 --~i~~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 249 --KIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp --HHHHCC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred --HHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 000000 0122333455889999999999999998 7887653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=358.82 Aligned_cols=253 Identities=24% Similarity=0.284 Sum_probs=189.1
Q ss_pred HhhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 222 HATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 222 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
.+.++|.+.+.||+|+||.||+|.+.. ++.||||+++... ..+.+.+|+.+|++++||||+++++++.. ...
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~ 122 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFET----PTE 122 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEEC----SSE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEec----CCe
Confidence 346789999999999999999999874 8899999998643 23458899999999999999999999875 457
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC---CCCeEEecccc
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLNAKITDLGM 377 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~---~~~vkL~DFGl 377 (632)
.++||||+++|+|.+++... ..+++.++..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 123 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~ 197 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGL 197 (349)
T ss_dssp EEEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred EEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcc
Confidence 89999999999999999753 45899999999999999999999998 999999999999975 88999999999
Q ss_pred ceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccc
Q 006750 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 457 (632)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~ 457 (632)
++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... .. +.
T Consensus 198 a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~-----i~- 264 (349)
T 2w4o_A 198 SKIVEHQV------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF-RR-----IL- 264 (349)
T ss_dssp ---------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHH-HH-----HH-
T ss_pred ccccCccc------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHH-HH-----HH-
Confidence 98764321 2234569999999999999999999999999999999999999996543221000 00 00
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 458 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.. ............+..+.+|+.+||..||++|||+.++++.
T Consensus 265 -----~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 265 -----NC--EYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp -----TT--CCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -----hC--CCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0000111112334458899999999999999999999874
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=362.25 Aligned_cols=249 Identities=22% Similarity=0.343 Sum_probs=201.3
Q ss_pred hhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCc
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~ 298 (632)
..++|.+.+.||+|+||.||+|+.+ +|+.||||+++... .......+..|..+|..+ +||||+++++++.. .
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~----~ 90 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT----K 90 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC----S
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe----C
Confidence 4578999999999999999999986 48999999997531 123344578899999987 99999999999875 4
Q ss_pred ceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccc
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 378 (632)
...|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhh
Confidence 5789999999999999999754 45999999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccc
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.............
T Consensus 166 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~--------- 231 (345)
T 1xjd_A 166 KENMLGD-----AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR--------- 231 (345)
T ss_dssp BCCCCTT-----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---------
T ss_pred hhcccCC-----CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH---------
Confidence 8643221 12345679999999999999999999999999999999999999997543221110000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS-EVV 504 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 504 (632)
. ..+ .++...+..+.+|+.+||..||.+||++. +|+
T Consensus 232 ----~--~~~----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 232 ----M--DNP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ----H--CCC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ----h--CCC----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 0 011 12223345588999999999999999987 554
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=357.61 Aligned_cols=265 Identities=24% Similarity=0.234 Sum_probs=202.0
Q ss_pred HHHHhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccC----CCCChHHHHHHHHHHHHhcCCCCccceeeeeec
Q 006750 219 ALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQ----GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE 293 (632)
Q Consensus 219 ~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~----~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~ 293 (632)
.+....++|.+.+.||+|+||.||+|... +++.||||++... ........+.+|+.+|++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 35667788999999999999999999875 4889999998643 234555679999999999999999999999875
Q ss_pred ccCCcceEEEEEEeCCCCChhhhhhccc--------------------------------------cCCCCHHHHHHHHH
Q 006750 294 FRGKRAMRLLVFEFMPNGNLRDCLDGVL--------------------------------------VEGMNWDTRVAIAI 335 (632)
Q Consensus 294 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~--------------------------------------~~~l~~~~~~~i~~ 335 (632)
....++||||+++|+|.+++.... ...+++..+..++.
T Consensus 100 ----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 175 (345)
T 3hko_A 100 ----EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR 175 (345)
T ss_dssp ----SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred ----CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence 557899999999999999985211 11145778889999
Q ss_pred HHHHhhHHHHhcCCCceeecCCCCCCeEecCCC--CeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhc--C
Q 006750 336 GAARGLEYLHEAAAPRILHRDIKSSNILLDENL--NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV--G 411 (632)
Q Consensus 336 ~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~--~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~ 411 (632)
|++.||+|||+.+ |+||||||+||||+.++ .+||+|||+++......... ........||+.|+|||++.+ .
T Consensus 176 qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~ 251 (345)
T 3hko_A 176 QIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE-YYGMTTKAGTPYFVAPEVLNTTNE 251 (345)
T ss_dssp HHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC---------CCCGGGCCHHHHTCSSS
T ss_pred HHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccc-cccccccCCCccccCchhhccCCC
Confidence 9999999999998 99999999999998776 89999999998765422111 112344569999999999975 6
Q ss_pred CCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcc
Q 006750 412 RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQ 491 (632)
Q Consensus 412 ~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~ 491 (632)
.++.++||||||+++|||++|+.||............. .... ..........+..+.+|+.+||+
T Consensus 252 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~-------------~~~~--~~~~~~~~~~~~~~~~li~~~l~ 316 (345)
T 3hko_A 252 SYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVL-------------NKKL--CFENPNYNVLSPLARDLLSNLLN 316 (345)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------------HCCC--CTTSGGGGGSCHHHHHHHHHHSC
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH-------------hccc--ccCCcccccCCHHHHHHHHHHcC
Confidence 78999999999999999999999996543321111000 0000 00001111234558899999999
Q ss_pred cCCCCCCCHHHHHHH
Q 006750 492 LDPDARPTMSEVVQI 506 (632)
Q Consensus 492 ~dP~~RPs~~evl~~ 506 (632)
.||.+||++.++++.
T Consensus 317 ~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 317 RNVDERFDAMRALQH 331 (345)
T ss_dssp SCTTTSCCHHHHHHS
T ss_pred CChhHCCCHHHHhcC
Confidence 999999999999873
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=360.51 Aligned_cols=210 Identities=25% Similarity=0.300 Sum_probs=181.6
Q ss_pred eeecHHHHHHhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-----CCCccc
Q 006750 213 IRFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-----HCHVVP 286 (632)
Q Consensus 213 ~~~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~-----Hpniv~ 286 (632)
..+++.......++|.+.+.||+|+||+||+|.+. +++.||||+++.. ......+..|+.+++.+. ||||++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 44555566667789999999999999999999985 5899999999742 233445788999999996 999999
Q ss_pred eeeeeecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC
Q 006750 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 366 (632)
Q Consensus 287 l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~ 366 (632)
+++++.. ....++||||+ +++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||||+.
T Consensus 101 ~~~~~~~----~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~ 172 (360)
T 3llt_A 101 YHGKFMY----YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDD 172 (360)
T ss_dssp EEEEEEE----TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESC
T ss_pred ccceeeE----CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcc
Confidence 9999876 45789999999 999999998765566999999999999999999999998 999999999999975
Q ss_pred -------------------------CCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHh
Q 006750 367 -------------------------NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFS 421 (632)
Q Consensus 367 -------------------------~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwS 421 (632)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Diws 244 (360)
T 3llt_A 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--------HGSIINTRQYRAPEVILNLGWDVSSDMWS 244 (360)
T ss_dssp TTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--------CCSCCSCGGGCCHHHHTTCCCCTTHHHHH
T ss_pred ccccccccchhcccccccccccccCCCCEEEEeccCceecCCC--------CcCccCcccccCcHHHcCCCCCCccchHH
Confidence 788999999999864422 23456899999999999999999999999
Q ss_pred HhHHHHHHHhCCCCCCCcc
Q 006750 422 FGVVLLELITGRQPIHRSI 440 (632)
Q Consensus 422 lGviL~eLltG~~P~~~~~ 440 (632)
||+++|||++|+.||....
T Consensus 245 lG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 245 FGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp HHHHHHHHHHSSCSCCCSS
T ss_pred HHHHHHHHHHCCCCCCCCc
Confidence 9999999999999997543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=351.33 Aligned_cols=274 Identities=25% Similarity=0.336 Sum_probs=202.8
Q ss_pred hhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC----CChHHHHHHHHHHHHhcC---CCCccceeeeeecc
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG----PNADSVFLTEVDMLSRLH---HCHVVPLVGYCSEF 294 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~----~~~~~~f~~Ei~~l~~l~---Hpniv~l~g~~~~~ 294 (632)
..++|++.+.||+|+||+||+|.+. +|+.||||++..... ......+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4678999999999999999999964 589999999874321 122345778888888775 99999999998764
Q ss_pred cCC-cceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEe
Q 006750 295 RGK-RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT 373 (632)
Q Consensus 295 ~~~-~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~ 373 (632)
... ....++||||+. |+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEe
Confidence 322 235799999996 69999998765556999999999999999999999999 9999999999999999999999
Q ss_pred ccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecc--
Q 006750 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA-- 451 (632)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~-- 451 (632)
|||+++..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...............
T Consensus 163 Dfg~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (308)
T 3g33_A 163 DFGLARIYSYQ------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236 (308)
T ss_dssp SCSCTTTSTTC------CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHC
T ss_pred eCccccccCCC------cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999865432 2234567999999999999999999999999999999999999999754432211100000
Q ss_pred cc---ccccccccccccCCCCCCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 452 TP---RLQDSGTVISELPDPRLKG---DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 452 ~~---~~~~~~~~~~~~~~~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+ .+............+.... ......+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 00 0000000000000000000 0111233558899999999999999999999874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=358.83 Aligned_cols=278 Identities=26% Similarity=0.324 Sum_probs=210.6
Q ss_pred cCccccceeeeeCceEEEEEEE-----CCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQL-----TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
++|.+.+.||+|+||.||+|.+ .+++.||||++.... ....+.+.+|++++++++||||+++++++.... ..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~ 99 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPG--RQ 99 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--SC
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC--Cc
Confidence 5688889999999999999984 358899999997642 334456899999999999999999999886432 45
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred eEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 6899999999999999997643 34999999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
........ ........||+.|+|||++.+..++.++||||||+++|+|++|+.||............ +. ......
T Consensus 176 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~-~~-~~~~~~- 250 (327)
T 3lxl_A 176 LLPLDKDY--YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG-CE-RDVPAL- 250 (327)
T ss_dssp ECCTTCSE--EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCHH-
T ss_pred ecccCCcc--ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc-cc-cccccH-
Confidence 76543211 11223345888999999999999999999999999999999999998643321100000 00 000000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 514 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 514 (632)
..+.+..........+...+..+.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 251 SRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 0001111111122233444556899999999999999999999999999886443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=373.38 Aligned_cols=250 Identities=26% Similarity=0.318 Sum_probs=194.5
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccC--CCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQ--GGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
.++|.+.+.||+|+||.||+|... +|+.||||+++.. ........+.+|+.+|+.++||||+++++++.. ...
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~----~~~ 222 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT----HDR 222 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE----TTE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee----CCE
Confidence 467889999999999999999875 4899999999753 223334458899999999999999999999876 457
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHh-cCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+ .+ |+||||||+||||+.++.+||+|||+++
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~ 297 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCK 297 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred EEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCce
Confidence 89999999999999999754 459999999999999999999998 77 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
...... .......||+.|+|||++.+..++.++||||||++||||++|+.||.............
T Consensus 298 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~---------- 362 (446)
T 4ejn_A 298 EGIKDG-----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL---------- 362 (446)
T ss_dssp TTCC----------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----------
T ss_pred eccCCC-----cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHH----------
Confidence 643321 22344679999999999999999999999999999999999999996543221111000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQI 506 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 506 (632)
.. .. .+|...+..+.+|+.+||+.||.+|| ++.|+++.
T Consensus 363 ---~~--~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 363 ---ME--EI----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp ---HC--CC----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---hC--CC----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 00 01 12223345588999999999999999 99999874
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=361.88 Aligned_cols=253 Identities=23% Similarity=0.284 Sum_probs=203.2
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
.++|.+.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.+|++++||||+++++++.+ ....+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFED----KYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC----SSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe----CCEEE
Confidence 467999999999999999999876 58999999997543 2234468999999999999999999999875 45789
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC--CCCeEEecccccee
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE--NLNAKITDLGMAKR 380 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~--~~~vkL~DFGla~~ 380 (632)
+||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 125 lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp EEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEeccccee
Confidence 999999999999999753 235899999999999999999999998 999999999999974 46799999999987
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||............. ..
T Consensus 201 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~--~~------- 265 (387)
T 1kob_A 201 LNPDE------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK--RC------- 265 (387)
T ss_dssp CCTTS------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH--HC-------
T ss_pred cCCCc------ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHH--hC-------
Confidence 65432 2234569999999999999999999999999999999999999997543211100000 00
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
....++. .....+..+.+|+.+||+.||.+|||+.++++.
T Consensus 266 --~~~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 266 --DWEFDED----AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp --CCCCCSS----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --CCCCCcc----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0000111 112233458899999999999999999999874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=358.25 Aligned_cols=274 Identities=20% Similarity=0.209 Sum_probs=201.9
Q ss_pred hcCccccceeeeeCceEEEEEEEC----CCcEEEEEEeccCCCCC----------hHHHHHHHHHHHHhcCCCCccceee
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPN----------ADSVFLTEVDMLSRLHHCHVVPLVG 289 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~~~~----------~~~~f~~Ei~~l~~l~Hpniv~l~g 289 (632)
.++|.+.+.||+|+||.||+|.+. ++..||||++....... ....+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 356888999999999999999986 47889999997653211 1123667888999999999999999
Q ss_pred eeecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCC-
Q 006750 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL- 368 (632)
Q Consensus 290 ~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~- 368 (632)
++..........|+||||+ +++|.+++.... .+++.+++.++.|++.||+|||+.+ |+||||||+||||+.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSST
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCC
Confidence 9987544566889999999 999999997643 6999999999999999999999998 99999999999998887
Q ss_pred -CeEEeccccceecccCCCCCC--CCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccc
Q 006750 369 -NAKITDLGMAKRLKADGLPSC--SSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEE 445 (632)
Q Consensus 369 -~vkL~DFGla~~~~~~~~~~~--~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~ 445 (632)
.+||+|||+++.......... ........||+.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 999999999987754322111 11123457999999999999999999999999999999999999999643221111
Q ss_pred hheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 446 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
..... ..........+..... .. ..+..+.+++..||..||++||++.+|++.|+.+.
T Consensus 270 ~~~~~-~~~~~~~~~~~~~~~~---~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 270 VQTAK-TNLLDELPQSVLKWAP---SG----SSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHH-HHHHHTTTHHHHHHSC---TT----SCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHH-HhhcccccHHHHhhcc---cc----ccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 00000 0000000000000000 00 22345899999999999999999999999998764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=343.65 Aligned_cols=253 Identities=22% Similarity=0.300 Sum_probs=202.9
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
.++|.+.+.||+|+||.||+|.+.. |+.||||++..... ......+.+|+.++++++||||+++++++.. ....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 80 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE----ESFH 80 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC----SSEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc----CCEE
Confidence 5789999999999999999998764 89999999976432 2334568899999999999999999999875 4577
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCC---eEEeccccc
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN---AKITDLGMA 378 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~---vkL~DFGla 378 (632)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||++
T Consensus 81 ~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~ 155 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 155 (284)
T ss_dssp EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence 9999999999999988754 45899999999999999999999998 999999999999976655 999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccc
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...............
T Consensus 156 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~------- 222 (284)
T 3kk8_A 156 IEVNDSE------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG------- 222 (284)
T ss_dssp EECCSSC------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-------
T ss_pred EEcccCc------cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhc-------
Confidence 8765332 223456999999999999999999999999999999999999999654322111100000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
......+ .....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 223 ---~~~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 223 ---AYDYPSP-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp ---CCCCCTT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ---cccCCch-----hhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000111 111223458899999999999999999999874
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=358.92 Aligned_cols=249 Identities=22% Similarity=0.289 Sum_probs=201.6
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~ 299 (632)
.++|.+.+.||+|+||.||+|+... |+.||||+++... .......+..|..+|..+ +||||+++++++.. ..
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~----~~ 94 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT----MD 94 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC----SS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc----CC
Confidence 4679999999999999999999875 8899999997531 123345588999999988 89999999998875 45
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..|+||||++||+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 789999999999999999754 45999999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus 170 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~------------- 231 (353)
T 2i0e_A 170 ENIWDG-----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ------------- 231 (353)
T ss_dssp CCCCTT-----CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------------
T ss_pred ccccCC-----cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHH-------------
Confidence 643221 22345679999999999999999999999999999999999999997543221110
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT-----MSEVVQ 505 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 505 (632)
.+.... ..+|...+..+.+|+.+||..||.+||+ +.+|++
T Consensus 232 ----~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 232 ----SIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ----HHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ----HHHhCC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 000000 0123334455889999999999999995 466654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=364.37 Aligned_cols=253 Identities=23% Similarity=0.346 Sum_probs=197.0
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcC--CCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLH--HCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~--Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|.+.+.||+|+||.||++...+++.||||++..... ......|.+|+.+|++++ ||||+++++++.. ....
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~----~~~~ 131 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT----DQYI 131 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----SSEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec----CCEE
Confidence 45888999999999999999988899999999976532 233456999999999995 5999999999876 4568
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||| +.+++|.+++... ..+++.++..++.||+.||+|||+.+ |+||||||+||||+ ++.+||+|||+++..
T Consensus 132 ~lv~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp EEEEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred EEEEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 99999 5689999999764 46899999999999999999999998 99999999999996 578999999999876
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhc-----------CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMV-----------GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----------~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~ 450 (632)
...... .......||+.|+|||++.+ ..++.++|||||||+||||++|+.||........
T Consensus 205 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~------ 275 (390)
T 2zmd_A 205 QPDTTS---VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS------ 275 (390)
T ss_dssp ------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------
T ss_pred cCCCcc---ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH------
Confidence 543211 12234579999999999875 4689999999999999999999999964322110
Q ss_pred cccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006750 451 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507 (632)
Q Consensus 451 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 507 (632)
.+..+.++.....++...+..+.+|+.+||+.||.+|||+.|+++.-
T Consensus 276 ----------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 276 ----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp ----------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ----------HHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 01111122222222222234588999999999999999999998753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=356.05 Aligned_cols=252 Identities=23% Similarity=0.311 Sum_probs=197.8
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCC--ChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcce
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGP--NADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~--~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~ 300 (632)
++|.+.+.||+|+||.||+|+... ++.||||+++..... .....+.+|..++.++ +||||+++++++.. ...
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~----~~~ 84 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT----ESR 84 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----SSE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe----CCE
Confidence 568889999999999999999864 899999999765322 2334588999999988 89999999999875 457
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~ 159 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 159 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccc
Confidence 89999999999999999754 45999999999999999999999998 99999999999999999999999999986
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||............. ...
T Consensus 160 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~--------~~~ 226 (345)
T 3a8x_A 160 GLRPG-----DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT--------EDY 226 (345)
T ss_dssp SCCTT-----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------C--------HHH
T ss_pred ccCCC-----CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccccc--------HHH
Confidence 43221 22345679999999999999999999999999999999999999996432111000000 000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM 500 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 500 (632)
....+.... ..+|...+..+.+|+.+||+.||.+||++
T Consensus 227 ~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 227 LFQVILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HHHHHHcCC--CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 000000000 11233344558899999999999999995
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=371.04 Aligned_cols=262 Identities=21% Similarity=0.285 Sum_probs=205.7
Q ss_pred HHHHHHhhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeec
Q 006750 217 YSALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE 293 (632)
Q Consensus 217 ~~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~ 293 (632)
+.++....++|.+.+.||+|+||.||+|+... ++.||||+++... .......+.+|+.+|+.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 34555667899999999999999999999864 8999999986421 11112238899999999999999999999875
Q ss_pred ccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEe
Q 006750 294 FRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT 373 (632)
Q Consensus 294 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~ 373 (632)
....|+||||++||+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+
T Consensus 141 ----~~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~ 210 (410)
T 3v8s_A 141 ----DRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLA 210 (410)
T ss_dssp ----SSEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred ----CCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEe
Confidence 5578999999999999999975 35899999999999999999999998 9999999999999999999999
Q ss_pred ccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCC----CCcccchHhHhHHHHHHHhCCCCCCCccccccchhee
Q 006750 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR----ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 449 (632)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~----~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~ 449 (632)
|||+++....... .......||+.|+|||++.+.. ++.++|||||||+||||++|+.||...........+.
T Consensus 211 DFG~a~~~~~~~~----~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 286 (410)
T 3v8s_A 211 DFGTCMKMNKEGM----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286 (410)
T ss_dssp CCTTCEECCTTSE----EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred ccceeEeeccCCc----ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHH
Confidence 9999987654321 1123457999999999998655 7899999999999999999999997543221111000
Q ss_pred ccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 006750 450 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDA--RPTMSEVVQIL 507 (632)
Q Consensus 450 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L 507 (632)
.. ...+..|. ....+..+.+|+.+||..+|.+ ||++.||++.-
T Consensus 287 ~~----------~~~~~~p~-----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 287 NH----------KNSLTFPD-----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp TH----------HHHCCCCT-----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred hc----------cccccCCC-----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 00 00011110 1122345889999999999988 99999998753
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=351.95 Aligned_cols=253 Identities=22% Similarity=0.324 Sum_probs=203.8
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC-----hHHHHHHHHHHHHhcCCCCccceeeeeecccCC
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-----ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~-----~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 297 (632)
.++|.+.+.||+|+||.||+|... +|+.||||+++...... ....+.+|+.+|++++||||+++++++..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 86 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN---- 86 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec----
Confidence 456889999999999999999986 48999999997653322 35669999999999999999999999875
Q ss_pred cceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCC----CeEEe
Q 006750 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL----NAKIT 373 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~----~vkL~ 373 (632)
....++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~ 161 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLI 161 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEc
Confidence 45789999999999999999753 45899999999999999999999998 99999999999999888 79999
Q ss_pred ccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccc
Q 006750 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 453 (632)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~ 453 (632)
|||+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||............
T Consensus 162 Dfg~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i----- 230 (321)
T 2a2a_A 162 DFGLAHEIEDGV------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI----- 230 (321)
T ss_dssp CCTTCEECCTTC------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH-----
T ss_pred cCccceecCccc------cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-----
Confidence 999998765432 223456999999999999999999999999999999999999999654322110000
Q ss_pred ccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 454 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 454 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.... .......+...+..+.+|+.+||..||.+|||+.++++.
T Consensus 231 ---------~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 231 ---------TSVS-YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp ---------HTTC-CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred ---------Hhcc-cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 000000011223458899999999999999999999874
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=361.07 Aligned_cols=270 Identities=17% Similarity=0.230 Sum_probs=205.7
Q ss_pred cCccccceeeeeCceEEEEEEECC---------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccc---------
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD---------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVP--------- 286 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~---------g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~--------- 286 (632)
++|.+.+.||+|+||.||+|.+.. ++.||||++.... .+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~------~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDG------RLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTS------THHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccc------hHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 568889999999999999998764 7899999997542 3889999999999999998
Q ss_pred ------eeeeeecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCC
Q 006750 287 ------LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 360 (632)
Q Consensus 287 ------l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~ 360 (632)
+++++.. .....|+||||+ +++|.+++.......+++.+++.++.|++.||+|||+.+ |+||||||+
T Consensus 116 ~~~i~~~~~~~~~---~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~ 188 (352)
T 2jii_A 116 LLAIPTCMGFGVH---QDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAE 188 (352)
T ss_dssp TCSCCCCCEEEEE---TTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGG
T ss_pred ccCccchhhcccc---CCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHH
Confidence 4455443 245789999999 999999998654566999999999999999999999998 999999999
Q ss_pred CeEecCCC--CeEEeccccceecccCCCCC--CCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCC
Q 006750 361 NILLDENL--NAKITDLGMAKRLKADGLPS--CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 436 (632)
Q Consensus 361 NILl~~~~--~vkL~DFGla~~~~~~~~~~--~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~ 436 (632)
|||++.++ .+||+|||+++......... .........||+.|+|||++.+..++.++||||||++||||++|+.||
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 268 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPW 268 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999998 89999999998765432211 111223457999999999999999999999999999999999999999
Q ss_pred CCccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCcc
Q 006750 437 HRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKS 515 (632)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 515 (632)
............... .+. .....+...... ....+..+.+|+.+||..||.+|||+.+|++.|..+.....
T Consensus 269 ~~~~~~~~~~~~~~~--~~~---~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 269 TNCLPNTEDIMKQKQ--KFV---DKPGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp GGGTTCHHHHHHHHH--HHH---HSCCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ccCCcCHHHHHHHHH--hcc---CChhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 754322111100000 000 000001111000 01123448899999999999999999999999998865443
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=344.70 Aligned_cols=250 Identities=24% Similarity=0.395 Sum_probs=207.1
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
+.|...+.||+|+||.||+|... +++.||||++...........+.+|+.++++++||||+++++++.. ....++
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~l 97 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK----DTKLWI 97 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TTEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec----CCeEEE
Confidence 56888899999999999999875 5899999999876655666779999999999999999999999876 457899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 98 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp EEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred EEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCc
Confidence 9999999999999864 45899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (632)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......... .+.
T Consensus 172 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--------------~~~ 232 (303)
T 3a7i_A 172 TQI-----KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF--------------LIP 232 (303)
T ss_dssp TBC-----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--------------HHH
T ss_pred ccc-----ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHH--------------Hhh
Confidence 321 2234568999999999999999999999999999999999999996533211100 001
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006750 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507 (632)
Q Consensus 464 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 507 (632)
....+.+...++ ..+.+|+.+||+.||.+|||+.++++..
T Consensus 233 ~~~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 233 KNNPPTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp HSCCCCCCSSCC----HHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred cCCCCCCccccC----HHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 111222223344 3488999999999999999999998743
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=348.17 Aligned_cols=259 Identities=24% Similarity=0.350 Sum_probs=202.9
Q ss_pred hcCccccc-eeeeeCceEEEEEEEC---CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCccceeeeeecccCCc
Q 006750 224 TDKFSGSN-IVGQGGSSYVYRGQLT---DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 224 t~~f~~~~-~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 298 (632)
.++|.+.+ .||+|+||.||+|.+. +++.||||+++..... ...+.|.+|+.+++.++||||+++++++. .
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 89 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----A 89 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----S
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC-----C
Confidence 35577777 8999999999999653 3688999999865432 23566999999999999999999999983 3
Q ss_pred ceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccc
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 378 (632)
...++||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 4579999999999999999763 45999999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccc
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQD 457 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 457 (632)
+......... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..........
T Consensus 165 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~----------- 231 (291)
T 1xbb_A 165 KALRADENYY--KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA----------- 231 (291)
T ss_dssp EECCTTCSEE--EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-----------
T ss_pred eeeccCCCcc--cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-----------
Confidence 8765432110 11223346789999999998889999999999999999999 999996543221100
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 458 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
.+.....+. .+...+..+.+++.+||+.||.+||++.++++.|+.+..
T Consensus 232 ---~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 232 ---MLEKGERMG----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp ---HHHTTCCCC----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---HHHcCCCCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 011111111 223334558999999999999999999999999988753
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=348.21 Aligned_cols=262 Identities=23% Similarity=0.326 Sum_probs=196.7
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|.+.+.||+|+||.||+|... +|+.||||+++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~ 107 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE----DNEL 107 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE----TTEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCcE
Confidence 56888999999999999999874 589999999975432 2344568999999999999999999999886 4578
Q ss_pred EEEEEeCCCCChhhhhhcc--ccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 302 LLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
++||||+++|+|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~ 184 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGR 184 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC----
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEecccee
Confidence 9999999999999999653 2345899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||............
T Consensus 185 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~----------- 248 (310)
T 2wqm_A 185 FFSSKT-----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK----------- 248 (310)
T ss_dssp -------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHH-----------
T ss_pred eecCCC-----ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHH-----------
Confidence 664322 1223456899999999999999999999999999999999999999643221100000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 513 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 513 (632)
.+.....+.+. +...+..+.+|+.+||..||.+|||+.+|++.|..+.+.
T Consensus 249 -~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 249 -KIEQCDYPPLP---SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp -HHHTTCSCCCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HhhcccCCCCc---ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 00011111111 122334588999999999999999999999999988543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=353.11 Aligned_cols=262 Identities=20% Similarity=0.284 Sum_probs=205.6
Q ss_pred HHHHHHhhcCcccc-ceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhc-CCCCccceeeeee
Q 006750 217 YSALEHATDKFSGS-NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRL-HHCHVVPLVGYCS 292 (632)
Q Consensus 217 ~~~l~~~t~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~ 292 (632)
+...+...++|.+. +.||+|+||.||+|... +|+.||||+++.... ......+.+|+.++.++ +||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 34455667778877 88999999999999876 489999999975432 23355689999999999 6799999999987
Q ss_pred cccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC---CCC
Q 006750 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLN 369 (632)
Q Consensus 293 ~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~---~~~ 369 (632)
. ....++||||+++|+|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.
T Consensus 100 ~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 100 N----TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp C----SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCC
T ss_pred e----CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCc
Confidence 5 457899999999999999997655567999999999999999999999998 999999999999987 789
Q ss_pred eEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhee
Q 006750 370 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL 449 (632)
Q Consensus 370 vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~ 449 (632)
+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.............
T Consensus 173 ~kL~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 246 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHAC------ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS 246 (327)
T ss_dssp EEECCGGGCEEC---------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EEEeeCccccccCCcc------ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Confidence 9999999998765332 2234569999999999999999999999999999999999999996543221111000
Q ss_pred ccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 450 WATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 450 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.. ............+..+.+|+.+||+.||.+|||+.++++.
T Consensus 247 --------------~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 247 --------------QV-NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp --------------HT-CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred --------------hc-ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 00 0001111122334558899999999999999999999764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=351.93 Aligned_cols=276 Identities=25% Similarity=0.362 Sum_probs=211.6
Q ss_pred HHHHHHhhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHh--cCCCCccceeeeeecc
Q 006750 217 YSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSR--LHHCHVVPLVGYCSEF 294 (632)
Q Consensus 217 ~~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~--l~Hpniv~l~g~~~~~ 294 (632)
+..-....++|.+.+.||+|+||.||+|++ +|+.||||++... ....+.+|++++.. ++||||+++++++...
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~ 108 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKD 108 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence 334455678899999999999999999998 4899999999643 34558889999988 7999999999998875
Q ss_pred cCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHH--------hcCCCceeecCCCCCCeEecC
Q 006750 295 RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLH--------EAAAPRILHRDIKSSNILLDE 366 (632)
Q Consensus 295 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~iiHrDLKp~NILl~~ 366 (632)
.......++||||+++|+|.+++.. ..+++..++.++.|++.||+||| +.+ |+||||||+||||+.
T Consensus 109 ~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 109 NGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKK 182 (342)
T ss_dssp CSSCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECT
T ss_pred CCccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECC
Confidence 4433478999999999999999975 35899999999999999999999 666 999999999999999
Q ss_pred CCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCC------CCcccchHhHhHHHHHHHhC--------
Q 006750 367 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR------ASLMSDVFSFGVVLLELITG-------- 432 (632)
Q Consensus 367 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~------~s~ksDVwSlGviL~eLltG-------- 432 (632)
++.+||+|||+++......... ........||+.|+|||++.+.. ++.++||||||+++|||++|
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTI-DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEE-EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCEEEEECCCceecccccccc-ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 9999999999998765432110 01223456999999999987653 34789999999999999999
Q ss_pred --CCCCCCccccccchheeccccccccccccccccCCCCCCCC-CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006750 433 --RQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGD-FPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 509 (632)
Q Consensus 433 --~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 509 (632)
..||............ +.. ........+.+... .....+..+.+|+.+||+.||++|||+.+|++.|..
T Consensus 262 ~~~~p~~~~~~~~~~~~~-~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~ 333 (342)
T 1b6c_B 262 DYQLPYYDLVPSDPSVEE-MRK-------VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333 (342)
T ss_dssp CCCCTTTTTSCSSCCHHH-HHH-------HHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred ccccCccccCcCcccHHH-HHH-------HHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 6777543221110000 000 00011111221111 123566789999999999999999999999999998
Q ss_pred hCC
Q 006750 510 IAP 512 (632)
Q Consensus 510 i~~ 512 (632)
+..
T Consensus 334 i~~ 336 (342)
T 1b6c_B 334 LSQ 336 (342)
T ss_dssp HHH
T ss_pred HHH
Confidence 753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=342.13 Aligned_cols=255 Identities=26% Similarity=0.321 Sum_probs=205.0
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
.++|++.+.||+|+||.||+|... +++.||||++.........+.+.+|+.+++.++||||+++++++.+ ....+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 81 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE----GNIQY 81 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE----TTEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc----CCEEE
Confidence 467889999999999999999986 5899999999766555566779999999999999999999999875 45779
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 82 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 156 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (276)
T ss_dssp EEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence 999999999999999653 45899999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCC-CcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
.... ........||+.|+|||++.+..+ +.++||||||+++|||++|+.||......... ...|...
T Consensus 157 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~-------- 224 (276)
T 2yex_A 157 YNNR---ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEK-------- 224 (276)
T ss_dssp ETTE---ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHHHHTT--------
T ss_pred CCcc---hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHhhhc--------
Confidence 3321 112234568999999999987664 78999999999999999999999754332111 0111000
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
..........+..+.+|+.+||+.||.+|||+.++++.
T Consensus 225 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 225 -------KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp -------CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -------ccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 00001112234458899999999999999999999763
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=346.50 Aligned_cols=253 Identities=23% Similarity=0.373 Sum_probs=200.1
Q ss_pred hcCccccceeeeeCceEEEEEEECC-C-------cEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeeccc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTD-G-------RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR 295 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~-g-------~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~ 295 (632)
.++|.+.+.||+|+||.||+|.+.. + ..||+|++.... ....+.|.+|+.++++++||||+++++++..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 83 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVC-- 83 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECC--
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe--
Confidence 3568888999999999999998653 3 579999996543 3445669999999999999999999999876
Q ss_pred CCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCC------
Q 006750 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN------ 369 (632)
Q Consensus 296 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~------ 369 (632)
....++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 84 --~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 84 --GDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp --TTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBC
T ss_pred --CCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccc
Confidence 445699999999999999997643 34899999999999999999999998 999999999999998887
Q ss_pred --eEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccch
Q 006750 370 --AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES 446 (632)
Q Consensus 370 --vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~ 446 (632)
+||+|||++..... .....||+.|+|||++.+ ..++.++||||||+++|||++|..|+..........
T Consensus 158 ~~~kl~Dfg~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~ 228 (289)
T 4fvq_A 158 PFIKLSDPGISITVLP---------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL 228 (289)
T ss_dssp CEEEECCCCSCTTTSC---------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred ceeeeccCcccccccC---------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH
Confidence 99999999865432 223468999999999987 779999999999999999999655543322211100
Q ss_pred heeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006750 447 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 513 (632)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 513 (632)
... . ....+....+ ..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus 229 ~~~-------------~--~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 229 QFY-------------E--DRHQLPAPKA----AELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp HHH-------------H--TTCCCCCCSS----CTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred HHh-------------h--ccCCCCCCCC----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 000 0 0011111122 3378899999999999999999999999988654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=355.12 Aligned_cols=262 Identities=24% Similarity=0.354 Sum_probs=204.5
Q ss_pred hcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCC
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 297 (632)
.++|.+.+.||+|+||.||+|.+. +++.||||++...........|.+|+.++++++||||+++++++..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 104 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ---- 104 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC----
Confidence 467888999999999999999842 4779999999765544555679999999999999999999999876
Q ss_pred cceEEEEEEeCCCCChhhhhhcccc-----CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC---CCC
Q 006750 298 RAMRLLVFEFMPNGNLRDCLDGVLV-----EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLN 369 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~~L~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~---~~~ 369 (632)
....|+||||+++|+|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++. +..
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCC
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcce
Confidence 3456999999999999999976432 34899999999999999999999998 999999999999984 456
Q ss_pred eEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchhe
Q 006750 370 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLV 448 (632)
Q Consensus 370 vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~ 448 (632)
+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++ |+.||...........
T Consensus 182 ~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~- 257 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYY---RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF- 257 (327)
T ss_dssp EEECCCHHHHHHHC---------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-
T ss_pred EEECcccccccccccccc---ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHH-
Confidence 999999999865433211 12234568999999999999999999999999999999998 9999865332111000
Q ss_pred eccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006750 449 LWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 513 (632)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 513 (632)
+.....+. .+...+..+.+|+.+||+.||.+||++.++++.|+.+...
T Consensus 258 -------------~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 258 -------------VTSGGRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp -------------HHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -------------HhcCCCCC----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 00111111 1222334588999999999999999999999999887544
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=376.51 Aligned_cols=255 Identities=26% Similarity=0.392 Sum_probs=206.3
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
.++|...+.||+|+||.||+|... +|+.||||++.... .......+.+|+.+|+.++||||+++++++.. ...
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----~~~ 258 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET----KDA 258 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----SSE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee----CCE
Confidence 567999999999999999999986 59999999996431 12334558899999999999999999998875 457
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.|+||||++||+|.+++.......+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEeccccee
Confidence 899999999999999997655556999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||............. .
T Consensus 336 ~~~~~------~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~----------~ 399 (576)
T 2acx_A 336 VPEGQ------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE----------R 399 (576)
T ss_dssp CCTTC------CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH----------H
T ss_pred cccCc------cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH----------H
Confidence 65332 1233579999999999999899999999999999999999999997543221100000 0
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQI 506 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 506 (632)
.+... .. .++...+..+.+|+.+||+.||.+|| ++.||++.
T Consensus 400 ~i~~~-~~----~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 400 LVKEV-PE----EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp HHHHC-CC----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred Hhhcc-cc----cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 00000 11 12333445589999999999999999 78888764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=344.81 Aligned_cols=248 Identities=24% Similarity=0.378 Sum_probs=199.6
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
.++|.+.+.||+|+||.||+|.... ++.||||++.... .......+.+|+.++++++||||+++++++.. ...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 83 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD----ATR 83 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec----CCE
Confidence 4678899999999999999998764 7899999986431 11224558999999999999999999999875 457
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++..
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~ 158 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVH 158 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred EEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEecccccc
Confidence 89999999999999999754 45899999999999999999999998 99999999999999999999999999865
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........
T Consensus 159 ~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------------- 218 (279)
T 3fdn_A 159 APSS-------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR------------- 218 (279)
T ss_dssp C---------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-------------
T ss_pred CCcc-------cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHH-------------
Confidence 4332 22345689999999999999999999999999999999999999964332211100
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
+.. ... .++...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 219 -~~~-~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 219 -ISR-VEF----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -HHH-TCC----CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -HHh-CCC----CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 011 1222334458899999999999999999999974
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=348.02 Aligned_cols=268 Identities=24% Similarity=0.332 Sum_probs=198.3
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCC-hHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~-~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
++|.+.+.||+|+||+||+|.+.. |+.||||++....... ....+.+|+.++++++||||+++++++.. ....+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~ 78 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR----KRRLH 78 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TTEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec----CCeEE
Confidence 678999999999999999999864 8999999987654322 24558899999999999999999999875 45789
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 79 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 79 LVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLT 153 (311)
T ss_dssp EEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence 999999999999988643 45999999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccc-c----
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL-Q---- 456 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~-~---- 456 (632)
... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||................... .
T Consensus 154 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
T 4agu_A 154 GPS-----DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 228 (311)
T ss_dssp -----------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred Ccc-----cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccc
Confidence 322 12234568999999999986 678999999999999999999999997644322111100000000 0
Q ss_pred --cccccc--cccCCCCCCCCC---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 457 --DSGTVI--SELPDPRLKGDF---PKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 457 --~~~~~~--~~~~~~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
...... ..+.++...... ....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 229 VFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000 011111110000 01233458899999999999999999999874
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=344.37 Aligned_cols=253 Identities=24% Similarity=0.354 Sum_probs=200.0
Q ss_pred ccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEE
Q 006750 227 FSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV 304 (632)
|.+.+.||+|+||.||+|.+. ++..||+|++.... .......+.+|+.+|++++||||+++++++..........++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 666788999999999999875 48899999997543 2334456899999999999999999999987655556678999
Q ss_pred EEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEec-CCCCeEEeccccceeccc
Q 006750 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~-~~~~vkL~DFGla~~~~~ 383 (632)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||||+|||++ .++.+||+|||++.....
T Consensus 108 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 9999999999999754 45899999999999999999999875 3499999999999997 789999999999975432
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (632)
. ......||+.|+|||++. +.++.++||||||+++|+|++|+.||.......... .
T Consensus 185 ~-------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----------------~ 240 (290)
T 1t4h_A 185 S-------FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY----------------R 240 (290)
T ss_dssp T-------SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH----------------H
T ss_pred c-------ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH----------------H
Confidence 2 223456999999999876 569999999999999999999999996533221110 0
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 464 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+........++...+..+.+|+.+||+.||.+|||+.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 241 RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp HHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0000000001112222458899999999999999999999863
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=351.99 Aligned_cols=270 Identities=23% Similarity=0.337 Sum_probs=200.4
Q ss_pred HHHHHhhcCccccceeeeeCceEEEEEEECC----CcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeee
Q 006750 218 SALEHATDKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292 (632)
Q Consensus 218 ~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~ 292 (632)
.++....++|.+.+.||+|+||.||+|.+.. ++.||||+++.... ......|.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 3344456788899999999999999998642 45899999976532 233456899999999999999999999987
Q ss_pred cccCC-cceEEEEEEeCCCCChhhhhhcc----ccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCC
Q 006750 293 EFRGK-RAMRLLVFEFMPNGNLRDCLDGV----LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 367 (632)
Q Consensus 293 ~~~~~-~~~~~lV~Ey~~~gsL~~~L~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~ 367 (632)
..... ....++||||+++|+|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCC
Confidence 64321 23569999999999999998432 2345999999999999999999999998 9999999999999999
Q ss_pred CCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccch
Q 006750 368 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEES 446 (632)
Q Consensus 368 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~ 446 (632)
+.+||+|||+++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..||..........
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 260 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYY---RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD 260 (313)
T ss_dssp SCEEECSCSCC-------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CcEEEeecCcceeccccccc---CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH
Confidence 99999999999876543211 12233457889999999999999999999999999999999 888986543221110
Q ss_pred heeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 447 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
. +.....+. .+...+..+.+|+.+||..||.+|||+.++++.|..+.
T Consensus 261 ~--------------~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 261 Y--------------LLHGHRLK----QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp H--------------HHTTCCCC----CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H--------------HHcCCCCC----CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 00011111 22233345889999999999999999999999998875
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=349.26 Aligned_cols=270 Identities=25% Similarity=0.397 Sum_probs=185.9
Q ss_pred HHhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 221 EHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 221 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
....++|.+.+.||+|+||.||+|... +++.||||++...........+.+|+.++++++||||+++++++.. ..
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~ 86 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV----KD 86 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES----SS
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee----cC
Confidence 344578999999999999999999864 5899999998765444445568999999999999999999999876 44
Q ss_pred eEEEEEEeCCCCChhhhhhcc------ccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEe
Q 006750 300 MRLLVFEFMPNGNLRDCLDGV------LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT 373 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~ 373 (632)
..++||||+++|+|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~ 163 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIA 163 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEEC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEE
Confidence 679999999999999998642 2244899999999999999999999998 9999999999999999999999
Q ss_pred ccccceecccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccc
Q 006750 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 452 (632)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~ 452 (632)
|||++...................||+.|+|||++.+ ..++.++||||||+++|||++|+.||................
T Consensus 164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 243 (303)
T 2vwi_A 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND 243 (303)
T ss_dssp CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS
T ss_pred eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC
Confidence 9999976644321111122334579999999999876 578999999999999999999999997543322111000000
Q ss_pred cccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 453 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 453 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
. . .......++.....++ ..+.+|+.+||+.||.+||++.++++.
T Consensus 244 ~--~---~~~~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 244 P--P---SLETGVQDKEMLKKYG----KSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp C--C---CTTC-----CCCCCCC----HHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred C--C---ccccccccchhhhhhh----HHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0 0 0000111122222333 448899999999999999999999873
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=344.72 Aligned_cols=262 Identities=22% Similarity=0.299 Sum_probs=204.1
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
.++|.+.+.||+|+||.||++... +|+.||+|++..... ....+.+.+|+.++++++||||+++++++.... ....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--~~~~ 82 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT--NTTL 82 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG--GTEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC--CceE
Confidence 357888999999999999999986 589999999986532 234456899999999999999999999876432 4478
Q ss_pred EEEEEeCCCCChhhhhhccc--cCCCCHHHHHHHHHHHHHhhHHHHhcC--CCceeecCCCCCCeEecCCCCeEEecccc
Q 006750 302 LLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAA--APRILHRDIKSSNILLDENLNAKITDLGM 377 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDLKp~NILl~~~~~vkL~DFGl 377 (632)
++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 99999999999999997543 234999999999999999999999986 23499999999999999999999999999
Q ss_pred ceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccc
Q 006750 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 457 (632)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~ 457 (632)
++...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||..........
T Consensus 163 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----------- 226 (279)
T 2w5a_A 163 ARILNHDT-----SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG----------- 226 (279)
T ss_dssp HHHC---C-----HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-----------
T ss_pred heeecccc-----ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHH-----------
Confidence 97654321 11123468999999999999999999999999999999999999997543211000
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 458 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
.+.....+. .+...+..+.+++.+||+.||.+||++.+|++.+...
T Consensus 227 ---~i~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 227 ---KIREGKFRR----IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp ---HHHHTCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred ---HHhhccccc----CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 001111111 2223334588999999999999999999999876543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=366.58 Aligned_cols=265 Identities=22% Similarity=0.274 Sum_probs=206.3
Q ss_pred ecHHHHHHhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeee
Q 006750 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291 (632)
Q Consensus 215 ~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~ 291 (632)
+.+.++....++|.+.+.||+|+||.||+++.+ +|+.||||+++... .......+.+|..+|..++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 445566667889999999999999999999986 59999999996421 111222388999999999999999999998
Q ss_pred ecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeE
Q 006750 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAK 371 (632)
Q Consensus 292 ~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vk 371 (632)
.+ ....|+||||+++|+|.++|... ...+++..+..++.|++.||+|||+.+ |+||||||+||||+.++++|
T Consensus 131 ~~----~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vk 202 (412)
T 2vd5_A 131 QD----ENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIR 202 (412)
T ss_dssp EC----SSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEE
T ss_pred ee----CCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEE
Confidence 76 55789999999999999999754 246999999999999999999999998 99999999999999999999
Q ss_pred EeccccceecccCCCCCCCCCCCccccCCCCCChhhhh-------cCCCCcccchHhHhHHHHHHHhCCCCCCCcccccc
Q 006750 372 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM-------VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 444 (632)
Q Consensus 372 L~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-------~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~ 444 (632)
|+|||+++....... .......||+.|+|||++. ...++.++|||||||++|||++|+.||........
T Consensus 203 L~DFGla~~~~~~~~----~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~ 278 (412)
T 2vd5_A 203 LADFGSCLKLRADGT----VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET 278 (412)
T ss_dssp ECCCTTCEECCTTSC----EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred EeechhheeccCCCc----cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH
Confidence 999999987654321 1123457999999999997 35689999999999999999999999975433211
Q ss_pred chheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 006750 445 ESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDAR---PTMSEVVQI 506 (632)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~~ 506 (632)
...+... ......+.....+ +..+.+|+.+||. +|.+| |++.|+++.
T Consensus 279 ~~~i~~~----------~~~~~~p~~~~~~----s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 279 YGKIVHY----------KEHLSLPLVDEGV----PEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHHHTH----------HHHCCCC----CC----CHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHHHhc----------ccCcCCCccccCC----CHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 1100000 0011112111223 3458899999999 99998 589988763
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=338.56 Aligned_cols=247 Identities=24% Similarity=0.308 Sum_probs=198.9
Q ss_pred hhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcc
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~ 299 (632)
..++|.+.+.||+|+||.||+|... +++.||||+++.... ......+.+|+..+..+ +||||+++++++.+ ..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~----~~ 84 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE----DD 84 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE----TT
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec----CC
Confidence 3567899999999999999999986 699999999986533 33445689999999999 99999999999876 45
Q ss_pred eEEEEEEeCCCCChhhhhhcccc--CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC-----------
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLV--EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE----------- 366 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~----------- 366 (632)
..++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~ 161 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEG 161 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccc
Confidence 78999999999999999975432 45899999999999999999999998 999999999999984
Q ss_pred --------CCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCC
Q 006750 367 --------NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIH 437 (632)
Q Consensus 367 --------~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~ 437 (632)
...+||+|||++....... ...||+.|+|||++.+. .++.++||||||+++|||++|..|+.
T Consensus 162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~---------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 232 (289)
T 1x8b_A 162 DEDDWASNKVMFKIGDLGHVTRISSPQ---------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232 (289)
T ss_dssp --------CCCEEECCCTTCEETTCSC---------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred ccccccCCceEEEEcccccccccCCcc---------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 4479999999998765322 23489999999999866 56789999999999999999988764
Q ss_pred CccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 438 RSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
...... .+.....+.+...+ +..+.+|+.+||+.||.+|||+.++++.
T Consensus 233 ~~~~~~-----------------~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 233 NGDQWH-----------------EIRQGRLPRIPQVL----SQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp SSHHHH-----------------HHHTTCCCCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred chhHHH-----------------HHHcCCCCCCCccc----CHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 321100 00111112222223 3458899999999999999999999874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=354.32 Aligned_cols=270 Identities=25% Similarity=0.360 Sum_probs=206.5
Q ss_pred hcCccccceeeeeCceEEEEEEE-CCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQL-TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~-~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
.++|.+.+.||+|+||.||++.. .+|+.||||++.... ......+.+|+.++++++||||+++++++..........+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 46788899999999999999997 469999999986532 3345568999999999999999999999975544466789
Q ss_pred EEEEeCCCCChhhhhhcc--ccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 303 LVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
+||||+++|+|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999999753 2345999999999999999999999998 99999999999999999999999999876
Q ss_pred cccCCCCCC----CCCCCccccCCCCCChhhhhcCC---CCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccc
Q 006750 381 LKADGLPSC----SSSPARMQGTFGYFAPEYAMVGR---ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 453 (632)
Q Consensus 381 ~~~~~~~~~----~~~~~~~~GT~~Y~APE~~~~~~---~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~ 453 (632)
......... ........||+.|+|||++.+.. ++.++||||||+++|||++|+.||.............
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~---- 259 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA---- 259 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH----
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH----
Confidence 532110000 00012245799999999987544 6899999999999999999999995422111110000
Q ss_pred ccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006750 454 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 513 (632)
Q Consensus 454 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 513 (632)
+...... ..+...+..+.+|+.+||+.||.+|||+.++++.|..+.+.
T Consensus 260 --------~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 260 --------VQNQLSI----PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp --------HHCC--C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred --------hhccCCC----CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 0000000 11122334588999999999999999999999999987543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=342.27 Aligned_cols=250 Identities=28% Similarity=0.417 Sum_probs=182.1
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|.+.+.||+|+||.||+|... +|+.||||++.... .......+.+|+.++++++||||+++++++.. ....
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 86 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED----SNYV 86 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC----SSEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc----CCeE
Confidence 56888999999999999999874 69999999996432 12234568999999999999999999999875 4578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 87 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQL 162 (278)
T ss_dssp EEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence 9999999999999999754 245899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 163 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------- 221 (278)
T 3cok_A 163 KMPH-----EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL---------------- 221 (278)
T ss_dssp C---------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------------
T ss_pred cCCC-----CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH----------------
Confidence 4321 1123356899999999999989999999999999999999999999653322110
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
..+.... ...+...+..+.+|+.+||+.||++|||+.++++.
T Consensus 222 -~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 222 -NKVVLAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp ---CCSSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -HHHhhcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 0000000 01222334458899999999999999999999763
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=359.14 Aligned_cols=247 Identities=23% Similarity=0.306 Sum_probs=192.9
Q ss_pred cceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEEeC
Q 006750 230 SNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFM 308 (632)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey~ 308 (632)
.+.||+|+||.||+|... +|+.||||+++... ....+.|.+|+.+|++++||||+++++++.. ....++||||+
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~lv~E~~ 168 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFES----KNDIVLVMEYV 168 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSEEEEEEECC
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEE----CCEEEEEEeCC
Confidence 568999999999999875 58999999998643 2344569999999999999999999999876 45789999999
Q ss_pred CCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEe--cCCCCeEEeccccceecccCCC
Q 006750 309 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL--DENLNAKITDLGMAKRLKADGL 386 (632)
Q Consensus 309 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl--~~~~~vkL~DFGla~~~~~~~~ 386 (632)
++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++......
T Consensus 169 ~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~- 243 (373)
T 2x4f_A 169 DGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE- 243 (373)
T ss_dssp TTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-
Confidence 9999999986532 34899999999999999999999998 9999999999999 667889999999998765432
Q ss_pred CCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccC
Q 006750 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 466 (632)
Q Consensus 387 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (632)
......||+.|+|||++.+..++.++||||||+++|||++|+.||............. .... ..
T Consensus 244 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~--~~~~--------~~- 307 (373)
T 2x4f_A 244 -----KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNIL--ACRW--------DL- 307 (373)
T ss_dssp -----BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--HTCC--------CS-
T ss_pred -----ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hccC--------CC-
Confidence 1223469999999999999999999999999999999999999997543221111000 0000 00
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 467 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 467 ~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+. .....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 308 ~~~----~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 308 EDE----EFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp CSG----GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred Chh----hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 011223458899999999999999999999873
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=359.41 Aligned_cols=267 Identities=24% Similarity=0.347 Sum_probs=204.2
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
.++|.+.+.||+|+||.||+|.+. +++.||+|++...........+.+|+.+|++++||||+++++++.. ....+
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 107 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS----DGEIS 107 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE----TTEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE----CCEEE
Confidence 467889999999999999999986 5899999999876555555679999999999999999999999876 45789
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhc-CCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||++...
T Consensus 108 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp EEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 999999999999999764 4589999999999999999999996 7 999999999999999999999999999765
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecc-------c-c
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA-------T-P 453 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~-------~-~ 453 (632)
.... .....||+.|+|||++.+..++.++||||||+++|||++|+.||............... . +
T Consensus 183 ~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (360)
T 3eqc_A 183 IDSM-------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 255 (360)
T ss_dssp HHHC-----------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------
T ss_pred cccc-------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCC
Confidence 4321 22346999999999999999999999999999999999999999754322110000000 0 0
Q ss_pred cccccc-----------------ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 454 RLQDSG-----------------TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 454 ~~~~~~-----------------~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
...... ..+..+.........+...+..+.+|+.+||+.||.+|||+.++++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000000 00000000000000111234458899999999999999999999874
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=354.71 Aligned_cols=244 Identities=24% Similarity=0.296 Sum_probs=201.0
Q ss_pred hhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC-------hHHHHHHHHHHHHhcCCCCccceeeeeecc
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-------ADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 294 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~-------~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~ 294 (632)
..++|.+.+.||+|+||.||+|.+. +++.||||+++...... ....+.+|+.+|++++||||+++++++..
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~- 100 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN- 100 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC-
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 4578999999999999999999865 58999999998653211 22247889999999999999999999875
Q ss_pred cCCcceEEEEEEeCCCC-ChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEe
Q 006750 295 RGKRAMRLLVFEFMPNG-NLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT 373 (632)
Q Consensus 295 ~~~~~~~~lV~Ey~~~g-sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~ 373 (632)
....++||||+.+| +|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 101 ---~~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~ 172 (335)
T 3dls_A 101 ---QGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLI 172 (335)
T ss_dssp ---SSEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEEC
T ss_pred ---CCEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEe
Confidence 55789999999777 999999754 45999999999999999999999998 9999999999999999999999
Q ss_pred ccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCC-CcccchHhHhHHHHHHHhCCCCCCCccccccchheeccc
Q 006750 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 452 (632)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~ 452 (632)
|||+++...... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.......
T Consensus 173 Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------- 237 (335)
T 3dls_A 173 DFGSAAYLERGK------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV--------- 237 (335)
T ss_dssp CCTTCEECCTTC------CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT---------
T ss_pred ecccceECCCCC------ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH---------
Confidence 999998765432 2334679999999999988776 889999999999999999999996422110
Q ss_pred cccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 453 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 453 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.... ..+...+..+.+|+.+||+.||.+|||+.++++.
T Consensus 238 ----------~~~~------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 ----------EAAI------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----------TTCC------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----------hhcc------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0111123448899999999999999999999885
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=355.73 Aligned_cols=250 Identities=26% Similarity=0.382 Sum_probs=199.5
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC--ChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
.+.|...+.||+|+||.||+|... +|+.||||++...... .....|.+|+.+|++++||||+++++++.. ...
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~ 128 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR----EHT 128 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TTE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE----CCe
Confidence 355888999999999999999874 6899999999764322 223468999999999999999999999876 457
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.++||||+. |+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 129 ~~lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 203 (348)
T 1u5q_A 129 AWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASI 203 (348)
T ss_dssp EEEEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred EEEEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCcee
Confidence 899999996 7898888643 356999999999999999999999998 99999999999999999999999999976
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhh---cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 457 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~ 457 (632)
.... ....||+.|+|||++. .+.++.++||||||+++|||++|+.||...........
T Consensus 204 ~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~---------- 264 (348)
T 1u5q_A 204 MAPA---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH---------- 264 (348)
T ss_dssp SSSB---------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----------
T ss_pred cCCC---------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH----------
Confidence 5432 2346999999999985 56789999999999999999999999965432111000
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 458 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
+.....+.+. +...+..+.+|+.+||+.||.+|||+.++++...
T Consensus 265 ----~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 265 ----IAQNESPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp ----HHHSCCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred ----HHhcCCCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 0000011111 1122344889999999999999999999987543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=353.73 Aligned_cols=253 Identities=25% Similarity=0.325 Sum_probs=199.4
Q ss_pred hhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcce
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~ 300 (632)
..++|.+.+.||+|+||.||++..+ +|+.||||++...... +.+|+++|.++ +||||+++++++.+ ...
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~E~~~l~~~~~hp~iv~~~~~~~~----~~~ 90 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-----PTEEIEILLRYGQHPNIITLKDVYDD----GKY 90 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-----CHHHHHHHHHHTTSTTBCCEEEEEEC----SSE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-----hHHHHHHHHHhcCCCCcCeEEEEEEc----CCE
Confidence 3567999999999999999999986 4899999999765322 46788999888 89999999999875 557
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCC----CCeEEeccc
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN----LNAKITDLG 376 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~----~~vkL~DFG 376 (632)
.|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+.++ +.+||+|||
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 89999999999999999754 45999999999999999999999998 9999999999998443 349999999
Q ss_pred cceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccc
Q 006750 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 456 (632)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~ 456 (632)
+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..........+...
T Consensus 166 ~a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~------ 234 (342)
T 2qr7_A 166 FAKQLRAEN-----GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR------ 234 (342)
T ss_dssp TCEECBCTT-----CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHH------
T ss_pred CcccCcCCC-----CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHH------
Confidence 998765432 122345689999999999988899999999999999999999999975322111111000
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 457 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 457 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
+.. ....+....+...+..+.+|+.+||..||.+||++.++++.
T Consensus 235 -----i~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 235 -----IGS-GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp -----HHH-CCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred -----Hcc-CCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 00011111223344558899999999999999999999874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=348.19 Aligned_cols=262 Identities=22% Similarity=0.295 Sum_probs=198.7
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC--hHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~--~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
.++|.+.+.||+|+||.||+|... +++.||||++....... ....+.+|+.++++++||||+++++++.. ...
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~----~~~ 108 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI----DGQ 108 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE----TTE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee----CCe
Confidence 478999999999999999999976 58999999997543222 23568999999999999999999999876 457
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.|+||||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~ 183 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASA 183 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred EEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence 89999999999999999754 45899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||............
T Consensus 184 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~------------ 247 (309)
T 2h34_A 184 TTDEKL----TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI------------ 247 (309)
T ss_dssp -----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH------------
T ss_pred cccccc----ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh------------
Confidence 654321 1223456999999999999999999999999999999999999999654321100000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhhCCCc
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-TMSEVVQILSTIAPDK 514 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~~~ 514 (632)
......+ ...+...+..+.+++.+||+.||++|| ++.++++.|..+....
T Consensus 248 -~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 248 -NQAIPRP---STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp -HSCCCCG---GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred -ccCCCCc---cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 0000000 011222233488999999999999999 9999999999876554
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=337.09 Aligned_cols=247 Identities=20% Similarity=0.248 Sum_probs=200.9
Q ss_pred hhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
..++|.+.+.||+|+||.||+|.... +..||+|++..... ...+.+.+|++++++++||||+++++++.. ....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~ 81 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFED----NTDI 81 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SSEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEec----CCeE
Confidence 34678999999999999999999865 78999999976533 334569999999999999999999999875 4578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEe---cCCCCeEEeccccc
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMA 378 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl---~~~~~vkL~DFGla 378 (632)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 82 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~ 156 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156 (277)
T ss_dssp EEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccc
Confidence 9999999999999998754 45899999999999999999999998 9999999999999 78899999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccc
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
....... ......||+.|+|||++.+ .++.++||||||+++|||++|+.||.............
T Consensus 157 ~~~~~~~------~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--------- 220 (277)
T 3f3z_A 157 ARFKPGK------MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIR--------- 220 (277)
T ss_dssp EECCTTS------CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---------
T ss_pred eeccCcc------chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHH---------
Confidence 8765432 2234469999999998865 48999999999999999999999996543221110000
Q ss_pred cccccccCCCCCCCCCCH----HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 459 GTVISELPDPRLKGDFPK----EEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.... ..+. ..+..+.+|+.+||+.||.+|||+.++++
T Consensus 221 --------~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 221 --------EGTF--TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp --------HCCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --------hCCC--CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 1111 12345889999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=382.67 Aligned_cols=251 Identities=25% Similarity=0.380 Sum_probs=198.4
Q ss_pred ceeeeeCceEEEEEEEC---CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEE
Q 006750 231 NIVGQGGSSYVYRGQLT---DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~E 306 (632)
+.||+|+||.||+|.+. .++.||||+++.... ....+.|.+|+.+|++++|||||++++++.. ...++|||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----~~~~lv~E 449 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----ESWMLVME 449 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-----SSEEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCEEEEEE
Confidence 47999999999999763 367899999986432 2345679999999999999999999999853 24689999
Q ss_pred eCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCC
Q 006750 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (632)
Q Consensus 307 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 386 (632)
|+++|+|.++|... ..+++..++.|+.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 450 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 450 MAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp CCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred ccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 99999999999753 45999999999999999999999998 99999999999999999999999999987654321
Q ss_pred CCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccccccccccc
Q 006750 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 465 (632)
Q Consensus 387 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (632)
. ........||+.|+|||++.+..++.++||||||++||||++ |+.||.......... .+...
T Consensus 525 ~--~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~--------------~i~~~ 588 (635)
T 4fl3_A 525 Y--YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA--------------MLEKG 588 (635)
T ss_dssp ------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH--------------HHHTT
T ss_pred c--cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH--------------HHHcC
Confidence 1 112233457889999999999999999999999999999998 999996543321110 01111
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 466 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 466 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
... ..+..++..+.+|+..||+.||++||++.+|++.|+.+.
T Consensus 589 ~~~----~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 589 ERM----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp CCC----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCC----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111 223334456899999999999999999999999998763
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=352.30 Aligned_cols=264 Identities=26% Similarity=0.425 Sum_probs=202.1
Q ss_pred ecHHHHHHhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeee
Q 006750 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCS 292 (632)
Q Consensus 215 ~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~ 292 (632)
+++.++....++|.+.+.||+|+||.||+|.+. +|+.||||++.... .....+.+|+.+++++ +||||+++++++.
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc--ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 344455567788999999999999999999985 58999999997543 2345689999999999 8999999999987
Q ss_pred cccC--CcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCe
Q 006750 293 EFRG--KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA 370 (632)
Q Consensus 293 ~~~~--~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~v 370 (632)
.... .....++||||+++|+|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence 5321 1357899999999999999998765567999999999999999999999998 9999999999999999999
Q ss_pred EEeccccceecccCCCCCCCCCCCccccCCCCCChhhhh-----cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccc
Q 006750 371 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEE 445 (632)
Q Consensus 371 kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~ 445 (632)
||+|||++....... .......||+.|+|||++. ...++.++||||||+++|+|++|+.||.........
T Consensus 169 kl~Dfg~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 243 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTV-----GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 243 (326)
T ss_dssp EECCCTTTC------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred EEeeCcCceecCcCc-----cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH
Confidence 999999998654321 1223456999999999987 567899999999999999999999999643321110
Q ss_pred hheeccccccccccccccccCCCCC-CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 446 SLVLWATPRLQDSGTVISELPDPRL-KGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.. +.....+.+ ...++ ..+.+|+.+||..||.+||++.++++.
T Consensus 244 ~~--------------~~~~~~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 244 FL--------------IPRNPAPRLKSKKWS----KKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HH--------------HHHSCCCCCSCSCSC----HHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HH--------------hhcCccccCCccccC----HHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 000011111 11233 458899999999999999999999873
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=363.55 Aligned_cols=269 Identities=21% Similarity=0.257 Sum_probs=196.5
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeeccc--CCcc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR--GKRA 299 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~--~~~~ 299 (632)
.++|.+.+.||+|+||+||+|... +|+.||||++.... .......+.+|+.+|+.++||||+++++++.... ....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467999999999999999999875 48999999997542 2233456889999999999999999999986532 1235
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..|+||||+++ +|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 67999999965 57666643 3899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec--ccc----
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATP---- 453 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~---- 453 (632)
..... .......||+.|+|||++.+..++.++|||||||+||||++|+.||.............. ..+
T Consensus 213 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~ 286 (464)
T 3ttj_A 213 TAGTS------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 286 (464)
T ss_dssp ----C------CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ecCCC------cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 76432 223456799999999999999999999999999999999999999975432111000000 000
Q ss_pred --cccc------------ccccccccCCCCCCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 454 --RLQD------------SGTVISELPDPRLKGD---FPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 454 --~~~~------------~~~~~~~~~~~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+.. ............+... ........+.+|+.+||..||.+|||+.|+++.
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 0000000000000000 011225668999999999999999999999874
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=341.11 Aligned_cols=252 Identities=22% Similarity=0.350 Sum_probs=200.0
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-----ChHHHHHHHHHHHHhcCCCCccceeeeeecccCC
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-----NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-----~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 297 (632)
.++|.+.+.||+|+||.||+|... +|+.||||+++..... ...+.|.+|+.++++++||||+++++++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---- 79 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN---- 79 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC----
Confidence 356889999999999999999986 5899999998754322 135669999999999999999999999875
Q ss_pred cceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCC----CeEEe
Q 006750 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL----NAKIT 373 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~----~vkL~ 373 (632)
....++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++ .+||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~ 154 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLI 154 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred CCeEEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEE
Confidence 45789999999999999999753 45899999999999999999999998 99999999999998877 79999
Q ss_pred ccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccc
Q 006750 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 453 (632)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~ 453 (632)
|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.............
T Consensus 155 dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---- 224 (283)
T 3bhy_A 155 DFGIAHKIEAGN------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS---- 224 (283)
T ss_dssp CCTTCEECC--------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH----
T ss_pred ecccceeccCCC------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhH----
Confidence 999998764322 2234568999999999999999999999999999999999999996543221100000
Q ss_pred ccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 454 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 454 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.. ............+..+.+|+.+||..||.+||++.++++
T Consensus 225 ----------~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 225 ----------AV-NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp ----------TT-CCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----------hc-ccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 00 000000001122345889999999999999999999997
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=363.40 Aligned_cols=256 Identities=25% Similarity=0.307 Sum_probs=192.3
Q ss_pred HHhhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC-------CChHHHHHHHHHHHHhcCCCCccceeeeee
Q 006750 221 EHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG-------PNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292 (632)
Q Consensus 221 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~-------~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~ 292 (632)
....++|.+.+.||+|+||.||+|.... ++.||||++..... ......+.+|+.+|++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3457899999999999999999998764 89999999875321 111123889999999999999999999875
Q ss_pred cccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCC---C
Q 006750 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL---N 369 (632)
Q Consensus 293 ~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~---~ 369 (632)
. ...|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||||+.++ .
T Consensus 211 ~-----~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~ 280 (419)
T 3i6u_A 211 A-----EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCL 280 (419)
T ss_dssp S-----SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCC
T ss_pred c-----CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcce
Confidence 3 3469999999999999998753 45999999999999999999999998 99999999999996544 5
Q ss_pred eEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhc---CCCCcccchHhHhHHHHHHHhCCCCCCCccccccch
Q 006750 370 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES 446 (632)
Q Consensus 370 vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~---~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~ 446 (632)
+||+|||+++..... .......||+.|+|||++.+ ..++.++||||||++||||++|+.||..........
T Consensus 281 ~kl~DFG~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~ 354 (419)
T 3i6u_A 281 IKITDFGHSKILGET------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 354 (419)
T ss_dssp EEECCSSTTTSCC-----------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHH
T ss_pred EEEeecccceecCCC------ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHH
Confidence 999999999876432 12334679999999999853 668899999999999999999999996533221100
Q ss_pred heeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 447 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.. +...... .........+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 355 ~~-------------i~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 355 DQ-------------ITSGKYN-FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HH-------------HHTTCCC-CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HH-------------HhcCCCC-CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00 0000000 0000001223458899999999999999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=354.97 Aligned_cols=280 Identities=21% Similarity=0.272 Sum_probs=204.0
Q ss_pred ecHHHHHHhhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCC----------hHHHHHHHHHHHHhcCCCCc
Q 006750 215 FSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPN----------ADSVFLTEVDMLSRLHHCHV 284 (632)
Q Consensus 215 ~~~~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~----------~~~~f~~Ei~~l~~l~Hpni 284 (632)
....++..+.++|.+.+.||+|+||.||+|...+|+.||||++....... ..+.+.+|+.+|++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 44678899999999999999999999999998889999999996543221 12568999999999999999
Q ss_pred cceeeeeeccc-CCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeE
Q 006750 285 VPLVGYCSEFR-GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNIL 363 (632)
Q Consensus 285 v~l~g~~~~~~-~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NIL 363 (632)
+++++++.... ......|+||||++ |+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 99999986543 23447899999996 7898888753 345999999999999999999999998 999999999999
Q ss_pred ecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCcccc
Q 006750 364 LDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITK 442 (632)
Q Consensus 364 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~ 442 (632)
++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 240 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA------NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240 (362)
T ss_dssp ECTTCCEEECCTTC---------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred EcCCCCEEEEecCccccccccc------ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999999997544321 2234568999999999887 67999999999999999999999999754322
Q ss_pred ccchhe-e------------ccccccccc-cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 443 GEESLV-L------------WATPRLQDS-GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 443 ~~~~~~-~------------~~~~~~~~~-~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
...... . +..+..... ........... ....+......+.+|+.+||+.||.+|||+.|+++.
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 241 NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARA-WTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCC-HHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhh-HHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 110000 0 000000000 00000000000 000111223458899999999999999999999873
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=352.96 Aligned_cols=249 Identities=21% Similarity=0.281 Sum_probs=178.1
Q ss_pred cceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCccceeeeeecccCCcceEEEEEEe
Q 006750 230 SNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRLLVFEF 307 (632)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~~~~~lV~Ey 307 (632)
.+.||+|+||.||+|.+. +|+.||||++... ....+.+|+.+++.+. ||||+++++++.+ ....|+||||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~----~~~~~lv~e~ 87 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHD----QLHTFLVMEL 87 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----SSEEEEEECC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc----CCEEEEEEEc
Confidence 378999999999999986 4899999999643 3455889999999996 9999999999875 5578999999
Q ss_pred CCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCC---CeEEeccccceecccC
Q 006750 308 MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL---NAKITDLGMAKRLKAD 384 (632)
Q Consensus 308 ~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~---~vkL~DFGla~~~~~~ 384 (632)
+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++.....
T Consensus 88 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 88 LNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp CCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 9999999999764 46999999999999999999999998 99999999999997665 7999999999876543
Q ss_pred CCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccc
Q 006750 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 464 (632)
Q Consensus 385 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (632)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||............ ...+..
T Consensus 163 ~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~----------~~~~~~ 227 (325)
T 3kn6_A 163 N-----QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSA----------VEIMKK 227 (325)
T ss_dssp --------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCH----------HHHHHH
T ss_pred C-----CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccH----------HHHHHH
Confidence 2 1233456899999999999999999999999999999999999999754321100000 001111
Q ss_pred cCCCCCC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 465 LPDPRLK--GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 465 ~~~~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
+...... .......+..+.+|+.+||+.||.+|||+.++++.
T Consensus 228 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 228 IKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred HHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 1111111 11112234568999999999999999999998753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=358.69 Aligned_cols=246 Identities=22% Similarity=0.255 Sum_probs=191.0
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC--CChHHHHHHHHHH-HHhcCCCCccceeeeeecccCCcce
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDM-LSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~~f~~Ei~~-l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
++|.+.+.||+|+||.||+|+.+. ++.||||+++.... ......+.+|..+ ++.++||||+++++++.. ...
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~----~~~ 113 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT----ADK 113 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC----SSE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe----CCE
Confidence 568889999999999999999864 88999999975432 2223346677776 567899999999999876 557
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.|+||||++||+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 89999999999999999753 45899999999999999999999998 99999999999999999999999999986
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||............
T Consensus 189 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i------------ 251 (373)
T 2r5t_A 189 NIEHN-----STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI------------ 251 (373)
T ss_dssp GBCCC-----CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHH------------
T ss_pred cccCC-----CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------------
Confidence 43321 2334567999999999999999999999999999999999999999754322111100
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV 503 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 503 (632)
+.. .. .++...+..+.+|+.+||+.||.+||++.+.
T Consensus 252 -~~~--~~----~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 252 -LNK--PL----QLKPNITNSARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp -HHS--CC----CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred -Hhc--cc----CCCCCCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence 000 01 1222233458899999999999999998543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=366.74 Aligned_cols=247 Identities=25% Similarity=0.335 Sum_probs=202.0
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|.+.+.||+|+||.||+|.+. +|+.||||++.... .......+.+|+.+|+.++||||+++++++.. ....
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~----~~~~ 91 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST----PSDI 91 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----CCEE
Confidence 56888999999999999999986 59999999996432 12334568999999999999999999999875 4578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 92 ~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp EEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 9999999999999999753 45999999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCC-CcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
.... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.........
T Consensus 167 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~--------------- 225 (476)
T 2y94_A 167 SDGE------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLF--------------- 225 (476)
T ss_dssp CTTC------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHH---------------
T ss_pred cccc------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHH---------------
Confidence 5432 2234569999999999988765 78999999999999999999999753321110
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
..+.+... ..|...+..+.+|+.+||+.||.+|||+.++++
T Consensus 226 --~~i~~~~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 226 --KKICDGIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp --HHHHTTCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --HHHhcCCc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 00111000 112223345889999999999999999999997
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=342.18 Aligned_cols=249 Identities=26% Similarity=0.412 Sum_probs=203.2
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|.+.+.||+|+||.||++.+.+ ++.||+|++..... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~ 90 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED----NDFV 90 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SSEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc----CCEE
Confidence 568888999999999999999864 88999999875432 2334568999999999999999999999875 4578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 91 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 9999999999999998653 45899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
.... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||............
T Consensus 166 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~------------- 227 (294)
T 2rku_A 166 EYDG-----ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI------------- 227 (294)
T ss_dssp CSTT-----CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-------------
T ss_pred ccCc-----cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------------
Confidence 5332 1223356899999999999989999999999999999999999999654322110000
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.. ... ..+......+.+|+.+||+.||++|||+.++++.
T Consensus 228 -~~-~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 228 -KK-NEY----SIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -HT-TCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -hh-ccC----CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 001 1122233458899999999999999999999874
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=364.16 Aligned_cols=203 Identities=23% Similarity=0.317 Sum_probs=157.2
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCccceeeeeeccc-CCcce
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR-GKRAM 300 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~-~~~~~ 300 (632)
.++|.+.+.||+|+||+||+|.+. +|+.||||++...... .....+.+|+.+|++++||||+++++++.... .....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 367999999999999999999876 5899999999754322 23456899999999999999999999986432 23357
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.|+||||+ +|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchh
Confidence 89999998 68999998753 45999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCC----------------------CCCCCccccCCCCCChhhh-hcCCCCcccchHhHhHHHHHHHhC
Q 006750 381 LKADGLPSC----------------------SSSPARMQGTFGYFAPEYA-MVGRASLMSDVFSFGVVLLELITG 432 (632)
Q Consensus 381 ~~~~~~~~~----------------------~~~~~~~~GT~~Y~APE~~-~~~~~s~ksDVwSlGviL~eLltG 432 (632)
......... .......+||+.|+|||++ ....++.++||||||||||||++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 643221100 0123456789999999986 466799999999999999999994
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=347.93 Aligned_cols=267 Identities=24% Similarity=0.334 Sum_probs=195.8
Q ss_pred hcCcccc-ceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcce
Q 006750 224 TDKFSGS-NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 224 t~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~ 300 (632)
.+.|.+. +.||+|+||.||+|... +++.||||++.... ......+.+|+.+|.++ +||||+++++++.. ...
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~----~~~ 85 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEE----EDR 85 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE----TTE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEee----CCE
Confidence 3567764 78999999999999865 58999999997653 33455689999999995 79999999999876 457
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCC---eEEecccc
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN---AKITDLGM 377 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~---vkL~DFGl 377 (632)
.|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~ 160 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDL 160 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred EEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence 89999999999999999764 45899999999999999999999998 999999999999988776 99999999
Q ss_pred ceecccCCCCC--CCCCCCccccCCCCCChhhhhc-----CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec
Q 006750 378 AKRLKADGLPS--CSSSPARMQGTFGYFAPEYAMV-----GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450 (632)
Q Consensus 378 a~~~~~~~~~~--~~~~~~~~~GT~~Y~APE~~~~-----~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~ 450 (632)
++......... .........||+.|+|||++.. ..++.++||||||+++|||++|+.||......... |
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~----~ 236 (316)
T 2ac3_A 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG----W 236 (316)
T ss_dssp CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC----C
T ss_pred ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc----c
Confidence 98664322110 0112234569999999999875 56889999999999999999999999754322100 1
Q ss_pred ccccccc--ccccccccCCCCCCCCCCH----HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 451 ATPRLQD--SGTVISELPDPRLKGDFPK----EEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 451 ~~~~~~~--~~~~~~~~~~~~l~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
....... .......+..... .++. ..+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 237 DRGEACPACQNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp ----CCHHHHHHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccccchhHHHHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0000000 0000000000100 1121 123458899999999999999999999884
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=345.54 Aligned_cols=261 Identities=26% Similarity=0.339 Sum_probs=196.3
Q ss_pred cCccccceeeeeCceEEEEEEEC--CCc--EEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT--DGR--IVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~--~g~--~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 298 (632)
++|.+.+.||+|+||.||+|.+. +++ .||||+++... .....+.|.+|+.++++++||||+++++++...
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 93 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---- 93 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC----
Confidence 56888899999999999999864 233 69999987543 233456699999999999999999999998752
Q ss_pred ceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccc
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 378 (632)
..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 94 -~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 94 -PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred -CceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccc
Confidence 3689999999999999997643 45899999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccc
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQD 457 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 457 (632)
+......... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||............
T Consensus 169 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~--------- 237 (291)
T 1u46_A 169 RALPQNDDHY--VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI--------- 237 (291)
T ss_dssp EECCC-CCEE--EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH---------
T ss_pred ccccccccch--hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHH---------
Confidence 8765432110 11223457889999999998889999999999999999999 99999654322110000
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006750 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 513 (632)
Q Consensus 458 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 513 (632)
....... ..+...+..+.+++.+||..||.+|||+.++++.|..+.+.
T Consensus 238 ----~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 238 ----DKEGERL----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp ----HTSCCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ----HccCCCC----CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 0000011 11223345588999999999999999999999999987644
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=353.76 Aligned_cols=253 Identities=16% Similarity=0.184 Sum_probs=202.1
Q ss_pred HhhcCccccceeeeeCceEEEEEE------ECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC---CCCccceeeeee
Q 006750 222 HATDKFSGSNIVGQGGSSYVYRGQ------LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH---HCHVVPLVGYCS 292 (632)
Q Consensus 222 ~~t~~f~~~~~LG~G~fG~Vy~~~------~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~---Hpniv~l~g~~~ 292 (632)
...++|.+.+.||+|+||+||+|. ..+++.||||+++.. ....+..|+.++.+++ |+||+++++++.
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 345778999999999999999994 345899999999753 2445888999998886 999999999987
Q ss_pred cccCCcceEEEEEEeCCCCChhhhhhcc---ccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC---
Q 006750 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGV---LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE--- 366 (632)
Q Consensus 293 ~~~~~~~~~~lV~Ey~~~gsL~~~L~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~--- 366 (632)
. ....|+||||+++|+|.+++... ....+++..++.|+.|++.||+|||+.+ |+||||||+||||+.
T Consensus 138 ~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~ 210 (365)
T 3e7e_A 138 F----QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFL 210 (365)
T ss_dssp C----SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGT
T ss_pred c----CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEeccccc
Confidence 6 45679999999999999999643 2345999999999999999999999998 999999999999998
Q ss_pred --------CCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCC
Q 006750 367 --------NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHR 438 (632)
Q Consensus 367 --------~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~ 438 (632)
++.+||+|||+|+....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 211 EQDDEDDLSAGLALIDLGQSIDMKLFPK---GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp CC------CTTEEECCCTTCEEGGGSCT---TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred CccccccccCCEEEeeCchhhhhhccCC---CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 89999999999986543211 1122345699999999999999999999999999999999999999854
Q ss_pred ccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHhhhC
Q 006750 439 SITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDAR-PTMSEVVQILSTIA 511 (632)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~i~ 511 (632)
..... |. +... +. ..+ ....+.+++..|++.+|.+| |++.++.+.|..+.
T Consensus 288 ~~~~~------~~----------~~~~----~~-~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 288 NEGGE------CK----------PEGL----FR-RLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp EETTE------EE----------ECSC----CT-TCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred CCCCc------ee----------echh----cc-ccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 32210 00 0000 00 011 13457789999999999999 78888888887764
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=369.64 Aligned_cols=250 Identities=27% Similarity=0.403 Sum_probs=200.9
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
.++|...+.||+|+||.||+|+.. +|+.||||++.... .......+.+|+.+|++++||||+++++++.. ...
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----~~~ 259 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET----KTD 259 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----SSE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee----CCE
Confidence 367899999999999999999986 49999999996432 12334568899999999999999999998875 457
Q ss_pred EEEEEEeCCCCChhhhhhccc--cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccc
Q 006750 301 RLLVFEFMPNGNLRDCLDGVL--VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 378 (632)
.|+||||++||+|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla 336 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLA 336 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeeccee
Confidence 899999999999999997543 345999999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccc
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||............
T Consensus 337 ~~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~---------- 401 (543)
T 3c4z_A 337 VELKAGQ-----TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL---------- 401 (543)
T ss_dssp EECCTTC-----CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHH----------
T ss_pred eeccCCC-----cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHH----------
Confidence 8765432 1223457999999999999999999999999999999999999999754321110000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM 500 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 500 (632)
...+.... ..+|...+..+.+|+.+||+.||.+||++
T Consensus 402 ---~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 402 ---KQRVLEQA--VTYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp ---HHHHHHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred ---HHHHhhcc--cCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 00000000 11233344558899999999999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=356.05 Aligned_cols=257 Identities=25% Similarity=0.343 Sum_probs=200.9
Q ss_pred hcCccccceeeeeCceEEEEEEE----CCCcEEEEEEeccCC---CCChHHHHHHHHHHHHhc-CCCCccceeeeeeccc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQL----TDGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFR 295 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~----~~g~~vAVK~l~~~~---~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~ 295 (632)
.++|.+.+.||+|+||.||+++. .+|+.||||+++... .......+.+|+.+|+++ +||||+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 130 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 130 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--
Confidence 35788999999999999999987 368999999987432 112233477899999999 79999999998875
Q ss_pred CCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecc
Q 006750 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 375 (632)
Q Consensus 296 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DF 375 (632)
....++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+||
T Consensus 131 --~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Df 203 (355)
T 1vzo_A 131 --ETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDF 203 (355)
T ss_dssp --TTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCS
T ss_pred --CceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeC
Confidence 45789999999999999999754 45999999999999999999999998 999999999999999999999999
Q ss_pred ccceecccCCCCCCCCCCCccccCCCCCChhhhhc--CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccc
Q 006750 376 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 453 (632)
Q Consensus 376 Gla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~ 453 (632)
|+++....... .......||+.|+|||++.+ ..++.++||||||++||||++|+.||............. .
T Consensus 204 G~a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~--~- 276 (355)
T 1vzo_A 204 GLSKEFVADET----ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--R- 276 (355)
T ss_dssp SEEEECCGGGG----GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH--H-
T ss_pred CCCeecccCCC----CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHH--H-
Confidence 99987643221 12234579999999999986 347899999999999999999999996433221110000 0
Q ss_pred ccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHh
Q 006750 454 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQILS 508 (632)
Q Consensus 454 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~ 508 (632)
.+.. ..+ .++...+..+.+|+.+||..||.+|| ++.++++...
T Consensus 277 -------~~~~-~~~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 277 -------RILK-SEP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp -------HHHH-CCC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred -------HHhc-cCC----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 0000 011 12333445588999999999999999 9999987543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=349.46 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=203.8
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
.++|.+.+.||+|+||.||++.+.+ ++.||+|++..... ....+.+.+|+.++++++||||+++++++.+ ...
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~ 115 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED----NDF 115 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SSE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----CCe
Confidence 3568889999999999999999865 88999999875432 2344568999999999999999999999876 457
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.|+||||+++++|.+++... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 116 ~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 116 VFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATK 190 (335)
T ss_dssp EEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCcee
Confidence 89999999999999998753 45899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||............
T Consensus 191 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~------------ 253 (335)
T 2owb_A 191 VEYDG-----ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI------------ 253 (335)
T ss_dssp CCSTT-----CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------------
T ss_pred cccCc-----ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH------------
Confidence 65332 1223456999999999999999999999999999999999999999654321110000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.. .... .+......+.+|+.+||+.||++|||+.++++.
T Consensus 254 --~~-~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 254 --KK-NEYS----IPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp --HH-TCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --hc-CCCC----CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0011 122233458899999999999999999999873
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=350.38 Aligned_cols=268 Identities=22% Similarity=0.348 Sum_probs=193.7
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
++|.+.+.||+|+||+||+|... +++.||||++...........+.+|+.+|++++||||+++++++.. ....++
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~l 77 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT----EKSLTL 77 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC----SSCEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee----CCEEEE
Confidence 57889999999999999999986 5899999999755433322236689999999999999999999875 456799
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||++ |+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 78 v~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 78 VFEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp EEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred Eecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 999996 6999998764 345999999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec--cccc---ccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATPR---LQD 457 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~~---~~~ 457 (632)
.. .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.............. ..+. +..
T Consensus 153 ~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (324)
T 3mtl_A 153 PT-----KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 227 (324)
T ss_dssp ---------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred Cc-----cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchh
Confidence 21 12234568999999999876 5689999999999999999999999976433221110000 0000 000
Q ss_pred c--cccccccCCCCCCCC----CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 458 S--GTVISELPDPRLKGD----FPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 458 ~--~~~~~~~~~~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
. .........+..... ........+.+|+.+||+.||.+|||+.|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp GGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0 000000000000000 011223457899999999999999999999873
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=351.78 Aligned_cols=277 Identities=24% Similarity=0.323 Sum_probs=207.3
Q ss_pred hcCccccceeeeeCceEEEEEEE-----CCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQL-----TDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~-----~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 298 (632)
.++|.+.+.||+|+||.||++.+ .+|+.||||++... .......|.+|+.++++++||||+++++++.... .
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG--R 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC--C
Confidence 35688889999999999999984 35899999999764 3344556999999999999999999999886532 3
Q ss_pred ceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccc
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 378 (632)
...++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred CceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcch
Confidence 36799999999999999997643 45899999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccc
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
+......... .......+|..|+|||++.+..++.++||||||+++|||++|..||....................
T Consensus 193 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~-- 268 (326)
T 2w1i_A 193 KVLPQDKEYY--KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI-- 268 (326)
T ss_dssp EECCSSCSEE--ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHH--
T ss_pred hhcccccccc--ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhh--
Confidence 8765432110 112234577889999999998899999999999999999999999864311100000000000000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
...+.+..........+...+..+.+|+.+||+.||.+|||+.+|++.|+.+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 269 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00000000001111123334455899999999999999999999999998774
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=352.19 Aligned_cols=269 Identities=20% Similarity=0.264 Sum_probs=192.4
Q ss_pred hhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
..++|.+.+.||+|+||+||+|... +++.||||+++..... .....+.+|+.+|++++||||+++++++.. ...
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~ 107 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH----NHR 107 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE----TTE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec----CCE
Confidence 3467999999999999999999865 5899999999755322 223457899999999999999999999876 457
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEe-----cCCCCeEEecc
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL-----DENLNAKITDL 375 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl-----~~~~~vkL~DF 375 (632)
.++||||++ |+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||| +.++.+||+||
T Consensus 108 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 108 LHLIFEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp EEEEEECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred EEEEEecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcC
Confidence 899999996 5999999754 35899999999999999999999998 9999999999999 45556999999
Q ss_pred ccceecccCCCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec--cc
Q 006750 376 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--AT 452 (632)
Q Consensus 376 Gla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~ 452 (632)
|+++...... .......||+.|+|||++.+. .++.++||||||+++|||++|+.||.............. ..
T Consensus 182 g~a~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 256 (329)
T 3gbz_A 182 GLARAFGIPI-----RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGL 256 (329)
T ss_dssp THHHHHC----------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred CCccccCCcc-----cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCC
Confidence 9998764321 123345689999999999874 489999999999999999999999975432211100000 00
Q ss_pred cc---c------ccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 453 PR---L------QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 453 ~~---~------~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
+. + ..............+....+......+.+|+.+||+.||.+|||+.|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 00 0 000000000000000000111133558899999999999999999999873
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=339.36 Aligned_cols=246 Identities=24% Similarity=0.348 Sum_probs=201.4
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|.+.+.||+|+||.||+|... +++.||||++.... .......+.+|+.++++++||||+++++++.. ....
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 89 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD----RKRI 89 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SSEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc----CCEE
Confidence 56888999999999999999986 47899999986431 12234568999999999999999999999875 4578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 90 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHA 164 (284)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccC
Confidence 9999999999999999754 45899999999999999999999998 999999999999999999999999998765
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||............
T Consensus 165 ~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~------------- 224 (284)
T 2vgo_A 165 PSL-------RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI------------- 224 (284)
T ss_dssp SSS-------CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-------------
T ss_pred ccc-------ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHH-------------
Confidence 432 123356899999999999999999999999999999999999999654322110000
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.. .+. .++...+..+.+++.+||+.||.+||++.++++
T Consensus 225 -~~-~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 225 -VN-VDL----KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp -HT-TCC----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -hc-ccc----CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 00 011 122233445889999999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=356.29 Aligned_cols=210 Identities=23% Similarity=0.335 Sum_probs=165.8
Q ss_pred HhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcC-CCCccceeeeeecccCCc
Q 006750 222 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 222 ~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~ 298 (632)
...++|.+.+.||+|+||.||+|.+. +|+.||||++.... .......+.+|+.+|+++. ||||+++++++.... .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~--~ 83 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN--D 83 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT--S
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC--C
Confidence 45678999999999999999999875 58999999986542 2233455889999999996 999999999987532 3
Q ss_pred ceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccc
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 378 (632)
...|+||||++ |+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred CEEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 46799999996 699999875 35899999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCC----------------CCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCcc
Q 006750 379 KRLKADGLP----------------SCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (632)
Q Consensus 379 ~~~~~~~~~----------------~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~ 440 (632)
+........ ..........||+.|+|||++.+ ..++.++|||||||+||||++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 876431110 00112344679999999999986 678999999999999999999999997543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=350.74 Aligned_cols=258 Identities=26% Similarity=0.408 Sum_probs=205.5
Q ss_pred HHHHHHhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC-------hHHHHHHHHHHHHhc-CCCCccce
Q 006750 217 YSALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-------ADSVFLTEVDMLSRL-HHCHVVPL 287 (632)
Q Consensus 217 ~~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~-------~~~~f~~Ei~~l~~l-~Hpniv~l 287 (632)
+.......++|.+.+.||+|+||.||+|.+. +|+.||||++....... ..+.+.+|+.+++++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3445666788999999999999999999986 69999999997653221 134578999999999 89999999
Q ss_pred eeeeecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCC
Q 006750 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 367 (632)
Q Consensus 288 ~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~ 367 (632)
++++.. ....|+||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.+
T Consensus 166 ~~~~~~----~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~ 236 (365)
T 2y7j_A 166 IDSYES----SSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDN 236 (365)
T ss_dssp EEEEEB----SSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTT
T ss_pred EEEEee----CCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC
Confidence 999875 45789999999999999999753 45999999999999999999999998 9999999999999999
Q ss_pred CCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcC------CCCcccchHhHhHHHHHHHhCCCCCCCccc
Q 006750 368 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG------RASLMSDVFSFGVVLLELITGRQPIHRSIT 441 (632)
Q Consensus 368 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~------~~s~ksDVwSlGviL~eLltG~~P~~~~~~ 441 (632)
+.+||+|||++....... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||.....
T Consensus 237 ~~ikl~DfG~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 310 (365)
T 2y7j_A 237 MQIRLSDFGFSCHLEPGE------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ 310 (365)
T ss_dssp CCEEECCCTTCEECCTTC------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCEEEEecCcccccCCCc------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH
Confidence 999999999998765432 22345799999999998743 578999999999999999999999965322
Q ss_pred cccchheeccccccccccccccccCCCCCCCCCC--HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 442 KGEESLVLWATPRLQDSGTVISELPDPRLKGDFP--KEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 442 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
....... .........+ ...+..+.+|+.+||+.||.+|||+.++++.
T Consensus 311 ~~~~~~i-----------------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 311 ILMLRMI-----------------MEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHHHH-----------------HHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHH-----------------HhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1110000 0000000000 1123458899999999999999999999873
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=351.79 Aligned_cols=268 Identities=17% Similarity=0.212 Sum_probs=202.4
Q ss_pred hcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCCh----------------HHHHHHHHHHHHhcCCCCccce
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNA----------------DSVFLTEVDMLSRLHHCHVVPL 287 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~----------------~~~f~~Ei~~l~~l~Hpniv~l 287 (632)
.++|.+.+.||+|+||.||+|.. +|+.||||++........ ...|.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46799999999999999999999 899999999874421111 1669999999999999999999
Q ss_pred eeeeecccCCcceEEEEEEeCCCCChhhh------hhccccCCCCHHHHHHHHHHHHHhhHHHHh-cCCCceeecCCCCC
Q 006750 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDC------LDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSS 360 (632)
Q Consensus 288 ~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~------L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDLKp~ 360 (632)
++++.. ....++||||+++|+|.++ +.......+++..+..++.|++.||.|||+ .+ |+||||||+
T Consensus 109 ~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~ 181 (348)
T 2pml_X 109 EGIITN----YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPS 181 (348)
T ss_dssp SEEEES----SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGG
T ss_pred EEEEee----CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChH
Confidence 999876 4578999999999999999 655435669999999999999999999999 88 999999999
Q ss_pred CeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcC-CCCc-ccchHhHhHHHHHHHhCCCCCCC
Q 006750 361 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASL-MSDVFSFGVVLLELITGRQPIHR 438 (632)
Q Consensus 361 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~-ksDVwSlGviL~eLltG~~P~~~ 438 (632)
|||++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++||||||+++|||++|+.||..
T Consensus 182 Nil~~~~~~~kl~dfg~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 254 (348)
T 2pml_X 182 NILMDKNGRVKLSDFGESEYMVDK-------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254 (348)
T ss_dssp GEEECTTSCEEECCCTTCEECBTT-------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred hEEEcCCCcEEEeccccccccccc-------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999876432 12334689999999999877 5666 99999999999999999999975
Q ss_pred ccccccc-hheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 439 SITKGEE-SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 439 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
....... ......................+..........+..+.+|+.+||+.||.+|||+.++++.
T Consensus 255 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 255 KISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp SSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 4331110 0000000000000000000000000000112334558899999999999999999999873
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=356.28 Aligned_cols=268 Identities=22% Similarity=0.243 Sum_probs=206.0
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC--------CCCccceeeeeecc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH--------HCHVVPLVGYCSEF 294 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~--------Hpniv~l~g~~~~~ 294 (632)
.++|.+.+.||+|+||+||+|... +++.||||+++.. ......+.+|+.+|+.++ |+||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 467999999999999999999875 4899999999743 233456889999999995 78899999998754
Q ss_pred cCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhc-CCCceeecCCCCCCeEecCCC-----
Q 006750 295 RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENL----- 368 (632)
Q Consensus 295 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDLKp~NILl~~~~----- 368 (632)
.......++||||+ +++|.+++.......+++..+..++.|++.||+|||++ + |+||||||+||||+.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 43466889999999 67777777655446699999999999999999999998 8 99999999999998775
Q ss_pred --------------------------------------------CeEEeccccceecccCCCCCCCCCCCccccCCCCCC
Q 006750 369 --------------------------------------------NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 404 (632)
Q Consensus 369 --------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~A 404 (632)
.+||+|||+++..... .....||+.|+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--------~~~~~gt~~y~a 261 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--------FTEDIQTRQYRS 261 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--------SCSCCSCGGGCC
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--------CccCCCCCcccC
Confidence 7999999999876432 233468999999
Q ss_pred hhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccch----h---ee--------------cccccccccccccc
Q 006750 405 PEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES----L---VL--------------WATPRLQDSGTVIS 463 (632)
Q Consensus 405 PE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~----~---~~--------------~~~~~~~~~~~~~~ 463 (632)
||++.+..++.++||||||++||||++|+.||.......... . .. +....+... ..+.
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~-~~~~ 340 (397)
T 1wak_A 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKK-GDLK 340 (397)
T ss_dssp HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTT-SSBS
T ss_pred ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCc-cccc
Confidence 999999999999999999999999999999997543221100 0 00 000000000 0000
Q ss_pred ccCCCCC---------CCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 464 ELPDPRL---------KGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 464 ~~~~~~l---------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+.+... ....+...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 341 HITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp SCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0100000 113466777889999999999999999999999863
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=362.10 Aligned_cols=280 Identities=19% Similarity=0.255 Sum_probs=210.4
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
.++|.+.+.||+|+||.||+|.+. +++.||||++....... .+.+|+++++.|+|++.+..+.++.. .....+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~E~~il~~L~~~~~i~~i~~~~~---~~~~~~ 79 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP---QLLYESKIYRILQGGTGIPNVRWFGV---EGDYNV 79 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC---CHHHHHHHHHHTTTSTTCCCEEEEEE---ETTEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH---HHHHHHHHHHHhcCCCCCCeEEEEEe---eCCEEE
Confidence 467999999999999999999974 58999999987654322 38899999999977555544444332 245779
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEe---cCCCCeEEeccccce
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAK 379 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl---~~~~~vkL~DFGla~ 379 (632)
|||||+ +++|.+++... ...+++.+++.|+.||+.||+|||+.+ |+||||||+|||| +.++.+||+|||+++
T Consensus 80 lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp EEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 999999 99999999753 346999999999999999999999998 9999999999999 688999999999998
Q ss_pred ecccCCCCC--CCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccc
Q 006750 380 RLKADGLPS--CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 457 (632)
Q Consensus 380 ~~~~~~~~~--~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~ 457 (632)
......... .........||+.|+|||++.+..++.++||||||++||||++|+.||..................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~--- 231 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--- 231 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH---
T ss_pred eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc---
Confidence 876543211 112233567999999999999999999999999999999999999999764432211111000000
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCcccccccCcchh
Q 006750 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNISLNLF 525 (632)
Q Consensus 458 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~~~~~~~~~~~ 525 (632)
.+.. ....+...++ ..+.+|+..||+.+|++||++.+|++.|..+...........++|.
T Consensus 232 ---~~~~-~~~~l~~~~p----~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~ 291 (483)
T 3sv0_A 232 ---KVAT-SIEALCRGYP----TEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWT 291 (483)
T ss_dssp ---HHHS-CHHHHHTTSC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHH
T ss_pred ---cccc-cHHHHhcCCc----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCch
Confidence 0000 0000111233 4589999999999999999999999999988765544444444443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=355.42 Aligned_cols=258 Identities=12% Similarity=0.044 Sum_probs=183.5
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC--ChHHHHHHHHHHHHhc--CCCCcccee-------eeee
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRL--HHCHVVPLV-------GYCS 292 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~f~~Ei~~l~~l--~Hpniv~l~-------g~~~ 292 (632)
.+|...+.||+|+||.||+|.+. +|+.||||++...... .....+.+|+.+++.| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45788899999999999999976 5899999999875432 2334577886555555 699988755 2322
Q ss_pred cccC-------------CcceEEEEEEeCCCCChhhhhhccccCCCCHHHH------HHHHHHHHHhhHHHHhcCCCcee
Q 006750 293 EFRG-------------KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTR------VAIAIGAARGLEYLHEAAAPRIL 353 (632)
Q Consensus 293 ~~~~-------------~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~ii 353 (632)
.... .....|+||||++ |+|.+++.... ..+.+..+ ..++.|++.||+|||+++ |+
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---iv 216 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKG---LV 216 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Cc
Confidence 1110 0145799999998 89999997642 23566666 788899999999999998 99
Q ss_pred ecCCCCCCeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhc--CCCCcccchHhHhHHHHHHHh
Q 006750 354 HRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELIT 431 (632)
Q Consensus 354 HrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDVwSlGviL~eLlt 431 (632)
||||||+||||+.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++||||||++||||++
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR--------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCE--------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCC--------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 9999999999999999999999999865421 114457799999999987 679999999999999999999
Q ss_pred CCCCCCCccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 432 GRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 432 G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
|+.||.......... +..... .......+........+..+.+|+.+||+.||++|||+.++++
T Consensus 289 g~~Pf~~~~~~~~~~---~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 289 LFLPFGLVTPGIKGS---WKRPSL-------RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SSCSTTBCCTTCTTC---CCBCCT-------TSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCCcCcccccc---hhhhhh-------hhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999997653321111 110000 0001111111111233455889999999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=338.66 Aligned_cols=252 Identities=25% Similarity=0.371 Sum_probs=196.9
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV 304 (632)
+|.....||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.. ....++|
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~lv 97 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSE----NGFIKIF 97 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEE----TTEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe----CCcEEEE
Confidence 4555678999999999999975 58899999997653 3344568999999999999999999999875 4578999
Q ss_pred EEeCCCCChhhhhhcccc-CCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC-CCCeEEeccccceecc
Q 006750 305 FEFMPNGNLRDCLDGVLV-EGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKITDLGMAKRLK 382 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~-~~~vkL~DFGla~~~~ 382 (632)
|||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174 (295)
T ss_dssp EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccC
Confidence 999999999999976432 34679999999999999999999998 999999999999987 8999999999998764
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCC--CCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGR--ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~--~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
... .......||+.|+|||++.+.. ++.++||||||+++|||++|+.||........... ..
T Consensus 175 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~-------- 238 (295)
T 2clq_A 175 GIN-----PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF---KV-------- 238 (295)
T ss_dssp C----------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH---HH--------
T ss_pred CCC-----CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH---hh--------
Confidence 321 1223456899999999997654 89999999999999999999999964322111000 00
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
......+. .+...+..+.+|+.+||+.||++||++.++++.
T Consensus 239 -~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 239 -GMFKVHPE----IPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp -HHHCCCCC----CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred -cccccccc----ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00011122 223334458899999999999999999999863
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=341.08 Aligned_cols=252 Identities=24% Similarity=0.315 Sum_probs=184.4
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHH-HHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~-f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
.++|++.+.||+|+||.||+|... +|+.||||+++.......... +.++...++.++||||+++++++.. ....
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~----~~~~ 81 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR----EGDV 81 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSSE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec----cCCE
Confidence 467889999999999999999975 589999999976543333333 4444555778899999999999875 4467
Q ss_pred EEEEEeCCCCChhhhhhcc--ccCCCCHHHHHHHHHHHHHhhHHHHhc-CCCceeecCCCCCCeEecCCCCeEEeccccc
Q 006750 302 LLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 378 (632)
++||||++ |+|.+++... ....+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||++
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGIS 157 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC---
T ss_pred EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCc
Confidence 99999996 6998887542 234599999999999999999999998 8 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhh----hcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccc
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYA----MVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 454 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~----~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~ 454 (632)
+...... ......||+.|+|||++ ....++.++||||||+++|||++|+.||............
T Consensus 158 ~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------ 225 (290)
T 3fme_A 158 GYLVDDV------AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ------ 225 (290)
T ss_dssp ------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHH------
T ss_pred ccccccc------cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHH------
Confidence 8765432 12234699999999996 4667899999999999999999999999643221110000
Q ss_pred cccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 455 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 455 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.+... .+.. .+...+..+.+|+.+||+.||.+|||+.++++
T Consensus 226 ------~~~~~-~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 226 ------VVEEP-SPQL---PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ------HHHSC-CCCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ------HhccC-CCCc---ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 00000 1111 11123345889999999999999999999987
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=341.16 Aligned_cols=251 Identities=24% Similarity=0.318 Sum_probs=200.4
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
.++|.+.+.||+|+||.||++... +|+.||||+++.... .....+.+|+.++++++||||+++++++.. ....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYES----TTHYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEEC----SSEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhccc----CCEEE
Confidence 467888999999999999999976 589999999985432 223458999999999999999999999875 45789
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEe---cCCCCeEEeccccce
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAK 379 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl---~~~~~vkL~DFGla~ 379 (632)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 83 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~ 157 (304)
T 2jam_A 83 LVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSK 157 (304)
T ss_dssp EEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred EEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence 999999999999998653 45899999999999999999999998 9999999999999 788999999999987
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||............ .
T Consensus 158 ~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i-------~--- 220 (304)
T 2jam_A 158 MEQNG-------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI-------K--- 220 (304)
T ss_dssp CCCCB-------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------H---
T ss_pred ecCCC-------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-------H---
Confidence 54321 223456999999999999999999999999999999999999999654321110000 0
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.... ......+...+..+.+|+.+||..||.+|||+.++++.
T Consensus 221 ---~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 221 ---EGYY--EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp ---HCCC--CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ---cCCC--CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0000 00111122334558899999999999999999999873
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=354.49 Aligned_cols=271 Identities=23% Similarity=0.323 Sum_probs=197.9
Q ss_pred HHHhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeeccc---
Q 006750 220 LEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR--- 295 (632)
Q Consensus 220 l~~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~--- 295 (632)
++...++|.+.+.||+|+||.||+|.+. +|+.||||++...... +.+|+.+|+.++||||+++++++....
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-----HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 3456788999999999999999999874 5999999999754322 347999999999999999999985432
Q ss_pred -------------------------------CCcceEEEEEEeCCCCChhhhhhcc--ccCCCCHHHHHHHHHHHHHhhH
Q 006750 296 -------------------------------GKRAMRLLVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLE 342 (632)
Q Consensus 296 -------------------------------~~~~~~~lV~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~ 342 (632)
......++||||++ |+|.+.+... ....+++..+..++.|++.||+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 12345789999997 6888887642 2356999999999999999999
Q ss_pred HHHhcCCCceeecCCCCCCeEec-CCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchH
Q 006750 343 YLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVF 420 (632)
Q Consensus 343 yLH~~~~~~iiHrDLKp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVw 420 (632)
|||+.+ |+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+. .++.++|||
T Consensus 156 ~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 226 (383)
T 3eb0_A 156 FIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE------PSVAYICSRFYRAPELMLGATEYTPSIDLW 226 (383)
T ss_dssp HHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS------CCCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred HHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC------CCcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence 999998 99999999999997 68899999999998765432 22345689999999998865 489999999
Q ss_pred hHhHHHHHHHhCCCCCCCccccccchhee--cccccccc---ccccccccCCCCC-----CCCCCHHHHHHHHHHHHHhc
Q 006750 421 SFGVVLLELITGRQPIHRSITKGEESLVL--WATPRLQD---SGTVISELPDPRL-----KGDFPKEEMQIMAYLAKECL 490 (632)
Q Consensus 421 SlGviL~eLltG~~P~~~~~~~~~~~~~~--~~~~~~~~---~~~~~~~~~~~~l-----~~~~~~~~~~~l~~li~~cl 490 (632)
|||+++|||++|+.||............. ...+.... ......+..-+.+ ...++...+..+.+|+.+||
T Consensus 227 slG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 306 (383)
T 3eb0_A 227 SIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL 306 (383)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred hHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence 99999999999999997543221110000 00000000 0000000011111 11123334455889999999
Q ss_pred ccCCCCCCCHHHHHH
Q 006750 491 QLDPDARPTMSEVVQ 505 (632)
Q Consensus 491 ~~dP~~RPs~~evl~ 505 (632)
+.||.+|||+.|+++
T Consensus 307 ~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 307 RYEPDLRINPYEAMA 321 (383)
T ss_dssp CSSGGGSCCHHHHHT
T ss_pred cCChhhCCCHHHHhc
Confidence 999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=346.69 Aligned_cols=271 Identities=24% Similarity=0.334 Sum_probs=195.9
Q ss_pred HhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC----hHHHHHHHHHHHHhcCCCCccceeeeeecccC
Q 006750 222 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN----ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 296 (632)
Q Consensus 222 ~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~----~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 296 (632)
...++|.+.+.||+|+||.||+|.+. +|+.||||++....... ....+.+|+.++++++||||+++++++..
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--- 83 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--- 83 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC---
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee---
Confidence 34578999999999999999999976 48999999997542211 12358899999999999999999999875
Q ss_pred CcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccc
Q 006750 297 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 376 (632)
Q Consensus 297 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFG 376 (632)
....++||||+++ +|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 84 -~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (346)
T 1ua2_A 84 -KSNISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFG 157 (346)
T ss_dssp -TTCCEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCG
T ss_pred -CCceEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecc
Confidence 4467999999975 8998887532 45899999999999999999999998 9999999999999999999999999
Q ss_pred cceecccCCCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec--ccc
Q 006750 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATP 453 (632)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~ 453 (632)
+++...... .......||+.|+|||++.+. .++.++||||||+++|||++|..||.............. ..+
T Consensus 158 ~a~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~ 232 (346)
T 1ua2_A 158 LAKSFGSPN-----RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP 232 (346)
T ss_dssp GGSTTTSCC-----CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred cceeccCCc-----ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 998764322 223345689999999999764 589999999999999999999999865432211100000 000
Q ss_pred ccccccccccccCCCCC---CCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006750 454 RLQDSGTVISELPDPRL---KGDFP-----KEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507 (632)
Q Consensus 454 ~~~~~~~~~~~~~~~~l---~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 507 (632)
.. ..........+... ....+ ...+..+.+|+.+||+.||.+|||+.|+++.-
T Consensus 233 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 233 TE-EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp CT-TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred Ch-hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 00 00000000000000 00011 22335689999999999999999999998753
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=351.82 Aligned_cols=268 Identities=21% Similarity=0.294 Sum_probs=201.2
Q ss_pred HHHHHhhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccC
Q 006750 218 SALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 296 (632)
Q Consensus 218 ~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 296 (632)
.+++...++|.+.+.||+|+||.||+|.+.+ .||||+++.... ....+.|.+|+.++++++||||+++++++..
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--- 100 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS--- 100 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC---
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec---
Confidence 3444556789999999999999999999854 499999875422 2223447899999999999999999999886
Q ss_pred CcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccc
Q 006750 297 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 376 (632)
Q Consensus 297 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFG 376 (632)
....++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++ ++.+||+|||
T Consensus 101 -~~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg 174 (319)
T 2y4i_B 101 -PPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFG 174 (319)
T ss_dssp -SSCEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCS
T ss_pred -CCceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecC
Confidence 44679999999999999999764 245899999999999999999999998 99999999999998 6799999999
Q ss_pred cceecccCCCCCCCCCCCccccCCCCCChhhhhc---------CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchh
Q 006750 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV---------GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL 447 (632)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~---------~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~ 447 (632)
+++..................||+.|+|||++.. ..++.++||||||+++|||++|+.||...........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 254 (319)
T 2y4i_B 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ 254 (319)
T ss_dssp CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH
T ss_pred CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9876543221111223334569999999999874 4579999999999999999999999965432211000
Q ss_pred eeccccccccccccccccCCCCCC-CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006750 448 VLWATPRLQDSGTVISELPDPRLK-GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 514 (632)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 514 (632)
+.....+.+. ..++. .+.+|+.+||..||.+|||+.++++.|..+....
T Consensus 255 --------------~~~~~~~~~~~~~~~~----~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 255 --------------MGTGMKPNLSQIGMGK----EISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp --------------HHTTCCCCCCCSSCCT----THHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred --------------hccCCCCCCCcCCCCH----HHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 0000111111 12233 3889999999999999999999999999886554
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=364.82 Aligned_cols=251 Identities=25% Similarity=0.286 Sum_probs=199.1
Q ss_pred hhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCC------------ChHHHHHHHHHHHHhcCCCCccceee
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGP------------NADSVFLTEVDMLSRLHHCHVVPLVG 289 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~------------~~~~~f~~Ei~~l~~l~Hpniv~l~g 289 (632)
..++|.+.+.||+|+||+||+|.... ++.||||++...... ...+.+.+|+.+|++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45789999999999999999999864 889999999754321 33456899999999999999999999
Q ss_pred eeecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCC-
Q 006750 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL- 368 (632)
Q Consensus 290 ~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~- 368 (632)
++.. ....|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 114 ~~~~----~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~ 184 (504)
T 3q5i_A 114 VFED----KKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNS 184 (504)
T ss_dssp EEEC----SSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTC
T ss_pred EEEc----CCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCC
Confidence 9875 55789999999999999998654 45999999999999999999999998 99999999999998776
Q ss_pred --CeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccch
Q 006750 369 --NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES 446 (632)
Q Consensus 369 --~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~ 446 (632)
.+||+|||+++...... ......||+.|+|||++. +.++.++||||||+++|+|++|+.||..........
T Consensus 185 ~~~~kl~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 257 (504)
T 3q5i_A 185 LLNIKIVDFGLSSFFSKDY------KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIK 257 (504)
T ss_dssp CSSEEECCCTTCEECCTTS------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CccEEEEECCCCEEcCCCC------ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 69999999998765432 223456999999999876 568999999999999999999999997543321111
Q ss_pred heeccccccccccccccccCCCCCCCCC--CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 447 LVLWATPRLQDSGTVISELPDPRLKGDF--PKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+ ......... ....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 258 ~i-----------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 258 KV-----------------EKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HH-----------------HHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HH-----------------HcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00 000000000 01223458899999999999999999999863
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=359.08 Aligned_cols=247 Identities=16% Similarity=0.190 Sum_probs=188.1
Q ss_pred hhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccC--CCCChHHHHHHHH---HHHHhcCCCCccceeeee-----
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQ--GGPNADSVFLTEV---DMLSRLHHCHVVPLVGYC----- 291 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~--~~~~~~~~f~~Ei---~~l~~l~Hpniv~l~g~~----- 291 (632)
..++|.+.+.||+|+||.||+|.+. +|+.||||++... ......+.|.+|+ .+|++++||||+++++.+
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 3467888999999999999999964 5999999999754 2334456799999 455566899999998433
Q ss_pred --ecccC--------Cc-----ceEEEEEEeCCCCChhhhhhcccc-----CCCCHHHHHHHHHHHHHhhHHHHhcCCCc
Q 006750 292 --SEFRG--------KR-----AMRLLVFEFMPNGNLRDCLDGVLV-----EGMNWDTRVAIAIGAARGLEYLHEAAAPR 351 (632)
Q Consensus 292 --~~~~~--------~~-----~~~~lV~Ey~~~gsL~~~L~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 351 (632)
..... .. ...|+||||+ +|+|.+++..... ..+++..++.|+.|++.||+|||+.+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 32110 00 1378999999 6899999975321 11346888999999999999999998
Q ss_pred eeecCCCCCCeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcC-----------CCCcccchH
Q 006750 352 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-----------RASLMSDVF 420 (632)
Q Consensus 352 iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-----------~~s~ksDVw 420 (632)
|+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dvw 297 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAW 297 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC--------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC--------cccCCCC-cCccChhhhcccccccccccccccCChhhhHH
Confidence 99999999999999999999999999986432 1223457 999999999887 899999999
Q ss_pred hHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH
Q 006750 421 SFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM 500 (632)
Q Consensus 421 SlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 500 (632)
|||++||||++|+.||......... ..+... ...++ ..+.+|+.+||+.||++|||+
T Consensus 298 SlG~il~elltg~~Pf~~~~~~~~~-----------------~~~~~~--~~~~~----~~~~~li~~~L~~dp~~Rpt~ 354 (377)
T 3byv_A 298 ALGLVIYWIWCADLPITKDAALGGS-----------------EWIFRS--CKNIP----QPVRALLEGFLRYPKEDRLLP 354 (377)
T ss_dssp HHHHHHHHHHHSSCCC------CCS-----------------GGGGSS--CCCCC----HHHHHHHHHHTCSSGGGCCCH
T ss_pred HHHHHHHHHHHCCCCCcccccccch-----------------hhhhhh--ccCCC----HHHHHHHHHHcCCCchhCCCH
Confidence 9999999999999999643322110 000000 01233 348899999999999999999
Q ss_pred HHHHH
Q 006750 501 SEVVQ 505 (632)
Q Consensus 501 ~evl~ 505 (632)
.++++
T Consensus 355 ~e~l~ 359 (377)
T 3byv_A 355 LQAME 359 (377)
T ss_dssp HHHHT
T ss_pred HHHhh
Confidence 99986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=365.16 Aligned_cols=252 Identities=24% Similarity=0.315 Sum_probs=203.1
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC--CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~--~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
.++|.+.+.||+|+||.||+|... +|+.||||++..... ......+.+|+.+|++++||||+++++++.. ...
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~ 100 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED----KGY 100 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe----CCE
Confidence 467889999999999999999986 589999999975432 3345669999999999999999999999876 557
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEe---cCCCCeEEecccc
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGM 377 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl---~~~~~vkL~DFGl 377 (632)
.|+||||+.+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+
T Consensus 101 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp EEEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 89999999999999998753 45999999999999999999999998 9999999999999 5678999999999
Q ss_pred ceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccc
Q 006750 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 457 (632)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~ 457 (632)
++...... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||...........+..
T Consensus 176 a~~~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~------- 241 (484)
T 3nyv_A 176 STHFEASK------KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------- 241 (484)
T ss_dssp HHHBCCCC------SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------
T ss_pred eEEccccc------ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc-------
Confidence 98764321 2334569999999998875 699999999999999999999999975432211110000
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 458 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
... ....+.....+..+.+|+.+||+.||.+|||+.++++.
T Consensus 242 ------~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 242 ------GKY--TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp ------CCC--CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------CCC--CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 000 00001112334558899999999999999999999973
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=363.70 Aligned_cols=251 Identities=24% Similarity=0.317 Sum_probs=195.9
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
.++|.+.+.||+|+||+||+|... ++..||||++.... .......+.+|+.+|+.++||||+++++++.. ....
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~ 111 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED----KRNY 111 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe----CCEE
Confidence 456889999999999999999986 58999999997543 23334568999999999999999999999875 4578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCC---CCeEEeccccc
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN---LNAKITDLGMA 378 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~---~~vkL~DFGla 378 (632)
|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.+ +.+||+|||++
T Consensus 112 ~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 9999999999999988654 45899999999999999999999998 9999999999999764 45999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccc
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
+...... ......||+.|+|||++. +.++.++||||||+++|+|++|+.||................
T Consensus 187 ~~~~~~~------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~------ 253 (494)
T 3lij_A 187 AVFENQK------KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGK------ 253 (494)
T ss_dssp EECBTTB------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------
T ss_pred eECCCCc------cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------
Confidence 8765432 223456999999999876 569999999999999999999999997543321111000000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.....+. ....+..+.+|+.+||+.||.+|||+.++++
T Consensus 254 ----~~~~~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 254 ----YTFDSPE-----WKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp ----CCCCSGG-----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----CCCCchh-----cccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 0000000 1122345889999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=335.63 Aligned_cols=248 Identities=24% Similarity=0.300 Sum_probs=193.8
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|.+.+.||+|+||.||+|.+. +|+.||||++.... .......+.+|+.+++.++||||+++++++.. ....
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~ 86 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST----PTDF 86 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SSEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec----CCeE
Confidence 57888999999999999999986 59999999986432 22334568999999999999999999999875 4578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 87 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeeccccccc
Confidence 9999999999999999754 45899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCC-CcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
.... ......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||...........
T Consensus 162 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~------------- 222 (276)
T 2h6d_A 162 SDGE------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK------------- 222 (276)
T ss_dssp CC-------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------------
T ss_pred CCCc------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH-------------
Confidence 4332 1233468999999999987765 6899999999999999999999964322110000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
+... .. ..+...+..+.+++.+||+.||.+|||+.++++.
T Consensus 223 -~~~~-~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 223 -IRGG-VF----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -HHHC-CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -hhcC-cc----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000 00 1122233458899999999999999999999974
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=341.71 Aligned_cols=271 Identities=24% Similarity=0.365 Sum_probs=202.8
Q ss_pred hhcCccccceeeeeCceEEEEEEEC--CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhc---CCCCccceeeeeeccc-
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT--DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRL---HHCHVVPLVGYCSEFR- 295 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l---~Hpniv~l~g~~~~~~- 295 (632)
+.++|.+.+.||+|+||.||+|.+. +|+.||||+++.... ......+.+|+.+++.+ +||||+++++++....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999983 588999999874322 11222367888887777 8999999999986321
Q ss_pred CCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecc
Q 006750 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDL 375 (632)
Q Consensus 296 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DF 375 (632)
......++||||++ |+|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecC
Confidence 13567899999997 69999998765556999999999999999999999998 999999999999999999999999
Q ss_pred ccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe-------
Q 006750 376 GMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV------- 448 (632)
Q Consensus 376 Gla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~------- 448 (632)
|+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||............
T Consensus 165 g~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (326)
T 1blx_A 165 GLARIYSFQM------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238 (326)
T ss_dssp CSCCCCCGGG------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cccccccCCC------CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 9998654321 122356899999999999999999999999999999999999999754322111000
Q ss_pred ---eccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 449 ---LWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 449 ---~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.|...... ............ ...+....+..+.+|+.+||..||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 239 GEEDWPRDVAL-PRQAFHSKSAQP-IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CGGGSCTTCSS-CGGGSCCCCCCC-GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CcccCcccccc-chhhhcccCcch-hhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000 000000000000 00112223445889999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=346.73 Aligned_cols=276 Identities=21% Similarity=0.275 Sum_probs=201.8
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccC----Cc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG----KR 298 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~----~~ 298 (632)
++|.+.+.||+|+||.||+|... +|+.||||++..... ......+.+|+.+|++++||||+++++++..... ..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 57888999999999999999984 589999999865432 2334568899999999999999999999876321 13
Q ss_pred ceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccc
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 378 (632)
...++||||++ |+|.+.+.... ..+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 97 ~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 97 GSIYLVFDFCE-HDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp CEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 46799999996 58888776543 45999999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccc----
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP---- 453 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~---- 453 (632)
+......... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||.................
T Consensus 172 ~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 172 RAFSLAKNSQ-PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp EECCCCSSSS-CCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccc-ccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 8765332111 123345678999999999876 4589999999999999999999999976443211111000000
Q ss_pred -ccccc--cccccccCCCCC-CCCCCHHH-----HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 454 -RLQDS--GTVISELPDPRL-KGDFPKEE-----MQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 454 -~~~~~--~~~~~~~~~~~l-~~~~~~~~-----~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+... ......+..... ........ ...+.+|+.+||+.||.+|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00000 000000000000 00001111 2347899999999999999999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=350.08 Aligned_cols=267 Identities=27% Similarity=0.446 Sum_probs=198.0
Q ss_pred cCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCC-hHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPN-ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~-~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
++|.+.+.||+|+||.||+|.... |+.||||++....... ....+.+|+.++++++||||+++++++.. ....+
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~ 100 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK----KKRWY 100 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TTEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec----CCEEE
Confidence 568889999999999999999865 8999999987654332 23458899999999999999999999875 45789
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 101 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp EEEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred EEEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 999999999999886543 45999999999999999999999998 9999999999999999999999999998654
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecc-ccccc----
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA-TPRLQ---- 456 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~-~~~~~---- 456 (632)
... .......||+.|+|||++.+. .++.++||||||+++|||++|+.||............... .....
T Consensus 176 ~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (331)
T 4aaa_A 176 APG-----EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQE 250 (331)
T ss_dssp -------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred CCc-----cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Confidence 322 122345689999999999875 7899999999999999999999999754332111000000 00000
Q ss_pred --cccccccccCCCCCCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 457 --DSGTVISELPDPRLKGDFP-----KEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 457 --~~~~~~~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
...........+.+....+ ...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000001111111111111 123456899999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=346.96 Aligned_cols=274 Identities=21% Similarity=0.282 Sum_probs=204.2
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeeccc-CCcceE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR-GKRAMR 301 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~-~~~~~~ 301 (632)
.++|.+.+.||+|+||.||+|... +++.||||++...........+.+|+++|++++||||+++++++.... ......
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 467899999999999999999875 588999999986544444567899999999999999999999986532 223467
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||||++ |+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999996 699999865 35999999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec--ccccccc-
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATPRLQD- 457 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~~~~~- 457 (632)
...... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||.............. ..+....
T Consensus 179 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 179 DPDHDH--TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256 (364)
T ss_dssp CGGGCB--CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred CCCCCc--cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 543211 112344579999999998765 4589999999999999999999999975443221111000 0000000
Q ss_pred -------ccccccccCCCCCC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 458 -------SGTVISELPDPRLK--GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 458 -------~~~~~~~~~~~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
..........+... .......+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000000 00011223458899999999999999999999874
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=350.39 Aligned_cols=267 Identities=24% Similarity=0.316 Sum_probs=196.8
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCccceeeeeecccC--Ccc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRA 299 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~--~~~ 299 (632)
.++|...+.||+|+||.||+|.+. +|+.||||++...... .....+.+|+.+|+.++||||+++++++..... ...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467889999999999999999975 5999999999654322 234568899999999999999999999875321 124
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..|+||||+ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 569999999 8999999875 45899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec--cccc--
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATPR-- 454 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~~-- 454 (632)
..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.............. ..+.
T Consensus 177 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~ 248 (367)
T 1cm8_A 177 QADSE--------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 248 (367)
T ss_dssp ECCSS--------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ccccc--------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 75422 234568999999999887 7799999999999999999999999975432211100000 0000
Q ss_pred ----cccc--cc---cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 455 ----LQDS--GT---VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 455 ----~~~~--~~---~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
+... .. .+.......+. ......+..+.+|+.+||..||.+|||+.++++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 249 FVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0000 00 00001111111 1112234458899999999999999999999884
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=345.39 Aligned_cols=265 Identities=23% Similarity=0.310 Sum_probs=188.9
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCccceeeeeecc----cCC
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEF----RGK 297 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~----~~~ 297 (632)
..+|.+.+.||+|+||.||+|.+. +++.||||++.... ......+.+|+.+++++. ||||+++++++... ...
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 356888999999999999999975 58999999986542 233456899999999995 99999999998432 123
Q ss_pred cceEEEEEEeCCCCChhhhhhccc-cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccc
Q 006750 298 RAMRLLVFEFMPNGNLRDCLDGVL-VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 376 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFG 376 (632)
....++||||+. |+|.+++.... ...+++.+++.++.|++.||+|||+.+ ++|+||||||+||||+.++.+||+|||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 556899999995 89999986532 345999999999999999999999875 349999999999999999999999999
Q ss_pred cceecccCCCCCC-------CCCCCccccCCCCCChhhh---hcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccch
Q 006750 377 MAKRLKADGLPSC-------SSSPARMQGTFGYFAPEYA---MVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES 446 (632)
Q Consensus 377 la~~~~~~~~~~~-------~~~~~~~~GT~~Y~APE~~---~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~ 446 (632)
+++.......... ........||+.|+|||++ .+..++.++||||||+++|||++|+.||........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-- 261 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI-- 261 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh--
Confidence 9987654321100 0111245699999999998 566789999999999999999999999964322100
Q ss_pred heeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 447 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
+............+ ..+.+|+.+||+.||.+|||+.++++.|..+..
T Consensus 262 ---------------~~~~~~~~~~~~~~----~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 262 ---------------VNGKYSIPPHDTQY----TVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp -------------------CCCCTTCCSS----GGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------------hcCcccCCcccccc----hHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00000001111122 237889999999999999999999999988753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=340.09 Aligned_cols=253 Identities=25% Similarity=0.391 Sum_probs=199.0
Q ss_pred HhhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 222 HATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 222 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
...++|.+.+.||+|+||.||+|.+.. |+.||||++.... ....+.+|+.++++++||||+++++++.. ...
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~ 98 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFK----NTD 98 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEE----TTE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEe----CCE
Confidence 345789999999999999999999864 8999999997643 23458999999999999999999999876 457
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.++||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++..
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 174 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQ 174 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchh
Confidence 79999999999999999643 356999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
..... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........
T Consensus 175 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------------- 236 (314)
T 3com_A 175 LTDTM-----AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM------------- 236 (314)
T ss_dssp CBTTB-----SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------------
T ss_pred hhhhc-----cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH-------------
Confidence 65321 122345689999999999999999999999999999999999999964332111000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
+.....+.+ ..+...+..+.+|+.+||..||.+|||+.++++.
T Consensus 237 -~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 237 -IPTNPPPTF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp -HHHSCCCCC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -HhcCCCccc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000001111 1122334558899999999999999999999873
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=377.41 Aligned_cols=250 Identities=22% Similarity=0.289 Sum_probs=203.4
Q ss_pred hhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCC--CCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCc
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~ 298 (632)
..++|.+.+.||+|+||.||+|+... ++.||||+++... .......+..|..+|..+ +||||+++++++.. .
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~----~ 414 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT----M 414 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC----S
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe----C
Confidence 35689999999999999999999764 8899999997431 223345588999999988 89999999998875 5
Q ss_pred ceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccc
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 378 (632)
..+||||||+++|+|.++|... ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla 489 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC 489 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred CEEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeeccee
Confidence 5789999999999999999764 45999999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccc
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
+...... .......||+.|+|||++.+..++.++||||||++||||++|+.||..........
T Consensus 490 ~~~~~~~-----~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~------------ 552 (674)
T 3pfq_A 490 KENIWDG-----VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ------------ 552 (674)
T ss_dssp EECCCTT-----CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------------
T ss_pred eccccCC-----cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHH------------
Confidence 8644332 22345679999999999999999999999999999999999999997543221111
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM-----SEVVQ 505 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 505 (632)
.+.... ..+|...+..+.+|+.+||+.||.+||++ .+|++
T Consensus 553 -----~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 553 -----SIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -----HHHSSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -----HHHhCC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 111111 12333445568999999999999999997 55554
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=363.55 Aligned_cols=252 Identities=23% Similarity=0.283 Sum_probs=199.8
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
.++|.+.+.||+|+||+||+|... +++.||||++.... .......+.+|+.+|++++||||+++++++.. ....
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~~~~ 96 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED----SSSF 96 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----SSEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc----CCEE
Confidence 467899999999999999999986 58999999986432 22334568999999999999999999999875 5578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEec---CCCCeEEeccccc
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD---ENLNAKITDLGMA 378 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~---~~~~vkL~DFGla 378 (632)
|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++ .++.+||+|||++
T Consensus 97 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 9999999999999998654 45999999999999999999999998 99999999999995 4567999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccc
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
+...... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||...........+..
T Consensus 172 ~~~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~-------- 236 (486)
T 3mwu_A 172 TCFQQNT------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET-------- 236 (486)
T ss_dssp TTBCCC----------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------
T ss_pred eECCCCC------ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------
Confidence 8664321 2234569999999998875 599999999999999999999999975432211110000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
... ....+.....+..+.+|+.+||+.||.+|||+.++++.
T Consensus 237 -----~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 237 -----GKY--AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -----TCC--CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -----CCC--CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 00001112334558899999999999999999999984
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=357.22 Aligned_cols=199 Identities=22% Similarity=0.291 Sum_probs=172.6
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhc------CCCCccceeeeeecccC
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL------HHCHVVPLVGYCSEFRG 296 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l------~Hpniv~l~g~~~~~~~ 296 (632)
..+|.+.+.||+|+||.||+|.... ++.||||+++.. ......+.+|+.+++.+ +|+||+++++++..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~--- 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF--- 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE---
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc---
Confidence 4678999999999999999998764 899999999753 23345578899998887 56799999999876
Q ss_pred CcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCC--eEEec
Q 006750 297 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN--AKITD 374 (632)
Q Consensus 297 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~--vkL~D 374 (632)
....++||||+. ++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||||+.++. +||+|
T Consensus 171 -~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~D 245 (429)
T 3kvw_A 171 -RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVID 245 (429)
T ss_dssp -TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECC
T ss_pred -CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEee
Confidence 457899999995 79999998766566999999999999999999999998 999999999999999887 99999
Q ss_pred cccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCcc
Q 006750 375 LGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (632)
Q Consensus 375 FGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~ 440 (632)
||+++..... .....||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 246 FG~a~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 246 FGSSCYEHQR--------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CTTCEETTCC--------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccceecCCc--------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9999765322 234578999999999999999999999999999999999999997543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=352.95 Aligned_cols=208 Identities=22% Similarity=0.295 Sum_probs=168.5
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCccceeeeeecccC-Ccce
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG-KRAM 300 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~-~~~~ 300 (632)
.++|.+.+.||+|+||.||+|.+.. |+.||||+++..... .....+.+|+.+|++++||||+++++++..... ....
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4679999999999999999998764 889999999754322 234568999999999999999999999865321 1246
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.|+||||++ |+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 899999995 6999999753 45999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCC-----------------CCCCCccccCCCCCChhhh-hcCCCCcccchHhHhHHHHHHHhCCCCCC
Q 006750 381 LKADGLPSC-----------------SSSPARMQGTFGYFAPEYA-MVGRASLMSDVFSFGVVLLELITGRQPIH 437 (632)
Q Consensus 381 ~~~~~~~~~-----------------~~~~~~~~GT~~Y~APE~~-~~~~~s~ksDVwSlGviL~eLltG~~P~~ 437 (632)
......... ........||+.|+|||++ ....++.++|||||||+||||++|..||.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 654321100 0123556799999999986 46679999999999999999999766654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=341.57 Aligned_cols=258 Identities=18% Similarity=0.239 Sum_probs=198.7
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCccceeeeeecccCCcceEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
++|++.+.||+|+||.||+|... +++.||||+++.. ....+.+|+.+|++++ ||||+++++++.... ....+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~--~~~~~ 109 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPV--SRTPA 109 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT--TCCEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCC--CCceE
Confidence 67889999999999999999874 5899999999743 2456899999999996 999999999987532 34679
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCC-CeEEeccccceec
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITDLGMAKRL 381 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~-~vkL~DFGla~~~ 381 (632)
+||||+++++|.+++.. +++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++..
T Consensus 110 lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 99999999999998853 889999999999999999999998 99999999999999776 8999999999876
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe-----------e
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV-----------L 449 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~-----------~ 449 (632)
.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||............ .
T Consensus 182 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 255 (330)
T 3nsz_A 182 HPGQ------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 255 (330)
T ss_dssp CTTC------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred CCCC------ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhh
Confidence 5432 2234468999999999987 67899999999999999999999999543221100000 0
Q ss_pred cc---ccccc---------cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 450 WA---TPRLQ---------DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 450 ~~---~~~~~---------~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
+. ..... .....+.... ....+...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 256 YIDKYNIELDPRFNDILGRHSRKRWERFV----HSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHTTCCCCTHHHHHHCCCCCCCGGGGC----CTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHhccccccchhhhhhhccccchhhhc----cccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 00000 0000000111 111122234568999999999999999999999873
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=334.31 Aligned_cols=256 Identities=25% Similarity=0.303 Sum_probs=200.1
Q ss_pred hhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC---CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCc
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~---~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 298 (632)
..++|.+.+.||+|+||.||++... +++.||||+++... .......+.+|+.++++++||||+++++++.... .
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~ 80 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE--K 80 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC----
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC--C
Confidence 3478999999999999999999975 48999999997532 2344567999999999999999999999985322 4
Q ss_pred ceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccc
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 378 (632)
...++||||++++ |.+++.......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~ 156 (305)
T 2wtk_C 81 QKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVA 156 (305)
T ss_dssp -CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccc
Confidence 4679999999766 888887655567999999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhcCC--CCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccc
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR--ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 456 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~--~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~ 456 (632)
......... .......||+.|+|||++.+.. ++.++||||||+++|||++|+.||...........
T Consensus 157 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--------- 224 (305)
T 2wtk_C 157 EALHPFAAD---DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN--------- 224 (305)
T ss_dssp EECCTTCSS---CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---------
T ss_pred cccCccccc---cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH---------
Confidence 876432111 1122346899999999987644 47899999999999999999999965322110000
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 457 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 457 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
+... ... .+...+..+.+|+.+||+.||.+|||+.++++.
T Consensus 225 -----i~~~-~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 225 -----IGKG-SYA----IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -----HHHC-CCC----CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -----HhcC-CCC----CCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 011 122233458899999999999999999999974
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=343.33 Aligned_cols=254 Identities=26% Similarity=0.314 Sum_probs=195.0
Q ss_pred hhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCC-------CChHHHHHHHHHHHHhcCCCCccceeeeeecc
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGG-------PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF 294 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~-------~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~ 294 (632)
..++|.+.+.||+|+||.||+|.... ++.||||++..... ......+.+|+.+|++++||||+++++++..
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 86 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 86 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC-
Confidence 45679999999999999999998764 89999999875421 1122348899999999999999999999864
Q ss_pred cCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCC---eE
Q 006750 295 RGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN---AK 371 (632)
Q Consensus 295 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~---vk 371 (632)
...|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++. +|
T Consensus 87 ----~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 87 ----EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp ----SSEEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEE
T ss_pred ----CceEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEE
Confidence 2369999999999999998653 45999999999999999999999998 999999999999987665 99
Q ss_pred EeccccceecccCCCCCCCCCCCccccCCCCCChhhhh---cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe
Q 006750 372 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 448 (632)
Q Consensus 372 L~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~ 448 (632)
|+|||+++...... ......||+.|+|||++. ...++.++||||||+++|+|++|+.||............
T Consensus 158 l~Dfg~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 231 (322)
T 2ycf_A 158 ITDFGHSKILGETS------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ 231 (322)
T ss_dssp ECCCTTCEECCCCH------HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHH
T ss_pred EccCccceeccccc------ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHH
Confidence 99999998754321 122356899999999975 467899999999999999999999999654322110000
Q ss_pred eccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 449 LWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
+...... .........+..+.+|+.+||..||.+||++.++++.
T Consensus 232 -------------~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 232 -------------ITSGKYN-FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp -------------HHHTCCC-CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -------------HHhCccc-cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 0000000 0000001223458899999999999999999999863
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=334.46 Aligned_cols=253 Identities=26% Similarity=0.351 Sum_probs=201.7
Q ss_pred hhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC--------ChHHHHHHHHHHHHhcC-CCCccceeeeee
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--------NADSVFLTEVDMLSRLH-HCHVVPLVGYCS 292 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--------~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~ 292 (632)
..++|.+.+.||+|+||.||+|... +|+.||||++...... ...+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 4578999999999999999999986 4899999999755321 12345889999999995 999999999987
Q ss_pred cccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEE
Q 006750 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKI 372 (632)
Q Consensus 293 ~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL 372 (632)
. ....++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||
T Consensus 95 ~----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl 165 (298)
T 1phk_A 95 T----NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKL 165 (298)
T ss_dssp C----SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred c----CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEE
Confidence 5 55789999999999999999753 45899999999999999999999998 999999999999999999999
Q ss_pred eccccceecccCCCCCCCCCCCccccCCCCCChhhhh------cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccch
Q 006750 373 TDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAM------VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES 446 (632)
Q Consensus 373 ~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~------~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~ 446 (632)
+|||++....... ......||+.|+|||++. ...++.++||||||+++|||++|+.||..........
T Consensus 166 ~dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 239 (298)
T 1phk_A 166 TDFGFSCQLDPGE------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR 239 (298)
T ss_dssp CCCTTCEECCTTC------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ecccchhhcCCCc------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHH
Confidence 9999998765332 223456899999999985 4568899999999999999999999996533211100
Q ss_pred heeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 447 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
... ... ...........+..+.+|+.+||+.||.+|||+.++++
T Consensus 240 ~~~-------------~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 240 MIM-------------SGN--YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHH-------------HTC--CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHh-------------cCC--cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 000 000 00000111233455899999999999999999999976
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=346.50 Aligned_cols=269 Identities=22% Similarity=0.254 Sum_probs=193.8
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeeccc--CCcc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR--GKRA 299 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~--~~~~ 299 (632)
.++|.+.+.||+|+||.||+|... +++.||||++..... ......+.+|+.+++.++||||+++++++.... ....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 367999999999999999999875 489999999975432 233456889999999999999999999987532 1234
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..|+||||++ |+|.+++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 6799999996 57888875 34899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec--ccc----
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATP---- 453 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~---- 453 (632)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.............. ..+
T Consensus 176 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 249 (371)
T 2xrw_A 176 TAGTSF------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 249 (371)
T ss_dssp --------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHH
T ss_pred cccccc------ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 654321 22345799999999999999999999999999999999999999975432211000000 000
Q ss_pred --cccc------------ccccccccCCCCCCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 454 --RLQD------------SGTVISELPDPRLKG---DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 454 --~~~~------------~~~~~~~~~~~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+.. ............... ..+...+..+.+|+.+||..||.+|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000 000000000000000 0112335678999999999999999999999974
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=339.28 Aligned_cols=252 Identities=21% Similarity=0.346 Sum_probs=196.9
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
.++|++.+.||+|+||.||+|.+.. ++.||+|++.... ......+.+|+.++++++||||+++++++.. ....+
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~~~~ 92 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYIVEIEILATCDHPYIVKLLGAYYH----DGKLW 92 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----C-CEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC-HHHHHHHHHHHHHHhcCCCCCEeeeeeeeee----CCeEE
Confidence 4678899999999999999999864 8999999997653 3345568999999999999999999999876 45779
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 93 lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNL 168 (302)
T ss_dssp EEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred EEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999999998653 345999999999999999999999998 9999999999999999999999999976432
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhh-----cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 457 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~ 457 (632)
... .......||+.|+|||++. ...++.++||||||+++|||++|+.||...........
T Consensus 169 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---------- 233 (302)
T 2j7t_A 169 KTL-----QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK---------- 233 (302)
T ss_dssp HHH-----HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----------
T ss_pred ccc-----cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH----------
Confidence 211 1122346899999999984 56789999999999999999999999965432111000
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 458 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
+.....+.. ..+...+..+.+|+.+||+.||.+|||+.++++
T Consensus 234 ----~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 234 ----IAKSDPPTL--LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ----HHHSCCCCC--SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ----HhccCCccc--CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000000000 112333455889999999999999999999976
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=342.78 Aligned_cols=256 Identities=22% Similarity=0.255 Sum_probs=177.3
Q ss_pred hcCcccc-ceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHH-HHHhcCCCCccceeeeeecccCCcce
Q 006750 224 TDKFSGS-NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVD-MLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 224 t~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~-~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
.++|.+. +.||+|+||.||+|.+. +|+.||||++.... ...+|+. .++.+.||||+++++++.........
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP------KARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH------HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 4677774 46999999999999987 59999999996431 2334443 45667999999999998765554567
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC---CCCeEEecccc
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLNAKITDLGM 377 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~---~~~vkL~DFGl 377 (632)
.++||||+++|+|.+++.......+++.+++.++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 899999999999999998765567999999999999999999999998 999999999999976 45599999999
Q ss_pred ceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccc
Q 006750 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 457 (632)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~ 457 (632)
++..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||............. ...
T Consensus 178 ~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~-- 245 (336)
T 3fhr_A 178 AKETTQN-------ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK---RRI-- 245 (336)
T ss_dssp CEEC-----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred ceecccc-------ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH---Hhh--
Confidence 9865432 1234568999999999988889999999999999999999999996543221100000 000
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 458 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
......+........+..+.+|+.+||+.||.+|||+.++++.
T Consensus 246 ------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 246 ------RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp -----------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ------hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000001111112334458899999999999999999999984
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.27 Aligned_cols=256 Identities=25% Similarity=0.352 Sum_probs=179.5
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHH-HHHhcCCCCccceeeeeecccCCcceE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVD-MLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~-~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
.++|...+.||+|+||.||+|... +|+.||||+++..........+..|+. +++.++||||+++++++.. ....
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~----~~~~ 96 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR----EGDC 96 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC----SSEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe----CCce
Confidence 367888999999999999999985 589999999986644444455667776 6777799999999999876 4577
Q ss_pred EEEEEeCCCCChhhhhhc---cccCCCCHHHHHHHHHHHHHhhHHHHhc-CCCceeecCCCCCCeEecCCCCeEEecccc
Q 006750 302 LLVFEFMPNGNLRDCLDG---VLVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGM 377 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 377 (632)
++||||++ |+|.+++.. .....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+
T Consensus 97 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~ 172 (327)
T 3aln_A 97 WICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGI 172 (327)
T ss_dssp EEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred EEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCC
Confidence 99999997 588888753 2235689999999999999999999998 8 99999999999999999999999999
Q ss_pred ceecccCCCCCCCCCCCccccCCCCCChhhh----hcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccc
Q 006750 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYA----MVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 453 (632)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~----~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~ 453 (632)
++...... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||.......... .
T Consensus 173 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~----- 240 (327)
T 3aln_A 173 SGQLVDSI------AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL-T----- 240 (327)
T ss_dssp SCC------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------C-----
T ss_pred ceeccccc------ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH-H-----
Confidence 98764321 12234699999999998 45678999999999999999999999996532211000 0
Q ss_pred ccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 454 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 454 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+.....+.+........+..+.+|+.+||+.||.+|||+.++++.
T Consensus 241 -------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 241 -------QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp -------CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred -------HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 0000111111111112233458899999999999999999999863
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=343.37 Aligned_cols=275 Identities=23% Similarity=0.313 Sum_probs=201.8
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecc-cCCcceE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEF-RGKRAMR 301 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~-~~~~~~~ 301 (632)
.++|.+.+.||+|+||.||+|.+. +|+.||||++...........+.+|+.++++++||||+++++++... .......
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467899999999999999999986 58999999997554444455688999999999999999999987642 1223578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
++||||+. |+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999996 699999875 45999999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCC-----CCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhee--cccc
Q 006750 382 KADGLPSC-----SSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL--WATP 453 (632)
Q Consensus 382 ~~~~~~~~-----~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~--~~~~ 453 (632)
........ ........||+.|+|||++.. ..++.++||||||+++|||++|+.||............. ...+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 54321110 011234578999999998765 778999999999999999999999997543221100000 0000
Q ss_pred ccccc---------cccccccCC---CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 454 RLQDS---------GTVISELPD---PRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 454 ~~~~~---------~~~~~~~~~---~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
..... ...+..+.. ..+. ......+..+.+|+.+||+.||.+|||+.++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLE-KMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred chhccccccccchhhHHhhcccCCCCcchh-hhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000 000000000 0000 0011233458899999999999999999999873
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=354.80 Aligned_cols=266 Identities=24% Similarity=0.324 Sum_probs=195.4
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccC--CcceEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRAMRL 302 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~--~~~~~~ 302 (632)
+|...+.||+|+||.||+|++. +|+.||||++...... +.+|+++|++++||||+++++++..... ...+.+
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh-----HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 5778899999999999999986 4999999999754321 4579999999999999999999865332 234567
Q ss_pred EEEEeCCCCChhhhhhcc--ccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCC-CCeEEeccccce
Q 006750 303 LVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN-LNAKITDLGMAK 379 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~-~~vkL~DFGla~ 379 (632)
+||||+++ +|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999964 777766432 2356999999999999999999999998 9999999999999965 568999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec--cccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATPRLQ 456 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~~~~ 456 (632)
...... ......||+.|+|||++.+. .++.++|||||||+||||++|+.||.............. ..+...
T Consensus 206 ~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 206 QLVRGE------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 279 (420)
T ss_dssp ECCTTC------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred hcccCC------CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 764332 22345789999999999764 799999999999999999999999975432211100000 000000
Q ss_pred ---cccccccccCCCCCCC-----CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 457 ---DSGTVISELPDPRLKG-----DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 457 ---~~~~~~~~~~~~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.......+...+.+.. .++...+..+.+|+.+||..||.+|||+.|+++.
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0000001111111111 0122234558899999999999999999999863
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=371.87 Aligned_cols=260 Identities=24% Similarity=0.367 Sum_probs=206.6
Q ss_pred HHhhcCccccceeeeeCceEEEEEEECC----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccC
Q 006750 221 EHATDKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 296 (632)
Q Consensus 221 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 296 (632)
+...++|.+.+.||+|+||.||+|.+.. +..||||+++........+.|.+|+.+|++++||||+++++++.+
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--- 462 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--- 462 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---
Confidence 3445778999999999999999998743 567999998865544455679999999999999999999999853
Q ss_pred CcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccc
Q 006750 297 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 376 (632)
Q Consensus 297 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFG 376 (632)
...|+||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 463 --~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 463 --NPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred --CceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecC
Confidence 3469999999999999999753 245899999999999999999999998 9999999999999999999999999
Q ss_pred cceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccc
Q 006750 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRL 455 (632)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~ 455 (632)
+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||...........
T Consensus 537 ~a~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~-------- 604 (656)
T 2j0j_A 537 LSRYMEDSTY----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-------- 604 (656)
T ss_dssp CCCSCCC--------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH--------
T ss_pred CCeecCCCcc----eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH--------
Confidence 9987643321 11223457889999999999999999999999999999997 9999965432211000
Q ss_pred ccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 456 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 456 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
+....... .+..++..+.+|+.+||..||.+|||+.+|++.|..+.
T Consensus 605 ------i~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 605 ------IENGERLP----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp ------HHHTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------HHcCCCCC----CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 00001111 22333455889999999999999999999999998875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=334.37 Aligned_cols=261 Identities=25% Similarity=0.383 Sum_probs=195.0
Q ss_pred hhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeeccc------
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR------ 295 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~------ 295 (632)
..++|++.+.||+|+||.||+|... +|+.||||++... ......+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 3567899999999999999999975 6999999999643 233456899999999999999999999886532
Q ss_pred ---CCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEE
Q 006750 296 ---GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKI 372 (632)
Q Consensus 296 ---~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL 372 (632)
......|+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence 12467899999999999999997532 34789999999999999999999998 999999999999999999999
Q ss_pred eccccceecccCCC---------CCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCcccc
Q 006750 373 TDLGMAKRLKADGL---------PSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITK 442 (632)
Q Consensus 373 ~DFGla~~~~~~~~---------~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~ 442 (632)
+|||+++....... ...........||+.|+|||++.+. .++.++||||||+++|||++ ||......
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~ 234 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER 234 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH
Confidence 99999986543210 0011223445699999999999864 78999999999999999998 55322111
Q ss_pred ccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 443 GEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 443 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.. ... .+.. ....+...++...+..+.+|+.+||+.||.+|||+.++++.
T Consensus 235 ~~--~~~-----------~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 235 VN--ILK-----------KLRS-VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HH--HHH-----------HHHS-TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HH--HHH-----------hccc-cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 00 000 0000 01111222344444568899999999999999999999874
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=342.46 Aligned_cols=257 Identities=23% Similarity=0.350 Sum_probs=196.9
Q ss_pred HHHhhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcC--CCCccceeeeeecccC
Q 006750 220 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLH--HCHVVPLVGYCSEFRG 296 (632)
Q Consensus 220 l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~--Hpniv~l~g~~~~~~~ 296 (632)
+....++|.+.+.||+|+||.||++...+++.||||++..... ......+.+|+.++++++ ||||+++++++..
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--- 99 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--- 99 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC---
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec---
Confidence 3344567889999999999999999988899999999976432 234456899999999996 5999999999876
Q ss_pred CcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccc
Q 006750 297 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 376 (632)
Q Consensus 297 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFG 376 (632)
....++||| +.+++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++ +.+||+|||
T Consensus 100 -~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 100 -DQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp -SSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCS
T ss_pred -CCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecc
Confidence 457899999 5589999999754 46899999999999999999999998 999999999999965 799999999
Q ss_pred cceecccCCCCCCCCCCCccccCCCCCChhhhhc-----------CCCCcccchHhHhHHHHHHHhCCCCCCCccccccc
Q 006750 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-----------GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEE 445 (632)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----------~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~ 445 (632)
+++........ .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.........
T Consensus 172 ~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (313)
T 3cek_A 172 IANQMQPDTTS---VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 248 (313)
T ss_dssp SSCC-----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH
T ss_pred ccccccCcccc---ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH
Confidence 99876543211 11234569999999999875 47889999999999999999999999643221100
Q ss_pred hheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 446 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
+..+.++.....++...+..+.+|+.+||+.||.+||++.++++.
T Consensus 249 ----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 249 ----------------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp ----------------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----------------HHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 011111111112222223458899999999999999999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=349.96 Aligned_cols=268 Identities=23% Similarity=0.271 Sum_probs=195.1
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccC--CcceEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRAMRL 302 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~--~~~~~~ 302 (632)
.+|.+.+.||+|+||.||+|++..+..||+|++...... ..+|+.+|+.++||||+++++++..... .....+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 458888999999999999999987777999988654322 3479999999999999999999865432 234578
Q ss_pred EEEEeCCCCChhhhhh-ccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEec-CCCCeEEecccccee
Q 006750 303 LVFEFMPNGNLRDCLD-GVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKR 380 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~-~~~~vkL~DFGla~~ 380 (632)
+||||++++.+..... ......+++..+..++.|++.||+|||+.+ |+||||||+||||+ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 9999997644433322 122356999999999999999999999998 99999999999999 799999999999987
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec--ccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATPRLQD 457 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~~~~~ 457 (632)
..... ......||+.|+|||++.+. .++.++||||||++||||++|+.||.............. ..+....
T Consensus 192 ~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 192 LIAGE------PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ 265 (394)
T ss_dssp CCTTC------CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccCCC------CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 64432 22345689999999998764 589999999999999999999999975432211100000 0000000
Q ss_pred ---cc-----ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 458 ---SG-----TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 458 ---~~-----~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.. .....+....+...++...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00 00000000000011122234568999999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=338.84 Aligned_cols=265 Identities=22% Similarity=0.262 Sum_probs=202.3
Q ss_pred hcCccccceeeeeCceEEEEEEE-C-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCC------ccceeeeeeccc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQL-T-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH------VVPLVGYCSEFR 295 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~-~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpn------iv~l~g~~~~~~ 295 (632)
.++|.+.+.||+|+||.||+|.+ . +++.||||+++.. ......+.+|+.+++.++|+| ++++++++..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~-- 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH-- 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE--
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc--
Confidence 46788999999999999999987 3 5899999999743 233456889999999997665 8999998875
Q ss_pred CCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC---------
Q 006750 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE--------- 366 (632)
Q Consensus 296 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~--------- 366 (632)
....++||||+ +++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 89 --~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 89 --HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp --TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC-
T ss_pred --CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCC
Confidence 45789999999 899999998765556899999999999999999999998 999999999999987
Q ss_pred ----------CCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCC
Q 006750 367 ----------NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 436 (632)
Q Consensus 367 ----------~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~ 436 (632)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 234 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDEH--------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTSC--------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccccccccCCCceEeeCcccccCccc--------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 678999999999864422 23456899999999999999999999999999999999999999
Q ss_pred CCccccccchheecccccccc------------------------ccccccccCCCCC-CCCCCHHHHHHHHHHHHHhcc
Q 006750 437 HRSITKGEESLVLWATPRLQD------------------------SGTVISELPDPRL-KGDFPKEEMQIMAYLAKECLQ 491 (632)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~l-~~~~~~~~~~~l~~li~~cl~ 491 (632)
..................... ....+.....+.. ....+...+..+.+|+.+||+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 314 (339)
T 1z57_A 235 PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE 314 (339)
T ss_dssp CCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence 754322111000000000000 0000000000000 011234556779999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 006750 492 LDPDARPTMSEVVQI 506 (632)
Q Consensus 492 ~dP~~RPs~~evl~~ 506 (632)
.||.+|||+.|+++.
T Consensus 315 ~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 315 YDPAKRITLREALKH 329 (339)
T ss_dssp SSTTTSCCHHHHTTS
T ss_pred cCcccccCHHHHhcC
Confidence 999999999999863
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=343.58 Aligned_cols=269 Identities=22% Similarity=0.294 Sum_probs=204.2
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-----------CCCccceeeee
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-----------HCHVVPLVGYC 291 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~-----------Hpniv~l~g~~ 291 (632)
.++|.+.+.||+|+||.||+|... +++.||||++... ......+.+|+.++++++ ||||+++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC--ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 357888999999999999999974 5899999999743 223455889999999886 89999999998
Q ss_pred ecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhc-CCCceeecCCCCCCeEec-----
Q 006750 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLD----- 365 (632)
Q Consensus 292 ~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDLKp~NILl~----- 365 (632)
..........++||||+ +++|.+++.......+++..+..++.|++.||+|||++ + |+||||||+||||+
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 86544455789999999 99999999876556699999999999999999999998 8 99999999999994
Q ss_pred -CCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCcccccc
Q 006750 366 -ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 444 (632)
Q Consensus 366 -~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~ 444 (632)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++||||||++||||++|+.||........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 243 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH--------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 243 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC--------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred cCcceEEEcccccccccCCC--------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccccc
Confidence 4457999999999876432 2234689999999999999999999999999999999999999975432110
Q ss_pred c----hh---eeccc--c-------c----cccccccccccCCCC---------CCCCCCHHHHHHHHHHHHHhcccCCC
Q 006750 445 E----SL---VLWAT--P-------R----LQDSGTVISELPDPR---------LKGDFPKEEMQIMAYLAKECLQLDPD 495 (632)
Q Consensus 445 ~----~~---~~~~~--~-------~----~~~~~~~~~~~~~~~---------l~~~~~~~~~~~l~~li~~cl~~dP~ 495 (632)
. .+ ..... + . ..........+.... ....++...+..+.+|+.+||+.||.
T Consensus 244 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 323 (373)
T 1q8y_A 244 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 323 (373)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred CChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcc
Confidence 0 00 00000 0 0 000000000000000 01235677888899999999999999
Q ss_pred CCCCHHHHHHH
Q 006750 496 ARPTMSEVVQI 506 (632)
Q Consensus 496 ~RPs~~evl~~ 506 (632)
+|||+.|+++.
T Consensus 324 ~Rpt~~ell~h 334 (373)
T 1q8y_A 324 KRADAGGLVNH 334 (373)
T ss_dssp TCBCHHHHHTC
T ss_pred ccCCHHHHhhC
Confidence 99999999873
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=330.89 Aligned_cols=253 Identities=23% Similarity=0.287 Sum_probs=200.3
Q ss_pred HhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 222 HATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 222 ~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
...++|.+.+.||+|+||.||+|... +++.||||++.... .......+.+|+.++++++||||+++++++.. ..
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~ 94 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED----SS 94 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SS
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC----CC
Confidence 44578999999999999999999986 58999999986542 23445669999999999999999999999875 45
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCC---CCeEEeccc
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN---LNAKITDLG 376 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~---~~vkL~DFG 376 (632)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.+ +.+||+|||
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 95 SFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred eEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccC
Confidence 789999999999999988653 45899999999999999999999998 9999999999999754 469999999
Q ss_pred cceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccc
Q 006750 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQ 456 (632)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~ 456 (632)
++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||.............
T Consensus 170 ~~~~~~~~~------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------- 235 (287)
T 2wei_A 170 LSTCFQQNT------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE------- 235 (287)
T ss_dssp GGGTBCCCS------SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------
T ss_pred cceeecCCC------ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------
Confidence 998654321 2234568999999998865 58999999999999999999999997543221100000
Q ss_pred cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 457 DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 457 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
........ ......+..+.+++.+||..||.+|||+.++++
T Consensus 236 ------~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 236 ------TGKYAFDL--PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp ------HCCCCCCS--GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------cCCCCCCc--hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00000000 000122345889999999999999999999987
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=349.60 Aligned_cols=205 Identities=25% Similarity=0.341 Sum_probs=156.3
Q ss_pred cCccc-cceeeeeCceEEEEEEEC---CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 225 DKFSG-SNIVGQGGSSYVYRGQLT---DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 225 ~~f~~-~~~LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
+.|.+ .++||+|+||+||+|++. +++.||||++..... ...+.+|+.+|++++||||+++++++.... ...
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHA--DRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETT--TTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCC--CCe
Confidence 34555 457999999999999976 478999999975432 235889999999999999999999986432 457
Q ss_pred EEEEEEeCCCCChhhhhhccc-------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEe----cCCCC
Q 006750 301 RLLVFEFMPNGNLRDCLDGVL-------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL----DENLN 369 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl----~~~~~ 369 (632)
.|+||||++ |+|.+++.... ...+++..+..|+.|++.||+|||+.+ |+||||||+|||| +.++.
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTC
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCc
Confidence 899999995 68888885321 124899999999999999999999998 9999999999999 77889
Q ss_pred eEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCcc
Q 006750 370 AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (632)
Q Consensus 370 vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~ 440 (632)
+||+|||+++........ ........||+.|+|||++.+ ..++.++|||||||+||||++|+.||....
T Consensus 171 ~kl~Dfg~a~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKP--LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp EEECCTTCCC------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred EEEEECCCceecCCCCcc--cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 999999999876532111 122344679999999999987 458999999999999999999999996543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=340.26 Aligned_cols=277 Identities=22% Similarity=0.274 Sum_probs=192.3
Q ss_pred HHHHHhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccC
Q 006750 218 SALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG 296 (632)
Q Consensus 218 ~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 296 (632)
.......++|.+.+.||+|+||.||+|.+. +|+.||||++....... ..+.+++..++.++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR--NRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC--CHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc--HHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 345666789999999999999999999985 58999999987543322 346788999999999999999999865332
Q ss_pred ---CcceEEEEEEeCCCCChhhhhhc--cccCCCCHHHHHHHHHHHHHhhHHHH--hcCCCceeecCCCCCCeEecC-CC
Q 006750 297 ---KRAMRLLVFEFMPNGNLRDCLDG--VLVEGMNWDTRVAIAIGAARGLEYLH--EAAAPRILHRDIKSSNILLDE-NL 368 (632)
Q Consensus 297 ---~~~~~~lV~Ey~~~gsL~~~L~~--~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~iiHrDLKp~NILl~~-~~ 368 (632)
.....++||||+++ +|.+.+.. .....+++..+..++.|++.||.||| +.+ |+||||||+||||+. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCC
Confidence 23347899999975 66555532 12345899999999999999999999 887 999999999999996 89
Q ss_pred CeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccchh
Q 006750 369 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL 447 (632)
Q Consensus 369 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~ 447 (632)
.+||+|||+++...... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||...........
T Consensus 170 ~~kl~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 243 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSE------PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHE 243 (360)
T ss_dssp EEEECCCTTCBCCCTTS------CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred cEEEeeCCCceecCCCC------CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHH
Confidence 99999999998765432 22345689999999998764 489999999999999999999999976433211110
Q ss_pred eecc--c----------ccccccc-ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 448 VLWA--T----------PRLQDSG-TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 448 ~~~~--~----------~~~~~~~-~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.... . +...... ...............+...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000 0 0000000 00000000000111222345678999999999999999999999873
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=345.99 Aligned_cols=267 Identities=25% Similarity=0.330 Sum_probs=184.2
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccC--Ccc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRA 299 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~--~~~ 299 (632)
.++|.+.+.||+|+||.||+|.+. +|+.||||++..... ......+.+|+.+|+.++||||+++++++..... ...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 468999999999999999999865 589999999975432 2234568899999999999999999999865321 124
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..|+||||+ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 579999999 7899999865 45999999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec--cccc--
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATPR-- 454 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~~-- 454 (632)
..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.............. ..+.
T Consensus 181 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~ 252 (367)
T 2fst_X 181 HTADE--------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252 (367)
T ss_dssp ------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred ccccc--------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 65422 234579999999999887 6789999999999999999999999975432211110000 0000
Q ss_pred ----ccc--ccccccccCC---CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 455 ----LQD--SGTVISELPD---PRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 455 ----~~~--~~~~~~~~~~---~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
... ....+..+.. ..+. .........+.+|+.+||..||.+|||+.++++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHH-HHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHH-HHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000 0000000000 0000 0001123458899999999999999999999874
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=334.41 Aligned_cols=273 Identities=21% Similarity=0.328 Sum_probs=194.7
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeeccc-------
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR------- 295 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~------- 295 (632)
.++|.+.+.||+|+||.||+|.... |+.||||++.... ....+.+.+|+.++++++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 4678899999999999999999875 8999999987542 334456899999999999999999999874321
Q ss_pred ---CCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEec-CCCCeE
Q 006750 296 ---GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAK 371 (632)
Q Consensus 296 ---~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~-~~~~vk 371 (632)
......++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 22457899999997 699999864 45899999999999999999999998 99999999999997 567999
Q ss_pred EeccccceecccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec
Q 006750 372 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450 (632)
Q Consensus 372 L~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~ 450 (632)
|+|||+++........ ........||..|+|||.+.. ..++.++||||||+++|||++|+.||..............
T Consensus 162 l~Dfg~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 239 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSH--KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILE 239 (320)
T ss_dssp ECCCTTCBCC----------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EccCccccccCCCccc--ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999876432111 122344568999999998875 6789999999999999999999999975433211110000
Q ss_pred cccccccc-cccc---------cccCCCCCC-CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 451 ATPRLQDS-GTVI---------SELPDPRLK-GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 451 ~~~~~~~~-~~~~---------~~~~~~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
..+..... ...+ .....+... .......+..+.+|+.+||+.||.+|||+.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 00000000 0000 000000000 00111234558899999999999999999999873
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=339.91 Aligned_cols=200 Identities=26% Similarity=0.296 Sum_probs=170.3
Q ss_pred hhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCC-----ccceeeeeeccc
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCH-----VVPLVGYCSEFR 295 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~-Hpn-----iv~l~g~~~~~~ 295 (632)
..++|.+.+.||+|+||+||+|... +++.||||+++.. ......+..|+.+++.++ |+| |+++++++..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-- 127 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-- 127 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc--
Confidence 4578999999999999999999876 4889999999743 223455788999999884 554 8899988876
Q ss_pred CCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHh--cCCCceeecCCCCCCeEec--CCCCeE
Q 006750 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE--AAAPRILHRDIKSSNILLD--ENLNAK 371 (632)
Q Consensus 296 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~--~~~~~iiHrDLKp~NILl~--~~~~vk 371 (632)
....++||||++ |+|.+++.......+++..+..++.|++.||.|||. .+ |+||||||+||||+ .++.+|
T Consensus 128 --~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 128 --RNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp --TTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEE
T ss_pred --CCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEE
Confidence 457899999995 699999987655669999999999999999999994 45 99999999999994 477899
Q ss_pred EeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCcc
Q 006750 372 ITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSI 440 (632)
Q Consensus 372 L~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~ 440 (632)
|+|||+++..... .....||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 202 L~DFG~a~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 202 IVDFGSSCQLGQR--------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp ECCCTTCEETTCC--------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEeccCceecccc--------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999876432 234568999999999999999999999999999999999999997543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=341.33 Aligned_cols=267 Identities=23% Similarity=0.322 Sum_probs=196.0
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCccceeeeeecccCC--cc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK--RA 299 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~--~~ 299 (632)
.++|...+.||+|+||.||+|.+. +|+.||||++...... .....+.+|+.+++.++||||+++++++...... ..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 467888999999999999999876 4899999999765332 2245688999999999999999999998754321 11
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..++||||+. ++|.+++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 3499999996 78988874 34899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec-c-cc---
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW-A-TP--- 453 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~-~-~~--- 453 (632)
..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.............. . .+
T Consensus 193 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 264 (371)
T 4exu_A 193 HADAE--------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 264 (371)
T ss_dssp ---------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ccccC--------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHH
Confidence 65432 233568999999999987 7899999999999999999999999975432111000000 0 00
Q ss_pred ---cccc--ccccccccCCCCCCC--CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 454 ---RLQD--SGTVISELPDPRLKG--DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 454 ---~~~~--~~~~~~~~~~~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+.. .......+....... ..+...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000 000000000000000 0111224558899999999999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=333.57 Aligned_cols=246 Identities=24% Similarity=0.362 Sum_probs=191.9
Q ss_pred HHHhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC-----hHHHHHHHHHHHHhc----CCCCccceee
Q 006750 220 LEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-----ADSVFLTEVDMLSRL----HHCHVVPLVG 289 (632)
Q Consensus 220 l~~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~-----~~~~f~~Ei~~l~~l----~Hpniv~l~g 289 (632)
.+...++|.+.+.||+|+||.||+|... +++.||||++....... ....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 4455688999999999999999999874 58999999997543221 122367899999999 8999999999
Q ss_pred eeecccCCcceEEEEEEe-CCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEec-CC
Q 006750 290 YCSEFRGKRAMRLLVFEF-MPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-EN 367 (632)
Q Consensus 290 ~~~~~~~~~~~~~lV~Ey-~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~-~~ 367 (632)
++.. ....++|||| +.+++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++ .+
T Consensus 106 ~~~~----~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 176 (312)
T 2iwi_A 106 WFET----QEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRR 176 (312)
T ss_dssp EC---------CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTT
T ss_pred EEec----CCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCC
Confidence 9875 3466999999 7899999999763 45999999999999999999999998 99999999999999 88
Q ss_pred CCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCC-CcccchHhHhHHHHHHHhCCCCCCCccccccch
Q 006750 368 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEES 446 (632)
Q Consensus 368 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~ 446 (632)
+.+||+|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.......
T Consensus 177 ~~~kl~dfg~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--- 246 (312)
T 2iwi_A 177 GCAKLIDFGSGALLHDEP-------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL--- 246 (312)
T ss_dssp TEEEECCCSSCEECCSSC-------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH---
T ss_pred CeEEEEEcchhhhcccCc-------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHh---
Confidence 999999999998765432 233468999999999987766 458999999999999999999996421100
Q ss_pred heeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 447 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.. .. .++...+..+.+|+.+||+.||++|||+.++++.
T Consensus 247 ----------------~~--~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 247 ----------------EA--EL----HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ----------------HT--CC----CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----------------hh--cc----CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00 1122233458899999999999999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=335.43 Aligned_cols=264 Identities=19% Similarity=0.232 Sum_probs=198.9
Q ss_pred hcCccccceeeeeCceEEEEEEECC-C-cEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCC------ccceeeeeeccc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTD-G-RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH------VVPLVGYCSEFR 295 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~-g-~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpn------iv~l~g~~~~~~ 295 (632)
.++|.+.+.||+|+||.||+|.... + +.||||+++.. ......+.+|+.++++++|++ ++.+++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~-- 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF-- 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE--
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee--
Confidence 4678999999999999999998753 4 78999999743 233456889999999997766 8888887765
Q ss_pred CCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEe-----------
Q 006750 296 GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILL----------- 364 (632)
Q Consensus 296 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl----------- 364 (632)
....++||||+ +++|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||||
T Consensus 94 --~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 94 --HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp --TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECC
T ss_pred --CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccc
Confidence 45789999999 778888887655456999999999999999999999998 9999999999999
Q ss_pred --------cCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCC
Q 006750 365 --------DENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 436 (632)
Q Consensus 365 --------~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~ 436 (632)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 239 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHEH--------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF 239 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTSC--------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccccCCCcEEEeecCcccccccc--------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCC
Confidence 56789999999999864322 23456999999999999999999999999999999999999999
Q ss_pred CCccccccchheecccccccc--------------cc----------ccccccCCC-CCCCCCCHHHHHHHHHHHHHhcc
Q 006750 437 HRSITKGEESLVLWATPRLQD--------------SG----------TVISELPDP-RLKGDFPKEEMQIMAYLAKECLQ 491 (632)
Q Consensus 437 ~~~~~~~~~~~~~~~~~~~~~--------------~~----------~~~~~~~~~-~l~~~~~~~~~~~l~~li~~cl~ 491 (632)
..................... .. ....+...+ .............+.+|+.+||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 240 QTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence 754322110000000000000 00 000000000 00001223445678999999999
Q ss_pred cCCCCCCCHHHHHH
Q 006750 492 LDPDARPTMSEVVQ 505 (632)
Q Consensus 492 ~dP~~RPs~~evl~ 505 (632)
.||.+|||+.|+++
T Consensus 320 ~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 320 FDPAQRITLAEALL 333 (355)
T ss_dssp SSTTTSCCHHHHTT
T ss_pred CChhhCcCHHHHhc
Confidence 99999999999975
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=335.21 Aligned_cols=266 Identities=22% Similarity=0.312 Sum_probs=197.1
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCccceeeeeecccCC--cc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK--RA 299 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~--~~ 299 (632)
.++|...+.||+|+||.||+|.+. +|+.||||++...... .....+.+|+.+++.++||||+++++++...... ..
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 367888999999999999999975 5899999999764322 2245688999999999999999999998753321 12
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..|+||||+. |+|.+++.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccccc
Confidence 4599999996 699888753 4899999999999999999999998 9999999999999999999999999997
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec--ccc---
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATP--- 453 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~--- 453 (632)
..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.............. ..+
T Consensus 175 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 175 HADAE--------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246 (353)
T ss_dssp C----------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHH
T ss_pred CCCCC--------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 65322 234568999999999887 6789999999999999999999999975432111000000 000
Q ss_pred ---ccccc--ccc---ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 454 ---RLQDS--GTV---ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 454 ---~~~~~--~~~---~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+... ... +.....+.+. ......+..+.+|+.+||+.||++|||+.++++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000 000 0001111111 1222334558999999999999999999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=337.87 Aligned_cols=247 Identities=23% Similarity=0.336 Sum_probs=198.3
Q ss_pred HHHHhhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC-----hHHHHHHHHHHHHhcC--CCCccceeee
Q 006750 219 ALEHATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN-----ADSVFLTEVDMLSRLH--HCHVVPLVGY 290 (632)
Q Consensus 219 ~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~-----~~~~f~~Ei~~l~~l~--Hpniv~l~g~ 290 (632)
+.+...++|.+.+.||+|+||.||+|... +++.||||++....... ....+.+|+.++++++ ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 34445678999999999999999999865 58999999997543221 1233778999999995 5999999999
Q ss_pred eecccCCcceEEEEEEeCCC-CChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEec-CCC
Q 006750 291 CSEFRGKRAMRLLVFEFMPN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENL 368 (632)
Q Consensus 291 ~~~~~~~~~~~~lV~Ey~~~-gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~-~~~ 368 (632)
+.. ....++||||+.+ ++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++ +++
T Consensus 117 ~~~----~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~ 187 (320)
T 3a99_A 117 FER----PDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRG 187 (320)
T ss_dssp EEC----SSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTT
T ss_pred Eec----CCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCC
Confidence 875 4578999999976 8999999763 45899999999999999999999998 99999999999999 788
Q ss_pred CeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCC-CcccchHhHhHHHHHHHhCCCCCCCccccccchh
Q 006750 369 NAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESL 447 (632)
Q Consensus 369 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~ 447 (632)
.+||+|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.......
T Consensus 188 ~~kL~Dfg~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---- 256 (320)
T 3a99_A 188 ELKLIDFGSGALLKDTV-------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII---- 256 (320)
T ss_dssp EEEECCCTTCEECCSSC-------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH----
T ss_pred CEEEeeCcccccccccc-------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh----
Confidence 99999999998765321 223469999999999987765 788999999999999999999996432100
Q ss_pred eeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 448 VLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.. ...+...++ ..+.+|+.+||+.||.+|||+.+|++.
T Consensus 257 ---------------~~--~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 257 ---------------RG--QVFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ---------------HC--CCCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---------------cc--cccccccCC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 000111233 448899999999999999999999873
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=345.22 Aligned_cols=255 Identities=24% Similarity=0.342 Sum_probs=187.4
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+|+++ +||||+++++++.. ....|+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~----~~~~~l 86 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETT----DRFLYI 86 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC----SSEEEE
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEec----CCeEEE
Confidence 345556889999999998777677999999998753 234578999999987 89999999998765 557899
Q ss_pred EEEeCCCCChhhhhhccccCC-----CCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCC-----------
Q 006750 304 VFEFMPNGNLRDCLDGVLVEG-----MNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN----------- 367 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~-----l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~----------- 367 (632)
||||++ |+|.+++....... .++..++.++.|++.||+|||+.+ |+||||||+||||+.+
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~ 162 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGA 162 (434)
T ss_dssp EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCC
Confidence 999995 79999997543211 133456789999999999999998 9999999999999654
Q ss_pred --CCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhc-------CCCCcccchHhHhHHHHHHHh-CCCCCC
Q 006750 368 --LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-------GRASLMSDVFSFGVVLLELIT-GRQPIH 437 (632)
Q Consensus 368 --~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-------~~~s~ksDVwSlGviL~eLlt-G~~P~~ 437 (632)
+.+||+|||+++......... ........||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.
T Consensus 163 ~~~~~kL~DFG~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 241 (434)
T 2rio_A 163 ENLRILISDFGLCKKLDSGQSSF-RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241 (434)
T ss_dssp CSCEEEECCCTTCEECCC---------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred CceEEEEcccccceecCCCCccc-eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence 479999999998875432110 112234579999999999975 678999999999999999999 999996
Q ss_pred CccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 438 RSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 438 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
....... .... .....+......+...+..+.+|+.+||+.||.+|||+.+|++.
T Consensus 242 ~~~~~~~-~i~~-------------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 242 DKYSRES-NIIR-------------GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp STTTHHH-HHHH-------------TCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CchhhHH-HHhc-------------CCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 4322110 0000 00001111122345667789999999999999999999999863
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=326.52 Aligned_cols=252 Identities=24% Similarity=0.363 Sum_probs=178.0
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHH-HHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~-f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
.++|...+.||+|+||.||+|.+. +|+.||||++........... +.++..+++.++||||+++++++.. ....
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~----~~~~ 99 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT----NTDV 99 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC----SSEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec----CCcE
Confidence 467888999999999999999986 589999999986544333333 4444556788899999999999876 4578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhc-CCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
++||||+ ++.+..++.. ....+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++..
T Consensus 100 ~lv~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp EEEECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred EEEEecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 9999999 5555555443 345699999999999999999999995 8 99999999999999999999999999976
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhh-----cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL 455 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~ 455 (632)
..... ......||+.|+|||++. ...++.++||||||+++|||++|+.||............
T Consensus 175 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~------- 241 (318)
T 2dyl_A 175 LVDDK------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTK------- 241 (318)
T ss_dssp ------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH-------
T ss_pred ccCCc------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHH-------
Confidence 54322 123346999999999984 566899999999999999999999999653221110000
Q ss_pred ccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 456 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 456 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
+.....+.+.. ....+..+.+|+.+||+.||.+||++.++++
T Consensus 242 ------~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 242 ------VLQEEPPLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ------HHHSCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ------HhccCCCCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00000111110 0112344889999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=342.19 Aligned_cols=250 Identities=25% Similarity=0.372 Sum_probs=185.6
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
.+|...+.||+|+||+||.....+|+.||||++...... .+.+|+.+|+++ +||||+++++++.+ ....|+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~----~~~~E~~~l~~l~~HpnIv~l~~~~~~----~~~~~l 95 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS----FADREVQLLRESDEHPNVIRYFCTEKD----RQFQYI 95 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE----ECHHHHHHHHHSCCCTTBCCEEEEEEE----TTEEEE
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH----HHHHHHHHHHhccCCCCcCeEEEEEec----CCEEEE
Confidence 457788999999999976665667999999999754322 267899999999 89999999998875 557899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC-----CCCeEEeccccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-----NLNAKITDLGMA 378 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~-----~~~vkL~DFGla 378 (632)
||||++ |+|.+++.... ..+.+..++.++.|++.||+|||+.+ |+||||||+||||+. ...+||+|||++
T Consensus 96 v~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 96 AIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 999995 69999997643 23555567899999999999999998 999999999999943 345889999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhh---cCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccc
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAM---VGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPR 454 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~ 454 (632)
+........ ........||+.|+|||++. ...++.++|||||||++|||++ |..||...........
T Consensus 171 ~~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~------- 241 (432)
T 3p23_A 171 KKLAVGRHS--FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL------- 241 (432)
T ss_dssp ECC--------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH-------
T ss_pred eeccCCCcc--eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH-------
Confidence 876543211 11233457999999999997 4667889999999999999999 8999854322111000
Q ss_pred cccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 455 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 455 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
......... ..+......+.+|+.+||+.||.+|||+.+|++
T Consensus 242 -------~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 242 -------LGACSLDCL--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -------TTCCCCTTS--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -------hccCCcccc--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 000000000 112334556889999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=355.13 Aligned_cols=274 Identities=25% Similarity=0.347 Sum_probs=205.8
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeeccc--CCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR--GKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~--~~~~~~ 301 (632)
++|.+.+.||+|+||.||+|.+. +|+.||||+++..........|.+|+.+|++++||||+++++++.... ......
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 67999999999999999999875 589999999987655555667999999999999999999999875422 124567
Q ss_pred EEEEEeCCCCChhhhhhccc-cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCC---eEEecccc
Q 006750 302 LLVFEFMPNGNLRDCLDGVL-VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLN---AKITDLGM 377 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~---vkL~DFGl 377 (632)
++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999997643 235899999999999999999999998 999999999999987665 99999999
Q ss_pred ceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccc--
Q 006750 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL-- 455 (632)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~-- 455 (632)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .|.....
T Consensus 171 a~~~~~~~------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-----~~~~~i~~~ 239 (676)
T 3qa8_A 171 AKELDQGE------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-----QWHGKVREK 239 (676)
T ss_dssp CCBTTSCC------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-----HSSTTCC--
T ss_pred cccccccc------ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-----hhhhhhhcc
Confidence 98765432 2234579999999999999999999999999999999999999996432110 0100000
Q ss_pred --------ccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHH-----HHHHHhhhCC
Q 006750 456 --------QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE-----VVQILSTIAP 512 (632)
Q Consensus 456 --------~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-----vl~~L~~i~~ 512 (632)
...................+...+..+.+|+.+||..||.+|||+.+ +++.+..+..
T Consensus 240 ~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 240 SNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp ----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred cchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 00000000000011122345667788999999999999999999988 4455555543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=357.79 Aligned_cols=244 Identities=22% Similarity=0.385 Sum_probs=195.1
Q ss_pred hcCccccceeeeeCceEEEEEEEC--CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCC-cce
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT--DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK-RAM 300 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~--~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~-~~~ 300 (632)
.++|.+.+.||+|+||.||+|.+. +|+.||||++...........|.+|+.+|++++||||+++++++...... ...
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 478999999999999999999986 58999999997654444556689999999999999999999998864332 223
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.||||||++|++|.+++.. .+++.+++.|+.||+.||.|||+.+ |+||||||+||||+.+ .+||+|||+++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence 6999999999999988754 5999999999999999999999998 9999999999999986 899999999987
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
.... ....||+.|+|||++.++. +.++||||||++||+|++|..||......
T Consensus 231 ~~~~---------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~------------------ 282 (681)
T 2pzi_A 231 INSF---------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD------------------ 282 (681)
T ss_dssp TTCC---------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS------------------
T ss_pred cccC---------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc------------------
Confidence 6432 3346999999999987764 89999999999999999998887532110
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHHhhh
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT-MSEVVQILSTI 510 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L~~i 510 (632)
.+. ...........+.+|+.+||+.||.+||+ +.++.+.|..+
T Consensus 283 ---~~~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 283 ---GLP----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ---SCC----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---ccc----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 000 00011223456889999999999999995 56666666554
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=315.87 Aligned_cols=231 Identities=22% Similarity=0.318 Sum_probs=181.2
Q ss_pred cCcccc-ceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHH-HhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGS-NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDML-SRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~-~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l-~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|.+. +.||+|+||.||+|... +++.||||+++.. ..+.+|+.++ +.++||||+++++++..........
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 456666 77999999999999875 5899999999642 3478899988 5559999999999987644446678
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC---CCCeEEeccccc
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLNAKITDLGMA 378 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~---~~~vkL~DFGla 378 (632)
++||||+++|+|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 99999999999999998765557999999999999999999999998 999999999999998 788999999998
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccc
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
.... +..++.++||||||+++|||++|+.||.......... .
T Consensus 168 ~~~~---------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-------~---- 209 (299)
T 3m2w_A 168 KETT---------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-------G---- 209 (299)
T ss_dssp EECT---------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-------C----
T ss_pred cccc---------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-------H----
Confidence 7543 1345678999999999999999999996533211000 0
Q ss_pred cccccccCCCCCCCCCC----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 459 GTVISELPDPRLKGDFP----KEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
....+..... ..+ ...+..+.+|+.+||+.||.+|||+.++++.
T Consensus 210 --~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 210 --MKTRIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp --SCCSSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --HHHHHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000000000 111 1234568999999999999999999999874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=314.77 Aligned_cols=235 Identities=17% Similarity=0.148 Sum_probs=183.1
Q ss_pred hcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCC--hHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPN--ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~--~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
.++|.+.+.||+|+||.||+|.+.. |+.||||++....... ....|.+|+.++++++||||+++++++.. ...
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~----~~~ 105 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT----RAG 105 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE----TTE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE----CCc
Confidence 3578889999999999999999865 8999999998654332 23569999999999999999999999876 457
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.|+||||++|++|.++++.. ....++..|+.|++.||+|||+.+ |+||||||+||||+.++.+||+++|
T Consensus 106 ~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~---- 174 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA---- 174 (286)
T ss_dssp EEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC----
T ss_pred EEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc----
Confidence 89999999999999999642 456678999999999999999998 9999999999999999999998543
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
|++| ++.++||||||++||||++|+.||........... ......
T Consensus 175 ---------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~---~~~~~~---- 219 (286)
T 3uqc_A 175 ---------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---AERDTA---- 219 (286)
T ss_dssp ---------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE---CCBCTT----
T ss_pred ---------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH---HHHHhc----
Confidence 3332 68899999999999999999999975433211100 000000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 514 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 514 (632)
.....+ ...+...+..+.+|+.+||+.||.+| |+.++++.|..+....
T Consensus 220 --~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 220 --GQPIEP---ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp --SCBCCH---HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred --cCCCCh---hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 000000 00112233458999999999999999 9999999999886543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=331.60 Aligned_cols=247 Identities=16% Similarity=0.145 Sum_probs=182.4
Q ss_pred hhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC--ChHHHHHHHHHHHHhcCC-CCccceeee--------
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHH-CHVVPLVGY-------- 290 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~f~~Ei~~l~~l~H-pniv~l~g~-------- 290 (632)
.+.+|...+.||+|+||.||+|.+. +|+.||||+++..... ...+.|.+|+.+++.++| +|...+..+
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 4455777889999999999999965 5999999999844322 234569999999999977 332211111
Q ss_pred -------------eecc-cCCcceEEEEEEeCCCCChhhhhhc-----cccCCCCHHHHHHHHHHHHHhhHHHHhcCCCc
Q 006750 291 -------------CSEF-RGKRAMRLLVFEFMPNGNLRDCLDG-----VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 351 (632)
Q Consensus 291 -------------~~~~-~~~~~~~~lV~Ey~~~gsL~~~L~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 351 (632)
.... .......+++|+++ +++|.++++. .....+++..++.++.|++.||+|||+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 1100 00122457777776 7899999852 22334889999999999999999999998
Q ss_pred eeecCCCCCCeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhh----------hcCCCCcccchHh
Q 006750 352 ILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYA----------MVGRASLMSDVFS 421 (632)
Q Consensus 352 iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~----------~~~~~s~ksDVwS 421 (632)
|+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ ....++.++||||
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwS 302 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT 302 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE--------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc--------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHH
Confidence 999999999999999999999999999875432 223457 999999999 4455888999999
Q ss_pred HhHHHHHHHhCCCCCCCccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 006750 422 FGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS 501 (632)
Q Consensus 422 lGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 501 (632)
|||+||||++|+.||......... ..+... ...++ ..+.+|+.+||+.||++||++.
T Consensus 303 lGvil~elltg~~Pf~~~~~~~~~-----------------~~~~~~--~~~~~----~~~~~li~~~l~~dP~~Rpt~~ 359 (413)
T 3dzo_A 303 LGLAIYWIWCADLPNTDDAALGGS-----------------EWIFRS--CKNIP----QPVRALLEGFLRYPKEDRLLPL 359 (413)
T ss_dssp HHHHHHHHHHSSCCCCTTGGGSCS-----------------GGGGSS--CCCCC----HHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHHHHHCCCCCCCcchhhhH-----------------HHHHhh--cccCC----HHHHHHHHHHccCChhhCcCHH
Confidence 999999999999999654322110 000000 01233 4488999999999999999998
Q ss_pred HHHH
Q 006750 502 EVVQ 505 (632)
Q Consensus 502 evl~ 505 (632)
++++
T Consensus 360 ~~l~ 363 (413)
T 3dzo_A 360 QAME 363 (413)
T ss_dssp HHTT
T ss_pred HHHh
Confidence 8865
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=317.81 Aligned_cols=246 Identities=14% Similarity=0.136 Sum_probs=185.3
Q ss_pred hcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCC-------CChHHHHHHHHHHHHhcC---------CCCccce
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGG-------PNADSVFLTEVDMLSRLH---------HCHVVPL 287 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~-------~~~~~~f~~Ei~~l~~l~---------Hpniv~l 287 (632)
.++|.+.+.||+|+||+||+|++ +|+.||||++..... ......+.+|+.+|+.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45688899999999999999998 689999999986532 223366899999999986 6666666
Q ss_pred eeeee-----------------ccc---------CCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhh
Q 006750 288 VGYCS-----------------EFR---------GKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 341 (632)
Q Consensus 288 ~g~~~-----------------~~~---------~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL 341 (632)
.+++. ... ......|+||||+++|+|.+.+.+ ..+++..+..++.|++.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 66542 200 014578999999999987776643 4589999999999999999
Q ss_pred HHHH-hcCCCceeecCCCCCCeEecCCC--------------------CeEEeccccceecccCCCCCCCCCCCccccCC
Q 006750 342 EYLH-EAAAPRILHRDIKSSNILLDENL--------------------NAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400 (632)
Q Consensus 342 ~yLH-~~~~~~iiHrDLKp~NILl~~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~ 400 (632)
+||| +.+ |+||||||+||||+.++ .+||+|||+|+..... ...||+
T Consensus 175 ~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----------~~~gt~ 241 (336)
T 2vuw_A 175 AVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----------IVVFCD 241 (336)
T ss_dssp HHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----------EEECCC
T ss_pred HHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----------cEEEee
Confidence 9999 898 99999999999999887 8999999999876532 347999
Q ss_pred CCCChhhhhcCCCCcccchHhHhHH-HHHHHhCCCCCCCccccccchheecccccccccccccccc-CCCCCCCCCCHHH
Q 006750 401 GYFAPEYAMVGRASLMSDVFSFGVV-LLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL-PDPRLKGDFPKEE 478 (632)
Q Consensus 401 ~Y~APE~~~~~~~s~ksDVwSlGvi-L~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~~~~~~~ 478 (632)
.|+|||++.+.. +.++||||||++ .+++++|..||.... |...... ...... .........+...
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~---------~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 308 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL---------WLHYLTD---KMLKQMTFKTKCNTPAMKQI 308 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH---------HHHHHHH---HHHHTCCCSSCCCSHHHHHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh---------hhhHHHH---hhhhhhccCcccchhhhhhc
Confidence 999999998666 899999998776 778899999984310 0000000 000000 0111111234467
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHH
Q 006750 479 MQIMAYLAKECLQLDPDARPTMSEVV 504 (632)
Q Consensus 479 ~~~l~~li~~cl~~dP~~RPs~~evl 504 (632)
+..+.+|+.+||+.| |+.|++
T Consensus 309 s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 309 KRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHGGGSS-----SHHHHH
T ss_pred CHHHHHHHHHHhccC-----CHHHHH
Confidence 788999999999976 999988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-30 Score=288.09 Aligned_cols=187 Identities=19% Similarity=0.151 Sum_probs=130.5
Q ss_pred eeeeeCceEEEEEE-ECCCcEEEEEEeccCCCC---------ChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcce
Q 006750 232 IVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGP---------NADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 232 ~LG~G~fG~Vy~~~-~~~g~~vAVK~l~~~~~~---------~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~ 300 (632)
.++.|++|.+..++ .--|+.+|||++...... ...++|.+|+++|+++ .|+||+++++++.+ ...
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed----~~~ 316 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN----AQS 316 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC----SSE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE----CCE
Confidence 35667777777654 234889999999754211 1234599999999999 89999999999876 567
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.||||||++|++|.++|... ..++.. +|+.||+.||+|||++| ||||||||+||||+.++.+||+|||+|+.
T Consensus 317 ~yLVMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~ 388 (569)
T 4azs_A 317 GWLVMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVT 388 (569)
T ss_dssp EEEEEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred EEEEEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCee
Confidence 89999999999999999764 346654 58899999999999999 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCC
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 436 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~ 436 (632)
...+. .......||+.|||||++.+ .+..++|+||+|++++++.++..++
T Consensus 389 ~~~~~-----~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 389 TPQDC-----SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp CC--------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCCCC-----ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 65432 23456789999999998865 4677899999999999887765554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.2e-27 Score=259.97 Aligned_cols=189 Identities=15% Similarity=0.166 Sum_probs=143.8
Q ss_pred cccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCCh-------HHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 228 SGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNA-------DSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 228 ~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~-------~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
...+.||+|+||.||+|.. .++.+|+|+......... .+.|.+|+++|++++||||+++..++.. ...
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~----~~~ 413 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD----LDN 413 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE----TTT
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe----CCc
Confidence 4457899999999999954 578899998765332211 2348999999999999999965555553 234
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.|+||||+++|+|.+++.. +..++.|++.||+|||+++ |+||||||+|||++. .+||+|||+++.
T Consensus 414 ~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~ 478 (540)
T 3en9_A 414 KRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKI 478 (540)
T ss_dssp TEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEE
T ss_pred cEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEE
Confidence 5999999999999999875 5689999999999999998 999999999999998 999999999997
Q ss_pred cccCCCCC--CCCCCCccccCCCCCChhhhhc--CCCCcccchHhHhHHHHHHHhCCCCC
Q 006750 381 LKADGLPS--CSSSPARMQGTFGYFAPEYAMV--GRASLMSDVFSFGVVLLELITGRQPI 436 (632)
Q Consensus 381 ~~~~~~~~--~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDVwSlGviL~eLltG~~P~ 436 (632)
........ .........||+.|||||++.. ..|+..+|+||..+-.++-+.++.+|
T Consensus 479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 64321000 0001134679999999999986 56888899999999999988888776
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.6e-24 Score=220.14 Aligned_cols=164 Identities=15% Similarity=0.044 Sum_probs=127.9
Q ss_pred HHHHhhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCC-----------------ChHHHHHHHHHHHHhcCC
Q 006750 219 ALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGP-----------------NADSVFLTEVDMLSRLHH 281 (632)
Q Consensus 219 ~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~-----------------~~~~~f~~Ei~~l~~l~H 281 (632)
.+......|.+.+.||+|+||.||+|.+.+|+.||||+++..... .....+.+|+.+|++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 344455667777999999999999999977999999999743211 12445899999999999
Q ss_pred CCccceeeeeecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCC
Q 006750 282 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSN 361 (632)
Q Consensus 282 pniv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~N 361 (632)
| +++.+++.. ...|+||||++||+|.+ +.. .....++.|++.||.|||+.+ |+||||||+|
T Consensus 163 -~-~~v~~~~~~-----~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~N 223 (282)
T 1zar_A 163 -G-LAVPKVYAW-----EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYN 223 (282)
T ss_dssp -T-SSSCCEEEE-----ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTS
T ss_pred -C-CCcCeEEec-----cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHH
Confidence 5 666665532 34599999999999998 521 124579999999999999998 9999999999
Q ss_pred eEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhc----------CCCCcccchHh
Q 006750 362 ILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV----------GRASLMSDVFS 421 (632)
Q Consensus 362 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~----------~~~s~ksDVwS 421 (632)
|||+ ++.+||+|||+|+. +..|+|||++.. ..+...+|+|.
T Consensus 224 ILl~-~~~vkl~DFG~a~~------------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSVE------------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp EEEE-TTEEEECCCTTCEE------------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred EEEE-CCcEEEEECCCCeE------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 9999 99999999999863 345899998753 34455566654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=9.2e-20 Score=183.91 Aligned_cols=137 Identities=20% Similarity=0.231 Sum_probs=106.0
Q ss_pred ccccceeeeeCceEEEEEEE-CCCcE--EEEEEeccCCCCC-----------------------hHHHHHHHHHHHHhcC
Q 006750 227 FSGSNIVGQGGSSYVYRGQL-TDGRI--VAVKRFKTQGGPN-----------------------ADSVFLTEVDMLSRLH 280 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~-~~g~~--vAVK~l~~~~~~~-----------------------~~~~f~~Ei~~l~~l~ 280 (632)
|.+.+.||+|+||.||+|.+ .+|+. ||||+++...... ....+.+|+.+|.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999998 67888 9999976432110 0124789999999998
Q ss_pred CCCc--cceeeeeecccCCcceEEEEEEeCCC-C----ChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHH-hcCCCce
Q 006750 281 HCHV--VPLVGYCSEFRGKRAMRLLVFEFMPN-G----NLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLH-EAAAPRI 352 (632)
Q Consensus 281 Hpni--v~l~g~~~~~~~~~~~~~lV~Ey~~~-g----sL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~i 352 (632)
|+++ ..++++ ...+|||||+.+ | +|.+++.. .++..+..++.|++.||.||| +.+ |
T Consensus 129 ~~~i~~p~~~~~--------~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g---i 192 (258)
T 1zth_A 129 EAGVSVPQPYTY--------MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE---L 192 (258)
T ss_dssp HTTCCCCCEEEE--------ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC---E
T ss_pred hCCCCCCeEEEc--------CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 8864 344432 134899999942 4 66665432 234567889999999999999 888 9
Q ss_pred eecCCCCCCeEecCCCCeEEeccccceec
Q 006750 353 LHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 353 iHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
+||||||+|||++. .++|+|||+|...
T Consensus 193 vHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 193 VHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred EeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999999998 9999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.70 E-value=1.4e-17 Score=175.54 Aligned_cols=145 Identities=14% Similarity=0.126 Sum_probs=103.7
Q ss_pred HHHHhhcC---ccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCC-------------ChHHH--------HHHHHH
Q 006750 219 ALEHATDK---FSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGP-------------NADSV--------FLTEVD 274 (632)
Q Consensus 219 ~l~~~t~~---f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~-------------~~~~~--------f~~Ei~ 274 (632)
.|....++ |.+.+.||.|+||.||+|...+|+.||||+++..... ..... ..+|..
T Consensus 86 AL~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~ 165 (397)
T 4gyi_A 86 ALHTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFA 165 (397)
T ss_dssp HHHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHH
Confidence 44555444 8899999999999999999989999999998643100 00111 234666
Q ss_pred HHHhcCCCCccceeeeeecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceee
Q 006750 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILH 354 (632)
Q Consensus 275 ~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH 354 (632)
.|.++.+.++.-..-+.. ...+|||||++|++|.++... .....++.|++.+|.|||+.+ |||
T Consensus 166 nL~rL~~~gv~vp~p~~~------~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~g---IVH 228 (397)
T 4gyi_A 166 FMKALYEEGFPVPEPIAQ------SRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKHG---LIH 228 (397)
T ss_dssp HHHHHHHTTCSCCCEEEE------ETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHHHHhcCCCCCeeeec------cCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHCC---CcC
Confidence 666665444321111111 112799999999998776432 124567899999999999998 999
Q ss_pred cCCCCCCeEecCCCC----------eEEecccccee
Q 006750 355 RDIKSSNILLDENLN----------AKITDLGMAKR 380 (632)
Q Consensus 355 rDLKp~NILl~~~~~----------vkL~DFGla~~ 380 (632)
|||||.||||++++. +.|+||+-+..
T Consensus 229 rDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 229 GDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 999999999988763 89999997754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=1.8e-11 Score=122.89 Aligned_cols=148 Identities=16% Similarity=0.098 Sum_probs=112.1
Q ss_pred HHHhhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCc
Q 006750 220 LEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 220 l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~ 298 (632)
+......|.....++.|+++.||++... ++.+++|+....... ....+.+|+.+|+.+ .|.++.++++++.. .
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~-~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~----~ 82 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERH----D 82 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEE----T
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCC-CHHHHHHHHHHHHHHhcCCCCCeEEEEEec----C
Confidence 3444567888888898999999999854 789999998752111 112388999999999 46778889888764 3
Q ss_pred ceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcC------------------------------
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA------------------------------ 348 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------ 348 (632)
...|+||||++|.+|.+.+.. ......++.+++++|..||+..
T Consensus 83 ~~~~lv~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T 3tm0_A 83 GWSNLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp TEEEEEEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred CceEEEEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence 467999999999999876421 1223477889999999999811
Q ss_pred --------------------------CCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 349 --------------------------APRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 349 --------------------------~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.+.++|+|++|.|||++++..+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13489999999999998765567999998754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.19 E-value=3.6e-11 Score=119.98 Aligned_cols=136 Identities=15% Similarity=0.115 Sum_probs=97.1
Q ss_pred ccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCC--ccceeeeeecccCCcceEEEE
Q 006750 227 FSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH--VVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 227 f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpn--iv~l~g~~~~~~~~~~~~~lV 304 (632)
+.+..+.+.|..+.||++...+|+.++||+..... ...+.+|+.+|+.+.+.+ +.+++++... ....++|
T Consensus 22 ~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~----~~~~~~v 93 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTE----AGRDWLL 93 (264)
T ss_dssp CEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC----SSCEEEE
T ss_pred CceEecccCCCCceEEEEecCCCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccC----CCCCEEE
Confidence 33333334556699999987778889999976541 123789999999995545 4457776554 2357999
Q ss_pred EEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcC------------------------------------
Q 006750 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA------------------------------------ 348 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------ 348 (632)
|||++|.+|. ... .. ...++.++++.|..||...
T Consensus 94 ~e~i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 94 LGEVPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp EECCSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEecCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 9999998884 221 11 2356777778888888643
Q ss_pred -------------------CCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 349 -------------------APRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 349 -------------------~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.+.++|+|++|.|||++++..+.|+|||.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776667999999764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.09 E-value=4.4e-10 Score=118.27 Aligned_cols=145 Identities=16% Similarity=0.196 Sum_probs=106.5
Q ss_pred cceeeeeCceEEEEEEECCCcEEEEEEec--cCCCCChHHHHHHHHHHHHhcC--CCCccceeeeeecccCCcceEEEEE
Q 006750 230 SNIVGQGGSSYVYRGQLTDGRIVAVKRFK--TQGGPNADSVFLTEVDMLSRLH--HCHVVPLVGYCSEFRGKRAMRLLVF 305 (632)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~--~~~~~~~~~~f~~Ei~~l~~l~--Hpniv~l~g~~~~~~~~~~~~~lV~ 305 (632)
.+.|+.|.++.||+.... +..+++|+.. ..........+.+|+.+|+.|. +..+.++++++.+... ....|+||
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~-~g~~~~vm 120 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESV-IGRAFYIM 120 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT-TSSCEEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc-cCCeEEEE
Confidence 567899999999999875 4678888876 3322222334889999999996 4567888888765321 13468999
Q ss_pred EeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcC-------------------------------------
Q 006750 306 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA------------------------------------- 348 (632)
Q Consensus 306 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------- 348 (632)
||++|..|.+.. ...++..++..++.++++.|..||...
T Consensus 121 e~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 121 EFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp ECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 999998885422 123778888999999999999999731
Q ss_pred ------------------CCceeecCCCCCCeEecCCCC--eEEecccccee
Q 006750 349 ------------------APRILHRDIKSSNILLDENLN--AKITDLGMAKR 380 (632)
Q Consensus 349 ------------------~~~iiHrDLKp~NILl~~~~~--vkL~DFGla~~ 380 (632)
.+.++|+|+++.|||++.++. +.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999987753 68999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.04 E-value=4.2e-10 Score=115.60 Aligned_cols=187 Identities=21% Similarity=0.228 Sum_probs=124.1
Q ss_pred cceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCC--ccceeeeeecccCCcceEEEEEE
Q 006750 230 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCH--VVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpn--iv~l~g~~~~~~~~~~~~~lV~E 306 (632)
.+.++.|.+..||+.. ..+++|+.... .....+.+|..+|+.+ .+.. +.+++..... .......|+||+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~-~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMP-SETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCC-CSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCC-CCCCCcceEEEc
Confidence 3568999999999864 45889986532 2345689999999988 4333 3344443322 111124489999
Q ss_pred eCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcC--------------------------------------
Q 006750 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA-------------------------------------- 348 (632)
Q Consensus 307 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------- 348 (632)
|++|.+|.+... ..++..++..++.++++.|..||...
T Consensus 97 ~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 97 KIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred ccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 999988875432 23677788888889999888888621
Q ss_pred -----------------CCceeecCCCCCCeEecC--CCCeEEeccccceecccCCCCCCCCCCCccccCCCC---CChh
Q 006750 349 -----------------APRILHRDIKSSNILLDE--NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY---FAPE 406 (632)
Q Consensus 349 -----------------~~~iiHrDLKp~NILl~~--~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y---~APE 406 (632)
.+.++|+|++|.||++++ +..+.|+||+.+....... .......+ ..|+
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~---------Dl~~~~~~~~~~~~~ 243 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN---------DFISLMEDDEEYGME 243 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH---------HHHTTCCTTTSCCHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH---------HHHHHHhhccccCHH
Confidence 245899999999999998 4567899999987643210 00011111 2333
Q ss_pred hhhc-----CCC---------CcccchHhHhHHHHHHHhCCCCCC
Q 006750 407 YAMV-----GRA---------SLMSDVFSFGVVLLELITGRQPIH 437 (632)
Q Consensus 407 ~~~~-----~~~---------s~ksDVwSlGviL~eLltG~~P~~ 437 (632)
.... +.. ....+.|+++.++|.+.+|..+|.
T Consensus 244 ~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 244 FVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 2210 111 123689999999999999998873
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=8e-07 Score=91.19 Aligned_cols=137 Identities=17% Similarity=0.166 Sum_probs=92.8
Q ss_pred cceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCC---CccceeeeeecccCCcceEEEEEE
Q 006750 230 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC---HVVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hp---niv~l~g~~~~~~~~~~~~~lV~E 306 (632)
.+.++.|....||+. |..++||+-.. ......+.+|..+|+.|.+. .+.+.+.+.... ....|+|||
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~---~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRS---DGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECT---TSCEEEEEE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccC---CCceEEEEe
Confidence 356788888999998 56688888532 22345689999999999653 345666655421 334689999
Q ss_pred eCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhc---------------------------------------
Q 006750 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA--------------------------------------- 347 (632)
Q Consensus 307 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------------- 347 (632)
|++|.+|.+..- ..++..+...++.++++.|..||..
T Consensus 94 ~i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 94 KVQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp CCCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred ccCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 999988876321 1234444555555555555555532
Q ss_pred ------------------CCCceeecCCCCCCeEecC---CCC-eEEecccccee
Q 006750 348 ------------------AAPRILHRDIKSSNILLDE---NLN-AKITDLGMAKR 380 (632)
Q Consensus 348 ------------------~~~~iiHrDLKp~NILl~~---~~~-vkL~DFGla~~ 380 (632)
..+.++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2345799999999999987 455 48999998865
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=2.8e-06 Score=85.03 Aligned_cols=135 Identities=19% Similarity=0.132 Sum_probs=94.3
Q ss_pred eeeeeCce-EEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCccceeeeeecccCCcceEEEEEEeC
Q 006750 232 IVGQGGSS-YVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRLLVFEFM 308 (632)
Q Consensus 232 ~LG~G~fG-~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~~~~~lV~Ey~ 308 (632)
.+..|..| .||+.... ++..++||+-... ....+.+|...|+.|. +--+.++++++.. ....|+|||++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~----~~~~~lvme~l 102 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRT----PDDAWLLTTAI 102 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEE----TTEEEEEEECC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEE----CCeEEEEEEee
Confidence 34445555 69998765 4678999986532 3345889999999883 3346678877765 34569999999
Q ss_pred CCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcC----------------------------------------
Q 006750 309 PNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA---------------------------------------- 348 (632)
Q Consensus 309 ~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------- 348 (632)
+|.++.+..... ......++.+++..|.-||...
T Consensus 103 ~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 103 PGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred CCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 998887764321 1123345566666666676421
Q ss_pred ---------------CCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 349 ---------------APRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 349 ---------------~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12479999999999999877777999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=2.2e-06 Score=89.61 Aligned_cols=84 Identities=7% Similarity=-0.084 Sum_probs=55.7
Q ss_pred cee-eeeCceEEEEEEEC-------CCcEEEEEEeccCCC--CChHHHHHHHHHHHHhcC-C--CCccceeeeeecccCC
Q 006750 231 NIV-GQGGSSYVYRGQLT-------DGRIVAVKRFKTQGG--PNADSVFLTEVDMLSRLH-H--CHVVPLVGYCSEFRGK 297 (632)
Q Consensus 231 ~~L-G~G~fG~Vy~~~~~-------~g~~vAVK~l~~~~~--~~~~~~f~~Ei~~l~~l~-H--pniv~l~g~~~~~~~~ 297 (632)
+.| +.|....+|+.... +++.+++|+...... ......+.+|+.+|+.|. + -.+.++++++.....
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~- 104 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV- 104 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT-
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc-
Confidence 557 77889999998764 267889998654320 001123788999999883 3 356778877654211
Q ss_pred cceEEEEEEeCCCCChhh
Q 006750 298 RAMRLLVFEFMPNGNLRD 315 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~ 315 (632)
....|+||||++|..|.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 124589999999877654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.05 E-value=1.9e-05 Score=81.52 Aligned_cols=141 Identities=17% Similarity=0.256 Sum_probs=80.6
Q ss_pred ceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC--CCCccceeee-----eecccCCcceEEE
Q 006750 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH--HCHVVPLVGY-----CSEFRGKRAMRLL 303 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~--Hpniv~l~g~-----~~~~~~~~~~~~l 303 (632)
+.|+.|..+.||+....+| .+++|+.... ...+..|+.+++.|. .-.+.+++.. +.. .....++
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~---~~~~~~~ 108 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSK---HGSFLFV 108 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC-----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEE---ETTEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC-----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEE---ECCEEEE
Confidence 3466677899999987655 4899998752 123455666666663 1133444431 111 1335689
Q ss_pred EEEeCCCCChh-----------hh---hhcccc------------CCCCHHHHH--------------------------
Q 006750 304 VFEFMPNGNLR-----------DC---LDGVLV------------EGMNWDTRV-------------------------- 331 (632)
Q Consensus 304 V~Ey~~~gsL~-----------~~---L~~~~~------------~~l~~~~~~-------------------------- 331 (632)
||+|++|..+. .. |+.... ....|....
T Consensus 109 l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 188 (346)
T 2q83_A 109 VYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLY 188 (346)
T ss_dssp EEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHH
T ss_pred EEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHH
Confidence 99999987653 11 111110 001343211
Q ss_pred -----HHHHHHHHhhHHHHh----------cCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 332 -----AIAIGAARGLEYLHE----------AAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 332 -----~i~~~ia~gL~yLH~----------~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.+...+..++.+|+. ...+.++|+|+++.|||++.++.+.|+||+.+..
T Consensus 189 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 189 LQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 011123345667763 1235699999999999998888899999998753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.00 E-value=6.8e-05 Score=75.80 Aligned_cols=79 Identities=24% Similarity=0.326 Sum_probs=57.4
Q ss_pred CccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCC---CccceeeeeecccCCcceEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC---HVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hp---niv~l~g~~~~~~~~~~~~~ 302 (632)
.....+.+|.|..+.||+.++.||+.|+||+..... ......|..|...|+.|.-. .+.+++++.. .+
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~--------~~ 86 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGWDD--------RT 86 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEET--------TE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEeccC--------ce
Confidence 344567799999999999999999999999876443 22233488999999988422 3445554422 27
Q ss_pred EEEEeCCCCCh
Q 006750 303 LVFEFMPNGNL 313 (632)
Q Consensus 303 lV~Ey~~~gsL 313 (632)
+||||++++..
T Consensus 87 lv~e~l~~~~~ 97 (288)
T 3f7w_A 87 LAMEWVDERPP 97 (288)
T ss_dssp EEEECCCCCCC
T ss_pred EEEEeecccCC
Confidence 99999987754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.95 E-value=2.4e-05 Score=83.07 Aligned_cols=76 Identities=20% Similarity=0.159 Sum_probs=48.6
Q ss_pred cceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC------CChHHHHHHHHHHHHhcCC--CC-ccceeeeeecccCCcc
Q 006750 230 SNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG------PNADSVFLTEVDMLSRLHH--CH-VVPLVGYCSEFRGKRA 299 (632)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~------~~~~~~f~~Ei~~l~~l~H--pn-iv~l~g~~~~~~~~~~ 299 (632)
.+.||.|.++.||++... +++.++||....... ......+..|.++|+.+.. +. +.+++.+.. .
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d~------~ 108 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT------E 108 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET------T
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEcC------C
Confidence 457899999999999754 468899998653211 1122346789999988842 33 445554321 1
Q ss_pred eEEEEEEeCCCC
Q 006750 300 MRLLVFEFMPNG 311 (632)
Q Consensus 300 ~~~lV~Ey~~~g 311 (632)
..++||||+++.
T Consensus 109 ~~~lvmE~l~g~ 120 (397)
T 2olc_A 109 MAVTVMEDLSHL 120 (397)
T ss_dssp TTEEEECCCTTS
T ss_pred ccEEEEEeCCCc
Confidence 348999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.86 E-value=9.7e-05 Score=75.72 Aligned_cols=137 Identities=17% Similarity=0.194 Sum_probs=89.7
Q ss_pred cceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC---CCCccceeeeeecccCCcceEEEEEE
Q 006750 230 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH---HCHVVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~---Hpniv~l~g~~~~~~~~~~~~~lV~E 306 (632)
.+.|+.|.+..+|+... ++..++||+.... ....|..|...|+.|. ...+.++++++.. ....++|||
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~----~g~~~lvme 111 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNS----QGHSFLLLE 111 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC----SSEEEEEEE
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec----CCceEEEEE
Confidence 46689999999999986 4678899987642 2455899999999883 2567788877654 245799999
Q ss_pred eCCCCChhh--------h---hhcccc-C-------------------CCCHHHHH---HHHH--H--------------
Q 006750 307 FMPNGNLRD--------C---LDGVLV-E-------------------GMNWDTRV---AIAI--G-------------- 336 (632)
Q Consensus 307 y~~~gsL~~--------~---L~~~~~-~-------------------~l~~~~~~---~i~~--~-------------- 336 (632)
|+++..+.. . |+.... . .-+|.... ++.. +
T Consensus 112 ~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~ 191 (312)
T 3jr1_A 112 ALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDL 191 (312)
T ss_dssp CCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHH
T ss_pred eccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHH
Confidence 999886521 1 122111 0 02465432 1111 1
Q ss_pred HHH-hhHHHHh-cCCCceeecCCCCCCeEecCCCCeEEeccc
Q 006750 337 AAR-GLEYLHE-AAAPRILHRDIKSSNILLDENLNAKITDLG 376 (632)
Q Consensus 337 ia~-gL~yLH~-~~~~~iiHrDLKp~NILl~~~~~vkL~DFG 376 (632)
++. ....|.. ...|.++|+|+.+.|++++.++ +.|.||.
T Consensus 192 l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 192 IVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 111 1123322 2356799999999999999887 8899984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00025 Score=75.84 Aligned_cols=32 Identities=13% Similarity=0.335 Sum_probs=27.7
Q ss_pred CCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 349 APRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 349 ~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
.+.++|+|+++.|||++.++ ++|+||+.+...
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 45699999999999998876 999999988653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00053 Score=70.17 Aligned_cols=161 Identities=9% Similarity=0.057 Sum_probs=88.5
Q ss_pred ecHHHHHHhhcCccc-----cceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCC--ccce
Q 006750 215 FSYSALEHATDKFSG-----SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH--VVPL 287 (632)
Q Consensus 215 ~~~~~l~~~t~~f~~-----~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpn--iv~l 287 (632)
++.+++......|.. .+.|+.|....+|+....+| .+++|+....... ..+..|+.++..|.... +.++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~---~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCCH---HHHHHHHHHHHHHHHCCCCCCcc
Confidence 344555555555654 23466688899999987666 5889988753222 23667888888774222 3344
Q ss_pred eeeeeccc---CCcceEEEEEEeCCCCChhhh--------------hhccc---cCC-------CCHHHHHHH-------
Q 006750 288 VGYCSEFR---GKRAMRLLVFEFMPNGNLRDC--------------LDGVL---VEG-------MNWDTRVAI------- 333 (632)
Q Consensus 288 ~g~~~~~~---~~~~~~~lV~Ey~~~gsL~~~--------------L~~~~---~~~-------l~~~~~~~i------- 333 (632)
+... +.. ......+++|+|++|..+... ++... ... ..|.....-
T Consensus 83 ~~~~-~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 83 LPRK-DGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp CCBT-TCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred cCCC-CCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence 3211 000 012346899999998654210 11110 000 123321110
Q ss_pred -----HHHHHHhhHHHHhc----CCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 334 -----AIGAARGLEYLHEA----AAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 334 -----~~~ia~gL~yLH~~----~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
...+...+++|+.. ..+.++|+|+.+.|||++++..+.|+||+.+..
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 11134455566542 134589999999999999876568999998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00067 Score=68.87 Aligned_cols=71 Identities=8% Similarity=-0.009 Sum_probs=45.2
Q ss_pred cceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCc-cceeeeeecccCCcceEEEEEEeC
Q 006750 230 SNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV-VPLVGYCSEFRGKRAMRLLVFEFM 308 (632)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpni-v~l~g~~~~~~~~~~~~~lV~Ey~ 308 (632)
.+.|+.|....+|+. ..+++|+......... ...+|+.+++.+....+ .+++++..+ .-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~--~r~~E~~~l~~l~~~g~~P~~~~~~~~------~~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYI--NRANEAVAAREAAKAGVSPEVLHVDPA------TGVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----CC--CHHHHHHHHHHHHHTTSSCCEEEECTT------TCCEEEECC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCcccee--CHHHHHHHHHHHHHcCCCCceEEEECC------CCEEEEeec
Confidence 577888999999999 4588998865322111 14578888888743333 466654321 227899999
Q ss_pred -CCCCh
Q 006750 309 -PNGNL 313 (632)
Q Consensus 309 -~~gsL 313 (632)
+|.+|
T Consensus 90 ~~g~~l 95 (301)
T 3dxq_A 90 AGAQTM 95 (301)
T ss_dssp TTCEEC
T ss_pred CCCccC
Confidence 66554
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00088 Score=68.96 Aligned_cols=141 Identities=15% Similarity=0.123 Sum_probs=73.9
Q ss_pred ceeeeeCceE-EEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-C-CCccceeeeeecccCCcceEEEEEEe
Q 006750 231 NIVGQGGSSY-VYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-H-CHVVPLVGYCSEFRGKRAMRLLVFEF 307 (632)
Q Consensus 231 ~~LG~G~fG~-Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~-H-pniv~l~g~~~~~~~~~~~~~lV~Ey 307 (632)
+.|+.|.... +|+....+|..+++|....... ..+..|+.+++.+. + -.+.+++.+... .. +++||+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~----~g--~ll~e~ 93 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG----GDTQPFVDLAQYLRNLDISAPEIYAEEHA----RG--LLLIED 93 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT----CCSHHHHHHHHHHHHTTCBCCCEEEEETT----TT--EEEECC
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC----ccccHHHHHHHHHHhCCCCCCceeeecCC----CC--EEEEee
Confidence 3455555444 6677654467787776543221 12456778877773 2 235566665321 12 789999
Q ss_pred CCCCChhhhhhcccc------------------------CCCCHHHHH-------H-H------------HHHHHHhhHH
Q 006750 308 MPNGNLRDCLDGVLV------------------------EGMNWDTRV-------A-I------------AIGAARGLEY 343 (632)
Q Consensus 308 ~~~gsL~~~L~~~~~------------------------~~l~~~~~~-------~-i------------~~~ia~gL~y 343 (632)
+.+..+.+++..... ..++..... . + ...+...+..
T Consensus 94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 173 (333)
T 3csv_A 94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ 173 (333)
T ss_dssp CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 977676554422100 001111100 0 0 0011122223
Q ss_pred HHh---cCCCceeecCCCCCCeEecCC----CCeEEeccccceec
Q 006750 344 LHE---AAAPRILHRDIKSSNILLDEN----LNAKITDLGMAKRL 381 (632)
Q Consensus 344 LH~---~~~~~iiHrDLKp~NILl~~~----~~vkL~DFGla~~~ 381 (632)
|.. ...+.++|+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 311 123469999999999999874 67899999998753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0023 Score=69.04 Aligned_cols=74 Identities=11% Similarity=0.050 Sum_probs=48.5
Q ss_pred cceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCc-cceeeeeecccCCcceEEEEEEe
Q 006750 230 SNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV-VPLVGYCSEFRGKRAMRLLVFEF 307 (632)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpni-v~l~g~~~~~~~~~~~~~lV~Ey 307 (632)
.+.|+.|-...+|+....+ +..+++|+......... ...+|..+++.|...++ .++++++.. .+||||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i--dR~~E~~vl~~L~~~gl~P~ll~~~~~--------G~v~e~ 182 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII--NREREKKISCILYNKNIAKKIYVFFTN--------GRIEEF 182 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS--CHHHHHHHHHHHTTSSSBCCEEEEETT--------EEEEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc--CHHHHHHHHHHHHhcCCCCCEEEEeCC--------eEEEEe
Confidence 3567778889999998865 47888998754321111 12689999999965555 467766521 359999
Q ss_pred CCCCCh
Q 006750 308 MPNGNL 313 (632)
Q Consensus 308 ~~~gsL 313 (632)
++|.+|
T Consensus 183 I~G~~l 188 (458)
T 2qg7_A 183 MDGYAL 188 (458)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 987555
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0018 Score=69.32 Aligned_cols=73 Identities=19% Similarity=0.283 Sum_probs=50.4
Q ss_pred cceeeeeCceEEEEEEECC--------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCc-cceeeeeecccCCcce
Q 006750 230 SNIVGQGGSSYVYRGQLTD--------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV-VPLVGYCSEFRGKRAM 300 (632)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpni-v~l~g~~~~~~~~~~~ 300 (632)
.+.|+.|....||+....+ +..+++|+.... .....+.+|..+++.|...++ .++++.+..
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~------- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG------- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT-------
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC-------
Confidence 3567778889999998753 578999988432 111346689999998843344 567765432
Q ss_pred EEEEEEeCCCCCh
Q 006750 301 RLLVFEFMPNGNL 313 (632)
Q Consensus 301 ~~lV~Ey~~~gsL 313 (632)
.+||||++|.+|
T Consensus 148 -g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 -GRLEEYIPSRPL 159 (429)
T ss_dssp -EEEECCCCEEEC
T ss_pred -CEEEEEeCCccc
Confidence 389999986444
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0034 Score=64.19 Aligned_cols=143 Identities=16% Similarity=0.147 Sum_probs=82.7
Q ss_pred ceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCC--CccceeeeeecccC---CcceEEEEE
Q 006750 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC--HVVPLVGYCSEFRG---KRAMRLLVF 305 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hp--niv~l~g~~~~~~~---~~~~~~lV~ 305 (632)
..|+ |....||+....+|+.+++|+...... ....+..|..++..|... .+++++.. +... .....++||
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVF 106 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEE
Confidence 4566 888899998877787899999874321 234577888888888422 24445443 1100 123568899
Q ss_pred EeCCCCChhh-----------h---hhcccc-------CCCCHHHH----HHHH---------------HHHHHhhHHHH
Q 006750 306 EFMPNGNLRD-----------C---LDGVLV-------EGMNWDTR----VAIA---------------IGAARGLEYLH 345 (632)
Q Consensus 306 Ey~~~gsL~~-----------~---L~~~~~-------~~l~~~~~----~~i~---------------~~ia~gL~yLH 345 (632)
+|++|..+.. . ++.... ...++... ..+. ..+...++.+.
T Consensus 107 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~ 186 (328)
T 1zyl_A 107 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT 186 (328)
T ss_dssp ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHH
Confidence 9998755421 1 111100 01222211 0010 01112233333
Q ss_pred hc----CCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 346 EA----AAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 346 ~~----~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.. ..+.++|+|+++.|||++ + .+.|+||+.+..
T Consensus 187 ~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 187 AHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 21 234589999999999999 4 899999998754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0026 Score=66.46 Aligned_cols=73 Identities=10% Similarity=0.100 Sum_probs=44.5
Q ss_pred ceeeeeCceEEEEEEECC---------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCC-ccceeeeeecccCCcce
Q 006750 231 NIVGQGGSSYVYRGQLTD---------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH-VVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~---------g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpn-iv~l~g~~~~~~~~~~~ 300 (632)
..|+.|....+|+....+ +..+++|+...... .......|..+++.|...+ +.++++...
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~~~~E~~~l~~L~~~g~~P~~~~~~~-------- 108 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD--ELYNTISEFEVYKTMSKYKIAPQLLNTFN-------- 108 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG--GTSCHHHHHHHHHHHHHTTSSCCEEEEET--------
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc--ceecHHHHHHHHHHHHhcCCCCceEEecC--------
Confidence 457778888999998754 26888998754321 1112467888888884334 346665431
Q ss_pred EEEEEEeCCCCCh
Q 006750 301 RLLVFEFMPNGNL 313 (632)
Q Consensus 301 ~~lV~Ey~~~gsL 313 (632)
-++||||++|..|
T Consensus 109 ~~~v~e~i~G~~l 121 (369)
T 3c5i_A 109 GGRIEEWLYGDPL 121 (369)
T ss_dssp TEEEEECCCSEEC
T ss_pred CcEEEEEecCCcC
Confidence 1689999987654
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.92 E-value=0.004 Score=65.42 Aligned_cols=140 Identities=19% Similarity=0.225 Sum_probs=82.9
Q ss_pred ceeeeeCceEEEEEEEC--------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCccceeeeeecccCCcceE
Q 006750 231 NIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~--------~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~~~~ 301 (632)
+.|..|-...+|+.... +++.+++|+.... ......+.+|..+++.|. +.-..++++++..
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~-------- 125 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE-------- 125 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT--------
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC--------
Confidence 45666888889998864 2478999986432 123345679999999884 3333567665532
Q ss_pred EEEEEeCCCCChhhh--------------h---hcc---ccCCCC--HHHHHHHHHHHHH-------------------h
Q 006750 302 LLVFEFMPNGNLRDC--------------L---DGV---LVEGMN--WDTRVAIAIGAAR-------------------G 340 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~--------------L---~~~---~~~~l~--~~~~~~i~~~ia~-------------------g 340 (632)
.+||||++|..|..- | +.. ..+... |.++.++..++.. .
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 289999998665321 0 111 011122 4455555444322 2
Q ss_pred hHHHH----hc-CCCceeecCCCCCCeEecCC----CCeEEecccccee
Q 006750 341 LEYLH----EA-AAPRILHRDIKSSNILLDEN----LNAKITDLGMAKR 380 (632)
Q Consensus 341 L~yLH----~~-~~~~iiHrDLKp~NILl~~~----~~vkL~DFGla~~ 380 (632)
+..|. .. ....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 33332 22 22358999999999999876 7899999998764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0071 Score=62.47 Aligned_cols=32 Identities=22% Similarity=0.248 Sum_probs=28.0
Q ss_pred CceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 350 PRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 350 ~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
..++|+|+.+.||+++.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 46999999999999998888999999887653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0059 Score=58.32 Aligned_cols=100 Identities=13% Similarity=0.102 Sum_probs=65.1
Q ss_pred CChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCCCCCC
Q 006750 311 GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 390 (632)
Q Consensus 311 gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 390 (632)
-||.+.|+.. ..++++.+++.++.|.+.+|.-+-....+ ..+=+-|..|+|..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc-----------
Confidence 4799998764 47899999999999999988766221111 1233357899999999887764 2111
Q ss_pred CCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhC
Q 006750 391 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITG 432 (632)
Q Consensus 391 ~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG 432 (632)
.....+.|||... ...+.+.=|||||+++|.-+-=
T Consensus 98 ------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 ------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp ---------------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred ------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 0123466888653 4557788999999999988853
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.78 E-value=0.076 Score=56.45 Aligned_cols=73 Identities=11% Similarity=0.081 Sum_probs=48.5
Q ss_pred ceeeeeCceEEEEEEECC--------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCccceeeeeecccCCcceE
Q 006750 231 NIVGQGGSSYVYRGQLTD--------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~~~~ 301 (632)
+.|..|-...+|+....+ +..+++|+......... ...+|..+++.|. +.-..++++.+. -
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~i--dR~~E~~~l~~L~~~gi~P~l~~~~~--------~ 145 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFY--DSKVELDVFRYLSNINIAPNIIADFP--------E 145 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCC--CHHHHHHHHHHHHHTTSSCCEEEEET--------T
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhc--CHHHHHHHHHHHHhcCCCCCEEEEcC--------C
Confidence 456668889999998753 57899998754321111 2468899998884 333446665332 1
Q ss_pred EEEEEeCCCCCh
Q 006750 302 LLVFEFMPNGNL 313 (632)
Q Consensus 302 ~lV~Ey~~~gsL 313 (632)
++||||++|..|
T Consensus 146 ~~I~efI~G~~l 157 (424)
T 3mes_A 146 GRIEEFIDGEPL 157 (424)
T ss_dssp EEEEECCCSEEC
T ss_pred CEEEEEeCCccC
Confidence 789999998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.68 E-value=0.25 Score=52.03 Aligned_cols=29 Identities=28% Similarity=0.416 Sum_probs=24.8
Q ss_pred eeecCCCCCCeEe------cCCCCeEEecccccee
Q 006750 352 ILHRDIKSSNILL------DENLNAKITDLGMAKR 380 (632)
Q Consensus 352 iiHrDLKp~NILl------~~~~~vkL~DFGla~~ 380 (632)
++|+|+.+.|||+ +++..+.++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999998764
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=93.26 E-value=0.039 Score=37.98 Aligned_cols=27 Identities=15% Similarity=0.208 Sum_probs=11.1
Q ss_pred EehHHHHHHHHHHHHHHHHHhhhccCC
Q 006750 122 IVLLLCVILTTIAFLMLVLCYVYRKGK 148 (632)
Q Consensus 122 ii~i~~~~~~~l~~l~~~~~~~~rr~k 148 (632)
++++++++++++++++.+++|++||+.
T Consensus 14 Ia~~vVGvll~vi~~l~~~~~~RRR~~ 40 (44)
T 2jwa_A 14 IISAVVGILLVVVLGVVFGILIKRRQQ 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHCS
T ss_pred hHHHHHHHHHHHHHHHHHHhheehhhh
Confidence 333333433333333334445555443
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.99 E-value=0.047 Score=37.75 Aligned_cols=27 Identities=15% Similarity=0.122 Sum_probs=10.6
Q ss_pred EehHHHHHHHHHHHHHHHHHhhhccCC
Q 006750 122 IVLLLCVILTTIAFLMLVLCYVYRKGK 148 (632)
Q Consensus 122 ii~i~~~~~~~l~~l~~~~~~~~rr~k 148 (632)
|++.+++.++++++++++++++.||++
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence 333333333333344444444444433
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.84 E-value=0.047 Score=37.64 Aligned_cols=27 Identities=15% Similarity=0.057 Sum_probs=10.5
Q ss_pred EehHHHHHHHHHHHHHHHHHhhhccCC
Q 006750 122 IVLLLCVILTTIAFLMLVLCYVYRKGK 148 (632)
Q Consensus 122 ii~i~~~~~~~l~~l~~~~~~~~rr~k 148 (632)
|++.+++.++++++++++++++.||++
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~RRRr 38 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYVRRKS 38 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEeehHHHHHHHHHHHHHHHHhhhhh
Confidence 333333333333344444444444443
|
| >3h5c_B Vitamin K-dependent protein Z; protein Z-protein Z inhibitor complex, blood coagulation, CL PAIR of basic residues, disulfide bond, EGF-like domain; HET: NAG BGC; 3.26A {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.23 E-value=0.73 Score=46.55 Aligned_cols=68 Identities=25% Similarity=0.676 Sum_probs=38.7
Q ss_pred hhccccccccccCCccceEEecCCCCCCcccccccCCC-CCcccCC--------CCCCCCCCceeeeecCCCCCcccccc
Q 006750 19 QRSICDKLSERSGQKNWKCTCSSSLQGDQSNILKLNCS-RSCDCSP--------AVGGSSEGKWTCICAADGLPKVAANS 89 (632)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~c~~--------~~~~~~~~~~~c~~~~~g~~~~~~~~ 89 (632)
.++.|.+ ..++|+|.|..||.|+. |. ...+|.. ... ...|.|+|.|. +|+- ...
T Consensus 15 ~~g~C~~-----~~~~~~C~C~~g~~g~~-------C~~~~~eC~~~~~~~C~~~C~-~~~g~~~C~C~-~g~~---~~~ 77 (317)
T 3h5c_B 15 HNGSCQD-----SIWGYTCTCSPGYEGSN-------CELAKNECHPERTDGCQHFCL-PGQESYTCSCA-QGYR---LGE 77 (317)
T ss_dssp TTCCCCC-----CSSSCCCCCSSSCCSSS-------SCCCSSSCCTTCTTSCSSEEE-CCSSSCEEECC-TTEE---CCT
T ss_pred CCCEeEC-----CCCCeEEECCCCCcCCc-------cccCcccCCCCCCCCCcCccc-cCCCeeEEecc-cccc---ccc
Confidence 3455644 34689999999999863 32 2233322 111 14578999994 4543 223
Q ss_pred cCcccccccccCCC
Q 006750 90 YDTTCFASCTCTSG 103 (632)
Q Consensus 90 ~~~~c~~~c~c~~~ 103 (632)
....|.....|..+
T Consensus 78 ~~~~C~~~~~c~cg 91 (317)
T 3h5c_B 78 DHKQCVPHDQCACG 91 (317)
T ss_dssp TSSCCEECSSCCCC
T ss_pred cccccccccccccc
Confidence 34577765555444
|
| >1z6c_A Vitamin K-dependent protein S; EGF module, blood clotting; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.53 E-value=0.1 Score=42.11 Aligned_cols=49 Identities=20% Similarity=0.510 Sum_probs=28.2
Q ss_pred CCccceEEecCCCCCCcccccccCCCCCcccCCC----CCCCCCCceeeeecCCCCCc
Q 006750 31 GQKNWKCTCSSSLQGDQSNILKLNCSRSCDCSPA----VGGSSEGKWTCICAADGLPK 84 (632)
Q Consensus 31 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c~~~----~~~~~~~~~~c~~~~~g~~~ 84 (632)
...+|+|.|..||+|++ +- ..|..+-+|..+ .=....|.|+|.|. |+++
T Consensus 21 ~~g~y~C~C~~G~~~~~-~g--~~C~dideC~~~~C~~~C~n~~g~y~C~C~--g~~G 73 (87)
T 1z6c_A 21 IPGDFECECPEGYRYNL-KS--KSCEDIDECSENMCAQLCVNYPGGYTCYCD--GKKG 73 (87)
T ss_dssp BTTBCCCSSSTTCEEET-TT--TEEECCCHHHHSCCSSEECCCSSSCCEECC--SSSC
T ss_pred CCCCEEEECCCCceECC-CC--CcCCCcCeeCCCCCCCEEEccCCCEEEECC--CCcC
Confidence 35689999999999765 21 244444333211 00113577888885 4444
|
| >1lmj_A Fibrillin 1; EGF, calcium, microfibril, neonatal, marfan syndrome, connective tissue, extracellular matrix, structural protein; NMR {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 | Back alignment and structure |
|---|
Probab=86.65 E-value=0.17 Score=40.67 Aligned_cols=46 Identities=20% Similarity=0.611 Sum_probs=27.6
Q ss_pred CCccceEEecCCCCCCcccccccCCCCCcccCCCC---C----CCCCCceeeeec
Q 006750 31 GQKNWKCTCSSSLQGDQSNILKLNCSRSCDCSPAV---G----GSSEGKWTCICA 78 (632)
Q Consensus 31 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~---~----~~~~~~~~c~~~ 78 (632)
...+|+|.|..||+|++ +.- ..|..+-+|...- . ....|.|+|.|.
T Consensus 21 ~~g~y~C~C~~Gy~~~~-~~g-~~C~dideC~~~~~~C~~~~C~n~~g~y~C~C~ 73 (86)
T 1lmj_A 21 TPGDFECKCDEGYESGF-MMM-KNCMDIDECQRDPLLCRGGVCHNTEGSYRCECP 73 (86)
T ss_dssp ETTEEEECCCSSEEECT-TTS-SSEEECCHHHHCSSTTTTSEEEEETTEEEEESC
T ss_pred CCCCEEeeCCCCcCccC-CCC-CccCCcccccCCCCcCCCCEeEcCCCCEEEECc
Confidence 34589999999999775 222 3566555553211 0 013467888873
|
| >1aut_L Activated protein C; serine proteinase, plasma calcium binding, glycoprotein, HYD hydrolase inhibitor complex, blood clotting; HET: 0G6; 2.80A {Homo sapiens} SCOP: g.3.11.1 g.3.11.1 PDB: 3f6u_L* | Back alignment and structure |
|---|
Probab=83.63 E-value=0.56 Score=39.73 Aligned_cols=24 Identities=25% Similarity=0.638 Sum_probs=18.0
Q ss_pred hhccccccccccCCccceEEecCCCCCCc
Q 006750 19 QRSICDKLSERSGQKNWKCTCSSSLQGDQ 47 (632)
Q Consensus 19 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 47 (632)
.++.|.+ ..++|+|.|..||.|+.
T Consensus 24 ~~g~C~~-----~~~~y~C~C~~G~~G~~ 47 (114)
T 1aut_L 24 GHGTCID-----GIGSFSCDCRSGWEGRF 47 (114)
T ss_dssp TSEEECC-----CSSCCCEEECTTEESTT
T ss_pred CcCCCCC-----CCCCcEeeCCCCCcCCC
Confidence 4556654 45689999999999864
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.09 E-value=0.13 Score=55.46 Aligned_cols=62 Identities=8% Similarity=-0.020 Sum_probs=18.2
Q ss_pred ccceeeeeCceEEEEEEECC-CcEEEE------EEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeec
Q 006750 229 GSNIVGQGGSSYVYRGQLTD-GRIVAV------KRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE 293 (632)
Q Consensus 229 ~~~~LG~G~fG~Vy~~~~~~-g~~vAV------K~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~ 293 (632)
..+.|| ||.||+|.+.. ..+||| |..+... ..+....|.+|..+++.++|||+++.+++...
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 345676 99999999864 467899 7766432 22333458899999999999999999887653
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=82.81 E-value=0.81 Score=30.53 Aligned_cols=14 Identities=29% Similarity=0.517 Sum_probs=6.0
Q ss_pred HHHHHHHHHhhhcc
Q 006750 133 IAFLMLVLCYVYRK 146 (632)
Q Consensus 133 l~~l~~~~~~~~rr 146 (632)
+++++.+.++++||
T Consensus 24 v~li~~l~~~~~rr 37 (38)
T 2k1k_A 24 AALLLGILVFRSRR 37 (38)
T ss_dssp HHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHHeec
Confidence 33333344444544
|
| >1x7a_L Coagulation factor IX, light chain; inhibition, blood clotting,hydrolase; HET: 187; 2.90A {Sus scrofa} SCOP: g.3.11.1 g.3.11.1 PDB: 1pfx_L* | Back alignment and structure |
|---|
Probab=82.33 E-value=1.6 Score=38.74 Aligned_cols=65 Identities=17% Similarity=0.456 Sum_probs=33.5
Q ss_pred CCccceEEecCCCCCCcccccccCCCCC-cccCCCCCCCCCCceeeeecCCCCCcccccccCccccccccc
Q 006750 31 GQKNWKCTCSSSLQGDQSNILKLNCSRS-CDCSPAVGGSSEGKWTCICAADGLPKVAANSYDTTCFASCTC 100 (632)
Q Consensus 31 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~c~~~~~~~~~~~~~c~~~~~g~~~~~~~~~~~~c~~~c~c 100 (632)
..++|+|.|..||.|.. =...+-|... +.|.........|.|+|.|. +|+- ....+..|-....+
T Consensus 65 ~~~~y~C~C~~G~~G~~-C~~~deC~~~~~~C~~~C~~n~~g~y~C~C~-~Gy~---l~~dG~~C~~~~~~ 130 (146)
T 1x7a_L 65 DINSYECWCQVGFEGKN-CELDATCNIKNGRCKQFCKTGADSKVLCSCT-TGYR---LAPDQKSCKPAVPF 130 (146)
T ss_dssp CSSCEEEECCSSEESTT-TCEECCTTSGGGSCSSBCCCCSSSCCCCBCC-TTEE---ECTTSSSEEECSSS
T ss_pred CCCCEEEecCCCCcCCc-CCCCccccCCCCCCcCCCCCCCCCCEEeEcC-CCcE---eCCCCCcCCCCCCC
Confidence 34589999999999842 1100223321 23322220124678999984 4443 22234566554333
|
| >2w2n_E LDL receptor, low-density lipoprotein receptor; hydrolase-receptor complex, PCSK9, proprotein converta low-density lipoprotein receptor, EGF; 2.30A {Homo sapiens} PDB: 2w2q_E 2w2o_E 2w2p_E 2w2m_E 3gcw_E 3bps_E 3gcx_E 1hz8_A 1i0u_A 1hj7_A | Back alignment and structure |
|---|
Probab=80.15 E-value=0.38 Score=40.39 Aligned_cols=43 Identities=21% Similarity=0.538 Sum_probs=16.5
Q ss_pred CCccceEEecCCCCCCcccccccCCCCCcccCC-C-CC---CCCCCceeeee
Q 006750 31 GQKNWKCTCSSSLQGDQSNILKLNCSRSCDCSP-A-VG---GSSEGKWTCIC 77 (632)
Q Consensus 31 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~c~~-~-~~---~~~~~~~~c~~ 77 (632)
..++|+|.|..||+|+.. ..|..+-+|.. . .. ....|.|+|.|
T Consensus 46 ~~g~y~C~C~~Gy~g~~g----~~C~dideC~~~~~C~~~C~n~~gsy~C~C 93 (107)
T 2w2n_E 46 LKIGYECLCPDGFQLVAQ----RRCEDIDECQDPDTCSQLCVNLEGGYKCQC 93 (107)
T ss_dssp CSBSCEEECCTTCEEETT----TEEEC-------------------------
T ss_pred CCCCeEEECCCCccccCC----CccccccccCCCCCcCCeeecCCCCEEEEC
Confidence 356899999999998531 34555545531 0 00 11356677776
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.11 E-value=0.48 Score=32.18 Aligned_cols=9 Identities=22% Similarity=0.394 Sum_probs=3.8
Q ss_pred HHHhhhccC
Q 006750 139 VLCYVYRKG 147 (632)
Q Consensus 139 ~~~~~~rr~ 147 (632)
++++++||+
T Consensus 32 ~~~~~~rRr 40 (41)
T 2k9y_A 32 VGFFIHRRR 40 (41)
T ss_dssp HHHSSSSSC
T ss_pred HheeEeeec
Confidence 334444443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 632 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-64 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-63 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-61 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-60 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-60 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-58 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-58 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-58 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-57 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-55 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-55 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-55 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-54 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-54 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-53 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-53 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-53 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-51 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-49 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-45 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-39 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-36 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-30 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-17 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 1e-64
Identities = 76/291 (26%), Positives = 122/291 (41%), Gaps = 31/291 (10%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFK-TQGGPNADSVFLTEVDMLSRLHHCH 283
+ + +G G VY+G+ VAVK T P F EV +L + H +
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 343
++ +GY + +V ++ +L L + + IA A+G++Y
Sbjct: 66 ILLFMGYSTAP-----QLAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDY 119
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
LH I+HRD+KS+NI L E+L KI D G+A S S ++ G+ +
Sbjct: 120 LHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW---SGSHQFEQLSGSILWM 173
Query: 404 APEYAMV---GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460
APE + S SDV++FG+VL EL+TG+ P + + ++ D
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 233
Query: 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511
V S P M L ECL+ D RP +++ + +A
Sbjct: 234 VRSNCPKA-------------MKRLMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 3e-63
Identities = 71/297 (23%), Positives = 124/297 (41%), Gaps = 21/297 (7%)
Query: 233 VGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCS 292
+G+G V+RG+ G VAVK F ++ E+ L H +++ + +
Sbjct: 11 IGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADN 67
Query: 293 EFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA--- 349
+ G LV ++ +G+L D L+ + + + +A+ A GL +LH
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 350 --PRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
P I HRD+KS NIL+ +N I DLG+A R + + +P GT Y APE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT-DTIDIAPNHRVGTKRYMAPEV 183
Query: 408 ------AMVGRASLMSDVFSFGVVLLELITGRQP--IHRSITKGEESLVLWATPRLQDSG 459
+ +D+++ G+V E+ IH LV +
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 460 TVISELPDPRLKGDF-PKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKS 515
V + P + + E +++MA + +EC + AR T + + LS ++ +
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 203 bits (518), Expect = 3e-61
Identities = 66/309 (21%), Positives = 127/309 (41%), Gaps = 38/309 (12%)
Query: 215 FSYSALEHATDKFSGS---------NIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQG 261
F++ A +F+ ++G G V G L VA+K K+
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 262 GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL 321
FL+E ++ + H +V+ L G ++ +++ EFM NG+L D
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK----STPVMIITEFMENGSL-DSFLRQN 121
Query: 322 VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381
V + G A G++YL + +HRD+ + NIL++ NL K++D G+++ L
Sbjct: 122 DGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178
Query: 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441
+ D +S + + APE + + SDV+S+G+V+ E+++ + + +T
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238
Query: 442 KGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS 501
+ + + + P + + L +C Q D + RP
Sbjct: 239 NQD-----------------VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG 281
Query: 502 EVVQILSTI 510
++V L +
Sbjct: 282 QIVNTLDKM 290
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 6e-61
Identities = 66/312 (21%), Positives = 118/312 (37%), Gaps = 41/312 (13%)
Query: 220 LEHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSR 278
+E D F + +G G V++ G ++A K + P + + E+ +L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 279 LHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA 338
+ ++V G + E M G+L L + ++I
Sbjct: 61 CNSPYIVGFYGAFYS----DGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVI 114
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
+GL YL E +I+HRD+K SNIL++ K+ D G++ +L S G
Sbjct: 115 KGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-------DSMANSFVG 165
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP-----------IHRSITKGEES- 446
T Y +PE S+ SD++S G+ L+E+ GR P + +G+ +
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 225
Query: 447 ---------LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----CLQLD 493
L + I EL D + PK + + ++ CL +
Sbjct: 226 TPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 285
Query: 494 PDARPTMSEVVQ 505
P R + +++
Sbjct: 286 PAERADLKQLMV 297
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 5e-60
Identities = 68/283 (24%), Positives = 125/283 (44%), Gaps = 31/283 (10%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 284
+ +G G V+ G VAVK K G + FL E +++ +L H +
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRL 70
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 344
V L ++ ++ E+M NG+L D L + + + +A A G+ ++
Sbjct: 71 VRLYAVVTQEP-----IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 404
E +HRD++++NIL+ + L+ KI D G+A+ ++ + + + + A
Sbjct: 126 EE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK----FPIKWTA 178
Query: 405 PEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 464
PE G ++ SDV+SFG++L E++T + + +T E L R+
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM--------V 230
Query: 465 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507
PD + P+E + L + C + P+ RPT + +L
Sbjct: 231 RPD-----NCPEE----LYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 9e-60
Identities = 69/298 (23%), Positives = 120/298 (40%), Gaps = 29/298 (9%)
Query: 230 SNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV 285
+ ++G+G VY G L D AVK S FLTE ++ H +V+
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 286 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLH 345
L+G C G L+V +M +G+LR+ + + A+G+++L
Sbjct: 92 SLLGICLRSEGSP---LVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFGLQVAKGMKFLA 147
Query: 346 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 405
+ +HRD+ + N +LDE K+ D G+A+ + S + + A
Sbjct: 148 S---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK-LPVKWMAL 203
Query: 406 EYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 465
E + + SDV+SFGV+L EL+T P + + + ++ L RL
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-------- 255
Query: 466 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNISLN 523
P+ + + +C + RP+ SE+V +S I + +N
Sbjct: 256 ---------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVN 304
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 1e-58
Identities = 69/286 (24%), Positives = 116/286 (40%), Gaps = 35/286 (12%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 284
+ +G+G V G G VAVK K A FL E ++++L H ++
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNL 62
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 344
V L+G E +G +V E+M G+L D L + D + ++ +EYL
Sbjct: 63 VQLLGVIVEEKGGL---YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 404
+HRD+ + N+L+ E+ AK++D G+ K SS+ + + A
Sbjct: 120 EG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA--------SSTQDTGKLPVKWTA 168
Query: 405 PEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 464
PE + S SDV+SFG++L E+ + + P + +
Sbjct: 169 PEALREKKFSTKSDVWSFGILLWEIYSFGRV-----------------PYPRIPLKDVVP 211
Query: 465 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
+ K D P + + K C LD RP+ ++ + L I
Sbjct: 212 RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 3e-58
Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 31/287 (10%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 284
+ + +G G V+ G + VA+K + G ++ F+ E +++ +L H +
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKL 62
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 344
V L G C E +A LVFEFM +G L D +T + + + G+ YL
Sbjct: 63 VQLYGVCLE----QAPICLVFEFMEHGCLSD-YLRTQRGLFAAETLLGMCLDVCEGMAYL 117
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 404
E ++HRD+ + N L+ EN K++D GM + + D S + + + +
Sbjct: 118 EE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG----TKFPVKWAS 170
Query: 405 PEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 464
PE R S SDV+SFGV++ E+ + + + + + E + RL
Sbjct: 171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK------- 223
Query: 465 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511
P+ + + C + P+ RP S +++ L+ IA
Sbjct: 224 ----------PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 194 bits (495), Expect = 5e-58
Identities = 71/312 (22%), Positives = 129/312 (41%), Gaps = 31/312 (9%)
Query: 214 RFSYSALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTE 272
+Y E + + +G G VY G VAVK K + FL E
Sbjct: 6 SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE--FLKE 63
Query: 273 VDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVA 332
++ + H ++V L+G C+ ++ EFM GNL D L + ++ +
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTR----EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 119
Query: 333 IAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSS 392
+A + +EYL + +HRD+ + N L+ EN K+ D G+++ + D + + +
Sbjct: 120 MATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 176
Query: 393 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 452
+ APE + S+ SDV++FGV+L E+ T + I +
Sbjct: 177 K----FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------- 224
Query: 453 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512
+ EL + + + P+ + + L + C Q +P RP+ +E+ Q T+
Sbjct: 225 ---------VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
Query: 513 DKSRRRNISLNL 524
+ S + L
Sbjct: 276 ESSISDEVEKEL 287
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 5e-58
Identities = 71/283 (25%), Positives = 123/283 (43%), Gaps = 31/283 (10%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV 284
+ +GQG V+ G VA+K K G + FL E ++ +L H +
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKL 74
Query: 285 VPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYL 344
V L SE +V E+M G+L D L G + + V +A A G+ Y+
Sbjct: 75 VQLYAVVSEEP-----IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 345 HEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFA 404
+HRD++++NIL+ ENL K+ D G+A+ ++ + + + + A
Sbjct: 130 ER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG----AKFPIKWTA 182
Query: 405 PEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 464
PE A+ GR ++ SDV+SFG++L EL T + + + E + +
Sbjct: 183 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----------------VLD 225
Query: 465 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507
+ + P E + + L +C + +P+ RPT + L
Sbjct: 226 QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 7e-57
Identities = 65/302 (21%), Positives = 129/302 (42%), Gaps = 32/302 (10%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTDG-----RIVAVKRFKTQGGPNADSVFLTEVDMLSRL 279
+ ++G G VY+G L VA+K K FL E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 280 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR 339
H +++ L G S+++ +++ E+M NG L L + V + G A
Sbjct: 67 SHHNIIRLEGVISKYKP----MMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAA 121
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
G++YL +HRD+ + NIL++ NL K++D G+++ L+ D P + + + +
Sbjct: 122 GMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD--PEATYTTSGGKIP 176
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459
+ APE + + SDV+SFG+V+ E++T + + ++ E
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--------------- 221
Query: 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRN 519
+ + + + P + + L +C Q + RP +++V IL + +
Sbjct: 222 --VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKT 279
Query: 520 IS 521
++
Sbjct: 280 LA 281
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (482), Expect = 4e-56
Identities = 65/323 (20%), Positives = 124/323 (38%), Gaps = 55/323 (17%)
Query: 216 SYSALEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVF 269
+LE+ + +G+G V++ + +VAVK K + + + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 270 LTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL------------ 317
E +++ + ++V L+G C+ L+FE+M G+L + L
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAV----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119
Query: 318 ----------DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN 367
++ ++ IA A G+ YL E + +HRD+ + N L+ EN
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGEN 176
Query: 368 LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLL 427
+ KI D G+++ + + + A + PE R + SDV+++GVVL
Sbjct: 177 MVVKIADFGLSRNIYSADYYKADGNDA---IPIRWMPPESIFYNRYTTESDVWAYGVVLW 233
Query: 428 ELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAK 487
E+ + + + E VI + D + P+ + L +
Sbjct: 234 EIFSYGLQPYYGMAHEE----------------VIYYVRDGNIL-ACPENCPLELYNLMR 276
Query: 488 ECLQLDPDARPTMSEVVQILSTI 510
C P RP+ + +IL +
Sbjct: 277 LCWSKLPADRPSFCSIHRILQRM 299
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 4e-56
Identities = 58/287 (20%), Positives = 109/287 (37%), Gaps = 31/287 (10%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHC 282
+ + +G G + + +DG+I+ K + ++EV++L L H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEG--MNWDTRVAIAIGAARG 340
++V + +V E+ G+L + E ++ + + +
Sbjct: 64 NIVRYYDRIIDRTNTTLY--IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 341 LEYLHE--AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
L+ H +LHRD+K +N+ LD N K+ D G+A+ L D +S G
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-----TSFAKAFVG 176
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 458
T Y +PE + SD++S G +L EL P + ++
Sbjct: 177 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP--------------FTAFSQKEL 222
Query: 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
I E R+ + E +I+ L L RP++ E+++
Sbjct: 223 AGKIREGKFRRIPYRYSDELNEII----TRMLNLKDYHRPSVEEILE 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 2e-55
Identities = 67/295 (22%), Positives = 111/295 (37%), Gaps = 32/295 (10%)
Query: 220 LEHATDKFSGSNIV-GQGGSSYVYRGQL---TDGRIVAVKRFKTQGGPNADSVFLTEVDM 275
L D ++I G G V +G VA+K K + E +
Sbjct: 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62
Query: 276 LSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI 335
+ +L + ++V L+G C +LV E G L L G E + +
Sbjct: 63 MHQLDNPYIVRLIGVCQAEA-----LMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLH 116
Query: 336 GAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPAR 395
+ G++YL E +HRD+ + N+LL AKI+D G++K L AD + S
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--A 171
Query: 396 MQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL 455
+ ++APE + S SDV+S+GV + E ++ Q P
Sbjct: 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK-----------------PYK 214
Query: 456 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
+ G + + + + P E + L +C + RP V Q +
Sbjct: 215 KMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 3e-55
Identities = 60/278 (21%), Positives = 108/278 (38%), Gaps = 30/278 (10%)
Query: 231 NIVGQGGSSYVYRGQLTD-GRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHCHVVPLV 288
+G+G VY+G T+ VA + + F E +ML L H ++V
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 289 GYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA 348
+ +LV E M +G L+ L + M + +GL++LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHT-R 131
Query: 349 APRILHRDIKSSNILL-DENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
P I+HRD+K NI + + KI DLG+A + +S + GT + APE
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-------ASFAKAVIGTPEFMAPEM 184
Query: 408 AMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPD 467
+ DV++FG+ +LE+ T P + + +
Sbjct: 185 YE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ----------------IYRRVTS 227
Query: 468 PRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
F K + + + + C++ + D R ++ +++
Sbjct: 228 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 4e-55
Identities = 76/338 (22%), Positives = 136/338 (40%), Gaps = 47/338 (13%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTD-----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL 279
+F ++G G VY+G VA+K + P A+ L E +++ +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 280 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR 339
+ HV L+G C + L+ + MP G L D + + + + + A+
Sbjct: 69 DNPHVCRLLGICLT-----STVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 122
Query: 340 GLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGT 399
G+ YL + R++HRD+ + N+L+ + KITD G+AK L A+ + +
Sbjct: 123 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG---GKVP 176
Query: 400 FGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459
+ A E + + SDV+S+GV + EL+T + I E S +L RL
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---- 232
Query: 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRN 519
P + + +C +D D+RP E++ S +A D R
Sbjct: 233 -------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLV 279
Query: 520 ISLNLFQIFSAGGMEKEPSIERPD--NLFETLIESEEL 555
I ++ + P N + L++ E++
Sbjct: 280 IQ-----------GDERMHLPSPTDSNFYRALMDEEDM 306
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 8e-55
Identities = 70/328 (21%), Positives = 136/328 (41%), Gaps = 50/328 (15%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTDG---RIVAVKRFKTQGGPNADSVFLTEVDMLSRL-H 280
+ +++G+G V + ++ A+KR K + F E+++L +L H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 281 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------------DGVLVEGMN 326
H +++ L+G C R L E+ P+GNL D L ++
Sbjct: 70 HPNIINLLGACE----HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125
Query: 327 WDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386
+ A ARG++YL + + +HRD+ + NIL+ EN AKI D G+++
Sbjct: 126 SQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR------G 176
Query: 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEES 446
+ + A E + SDV+S+GV+L E+++ + +T E
Sbjct: 177 QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 236
Query: 447 LVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506
L RL + P + L ++C + P RP+ ++++
Sbjct: 237 EKLPQGYRL-----------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
Query: 507 LSTIAPDKSRRRNISLNLFQIFSAGGME 534
L+ + + R+ ++ L++ F+ G++
Sbjct: 280 LNRMLEE--RKTYVNTTLYEKFTYAGID 305
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 3e-54
Identities = 69/284 (24%), Positives = 115/284 (40%), Gaps = 33/284 (11%)
Query: 231 NIVGQGGSSYVYRGQLTD---GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVP 286
+G G V +G + VAVK K + P L E +++ +L + ++V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE 346
++G C +LV E G L L + + + + G++YL E
Sbjct: 73 MIGICEAES-----WMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE 125
Query: 347 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 406
+HRD+ + N+LL AKI+D G++K L+AD + + + ++APE
Sbjct: 126 ---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD--ENYYKAQTHGKWPVKWYAPE 180
Query: 407 YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 466
+ S SDV+SFGV++ E + Q +R + E + +L R+ P
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM--------GCP 232
Query: 467 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
P+E M L C D + RP + V L
Sbjct: 233 A-----GCPRE----MYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 184 bits (469), Expect = 5e-54
Identities = 65/288 (22%), Positives = 106/288 (36%), Gaps = 41/288 (14%)
Query: 224 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLH 280
FS +G G VY + + + +VA+K+ G + + + EV L +L
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 281 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 340
H + + G LV E+ V + + A+ GA +G
Sbjct: 74 HPNTIQYRGCYLR----EHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQG 127
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
L YLH ++HRD+K+ NILL E K+ D G A + GT
Sbjct: 128 LAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---------SFVGTP 175
Query: 401 GYFAPEYAM---VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 457
+ APE + G+ DV+S G+ +EL + P+ ++
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-----NMNAMSALYH----- 225
Query: 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
I++ P L+ E + CLQ P RPT +++
Sbjct: 226 ----IAQNESPALQSGHWSEYFR---NFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 1e-53
Identities = 63/314 (20%), Positives = 116/314 (36%), Gaps = 49/314 (15%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSR 278
++ S +G G V VAVK K ++E+ +LS
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 279 L-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVE-------------- 323
L +H ++V L+G C+ L++ E+ G+L + L
Sbjct: 83 LGNHMNIVNLLGACTI----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 324 --GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381
++ + ++ + A+G+ +L +HRD+ + NILL KI D G+A+ +
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441
K D S + + APE + SDV+S+G+ L EL + + +
Sbjct: 196 KND---SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252
Query: 442 KGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS 501
+ ++ + P+ M + K C DP RPT
Sbjct: 253 VDSK----------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK 296
Query: 502 EVVQILSTIAPDKS 515
++VQ++ + +
Sbjct: 297 QIVQLIEKQISEST 310
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 1e-53
Identities = 60/311 (19%), Positives = 115/311 (36%), Gaps = 54/311 (17%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTD------GRIVAVKRFKTQGGPNADSVFLTEVDMLSR 278
+ ++G G V VAVK K + + ++E+ M+++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 279 L-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL-------------------- 317
L H ++V L+G C+ L+FE+ G+L + L
Sbjct: 97 LGSHENIVNLLGACTL----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 318 -DGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 376
+ + + ++ + A A+G+E+L +HRD+ + N+L+ KI D G
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFG 209
Query: 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPI 436
+A+ + +D S + + APE G ++ SDV+S+G++L E+ +
Sbjct: 210 LARDIMSD---SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266
Query: 437 HRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDA 496
+ I +L K D P + + + + C D
Sbjct: 267 YPGIPVDAN----------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRK 310
Query: 497 RPTMSEVVQIL 507
RP+ + L
Sbjct: 311 RPSFPNLTSFL 321
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 2e-53
Identities = 57/277 (20%), Positives = 109/277 (39%), Gaps = 31/277 (11%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290
+G G V G+ VA+K K G ++ F+ E ++ L H +V L G
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAP 350
C++ + ++ E+M NG L + L + + + +EYL
Sbjct: 68 CTK----QRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLES---K 119
Query: 351 RILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV 410
+ LHRD+ + N L+++ K++D G+++ + D S + + PE M
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG----SKFPVRWSPPEVLMY 175
Query: 411 GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRL 470
+ S SD+++FGV++ E+ + + + T E +E L
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-----------------TAEHIAQGL 218
Query: 471 KGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507
+ P + + + C D RPT ++ +
Sbjct: 219 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 3e-53
Identities = 66/284 (23%), Positives = 104/284 (36%), Gaps = 38/284 (13%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHH 281
+ F +G+G VY + I+A+K A EV++ S L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 282 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 341
+++ L GY + L+ E+ P G + L + + A L
Sbjct: 66 PNILRLYGYFHD----ATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANAL 119
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
Y H R++HRDIK N+LL KI D G + SS + GT
Sbjct: 120 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-------SSRRTTLCGTLD 169
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461
Y PE D++S GV+ E + G+ P + Q++
Sbjct: 170 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP--------------FEANTYQETYKR 215
Query: 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
IS R++ FP + L L+ +P RP + EV++
Sbjct: 216 IS-----RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 1e-51
Identities = 63/297 (21%), Positives = 114/297 (38%), Gaps = 34/297 (11%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH 280
++ +G+G V++G VA+K K + FL E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 281 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 340
H H+V L+G +E ++ E G LR V ++ + + A +
Sbjct: 67 HPHIVKLIGVITEN-----PVWIIMELCTLGELRS-FLQVRKYSLDLASLILYAYQLSTA 120
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
L YL R +HRDI + N+L+ N K+ D G+++ ++ S + +
Sbjct: 121 LAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS----KGKLPI 173
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460
+ APE R + SDV+ FGV + E++ + + + V+
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGR--------- 221
Query: 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRR 517
I + + P + L +C DP RP +E+ LSTI ++ +
Sbjct: 222 -IENGERLPMPPNCPPT----LYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ 273
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 4e-51
Identities = 62/283 (21%), Positives = 103/283 (36%), Gaps = 30/283 (10%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
+ + +G+G V VAVK + + E+ + L+H +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 343
VV G+ + ++ L E+ G L D ++ GM G+ Y
Sbjct: 65 VVKFYGHRR----EGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVY 118
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
LH I HRDIK N+LLDE N KI+D G+A + + + M GT Y
Sbjct: 119 LHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK---MCGTLPYV 172
Query: 404 APEYAMVGR-ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 462
APE + DV+S G+VL ++ G P + Q+
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD------------QPSDSCQEYSDWK 220
Query: 463 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
+ + ++ + L +P AR T+ ++ +
Sbjct: 221 EKKTYLNPWKKIDSAPLALL----HKILVENPSARITIPDIKK 259
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 6e-51
Identities = 62/288 (21%), Positives = 109/288 (37%), Gaps = 36/288 (12%)
Query: 224 TDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 282
D + +G G VY+ Q + + A K T+ + ++ E+D+L+ H
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELED-YMVEIDILASCDHP 69
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 342
++V L+ ++ EF G + + L + + L
Sbjct: 70 NIVKLLDAFYY----ENNLWILIEFCAGGAVDAVMLE-LERPLTESQIQVVCKQTLDALN 124
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
YLH+ +I+HRD+K+ NIL + + K+ D G++ + S GT +
Sbjct: 125 YLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-----FIGTPYW 176
Query: 403 FAPEYAMVGRA-----SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 457
APE M + +DV+S G+ L+E+ P H P
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL------------NPMRVL 224
Query: 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
SE P + + K+CL+ + DAR T S+++Q
Sbjct: 225 LKIAKSEPPTLAQPSRWSSNFKDFL----KKCLEKNVDARWTTSQLLQ 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 5e-50
Identities = 64/283 (22%), Positives = 119/283 (42%), Gaps = 33/283 (11%)
Query: 224 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 282
K++ +GQG S VY + G+ VA+++ Q P + + E+ ++ +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNP 77
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 342
++V + +V E++ G+L D + M+ A+ + LE
Sbjct: 78 NIVNYLDSYLVGD----ELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALE 130
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
+LH +++HRDIKS NILL + + K+TD G ++ + S + M GT +
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-----SKRSTMVGTPYW 182
Query: 403 FAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVI 462
APE D++S G++ +E+I G P + + +I
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP--------------YLNENPLRALYLI 228
Query: 463 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
+ P L+ P++ I CL +D + R + E++Q
Sbjct: 229 ATNGTPELQ--NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 3e-49
Identities = 64/281 (22%), Positives = 104/281 (37%), Gaps = 33/281 (11%)
Query: 233 VGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVP 286
+G G V RG+ VAVK K +++ F+ EV+ + L H +++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 287 LVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE 346
L G +V E P G+L D L T A+ A G+ YL
Sbjct: 76 LYGVVLTPP-----MKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 347 AAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 406
R +HRD+ + N+LL KI D G+ + L + + F + APE
Sbjct: 130 ---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPE 184
Query: 407 YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 466
S SD + FGV L E+ T Q + + ++ ++
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ----------------ILHKID 228
Query: 467 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507
+ P++ Q + + +C P+ RPT + L
Sbjct: 229 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 5e-48
Identities = 71/307 (23%), Positives = 120/307 (39%), Gaps = 46/307 (14%)
Query: 225 DKFSGSNIVGQGGSSYVYRG------QLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSR 278
D+ +G+G V + R VAVK K + ++E+ +L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 279 -LHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------------DGVLVE 323
HH +VV L+G C++ G +++ EF GNL L + + +
Sbjct: 73 IGHHLNVVNLLGACTKPGGPL---MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 324 GMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383
+ + + + A+G+E+L + +HRD+ + NILL E KI D G+A+ +
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKG 443
D + + APE ++ SDV+SFGV+L E+ + + +
Sbjct: 187 DPDYVRKGD---ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243
Query: 444 EESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV 503
EE + E R E M +C +P RPT SE+
Sbjct: 244 EEFC------------RRLKEGTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSEL 287
Query: 504 VQILSTI 510
V+ L +
Sbjct: 288 VEHLGNL 294
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 6e-48
Identities = 65/297 (21%), Positives = 116/297 (39%), Gaps = 41/297 (13%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSR 278
+K + S +GQG VY G VA+K FL E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 279 LHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------DGVLVEGMNWDTR 330
+ HVV L+G S + L++ E M G+L+ L + ++ +
Sbjct: 80 FNCHHVVRLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 331 VAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCS 390
+ +A A G+ YL+ + +HRD+ + N ++ E+ KI D GM + +
Sbjct: 136 IQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 391 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450
+ + +PE G + SDV+SFGVVL E+ T + ++ ++ + +
Sbjct: 193 G---KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 249
Query: 451 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507
L D P ++ L + C Q +P RP+ E++ +
Sbjct: 250 EGGLL-----------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 9e-48
Identities = 68/309 (22%), Positives = 123/309 (39%), Gaps = 50/309 (16%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLT--------DGRIVAVKRFKTQGGPNADSVFLTEVDML 276
D+ +G+G V + VAVK K+ S ++E++M+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 277 SRL-HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------------DGVL 321
+ H +++ L+G C++ ++ E+ GNLR+ L
Sbjct: 73 KMIGKHKNIINLLGACTQ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 322 VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381
E ++ V+ A ARG+EYL + +HRD+ + N+L+ E+ KI D G+A+ +
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSIT 441
+++ + + APE + SDV+SFGV+L E+ T + +
Sbjct: 186 HHIDYYKKTTN---GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242
Query: 442 KGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS 501
E +L R+ D P + + ++C P RPT
Sbjct: 243 VEELFKLLKEGHRM-----------------DKPSNCTNELYMMMRDCWHAVPSQRPTFK 285
Query: 502 EVVQILSTI 510
++V+ L I
Sbjct: 286 QLVEDLDRI 294
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 165 bits (418), Expect = 4e-47
Identities = 66/290 (22%), Positives = 113/290 (38%), Gaps = 26/290 (8%)
Query: 222 HATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSR 278
H +D++ I+G GG S V+ + L R VAVK + + F E +
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 279 LHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA 338
L+H +V + + +V E++ LRD + M + + A
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADAC 121
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
+ L + H+ I+HRD+K +NI++ K+ D G+A+ + G + + A + G
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSG--NSVTQTAAVIG 176
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 458
T Y +PE A SDV+S G VL E++TG P + P
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI---- 232
Query: 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-TMSEVVQIL 507
P + ++ + L +P+ R T +E+ L
Sbjct: 233 -------PPSARHEGLSADLDAVV----LKALAKNPENRYQTAAEMRADL 271
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 4e-46
Identities = 69/290 (23%), Positives = 109/290 (37%), Gaps = 50/290 (17%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHH 281
+ F I+G+G S V + L R A+K + + + V E D++SRL H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 282 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 341
V L + + NG L + + + L
Sbjct: 68 PFFVKLYFTFQD----DEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSAL 121
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
EYLH I+HRD+K NILL+E+++ +ITD G AK L + + ++S GT
Sbjct: 122 EYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS---FVGTAQ 175
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESLVLWATP 453
Y +PE A SD+++ G ++ +L+ G P I + I K E P
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFP 235
Query: 454 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEV 503
+ +D L ++ L LD R E+
Sbjct: 236 KARD---------------------------LVEKLLVLDATKRLGCEEM 258
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (411), Expect = 7e-46
Identities = 50/292 (17%), Positives = 92/292 (31%), Gaps = 28/292 (9%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
+++ +G G +Y G + G VA+K + E + +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK---TKHPQLHIESKIYKMMQGGV 63
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 343
+P + +C ++V E + + T + +A +EY
Sbjct: 64 GIPTIRWCGAEGD---YNVMVMELLGPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEY 118
Query: 344 LHEAAAPRILHRDIKSSNIL---LDENLNAKITDLGMAKRLKADGLPSCSSSPAR--MQG 398
+H +HRD+K N L + I D G+AK+ + + G
Sbjct: 119 IHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 175
Query: 399 TFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 458
T Y + + S D+ S G VL+ G P + + +
Sbjct: 176 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-- 233
Query: 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510
P L +P E + + C L D +P S + Q+ +
Sbjct: 234 -----STPIEVLCKGYPSEFATYLNF----CRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 162 bits (411), Expect = 2e-45
Identities = 60/284 (21%), Positives = 104/284 (36%), Gaps = 33/284 (11%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
D + +G G V+R GR+ K T P E+ ++++LHH
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPK 87
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 343
++ L + + +L+ EF+ G L D + M+ + A GL++
Sbjct: 88 LINLHDAFED----KYEMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKH 142
Query: 344 LHEAAAPRILHRDIKSSNILLD--ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
+HE I+H DIK NI+ + + + KI D G+A +L D + T
Sbjct: 143 MHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV------TTATAE 193
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461
+ APE +D+++ GV+ L++G P V
Sbjct: 194 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE------- 246
Query: 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
D E + K LQ +P R T+ + ++
Sbjct: 247 ----FDEDAFSSVSPEAKDFI----KNLLQKEPRKRLTVHDALE 282
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 162 bits (410), Expect = 4e-45
Identities = 58/288 (20%), Positives = 102/288 (35%), Gaps = 33/288 (11%)
Query: 221 EHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL 279
+H D + +G G V+R G A K T + ++ E+ +S L
Sbjct: 22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET-VRKEIQTMSVL 80
Query: 280 HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAAR 339
H +V L + ++++EFM G L + + M+ D V +
Sbjct: 81 RHPTLVNLHDAFED----DNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCK 135
Query: 340 GLEYLHEAAAPRILHRDIKSSNILL--DENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
GL ++HE +H D+K NI+ + K+ D G+ L S
Sbjct: 136 GLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK------QSVKVTT 186
Query: 398 GTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 457
GT + APE A +D++S GV+ L++G P V
Sbjct: 187 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN--- 243
Query: 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
D ++ + ++ L DP+ R T+ + ++
Sbjct: 244 --------MDDSAFSGISEDGKDFI----RKLLLADPNTRMTIHQALE 279
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 157 bits (398), Expect = 2e-44
Identities = 66/297 (22%), Positives = 107/297 (36%), Gaps = 46/297 (15%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--------FLTEVDM 275
+ + I+G+G SS V R + AVK GG + + L EVD+
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 276 LSRLH-HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 334
L ++ H +++ L LVF+ M G L D L ++ I
Sbjct: 63 LRKVSGHPNIIQLKDTYET----NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIM 116
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPA 394
+ LH+ I+HRD+K NILLD+++N K+TD G + +L
Sbjct: 117 RALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG------EKLR 167
Query: 395 RMQGTFGYFAPEYAMVGRA------SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV 448
+ GT Y APE D++S GV++ L+ G P ++
Sbjct: 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 227
Query: 449 LWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
+ + P D+ ++ L + P R T E +
Sbjct: 228 MSGNYQ----------FGSPEWD-DYSDTVKDLV----SRFLVVQPQKRYTAEEALA 269
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-44
Identities = 66/297 (22%), Positives = 115/297 (38%), Gaps = 23/297 (7%)
Query: 223 ATDKFSGSNIVGQGGSSYVYRGQ--LTDGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRL 279
A ++ +G+G V++ + GR VA+KR + Q G + + EV +L L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 280 ---HHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIG 336
H +VV L C+ R R +L + + +L LD V G+ +T +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 337 AARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARM 396
RGL++LH R++HRD+K NIL+ + K+ D G+A+ + S + +
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR------IYSFQMALTSV 175
Query: 397 QGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESLV 448
T Y APE + + D++S G + E+ + I
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235
Query: 449 LWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
PR + F + ++ L +CL +P R + +
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (399), Expect = 4e-44
Identities = 65/320 (20%), Positives = 117/320 (36%), Gaps = 37/320 (11%)
Query: 217 YSALEHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDM 275
+ E D + +++G G S V + ++VA+K + + E+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 276 LSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAI 335
L ++ H ++V L L+ + + G L D + +
Sbjct: 61 LHKIKHPNIVALDDIYES----GGHLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIF 114
Query: 336 GAARGLEYLHEAAAPRILHRDIKSSNILL---DENLNAKITDLGMAKRLKADGLPSCSSS 392
++YLH+ I+HRD+K N+L DE+ I+D G++K + S
Sbjct: 115 QVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST--- 168
Query: 393 PARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 452
GT GY APE S D +S GV+ L+ G P + +L A
Sbjct: 169 ---ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE 225
Query: 453 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ---ILST 509
D D + + ++ DP+ R T + +Q I
Sbjct: 226 YE-----------FDSPYWDDISDSAKDFI----RHLMEKDPEKRFTCEQALQHPWIAGD 270
Query: 510 IAPDKSRRRNISLNLFQIFS 529
A DK+ +++S + + F+
Sbjct: 271 TALDKNIHQSVSEQIKKNFA 290
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 3e-43
Identities = 58/279 (20%), Positives = 99/279 (35%), Gaps = 31/279 (11%)
Query: 232 IVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVG 289
++G G + V + A+K + EV++ R H+V +V
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVD 72
Query: 290 YCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAA 349
R L+V E + G L + + I ++YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI-- 130
Query: 350 PRILHRDIKSSNILLD---ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE 406
I HRD+K N+L N K+TD G AK + +S T Y APE
Sbjct: 131 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH------NSLTTPCYTPYYVAPE 183
Query: 407 YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISELP 466
+ D++S GV++ L+ G P + + + G E P
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN----HGLAISPGMKTRIRMGQY--EFP 237
Query: 467 DPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
+P + +E ++ + L+ +P R T++E +
Sbjct: 238 NPEWS-EVSEEVKMLI----RNLLKTEPTQRMTITEFMN 271
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 3e-43
Identities = 68/291 (23%), Positives = 114/291 (39%), Gaps = 31/291 (10%)
Query: 231 NIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSV----FLTEVDMLSRLHHCHVV 285
+ +G+G + VY+ + +IVA+K+ K A L E+ +L L H +++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 286 PLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLH 345
L+ ++ LVF+FM D L + A + +GLEYLH
Sbjct: 64 GLLDAFGH----KSNISLVFDFMETDLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLH 117
Query: 346 EAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAP 405
+ ILHRD+K +N+LLDEN K+ D G+AK + + + T Y AP
Sbjct: 118 Q---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-----NRAYTHQVVTRWYRAP 169
Query: 406 EYAMVGRA-SLMSDVFSFGVVLLELITGRQP--------IHRSITK--GEESLVLWATPR 454
E R + D+++ G +L EL+ I + G + W
Sbjct: 170 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229
Query: 455 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
P L F ++ + +P AR T ++ ++
Sbjct: 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQG-LFLFNPCARITATQALK 279
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 3e-43
Identities = 55/296 (18%), Positives = 104/296 (35%), Gaps = 22/296 (7%)
Query: 224 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC 282
+++ + +G+G V + VA+K+ L E+ +L R H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 342
+++ + ++ + + + +L L + ++ D RGL+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLK 123
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
Y+H A +LHRD+K SN+LL+ + KI D G+A+ D + T Y
Sbjct: 124 YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH--DHTGFLTEYVATRWY 178
Query: 403 FAPEYAMVGRASLMS-DVFSFGVVLLELITGRQP--------IHRSITKGEESLVLWATP 453
APE + + S D++S G +L E+++ R I S
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238
Query: 454 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----CLQLDPDARPTMSEVVQ 505
+ + L P A + L +P R + + +
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 156 bits (395), Expect = 5e-43
Identities = 68/285 (23%), Positives = 109/285 (38%), Gaps = 39/285 (13%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLH- 280
+ FS I+G+GG VY + D G++ A+K + +++ L E MLS +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 281 --HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA 338
+V + + + M G+L L + A
Sbjct: 64 GDCPFIVCMSYAFHT----PDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEII 117
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
GLE++H +++RD+K +NILLDE+ + +I+DLG+A P G
Sbjct: 118 LGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS-------KKKPHASVG 167
Query: 399 TFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 457
T GY APE G A +D FS G +L +L+ G P + TK + +
Sbjct: 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT---- 223
Query: 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 502
L F E ++ + LQ D + R
Sbjct: 224 --------MAVELPDSFSPELRSLL----EGLLQRDVNRRLGCLG 256
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 154 bits (389), Expect = 5e-43
Identities = 55/299 (18%), Positives = 98/299 (32%), Gaps = 34/299 (11%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYC 291
+G+G ++ G L + + VA+K + + E L C +P V Y
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRR---SDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 292 SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPR 351
+ +LV + + G + L + + T A ++ +HE
Sbjct: 70 GQEGL---HNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---S 121
Query: 352 ILHRDIKSSNILLDENLN-----AKITDLGMAKRLKAD--GLPSCSSSPARMQGTFGYFA 404
+++RDIK N L+ + + D GM K + + GT Y +
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 405 PEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 464
+ S D+ + G V + + G P + + Q
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS------- 234
Query: 465 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDKSRRRNISLN 523
P L FP+E + M Y L DA P + + S + R N + +
Sbjct: 235 TPLRELCAGFPEEFYKYMHY----ARNLAFDATPDYDYLQGLFSKVL----ERLNTTED 285
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 7e-43
Identities = 60/338 (17%), Positives = 122/338 (36%), Gaps = 48/338 (14%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCH 283
+K+ + +G+G V+R + + K K +G + E+ +L+ H +
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRN 62
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 343
++ L +++FEF+ ++ + ++ E +N V+ L++
Sbjct: 63 ILHLHESFES----MEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQF 117
Query: 344 LHEAAAPRILHRDIKSSNILLD--ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
LH I H DI+ NI+ + KI + G A++LK + +
Sbjct: 118 LHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK------PGDNFRLLFTAPE 168
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461
Y+APE S +D++S G ++ L++G P + ++ A
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT------- 221
Query: 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ--------------IL 507
D + E M + L + +R T SE +Q ++
Sbjct: 222 ----FDEEAFKEISIEAMDFV----DRLLVKERKSRMTASEALQHPWLKQKIERVSTKVI 273
Query: 508 STIAPDKSRRRNISLNLFQIFSAGGMEKEPSIERPDNL 545
T+ + I +L + SA + +I +
Sbjct: 274 RTLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKGV 311
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 7e-41
Identities = 60/295 (20%), Positives = 111/295 (37%), Gaps = 28/295 (9%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHC 282
+ F +G+G VY+ + G +VA+K+ + S + E+ +L L+H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 342
++V L+ +L + + +L+ +D + G+ + +GL
Sbjct: 62 NIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
+ H R+LHRD+K N+L++ K+ D G+A+ T Y
Sbjct: 117 FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH-----EVVTLWY 168
Query: 403 FAPE-YAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461
APE S D++S G + E++T R ++ ++ ++ T D
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD-SEIDQLFRIFRTLGTPDEVVW 227
Query: 462 ISELPDPRLKGDFPKEEMQIMAY-----------LAKECLQLDPDARPTMSEVVQ 505
P K FPK Q + L + L DP+ R + +
Sbjct: 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 146 bits (370), Expect = 2e-40
Identities = 60/292 (20%), Positives = 110/292 (37%), Gaps = 24/292 (8%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCH 283
+K+ G +G+G VY+ Q G A+K+ + + S + E+ +L L H +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 343
+V L RL++ + +L+ LD V G+ T + + G+ Y
Sbjct: 62 IVKLYDVIHTK-----KRLVLVFEHLDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAY 115
Query: 344 LHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYF 403
H+ R+LHRD+K N+L++ KI D G+A+ + +
Sbjct: 116 CHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH----EIVTLWYRA 168
Query: 404 APEYAMVGRASLMSDVFSFGVVLLELITGRQPIH--------RSITK--GEESLVLWATP 453
+ S D++S G + E++ G I + G + W
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 454 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
+ +P F K + L + L+LDP+ R T + ++
Sbjct: 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 3e-40
Identities = 64/295 (21%), Positives = 102/295 (34%), Gaps = 30/295 (10%)
Query: 227 FSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVV 285
++ + ++G G VY+ +L D G +VA+K+ E+ ++ +L HC++V
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKRFKNRELQIMRKLDHCNIV 76
Query: 286 PLVGYCSEF--RGKRAMRLLVFEFMPNGNLRDCLDGVLVEG-MNWDTRVAIAIGAARGLE 342
L + + LV +++P R + + R L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 343 YLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
Y+H I HRDIK N+LLD + K+ D G AK+L +
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG------EPNVSYICSRY 187
Query: 402 YFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQP--------IHRSITK--GEESLVLW 450
Y APE + DV+S G VL EL+ G+ I K G +
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247
Query: 451 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
+ ++ F L L+ P AR T E
Sbjct: 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 146 bits (368), Expect = 1e-39
Identities = 65/308 (21%), Positives = 104/308 (33%), Gaps = 62/308 (20%)
Query: 231 NIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHHCHVVPL 287
+G G V+ + +GR A+K K + V E MLS + H ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 288 VGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA 347
G + ++ +++ G L L + A LEYLH
Sbjct: 70 WGTFQD----AQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHS- 122
Query: 348 AAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEY 407
I++RD+K NILLD+N + KITD G AK + + GT Y APE
Sbjct: 123 --KDIIYRDLKPENILLDKNGHIKITDFGFAKYV--------PDVTYTLCGTPDYIAPEV 172
Query: 408 AMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESLVLWATPRLQDSG 459
+ D +SFG+++ E++ G P + I E + ++D
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKD-- 230
Query: 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDAR-----PTMSEVVQ--ILSTIAP 512
L + D R +V +
Sbjct: 231 -------------------------LLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 265
Query: 513 DKSRRRNI 520
+K RNI
Sbjct: 266 EKLLSRNI 273
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-39
Identities = 64/303 (21%), Positives = 117/303 (38%), Gaps = 40/303 (13%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSV--FLTEVDMLSR-LH 280
+ F ++G+G V+ + + A+K K D V + E +LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 281 HCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 340
H + + + V E++ G+L + + A G
Sbjct: 62 HPFLTHMFCTFQT----KENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILG 115
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
L++LH I++RD+K NILLD++ + KI D GM K + GT
Sbjct: 116 LQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-----AKTNTFCGTP 167
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460
Y APE + + + D +SFGV+L E++ G+ P H G++ L+ + R+
Sbjct: 168 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH-----GQDEEELFHSIRMD---- 218
Query: 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ---ILSTIAPDKSRR 517
+P KE ++ + +P+ R + ++ + I ++ R
Sbjct: 219 ------NPFYPRWLEKEAKDLL----VKLFVREPEKRLGVRGDIRQHPLFREINWEELER 268
Query: 518 RNI 520
+ I
Sbjct: 269 KEI 271
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 3e-39
Identities = 59/295 (20%), Positives = 109/295 (36%), Gaps = 40/295 (13%)
Query: 221 EHATDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV-----FLTEVD 274
E+ D + +G G + V + + + G A K K + ++ EV
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 275 MLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIA 334
+L + H +V+ L + +L+ E + G L D L E + +
Sbjct: 66 ILKEIQHPNVITLHEVYEN----KTDVILILELVAGGELFDFLAEK--ESLTEEEATEFL 119
Query: 335 IGAARGLEYLHEAAAPRILHRDIKSSNILLDEN----LNAKITDLGMAKRLKADGLPSCS 390
G+ YLH +I H D+K NI+L + KI D G+A ++
Sbjct: 120 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN- 175
Query: 391 SSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW 450
+ GT + APE L +D++S GV+ L++G P +
Sbjct: 176 -----IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP--------------F 216
Query: 451 ATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
Q++ +S + + + ++ + + L DP R T+ + +Q
Sbjct: 217 LGDTKQETLANVSAV-NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 6e-39
Identities = 60/301 (19%), Positives = 116/301 (38%), Gaps = 26/301 (8%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRLHHC 282
K+ +GQG V++ + G+ VA+K+ + + L E+ +L L H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 283 HVVPLVGYC----SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAA 338
+VV L+ C S + + LVF+F + + ++ ++ RV +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 339 RGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQG 398
L L+ +ILHRD+K++N+L+ + K+ D G+A+ S +
Sbjct: 127 --LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK-NSQPNRYTNRVV 183
Query: 399 TFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRS--------ITKGEESLVL 449
T Y PE + R D++ G ++ E+ T + + I++ S+
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 450 WATPRLQD----SGTVISELPDPRLKGDFPKEEMQIMAY-LAKECLQLDPDARPTMSEVV 504
P + + + + ++K A L + L LDP R + +
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303
Query: 505 Q 505
Sbjct: 304 N 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 8e-37
Identities = 54/294 (18%), Positives = 105/294 (35%), Gaps = 26/294 (8%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHC 282
K+ +G+G V++ + IVA+KR + S L E+ +L L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 342
++V L LVFEF + ++ + + +GL
Sbjct: 62 NIVRLHDVLHS----DKKLTLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLG 115
Query: 343 YLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
+ H +LHRD+K N+L++ N K+ + G+A+ A + +
Sbjct: 116 FCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV----RCYSAEVVTLWYR 168
Query: 403 FAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE--ESLVLWATPRLQDSGT 460
S D++S G + EL +P+ + + + ++
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228
Query: 461 VISELPDPRLKGDFPKEEMQIMAY---------LAKECLQLDPDARPTMSEVVQ 505
+++LPD + +P + L + L+ +P R + E +Q
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 6e-36
Identities = 72/355 (20%), Positives = 121/355 (34%), Gaps = 55/355 (15%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHC 282
+ VG G V G VA+K+ E+ +L + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 283 HVVPLVGYC--SEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 340
+V+ L+ E LV FM + + D + +G
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE----KLGEDRIQFLVYQMLKG 133
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
L Y+H I+HRD+K N+ ++E+ KI D G+A++ S T
Sbjct: 134 LRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA--------DSEMTGYVVTR 182
Query: 401 GYFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESLVLWA 451
Y APE + R + D++S G ++ E+ITG+ + I K +
Sbjct: 183 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242
Query: 452 TPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKE----CLQLDPDARPTMSEVVQ-- 505
RLQ P L+ + + LA L LD + R T E +
Sbjct: 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 302
Query: 506 ILSTIAPDKSRRRNISLNLFQIFSAGGMEKEPSIERPDNLFETLIES-EELKKAT 559
++ E EP +++ D+ F+ + + +E K+ T
Sbjct: 303 YFESLHDT--------------------EDEPQVQKYDDSFDDVDRTLDEWKRVT 337
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 1e-35
Identities = 62/279 (22%), Positives = 95/279 (34%), Gaps = 36/279 (12%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHH 281
+ F ++G+G V + GR A+K + + D V +TE +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 282 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 341
+ L V E+ G L L + L
Sbjct: 65 PFLTALKYAFQT----HDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSAL 118
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
EYLH +++RDIK N++LD++ + KITD G+ K +DG GT
Sbjct: 119 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK-----TFCGTPE 170
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461
Y APE D + GVV+ E++ GR P + + L+L R
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR---- 226
Query: 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTM 500
E ++ L+ DP R
Sbjct: 227 -----------TLSPEAKSLL----AGLLKKDPKQRLGG 250
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 2e-35
Identities = 58/286 (20%), Positives = 95/286 (33%), Gaps = 54/286 (18%)
Query: 232 IVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV-----FLTEVDMLSRLHHCH-- 283
++G GG VY G ++D VA+K + + + EV +L ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 284 VVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEY 343
V+ L+ + +L+ E + + + + +
Sbjct: 71 VIRLLDWFER----PDSFVLILERPEPVQDLFDFI-TERGALQEELARSFFWQVLEAVRH 125
Query: 344 LHEAAAPRILHRDIKSSNILLDEN-LNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGY 402
H +LHRDIK NIL+D N K+ D G LK GT Y
Sbjct: 126 CHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-------FDGTRVY 175
Query: 403 FAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRS--ITKGEESLVLWATPRLQDSG 459
PE+ R + V+S G++L +++ G P I +G+ + Q
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQH-- 233
Query: 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
L + CL L P RPT E+
Sbjct: 234 -------------------------LIRWCLALRPSDRPTFEEIQN 254
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 129 bits (325), Expect = 9e-34
Identities = 54/304 (17%), Positives = 108/304 (35%), Gaps = 43/304 (14%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHC 282
D + +G+G S V+ +T+ V VK K P E+ +L L
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK----PVKKKKIKREIKILENLRGGP 90
Query: 283 HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLE 342
+++ L + + LVFE + N + + L + + + L+
Sbjct: 91 NIITLADIVKDPVSRTPA--LVFEHVNNTDFKQ-----LYQTLTDYDIRFYMYEILKALD 143
Query: 343 YLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
Y H I+HRD+K N+++D E+ ++ D G+A+ + +
Sbjct: 144 YCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV------RVASRY 194
Query: 402 YFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQPIHRS---------ITKGEESLVLWA 451
+ PE + D++S G +L +I ++P I K + L+
Sbjct: 195 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 254
Query: 452 TPRLQDS------GTVISELPDPRLKGDFPKEEMQIMAYLAKE----CLQLDPDARPTMS 501
+ ++ R + E +++ A + L+ D +R T
Sbjct: 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 314
Query: 502 EVVQ 505
E ++
Sbjct: 315 EAME 318
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 126 bits (317), Expect = 2e-32
Identities = 55/306 (17%), Positives = 105/306 (34%), Gaps = 46/306 (15%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV--FLTEVDMLSRLHH 281
D+F +G G V + G A+K Q + L E +L ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 282 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 341
+V L + +V E++ G + L + + A
Sbjct: 101 PFLVKLEFSFKDNS----NLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTF 154
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
EYLH +++RD+K N+L+D+ ++TD G AKR + GT
Sbjct: 155 EYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKR--------VKGRTWTLCGTPE 203
Query: 402 YFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461
APE + + D ++ GV++ E+ G P ++ + ++
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF-----ADQPIQIYE---------- 248
Query: 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDP-----DARPTMSEVVQ--ILSTIAPDK 514
K FP + L + LQ+D + + ++++ +T
Sbjct: 249 ----KIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304
Query: 515 SRRRNI 520
+R +
Sbjct: 305 IYQRKV 310
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (313), Expect = 5e-32
Identities = 64/298 (21%), Positives = 112/298 (37%), Gaps = 30/298 (10%)
Query: 224 TDKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSV-FLTEVDMLSRLHH 281
+++ + VG G V G VAVK+ + E+ +L + H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 282 CHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGL 341
+V+ L+ + R + G D + V + + D + RGL
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMG--ADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 342 EYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFG 401
+Y+H I+HRD+K SN+ ++E+ KI D G+A+ T
Sbjct: 135 KYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH--------TDDEMTGYVATRW 183
Query: 402 YFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQP-------------IHRSITKGEESL 447
Y APE + + D++S G ++ EL+TGR + T G E L
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 448 VLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505
++ ++ ++++P F + L K L LD D R T ++ +
Sbjct: 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK-MLVLDSDKRITAAQALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 2e-30
Identities = 54/308 (17%), Positives = 112/308 (36%), Gaps = 41/308 (13%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQ-LTDGRIVAVKRF-KTQGGPNADSVFLTEVDMLSRLHHC 282
++ +G G V R VA+K+ + E+ ++ ++H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 283 HVVPLVGYCSEFRGKRAMR--LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 340
+++ L+ + + + LV E M + V+ ++ + + G
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ-----VIQMELDHERMSYLLYQMLCG 131
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
+++LH I+HRD+K SNI++ + KI D G+A+ + + T
Sbjct: 132 IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP------YVVTR 182
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP--------IHRSITKGEESLVLWAT 452
Y APE + D++S G ++ E++ + + + +
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242
Query: 453 PRLQDSGTVISELPDPRLKGDFPK-----------EEMQIMAYLAKE----CLQLDPDAR 497
+LQ + E FPK E ++ A A++ L +DP R
Sbjct: 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302
Query: 498 PTMSEVVQ 505
++ + +Q
Sbjct: 303 ISVDDALQ 310
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 4e-29
Identities = 58/287 (20%), Positives = 99/287 (34%), Gaps = 36/287 (12%)
Query: 225 DKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQGGPNADSV---FLTEVDMLS 277
+ F ++G G V+ + G++ A+K K TE +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 278 RLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGA 337
+ + + Y + K + L +++ G L L T + I
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLIL---DYINGGELFTHL-----SQRERFTEHEVQIYV 135
Query: 338 ARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQ 397
+ L I++RDIK NILLD N + +TD G++K AD +
Sbjct: 136 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD----ETERAYDFC 191
Query: 398 GTFGYFAPEYAMVGRA--SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL 455
GT Y AP+ G + D +S GV++ EL+TG P K ++ + +
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK- 250
Query: 456 QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSE 502
+P + ++ + L DP R
Sbjct: 251 ----------SEPPYPQEMSALAKDLI----QRLLMKDPKKRLGCGP 283
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (279), Expect = 2e-27
Identities = 56/314 (17%), Positives = 107/314 (34%), Gaps = 48/314 (15%)
Query: 233 VGQGGSSYVYRGQ-LTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC--------- 282
+G G S V+ + + + VA+K + E+ +L R++
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 283 --HVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARG 340
H++ L+ + + ++VFE + L G+ I+ G
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKY-EHRGIPLIYVKQISKQLLLG 137
Query: 341 LEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTF 400
L+Y+H I+H DIK N+L++ + + +L K T
Sbjct: 138 LDYMHRR--CGIIHTDIKPENVLMEIVDSPE--NLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 401 GYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIH----------------------- 437
Y +PE + +D++S ++ ELITG
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 253
Query: 438 ---RSITKGEESLVLWATPRLQDSGTVISELPDPRL---KGDFPKEEMQIMAYLAKECLQ 491
+ G+ + + + L + + + P + K F K+E + ++ LQ
Sbjct: 254 LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 313
Query: 492 LDPDARPTMSEVVQ 505
LDP R +V
Sbjct: 314 LDPRKRADAGGLVN 327
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 77.5 bits (190), Expect = 4e-17
Identities = 22/168 (13%), Positives = 43/168 (25%), Gaps = 38/168 (22%)
Query: 231 NIVGQGGSSYVYRGQLTDGRIVAVKRFKT---------QGGPNADSVFLTE--------V 273
++G+G S V+ VK K + D F
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 274 DMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAI 333
L +L V + + ++ E + L + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNA--------VLMELIDAKELYRV---------RVENPDEV 108
Query: 334 AIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381
+ + I+H D+ N+L+ E I D + +
Sbjct: 109 LDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEV 152
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 632 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.4 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.2 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.64 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.13 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.77 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.75 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 91.6 | |
| d1autl1 | 48 | Activated protein c (autoprothrombin IIa) {Human ( | 82.03 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-53 Score=438.69 Aligned_cols=263 Identities=25% Similarity=0.388 Sum_probs=200.0
Q ss_pred cCccccceeeeeCceEEEEEEECC-C---cEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-G---RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g---~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
++|++.++||+|+||+||+|.++. + ..||||++.........+.|.+|+.+|++++|||||+++|++.. ...
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~----~~~ 101 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK----STP 101 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----SSS
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee----CCE
Confidence 345667899999999999998753 3 36999998876655566679999999999999999999999976 446
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.|+||||+++|+|.+++.... ..++|.+++.++.|||+||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceE
Confidence 799999999999999887543 45999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
.................||+.|||||++.++.++.++|||||||+||||+| |+.||...........
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~------------ 245 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA------------ 245 (299)
T ss_dssp ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH------------
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHH------------
Confidence 765432221222333568999999999999999999999999999999998 8999965432211100
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 513 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 513 (632)
+..-.. .+.+..++..+.+|+.+||+.||++|||+.||++.|++++..
T Consensus 246 --i~~~~~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 246 --IEQDYR----LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp --HHTTCC----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --HHcCCC----CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 011111 122334445689999999999999999999999999987543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=426.43 Aligned_cols=258 Identities=24% Similarity=0.386 Sum_probs=209.7
Q ss_pred HhhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 222 HATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 222 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
...++|++.+.||+|+||+||+|.+++++.||||+++... ...+.|.+|+++|++++|||||+++|++.+ ...
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-----~~~ 82 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-----EPI 82 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSC
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc--CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-----CCe
Confidence 3456788889999999999999999888999999997543 334569999999999999999999998764 245
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||||+++|+|.+++.......++|..++.|+.||++||+|||+.+ |+||||||+||||++++.+||+|||+|+..
T Consensus 83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEc
Confidence 89999999999999887665566999999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
..... .......||+.|+|||++..+.++.++|||||||+||||+||..|+.......+ ... .
T Consensus 160 ~~~~~----~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~--~~~-----------~ 222 (272)
T d1qpca_ 160 EDNEY----TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQ-----------N 222 (272)
T ss_dssp SSSCE----ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHH-----------H
T ss_pred cCCcc----ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH--HHH-----------H
Confidence 54321 122345689999999999999999999999999999999997666543222111 000 0
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
+.....+. .|...+..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 223 i~~~~~~~----~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 223 LERGYRMV----RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp HHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhcCCCC----CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 11111111 2233344588999999999999999999999999865
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-53 Score=430.35 Aligned_cols=262 Identities=27% Similarity=0.447 Sum_probs=204.5
Q ss_pred hhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
..++|.+.+.||+|+||+||+|+++ ..||||+++... .....+.|.+|+.+|++++|||||+++|++.+ ...
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-----~~~ 78 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-----PQL 78 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----SSC
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-----cEE
Confidence 3567899999999999999999874 359999997543 34556679999999999999999999998753 346
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
++||||+++|+|.++|.... ..+++..++.++.|||+||+|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred EEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeec
Confidence 99999999999999997543 45999999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhc---CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~---~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
..... ........||+.|||||++.+ ..++.++|||||||+||||+||+.||.............
T Consensus 155 ~~~~~---~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~--------- 222 (276)
T d1uwha_ 155 SRWSG---SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV--------- 222 (276)
T ss_dssp --------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH---------
T ss_pred cccCC---cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHH---------
Confidence 53221 122345679999999999864 358999999999999999999999997543322111100
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
......|.+ ...+..++..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 223 ---~~~~~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 223 ---GRGYLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp ---HHTSCCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---hcCCCCCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 001111111 1122333455899999999999999999999999998774
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-53 Score=434.98 Aligned_cols=265 Identities=25% Similarity=0.387 Sum_probs=215.3
Q ss_pred HHHHhhcCccccceeeeeCceEEEEEEECC-CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCC
Q 006750 219 ALEHATDKFSGSNIVGQGGSSYVYRGQLTD-GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (632)
Q Consensus 219 ~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 297 (632)
+|+...++|++.+.||+|+||+||+|.+.+ |+.||||+++... ...++|.+|+.+|++++|||||+++|++.+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---- 84 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR---- 84 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc--chHHHHHHHHHHHHhCCCCCEecCCccEee----
Confidence 344445678889999999999999999864 8899999997543 345569999999999999999999999976
Q ss_pred cceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccc
Q 006750 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGM 377 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGl 377 (632)
....|+||||+++|+|.++|.......+++..++.|+.|++.||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 85 ~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~ 161 (287)
T d1opja_ 85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGL 161 (287)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccc
Confidence 456799999999999999998766667999999999999999999999998 99999999999999999999999999
Q ss_pred ceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccc
Q 006750 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 457 (632)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~ 457 (632)
|+....+.. .......||+.|+|||++.+..++.++|||||||+||||++|..||.......... .
T Consensus 162 a~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~--~-------- 227 (287)
T d1opja_ 162 SRLMTGDTY----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY--E-------- 227 (287)
T ss_dssp TTTCCSSSS----EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH--H--------
T ss_pred eeecCCCCc----eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHH--H--------
Confidence 987654321 11233458999999999999999999999999999999999877765432211100 0
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006750 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 513 (632)
Q Consensus 458 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 513 (632)
.+.. ......+...+..+.+|+.+||+.||++|||+.+|++.|+.+..+
T Consensus 228 ---~i~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 228 ---LLEK----DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp ---HHHT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred ---HHhc----CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 0111 111123333445689999999999999999999999999887544
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=422.59 Aligned_cols=256 Identities=28% Similarity=0.409 Sum_probs=197.9
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV 304 (632)
++|+..+.||+|+||+||+|.+.+++.||||+++... ...++|.+|+++|++++|||||+++|+|.. ....++|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE----QAPICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS----SSSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc--CcHHHHHHHHHHHHhcCCCCcccccceecc----CCceEEE
Confidence 4678889999999999999999889999999997543 344569999999999999999999999976 4467999
Q ss_pred EEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccC
Q 006750 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 384 (632)
|||+++|+|.+++.... ..++|..++.++.|+|.||+|||+.+ |+||||||+||||++++.+||+|||+++.....
T Consensus 79 ~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp EECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred EEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCC
Confidence 99999999999987543 45899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccc
Q 006750 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 464 (632)
Q Consensus 385 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (632)
.. .......||+.|+|||++.+..++.++|||||||+||||+|+..|+.......+ ... .+..
T Consensus 155 ~~----~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~--~~~-----------~i~~ 217 (263)
T d1sm2a_ 155 QY----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVE-----------DIST 217 (263)
T ss_dssp --------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH--HHH-----------HHHH
T ss_pred Cc----eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH--HHH-----------HHHh
Confidence 22 122345699999999999999999999999999999999996544432221110 000 0001
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 465 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 465 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
...+ ..|..++..+.+|+.+||+.||++|||+.+|++.|++++
T Consensus 218 ~~~~----~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 218 GFRL----YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp TCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCC----CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 1111 122233455889999999999999999999999998874
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-52 Score=421.17 Aligned_cols=254 Identities=26% Similarity=0.328 Sum_probs=202.6
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
.++|++.+.||+|+||+||+|+++ +|+.||||+++........+.|.+|+.+|++++|||||++++++.+ ....|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~----~~~~~ 79 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE----GNIQY 79 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE----TTEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc----CceeE
Confidence 357889999999999999999985 5999999999766544445569999999999999999999999986 55789
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||+++|+|.++|... ..+++.++..++.|++.||+|||+++ |+||||||+||||++++.+||+|||+|+...
T Consensus 80 ivmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~ 154 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR 154 (271)
T ss_dssp EEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeec
Confidence 999999999999999653 45999999999999999999999998 9999999999999999999999999999875
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCCC-CcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
.... ........||+.|||||++.+..+ +.++|||||||+||||++|+.||............ +
T Consensus 155 ~~~~---~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~-~----------- 219 (271)
T d1nvra_ 155 YNNR---ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-W----------- 219 (271)
T ss_dssp ETTE---ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH-H-----------
T ss_pred cCCc---cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH-H-----------
Confidence 4321 122345679999999999988775 67899999999999999999999754332211100 0
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.............+..+.+|+.+||+.||++|||+.|+++
T Consensus 220 ----~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 220 ----KEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ----HTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----hcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0000000112233455789999999999999999999865
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=421.48 Aligned_cols=257 Identities=25% Similarity=0.369 Sum_probs=207.8
Q ss_pred cCccccce-eeeeCceEEEEEEEC---CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 225 DKFSGSNI-VGQGGSSYVYRGQLT---DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 225 ~~f~~~~~-LG~G~fG~Vy~~~~~---~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
++|.+.+. ||+|+||+||+|.++ ++..||||+++........+.|.+|+++|++++|||||+++|++.. ..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-----~~ 82 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-----EA 82 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-----SS
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----Ce
Confidence 44555664 999999999999764 3568999999876655556779999999999999999999999863 24
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.|+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+||||+.++.+||+|||+|+.
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhc
Confidence 699999999999999986532 45999999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
........ .......||+.|+|||++..+.++.++|||||||+||||+| |+.||..........
T Consensus 159 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~------------- 223 (285)
T d1u59a_ 159 LGADDSYY--TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA------------- 223 (285)
T ss_dssp CTTCSCEE--CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH-------------
T ss_pred cccccccc--ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHH-------------
Confidence 75433211 12234568999999999999999999999999999999998 899997543221100
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
.+.....+ ..|..++..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 224 -~i~~~~~~----~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 224 -FIEQGKRM----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp -HHHTTCCC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHcCCCC----CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 01111112 22334445688999999999999999999999998765
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=420.57 Aligned_cols=262 Identities=25% Similarity=0.383 Sum_probs=203.2
Q ss_pred cCccccceeeeeCceEEEEEEECCC-----cEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTDG-----RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g-----~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
+.|+..++||+|+||+||+|.+++. ..||||+++..........|.+|+.+|++++|||||+++|++.+ ..
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~----~~ 82 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK----YK 82 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----SS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec----CC
Confidence 4577789999999999999987642 47999999876655556679999999999999999999999976 45
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..++||||+.+|+|.+++.... ..++|.+++.++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred ceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhh
Confidence 6799999999999999886543 45999999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
........ ........||+.|||||++.++.++.++|||||||+||||++|..|+.......+ ...
T Consensus 159 ~~~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~--~~~---------- 224 (283)
T d1mqba_ 159 VLEDDPEA--TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMK---------- 224 (283)
T ss_dssp -----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHH----------
T ss_pred cccCCCcc--ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH--HHH----------
Confidence 76543211 1122345689999999999999999999999999999999997666643222111 000
Q ss_pred ccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006750 460 TVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 513 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 513 (632)
.+.... +.+.+..++..+.+|+.+||+.||++|||+.||++.|+.+...
T Consensus 225 -~i~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 225 -AINDGF----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -HHHTTC----CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -HHhccC----CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 011111 1123334455689999999999999999999999999887644
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-51 Score=410.98 Aligned_cols=253 Identities=22% Similarity=0.361 Sum_probs=210.1
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV 304 (632)
++|+..+.||+|+||+||+|++++++.||||+++... ...+.|++|+.++++++||||++++|+|.+ ....++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~--~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~----~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK----QRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS--SCHHHHHHHHHHHHTCCCTTBCCEEEEECC----SSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc--CCHHHHHHHHHHHHhcCCCceeeEEEEEee----CCceEEE
Confidence 5788999999999999999999889999999998643 334569999999999999999999999976 4568999
Q ss_pred EEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccC
Q 006750 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 384 (632)
|||+++|+|.+++.... ..+++..+.+++.|+++||+|||+.+ |+||||||+||||++++.+||+|||+++.....
T Consensus 78 ~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp EECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred EEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 99999999999976543 45899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccccccccc
Q 006750 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463 (632)
Q Consensus 385 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (632)
.. .......||+.|+|||++.+..++.++||||||+++|||+| |+.||........... +.
T Consensus 154 ~~----~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~--------------i~ 215 (258)
T d1k2pa_ 154 EY----TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH--------------IA 215 (258)
T ss_dssp SC----CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH--------------HH
T ss_pred Cc----eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHH--------------HH
Confidence 32 22334569999999999999999999999999999999998 8999975543211110 11
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 006750 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILST 509 (632)
Q Consensus 464 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 509 (632)
....+ ..|...+..+.+|+.+||+.||++|||+.+|++.|..
T Consensus 216 ~~~~~----~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 216 QGLRL----YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TTCCC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred hCCCC----CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 11111 1233334568999999999999999999999998864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=415.80 Aligned_cols=256 Identities=22% Similarity=0.309 Sum_probs=195.0
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
++|++.+.||+|+||+||+|+.+ +|+.||||+++.... ....+.|.+|+++|++++|||||++++++.+.. ...+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~~~ 81 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT--NTTLY 81 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC------CEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC--CCEEE
Confidence 56889999999999999999875 589999999976543 233456899999999999999999999986532 34679
Q ss_pred EEEEeCCCCChhhhhhcc--ccCCCCHHHHHHHHHHHHHhhHHHHhcCC--CceeecCCCCCCeEecCCCCeEEeccccc
Q 006750 303 LVFEFMPNGNLRDCLDGV--LVEGMNWDTRVAIAIGAARGLEYLHEAAA--PRILHRDIKSSNILLDENLNAKITDLGMA 378 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~--~~iiHrDLKp~NILl~~~~~vkL~DFGla 378 (632)
+||||+++|+|.+++... ....+++..++.++.|++.||+|||+.+. .+|+||||||+||||+.++.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 999999999999999643 23569999999999999999999998752 35999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccc
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
+....+. .......||+.|||||++.+..++.++|||||||+||||++|+.||..........
T Consensus 162 ~~~~~~~-----~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~------------ 224 (269)
T d2java1 162 RILNHDT-----SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG------------ 224 (269)
T ss_dssp HHC----------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------------
T ss_pred eecccCC-----CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHH------------
Confidence 8765432 22345679999999999999999999999999999999999999996533221100
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.+.....+. .+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 225 --~i~~~~~~~----~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 225 --KIREGKFRR----IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --HHHHTCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHcCCCCC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 001111111 22233445899999999999999999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-51 Score=413.27 Aligned_cols=246 Identities=24% Similarity=0.379 Sum_probs=204.6
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|++.+.||+|+||+||+|+++ +|+.||||++.... .......+.+|+.+|++++|||||++++++.+ ....
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~~~ 81 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD----ATRV 81 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----SSEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE----CCEE
Confidence 46888999999999999999986 58999999986431 22345568999999999999999999999886 5578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 82 ~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~ 156 (263)
T d2j4za1 82 YLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA 156 (263)
T ss_dssp EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCC
T ss_pred EEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeec
Confidence 9999999999999999754 45999999999999999999999998 999999999999999999999999999765
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
... ......||+.|||||++.+..++.++|||||||+||||++|+.||..........
T Consensus 157 ~~~-------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~--------------- 214 (263)
T d2j4za1 157 PSS-------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK--------------- 214 (263)
T ss_dssp CCC-------CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---------------
T ss_pred CCC-------cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHH---------------
Confidence 432 2345679999999999999999999999999999999999999996543221111
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.+.... ..+|...+..+.+|+.+||+.||++|||+.|+++
T Consensus 215 --~i~~~~--~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 215 --RISRVE--FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --HHHTTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHcCC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 000000 1123334455889999999999999999999986
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=415.54 Aligned_cols=249 Identities=25% Similarity=0.417 Sum_probs=205.8
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
++|++.+.||+|+||+||+|... +|+.||||+++..... ..+.+.+|+.+|++++|||||++++++.+ ....|+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~----~~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLV----GDELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEE----TTEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-HHHHHHHHHHHHHhCCCCCEeeEeEEEEE----CCEEEE
Confidence 57999999999999999999875 5999999999765433 34569999999999999999999999886 557899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||++||+|.+++.. +.+++.++..++.|++.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+..
T Consensus 95 vmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp EEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 9999999999998764 45999999999999999999999998 99999999999999999999999999998754
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (632)
.. .......||+.|+|||++.+..++.++|||||||+||||++|+.||............ ..
T Consensus 169 ~~-----~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~-------------~~ 230 (293)
T d1yhwa1 169 EQ-----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-------------AT 230 (293)
T ss_dssp TT-----CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------------HH
T ss_pred cc-----ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHH-------------Hh
Confidence 32 1233457999999999999999999999999999999999999999654322111000 00
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 464 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
. ..+. ...+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 231 ~-~~~~--~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 231 N-GTPE--LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp H-CSCC--CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred C-CCCC--CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0011 1223444566899999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-51 Score=415.99 Aligned_cols=250 Identities=26% Similarity=0.385 Sum_probs=198.5
Q ss_pred ceeeeeCceEEEEEEECC---CcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEEE
Q 006750 231 NIVGQGGSSYVYRGQLTD---GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVFE 306 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~---g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~E 306 (632)
++||+|+||+||+|.+++ ++.||||+++.... ....+.|.+|+++|++++|||||+++|+|.. ...+||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-----~~~~lvmE 87 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----ESWMLVME 87 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-----SSEEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-----CCEEEEEE
Confidence 579999999999998753 56899999975433 3345679999999999999999999999853 24689999
Q ss_pred eCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCCC
Q 006750 307 FMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGL 386 (632)
Q Consensus 307 y~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~ 386 (632)
|+++|+|.++++.. ..+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 88 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 88 MAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp CCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred cCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 99999999999754 45999999999999999999999998 99999999999999999999999999987654321
Q ss_pred CCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccccccccccc
Q 006750 387 PSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 465 (632)
Q Consensus 387 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (632)
. ........||+.|||||++.+..++.++|||||||++|||+| |+.||.......... .+..-
T Consensus 163 ~--~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~--------------~i~~~ 226 (277)
T d1xbba_ 163 Y--YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA--------------MLEKG 226 (277)
T ss_dssp E--EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH--------------HHHTT
T ss_pred c--cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHH--------------HHHcC
Confidence 1 112234568999999999999999999999999999999998 899997543221110 01111
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 466 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 466 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
..+ ..|..++..+.+|+.+||+.||++|||+.+|++.|+..
T Consensus 227 ~~~----~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 227 ERM----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCC----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCC----CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 111 22333445688999999999999999999999888654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=427.15 Aligned_cols=259 Identities=23% Similarity=0.408 Sum_probs=205.6
Q ss_pred hhcCccccceeeeeCceEEEEEEECC-C-----cEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeeccc
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLTD-G-----RIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFR 295 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~~-g-----~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~ 295 (632)
..++|++.+.||+|+||+||+|++.. + ..||||++...........|.+|+.+|.++ +|||||++++++.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-- 112 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL-- 112 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee--
Confidence 34678889999999999999998753 2 369999997665555666799999999998 89999999999986
Q ss_pred CCcceEEEEEEeCCCCChhhhhhcccc---------------------CCCCHHHHHHHHHHHHHhhHHHHhcCCCceee
Q 006750 296 GKRAMRLLVFEFMPNGNLRDCLDGVLV---------------------EGMNWDTRVAIAIGAARGLEYLHEAAAPRILH 354 (632)
Q Consensus 296 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH 354 (632)
....|+||||+++|+|.++|+.... ..+++..++.++.|++.||+|||+++ |+|
T Consensus 113 --~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiH 187 (325)
T d1rjba_ 113 --SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVH 187 (325)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred --CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 4567999999999999999965321 24899999999999999999999998 999
Q ss_pred cCCCCCCeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CC
Q 006750 355 RDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GR 433 (632)
Q Consensus 355 rDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~ 433 (632)
|||||+|||++.++.+||+|||+|+........ .......||+.|||||++.++.++.++|||||||+||||+| |+
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~ 264 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNY---VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 264 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS---EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred ccCchhccccccCCeEEEeeccccccccCCCce---eeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCC
Confidence 999999999999999999999999876543211 11234568999999999999999999999999999999998 89
Q ss_pred CCCCCccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 006750 434 QPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILS 508 (632)
Q Consensus 434 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 508 (632)
.||........... .+.. ....+.|..++..+.+|+.+||+.||++|||+.||++.|.
T Consensus 265 ~Pf~~~~~~~~~~~-------------~~~~----~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 265 NPYPGIPVDANFYK-------------LIQN----GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CSSTTCCCSHHHHH-------------HHHT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCHHHHHHH-------------HHhc----CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 99965432211100 0111 1112233344456899999999999999999999999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=411.14 Aligned_cols=251 Identities=25% Similarity=0.360 Sum_probs=199.2
Q ss_pred cccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEE
Q 006750 228 SGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 305 (632)
Q Consensus 228 ~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~ 305 (632)
...++||+|+||+||+|.+. +++.||||++.... .....+.|.+|+++|++++|||||++++++.........+|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 34567999999999999986 48899999987653 33344569999999999999999999999876555566789999
Q ss_pred EeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEec-CCCCeEEeccccceecccC
Q 006750 306 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD-ENLNAKITDLGMAKRLKAD 384 (632)
Q Consensus 306 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~-~~~~vkL~DFGla~~~~~~ 384 (632)
||+++|+|.+++... ..+++.++..++.||+.||+|||+++ ++|+||||||+||||+ +++.+||+|||+|+.....
T Consensus 92 E~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred eCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence 999999999999754 45999999999999999999999875 4499999999999996 5789999999999764322
Q ss_pred CCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccccccc
Q 006750 385 GLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISE 464 (632)
Q Consensus 385 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (632)
......||+.|||||++.+ .++.++|||||||+||||++|+.||.......... .. ....
T Consensus 169 -------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~--~~----------i~~~ 228 (270)
T d1t4ha_ 169 -------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY--RR----------VTSG 228 (270)
T ss_dssp -------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH--HH----------HTTT
T ss_pred -------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHH--HH----------HHcC
Confidence 2345679999999998865 69999999999999999999999996433221100 00 0000
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 465 LPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 465 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
...+. ++...+..+.+|+.+||+.||++|||+.|+++
T Consensus 229 ~~~~~----~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 229 VKPAS----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CCCGG----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCcc----cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11111 12222344889999999999999999999976
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-51 Score=417.37 Aligned_cols=259 Identities=27% Similarity=0.402 Sum_probs=205.8
Q ss_pred hcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
.++|++.+.||+|+||.||+|++++++.||||+++... ...+.|.+|+.+|++++|||||+++|++.+ ...++
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-----~~~~l 88 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-----EPIYI 88 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSCEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc--CCHHHHHHHHHHHHhcccCCEeEEEEEEec-----CCeEE
Confidence 35788899999999999999999888899999997543 334569999999999999999999999853 24689
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||+++|+|..++.......++|.+++.++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+|+....
T Consensus 89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~ 165 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 165 (285)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccC
Confidence 999999999999997766567999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVIS 463 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (632)
... .......||+.|+|||++..+.++.++||||||++||||++|..||.......+ ...+ +.
T Consensus 166 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~--~~~~-----------i~ 228 (285)
T d1fmka3 166 NEY----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQ-----------VE 228 (285)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHH-----------HH
T ss_pred CCc----eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH--HHHH-----------HH
Confidence 322 122345699999999999999999999999999999999997766644322111 0000 11
Q ss_pred ccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006750 464 ELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 513 (632)
Q Consensus 464 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 513 (632)
....+ +.+..++..+.+|+.+||+.||++||++.+|++.|+.....
T Consensus 229 ~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 229 RGYRM----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp TTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred hcCCC----CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 11111 23334445689999999999999999999999999876644
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-51 Score=424.00 Aligned_cols=265 Identities=24% Similarity=0.363 Sum_probs=207.2
Q ss_pred hhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
..++|++.+.||+|+||+||+|++. +|+.||||+++..........+.+|+.+|++++|||||++++++.+ ....
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~ 79 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS----DGEI 79 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC----SSEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----CCEE
Confidence 4578999999999999999999975 5899999999876666666779999999999999999999999986 5578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhc-CCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
|+||||++||+|.+++.+. ..+++..+..++.|++.||.|||+. + |+||||||+||||+.++.+||+|||+|+.
T Consensus 80 ~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~ 154 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQ 154 (322)
T ss_dssp EEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred EEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccc
Confidence 9999999999999999754 4599999999999999999999974 7 99999999999999999999999999987
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecc-ccc-----
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA-TPR----- 454 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~-~~~----- 454 (632)
..... ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||............... ...
T Consensus 155 ~~~~~-------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 227 (322)
T d1s9ja_ 155 LIDSM-------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227 (322)
T ss_dssp HHHHT-------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------
T ss_pred cCCCc-------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCC
Confidence 65432 23457999999999999999999999999999999999999999754322110000000 000
Q ss_pred --cccccc--------------------cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 455 --LQDSGT--------------------VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 455 --~~~~~~--------------------~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
...... .+.....+.+. ....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLP---SGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ------------------CCCCHHHHHHHHHTSCCCCCC---BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccccccchhHHHHHhhhhccCCccCc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 000000 00000001111 01123458899999999999999999999873
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=413.34 Aligned_cols=251 Identities=24% Similarity=0.329 Sum_probs=203.2
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
+.|++.+.||+|+||+||+|++. +|+.||||+++... ....+.|.+|+++|++++|||||++++++.+ ....|+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYY----ENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE----TTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEee----CCeEEE
Confidence 45888999999999999999976 58999999997653 3344568999999999999999999999886 557899
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||+++|+|.+++.+. .+.+++.++..++.|++.||.|||+++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 87 vmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp EEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred EEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 99999999999998653 356999999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhh-----cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAM-----VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
.. .......||+.|+|||++. ...++.++|||||||+||||++|+.||............
T Consensus 163 ~~-----~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i---------- 227 (288)
T d2jfla1 163 TI-----QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI---------- 227 (288)
T ss_dssp HH-----HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH----------
T ss_pred Cc-----ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH----------
Confidence 21 1122356999999999984 456899999999999999999999999754332111100
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.....+.+ ..+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 228 ----~~~~~~~~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 228 ----AKSEPPTL--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ----HHSCCCCC--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----HcCCCCCC--CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00001111 123344556899999999999999999999976
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-50 Score=415.12 Aligned_cols=254 Identities=21% Similarity=0.297 Sum_probs=190.6
Q ss_pred hhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
..+.|++.+.||+|+||+||+|+.+ +|+.||||++...........+.+|+.+|++++|||||++++++.+ ....
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~ 82 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES----GGHL 82 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC----SSEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----CCEE
Confidence 4567999999999999999999986 5899999999865544444568899999999999999999999875 5578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEec---CCCCeEEeccccc
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD---ENLNAKITDLGMA 378 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~---~~~~vkL~DFGla 378 (632)
|+||||++||+|.++|... ..+++..+..++.|++.||+|||+++ |+||||||+|||+. +++.+||+|||+|
T Consensus 83 ~lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp EEEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred EEEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEecccee
Confidence 9999999999999999753 46999999999999999999999998 99999999999994 5789999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccc
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
+...... ......||+.|||||++.+..++.++|||||||+||||++|+.||.............
T Consensus 158 ~~~~~~~------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~--------- 222 (307)
T d1a06a_ 158 KMEDPGS------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL--------- 222 (307)
T ss_dssp ---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---------
T ss_pred EEccCCC------eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHh---------
Confidence 8764332 2334679999999999999999999999999999999999999997543221111000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.. ........+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 223 ----~~--~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 223 ----KA--EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp ----TT--CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ----cc--CCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 00 0011111223344558899999999999999999999874
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=410.93 Aligned_cols=258 Identities=24% Similarity=0.369 Sum_probs=199.9
Q ss_pred hcCccccceeeeeCceEEEEEEECC----CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTD----GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~----g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
.++|++.+.||+|+||.||+|.+.. +..||||+++........+.|.+|+.+|++++|||||+++|++.+ .
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-----~ 80 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-----N 80 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----S
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----C
Confidence 4678889999999999999998753 457999998766555556679999999999999999999999853 3
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..|+||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred eEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhe
Confidence 569999999999999988653 345999999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
....... .......||+.|+|||++.+..++.++|||||||+||||++ |.+||...........
T Consensus 157 ~~~~~~~----~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~----------- 221 (273)
T d1mp8a_ 157 YMEDSTY----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR----------- 221 (273)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-----------
T ss_pred eccCCcc----eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHH-----------
Confidence 7654321 12334568999999999999999999999999999999998 8889865433211100
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
+..-..+ +.+..++..+.+|+.+||..||++|||+.||++.|..+..
T Consensus 222 ---i~~~~~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 222 ---IENGERL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp ---HHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHcCCCC----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0111111 2233444568999999999999999999999999988753
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-49 Score=410.81 Aligned_cols=267 Identities=23% Similarity=0.380 Sum_probs=214.2
Q ss_pred HHHHHHhhcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeee
Q 006750 217 YSALEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGY 290 (632)
Q Consensus 217 ~~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~ 290 (632)
+.+|+...++|++.+.||+|+||+||+|+++ +++.||||+++..........|.+|+++|++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3456667789999999999999999999864 3578999999876655556779999999999999999999999
Q ss_pred eecccCCcceEEEEEEeCCCCChhhhhhccc----------------------cCCCCHHHHHHHHHHHHHhhHHHHhcC
Q 006750 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL----------------------VEGMNWDTRVAIAIGAARGLEYLHEAA 348 (632)
Q Consensus 291 ~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~ 348 (632)
+.. ....++||||+++|+|.++|.... ...+++..++.|+.|++.||+|||+.+
T Consensus 85 ~~~----~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ 160 (301)
T d1lufa_ 85 CAV----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK 160 (301)
T ss_dssp ECS----SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ecc----CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC
Confidence 976 446799999999999999996421 124899999999999999999999998
Q ss_pred CCceeecCCCCCCeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHH
Q 006750 349 APRILHRDIKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLE 428 (632)
Q Consensus 349 ~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~e 428 (632)
|+||||||+||||+.++.+||+|||+|+........ .......||+.|+|||.+.+..++.++|||||||+|||
T Consensus 161 ---ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~e 234 (301)
T d1lufa_ 161 ---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY---KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 234 (301)
T ss_dssp ---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB---C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred ---eEeeEEcccceEECCCCcEEEccchhheeccCCccc---cccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHH
Confidence 999999999999999999999999999866443211 12234568999999999999999999999999999999
Q ss_pred HHhCC-CCCCCccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 006750 429 LITGR-QPIHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQIL 507 (632)
Q Consensus 429 LltG~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 507 (632)
|++|. +||........... +.+-..+ ..|..++..+.+|+.+||+.||.+||||.||++.|
T Consensus 235 ll~~~~~p~~~~~~~e~~~~--------------v~~~~~~----~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L 296 (301)
T d1lufa_ 235 IFSYGLQPYYGMAHEEVIYY--------------VRDGNIL----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296 (301)
T ss_dssp HHTTTCCTTTTSCHHHHHHH--------------HHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHccCCCCCCCCCHHHHHHH--------------HHcCCCC----CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 99996 46654332211110 1111111 22333445589999999999999999999999999
Q ss_pred hhhC
Q 006750 508 STIA 511 (632)
Q Consensus 508 ~~i~ 511 (632)
+++.
T Consensus 297 ~~i~ 300 (301)
T d1lufa_ 297 QRMC 300 (301)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 8874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=412.03 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=204.3
Q ss_pred cCccccceeeeeCceEEEEEEECC-Cc----EEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GR----IVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRA 299 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~----~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~ 299 (632)
.+|++.++||+|+||+||+|.+.. |+ .||||+++........+.|.+|+++|++++|||||+++|+|.+ .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-----~ 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-----S 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-----S
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----C
Confidence 358899999999999999998753 43 6999999876666667789999999999999999999999975 2
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..+++|||+.+|+|.+++... ...+++..++.++.|||.||+|||+++ |+||||||+||||+.++.+||+|||+|+
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred CeeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccce
Confidence 458899999999999988764 356999999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
........ .......||+.|+|||++.++.++.++|||||||+||||+| |+.||...........
T Consensus 160 ~~~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~----------- 225 (317)
T d1xkka_ 160 LLGAEEKE---YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI----------- 225 (317)
T ss_dssp HTTTTCC-----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHH-----------
T ss_pred eccccccc---ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHH-----------
Confidence 76543221 12234568999999999999999999999999999999999 7888865432211110
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
+..-..+ ..|..++..+.+|+.+||+.||.+|||+.||++.|..+..
T Consensus 226 ---i~~~~~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 226 ---LEKGERL----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp ---HHHTCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHcCCCC----CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 1111111 2233444568999999999999999999999999987753
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-50 Score=404.56 Aligned_cols=251 Identities=27% Similarity=0.401 Sum_probs=199.5
Q ss_pred hcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
.++|+..+.||+|+||.||+|+++ |+.||||+++... ..+.|.+|+++|++++||||++++|++.+. ...+|+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~---~~~~~l 78 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEE---KGGLYI 78 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC-----CCEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEec---CCcEEE
Confidence 356777899999999999999985 7899999997543 345699999999999999999999998652 234699
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
||||+++|+|.++|.......++|..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC
Confidence 999999999999997655456999999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheeccccccccccccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQDSGTVI 462 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 462 (632)
. .....+|+.|+|||++.++.++.++||||||+++|||+| |++||.......... .+
T Consensus 156 ~--------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~--------------~i 213 (262)
T d1byga_ 156 T--------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP--------------RV 213 (262)
T ss_dssp --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH--------------HH
T ss_pred C--------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHH--------------HH
Confidence 2 223458899999999999999999999999999999998 677776433221110 01
Q ss_pred cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 463 SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 463 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
..-..+ +++...+..+.+|+.+||+.||.+|||+.+|++.|+.+
T Consensus 214 ~~~~~~----~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 214 EKGYKM----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp TTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HcCCCC----CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 111122 23334445689999999999999999999999999876
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-50 Score=410.03 Aligned_cols=251 Identities=25% Similarity=0.346 Sum_probs=202.4
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|++.+.||+|+||+||+|+.. +|+.||||+++... .....+.+.+|+++|++++||||+++++++.+ ....
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~ 83 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD----DEKL 83 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC----SSEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE----CCEE
Confidence 56889999999999999999985 59999999986431 22334569999999999999999999999875 5578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||||++||+|.+++... +.+++..+..++.|++.||+|||+.+ |+||||||+||||++++.+||+|||+|+.+
T Consensus 84 ~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 158 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVL 158 (288)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceec
Confidence 9999999999999998754 45999999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
...... .......||+.|+|||++.+..++.++|||||||+||||++|+.||..........
T Consensus 159 ~~~~~~---~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~--------------- 220 (288)
T d1uu3a_ 159 SPESKQ---ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ--------------- 220 (288)
T ss_dssp C-------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---------------
T ss_pred ccCCcc---cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHH---------------
Confidence 543211 12334579999999999999999999999999999999999999997543221100
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+.... ..+|...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 221 --~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 221 --KIIKLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp --HHHTTC--CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred --HHHcCC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 000000 11233344558899999999999999999997553
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=409.14 Aligned_cols=268 Identities=27% Similarity=0.391 Sum_probs=203.2
Q ss_pred HHHHHhhcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeee
Q 006750 218 SALEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGY 290 (632)
Q Consensus 218 ~~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~ 290 (632)
..|+...++|++.+.||+|+||.||+|.+. +++.||||+++........+.|.+|+.++.++ +|+||+.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 445555678999999999999999999864 24689999998765555566788999988888 78999999998
Q ss_pred eecccCCcceEEEEEEeCCCCChhhhhhccc--------------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecC
Q 006750 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRD 356 (632)
Q Consensus 291 ~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrD 356 (632)
+.+. ....++|||||++|+|.++|+... ...+++.+++.++.||++||+|||+++ |+|||
T Consensus 86 ~~~~---~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrD 159 (299)
T d1ywna1 86 CTKP---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 159 (299)
T ss_dssp ECST---TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred eccC---CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCc
Confidence 7652 345799999999999999996532 234899999999999999999999998 99999
Q ss_pred CCCCCeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCC-CC
Q 006750 357 IKSSNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR-QP 435 (632)
Q Consensus 357 LKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~-~P 435 (632)
|||+||||++++++||+|||+|+....... ........||+.|+|||++.+..++.++|||||||++|||++|. .|
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~---~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p 236 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPD---YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 236 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTT---SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCccceeECCCCcEEEccCcchhhcccccc---ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCC
Confidence 999999999999999999999987654321 12234467999999999999999999999999999999999975 56
Q ss_pred CCCccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 436 IHRSITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 436 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
|.......... ..+.+...+. .+...+..+.+|+.+||+.||++|||+.||++.|+.++
T Consensus 237 ~~~~~~~~~~~-------------~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 237 YPGVKIDEEFC-------------RRLKEGTRMR----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp STTCCCSHHHH-------------HHHHHTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCHHHHHH-------------HHHhcCCCCC----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 65432211100 0111111222 23333445889999999999999999999999998874
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-49 Score=403.43 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=204.5
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-----CChHHHHHHHHHHHHhcCCCCccceeeeeecccCC
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-----PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGK 297 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-----~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 297 (632)
.++|.+.+.||+|+||+||+|+.+ +|+.||||+++.... ....+.|.+|+.+|++++|||||++++++.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---- 84 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN---- 84 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----
Confidence 467999999999999999999985 599999999865422 2235679999999999999999999999876
Q ss_pred cceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCC----CeEEe
Q 006750 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL----NAKIT 373 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~----~vkL~ 373 (632)
....|||||||++|+|.++|... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~ 159 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKII 159 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred CCEEEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEec
Confidence 56789999999999999999764 46999999999999999999999998 99999999999998776 49999
Q ss_pred ccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccc
Q 006750 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATP 453 (632)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~ 453 (632)
|||+|+...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||.............
T Consensus 160 DfG~a~~~~~~~------~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~---- 229 (293)
T d1jksa_ 160 DFGLAHKIDFGN------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS---- 229 (293)
T ss_dssp CCTTCEECTTSC------BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----
T ss_pred chhhhhhcCCCc------cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHH----
Confidence 999998765432 2334579999999999999999999999999999999999999997543221111000
Q ss_pred ccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 454 RLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 454 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.. ........+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 230 ----------~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 230 ----------AV-NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ----------TT-CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----------hc-CCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 000000111223445889999999999999999999987
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-49 Score=409.01 Aligned_cols=246 Identities=25% Similarity=0.363 Sum_probs=198.9
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC--ChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
..|+..+.||+|+||+||+|+.. +|+.||||+++..... ...+.|.+|+.+|++++|||||++++++.+ ....
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~----~~~~ 90 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR----EHTA 90 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE----TTEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE----CCEE
Confidence 34888999999999999999875 5899999999765432 223458999999999999999999999876 5578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+|||||++|+|..++... ..+++.++..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 91 ~iv~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~ 165 (309)
T d1u5ra_ 91 WLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (309)
T ss_dssp EEEEECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred EEEEEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeeccccccc
Confidence 9999999999998766543 56999999999999999999999998 999999999999999999999999999865
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhc---CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMV---GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDS 458 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~---~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~ 458 (632)
... ....||+.|||||++.+ +.|+.++|||||||++|||++|+.||...........
T Consensus 166 ~~~---------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~----------- 225 (309)
T d1u5ra_ 166 APA---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----------- 225 (309)
T ss_dssp SSB---------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-----------
T ss_pred CCC---------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHH-----------
Confidence 432 23469999999999864 4689999999999999999999999965432211000
Q ss_pred cccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 459 GTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.. ....+.+. +...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 226 --i~-~~~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 226 --IA-QNESPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --HH-HSCCCCCS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --HH-hCCCCCCC---CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 00 00111111 1222345889999999999999999999976
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-48 Score=398.51 Aligned_cols=258 Identities=25% Similarity=0.398 Sum_probs=205.7
Q ss_pred cceeeeeCceEEEEEEECCC----cEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEEE
Q 006750 230 SNIVGQGGSSYVYRGQLTDG----RIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLVF 305 (632)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~~g----~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV~ 305 (632)
.++||+|+||+||+|.+.++ ..||||+++........+.|.+|+++|++++||||++++|++.+. +...++||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~---~~~~~lv~ 108 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS---EGSPLVVL 108 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET---TTEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec---CCceEEEE
Confidence 36799999999999997542 369999998655555567799999999999999999999998753 34679999
Q ss_pred EeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccCC
Q 006750 306 EFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKADG 385 (632)
Q Consensus 306 Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~~ 385 (632)
||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||||++++.+||+|||+++......
T Consensus 109 E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp ECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 9999999999987543 45889999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccccccc
Q 006750 386 LPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTVISEL 465 (632)
Q Consensus 386 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (632)
... ........||+.|+|||++..+.++.++||||||++||||++|+.||.......... . .+...
T Consensus 185 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~--~-----------~i~~g 250 (311)
T d1r0pa_ 185 FDS-VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT--V-----------YLLQG 250 (311)
T ss_dssp CCC-TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CH--H-----------HHHTT
T ss_pred ccc-ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHH--H-----------HHHcC
Confidence 322 122334579999999999999999999999999999999999888875432211100 0 00111
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 466 PDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 466 ~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
..+. .|..++..+.+|+.+||+.||++||++.||++.|+.+..
T Consensus 251 ~~~~----~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 251 RRLL----QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp CCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCC----CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1111 222334458899999999999999999999999998853
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.6e-48 Score=409.21 Aligned_cols=253 Identities=23% Similarity=0.276 Sum_probs=205.1
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
-++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+ ....|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~----~~~~~ 99 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFED----DNEMV 99 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE----TTEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE----CCEEE
Confidence 357999999999999999999975 59999999997543 2334568999999999999999999999886 56789
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEec--CCCCeEEecccccee
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD--ENLNAKITDLGMAKR 380 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~--~~~~vkL~DFGla~~ 380 (632)
+|||||+||+|.+++.... ..+++..+..++.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+|+.
T Consensus 100 ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp EEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchhee
Confidence 9999999999999986532 45999999999999999999999999 99999999999995 467899999999987
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
..... ......||+.|||||++.+..++.++|||||||++|||++|+.||...............
T Consensus 176 ~~~~~------~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--------- 240 (350)
T d1koaa2 176 LDPKQ------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC--------- 240 (350)
T ss_dssp CCTTS------CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT---------
T ss_pred ccccc------ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhC---------
Confidence 65432 234567999999999999999999999999999999999999999654322111100000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
............+..+.+|+.+||+.||++|||+.|+++.
T Consensus 241 ------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 241 ------DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ------CCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ------CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0001111122334558899999999999999999999874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.1e-48 Score=396.11 Aligned_cols=265 Identities=25% Similarity=0.330 Sum_probs=205.0
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC--ChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcce
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP--NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~--~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
.++|.+.+.||+|+||+||+|.+. +|+.||||+++..... .....|.+|+.+|++++||||+++++++.........
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999875 5999999999865433 2345699999999999999999999998875555567
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.|+||||++||+|.+++... +.+++.+++.++.|++.||+|||+++ |+||||||+||||+.++.++|+|||.+..
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhh
Confidence 89999999999999988654 45999999999999999999999998 99999999999999999999999999876
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
....... ........||+.|+|||++.+..++.++|||||||+||||+||+.||............
T Consensus 161 ~~~~~~~--~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~------------ 226 (277)
T d1o6ya_ 161 IADSGNS--VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH------------ 226 (277)
T ss_dssp CC------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH------------
T ss_pred hcccccc--ccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHH------------
Confidence 5433211 12334567999999999999999999999999999999999999999754322111000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhh
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-TMSEVVQILSTI 510 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i 510 (632)
+..-..+ ........+..+.+|+.+||+.||.+|| |++++++.|.++
T Consensus 227 -~~~~~~~--~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 227 -VREDPIP--PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp -HHCCCCC--GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -HhcCCCC--CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 0000000 0011122334588999999999999999 899999988766
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-49 Score=405.14 Aligned_cols=258 Identities=24% Similarity=0.403 Sum_probs=203.7
Q ss_pred cCccccceeeeeCceEEEEEEECC-Cc--EEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcce
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD-GR--IVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~-g~--~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~ 300 (632)
++|++.++||+|+||+||+|.+++ |. .||||+++........+.|.+|+++|+++ +|||||+++|++.+ ...
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~----~~~ 85 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH----RGY 85 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE----TTE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec----CCe
Confidence 568888999999999999998764 43 58888887655555556699999999999 79999999999986 557
Q ss_pred EEEEEEeCCCCChhhhhhcc--------------ccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC
Q 006750 301 RLLVFEFMPNGNLRDCLDGV--------------LVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE 366 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~ 366 (632)
.++||||+++|+|.++|+.. ....++|..++.++.|||.||.|||+.+ |+||||||+|||++.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~ 162 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGE 162 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECG
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcC
Confidence 89999999999999999643 2356999999999999999999999998 999999999999999
Q ss_pred CCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCC-CCCCccccccc
Q 006750 367 NLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQ-PIHRSITKGEE 445 (632)
Q Consensus 367 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~-P~~~~~~~~~~ 445 (632)
++.+||+|||+++...... ......||..|+|||.+.++.++.++||||||+++|||++|.. ||.........
T Consensus 163 ~~~~kl~DfG~a~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~ 236 (309)
T d1fvra_ 163 NYVAKIADFGLSRGQEVYV------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 236 (309)
T ss_dssp GGCEEECCTTCEESSCEEC------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred CCceEEccccccccccccc------cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 9999999999998654321 2234568999999999999999999999999999999999765 55433221110
Q ss_pred hheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006750 446 SLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 513 (632)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 513 (632)
. .+.+-.++ +.+..++..+.+|+.+||+.||++|||+.||++.|+.+...
T Consensus 237 ~--------------~i~~~~~~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 237 E--------------KLPQGYRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp H--------------HGGGTCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred H--------------HHHhcCCC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 0 01111111 22333445699999999999999999999999999988643
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-49 Score=400.17 Aligned_cols=258 Identities=26% Similarity=0.337 Sum_probs=196.4
Q ss_pred cCccccceeeeeCceEEEEEEECC--C--cEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTD--G--RIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~--g--~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 298 (632)
++|++.+.||+|+||.||+|++.. + ..||||+++... .....+.|.+|+.+|++++|||||+++|++.+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~----- 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----- 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence 458888999999999999998642 2 379999987543 23334579999999999999999999999964
Q ss_pred ceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccc
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 378 (632)
...++||||+++|+|.+++.... ..+++..++.++.|+|.||.|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 83 ~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~ 158 (273)
T d1u46a_ 83 PPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLM 158 (273)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred cchheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhh
Confidence 24589999999999999887543 45999999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCccccccchheecccccccc
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRSITKGEESLVLWATPRLQD 457 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~~~~~~~~~~~~~~~~~~~ 457 (632)
+......... .......||..|+|||++.+..++.++||||||+++|||+| |+.||..........
T Consensus 159 ~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~----------- 225 (273)
T d1u46a_ 159 RALPQNDDHY--VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH----------- 225 (273)
T ss_dssp EECCC-CCEE--EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-----------
T ss_pred hhcccCCCcc--eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHH-----------
Confidence 9875432211 12234468899999999999999999999999999999998 899996543221110
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhh
Q 006750 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTI 510 (632)
Q Consensus 458 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 510 (632)
.+.......+.+...+..+.+|+.+||+.||++|||+.+|++.|.++
T Consensus 226 ------~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 226 ------KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ------HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------HHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11111111122333345588999999999999999999999998764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.7e-48 Score=406.80 Aligned_cols=253 Identities=24% Similarity=0.303 Sum_probs=205.4
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
.++|++.+.||+|+||.||+|... +|+.||||+++... ......+.+|+.+|++|+|||||++++++.+ ....|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~----~~~~~ 102 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFED----KYEMV 102 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC----SSEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE----CCEEE
Confidence 357999999999999999999975 59999999997643 2334568899999999999999999999875 56789
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEec--CCCCeEEecccccee
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD--ENLNAKITDLGMAKR 380 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~--~~~~vkL~DFGla~~ 380 (632)
||||||+||+|.+++... ...+++.++..|+.||+.||+|||+.+ |+||||||+||||+ .++.+||+|||+|+.
T Consensus 103 ivmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATK 178 (352)
T ss_dssp EEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeeccccee
Confidence 999999999999987653 245999999999999999999999998 99999999999997 678999999999998
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
..... ......||+.|+|||++.+..++.++|||||||+||||++|+.||.............
T Consensus 179 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~----------- 241 (352)
T d1koba_ 179 LNPDE------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK----------- 241 (352)
T ss_dssp CCTTS------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH-----------
T ss_pred cCCCC------ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----------
Confidence 75432 2344679999999999999999999999999999999999999996543221110000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
. .........+...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 242 ---~-~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 242 ---R-CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp ---H-CCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ---h-CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00011111222334458899999999999999999999763
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=400.75 Aligned_cols=278 Identities=24% Similarity=0.339 Sum_probs=204.3
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHH--HHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLT--EVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~--Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
..|...+.||+|+||.||+|++ +|+.||||+++... ...+.+ |+..+.+++|||||+++|++.+.......+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 3566778999999999999997 58999999996532 233444 4555567899999999999987665556789
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcC-----CCceeecCCCCCCeEecCCCCeEEecccc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA-----APRILHRDIKSSNILLDENLNAKITDLGM 377 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiHrDLKp~NILl~~~~~vkL~DFGl 377 (632)
+||||+++|+|.++|++ ..++|..++.++.|+|.||+|||+.. .++|+||||||+||||+.++.+||+|||+
T Consensus 78 lv~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 99999999999999976 35899999999999999999999741 23599999999999999999999999999
Q ss_pred ceecccCCCCCCCCCCCccccCCCCCChhhhhcCC------CCcccchHhHhHHHHHHHhCCCCCCCccccccchhe-ec
Q 006750 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGR------ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV-LW 450 (632)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~------~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~-~~ 450 (632)
++......... ........||+.|+|||++.+.. ++.++|||||||+||||+||..||............ ..
T Consensus 155 ~~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 155 AVRHDSATDTI-DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp CEEEETTTTEE-CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred cccccCCCcce-eccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 99875433211 12334567999999999987543 577899999999999999999887543322111100 00
Q ss_pred cccccccc-cccccccCCCCCCCCC-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 451 ATPRLQDS-GTVISELPDPRLKGDF-PKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 451 ~~~~~~~~-~~~~~~~~~~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
..+..... ........+|.+.... +.+....+.+|+.+||+.||++|||+.||++.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 00000000 0011112222222211 2345567999999999999999999999999998874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=399.33 Aligned_cols=260 Identities=26% Similarity=0.403 Sum_probs=206.5
Q ss_pred hcCccccceeeeeCceEEEEEEECC--------CcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLTD--------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEF 294 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~ 294 (632)
.++|.+.+.||+|+||.||+|+... +..||||+++..........+.+|+..+.++ +|||||+++++|.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~- 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc-
Confidence 4568888999999999999998632 3479999998766555567799999999998 89999999999986
Q ss_pred cCCcceEEEEEEeCCCCChhhhhhccc--------------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCC
Q 006750 295 RGKRAMRLLVFEFMPNGNLRDCLDGVL--------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSS 360 (632)
Q Consensus 295 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~ 360 (632)
....++||||+++|+|.++|.... ...+++.+++.++.|++.||+|||+.+ |+||||||+
T Consensus 91 ---~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~ 164 (299)
T d1fgka_ 91 ---DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAAR 164 (299)
T ss_dssp ---SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred ---CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeeccc
Confidence 456799999999999999996442 234899999999999999999999998 999999999
Q ss_pred CeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHh-CCCCCCCc
Q 006750 361 NILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELIT-GRQPIHRS 439 (632)
Q Consensus 361 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLlt-G~~P~~~~ 439 (632)
|||++.++.+||+|||+++........ .......||+.|+|||.+.++.++.++||||||+++|||++ |.+||...
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~ 241 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYY---KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTT---CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceeecCCCCeEeccchhhccccccccc---cccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC
Confidence 999999999999999999987654322 22345678999999999999999999999999999999998 67887543
Q ss_pred cccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhC
Q 006750 440 ITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIA 511 (632)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 511 (632)
....... .+..-..+ ..|...+..+.+|+.+||+.||++|||+.||++.|+++.
T Consensus 242 ~~~~~~~--------------~i~~~~~~----~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 242 PVEELFK--------------LLKEGHRM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp CHHHHHH--------------HHHTTCCC----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHH--------------HHHcCCCC----CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 3221100 11111112 223333455899999999999999999999999998874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-48 Score=402.08 Aligned_cols=248 Identities=25% Similarity=0.318 Sum_probs=204.9
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|++.+.||+|+||.||+|+.+ +|+.||||+++... .......+.+|+.+|++++||||+++++++.+ ...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~~~~ 80 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT----HDRL 80 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC----SSEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc----cccc
Confidence 56899999999999999999975 59999999997431 23345568999999999999999999999886 5678
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||||++||+|.+++... ..+++..+..++.|++.||+|||+++ |+||||||+||||+.+|.+||+|||+|+..
T Consensus 81 ~iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~ 155 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred ccceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccc
Confidence 9999999999999999764 45899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
.... .......||+.|+|||++.+..|+.++|||||||+||||++|+.||.............
T Consensus 156 ~~~~-----~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~------------ 218 (337)
T d1o6la_ 156 ISDG-----ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL------------ 218 (337)
T ss_dssp CCTT-----CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------------
T ss_pred ccCC-----cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHh------------
Confidence 4332 22345689999999999999999999999999999999999999997543321111000
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT-----MSEVVQ 505 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 505 (632)
. ... .+|...+..+.+|+.+||+.||.+||+ +.|+++
T Consensus 219 -~--~~~----~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 219 -M--EEI----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -H--CCC----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -c--CCC----CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 0 011 123334455889999999999999995 777765
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=401.74 Aligned_cols=263 Identities=24% Similarity=0.347 Sum_probs=209.9
Q ss_pred hhcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeeccc
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFR 295 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~ 295 (632)
..++|++.+.||+|+||.||+|++. +++.||||+++..........|.+|+.+++++ +|||||+++|++.+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~-- 98 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee--
Confidence 3467888899999999999999863 36789999998766555566799999999999 79999999999976
Q ss_pred CCcceEEEEEEeCCCCChhhhhhccc----------------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCC
Q 006750 296 GKRAMRLLVFEFMPNGNLRDCLDGVL----------------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKS 359 (632)
Q Consensus 296 ~~~~~~~lV~Ey~~~gsL~~~L~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp 359 (632)
....++||||+++|+|.++|+... ...+++..+..++.||+.||+|||+++ |+||||||
T Consensus 99 --~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp 173 (311)
T d1t46a_ 99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAA 173 (311)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred --CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccc
Confidence 446799999999999999996532 224899999999999999999999998 99999999
Q ss_pred CCeEecCCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCC-CCC
Q 006750 360 SNILLDENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQP-IHR 438 (632)
Q Consensus 360 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P-~~~ 438 (632)
+|||++.++.+||+|||+++........ .......||+.|+|||++..+.++.++||||||++||||+|+..| |..
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~ 250 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNY---VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTS---EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ccccccccCcccccccchheeccCCCcc---eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999876543221 122345799999999999999999999999999999999995555 433
Q ss_pred ccccccchheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 439 SITKGEESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
......... .+..-..+ ..+...+..+.+|+.+||+.||.+|||+.+|++.|++++.
T Consensus 251 ~~~~~~~~~-------------~i~~~~~~----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 251 MPVDSKFYK-------------MIKEGFRM----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp CCSSHHHHH-------------HHHHTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHH-------------HHhcCCCC----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 222111000 01111111 2233334558999999999999999999999999987643
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=400.37 Aligned_cols=255 Identities=22% Similarity=0.262 Sum_probs=203.1
Q ss_pred hcCccccc-eeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhc-CCCCccceeeeeecccCCcce
Q 006750 224 TDKFSGSN-IVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRL-HHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 224 t~~f~~~~-~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~~~ 300 (632)
.++|.+.+ .||+|+||+||+|.+. +|+.||||+++.. ..+.+|+.++.++ +|||||++++++.........
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 35788765 5999999999999874 5899999999642 3478999987665 899999999998765444668
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC---CCCeEEecccc
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE---NLNAKITDLGM 377 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~---~~~vkL~DFGl 377 (632)
+|+|||||+||+|.++|.......+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 899999999999999998655567999999999999999999999998 999999999999975 56799999999
Q ss_pred ceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccc
Q 006750 378 AKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 457 (632)
Q Consensus 378 a~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~ 457 (632)
|+...... ......||+.|+|||++.+..|+.++|||||||+||||+||+.||...........
T Consensus 161 a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~---------- 224 (335)
T d2ozaa1 161 AKETTSHN------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---------- 224 (335)
T ss_dssp CEECCCCC------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------------
T ss_pred eeeccCCC------ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH----------
Confidence 98765432 23345799999999999999999999999999999999999999965432211000
Q ss_pred ccccccccCCCCCC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 458 SGTVISELPDPRLK--GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 458 ~~~~~~~~~~~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
....+...... .......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 225 ---~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 225 ---MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---HHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00111111111 11113445678999999999999999999999873
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.5e-48 Score=398.11 Aligned_cols=246 Identities=25% Similarity=0.289 Sum_probs=202.7
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|++.+.||+|+||+||+|+.+ +|+.||||+++... .....+.+.+|+.+|++++|||||++++++.+ ....
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~----~~~~ 79 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD----AQQI 79 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC----SSEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee----CCee
Confidence 46889999999999999999975 59999999996431 22344568999999999999999999999876 5688
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
|+||||++||+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 80 ~ivmE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~ 154 (316)
T d1fota_ 80 FMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV 154 (316)
T ss_dssp EEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred eeEeeecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEe
Confidence 9999999999999988754 45889999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
... .....||+.|||||++.+..++.++|||||||+||||++|+.||...........
T Consensus 155 ~~~--------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~-------------- 212 (316)
T d1fota_ 155 PDV--------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK-------------- 212 (316)
T ss_dssp SSC--------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH--------------
T ss_pred ccc--------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHH--------------
Confidence 532 2345799999999999999999999999999999999999999975432211110
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQI 506 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 506 (632)
+.... ..+|...+..+.+++.+||..||.+|| |++++++.
T Consensus 213 ---i~~~~--~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 213 ---ILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ---HHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---HHcCC--CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 00000 012233344588999999999999996 88888763
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=401.33 Aligned_cols=265 Identities=26% Similarity=0.381 Sum_probs=210.6
Q ss_pred HHHhhcCccccceeeeeCceEEEEEEEC------CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeec
Q 006750 220 LEHATDKFSGSNIVGQGGSSYVYRGQLT------DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSE 293 (632)
Q Consensus 220 l~~~t~~f~~~~~LG~G~fG~Vy~~~~~------~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~ 293 (632)
|+...++|...+.||+|+||+||+|.+. +++.||||+++..........|.+|++++++++||||++++|++..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 3334567888899999999999999864 2578999999866555555669999999999999999999999975
Q ss_pred ccCCcceEEEEEEeCCCCChhhhhhccc--------cCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEec
Q 006750 294 FRGKRAMRLLVFEFMPNGNLRDCLDGVL--------VEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD 365 (632)
Q Consensus 294 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~ 365 (632)
....++||||+++|+|.+++.... ...+++..+..++.|+|+||.|||+.+ |+||||||+||||+
T Consensus 95 ----~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld 167 (308)
T d1p4oa_ 95 ----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVA 167 (308)
T ss_dssp ----SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEEC
T ss_pred ----CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeec
Confidence 446799999999999999986421 124799999999999999999999998 99999999999999
Q ss_pred CCCCeEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCC-CCCCCcccccc
Q 006750 366 ENLNAKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGR-QPIHRSITKGE 444 (632)
Q Consensus 366 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~-~P~~~~~~~~~ 444 (632)
.++++||+|||+|+........ .......||+.|+|||.+.++.++.++||||||++||||+||. .||........
T Consensus 168 ~~~~~Kl~DFGla~~~~~~~~~---~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~ 244 (308)
T d1p4oa_ 168 EDFTVKIGDFGMTRDIYETDYY---RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 244 (308)
T ss_dssp TTCCEEECCTTCCCGGGGGGCE---EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH
T ss_pred CCceEEEeecccceeccCCcce---eeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999876543221 1123346899999999999999999999999999999999985 66643322111
Q ss_pred chheeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCC
Q 006750 445 ESLVLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAP 512 (632)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 512 (632)
.. .+.+.. ..+.+..++..+.+|+.+||+.||++|||+.+|++.|++...
T Consensus 245 ~~-----------------~i~~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 245 LR-----------------FVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HH-----------------HHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HH-----------------HHHhCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 10 011111 011233334559999999999999999999999999987653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.9e-47 Score=386.09 Aligned_cols=252 Identities=26% Similarity=0.365 Sum_probs=203.7
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC--------hHHHHHHHHHHHHhcC-CCCccceeeeeec
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN--------ADSVFLTEVDMLSRLH-HCHVVPLVGYCSE 293 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~--------~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~ 293 (632)
.++|++.+.||+|+||+||+|+.. +|+.||||+++...... ..+.+.+|+.+|++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 367999999999999999999875 59999999997653221 1235889999999996 9999999999876
Q ss_pred ccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEe
Q 006750 294 FRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKIT 373 (632)
Q Consensus 294 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~ 373 (632)
....||||||+++|+|.++|... ..+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+
T Consensus 82 ----~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~ 152 (277)
T d1phka_ 82 ----NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLT 152 (277)
T ss_dssp ----SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred ----CcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEc
Confidence 56789999999999999999754 46999999999999999999999998 9999999999999999999999
Q ss_pred ccccceecccCCCCCCCCCCCccccCCCCCChhhhhc------CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchh
Q 006750 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMV------GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESL 447 (632)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~------~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~ 447 (632)
|||+++...... ......||+.|+|||++.+ ..++.++||||+||+||||++|+.||...........
T Consensus 153 DFG~a~~~~~~~------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~ 226 (277)
T d1phka_ 153 DFGFSCQLDPGE------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 226 (277)
T ss_dssp CCTTCEECCTTC------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred cchheeEccCCC------ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHH
Confidence 999998875432 2334679999999999863 3468899999999999999999999975433211111
Q ss_pred eeccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 448 VLWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.. .. ............+..+.+|+.+||+.||.+|||+.||++
T Consensus 227 i~-------------~~--~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 227 IM-------------SG--NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HH-------------HT--CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HH-------------hC--CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00 00 001111122344456899999999999999999999876
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3e-47 Score=399.71 Aligned_cols=245 Identities=22% Similarity=0.294 Sum_probs=202.5
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
++|++.+.||+|+||.||+|+++ +|+.||||++.... .....+.+.+|+.+|+.++|||||++++++.. ....
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~~~ 116 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD----NSNL 116 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc----cccc
Confidence 57999999999999999999985 59999999986431 22334568999999999999999999999876 5578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceec
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRL 381 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~ 381 (632)
++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+..
T Consensus 117 ~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~ 191 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence 9999999999999999754 45999999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccccc
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGTV 461 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 461 (632)
... .....||+.|||||++.+..++.++|||||||+||||++|+.||...........+
T Consensus 192 ~~~--------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i------------- 250 (350)
T d1rdqe_ 192 KGR--------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI------------- 250 (350)
T ss_dssp SSC--------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------------
T ss_pred ccc--------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHH-------------
Confidence 532 23457999999999999999999999999999999999999999754322111100
Q ss_pred ccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006750 462 ISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQ 505 (632)
Q Consensus 462 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 505 (632)
... .+ ..+...+..+.+|+.+||+.||.+|+ |+.++++
T Consensus 251 ~~~--~~----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 251 VSG--KV----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp HHC--CC----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred hcC--CC----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 000 01 12223344588999999999999994 8898876
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8.2e-47 Score=398.53 Aligned_cols=250 Identities=26% Similarity=0.341 Sum_probs=197.6
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHH---HHHHHhcCCCCccceeeeeecccCCc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTE---VDMLSRLHHCHVVPLVGYCSEFRGKR 298 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~E---i~~l~~l~Hpniv~l~g~~~~~~~~~ 298 (632)
++|++.+.||+|+||.||+|+.. +|+.||||++.... .......+.+| +.+++.++|||||++++++.. .
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~----~ 79 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT----P 79 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC----S
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE----C
Confidence 57999999999999999999976 59999999986321 11122234444 666777789999999999876 5
Q ss_pred ceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccc
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 378 (632)
...|+||||++||+|.++|... ..+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla 154 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA 154 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTC
T ss_pred CEEEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeecee
Confidence 5789999999999999999764 45899999999999999999999999 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccc
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQD 457 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~ 457 (632)
+.+.... .....||+.|+|||++.. ..++.++|||||||+||||++|+.||..........+.
T Consensus 155 ~~~~~~~-------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~--------- 218 (364)
T d1omwa3 155 CDFSKKK-------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--------- 218 (364)
T ss_dssp EECSSSC-------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH---------
T ss_pred eecCCCc-------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH---------
Confidence 8765432 234579999999999975 56899999999999999999999999754332211110
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 006750 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPT-----MSEVVQI 506 (632)
Q Consensus 458 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 506 (632)
...... ...++...+..+.+|+.+||+.||.+||| +.|+++.
T Consensus 219 -----~~~~~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 219 -----RMTLTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp -----HHSSSC--CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred -----HhcccC--CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 000000 01122333445899999999999999999 6888763
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=394.74 Aligned_cols=249 Identities=21% Similarity=0.281 Sum_probs=203.6
Q ss_pred hhcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceE
Q 006750 223 ATDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 223 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~ 301 (632)
..++|.+.+.||+|+||+||+|.+. +|+.||||+++... .....+.+|+++|++++|||||++++++.+ ....
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~----~~~~ 76 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFES----MEEL 76 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE----TTEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEE----CCEE
Confidence 3578999999999999999999986 58999999997643 233458899999999999999999999876 5578
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCC--CCeEEeccccce
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDEN--LNAKITDLGMAK 379 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~--~~vkL~DFGla~ 379 (632)
|+|||||+||+|.++|... ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.+ ..+||+|||+++
T Consensus 77 ~lvmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~ 152 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp EEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhh
Confidence 9999999999999999753 235999999999999999999999998 9999999999999854 579999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccccccc
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSG 459 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~ 459 (632)
...... ......||+.|+|||.+.+..++.++|||||||+||||++|+.||..........
T Consensus 153 ~~~~~~------~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~------------- 213 (321)
T d1tkia_ 153 QLKPGD------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE------------- 213 (321)
T ss_dssp ECCTTC------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------------
T ss_pred ccccCC------cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHH-------------
Confidence 764322 2334568999999999999999999999999999999999999997543221111
Q ss_pred ccccccCCCCCCCCCCH----HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 460 TVISELPDPRLKGDFPK----EEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 460 ~~~~~~~~~~l~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.+..... .++. ..+..+.+|+.+||..||.+|||+.|+++.
T Consensus 214 ----~i~~~~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 214 ----NIMNAEY--TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ----HHHHTCC--CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----HHHhCCC--CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000 1111 233458899999999999999999999873
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-47 Score=394.37 Aligned_cols=248 Identities=23% Similarity=0.358 Sum_probs=200.8
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC--CCChHHHHHHHHHHHH-hcCCCCccceeeeeecccCCcce
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG--GPNADSVFLTEVDMLS-RLHHCHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~--~~~~~~~f~~Ei~~l~-~l~Hpniv~l~g~~~~~~~~~~~ 300 (632)
++|.+.+.||+|+||+||+|+.. +|+.||||+++... .......+..|..++. .++|||||++++++.+ ...
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~----~~~ 77 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT----KEN 77 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC----SSE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc----CCc
Confidence 57899999999999999999986 49999999996431 1233445677777765 6799999999999886 557
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 78 ~yivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~ 152 (320)
T d1xjda_ 78 LFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 152 (320)
T ss_dssp EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred eeEEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhh
Confidence 89999999999999999754 45899999999999999999999998 99999999999999999999999999986
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccccccccc
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRLQDSGT 460 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 460 (632)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.............
T Consensus 153 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~----------- 216 (320)
T d1xjda_ 153 NMLGD-----AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR----------- 216 (320)
T ss_dssp CCCTT-----CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----------
T ss_pred ccccc-----ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH-----------
Confidence 54332 22334579999999999999999999999999999999999999997543321111000
Q ss_pred cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 006750 461 VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMS-EVVQ 505 (632)
Q Consensus 461 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 505 (632)
...+ .+|...+..+.+|+.+||..||.+||++. ++++
T Consensus 217 ----~~~~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 217 ----MDNP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ----HCCC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----cCCC----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 0011 12333345589999999999999999985 6654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=384.89 Aligned_cols=261 Identities=25% Similarity=0.316 Sum_probs=192.0
Q ss_pred cceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCC----hHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEEE
Q 006750 230 SNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPN----ADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLLV 304 (632)
Q Consensus 230 ~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~----~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~lV 304 (632)
+++||+|+||+||+|++. +|+.||||+++...... ....+.+|+.+|++++|||||++++++.. ....|+|
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~----~~~~~iv 78 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH----KSNISLV 78 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC----TTCCEEE
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc----CCceeeh
Confidence 578999999999999975 49999999997543221 12358999999999999999999999876 4567999
Q ss_pred EEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecccC
Q 006750 305 FEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKAD 384 (632)
Q Consensus 305 ~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~~ 384 (632)
|||+.++++..++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 79 mE~~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~ 153 (299)
T d1ua2a_ 79 FDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153 (299)
T ss_dssp EECCSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred hhhhcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCC
Confidence 999988877766543 245899999999999999999999998 999999999999999999999999999876543
Q ss_pred CCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhee--cccccc---ccc
Q 006750 385 GLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL--WATPRL---QDS 458 (632)
Q Consensus 385 ~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~--~~~~~~---~~~ 458 (632)
. .......||+.|+|||++.. ..++.++|||||||++|||++|..||............. ...+.. ...
T Consensus 154 ~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~ 228 (299)
T d1ua2a_ 154 N-----RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 228 (299)
T ss_dssp C-----CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred c-----ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccch
Confidence 2 22334579999999999875 468999999999999999999999997543221110000 000000 000
Q ss_pred cccccccCCCCCCCCCC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 459 GTVISELPDPRLKGDFP-----KEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 459 ~~~~~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
............. ..+ ...+..+.+|+.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 229 CSLPDYVTFKSFP-GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TSSTTCCCCCCCC-CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hccchhhhhccCC-CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000000000000 011 122345889999999999999999999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=383.73 Aligned_cols=268 Identities=22% Similarity=0.360 Sum_probs=199.1
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
++|++.+.||+|+||+||+|++. +|+.||||+++.... ......+.+|+++|++++|||||++++++.+ ....|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~----~~~~~ 77 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT----ENKLY 77 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE----TTEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc----cccee
Confidence 57999999999999999999975 599999999975432 2234569999999999999999999999986 55789
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||||+. |++.+++.......+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 78 iv~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~ 153 (298)
T d1gz8a_ 78 LVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG 153 (298)
T ss_dssp EEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred EEEeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceecc
Confidence 9999995 55666665444566999999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCC-CCcccchHhHhHHHHHHHhCCCCCCCccccccchhee--cccccccccc
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGR-ASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVL--WATPRLQDSG 459 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~--~~~~~~~~~~ 459 (632)
... .......||+.|+|||.+.... ++.++|||||||++|+|++|+.||............. ...+. ....
T Consensus 154 ~~~-----~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~ 227 (298)
T d1gz8a_ 154 VPV-----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EVVW 227 (298)
T ss_dssp CCS-----BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC-TTTS
T ss_pred CCc-----ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCc-hhhc
Confidence 432 2334457999999999887655 5899999999999999999999997543211100000 00000 0000
Q ss_pred ccccccCC------CCCCCC---CCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 460 TVISELPD------PRLKGD---FPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 460 ~~~~~~~~------~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.......+ ...... .....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000000 000000 001223458899999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1e-45 Score=377.96 Aligned_cols=267 Identities=23% Similarity=0.330 Sum_probs=198.9
Q ss_pred cCccccceeeeeCceEEEEEEECCCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
++|.+.+.||+|+||+||+|++++|+.||||+++... .......|.+|+.+|++++||||+++++++.. ....++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~~~~i 77 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT----KKRLVL 77 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC----SSCEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc----CCceeE
Confidence 5789999999999999999999999999999997543 22334569999999999999999999999886 457799
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceeccc
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLKA 383 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~~ 383 (632)
+|||+.++.+..+.... +.+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 78 ~~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~ 152 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (286)
T ss_dssp EEECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred EEEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceeccc
Confidence 99999877776665432 56999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec--ccc---cccc
Q 006750 384 DGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATP---RLQD 457 (632)
Q Consensus 384 ~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~---~~~~ 457 (632)
.. .......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||.............. ..+ ....
T Consensus 153 ~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (286)
T d1ob3a_ 153 PV-----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227 (286)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred Cc-----cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccc
Confidence 32 12234468999999999875 4579999999999999999999999975432111000000 000 0000
Q ss_pred cccc---c--cccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 458 SGTV---I--SELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 458 ~~~~---~--~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
.... . .....+..........+..+.+|+.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0 0000000001122233456889999999999999999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=379.86 Aligned_cols=242 Identities=23% Similarity=0.354 Sum_probs=194.8
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-----ChHHHHHHHHHHHHhcC--CCCccceeeeeeccc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-----NADSVFLTEVDMLSRLH--HCHVVPLVGYCSEFR 295 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-----~~~~~f~~Ei~~l~~l~--Hpniv~l~g~~~~~~ 295 (632)
.++|++.+.||+|+||+||+|+.. +|+.||||+++..... .....+.+|+.+|++++ |||||++++++.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-- 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-- 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee--
Confidence 367999999999999999999975 5899999998743211 11123678999999996 9999999999876
Q ss_pred CCcceEEEEEEeCCC-CChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC-CCCeEEe
Q 006750 296 GKRAMRLLVFEFMPN-GNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-NLNAKIT 373 (632)
Q Consensus 296 ~~~~~~~lV~Ey~~~-gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~-~~~vkL~ 373 (632)
....|+||||+.+ ++|.+++... ..+++.++..++.|++.||+|||+++ |+||||||+||||+. ++.+||+
T Consensus 81 --~~~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~ 153 (273)
T d1xwsa_ 81 --PDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 153 (273)
T ss_dssp --SSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEEC
T ss_pred --CCeEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEEC
Confidence 5578999999976 6888888653 45999999999999999999999998 999999999999985 4789999
Q ss_pred ccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCC-CcccchHhHhHHHHHHHhCCCCCCCccccccchheeccc
Q 006750 374 DLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRA-SLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWAT 452 (632)
Q Consensus 374 DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~ 452 (632)
|||+|+..... ......||+.|+|||++.+..+ +.++|||||||+||||++|+.||..... . ...
T Consensus 154 DFG~a~~~~~~-------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----i-~~~- 219 (273)
T d1xwsa_ 154 DFGSGALLKDT-------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I-IRG- 219 (273)
T ss_dssp CCTTCEECCSS-------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H-HHC-
T ss_pred ccccceecccc-------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----H-hhc-
Confidence 99999875432 2234579999999999987765 6779999999999999999999964321 0 000
Q ss_pred cccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 453 PRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 453 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
...+...++ ..+.+|+.+||+.||++|||+.|+++.
T Consensus 220 --------------~~~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 220 --------------QVFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp --------------CCCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --------------ccCCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 001111233 458899999999999999999999863
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=379.81 Aligned_cols=271 Identities=23% Similarity=0.334 Sum_probs=200.0
Q ss_pred hcCccccceeeeeCceEEEEEEEC-C-CcEEEEEEeccCCC-CChHHHHHHHHHHHHhc---CCCCccceeeeeeccc-C
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-D-GRIVAVKRFKTQGG-PNADSVFLTEVDMLSRL---HHCHVVPLVGYCSEFR-G 296 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~-g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l---~Hpniv~l~g~~~~~~-~ 296 (632)
.++|++.+.||+|+||+||+|++. + ++.||||+++.... ......+.+|+.+|+.| +||||+++++++.... .
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999974 3 67899999864322 22223367888887776 7999999999986432 2
Q ss_pred CcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccc
Q 006750 297 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 376 (632)
Q Consensus 297 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFG 376 (632)
.....+++|||+.++++..... .....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchh
Confidence 3457899999998776654443 33456999999999999999999999998 9999999999999999999999999
Q ss_pred cceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe--------
Q 006750 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV-------- 448 (632)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~-------- 448 (632)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||............
T Consensus 162 ~~~~~~~~~------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 235 (305)
T d1blxa_ 162 LARIYSFQM------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235 (305)
T ss_dssp SCCCCCGGG------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hhhhhcccc------cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCc
Confidence 988654322 233457999999999999999999999999999999999999999754322111100
Q ss_pred --eccccccccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 449 --LWATPRLQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 449 --~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.|...... ......... ......++...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 236 EEDWPRDVAL-PRQAFHSKS-AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGGSCTTCSS-CGGGSCCCC-CCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhcccccccc-hhhhhcccc-ccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000 000000000 000011222334558899999999999999999999873
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-44 Score=372.22 Aligned_cols=266 Identities=20% Similarity=0.268 Sum_probs=201.4
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRLL 303 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~l 303 (632)
++|++.+.||+|+||.||+|++. +|+.||||++....... .+..|+++++.++|+|++..++.+... ....++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~E~~i~~~l~~~~~i~~~~~~~~~---~~~~~i 80 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP---QLHIESKIYKMMQGGVGIPTIRWCGAE---GDYNVM 80 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSC---CHHHHHHHHHHSTTSTTCCCEEEEEEE---TTEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCH---HHHHHHHHHHHccCCCcccEEEEEEec---CCEEEE
Confidence 56899999999999999999875 58999999987653322 378999999999888777666655442 457799
Q ss_pred EEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEec---CCCCeEEecccccee
Q 006750 304 VFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLD---ENLNAKITDLGMAKR 380 (632)
Q Consensus 304 V~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~---~~~~vkL~DFGla~~ 380 (632)
||||+ +|+|.+.+... .+.+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+|+.
T Consensus 81 vme~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 81 VMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp EEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCccee
Confidence 99999 67777766543 356999999999999999999999999 99999999999975 456799999999998
Q ss_pred cccCCCCC--CCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe-ecccccccc
Q 006750 381 LKADGLPS--CSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV-LWATPRLQD 457 (632)
Q Consensus 381 ~~~~~~~~--~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~-~~~~~~~~~ 457 (632)
........ .........||+.|||||++.+..++.++|||||||++|||++|+.||............ .+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~--- 232 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK--- 232 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH---
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc---
Confidence 76543221 112334567999999999999999999999999999999999999999754332211110 000000
Q ss_pred ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCC
Q 006750 458 SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPD 513 (632)
Q Consensus 458 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 513 (632)
.....+.+...+| ..+.+|+..||+.+|++||++.++.+.|+.+...
T Consensus 233 -----~~~~~~~~~~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 233 -----MSTPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp -----HHSCHHHHTTTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred -----CCCChhHhccCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 0001111122233 4488999999999999999999999998877543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=380.34 Aligned_cols=275 Identities=20% Similarity=0.271 Sum_probs=199.4
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
+++|.+.+.||+|+||+||+|... +|+.||||+++........+.+.+|+.+|++++||||+++++++..........+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 457999999999999999999874 6999999999765544455678999999999999999999999865332222334
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
++++|+.+|+|.+++.. +.+++..+..++.|++.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 87 ~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 55566779999999964 35999999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhh-cCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecc--ccccc---
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAM-VGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWA--TPRLQ--- 456 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~--~~~~~--- 456 (632)
..... ........||+.|+|||++. ...++.++||||+||++|||++|+.||............... .+...
T Consensus 161 ~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 161 PDHDH--TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp GGGCB--CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred CCCcc--ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 43221 12234567999999999985 456799999999999999999999999754322111100000 00000
Q ss_pred -----cccccccccCCCCCC--CCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 457 -----DSGTVISELPDPRLK--GDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 457 -----~~~~~~~~~~~~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
............... .......+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000000000 00011123458899999999999999999999874
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.5e-44 Score=370.56 Aligned_cols=268 Identities=18% Similarity=0.199 Sum_probs=207.8
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCC-CCccceeeeeecccCCcceE
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHH-CHVVPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~H-pniv~l~g~~~~~~~~~~~~ 301 (632)
.++|.+.+.||+|+||+||+|++. +|+.||||++....... .+.+|++.++.|+| +|++.+++++.. ....
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~e~~~~~~l~~~~~i~~~~~~~~~----~~~~ 76 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP---QLRDEYRTYKLLAGCTGIPNVYYFGQE----GLHN 76 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSC---CHHHHHHHHHHTTTCTTCCCEEEEEEE----TTEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcH---HHHHHHHHHHHhcCCCCCCEEEEEeec----CCcc
Confidence 367999999999999999999976 58999999987554322 37889999999954 899999988875 5577
Q ss_pred EEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecC-----CCCeEEeccc
Q 006750 302 LLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDE-----NLNAKITDLG 376 (632)
Q Consensus 302 ~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~-----~~~vkL~DFG 376 (632)
++||||+ +|+|.+++... ...+++.++..++.|++.||+|||+++ |+||||||+||||+. ++.+||+|||
T Consensus 77 ~~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG 151 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFG 151 (293)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEEEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccc
Confidence 9999999 79999998653 346999999999999999999999998 999999999999964 5679999999
Q ss_pred cceecccCCCC--CCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccc
Q 006750 377 MAKRLKADGLP--SCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 454 (632)
Q Consensus 377 la~~~~~~~~~--~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~ 454 (632)
+|+.+...... ..........||+.|||||++.+..++.++||||||+++|||++|+.||...............
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i--- 228 (293)
T d1csna_ 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI--- 228 (293)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH---
T ss_pred eeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHH---
Confidence 99987643221 1122344568999999999999999999999999999999999999999754332211110000
Q ss_pred cccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhhCCCc
Q 006750 455 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQILSTIAPDK 514 (632)
Q Consensus 455 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 514 (632)
... ......+.+...+| ..+.+++..||..+|++||+++.+.+.|..+..+.
T Consensus 229 -~~~---~~~~~~~~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 229 -GEK---KQSTPLRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp -HHH---HHHSCHHHHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -Hhc---cCCCChHHhcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 000 00000111122344 34888999999999999999999999988876443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-44 Score=377.48 Aligned_cols=267 Identities=23% Similarity=0.294 Sum_probs=193.9
Q ss_pred CccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCccceeeeeeccc--CCcceEE
Q 006750 226 KFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR--GKRAMRL 302 (632)
Q Consensus 226 ~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~--~~~~~~~ 302 (632)
+|+..++||+|+||+||+|++. +|+.||||+++..... +.+|+++|++++||||+++++++.... ....++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 3667789999999999999986 4999999999765322 357999999999999999999986533 2345679
Q ss_pred EEEEeCCCCChhhhhhc-cccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCC-CeEEecccccee
Q 006750 303 LVFEFMPNGNLRDCLDG-VLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITDLGMAKR 380 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~-~vkL~DFGla~~ 380 (632)
|||||++++.+..+... .....+++.++..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+++.
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999976544433322 22345999999999999999999999998 99999999999999775 899999999987
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheec--ccccc--
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLW--ATPRL-- 455 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~--~~~~~-- 455 (632)
..... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.............. ..+..
T Consensus 173 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 246 (350)
T d1q5ka_ 173 LVRGE------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246 (350)
T ss_dssp CCTTS------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccCCc------ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHh
Confidence 65432 2334579999999998875 5789999999999999999999999975432211100000 00000
Q ss_pred -cc-----ccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 456 -QD-----SGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 456 -~~-----~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.. .....................+..+.+|+.+||..||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 0000000000000001112233458899999999999999999999863
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=368.13 Aligned_cols=276 Identities=20% Similarity=0.250 Sum_probs=196.4
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCC-CCChHHHHHHHHHHHHhcCCCCccceeeeeeccc----CCc
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQG-GPNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFR----GKR 298 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~-~~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~----~~~ 298 (632)
++|++.+.||+|+||+||+|++. +|+.||||++.... .......+.+|+++|++++||||+++++++.... ...
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 67889999999999999999975 69999999986543 2334566899999999999999999999986532 123
Q ss_pred ceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccc
Q 006750 299 AMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMA 378 (632)
Q Consensus 299 ~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla 378 (632)
...|+||||+.++.+..+... ...++...+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeeccee
Confidence 467999999987776655433 345899999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccc-c
Q 006750 379 KRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL-Q 456 (632)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~-~ 456 (632)
+......... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||................... .
T Consensus 165 ~~~~~~~~~~-~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 165 RAFSLAKNSQ-PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp EECCC------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eecccccccc-cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 8765433221 1233345799999999998765 68999999999999999999999997543222111100000000 0
Q ss_pred ccc------ccccccCCCCCCCC-CCHH-----HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 457 DSG------TVISELPDPRLKGD-FPKE-----EMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 457 ~~~------~~~~~~~~~~l~~~-~~~~-----~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
... .....+........ .+.. ....+.+|+.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000 00000000000000 0111 12346789999999999999999999874
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-43 Score=360.56 Aligned_cols=267 Identities=21% Similarity=0.282 Sum_probs=203.4
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCC-CChHHHHHHHHHHHHhcCCCCccceeeeeecccCCcceEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGG-PNADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~-~~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
++|++.+.||+|+||+||+|++. +|+.||||+++.... ......+.+|+.+|+.++||||+++++++.. ....+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~----~~~~~ 77 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS----DKKLT 77 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC----SSEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc----cccee
Confidence 57899999999999999999975 589999999976543 3445679999999999999999999999986 55779
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccceecc
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKRLK 382 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~~~ 382 (632)
+||+++.+++|..++... +.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++...
T Consensus 78 iv~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~ 152 (292)
T d1unla_ 78 LVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFG 152 (292)
T ss_dssp EEEECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEeeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhccc
Confidence 999999999998877643 56899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCCCCCCCCCCccccCCCCCChhhhhcCC-CCcccchHhHhHHHHHHHhCCCCCCCccccccch--he-eccccc---c
Q 006750 383 ADGLPSCSSSPARMQGTFGYFAPEYAMVGR-ASLMSDVFSFGVVLLELITGRQPIHRSITKGEES--LV-LWATPR---L 455 (632)
Q Consensus 383 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~--~~-~~~~~~---~ 455 (632)
... .......+++.|+|||.+.... ++.++|||||||++|||++|+.||.......+.. .. .+..+. .
T Consensus 153 ~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (292)
T d1unla_ 153 IPV-----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp SCC-----SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred CCC-----ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhh
Confidence 432 2233345788999999987654 6999999999999999999999985433221100 00 000000 0
Q ss_pred ccccc-----cccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 456 QDSGT-----VISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 456 ~~~~~-----~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
..... .....................+.+|+.+||+.||.+|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 000000011111222334456889999999999999999999976
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-44 Score=373.39 Aligned_cols=267 Identities=24% Similarity=0.301 Sum_probs=195.7
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCccceeeeeecccC--Ccc
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRA 299 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~--~~~ 299 (632)
.++|++.+.||+|+||+||+|.+. +|+.||||+++..... ...+.+.+|+++|++++|||||++++++..... ...
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 467999999999999999999975 4999999999754322 334568999999999999999999999875432 234
Q ss_pred eEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccccce
Q 006750 300 MRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAK 379 (632)
Q Consensus 300 ~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~ 379 (632)
..|+||||+ +.+|..+++. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccccccee
Confidence 679999999 6788887654 45999999999999999999999999 9999999999999999999999999998
Q ss_pred ecccCCCCCCCCCCCccccCCCCCChhhhhc-CCCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccc----
Q 006750 380 RLKADGLPSCSSSPARMQGTFGYFAPEYAMV-GRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR---- 454 (632)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~---- 454 (632)
..... .....||+.|+|||++.+ ..++.++||||+||+||||++|+.||..................
T Consensus 170 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (346)
T d1cm8a_ 170 QADSE--------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241 (346)
T ss_dssp ECCSS--------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred ccCCc--------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHH
Confidence 76432 234579999999999876 45799999999999999999999999754322110000000000
Q ss_pred ----cc-----cccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 455 ----LQ-----DSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 455 ----~~-----~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
.. .......+.....+. .........+.+|+.+||..||.+|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 242 FVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 000000011111111 1112233457899999999999999999999974
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.3e-42 Score=361.82 Aligned_cols=261 Identities=17% Similarity=0.225 Sum_probs=197.1
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCccceeeeeecccCCcceEE
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGKRAMRL 302 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~~~~~ 302 (632)
++|++.++||+|+||+||+|+.. +|+.||||+++.. ..+.+.+|+++|+.++ ||||+++++++.... ....+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~--~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPV--SRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT--TCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecC--CCcee
Confidence 57999999999999999999975 5999999999743 2456899999999995 999999999986532 34689
Q ss_pred EEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCC-CeEEeccccceec
Q 006750 303 LVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENL-NAKITDLGMAKRL 381 (632)
Q Consensus 303 lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~-~vkL~DFGla~~~ 381 (632)
+||||+.+|+|.++. +.+++..+..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+|+..
T Consensus 109 ~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp EEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceec
Confidence 999999999998764 34899999999999999999999999 99999999999998655 5899999999876
Q ss_pred ccCCCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe-----------e
Q 006750 382 KADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV-----------L 449 (632)
Q Consensus 382 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~-----------~ 449 (632)
.... ......||+.|+|||.+.+. .++.++||||+|+++|||++|+.||............ .
T Consensus 181 ~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~ 254 (328)
T d3bqca1 181 HPGQ------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 254 (328)
T ss_dssp CTTC------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred cCCC------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhh
Confidence 5432 23445689999999998865 4799999999999999999999999654321110000 0
Q ss_pred cc----ccccccccccccccCC----CCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 006750 450 WA----TPRLQDSGTVISELPD----PRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQ 505 (632)
Q Consensus 450 ~~----~~~~~~~~~~~~~~~~----~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 505 (632)
+. ................ ...........+..+.+|+.+||+.||.+|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0000000000000000 00111112233455889999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-43 Score=365.13 Aligned_cols=253 Identities=25% Similarity=0.346 Sum_probs=198.0
Q ss_pred cCccccceeeeeCceEEEEEEEC----CCcEEEEEEeccCC---CCChHHHHHHHHHHHHhcCC-CCccceeeeeecccC
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT----DGRIVAVKRFKTQG---GPNADSVFLTEVDMLSRLHH-CHVVPLVGYCSEFRG 296 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~----~g~~vAVK~l~~~~---~~~~~~~f~~Ei~~l~~l~H-pniv~l~g~~~~~~~ 296 (632)
++|++.+.||+|+||+||+|+.. +|+.||||+++... .....+.+.+|+++|++++| |||+++++++.+
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~--- 100 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--- 100 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE---
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc---
Confidence 56999999999999999999852 38899999986432 12223458899999999966 899999998876
Q ss_pred CcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEeccc
Q 006750 297 KRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLG 376 (632)
Q Consensus 297 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFG 376 (632)
....++||||+.+|+|.+++... ..++...+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 101 -~~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG 174 (322)
T d1vzoa_ 101 -ETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFG 174 (322)
T ss_dssp -TTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSS
T ss_pred -CCceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeecc
Confidence 45789999999999999999764 45788999999999999999999998 9999999999999999999999999
Q ss_pred cceecccCCCCCCCCCCCccccCCCCCChhhhhcC--CCCcccchHhHhHHHHHHHhCCCCCCCccccccchheeccccc
Q 006750 377 MAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVG--RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPR 454 (632)
Q Consensus 377 la~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~--~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~ 454 (632)
+++.+..... .......||+.|+|||.+.+. .++.++|||||||+||||++|+.||.............
T Consensus 175 ~a~~~~~~~~----~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~----- 245 (322)
T d1vzoa_ 175 LSKEFVADET----ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS----- 245 (322)
T ss_dssp EEEECCGGGG----GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH-----
T ss_pred chhhhccccc----ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----
Confidence 9987643321 123346799999999999754 47889999999999999999999997543322111100
Q ss_pred cccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 006750 455 LQDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARP-----TMSEVVQ 505 (632)
Q Consensus 455 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 505 (632)
...... ...++...+..+.+|+.+||+.||++|| |++|+++
T Consensus 246 --------~~~~~~--~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 246 --------RRILKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp --------HHHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred --------HhcccC--CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 000000 0122334455689999999999999999 4788875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-42 Score=362.88 Aligned_cols=268 Identities=20% Similarity=0.237 Sum_probs=191.8
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCccceeeeeecccC--Ccce
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG--KRAM 300 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~--~~~~ 300 (632)
++|++.++||+|+||+||+|.+. +|+.||||+++..... .....+.+|+.+|++++||||+++++++..... ....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999986 5999999999865332 334468899999999999999999999865322 3468
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
+|+||||+.++ |.+.+. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+|++|||+++.
T Consensus 97 ~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhc
Confidence 89999999655 444443 34899999999999999999999999 99999999999999999999999999886
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCccccccchhe----------ec
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLV----------LW 450 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~----------~~ 450 (632)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||............ .|
T Consensus 169 ~~~~------~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 169 AGTS------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp ------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccc------cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence 6543 2334557999999999999999999999999999999999999999643211100000 00
Q ss_pred c----------ccccccccccccccCCCCCCC---CCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 451 A----------TPRLQDSGTVISELPDPRLKG---DFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 451 ~----------~~~~~~~~~~~~~~~~~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
. ..................... ..+...+..+.+|+.+||..||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 000000000000001000100 1123456678999999999999999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-42 Score=359.51 Aligned_cols=268 Identities=22% Similarity=0.308 Sum_probs=195.1
Q ss_pred hcCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCC-ChHHHHHHHHHHHHhcCCCCccceeeeeecccC-Ccce
Q 006750 224 TDKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGP-NADSVFLTEVDMLSRLHHCHVVPLVGYCSEFRG-KRAM 300 (632)
Q Consensus 224 t~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~-~~~~~f~~Ei~~l~~l~Hpniv~l~g~~~~~~~-~~~~ 300 (632)
.++|++.+.||+|+||+||+|++. +|+.||||+++..... ...+.+.+|+.+|++++|||||++++++..... ....
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 467999999999999999999875 5999999999765322 233468899999999999999999998864322 1223
Q ss_pred EEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 301 RLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 301 ~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.++||+|+.+|+|.+++.. +.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcc
Confidence 4666778889999999864 45999999999999999999999999 99999999999999999999999999976
Q ss_pred cccCCCCCCCCCCCccccCCCCCChhhhhcC-CCCcccchHhHhHHHHHHHhCCCCCCCccccccchheecccccc----
Q 006750 381 LKADGLPSCSSSPARMQGTFGYFAPEYAMVG-RASLMSDVFSFGVVLLELITGRQPIHRSITKGEESLVLWATPRL---- 455 (632)
Q Consensus 381 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~~~~~~~~~~~~---- 455 (632)
.... .....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...................
T Consensus 171 ~~~~--------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 171 TDDE--------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242 (348)
T ss_dssp CTGG--------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cCcc--------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 5432 2345699999999987764 56899999999999999999999996543221110000000000
Q ss_pred ---------ccccccccccCCCCCCCCCCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 006750 456 ---------QDSGTVISELPDPRLKGDFPKEEMQIMAYLAKECLQLDPDARPTMSEVVQI 506 (632)
Q Consensus 456 ---------~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 506 (632)
..............+.. .....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccchhhhhhhhhcccCCCcchhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00000000000000000 001123457899999999999999999999873
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.1e-38 Score=329.56 Aligned_cols=267 Identities=21% Similarity=0.237 Sum_probs=191.0
Q ss_pred cCccccceeeeeCceEEEEEEEC-CCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-----------CCCccceeeeee
Q 006750 225 DKFSGSNIVGQGGSSYVYRGQLT-DGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-----------HCHVVPLVGYCS 292 (632)
Q Consensus 225 ~~f~~~~~LG~G~fG~Vy~~~~~-~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~-----------Hpniv~l~g~~~ 292 (632)
++|++.++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+.+|+.++ |+||+++++++.
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 35889999999999999999975 59999999997542 23345788999998885 578999998876
Q ss_pred cccCCcceEEEEEEeCCCCCh-hhhhhccccCCCCHHHHHHHHHHHHHhhHHHHh-cCCCceeecCCCCCCeEecCCCC-
Q 006750 293 EFRGKRAMRLLVFEFMPNGNL-RDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHE-AAAPRILHRDIKSSNILLDENLN- 369 (632)
Q Consensus 293 ~~~~~~~~~~lV~Ey~~~gsL-~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDLKp~NILl~~~~~- 369 (632)
... ....+++|+++..+.. ...........+++..+..++.|++.||+|||+ .+ |+||||||+||||+.++.
T Consensus 91 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 91 HKG--PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp EEE--TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ecc--ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcc
Confidence 533 2345666666655443 333334444568999999999999999999998 77 999999999999986654
Q ss_pred -----eEEeccccceecccCCCCCCCCCCCccccCCCCCChhhhhcCCCCcccchHhHhHHHHHHHhCCCCCCCcccccc
Q 006750 370 -----AKITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPEYAMVGRASLMSDVFSFGVVLLELITGRQPIHRSITKGE 444 (632)
Q Consensus 370 -----vkL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSlGviL~eLltG~~P~~~~~~~~~ 444 (632)
++++|||.+...... .....||+.|+|||++....++.++||||+||+++||++|+.||........
T Consensus 166 ~~~~~~kl~dfg~s~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~ 237 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDEH--------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 237 (362)
T ss_dssp TTEEEEEECCCTTCEETTBC--------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred cccceeeEeecccccccccc--------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccc
Confidence 899999999865432 2345699999999999999999999999999999999999999964322110
Q ss_pred ch----he--eccccc--------------cccccccccccCCC---------CCCCCCCHHHHHHHHHHHHHhcccCCC
Q 006750 445 ES----LV--LWATPR--------------LQDSGTVISELPDP---------RLKGDFPKEEMQIMAYLAKECLQLDPD 495 (632)
Q Consensus 445 ~~----~~--~~~~~~--------------~~~~~~~~~~~~~~---------~l~~~~~~~~~~~l~~li~~cl~~dP~ 495 (632)
.. .. .+.... ..........+... ......+...+..+.+|+.+||..||.
T Consensus 238 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~ 317 (362)
T d1q8ya_ 238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 317 (362)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred cchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChh
Confidence 00 00 000000 00000000000000 012234567778899999999999999
Q ss_pred CCCCHHHHHHH
Q 006750 496 ARPTMSEVVQI 506 (632)
Q Consensus 496 ~RPs~~evl~~ 506 (632)
+|||+.|+++.
T Consensus 318 ~Rpta~e~L~H 328 (362)
T d1q8ya_ 318 KRADAGGLVNH 328 (362)
T ss_dssp TCBCHHHHHTC
T ss_pred HCcCHHHHhcC
Confidence 99999999863
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=2.4e-24 Score=205.12 Aligned_cols=165 Identities=15% Similarity=0.120 Sum_probs=120.7
Q ss_pred cccceeeeeCceEEEEEEECCCcEEEEEEeccCCCC-------------C----hHHHHHHHHHHHHhcCCCCccceeee
Q 006750 228 SGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGP-------------N----ADSVFLTEVDMLSRLHHCHVVPLVGY 290 (632)
Q Consensus 228 ~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~-------------~----~~~~f~~Ei~~l~~l~Hpniv~l~g~ 290 (632)
.+.++||+|+||+||+|.+.+|+.||||+++..... . ....+..|...|.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 456899999999999999988999999987642110 0 01224568889999999999988765
Q ss_pred eecccCCcceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcCCCceeecCCCCCCeEecCCCCe
Q 006750 291 CSEFRGKRAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAAAPRILHRDIKSSNILLDENLNA 370 (632)
Q Consensus 291 ~~~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDLKp~NILl~~~~~v 370 (632)
.. .+++|||++++.+.+ ++......++.|++.+|+|||+.+ |+||||||+|||++++ .+
T Consensus 83 ~~--------~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~ 141 (191)
T d1zara2 83 EG--------NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GI 141 (191)
T ss_dssp ET--------TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EE
T ss_pred cC--------CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CE
Confidence 32 279999998765543 334446678999999999999998 9999999999999965 58
Q ss_pred EEeccccceecccCCCCCCCCCCCccccCCCCCChh-----hhhcCCCCcccchHhHhHHH
Q 006750 371 KITDLGMAKRLKADGLPSCSSSPARMQGTFGYFAPE-----YAMVGRASLMSDVFSFGVVL 426 (632)
Q Consensus 371 kL~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y~APE-----~~~~~~~s~ksDVwSlGviL 426 (632)
+|+|||+|....... ...|.... .+....|+.++|+||..--+
T Consensus 142 ~liDFG~a~~~~~~~-------------~~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 142 WIIDFPQSVEVGEEG-------------WREILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EECCCTTCEETTSTT-------------HHHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred EEEECCCcccCCCCC-------------cHHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 999999997653211 01121111 01245678899999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.40 E-value=7.9e-07 Score=86.20 Aligned_cols=149 Identities=15% Similarity=0.108 Sum_probs=98.1
Q ss_pred HHHHhhcCccccceeeeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcC-CCCccceeeeeecccCC
Q 006750 219 ALEHATDKFSGSNIVGQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLH-HCHVVPLVGYCSEFRGK 297 (632)
Q Consensus 219 ~l~~~t~~f~~~~~LG~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~ 297 (632)
+|......|...+..+.++.+.||+... +++.++||+........ ...+.+|...+..|. +--+.+++.+...
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~-~~~~~~E~~~l~~l~~~vpvP~vl~~~~~---- 81 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGT-TYDVEREKDMMLWLEGKLPVPKVLHFERH---- 81 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTS-TTCHHHHHHHHHHHTTTSCCCCEEEEEEE----
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccc-hhhHHHHHHHHHHHhccCCCCcEEEEEec----
Confidence 5566666777666555455678999875 46677888876442211 123678999988873 4335677766543
Q ss_pred cceEEEEEEeCCCCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHHhcC-----------------------------
Q 006750 298 RAMRLLVFEFMPNGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLHEAA----------------------------- 348 (632)
Q Consensus 298 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------- 348 (632)
....++||++++|.++.+..... .. ...++.++++.|..||+..
T Consensus 82 ~~~~~lv~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (263)
T d1j7la_ 82 DGWSNLLMSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD 154 (263)
T ss_dssp TTEEEEEEECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred CCceEEEEEeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence 34679999999998886543211 11 2234555556666666421
Q ss_pred ---------------------------CCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 349 ---------------------------APRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 349 ---------------------------~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.+.++|+|+.|.|||+++++..-|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999876667999998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.20 E-value=2.3e-06 Score=82.42 Aligned_cols=130 Identities=17% Similarity=0.126 Sum_probs=83.5
Q ss_pred eeeeC-ceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCC--CccceeeeeecccCCcceEEEEEEeCC
Q 006750 233 VGQGG-SSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHC--HVVPLVGYCSEFRGKRAMRLLVFEFMP 309 (632)
Q Consensus 233 LG~G~-fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hp--niv~l~g~~~~~~~~~~~~~lV~Ey~~ 309 (632)
+..|. .+.||+...+++..+++|........ .+..|...|+.|... .+.+++++..+ ....++||+|++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~----~l~~E~~~l~~L~~~gvpvP~v~~~~~~----~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN----ELQDEAARLSWLATTGVPCAAVLDVVTE----AGRDWLLLGEVP 89 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTTS----CHHHHHHHHHHHHTTTCCBCCEEEEEEC----SSCEEEEEECCS
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCHh----HHHHHHHHHHHHHhcCCCCCceeeeccc----ccceEEEEEeee
Confidence 34444 36899999888888999987654322 267888888888433 34567766554 345699999998
Q ss_pred CCChhhhhhccccCCCCHHHHHHHHHHHHHhhHHHH--------------------------------------------
Q 006750 310 NGNLRDCLDGVLVEGMNWDTRVAIAIGAARGLEYLH-------------------------------------------- 345 (632)
Q Consensus 310 ~gsL~~~L~~~~~~~l~~~~~~~i~~~ia~gL~yLH-------------------------------------------- 345 (632)
|.++.+.. +.. ..++.++++.|.-||
T Consensus 90 G~~~~~~~-------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
T d1nd4a_ 90 GQDLLSSH-------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 159 (255)
T ss_dssp SEETTTSC-------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred cccccccc-------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHH
Confidence 87764421 010 111122222333333
Q ss_pred -------hc----CCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 346 -------EA----AAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 346 -------~~----~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.. ..+.++|+|+.|.|||++++..+-|+||+.+..
T Consensus 160 ~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 160 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 21 112479999999999999876678999998754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.64 E-value=6.5e-05 Score=77.14 Aligned_cols=76 Identities=21% Similarity=0.196 Sum_probs=47.8
Q ss_pred ceeeeeCceEEEEEEECC-CcEEEEEEecc------CCCCChHHHHHHHHHHHHhc-CC--CCccceeeeeecccCCcce
Q 006750 231 NIVGQGGSSYVYRGQLTD-GRIVAVKRFKT------QGGPNADSVFLTEVDMLSRL-HH--CHVVPLVGYCSEFRGKRAM 300 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~-g~~vAVK~l~~------~~~~~~~~~f~~Ei~~l~~l-~H--pniv~l~g~~~~~~~~~~~ 300 (632)
+.||.|....||+....+ ++.|+||.-.. ...+....+...|.+.|+.+ .+ ..+.+++.+..+ .
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~------~ 105 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTE------M 105 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT------T
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCC------C
Confidence 468999999999998654 67899996432 11122223356788888877 33 345566654322 3
Q ss_pred EEEEEEeCCCCC
Q 006750 301 RLLVFEFMPNGN 312 (632)
Q Consensus 301 ~~lV~Ey~~~gs 312 (632)
.++|||++++..
T Consensus 106 ~~lvmE~L~~~~ 117 (392)
T d2pula1 106 AVTVMEDLSHLK 117 (392)
T ss_dssp TEEEECCCTTSE
T ss_pred CEEEEeccCCcc
Confidence 489999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.13 E-value=0.0013 Score=65.13 Aligned_cols=139 Identities=18% Similarity=0.196 Sum_probs=78.2
Q ss_pred ceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCc--cceeeeee-cccCCcceEEEEEEeCCCCChh
Q 006750 238 SSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV--VPLVGYCS-EFRGKRAMRLLVFEFMPNGNLR 314 (632)
Q Consensus 238 fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpni--v~l~g~~~-~~~~~~~~~~lV~Ey~~~gsL~ 314 (632)
--.||++...+|+.|++|+.+... ....++..|...|..|....+ +..+.... .........+.++++++|..+.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~--~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC--CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 358999999999999999987542 234557889999988843322 22211100 0001244678999999765432
Q ss_pred h-----h------h---hc----c---ccCCCCHHH-------------------HHHHHHHHHHhhHHHHhc----CCC
Q 006750 315 D-----C------L---DG----V---LVEGMNWDT-------------------RVAIAIGAARGLEYLHEA----AAP 350 (632)
Q Consensus 315 ~-----~------L---~~----~---~~~~l~~~~-------------------~~~i~~~ia~gL~yLH~~----~~~ 350 (632)
. + | +. . ....+++.. ...+...+.+.++.+... ...
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 1 0 0 00 0 000122211 111222222333333322 234
Q ss_pred ceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 351 RILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 351 ~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.+||+|+.+.|||++++ ..++||+-+..
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeCC--ceEEechhccc
Confidence 58999999999999754 56899998764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.77 E-value=0.0049 Score=60.30 Aligned_cols=160 Identities=10% Similarity=0.036 Sum_probs=83.8
Q ss_pred ecHHHHHHhhcCcccccee-----eeeCceEEEEEEECCCcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCc--cce
Q 006750 215 FSYSALEHATDKFSGSNIV-----GQGGSSYVYRGQLTDGRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV--VPL 287 (632)
Q Consensus 215 ~~~~~l~~~t~~f~~~~~L-----G~G~fG~Vy~~~~~~g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpni--v~l 287 (632)
++-++++....+|.+.+.. ..|---+.|+.+.++|+ +++|+........ .+..|+++|..|.+.++ ...
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~~---~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEKN---DLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---CC---HHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCHH---HHHHHHHHHHhhhhcccccccc
Confidence 4557788888888775544 34555778999887665 8999986543222 24567777777743222 211
Q ss_pred e----eeeecccCCcceEEEEEEeCCCCChhhhh--------------hc----c---ccCCCCHH--------------
Q 006750 288 V----GYCSEFRGKRAMRLLVFEFMPNGNLRDCL--------------DG----V---LVEGMNWD-------------- 328 (632)
Q Consensus 288 ~----g~~~~~~~~~~~~~lV~Ey~~~gsL~~~L--------------~~----~---~~~~l~~~-------------- 328 (632)
+ |..... .......++.+..+......- +. . ........
T Consensus 79 i~~~~g~~~~~--~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (316)
T d2ppqa1 79 LPRKDGELLGE--LSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD 156 (316)
T ss_dssp CCBTTCCSCEE--ETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred ceecCCCccee--eecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhh
Confidence 1 111000 123456677777665442211 00 0 00000000
Q ss_pred ----HHHHHHHHHHHhhHHHHhc-CCCceeecCCCCCCeEecCCCCeEEecccccee
Q 006750 329 ----TRVAIAIGAARGLEYLHEA-AAPRILHRDIKSSNILLDENLNAKITDLGMAKR 380 (632)
Q Consensus 329 ----~~~~i~~~ia~gL~yLH~~-~~~~iiHrDLKp~NILl~~~~~vkL~DFGla~~ 380 (632)
.....+..+...+.-.+.. -+.++||+|+.+.||+++.+...-|.||+.+..
T Consensus 157 ~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 157 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 0111122222222222211 123599999999999999887778999998853
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.75 E-value=0.0038 Score=63.44 Aligned_cols=73 Identities=19% Similarity=0.284 Sum_probs=50.1
Q ss_pred ceeeeeCceEEEEEEECC--------CcEEEEEEeccCCCCChHHHHHHHHHHHHhcCCCCc-cceeeeeecccCCcceE
Q 006750 231 NIVGQGGSSYVYRGQLTD--------GRIVAVKRFKTQGGPNADSVFLTEVDMLSRLHHCHV-VPLVGYCSEFRGKRAMR 301 (632)
Q Consensus 231 ~~LG~G~fG~Vy~~~~~~--------g~~vAVK~l~~~~~~~~~~~f~~Ei~~l~~l~Hpni-v~l~g~~~~~~~~~~~~ 301 (632)
+.|+.|-.-.+|+....+ ++.|.+++.... .. .....+|..+++.+.-.++ .++++++..
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~-------- 116 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET-ESHLVAESVIFTLLSERHLGPKLYGIFSG-------- 116 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT--------
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--ch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC--------
Confidence 567778889999998754 356777776522 22 2346789999998843344 477777643
Q ss_pred EEEEEeCCCCChh
Q 006750 302 LLVFEFMPNGNLR 314 (632)
Q Consensus 302 ~lV~Ey~~~gsL~ 314 (632)
.+||||++|..|.
T Consensus 117 g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 117 GRLEEYIPSRPLS 129 (395)
T ss_dssp EEEECCCCEEECC
T ss_pred ceEEEEeccccCC
Confidence 6899999876543
|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-like domain of nidogen-1 domain: EGF-like domain of nidogen-1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=91.60 E-value=0.02 Score=37.28 Aligned_cols=26 Identities=15% Similarity=0.451 Sum_probs=20.2
Q ss_pred hhhhccccccccccCCccceEEecCCCCCCc
Q 006750 17 WIQRSICDKLSERSGQKNWKCTCSSSLQGDQ 47 (632)
Q Consensus 17 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 47 (632)
+..++.|.+ ...+|+|+|..||.||=
T Consensus 9 C~~~A~C~N-----t~Gsy~C~C~~Gy~GdG 34 (40)
T d1gl4a2 9 CSVHAECRD-----YATGFCCRCVANYTGNG 34 (40)
T ss_dssp SCTTEEEEE-----CSSCEEEEECTTEEECS
T ss_pred CCCCCEeec-----CCCCeEeECCCCCcCCC
Confidence 455677765 35589999999999985
|
| >d1autl1 g.3.11.1 (L:49-96) Activated protein c (autoprothrombin IIa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Activated protein c (autoprothrombin IIa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.03 E-value=0.21 Score=33.59 Aligned_cols=21 Identities=29% Similarity=0.790 Sum_probs=16.0
Q ss_pred hccccccccccCCccceEEecCCCCC
Q 006750 20 RSICDKLSERSGQKNWKCTCSSSLQG 45 (632)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 45 (632)
|..|-+ ..++|+|.|+.||.|
T Consensus 18 nG~C~~-----~~~~y~C~C~~G~~G 38 (48)
T d1autl1 18 HGTCID-----GIGSFSCDCRSGWEG 38 (48)
T ss_dssp SEEECC-----CSSCCCEEECTTEES
T ss_pred CCEEEC-----CCCCCeEeCCCCCcC
Confidence 455654 466899999999887
|